PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	SC	GA	UT	PM	OA	HC	HP	DA
J	Mouilso, ER; Tuerk, PW; Schnurr, PP; Rauch, SAM				Mouilso, Emily R.; Tuerk, Peter W.; Schnurr, Paula P.; Rauch, Sheila A. M.			Addressing the Gender Gap: Prolonged Exposure for PTSD in Veterans	PSYCHOLOGICAL SERVICES			English	Article						effectiveness; female veterans; posttraumatic stress disorder; prolonged exposure therapy	POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE PROCESSING THERAPY; TRAUMATIC BRAIN-INJURY; HEALTH-STATUS; SEXUAL TRAUMA; WOMEN; MILITARY; OUTCOMES; FEMALE; CARE	As the proportion of women serving in the United States military continues to increase, more female veterans are being treated for posttraumatic stress disorder (PTSD) in Department of Veterans Affairs (VA) health care settings. Prolonged Exposure (PE) therapy is an evidence-based treatment for PTSD and is often used in VA settings. However, only a few studies have investigated the effectiveness of PE specifically for female veterans with appropriate power. Results of these studies have varied, with similar effects between female and male veterans on par with civilian effects, and more recently, better outcomes for female veterans receiving PE compared with male veterans. The current study contextualizes the evidence from those studies and considers new data regarding clinical outcomes pre- and posttreatment for a large (N = 325) sample of male and female veterans treated with PE in a PTSD specialty clinic. Results indicate a large statistically significant decrease in PTSD as measured by PTSD Checklist (PCL) scores for both male and female veterans treated with PE (d = 1.33). No difference in effectiveness and no difference in treatment completion rates were found between male and female veterans. Our findings support the effectiveness of PE for the treatment of PTSD in female as well as male veterans. Results are compared and contrasted to previous findings in the literature taking into account heterogeneity in methodological and ecological factors among the studies. Emphasis is placed on context of care issues to further the empirical conversation regarding meeting the mental health needs of female veterans.	[Mouilso, Emily R.; Tuerk, Peter W.] Ralph H Johnson VA Med Ctr, Charleston, SC USA; [Mouilso, Emily R.; Tuerk, Peter W.] Med Univ South Carolina, Charleston, SC USA; [Schnurr, Paula P.] Natl Ctr PTSD, White River Jct, VT USA; [Schnurr, Paula P.] Geisel Sch Med Dartmouth, Hanover, NH USA; [Rauch, Sheila A. M.] Dept Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Rauch, Sheila A. M.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; [Mouilso, Emily R.] Charlie Norwood VA Med Ctr, Augusta, GA 30901 USA	Mouilso, ER (corresponding author), Charlie Norwood VA Med Ctr, Augusta, GA 30901 USA.	emilymouilso@gmail.com	Rauch, Sheila A.M./K-4450-2015		Department of Veteran Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences Research and Development	Dr. Peter W. Tuerk's contribution to this article was partially supported by a Career Development Award (CDA-2) from the Department of Veteran Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences Research and Development (PI: Peter W. Tuerk).	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bean-Mayberry BA, 2003, J GEN INTERN MED, V18, P175, DOI 10.1046/j.1525-1497.2003.20512.x; BECKER BJ, 1988, BRIT J MATH STAT PSY, V41, P257, DOI 10.1111/j.2044-8317.1988.tb00901.x; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Department of Defense, 2013, 2013 DEM PROF MIL CO; Eftekhari A, 2013, JAMA PSYCHIAT, V70, P949, DOI 10.1001/jamapsychiatry.2013.36; Eisen SV, 2012, AM J PUBLIC HEALTH, V102, pS66, DOI 10.2105/AJPH.2011.300609; Feeny NC, 2009, DEPRESS ANXIETY, V26, P724, DOI 10.1002/da.20588; Foa EB, 2007, PROLONGED EXPOSURE T; Frayne SM, 2006, J GEN INTERN MED, V21, pS40, DOI 10.1111/j.1525-1497.2006.00373.x; Goodson JT, 2013, J TRAUMA STRESS, V26, P419, DOI 10.1002/jts.21830; Gros DF, 2011, BEHAV THER, V42, P276, DOI 10.1016/j.beth.2010.07.005; Harned MS, 2012, BEHAV RES THER, V50, P381, DOI 10.1016/j.brat.2012.02.011; Himmelfarb N, 2006, J TRAUMA STRESS, V19, P837, DOI 10.1002/jts.20163; House H., 2003, J FAMILY SOCIAL WORK, V7, P15, DOI DOI 10.1300/J039V07N01_; Insightful Corporation, 2001, S PLUS 6 COMP SOFTW; Katz LS, 2014, J CONTEMP PSYCHOTHER, V44, P9, DOI 10.1007/s10879-013-9248-6; Kimerling R, 2007, AM J PUBLIC HEALTH, V97, P2160, DOI 10.2105/AJPH.2006.092999; Koola MM, 2013, J NERV MENT DIS, V201, P348, DOI 10.1097/NMD.0b013e318288e333; Kulka R. A., 1990, TRAUMA VIETNAM WAR G; McLean CP, 2011, EXPERT REV NEUROTHER, V11, P1151, DOI [10.1586/ern.11.94, 10.1586/ERN.11.94]; Meyers LL, 2013, MIL MED, V178, P95, DOI 10.7205/MILMED-D-12-00302; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Nacasch N, 2007, CNS SPECTRUMS, V12, P690, DOI 10.1017/S1092852900021520; Nacasch N, 2011, J CLIN PSYCHIAT, V72, P1174, DOI 10.4088/JCP.09m05682blu; National Center for PTSD, 2014, US PTSD CHECKL DSM 4; National Center for Veterans Analysis and Statistics, 2011, AM WOM VET MIL SERV; Pereira A, 2002, MIL MED, V167, P23; Powers MB, 2010, CLIN PSYCHOL REV, V30, P635, DOI 10.1016/j.cpr.2010.04.007; Rauch SAM, 2009, J TRAUMA STRESS, V22, P60, DOI 10.1002/jts.20380; Sadler AG, 2004, J WOMENS HEALTH, V13, P799, DOI 10.1089/jwh.2004.13.799; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; SNIJDERS TAB, 1994, SOCIOL METHOD RES, V22, P342, DOI 10.1177/0049124194022003004; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Street AE, 2013, J GEN INTERN MED, V28, pS556, DOI 10.1007/s11606-013-2333-4; Thorp SR, 2012, AM J GERIAT PSYCHIAT, V20, P276, DOI 10.1097/JGP.0b013e3182435ee9; Tuerk PW, 2013, PSYCHOL SERV, V10, P401, DOI 10.1037/a0030549; Tuerk PW, 2011, J ANXIETY DISORD, V25, P397, DOI 10.1016/j.janxdis.2010.11.002; Tuerk PW, 2010, J TRAUMA STRESS, V23, P116, DOI 10.1002/jts.20494; Turchik JA, 2010, AGGRESS VIOLENT BEH, V15, P267, DOI 10.1016/j.avb.2010.01.005; United States Government Accountability Office, 2009, VA HLTH CAR PREL FIN; University of Colorado Denver, 2012, GLIMMPSE COMP SOFTW; US Department of Veterans Affairs, 2011, AM WOM VET MIL SERV; van Minnen A, 2002, BEHAV RES THER, V40, P439, DOI 10.1016/S0005-7967(01)00024-9; Weathers F., 1991, PTSD CHECKLIST MILIT; Wolf GK, 2012, J HEAD TRAUMA REHAB, V27, P26, DOI 10.1097/HTR.0b013e31823cd01f; Yano EM, 2006, WOMEN HEALTH ISS, V16, P226, DOI 10.1016/j.whi.2006.07.002; Yoder M, 2012, PSYCHOL SERV, V9, P16, DOI 10.1037/a0026279; Zatzick DF, 1997, MIL MED, V162, P661; Zayfert C, 2002, J NERV MENT DIS, V190, P233, DOI 10.1097/00005053-200204000-00004	54	12	12	0	5	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1541-1559	1939-148X		PSYCHOL SERV	Psychol. Serv.	AUG	2016	13	3					308	316		10.1037/ser0000040			9	Psychology, Clinical	Psychology	DV7HC	WOS:000383106000012	26121077				2021-06-18	
J	Sun, GZ; Gao, FF; Zhao, ZM; Sun, H; Xu, W; Wu, LW; He, YC				Sun, Guo-zhu; Gao, Fen-fei; Zhao, Zong-mao; Sun, Hai; Xu, Wei; Wu, Li-wei; He, Yong-chang			Endoplasmic reticulum stress-induced apoptosis in the penumbra aggravates secondary damage in rats with traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; endoplasmic reticulum stress; apoptosis; caspase-12; caspase-3; traumatic penumbra; traumatic brain injury; neural regeneration	CELL-DEATH; IN-VITRO; CASPASE-12; PATHWAY; ACTIVATION; INVOLVEMENT; INHIBITION; EXPRESSION; MANAGEMENT; CONTUSION	Neuronal apoptosis is mediated by intrinsic and extrinsic signaling pathways such as the membrane-mediated, mitochondrial, and endoplasmic reticulum stress pathways. Few studies have examined the endoplasmic reticulum-mediated apoptosis pathway in the penumbra after traumatic brain injury, and it remains unclear whether endoplasmic reticulum stress can activate the caspase-12-dependent apoptotic pathway in the traumatic penumbra. Here, we established rat models of fluid percussion-induced traumatic brain injury and found that protein expression of caspase-12, caspase-3 and the endoplasmic reticulum stress marker 78 kDa glucose-regulated protein increased in the traumatic penumbra 6 hours after injury and peaked at 24 hours. Furthermore, numbers of terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling-positive cells in the traumatic penumbra also reached peak levels 24 hours after injury. These findings suggest that caspase-12-mediated endoplasmic reticulum-related apoptosis is activated in the traumatic penumbra, and may play an important role in the pathophysiology of secondary brain injury.	[Sun, Guo-zhu; Zhao, Zong-mao; Xu, Wei; Wu, Li-wei; He, Yong-chang] Hebei Med Univ, Dept Neurosurg, Hosp 2, Shijiazhuang, Hebei Province, Peoples R China; [Gao, Fen-fei] Shantou Univ, Coll Med, Dept Pharmacol, Shantou, Guangdong, Peoples R China; [Sun, Hai] St Josephs Hosp, Div Neurol Surg, Barrow Neurol Inst, Phoenix, AZ USA	Sun, GZ (corresponding author), Hebei Med Univ, Dept Neurosurg, Hosp 2, Shijiazhuang, Hebei Province, Peoples R China.	sungzh705@163.com	Gao, Fenfei/S-5331-2019	Gao, Fenfei/0000-0003-4144-8891	Natural Science Foundation of Hebei Province of ChinaNatural Science Foundation of Hebei Province [H2014206383]; Foundation for High-Level Personnel Projects in Hebei Province of China [A201401041]	This study was supported by the Natural Science Foundation of Hebei Province of China, No. H2014206383; and Foundation for High-Level Personnel Projects in Hebei Province of China, No. A201401041.	Ang BT, 2003, J NEUROSURG, V99, P125, DOI 10.3171/jns.2003.99.1.0125; Borkham-Kamphorst E, 2016, CELL SIGNAL, V28, P34, DOI 10.1016/j.cellsig.2015.10.013; Brewster JL, 2006, MOL CELL NEUROSCI, V32, P242, DOI 10.1016/j.mcn.2006.04.006; Chakrabarti S, 2016, AGING DIS, V7, P111, DOI 10.14336/AD.2016.0312; Chuang WL, 2016, MOLECULES, DOI [10.3390/mole-cules21040460, DOI 10.3390/MOLE-CULES21040460]; Ding K, 2015, J SURG RES, V194, P239, DOI 10.1016/j.jss.2014.09.026; de la Cadena SC, 2014, APOPTOSIS, V19, P414, DOI 10.1007/s10495-013-0930-7; Han Y, 2015, NEUROSCI LETT, V585, P126, DOI 10.1016/j.neulet.2014.11.040; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Jin M, 2015, NEURAL REGEN RES, V10, P1830, DOI 10.4103/1673-5374.170313; Kabadi SV, 2014, NEURAL REGEN RES, V9, P1578, DOI 10.4103/1673-5374.141779; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larner SF, 2004, J NEUROCHEM, V88, P78, DOI 10.1046/j.1471-4159.2003.02141.x; Lee JY, 2014, J NEUROTRAUM, V31, P582, DOI 10.1089/neu.2013.3146; Li HF, 2015, NEURAL REGEN RES, V10, P467, DOI 10.4103/1673-5374.153698; Li L, 2016, NEURAL REGEN RES, V11, P326, DOI 10.4103/1673-5374.177742; Liu D, 2013, INT J NEUROSCI, V123, P155, DOI 10.3109/00207454.2012.746974; Liu H, 2014, WORLD J GASTROENTERO, V20, P18189, DOI 10.3748/wjg.v20.i48.18189; Logsdon AF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00421; Long J, 2013, NEURAL REGEN RES, V8, P1491, DOI 10.3969/j.issn.1673-5374.2013.16.006; Ma T, 2008, EUR SURG RES, V41, P219, DOI 10.1159/000135631; Martinez JA, 2010, APOPTOSIS, V15, P1480, DOI 10.1007/s10495-010-0526-4; Martinez-Pizarro A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150357; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Newcombe VFJ, 2013, J CEREBR BLOOD F MET, V33, P855, DOI 10.1038/jcbfm.2013.11; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Shah A, 2016, SCI REP-UK, V6, DOI 10.1038/srep18929; Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238; Stoffel M, 1997, ACT NEUR S, V70, P91; Stoffel M, 2002, NEUROSCI LETT, V324, P201, DOI 10.1016/S0304-3940(02)00196-9; Tomura S, 2011, J NEUROTRAUM, V28, P237, DOI 10.1089/neu.2010.1443; Wei XW, 2016, BRAIN RES BULL, V124, P123, DOI 10.1016/j.brainresbull.2016.04.005; Wu HM, 2013, J NEUROTRAUM, V30, P352, DOI 10.1089/neu.2012.2610; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Zhang H, 2013, INT J CLIN EXP MED, V6, P546; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhao SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073665; Ziebell JM, 2011, BRAIN RES, V1414, P94, DOI 10.1016/j.brainres.2011.07.056	41	12	13	0	4	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	AUG	2016	11	8					1260	1266		10.4103/1673-5374.189190			7	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	DX1RZ	WOS:000384146000021	27651773	DOAJ Gold, Green Published			2021-06-18	
J	Chan, V; Pole, JD; Keightley, M; Mann, RE; Colantonio, A				Chan, Vincy; Pole, Jason D.; Keightley, Michelle; Mann, Robert E.; Colantonio, Angela			Children and youth with non-traumatic brain injury: a population based perspective	BMC NEUROLOGY			English	Article						Non-traumatic brain injury; International Classification of Diseases; Pediatrics	INPATIENT REHABILITATION; OLDER-ADULTS; ONTARIO; CANADA; ENCEPHALITIS; CHILDHOOD; DISCHARGE; VERSION	Background: Children and youth with non-traumatic brain injury (nTBI) are often overlooked in regard to the need for post-injury health services. This study provided population-based data on their burden on healthcare services, including data by subtypes of nTBI, to provide the foundation for future research to inform resource allocation and healthcare planning for this population. Methods: A retrospective cohort study design was used. Children and youth with nTBI in population-based healthcare data were identified using International Classification of Diseases Version 10 codes. The rate of nTBI episodes of care, demographic and clinical characteristics, and discharge destinations from acute care and by type of nTBI were identified. Results: The rate of pediatric nTBI episodes of care was 82.3 per 100,000 (N = 17,977); the average stay in acute care was 13.4 days (SD = 25.6 days) and 35 % were in intensive care units. Approximately 15 % were transferred to another inpatient setting and 6 % died in acute care. By subtypes of nTBI, the highest rates were among those with a diagnosis of toxic effect of substances (22.7 per 100,000), brain tumours (18.4 per 100,000), and meningitis (15.4 per 100,000). Clinical characteristics and discharge destinations from the acute care setting varied by subtype of nTBI; the proportion of patients that spent at least one day in intensive care units and the proportion discharged home ranged from 25.9 % to 58.2 % and from 50.6 % to 76.4 %, respectively. Conclusions: Children and youth with nTBI currently put an increased demand on the healthcare system. Active surveillance of and in-depth research on nTBI, including subtypes of nTBI, is needed to ensure that timely, appropriate, and targeted care is available for this pediatric population.	[Chan, Vincy; Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G 2A2, Canada; [Chan, Vincy; Keightley, Michelle; Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, 500 Univ Ave, Toronto, ON M5G 1V7, Canada; [Chan, Vincy; Pole, Jason D.] Pediat Oncol Grp Ontario, 480 Univ Ave, Toronto, ON M5G 1V2, Canada; [Pole, Jason D.; Mann, Robert E.; Colantonio, Angela] Univ Toronto, Dalla Lana Sch Publ Hlth, 155 Coll St, Toronto, ON M5T 3M7, Canada; [Keightley, Michelle] Holland Bloorview Kids Rehabil Hosp, 150 Kilgour Rd, Toronto, ON M5G 1R8, Canada; [Mann, Robert E.] Ctr Addict & Mental Hlth, 33 Russell St, Toronto, ON M5S 3M1, Canada	Chan, V (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.; Chan, V (corresponding author), Univ Toronto, Rehabil Sci Inst, 500 Univ Ave, Toronto, ON M5G 1V7, Canada.; Chan, V (corresponding author), Pediat Oncol Grp Ontario, 480 Univ Ave, Toronto, ON M5G 1V2, Canada.	vincy.chan@uhn.ca	Pole, Jason D./AAD-9148-2020; Chan, Vincy/AAA-7813-2020	Pole, Jason D./0000-0002-0413-5434; Chan, Vincy/0000-0002-6884-044X; Colantonio, Angela/0000-0003-2094-4765	Jane Gillett Pediatric ABI Studentship through the Ontario Neurotrauma Foundation; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Pediatric Oncology Group of Ontario; Brain Canada; CIBC; CIHR Research Chair in Gender, Work and Health [CGW-126580]	VC received support from the Jane Gillett Pediatric ABI Studentship through the Ontario Neurotrauma Foundation, the Doctoral Research Award from the Canadian Institutes of Health Research (CIHR) and Pediatric Oncology Group of Ontario, and a Brain Canada-CIBC Brain Cancer Training Award from Brain Canada and CIBC. AC received support through a CIHR Research Chair in Gender, Work and Health (#CGW-126580). The authors have no conflicts of interest.	[Anonymous], 2015, BRAIN INJURY REHABIL; [Anonymous], 2015, BRAIN INJURY REHAB I; [Anonymous], 2009, J HOPKINS ACG SYSTEM; [Anonymous], 2011, EVIDENCE BASED REV R; Barbadoro P, 2012, EPIDEMIOL INFECT, V140, P753, DOI 10.1017/S0950268811001002; Britton PN, 2015, J PAEDIATR CHILD H, V51, P147, DOI 10.1111/jpc.12650; Canadian Institute for Health Information, 2007, BURD NEUR DIS DIS IN; Canadian Institute for Health Information, 2006, HEAD INJ CAN DEC CHA; CARF International, CARF CCAC STAND MAN; Centers for Medicare & Medicaid Serices, 2012, INP REH FAC PAT ASS; Chan V, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0259-7; Chan V, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-97; Chan V, 2013, CAN J AGING, V32, P278, DOI 10.1017/S0714980813000317; Charlson M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112479; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen A, 2013, HEALTHCARE POLICY, V7, P41; Chen A, 2014, J REHABIL MED, V46, P144, DOI 10.2340/16501977-1243; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; Chen AY, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-16; Colantonio A, 2012, ONTARIO ACQUIRED BRA; Colantonio A, 2009, ABI DATASET PILOT PR; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Cullen NK, 2009, PM&R, V1, P1069, DOI 10.1016/j.pmrj.2009.09.013; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; DeMatteo CA, 2008, ARCH PHYS MED REHAB, V89, P1803, DOI 10.1016/j.apmr.2008.02.025; Donoghue AJ, 2005, ANN EMERG MED, V46, P512, DOI 10.1016/j.annemergmed.2005.05.028; Faul M, 2010, TRAUAMTIC BRAIN INJU; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Forsyth R, 2012, CAN MED ASSOC J, V184, P1257, DOI 10.1503/cmaj.111045; Giustini Alessandro, 2013, Handb Clin Neurol, V110, P401, DOI 10.1016/B978-0-444-52901-5.00034-4; Greenberg ML, 2015, ATLAS CHILDHOOD CANC; Hviid A, 2007, EPIDEMIOLOGY, V18, P695, DOI 10.1097/EDE.0b013e3181567d31; Inoue, 2001, AGE STANDARDIZATION; Johnson AR, 2009, DEV DISABIL RES REV, V15, P124, DOI 10.1002/ddrr.63; Juurlink D., 2006, Canadian Institute for Health Information Discharge Abstract Database: a validation study; Kneen R, 2012, J INFECTION, V64, P449, DOI 10.1016/j.jinf.2011.11.013; Koskiniemi M, 2001, J NEUROVIROL, V7, P400, DOI 10.1080/135502801753170255; Olsen SJ, 2015, EMERG INFECT DIS, V21, P280, DOI 10.3201/eid2102.140291; Parsons Daria, 2012, BMC Res Notes, V5, P584, DOI 10.1186/1756-0500-5-584; Saverino C, 2016, ARCH PHYS MED REHAB, V97, pS19, DOI 10.1016/j.apmr.2015.04.016; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Weingarten L, 2013, PEDIATR EMERG CARE, V29, P235, DOI 10.1097/PEC.0b013e318280d7f3; Wong CP, 2001, ARCH DIS CHILD, V84, P193, DOI 10.1136/adc.84.3.193	43	12	12	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	JUL 20	2016	16								110	10.1186/s12883-016-0631-2			10	Clinical Neurology	Neurosciences & Neurology	DS0MG	WOS:000380289300001	27439699	DOAJ Gold, Green Published			2021-06-18	
J	Cartagena, CM; Mountney, A; Hwang, H; Swiercz, A; Rammelkamp, Z; Boutte, AM; Shear, DA; Tortella, FC; Schmid, KE				Cartagena, Casandra M.; Mountney, Andrea; Hwang, Hye; Swiercz, Adam; Rammelkamp, Zoe; Boutte, Angela M.; Shear, Deborah A.; Tortella, Frank C.; Schmid, Kara E.			Subacute Changes in Cleavage Processing of Amyloid Precursor Protein and Tau following Penetrating Traumatic Brain Injury	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; BETA ACCUMULATION; CASPASE CLEAVAGE; PROGENITOR CELLS; HEAD-INJURY; PROLIFERATION; MITOCHONDRIA; AGGREGATION; FRAGMENT	Traumatic brain injury (TBI) is an established risk factor for the development of Alzheimer's disease (AD). Here the effects of severe penetrating TBI on APP and tau cleavage processing were investigated in a rodent model of penetrating ballistic-like brain injury (PBBI). PBBI was induced by stereotactically inserting a perforated steel probe through the right frontal cortex of the anesthetized rat and rapidly inflating/deflating the probe's elastic tubing into an elliptical shaped balloon to 10% of total rat brain volume causing temporary cavitation injury. Separate animals underwent probe injury (PrI) alone without balloon inflation. Shams underwent craniectomy. Brain tissue was collected acutely (4h, 24h, 3d) and subacutely (7d) post-injury and analyzed by immunoblot for full length APP (APP-FL) and APP beta c-terminal fragments (beta CTFs), full length tau (tau-FL) and tau truncation fragments and at 7d for cytotoxic Beta amyloid (A beta) peptides A beta 40 and A beta 42 analysis. APP-FL was significantly decreased at 3d and 7d following PBBI whereas APP beta CTFs were significantly elevated by 4h post-injury and remained elevated through 7d post-injury. Effects on beta CTFs were mirrored with PrI, albeit to a lesser extent. A beta 40 and A beta 42 were significantly elevated at 7d following PBBI and PrI. Tau-FL decreased substantially 3d and 7d post-PBBI and PrI. Importantly, a 22 kDa tau fragment (tau22), similar to that found in AD, was significantly elevated by 4h and remained elevated through 7d post-injury. Thus both APP and tau cleavage was dramatically altered in the acute and subacute periods post-injury. As cleavage of these proteins has also been implicated in AD, TBI pathology shown here may set the stage for the later development of AD or other tauopathies.	[Cartagena, Casandra M.; Mountney, Andrea; Hwang, Hye; Swiercz, Adam; Rammelkamp, Zoe; Boutte, Angela M.; Shear, Deborah A.; Tortella, Frank C.; Schmid, Kara E.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD 20910 USA	Cartagena, CM (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD 20910 USA.	casandra.m.cartagena@gmail.com			U.S. Army Medical Research and Material Command, Combat Casualty Care Research Program	This research was funded by the U.S. Army Medical Research and Material Command, Combat Casualty Care Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Rebecca Pedersen and Weihong Yang for their excellent technical assistance. This research was funded by the U.S. Army Medical Research and Material Command, Combat Casualty Care Research Program. This material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the authors, and are not to be construed as official, or reflecting true views of the Department of the Army or the Department of Defense.	Amadoro G, 2014, NEUROBIOL DIS, V62, P489, DOI 10.1016/j.nbd.2013.10.018; Amadoro G, 2014, J ALZHEIMERS DIS, V42, P211, DOI 10.3233/JAD-140267; Amadoro G, 2010, J ALZHEIMERS DIS, V21, P445, DOI 10.3233/JAD-2010-100120; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Avila J, 2006, FEBS LETT, V580, P2922, DOI 10.1016/j.febslet.2006.02.067; Baratchi S, 2012, HIPPOCAMPUS, V22, P1517, DOI 10.1002/hipo.20988; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P213, DOI 10.1177/0891988710383571; Berry RW, 2003, BIOCHEMISTRY-US, V42, P8325, DOI 10.1021/bi027348m; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Demars MP, 2013, NEUROBIOL AGING, V34, P2431, DOI 10.1016/j.neurobiolaging.2013.04.016; Demars MP, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt77; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hill T., 2006, STAT METHODS APPL CO; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; Kay AD, 2003, J NEUROTRAUM, V20, P943, DOI 10.1089/089771503770195795; Koike MA, 2011, NEUROSCI LETT, V495, P55, DOI 10.1016/j.neulet.2011.03.034; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; Li RN, 2013, LIFE SCI, V92, P747, DOI 10.1016/j.lfs.2013.02.014; Loane DJ, 2011, J NEUROTRAUM, V28, P225, DOI 10.1089/neu.2010.1595; Magnoni S, 2010, ARCH NEUROL-CHICAGO, V67, P1068, DOI 10.1001/archneurol.2010.214; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; Muller K. E., 2002, REGRESSION ANOVA INT; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Park SY, 2007, NEUROSCIENCE, V144, P119, DOI 10.1016/j.neuroscience.2006.09.012; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Porzig R, 2007, BIOCHEM BIOPH RES CO, V358, P644, DOI 10.1016/j.bbrc.2007.04.187; Reddy PH, 2011, BRAIN RES, V1415, P136, DOI 10.1016/j.brainres.2011.07.052; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078851; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tyan SH, 2012, MOL CELL NEUROSCI, V51, P43, DOI 10.1016/j.mcn.2012.07.009; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3; Zilka N, 2012, BIOCHEM SOC T, V40, P681, DOI 10.1042/BST20120015	44	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158576	10.1371/journal.pone.0158576			19	Multidisciplinary Sciences	Science & Technology - Other Topics	DR8TD	WOS:000380169300013	27428544	DOAJ Gold, Green Published			2021-06-18	
J	Barton, DJ; Kumar, RG; McCullough, EH; Galang, G; Arenth, PM; Berga, SL; Wagner, AK				Barton, David J.; Kumar, Raj G.; McCullough, Emily H.; Galang, Gary; Arenth, Patricia M.; Berga, Sarah L.; Wagner, Amy K.			Persistent Hypogonadotropic Hypogonadism in Men After Severe Traumatic Brain Injury: Temporal Hormone Profiles and Outcome Prediction	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						biomarker screening assay; brain injury; hypopituitarism; outcome; posttraumatic hypogonadotrophic hypogonadism; Rehabilomics; sensitivity and specificity; TBI	ANEURYSMAL SUBARACHNOID HEMORRHAGE; FUNCTIONAL INDEPENDENCE MEASURE; ANTERIOR-PITUITARY FUNCTION; HEAD TRAUMA; TESTOSTERONE LEVELS; LONG-TERM; HYPOPITUITARISM; REHABILITATION; DYSFUNCTION; VALIDITY	Objective: To (1) examine relationships between persistent hypogonadotropic hypogonadism (PHH) and long-term outcomes after severe traumatic brain injury (TBI); and (2) determine whether subacute testosterone levels can predict PHH. Setting: Level 1 trauma center at a university hospital. Participants: Consecutive sample of men with severe TBI between 2004 and 2009. Design: Prospective cohort study. Main Measures: Post-TBI blood samples were collected during week 1, every 2 weeks until 26 weeks, and at 52 weeks. Serum hormone levels were measured, and individuals were designated as having PHH if 50% or more of samples met criteria for hypogonadotropic hypogonadism. At 6 and 12 months postinjury, we assessed global outcome, disability, functional cognition, depression, and quality of life. Results: We recruited 78 men; median (interquartile range) age was 28.5 (22-42) years. Thirty-four patients (44%) had PHH during the first year postinjury. Multivariable regression, controlling for age, demonstrated PHH status predicted worse global outcome scores, more disability, and reduced functional cognition at 6 and 12 months post-TBI. Two-step testosterone screening for PHH at 12 to 16 weeks postinjury yielded a sensitivity of 79% and specificity of 100%. Conclusion: PHH status in men predicts poor outcome after severe TBI, and PHH can accurately be predicted at 12 to 16 weeks.	[Barton, David J.; Kumar, Raj G.; McCullough, Emily H.; Galang, Gary; Arenth, Patricia M.; Wagner, Amy K.] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, 3471 Fifth Ave,Ste 202, Pittsburgh, PA 15213 USA; [Berga, Sarah L.] Wake Forest Sch Med, Dept Obstet & Gynecol, Winston Salem, NC USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, 3471 Fifth Ave,Ste 202, Pittsburgh, PA 15213 USA	Wagner, AK (corresponding author), Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, 3471 Fifth Ave,Ste 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu	Barton, David J/C-9282-2011	Barton, David J/0000-0003-0976-0383	Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49 CCR 323155-03]; NIDRR [H133A120087]; Rehabilitation Research Experience for Medical Students (RREMS) Program; UPMC Rehabilitation Institute; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE323155] Funding Source: NIH RePORTER	This work was supported by Centers for Disease Control and Prevention grant no. R49 CCR 323155-03, NIDRR grant no. H133A120087, the Rehabilitation Research Experience for Medical Students (RREMS) Program, and the UPMC Rehabilitation Institute.	American Psychiatry Association, 2000, DIAGN STAT MAN MENT; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Beninato M, 2006, ARCH PHYS MED REHAB, V87, P32, DOI 10.1016/j.apmr.2005.08.130; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Brain Trauma Foundation American Association of Neurological Surgeons, 2007, J NEUROTRAUMA S, V24, pS1, DOI DOI 10.1089/NEU.2007.9997; Carlson NE, 2009, BRAIN INJURY, V23, P336, DOI 10.1080/02699050902788535; Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; Centers for Disease Control and Prevention, 2001, RAT TBI REL EM DEP V; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; CUMMING DC, 1983, J CLIN ENDOCR METAB, V57, P671, DOI 10.1210/jcem-57-3-671; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Delis DC, 2000, CALIFORNIA VERBAL LE; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Donnelly P, 2000, CLIN ENDOCRINOL, V52, P197, DOI 10.1046/j.1365-2265.2000.00918.x; Dusick JR, 2012, PITUITARY, V15, P2, DOI 10.1007/s11102-008-0130-6; Failla MD, 2015, J HEAD TRAUMA REHAB, V30, pE54, DOI 10.1097/HTR.0000000000000118; Failla MD, 2015, NEUROREHAB NEURAL RE, V29, P234, DOI 10.1177/1545968314542617; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fernez-Rodriguez E., 2011, FRONT ENDOCRINOL, DOI [10.3389/fendo.2011.00025, DOI 10.3389/FENDO.2011.00025, DOI 10.3389/FEND0.2011.00025]; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Giordano Giulio, 2005, Pituitary, V8, P227, DOI 10.1007/s11102-006-6045-1; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Hohl A., 2014, OPEN J ENDOCR METAB, V4, P13; Huang WJ, 2001, J CELL BIOCHEM, V80, P313, DOI 10.1002/1097-4644(20010301)80:3<313::AID-JCB30>3.0.CO;2-E; Huhtaniemi I, 2011, NAT REV UROL, V8, P335, DOI 10.1038/nrurol.2011.47; JENNETT B, 1975, LANCET, V1, P480; Kleindienst A, 2009, J NEUROTRAUM, V26, P1435, DOI 10.1089/neu.2008.0601; Kopczak A, 2014, J NEUROTRAUM, V31, P99, DOI 10.1089/neu.2013.3002; LARRABEE GJ, 1995, J CLIN EXP NEUROPSYC, V17, P536, DOI 10.1080/01688639508405144; Liu M, 2010, MINERVA ENDOCRINOL, V35, P127; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; Moreau OK, 2012, J NEUROTRAUM, V29, P81, DOI 10.1089/neu.2011.2048; Petak Steven M, 2002, Endocr Pract, V8, P440; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reitan RM., 1985, HALSTEAD REITAN NEUR; Schneider HJ, 2007, J ENDOCRINOL INVEST, V30, pRC9, DOI 10.1007/BF03346291; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Shin MS, 2006, NAT PROTOC, V1, P892, DOI 10.1038/nprot.2006.115; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; SMITH MS, 1987, BIOL REPROD, V36, P138, DOI 10.1095/biolreprod36.1.138; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tajar A, 2010, J CLIN ENDOCR METAB, V95, P1810, DOI 10.1210/jc.2009-1796; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; TEASDALE G, 1974, LANCET, V2, P81; Wagner AK, 2014, AM J PHYS MED REHAB, V93, P913, DOI 10.1097/PHM.0000000000000114; Wagner Amy K, 2013, Pathophysiology, V20, P39, DOI 10.1016/j.pathophys.2012.02.007; Wagner AK, 2012, BRAIN INJURY, V26, P1226, DOI 10.3109/02699052.2012.667594; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; WELSH TH, 1982, BIOL REPROD, V27, P1138, DOI 10.1095/biolreprod27.5.1138; Young TP, 2007, BRAIN INJURY, V21, P645, DOI 10.1080/02699050701210426; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698	58	12	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2016	31	4					277	287		10.1097/HTR.0000000000000188			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DR3FW	WOS:000379789000013	26360007	Green Accepted			2021-06-18	
J	Epstein, DS; Mitra, B; Cameron, PA; Fitzgerald, M; Rosenfeld, JV				Epstein, Daniel S.; Mitra, Biswadev; Cameron, Peter A.; Fitzgerald, Mark; Rosenfeld, Jeffrey V.			Normalization of coagulopathy is associated with improved outcome after isolated traumatic brain injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Blood coagulation; Coagulopathy; Craniocerebral trauma; Injuries; Isolated head trauma; Traumatic brain injury	INTRACRANIAL HEMORRHAGE; COAGULATION DISORDERS; MASSIVE TRANSFUSION; PROGRESSION; DEFINITION; MORTALITY; COMPLEX; PATIENT; MILD	Acute traumatic coagulopathy (ATC) has been reported in the setting of isolated traumatic brain injury (iTBI) and is associated with poor outcomes. We aimed to evaluate the effectiveness of procoagulant agents administered to patients with ATC and iTBI during resuscitation, hypothesizing that timely normalization of coagulopathy may be associated with a decrease in mortality. A retrospective review of the Alfred Hospital trauma registry, Australia, was conducted and patients with iTBI (head Abbreviated Injury Score [AIS] >= 3 and all other body AIS <3) and coagulopathy (international normalized ratio >= 1.3) were selected for analysis. Data on procoagulant agents used (fresh frozen plasma, platelets, cryoprecipitate, prothrombin complex concentrates, tranexamic acid, vitamin K) were extracted. Among patients who had achieved normalization of INR or survived beyond 24 hours and were not taking oral anticoagulants, the association of normalization of INR and death at hospital discharge was analyzed using multivariable logistic regression analysis. There were 157 patients with ATC of whom 68 (43.3%) received procoagulant products within 24 hours of presentation. The median time to delivery of first products was 182.5 (interquartile range [IQR] 115-375) minutes, and following administration of coagulants, time to normalization of INR was 605 (IQR 274-1146) minutes. Normalization of INR was independently associated with significantly lower mortality (adjusted odds ratio 0.10; 95% confidence interval 0.03-0.38). Normalization of INR was associated with improved mortality in patients with ATC in the setting of iTBI. As there was a substantial time lag between delivery of products and eventual normalization of coagulation, specific management of coagulopathy should be implemented as early as possible. (c) 2016 Elsevier Ltd. All rights reserved.	[Epstein, Daniel S.; Mitra, Biswadev; Cameron, Peter A.] Alfred Hosp, Emergency & Trauma Ctr, Commercial Rd, Melbourne, Vic 3004, Australia; [Epstein, Daniel S.; Mitra, Biswadev; Cameron, Peter A.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Mitra, Biswadev; Fitzgerald, Mark] Natl Trauma Res Inst, Melbourne, Vic, Australia; [Cameron, Peter A.] Hamad Med Corp, Emergency Med, Doha, Qatar; [Fitzgerald, Mark] Alfred Hosp, Trauma Serv, Melbourne, Vic 3004, Australia; [Fitzgerald, Mark; Rosenfeld, Jeffrey V.] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia; [Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic 3004, Australia; [Rosenfeld, Jeffrey V.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Surg, Bethesda, MD 20814 USA	Mitra, B (corresponding author), Alfred Hosp, Emergency & Trauma Ctr, Commercial Rd, Melbourne, Vic 3004, Australia.; Mitra, B (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia.; Mitra, B (corresponding author), Natl Trauma Res Inst, Melbourne, Vic, Australia.	biswadev.mitra@monash.edu	Mitra, Biswadev/AAC-3724-2019; Epstein, Daniel/AAQ-4181-2020	Mitra, Biswadev/0000-0002-0508-2450; Epstein, Daniel/0000-0003-2215-7749; Cameron, Peter/0000-0002-1443-557X; Fitzgerald, Mark/0000-0003-0183-7761			Brophy GM, 2013, ANN PHARMACOTHER, V47, P447, DOI 10.1345/aph.1R729; Cameron PA, 2014, BRIT J ANAESTH, V113, P226, DOI 10.1093/bja/aeu231; Davenport R, 2011, CRIT CARE MED, V39, P2652, DOI 10.1097/CCM.0b013e3182281af5; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Epstein DS, 2015, BRIT J NEUROSURG, V29, P118, DOI 10.3109/02688697.2014.950632; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Fitzgerald M, 2011, ARCH SURG-CHICAGO, V146, P218, DOI 10.1001/archsurg.2010.333; Franschman G, 2012, BRAIN INJURY, V26, P1464, DOI 10.3109/02699052.2012.694566; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Huynh TK, 2014, PHARMACOTHERAPY, V34, P260, DOI 10.1002/phar.1384; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Joseph B, 2015, BRAIN INJURY, V29, P11, DOI 10.3109/02699052.2014.945959; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P121, DOI 10.1097/TA.0b013e3182a9cc95; Joseph B, 2012, J TRAUMA ACUTE CARE, V72, P828, DOI 10.1097/TA.0b013e318247c944; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Kalina M, 2008, AM SURGEON, V74, P858; Kunio NR, 2012, AM J SURG, V203, P584, DOI 10.1016/j.amjsurg.2011.12.011; Lee TH, 2014, J TRAUMA ACUTE CARE, V77, P67, DOI 10.1097/TA.0000000000000255; Lemcke J, 2014, BLOOD COAGUL FIBRIN, V25, P353, DOI 10.1097/MBC.0000000000000042; Lier H, 2011, INTENS CARE MED, V37, P572, DOI 10.1007/s00134-011-2139-y; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Mitra B, 2014, SHOCK, V42, P307, DOI 10.1097/SHK.0000000000000219; Mitra B, 2012, EMERG MED AUSTRALAS, V24, P363, DOI 10.1111/j.1742-6723.2012.01556.x; Nascimento B, 2014, BRIT J ANAESTH, V113, P922, DOI 10.1093/bja/aeu158; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Rugeri L, 2007, J THROMB HAEMOST, V5, P289, DOI 10.1111/j.1538-7836.2007.02319.x; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tran HA, 2013, MED J AUSTRALIA, V198, P198, DOI 10.5694/mja12.10614; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024	36	12	13	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JUL	2016	29						64	69		10.1016/j.jocn.2015.11.024			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	DP4EU	WOS:000378449800013	26947341				2021-06-18	
J	Gill, J; Merchant-Borna, K; Lee, H; Livingston, WS; Olivera, A; Cashion, A; Wang, D; Bazarian, JJ				Gill, Jessica; Merchant-Borna, Kian; Lee, Hyunhwa; Livingston, Whitney S.; Olivera, Anlys; Cashion, Ann; Wang, Dan; Bazarian, Jeffrey J.			Sports-Related Concussion Results in Differential Expression of Nuclear Factor-kappa B Pathway Genes in Peripheral Blood During the Acute and Subacute Periods	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acute-phase reaction; brain concussion; gene expression; inflammation; sports-related concussion; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; MICROGLIA ACTIVATION; CCL2; INTERLEUKIN-6; BIOMARKERS; CHEMOKINES; APOPTOSIS; RELEASE; PLASMA	Objective: To determine changes in global gene expression in peripheral leukocytes in the acute and subacute periods following a sports-related concussion in athletes. Setting: Samples were collected at 2 universities in Rochester, New York. Participants: Fifteen contact sport athletes who experienced a sports-related concussion, and 16 nonconcussed teammates served as controls. Design: Blood samples were collected at the start of the season (baseline), within 6 hours of injury (acute), and at 7 days (subacute) postinjury. Differential gene expression was measured using the GeneChip 3' in vitro transcription Expression kit and Affymetrix microarrays, and genes with fold difference of 2 or more were identified using Partek. Main Measures: Whole genome differential gene expression, and cognitive and balance measures to asses for clinical symptoms pre- and postinjury. Results: In the concussed athletes, we observed 67 downregulated and 4 upregulated genes in the acute period and 63 downregulated and 2 upregulated genes in the subacute period compared with baseline. Of these, there were 28 genes from both time points involved in the inflammatory response. No significant differences in gene expression were detected in the control group. Conclusions: Our findings suggest that recovery from sports-related concussion relates to modulation of inflammation through cytokine and chemokine gene pathways, which can contribute to future development of personalized therapeutic agents.	[Gill, Jessica; Livingston, Whitney S.; Olivera, Anlys; Cashion, Ann; Wang, Dan] NINR, NIH, 1 Cloister Ct,Rm 259, Bethesda, MD 20814 USA; [Lee, Hyunhwa] Univ Nevada, Sch Nursing, Las Vegas, NV 89154 USA; [Merchant-Borna, Kian; Bazarian, Jeffrey J.] Univ Rochester, Rochester, NY USA	Livingston, WS (corresponding author), NINR, NIH, 1 Cloister Ct,Rm 259, Bethesda, MD 20814 USA.	whitney.livingston@nih.gov	Gill, Gill M/Q-2020-2017	Lee, Hyunhwa/0000-0002-5625-3141	NIH/NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD064754]; NIH Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD064754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [ZIANR000030] Funding Source: NIH RePORTER	This work was supported by funds from the NIH/NICHD (award no. K24HD064754) and the NIH Intramural Research Program. Dr Sijung Yun provided additional review of data analyses methods and results from this study.	Bachstetter AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0289-5; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Connolly PH, 2004, J APPL PHYSIOL, V97, P1461, DOI 10.1152/japplphysiol.00316.2004; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gopcevic A, 2007, TOHOKU J EXP MED, V211, P387, DOI 10.1620/tjem.211.387; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Lin Y, 2013, INT J MED SCI, V10, P515, DOI 10.7150/ijms.5423; Liu S, 2013, J MOL NEUROSCI, V51, P1021, DOI 10.1007/s12031-013-0091-8; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Matsuoka Y, 1999, NEUROCHEM INT, V34, P91, DOI 10.1016/S0197-0186(98)00053-9; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Owen JL, 2011, CELL IMMUNOL, V270, P172, DOI 10.1016/j.cellimm.2011.05.004; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Robertson CS, 2013, J NEUROTRAUM, V30, P765, DOI 10.1089/neu.2012.2431; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Stein DM, 2012, SHOCK, V37, P563, DOI 10.1097/SHK.0b013e3182534f93; Stein DM, 2011, J TRAUMA, V70, P1096, DOI 10.1097/TA.0b013e318216930d; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Weiss N, 2010, J NEUROIMMUNOL, V223, P131, DOI 10.1016/j.jneuroim.2010.03.009; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zhai PP, 2015, NEUROPHARMACOLOGY, V95, P1, DOI 10.1016/j.neuropharm.2015.02.026	34	12	13	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2016	31	4					269	276		10.1097/HTR.0000000000000191			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DR3FW	WOS:000379789000012	26479397				2021-06-18	
J	van Zellem, L; Utens, EM; Madderom, M; Legerstee, JS; Aarsen, F; Tibboel, D; Buysse, C				van Zellem, Lennart; Utens, Elisabeth M.; Madderom, Marlous; Legerstee, Jeroen S.; Aarsen, Femke; Tibboel, Dick; Buysse, Corinne			Cardiac arrest in infants, children, and adolescents: long-term emotional and behavioral functioning	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						Heart arrest; Follow-up studies; Psychopathology; Pediatrics	TRAUMATIC BRAIN-INJURY; CONGENITAL HEART-DISEASE; NEONATAL ENCEPHALOPATHY; SCHOOL-AGE; PERINATAL ASPHYXIA; RESUSCITATION; ASSOCIATION; OUTCOMES; MULTICENTER	Very little is known about the psychological consequences of a cardiac arrest (CA) during childhood. Our aim was to assess long-term emotional and behavioral functioning, and its predictors, in survivors of CA in childhood. This long-term follow-up study involved all consecutive infants, children, and adolescents surviving CA in a tertiary-care university children's hospital between January 2002 and December 2011. Emotional and behavioral functioning was assessed with the Child Behavior Checklist (CBCL), Teacher's Report Form (TRF), and Youth Self-Report (YSR). Of the eligible 107 CA survivors, 52 patients, parents, and/or teachers filled out online questionnaires. Compared with normative data, parents and teachers reported significantly more attention and somatic problems (age range 6-18 years). Parents also reported more attention problems for age range 1.5-5 years. Twenty-eight percent of the children (n = 14) scored in the psychopathological range (i.e., for age range 1.5-18 years; p < 0.001) according to parent reports. Male gender, older age, and basic life support were significantly related to worse scores on the scales internalizing problems, externalizing problems, and total problems and subscale attention problems. Conclusion: Long-term deficits in attention and somatic complaints were reported. Attention problems after childhood CA can interfere with school performance. Long-term follow-up with neuropsychological assessment should be organized.	[van Zellem, Lennart; Madderom, Marlous; Aarsen, Femke; Tibboel, Dick; Buysse, Corinne] Erasmus MC Sophia Childrens Hosp, Intens Care, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands; [van Zellem, Lennart; Madderom, Marlous; Aarsen, Femke; Tibboel, Dick; Buysse, Corinne] Erasmus MC Sophia Childrens Hosp, Dept Pediat Surg, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands; [Utens, Elisabeth M.; Madderom, Marlous; Legerstee, Jeroen S.; Aarsen, Femke] Erasmus MC Sophia Childrens Hosp, Dept Child & Adolescent Psychiatry Psychol, NL-3015 CN Rotterdam, Netherlands	Buysse, C (corresponding author), Erasmus MC Sophia Childrens Hosp, Intens Care, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.; Buysse, C (corresponding author), Erasmus MC Sophia Childrens Hosp, Dept Pediat Surg, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.	c.buysse@erasmusmc.nl					Aarsen FK, 2006, CANCER-AM CANCER SOC, V106, P396, DOI 10.1002/cncr.21612; Achenbach TM, 2001, MANUAL ASEBA SCH AGE; Anderson V.A, 2001, DEV NEUROPSYCHOLOGY; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Biarent D, 2010, RESUSCITATION, V81, P1364, DOI 10.1016/j.resuscitation.2010.08.012; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Centraal Bureau voor de Statistiek, 2010, DUTCH STAND CLASS OC; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Donoghue AJ, 2005, ANN EMERG MED, V46, P512, DOI 10.1016/j.annemergmed.2005.05.028; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Madderom MJ, 2013, INTENS CARE MED, V39, P1584, DOI 10.1007/s00134-013-2973-1; Marino BS, 2012, CIRCULATION, V126, P1143, DOI 10.1161/CIR.0b013e318265ee8a; Marlow N, 2005, ARCH DIS CHILD-FETAL, V90, pF380, DOI 10.1136/adc.2004.067520; Maryniak A, 2008, RESUSCITATION, V77, P46, DOI 10.1016/j.resuscitation.2007.10.024; Meert KL, 2009, PEDIATR CRIT CARE ME, V10, P544, DOI 10.1097/PCC.0b013e3181a7045c; MORRIS RD, 1993, J LEARN DISABIL, V26, P46, DOI 10.1177/002221949302600105; Moster D, 2002, ARCH DIS CHILD-FETAL, V86, pF16, DOI 10.1136/fn.86.1.F16; Osorio MB, 2013, PM&R, V5, P554, DOI 10.1016/j.pmrj.2012.11.006; Shillingford AJ, 2008, PEDIATRICS, V121, pE759, DOI 10.1542/peds.2007-1066; Spijkerboer AW, 2008, INT J CARDIOL, V125, P66, DOI 10.1016/j.ijcard.2007.02.025; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tick NT, 2007, ACTA PSYCHIAT SCAND, V116, P473, DOI 10.1111/j.1600-0447.2007.01068.x; Topjian AA, 2009, CURR OPIN CRIT CARE, V15, P203, DOI 10.1097/MCC.0b013e32832931e1; van Handel M, 2007, EUR J PEDIATR, V166, P645, DOI 10.1007/s00431-007-0437-8; van Handel M, 2010, J PEDIATR PSYCHOL, V35, P286, DOI 10.1093/jpepsy/jsp049; van Zellem L, 2015, INTENS CARE MED, V41, P1057, DOI 10.1007/s00134-015-3789-y; Vermunt LCAC, 2008, BRIT J CLIN PSYCHOL, V47, P251, DOI 10.1348/014466507X258868; Visconti KJ, 1999, CIRCULATION, V100, P145; Wernovsky G, 2006, CARDIOL YOUNG, V16, P92, DOI 10.1017/S1047951105002398; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446	30	12	12	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6199	1432-1076		EUR J PEDIATR	Eur. J. Pediatr.	JUL	2016	175	7					977	986		10.1007/s00431-016-2728-4			10	Pediatrics	Pediatrics	DP5XH	WOS:000378571000010	27177532	Green Published			2021-06-18	
J	Yang, GM; Peng, XY; Hu, Y; Lan, D; Wu, Y; Li, T; Liu, LM				Yang, Guangming; Peng, Xiaoyong; Hu, Yi; Lan, Dan; Wu, Yue; Li, Tao; Liu, Liangming			4-Phenylbutyrate Benefits Traumatic Hemorrhagic Shock in Rats by Attenuating Oxidative Stress, Not by Attenuating Endoplasmic Reticulum Stress	CRITICAL CARE MEDICINE			English	Article						4-phenylbutyrate; endoplasmic reticulum stress; mitochondria; oxidative stress; traumatic hemorrhagic shock; vascular hyporeactivity	REGULATE VASCULAR REACTIVITY; UREA CYCLE DISORDERS; EARLY BRAIN-INJURY; ARGININE-VASOPRESSIN; SHORT-TERM; ER STRESS; ISCHEMIA; PROTECTS; PLAYS; MITOCHONDRIA	Objective: Vascular dysfunction such as vascular hyporeactivity following severe trauma and shock is a major cause of death in injured patients. Oxidative stress and endoplasmic reticulum stress play an important role in vascular dysfunction. The objective of the present study was to determine whether or not 4-phenylbutyrate can improve vascular dysfunction and elicit antishock effects by inhibiting oxidative and endoplasmic reticulum stress. Design: Prospective, randomized, controlled laboratory experiment. Setting: State key laboratory of trauma, burns, and combined injury. Subjects: Five hundred and fifty-two Sprague-Dawley rats. Interventions: Rats were anesthetized, and a model of traumatic hemorrhagic shock was established by left femur fracture and hemorrhage. The effects of 4-phenylbutyrate (5, 20, 50, 100, 200, and 300 mg/kg) on vascular reactivity, animal survival, hemodynamics, and vital organ function in traumatic hemorrhagic shock rats and cultured vascular smooth muscle cells, and the relationship to oxidative stress and endoplasmic reticulum stress was observed. Measurements and Main Results: Lower doses of 4-phenylbutyrate significantly improved the vascular function, stabilized the hemodynamics, and increased the tissue blood flow and vital organ function in traumatic hemorrhagic shock rats, and markedly improved the survival outcomes. Among all dosages observed in the present study, 20 mg/kg of 4-phenylbutyrate had the best effect. Further results indicated that 4-phenylbutyrate significantly inhibited the oxidative stress, decreased shock-induced oxidative stress index such as the production of reactive oxygen species, increased the antioxidant enzyme levels such as superoxide dismutase, catalase, and glutathione, and improved the mitochondrial function by inhibiting the opening of the mitochondrial permeability transition pore in rat artery and vascular smooth muscle cells. In contrast, 4-phenylbutyrate did not affect the changes of endoplasmic reticulum stress markers following traumatic hemorrhagic shock. Furthermore, 4-phenylbutyrate increased the nuclear levels of nuclear factor-E2-related factor 2, and decreased the nuclear levels of nuclear factor kappa B in hypoxic vascular smooth muscle cells. Conclusions: 4-phenylbutyrate has beneficial effects for traumatic hemorrhagic shock including improving animal survival and protecting organ function. These beneficial effects of 4-phenylbutyrate in traumatic hemorrhagic shock result from its vascular function protection via attenuation of the oxidative stress and mitochondrial permeability transition pore opening. Nuclear factor-E2-related factor 2 and nuclear factor-kappa B may be involved in 4-phenylbutyrate-mediated inhibition of oxidative stress.	[Yang, Guangming; Peng, Xiaoyong; Hu, Yi; Lan, Dan; Wu, Yue; Li, Tao; Liu, Liangming] Third Mil Med Univ, Daping Hosp, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury,Dept, Chongqing, Peoples R China	Li, T; Liu, LM (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury,Dept, Chongqing, Peoples R China.	lt200132@163.com; liangmingliu@yahoo.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81270400, 81571886]; Natural Science Foundation of Chongqing CityNatural Science Foundation of Chongqing [stc2013j-cyjA10012]; State Key Laboratory of Trauma, Burns and Combined Injury [SKLZZ200912, SKLZZ201020]	All authors received support for article research from the National Natural Science Foundation of China (grant no. 81270400 and 81571886), the Natural Science Foundation of Chongqing City (grant no. stc2013j-cyjA10012), and the Foundation of State Key Laboratory of Trauma, Burns and Combined Injury (grant no. SKLZZ200912 and SKLZZ201020).	Ayala P, 2012, EXP MOL PATHOL, V92, P97, DOI 10.1016/j.yexmp.2011.10.012; Baines CP, 2009, BASIC RES CARDIOL, V104, P181, DOI 10.1007/s00395-009-0004-8; Bhandary B, 2013, INT J MOL SCI, V14, P434, DOI 10.3390/ijms14010434; Chen G, 2013, CRIT CARE, V17, DOI 10.1186/cc12820; Chung YL, 2009, CARCINOGENESIS, V30, P1387, DOI 10.1093/carcin/bgp079; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Dodson M, 2015, BIOCHEM J, V469, P347, DOI 10.1042/BJ20150568; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; Fessler EB, 2013, CURR PHARM DESIGN, V19, P5105, DOI 10.2174/1381612811319280009; Hasan A, 1997, SHOCK, V8, P305, DOI 10.1097/00024382-199710000-00011; Kaste M, 2013, CEREBROVASC DIS, V36, P196, DOI 10.1159/000353680; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kusaczuk M, 2015, CURR PHARM DESIGN, V21, P2147, DOI 10.2174/1381612821666150105160059; Li T, 2012, ANESTHESIOLOGY, V116, P1288, DOI 10.1097/ALN.0b013e318256f09d; Li T, 2011, ANN SURG, V253, P185, DOI 10.1097/SLA.0b013e3181f9b88b; Liu LM, 2013, ANESTHESIOLOGY, V119, P379, DOI 10.1097/ALN.0b013e31829b3804; Lupachyk S, 2013, DIABETES, V62, P944, DOI 10.2337/db12-0716; Luu K, 2014, IMMUNOL CELL BIOL, V92, P761, DOI 10.1038/icb.2014.51; Miki T, 2009, DIABETES, V58, P2863, DOI 10.2337/db09-0158; Mimori S, 2013, BIOORG MED CHEM LETT, V23, P6015, DOI 10.1016/j.bmcl.2013.08.001; Minamino T, 2010, J MOL CELL CARDIOL, V48, P1105, DOI 10.1016/j.yjmcc.2009.10.026; Mizukami T, 2010, J VASC SURG, V52, P1580, DOI 10.1016/j.jvs.2010.06.172; Mokhtarani M, 2013, MOL GENET METAB, V110, P446, DOI 10.1016/j.ymgme.2013.09.017; Mujumdar N, 2014, AM J PHYSIOL-GASTR L, V306, pG1011, DOI 10.1152/ajpgi.00466.2013; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; Pagano G, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/541230; Persson T, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/427318; Petronilli V, 1998, BIOFACTORS, V8, P263, DOI 10.1002/biof.5520080314; Pizzo P, 2007, TRENDS CELL BIOL, V17, P511, DOI 10.1016/j.tcb.2007.07.011; Qi X, 2004, MOL PHARMACOL, V66, P899, DOI 10.1124/mol.104.001339; Roy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038113; Sennoun N, 2009, CRIT CARE MED, V37, P246, DOI 10.1097/CCM.0b013e318192fe4f; Siomek A, 2012, ACTA BIOCHIM POL, V59, P323; Smith W, 2013, J PEDIATR-US, V162, P1228, DOI 10.1016/j.jpeds.2012.11.084; Tang C, 2012, DIABETOLOGIA, V55, P1366, DOI 10.1007/s00125-012-2474-8; van der Meer AJ, 2015, CRIT CARE MED, V43, pE199, DOI 10.1097/CCM.0000000000000949; Wang CH, 2014, CRIT CARE MED, V42, P954, DOI 10.1097/CCM.0000000000000050; WEBSTER KA, 1993, J BIOL CHEM, V268, P16852; Wu MY, 2012, INVEST OPHTH VIS SCI, V53, P4595, DOI 10.1167/iovs.12-9910; Wu Y, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/752387; Xu J, 2012, CARDIOVASC RES, V96, P308, DOI 10.1093/cvr/cvs254; Yang GM, 2006, J TRAUMA, V61, P1336, DOI 10.1097/01.ta.0000197928.99745.22; Yang GM, 2013, J TRAUMA ACUTE CARE, V74, P1033, DOI 10.1097/TA.0b013e31828586a2; Yang GM, 2010, EUR J PHARMACOL, V628, P148, DOI 10.1016/j.ejphar.2009.11.040; Zhan Y, 2012, CRIT CARE MED, V40, P1291, DOI 10.1097/CCM.0b013e31823da96d; Zhang XS, 2014, J NEUROSURG, V121, P42, DOI 10.3171/2014.2.JNS13730	46	12	15	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUL	2016	44	7					E477	E491		10.1097/CCM.0000000000001469			15	Critical Care Medicine	General & Internal Medicine	DO9BX	WOS:000378080400004	26646458				2021-06-18	
J	Bloch, A; Tamir, D; Vakil, E; Zeilig, G				Bloch, Ayala; Tamir, Dror; Vakil, Eli; Zeilig, Gabi			Specific Deficit in Implicit Motor Sequence Learning following Spinal Cord Injury	PLOS ONE			English	Article							CLOSED HEAD-INJURY; REACTION-TIME-TASK; BASAL GANGLIA; SUPPORTED EMPLOYMENT; DEPRESSION; BRAIN; ANXIETY; MULTISITE; VETERANS; AMNESIA	Background Physical and psychosocial rehabilitation following spinal cord injury (SCI) leans heavily on learning and practicing new skills. However, despite research relating motor sequence learning to spinal cord activity and clinical observations of impeded skill-learning after SCI, implicit procedural learning following spinal cord damage has not been examined. Objective To test the hypothesis that spinal cord injury (SCI) in the absence of concomitant brain injury is associated with a specific implicit motor sequence learning deficit that cannot be explained by depression or impairments in other cognitive measures. Methods Ten participants with SCI in T1-T11, unharmed upper limb motor and sensory functioning, and no concomitant brain injury were compared to ten matched control participants on measures derived from the serial reaction time (SRT) task, which was used to assess implicit motor sequence learning. Explicit generation of the SRT sequence, depression, and additional measures of learning, memory, and intelligence were included to explore the source and specificity of potential learning deficits. Results There was no between-group difference in baseline reaction time, indicating that potential differences between the learning curves of the two groups could not be attributed to an overall reduction in response speed in the SCI group. Unlike controls, the SCI group showed no decline in reaction time over the first six blocks of the SRT task and no advantage for the initially presented sequence over the novel interference sequence. Meanwhile, no group differences were found in explicit learning, depression, or any additional cognitive measures. Conclusions The dissociation between impaired implicit learning and intact declarative memory represents novel empirical evidence of a specific implicit procedural learning deficit following SCI, with broad implications for rehabilitation and adjustment.	[Bloch, Ayala] Natl Inst Rehabil Brain Injured, Tel Aviv, Israel; [Tamir, Dror] Hebrew Univ Jerusalem, Dept Psychol, Jerusalem, Israel; [Vakil, Eli] Bar Ilan Univ, Leslie & Susan Gonda Goldschmied Multidisciplinar, Ramat Gan, Israel; [Vakil, Eli] Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel; [Zeilig, Gabi] Chaim Sheba Med Ctr, Dept Neurol Rehabil, Tel Hashomer, Israel; [Zeilig, Gabi] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	Bloch, A (corresponding author), Natl Inst Rehabil Brain Injured, Tel Aviv, Israel.	ayalabl@shikumil.org.il					ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; BADDELEY AD, 1992, NEUROPSYCHOLOGY MEMO, P309; Bonanno GA, 2012, REHABIL PSYCHOL, V57, P236, DOI 10.1037/a0029256; Bruehlmeier M, 1998, EUR J NEUROSCI, V10, P3918, DOI 10.1046/j.1460-9568.1998.00454.x; Castaneda AE, 2008, J AFFECT DISORDERS, V106, P1, DOI 10.1016/j.jad.2007.06.006; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; CRAIG AR, 1994, BRIT J CLIN PSYCHOL, V33, P221, DOI 10.1111/j.2044-8260.1994.tb01116.x; Craig A, 2015, BRIT J HEALTH PSYCH, V20, P807, DOI 10.1111/bjhp.12143; Cramer SC, 2005, BRAIN, V128, P2941, DOI 10.1093/brain/awh648; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; Davidoff G, 1990, Arch Clin Neuropsychol, V5, P77, DOI 10.1016/0887-6177(90)90009-E; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; Hess DW, 2003, REHABIL PSYCHOL, V48, P151, DOI 10.1037/0090-5550.48.3.151; Jegede AB, 2010, CLIN AUTON RES, V20, P3, DOI 10.1007/s10286-009-0036-z; Kennedy P, 2000, ARCH PHYS MED REHAB, V81, P932, DOI 10.1053/apmr.2000.5580; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; KNOPMAN D, 1991, NEUROPSYCHOLOGIA, V29, P245, DOI 10.1016/0028-3932(91)90085-M; Lum JAG, 2014, CORTEX, V51, P1, DOI 10.1016/j.cortex.2013.10.011; Lungu O, 2010, J NEUROPHYSIOL, V103, P2675, DOI 10.1152/jn.00006.2010; Macartney-Filgate M S, 1988, Arch Clin Neuropsychol, V3, P121, DOI 10.1016/0887-6177(88)90057-1; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Osterrieth P. A, 1944, ARCH PSYCHOL, V30, P286; Ottomanelli L, 2012, ARCH PHYS MED REHAB, V93, P740, DOI 10.1016/j.apmr.2012.01.002; Ottomanelli L, 2009, J REHABIL RES DEV, V46, P919, DOI 10.1682/JRRD.2008.10.0145; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; REED J, 1994, J EXP PSYCHOL LEARN, V20, P585, DOI 10.1037/0278-7393.20.3.585; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Robertson EM, 2007, J NEUROSCI, V27, P10073, DOI 10.1523/JNEUROSCI.2747-07.2007; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Rush AJ, 2005, NEUROPSYCHOPHARMACOL, V30, P405, DOI 10.1038/sj.npp.1300614; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sabbah P, 2002, J NEUROTRAUM, V19, P53, DOI 10.1089/089771502753460231; Schueneman AL, 1982, SCI DIG, V4, P64; SEGER CA, 1994, PSYCHOL BULL, V115, P163, DOI 10.1037/0033-2909.115.2.163; Siegert RJ, 2006, NEUROPSYCHOLOGY, V20, P490, DOI 10.1037/0894-4105.20.4.490; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; Taylor L, 1991, COMPENDIUM NEUROPSYC; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Trieschmann R.B., 1988, SPINAL CORD INJURIES, V2nd edition; Vahdat S, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002186; Vakil E, 1998, CHILD NEUROPSYCHOL, V4, P161, DOI 10.1076/chin.4.3.161.3173; Vakil E, 2000, NEUROPSYCHOLOGIA, V38, P1, DOI 10.1016/S0028-3932(99)00058-5; Warren AM, 2008, NEUROPSYCHOLOGY INPA, P79; Wechsler D., 1997, WECHSLER ADULT INTEL; Wilkinson L, 2004, J EXP PSYCHOL LEARN, V30, P354, DOI 10.1037/0278-7393.30.2.354; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; Yang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042993	51	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158396	10.1371/journal.pone.0158396			13	Multidisciplinary Sciences	Science & Technology - Other Topics	DQ0AM	WOS:000378859400058	27355834	DOAJ Gold, Green Published			2021-06-18	
J	Beck, B; Bray, JE; Cameron, PA; Cooper, DJ; Gabbe, BJ				Beck, Ben; Bray, Janet E.; Cameron, Peter A.; Cooper, D. James; Gabbe, Belinda J.			Trends in severe traumatic brain injury in Victoria, 2006-2014	MEDICAL JOURNAL OF AUSTRALIA			English	Article							EPIDEMIOLOGY; AUSTRALIA; MORTALITY; OUTCOMES; SCALE; RISK	Objective: To describe the incidence and causes of hospitalisation for severe traumatic brain injury (TBI) in Victoria over a 9-year period. Design, setting and participants: A retrospective review of data from the population-based Victorian State Trauma Registry for hospitalised cases of severe TBI, 2006-2014. Main outcome measures: Temporal trends in the incidence of severe TBI and in causes of injury. Results: There were 2062 patients hospitalised with severe TBI in Victoria during the 9-year study period. The incidence of severe TBI declined significantly over this period, from 5.0 to 3.2 cases per 100000 population per year, mainly because of reductions in severe TBI resulting from motor vehicle crashes (incidence rate ratio [IRR], 0.89; 95% CI, 0.86-0.92; P < 0.001), which largely involved people in the 15-34-year-old age group (64.7%). A decline was also observed in severe TBI in motorcyclists, but this was not statistically significant (IRR, 0.94; 95% CI, 0.89-1.00; P = 0.06). The incidence of severe TBI resulting from low falls, which occurred mostly in people aged 65 years or more (68.1%), increased (IRR, 1.04; 95% CI, 1.00-1.08; P = 0.03). The overall incidence of severe TBI resulting from intentional events was 0.60 cases per 100000 population, and declined over the study period (IRR, 0.95; 95% CI, 0.91e1.00; P = 0.03). Conclusions: The decline in the incidence of motor vehicle-related severe TBI suggests that road injury prevention measures have been effective. Additional targeted measures for reducing the incidence of major head injuries from falls should be explored.	[Beck, Ben; Bray, Janet E.; Cameron, Peter A.; Cooper, D. James; Gabbe, Belinda J.] Monash Univ, Melbourne, Vic, Australia; [Cameron, Peter A.] Alfred, Melbourne, Vic, Australia; [Cooper, D. James] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic, Australia	Beck, B (corresponding author), Monash Univ, Melbourne, Vic, Australia.	ben.beck@monash.edu	Beck, Ben/ABD-5556-2020; Cooper, D. James/G-7961-2013; Bray, Janet/H-7089-2014	Beck, Ben/0000-0003-3262-5956; Cooper, D. James/0000-0002-5872-9051; Cameron, Peter/0000-0002-1443-557X; Gabbe, Belinda/0000-0001-7096-7688; Bray, Janet/0000-0002-1559-5882	Victorian Department of Health and Human Services; Transport Accident Commission; National Health and Medical Research Council (NHRMC) Australian Resuscitation Outcomes Consortium (Aus-ROC) Centre of Research ExcellenceNational Health and Medical Research Council of Australia [1029983]; NHMRC-National Heart Foundation FellowshipNational Health and Medical Research Council of Australia [1069985/100136]; Practitioner FellowshipNational Health and Medical Research Council of Australia [545926]; Career Development Fellowship from the NHMRCNational Health and Medical Research Council of Australia [GNT1048731]	The Victorian State Trauma Registry (VSTR) is funded by the Victorian Department of Health and Human Services and the Transport Accident Commission. We thank the Victorian State Trauma Outcome Registry and Monitoring (VSTORM) group for providing VSTR data. We also thank Sue McLellan for her assistance with analysing the data. Ben Beck and Janet Bray received salary support from the National Health and Medical Research Council (NHRMC) Australian Resuscitation Outcomes Consortium (Aus-ROC) Centre of Research Excellence (#1029983). Janet Bray was also supported by a co-funded NHMRC-National Heart Foundation Fellowship (#1069985/100136). Peter Cameron and Belinda Gabbe were respectively supported by a Practitioner Fellowship (#545926) and a Career Development Fellowship (GNT1048731) from the NHMRC.	Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Association for the Advancement of Automotive Medicine, 2008, ABBR INJ SCAL 2005 U; Australian Bureau of Statistics, 2008, 3222 0 POP PROJ AUST; Australian Bureau of Statistics, 2015, 3235 0 POP AG SEX RE; Australian Institute of Health and Welfare, 2014, SUIC HOSP SELF HARM; Bambach MR, 2012, AUSTR ROAD SAF RES P; Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Helps Y., 2008, INJURY RES STAT SERI, V45; Lyckegaard A, 2015, TRAFFIC INJ PREV, V16, P380, DOI 10.1080/15389588.2014.948618; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; McGwin G, 2004, J TRAUMA, V56, P512, DOI 10.1097/01.TA.0000114272.37352.21; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Palmer CS, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-1; Pilgrim JL, 2014, DRUG ALCOHOL DEPEN, V135, P119, DOI 10.1016/j.drugalcdep.2013.11.019; Singer DE, 2009, ANN INTERN MED, V151, P297, DOI 10.7326/0003-4819-151-5-200909010-00003; State Government of Victoria Department of Health, 2015, MAPS HOSP LOC; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; TEASDALE G, 1974, LANCET, V2, P81; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; World Health Organization, 2006, NEUR DIS PUBL HLTH C; Zygun DA, 2005, CAN J NEUROL SCI, V32, P87, DOI 10.1017/S0317167100016930	26	12	13	1	2	AUSTRALASIAN MED PUBL CO LTD	PYRMONT	LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA	0025-729X	1326-5377		MED J AUSTRALIA	Med. J. Aust.	JUN 20	2016	204	11					407	+		10.5694/mja15.01369			6	Medicine, General & Internal	General & Internal Medicine	FG6ZZ	WOS:000410554800012	27318397				2021-06-18	
J	Boverman, G; Kao, TJ; Wang, X; Ashe, JM; Davenport, DM; Amm, BC				Boverman, Gregory; Kao, Tzu-Jen; Wang, Xin; Ashe, Jeffrey M.; Davenport, David M.; Amm, Bruce C.			Detection of small bleeds in the brain with electrical impedance tomography	PHYSIOLOGICAL MEASUREMENT			English	Article; Proceedings Paper	16th International Conference on Biomedical Applications of Electrical Impedance Tomography (EIT)	JUN 02-05, 2015	Neuchatel, SWITZERLAND	Nano Tera ch, Bioalps, Drager, ScioSpec, SICHH, IOP Publishing, Swisstom		electrical impedance tomography; contact impedance; hemorrhagic stroke; complete electrode model; statistical detection theory	CURRENT COMPUTED-TOMOGRAPHY; DIELECTRIC-PROPERTIES; BIOLOGICAL TISSUES; ELECTRODE MODELS; BREAST; EIT	In this paper, we describe and assess feasibility of instrumentation and algorithms for detecting bleeding due to hemorrhagic strokes and traumatic brain injury using electrical impedance tomography, a novel biomedical diagnostic modality in which the body is probed noninvasively with generally imperceptible alternating currents applied in patterns to a set of electrodes placed in contact with the skin. We focus on the GENESIS instrument developed by GE Global Research and on the achievability of our goal to detect a bleed in the center of the head with a volume of several ml. Our main topic is compensation for the large changes in voltages that tend to occur when the electrodes are in contact with biological media, specifically either human subjects or with vegetable matter proxies which seem to exhibit the same 'drift' phenomenon. We show that these changes in voltages can be modeled by assuming that each electrode is attached to the body via a discrete complex impedance whose value is time-varying and describe how this discrete component value can be estimated and largely compensated-for. We compare this discrete model with changes in contact impedances estimated using the complete electrode model showing that the two models are roughly comparable in their ability to explain the data from a single human subject experiment with electrodes attached to the head. In a simulation study, we demonstrate that it is possible to detect a small bleed in the center of the head even in the case of large changes in electrode impedances, which can be treated as nuisance parameters.	[Boverman, Gregory; Kao, Tzu-Jen; Wang, Xin; Ashe, Jeffrey M.; Davenport, David M.; Amm, Bruce C.] GE Global Res Ctr, 1 Res Circle, Niskayuna, NY 12309 USA	Boverman, G (corresponding author), GE Global Res Ctr, 1 Res Circle, Niskayuna, NY 12309 USA.	boverman@ge.com		Boverman, Gregory/0000-0002-7223-3714			BARBER DC, 1984, J PHYS E SCI INSTRUM, V17, P723, DOI 10.1088/0022-3735/17/9/002; CHENG KS, 1989, IEEE T BIO-MED ENG, V36, P918, DOI 10.1109/10.35300; Cherepenin V, 2001, PHYSIOL MEAS, V22, P9, DOI 10.1088/0967-3334/22/1/302; Fabri A., 2009, P 17 ACM SIGSPATIAL, P538, DOI DOI 10.1145/1653771.1653865; Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001; Gabriel S, 1996, PHYS MED BIOL, V41, P2271, DOI 10.1088/0031-9155/41/11/003; Gordon C. C., 1989, ANTHROPOMETRIC SURVE; ISAACSON D, 1986, IEEE T MED IMAGING, V5, P91, DOI 10.1109/TMI.1986.4307752; Kerner TE, 2002, IEEE T MED IMAGING, V21, P638, DOI 10.1109/TMI.2002.800606; Kim BS, 2007, PHYSIOL MEAS, V28, pS57, DOI 10.1088/0967-3334/28/7/S05; LEATHARD AD, 1994, PHYSIOL MEAS, V15, pA137, DOI 10.1088/0967-3334/15/2A/018; Polydorides N, 2002, MEAS SCI TECHNOL, V13, P1871, DOI 10.1088/0957-0233/13/12/310; SOMERSALO E, 1992, SIAM J APPL MATH, V52, P1023, DOI 10.1137/0152060; Soni NK, 2004, PHYSIOL MEAS, V25, P301, DOI 10.1088/0967-3334/25/1/034; Tidswell T, 2001, NEUROIMAGE, V13, P283, DOI 10.1006/nimg.2000.0698	15	12	12	2	23	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0967-3334	1361-6579		PHYSIOL MEAS	Physiol. Meas.	JUN	2016	37	6					727	750		10.1088/0967-3334/37/6/727			24	Biophysics; Engineering, Biomedical; Physiology	Biophysics; Engineering; Physiology	DM7BE	WOS:000376506600004	27203851				2021-06-18	
J	Edlow, BL; Copen, WA; Izzy, S; van der Kouwe, A; Glenn, MB; Greenberg, SM; Greer, DM; Wu, O				Edlow, Brian L.; Copen, William A.; Izzy, Saef; van der Kouwe, Andre; Glenn, Mel B.; Greenberg, Steven M.; Greer, David M.; Wu, Ona			Longitudinal Diffusion Tensor Imaging Detects Recovery of Fractional Anisotropy Within Traumatic Axonal Injury Lesions	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Diffusion tensor imaging; Traumatic axonal injury; Fractional anisotropy; Apparent diffusion coefficient	WHITE-MATTER INJURY; BRAIN-INJURY; CORPUS-CALLOSUM; HEAD-INJURY; ACUTE MILD; DAMAGE; COMA; DISCONNECTION; DEGENERATION; DIAGNOSIS	Traumatic axonal injury (TAI) may be reversible, yet there are currently no clinical imaging tools to detect axonal recovery in patients with traumatic brain injury (TBI). We used diffusion tensor imaging (DTI) to characterize serial changes in fractional anisotropy (FA) within TAI lesions of the corpus callosum (CC). We hypothesized that recovery of FA within a TAI lesion correlates with better functional outcome. Patients who underwent both an acute DTI scan (a parts per thousand currency signday 7) and a subacute DTI scan (day 14 to inpatient rehabilitation discharge) at a single institution were retrospectively analyzed. TAI lesions were manually traced on the acute diffusion-weighted images. Fractional anisotropy (FA), apparent diffusion coefficient (ADC), axial diffusivity (AD), and radial diffusivity (RD) were measured within the TAI lesions at each time point. FA recovery was defined by a longitudinal increase in CC FA that exceeded the coefficient of variation for FA based on values from healthy controls. Acute FA, ADC, AD, and RD were compared in lesions with and without FA recovery, and correlations were tested between lesional FA recovery and functional recovery, as determined by disability rating scale score at discharge from inpatient rehabilitation. Eleven TAI lesions were identified in 7 patients. DTI detected FA recovery within 2 of 11 TAI lesions. Acute FA, ADC, AD, and RD did not differ between lesions with and without FA recovery. Lesional FA recovery did not correlate with disability rating scale scores. In this retrospective longitudinal study, we provide initial evidence that FA can recover within TAI lesions. However, FA recovery did not correlate with improved functional outcomes. Prospective histopathological and clinical studies are needed to further elucidate whether lesional FA recovery indicates axonal healing and has prognostic significance.	[Edlow, Brian L.; Izzy, Saef; Greenberg, Steven M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, 175 Cambridge St,Suite 300, Boston, MA 02114 USA; [Edlow, Brian L.; van der Kouwe, Andre; Wu, Ona] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Copen, William A.; van der Kouwe, Andre; Wu, Ona] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol, Boston, MA USA; [Glenn, Mel B.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Spaulding Rehabil Hosp,Dept Phys Med & Rehabil, Boston, MA USA; [Greer, David M.] Yale Univ, Sch Med, Yale New Haven Hosp, Dept Neurol, New Haven, CT USA	Edlow, BL (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, 175 Cambridge St,Suite 300, Boston, MA 02114 USA.; Edlow, BL (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA.	bedlow@mgh.harvard.edu	Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789; Greer, David/0000-0002-2026-8333; Wu, Ona/0000-0002-5509-9461	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R25NS065743, K23NS094538, R01NS059775, P41EB015896]; American Academy of Neurology/American Brain Foundation; National Institute on Disability, Independent Living, and Rehabilitation Research, Administration for Community Living, U.S. Department Health and Human Services to Spaulding Rehabilitation Hospital [H133A120085]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS094538, R25NS065743, R01NS059775] Funding Source: NIH RePORTER	This study was supported by the National Institutes of Health (R25NS065743, K23NS094538, R01NS059775, and P41EB015896), the American Academy of Neurology/American Brain Foundation, and the National Institute on Disability, Independent Living, and Rehabilitation Research, Administration for Community Living, U.S. Department Health and Human Services to Spaulding Rehabilitation Hospital (H133A120085). However, the contents of this manuscript do not necessarily represent the policy of the Department of Health and Human Services and endorsement by the Federal Government should not be assumed.	Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Armstrong R.C., 2015, EXP NEUROL; Armstrong RC, 2015, NEUROPHARMACOLOGY; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Edlow BL, 2013, J NEUROPATH EXP NEUR, V72, P505, DOI 10.1097/NEN.0b013e3182945bf6; Edlow BL, 2012, SEMIN NEUROL, V32, P374, DOI 10.1055/s-0032-1331810; Fernandez-Espejo D, 2012, ANN NEUROL, V72, P335, DOI 10.1002/ana.23635; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jang SH, 2015, AM J PHYS MED REHAB, V94, P250, DOI 10.1097/PHM.0000000000000274; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Kessler LG, 2015, STAT METHODS MED RES, V24, P9, DOI 10.1177/0962280214537333; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Pasco A, 2006, EUR RADIOL, V16, P1501, DOI 10.1007/s00330-005-0086-0; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Schwamm LH, 1998, STROKE, V29, P2268, DOI 10.1161/01.STR.29.11.2268; Shin SS, 2012, J NEUROSURG, V116, P1062, DOI 10.3171/2012.1.JNS111282; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sorensen AG, 1999, RADIOLOGY, V212, P785, DOI 10.1148/radiology.212.3.r99se24785; STRICH SJ, 1961, LANCET, V2, P443; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; van de Looij Y, 2012, NMR BIOMED; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wang JY, 2012, NEUROIMAGE, V60, P1127, DOI 10.1016/j.neuroimage.2011.12.062; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208	56	12	12	0	8	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2016	24	3					342	352		10.1007/s12028-015-0216-8			11	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	DN2ZP	WOS:000376932100004	26690938	Green Accepted			2021-06-18	
J	Gatson, JW; Stebbins, C; Mathews, D; Harris, TS; Madden, C; Batjer, H; Diaz-Arrastia, R; Minei, JP				Gatson, Joshua W.; Stebbins, Cari; Mathews, Dana; Harris, Thomas S.; Madden, Christopher; Batjer, Hunt; Diaz-Arrastia, Ramon; Minei, Joseph P.			Evidence of increased brain amyloid in severe TBI survivors at 1, 12, and 24 months after injury: report of 2 cases	JOURNAL OF NEUROSURGERY			English	Article						amyloid; florbetapir F18; traumatic brain injury	APOLIPOPROTEIN-E EPSILON-4; ALZHEIMERS-DISEASE; HEAD-INJURY; RISK-FACTOR; BETA; ASSOCIATION; MILD; DEPOSITION; GENOTYPE; PROTEIN	Traumatic brain injury (TBI) is a major risk factor for Alzheimer's disease. With respect to amyloid deposition, there are no published serial data regarding the deposition rate of amyloid throughout the brain after TBI. The authors conducted serial F-18-AV-45 (florbetapir F18) positron emission tomography (PET) imaging in 2 patients with severe TBI at 1, 12, and 24 months after injury. A total of 12 brain regions were surveyed for changes in amyloid levels. Case 1 involved a 50-year-old man who experienced a severe TBI. Compared with the 1-month time point, of the 12 brain regions that were surveyed, a decrease in amyloid (as indicated by standard uptake value ratios) was only observed in the hippocampus (-16%, left;-12%, right) and caudate nucleus (-18%, left;-18%, right), suggesting that initial amyloid accumulation in the brain was cleared between time points 1 and 12 months after injury. Compared to the scan at 1 year, a greater increase in amyloid (+15%) was observed in the right hippocampus at the 24-month time point. The patient in Case 2 was a 37-year-old man who suffered severe trauma to the head and a subsequent stroke; he had poor cognitive/functional outcomes and underwent 1.5 years of rehabilitation. Due to a large infarct area on the injured side of the brain (right side), the authors focused primarily on brain regions affected within the left hemisphere. Compared with the 1-month scan, they only found an increase in brain amyloid within the left anterior putamen (+11%) at 12 months after injury. In contrast, decreased amyloid burden was detected in the left caudate nucleus (-48%), occipital cortex (-21%), and precuneus (-19%) brain regions at the 12-month time point, which is indicative of early accumulation and subsequent clearance. In comparison with 12-month values, more clearance was observed, since a reduction in amyloid was found at 24 months after trauma within the left anterior putamen (-12%) and occipital cortex (-15%). Also, by 24 months, most of the amyloid had been cleared and the patient demonstrated improved results on the Rivermead symptom questionnaire, Glasgow Outcome Scale-Extended, and Disability Rating Scale. With respect to APOE status, the patient in Case 1 had two epsilon 3 alleles and the patient in Case 2 had one epsilon 2 and one epsilon 3 allele. In comparison to the findings of the initial scan at 1 month after TBI, by 12 and 24 month's after injury amyloid was cleared in some brain regions and increased in others. Serial imaging conducted here suggests that florbetapir F18 PET imaging may be useful in monitoring amyloid dynamics within specific brain regions following severe TBI and may be predictive of cognitive deficits.	[Gatson, Joshua W.; Stebbins, Cari; Minei, Joseph P.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Gatson, Joshua W.; Madden, Christopher; Batjer, Hunt] Univ Texas SW Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA; [Mathews, Dana] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Harris, Thomas S.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Rockville, MD USA	Gatson, JW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, Dept Neurosurg, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	joshua.gatson@utsw.edu		Diaz-Arrastia, Ramon/0000-0001-6051-3594			Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Choi SR, 2009, J NUCL MED, V50, P1887, DOI 10.2967/jnumed.109.065284; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; Diaz-Arrastia R, 2006, J HEAD TRAUMA REHAB, V21, P361, DOI 10.1097/00001199-200607000-00007; Fleisher AS, 2011, ARCH NEUROL-CHICAGO, V68, P1404, DOI 10.1001/archneurol.2011.150; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gatson JW, 2013, J NEUROSURG, V118, P1336, DOI 10.3171/2013.2.JNS121771; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Johnson KA, 2013, ALZHEIMERS DEMENT, V9, pE1, DOI [10.1016/j.jalz.2013.06.001, 10.1016/j.jalz.2013.01.002, 10.1016/j.jalz.2012.10.007]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Marklund N, 2014, J NEUROTRAUM, V31, P42, DOI 10.1089/neu.2013.2964; Mattsson N, 2014, BRAIN, V137, P1550, DOI 10.1093/brain/awu043; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; REBECK GW, 1993, NEURON, V11, P575; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Rodrigue KM, 2012, NEUROLOGY, V78, P387, DOI 10.1212/WNL.0b013e318245d295; ROSES AD, 1995, ANN NEUROL, V38, P6, DOI 10.1002/ana.410380105; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Salib E, 1997, INT J GERIATR PSYCH, V12, P363, DOI 10.1002/(SICI)1099-1166(199703)12:3<363::AID-GPS515>3.0.CO;2-F; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Simpkins JW, 2009, ALZHEIMERS DEMENT, V5, P433, DOI 10.1016/j.jalz.2009.06.004; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Tiraboschi P, 2004, NEUROLOGY, V62, P1977, DOI 10.1212/01.WNL.0000128091.92139.0F; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; Wu KY, 2014, EUR J NUCL MED MOL I, V41, P714, DOI 10.1007/s00259-013-2627-0	35	12	12	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2016	124	6					1646	1653		10.3171/2015.6.JNS15639			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DM6PZ	WOS:000376476200015	26613169	Bronze			2021-06-18	
J	Murphy, MA; Horstemeyer, MF; Gwaltney, SR; Stone, T; LaPlaca, M; Liao, J; Williams, L; Prabhu, R				Murphy, M. A.; Horstemeyer, M. F.; Gwaltney, Steven R.; Stone, Tonya; LaPlaca, Michelle; Liao, Jun; Williams, Lakiesha; Prabhu, R.			Nanomechanics of phospholipid bilayer failure under strip biaxial stretching using molecular dynamics	MODELLING AND SIMULATION IN MATERIALS SCIENCE AND ENGINEERING			English	Article						traumatic brain injury (TBI); molecular dynamics (MD); nanoscale deformations; phospholipid bilayer; POPC; neuron; cell membrane	TRAUMATIC BRAIN-INJURY; LIPID-BILAYERS; PORE FORMATION; SIMULATIONS; DAMAGE; MEMBRANES; RUPTURE; TENSION; STRESS	The current study presents a nanoscale in silico investigation of strain rate dependency of membrane (phospholipid bilayer) failure when placed under strip biaxial tension with two planar areas. The nanoscale simulations were conducted in the context of a multiscale modelling framework in which the macroscale damage (pore volume fraction) progression is delineated into pore nucleation (number density of pores), pore growth (size of pores), and pore coalescence (inverse of nearest neighbor distance) mechanisms. As such, the number density, area fraction, and nearest neighbor distances were quantified in association with the stress-strain behavior. Deformations of a 1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC) bilayer were performed using molecular dynamics to simulate mechanoporation of a neuronal cell membrane due to injury, which in turn can result in long-term detrimental effects that could ultimately lead to cell death. Structures with 72 and 144 phospholipids were subjected to strip biaxial tensile deformations at multiple strain rates. Formation of a water bridge through the phospholipid bilayer was the metric to indicate structural failure. Both the larger and smaller bilayers had similar behavior regarding pore nucleation and the strain rate effect on pore growth post water penetration. The applied strain rates, planar area, and cross-sectional area had no effect on the von Mises strains at which pores greater than 0.1 nm(2) were detected (0.509 +/- 7.8%) or the von Mises strain at failure (epsilon(failure) = 0.68 +/- 4.8%). Additionally, changes in bilayer planar and cross-sectional areas did not affect the stress response. However, as the strain rate increased from 2.0 x 10(8) s(-1) to 1.0 x 10(9) s(-1), the yield stress increased from 26.5 MPa to 66.7 MPa and the yield strain increased from 0.056 to 0.226.	[Murphy, M. A.; Liao, Jun; Williams, Lakiesha; Prabhu, R.] Mississippi State Univ, Dept Agr & Biol Engn, Mississippi State, MS 39762 USA; [Murphy, M. A.; Horstemeyer, M. F.; Stone, Tonya; Liao, Jun; Williams, Lakiesha; Prabhu, R.] Mississippi State Univ, CAVS, Mississippi State, MS 39759 USA; [Horstemeyer, M. F.; Stone, Tonya] Mississippi State Univ, Dept Mech Engn, Mississippi State, MS 39762 USA; [Gwaltney, Steven R.] Mississippi State Univ, Dept Chem, Mississippi State, MS 39762 USA; [Gwaltney, Steven R.] Mississippi State Univ, Ctr Computat Sci, Mississippi State, MS 39762 USA; [LaPlaca, Michelle] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA	Williams, L; Prabhu, R (corresponding author), 130 Creelman St, Mississippi State, MS 39762 USA.	lwilliams@abe.msstate.edu; rprabhu@abe.msstate.edu	Stone, Tonya/L-9575-2019; Gwaltney, Steven/W-2783-2019; Prabhu, Raj/M-7188-2017	Stone, Tonya/0000-0002-8070-1928; Gwaltney, Steven/0000-0003-3833-5087; Murphy, Michael/0000-0001-9158-1709; Prabhu, Raj/0000-0002-6073-4802; Horstemeyer, Mark/0000-0003-4230-0063; Liao, Jun/0000-0003-1049-5783	Center for Advanced Vehicular Systems (CAVS) through the Department of Agricultural and Biological Engineering at Mississippi State University; Tissue Engineering Research Center (TERC) through the Department of Agricultural and Biological Engineering at Mississippi State University; NSF EPSCoR research program [EPS_0903787]	This material is based upon work supported by the Center for Advanced Vehicular Systems (CAVS) and the Tissue Engineering Research Center (TERC) through the Department of Agricultural and Biological Engineering at Mississippi State University. We would also like to thank the NSF EPSCoR research program (EPS_0903787) for funding the multiscale aspect of the current research. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the NSF.	[Anonymous], 2013, MATLAB 8 1 0 604 EDN; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Colgan NC, 2010, PROG BIOPHYS MOL BIO, V103, P304, DOI 10.1016/j.pbiomolbio.2010.09.008; Evans E, 2003, BIOPHYS J, V85, P2342, DOI 10.1016/S0006-3495(03)74658-X; Evans E, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/9/095010; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Horstemeyer MF, 2000, THEOR APPL FRACT MEC, V33, P31, DOI 10.1016/S0167-8442(99)00049-X; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Koshiyama K, 2011, J BIOMECH, V44, P2053, DOI 10.1016/j.jbiomech.2011.05.014; Leach A. R., 2001, MOL MODELLING PRINCI; Leontiadou H, 2004, BIOPHYS J, V86, P2156, DOI 10.1016/S0006-3495(04)74275-7; NARTEN AH, 1971, J CHEM PHYS, V55, P2263, DOI 10.1063/1.1676403; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; NOCSAE, 2013, ND00213M13 NOCSAE DO; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Prabhu R, 2011, J MECH BEHAV BIOMED, V4, P1067, DOI 10.1016/j.jmbbm.2011.03.015; Prabhu R, 2014, PNAS UNPUB; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shinoda W, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.134103; Stukowski A, 2010, MODEL SIMUL MATER SC, V18, DOI 10.1088/0965-0393/18/1/015012; Tieleman DP, 2003, J AM CHEM SOC, V125, P6382, DOI 10.1021/ja029504i; Tolpekina TV, 2004, J CHEM PHYS, V121, P8014, DOI 10.1063/1.1796254; Tomasini MD, 2010, EXP BIOL MED, V235, P181, DOI 10.1258/ebm.2009.009187; YANG B, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/408278; ZHANG YH, 1995, J CHEM PHYS, V103, P10252, DOI 10.1063/1.469927	29	12	12	1	14	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0965-0393	1361-651X		MODEL SIMUL MATER SC	Model. Simul. Mater. Sci. Eng.	JUN	2016	24	5							055008	10.1088/0965-0393/24/5/055008			19	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	DP1ZX	WOS:000378289000008					2021-06-18	
J	Ruff, RM; Klopfer, J; Blank, J				Ruff, Ronald M.; Klopfer, Jasmin; Blank, Jeremy			Homogenous Base Rates for Malingering in Neuropsychological Examination of Litigants	PSYCHOLOGICAL INJURY & LAW			English	Article						Malingering; Base rates; Neuropsychological assessment	SYMPTOM VALIDITY; PSYCHOLOGICAL INJURY; PERFORMANCE VALIDITY; RESPONSE BIAS; BRAIN-INJURY; SCALES	Base rates for malingering are often obtained and averaged across multiple clinicians who apply heterogeneous methods for detection (Mittenberg et al., J Clin Exp Neuropsychol 24: 1094-1102, 2002; Young, Psychol Inj Law 8: 200-218, 2015). Our aims of obtaining homogenous base rates included the following: (a) evaluation of all our legal cases in accordance with the guidelines set forth in the position papers by both the National Academy of Neuropsychology and the Association for Psychological Advancement in Psychological Injury and Law, (b) minimal variation between our comprehensive neuropsychological examinations, and (c) determination of base rates of failed effort in 150 consecutively examined legal cases in one medical setting. To assess the various levels of volitional exaggeration, we introduced four gradations of poor effort definitions, which relied on performance validity tests (PVTs). A comparison between two consecutive samples of 75 litigants indicated less frequent poor effort with increasingly more conservative criteria. In our analysis of a subset of litigants who sustained traumatic brain injuries (N= 115), the four base rates for mild versus moderate-severe TBI groups were equivalent for the two more lenient malingering definitions but varied for the two more conservative definitions. Specifically, for the mild TBI cases investigated, the percentage of three PVT failures (or one PVT failure significantly below chance) arrived at 3.4 %. Our final aim was to compare the base rates of poor effort that were obtained with PVTs to the base rates of emotional and physical symptom endorsement, which were obtained with symptom validity tests (SVTs). No significant correlations emerged in this analysis. The discussion emphasizes the relatively lower base rates of poor effort found in the convenience sample studied in neuropsychological evaluations relative to the higher estimates in the literature (40 +/- 10%, Larrabee et al., Clin Neuropsychol 23: 841-849, 2009) but not others based on comprehensive review.	[Ruff, Ronald M.; Klopfer, Jasmin; Blank, Jeremy] Univ Calif San Francisco, San Francisco, CA 94143 USA	Ruff, RM (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	ronruff@mindspring.com					Boone K., 2002, DOT COUNTING TEST; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2004, MED SYMPTOM VALIDITY; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Haggerty KA, 2007, CLIN NEUROPSYCHOL, V21, P917, DOI 10.1080/13854040600899724; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Jamora CW, 2013, BRAIN INJURY, V27, P1134, DOI 10.3109/02699052.2013.804196; Johansson SH, 2008, BRAIN INJURY, V22, P999, DOI 10.1080/02699050802530573; Kaufmann P. M., 2013, NATL ACAD NEUROPSYCH, V27, P11; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P841, DOI 10.1080/13854040902796735; Lees-Haley P. R., 1999, J FORENSIC NEUROPSYC, V1, P43, DOI [10.1300/J151v01n03_04, DOI 10.1300/J151V01N03_04]; Millon T., 2009, MCMI 3 MILLON CLIN M, V4th; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Morey LC., 2007, PERSONALITY ASSESSME; Murray RF, 2007, SPINAL CORD, V45, P429, DOI 10.1038/sj.sc.3102022; Rey A., 1964, CLIN EXAMINATION PSY; ROGERS R, 1988, CLIN ASSESSMENT MALI; Ruff R. M., 2003, RNBI RUFF NEUROBEHAV; Ruff R, 2009, J HEAD TRAUMA REHAB, V24, P131, DOI 10.1097/01.HTR.0000348755.42649.e9; Ruocco AC, 2008, CLIN NEUROPSYCHOL, V22, P547, DOI 10.1080/13854040701336444; Schroeder SC, 2015, Z NEUROPSYCHOL, V26, P35, DOI 10.1024/1016-264x/a000132; Slick D., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Wechsler D, 2009, WAIS 4 ADM SCORING M; Wechsler D., 2009, ADV CLIN SOLUTIONS W; Whiteside DM, 2009, CLIN NEUROPSYCHOL, V23, P523, DOI 10.1080/13854040802389169; Young G, 2015, PSYCHOL INJ LAW, V8, P200, DOI 10.1007/s12207-015-9230-6; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593	36	12	12	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	JUN	2016	9	2					143	153		10.1007/s12207-016-9259-1			11	Psychology, Clinical	Psychology	FG6MZ	WOS:000410496200006					2021-06-18	
J	Tan, SKR; Kolmodin, L; Sekhon, MS; Qiao, L; Zou, J; Henderson, WR; Griesdale, DEG				Tan, Sean K. R.; Kolmodin, Leif; Sekhon, Mypinder S.; Qiao, Lu; Zou, Jie; Henderson, William R.; Griesdale, Donald E. G.			The effect of continuous hypertonic saline infusion and hypernatremia on mortality in patients with severe traumatic brain injury: a retrospective cohort study	CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE			English	Article							INCREASED INTRACRANIAL-PRESSURE; CEREBRAL PERFUSION-PRESSURE; INTENSIVE-CARE-UNIT; HYPEROSMOLAR THERAPY; CRITICALLY-ILL; HEAD-INJURY; EPIDEMIOLOGY; HYPERTENSION; MANNITOL; EDEMA	Hypertonic saline (HTS) is used to control intracranial pressure (ICP) in patients with traumatic brain injury (TBI); however, in prior studies, the resultant hypernatremia has been associated with increased mortality. We aimed to study the effect of HTS on ICP and mortality in patients with severe TBI. We performed a retrospective cohort study of 231 patients with severe TBI (Glasgow Coma Scale [GCS] a parts per thousand currency sign 8) admitted to two neurotrauma units from 2006-2012. We recorded daily HTS, ICP, and serum sodium (Na) concentration. We used Cox proportional regression modelling for hospital mortality and incorporated the following time-dependent variables: use of HTS, hypernatremia, and desmopressin administration. The mean [standard deviation (SD)] age of patients was 34 (17) and the median (interquartile range [IQR]) GCS was 6 [3-8]. Hypertonic saline was administered as a continuous infusion in 124 of 231 (54%) patients over 788 of 2,968 (27%) patient-days. Hypernatremia (Na > 145 mmol center dot L-1) developed in 151 of 231 (65%) patients over 717 of 2,968 (24%) patients-days. In patients who developed hypernatremia, the median [IQR] Na was 146 [142-147] mmol center dot L-1. Overall hospital mortality was 26% (59 of 231 patients). After adjusting for baseline covariates, neither HTS (hazard ratio [HR], 1.07; 95% confidence interval [CI], 0.56 to 2.05; P = 0.84) nor hypernatremia (HR, 1.31; 95% CI, 0.68 to 2.55; P = 0.42) was associated with hospital mortality. There was no effect modification by either HTS or hypernatremia on each another. Patients who received HTS observed a significant decrease in ICP during their ICU stay compared with those who did not receive HTS (4 mmHg; 95% CI, 2 to 6; P < 0.001 vs 2 mmHg; 95% CI, -1 to 5; P = 0.14). Hypertonic saline and hypernatremia are not associated with hospital mortality in patients with severe TBI.	[Tan, Sean K. R.; Kolmodin, Leif; Qiao, Lu; Zou, Jie] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Sekhon, Mypinder S.; Henderson, William R.; Griesdale, Donald E. G.] Univ British Columbia, Dept Med, Div Crit Care Med, Vancouver, BC, Canada; [Griesdale, Donald E. G.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Griesdale, Donald E. G.] Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada; [Griesdale, Donald E. G.] Vancouver Gen Hosp, Crit Care Med, Room 2438,Jim Pattison Pavil,2nd Floor, Vancouver, BC V5Z 1M9, Canada	Griesdale, DEG (corresponding author), Vancouver Gen Hosp, Crit Care Med, Room 2438,Jim Pattison Pavil,2nd Floor, Vancouver, BC V5Z 1M9, Canada.	donald.griesdale@vch.ca		Griesdale, Donald/0000-0001-5985-8624	VGH & UBC Hospital Foundation Best of Health Fund	Dr. Griesdale is funded by the VGH & UBC Hospital Foundation Best of Health Fund.	Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Aiyagari V, 2006, J CRIT CARE, V21, P163, DOI 10.1016/j.jcrc.2005.10.002; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Diringer MN, 2013, CURR OPIN CRIT CARE, V19, P77, DOI 10.1097/MCC.0b013e32835eba30; Ertmer C, 2009, CRIT CARE MED, V37, P2490, DOI 10.1097/CCM.0b013e3181aee67e; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Griesdale DEG, 2013, CRIT CARE, V17, DOI 10.1186/cc11888; Hadjizacharia P, 2008, J AM COLL SURGEONS, V207, P477, DOI 10.1016/j.jamcollsurg.2008.04.017; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kahle KT, 2013, J CLIN NEUROSCI, V20, P30, DOI 10.1016/j.jocn.2012.10.004; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kolmodin L, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-35; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; Li M, 2013, INJURY, V44, P1213, DOI 10.1016/j.injury.2012.05.021; Lindner G, 2007, AM J KIDNEY DIS, V50, P952, DOI 10.1053/j.ajkd.2007.08.016; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; MARMAROU A, 1992, J NEUROTRAUM, V9, pS327; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Muizelaar JP, 2009, CRIT CARE MED, V37, P1521, DOI 10.1097/CCM.0b013e31819d3ea0; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Rockswold GL, 2009, NEUROSURGERY, V65, P1035, DOI 10.1227/01.NEU.0000359533.16214.04; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Roquilly A, 2011, CRIT CARE, V15, DOI 10.1186/cc10522; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Shehata M, 2010, CRIT CARE S1, V14, pP355; Stelfox HT, 2008, CRIT CARE, V12, DOI 10.1186/cc7162; Torre-Healy A, 2012, NEUROCRIT CARE, V17, P117, DOI 10.1007/s12028-011-9649-x; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vandenbroucke JP, 2007, PLOS MED, V4, P1628, DOI 10.1371/journal.pmed.0040297; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zygun DA, 2009, CRIT CARE, V13, DOI 10.1186/cc8014	42	12	15	1	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0832-610X	1496-8975		CAN J ANESTH	Can. J. Anesth.	JUN	2016	63	6					664	673		10.1007/s12630-016-0633-y			10	Anesthesiology	Anesthesiology	DL6DC	WOS:000375727500004	27030131	Bronze			2021-06-18	
J	Varner, EL; Jaquins-Gerstl, A; Michael, AC				Varner, Erika L.; Jaquins-Gerstl, Andrea; Michael, Adrian C.			Enhanced Intracranial Microdialysis by Reduction of Traumatic Penetration Injury at the Probe Track	ACS CHEMICAL NEUROSCIENCE			English	Article						Microdialysis; dexamethasone; dopamine; voltammetry; penetration injury; retrodialysis	STRIATAL DOPAMINE RELEASE; NUCLEUS-ACCUMBENS SHELL; IN-VIVO; EXTRACELLULAR DOPAMINE; RAT; DEXAMETHASONE; IMPLANTATION; CORTICOSTERONE; TRANSMISSION; VOLTAMMETRY	Microdialysis provides deep insight into chemical neuroscience by enabling in vivo intracranial chemical monitoring. Nevertheless, implanting a microdialysis probe causes a traumatic penetration injury (TPI) of brain tissue at the probe track. The TPI, which is clearly documented by voltammetry and histochemical imaging, is a drawback because it perturbs the exact tissue from which the brain dialysate samples are derived. Our goal is to reduce, if not eventually eliminate, the TPI and its detrimental effects on neurochemical monitoring. Here, we demonstrate that combining a 5-day wait period after probe implantation with the continuous retrodialysis of a low-micromolar concentration of dexamethasone vastly reduces the TPI. Our approach to reducing the TPI reinstates normal evoked dopamine release activity in the tissue adjacent to the microdialysis probe, brings evoked dopamine release at the probe outlet into quantitative agreement with evoked dopamine release next to the probe, reinstates normal immunoreactivity for tyrosine hydroxylase and the dopamine transporter near the probe track, and greatly suppresses glial activation and scaring near the probe track. This reduction of the TPI and reinstatement of normal evoked dopamine release activity adjacent to the probe track appears to be due to dexamethasone's anti-inflammatory actions.	[Varner, Erika L.; Jaquins-Gerstl, Andrea; Michael, Adrian C.] Univ Pittsburgh, Dept Chem, 219 Parkman Ave, Pittsburgh, PA 15260 USA	Michael, AC (corresponding author), Univ Pittsburgh, Dept Chem, 219 Parkman Ave, Pittsburgh, PA 15260 USA.	amichael@pitt.edu		/0000-0002-0101-0249	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 081744]; NSF Graduate Research Fellowship ProgramNational Science Foundation (NSF) [1247842]	This work was funded by the NIH (NS 081744) and by the NSF Graduate Research Fellowship Program (to E.L.V.; 1247842).	Bassareo V, 2015, BEHAV BRAIN RES, V287, P200, DOI 10.1016/j.bbr.2015.03.056; BENVENISTE H, 1987, ACTA NEUROPATHOL, V74, P234, DOI 10.1007/BF00688186; Borland LM, 2005, J NEUROSCI METH, V146, P149, DOI 10.1016/j.jneumeth.2005.02.002; Bungay PM, 2003, J NEUROCHEM, V86, P932, DOI 10.1046/j.1471-4159.2003.01904.x; Clapp-Lilly KL, 1999, J NEUROSCI METH, V90, P129, DOI 10.1016/S0165-0270(99)00064-3; Davies MI, 2000, ADV DRUG DELIVER REV, V45, P169, DOI 10.1016/S0169-409X(00)00114-9; Dietrich Jorg, 2011, Expert Rev Clin Pharmacol, V4, P233, DOI 10.1586/ecp.11.1; Ferrari CC, 2004, AM J PATHOL, V165, P1827, DOI 10.1016/S0002-9440(10)63438-4; Feuerstein D, 2010, J CEREBR BLOOD F MET, V30, P1343, DOI 10.1038/jcbfm.2010.17; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Gasser PJ, 2006, J NEUROSCI, V26, P8758, DOI 10.1523/JNEUROSCI.0570-06.2006; GRAEBER MB, 1989, J NEUROSCI RES, V22, P103, DOI 10.1002/jnr.490220114; Groothuis J, 2014, BRAIN STIMUL, V7, P1, DOI 10.1016/j.brs.2013.07.001; Gu H, 2015, ANAL CHEM, V87, P6088, DOI 10.1021/acs.analchem.5b00633; Hascup ER, 2009, BRAIN RES, V1291, P12, DOI 10.1016/j.brainres.2009.06.084; Holson RR, 1996, BRAIN RES, V739, P301, DOI 10.1016/S0006-8993(96)00837-2; Holson RR, 1998, BRAIN RES, V808, P182, DOI 10.1016/S0006-8993(98)00816-6; Huston J. P., 1991, TECHNIQUES BEHAV NEU, V7; Iasevoli F., 2014, CURR MOL PHARM, V6, P149; Jaquins-Gerstl A, 2011, ANAL CHEM, V83, P7662, DOI 10.1021/ac200782h; Lammers CH, 1999, MOL BRAIN RES, V69, P281, DOI 10.1016/S0169-328X(99)00105-9; Lecca D, 2006, PSYCHOPHARMACOLOGY, V184, P435, DOI 10.1007/s00213-005-0280-4; Lecca D, 2007, PSYCHOPHARMACOLOGY, V191, P653, DOI 10.1007/s00213-006-0496-y; Lindley SE, 2002, BRAIN RES, V958, P414, DOI 10.1016/S0006-8993(02)03719-8; Lindley SE, 1999, NEUROPSYCHOPHARMACOL, V21, P399, DOI 10.1016/S0893-133X(98)00103-1; Lu Y, 1998, J NEUROCHEM, V70, P584; Nesbitt KM, 2015, ACS CHEM NEUROSCI, V6, P163, DOI 10.1021/cn500257x; Nesbitt KM, 2013, ANAL CHEM, V85, P8173, DOI 10.1021/ac401201x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peters JL, 1998, J NEUROCHEM, V70, P594; Qian JH, 1999, ANAL CHEM, V71, P4486, DOI 10.1021/ac990338f; ROBINSON TE, 1991, J NEUROSCI METH, V40, P211, DOI 10.1016/0165-0270(91)90070-G; SHARP T, 1986, PHARMACOL BIOCHEM BE, V24, P1755, DOI 10.1016/0091-3057(86)90516-2; Vander Weele CM, 2014, EUR J NEUROSCI, V40, P3041, DOI 10.1111/ejn.12709; Walters SH, 2015, ACS CHEM NEUROSCI, V6, P1468, DOI 10.1021/acschemneuro.5b00128; Wang YX, 2012, J NEUROSCI METH, V208, P34, DOI 10.1016/j.jneumeth.2012.04.009; Watson CJ, 2006, ANAL CHEM, V78, P1391, DOI 10.1021/ac0693722; Westerink  B. H, 2007, HDB MICRODILAYSIS ME; Yang H, 2000, ANAL CHEM, V72, P2042, DOI 10.1021/ac991186r; Yang H, 1998, J NEUROCHEM, V71, P684; Yang HY, 2013, ACS CHEM NEUROSCI, V4, P790, DOI 10.1021/cn400072f; Yang H, 2007, FRONT NEUROENG, V1, P489; Zhong YH, 2007, BRAIN RES, V1148, P15, DOI 10.1016/j.brainres.2007.02.024; Zhou F, 2001, AM J PATHOL, V158, P2145, DOI 10.1016/S0002-9440(10)64686-X	44	12	13	0	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	JUN	2016	7	6					728	736		10.1021/acschemneuro.5b00331			9	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	DP0QY	WOS:000378195500006	27003503	Green Accepted			2021-06-18	
J	Wright, MJ; Woo, E; Birath, JB; Siders, CA; Kelly, DF; Wang, C; Swerdloff, R; Romero, E; Kernan, C; Cantu, RC; Guskiewicz, K				Wright, Mathew J.; Woo, Ellen; Birath, J. Brandon; Siders, Craig A.; Kelly, Daniel F.; Wang, Christina; Swerdloff, Ronald; Romero, Elizabeth; Kernan, Claudia; Cantu, Robert C.; Guskiewicz, Kevin			An index predictive of cognitive outcome in retired professional American Football players with a history of sports concussion	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Cognitive reserve; Cerebral concussion; Sports; Cognition	TRAUMATIC BRAIN-INJURY; RECURRENT CONCUSSION; METABOLIC SYNDROME; NCAA CONCUSSION; LEAGUE PLAYERS; BODY-MASS; DEPRESSION; VALIDITY; RESERVE; IMPACT	Objective: Various concussion characteristics and personal factors are associated with cognitive recovery in athletes. We developed an index based on concussion frequency, severity, and timeframe, as well as cognitive reserve (CR), and we assessed its predictive power regarding cognitive ability in retired professional football players. Method: Data from 40 retired professional American football players were used in the current study. On average, participants had been retired from football for 20 years. Current neuropsychological performances, indicators of CR, concussion history, and play data were used to create an index for predicting cognitive outcome. Results: The sample displayed a range of concussions, concussion severities, seasons played, CR, and cognitive ability. Many of the participants demonstrated cognitive deficits. The index strongly predicted global cognitive ability (R-2 = .31). The index also predicted the number of areas of neuropsychological deficit, which varied as a function of the deficit classification system used (Heaton: R-2 = .15; Wechsler: R-2 = .28). Conclusions: The current study demonstrated that a unique combination of CR, sports concussion, and game-related data can predict cognitive outcomes in participants who had been retired from professional American football for an average of 20 years. Such indices may prove to be useful for clinical decision making and research.	[Wright, Mathew J.; Birath, J. Brandon; Siders, Craig A.; Wang, Christina; Swerdloff, Ronald; Romero, Elizabeth] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Wright, Mathew J.; Kernan, Claudia] Univ Calif Los Angeles, Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA; [Wright, Mathew J.; Birath, J. Brandon; Siders, Craig A.] Harbor UCLA Med Ctr, Dept Psychiat, Div Psychol, Torrance, CA 90509 USA; [Woo, Ellen] Univ Calif Los Angeles, Sch Med, Dept Neurol, Easton Ctr Alzheimers Dis Res, Los Angeles, CA USA; [Kelly, Daniel F.] St Johns Hlth Ctr, Brain Tumor Ctr, Santa Monica, CA USA; [Kelly, Daniel F.] St Johns Hlth Ctr, John Wayne Canc Inst, Pituitary Disorders Program, Santa Monica, CA USA; [Wang, Christina; Swerdloff, Ronald] Harbor UCLA Med Ctr, Dept Med, Div Endocrinol, Torrance, CA 90509 USA; [Cantu, Robert C.] Boston Univ, Sch Med, Boston, MA 02215 USA; [Guskiewicz, Kevin] Univ N Carolina, Ctr Study Retired Athletes, Chapel Hill, NC USA	Wright, MJ (corresponding author), Harbor UCLA Med Ctr, 1124 W Carson St B-4 South,Box 490, Torrance, CA 90502 USA.	mwright@labiomed.org			National Operating Committee on Standards for Athletic Equipment; National Center for Research Resources, USAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR 19975]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR019975] Funding Source: NIH RePORTER	This research was supported by National Operating Committee on Standards for Athletic Equipment and the National Center for Research Resources, USA [grant number M01 RR 19975].	Army Individual Test Battery, 1944, MAN DIR SCOR; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Backhaus SL, 2004, CLIN NEUROPSYCHOL, V18, P591, DOI 10.1080/13854040490888558; Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; Bigler Erin D, 2015, Handb Clin Neurol, V128, P691, DOI 10.1016/B978-0-444-63521-1.00043-1; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Brooks BL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P893, DOI 10.1007/978-0-387-76978-3_31; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Collie A., 2006, SPORTS NEUROPSYCHOLO, P240; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; CORWIN J, 1993, CLIN NEUROPSYCHOL, V7, P3, DOI 10.1080/13854049308401883; DALY J J, 1958, Calif Med, V88, P441; De Beaumont L., 2013, BMC NEUROLOGY, V13; De Beaumont L, 2013, J CLIN EXP NEUROPSYC, V35, P596, DOI 10.1080/13803395.2013.800023; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delis DC, 2000, CALIFORNIA VERBAL LE; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Gilchrist J, 2011, JAMA-J AM MED ASSOC, V306, P2318; Giza CC, 2001, J ATHL TRAINING, V36, P228; GROBER E, 1991, J CLIN EXP NEUROPSYC, V13, P933, DOI 10.1080/01688639108405109; GRONWALL D, 1975, LANCET, V2, P995; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Horn S, 2009, AM J PHYS MED REHAB, V88, P192, DOI 10.1097/PHM.0b013e318198b622; HUGENHOLTZ H, 1982, CAN MED ASSOC J, V127, P827; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P923, DOI 10.1007/978-0-387-76978-3_32; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Levi Y, 2013, J INT NEUROPSYCH SOC, V19, P664, DOI 10.1017/S1355617713000192; LYNCH S, 1973, AM J PSYCHOL, V86, P643, DOI 10.2307/1421950; Macciocchi S, 2006, SPORTS NEUROPSYCHOLO, P71; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Miller MA, 2008, AM J CARDIOL, V101, P1281, DOI 10.1016/j.amjcard.2007.12.029; Mitrushina M., 2005, HDB NORMATIVE DATA N; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Satz P, 2011, J CLIN EXP NEUROPSYC, V33, P121, DOI 10.1080/13803395.2010.493151; Scott JG, 1997, CLIN NEUROPSYCHOL, V11, P146, DOI 10.1080/13854049708407043; Smith A., 1991, SYMBOL DIGIT MODALIT; Spreen O., 1977, NEUROSENSORY CTR COM; Stern Y, 2000, NEUROLOGY, V55, P1291, DOI 10.1212/WNL.55.9.1291; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Willeumier K, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.67; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zillmer E. A., 2001, PRINCIPLES NEUROPSYC	54	12	12	0	45	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAY 27	2016	38	5					561	571		10.1080/13803395.2016.1139057			11	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	DG4HN	WOS:000372033100007	26898803				2021-06-18	
J	Charry, JD; Rubiano, AM; Puyana, JC; Carney, N; Adelson, PD				Charry, Jose D.; Rubiano, Andres M.; Puyana, Juan C.; Carney, Nancy; Adelson, P. David			Damage control of civilian penetrating brain injuries in environments of low neuro-monitoring resources	BRITISH JOURNAL OF NEUROSURGERY			English	Article						cranial decompression; damage control; gunshot injuries; neurotrauma	GUNSHOT WOUNDS; HEAD-INJURY; TRAUMA CARE; EXPERIENCE; PROTOCOL; CHILDREN	Introduction. Gunshot wounds to the head are more common in military settings. Recently, a damage control (DC) approach for the management of these lesions has been used in combat areas. The aim of this study was to evaluate the results of civilian patients with penetrating gunshot wounds to the head, managed with a strategy of early cranial decompression (ECD) as a DC procedure in a university hospital with few resources for intensive care unit (ICU) neuro-monitoring in Colombia.Materials and methods. Fifty-four patients were operated according to the DC strategy (<12 h after injury), over a 4-year period. Variables were analysed and results were evaluated according to the Glasgow Outcome Scale (GOS) at 12 months post injury; a dichotomous variable was established as favourable' (GOS 4-5) or unfavourable' (GOS 1-3). A univariate analysis was performed using a (2) test.Results. Forty (74.1%) of the patients survived and 36 (90%) of them had favourable GOS. Factors associated with adverse outcomes were: Injury Severity Score (ISS) greater than 25, bi-hemispheric involvement, intra-cerebral haematoma on the first CT, closed basal cisterns and non-reactive pupils in the emergency room.Conclusion. DC for neurotrauma with ECD is an option to improve survival and favourable neurological outcomes 12 months after injury in patients with penetrating traumatic brain injury treated in a university hospital with few resources for ICU neuro-monitoring.	[Charry, Jose D.; Rubiano, Andres M.] Univ Surcolombiana, Univ Hosp, Fac Salud, Neiva, Colombia; [Rubiano, Andres M.] Fdn MEDITECH, Calle 5 11-19, Neiva, Colombia; [Puyana, Juan C.] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA USA; [Carney, Nancy] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR USA; [Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA	Rubiano, AM (corresponding author), Fdn MEDITECH, Calle 5 11-19, Neiva, Colombia.	rubianoam@gmail.com	RUBIANO, ANDRES M/K-6704-2012; Adelson, David/W-2083-2019	RUBIANO, ANDRES M/0000-0001-8931-3254; Charry, Jose D./0000-0002-8789-7281	NIH-FIC Grant [R21TW009332]; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R21TW009332] Funding Source: NIH RePORTER	Authors are supported by the NIH-FIC Grant # R21TW009332.	Aarabi B, 2003, NEUROSURG QUART, V13, P87, DOI 10.1097/00013414-200306000-00004; Abdolvahabi RM, 2001, NEUROL RES, V23, P210, DOI 10.1179/016164101101198361; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Byass P, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001477; Coughlan MD, 2003, CHILD NERV SYST, V19, P348, DOI 10.1007/s00381-003-0736-y; De la Hoz GA, 2013, FORENSIS, V1, P79; Gouello G, 2014, SCI WORLD J, DOI 10.1155/2014/207585; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; GURDJIAN ES, 1974, J NEUROSURG, V40, P157, DOI 10.3171/jns.1974.40.2.0157; Horton R, 2012, LANCET, V380, P2053, DOI 10.1016/S0140-6736(12)62133-3; Karabagli H, 2005, PEDIATR NEUROSURG, V41, P148, DOI 10.1159/000085873; Kesinger MR, 2014, INJURY, V45, P1350, DOI 10.1016/j.injury.2014.04.037; Kesinger MR, 2014, WORLD J SURG, V38, P1869, DOI 10.1007/s00268-014-2534-y; Levy M L, 2000, Neurosurg Focus, V8, pe2, DOI 10.3171/foc.2000.8.1.153; Mackerle Z, 2009, CHILD NERV SYST, V25, P909, DOI 10.1007/s00381-009-0901-z; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Rubiano AM, 2007, NEUROTRAUMA NEUROINT, P231; Rubiano AM, 2009, ULUS TRAVMA ACIL CER, V15, P28; Smith JE, 2014, INJURY, V45, P874, DOI 10.1016/j.injury.2013.12.004; STONE JL, 1995, NEUROSURGERY, V37, P1104, DOI 10.1227/00006123-199512000-00010; Zafonte RD, 2001, ARCH PHYS MED REHAB, V82, P306, DOI 10.1053/apmr.2001.18226	21	12	12	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	MAY 3	2016	30	2					235	239		10.3109/02688697.2015.1096905			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DI3LK	WOS:000373399900014	26469861				2021-06-18	
J	Alway, Y; Gould, KR; McKay, A; Johnston, L; Ponsford, J				Alway, Yvette; Gould, Kate Rachel; McKay, Adam; Johnston, Lisa; Ponsford, Jennie			The Evolution of Post-Traumatic Stress Disorder following Moderate-to-Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						anxiety disorder; post-traumatic stress disorder; psychiatric disorder; traumatic brain injury	PSYCHIATRIC-DISORDERS; HEAD-INJURY; SELF-REPORT; AXIS I; PTSD; DEPRESSION; SYMPTOMS; COMORBIDITY; POPULATION; PREVALENCE	Increasing evidence indicates that post-traumatic stress disorder (PTSD) may develop following traumatic brain injury (TBI), despite most patients having no conscious memory of their accident. This prospective study examined the frequency, timing of onset, symptom profile, and trajectory of PTSD and its psychiatric comorbidities during the first 4 years following moderate-to-severe TBI. Participants were 85 individuals (78.8% male) with moderate or severe TBI recruited following admission to acute rehabilitation between 2005 and 2010. Using the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Disorders (SCID-I), participants were evaluated for pre- and post-injury PTSD soon after injury and reassessed at 6 months, 12 months, 2 years, 3 years, and 4 years postinjury. Over the first 4 years post-injury, 17.6% developed injury-related PTSD, none of whom had PTSD prior to injury. PTSD onset peaked between 6 and 12 months post-injury. The majority of PTSD cases (66.7%) had a delayed-onset, which for a third was preceded by subsyndromal symptoms in the first 6 months post-injury. PTSD frequency increased over the first year post-injury, remained stable during the second year, and gradually declined thereafter. The majority of subjects with PTSD experienced a chronic symptom course and all developed one or more than one comorbid psychiatric disorder, with mood, other anxiety, and substance-use disorders being the most common. Despite event-related amnesia, post-traumatic stress symptoms, including vivid re-experiencing phenomena, may develop following moderate-to-severe TBI. Onset is typically delayed and symptoms may persist for several years post-injury.	[Alway, Yvette; Gould, Kate Rachel; McKay, Adam; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia; [Alway, Yvette; Gould, Kate Rachel; McKay, Adam; Johnston, Lisa; Ponsford, Jennie] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Gould, Kate Rachel; Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia	Alway, Y (corresponding author), Monash Univ, Sch Psychol Sci, Clayton Campus, Clayton, Vic 3800, Australia.	yvette.alway@monash.edu	Gould, Kate/AAA-5511-2020; McKay, Adam/M-6003-2017	Gould, Kate/0000-0002-3564-7408; McKay, Adam/0000-0002-0479-7681			Alway Y., 2015, ANXIETY; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andrews B, 2007, AM J PSYCHIAT, V164, P1319, DOI 10.1176/appi.ajp.2007.06091491; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Barker-Collo S, 2013, BRAIN IMPAIR, V14, P425, DOI 10.1017/BrImp.2013.27; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Brady KT, 2000, J CLIN PSYCHIAT, V61, P22; Breslau N, 2000, BIOL PSYCHIAT, V48, P902, DOI 10.1016/S0006-3223(00)00933-1; Breslau N, 2008, ARCH GEN PSYCHIAT, V65, P431, DOI 10.1001/archpsyc.65.4.431; Brewin CR, 2001, BEHAV RES THER, V39, P373, DOI 10.1016/S0005-7967(00)00087-5; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 2002, AUST NZ J PSYCHIAT, V36, P205, DOI 10.1046/j.1440-1614.2002.01009.x; Bryant RA, 1996, J TRAUMA STRESS, V9, P621; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2013, JAMA PSYCHIAT, V70, P839, DOI 10.1001/jamapsychiatry.2013.1137; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carty J, 2006, J AFFECT DISORDERS, V90, P257, DOI 10.1016/j.jad.2005.11.011; Chalton LD, 2009, BRAIN INJURY, V23, P77, DOI 10.1080/02699050802635273; Chapman C, 2012, PSYCHOL MED, V42, P1695, DOI 10.1017/S0033291711002856; Creamer M, 2001, PSYCHOL MED, V31, P1237, DOI 10.1017/S0033291701004287; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Edmondson D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066435; First MB., 2002, STRUCTURED CLIN INTE; Forbes D, 2010, J AFFECT DISORDERS, V127, P147, DOI 10.1016/j.jad.2010.05.005; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069; Heron-Delaney M, 2013, INJURY, V44, P1413, DOI 10.1016/j.injury.2013.07.011; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hickling EJ, 1998, BRAIN INJURY, V12, P265, DOI 10.1080/026990598122566; Jacobsen LK, 2001, AM J PSYCHIAT, V158, P1184, DOI 10.1176/appi.ajp.158.8.1184; Johnson SD, 2002, COMMUNITY MENT HLT J, V38, P181, DOI 10.1023/A:1015269521969; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; King NS, 1997, J NEUROL NEUROSUR PS, V62, P82, DOI 10.1136/jnnp.62.1.82; Koponen S, 2011, BRAIN INJURY, V25, P1029, DOI 10.3109/02699052.2011.607783; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Mayou R, 1997, PSYCHOSOM MED, V59, P578, DOI 10.1097/00006842-199711000-00004; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McMillan TM, 2003, NEUROPSYCHOL REHABIL, V13, P149, DOI 10.1080/09602010244000453; MCMILLAN TM, 1991, BRIT J PSYCHIAT, V159, P431, DOI 10.1192/bjp.159.3.431; Mylle J, 2004, J AFFECT DISORDERS, V78, P37, DOI 10.1016/S0165-0327(02)00218-5; O'Donnell ML, 2013, PSYCHOSOM MED, V75, P68, DOI 10.1097/PSM.0b013e3182761e8b; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P1390, DOI 10.1176/appi.ajp.161.8.1390; O'Donnell ML, 2003, CLIN PSYCHOL REV, V23, P587, DOI 10.1016/S0272-7358(03)00036-9; Pietrzak RH, 2011, J ANXIETY DISORD, V25, P456, DOI 10.1016/j.janxdis.2010.11.010; Ponsford J., 2013, TRAUMATIC BRAIN INJU; Reid LM, 2011, J NEUROPSYCH CLIN N, V23, P454, DOI 10.1176/jnp.23.4.jnp454; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Smid GE, 2009, J CLIN PSYCHIAT, V70, P1572, DOI 10.4088/JCP.08r04484; Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090; Sumpter RE, 2005, BRIT J PSYCHIAT, V186, P423, DOI 10.1192/bjp.186.5.423; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Turnbull SJ, 2001, BRAIN INJURY, V15, P775, DOI 10.1080/02699050110034334; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Williams WH, 2002, BRAIN INJURY, V16, P673, DOI 10.1080/02699050210128861	59	12	12	0	18	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 1	2016	33	9					825	831		10.1089/neu.2015.3992			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DK7SA	WOS:000375124800004	26176500				2021-06-18	
J	Burkovskiy, I; Zhou, J; Lehmann, C				Burkovskiy, Ian; Zhou, Juan; Lehmann, Christian			Experimental Cannabinoid 2 Receptor Inhibition in CNS Injury-Induced Immunodeficiency Syndrome	MICROCIRCULATION			English	Article						stroke; immunodeficiency; cannabinoids; microcirculation	ISCHEMIC BRAIN-DAMAGE; SPINAL-CORD-INJURY; ENDOCANNABINOID SYSTEM; CB2 RECEPTORS; STROKE; INFLAMMATION; ACTIVATION; EXPRESSION; MIGRATION; BIOLOGY	ObjectiveSevere CNS injury, such as stroke, traumatic brain injury, or spinal cord injury, is known to increase susceptibility to infections. The increased susceptibility to infection is due to an impaired immune response and is referred to as CIDS. The CB2 receptor on immune cells presents a potential therapeutic target in CIDS as activation of this receptor has been shown to be involved in immunosuppression. The main purpose of this study was to determine the impact of CB2 receptor inhibition on leukocyte activation within the microcirculation following endotoxin challenge in an experimental stroke model. MethodsFive experimental groups (male C57BL/6 mice, age: 6-8 weeks) were subjected to the following treatments: control; endotoxemia (LPS 5 mg/kg, i.v.); transient cerebral hypoxia-ischemia (HI) + endotoxemia; HI + endotoxemia + CB2 receptor antagonist (AM630 2.5 mg/kg, i.v.). HI was induced by unilateral carotid artery occlusion, followed by 50 minute exposure to a low oxygen atmosphere (8% O-2). The CB2 receptor antagonist was given 15 min prior to LPS administration. Intravital microscopy (IVM) was carried out 2h after LPS administration. Brains were extracted and stained with tetrazolium chloride (TTC) to measure infarct volume. ResultsCompared to endotoxemic animals without CNS injury, mice subjected to HI displayed reduced leukocyte activation in intestinal submucosal venules indicative of CIDS. Administration of the CB2 receptor antagonist in animals with CIDS challenged with endotoxin restored peripheral leukocyte recruitment without a detrimental impact on infarct size. ConclusionWe conclude that the ECS is involved in the impaired immune response following CNS injury. Future studies should further explore the CB2 receptor pathway to develop novel therapies for CIDS.	[Burkovskiy, Ian; Lehmann, Christian] Dalhousie Univ, Dept Anaesthesia, Halifax, NS B3H 2Y, Canada; [Burkovskiy, Ian; Zhou, Juan; Lehmann, Christian] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 2Y, Canada; [Zhou, Juan; Lehmann, Christian] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 2Y, Canada	Lehmann, C (corresponding author), Dalhousie Univ, Dept Anaesthesia, Halifax, NS B3H 2Y, Canada.	chlehmann@dal.ca	Lehmann, Christian/G-4837-2013	Lehmann, Christian/0000-0001-6419-9168; Zhou, juan/0000-0002-3040-0238			Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Arevalo-Martin A, 2008, BRIT J PHARMACOL, V153, P216, DOI 10.1038/sj.bjp.0707466; Basu S, 2011, IMMUNOL RES, V51, P26, DOI 10.1007/s12026-011-8210-5; Binion DG, 1997, GASTROENTEROLOGY, V112, P1895, DOI 10.1053/gast.1997.v112.pm9178682; Cabral GA, 2008, BRIT J PHARMACOL, V153, P240, DOI 10.1038/sj.bjp.0707584; Cinel I, 2009, CRIT CARE MED, V37, P291, DOI 10.1097/CCM.0b013e31819267fb; CRUSE JM, 1992, IMMUNOL RES, V11, P104, DOI 10.1007/BF02918615; De Backer D, 2002, AM J RESP CRIT CARE, V166, P98, DOI 10.1164/rccm.200109-016OC; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; Fernandez-Lopez D, 2007, PEDIATR RES, V62, P255, DOI 10.1203/PDR.0b013e318123fbb8; Fukumura D, 1996, DIGEST DIS SCI, V41, P2482, DOI 10.1007/BF02100147; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Garcia-Ovejero D, 2009, NEUROBIOL DIS, V33, P57, DOI 10.1016/j.nbd.2008.09.015; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; GRANGER DN, 1994, J LEUKOCYTE BIOL, V55, P662; Granger ND, 2010, INFLAMMATION MICROCI; Haraldsen G, 1996, J IMMUNOL, V156, P2558; Hillard CJ, 2008, CURR PHARM DESIGN, V14, P2347, DOI 10.2174/138161208785740054; Hug A, 2009, STROKE, V40, P3226, DOI 10.1161/STROKEAHA.109.557967; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Langhorne P, 2000, STROKE, V31, P1223, DOI 10.1161/01.STR.31.6.1223; Orgado JM, 2009, INT REV PSYCHIATR, V21, P172, DOI 10.1080/09540260902782828; Matsuda Naoyuki, 2007, Journal of Smooth Muscle Research, V43, P117, DOI 10.1540/jsmr.43.117; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Miller AM, 2008, BRIT J PHARMACOL, V153, P299, DOI 10.1038/sj.bjp.0707523; MILLER C H, 1991, Neurological Research, V13, P117; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Pandey R, 2009, PHARMACOL RES, V60, P85, DOI 10.1016/j.phrs.2009.03.019; Rahman SH, 2003, J GASTROINTEST SURG, V7, P26, DOI 10.1016/S1091-255X(02)00090-2; Rasband W. S, 2012, IMAGEJ; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Romero-Sandoval EA, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-25; Ross RA, 1999, BRIT J PHARMACOL, V126, P665, DOI 10.1038/sj.bjp.0702351; Salgado DR, 2010, CAN J ANESTH, V57, P940, DOI 10.1007/s12630-010-9365-6; Vannucci RC, 2005, DEV NEUROSCI-BASEL, V27, P81, DOI 10.1159/000085978; Varga K, 1998, FASEB J, V12, P1035; Vogelgesang A, 2014, ACTA NEUROL SCAND, V129, P1, DOI 10.1111/ane.12165; Vogelgesang A, 2011, J NEUROIMMUNOL, V231, P105, DOI 10.1016/j.jneuroim.2010.09.023; Wolach B, 2001, J NEUROSURG, V94, P706, DOI 10.3171/jns.2001.94.5.0706; Yu SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132487; Zhao Y, 2010, J CARDIOVASC PHARM, V55, P292, DOI 10.1097/FJC.0b013e3181d2644d	41	12	12	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1073-9688	1549-8719		MICROCIRCULATION	Microcirculation	MAY	2016	23	4					283	292		10.1111/micc.12276			10	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	DM8KS	WOS:000376612100002	26999797				2021-06-18	
J	Kuenemund, A; Zwick, S; Rief, W; Exner, C				Kuenemund, Anna; Zwick, Sarah; Rief, Winfried; Exner, Cornelia			(Re-)defining the self - Enhanced posttraumatic growth and event centrality in stroke survivors: A mixed-method approach and control comparison study	JOURNAL OF HEALTH PSYCHOLOGY			English	Article						control comparison; event centrality; mixed-method; posttraumatic growth; stroke	TRAUMATIC BRAIN-INJURY; BREAST-CANCER; PERCEIVED GROWTH; IDENTITY; OUTCOMES; SUPPORT; REHABILITATION; FOUNDATIONS; RECOVERY; DECLINE	Growing evidences highlight the co-existence of negative and positive (e.g. posttraumatic growth) identity changes following stroke. Identity changes were assessed by comparing 42 survivors 21 months after stroke and healthy controls. A total of 26 stroke survivors participated in a semi-structured interview. Stroke survivors showed significantly higher posttraumatic growth (F(1, 75) = 9.79, p = .003) and integrated the critical life event to a higher extent into their identity (event centrality) (F(1, 74) = 37.54, p < .001). Qualitative analysis revealed increased appreciation of life and more intense/selective relationships as the most common positive changes. Considering positive changes might provide additional perspectives for rehabilitation.	[Kuenemund, Anna; Zwick, Sarah; Rief, Winfried] Univ Marburg, Gutenbergstr 18, D-35037 Marburg, Germany; [Exner, Cornelia] Univ Leipzig, Leipzig, Germany	Kuenemund, A (corresponding author), Univ Marburg, Dept Clin Psychol & Psychotherapy, Gutenbergstr 18, D-35037 Marburg, Germany.	anna.kuenemund@yahoo.de		Exner, Cornelia/0000-0001-5904-6511			AFFLECK G, 1987, J CONSULT CLIN PSYCH, V55, P29, DOI 10.1037/0022-006X.55.1.29; Andrykowski M.A., 1993, PSYCHO-ONCOLOGY, V2, P261, DOI DOI 10.1002/PON.2960020406; Barger SD, 2012, J HEALTH PSYCHOL, V17, P169, DOI 10.1177/1359105311412837; Berntsen D, 2006, BEHAV RES THER, V44, P219, DOI 10.1016/j.brat.2005.01.009; Boals A, 2011, APPL COGNITIVE PSYCH, V25, P817, DOI 10.1002/acp.1753; Bocker M., 2009, 18 REH K INN REH KOM; Calhoun LG, 2004, PSYCHOL INQ, V15, P93, DOI 10.1207/s15327965pli1501_03; Ch'ng AM, 2008, J HEALTH PSYCHOL, V13, P1136, DOI 10.1177/1359105308095967; Coetzer R, 2008, NEUROPSYCHOL REHABIL, V18, P766, DOI 10.1080/09602010701860266; Cordova MJ, 2001, HEALTH PSYCHOL, V20, P176, DOI 10.1037//0278-6133.20.3.176; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Doering B, 2011, CURR OPIN PSYCHIATR, V24, P156, DOI 10.1097/YCO.0b013e328343804e; Ellis-Hill CS, 2000, CLIN REHABIL, V14, P279, DOI 10.1191/026921500671231410; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Essue BM, 2012, STROKE, V43, P3110, DOI 10.1161/STROKEAHA.112.666453; Field EL, 2008, BEHAV RES THER, V46, P62, DOI 10.1016/j.brat.2007.10.006; Fleiss JL, 1981, STAT METHODS RATES P, V2nd; Gangstad B, 2009, REHABIL PSYCHOL, V54, P69, DOI 10.1037/a0014639; Gillen G, 2005, AM J OCCUP THER, V59, P346, DOI 10.5014/ajot.59.3.346; Glaser B. G., 1967, DISCOVERY GROUNDED T; Groleau JM, 2013, PSYCHOL TRAUMA-US, V5, P477, DOI 10.1037/a0028809; Hautzinger M., 1993, ALLGEMEINE DEPRESSIO; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Heine SJ, 2006, PERS SOC PSYCHOL REV, V10, P88, DOI 10.1207/s15327957pspr1002_1; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; Janoff-Bulman R., 1992, SHATTERED ASSUMPTION; Knaevelsrud C, 2010, J HEALTH PSYCHOL, V15, P1030, DOI 10.1177/1359105309360073; Kuenemund A, 2013, NEUROPSYCHOL REHABIL, V23, P678, DOI 10.1080/09602011.2013.801779; Lelorain S, 2012, J HEALTH PSYCHOL, V17, P627, DOI 10.1177/1359105311427475; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; Maercker A, 2004, PSYCHOL INQ, V15, P41; Maercker A, 2001, DIAGNOSTICA, V47, P153, DOI 10.1026//0012-1924.47.3.153; McGrath J, 2004, CLIN REHABIL, V18, P767, DOI 10.1191/0269215504cr802oa; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Myles SM, 2004, INT J PSYCHOL PSYCHO, V4, P487; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Proulx T, 2006, PSYCHOL INQ, V17, P309, DOI 10.1080/10478400701366985; Silva J, 2011, BRAIN IMPAIR, V12, P93, DOI 10.1375/brim.12.2.93; Smith C.P., 2000, HDB RES METHODS SOCI, P313; Stewart TL, 2016, J HEALTH PSYCHOL, V21, P40, DOI 10.1177/1359105314521477; Sumalla EC, 2009, CLIN PSYCHOL REV, V29, P24, DOI 10.1016/j.cpr.2008.09.006; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tibshirani, 1994, INTRO BOOTSTRAP, DOI 10.1201/9780429246593; Tomich PL, 2005, PSYCHO-ONCOL, V14, P1018, DOI 10.1002/pon.914	45	12	12	0	22	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1359-1053	1461-7277		J HEALTH PSYCHOL	J. Health Psychol.	MAY	2016	21	5					679	689		10.1177/1359105314535457			11	Psychology, Clinical	Psychology	DM3NC	WOS:000376252100011	24913010				2021-06-18	
J	Smith, E; Comiskey, C; Carroll, A				Smith, E.; Comiskey, C.; Carroll, A.			Prevalence of and risk factors for osteoporosis in adults with acquired brain injury	IRISH JOURNAL OF MEDICAL SCIENCE			English	Article						Osteoporosis; Fracture risk; Dual energy X-ray absorptiometry; Stroke; Acquired brain injury; Traumatic brain injury	BONE-MINERAL DENSITY; VITAMIN-D STATUS; STROKE PATIENTS; REHABILITATION; IMMOBILIZATION; DIAGNOSIS; MASS; DENSITOMETRY; INDIVIDUALS; FRACTURES	Low bone mineral density (BMD) is common in older people with stroke, particularly in the paretic limb. Younger people with acquired brain injury (ABI), of all causes, are at increased risk of low BMD. To examine prevalence of low BMD, based on World Health Organisation diagnostic criteria, in patients with ABI. This is a cross-sectional study of 112 ABI patients. All completed a questionnaire, had laboratory investigations and DXA assessment of lumbar spine and one or both hips. Mean age +/- A SD of participants was 45.7 +/- A 13.7 years. Risk of vitamin D deficiency (25-OHD < 30 nmol/L) occurred in 27.7 %, 34.3 % had adequate levels (30-50 nmol/L) and 36.6 % had levels in excess of this. Based on T-scores, 41.1 % had osteopenia and 21.4 % had osteoporosis. A Z score of -1 or less but greater than -2 occurred in 25 %; a further 21.4 % had a Z score of -2 or less. Patients who could walk outdoors had significantly higher BMD at the neck of femur than those who walked indoors only and those who could not walk at all (p < 0.001). On multiple linear regression analysis, ambulatory ability and duration of disability were independent predictors of BMD at sound neck of femur and total proximal femur. Osteopenia and osteoporosis are common in young adults with ABI compared with the general population. Bone heath monitoring should form part of the long-term follow-up of this patient group.	[Smith, E.; Carroll, A.] Natl Rehabil Hosp, Dept Rehabil Med, Rochestown Ave, Dublin, Ireland; [Comiskey, C.] Trinity Coll Dublin, Sch Nursing & Midwifery, Hlth Care Stat, Gas Bldg,Dolier St, Dublin 2, Ireland	Smith, E (corresponding author), Natl Rehabil Hosp, Dept Rehabil Med, Rochestown Ave, Dublin, Ireland.	eimear.smith@nrh.ie	Comiskey, Catherine M/L-3794-2014; Carroll, Aine/ABG-2309-2020	Comiskey, Catherine M/0000-0003-3528-777X; Carroll, Aine/0000-0002-4383-8650	National Medical Rehabilitation Trust Ltd.	This study was funded by the National Medical Rehabilitation Trust Ltd. (There is no research grant number).	Agha Amar, 2005, Pituitary, V8, P245, DOI 10.1007/s11102-005-3463-4; Baim S, 2005, J CLIN DENSITOM, V8, P371, DOI 10.1385/JCD:8:4:371; Banham-Hall N, 2013, PHYSIOTHERAPY, V99, P328, DOI 10.1016/j.physio.2012.12.009; Beaupre GS, 2006, AM J PHYS MED REHAB, V85, P464, DOI 10.1097/01.phm.0000214275.69286.7a; Cashman KD, 2013, BRIT J NUTR, V109, P1248, DOI 10.1017/S0007114512003212; delPuente A, 1996, OSTEOPOROSIS INT, V6, P50, DOI 10.1007/BF01626538; Demirbag D, 2005, ANN NUCL MED, V19, P695, DOI 10.1007/BF02985119; Dennison E, 2005, CURR OPIN RHEUMATOL, V17, P456, DOI 10.1097/01.bor.0000166384.80777.0d; Iwamoto J, 1999, AM J PHYS MED REHAB, V78, P202, DOI 10.1097/00002060-199905000-00002; Jorgensen L, 2002, STROKE, V33, P542, DOI 10.1161/hs0202.102375; Jorgensen L, 2004, AM J EPIDEMIOL, V160, P549, DOI 10.1093/aje/kwh252; Jorgensen L, 2001, CALCIFIED TISSUE INT, V68, P11, DOI 10.1007/BF02684997; Jorgensen L, 2001, BONE, V28, P655, DOI 10.1016/S8756-3282(01)00434-3; Jorgensen L, 2000, OSTEOPOROSIS INT, V11, P381, DOI 10.1007/s001980070103; Jorgensen L, 2000, BONE, V27, P701, DOI 10.1016/S8756-3282(00)00374-4; Kanis JA, 2000, OSTEOPOROSIS INT, V11, P192, DOI 10.1007/s001980050281; Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5; Pack Alison M., 2003, Epilepsy Curr, V3, P91, DOI 10.1046/j.1535-7597.2003.03306.x; Pang MYC, 2005, OSTEOPOROSIS INT, V16, P1769, DOI 10.1007/s00198-005-1925-1; Pang MYC, 2005, BONE, V37, P103, DOI 10.1016/j.bone.2005.03.009; Poole KES, 2006, BMJ-BRIT MED J, V333, P1251, DOI 10.1136/bmj.39050.597350.47; Poole KES, 2006, STROKE, V37, P243, DOI 10.1161/01.STR.0000195184.24297.c1; Ramnemark A, 2000, STROKE, V31, P1572, DOI 10.1161/01.STR.31.7.1572; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sato Y, 2001, STROKE, V32, P1673, DOI 10.1161/01.STR.32.7.1673; Sato Y, 1999, AGE AGEING, V28, P265, DOI 10.1093/ageing/28.3.265; Schousboe JT, 2013, J CLIN DENSITOM, V16, P455, DOI 10.1016/j.jocd.2013.08.004; Schulz E, 2004, J CLIN ENDOCR METAB, V89, P4246, DOI 10.1210/jc.2003-030964; Suzuki T, 2005, EXP AGING RES, V31, P457, DOI 10.1080/03610730500206881; TAKAMOTO S, 1995, CALCIFIED TISSUE INT, V56, P259, DOI 10.1007/BF00318043; Watanabe Y, 2004, INT J REHABIL RES, V27, P163, DOI 10.1097/01.mrr.0000128062.38817.77; Worthen LC, 2005, J REHABIL RES DEV, V42, P761, DOI 10.1682/JRRD.2005.02.0036	32	12	14	0	2	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0021-1265	1863-4362		IRISH J MED SCI	Irish J. Med. Sci.	MAY	2016	185	2					473	481		10.1007/s11845-016-1399-5			9	Medicine, General & Internal	General & Internal Medicine	DK0AZ	WOS:000374576100026	26787314				2021-06-18	
J	Wang, F; Wang, Y; Sun, T; Yu, HL				Wang, Fei; Wang, Yong; Sun, Tao; Yu, Hua-lin			Hyperbaric oxygen therapy for the treatment of traumatic brain injury: a meta-analysis	NEUROLOGICAL SCIENCES			English	Article						Glasgow coma scale; Glasgow outcome score; Oxygen therapy; Post-concussion syndrome; Traumatic brain injury	CEREBRAL METABOLISM; INTRACRANIAL-PRESSURE; NORMOBARIC HYPEROXIA; SYMPTOMS; TRIAL	Compelling evidence suggests the advantage of hyperbaric oxygen therapy (HBOT) in traumatic brain injury. The present meta-analysis evaluated the outcomes of HBOT in patients with traumatic brain injury (TBI). Prospective studies comparing hyperbaric oxygen therapy vs. control in patients with mild (GCS 13-15) to severe (GCS 3-8) TBI were hand-searched from medical databases using the terms "hyperbaric oxygen therapy, traumatic brain injury, and post-concussion syndrome". Glasgow coma scale (GCS) was the primary outcome, while Glasgow outcome score (GOS), overall mortality, and changes in post-traumatic stress disorder (PTSD) score, constituted the secondary outcomes. The results of eight studies (average age of patients, 23-41 years) reveal a higher post-treatment GCS score in the HBOT group (pooled difference in means = 3.13, 95 % CI 2.34-3.92, P < 0.001), in addition to greater improvement in GOS and lower mortality, as compared to the control group. However, no significant change in the PTSD score was observed. Patients undergoing hyperbaric therapy achieved significant improvement in the GCS and GOS with a lower overall mortality, suggesting its utility as a standard intensive care regimen in traumatic brain injury.	[Wang, Fei; Wang, Yong; Sun, Tao; Yu, Hua-lin] Kunming Med Univ, Affiliated Hosp 1, Dept Neurosurg 2, 295 Xichang Rd, Kunming 650032, Yunnan, Peoples R China	Yu, HL (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Dept Neurosurg 2, 295 Xichang Rd, Kunming 650032, Yunnan, Peoples R China.	hualin_yu@sina.com					Bennett MH, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD004609.PUB3; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Cifu DX, 2014, J HEAD TRAUMA REHAB, V29, P11, DOI 10.1097/HTR.0b013e3182a6aaf0; Davis MC, 2014, MED GAS RES, V4, DOI 10.1186/2045-9912-4-8; Golden ZL, 2002, INT J NEUROSCI, V112, P119, DOI 10.1080/00207450212027; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hills BA, 1999, MED HYPOTHESES, V52, P259, DOI 10.1054/mehy.1997.0640; Huang L, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-21; Kumaria A, 2009, BRIT J NEUROSURG, V23, P576, DOI 10.3109/02688690903050352; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P145; Mao J-H, 2010, J CLIN NEUROL, V23, P386; Miller RS, 2015, JAMA INTERN MED, V175, P43, DOI 10.1001/jamainternmed.2014.5479; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Neubauer RA, 1998, NEUROL RES, V20, pS33; Ren H, 2001, Chin J Traumatol, V4, P239; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rockswold SB, 2001, J NEUROSURG, V94, P403, DOI 10.3171/jns.2001.94.3.0403; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Walker WC, 2014, NEUROREHAB NEURAL RE, V28, P420, DOI 10.1177/1545968313516869; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Zeyu Xie, 2007, Neural Regeneration Research, V2, P314	26	12	16	0	13	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	MAY	2016	37	5					693	701		10.1007/s10072-015-2460-2			9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	DO8PL	WOS:000378045500005	26746238				2021-06-18	
J	Weber, KT; Guimaraes, VA; Pontes-Neto, OM; Leite, JP; Takayanagui, OM; Santos-Pontelli, TEG				Weber, Karina Tavares; Guimaraes, Viviane Assuncao; Pontes-Neto, Octavio M.; Leite, Joao P.; Takayanagui, Osvaldo Massaiti; Santos-Pontelli, Taiza E. G.			Predictors of quality of life after moderate to severe traumatic brain injury	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						brain injuries; epidemiology; quality of life	SYSTEMS NATIONAL DATABASE; LONGITUDINAL DESCRIPTION; OUTCOME MEASURES; MODEL SYSTEMS; SCALE; INDIVIDUALS; DISABILITY; INSTITUTE; DISCHARGE; MORTALITY	Objective: To verify correlations between age, injury severity, length of stay (LOS), cognition, functional capacity and quality of life (QOL) six months after hospital discharge (HD) of victims of traumatic brain injury (TBI). Method: 50 patients consecutively treated in a Brazilian emergency hospital were assessed at admission, HD and six months after HD. The assessment protocol consisted in Abbreviated Injury Scale, Injury Severity Score, Glasgow Coma Scale (GCS), Revised Trauma Score (RTS), Mini Mental Test, Barthel Index and World Health Organization QOL - Brief. Results: Strong negative correlation was observed between LOS and GCS and LOS and RTS. An almost maximal correlation was found between RTS and GCS and functional capacity and GCS at HD. Age and LOS were considered independent predictors of QOL. Conclusion: Age and LOS are independent predictors of QOL after moderate to severe TBI.	[Weber, Karina Tavares; Guimaraes, Viviane Assuncao; Pontes-Neto, Octavio M.; Leite, Joao P.; Takayanagui, Osvaldo Massaiti; Santos-Pontelli, Taiza E. G.] Univ Sao Paulo, Fac Med, Dept Neurociencias & Ciencias Comportamento, BR-14049900 Ribeirao Preto, SP, Brazil; [Pontes-Neto, Octavio M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA USA	Santos-Pontelli, TEG (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurociencias & Ciencias Comportamento, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.	taiza@fmrp.usp.br	Neto, Octavio Marques Pontes/G-4294-2012; Santos, Taiza EG/F-9214-2012; Leite, Joao/B-9070-2012	Neto, Octavio Marques Pontes/0000-0003-0317-843X; Santos, Taiza EG/0000-0003-3033-2981; Leite, Joao/0000-0003-0558-3519	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - BrazilCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	This work was supported by funds from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil.	Vieira RDA, 2013, REV LAT-AM ENFERM, V21, P868, DOI 10.1590/S0104-11692013000400006; Alves ALA, 2009, REV SAUDE PUBL, V43, P154, DOI 10.1590/s0034-89102009000100020; Cartaxo CKA, 2012, CLINICS, V67, P1133, DOI 10.6061/clinics/2012(10)03; Ardolino A, 2012, INJURY, V43, P1662, DOI 10.1016/j.injury.2012.05.008; Batista Sandra Elisa Adami, 2006, Rev. Col. Bras. Cir., V33, P6; Breed ST, 2004, ARCH PHYS MED REHAB, V85, pS61, DOI 10.1016/j.apmr.2003.08.115; Carvalho AO, 2004, EINSTEIN, V2, P199; Costa Carlos Dario da Silva, 2012, Rev. Col. Bras. Cir., V39, P249; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Duncan R, 2009, J EMERG MED, V37, P451, DOI 10.1016/j.jemermed.2008.11.026; Fleck MPA, 2000, REV SAUDE PUBL, V34, P178, DOI 10.1590/S0034-89102000000200012; Silva SCFE, 2012, REV ESC ENFERM USP, V46, P30, DOI 10.1590/S0080-62342012000700005; Fukuda CC, 2002, AVAL PSICOL, V1, P1; Gabriel SE, 2012, NEW ENGL J MED, V367, P787, DOI 10.1056/NEJMp1207437; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Kondo Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10348; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Melo JRT, 2004, ARQ NEURO-PSIQUIAT, V62, P711, DOI 10.1590/S0004-282X2004000400027; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2478, DOI 10.1016/j.apmr.2013.06.019; Rocha GD, 2013, CIENC SAUDE COLETIVA, V18, P721, DOI 10.1590/S1413-81232013000300018; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Shah S, 2003, OTJR-OCCUP PARTICI H, V23, P2, DOI 10.1177/153944920302300101; Shivaji T, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-2; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Sloan EP, 2012, PREHOSP DISASTER MED, V27, P330, DOI 10.1017/S1049023X12000970; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034	30	12	15	0	8	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	MAY	2016	74	5					409	415		10.1590/0004-282X20160053			7	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	DN3WT	WOS:000376995500010	27191238	DOAJ Gold			2021-06-18	
J	Zeiler, FA; AlSubaie, F; Zeiler, K; Bernard, F; Skrobik, Y				Zeiler, Frederick A.; AlSubaie, Fand; Zeiler, Kaitlin; Bernard, Francis; Skrobik, Yoanna			Analgesia in Neurocritical Care: An International Survey and Practice Audit	CRITICAL CARE MEDICINE			English	Article						analgesia; intensive care; neurologic critical care; practice audit; pharmacology; survey	CRITICALLY-ILL PATIENTS; POSTOPERATIVE PAIN; DOUBLE-BLIND; SEDATION; DELIRIUM; ACETAMINOPHEN; EFFICACY; ICU; MULTICENTER; GUIDELINES	Objective: To characterize analgesic administration in neurocritical care. Design: ICU pharmacy database analgesic delivery audits from five countries. A 31-question analgesic agent survey was constructed, validated, and e-distributed in four countries. Setting: International multicenter neuro-ICU database audit and electronic survey. Patients: Six ICUs provided individual, anonymized analgesic delivery data in primary neurological diagnosis patients. Prescriber surveys were disseminated by neurocritical care societies. Interventions: None. Measurements and Main Results: Analgesic delivery data from 173 patients in French, Canadian, American, and Australian and New Zealand ICUs suggest that acetaminophen/paracetamol is the most common first-line analgesic (49.1% of patients); opiates are the "second line" in 31.5% of patients; however, 33% patients received no second agent. In the 2.3% with demyelinating disease, gabapentin was the most likely second analgesic (50.0%). Third-line analgesics were scarce across sites and neuropathologies. Few national or regional differences were found. The analgesic preference rankings noted by the 95 international physicians who completed the survey matched the audits. However, self-reported analgesic prescription rates were much higher than pharmacy records indicate, with self reported prescribing of both acetaminophen/paracetamol and opiates in 97% of patients and gabapentin in 45% of patients. Third-line analgesic variability appeared to be driven by neuropathology; ibuprofen was preferred for traumatic brain injury, postcraniotomy, and thromboembolic stroke patients, whereas gabapentin/pregabalin were favored in subarachnoid hemorrhage, intracranial hemorrhage, spine, demyelinating disease, and epileptic patients. Conclusions: Opiates and acetaminophen are preferred analgesic agents, and gabapentin is a contextual third choice, in neurocritically ill patients. Other agents are rarely prescribed. The discordance in physician self-reports and objective audits suggest that pain management optimization studies are warranted.	[Zeiler, Frederick A.] Univ Manitoba, Dept Surg, Neurosurg Sect, Winnipeg, MB R3T 2N2, Canada; [AlSubaie, Fand] Natl Inst Neurosci, Dept Neurosci, Riyadh, Saudi Arabia; [Zeiler, Kaitlin] Misericordia Hosp, Dept Nursing, Winnipeg, MB, Canada; [Zeiler, Kaitlin] McGill Univ, Montreal Neurol Inst, Sect Neurocrit Care, Montreal, PQ, Canada; [Bernard, Francis] McGill & Queens Univ, Dept Med, Montreal, PQ, Canada; [Skrobik, Yoanna] McGill Univ, Dept Med, Montreal, PQ, Canada	Skrobik, Y (corresponding author), McGill Univ, Ctr Hlth, Dept Med, Desk D05-5133,1001 Boul Decarie,Suite D05-2013, Montreal, PQ H4A 3J1, Canada.	skrobik@sympatico.ca	Skrobik, Yoanna/J-6393-2013; Skrobik, Yoanna/K-8165-2014	Skrobik, Yoanna/0000-0002-5315-6020; Teitelbaum, Jeanne/0000-0002-9834-3882; Zeiler, Frederick/0000-0003-1737-0510			Adams AS, 1999, INT J QUAL HEALTH C, V11, P187, DOI 10.1093/intqhc/11.3.187; AlSubaie F, 2014, CAN J NEUROL SCI S3, V41; Azzam PN, 2013, J INTENSIVE CARE MED, V28, P140, DOI 10.1177/0885066611432417; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Burry LD, 2014, CAN J ANESTH, V61, P619, DOI 10.1007/s12630-014-0174-1; Chanques G, 2011, BRIT J ANAESTH, V106, P336, DOI 10.1093/bja/aeq375; Chanques G, 2007, ANESTHESIOLOGY, V107, P858, DOI 10.1097/01.anes.0000287211.98642.51; Crews KR, 2014, CLIN PHARMACOL THER, V95, P376, DOI 10.1038/clpt.2013.254; Czaja R, 2005, DESIGNING SURVEYS, P103; Derry CJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010210.pub2; Flexman AM, 2010, CURR OPIN ANESTHESIO, V23, P551, DOI 10.1097/ACO.0b013e32833e15b9; Gelinas C, 2013, SEMIN RESP CRIT CARE, V34, P236, DOI 10.1055/s-0033-1342986; Hall JB, 2010, CRIT CARE MED, V38, pS668, DOI 10.1097/CCM.0b013e3181f203aa; Hynninen MS, 2000, CAN J ANAESTH, V47, P1182, DOI 10.1007/BF03019866; Ilan R, 2007, CRIT CARE MED, V35, P1696, DOI 10.1097/01.CCM.0000269041.05527.80; Ivers N, 2012, COCHRANE DATABASE SY, V6, DOI DOI 10.1002/14651858.CD000259.PUB3; Martin J, 2010, GER MED SCI, V8; McMillian Wesley D, 2011, J Pharm Pract, V24, P27, DOI 10.1177/0897190010388139; Memis D, 2010, J CRIT CARE, V25, P458, DOI 10.1016/j.jcrc.2009.12.012; Mordhorst C, 2010, J NEUROSURG ANESTH, V22, P202, DOI 10.1097/ANA.0b013e3181df0600; Mullins ME, 2011, NEUROCRIT CARE, V15, P375, DOI 10.1007/s12028-011-9533-8; Nair S, 2011, BRIT J NEUROSURG, V25, P100, DOI 10.3109/02688697.2010.534199; Payen JF, 2007, ANESTHESIOLOGY, V106, P687, DOI 10.1097/01.anes.0000264747.09017.da; Payen JF, 2009, ANESTHESIOLOGY, V111, P1308, DOI 10.1097/ALN.0b013e3181c0d4f0; Pierce CA, 2010, ANN PHARMACOTHER, V44, P489, DOI 10.1345/aph.1M332; Preslaski CR, 2013, CHEST, V144, P1687, DOI 10.1378/chest.12-1615; Puntillo KA, 2004, CRIT CARE MED, V32, P421, DOI 10.1097/01.CCM.0000108875.35298.D2; Qi DS, 2012, CLIN THER, V34, P2247, DOI 10.1016/j.clinthera.2012.11.003; Rivkin A, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.04.014; Singla NK, 2012, PAIN PRACT, V12, P523, DOI 10.1111/j.1533-2500.2012.00556.x; Skrobik Y, 2013, BRAIN DISORDERS IN CRITICAL ILLNESS: MECHANISMS, DIAGNOSIS, AND TREATMENT, P305; Skrobik Y, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-9; Skrobik Y, 2010, ANESTH ANALG, V111, P451, DOI 10.1213/ANE.0b013e3181d7e1b8; Teitelbaum JS, 2011, CAN J NEUROL SCI, V38, P815, DOI 10.1017/S0317167100012385; Yu A, 2013, CRIT CARE MED, V41, P2002, DOI 10.1097/CCM.0b013e31828e96c0; Yue Y, 2013, CLIN THER, V35, P1306, DOI 10.1016/j.clinthera.2013.07.422	37	12	12	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	MAY	2016	44	5					973	980		10.1097/CCM.0000000000001602			8	Critical Care Medicine	General & Internal Medicine	DJ7BF	WOS:000374366200015	26983164				2021-06-18	
J	Hsieh, JT; Ang, BT; Ng, YP; Allen, JC; King, NKK				Hsieh, Justin T.; Ang, Beng Ti; Ng, Yew Poh; Allen, John C.; King, Nicolas K. K.			Comparison of Gender Differences in Intracerebral Hemorrhage in a Multi-Ethnic Asian Population	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SEX-DIFFERENCES; STROKE INCIDENCE; CASE-FATALITY; INFLAMMATORY RESPONSE; CEREBRAL-ISCHEMIA; PROGESTERONE; HEART; ESTROGEN; SUBTYPES	Background Intracerebral hemorrhage (ICH) accounts for 10-15% of all first time strokes and with incidence twice as high in the Asian compared to Western population. This study aims to investigate gender differences in ICH patient outcomes in a multi-ethnic Asian population. Method Data for 1,192 patients admitted for ICH were collected over a four-year period. Multivariate logistic regression was used to identify independent predictors and odds ratios were computed for 30-day mortality and Glasgow Outcome Scale (GOS) comparing males and females. Result Males suffered ICH at a younger age than females (62.2 +/- 13.2 years vs. 66.3 +/- 15.3 years; P<0.001). The occurrence of ICH was higher among males than females at all ages until 80 years old, beyond which the trend was reversed. Females exhibited increased severity on admission as measured by Glasgow Coma Scale compared to males (10.9 +/- 4.03 vs. 11.4 +/- 4.04; P = 0.030). No difference was found in 30-day mortality between females and males (F: 30.5% [155/508] vs. M: 27.0%[186/688]), with unadjusted and adjusted odds ratio (F/M) of 1.19 (P = 0.188) and 1.21 (P = 0.300). At discharge, there was a non-statistically significant but potentially clinically relevant morbidity difference between the genders as measured by GOS (dichotomized GOS of 4-5: F: 23.7% [119/503] vs. M: 28.7% [194/677]), with unadjusted and adjusted odds ratio (F/M) of 0.77 (P = 0.055) and 0.87 (P = 0.434). Conclusion In our multi-ethnic Asian population, males developed ICH at a younger age and were more susceptible to ICH than women at all ages other than the beyond 80-year old age group. In contrast to the Western population, neurological status of female ICH patients at admission was poorer and their 30-day mortality was not reduced. Although the study was not powered to detect significance, female showed a trend toward worse 30-day morbidity at discharge.	[Hsieh, Justin T.] Duke Natl Univ Singapore Med Sch, Sch Med, Singapore, Singapore; [Ang, Beng Ti; Ng, Yew Poh; King, Nicolas K. K.] Natl Neurosci Inst, Dept Neurosurg, Singapore, Singapore; [Allen, John C.] Duke Natl Univ Singapore Med Sch, Ctr Quantitat Med, Singapore, Singapore	Hsieh, JT (corresponding author), Duke Natl Univ Singapore Med Sch, Sch Med, Singapore, Singapore.	Justin.hsieh@u.duke.nus.edu		Kon Kam King, Nicolas/0000-0002-6009-4411; Hsieh, Justin/0000-0002-9701-0998			Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; Chen Z, 2011, ACTA NEUROCHIR SUPPL, V111, P289, DOI 10.1007/978-3-7091-0693-8_48; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Flaherty ML, 2005, STROKE, V36, P934, DOI 10.1161/01.STR.0000160756.72109.95; Furlan JC, 2005, J NEUROTRAUM, V22, P368, DOI 10.1089/neu.2005.22.368; Ganti L, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/219097; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gibson CL, 2011, BRAIN, V134, P2125, DOI 10.1093/brain/awr132; Gokhale S, 2015, STROKE, V46, P886, DOI 10.1161/STROKEAHA.114.007682; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hsieh JT, 2016, NEUROENDOCRINOLOGY, V103, P518, DOI 10.1159/000440883; Inagawa T, 2003, NEUROSURGERY, V53, P1283, DOI 10.1227/01.NEU.0000093825.04365.F3; Ishikawa S, 2008, J EPIDEMIOL, V18, P144, DOI 10.2188/jea.JE2007438; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; Lei BL, 2016, NEUROENDOCRINOLOGY, V103, P665, DOI 10.1159/000442204; Leonelli E, 2007, NEUROSCIENCE, V144, P1293, DOI 10.1016/j.neuroscience.2006.11.014; Morikawa Y, 2000, STROKE, V31, P1583, DOI 10.1161/01.STR.31.7.1583; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI [10.1161/01.cir.0000441139.02102.80, 10.1161/CIR.0000000000000152, 10.1161/CIR.0b013e31828124ad]; Nakamura T, 2005, J NEUROSURG, V103, P97, DOI 10.3171/jns.2005.103.1.0097; Ng I, 2006, BRIT J NEUROSURG, V20, P73, DOI 10.1080/02688690600682259; Samai AA, 2015, VASC HEALTH RISK MAN, V11, P427, DOI 10.2147/VHRM.S65886; Simon JA, 2001, CIRCULATION, V103, P638, DOI 10.1161/01.cir.103.5.638; Thrift AG, 2009, NEUROEPIDEMIOLOGY, V32, P11, DOI 10.1159/000170086; Tveiten A, 2012, EUR NEUROL, V67, P240, DOI 10.1159/000336299; Umeano O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081664; Vaartjes I, 2009, CEREBROVASC DIS, V28, P564, DOI 10.1159/000247600; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Vemmos KN, 1999, STROKE, V30, P363, DOI 10.1161/01.STR.30.2.363; Wagner I, 2012, EUR J NEUROL, V19, P1477, DOI 10.1111/j.1468-1331.2011.03628.x; Wright DW, 2015, NEW ENGL J MED, V372, P1766, DOI 10.1056/NEJMc1503138; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wu SH, 2012, NEUROEPIDEMIOLOGY, V38, P69, DOI 10.1159/000335040; Young AMH, 2012, CURR DRUG SAF, V7, P202, DOI 10.2174/157488612803251261; Zhang LF, 2003, STROKE, V34, P2091, DOI 10.1161/01.STR.0000087149.42294.8C; Zhou JS, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0172-5; Zia E, 2009, STROKE, V40, P3567, DOI 10.1161/STROKEAHA.109.556324	40	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152945	10.1371/journal.pone.0152945			10	Multidisciplinary Sciences	Science & Technology - Other Topics	DI6IX	WOS:000373603500071	27050549	DOAJ Gold, Green Published			2021-06-18	
J	Cinnera, AM; Bonni, S; Iosa, M; Ponzo, V; Fusco, A; Caltagirone, C; Koch, G				Cinnera, Alex Martino; Bonni, Sonia; Iosa, Marco; Ponzo, Viviana; Fusco, Augusto; Caltagirone, Carlo; Koch, Giacomo			Clinical effects of non-invasive cerebellar magnetic stimulation treatment combined with neuromotor rehabilitation in traumatic brain injury. A single case study	FUNCTIONAL NEUROLOGY			English	Article						cerebellar cortex; physical therapy; rehabilitation; transcranial magnetic stimulation; traumatic brain injury	MOTOR; CIRCUITS; HUMANS; STROKE	Multimodal treatments are emerging as effective approaches for motor recovery in traumatic brain injury (TBI). Various evidence has demonstrated that repetitive transcranial magnetic stimulation (rTMS) may improve outcomes in people with motor disorders. Behavioral gains from rTMS protocols may be maximized when brain stimulation is coupled with carefully designed occupational/physical therapy. We present the case of a 25-year-old man with chronic TBI (a bilateral cortico-subcortical parieto-occipital lesion) who underwent three weeks of cerebellar intermittent theta burst stimulation (iTBS), a form of rTMS, combined with neurorehabilitation treatment. The Fugl-Meyer Assessment (FMA), Berg Balance Scale (BBS), Jebsen-Taylor Hand Function Test, and accelerometer gait analysis were administered before and after treatment. The results showed improvements in balance performance (BBS: T0=47; T1=53; +10.72%), motor recovery (FMA: T0=93/100; T1=96/100; +3.00%), step length (T0=50.4 +/- 7.2; T1=53.8 +/- 2.2 cm, p<0.001), and walking speed (T0=0.87 +/- 0.06; T1=0.91 +/- 0.04 m/sec, p<0.001). Combined cerebellar rTMS and neurore-habilitation seems to be a promising treatment for motor and balance dysfunctions in TBI patients.	[Cinnera, Alex Martino; Bonni, Sonia; Ponzo, Viviana; Caltagirone, Carlo; Koch, Giacomo] IRCCS Santa Lucia Fdn, Non Invas Brain Stimulat Unit, Rome, Italy; [Iosa, Marco; Fusco, Augusto] IRCCS Santa Lucia Fdn, Clin Lab Expt Neurorehabil, Rome, Italy; [Caltagirone, Carlo] Tor Vergata Univ, Dept Syst Med, Rome, Italy; [Koch, Giacomo] Policlin Tor Vergata, Stroke Unit, Rome, Italy	Koch, G (corresponding author), IRCCS Santa Lucia Fdn, Non Invas Brain Stimulat Unit, Rome, Italy.; Koch, G (corresponding author), Policlin Tor Vergata, Stroke Unit, Rome, Italy.	g.koch@hsantalucia.it	Cinnera, Alex Martino/K-4259-2018; Fusco, Augusto/K-5794-2012; Iosa, Marco/B-9531-2012; Koch, Giacomo/G-3155-2012; Ponzo, Viviana/AAA-7894-2019	Cinnera, Alex Martino/0000-0001-7267-3253; Fusco, Augusto/0000-0002-8528-7834; KOch, Giacomo/0000-0001-6155-9439			BERG K, 1995, SCAND J REHABIL MED, V27, P27; Bonni S, 2014, FUNCT NEUROL, V29, P41, DOI 10.11138/FNeur/2014.29.1.041; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Groiss Stefan Jun, 2013, Handb Clin Neurol, V116, P643, DOI 10.1016/B978-0-444-53497-2.00051-6; Hart T, 2014, ARCH PHYS MED REHAB, V95, P2103, DOI 10.1016/j.apmr.2014.07.001; JEBSEN R H, 1969, Archives of Physical Medicine and Rehabilitation, V50, P311; Koch G, 2008, CLIN NEUROPHYSIOL, V119, P2559, DOI 10.1016/j.clinph.2008.08.008; KRAFT GH, 1992, ARCH PHYS MED REHAB, V73, P220; Luft AR, 2005, MOL NEUROBIOL, V32, P205, DOI 10.1385/MN:32:3:205; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Morton SM, 2006, J NEUROSCI, V26, P9107, DOI 10.1523/JNEUROSCI.2622-06.2006; Oliveri M, 2005, NEUROSCI LETT, V376, P188, DOI 10.1016/j.neulet.2004.11.053; Pape TLB, 2006, J HEAD TRAUMA REHAB, V21, P437, DOI 10.1097/00001199-200609000-00063; Rossini PM, 1996, MUSCLE NERVE, V19, P1302; Theoret H, 2001, NEUROSCI LETT, V306, P29, DOI 10.1016/S0304-3940(01)01860-2; Villamar MF, 2012, NEUROMODULATION, V15, P326, DOI 10.1111/j.1525-1403.2012.00474.x	17	12	12	0	5	C I C-EDIZIONI INT SRL	ROME	CORSO TRIESTE, 42, 00198 ROME, ITALY	0393-5264	1971-3274		FUNCT NEUROL	Funct. Neurol.	APR-JUN	2016	31	2					117	120					4	Clinical Neurology	Neurosciences & Neurology	DR5RH	WOS:000379959600009	27358225				2021-06-18	
J	Ekmark-Lewen, S; Flygt, J; Fridgeirsdottir, GA; Kiwanuka, O; Hanell, A; Meyerson, BJ; Mir, AK; Gram, H; Lewen, A; Clausen, F; Hillered, L; Marklund, N				Ekmark-Lewen, Sara; Flygt, Johanna; Fridgeirsdottir, Gudrun A.; Kiwanuka, Olivia; Hanell, Anders; Meyerson, Bengt J.; Mir, Anis K.; Gram, Hermann; Lewen, Anders; Clausen, Fredrik; Hillered, Lars; Marklund, Niklas			Diffuse traumatic axonal injury in mice induces complex behavioural alterations that are normalized by neutralization of interleukin-1	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						axonal injury; behavioural outcome; central fluid percussion injury; interleukin-1; traumatic brain injury	EXPERIMENTAL BRAIN-INJURY; CONCENTRIC SQUARE FIELD; FLUID PERCUSSION INJURY; ROAD TRAFFIC ACCIDENT; CLOSED-HEAD INJURY; RECEPTOR ANTAGONIST; INFLAMMATORY RESPONSE; UP-REGULATION; PERIPHERAL LIPOPOLYSACCHARIDE; NEUROINFLAMMATORY RESPONSES	Widespread traumatic axonal injury (TAI) results in brain network dysfunction, which commonly leads to persisting cognitive and behavioural impairments following traumatic brain injury (TBI). TBI induces a complex neuroinflammatory response, frequently located at sites of axonal pathology. The role of the pro-inflammatory cytokine interleukin (IL)-1 has not been established in TAI. An IL-1-neutralizing or a control antibody was administered intraperitoneally at 30min following central fluid percussion injury (cFPI), a mouse model of widespread TAI. Mice subjected to moderate cFPI (n=41) were compared with sham-injured controls (n=20) and untreated, naive mice (n=9). The anti-IL-1 antibody reached the target brain regions in adequate therapeutic concentrations (up to similar to 30g/brain tissue) at 24h post-injury in both cFPI (n=5) and sham-injured (n=3) mice, with lower concentrations at 72h post-injury (up to similar to 18g/g brain tissue in three cFPI mice). Functional outcome was analysed with the multivariate concentric square field (MCSF) test at 2 and 9days post-injury, and the Morris water maze (MWM) at 14-21days post-injury. Following TAI, the IL-1-neutralizing antibody resulted in an improved behavioural outcome, including normalized behavioural profiles in the MCSF test. The performance in the MWM probe (memory) trial was improved, although not in the learning trials. The IL-1-neutralizing treatment did not influence cerebral ventricle size or the number of microglia/macrophages. These findings support the hypothesis that IL-1 is an important contributor to the processes causing complex cognitive and behavioural disturbances following TAI.	[Ekmark-Lewen, Sara; Flygt, Johanna; Fridgeirsdottir, Gudrun A.; Kiwanuka, Olivia; Hanell, Anders; Lewen, Anders; Clausen, Fredrik; Hillered, Lars; Marklund, Niklas] Uppsala Univ, Dept Neurosci, Neurosurg, Uppsala, Sweden; [Meyerson, Bengt J.] Uppsala Univ, Biomed Ctr, Dept Neurosci, Pharmacol, Uppsala, Sweden; [Mir, Anis K.; Gram, Hermann] Novartis Inst Biomed Res, Basel, Switzerland; [Marklund, Niklas] Univ Uppsala Hosp, Dept Neurosurg, Ing 85,2 Tr, SE-75655 Uppsala, Sweden	Marklund, N (corresponding author), Uppsala Univ, Dept Neurosci, Neurosurg, Uppsala, Sweden.; Marklund, N (corresponding author), Univ Uppsala Hosp, Dept Neurosurg, Ing 85,2 Tr, SE-75655 Uppsala, Sweden.	niklas.marklund@neuro.uu.se	Lewen, Anders/A-5156-2013	Lewen, Anders/0000-0003-4925-1348; Marklund, Niklas/0000-0002-9797-5626; Clausen, Fredrik/0000-0003-3592-4417; Kiwanuka, Olivia/0000-0003-3562-5513	Swedish Research CouncilSwedish Research CouncilEuropean Commission; Uppsala University Hospital; Selander Foundation; Ahlen Foundation	This work was funded by grants from Swedish Research Council, Uppsala University Hospital, The Selander Foundation and The Ahlen Foundation.	AbouHamden A, 1997, J NEUROTRAUM, V14, P699, DOI 10.1089/neu.1997.14.699; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Campbell SJ, 2007, NEUROBIOL DIS, V27, P151, DOI 10.1016/j.nbd.2007.04.013; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Chao PK, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-121; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Depino AM, 2004, HIPPOCAMPUS, V14, P526, DOI 10.1002/hipo.10164; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Ekmark-Lewen S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-44; Ekmark-Lewen S, 2010, J NEUROTRAUM, V27, P1643, DOI 10.1089/neu.2009.0953; Eriksson L., 2006, MULTI MEGAVARIATE 1; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Folkersma H, 2008, ACTA NEUROCHIR, V150, P1277, DOI 10.1007/s00701-008-0151-y; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Hanell Anders, 2012, Front Neurol, V3, P29, DOI 10.3389/fneur.2012.00029; Hein AM, 2010, BRAIN BEHAV IMMUN, V24, P243, DOI 10.1016/j.bbi.2009.10.002; Hellewell SC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-156; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Israelsson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104754; Jia XX, 2012, J TRAUMA ACUTE CARE, V73, P1168, DOI 10.1097/TA.0b013e318246eaf4; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones C, 2005, J TRAUMA STRESS, V18, P181, DOI 10.1002/jts.20031; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Knoblach SM, 2000, NEUROSCI LETT, V289, P5, DOI 10.1016/S0304-3940(00)01263-5; Lawrence CB, 1998, EUR J NEUROSCI, V10, P1188, DOI 10.1046/j.1460-9568.1998.00136.x; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P344, DOI 10.1097/00004647-200104000-00003; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Maruichi K, 2009, NEUROPATHOLOGY, V29, P132, DOI 10.1111/j.1440-1789.2008.00956.x; Meyerson BJ, 2006, BEHAV BRAIN RES, V168, P100, DOI 10.1016/j.bbr.2005.10.020; Moore AH, 2009, NEUROSCIENCE, V164, P1484, DOI 10.1016/j.neuroscience.2009.08.073; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Oehmichen M, 1999, ACTA NEUROPATHOL, V97, P491, DOI 10.1007/s004010051018; Perez AM, 2014, J NEUROTRAUM, V31, P1478, DOI 10.1089/neu.2013.3216; Pittella JEH, 2004, ARQ NEURO-PSIQUIAT, V62, P406, DOI 10.1590/S0004-282X2004000300007; Rooker S, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/90123; Rothwell NJ, 1999, J PHYSIOL-LONDON, V514, P3, DOI 10.1111/j.1469-7793.1999.003af.x; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Schmitter-Edgecombe M, 2012, J CLIN EXP NEUROPSYC, V34, P256, DOI 10.1080/13803395.2011.633497; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Soblosky JS, 1996, BEHAV BRAIN RES, V80, P185, DOI 10.1016/0166-4328(96)00034-4; Sparkman NL, 2005, PHYSIOL BEHAV, V85, P278, DOI 10.1016/j.physbeh.2005.04.015; Sparkman NL, 2005, BEHAV BRAIN RES, V159, P145, DOI 10.1016/j.bbr.2004.10.011; Su ZJ, 2009, J NEUROTRAUM, V26, P1695, DOI 10.1089/neu.2008.0519; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Thomale UW, 2007, IMMUNOBIOLOGY, V212, P567, DOI 10.1016/j.imbio.2007.01.007; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Tramontana MG, 2014, BRAIN INJURY, V28, P1461, DOI 10.3109/02699052.2014.930179; Van Dam D, 2006, NEUROBIOL LEARN MEM, V85, P164, DOI 10.1016/j.nlm.2005.09.006; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; Wang X, 2015, GLIA, V63, P635, DOI 10.1002/glia.22774; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wright MJ, 2013, BRAIN IMAGING BEHAV, V7, P307, DOI 10.1007/s11682-013-9231-6; Wu CW, 2007, J NEUROCHEM, V103, P2471, DOI 10.1111/j.1471-4159.2007.04987.x; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yang GY, 1997, BRAIN RES, V751, P181, DOI 10.1016/S0006-8993(96)01277-2; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yirmiya R, 2002, NEUROBIOL LEARN MEM, V78, P379, DOI 10.1006/nlme.2002.4072; Zawadzka M, 2005, GLIA, V49, P36, DOI 10.1002/glia.20092; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247	90	12	12	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	APR	2016	43	8					1016	1033		10.1111/ejn.13190			18	Neurosciences	Neurosciences & Neurology	DK1BA	WOS:000374645700004	27091435				2021-06-18	
J	Fink, EL; Berger, RP; Clark, RSB; Watson, RS; Angus, DC; Panigrahy, A; Richichi, R; Callaway, CW; Bell, MJ; Mondello, S; Hayes, RL; Kochanek, PM				Fink, Ericka L.; Berger, Rachel P.; Clark, Robert S. B.; Watson, R. Scott; Angus, Derek C.; Panigrahy, Ashok; Richichi, Rudolph; Callaway, Clifton W.; Bell, Michael J.; Mondello, Stefania; Hayes, Ronald L.; Kochanek, Patrick M.			Exploratory study of serum ubiquitin carboxyl-terminal esterase L1 and glial fibrillary acidic protein for outcome prognostication after pediatric cardiac arrest	RESUSCITATION			English	Article						Biomarker; Pediatric; Brain injury; Outcomes; Cardiac arrest	DELAYED NEURONAL DEATH; TRAUMATIC BRAIN-INJURY; BIOMARKERS; CHILDREN; HYDROLASE	Introduction: Brain injury is the leading cause of morbidity and death following pediatric cardiac arrest. Serum biomarkers of brain injury may assist in outcome prognostication. The objectives of this study were to evaluate the properties of serum ubiquitin carboxyl-terminal esterase-L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) to classify outcome in pediatric cardiac arrest. Methods: Single center prospective study. Serum biomarkers were measured at 2 time points during the initial 72 h in children after cardiac arrest (n = 19) and once in healthy children (controls, n = 43). We recorded demographics and details of the cardiac arrest and resuscitation. We determined the associations between serum biomarker concentrations and Pediatric Cerebral Performance Category (PCPC) at 6 months (favorable (PCPC 1-3) or unfavorable (PCPC 4-6)). Results: The initial assessment (time point 1) occurred at a median (IQR) of 10.5 (5.5-17.0) h and the second assessment (time point 2) at 59.0 (54.5-65.0) h post-cardiac arrest. Serum UCH-L1 was higher among children following cardiac arrest than among controls at both time points (p < 0.05). Serum GFAP in subjects with unfavorable outcome was higher at time point 2 than in controls (p < 0.05). Serum UCH-L1 at time point 1 (AUC 0.782) and both UCH-L1 and GFAP at time point 2 had good classification accuracy for outcome (AUC 0.822 and 0.796), p < 0.05 for all. Conclusion: Preliminary data suggest that serum UCH-L1 and GFAP may be of use to prognosticate outcome after pediatric cardiac arrest at clinically-relevant time points and should be validated prospectively. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Fink, Ericka L.; Clark, Robert S. B.; Bell, Michael J.; Kochanek, Patrick M.] UPMC, Childrens Hosp Pittsburgh, Crit Care Med, Pittsburgh, PA USA; [Angus, Derek C.] Univ Pittsburgh, Med Ctr, Crit Care Med, Pittsburgh, PA USA; [Callaway, Clifton W.] Univ Pittsburgh, Med Ctr, Emergency Med, Pittsburgh, PA USA; [Panigrahy, Ashok] UPMC, Childrens Hosp Pittsburgh, Radiol, Pittsburgh, PA USA; [Richichi, Rudolph] Stat Anal & Measurement Consultants Inc, Lanexa, VA USA; [Hayes, Ronald L.] Banyan Biomarkers Inc, Banyan Labs, Alachua, FL USA; [Watson, R. Scott] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Fink, Ericka L.; Watson, R. Scott; Angus, Derek C.] Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA USA; [Fink, Ericka L.; Clark, Robert S. B.; Callaway, Clifton W.; Bell, Michael J.; Kochanek, Patrick M.] Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Mondello, Stefania] Univ Messina, Neurosci, Messina, Italy; [Berger, Rachel P.] UPMC, Childrens Hosp Pittsburgh, Child Advocacy, Pittsburgh, PA USA	Fink, EL (corresponding author), UPMC, Childrens Hosp Pittsburgh, Div Pediat Crit Care Med, 4401 Penn Ave,Fac Pavil,2nd Floor, Pittsburgh, PA 15224 USA.	finkel@ccm.upmc.edu	Mondello, Stefania/A-1813-2012; Angus, Derek C/E-9671-2012	Mondello, Stefania/0000-0002-8587-3614; Watson, R. Scott/0000-0002-2581-7186	NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12 HD047349]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS065132]; Laerdal Foundation; Banyan Biomarkers, Inc.; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1 RR024153, UL1TR000005]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS065132] Funding Source: NIH RePORTER	NICHD K12 HD047349 (E.L.F.), NINDS K23 NS065132 (E.L.F.), the Laerdal Foundation (E.L.F.), and Banyan Biomarkers, Inc. (E.L.F.). The project described was supported by the National Institutes of Health through grant numbers UL1 RR024153 and UL1TR000005. Banyan Biomarkers, Inc. performed all biomarker measurements without charge.	Abend NS, 2008, PEDIATR CRIT CARE ME, V9, P32, DOI 10.1097/01.PCC.0000288714.61037.56; Bedell GM, 2008, BRAIN INJURY, V22, P313, DOI 10.1080/02699050801978948; Bembea MM, 2011, PEDIATR CRIT CARE ME, V12, P572, DOI 10.1097/PCC.0b013e3181fe3ec7; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; Blennow M, 2001, ACTA PAEDIATR, V90, P1171, DOI 10.1080/080352501317061594; Chalak LF, 2014, J PEDIATR-US, V164, P468, DOI 10.1016/j.jpeds.2013.10.067; Chen J, 1998, J NEUROSCI, V18, P4914; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Day INM, 2010, PROG NEUROBIOL, V90, P327, DOI 10.1016/j.pneurobio.2009.10.020; Douglas-Escobar M, 2010, PEDIATR RES, V68, P531, DOI 10.1203/PDR.0b013e3181f85a03; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; Ennen CS, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.025; Fink EL, 2014, CRIT CARE MED, V42, P664, DOI 10.1097/01.ccm.0000435668.53188.80; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; FRASER DD, 2011, CRIT CARE MED, V12, P319, DOI DOI 10.1097/PCC.0B013E3181E8B32D; Fugate JE, 2010, ANN NEUROL, V68, P907, DOI 10.1002/ana.22133; Hayashida H, 2010, NEUROCRIT CARE, V12, P252, DOI 10.1007/s12028-009-9318-5; HORN M, 1992, ACTA NEUROPATHOL, V85, P79, DOI 10.1007/BF00304636; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Jin KL, 1999, J NEUROCHEM, V72, P1204, DOI 10.1046/j.1471-4159.1999.0721204.x; Kaneko T, 2009, RESUSCITATION, V80, P790, DOI 10.1016/j.resuscitation.2009.04.003; Kochanek PM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00040; Langhelle A, 2005, RESUSCITATION, V66, P271, DOI 10.1016/j.resuscitation.2005.06.005; Larsson IM, 2014, RESUSCITATION, V85, P1654, DOI 10.1016/j.resuscitation.2014.09.007; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Moler FW, 2009, CRIT CARE MED, V37, P2259, DOI 10.1097/CCM.0b013e3181a00a6a; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Mortberg E, 2011, RESUSCITATION, V82, P26, DOI 10.1016/j.resuscitation.2010.10.011; Northington FJ, 2001, NEUROBIOL DIS, V8, P207, DOI 10.1006/nbdi.2000.0371; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Tiainen M, 2003, STROKE, V34, P2881, DOI 10.1161/01.STR.0000103320.90706.35; Topjian AA, 2009, PEDIATR CRIT CARE ME, V10, P479, DOI 10.1097/PCC.0b013e318198bdb5; Young KD, 2004, PEDIATRICS, V114, P157, DOI 10.1542/peds.114.1.157	37	12	12	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572	1873-1570		RESUSCITATION	Resuscitation	APR	2016	101						65	70		10.1016/j.resuscitation.2016.01.024			6	Critical Care Medicine; Emergency Medicine	General & Internal Medicine; Emergency Medicine	DL8HR	WOS:000375882300024	26855294	Green Accepted			2021-06-18	
J	Garzon, D; Cabezas, R; Vega, N; Avila-Rodriguez, M; Gonzalez, J; Gomez, RM; Echeverria, V; Aliev, G; Barreto, GE				Garzon, Daniel; Cabezas, Ricardo; Vega, Nelson; Avila-Rodriguez, Marcos; Gonzalez, Janneth; Margarita Gomez, Rosa; Echeverria, Valentina; Aliev, Gjumrakch; Barreto, George E.			Novel Approaches in Astrocyte Protection: from Experimental Methods to Computational Approaches	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Astrocytes; Neurosteroids; Growth factors; Mesenchymal stemfactors; Nicotine; Computational biology	MESENCHYMAL STEM-CELLS; NICOTINIC ACETYLCHOLINE-RECEPTORS; TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; GROWTH-FACTORS; NEUROTROPHIC FACTOR; NEURODEGENERATIVE DISEASES; THERAPEUTIC TARGETS; OXIDATIVE STRESS; HUMAN METABOLISM	Astrocytes are important for normal brain functioning. Astrocytes are metabolic regulators of the brain that exert many functions such as the preservation of blood-brain barrier (BBB) function, clearance of toxic substances, and generation of antioxidant molecules and growth factors. These functions are fundamental to sustain the function and survival of neurons and other brain cells. For these reasons, the protection of astrocytes has become relevant for the prevention of neuronal death during brain pathologies such as Parkinson's disease, Alzheimer's disease, stroke, and other neurodegenerative conditions. Currently, different strategies are being used to protect the main astrocytic functions during neurological diseases, including the use of growth factors, steroid derivatives, mesenchymal stem cell paracrine factors, nicotine derivatives, and computational biology tools. Moreover, the combined use of experimental approaches with bioinformatics tools such as the ones obtained through system biology has allowed a broader knowledge in astrocytic protection both in normal and pathological conditions. In the present review, we highlight some of these recent paradigms in assessing astrocyte protection using experimental and computational approaches and discuss how they could be used for the study of restorative therapies for the brain in pathological conditions.	[Garzon, Daniel; Cabezas, Ricardo; Vega, Nelson; Avila-Rodriguez, Marcos; Gonzalez, Janneth; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Margarita Gomez, Rosa] Univ La Sabana, Grp Neurociencias, Chia, Cundinamarca, Colombia; [Echeverria, Valentina] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33647 USA; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Concepcion 1457, Chile; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci, E Johns Crossing 175, Johns Creek, GA 30097 USA; [Aliev, Gjumrakch] Univ Atlanta, Healthcare Adm, E Johns Crossing 175, Johns Creek, GA USA; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile	Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia.; Barreto, GE (corresponding author), Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile.	gesbarreto@gmail.com	Janneth Gonzalez Santos, M.Sc./AAB-9948-2020; Aliev, Gjumrakch/K-7302-2017; Barreto, George E./AAD-7420-2020; Valentina Echeverria Moran, BCh/E-7765-2013; Aliev, Gjumrakch/AAE-7734-2020; Barreto, George E./B-5747-2014	Janneth Gonzalez Santos, M.Sc./0000-0003-2009-3374; Barreto, George E./0000-0002-6644-1971; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Aliev, Gjumrakch/0000-0001-7373-3182; Barreto, George E./0000-0002-6644-1971; Vega, Nelson/0000-0003-2404-6858; Avila-Rodriguez, Marco/0000-0003-4612-3236; Gonzalez, Janneth/0000-0003-4482-256X	grants PUJ [4509, 5024, 5608]; Colciencias projectDepartamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias [528, 511]; GALLY International Biomedical Research Consulting LLC, San Antonio, TX, USA	This work was supported in part by grants PUJ IDs 4509, 5024, and 5608 to GEB, Colciencias project (convocatoria 528) to RC and Colciencias project (convocatoria 511). G. Aliev work was supported by the GALLY International Biomedical Research Consulting LLC, San Antonio, TX, USA.	Aberg ND, 2006, THESCIENTIFICWORLDJO, V6, P53, DOI 10.1100/tsw.2006.22; Adelson JD, 2012, NEURON, V73, P1100, DOI 10.1016/j.neuron.2012.01.020; Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Posada-Duque RA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00231; Andriamaharavo NR, 2005, J NAT PROD, V68, P1743, DOI 10.1021/np058089f; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Barragan-Osorio L., 2015, CENT NERV SYST AGENT; Barreto G, 2007, EUR J NEUROSCI, V25, P3039, DOI 10.1111/j.1460-9568.2007.05563.x; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; Barreto GE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00132; Barreto GE, 2015, CURR PHARM DESIGN, V21, P3589, DOI 10.2174/1381612821666150710145250; Barreto GE, 2015, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00340; Barreto GE, 2012, EXP NEUROL, V238, P284, DOI 10.1016/j.expneurol.2012.08.015; Barreto GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027881; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bouzier-Sore AK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00179; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Burkhalter J, 2003, J NEUROSCI, V23, P8212; Cabezas R., 2015, MED CHEM IN PRESS; Cabezas R, 2015, NEUROTOX RES, V27, P355, DOI 10.1007/s12640-014-9509-5; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Caiazzo M, 2015, STEM CELL REP, V4, P25, DOI 10.1016/j.stemcr.2014.12.002; Cakir T, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-48; Castellani G, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00253; Chen H, 2010, NEUROLOGY, V74, P878, DOI 10.1212/WNL.0b013e3181d55f38; CHENG B, 1995, J NEUROSCI, V15, P7095; COLDITZ GA, 1993, AM J OBSTET GYNECOL, V168, P1473, DOI 10.1016/S0002-9378(11)90784-4; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; Coulter DA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022434; Daly JW, 2005, J NAT PROD, V68, P1556, DOI 10.1021/np0580560; De Schutter E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000078; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Duffy P, 2009, J NEUROSCI, V29, P15266, DOI 10.1523/JNEUROSCI.4650-09.2009; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fujita KA, 2014, MOL NEUROBIOL, V49, P88, DOI 10.1007/s12035-013-8489-4; Funa K, 2014, J NEUROIMMUNE PHARM, V9, P168, DOI 10.1007/s11481-013-9479-z; Geschwind DH, 2009, NATURE, V461, P908, DOI 10.1038/nature08537; Gibson W. G., 2008, MATH MODELING BIOL S, VII, P193; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Gompel A, 1999, CONTRACEPT FERTIL S, V27, P368; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Han D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-95; He T, 2012, MICROVASC RES, V83, P366, DOI 10.1016/j.mvr.2012.01.001; Henriques A, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00032; Kang WF, 2011, MOL NEUROBIOL, V43, P147, DOI 10.1007/s12035-011-8163-7; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Krupinski J, 1997, STROKE, V28, P564, DOI 10.1161/01.STR.28.3.564; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Lanussa O.H., 2015, CNS NEUROLO IN PRESS; Likic Vladimir A., 2010, Advances in Bioinformatics, V2010, P268925, DOI 10.1155/2010/268925; Lin CH, 2006, EXP NEUROL, V201, P225, DOI 10.1016/j.expneurol.2006.04.014; Liu Y, 2015, NEUROPHARMACOLOGY, V91, P87, DOI 10.1016/j.neuropharm.2014.11.028; Liu Y, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-98; Lunn JS, 2011, ANN NEUROL, V70, P353, DOI 10.1002/ana.22487; Malik N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096139; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; McMurray R, 2003, BRAIN RES, V980, P140, DOI 10.1016/S0006-8993(03)02984-6; Miller RH, 2010, DISCOV MED, V9, P236; MORENS DM, 1995, NEUROLOGY, V45, P1041, DOI 10.1212/WNL.45.6.1041; Nimmerjahn A, 2015, CURR OPIN NEUROBIOL, V32, P95, DOI 10.1016/j.conb.2015.01.015; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oliveira SLB, 2013, CYTOM PART A, V83A, P76, DOI 10.1002/cyto.a.22161; Onose G., 2011, ROMANIAN NEUROSURG, V15, P11; Parpura V, 2011, BBA-MOL CELL RES, V1813, P984, DOI 10.1016/j.bbamcr.2010.11.006; Paul G, 2015, J CLIN INVEST, V125, P1339, DOI 10.1172/JCI79635; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Perez-Alvarez A, 2013, CURR DRUG TARGETS, V14, P1220; Pogocki D, 2007, EUR J PHARMACOL, V563, P18, DOI 10.1016/j.ejphar.2007.02.038; Proschel C, 2014, EMBO MOL MED, V6, P504, DOI 10.1002/emmm.201302878; Ramaswamy S, 2009, PARKINSONISM RELAT D, V15, pS176, DOI 10.1016/S1353-8020(09)70809-0; Ritz B, 2007, ARCH NEUROL-CHICAGO, V64, P990, DOI 10.1001/archneur.64.7.990; Rossignol J, 2014, STEM CELLS, V32, P500, DOI 10.1002/stem.1508; Safi R, 2012, J MOL NEUROSCI, V46, P654, DOI 10.1007/s12031-011-9654-8; Salazar DA, 2016, MOL GENET METAB, V117, P129, DOI 10.1016/j.ymgme.2015.08.001; Sejnowski TJ, 2015, INT ENCY SOCIAL BEHA, P480; Sertbas M, 2014, FEBS OPEN BIO, V4, P542, DOI 10.1016/j.fob.2014.05.006; Tegner JN, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-56; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; [田文艳 TIAN Wen-yan], 2009, [第二军医大学学报, Academic Journal of Second Military Medical University], V30, P790; Tonder JE, 2001, CURR MED CHEM, V8, P651, DOI 10.2174/0929867013373165; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Torrente Daniel, 2015, Front Biosci (Elite Ed), V7, P434; Uccelli A, 2011, BEST PRACT RES CL HA, V24, P59, DOI 10.1016/j.beha.2011.01.004; Vercelli A, 2008, NEUROBIOL DIS, V31, P395, DOI 10.1016/j.nbd.2008.05.016; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Vos RME, 2002, DRUG METAB DISPOS, V30, P106, DOI 10.1124/dmd.30.2.106; Xiong XX, 2011, STROKE, V42, P2026, DOI 10.1161/STROKEAHA.110.593772; Yasuda T, 2010, EXPERT REV NEUROTHER, V10, P915, DOI [10.1586/ern.10.55, 10.1586/ERN.10.55]; Yildiz D, 2004, TOXICON, V43, P619, DOI 10.1016/j.toxicon.2004.01.017; Yu JH, 2003, J BIOCHEM MOL BIOL, V36, P49; Zheng LS, 2010, J NEUROSCI RES, V88, P1273, DOI 10.1002/jnr.22302	97	12	12	0	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	APR	2016	58	4					483	492		10.1007/s12031-016-0719-6			10	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	DJ5YI	WOS:000374286300011	26803310				2021-06-18	
J	Huang, YH; Ou, CY				Huang, Yu-Hua; Ou, Chien-Yu			Prognostic Impact of Intracranial Pressure Monitoring After Primary Decompressive Craniectomy for Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Intracranial pressure; Outcome measures; Traumatic brain injury	HEMICRANIECTOMY; HEMORRHAGE	OBJECTIVE: Decompressive craniectomy (DC) for traumatic brain injury (TBI) can be used in 2 completely different situations: primary and secondary DC. Although intracranial pressure (ICP) monitoring has proved to be helpful in guiding therapy for head injuries, its role after primary DC is not well analyzed. The aim of this study was to elucidate the relationship between ICP monitoring and outcomes in patients undergoing primary DC for TBI. METHODS: We enrolled 187 head-injured patients undergoing primary DC in this retrospective study. The patients were subdivided into 2 groups based on whether postoperative ICP was monitored (n = 34) or not (n = 153). We identified the intergroup differences in clinical parameters and prognosis. Unfavorable and favorable neurologic outcomes were defined by Glasgow Outcome Scale scores of 1-3 and 4-5, respectively. RESULTS: The rate of ICP monitoring was 18.2% for our head-injured patients after primary DC. There was no difference in preoperative Glasgow Coma Score, pupil reactivity, features of computed tomography images, or other demographic variables between patients with or without ICP monitoring. The mortality at discharge was 14.7% for patients with ICP monitoring and 32.7% for patients without, which showed a statistically significant difference (P = 0.037). The neurologic outcomes did not differ between the patient groups at discharge or the end of follow-up. CONCLUSIONS: Our data suggest that ICP monitoring after primary DC for head-injured patients significantly decreases in-hospital mortality and should be implemented in neurocritical care to ensure the highest chances of surviving TBI.	[Huang, Yu-Hua; Ou, Chien-Yu] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Huang, Yu-Hua; Ou, Chien-Yu] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Ou, Chien-Yu] Kaohsiung Armed Forces Gen Hosp, Dept Surg, Kaohsiung, Taiwan	Ou, CY (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan.; Ou, CY (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Ou, CY (corresponding author), Kaohsiung Armed Forces Gen Hosp, Dept Surg, Kaohsiung, Taiwan.	oucu2003@yahoo.com.tw					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Al-Jishi A, 2011, CAN J NEUROL SCI, V38, P612, DOI 10.1017/S0317167100012154; Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Huang YH, 2013, J NEUROTRAUM, V30, P96, DOI 10.1089/neu.2012.2563; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Plesnila N, 2007, PROG BRAIN RES, V161, P393, DOI 10.1016/S0079-6123(06)61028-5; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Servadei F, 2002, ACT NEUR S, V81, P81; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4	19	12	13	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2016	88						59	63		10.1016/j.wneu.2015.12.041			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DK1CI	WOS:000374649700012	26732966				2021-06-18	
J	Huguenard, AL; Miller, BA; Sarda, S; Capasse, M; Reisner, A; Chern, JJ				Huguenard, Anna L.; Miller, Brandon A.; Sarda, Samir; Capasse, Meredith; Reisner, Andrew; Chern, Joshua J.			Mild traumatic brain injury in children is associated with a low risk for posttraumatic seizures	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						antiepileptic drug; electroencephalography; mild traumatic brain injury; posttraumatic seizure; trauma	BLUNT HEAD TRAUMA; ANTISEIZURE PROPHYLAXIS; SHUNT SURGERY; SYSTEM; RETURN; PREVALENCE; MECHANISMS; EPILEPSY; IMPACT	OBJECTIVE Of the 1.7 million traumatic brain injuries (TBIs) in the US, a third occur in patients under 14 years of age. The rate of posttraumatic epilepsy (PTE) may be as high as 19% after severe pediatric TBI, but the risk for seizures after mild TBI is unknown. Although the rate of seizures after mild TBI may be low, current practice is often driven by high clinical concern for posttraumatic seizures. In this study, the authors evaluated electroencephalography (EEG) results and antiepileptic drug (AED) use in a large cohort of children with mild TBI to estimate the incidence of posttraumatic seizures in this population. METHODS Patients presenting to Children's Hospital of Atlanta for mild TBI from 2010 to 2013 were evaluated. Five thousand one hundred forty-eight patients with mild TBI were studied and divided into 3 groups: 4168 who were discharged from the emergency department, 868 who, ere admitted without neurosurgical intervention, and 112 who underwent neurosurgical procedures (craniotomy for hematoma evacuation or elevation of depressed skull fractures) but were discharged without an extended stay. Demographic information, CT characteristics, EEG reports, and prescriptions for AEDs were analyzed. Long-term follow-up was sought for all patients who underwent EEG. Correlation between EEG result and AED use was also evaluated. RESULTS All patients underwent head CT, and admitted patients were more likely to have an abnormal study (p < 0.0001). EEG evaluations were performed for less than 1.0% of patients in all 3 categories, without significant differences between groups (p = 0.97). Clinicians prescribed AEDs in less than 2.0% of patients for all groups, without significant differences between groups (p = 0.094). Even fewer children continue to see a neurologist for long-term seizure management. The EEG result had good negative predictive value, but only an abnormal EEG reading that was diagnostic of seizures correlated significantly with AED prescription (p = 0.04). CONCLUSIONS EEG utilization and AED prescription was low in all 3 groups, indicating that seizures following mild TBI are likely rare events. EEG has good negative predictive value for patients who did not receive AEDs, but has poorer positive predictive value for AED use.	[Huguenard, Anna L.; Miller, Brandon A.; Reisner, Andrew; Chern, Joshua J.] Emory Univ, Dept Neurosurg, Atlanta, GA 30322 USA; [Sarda, Samir; Capasse, Meredith; Reisner, Andrew; Chern, Joshua J.] Childrens Healthcare Atlanta, Pediat Neurosurg Associates, Atlanta, GA USA	Miller, BA (corresponding author), 1365 Clifton Rd NE,Bldg B,Ste 2200, Atlanta, GA 30322 USA.	brandon.miller@emory.edu		Huguenard, Anna/0000-0002-8625-4698			ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Bhullar IS, 2014, J TRAUMA ACUTE CARE, V76, P54, DOI 10.1097/TA.0b013e3182aafd15; Centers for Disease Control and Prevention, CDCS INJ CTR TRAUM B; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; Chern JJ, 2014, J NEUROSURG-PEDIATR, V14, P306, DOI 10.3171/2014.6.PEDS13682; Chern JJ, 2014, J NEUROSURG-PEDIATR, V13, P525, DOI 10.3171/2014.2.PEDS13493; ENGEL J, 1983, NEUROLOGY, V33, P400, DOI 10.1212/WNL.33.4.400; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gaggero R, 2014, EUR J PAEDIATR NEURO, V18, P376, DOI 10.1016/j.ejpn.2014.01.011; Gordon Kevin E, 2006, Semin Pediatr Neurol, V13, P243, DOI 10.1016/j.spen.2006.09.005; Greenberg JK, 2014, J TRAUMA ACUTE CARE, V76, P1089, DOI 10.1097/TA.0000000000000155; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Kim K, 2002, J KOREAN CHILD NEROL, V10, P63; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS72, DOI 10.1097/PCC.0b013e31823f681d; Lee HS, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-211; Matsumoto JH, 2013, EPILEPSY BEHAV, V27, P233, DOI 10.1016/j.yebeh.2013.01.024; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; O'Neill BR, 2015, J NEUROSURG-PEDIATR, V16, P167, DOI 10.3171/2014.12.PEDS14263; Park JT, 2015, PEDIATR NEUROL, V52, P174, DOI 10.1016/j.pediatrneurol.2014.09.013; Sarda S, 2014, J NEUROSURG-PEDIATR, V14, P654, DOI 10.3171/2014.8.PEDS14109; Tavarez MM, 2012, CURR OPIN PEDIATR, V24, P307, DOI 10.1097/MOP.0b013e3283531ce6; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Wrubel DM, 2014, J NEUROSURG-PEDIATR, V13, P216, DOI 10.3171/2013.10.PEDS13248	26	12	12	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	APR	2016	17	4					476	482		10.3171/2015.7.PEDS14723			7	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	DH3EF	WOS:000372669600015	26613272	Bronze			2021-06-18	
J	Roscigno, CI				Roscigno, Cecelia I.			Parent Perceptions of How Nurse Encounters Can Provide Caring Support for the Family in Early Acute Care After Children's Severe Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE NURSING			English	Article						parenting; caring; palliative care; family centered; phenomenology; traumatic brain injury; content analysis	SECONDARY ANALYSIS; QUALITATIVE DATA; DECISION-MAKING; UNITED-STATES; NEEDS; ICU; CONSCIOUSNESS; COMMUNICATION; PROFESSIONALS; PERSPECTIVES	Objective: A child's severe traumatic brain injury (TBI) creates a family crisis requiring extensive cultural, informational, psychological, and environmental support. Nurses need to understand parents' expectations of caring in early acute care so they can tailor their attitudes, beliefs, and behaviors appropriately to accommodate the family's needs. Methods: In a previous qualitative study of 42 parents or caregivers from 37 families of children with moderate-to-severe TBI, parents of children with severe TBI (n = 25) described their appraisals of nurse caring and uncaring behaviors in early acute care. Swanson's theory of caring was used to categorize parents' descriptions to inform nursing early acute care practices and family-centered care. Results: Caring nurse encounters included (a) involving parents in the care of their child and reflecting on all sociocultural factors shaping family resources and responses (knowing); (b) respecting that family grief can be co-mingled with resilience and that parents are typically competent to be involved in decision making (maintaining belief); (d) actively listening and engaging parents to fully understand family values and needs (being with); (e) decreasing parents' workload to get information and emotional support and provide a safe cultural, psychological, and physical environment for the family (doing for); and (f) providing anticipatory guidance to navigate the early acute care system and giving assistance to learn and adjust to their situation (enabling). Conclusion: Application of Swanson's caring theory is prescriptive in helping individual nurses and early acute care systems to meet important family needs after children's severe TBI.	[Roscigno, Cecelia I.] Univ N Carolina, Sch Nursing, Family Hlth Div, Chapel Hill, NC USA	Roscigno, CI (corresponding author), Univ N Carolina, Sch Nursing, Family Hlth Div, Chapel Hill, NC USA.	croscign@email.unc.edu			National Institutes of Nursing Research postdoctoral fellowship Interventions for Preventing and Managing Chronic Illness [5T32NR007091-17]; NINR Ruth L. Kirschstein Predoctoral Research Fellowship [1 F31 NR009599-02]; Psi Chapter of Sigma Theta Tau Grant; American Nurses Foundation Martha E. Brill Scholars Award; University of Washington School of Nursing Hester McLaws Scholarship Fund; University of Washington LEND Training Grant (TG) [6 T73 MC 00041-11-03]; University of Washington Gatzert Child Welfare Fellowship; Integra Lifesciences Grant; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32NR007091, F31NR009599] Funding Source: NIH RePORTER	The author disclosed receipt of the following financial support: Training during the analysis was funded by a National Institutes of Nursing Research postdoctoral fellowship Interventions for Preventing and Managing Chronic Illness (5T32NR007091-17; PI: M. Mishel, PhD). The original research study and predoctoral training was funded by an NINR Ruth L. Kirschstein Predoctoral Research Fellowship (1 F31 NR009599-02), a Psi Chapter of Sigma Theta Tau Grant, a 2006 American Nurses Foundation Martha E. Brill Scholars Award, a University of Washington School of Nursing Hester McLaws Scholarship Fund, a University of Washington LEND Training Grant (TG #6 T73 MC 00041-11-03), a University of Washington Gatzert Child Welfare Fellowship, and an Integra Lifesciences Grant. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of any of the funders.	Adams JA, 2014, HEART LUNG, V43, P406, DOI 10.1016/j.hrtlng.2014.02.001; Adler R. B., 2013, INTERPLAY PROCESS IN; Aitken ME, 2004, ARCH PHYS MED REHAB, V85, P567, DOI 10.1016/j.apmr.2003.06.018; Albrecht T.L., 1987, COMMUNICATING SOCIAL; Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; Auerbach SM, 2005, AM J CRIT CARE, V14, P202, DOI 10.4037/ajcc2005.14.3.202; Bach JR, 2003, ARCH PHYS MED REHAB, V84, pS23, DOI 10.1053/apmr.2003.50243; Beard D, 2009, INT J LISTENING, V23, P7, DOI DOI 10.1080/10904010802591771; Bernat JL, 2009, ANN NY ACAD SCI, V1157, P117, DOI 10.1111/j.1749-6632.2008.04124.x; Bond A Elaine, 2003, Crit Care Nurse, V23, P63; BOURHIS RY, 1989, SOC SCI MED, V28, P339, DOI 10.1016/0277-9536(89)90035-X; Cegala DJ, 2013, PATIENT EDUC COUNS, V93, P34, DOI 10.1016/j.pec.2013.03.015; Coronado V. G., 2010, TRAUMATIC BRAIN INJU; Cronenwett L, 2007, NURS OUTLOOK, V55, P122, DOI 10.1016/j.outlook.2007.02.006; Duff Diane, 2006, Axone, V27, P9; Fins JJ, 2005, HASTINGS CENT REP, V35, P22, DOI 10.1353/hcr.2005.0020; Fins JJ, 2013, ARCH PHYS MED REHAB, V94, P1934, DOI 10.1016/j.apmr.2012.12.028; Gan C, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P621; Gee J. P., 2014, INTRO DISCOURSE ANAL; Grant A M, 1995, Rehabil Nurs, V20, P306; Heyland DK, 2003, INTENS CARE MED, V29, P75, DOI 10.1007/s00134-002-1569-y; Hinds PS, 1997, QUAL HEALTH RES, V7, P408, DOI 10.1177/104973239700700306; Holloway RG, 2010, NEW ENGL J MED, V362, P1757, DOI 10.1056/NEJMp0907808; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Iverson E, 2014, INTENS CRIT CARE NUR, V30, P77, DOI 10.1016/j.iccn.2013.08.008; Jee RA, 2012, PEDIATR CRIT CARE ME, V13, pE166, DOI 10.1097/PCC.0b013e31823893ad; Larson E, 1998, SOC SCI MED, V47, P865, DOI 10.1016/S0277-9536(98)00113-0; LATHER P, 1986, INTERCHANGE, V17, P63, DOI 10.1007/BF01807017; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Marris P., 1986, LOSS AND CHANGE, V2; McMillan TM, 2004, BRAIN INJURY, V18, P935, DOI 10.1080/02699050410001675915; Meert KL, 2013, PEDIATR CLIN N AM, V60, P761, DOI 10.1016/j.pcl.2013.02.011; Michelson KN, 2013, PEDIATR CRIT CARE ME, V14, pE34, DOI 10.1097/PCC.0b013e31826e7408; Miller KS, 2012, PEDIATR BLOOD CANCER, V59, P914, DOI 10.1002/pbc.24146; Morse J, 1994, CRITICAL ISSUES QUAL; Morse JM., 1995, QUALITATIVE RES METH, V2; Nichols R. G., 2006, INT J LISTENING, V20, P4, DOI [10. 1080/10904018. 2006. 10499081, DOI 10.1080/10904018.2006.10499081]; October TW, 2014, PEDIATR CRIT CARE ME, V15, P291, DOI 10.1097/PCC.0000000000000076; Patterson JM, 2002, J CLIN PSYCHOL, V58, P233, DOI 10.1002/jclp.10019; Patton M.Q., 2002, QUALITATIVE RES EVAL; Pelchat D, 2009, J CHILD HEALTH CARE, V13, P239, DOI 10.1177/1367493509336684; Piatt JH, 2012, J NEUROSURG-PEDIATR, V10, P257, DOI 10.3171/2012.7.PEDS11532; Purkis M E, 1997, Can J Nurs Res, V29, P47; Rehling D., 2008, INT J LISTENING, V22, P83, DOI [10.1080/10904010701808516, DOI 10.1080/10904010701808516]; Rolfe G, 2006, J ADV NURS, V53, P304, DOI 10.1111/j.1365-2648.2006.03727.x; Roscigno CI, 2013, BRAIN INJURY, V27, P1536, DOI 10.3109/02699052.2013.831122; Roscigno CI, 2013, SOC SCI MED, V90, P32, DOI 10.1016/j.socscimed.2013.04.017; Roscigno CI, 2012, QUAL HEALTH RES, V22, P1232, DOI 10.1177/1049732312449210; Roscigno CI, 2011, QUAL HEALTH RES, V21, P1413, DOI 10.1177/1049732311410988; Rutter M, 2012, DEV PSYCHOPATHOL, V24, P335, DOI 10.1017/S0954579412000028; Ryan-Nicholls Kimberley D, 2009, Nurse Res, V16, P70; Sandelowski M, 2011, RES NURS HEALTH, V34, P342, DOI 10.1002/nur.20437; Schenker Y, 2013, J PALLIAT MED, V16, P243, DOI 10.1089/jpm.2012.0331; Shapiro J. P., 1993, NO PITY PEOPLE DISAB; Shotter J., 2009, INTJ LISTENING, V23, P21, DOI [10.1080/10904010802591904, DOI 10.1080/10904010802591904]; Shudy M, 2006, PEDIATRICS, V118, pS203, DOI 10.1542/peds.2006-0951B; Solomon Andrew, 2012, FAR TREE PARENTS CHI; Stark M, 2013, HASTINGS CENT REP, V43, P13, DOI 10.1002/hast.188; Swanson K., 1999, HDB CLIN NURSING RES, P31; Swanson K M, 1993, Image J Nurs Sch, V25, P352; Szabo V, 1997, ADV NURS SCI, V20, P66, DOI 10.1097/00012272-199712000-00008; Van Hook MP, 2008, SOCIAL WORK PRACTICE	62	12	12	0	21	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	APR	2016	48	2					E2	E15		10.1097/JNN.0000000000000192			14	Clinical Neurology; Nursing	Neurosciences & Neurology; Nursing	DG5WI	WOS:000372149600002	26871242	Green Accepted			2021-06-18	
J	Tsermoulas, G; Shah, O; Wijesinghe, HE; Silva, AHD; Ramalingam, SK; Belli, A				Tsermoulas, Georgios; Shah, Omid; Wijesinghe, Haren Eranga; Silva, Adikarige Haritha Dulanka; Ramalingam, Satheesh K.; Belli, Antonio			Surgery for Acute Subdural Hematoma: Replace or Remove the Bone Flap?	WORLD NEUROSURGERY			English	Article						Acute subdural hematoma; Brain edema; Craniotomy; Decompressive craniectomy; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; HEAD-INJURY; RETROSPECTIVE ANALYSIS; SURGICAL-MANAGEMENT; CRANIOTOMY; CRANIOPLASTY; IMPACT; EPIDEMIOLOGY; MULTICENTER	OBJECTIVE: In surgery for acute subdural hematoma (ASDH), the bone flap can be fixed onto the skull, left riding to provide partial skull decompression, or removed. This study assessed whether removing the bone flap improved outcome. METHODS: We conducted an observational study on consecutive patients who were operated for ASDH in our hospital from July 2011 to June 2014. We retrospectively collected data on demographics, injury severity, and predicted and observed outcomes at 6 months. The cohort was divided into 2 groups based on whether the bone flap was replaced (fixed and riding flap craniotomy) or removed (decompressive craniectomy). The differences in functional status, postoperative control of intracranial hypertension, and number of cranial reoperations were analyzed. A subgroup analysis compared decompressive craniectomy with riding flap craniotomy alone. RESULTS: Data were obtained for 99 patients; 69 had decompressive craniectomy, 17 had riding flap craniotomy, and 13 had fixed flap craniotomy. The decompressive craniectomy group had statistically worse injuries, more predicted poor outcomes (69% vs. 57%, P = 0.013), more observed poor outcomes (59% vs. 37%, P = 0.037), equivalent control of intracranial hypertension, and a similar number of reoperations compared with the craniotomy groups. Subgroup analysis between decompressive craniectomy and riding flap craniotomy showed no significant difference in baseline characteristics and outcomes. CONCLUSIONS: Our study concluded that removing the bone flap after ASDH evacuation was not associated with a better outcome. We recommend replacing the bone flap if brain conditions allow. Further research is required to evaluate the role of skull decompression in surgery for ASDH.	[Tsermoulas, Georgios; Shah, Omid; Wijesinghe, Haren Eranga; Silva, Adikarige Haritha Dulanka; Belli, Antonio] Queen Elizabeth Hosp, Dept Neurosurg, Birmingham B15 2TH, W Midlands, England; [Ramalingam, Satheesh K.] Queen Elizabeth Hosp, Dept Neuroradiol, Birmingham B15 2TH, W Midlands, England	Tsermoulas, G (corresponding author), Queen Elizabeth Hosp, Dept Neurosurg, Birmingham B15 2TH, W Midlands, England.	georgios.tsermoulas@nhs.net	Belli, Antonio/I-3799-2015	Belli, Antonio/0000-0002-3211-9933			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Bor-Seng-Shu E, 2013, NEUROSURG REV, V36, P361, DOI 10.1007/s10143-013-0453-2; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Chen SH, 2011, J TRAUMA, V71, P1632, DOI 10.1097/TA.0b013e3182367b3c; Chibbaro S, 2013, REV NEUROL-FRANCE, V169, P240, DOI 10.1016/j.neurol.2012.06.016; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Cruz-Flores S, 2012, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858; Dujovny M, 1997, NEUROL RES, V19, P311, DOI 10.1080/01616412.1997.11740818; Edlow BL, 2010, POCKET NEUROLOGY, P34; Honeybul S, 2013, BRIT J NEUROSURG, V27, P636, DOI 10.3109/02688697.2013.817532; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kano T, 2012, NEUROL MED-CHIR, V52, P816, DOI 10.2176/nmc.52.816; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Kenning TJ, 2012, J NEUROSURG, V116, P1289, DOI 10.3171/2012.2.JNS111772; Kim KH, 2009, J KOREAN NEUROSURG S, V45, P143, DOI 10.3340/jkns.2009.45.3.143; Kolias AG, 2013, BRIT J NEUROSURG, V27, P330, DOI 10.3109/02688697.2013.779365; Lee L, 2013, BRIT J NEUROSURG, V27, P629, DOI 10.3109/02688697.2013.815313; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Lu XC, 2014, SCI REP-UK, V4, DOI 10.1038/srep07070; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; Meyer SH, 1996, PRACTICE NEUROSURGER, V2, P1443; Paci GM, 2009, J TRAUMA, V67, P531, DOI 10.1097/TA.0b013e3181b840e8; Perel P, 2012, BMJ-BRIT MED J, V336, P425; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Schmidt JH, 2007, J NEUROSURG, V107, P678, DOI 10.3171/JNS-07/09/0678; Shi SS, 2011, CHIN J TRAUMATOL, V14, P343, DOI 10.3760/cma.j.issn.1008-1275.2011.06.004; Taussky P, 2012, WORLD NEUROSURG, V78, P306, DOI 10.1016/j.wneu.2011.10.030; TJUVAJEV J, 1990, ACT NEUR S, V51, P305; Venkatesh B, 2004, INTENS CARE MED, V30, P510, DOI 10.1007/s00134-003-2102-7; von Elm E, 2007, BMJ-BRIT MED J, V335, P806; Woertgen C, 2006, J CLIN NEUROSCI, V13, P718, DOI 10.1016/j.jocn.2005.08.019	34	12	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2016	88						569	575		10.1016/j.wneu.2015.10.045			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DK1CI	WOS:000374649700074	26523763				2021-06-18	
J	Wee, HY; Ho, CH; Liang, FW; Hsieh, KY; Wang, CC; Wang, JJ; Chio, CC; Chang, CH; Kuo, JR				Wee, Hsiao-Yue; Ho, Chung-Han; Liang, Fu-Wen; Hsieh, Kuang-Yang; Wang, Che-Chuan; Wang, Jhi-Joung; Chio, Chung-Ching; Chang, Chin-Hung; Kuo, Jinn-Rung			Increased Risk of New-Onset Depression in Patients With Traumatic Brain Injury and Hyperlipidemia: The Important Role of Statin Medications	JOURNAL OF CLINICAL PSYCHIATRY			English	Article							UNITED-STATES; PREVALENCE; DISORDERS; COMORBIDITY; POPULATION; SYMPTOMS; OUTCOMES; HEALTH; CONSEQUENCES; CHOLESTEROL	Objective: Depression is a common complication after traumatic brain injury (TBI). This study aimed to evaluate the risk of hyperlipidemia for new-onset depression after TBI and the role of statin medications using a longitudinal population database. Method: A matched longitudinal cohort study of 3,792 subjects (1,264 TBI patients [ICD-9-CM code: 801-804 and 850-854] with preexisting hyperlipidemia [ICD-9-CM code: 272.0, 272.1, 272.2, 272.4] and 2,528 age-and sex-matched TBI patients without hyperlipidemia) was conducted using the Taiwan Longitudinal Health Insurance Database from January 2001 to December 2008. The incidence and hazard ratios (HRs) for the development of new-onset depression (ICD-9-CM code: 296.2X-296.3X, 300.4, and 311.X) after TBI were compared between the 2 groups. Results: The incidence rate of depression in TBI with preexisting hyperlipidemia was 136.61 per 10,000 person-years. TBI patients with preexisting hyperlipidemia had a 1.72-fold increased incidence rate ratio compared with those without hyperlipidemia (P=.0056). A Cox model showed hyperlipidemia to be an independent predictor of depression (HR = 1.61; 95% CI, 1.03-2.53). TBI patients with hyperlipidemia who were not treated with statins experienced a 1.95-fold incidence risk ratio (P=.0017) and higher risk of new-onset depression (HR = 1.61; 95% CI, 1.03-2.53) compared to TBI patients without hyperlipidemia. Conclusions: Preexisting hyperlipidemia could be an independent predictor of new-onset depression in TBI patients, and TBI patients with preexisting hyperlipidemia who were not treated with statins presented a higher risk of new-onset depression than TBI patients without hyperlipidemia. Our findings may provide some insight into the important role of statin medications in the development of new-onset depression in patients with traumatic brain injury. (C) Copyright 2016 Physicians Postgraduate Press, Inc.	[Wee, Hsiao-Yue; Wang, Che-Chuan; Chio, Chung-Ching; Chang, Chin-Hung; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Ho, Chung-Han; Wang, Jhi-Joung; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Hsieh, Kuang-Yang] Chi Mei Med Ctr, Dept Psychiat, Tainan, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan; [Liang, Fu-Wen] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan, Taiwan; [Hsieh, Kuang-Yang; Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Wang, Che-Chuan] Southern Taiwan Univ Sci & Technol, Dept Child Care, Tainan, Taiwan	Kuo, JR (corresponding author), Chi Mei Med Ctr, Traumat Brain Ctr, Dept Neurosurg, 901 Jong Hwa Rd, Tainan 710, Taiwan.	kuojinnrung@gmail.com		Ho, Chung-Han/0000-0001-5925-8477; Liang, Fu-Wen/0000-0002-3396-037X	Chi-Mei Medical Center [CMFHR10337]	This work was supported by Chi-Mei Medical Center grant number CMFHR10337.	Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Aijanseppa S, 2002, INT J GERIATR PSYCH, V17, P629, DOI 10.1002/gps.666; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Can OD, 2012, BEHAV PHARMACOL, V23, P582, DOI 10.1097/FBP.0b013e328356c3f2; Chang HY, 2002, CHINESE J PHYSIOL, V45, P187; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chuang CS, 2014, GEN HOSP PSYCHIAT, V36, P497, DOI 10.1016/j.genhosppsych.2014.05.008; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Dortland AKBV, 2010, J CLIN PSYCHIAT, V71, P729, DOI 10.4088/JCP.08m04865blu; Fang CY, 2013, J BEHAV MED, V36, P143, DOI 10.1007/s10865-012-9409-1; Hadley J, 2003, MED CARE RES REV, V60, p3S, DOI 10.1177/1077558703254101; Hare DL, 2014, EUR HEART J, V35, P1365, DOI 10.1093/eurheartj/eht462; Harpole LH, 2005, GEN HOSP PSYCHIAT, V27, P4, DOI 10.1016/j.genhosppsych.2004.09.004; Higgins TL, 2003, CRIT CARE MED, V31, P45, DOI 10.1097/00003246-200301000-00007; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Kamezaki F, 2011, INTERNAL MED, V50, P2485, DOI 10.2169/internalmedicine.50.5667; Kaufert PA, 2008, MATURITAS, V61, P54, DOI 10.1016/j.maturitas.2008.09.009; Kawamoto R, 2012, ENDOCRINE, V42, P321, DOI 10.1007/s12020-012-9625-z; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Krentz AJ, 2003, DIABETES OBES METAB, V5, pS19, DOI 10.1046/j.1462-8902.2003.0310.x; Kuklina E. V., 2011, Morbidity and Mortality Weekly Report, V60, P109; Leone T, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-39; Llaneza P, 2012, MATURITAS, V71, P120, DOI 10.1016/j.maturitas.2011.11.017; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; McElroy SL, 2014, J CLIN PSYCHIAT, V75, P46, DOI [10.4088/JCP.13r08634, 10.4088/JCP.13010tx4c]; Miller RS, 2000, J TRAUMA, V48, P229, DOI 10.1097/00005373-200002000-00006; Morales K, 2006, J AM GERIATR SOC, V54, P70, DOI 10.1111/j.1532-5415.2005.00542.x; Nelson RH, 2013, PRIMARY CARE, V40, P195, DOI 10.1016/j.pop.2012.11.003; Oetting ER, 1999, SUBST USE MISUSE, V34, P947, DOI 10.3109/10826089909039389; Oquendo MA, 2013, J AFFECT DISORDERS, V150, P1179, DOI 10.1016/j.jad.2013.05.010; Pabayo R, 2014, J EPIDEMIOL COMMUN H, V68, P110, DOI 10.1136/jech-2013-203093; Pan A, 2011, ARCH GEN PSYCHIAT, V68, P42, DOI 10.1001/archgenpsychiatry.2010.176; Rapoport M, 2002, NEUROPSY NEUROPSY BE, V15, P123, DOI 10.1097/01.WNN.0000016801.80266.36; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; Thomas J, 2003, DIABETES CARE, V26, P2311, DOI 10.2337/diacare.26.8.2311; Tsai TY, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-976; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	45	12	12	0	4	PHYSICIANS POSTGRADUATE PRESS	MEMPHIS	P O BOX 752870, MEMPHIS, TN 38175-2870 USA	0160-6689	1555-2101		J CLIN PSYCHIAT	J. Clin. Psychiatry	APR	2016	77	4					505	511		10.4088/JCP.14m09749			7	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	DQ5LU	WOS:000379247700016	27035519				2021-06-18	
J	Sacco, K; Gabbatore, I; Geda, E; Duca, S; Cauda, F; Bara, BG; Bosco, FM				Sacco, Katiuscia; Gabbatore, Ilaria; Geda, Elisabetta; Duca, Sergio; Cauda, Franco; Bara, Bruno G.; Bosco, Francesca M.			Rehabilitation of Communicative Abilities in Patients with a History of TBI: Behavioral Improvements and Cerebral Changes in Resting-State Activity	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						cognitive rehabilitation; communicative abilities; traumatic brain injury (TBI); functional magnetic resonance imaging (fMRI); cerebral plasticity	TRAUMATIC BRAIN-INJURY; LOW-FREQUENCY FLUCTUATIONS; EMOTIONAL PROSODY; COGNITIVE REHABILITATION; FUNCTIONAL NEUROANATOMY; PRAGMATIC TREATMENT; CONNECTIVITY; PLASTICITY; AMPLITUDE; FMRI	A targeted training program for the rehabilitation of communicative abilities Cognitive Pragmatic Treatment (CPT) has been developed and previously tested on a sample of patients with traumatic brain injury (TBI), whose performance was found to have improved. Since cortical plasticity has been recognized as the main mechanism of functional recovery, we investigated whether and how behavioral improvements following the training program are accompanied by brain modifications. Eight TBI patients took part in the training program and were behaviorally assessed pre- and post-treatment; six of these patients were also evaluated with pre- and post-treatment resting state (rs) functional magnetic resonance imaging (fMRI). At the end of the rehabilitation program patients showed improvement in overall communicative performance, in both comprehension and production tasks. A follow-up retest revealed the stability of these results 3 months after completing the training program. At the brain level, we found significant increases in the amplitude of low frequency fluctuation (ALFF) index in the bilateral precentral gyrus, in the right middle and superior temporal gyri, in the right cingulate gyrus, and in the left inferior parietal lobule. We discuss these differences of brain activity in terms of their possible contribution to promoting recovery.	[Sacco, Katiuscia; Geda, Elisabetta] Univ Turin, Dept Psychol, Imaging & Cerebral Plast Res Grp, Turin, Italy; [Sacco, Katiuscia; Bara, Bruno G.; Bosco, Francesca M.] Univ Turin, Dept Psychol, Ctr Cognit Sci, Turin, Italy; [Sacco, Katiuscia; Duca, Sergio; Cauda, Franco; Bara, Bruno G.; Bosco, Francesca M.] Univ Turin, Neurosci Inst Turin, Turin, Italy; [Gabbatore, Ilaria] Univ Oulu, Child Language Res Ctr, Res Unit Logoped, Fac Humanities, Oulu, Finland; [Duca, Sergio; Cauda, Franco] Univ Turin, Dept Psychol, Koelliker Hosp, GCS fMRI, Turin, Italy	Gabbatore, I (corresponding author), Univ Oulu, Child Language Res Ctr, Res Unit Logoped, Fac Humanities, Oulu, Finland.	ilaria.gabbatore@oulu.fi	bosco, francesca marina/B-6746-2013; Gabbatore, Ilaria/AAC-1925-2019; Cauda, Franco/G-5021-2010	bosco, francesca marina/0000-0001-6101-8587; Gabbatore, Ilaria/0000-0002-9724-8066; Cauda, Franco/0000-0003-1526-8475	Brain Imaging Group ONL US	This study has been supported by Brain Imaging Group ONL US and by local research funds (ex 60%) managed by University of Turin, Department of Psychology, year 2014. We are grateful to the reviewers, whose comments helped us greatly to improve the article.	Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Angeleri R., 2015, BATTERIA ASSESSMENT; Angeleri R, 2012, BEHAV RES METHODS, V44, P845, DOI 10.3758/s13428-011-0174-9; Bara BG, 2001, BRAIN LANG, V77, P72, DOI 10.1006/brln.2000.2430; Bara BG., 2010, COGNITIVE PRAGMATICS; Barkley RA, 2001, J CONSULT CLIN PSYCH, V69, P926, DOI 10.1037//0022-006X.69.6.926; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Berlucchi G, 2011, NEUROPSYCHOL REHABIL, V21, P560, DOI 10.1080/09602011.2011.573255; Bosco FM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00166; Bosco FM, 2015, INT J LANG COMM DIS, V50, P63, DOI 10.1111/1460-6984.12114; Bosco FM, 2013, J CHILD LANG, V40, P741, DOI 10.1017/S0305000913000081; Bosco FM, 2012, J COMMUN DISORD, V45, P290, DOI 10.1016/j.jcomdis.2012.03.002; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Buchanan TW, 2000, COGNITIVE BRAIN RES, V9, P227, DOI 10.1016/S0926-6410(99)00060-9; Carlomagno S, 2011, BRAIN INJURY, V25, P1010, DOI 10.3109/02699052.2011.605097; Champagne-Lavau M, 2006, CURR PSYCHIATRY REV, V2, P309, DOI 10.2174/157340006778018184; Chen HW, 2010, PM&R, V2, pS306, DOI 10.1016/j.pmrj.2010.10.006; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Coelho C, 2013, AM J SPEECH-LANG PAT, V22, pS438, DOI 10.1044/1058-0360(2013/12-0076); Colle L, 2013, J COMMUN DISORD, V46, P294, DOI 10.1016/j.jcomdis.2013.01.003; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Ethofer T, 2006, NEUROIMAGE, V30, P580, DOI 10.1016/j.neuroimage.2005.09.059; Eviatar Z, 2006, NEUROPSYCHOLOGIA, V44, P2348, DOI 10.1016/j.neuropsychologia.2006.05.007; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gabbatore I, 2015, J HEAD TRAUMA REHAB, V30, pE14, DOI 10.1097/HTR.0000000000000087; Gabbatore L, 2014, MINERVA PSICHIATR, V55, P45; Glasser MF, 2008, CEREB CORTEX, V18, P2471, DOI 10.1093/cercor/bhn011; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Huber W., 1983, AACHENER APHASIE TES; Kou ZF, 2014, NEURAL REGEN RES, V9, P693, DOI 10.4103/1673-5374.131568; Krawczyk DC, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-29; Kuchinke L, 2005, NEUROIMAGE, V28, P1022, DOI 10.1016/j.neuroimage.2005.06.050; Kuperberg GR, 2000, J COGNITIVE NEUROSCI, V12, P321, DOI 10.1162/089892900562138; Laatsch L, 2006, BRAIN INJURY, V20, P1367, DOI 10.1080/02699050600983743; Lampit A, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00014; Li CM, 2014, BEHAV BRAIN RES, V274, P205, DOI 10.1016/j.bbr.2014.08.019; Liu XN, 2014, J ALZHEIMERS DIS, V40, P387, DOI 10.3233/JAD-131322; Long DL, 2002, J COGNITIVE NEUROSCI, V14, P228, DOI 10.1162/089892902317236867; Mashal N, 2007, BRAIN LANG, V100, P115, DOI 10.1016/j.bandl.2005.10.005; McDonald S., 2000, COMMUNICATION DISORD; Mitchell RLC, 2003, NEUROPSYCHOLOGIA, V41, P1410, DOI 10.1016/S0028-3932(03)00017-4; Munoz-Cespedes JM, 2005, NEUROPSYCHOL REV, V15, P169, DOI 10.1007/s11065-005-9178-5; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nordvik JE, 2014, NEUROREHABILITATION, V34, P81, DOI 10.3233/NRE-131017; Nudo RJ, 2011, J COMMUN DISORD, V44, P515, DOI 10.1016/j.jcomdis.2011.04.004; Parola A, 2016, J NEUROLINGUIST, V39, P10, DOI 10.1016/j.jneuroling.2015.12.003; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Pieramico V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043901; Rapp AM, 2012, NEUROIMAGE, V63, P600, DOI 10.1016/j.neuroimage.2012.06.022; Robertson DA, 2000, PSYCHOL SCI, V11, P255, DOI 10.1111/1467-9280.00251; Sacco K, 2008, J COGN SCI, V9, P111; Sacco K., 2015, 5 SCI M ESN 12 NORD; Sacco K, 2013, B PSICOL APPL, P55; Sacco K, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00146; Sacco K, 2009, BRAIN RES, V1297, P124, DOI 10.1016/j.brainres.2009.08.049; Silasi G, 2014, NEURON, V83, P1354, DOI 10.1016/j.neuron.2014.08.052; STARKSTEIN SE, 1994, NEUROLOGY, V44, P515, DOI 10.1212/WNL.44.3_Part_1.515; Strangman G, 2005, AM J PHYS MED REHAB, V84, P62, DOI 10.1097/01.PHM.0000150787.26860.12; Taylor SF, 1998, NEUROIMAGE, V8, P188, DOI 10.1006/nimg.1998.0356; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Torta DM, 2011, NEUROIMAGE, V56, P2157, DOI 10.1016/j.neuroimage.2011.03.066; Wang AT, 2006, SOC COGN AFFECT NEUR, V1, P107, DOI 10.1093/scan/nsl018; Yin SF, 2014, SCI REP-UK, V4, DOI 10.1038/srep07309; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zou QH, 2013, HUM BRAIN MAPP, V34, P3204, DOI 10.1002/hbm.22136	69	12	12	0	13	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	MAR 22	2016	10								48	10.3389/fnbeh.2016.00048			10	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	DH1TR	WOS:000372568300001	27047353	DOAJ Gold, Green Published			2021-06-18	
J	Vlagsma, TT; Koerts, J; Fasotti, L; Tucha, O; van Laar, T; Dijkstra, H; Spikman, JM				Vlagsma, T. T.; Koerts, J.; Fasotti, L.; Tucha, O.; van Laar, T.; Dijkstra, H.; Spikman, J. M.			Parkinson's patients' executive profile and goals they set for improvement: Why is cognitive rehabilitation not common practice?	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Neuropsychological rehabilitation; Parkinson's disease; Acquired brain injury; Goal setting; Executive functions	TRAUMATIC BRAIN-INJURY; DISEASE PATIENTS; IMPAIRMENT; AWARENESS; DEFICITS; DYSFUNCTION; MEDICATION; LIFE	Impairments in executive functions (EF) are the core cognitive impairment in patients with Parkinson's disease (PD). Surprisingly, cognitive rehabilitation is not routinely offered to patients with PD. However, in patients with acquired brain injury (ABI), cognitive rehabilitation, in particular strategic executive training, is common practice and has been shown to be effective. In this study, we determined whether PD patients have different needs and aims with regard to strategic executive training than ABI patients, and whether possible differences might be a reason for not offering this kind of cognitive rehabilitation programme to patients with PD. Patients' needs and aims were operationalised by individually set goals, which were classified into domains of EF and daily life. In addition, patients with PD and ABI were compared on their cognitive, in particular EF, profile. Overall, PD patients' goals and cognitive profile were similar to those of patients with ABI. Therefore, based on the findings of this study, there is no reason to assume that strategic executive training cannot be part of standard therapy in PD. However, when strategic executive training is applied in clinical practice, disease-specific characteristics need to be taken into account.	[Vlagsma, T. T.; Koerts, J.; Tucha, O.; Spikman, J. M.] Univ Groningen, Dept Clin & Dev Neuropsychol, NL-9712 TS Groningen, Netherlands; [Fasotti, L.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Fasotti, L.] Rehabil Med Ctr Groot Klimmendaal, Arnhem, Netherlands; [van Laar, T.; Spikman, J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9712 TS Groningen, Netherlands; [Dijkstra, H.] Med Ctr Nij Smellinghe, Dept Med Psychol, Drachten, Netherlands	Vlagsma, TT (corresponding author), Univ Groningen, RuG,Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands.	t.t.vlagsma@rug.nl	Tucha, Oliver/AAD-1403-2019; van Laar, Teus/AAO-3906-2021	Spikman, Jacoba/0000-0002-6477-0763; van Laar, Teus/0000-0001-5088-480X	Dutch Organization for Scientific Research (NWO)Netherlands Organization for Scientific Research (NWO); National Initiative Brain and Cognition (NIHC) [056-11-012]	This work was supported by the Dutch Organization for Scientific Research (NWO), the National Initiative Brain and Cognition (NIHC) under Grant [056-11-012]. This quick-result project is embedded in the pillar "The Healthy Brain, Program Cognitive Rehabilitation".	Barkley R., 2011, DEFICITS EXECUTIVE F; Bloem BR, 2010, MULTIDISCIPLINAIRE R; Bouwens SFM, 2009, CLIN REHABIL, V23, P310, DOI 10.1177/0269215508101744; Broeders M, 2013, J INT NEUROPSYCH SOC, V19, P695, DOI 10.1017/S1355617713000295; Cahn DA, 1998, ARCH CLIN NEUROPSYCH, V13, P575, DOI 10.1016/S0887-6177(98)00024-9; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Colman KSF, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/213983; Colman KSF, 2009, CORTEX, V45, P930, DOI 10.1016/j.cortex.2008.12.010; Cools R, 2001, CEREB CORTEX, V11, P1136, DOI 10.1093/cercor/11.12.1136; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; Deelman B. G., 1980, NEUROPSYCHOLOGIE NED, P253; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Edwards JD, 2013, NEUROLOGY, V81, P1284, DOI 10.1212/WNL.0b013e3182a823ba; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Ertzgaard P, 2011, J REHABIL MED, V43, P8, DOI 10.2340/16501977-0664; Esselink RAJ, 2004, NEUROLOGY, V62, P201, DOI 10.1212/01.WNL.0000103235.12621.C3; Evans JJ, 2012, CURR OPIN NEUROL, V25, P651, DOI 10.1097/WCO.0b013e3283598f75; Fahn S, 1987, RECENT DEV PARKINSON, V2, P153; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; Goldman JG, 2012, MOVEMENT DISORD, V27, P1129, DOI 10.1002/mds.25062; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Heerkens Y. F., 2002, NEDERLANDS VERTALING; Herrera E, 2011, J NEUROL SCI, V310, P237, DOI 10.1016/j.jns.2011.06.034; Hindle JV, 2013, MOVEMENT DISORD, V28, P1034, DOI 10.1002/mds.25377; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Klepac N, 2008, EUR J NEUROL, V15, P128, DOI 10.1111/j.1468-1331.2007.02011.x; Koerts J, 2012, PARKINSONISM RELAT D, V18, P194, DOI 10.1016/j.parkreldis.2011.10.002; Koerts J, 2011, J NEUROL SCI, V310, P172, DOI 10.1016/j.jns.2011.07.009; Kudlicka A, 2011, MOVEMENT DISORD, V26, P2305, DOI 10.1002/mds.23868; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Luteijn F., 1983, GRONINGER INTELLIGEN; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McKinlay A, 2010, J INT NEUROPSYCH SOC, V16, P268, DOI 10.1017/S1355617709991299; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mohlman Jan, 2010, Clin Case Stud, V9, P74; Mohlman J, 2011, J GERIATR PSYCH NEUR, V24, P91, DOI 10.1177/0891988711402350; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; Naismith SL, 2013, MOVEMENT DISORD, V28, P1097, DOI 10.1002/mds.25457; Nombela Cristina, 2011, Front Neurol, V2, P82, DOI 10.3389/fneur.2011.00082; Perbal-Hatif Severine, 2012, Dialogues Clin Neurosci, V14, P425; Perna R, 2012, APPL NEUROPSYCH-ADUL, V19, P263, DOI 10.1080/09084282.2012.670147; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Paris AP, 2011, MOVEMENT DISORD, V26, P1251, DOI 10.1002/mds.23688; Rasquin SMC, 2004, DEMENT GERIATR COGN, V18, P138, DOI 10.1159/000079193; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reuter I, 2012, J AGING RES, V2012, P1, DOI DOI 10.1155/2012/235765; Sammer G, 2006, J NEUROL SCI, V248, P115, DOI 10.1016/j.jns.2006.05.028; Simons J.S., 2005, EFFECTIVENESS REHABI, V211, DOI [10.1093/acprof:oso/9780198526544.003.0018, DOI 10.1093/ACPROF:OSO/9780198526544.001.0001]; Sinforiani E, 2004, ARCH GERONTOL GERIAT, P387; Solla P, 2014, J NEUROL, V261, P382, DOI 10.1007/s00415-013-7207-5; Spikman J. M., 2012, KLIN NEUROPSYCHOLOGI, P125; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Vale S, 2008, EXP BIOL MED, V233, P941, DOI 10.3181/0707-MR-193; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wilson BA, 1996, BEHAV ASSESSMENT DYS; Wilson BA, 2008, ANNU REV CLIN PSYCHO, V4, P141, DOI 10.1146/annurev.clinpsy.4.022007.141212; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU	64	12	12	0	38	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAR 3	2016	26	2					216	235		10.1080/09602011.2015.1013138			20	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	DA5AT	WOS:000367815200003	25693688				2021-06-18	
J	Galgano, MA; Cantu, R; Chin, LS				Galgano, Michael A.; Cantu, Robert; Chin, Lawrence S.			Chronic Traumatic Encephalopathy: The Impact on Athletes	CUREUS			English	Article						chronic traumatic encephalopathy; mild traumatic brain injury; repetitive traumatic brain injury; athletics; sports; high impact sports	BRAIN-INJURY; HIGH-SCHOOL; MOUSE MODEL; CONCUSSION; SPORTS; TAUOPATHY; DISEASE; TDP-43; TAU	Chronic traumatic encephalopathy (CTE) is a devastating neuropsychological condition afflicting a small percentage of athletes partaking in high-impact sports. The onset of symptoms lags years behind the inciting events. Repetitive minor head injuries are felt to be the main etiology behind CTE. Routine radiographic imaging generally is unremarkable in cases of CTE. Functional magnetic resonance imaging (fMRI), magnetic resonance spectroscopy (MRS), and diffusion tensor imaging (DTI) are advanced MRI-based sequences that have shown promise in detecting early radiographic findings that may be reflective of CTE. Progressive neuronal loss is the histopathological hallmark of this neurodegenerative disease. Strategizing earlier detection techniques is paramount in delivering optimal care to athletes afflicted with CTE.	[Galgano, Michael A.; Chin, Lawrence S.] SUNY Upstate Med Univ, Neurosurg, Syracuse, NY 13210 USA; [Cantu, Robert] Emerson Hosp, Neurosurg, Concord, MA USA	Galgano, MA (corresponding author), SUNY Upstate Med Univ, Neurosurg, Syracuse, NY 13210 USA.	mgalgano13@gmail.com					[Anonymous], 2015, NON TRADITIONAL REF; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; BUEE L, 1994, ACTA NEUROPATHOL, V87, P469; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Flannagan P.P., 1998, CONT NEUROSURG, V20, P1; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; JORDAN BD, 1987, ARCH NEUROL-CHICAGO, V44, P453, DOI 10.1001/archneur.1987.00520160083020; Lakis N, 2013, NEUROL RES, V35, P290, DOI 10.1179/1743132813Y.0000000177; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; Maxwell WL, 2006, J NEUROPATH EXP NEUR, V65, P478, DOI 10.1097/01.jnen.0000229241.28619.75; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Millspaugh J., 1937, US NAVAL MED B, V35, P297; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Pulsipher DT, 2011, CURR SPORT MED REP, V10, P14, DOI 10.1249/JSR.0b013e31820711b8; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; STILLER JW, 1985, PSYCHIAT CLIN N AM, V8, P339; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5; Zhang L, 2006, AM J NEURORADIOL, V27, P2000	37	12	12	0	10	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	MAR	2016	8	3							e532	10.7759/cureus.532			10	Medicine, General & Internal	General & Internal Medicine	VH6DZ	WOS:000453611000018	27088064	Other Gold, Green Published			2021-06-18	
J	Guernsey, DT; Leder, A; Yao, S				Guernsey, David T., III; Leder, Adena; Yao, Sheldon			Resolution of Concussion Symptoms After Osteopathic Manipulative Treatment: A Case Report	JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION			English	Article							TRAUMATIC BRAIN-INJURY; BALANCE	A concussion is the result of a biomechanical force directed toward the head, causing neurologic dysfunction. The inflammatory response and the production of reactive oxygen species are proposed mechanisms for the symptoms and long-term sequelae of concussion. Osteopathic manipulative treatment (OMT) may help reduce inflammation by improving glymphatic flow. The authors describe the effect of OMT on a patient with mild concussion symptoms, including nausea, dizziness, tinnitus, and imbalance. The patient was evaluated with the Sensory Organization Test before and after undergoing a 25-minute session of OMT. After the session, the patient reported resolution of symptoms, and his sensory organization test score improved by 6 points. The role of OMT must be further investigated as an essential and cost-effective tool in the management of concussions.	[Guernsey, David T., III; Leder, Adena; Yao, Sheldon] New York Inst Technol, Dept Osteopath Manipulat Med, Coll Osteopath Med, Northern Blvd,POB 8000, Old Westbury, NY 11568 USA	Yao, S (corresponding author), New York Inst Technol, Dept Osteopath Manipulat Med, Coll Osteopath Med, Northern Blvd,POB 8000, Old Westbury, NY 11568 USA.	syao@nyit.edu					Anderson RE, 2006, HEADACHE, V46, P1273, DOI 10.1111/j.1526-4610.2006.00535.x; Bell JM, 2015, J HEAD TRAUMA REHAB, V30, P148, DOI 10.1097/HTR.0000000000000143; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Brolinson P Gunnar, 2014, Clin J Sport Med, V24, P89, DOI 10.1097/JSM.0000000000000062; Centers for Disease Control and Prevention, 2015, C TRAUM BRAIN INJ US; Chappell C, 2015, OSTEOPATH FAM PHYS, V7, P30; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dreha-Kulaczewski S, 2015, J NEUROSCI, V35, P2485, DOI 10.1523/JNEUROSCI.3246-14.2015; Drijkoningen D, 2015, NEUROIMAGE-CLIN, V7, P240, DOI 10.1016/j.nicl.2014.12.006; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fraix M, 2013, J AM OSTEOPATH ASSOC, V113, P394; Knott EM, 2005, J AM OSTEOPATH ASSOC, V105, P447; Kraus J. F., 1999, REHABILITATION ADULT, P3; Lopez D, 2011, J AM OSTEOPATH ASSOC, V111, P382, DOI 10.7556/jaoa.2011.111.6.382; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Marinides Zoe, 2015, Neurol Clin Pract, V5, P25, DOI 10.1212/CPJ.0000000000000060; MCLAIN RF, 1994, SPINE, V19, P495, DOI 10.1097/00007632-199403000-00001; Mechtler LL, 2014, NEUROL CLIN, V32, P31, DOI 10.1016/j.ncl.2013.08.002; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Sergueef N, 2002, ALTERN THER HEALTH M, V8, P74	21	12	12	0	6	AMER OSTEOPATHIC ASSN	CHICAGO	142 EAST ONTARIO STREET, CHICAGO, IL 60611-2864 USA	0098-6151	1945-1997		J AM OSTEOPATH ASSOC	J. Am. Osteopath. Assoc.	MAR	2016	116	3					E13	E17		10.7556/jaoa.2016.036			5	Medicine, General & Internal	General & Internal Medicine	DT8NE	WOS:000381746700001	26927914				2021-06-18	
J	Guevara, AB; Demonet, JF; Polejaeva, E; Knutson, KM; Wassermann, EM; Grafman, J; Krueger, F				Guevara, Andrea Brioschi; Demonet, Jean-Francois; Polejaeva, Elena; Knutson, Kristine M.; Wassermann, Eric M.; Grafman, Jordan; Krueger, Frank			Association Between Traumatic Brain Injury-Related Brain Lesions and Long-term Caregiver Burden	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						traumatic brain injury (TBI); dorsal anterior cingulate cortex (dACC); caregiver burden; dorsolateral prefrontal cortex (dlPFC); executive functions (EFs); dysexecutive syndrome	MENTAL-HEALTH; ANTERIOR CINGULATE; VERBAL FLUENCY; FAMILY NEEDS; HEAD-INJURY; TBI; METAANALYSIS; ACTIVATION; PREDICTORS; CORTEX	Objective: To investigate the association between traumatic brain injury (TBI)-related brain lesions and long-term caregiver burden in relation to dysexecutive syndrome. Setting: National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland. Participants: A total of 256 participants: 105 combat veterans with TBI, 23 healthy control combat veterans (HCv), and 128 caregivers. Outcome Measure: Caregiver burden assessed by the Zarit Burden Interview at 40 years postinjury. Design: Participants with penetrating TBI were compared with HCv on perceived caregiver burden and neuropsychological assessment measures. Data of computed tomographic scans (overlay lesion maps of participants with a penetrating TBI whose caregivers have a significantly high burden) and behavioral statistical analyses were combined to identify brain lesions associated with caregiver burden. Results: Burden was greater in caregivers of veterans with TBI than in caregivers of HCv. Caregivers of participants with lesions affecting cognitive and behavioral indicators of dysexecutive syndrome (ie, left dorsolateral prefrontal cortex and dorsal anterior cingulate cortex) showed greater long-term burden than caregivers of participants with lesions elsewhere in the brain. Conclusion and Implication: The TBI-related brain lesions have a lasting effect on long-term caregiver burden due to cognitive and behavioral factors associated with dysexecutive syndrome.	[Guevara, Andrea Brioschi; Polejaeva, Elena; Knutson, Kristine M.; Wassermann, Eric M.] NINDS, Behav Neurol Unit, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Guevara, Andrea Brioschi] Univ Lausanne, Fac Biol & Med, Lausanne, VD, Switzerland; [Guevara, Andrea Brioschi; Demonet, Jean-Francois] Univ Lausanne, Leenaards Memory Ctr, CHUV, Lausanne, VD, Switzerland; [Grafman, Jordan] Northwestern Univ, Psychiat & Behav Sci & Cognit Neurol,Dept Phys Me, Rehabil Inst Chicago,Dept Psychol,Cognit Neurosci, Sch Med,Brain Injury Res,Azheimer Dis Ctr, Chicago, IL USA; [Krueger, Frank] George Mason Univ, Mol Neurosci Dept, 4400 Univ Dr,Mail Stop 2A1, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA	Krueger, F (corresponding author), George Mason Univ, Mol Neurosci Dept, 4400 Univ Dr,Mail Stop 2A1, Fairfax, VA 22030 USA.	FKrueger@gmu.edu	Wassermann, Eric M./AAC-9064-2020	Wassermann, Eric M./0000-0003-0628-0210; Demonet, Jean-Francois/0000-0003-0100-6175	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS002977] Funding Source: NIH RePORTER; Intramural NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [Z99 NS999999] Funding Source: Medline		Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Audenaert K, 2000, EUR J NUCL MED, V27, P1800, DOI 10.1007/s002590000351; Badre D, 2012, P NATL ACAD SCI USA, V109, P19878, DOI 10.1073/pnas.1216902109; Barch DM, 2000, J COGNITIVE NEUROSCI, V12, P298, DOI 10.1162/089892900562110; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; Buchsbaum BR, 2005, HUM BRAIN MAPP, V25, P35, DOI 10.1002/hbm.20128; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cosseddu M, 2013, INT J GERIATR PSYCH, V28, P655, DOI 10.1002/gps.3892; de Vugt ME, 2006, DEMENT GERIATR COGN, V22, P35, DOI 10.1159/000093102; Delis D.C., 2001, DELIS KAPLAN EXECUTI; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Doyle ST, 2013, BRAIN INJURY, V27, P1441, DOI 10.3109/02699052.2013.826505; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Feinberg L., 2011, VALUING INVALUABLE 2; Gauthier CT, 2009, CORTEX, V45, P164, DOI 10.1016/j.cortex.2007.09.006; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Guevara AB, 2015, J HEAD TRAUMA REHAB, V30, pE26, DOI 10.1097/HTR.0000000000000046; Hagen K, 2014, NEUROIMAGE, V85, P583, DOI 10.1016/j.neuroimage.2013.09.014; Jackson D, 2009, BRAIN INJURY, V23, P433, DOI 10.1080/02699050902788451; Jacobson SC, 2011, BRAIN COGNITION, V77, P60, DOI 10.1016/j.bandc.2011.06.001; JETTE AM, 1986, J GEN INTERN MED, V1, P143, DOI 10.1007/BF02602324; Kaplan E., 2001, Boston naming test; KEANE TM, 1988, J CONSULT CLIN PSYCH, V56, P85, DOI 10.1037/0022-006X.56.1.85; Knutson KM, 2008, DEMENT GERIATR COGN, V26, P467, DOI 10.1159/000167268; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kramer JH, 2007, J INT NEUROPSYCH SOC, V13, P386, DOI 10.1017/S1355617707070567; Laird AR, 2005, HUM BRAIN MAPP, V25, P6, DOI 10.1002/hbm.20129; Leggett AN, 2011, GERONTOLOGIST, V51, P76, DOI 10.1093/geront/gnq055; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Livingston LA, 2010, NEUROREHABILITATION, V27, P73, DOI 10.3233/NRE-2010-0582; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Malloy PF, 2001, FRONTAL SYSTEMS BEHA; Mars RB, 2011, NEURAL BASIS OF MOTIVATIONAL AND COGNITIVE CONTROL, P1; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Merkley TL, 2013, J INT NEUROPSYCH SOC, V19, P899, DOI 10.1017/S135561771300074X; Moules S, 1999, BRAIN INJURY, V13, P983; Nonterah CW, 2013, BRAIN INJURY, V27, P1287, DOI 10.3109/02699052.2013.812243; Pa J, 2010, J INT NEUROPSYCH SOC, V16, P640, DOI 10.1017/S1355617710000408; Papastavrou E, 2011, AGING MENT HEALTH, V15, P702, DOI 10.1080/13607863.2011.562178; Phelan SM, 2011, DISABIL HEALTH J, V4, P177, DOI 10.1016/j.dhjo.2011.03.003; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Scarmeas Nikolaos, 2004, Curr Neurol Neurosci Rep, V4, P374, DOI 10.1007/s11910-004-0084-7; Schintu S, 2014, CORTEX, V57, P244, DOI 10.1016/j.cortex.2014.04.009; Schreiner AS, 2006, AGING MENT HEALTH, V10, P107, DOI 10.1080/13607860500312142; Senhorini MCT, 2011, J CLIN EXP NEUROPSYC, V33, P864, DOI 10.1080/13803395.2011.561299; Shafritz KM, 2005, NEUROIMAGE, V25, P600, DOI 10.1016/j.neuroimage.2004.12.054; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Stern Y, 2013, FOLIA PHONIATR LOGO, V65, P49, DOI 10.1159/000353443; Su YL, 2012, NEUROSCI LETT, V525, P173, DOI 10.1016/j.neulet.2012.07.032; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; U. S. Department of Defense, 1984, TEST MAN ARM SERV VO; Warrington E., 1991, VISUAL OBJECT SPACE; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Yuan P, 2014, NEUROSCI BIOBEHAV R, V42, P180, DOI 10.1016/j.neubiorev.2014.02.005; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013; ZARIT SH, 1986, GERONTOLOGIST, V26, P260, DOI 10.1093/geront/26.3.260	66	12	12	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2016	31	2			SI		E48	E58		10.1097/HTR.0000000000000151			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DH7NQ	WOS:000372981300005	26098258	Green Accepted			2021-06-18	
J	Hui, H; Rao, W; Zhang, L; Xie, Z; Peng, C; Su, N; Wang, K; Wang, L; Luo, P; Hao, YL; Zhang, S; Fei, Z				Hui, Hao; Rao, Wei; Zhang, Lei; Xie, Zhen; Peng, Cheng; Su, Ning; Wang, Kai; Wang, Li; Luo, Peng; Hao, Ye-lu; Zhang, Sai; Fei, Zhou			Inhibition of Na+-K+-2Cl(-) Cotransporter-1 attenuates traumatic brain injury-induced neuronal apoptosis via regulation of Erk signaling	NEUROCHEMISTRY INTERNATIONAL			English	Article						Traumatic brain injury; Neurons; NKCC1; Erk; Apoptosis	ACTIVATED PROTEIN-KINASE; K-CL COTRANSPORTER; IN-VITRO; MEDIATED EXCITOTOXICITY; ENDOPLASMIC-RETICULUM; DOWN-REGULATION; HOMER 1A; EDEMA; NA+; MODEL	Traumatic brain injury (TBI) is the leading cause of mortality and morbidity worldwide and is characterized by immediate brain damage and secondary injuries, such as brain edema and ischemia. However, the exact pathological mechanisms that comprise these associated secondary injuries have not been fully elucidated. This study aimed to investigate the role of the Na+-K+-2Cl(-) cotransporter-1 (NKCC1) in the disruption of ion homeostasis and neuronal apoptosis in TBI. Using a traumatic neuron injury (TNI) model in vitro and a controlled cortex injury (CCI) model in vivo, the present study investigated changes in the expression and effects of NKCC1 in TBI using western blot, RNA interference, a lactate dehydrogenase (LDH) release assay, TdT-mediated dUTP Nick end-labeling (TUNEL) analysis, sodium imaging, brain water content, and neurological severity scoring. TBI induced the expression of NKCC1 to be significantly upregulated in the cortex, both in vitro and in vivo. Pharmacological inhibitor bumetanide (Bume) or NKCC1 RNA interference significantly attenuated TBI-induced intracellular Na+ increase, inhibited neuronal apoptosis, and improved brain edema and neurological function. Furthermore, NKCC1 inhibition also significantly inhibited TBI-induced extracellular signal-regulated kinase (Erk) activation. Erk inhibition significantly protected neurons from TBI injury; however, Erk inhibition had no effect on NKCC1 expression or the neuroprotective effect of NKCC1 inhibition against TBI. This study demonstrates the role of NKCC1 in MI-induced brain cortex injury, establishing that NKCC1 may play a neurotoxic role in TBI and that the inhibition of NKCC1 may protect neurons from TBI via the regulation of Erk signaling. (C) 2016 Elsevier Ltd. All rights reserved.	[Hui, Hao; Rao, Wei; Zhang, Lei; Xie, Zhen; Peng, Cheng; Su, Ning; Wang, Kai; Wang, Li; Luo, Peng; Hao, Ye-lu; Fei, Zhou] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China; [Zhang, Sai] Univ Chinese Armed Police Forces, Affiliated Hosp Logist, Dept Neurosurg, Chenglin Rd, Tianjin 300162, Peoples R China	Fei, Z (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China.; Zhang, S (corresponding author), Univ Chinese Armed Police Forces, Affiliated Hosp Logist, Dept Neurosurg, Chenglin Rd, Tianjin 300162, Peoples R China.	zhangsai718@vip.126.com; feizhou@fmmu.edu.cn		Luo, Peng/0000-0003-0746-939X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81430043, 81200949, 30930093]; National Science and Technology Major Project of China [2013ZX09J13109-02C]; National Science and Technology Pillar Program of China [2012BAI11B02]; Science and Technology Project of Shaanxi [2013KTCQ03-01]; Program for Changjiang Scholars and Innovative Research Team in UniversityProgram for Changjiang Scholars & Innovative Research Team in University (PCSIRT) [IRT-14208]; Key Project of the Twelfth Five-year Plan of Scientific Research of China [AWS11J008]	We are indebted to the members of our laboratories in the Department of Neurosurgery, Xijing Hospital of the Fourth Military Medical University. This work was supported by the National Natural Science Foundation of China (Nos. 81430043, 81200949, 30930093), the National Science and Technology Major Project of China (2013ZX09J13109-02C), the National Science and Technology Pillar Program of China (No. 2012BAI11B02), the Science and Technology Project of Shaanxi (No. 2013KTCQ03-01), the Program for Changjiang Scholars and Innovative Research Team in University (No. IRT-14208), and the Key Project of the Twelfth Five-year Plan of Scientific Research of China (AWS11J008).	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Beck J, 2003, J NEUROSCI, V23, P5061; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; Brandt C, 2010, J NEUROSCI, V30, P8602, DOI 10.1523/JNEUROSCI.0633-10.2010; Cetin A, 2006, NAT PROTOC, V1, P3166, DOI 10.1038/nprot.2006.450; Chen H, 2005, J CEREBR BLOOD F MET, V25, P54, DOI 10.1038/sj.jcbfm.9600006; Chen H, 2007, J NEUROCHEM, V102, P1783, DOI 10.1111/j.1471-4159.2007.04638.x; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Chen XZ, 2008, J NEUROCHEM, V106, P1563, DOI 10.1111/j.1471-4159.2008.05501.x; Chen XZ, 2010, J NEUROCHEM, V112, P173, DOI 10.1111/j.1471-4159.2009.06438.x; Cote MP, 2014, J NEUROSCI, V34, P8976, DOI 10.1523/JNEUROSCI.0678-14.2014; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Garzon-Muvdi T, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001320; HAAS M, 1994, AM J PHYSIOL-CELL PH, V267, pC869; Hasbargen T, 2010, ANN NY ACAD SCI, V1198, P168, DOI 10.1111/j.1749-6632.2010.05462.x; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Jayakumar AR, 2011, J NEUROCHEM, V117, P437, DOI 10.1111/j.1471-4159.2011.07211.x; Jayakumar AR, 2010, METAB BRAIN DIS, V25, P31, DOI 10.1007/s11011-010-9180-3; Kahle KT, 2009, PHYSIOLOGY, V24, P257, DOI 10.1152/physiol.00015.2009; Kimelberg HK, 2004, NEUROSCIENCE, V129, P851, DOI 10.1016/j.neuroscience.2004.07.033; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Lee HA, 2010, J NEUROCHEM, V114, P520, DOI 10.1111/j.1471-4159.2010.06772.x; Li Q, 2014, FRONT BIOSCI-LANDMRK, V19, P1411, DOI 10.2741/4291; Liedtke CM, 2002, BBA-MOL CELL RES, V1589, P77, DOI 10.1016/S0167-4889(01)00189-6; Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Lu KT, 2006, EUR J PHARMACOL, V548, P99, DOI 10.1016/j.ejphar.2006.07.048; Luo J, 2008, J CEREBR BLOOD F MET, V28, P737, DOI 10.1038/sj.jcbfm.9600561; Luo P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.116; Luo P, 2012, APOPTOSIS, V17, P975, DOI 10.1007/s10495-012-0736-z; Ma YH, 2011, BRAIN RES BULL, V86, P441, DOI 10.1016/j.brainresbull.2011.07.007; Majewska A.K., 2010, J VIS EXP; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Mukhin AG, 1997, J NEUROTRAUM, V14, P651, DOI 10.1089/neu.1997.14.651; O'Donnell ME, 2004, J CEREBR BLOOD F MET, V24, P1046, DOI 10.1097/01.WCB.0000130867.32663.90; Panet R, 2002, J CELL PHYSIOL, V190, P227, DOI 10.1002/JCP.10055; Papadopoulos MC, 2002, MT SINAI J MED, V69, P242; Rao W, 2015, BBA-MOL BASIS DIS, V1852, P2402, DOI 10.1016/j.bbadis.2015.08.014; Rungta RL, 2015, CELL, V161, P610, DOI 10.1016/j.cell.2015.03.029; Tu P, 2009, J NEUROCHEM, V108, P126, DOI 10.1111/j.1471-4159.2008.05752.x; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004	44	12	12	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	MAR	2016	94						23	31		10.1016/j.neuint.2016.02.002			9	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	DI6ZT	WOS:000373649600003	26854573				2021-06-18	
J	Orr, R; Cheng, HL				Orr, Rhonda; Cheng, Hoi Lun			Incidence and characteristics of injuries in elite Australian junior rugby league players	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Adolescent; Rugby; Athletic injuries; Accident; Ankle; Brain concussion	DATA-COLLECTION PROCEDURES; CONSENSUS STATEMENT; TRAINING INJURIES; DEFINITIONS; SPORTS; PREVENTION; SEASONS; UNION; MATCH	Objectives: Rugby league (RL) is a physically demanding collision sport, yet few studies describe injuries at the junior level despite their potential impact on career pathways and long-term health. With the absence of an injury surveillance paradigm in junior competition, this study aimed to investigate injury incidence in an Australian setting. Design: Prospective cohort study. Methods: A set of injury surveillance forms were developed and used to record injury characteristics, mechanism, severity and follow-up throughout one season. Results: Junior RL players (n =368, ages 15.8 +/- 1.0 years) from 15 clubs provided baseline information. Of these, approximately six clubs (n = 122) provided longitudinal injury data. A total of 109 injuries (90% matchrelated) were recorded, with the tackle accounting for 61%. Injury incidence (37.1 injuries per 1000 match hours) was consistent with previous literature. Most injuries did not result in missed matches. The ankle and head/face were most frequently injured (both 13%), with ankle injuries leading to the highest losses of matchplay. Contusions were common (38%), although ligament injuries caused the greatest matchplay losses. Injury site significantly differed between forwards and backs (p = 0.003), with forwards sustaining more head/face and sternum injuries, and backs more ankle injuries. Injury type (p = 0.25) and severity (p = 0.09) were similar between positions. Conclusions: Given the ongoing biological maturation in adolescent players and the injury risks related to RL, playing intensity, training regimes and injury incidence warrant rigorous documentation and monitoring. This study argues for functional but low-burden injury surveillance systems (e.g. electronic platforms) to be developed and implemented in junior RL. (C) 2015 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Orr, Rhonda; Cheng, Hoi Lun] Univ Sydney, Fac Hlth Sci, Discipline Exercise & Sport Sci, Sydney, NSW 2006, Australia; [Cheng, Hoi Lun] Childrens Hosp Westmead, Acad Dept Adolescent Med, Sydney, NSW, Australia	Orr, R (corresponding author), Univ Sydney, Fac Hlth Sci, Discipline Exercise & Sport Sci, Sydney, NSW 2006, Australia.	rhonda.orr@sydney.edu.au	Orr, Rhonda/C-1817-2008; Cheng, Hoi Lun/AAK-8937-2021	Cheng, Hoi Lun/0000-0002-2144-9195	NSW Sporting Injuries Committee	This study is supported by the NSW Sporting Injuries Committee. The authors thank the players and clubs for their participation and students who assisted with data entry. The authors acknowledge Martin Meredith (NSW Rugby League) and Brian Canavan (Chairman, National Rugby League Research Committee) for their support and assistance.	Breivik SL, 2007, SPORT EXERCISE PHYSL, VI; Cheng HL, 2014, J SCI MED SPORT, V17, P546, DOI 10.1016/j.jsams.2013.07.020; Donaldson A, 2013, BRIT J SPORT MED, V47, P473, DOI 10.1136/bjsports-2013-092323; Emery CA, 2009, PAED CHILD HEALT-CAN, V14, P439, DOI 10.1093/pch/14.7.439; Estell J, 1995, Aust J Sci Med Sport, V27, P95; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Gabbe BJ, 2010, BRIT J SPORT MED, V44, P799, DOI 10.1136/bjsm.2009.062554; Gabbett T, 2008, SPORTS MED, V38, P119, DOI 10.2165/00007256-200838020-00003; Gabbett TJ, 2008, J SCI MED SPORT, V11, P323, DOI 10.1016/j.jsams.2007.06.003; Gabbett TJ, 2000, BRIT J SPORT MED, V34, P98, DOI 10.1136/bjsm.34.2.98; Gabbett TJ, 2003, BRIT J SPORT MED, V37, P36, DOI 10.1136/bjsm.37.1.36; Gabbett TJ, 2002, BRIT J SPORT MED, V36, P334, DOI 10.1136/bjsm.36.5.334; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hodgson L, 2007, CLIN J SPORT MED, V17, P188, DOI 10.1097/JSM.0b013e3180547513; Junge A, 2008, BRIT J SPORT MED, V42, P413, DOI 10.1136/bjsm.2008.046631; King D, 2006, NZ J SPORTS MED, V34, P21; King DA, 2009, J SCI MED SPORT, V12, P12, DOI 10.1016/j.jsams.2007.12.001; King D, 2014, INT J SPORTS SCI COA, V9, P417, DOI 10.1260/1747-9541.9.2.417; King DA, 2010, SPORTS MED, V40, P163, DOI 10.2165/11319740-000000000-00000; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; National Rugby League, 2014, NRL COACH MAN; Orchard J, 2002, BRIT J SPORT MED, V36, P39, DOI 10.1136/bjsm.36.1.39; Orchard J, 2010, OPEN ACCESS J SPORTS, V1, P207, DOI 10.2147/OAJSM.S7715; Pringle RG, 1998, BRIT J SPORT MED, V32, P49, DOI 10.1136/bjsm.32.1.49; Raftery M., 1999, INCIDENCE INJURY JUN; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Williams Jay H, 2013, J Sports Med (Hindawi Publ Corp), V2013, P380523, DOI 10.1155/2013/380523; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1	30	12	13	1	19	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	MAR	2016	19	3					212	217		10.1016/j.jsams.2015.03.007			6	Sport Sciences	Sport Sciences	DF6DH	WOS:000371445600005	25882397				2021-06-18	
J	Ubukata, S; Ueda, K; Sugihara, G; Yassin, W; Aso, T; Fukuyama, H; Murai, T				Ubukata, Shiho; Ueda, Keita; Sugihara, Genichi; Yassin, Walid; Aso, Toshihiko; Fukuyama, Hidenao; Murai, Toshiya			Corpus Callosum Pathology as a Potential Surrogate Marker of Cognitive Impairment in Diffuse Axonal Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							TRAUMATIC BRAIN-INJURY; WHITE-MATTER; TENSOR; ATTENTION; SEQUELAE; MODERATE; DAMAGE; SPEED; MR	Diffuse axonal injury is a major form of traumatic brain injury. Neuropsychological assessments and high-resolution structural MRI were conducted using T1-weighted and diffusion tensor imaging. This study included 10 patients with diffuse axonal injury (all men, mean age 30.8 +/- 10.5 years) and 12 age-and sex-matched normal control participants. Patients with diffuse axonal injury had widespread volume reductions and lower fractional anisotropy in the corpus callosum (CC) compared with controls. Furthermore, cognitive processing speed was associated with reductions in white matter volume and fractional anisotropy in the CC. These findings suggest that CC pathology may be a potential surrogate marker of the cognitive deficits in these patients.	[Ubukata, Shiho; Ueda, Keita; Sugihara, Genichi; Yassin, Walid; Murai, Toshiya] Kyoto Univ, Dept Psychiat, Grad Sch Med, Kyoto, Japan; [Aso, Toshihiko; Fukuyama, Hidenao] Kyoto Univ, Human Brain Res Ctr, Grad Sch Med, Kyoto, Japan	Ubukata, S (corresponding author), Kyoto Univ, Dept Psychiat, Grad Sch Med, Kyoto, Japan.	ubukata@kuhp.kyoto-u.ac.jp	Aso, Toshihiko/C-2798-2018; Yassin, Walid/ABD-4751-2020; Fukuyama, Hidenao/AAI-7118-2020	Aso, Toshihiko/0000-0003-4814-089X; Yassin, Walid/0000-0001-9612-0485	Industrial Disease Clinical Research Grant [150502-02]; Ministry of Education, Culture, Sports, Science, and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [23118004]; Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [15K19722, 26461766]; General Insurance Association of Japan; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [26461766, 15K09825, 25117008, 15K19722, 15H01690] Funding Source: KAKEN	This work was supported by an Industrial Disease Clinical Research Grant (150502-02); a Grant-in-Aid for Scientific Research in Innovative Areas (23118004) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Young Scientists B (15K19722) and C (26461766) from the Japan Society for the Promotion of Science; and a research grant from the General Insurance Association of Japan.	Arlinghaus KA, 2011, TXB TRAUMATIC BRAIN, P5; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Chan JHM, 2003, NEURORADIOLOGY, V45, P34, DOI 10.1007/s00234-002-0891-y; Forn C, 2013, BRAIN COGNITION, V82, P152, DOI 10.1016/j.bandc.2013.04.003; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Kerchner GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050425; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Krause MO, 2014, BRAIN INJURY, V28, P1473, DOI 10.3109/02699052.2014.920520; Kurki T, 2014, NEURORADIOLOGY, V56, P833, DOI 10.1007/s00234-014-1410-7; Kuznetsova K.A., 2015, BRAIN STRUCT FUNCT; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Matsuoka K., 2007, JAPANESE ADULT READI; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Muri RM, 2002, EXP BRAIN RES, V143, P426, DOI 10.1007/s00221-002-1009-9; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Park HJ, 2008, HUM BRAIN MAPP, V29, P503, DOI 10.1002/hbm.20314; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Rypma B, 2009, INTELLIGENCE, V37, P207, DOI 10.1016/j.intell.2008.12.004; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Sbardella E, 2015, MULT SCLER; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Sweet L.H., 2011, ENCY CLIN NEUROPSYCH, P1317, DOI [10.1007/978-0-387-79948-3_1321, DOI 10.1007/978-0-387-79948-3_1321]; Tomaiuolo F, 2005, J NEUROTRAUM, V22, P76, DOI 10.1089/neu.2005.22.76; Vannorsdall TD, 2010, J NEUROPSYCH CLIN N, V22, P173, DOI 10.1176/appi.neuropsych.22.2.173; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Winardi W, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/129796; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208	40	12	13	0	3	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2016	28	2					97	103		10.1176/appi.neuropsych.15070159			7	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	DM0PE	WOS:000376047100011	26569151	Bronze			2021-06-18	
J	Yang, DS; Kwon, HG; Jang, SH				Yang, Dong Seok; Kwon, Hyeok Gyu; Jang, Sung Ho			Injury of the Thalamocingulate Tract in the Papez Circuit in Patients with Mild Traumatic Brain Injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Thalamocortical Tract; Mild Traumatic Brain Injury; Papez Circuit; Diffusion Tensor Imaging; Memory	DIFFUSION TENSOR TRACTOGRAPHY; THALAMOCORTICAL TRACT; ABNORMALITIES; HEMORRHAGE; FORNIX; MEMORY	The thalamocingulate tract between the anterior thalamic nuclei and the cingulate gyrus is a part of the Papez circuit. Using diffusion tensor tractography, injury of the thalamocingulate tract was investigated in patients with mild traumatic brain injury. Two patients (patient 1: a 58-yr-old woman and patient 2: a 49-yr-old man) with head trauma resulting from a car accident were enrolled. They were classified as mild traumatic brain injury and no specific lesion was observed on brain magnetic resonance imaging. These patients complained of memory impairment after head trauma. The entire Papez circuits, including thalamocingulate tract, fornix, mammillothalamic tract, and cingulum, were reconstructed in both hemispheres except for the left thalamocingulate tract: patient 1, it was thinner and discontinued compared with the right thalamocingulate tract; and patient 2, it was not reconstructed. The injury of the left thalamocingulate tract appeared to be related to the memory impairment in these patients.	[Yang, Dong Seok] Univ Ulsan, Ulsan Univ Hosp, Coll Med, Dept Phys Med & Rehabil, Ulsan 680749, South Korea; [Kwon, Hyeok Gyu; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyung Dong, Daegu 705717, South Korea	Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyung Dong, Daegu 705717, South Korea.				Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [2013R1A1A4A01013178]	Supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (grant no. 2013R1A1A4A01013178).	Concha L, 2005, AM J NEURORADIOL, V26, P2267; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Jang SH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005613; Jang SH, 2014, NEUROLOGY, V82, pE178, DOI 10.1212/WNL.0000000000000444; Jang SH, 2013, BRAIN IMAGING BEHAV, V7, P236, DOI 10.1007/s11682-013-9222-7; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Kwon HG, 2015, NEURAL REGEN RES, V10, P321, DOI 10.4103/1673-5374.152390; Kwon HG, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00366; Kwon HG, 2010, NEUROSCI LETT, V481, P51, DOI 10.1016/j.neulet.2010.06.052; Lee HD, 2014, BRAIN INJURY, V28, P1485, DOI 10.3109/02699052.2014.930178; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; PAPEZ JW, 1995, J NEUROPSYCH CLIN N, V7, P103; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Seo JP, 2014, J REHABIL MED, V46, P374, DOI 10.2340/16501977-1783; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wechsler D., 1981, WAIS R MANUAL WECHSL; Williams JM, 1991, MAS MEMORY ASSESSMEN; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yeo SS, 2013, J REHABIL MED, V45, P595, DOI 10.2340/16501977-1145	26	12	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAR	2016	95	3					E34	E38		10.1097/PHM.0000000000000413			5	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	DE9LJ	WOS:000370958700002	26544855				2021-06-18	
J	Tverdov, AH; McClure, KS; Brownsberger, MG; Armstrong, SL				Tverdov, Alison H.; McClure, Kelly S.; Brownsberger, Mary G.; Armstrong, Sharon Lee			Family needs at a post-acute rehabilitation setting and suggestions for supports	BRAIN INJURY			English	Article						ABI; Family members; distress; needs; obstacles	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; LARGE NONCLINICAL SAMPLE; SOCIAL SUPPORT; INTERVENTION IMPACT; NORMATIVE DATA; CAREGIVERS; DEPRESSION; QUALITY; MEMBERS	Objective: To explore the perceived needs, obstacles to services, psychological distress and social problem-solving abilities of family members of persons with ABI at a post-acute community-based brain injury rehabilitation facility and offer suggestions for methods of assessment and providing support. Participants: Twenty-nine family members who did not provide daily care, but were involved in the care process. Design: Participants completed self-report questionnaires including the FNQ:R, SOS, DASS-21, WHO-QOL BREF and SPSI:R-S. Results: Participants reported informational and professional needs as most met and involvement in care, instrumental support and emotional support as most unmet. Most were satisfied with the amount of professional help and services and had confidence in the quality of care. Nearly half of the family members felt there were few ABI-related resources in the community and one third were unaware of good ABI treatment resources in their community. Psychosocial functioning was generally average. Conclusion: Family members who do not provide daily care are still impacted by the neurobehavioural changes that progress throughout the long-term, post-acute community phase. This study offers suggestions regarding an effective methodology for assessing family needs and recommends accessible and practical supports.	[Tverdov, Alison H.; McClure, Kelly S.; Armstrong, Sharon Lee] La Salle Univ, Dept Psychol, 1900 W Olney Ave, Philadelphia, PA 19141 USA; [Brownsberger, Mary G.] Bancroft NeuroRehab, Plainsboro, NJ USA	Tverdov, AH (corresponding author), La Salle Univ, Dept Psychol, 1900 W Olney Ave, Philadelphia, PA 19141 USA.	alison.tverdov@outlook.com					[Anonymous], 2000, FAM NEEDS QUEST; Bonomi AE, 2000, J CLIN EPIDEMIOL, V53, P1, DOI 10.1016/S0895-4356(99)00123-7; Boschen K, 2007, NEUROREHABILITATION, V22, P19; Commission on Accreditation of Rehabilitation Facilities, 2011, MED REH STAND MAN, P109; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; Damianakis T, J HEAD TRAUMA REHAB, DOI [10.1097/HTR.0000000000000178, DOI 10.1097/HTR.0000000000000178.ACCESSED]; DILLAHUNTASPILL.C, 2013, PLOS ONE, V8, P1; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; DZurilla T. J., 2002, SOCIAL PROBLEM SOLVI; Elliott TR, 2009, J CLIN PSYCHOL, V65, P406, DOI 10.1002/jclp.20527; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; Grant JS, 2001, REHABIL PSYCHOL, V46, P44, DOI 10.1037/0090-5550.46.1.44; Groom KN, 1998, ARCH CLIN NEUROPSYCH, V13, P695, DOI 10.1016/S0887-6177(98)00005-5; Hart T, 2007, J HEAD TRAUMA REHAB, V22, P122, DOI 10.1097/01.HTR.0000265100.37059.44; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Kitter B, 2015, BRAIN INJURY, V29, P1082, DOI 10.3109/02699052.2015.1018323; Kolakowsky-Hayner SA, 2000, NEUROREHABILITATION, V14, P151; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreutzer J, SERVICE OBSTACLES SC; Kreutzer JS, 2015, J HEAD TRAUMA REHAB, V30, P249, DOI 10.1097/HTR.0000000000000144; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; Kreutzer JS, 2008, FAMILY NEEDS QUESTIO; Hayas CL, 2015, REHABIL PSYCHOL, V60, P295, DOI 10.1037/rep0000040; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Lovibond S.H., 1995, MANUAL DEPRESSION AN; Marwitz J, 1996, SERVICE OBSTACLES SC; McLaughlin KA, 2013, J HEAD TRAUMA REHAB, V28, P341, DOI 10.1097/HTR.0b013e31824e1d43; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Nezu AM., 2013, PROBLEM SOLVING THER; NOVACK TA, 1991, J HEAD TRAUMA REHAB, V6, P69, DOI DOI 10.1097/00001199-199112000-00014; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Petranovich CL, 2015, J PEDIATR PSYCHOL, V40, P680, DOI 10.1093/jpepsy/jsv001; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ramkumar NA, 2010, NEUROREHABILITATION, V27, P105, DOI 10.3233/NRE-2010-0585; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sander AM, 2007, NEUROREHABILITATION, V22, P9; Simpson G, 2013, CLIN REHABIL, V27, P367, DOI 10.1177/0269215512457961; SINGER GHS, 1994, J HEAD TRAUMA REHAB, V9, P38, DOI DOI 10.1097/00001199-199412000-00006; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Smith GC, 2012, REHABIL PSYCHOL, V57, P196, DOI 10.1037/a0029587; Turner B, 2010, BRAIN IMPAIR, V11, P281, DOI 10.1375/brim.11.3.281; World Health Organization, 1998, PROBL INV VIL ENC CO, P13	49	12	12	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2016	30	3					324	333		10.3109/02699052.2015.1113566			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DG9QM	WOS:000372418900010	26853184				2021-06-18	
J	Echemendia, RJ; Bruce, JM; Meeuwisse, W; Comper, P; Aubry, M; Hutchison, M				Echemendia, Ruben J.; Bruce, Jared M.; Meeuwisse, Willem; Comper, Paul; Aubry, Mark; Hutchison, Michael			Long-term reliability of ImPACT in professional ice hockey	CLINICAL NEUROPSYCHOLOGIST			English	Article						Concussion; ImPACT; reliability	TEST-RETEST RELIABILITY; SPORT-RELATED CONCUSSION; COUNSELING PSYCHOMETRIC ISSUES; REDICK CLINICAL UTILITY; NORMATIVE DATA; MANAGEMENT; MAYERS	Objective: This study sought to assess the test-retest reliability of Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) across 2-4year time intervals and evaluate the utility of a newly proposed two-factor (Speed/Memory) model of ImPACT across multiple language versions. Method: Test-retest data were collected from non-concussed National Hockey League (NHL) players across 2-, 3-, and 4-year time intervals. The two-factor model was examined using different language versions (English, French, Czech, Swedish) of the test using a one-year interval, and across 2-4year intervals using the English version of the test. Results: The two-factor Speed index improved reliability across multiple language versions of ImPACT. The Memory factor also improved but reliability remained below the traditional cutoff of .70 for use in clinical decision-making. ImPACT reliabilities remained low (below .70) regardless of whether the four-composite or the two-factor model was used across 2-, 3-, and 4-year time intervals. Conclusions: The two-factor approach increased ImPACT's one-year reliability over the traditional four-composite model among NHL players. The increased stability in test scores improves the test's ability to detect cognitive changes following injury, which increases the diagnostic utility of the test and allows for better return to play decision-making by reducing the risk of exposing an athlete to additional trauma while the brain may be at a heightened vulnerability to such trauma. Although the Speed Index increases the clinical utility of the test, the stability of the Memory index remains low. Irrespective of whether the two-factor or traditional four-composite approach is used, these data suggest that new baselines should occur on a yearly basis in order to maximize clinical utility.	[Echemendia, Ruben J.] Psychol & Neurobehav Associates Inc, State Coll, PA USA; [Echemendia, Ruben J.; Bruce, Jared M.] Univ Missouri Kansas City, Dept Psychol, Kansas City, MO 64110 USA; [Meeuwisse, Willem] Univ Calgary, Sport Injury Prevent Res Ctr, Fac Kinesiol, Calgary, AB, Canada; [Comper, Paul] Toronto Rehabil Inst, Toronto, ON, Canada; [Aubry, Mark] Ottawa Sport Med Ctr, Ottawa, ON, Canada; [Hutchison, Michael] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada	Echemendia, RJ (corresponding author), Psychol & Neurobehav Associates Inc, State Coll, PA USA.; Echemendia, RJ (corresponding author), Univ Missouri Kansas City, Dept Psychol, Kansas City, MO 64110 USA.	rechemendia@comcast.net	Echemendia, Ruben/R-6939-2019				Broglio SP, 2007, J ATHL TRAINING, V42, P509; Bruce J., 2013, CLIN NEUROPSYCHOL, P1; Bruce J, 2016, APPL NEUROPSYCH-ADUL, V23, P336, DOI 10.1080/23279095.2015.1064002; BURLINGAME GM, 1995, J MENT HEALTH ADMIN, V22, P226, DOI 10.1007/BF02521118; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P435, DOI 10.1080/13803395.2012.667790; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Randolph C, 2005, J ATHL TRAINING, V40, P139; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Schatz P, 2012, J CLIN EXP NEUROPSYC, V34, P428, DOI 10.1080/13803395.2012.667789; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; SLICK D, 2006, COMPENDIUM NEUROPSYC, P1; Teesson M., 1994, MEASUREMENT CONSUMER; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	25	12	12	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB 17	2016	30	2					311	320		10.1080/13854046.2016.1158320			10	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	DI3LQ	WOS:000373400600010	26999705				2021-06-18	
J	Hong, S; Washington, PM; Kim, A; Yang, CP; Yu, TS; Kernie, SG				Hong, Sue; Washington, Patricia M.; Kim, Ahleum; Yang, Cui-Ping; Yu, Tzong-Shiue; Kernie, Steven G.			Apolipoprotein E Regulates Injury-Induced Activation of Hippocampal Neural Stem and Progenitor Cells	JOURNAL OF NEUROTRAUMA			English	Article						apolipoprotein E; hippocampus; neural stem; progenitor cells; neurogenesis; traumatic brain injury	TRAUMATIC BRAIN-INJURY; FIBRILLARY ACIDIC PROTEIN; AMYLOID-BETA-PEPTIDE; ALZHEIMERS-DISEASE; DENTATE GYRUS; EXPRESSING PROGENITORS; STEM/PROGENITOR CELLS; CEREBRAL-ISCHEMIA; ADULT HIPPOCAMPUS; TRANSGENIC MICE	Partial recovery from even severe traumatic brain injury (TBI) is ubiquitous and occurs largely through unknown mechanisms. Recent evidence suggests that hippocampal neural stem/progenitor cell (NSPC) activation and subsequent neurogenesis are responsible for at least some aspects of spontaneous recovery following TBI. Apolipoprotein E (ApoE) regulates postnatal neurogenesis in the hippocampus and is therefore a putative mediator of injury-induced neurogenesis. Further, ApoE isoforms in humans are associated with different cognitive outcomes following TBI. To investigate the role of ApoE in injury-induced neurogenesis, we exposed wild-type, ApoE-deficient, and human ApoE isoform-specific (ApoE3 and ApoE4) transgenic mice crossed with nestin-green fluorescent protein (GFP) reporter mice to controlled cortical impact (CCI) and assessed progenitor activation at 2 d post-injury using unbiased stereology. GFP+ progenitor cells were increased by approximately 120% in the ipsilateral hippocampus in injured wild-type mice, compared with sham mice (p<0.01). Co-localization of GFP+ cells with bromodeoxyrudine (BrdU) to label dividing cells indicated increased proliferation of progenitors in the injured hippocampus (p<0.001). This proliferative injury response was absent in ApoE-deficient mice, as no increase in GFP+ cells was observed in the injured hippocampus, compared with sham mice, despite an overall increase in proliferation indicated by increased BrdU+ cells (86%; p<0.05). CCI-induced proliferation of GFP+ cells in both ApoE3 and ApoE4 mice but the overall response was attenuated in ApoE4 mice due to fewer GFP+ cells at baseline. We demonstrate that ApoE is required for injury-induced proliferation of NSPCs after experimental TBI, and that this response is influenced by human APOE genotype.	[Hong, Sue; Washington, Patricia M.; Kim, Ahleum; Yu, Tzong-Shiue; Kernie, Steven G.] Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; [Hong, Sue; Washington, Patricia M.; Kim, Ahleum; Yu, Tzong-Shiue; Kernie, Steven G.] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Yang, Cui-Ping] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China	Kernie, SG (corresponding author), Columbia Univ Coll Phys & Surg, 3959 Broadway,CHN 10-24, New York, NY 10032 USA.	sk3516@columbia.edu	Kernie, Steven/AAT-9912-2020	Kernie, Steven/0000-0003-1371-0549; Yu, Tzong-Shiue/0000-0003-4277-6213	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56NS089523, R21NS083077, R01NS095803] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56 NS089523, R01 NS095803, R21 NS083077] Funding Source: Medline		Bartkowska K, 2007, DEVELOPMENT, V134, P4369, DOI 10.1242/dev.008227; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Crawford F, 2009, NEUROSCIENCE, V159, P1349, DOI 10.1016/j.neuroscience.2009.01.033; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dean DC, 2014, JAMA NEUROL, V71, P11, DOI 10.1001/jamaneurol.2013.4544; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fukuda S, 2003, J NEUROSCI, V23, P9357; Gilley JA, 2011, HIPPOCAMPUS, V21, P33, DOI 10.1002/hipo.20719; Gu F, 2005, J NEUROSCI RES, V81, P163, DOI 10.1002/jnr.20561; Halliday MR, 2013, JAMA NEUROL, V70, P1198, DOI 10.1001/jamaneurol.2013.3841; Hartman RE, 2001, EXP NEUROL, V170, P326, DOI 10.1006/exnr.2001.7715; Hauser PS, 2011, PROG LIPID RES, V50, P62, DOI 10.1016/j.plipres.2010.09.001; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; James ML, 2009, J STROKE CEREBROVASC, V18, P144, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.012; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; Kasai M, 2005, GENES CELLS, V10, P777, DOI 10.1111/j.1365-2443.2005.00876.x; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Li G, 2009, CELL STEM CELL, V5, P634, DOI 10.1016/j.stem.2009.10.015; Loane DJ, 2011, J NEUROTRAUM, V28, P225, DOI 10.1089/neu.2010.1595; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Mauri M, 2006, FUNCT NEUROL, V21, P223; Methia N, 2001, MOL MED, V7, P810, DOI 10.1007/BF03401973; Miles DK, 2008, HIPPOCAMPUS, V18, P793, DOI 10.1002/hipo.20439; Nishitsuji K, 2011, J BIOL CHEM, V286, P17536, DOI 10.1074/jbc.M111.225532; Otaegi G, 2006, J CELL SCI, V119, P2739, DOI 10.1242/jcs.03012; Parent JM, 1997, J NEUROSCI, V17, P3727; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Qi JP, 2007, J ALZHEIMERS DIS, V12, P335; Quesseveur G, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.30; Rajat S., 2008, EXP NEUROL, V213, P372; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Shaw P, 2007, LANCET NEUROL, V6, P494, DOI 10.1016/S1474-4422(07)70106-0; Shetty AK, 2005, GLIA, V51, P173, DOI 10.1002/glia.20187; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; STERN Y, 1995, NEUROLOGY, V45, P55, DOI 10.1212/WNL.45.1.55; Sun D., 2014, J NEUROTRAU IN PRESS; Sun YL, 1998, J NEUROSCI, V18, P3261; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vance JE, 2000, BBA-MOL CELL BIOL L, V1486, P84, DOI 10.1016/S1388-1981(00)00050-0; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Yang CP, 2011, DEVELOPMENT, V138, P4351, DOI 10.1242/dev.065540; Yu TS, 2014, NEUROSCIENTIST; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	63	12	12	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2016	33	4					362	374		10.1089/neu.2014.3860			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DD2NH	WOS:000369758800006	25905575	Green Published			2021-06-18	
J	Mehos, CJ; Nelson, LH; Saldanha, CJ				Mehos, C. J.; Nelson, L. H.; Saldanha, C. J.			A Quantification of the Injury-Induced Changes in Central Aromatase, Oestrogenic Milieu and Steroid Receptor Expression in the Zebra Finch	JOURNAL OF NEUROENDOCRINOLOGY			English	Article						traumatic brain injury; aromatisation; steroid receptor; neuroprotection	TRAUMATIC BRAIN-INJURY; TAENIOPYGIA-GUTTATA; SONGBIRD BRAIN; GLIAL AROMATIZATION; GROWTH-FACTOR; SEXUAL-DIFFERENTIATION; MESSENGER-RNA; NEURAL INJURY; UP-REGULATION; ADULT-RATS	In songbirds and mammals, brain injury results in the up-regulation of aromatase (oestrogen synthase) expression in astroglia. The resulting presumed synthesis of neural oestradiol (E-2) has neuroprotective effects including a decrease in neurodegeneration, neuroinflammation and apoptosis. The development of therapeutic tools that exploit oestrogenic neuroprotection in the treatment of neurotrauma requires a precise quantification of the endogenous changes in neural aromatase and E-2 following brain injury. Surprisingly, the expected increase in neural oestrogens following brain injury has not been demonstrated. Furthermore, we are just beginning to unravel the mechanisms behind the protective effects of centrally synthesised E-2. In the present study, levels of aromatase immunoprotein, neural E-2 and steroid receptor mRNA were quantified in adult male and female zebra finches 48h following a unilateral penetrating brain injury. Both aromatase and E-2 were up-regulated in the injured hemisphere of the brain compared to the uninjured hemisphere, demonstrating for the first time a robust increase in neural E-2 levels following injury. We did not detect an effect of injury on mRNA expression of the oestrogen receptors (ER)-, ER- or GPER-1, but observed a significant decrease in androgen receptor transcription in the injured lobe relative to the contralateral uninjured hemisphere. We conclude that mechanical damage causes a dramatic increase in local aromatisation, and the resultant high levels of central E-2 are available to modulate steroid sensitive targets. Studies using alternate methods of receptor detection and/or time points may be necessary to understand the complete suite of mechanisms underlying the neuroprotective effects of induced oestrogen synthesis in this animal model.	[Saldanha, C. J.] Amer Univ, Dept Biol, 4400 Massachusetts Ave NW, Washington, DC 20016 USA; Amer Univ, Ctr Behav Neurosci, 4400 Massachusetts Ave NW, Washington, DC 20016 USA	Saldanha, CJ (corresponding author), Amer Univ, Dept Biol, 4400 Massachusetts Ave NW, Washington, DC 20016 USA.	saldanha@american.edu		Nelson, Lars/0000-0003-1143-8596	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [042767, 080585]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS080585, R01NS042767] Funding Source: NIH RePORTER	We thank Benjamin Kussin-Shoptaw for excellent technical assistance. This work was supported by NIH 042767 and 080585 to CJS. No competing financial interests exist.	Arevalo MA, 2013, HORM BEHAV, V63, P216, DOI 10.1016/j.yhbeh.2012.02.021; Azcoitia I, 2001, J NEUROBIOL, V47, P318, DOI 10.1002/neu.1038; Azcoitia I, 2003, ANN NY ACAD SCI, V1007, P298, DOI 10.1196/annals.1286.028; Balthazart J, 1996, J NEUROBIOL, V31, P129, DOI 10.1002/(SICI)1097-4695(199610)31:2<129::AID-NEU1>3.3.CO;2-2; Lopez-Rodriguez AB, 2015, PSYCHONEUROENDOCRINO, V56, P1, DOI 10.1016/j.psyneuen.2015.02.018; Buchanan CD, 2000, BIOL REPROD, V62, P1710, DOI 10.1095/biolreprod62.6.1710; Chao A, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00057; Dhandapani KM, 2002, BIOL REPROD, V67, P1379, DOI 10.1095/biolreprod.102.003848; DUENAS M, 1994, NEUROENDOCRINOLOGY, V59, P528, DOI 10.1159/000126702; Duncan KA, 2013, J NEUROTRAUM, V30, P1919, DOI 10.1089/neu.2013.2951; Duncan KA, 2013, HORM BEHAV, V63, P208, DOI 10.1016/j.yhbeh.2012.02.026; Elzer JG, 2010, J CEREBR BLOOD F MET, V30, P935, DOI 10.1038/jcbfm.2009.258; Flores C, 1999, J NEUROSCI, V19, P8665; Garcia-Ovejero D, 2002, J COMP NEUROL, V450, P256, DOI 10.1002/cne.10325; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Garcia-Segura LM, 1999, NEUROSCIENCE, V89, P567, DOI 10.1016/S0306-4522(98)00340-6; Garcia-Segura LM, 2003, PROG NEUROBIOL, V71, P31, DOI 10.1016/j.pneurobio.2003.09.005; Gingerich S, 2010, NEUROSCIENCE, V170, P54, DOI 10.1016/j.neuroscience.2010.06.076; GURNEY ME, 1980, SCIENCE, V208, P1380, DOI 10.1126/science.208.4450.1380; Johann S, 2013, J STEROID BIOCHEM, V137, P71, DOI 10.1016/j.jsbmb.2012.11.006; Karki P, 2014, MOL CELL ENDOCRINOL, V389, P58, DOI 10.1016/j.mce.2014.01.010; Lee DW, 2007, DEV NEUROBIOL, V67, P1107, DOI 10.1002/dneu.20399; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Mirzatoni A, 2010, J NEUROTRAUM, V27, P1875, DOI 10.1089/neu.2010.1330; Newman AEM, 2008, GEN COMP ENDOCR, V155, P503, DOI 10.1016/j.ygcen.2007.08.007; Peterson RS, 2001, J NEUROENDOCRINOL, V13, P317, DOI 10.1046/j.1365-2826.2001.00647.x; Pradhan DS, 2008, J NEUROCHEM, V104, P244, DOI 10.1111/j.1471-4159.2007.04953.x; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Remage-Healey L, 2009, J NEUROENDOCRINOL, V21, P191, DOI 10.1111/j.1365-2826.2009.01820.x; Remage-Healey L, 2008, NAT NEUROSCI, V11, P1327, DOI 10.1038/nn.2200; Remage-Healey L, 2011, J NEUROSCI, V31, P10034, DOI 10.1523/JNEUROSCI.0566-11.2011; Rohmann KN, 2007, DEV NEUROBIOL, V67, P1, DOI 10.1002/dneu.20303; Saldanha CJ, 2013, J NEUROENDOCRINOL, V25, P1032, DOI 10.1111/jne.12067; Saldanha CJ, 1997, GEN COMP ENDOCR, V105, P390, DOI 10.1006/gcen.1996.6841; Saldanha CJ, 2000, J COMP NEUROL, V423, P619, DOI 10.1002/1096-9861(20000807)423:4<619::AID-CNE7>3.0.CO;2-U; Saldanha CJ, 2005, J NEUROBIOL, V64, P192, DOI 10.1002/neu.20147; Sawada M, 2000, J CEREBR BLOOD F MET, V20, P112, DOI 10.1097/00004647-200001000-00015; Schlinger BA, 1997, BRAIN RES BULL, V44, P359, DOI 10.1016/S0361-9230(97)00215-3; SCHLINGER BA, 1994, J NEUROSCI, V14, P7541; Schlinger BA, 2008, NEUROCHEM INT, V52, P611, DOI 10.1016/j.neuint.2007.05.003; SCHUMACHER M, 1984, HORM BEHAV, V18, P298, DOI 10.1016/0018-506X(84)90018-7; SHEN P, 1995, J COMP NEUROL, V360, P172, DOI 10.1002/cne.903600113; SHEN P, 1994, MOL BRAIN RES, V24, P227, DOI 10.1016/0169-328X(94)90136-8; Soma KK, 2004, ENDOCRINOLOGY, V145, P1668, DOI 10.1210/en.2003-0883; Walters BJ, 2008, J NEUROCHEM, V106, P216, DOI 10.1111/j.1471-4159.2008.05352.x; Walters BJ, 2011, DEV NEUROBIOL, V71, P170, DOI 10.1002/dneu.20839; Wynne RD, 2004, J NEUROENDOCRINOL, V16, P676, DOI 10.1111/j.1365-2826.2004.01217.x; Wynne RD, 2008, GLIA, V56, P97, DOI 10.1002/glia.20594; Zheng JB, 1999, J STEROID BIOCHEM, V68, P65, DOI 10.1016/S0960-0760(98)00161-7	49	12	13	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-8194	1365-2826		J NEUROENDOCRINOL	J. Neuroendocrinol.	FEB	2016	28	2								10.1111/jne.12348			8	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	DF5ZS	WOS:000371434100005	26661058				2021-06-18	
J	Moeini-Naghani, I; Hashemi-Zonouz, T; Jabbari, B				Moeini-Naghani, Iman; Hashemi-Zonouz, Taraneh; Jabbari, Bahman			Botulinum Toxin Treatment of Spasticity in Adults and Children	SEMINARS IN NEUROLOGY			English	Article						Spasticity; Botulinum toxin; Botulinum neurotoxin; Stroke; Multiple sclerosis; Cerebral palsy; Trauma	UPPER-LIMB SPASTICITY; PLACEBO-CONTROLLED TRIAL; RANDOMIZED CONTROLLED-TRIAL; SPINAL-CORD-INJURY; QUALITY-OF-LIFE; MULTIPLE-SCLEROSIS PATIENTS; UPPER EXTREMITY SPASTICITY; TRAUMATIC BRAIN-INJURY; DOUBLE-BLIND; CEREBRAL-PALSY	Spasticity is a frequent symptom in stroke, multiple sclerosis, cerebral or spinal trauma, and cerebral palsy that affects and disables a large number of adults and children. In this review, we discuss the pathophysiology and nonpharmacologic and pharmacologic treatments of spasticity with emphasis on the role of botulinum neurotoxins (BoNTs). The world literature is reviewed on double-blind and placebo -controlled clinical trials reporting safety and efficacy of BoNT treatment in adult spasticity and spasticity of children with cerebral palsy. The evidence for efficacy is presented from recommendations of the Assessment and Therapeutics subcommittee of the American Academy of Neurology. A technical section describes the techniques and recommended doses of BoNTs in spasticity.	[Moeini-Naghani, Iman; Jabbari, Bahman] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Hashemi-Zonouz, Taraneh] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA	Jabbari, B (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.; Jabbari, B (corresponding author), 31 Silver Pine Dr, Newport Coast, CA USA.	Bahman.jabbari@yale.edu					Alter KE, 2010, PHYS MED REH CLIN N, V21, P607, DOI 10.1016/j.pmr.2010.05.001; Arroyo R, 2013, INT J NEUROSCI, V123, P850, DOI 10.3109/00207454.2013.812084; Baker R, 2002, DEV MED CHILD NEUROL, V44, P666, DOI 10.1111/j.1469-8749.2002.tb00268.x; Bakheit AMO, 2000, STROKE, V31, P2402, DOI 10.1161/01.STR.31.10.2402; Bakheit AMO, 2001, EUR J NEUROL, V8, P559, DOI 10.1046/j.1468-1331.2001.00277.x; Barnes MP, 2003, NEUROREHAB NEURAL RE, V17, P66, DOI 10.1177/0888439002250449; Bethoux F, 2015, PHYS MED REH CLIN N, V26, P625, DOI 10.1016/j.pmr.2015.07.003; Bhakta BB, 2000, J NEUROL NEUROSUR PS, V69, P217, DOI 10.1136/jnnp.69.2.217; Bose P., 2015, TRAUMATIC BRAIN INJU; Brashear A, 2004, ARCH PHYS MED REHAB, V85, P705, DOI 10.1016/j.apmr.2003.08.077; Brashear A, 2002, NEW ENGL J MED, V347, P395, DOI 10.1056/NEJMoa011892; CENDROWSKI W, 1977, EUR NEUROL, V16, P257, DOI 10.1159/000114906; Childers MK, 2004, ARCH PHYS MED REHAB, V85, P1063, DOI 10.1016/j.apmr.2003.10.015; Copeland L, 2014, J PEDIATR-US, V165, P140, DOI 10.1016/j.jpeds.2014.01.050; Corry IS, 1997, DEV MED CHILD NEUROL, V39, P185; Crone C, 2003, BRAIN, V126, P495, DOI 10.1093/brain/awg036; Dunne JW, 2012, CLIN REHABIL, V26, P787, DOI 10.1177/0269215511432016; Elovic EP, 2015, MUSCLE NERVE; Ferrari A, 2014, RES DEV DISABIL, V35, P2505, DOI 10.1016/j.ridd.2014.06.001; FIETZEK UM, 2014, LIVER TRANSPLANT, V21, P1089, DOI DOI 10.1111/ENE.12381; French J, 2008, NEUROLOGY, V71, P1634, DOI 10.1212/01.wnl.0000336533.19610.1b; Gillen G, 2010, STROKE REHABILITATIO; GIOUX M, 1993, J APPL PHYSIOL, V75, P2629; Goodin DS, 1999, MULT SCLER J, V5, P78; Gracies JM, 2015, LANCET NEUROL, V14, P992, DOI 10.1016/S1474-4422(15)00216-1; Gracies JM, 2014, ARCH PHYS MED REHAB, V95, P1303, DOI 10.1016/j.apmr.2014.03.016; Gracies JM, 2005, MUSCLE NERVE, V31, P535, DOI 10.1002/mus.20284; Gracies JM, 2005, MUSCLE NERVE, V31, P552, DOI 10.1002/mus.20285; Gronseth G, 2008, NEUROLOGY, V71, P1639, DOI 10.1212/01.wnl.0000336535.27773.c0; Hesse S, 1998, CLIN REHABIL, V12, P381, DOI 10.1191/026921598668275996; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Hyman N, 2000, J NEUROL NEUROSUR PS, V68, P707, DOI 10.1136/jnnp.68.6.707; Jain NB, 2015, JAMA-J AM MED ASSOC, V313, P2236, DOI 10.1001/jama.2015.6250; Kaji R, 2010, J NEUROL, V257, P1330, DOI 10.1007/s00415-010-5526-3; Kaji R, 2010, CURR MED RES OPIN, V26, P1983, DOI 10.1185/03007995.2010.497103; Kanovsky P, 2009, CLIN NEUROPHARMACOL, V32, P259, DOI 10.1097/WNF.0b013e3181b13308; KATZ R, 1982, BRAIN, V105, P103, DOI 10.1093/brain/105.1.103; Koman LA, 2013, J HAND SURG-AM, V38A, P435, DOI 10.1016/j.jhsa.2012.12.019; Koman LA, 2000, J PEDIATR ORTHOPED, V20, P108, DOI 10.1097/00004694-200001000-00022; Krause T, 2004, ANAESTHESIA, V59, P364, DOI 10.1111/j.1365-2044.2004.03658.x; Krigger KW, 2006, AM FAM PHYSICIAN, V73, P91; Lam K, 2012, J AM MED DIR ASSOC, V13, P477, DOI 10.1016/j.jamda.2012.03.005; Lance J. W., 1980, SPASTICITY DISORDERE, P485; Maanum G, 2011, J REHABIL MED, V43, P338, DOI 10.2340/16501977-0672; Mall V, 2006, DEV MED CHILD NEUROL, V48, P10, DOI 10.1017/S0012162206000041; Marco E, 2007, J REHABIL MED, V39, P440, DOI 10.2340/16501977-0066; Marque P, 2001, J NEUROL NEUROSUR PS, V70, P36, DOI 10.1136/jnnp.70.1.36; Martin A, 2014, NEUROPSYCH DIS TREAT, V10, P111, DOI 10.2147/NDT.S53913; Mathew A, 2005, J TROP PEDIATRICS, V51, P109, DOI 10.1093/tropej/fmh095; McCrory P, 2009, J REHABIL MED, V41, P536, DOI 10.2340/16501977-0366; Mills PB, 2015, CLIN REHABIL; Moore AP, 2008, NEUROLOGY, V71, P122, DOI 10.1212/01.wnl.0000316801.74683.c0; Nam HS, 2015, J NEUROL SCI, V357, P192, DOI 10.1016/j.jns.2015.07.028; Noreau L, 2000, AM J PHYS MED REHAB, V79, P526, DOI 10.1097/00002060-200011000-00009; Ota Tetsuo, 2014, Brain Nerve, V66, P1031; Pieper C, 2001, Pediatr Phys Ther, V13, P92, DOI 10.1097/00001577-200107000-00007; Pittock SJ, 2003, CEREBROVASC DIS, V15, P289, DOI 10.1159/000069495; Richardson D, 2000, J NEUROL NEUROSUR PS, V69, P499, DOI 10.1136/jnnp.69.4.499; Rizzo MA, 2004, MULT SCLER, V10, P589, DOI 10.1191/1352458504ms1085oa; Rosales RL, 2012, NEUROREHAB NEURAL RE, V26, P812, DOI 10.1177/1545968311430824; Santamato A, 2015, J NEUROL SCI, V350, P1, DOI 10.1016/j.jns.2015.01.033; Shaw LC, 2011, STROKE, V42, P1371, DOI 10.1161/STROKEAHA.110.582197; Simpson DM, 1996, NEUROLOGY, V46, P1306, DOI 10.1212/WNL.46.5.1306; Smith SJ, 2000, CLIN REHABIL, V14, P5, DOI 10.1191/026921500666642221; Sunnerhagen KS, 2013, NEUROLOGY, V80, pS35, DOI 10.1212/WNL.0b013e3182764aa2; Suputtitada A, 2005, DISABIL REHABIL, V27, P176, DOI 10.1080/09638280400009360; Svensson J, 2014, ACTA NEUROL SCAND, V129, P13, DOI 10.1111/ane.12139; Tao W, 2015, J PHYS THER SCI, V27, P759, DOI 10.1589/jpts.27.759; Ubhi T, 2000, ARCH DIS CHILD, V83, P481, DOI 10.1136/adc.83.6.481; Watkins CL, 2002, CLIN REHABIL, V16, P515, DOI 10.1191/0269215502cr512oa; Wedekind C, 2005, BRAIN INJURY, V19, P681, DOI 10.1080/02699050400025182; Wichers MJ, 2005, DISABIL REHABIL, V27, P583, DOI 10.1080/09638280400018445; WILLIAMS RG, 1980, J PHYSIOL-LONDON, V306, pP26; Wissel J, 1999, NEUROPEDIATRICS, V30, P120, DOI 10.1055/s-2007-973475; Yeargin-Allsopp M, 2008, PEDIATRICS, V121, P547, DOI 10.1542/peds.2007-1270; YOUNG RR, 1981, NEW ENGL J MED, V304, P96; Zwibel HL, 2009, ADV THER, V26, P1043, DOI 10.1007/s12325-009-0082-x	77	12	12	1	9	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	FEB	2016	36	1					64	72		10.1055/s-0036-1571847			9	Clinical Neurology	Neurosciences & Neurology	DE1NX	WOS:000370394800011	26866498				2021-06-18	
J	Ramsamy, Y; Muckart, DJJ; Bruce, JL; Hardcastle, TC; Han, KSS; Mlisana, KP				Ramsamy, Y.; Muckart, D. J. J.; Bruce, J. L.; Hardcastle, T. C.; Han, K. S. S.; Mlisana, K. P.			Empirical antimicrobial therapy for probable v. directed therapy for possible ventilator-associated pneumonia in critically injured patients	SAMJ SOUTH AFRICAN MEDICAL JOURNAL			English	Article							INTENSIVE-CARE-UNIT; ICU PATIENTS; SEPSIS; SURVEILLANCE; INFECTION; OUTCOMES	Background. Ventilator-associated pneumonia (VAP) has recently been classified as possible or probable. Although direct attributable mortality has been difficult to prove, delay in instituting appropriate therapy has been reported to increase morbidity and mortality. Recent literature suggests that in possible VAP, instituting directed therapy while awaiting microbiological culture does not prejudice outcome compared with best-guess empirical therapy. Objectives. To ascertain outcomes of directed v. empirical therapy in possible and probable VAP, respectively. Methods. Endotracheal aspirates were obtained from patients with suspected VAR Those considered to have possible VAP were given directed therapy following culture results, whereas patients with more convincing evidence of VAP were classed as having probable VAP and commenced on empirical antimicrobials based on microbiological surveillance. Results. Pneumonia was suspected in 106 (36.8%) of 288 patients admitted during January - December 2014. Of these, 13 did not, fulfil the criteria for VAR Of the remaining 93 (32.2%), 31 (33.3%) were considered to have probable and 62 (66.7%) possible VAP. The former were commenced on empirical antimicrobials, with 28 (90.3%) receiving appropriate therapy. Of those with possible VAR 34 (54.8%) were given directed therapy and in 28 (45.2%) no antimicrobials were prescribed. Of the latter, 24 recovered without antimicrobials and 4 died, 3 from severe traumatic brain injury and due to overwhelming intra-abdominal sepsis. No death was directly attributable to failure to treat VAR. No significant difference in mortality was found between the 34 patients with possible VAP who were commenced on directed therapy and the 31 with probable VAP who were commenced on empirical antimicrobials (p=0.75). Conclusions. Delaying antimicrobial therapy for VAP where clinical doubt exists does not adversely affect outcome. Furthermore, this policy limits the use of antimicrobials in patients with possible VAP following improvement in their clinical condition despite no-therapy.	[Ramsamy, Y.; Bruce, J. L.] Prince Mshiyeni Mem Hosp, Dept Med Microbiol, Durban, South Africa; [Ramsamy, Y.; Han, K. S. S.; Mlisana, K. P.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Coll Hlth Sci, Sch Lab Med & Med Sci,Dept Med Microbiol, Durban, South Africa; [Muckart, D. J. J.; Bruce, J. L.; Hardcastle, T. C.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Coll Hlth Sci, Dept Surg, Durban, South Africa; Univ KwaZulu Natal, Nelson R Mandela Sch Med, Coll Hlth Sci, Durban, South Africa; Pietermaritzburg Trauma Serv, Kwa Zulu, South Africa; [Ramsamy, Y.; Han, K. S. S.; Mlisana, K. P.] Natl Hlth Lab Serv, KZN Acad Complex, Durban, South Africa	Ramsamy, Y (corresponding author), Prince Mshiyeni Mem Hosp, Dept Med Microbiol, Durban, South Africa.; Ramsamy, Y (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Coll Hlth Sci, Sch Lab Med & Med Sci,Dept Med Microbiol, Durban, South Africa.; Ramsamy, Y (corresponding author), Natl Hlth Lab Serv, KZN Acad Complex, Durban, South Africa.	yogandree@gmail.com	Mlisana, Koleka/N-6204-2013	Mlisana, Koleka/0000-0002-8436-3268; SWE SWE HAN, KHINE/0000-0002-4574-6258; Hardcastle, Timothy/0000-0002-3967-0234			[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; BBC News Health, BBC NEWS HLTH; Bhagwanjee S, 1997, BRIT MED J, V314, P1077, DOI 10.1136/bmj.314.7087.1077a; Borgatta B, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-211; Cook A, 2010, J TRAUMA, V69, P1083, DOI 10.1097/TA.0b013e3181f9fb51; Cusini A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014011; de Groot B, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0936-3; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Gastmeier P, 2009, ANTIMICROB AGENTS CH, V53, P2714, DOI 10.1128/AAC.01070-08; Hranjec T, 2013, CURR OPIN CRIT CARE, V19, P461, DOI 10.1097/MCC.0b013e328364d525; Kale R, 1997, BRIT MED J, V314, P1081, DOI 10.1136/bmj.314.7087.1081; Kollef MH, 2013, CRIT CARE CLIN, V29, P33, DOI 10.1016/j.ccc.2012.10.004; Kollef MH, 2015, CHEST, V147, P1448, DOI 10.1378/chest.14-2745; Kumar A, 2014, VIRULENCE, V5, P80, DOI 10.4161/viru.26913; Magill SS, 2013, AM J CRIT CARE, V22, P469, DOI 10.4037/ajcc2013893; May AK, 2015, CHEST, V147, P1494, DOI 10.1378/chest.14-1687; McMillian WD, 2010, J TRAUMA, V69, P861, DOI 10.1097/TA.0b013e3181e83f8b; Munro N, 2014, AACN ADV CRIT CARE, V25, P163, DOI 10.1097/NCI.0000000000000019; National Health Laboratory Service, 2010, Q PULS STAND OP PROC; PCAST, 2014, REP PRES COMB ANT RE; Ramsamy Y, 2013, SAMJ S AFR MED J, V103, P371, DOI [10.7196/samj.6459, 10.7196/SAMJ.6459]; Simonetti A, 2012, CLIN MICROBIOL INFEC, V18, P1149, DOI 10.1111/j.1469-0691.2011.03709.x; Swanson JM, 2013, ANTIBIOTICS-BASEL, V2, P339, DOI 10.3390/antibiotics2030339; World Health Organization, 2016, ANT RES GLOB REP SUR	24	12	13	0	2	SA MEDICAL ASSOC	PRETORIA	BLOCK F CASTLE WALK CORPORATE PARK, NOSSOB STREET, ERASMUSKLOOF EXT3, PRETORIA, 0002, SOUTH AFRICA	0256-9574	2078-5135		SAMJ S AFR MED J	SAMJ S. Afr. Med. J.	FEB	2016	106	2					196	200		10.7196/SAMJ.2016.v106i2.9870			5	Medicine, General & Internal	General & Internal Medicine	DK3IJ	WOS:000374810000026	26821903	DOAJ Gold			2021-06-18	
J	Toor, GK; Harris, JE; Escobar, M; Yoshida, K; Velikonja, D; Rizoli, S; Cusimano, M; Cullen, N; Sokoloff, S; Colantonio, A				Toor, Gurjit K.; Harris, Jocelyn E.; Escobar, Michael; Yoshida, Karen; Velikonja, Diana; Rizoli, Sandro; Cusimano, Michael; Cullen, Nora; Sokoloff, Sandra; Colantonio, Angela			Long-Term Health Service Outcomes Among Women With Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Community health services; Rehabilitation Women	GENDER-DIFFERENCES; CARE ACCESS; PRECARIOUS EMPLOYMENT; PATIENT SATISFACTION; POPULATION; MODERATE; SEX; HOSPITALIZATION; EPIDEMIOLOGY; DISABILITIES	Objectives: To (1) assess long-term health care service utilization and satisfaction with health care services among women with traumatic brain injury (W-TBI); (2) examine bathers that prevent W-TBI from receiving care when needed; and (3) understand the perceived supports available for W-TBI. Design: Retrospective cohort study. Setting: Community. Participants: W-TBI (n = 105) 5 to 12 years postinjury and women without TBI (n = 105) matched on age, education, and geographic location. Interventions: Not applicable. Main Outcome Measures: Pre- and postinjury data were collected using a questionnaire administered via a semistructured interview. Questions on health services utilization, satisfaction with and quality of services, barriers to receiving care, and perceived social support were from the Canadian Community Health Survey; additional questions on perceived social support were from another large-scale study of people with moderate to severe brain injury. Results: Compared with women without TBI, W-TBI reported using more family physician and community health services. W-TBI reported that they did not receive care when needed (40%), particularly for emotional/mental health problems. Significantly more W-TBI reported financial and structural barriers. There were no significant differences in reported satisfaction with services between women with and without TBI. Conclusions: Health service providers and policymakers should recognize the long-term health and social needs of W-TBI and address societal factors that result in financial and structural barriers, to ensure access to needed services. (C) 2016 by the American Congress of Rehabilitation Medicine	[Toor, Gurjit K.; Escobar, Michael; Colantonio, Angela] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5G 1V7, Canada; [Harris, Jocelyn E.; Cullen, Nora; Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Harris, Jocelyn E.] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Yoshida, Karen] Univ Toronto, Dept Phys Therapy, Toronto, ON M5G 1V7, Canada; [Velikonja, Diana] Hamilton Hlth Sci, Acquired Brain Injury Program, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Rizoli, Sandro; Cusimano, Michael] St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Rizoli, Sandro; Cusimano, Michael] Univ Toronto, Dept Surg, Toronto, ON M5G 1V7, Canada; [Cullen, Nora] West Pk Healthcare Ctr, Toronto, ON, Canada; [Cullen, Nora] Univ Toronto, Dept Med, Div Physiatry, Toronto, ON M5G 1V7, Canada; [Sokoloff, Sandra; Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada	Colantonio, A (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca	Cusimano, Michael/X-4059-2019	Colantonio, Angela/0000-0003-2094-4765; Cullen, Nora/0000-0001-6359-9418; Escobar, Michael/0000-0001-9055-4709	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [200903MOP]; Toronto Rehabilitation Institute University Health Network (UHN); Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario; CIHR Fellowship AwardCanadian Institutes of Health Research (CIHR); CIHR Strategic Training Fellowship in Health Care, Technology and Place [FRN: STP 53911]; Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation; Saunderson Family Chair at the Toronto Rehabilitation Institute-UHN; Canadian Institutes of Health Research Research Chair in Gender, Work and Health from the Institute of Gender and Health [CGW-126580]	Supported by the Canadian Institutes of Health Research (CIHR) (grant no. 200903MOP); the Toronto Rehabilitation Institute University Health Network (UHN); a grant from the Ministry of Health and Long Term Care to the Toronto Rehabilitation Institute-UHN; a CIHR Fellowship Award and CIHR Strategic Training Fellowship in Health Care, Technology and Place (award no. FRN: STP 53911); a Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research (grant no. TIR-103946); the Ontario Neurotrauma Foundation; the Saunderson Family Chair at the Toronto Rehabilitation Institute-UHN; and a Canadian Institutes of Health Research Research Chair in Gender, Work and Health (grant no. CGW-126580) from the Institute of Gender and Health.	Acker J, 2009, SOCIOL TRAV, V51, P199, DOI 10.1016/j.soctra.2009.03.004; Alston M, 2012, AUST SOC WORK, V65, P39, DOI 10.1080/0312407X.2011.594898; Anderson Roger, 2007, J Med Pract Manage, V22, P255; Batchelor C, 1994, Int J Health Care Qual Assur, V7, P22; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Benoit C, 2009, SOCIOL RES ONLINE, V14, DOI 10.5153/sro.2024; Bierman AS, 2007, CAN MED ASSOC J, V177, P1520, DOI 10.1503/cmaj.071541; Bowleg L, 2012, AM J PUBLIC HEALTH, V102, P1267, DOI 10.2105/AJPH.2012.300750; Campbell C, 2013, SOC SCI RES, V42, P1693, DOI 10.1016/j.ssresearch.2013.07.014; Canadian Institutes of Health Research. Natural Sciences and Engineering Research Council of Canada and Social Sciences and Humanities Research Council of Canada, 2014, TRI COUN; Carlin CS, 2012, HEALTH SERV RES, V47, P2250, DOI 10.1111/j.1475-6773.2012.01412.x; Carrillo JE, 2011, J HEALTH CARE POOR U, V22, P562, DOI 10.1353/hpu.2011.0037; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carter KN, 2012, AUST NZ J PUBL HEAL, V36, P218, DOI 10.1111/j.1753-6405.2012.00867.x; CFHI, 2013, J HEALTH SERV RES PO, V18, P255, DOI 10.1177/1355819613501426; Clement W, 2009, ROUTL IAFFE ADV FEM, P240; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Colantonio Angela, 2010, Healthc Policy, V5, pe120; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cranford CJ, 2003, RELAT IND-IND RELAT, V58, P454, DOI 10.7202/007495ar; Cullen N, 2007, J HEAD TRAUMA REHAB, V22, P214, DOI 10.1097/01.HTR.0000281836.54602.6d; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fox J. B., 2010, Morbidity and Mortality Weekly Report, V59, P1448; Fraser R, 2006, J VOCAT REHABIL, V25, P141; Fuller S, 2008, SOC INDIC RES, V88, P31, DOI 10.1007/s11205-007-9201-8; Gibson BE, 2012, WOMEN HEALTH ISS, V22, pE111, DOI 10.1016/j.whi.2011.07.011; Gibson JC, 2010, SOCIAL CARE NEURODIS, V1, P21, DOI DOI 10.1080/09687599627598; Gill L, 2009, LEADERSH HEALTH SERV, V22, P8, DOI 10.1108/17511870910927994; Haldeman S, 2012, SPINE J, V12, P1138, DOI 10.1016/j.spinee.2012.09.002; Hankivsky O, 2012, SOC SCI MED, V74, P1712, DOI 10.1016/j.socscimed.2011.11.029; Harris JE, 2012, BRAIN INJURY, V26, P177, DOI 10.3109/02699052.2011.635361; Hudak PL, 2003, J CLIN EPIDEMIOL, V56, P103, DOI 10.1016/S0895-4356(02)00602-9; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iezzoni LI, 2001, AM J MED QUAL, V16, P135; Ioannidis JPA, 2013, AM J BIOETHICS, V13, P40, DOI 10.1080/15265161.2013.768864; Johnson JL, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-14; Keith RA, 1998, ARCH PHYS MED REHAB, V79, P1122, DOI 10.1016/S0003-9993(98)90182-4; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Lefebvre Helene, 2012, J Trauma Nurs, V19, P197, DOI 10.1097/JTN.0b013e318275990d; Liu SY, 2008, J WOMENS HEALTH, V17, P1321, DOI 10.1089/jwh.2007.0591; Lupu I., 2012, CRIT PERSPECT, V23, P351, DOI DOI 10.1016/J.CPA.2012.01.003; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; O'Callaghan AM, 2010, INT J SPEECH-LANG PA, V12, P107, DOI 10.3109/17549500903431774; Odette Fran, 2003, Health Care Women Int, V24, P125, DOI 10.1080/07399330304008; Parekh S, 2011, HYPATIA, V26, P672, DOI 10.1111/j.1527-2001.2010.01159.x; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Ponsford J, 1999, NEUROPSYCHOL REHABIL, V9, P517, DOI 10.1080/096020199389563; Ripley DL, 2008, ARCH PHYS MED REHAB, V89, P1090, DOI 10.1016/j.apmr.2007.10.038; Rothstein MA, 2013, AM J BIOETHICS, V13, P27, DOI 10.1080/15265161.2013.767955; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Schoen C, 2009, HEALTH AFFAIR, V28, pW1, DOI 10.1377/hlthaff.28.1.w1; Schopp LH, 2002, J MIDWIFERY WOM HEAL, V47, P74, DOI 10.1016/S1526-9523(02)00216-7; Schopp LH, 2001, J CLIN PSYCHOL MED S, V8, P181, DOI 10.1023/A:1011369620254; Shuey KM, 2013, WORK OCCUPATION, V40, P174, DOI 10.1177/0730888413481030; Spenceley SM, 2005, WESTERN J NURS RES, V27, P465, DOI 10.1177/0193945904272384; Statistics Canada, 2004, JOINT CAN US SURV; Statistics Canada. Canadian Community Health Survey (CCHS), QUEST CYCL; Talbot Y, 2001, CAN FAM PHYSICIAN, V47, P58; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; World Economic Forum, 2014, GLOB GEND; World Health Organization, 2009, WOMEN AND HEALTH: TODAY'S EVIDENCE TOMORROW'S AGENDA, P1; Young MC, 2010, RELAT IND-IND RELAT, V65, P74	73	12	12	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2016	97	2		1			S54	S63		10.1016/j.apmr.2015.02.010			10	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	DC4RI	WOS:000369207600008	25707697	Bronze			2021-06-18	
J	You, WD; Tang, QL; Wang, L; Lei, J; Feng, JF; Mao, Q; Gao, GY; Jiang, JY				You, Wen-Dong; Tang, Qi-Lin; Wang, Lei; Lei, Jin; Feng, Jun-Feng; Mao, Qing; Gao, Guo-Yi; Jiang, Ji-Yao			Alteration of microRNA expression in cerebrospinal fluid of unconscious patients after traumatic brain injury and a bioinformatic analysis of related single nucleotide polymorphisms	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						microRNAs; Polymorphism; Single nucleotide; Computational biology; Brain injuries; Coma		Purpose: It is becoming increasingly clear that genetic factors play a role in traumatic brain injury (TBI), whether in modifying clinical outcome after TBI or determining susceptibility to it. MicroRNAs are small RNA molecules involved in various pathophysiological processes by repressing target genes at the post-transcriptional level, and TBI alters microRNA expression levels in the hippocampus and cortex. This study was designed to detect differentially expressed microRNAs in the cerebrospinal fluid (CSF) of TBI patients remaining unconscious two weeks after initial injury and to explore related single nucleotide polymorphisms (SNPs). Methods: We used a microarray platform to detect differential microRNA expression levels in CSF samples from patients with post-traumatic coma compared with samples from controls. A bioinformatic scan was performed covering microRNA gene promoter regions to identify potential functional SNPs. Results: Totally 26 coma patients and 21 controls were included in this study, with similar distribution of age and gender between the two groups. Microarray showed that fourteen microRNAs were differentially expressed, ten at higher and four at lower expression levels in CSF of traumatic coma patients compared with controls (p < 0.05). One SNP (rs11851174 allele: C/T) was identified in the motif area of the microRNA hsa-miR-431-3P gene promoter region. Conclusion: The altered microRNA expression levels in CSF after brain injury together with SNP identified within the microRNA gene promoter area provide a new perspective on the mechanism of impaired consciousness after TBI. Further studies are needed to explore the association between the specific microRNAs and their related SNPs with post-traumatic unconsciousness. (c) 2016 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[You, Wen-Dong; Tang, Qi-Lin; Wang, Lei; Lei, Jin; Feng, Jun-Feng; Mao, Qing; Gao, Guo-Yi; Jiang, Ji-Yao] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai 200127, Peoples R China	Gao, GY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai 200127, Peoples R China.	gao3@sina.com					Alshatwi AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043939; Bandiera S, 2010, CLIN GENET, V77, P306, DOI 10.1111/j.1399-0004.2010.01370.x; Chu YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089930; Dardiotis E, 2012, CURR OPIN PSYCHIATR, V25, P231, DOI 10.1097/YCO.0b013e3283523c0e; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Dlouhy BJ, 2012, NEW ENGL J MED, V366, P2427, DOI 10.1056/NEJMc1204669; Edlow BL, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0375-y; Feng W, 2011, SCI CHINA LIFE SCI, V54, P1103, DOI 10.1007/s11427-011-4249-8; Genini S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-172; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Gupta OP, 2014, MOL BIOL REP, V41, P4623, DOI 10.1007/s11033-014-3333-0; Hutchison ER, 2013, GLIA, V61, P1018, DOI 10.1002/glia.22483; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kashyap N, 2013, MOL BIOSYST, V9, P1919, DOI 10.1039/c3mb70043g; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; Meyer MJ, 2010, BRAIN INJURY, V24, P722, DOI 10.3109/02699051003692134; Miao JL, 2013, TUMOR BIOL, V34, P2093, DOI 10.1007/s13277-013-0940-7; Estal RM, 2013, BREAST CANCER RES TR, V142, P19, DOI 10.1007/s10549-013-2723-7; Patel D, 2013, SURGERY, V154, P1224, DOI 10.1016/j.surg.2013.06.022; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Tanaka T, 2014, INT J ONCOL, V44, P1685, DOI 10.3892/ijo.2014.2317; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; VILMING EB, 2014, BMC CANC, V0014; Xu HD, 2014, CELL BIOCHEM BIOPHYS, V69, P319, DOI 10.1007/s12013-013-9801-7; Zhao H, 2014, BIOCHEM J, V460, P117, DOI 10.1042/BJ20131535	32	12	14	0	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	FEB	2016	19	1					11	15		10.1016/j.cjtee.2016.01.004			5	Orthopedics	Orthopedics	VF1OQ	WOS:000442099200004	27033266	DOAJ Gold, Green Published			2021-06-18	
J	Killgore, WDS; Singh, P; Kipman, M; Pisner, D; Fridman, A; Weber, M				Killgore, William D. S.; Singh, Prabhjyot; Kipman, Maia; Pisner, Derek; Fridman, Andrew; Weber, Mareen			Gray matter volume and executive functioning correlate with time since injury following mild traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						mTBI; Mild traumatic brain injury; Concussion; VBM; Voxel-based morphometry; SPM8; Gray matter; Emotion regulation; Motor speed; Psychomotor vigilance	VOXEL-BASED MORPHOMETRY; POST-CONCUSSIVE SYNDROME; COGNITIVE FUNCTION; UNITED-STATES; CORTEX; RECOVERY; DENSITY; FMRI; DISTRACTION; PERFORMANCE	Most people who sustain a mild traumatic brain injury (mTBI) will recover to baseline functioning within a period of several days to weeks. A substantial minority of patients, however, will show persistent symptoms and mild cognitive complaints for much longer. To more clearly delineate how the duration of time since injury (TSI) is associated with neuroplastic cortical volume changes and cognitive recovery, we employed voxel-based morphometry (VBM) and select neuropsychological measures in a cross-sectional sample of 26 patients with mTBI assessed at either two-weeks, one-month, three-months, six-months, or one-year post injury, and a sample of 12 healthy controls. Longer duration of TSI was associated with larger gray matter volume (GMV) within the ventromedial prefrontal cortex (vmPFC) and right fusiform gyrus, and better neurocognitive performance on measures of visuospatial design fluency and emotional functioning. In particular, volume within the vmPFC was positively correlated with design fluency and negatively correlated with symptoms of anxiety, whereas GMV of the fusiform gyrus was associated with greater design fluency and Sustained visual psychomotor vigilance performance. Moreover, the larger GMV seen among the more chronic individuals was significantly greater than healthy controls, suggesting possible enlargement of these regions with time since injury. These findings are interpreted in light of burgeoning evidence suggesting that cortical regions often exhibit structural changes following experience or practice, and suggest that with greater time since an mTBI, the brain displays compensatory remodeling of cortical regions involved in emotional regulation, which may reduce distractibility during attention demanding visuo-motor tasks. (c) 2015 Elsevier Ireland Ltd. All rights reserved.	[Killgore, William D. S.; Singh, Prabhjyot; Pisner, Derek; Fridman, Andrew] Univ Arizona, Coll Med, Social Cognit & Affect Neurosci Lab, Tucson, AZ 85724 USA; [Killgore, William D. S.] Harvard Univ, Sch Med, McLean Hosp, Cambridge, MA 02138 USA; [Kipman, Maia] Tufts Univ, Sch Med, Medford, MA USA; [Weber, Mareen] Stanford Univ, Sch Med, Stanford Concuss & Brain Performance Ctr, Stanford, CA 94305 USA	Killgore, WDS (corresponding author), Univ Arizona, Coll Med, Dept Psychiat, Social Cognit & Affect Neurosci Lab, 1501N Campbell Ave, Tucson, AZ 85724 USA.	killgore@psychiatry.arizona.edu		Killgore, William/0000-0002-5328-0208	USAMRAA [W81XWH-12-1-0386]	This research was supported by a USAMRAA grant to WDSK (W81XWH-12-1-0386).	Aydin K, 2007, AM J NEURORADIOL, V28, P1859, DOI 10.3174/ajnr.A0696; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Comeau WL, 2010, BEHAV BRAIN RES, V214, P91, DOI 10.1016/j.bbr.2010.04.033; Crawford JR, 2008, J INT NEUROPSYCH SOC, V14, P1069, DOI 10.1017/S1355617708081228; Dambacher F, 2014, J COGNITIVE NEUROSCI, V26, P1775, DOI 10.1162/jocn_a_00595; Deng Z, 2014, NEUROSCIENCE, V275, P500, DOI 10.1016/j.neuroscience.2014.06.040; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Dorfel D, 2014, NEUROIMAGE, V101, P298, DOI 10.1016/j.neuroimage.2014.06.051; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Hasan KM, 2014, J NEUROTRAUM, V31, P466, DOI [10.1089/NEU.2013.3085, 10.1089/neu.2013.3085]; Hinds O, 2013, J NEUROPHYSIOL, V109, P1250, DOI 10.1152/jn.00533.2011; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kerr AL, 2011, J COMMUN DISORD, V44, P538, DOI 10.1016/j.jcomdis.2011.04.011; Kolb B, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00015; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Leung MK, 2013, SOC COGN AFFECT NEUR, V8, P34, DOI 10.1093/scan/nss076; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; Lou AR, 2013, ACTA OPHTHALMOL, V91, P58, DOI 10.1111/j.1755-3768.2011.02304.x; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Morey LC., 2007, PERSONALITY ASSESSME; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Quallo MM, 2009, P NATL ACAD SCI USA, V106, P18379, DOI 10.1073/pnas.0909751106; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Sluming V, 2002, NEUROIMAGE, V17, P1613, DOI 10.1006/nimg.2002.1288; Soh DW, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00108; Sosin DM, 1996, BRAIN INJURY, V10, P47; Strong CAH, 2011, J INT NEUROPSYCH SOC, V17, P230, DOI 10.1017/S1355617710001451; Sumiyoshi A, 2014, NEUROIMAGE, V98, P82, DOI 10.1016/j.neuroimage.2014.04.075; Wechsler D, 1999, WASI WECHSLER ABBREV; Welborn BL, 2009, SOC COGN AFFECT NEUR, V4, P328, DOI 10.1093/scan/nsp028; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Ziaei M, 2014, NEUROIMAGE, V87, P276, DOI 10.1016/j.neuroimage.2013.10.048; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139	41	12	12	0	12	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 26	2016	612						238	244		10.1016/j.neulet.2015.12.033			7	Neurosciences	Neurosciences & Neurology	DC8LU	WOS:000369471900041	26711488				2021-06-18	
J	Isokuortti, H; Iverson, GL; Kataja, A; Brander, A; Ohman, J; Luoto, TM				Isokuortti, Harri; Iverson, Grant L.; Kataja, Anneli; Brander, Antti; Ohman, Juha; Luoto, Teemu M.			Who Gets Head Trauma or Recruited in Mild Traumatic Brain Injury Research?	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; comorbidity; concussion; head injury; patient recruitment	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; WHITE-MATTER INTEGRITY; MAJOR DEPRESSIVE DISORDER; TENSOR IMAGING FINDINGS; PSYCHIATRIC-DISORDERS; COGNITIVE IMPAIRMENT; EMERGENCY-DEPARTMENT; EXECUTIVE FUNCTION; SUBSTANCE-ABUSE; WORKING-MEMORY	Mild traumatic brain injury (mTBI) is a public health problem. Outcome from mTBI is heterogeneous in part due to pre-injury individual differences that typically are not well described or understood. Pre-injury health characteristics of all consecutive patients (n=3023) who underwent head computed tomography due to acute head trauma in the emergency department of Tampere University Hospital, Finland, between August 2010 and July 2012 were examined. Patients were screened to obtain a sample of working age adults with no pre-injury medical or mental health problems who had sustained a pure mTBI. Of all patients screened, 1990 (65.8%) fulfilled the mTBI criteria, 257 (8.5%) had a more severe TBI, and 776 (25.7%) had a head trauma without obvious signs of brain injury. Injury-related data and participant-related data (e.g., age, sex, diagnosed diseases, and medications) were collected from hospital records. The most common pre-injury diseases were circulatory (39.4%-43.2%), neurological (23.7%-25.2%), and psychiatric (25.8%-27.5%) disorders. Alcohol abuse was present in 18.4%-26.8%. The most common medications were for cardiovascular (33.1%-36.6%), central nervous system (21.4%-30.8%), and blood clotting and anemia indications (21.5%-22.6%). Of the screened patients, only 2.5% met all the enrollment criteria. Age, neurological conditions, and psychiatric problems were the most common reasons for exclusion. Most of the patients sustaining an mTBI have some pre-injury diseases or conditions that could affect clinical outcome. By excluding patients with pre-existing conditions, the patients with known risk factors for poor outcome remain poorly studied.	[Isokuortti, Harri] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Iverson, Grant L.] Harvard Univ, Dept Phys Med & Rehabil, Sch Med, Boston, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] MassGen Hosp Children, Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Kataja, Anneli; Brander, Antti] Tampere Univ Hosp, Dept Radiol, Tampere, Finland; [Ohman, Juha] Tampere Univ Hosp, Dept Neurosci & Rehabil, Tampere, Finland; [Luoto, Teemu M.] Tampere Univ Hosp, Dept Neurosurg, Tampere, Finland	Isokuortti, H (corresponding author), Univ Tampere, Sch Med, Tampereen Yliopisto 33014, Finland.	harri.isokuortti@gmail.com	Luoto, Teemu/W-6468-2018	Luoto, Teemu/0000-0002-7329-3284; Ohman, Juha/0000-0002-6592-1367; Iverson, Grant/0000-0001-7348-9570	INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium - Department of Defense Psychological Health/Traumatic Brain Injury Research Program [X81XWH-07-CC-CSDoD]	The authors thank research assistants Anne Simi and Marika Suopanki-Ervasti for their contribution in data collection. GLI notes that he was supported in part by the INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium funded by the Department of Defense Psychological Health/Traumatic Brain Injury Research Program (X81XWH-07-CC-CSDoD). This study was conducted as part of the first author's PhD thesis research program.	Alderson RM, 2013, NEUROPSYCHOLOGY, V27, P287, DOI 10.1037/a0032371; Ashley J, 1990, Health Trends, V22, P135; Backman L, 2005, NEUROPSYCHOLOGY, V19, P520, DOI 10.1037/0894-4105.19.4.520; Baker STE, 2013, NEUROSCI BIOBEHAV R, V37, P1713, DOI 10.1016/j.neubiorev.2013.06.015; Baldacchino A, 2012, NEUROSCI BIOBEHAV R, V36, P2056, DOI 10.1016/j.neubiorev.2012.06.006; Barker MJ, 2004, ARCH CLIN NEUROPSYCH, V19, P437, DOI 10.1016/S0887-6177(03)00096-9; Bell RP, 2011, DRUG ALCOHOL DEPEN, V114, P159, DOI 10.1016/j.drugalcdep.2010.10.001; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x; Colby JB, 2012, PSYCHIAT RES-NEUROIM, V204, P140, DOI 10.1016/j.pscychresns.2012.04.017; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; Frazier TW, 2004, NEUROPSYCHOLOGY, V18, P543, DOI 10.1037/0894-4105.18.3.543; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gifford KA, 2013, ARCH CLIN NEUROPSYCH, V28, P649, DOI 10.1093/arclin/act046; Gons RAR, 2010, STROKE, V41, P2801, DOI 10.1161/STROKEAHA.110.597237; Gordon KE, 2006, PEDIATR NEUROL, V34, P376, DOI 10.1016/j.pediatrneurol.2005.09.007; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hoogenboom WS, 2014, DIABETES, V63, P728, DOI 10.2337/db13-1219; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Iverson G.L., 2012, PTSD MILD TRAUMATIC, P37; Kloppenborg RP, 2014, NEUROLOGY, V82, P2127, DOI 10.1212/WNL.0000000000000505; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P478, DOI 10.1093/arclin/acu027; Lange RT, 2014, J NEUROTRAUM, V31, P198, DOI 10.1089/neu.2013.2866; Laws KR, 2007, HUM PSYCHOPHARM CLIN, V22, P381, DOI 10.1002/hup.857; Lebel C, 2013, PSYCHIAT RES-NEUROIM, V213, P161, DOI 10.1016/j.pscychresns.2013.04.002; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Luoto TM, 2014, J NEUROTRAUM, V31, P728, DOI 10.1089/neu.2013.3174; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Mack LR, 2003, J EMERG MED, V24, P157, DOI 10.1016/S0736-4679(02)00714-X; Madden DJ, 2012, BBA-MOL BASIS DIS, V1822, P386, DOI 10.1016/j.bbadis.2011.08.003; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; Monnig MA, 2013, PSYCHOL ADDICT BEHAV, V27, P455, DOI 10.1037/a0027168; Olaithe M, 2013, SLEEP, V36, P1297, DOI 10.5665/sleep.2950; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Poyry T, 2013, J HEAD TRAUMA REHAB, V28, P89, DOI 10.1097/HTR.0b013e318250eadd; Puljula J, 2007, ALCOHOL ALCOHOLISM, V42, P474, DOI 10.1093/alcalc/agm003; Sareen J, 2013, DEPRESS ANXIETY, V30, P321, DOI 10.1002/da.22077; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2014, BRAIN INJURY, V28, P1590, DOI 10.3109/02699052.2014.943287; Smith E, 2011, OBES REV, V12, P740, DOI 10.1111/j.1467-789X.2011.00920.x; Snyder HR, 2013, PSYCHOL BULL, V139, P81, DOI 10.1037/a0028727; Stanek KM, 2011, OBESITY, V19, P500, DOI 10.1038/oby.2010.312; Stavro K, 2013, ADDICT BIOL, V18, P203, DOI 10.1111/j.1369-1600.2011.00418.x; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Swanson HL, 2009, J LEARN DISABIL-US, V42, P260, DOI 10.1177/0022219409331958; Symonds C. P., 1937, GUYS HOSP GAZETTE; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; Umene-Nakano W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087890; van Ewijk H, 2012, NEUROSCI BIOBEHAV R, V36, P1093, DOI 10.1016/j.neubiorev.2012.01.003; Vandermosten M, 2012, NEUROSCI BIOBEHAV R, V36, P1532, DOI 10.1016/j.neubiorev.2012.04.002; Walhovd KB, 2010, AM J NEURORADIOL, V31, P894, DOI 10.3174/ajnr.A1957; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	76	12	12	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2016	33	2					232	241		10.1089/neu.2015.3888			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DA7PH	WOS:000367995800009	26054639				2021-06-18	
J	Watts, LT; Long, JA; Boggs, RC; Manga, H; Huang, SL; Shen, Q; Duong, TQ				Watts, Lora Talley; Long, Justin Alexander; Boggs, Robert Cole; Manga, Hemanth; Huang, Shiliang; Shen, Qiang; Duong, Timothy Q.			Delayed Methylene Blue Improves Lesion Volume, Multi-Parametric Quantitative Magnetic Resonance Imaging Measurements, and Behavioral Outcome after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						behavioral outcomes; CCI; methylene blue; mitochondria; MRI; TBI	DIFFUSE AXONAL INJURY; SEVERE HEAD-INJURIES; WHITE-MATTER INJURY; CYCLOSPORINE-A; OXIDATIVE STRESS; IN-VIVO; DAMAGE; NEUROPROTECTION; RAT; ISCHEMIA	Traumatic brain injury (TBI) remains a primary cause of death and disability in both civilian and military populations worldwide. There is a critical need for the development of neuroprotective agents that can circumvent damage and provide functional recovery. We previously showed that methylene blue (MB), a U.S. Food and Drug Administration-grandfathered drug with energy-enhancing and antioxidant properties, given 1 and 3h post-TBI, had neuroprotective effects in rats. This study aimed to further investigate the neuroprotection of delayed MB treatment (24h postinjury) post-TBI as measured by lesion volume and functional outcomes. Comparisons were made with vehicle and acute MB treatment. Multi-modal magnetic resonance imaging and behavioral studies were performed at 1 and 3h and 2, 7, and 14 days after an impact to the primary forelimb somatosensory cortex. We found that delaying MB treatment 24h postinjury still minimized lesion volume and functional deficits, compared to vehicle-treated animals. The data further support the potential for MB as a neuroprotective treatment, especially when medical teatment is not readily available. MB has an excellent safety profile and is clinically approved for other indications. MB clinical trials on TBI can thus be readily explored.	[Watts, Lora Talley; Long, Justin Alexander; Boggs, Robert Cole; Manga, Hemanth; Huang, Shiliang; Shen, Qiang; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Watts, Lora Talley; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol, San Antonio, TX 78229 USA; Univ Texas Hlth Sci Ctr San Antonio, Dept Ophthalmol, San Antonio, TX 78229 USA; [Duong, Timothy Q.] South Texas Vet Hlth Care Syst, Div Res, San Antonio, TX USA	Watts, LT (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, 8403 Floyd Curl Dr, San Antonio, TX 78229 USA.	wattsl@uthscsa.edu	Watts, Lora Talley/A-2724-2012; Duong, Tim/AAL-8357-2021	Watts, Lora Talley/0000-0002-2337-1504; Duong, Tim/0000-0001-6403-2827	National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS45879]; Clinical Translational Science Awards (CTSA) [TL1, KL2, 8UL1TR000149, TL1TR001119, TR001118]; Mike Hogg Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001118, TL1TR001119, UL1TR001120, UL1TR000149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045879] Funding Source: NIH RePORTER	This work was supported, in part, by the National Institutes of Health/National Institute of Neurological Disorders and Stroke (R01 NS45879; to T.Q.D.), a TL1 grant (to J.A.L.) and KL2 (to L.T.W.) through the Clinical Translational Science Awards (CTSA; parent grant 8UL1TR000149, TL1TR001119, and TR001118), and the Mike Hogg Fund (to L.T.W.).	Adelson PD, 1998, ACT NEUR S, V71, P104; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bardakci H, 2006, EUR SURG RES, V38, P482, DOI 10.1159/000096007; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Chaturvedi RK, 2008, ANN NY ACAD SCI, V1147, P395, DOI 10.1196/annals.1427.027; Clifton Jack 2nd, 2003, Am J Ther, V10, P289; Crack PJ, 2005, FREE RADICAL BIO MED, V38, P1433, DOI 10.1016/j.freeradbiomed.2005.01.019; Dore-Duffy P, 2011, NEUROL RES, V33, P176, DOI 10.1179/016164111X12881719352372; Evgenov OV, 2002, EUR RESPIR J, V20, P957, DOI 10.1183/09031936.02.00932001; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Huang SL, 2013, NEUROIMAGE, V72, P237, DOI 10.1016/j.neuroimage.2013.01.027; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Ishiwata A, 2006, ACTA NEUROL SCAND, V114, P91, DOI 10.1111/j.1600-0404.2006.00661.x; Lin AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046585; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P3248, DOI 10.1073/pnas.070049497; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Medina DX, 2011, BRAIN PATHOL, V21, P140, DOI 10.1111/j.1750-3639.2010.00430.x; Meng XJ, 2004, ANN NEUROL, V55, P207, DOI 10.1002/ana.10803; Miclescu A, 2010, CRIT CARE MED, V38, P2199, DOI 10.1097/CCM.0b013e3181f26b0c; MUTTAQIN Z, 1993, ACTA NEUROCHIR, V123, P76, DOI 10.1007/BF01476289; O'Leary JC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-45; Ohta M, 2013, BRAIN RES, V1490, P184, DOI 10.1016/j.brainres.2012.09.011; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Oz M, 2009, BIOCHEM PHARMACOL, V78, P927, DOI 10.1016/j.bcp.2009.04.034; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Poteet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048279; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Rodriguez P, 2014, BRAIN RES, V1588, P144, DOI 10.1016/j.brainres.2014.09.007; Rojas JC, 2012, PROG NEUROBIOL, V96, P32, DOI 10.1016/j.pneurobio.2011.10.007; Rojas JC, 2009, NEUROTOX RES, V15, P260, DOI 10.1007/s12640-009-9027-z; SALARIS SC, 1991, BIOCHEM PHARMACOL, V42, P499, DOI 10.1016/0006-2952(91)90311-R; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Scheindlin S, 2008, MOL INTERV, V8, P268, DOI 10.1124/mi.8.6.1; Shen Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079833; Shen YM, 2007, MAGN RESON IMAGING, V25, P219, DOI 10.1016/j.mri.2006.09.018; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Thomale UW, 2002, ACTA NEUROCHIR SUPPL, V81, P229; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Zhang XA, 2006, NEUROTOX RES, V9, P47, DOI 10.1007/BF03033307	55	12	12	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2016	33	2					194	202		10.1089/neu.2015.3904			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DA7PH	WOS:000367995800005	25961471	Green Published			2021-06-18	
J	Sigsbee, B; Bever, CT; Jones, LK				Sigsbee, Bruce; Bever, Christopher T., Jr.; Jones, Lyell K., Jr.			Practice improvement requires more than guidelines and quality measures	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; OF-CARE; ACUTE STROKE; ADHERENCE; EPILEPSY; OUTCOMES; INTERVENTION; INDICATORS; REGISTRIES; CHILDREN	Increasing emphasis on improving health care quality has led to a variety of programs that require neurologists to be familiar with the concept of systematic quality improvement. While they vary in extent, these quality improvement programs and their attendant costs now have implications for physician payment and certification. In response to these factors, the American Academy of Neurology is establishing a clinical quality data registry. This article reviews evidence demonstrating the ability of quality improvement initiatives to improve care, the role of clinical quality data registries in the identification and mitigation of gaps in care, and the principles to be considered in development of registry-based quality improvement programs. It addresses the key question: Is the effort worthwhile?	[Sigsbee, Bruce] Penobscot Bay Med Ctr, Rockport, ME 04856 USA; [Bever, Christopher T., Jr.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Jones, Lyell K., Jr.] Mayo Clin, Rochester, MN USA	Sigsbee, B (corresponding author), Penobscot Bay Med Ctr, Rockport, ME 04856 USA.	bsigsbee@aan.com		Jones, Lyell/0000-0002-5851-8705	Department of Veterans AffairsUS Department of Veterans Affairs	B. Sigsbee reports no disclosures relevant to the manuscript. C. Bever is an employee of and has merit award and center of excellence award support from the Department of Veterans Affairs, is a grantee of the of the National Multiple Sclerosis Society, and is a co-holder of a patent on the use of hematogenous stem cells for cell replacement and gene delivery therapy. He serves on the Quality and Safety Subcommittee and the Registry Work group of the American Academy of Neurology, and the program committees of the Paralyzed Veterans of America, the Consortium of MS Clinics, and the Americas Committee on Research and Treatment of MS. L. Jones reports no disclosures relevant to the manuscript. Go to Neurology.org for full disclosures.	Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; Barr CJ, 2012, J ARTHROPLASTY, V27, P1766, DOI 10.1016/j.arth.2012.04.028; Bejot Y, 2013, EUR J NEUROL, V20, P1177, DOI 10.1111/ene.12154; Bickell NA, 2013, MED CARE, V51, pE35, DOI 10.1097/MLR.0b013e3182422f7b; Cherry DL, 2004, AM J MANAG CARE, V10, P553; Ellrodt AG, 2013, CIRCULATION, V128, P2447, DOI 10.1161/01.cir.0000435779.48007.5c; Fonarow GC, 2014, JAMA-J AM MED ASSOC, V311, P1632, DOI 10.1001/jama.2014.3203; Fritz JM, 2007, MED CARE, V45, P973, DOI 10.1097/MLR.0b013e318070c6cd; Goodman MJ, 2012, INT J QUAL HEALTH C, V24, P293, DOI 10.1093/intqhc/mzs017; Hall BL, 2009, SURGERY, V145, P602, DOI 10.1016/j.surg.2009.03.002; Hixson ED, 2005, JT COMM J QUAL PATIE, V31, P447, DOI 10.1016/S1553-7250(05)31058-0; Hoyt DB, 2014, J PEDIATR SURG, V49, P25, DOI 10.1016/j.jpedsurg.2013.09.026; Kampman MT, 2005, EPILEPSIA, V46, P1286, DOI 10.1111/j.1528-1167.2005.04205.x; Koch CG, 2012, J AM COLL SURGEONS, V214, P798, DOI 10.1016/j.jamcollsurg.2011.12.037; Kohn LT, 2000, ERR IS HUMAN BUILDIN; Mays GP, TIERED PROVIDER NETW; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; Ornstein S, 2004, ANN INTERN MED, V141, P523, DOI 10.7326/0003-4819-141-7-200410050-00008; Rao SV, 2013, JACC-CARDIOVASC INTE, V6, P897, DOI 10.1016/j.jcin.2013.04.016; Reinke CE, 2013, DIS COLON RECTUM, V56, P638, DOI 10.1097/DCR.0b013e31827886db; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P1371, DOI 10.1016/j.apmr.2012.02.031; Rutten GM, 2010, PHYS THER, V90, P1111, DOI 10.2522/ptj.20090173; Schwamm LH, 2009, CIRCULATION, V119, P107, DOI 10.1161/CIRCULATIONAHA.108.783688; Shah BR, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001588; Siracusa CM, 2014, BMJ QUAL SAF, V23, P56, DOI 10.1136/bmjqs-2013-002361; Strasser DC, 2010, TOP STROKE REHABIL, V17, P282, DOI 10.1310/tsr1704-282; Swarztrauber K, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-26; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Wasade VS, 2012, EPILEPSY BEHAV, V24, P468, DOI 10.1016/j.yebeh.2012.05.017; Westfall JM, 2007, JAMA-J AM MED ASSOC, V297, P403, DOI 10.1001/jama.297.4.403	31	12	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JAN 12	2016	86	2					188	193		10.1212/WNL.0000000000002116			6	Clinical Neurology	Neurosciences & Neurology	DB4AJ	WOS:000368454800014	26519541				2021-06-18	
J	Oyesanya, TO; Ward, EC				Oyesanya, Tolu O.; Ward, Earlise C.			Mental Health in Women With Traumatic Brain Injury: A Systematic Review on Depression and Hope	HEALTH CARE FOR WOMEN INTERNATIONAL			English	Article							GENDER-DIFFERENCES; SEX-DIFFERENCES; MAJOR DEPRESSION; MODERATE; OUTCOMES; EXPERIENCE; PREDICTORS; ROLES	The prevalence of traumatic brain injury (TBI) in women has recently increased from 25% to 40%. Current literature inadequately captures challenges women face after injury, including depression. The limited focus on depression is problematic as rates of depression are increasing simultaneously with rates of TBI. A disabling symptom of depression is lack of hope; thus, depression, comorbid with TBI, leads to disability among women. Unfortunately, depression and hope among women with TBI has yet to be systematically examined. The purpose of this systematic review is to examine and synthesize current literature focusing on women with TBI, comorbid with depression, and hope.	[Oyesanya, Tolu O.; Ward, Earlise C.] Univ Wisconsin, Sch Nursing, Madison, WI 53705 USA	Oyesanya, TO (corresponding author), Univ Wisconsin, Sch Nursing, 701 Highland Ave, Madison, WI 53705 USA.	toyesanya@wisc.edu		Oyesanya, Tolu/0000-0001-8821-4510	NIH/NIGMS Initiative for Maximizing Student Development [R25GM083252]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM083252] Funding Source: NIH RePORTER	This research was supported by NIH/NIGMS Initiative for Maximizing Student Development (PI, M. Carnes) Grant# R25GM083252.	Agency for Healthcare Research and Quality, 2011, TRAUM BRIAN INJ DEPR; Alston M, 2012, AUST SOC WORK, V65, P39, DOI 10.1080/0312407X.2011.594898; Antetius E, 2007, MED ANTHROPOL Q, V21, P324, DOI 10.1525/MAQ.2007.21.3.324; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Bell K R, 2001, Phys Med Rehabil Clin N Am, V12, P169; Blazer D. G., 1994, AM J PSYCHIAT, V15, P24; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brain Injury Association of America (BIAA), 2012, BIAA FREQ ASK QUEST; Centers for Disease Control and Prevention, 2014, RAT TBI REL EM DEP V; Centre for Reviews and Dissemination, 2009, SYSTEMATIC REV CRDS, V3rd; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Chang EC, 2001, J SOC CLIN PSYCHOL, V20, P117, DOI 10.1521/jscp.20.2.117.22262; Chase S, 2012, HEALTH CARE WOMEN IN, V33, P631, DOI 10.1080/07399332.2012.673652; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Freeman M, 2000, LINES NARRATIVE PSYC, P81; Gerberich SG, 1997, NEUROEPIDEMIOLOGY, V16, P1, DOI 10.1159/000109665; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Howes H, 2005, PSYCHOL HEALTH, V20, P129, DOI 10.1080/0887044042000272903; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Isaki E, 2000, BRAIN INJURY, V14, P441; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; KANDEL DB, 1985, J HEALTH SOC BEHAV, V26, P64, DOI 10.2307/2136727; Kessler RC, 2003, J AFFECT DISORDERS, V74, P5, DOI 10.1016/S0165-0327(02)00426-3; Kmet LM., 2004, STANDARD QUALITY ASS; Liossi C, 2009, J NEUROPSYCH CLIN N, V21, P43, DOI 10.1176/appi.neuropsych.21.1.43; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b2535, 10.1371/journal.pmed.1000097, 10.1016/j.ijsu.2010.02.007]; Mukherjee D, 2003, WOMEN THER, V26, P3, DOI 10.1300/J015v26n01_01; Mukherjee D, 2006, TOP STROKE REHABIL, V13, P26, DOI 10.1310/tsr1304-26; Ng I, 2006, BRIT J NEUROSURG, V20, P73, DOI 10.1080/02688690600682259; NOLENHOEKSEMA S, 1991, J ABNORM PSYCHOL, V100, P569, DOI 10.1037/0021-843X.100.4.569; Peleg G, 2009, BRAIN INJURY, V23, P800, DOI 10.1080/02699050903196696; RADLOFF L, 1975, SEX ROLES, V1, P249; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Rapoport MJ, 2003, AM J GERIAT PSYCHIAT, V11, P365, DOI 10.1176/appi.ajgp.11.3.365; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; SNYDER CR, 1991, J PERS SOC PSYCHOL, V60, P570, DOI 10.1037/0022-3514.60.4.570; Strom TQ, 2007, BRAIN INJURY, V21, P1137, DOI 10.1080/02699050701687334; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van Vliet-Ruissen C, 2014, NEUROREHABILITATION, V34, P373, DOI 10.3233/NRE-131032; VENKATESH A, 1980, J CONSUM RES, V7, P189, DOI 10.1086/208806; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7	47	12	12	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0739-9332	1096-4665		HEALTH CARE WOMEN IN	Health Care Women Int.	JAN 2	2016	37	1					45	74		10.1080/07399332.2015.1005307			30	Public, Environmental & Occupational Health; Women's Studies	Public, Environmental & Occupational Health; Women's Studies	CZ3KY	WOS:000367004200004	25635844	Green Accepted			2021-06-18	
J	Barker-Collo, S; Theadom, A; Jones, K; Feigin, VL; Kahan, M				Barker-Collo, Suzanne; Theadom, Alice; Jones, Kelly; Feigin, Valery L.; Kahan, Michael			Accuracy of an International Classification of Diseases Code Surveillance System in the Identification of Traumatic Brain Injury	NEUROEPIDEMIOLOGY			English	Article						TBI; Surveillance; ICD-10; Incidence	CASE-FATALITY; EPIDEMIOLOGY; STROKE	Background: Use of International Classification of Disease (ICD) codes for traumatic brain injury (TBI) in healthcare administrative databases may underestimate the epidemiology of TBI. The present study examined the use of ICD-10 codes in a population-based New Zealand sample. Methods: TBI related ICD-codes within the New Zealand health database were examined for all incident cases from a population based TBI sample (n = 1,369). Impact of age, gender, ethnicity, presence/absence of skull fracture, where the case was located (i.e., hospital) on receipt of an ICD code was examined. Results: Individuals who received a TBI-related ICD-code accounted for 18.6% of the studied population. The most frequent codes were brief loss of consciousness, head injury not otherwise specified, and concussion. Receipt of a code was not impacted by gender. Those with skull fracture (x(2) (1) = 69.983, p < 0.001), and/or attending hospital (x(2) (2) = 81.507, p < 0.001), and of older age (x(2) (1) = 56.473, p < 0.001) were more likely to receive a code. Conclusions: Reported incidence of TBI, when based upon health registration data, is likely to be a significant underestimate. Specific research needs to be conducted to identify the barriers to medical personnel implementing the ICD head injury codes and to identify ways in which the use of the codes can be improved. (C) 2016 S. Karger AG, Basel	[Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Auckland, New Zealand; [Theadom, Alice; Jones, Kelly; Feigin, Valery L.] AUT Univ, Fac Hlth & Environm Studies, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Kahan, Michael] Waikato Occupat Serv Ltd, Hamilton, New Zealand	Barker-Collo, S (corresponding author), Univ Auckland, Sch Psychol, Clin Training Programme, Private Bag 892019, Auckland 1141, New Zealand.	s.barker-collo@auckland.ac.nz	Jones, Kelly/I-5199-2019; Feigin, Valery/AAF-2313-2019	Feigin, Valery L./0000-0002-6372-1740			Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; [Anonymous], 2009, J REHABIL RES DEV, V46, pCP1; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Centers for Disease Control and Prevention (CDC), CLASS DIS FUNCT DIS; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Deb S, 1999, BRAIN INJURY, V13, P369, DOI 10.1080/026990599121557; Department ot Health and Human services, 2016, ICD10CMPCS; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746	17	12	12	0	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350	1423-0208		NEUROEPIDEMIOLOGY	Neuroepidemiology		2016	47	1					46	52		10.1159/000448403			7	Public, Environmental & Occupational Health; Clinical Neurology	Public, Environmental & Occupational Health; Neurosciences & Neurology	DW0FA	WOS:000383315100008	27504965				2021-06-18	
J	Belanger, HG; Lange, RT; Bailie, J; Iverson, GL; Arrieux, JP; Ivins, BJ; Cole, WR				Belanger, Heather G.; Lange, Rael T.; Bailie, Jason; Iverson, Grant L.; Arrieux, Jacques P.; Ivins, Brian J.; Cole, Wesley R.			Interpreting change on the neurobehavioral symptom inventory and the PTSD checklist in military personnel	CLINICAL NEUROPSYCHOLOGIST			English	Article						Traumatic brain injury; mild TBI; PTSD; military; concussion; reliable change	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; POSTCONCUSSION SYMPTOMS; CLINICAL-SIGNIFICANCE; CIVILIAN VERSION; SERVICE MEMBERS; NATIONAL-GUARD; NORMATIVE DATA; IRAQ; ASSOCIATIONS	Objective: The purpose of this study was to examine the prevalence and stability of symptom reporting in a healthy military sample and to develop reliable change indices for two commonly used self-report measures in the military health care system. Participants and method: Participants were 215 U.S. active duty service members recruited from Fort Bragg, NC as normal controls as part of a larger study. Participants completed the Neurobehavioral Symptom Inventory (NSI) and Posttraumatic Checklist (PCL) twice, separated by approximately 30days. Results: Depending on the endorsement level used (i.e. ratings of mild' or greater vs. ratings of moderate' or greater), approximately 2-15% of this sample met DSM-IV symptom criteria for Postconcussional Disorder across time points, while 1-6% met DSM-IV symptom criteria for Posttraumatic Stress Disorder. Effect sizes for change from Time 1 to Time 2 on individual symptoms were small (Cohen's d=.01 to .13). The test-retest reliability for the NSI total score was r=.78 and the PCL score was r=.70. An eight-point change in symptom reporting represented reliable change on the NSI total score, with a seven-point change needed on the PCL. Conclusions: Postconcussion-like symptoms are not unique to mild TBI and are commonly reported in a healthy soldier sample. It is important for clinicians to use normative data when evaluating a service member or veteran and when evaluating the likelihood that a change in symptom reporting is reliable and clinically meaningful.	[Belanger, Heather G.] James A Haley VAMC, Dept Mental Hlth & Behav Sci, Tampa, FL 33612 USA; [Belanger, Heather G.] Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA; [Belanger, Heather G.; Lange, Rael T.; Bailie, Jason; Iverson, Grant L.; Arrieux, Jacques P.; Ivins, Brian J.; Cole, Wesley R.] Def & Vet Brain Injury Ctr, Silver Spring, MD 20910 USA; [Lange, Rael T.] Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada; [Bailie, Jason] Naval Hosp, Camp Pendleton, CA USA; [Iverson, Grant L.] Harvard Med Sch, Boston, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Arrieux, Jacques P.; Cole, Wesley R.] Womack Army Med Ctr, Ft Bragg, NC USA	Belanger, HG (corresponding author), James A Haley VAMC, Dept Mental Hlth & Behav Sci, Tampa, FL 33612 USA.; Belanger, HG (corresponding author), Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA.; Belanger, HG (corresponding author), Def & Vet Brain Injury Ctr, Silver Spring, MD 20910 USA.	Heather.Belanger@va.gov		Iverson, Grant/0000-0001-7348-9570			American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Belanger HG, 2017, J HEAD TRAUMA REHAB, V32, P46, DOI 10.1097/HTR.0000000000000208; Belanger HG, 2015, MIL MED, V180, P192, DOI 10.7205/MILMED-D-14-00388; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Chemtob CM, 1998, J NERV MENT DIS, V186, P701, DOI 10.1097/00005053-199811000-00007; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Conybeare D, 2012, J CLIN PSYCHOL, V68, P699, DOI 10.1002/jclp.21845; Department of Veterans Affairs, 2010, SCREEN EV POSS TRAUM; Department of Veterans Affairs Department of Defense, 2009, VA DOD CLIN PRACT GU; Dretsch M, 2016, J HEAD TRAUMA REHAB, V31, P23, DOI 10.1097/HTR.0000000000000109; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; Gewirtz AH, 2010, J CONSULT CLIN PSYCH, V78, P599, DOI 10.1037/a0020571; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Guyatt GH, 2002, MAYO CLIN PROC, V77, P371, DOI 10.4065/77.4.371; Heaton RK, 2001, ARCH CLIN NEUROPSYCH, V16, P75, DOI 10.1016/S0887-6177(99)00062-1; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Karatzias A, 2007, EUR ARCH PSY CLIN N, V257, P40, DOI 10.1007/s00406-006-0682-2; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lang AJ, 2012, GEN HOSP PSYCHIAT, V34, P332, DOI 10.1016/j.genhosppsych.2012.02.003; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Meyers JE, 2015, APPL NEUROPSYCH-ADUL, V22, P427, DOI 10.1080/23279095.2014.968919; Regasa LE, 2016, J HEAD TRAUMA REHAB, V31, pE28, DOI 10.1097/HTR.0000000000000155; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Sullivan KW, 2012, STUD HEALTH TECHNOL, V181, P71, DOI 10.3233/978-1-61499-121-2-71; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Weathers FW, 1991, PCL C FOR DSM 4	40	12	12	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2016	30	7					1063	1073		10.1080/13854046.2016.1193632			11	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	DY9FU	WOS:000385440100009	27266484				2021-06-18	
J	Boutte, AM; Deng-Bryant, Y; Johnson, D; Tortella, FC; Dave, JR; Shear, DA; Schmid, KE				Boutte, Angela M.; Deng-Bryant, Ying; Johnson, David; Tortella, Frank C.; Dave, Jitendra R.; Shear, Deborah A.; Schmid, Kara E.			Serum Glial Fibrillary Acidic Protein Predicts Tissue Glial Fibrillary Acidic Protein Break-Down Products and Therapeutic Efficacy after Penetrating Ballistic-Like Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						biomarker; CsA; GFAP-BDP; neuroprotection; proteolysis; SBDP; serum; TBI	ALPHA-II-SPECTRIN; C-TERMINAL HYDROLASE; CEREBRAL-ARTERY OCCLUSION; CYCLOSPORINE-A; TRANSFORMING RESEARCH; INTRACRANIAL LESIONS; CLINICAL KNOWLEDGE; PROTEOMIC ANALYSIS; SYSTEMS BIOLOGY; BIOMARKERS	Acute traumatic brain injury (TBI) is associated with neurological dysfunction, changes in brain proteins, and increased serum biomarkers. However, the relationship between these brain proteins and serum biomarkers, and the ability of these serum biomarkers to indicate a neuroprotective/therapeutic response, remains elusive. Penetrating ballistic-like brain injury (PBBI) was used to systematically analyze several key TBI biomarkers, glial fibrillary acidic protein (GFAP) and its break-down products (BDPs)ubiquitin C-terminal hydrolase-L1 (UCH-L1), -II spectrin, and -II spectrin BDPs (SBDPs)in brain tissues and serum during an extended acute-subacute time-frame. In addition, neurological improvement and serum GFAP theranostic value was evaluated after neuroprotective treatment. In brain tissues, total GFAP increased more than three-fold 2 to 7 d after PBBI. However, this change was primarily due to GFAP-BDPs which increased to 2.7-4.8 arbitrary units (AU). Alpha-II spectrin was nearly ablated 3 d after PBBI, but somewhat recovered after 7 d. In conjunction with -II spectrin loss, SBDP-145/150 increased approximately three-fold 2 to 7 d after PBBI (vs. sham, p<0.05). UCH-L1 protein levels were slightly decreased 7 d after PBBI but otherwise were unaffected. Serum GFAP was elevated by 3.2- to 8.8-fold at 2 to 4h (vs. sham; p<0.05) and the 4h increase was strongly correlated to 3 d GFAP-BDP abundance (r=0.66; p<0.05). Serum GFAP showed such a strong injury effect that it also was evaluated after therapeutic intervention with cyclosporin A (CsA). Administration of 2.5mg/kg CsA significantly reduced serum GFAP elevation by 22.4-fold 2h after PBBI (vs. PBBI+vehicle; p<0.05) and improved neurological function 1 d post-injury. Serum biomarkers, particularly GFAP, may be correlative tools of brain protein changes and feasible theranostic markers of TBI progression and recovery.	[Boutte, Angela M.; Deng-Bryant, Ying; Johnson, David; Tortella, Frank C.; Dave, Jitendra R.; Shear, Deborah A.; Schmid, Kara E.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD 20910 USA	Boutte, AM (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	angela.m.boutte.civ@mail.mil			Combat Casualty Care Research ProgramUnited States Department of Defense; Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-12-2-0134]	The views of the authors do not purport or reflect the position of the Department of the Army or the Department of Defense (para 43, AR 360-5). This research is funded by Combat Casualty Care Research Program and Congressionally Directed Medical Research Program (Contract #: W81XWH-12-2-0134). The authors thank Ms. Shonnette Grant, M.S.; SGT Myint, US Army; SPC Donkor, US Army; Ms. Rebecca Pedersen; and Mr. Francis Bustos for their technical expertise, as well as Dr. Ryan Readnower and Dr. Cartagena for their invaluable advice.	BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Boutte AM, 2012, ELECTROPHORESIS, V33, P3693, DOI 10.1002/elps.201200196; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Cartagena CM, 2013, J MOL NEUROSCI, V49, P301, DOI 10.1007/s12031-012-9828-z; Cunningham TL, 2014, J NEUROTRAUM, V31, P505, DOI 10.1089/neu.2013.2965; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Guingab-Cagmat JD, 2012, ELECTROPHORESIS, V33, P3786, DOI 10.1002/elps.201200326; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Krainin Benjamin M, 2011, J Spec Oper Med, V11, P38; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; McMahon LW, 2009, BIOCHEM BIOPH RES CO, V381, P288, DOI 10.1016/j.bbrc.2009.02.038; McMahon LW, 2001, BIOCHEMISTRY-US, V40, P7025, DOI 10.1021/bi002917g; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Ozkisacik EA, 2006, ANN VASC SURG, V20, P243, DOI 10.1007/s10016-006-9022-2; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Porchet R, 2003, PROTEOMICS, V3, P1476, DOI 10.1002/pmic.200300456; Ray SK, 2001, BRAIN RES, V916, P115, DOI 10.1016/S0006-8993(01)02874-8; Rohn TT, 2013, INT J CLIN EXP PATHO, V6, P41; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Schoch KM, 2012, EXP NEUROL, V236, P371, DOI 10.1016/j.expneurol.2012.04.022; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Shimshek DR, 2012, SCI REP-UK, V2, DOI 10.1038/srep00262; Stein DM, 2012, J NEUROTRAUM, V29, P1140, DOI 10.1089/neu.2011.2149; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Valiyaveettil M, 2014, BRAIN RES, V1549, P32, DOI 10.1016/j.brainres.2013.12.031; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wagner Amy K, 2013, Pathophysiology, V20, P39, DOI 10.1016/j.pathophys.2012.02.007; Walder B, 2013, J NEUROTRAUM, V30, P1631, DOI 10.1089/neu.2012.2791; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Xie ZY, 2012, BRAIN RES, V1472, P113, DOI 10.1016/j.brainres.2012.06.053; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698; Zhang ZQ, 2010, METHODS MOL BIOL, V662, P317, DOI 10.1007/978-1-60761-800-3_16; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zoltewicz JS, 2013, J NEUROTRAUM, V30, P1161, DOI 10.1089/neu.2012.2762; Zoltewicz JS, 2012, BIOMARK INSIGHTS, V7, P71, DOI 10.4137/BMI.S9873	50	12	12	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2016	33	1					147	156		10.1089/neu.2014.3672			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CZ4EW	WOS:000367057200017	25789543				2021-06-18	
J	Cuthbert, JP; Whiteneck, GG; Corrigan, JD; Bogner, J				Cuthbert, Jeffrey P.; Whiteneck, Gale G.; Corrigan, John D.; Bogner, Jennifer			The Reliability of a Computer-Assisted Telephone Interview Version of the Ohio State University Traumatic Brain Injury Identification Method	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						computer-assisted telephone interview; Ohio State University Traumatic Brain Injury Identification Method; test-retest reliability; traumatic brain injury	VALIDITY	Objectives: Provide test-retest reliability (>5 months) of the Ohio State University Traumatic Brain Injury Identification Method modified for use as a computer-assisted telephone interview (CATI) to capture traumatic brain injury (TBI) and other substantial bodily injuries among a representative sample of noninstitutionalized adults living in Colorado. Design: Four subsamples of 50 individuals, including people with no major lifetime injury, a major lifetime injury but no TBI, TBI with no loss of consciousness, and TBI with loss of consciousness, were interviewed using the CATI Ohio State University Traumatic Brain Injury Identification Method between 6 and 18 months after an initial interview. Participants: Stratified random sample of Coloradans (n = 200) selected from a larger study of TBI. Primary Measures: Cumulative, Severity and Age-related indices were assessed for long-term reliability. Cumulative indices were those that summed the total number of specific TBI severities across the lifetime; Severity indices included measures of the most severe type of injury incurred throughout the lifetime; and Age-related indices assessed the timing of specific injury types across the lifespan. Results: Test-retest reliabilities ranged from poor to excellent. The indices demonstrating the greatest reliability were Severity measures, with intraclass correlations for ordinal indices ranging from 0.62 to 0.78 and Cohen kappa ranging from 0.50 to 0.62. One Cumulative outcome demonstrated high reliability (0.70 for number of TBIs with loss of consciousness >= 30 minutes), while the remaining Cumulative outcomes demonstrated low reliability, ranging from 0.06 to 0.21. Age-related test-retest reliabilities were fair to poor, with intraclass correlations of 0.38 to 0.49 and Cohen kappa of 0.32 and 0.34. Conclusion: The CATI modified Ohio State University Traumatic Brain Injury Identification Method used in this study is an effective measure for evaluating the maximum TBI severity incurred throughout the lifetime within a general population survey. The CATI measure is not recommended for use in determining cumulative counts of lifetime incidence of TBI.	[Cuthbert, Jeffrey P.; Whiteneck, Gale G.] Craig Hosp, Res Dept, 3425 S Clarkson St, Englewood, CO 80113 USA; [Corrigan, John D.; Bogner, Jennifer] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA	Cuthbert, JP (corresponding author), Craig Hosp, Res Dept, 3425 S Clarkson St, Englewood, CO 80113 USA.	JCuthbert@Craighospital.org			Colorado Injury Control Research Center from the Centers for Disease Control and Prevention [R49 CE001168]; National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, U.S. Department of Education, TBI Model System Centers grants [H133A070029]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001168] Funding Source: NIH RePORTER	This publication was supported by the Colorado Injury Control Research Center through grant number R49 CE001168 from the Centers for Disease Control and Prevention and the National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, U.S. Department of Education, TBI Model System Centers grants to Ohio State University (H133A070029).	Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Sosin DM, 1996, BRAIN INJURY, V10, P47	5	12	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2016	31	1					E36	E42		10.1097/HTR.0000000000000075			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DK9CN	WOS:000375228000012	24922042				2021-06-18	
J	Fraiman, D; Miranda, MF; Erthal, F; Buur, PF; Elschot, M; Souza, L; Rombouts, SARB; Schimmelpenninck, CA; Norris, DG; Malessy, MJA; Galves, A; Vargas, CD				Fraiman, D.; Miranda, M. F.; Erthal, F.; Buur, P. F.; Elschot, M.; Souza, L.; Rombouts, S. A. R. B.; Schimmelpenninck, C. A.; Norris, D. G.; Malessy, M. J. A.; Galves, A.; Vargas, C. D.			Reduced functional connectivity within the primary motor cortex of patients with brachial plexus injury	NEUROIMAGE-CLINICAL			English	Article						Resting state; Gray matter; Peripheral lesion; Functional connectivity; Horizontal connections; Correlation decay	MUSCULOCUTANEOUS NERVE TRANSFER; RESTING-STATE FMRI; ROOT AVULSION; INTERCOSTAL; PLASTICITY; MAPS; REORGANIZATION; PROJECTIONS; BRAIN	This study aims at the effects of traumatic brachial plexus lesion with root avulsions (BPA) upon the organization of the primary motor cortex (M1). Nine right-handed patients with a right BPA in whom an intercostal to musculocutaneous (ICN-MC) nerve transfer was performed had post-operative resting state fMRI scanning. The analysis of empirical functional correlations between neighboring voxels revealed faster correlation decay as a function of distance in the M1 region corresponding to the arm in BPA patients as compared to the control group. No differences between the two groups were found in the face area. We also investigated whether such larger decay in patients could be attributed to a gray matter diminution in M1. Structural imaging analysis showed no difference in gray matter density between groups. Our findings suggest that the faster decay in neighboring functional correlations without significant gray matter diminution in BPA patients could be related to a reduced activity in intrinsic horizontal connections in M1 responsible for upper limb motor synergies. (C) 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license.	[Fraiman, D.] Univ San Andres, Dept Matemat & Ciencias, Buenos Aires, DF, Argentina; [Fraiman, D.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Miranda, M. F.; Galves, A.] Univ Sao Paulo, Inst Matemat & Estat, Sao Paulo, Brazil; [Buur, P. F.; Elschot, M.; Norris, D. G.] Spinoza Ctr Neuroimaging, Amsterdam, Netherlands; [Rombouts, S. A. R. B.] Leiden Inst Brain & Cognit, Leiden, Netherlands; [Rombouts, S. A. R. B.] Leiden Univ, Inst Psychol, Leiden, Netherlands; [Rombouts, S. A. R. B.; Schimmelpenninck, C. A.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Schimmelpenninck, C. A.; Malessy, M. J. A.] Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands; [Norris, D. G.] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Erthal, F.; Souza, L.; Vargas, C. D.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Erthal, F.; Elschot, M.; Vargas, C. D.] Univ Fed Rio de Janeiro, Inst Neurol Deolindo Couto, Rio De Janeiro, Brazil	Vargas, CD (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.	cdvargas@biof.ufrj.br	Elschot, Mattijs/AAD-4362-2021; Galves, Antonio/Q-6833-2019; Rombouts, Serge A./AAL-7691-2021; Norris, David G/A-1937-2010; Fraiman, Daniel/E-1581-2018; Vargas, Claudia D./A-1523-2016	Galves, Antonio/0000-0001-8757-715X; Rombouts, Serge A./0000-0001-6351-4779; Norris, David G/0000-0002-3699-6917; Fraiman, Daniel/0000-0002-0482-9137; Vargas, Claudia D./0000-0001-6202-3580; Elschot, Mattijs/0000-0002-8056-9103	Fundacao de amparo a pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/07699-0]; Conselho Nacional de Pesquisa (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [480108/2012-9, 478537/2012-3]; Fundacao de amparo a pesquisa do Rio de Janeiro FAPERJFundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ) [E-26/111.655/2012, E-26/110.526/2012]	This work is part of University of Sao Paulo (USP) project Mathematics, computation, language and the brain, Fundacao de amparo a pesquisa do Estado de Sao Paulo (FAPESP) project NeuroMat (grant 2013/07699-0), CAPES NUFFIC (038/12), Conselho Nacional de Pesquisa (CNPq) (grants 480108/2012-9 and 478537/2012-3), Fundacao de amparo a pesquisa do Rio de Janeiro FAPERJ (grants E-26/111.655/2012 and E-26/110.526/2012) and Programa de apoyo a la investigacion de la Universidad San Andre's (PAI UdeSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boucsein C, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00032; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Davis KD, 2011, NEUROSCIENTIST, V17, P407, DOI 10.1177/1073858410389185; Dy CJ, 2015, J HAND SURG-AM, V40, P308, DOI 10.1016/j.jhsa.2014.10.033; Garcia-Cordero I, 2015, STROKE, V46, P2673, DOI 10.1161/STROKEAHA.115.009598; Garraghty P E, 1992, Curr Opin Neurobiol, V2, P522, DOI 10.1016/0959-4388(92)90191-M; Gelfand AE, 2010, CH CRC HANDB MOD STA, P1, DOI 10.1201/9781420072884; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; HUNTLEY GW, 1991, J NEUROPHYSIOL, V66, P390; Ibey RJ, 2015, CLIN NEUROPHYSIOL, V126, P1934, DOI 10.1016/j.clinph.2014.12.006; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; Jaggi AS, 2011, BRAIN RES, V1381, P187, DOI 10.1016/j.brainres.2011.01.002; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.ne.14.030191.001033; Liu B, 2013, NEUROSCIENCE, V243, P33, DOI 10.1016/j.neuroscience.2013.03.048; Malessy MJA, 1998, J NEUROSURG, V88, P266, DOI 10.3171/jns.1998.88.2.0266; MALESSY MJA, 1993, CLIN NEUROL NEUROSUR, V95, pS95; Malessy MJA, 2003, J NEUROSURG, V98, P261, DOI 10.3171/jns.2003.98.2.0261; MANO Y, 1995, ANN NEUROL, V38, P15, DOI 10.1002/ana.410380106; Midha Rajiv, 2004, Neurosurg Focus, V16, pE5; Miranda MF, 2013, BIOMETRICS, V69, P1074, DOI 10.1111/biom.12085; NARAKAS AO, 1988, CLIN ORTHOP RELAT R, P43; Qiu TM, 2014, J NEUROL NEUROSUR PS, V85, P99, DOI 10.1136/jnnp-2013-304956; Rasmussen T., 1950, CEREBRAL CORTEX MAN; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125; Seddon H.J., 2005, EED RES COUNCIL SPEC, V282; Sherman M., 2011, STAT SPATIOTEMPORAL; Simoes EL, 2012, J NEUROSCI, V32, P3211, DOI 10.1523/JNEUROSCI.4592-11.2012; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Souza L, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00715; Swayne O, 2006, CLIN NEUROPHYSIOL, V117, P855, DOI 10.1016/j.clinph.2005.12.012; Taylor KS, 2009, BRAIN, V132, P3122, DOI 10.1093/brain/awp231; Ziemann U, 2004, REV NEUROSCIENCE, V15, P253	35	12	12	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2016	12						277	284		10.1016/j.nicl.2016.07.008			8	Neuroimaging	Neurosciences & Neurology	EF3AI	WOS:000390196400032	27547727	DOAJ Gold, Green Published			2021-06-18	
J	Gren, M; Shahim, P; Lautner, R; Wilson, DH; Andreasson, U; Norgren, N; Blennow, K; Zetterberg, H				Gren, Magnus; Shahim, Pashtun; Lautner, Ronald; Wilson, David H.; Andreasson, Ulf; Norgren, Niklas; Blennow, Kaj; Zetterberg, Henrik			Blood biomarkers indicate mild neuroaxonal injury and increased amyloid production after transient hypoxia during breath-hold diving	BRAIN INJURY			English	Article						Amyloid; breath-hold diving; tau; hypoxia; blood biomarkers; neuroaxonal injury	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; COGNITIVE DECLINE; BETA; SLEEP; TAU; DEMENTIA; PROTEIN; IMPAIRMENT	Objective: To determine whether transient hypoxia during breath-hold diving causes neuronal damage or dysfunction or alters amyloid metabolism as measured by certain blood biomarkers.Design: Sixteen divers competing in the national Swedish championship in breath-hold diving and five age-matched healthy control subjects were included. Blood samples were collected at baseline and over a course of 3 days where the divers competed in static apnea (STA), dynamic apnea without fins (DYN1) and dynamic apnea with fins (DYN2).Main outcomes: Biomarkers reflecting brain injury and amyloid metabolism were analysed in serum (S-100, NFL) and plasma (T-tau, A42) using immunochemical methods.Results: Compared to divers' baseline, A42 increased after the first event of static apnea (p = 0.0006). T-tau increased (p = 0.001) in STA vs baseline and decreased after one of the dynamic events, DYN2 (p = 0.03). Further, T-tau correlated with the length of the apneic time during STA ( = 0.7226, p = 0.004) and during DYN1 ( = 0.66, p = 0.01).Conclusion: The findings suggest that transient hypoxia may acutely increase the levels of A42 and T-tau in plasma of healthy adults, further supporting that general hypoxia may cause mild neuronal dysfunction or damage and stimulate A production.	[Gren, Magnus; Shahim, Pashtun; Lautner, Ronald; Andreasson, Ulf; Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Clin Neurochem Lab,Inst Neurosci & Physiol, SE-43180 Molndal, Sweden; [Shahim, Pashtun] Linkoping Univ Hosp, Dept Neurosurg, Linkoping, Sweden; [Wilson, David H.] Quanterix, Lexington, MA USA; [Norgren, Niklas] UmanDiagnostics, Umea, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Mol Neurosci, Reta Lila Weston Labs, London, England	Gren, M (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Clin Neurochem Lab,Inst Neurosci & Physiol, SE-43180 Molndal, Sweden.	magnus.gren@vgregion.se		Lautner, Ronald/0000-0003-3523-1602			Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Blackwell T, 2015, J AM GERIATR SOC, V63, P453, DOI 10.1111/jgs.13321; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Blennow K, 2015, NAT MED, V21, P217, DOI 10.1038/nm.3810; Bu XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13917; CRAIG AB, 1968, J APPL PHYSIOL, V24, P190; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; FERRETTI G, 1991, J APPL PHYSIOL, V70, P794; FRIEDE RL, 1970, ANAT REC, V167, P379, DOI 10.1002/ar.1091670402; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; JENDROSKA K, 1995, ACTA NEUROPATHOL, V90, P461, DOI 10.1007/bf00294806; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Kalaria RN, 1999, ALZ DIS ASSOC DIS, V13, pS115, DOI 10.1097/00002093-199912003-00017; Kann O, 2014, J CEREBR BLOOD F MET, V34, P1270, DOI 10.1038/jcbfm.2014.104; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Mondello S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06446; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Niwa K, 2001, AM J PHYSIOL-HEART C, V281, pH2417; Olsson B, 2011, PROG NEUROBIOL, V95, P520, DOI 10.1016/j.pneurobio.2011.04.006; Osorio RS, 2015, NEUROLOGY, V84, P1964, DOI 10.1212/WNL.0000000000001566; Parilkh U, 2015, CRITICAL CARE MED, V43, P2; Qi JP, 2007, J ALZHEIMERS DIS, V12, P335; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Randall J, 2013, RESUSCITATION, V84, P351, DOI 10.1016/j.resuscitation.2012.07.027; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shahim P, 2013, EUR J PAEDIATR NEURO, V17, P7, DOI 10.1016/j.ejpn.2012.09.005; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Thomas T, 1996, NATURE, V380, P168, DOI 10.1038/380168a0; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; Wang HC, 2014, BRAIN INJURY, V28, P1491, DOI 10.3109/02699052.2014.943288; Xie YY, 2003, J NEUROSCI RES, V73, P557, DOI 10.1002/jnr.10667; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zetterberg H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028263; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	38	12	12	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	10					1226	1230		10.1080/02699052.2016.1179792			5	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DX4BR	WOS:000384324300009	27389622				2021-06-18	
J	Guilliams, K; Wainwright, MS				Guilliams, Kristin; Wainwright, Mark S.			Pathophysiology and Management of Moderate and Severe Traumatic Brain Injury in Children	JOURNAL OF CHILD NEUROLOGY			English	Article						pediatric brain trauma; closed head injury; pediatric neurocritical care; intracranial pressure	REFRACTORY STATUS EPILEPTICUS; CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; NONCONVULSIVE STATUS EPILEPTICUS; ELEVATED INTRACRANIAL-PRESSURE; CEREBROSPINAL-FLUID PRESSURE; RECOVERY 10 YEARS; POSTTRAUMATIC SEIZURES; PEDIATRIC-PATIENTS; BLOOD-FLOW	Traumatic brain injury remains a leading cause of morbidity and mortality in children. Key pathophysiologic processes of traumatic brain injury are initiated by mechanical forces at the time of trauma, followed by complex excitotoxic cascades associated with compromised cerebral autoregulation and progressive edema. Acute care focuses on avoiding secondary insults, including hypoxia, hypotension, and hyperthermia. Children with moderate or severe traumatic brain injury often require intensive monitoring and treatment of multiple parameters, including intracranial pressure, blood pressure, metabolism, and seizures, to minimize secondary brain injury. Child neurologists can play an important role in acute and long-term care. Acutely, as members of a multidisciplinary team in the intensive care unit, child neurologists monitor for early signs of neurological change, guide neuroprotective therapies, and transition patients to long-term recovery. In the longer term, neurologists are uniquely positioned to treat complications of moderate and severe traumatic brain injury, including epilepsy and cognitive and behavioral issues.	[Guilliams, Kristin] Washington Univ, Sch Med, Dept Neurol, Div Pediat & Dev Neurol, St Louis, MO 63110 USA; [Guilliams, Kristin] Washington Univ, Sch Med, Dept Pediat, Div Crit Care Med, St Louis, MO 63110 USA; [Wainwright, Mark S.] Ann & Robert H Lurie Childrens Hosp Chicago, Ruth D & Ken M Davee Pediat Neurocrit Care Progra, Chicago, IL 60611 USA; [Wainwright, Mark S.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Div Neurol, Chicago, IL 60611 USA; [Wainwright, Mark S.] Northwestern Univ, Feinberg Sch Med, Div Crit Care Med, Chicago, IL 60611 USA	Guilliams, K (corresponding author), Washington Univ, Sch Med, Dept Neurol, Div Pediat & Dev Neurol, 660 S Euclid Ave,Box 8111, St Louis, MO 63110 USA.	guilliamsk@neuro.wustl.edu	Guilliams, Kristin/U-7100-2019	Guilliams, Kristin/0000-0002-5518-3778			AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Albanese J, 1997, ANESTHESIOLOGY, V87, P1328, DOI 10.1097/00000542-199712000-00011; Allen BB, 2014, PEDIATR CRIT CARE ME, V15, P62, DOI 10.1097/PCC.0b013e3182a556ea; Anderson V, 2012, J HEAD TRAUMA REHAB, V27, P199, DOI 10.1097/HTR.0b013e31821a9d2b; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Bar-Joseph G, 2009, J NEUROSURG-PEDIATR, V4, P40, DOI 10.3171/2009.1.PEDS08319; Beebe DW, 2007, J PEDIATR PSYCHOL, V32, P845, DOI 10.1093/jpepsy/jsm003; Ben Yehuda Y, 2006, J CHILD NEUROL, V21, P441, DOI 10.2310/7010.2006.00097; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Bouzat P, 2011, NEUROSURGERY, V68, P1603, DOI 10.1227/NEU.0b013e31820cd43e; Bramwell KJ, 2006, PEDIATR EMERG CARE, V22, P90, DOI 10.1097/01.pec.0000199563.64264.3a; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Chesnut RM, 2013, INTENS CARE MED, V39, P771, DOI 10.1007/s00134-013-2852-9; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Claassen J, 2001, NEUROLOGY, V57, P1036, DOI 10.1212/WNL.57.6.1036; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Coats B, 2008, J NEUROSURG-PEDIATR, V2, P321, DOI 10.3171/PED.2008.2.11.321; Coats B, 2006, J NEUROTRAUM, V23, P1222, DOI 10.1089/neu.2006.23.1222; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Curry R, 2008, PEDIATR CRIT CARE ME, V9, P141, DOI 10.1097/PCC.0B013e318166870e; Diringer MN, 2012, NEUROSURGERY, V70, P1215, DOI 10.1227/NEU.0b013e3182417bc2; Diringer MN, 2004, NEUROCRIT CARE, V1, P219, DOI 10.1385/NCC:1:2:219; ELIASJONES AC, 1992, ARCH DIS CHILD, V67, P1430, DOI 10.1136/adc.67.12.1430; FANCONI S, 1988, INTENS CARE MED, V14, P163; Figaji AA, 2009, SURG NEUROL, V72, P389, DOI 10.1016/j.surneu.2009.02.012; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Garcia Paul, 2007, Epilepsy Curr, V7, P70, DOI 10.1111/j.1535-7511.2007.00173.x; GARDNER AE, 1972, ANESTH ANAL CURR RES, V51, P741; Giza CC, 2009, DEV NEUROREHABIL, V12, P255, DOI 10.3109/17518420903087558; Goldstein JL, 2011, NEUROCRIT CARE, V15, P63, DOI 10.1007/s12028-010-9468-5; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Haltiner AM, 1999, J NEUROSURG, V91, P588, DOI 10.3171/jns.1999.91.4.0588; Herman BE, 2011, PEDIATR EMERG CARE, V27, P65, DOI 10.1097/PEC.0b013e31820349db; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Jette N, 2006, ARCH NEUROL-CHICAGO, V63, P1750, DOI 10.1001/archneur.63.12.1750; Jones PA, 2003, BRIT J NEUROSURG, V17, P29, DOI 10.1080/0268869031000093708; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kramer U, 2005, J CHILD NEUROL, V20, P184, DOI 10.1177/08830738050200030301; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Matsumoto JH, 2013, EPILEPSY BEHAV, V27, P233, DOI 10.1016/j.yebeh.2013.01.024; MAYBERG TS, 1995, ANESTH ANALG, V81, P84, DOI 10.1097/00000539-199507000-00017; Mayer SA, 2002, ARCH NEUROL-CHICAGO, V59, P205, DOI 10.1001/archneur.59.2.205; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; PAPAZIAN L, 1993, BRIT J ANAESTH, V71, P267, DOI 10.1093/bja/71.2.267; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Quinn CT, 2012, PEDIATR BLOOD CANCER, V59, P881, DOI 10.1002/pbc.24227; Robertson CL, 2001, CRIT CARE MED, V29, P2287, DOI 10.1097/00003246-200112000-00009; Ruppel RA, 2001, J PEDIATR-US, V138, P18, DOI 10.1067/mpd.2001.110979; Sahin M, 2001, EPILEPSIA, V42, P1461, DOI 10.1046/j.1528-1157.2001.21301.x; SARI A, 1972, ANESTH ANAL CURR RES, V51, P560; SHAPIRO K, 1982, J NEUROSURG, V56, P819, DOI 10.3171/jns.1982.56.6.0819; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Sorani MD, 2007, NEUROCRIT CARE, V7, P45, DOI 10.1007/s12028-007-0043-7; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Spitzfaden AC, 1999, PEDIATR NEUROSURG, V31, P194, DOI 10.1159/000028861; Stiefel MF, 2006, J NEUROSURG, V105, P281, DOI 10.3171/ped.2006.105.4.281; STRINGER WA, 1993, AM J NEURORADIOL, V14, P475; Taussky P, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2011.12.FOCUS11280; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P521, DOI [10.1089/neu.2000.17.521, DOI 10.1089/NEU.2000.17.521]; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; Tontisirin N, 2007, CHILD NERV SYST, V23, P1163, DOI 10.1007/s00381-007-0339-0; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; Tsai SF, 2010, CLIN NEPHROL, V74, P70; Melo JRT, 2011, CHILD NERV SYST, V27, P979, DOI 10.1007/s00381-010-1367-8; Melo JRT, 2010, ARQ NEURO-PSIQUIAT, V68, P381, DOI 10.1590/S0004-282X2010000300010; Vavilala MS, 2006, DEV NEUROSCI-BASEL, V28, P348, DOI 10.1159/000094161; Vavilala MS, 2008, NEUROCRIT CARE, V9, P45, DOI 10.1007/s12028-007-9036-9; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Wainwright M, 2011, PEDIAT CRITICAL CARE, P746; Wainwright Mark S, 2012, Acta Neurochir Suppl, V114, P67, DOI 10.1007/978-3-7091-0956-4_12; Wainwright MS, 2011, PEDIAT NEUROLOGY PRI, P1185; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Young KD, 2004, ANN EMERG MED, V43, P435, DOI 10.1016/j.annemergmed.2003.09.016; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006; Zonfrillo MR, 2014, J PEDIATR-US, V164, P130, DOI 10.1016/j.jpeds.2013.09.022	106	12	12	0	16	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JAN	2016	31	1			SI		35	45		10.1177/0883073814562626			11	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	CY8HW	WOS:000366650400004	25512361				2021-06-18	
J	Hernandez, A; Donovan, V; Grinberg, YY; Obenaus, A; Carson, MJ				Hernandez, Alfredo; Donovan, Virgina; Grinberg, Yelena Y.; Obenaus, Andre; Carson, Monica J.			Differential detection of impact site versus rotational site injury by magnetic resonance imaging and microglial morphology in an unrestrained mild closed head injury model	JOURNAL OF NEUROCHEMISTRY			English	Article						confocal microscopy; traumatic brain injury; T2-weighted imaging; neuroinflammation	TRAUMATIC BRAIN-INJURY; IN-VIVO; RAT; FRACTALKINE; ACTIVATION; EXPRESSION; DISEASE; CELLS; MICE	Seventy-five percent of all traumatic brain injuries are mild and do not cause readily visible abnormalities on routine medical imaging making it difficult to predict which individuals will develop unwanted clinical sequelae. Microglia are brain-resident macrophages and early responders to brain insults. Their activation is associated with changes in morphology or expression of phenotypic markers including P2Y12 and major histocompatibility complex class II. Using a murine model of unrestrained mild closed head injury (mCHI), we used microglia as reporters of acute brain injury at sites of impact versus sites experiencing rotational stress 24h post-mCHI. Consistent with mild injury, a modest 20% reduction in P2Y12 expression was detected by quantitative real-time PCR (qPCR) analysis but only in the impacted region of the cortex. Furthermore, neither an influx of blood-derived immune cells nor changes in microglial expression of CD45, TREM1, TREM2, major histocompatibility complex class II or CD40 were detected. Using magnetic resonance imaging (MRI), small reductions in T2 weighted values were observed but only near the area of impact and without overt tissue damage (blood deposition, edema). Microglial morphology was quantified without cryosectioning artifacts using ScaleA(2) clarified brains from CX3CR1-green fluorescence protein (GFP) mice. The cortex rostral to the mCHI impact site receives greater rotational stress but neither MRI nor molecular markers of microglial activation showed significant changes from shams in this region. However, microglia in this rostral region did display signs of morphologic activation equivalent to that observed in severe CHI. Thus, mCHI-triggered rotational stress is sufficient to cause injuries undetectable by routine MRI that could result in altered microglial surveillance of brain homeostasis.	[Hernandez, Alfredo; Donovan, Virgina; Grinberg, Yelena Y.; Obenaus, Andre; Carson, Monica J.] Univ Calif Riverside, Sch Med, Ctr Glial Neuronal Interact, Riverside, CA 92521 USA; [Hernandez, Alfredo] Univ Calif Riverside, MarcU Program, Riverside, CA 92521 USA; [Hernandez, Alfredo; Donovan, Virgina; Grinberg, Yelena Y.; Carson, Monica J.] Univ Calif Riverside, Div Biomed Sci, Sch Med, Riverside, CA 92521 USA; [Donovan, Virgina; Obenaus, Andre; Carson, Monica J.] Univ Calif Riverside, Cell Mol & Dev Biol Program, Riverside, CA 92521 USA; [Donovan, Virgina; Obenaus, Andre] Loma Linda Univ, Sch Med, Loma Linda, CA 92354 USA	Carson, MJ (corresponding author), Univ Calif Riverside, Div Biomed Sci, 900 Univ Ave, Riverside, CA 92521 USA.; Obenaus, A (corresponding author), Loma Linda Univ, Pediat Res Dept, Coleman Pavil,Room A-1120,11175 Campus St, Loma Linda, CA 92354 USA.	aobenaus@llu.edu; monica.carson@ucr.edu			MarcU scholarship; UCR PIC; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AG048099]; DCMRP [DR080470]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T34GM062756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RF1AG048099] Funding Source: NIH RePORTER	AH and VD contributed equally to these studies. AH was funded by a MarcU scholarship, VD is an IGERT fellow. Studies were supported by grants UCR PIC and NIH R01AG048099 (MJC) and DCMRP #DR080470 (AO).	Amadio S, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/975849; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Bianchi A, 2015, IEEE T BIO-MED ENG, V62, P145, DOI 10.1109/TBME.2014.2342653; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Carson MJ, 1998, GLIA, V22, P72, DOI 10.1002/(SICI)1098-1136(199801)22:1<72::AID-GLIA7>3.0.CO;2-A; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; Choy M, 2014, J NEUROSCI, V34, P8672, DOI 10.1523/JNEUROSCI.4806-13.2014; Conde JR, 2006, J NEUROPATH EXP NEUR, V65, P199, DOI 10.1097/01.jnen.0000202887.22082.63; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Donovan V, 2012, NEUROIMAGE-CLIN, V1, P18, DOI 10.1016/j.nicl.2012.08.001; Faul M., 2015, TRAUMATIC BRAIN INJU; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gerriets T, 2004, STROKE, V35, P2372, DOI 10.1161/01.STR.0000142134.37512.a7; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Huang L, 2013, BRAIN RES, V1499, P109, DOI 10.1016/j.brainres.2012.12.038; Irimia A, 2011, J NEUROTRAUM, V28, P2287, DOI 10.1089/neu.2011.1920; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Loane D, 2014, NEUROTHERAPEUTICS, V11, P857, DOI 10.1007/s13311-014-0298-6; Melchior B, 2010, ASN NEURO, V2, P157, DOI 10.1042/AN20100010; Mierzwa AJ, 2014, ASN NEURO, V6, DOI 10.1177/1759091414551782; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Obenaus A., 2015, ENCY MENTAL HLTH, P329; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Puntambekar S.S., 2011, BRAIN BEHAV IMMUN BB, V25, P883; Rancan M, 2004, J CEREBR BLOOD F MET, V24, P1110, DOI 10.1097/01.WCB.0000133470.91843.72; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sakhony OS, 2015, TISSUE BARRIERS, V3, DOI 10.1080/21688370.2015.1004975; Schmid CD, 2002, J NEUROCHEM, V83, P1309, DOI 10.1046/j.1471-4159.2002.01243.x; Schmid CD, 2009, J NEUROCHEM, V109, P117, DOI 10.1111/j.1471-4159.2009.05984.x; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Vinet J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-27; Wang J, 2011, J IMMUNOL, V187, P5277, DOI 10.4049/jimmunol.1102077	43	12	12	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	JAN	2016	136			1	SI		18	28		10.1111/jnc.13402			11	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	DB8SH	WOS:000368786400003	26806371	Green Published, Other Gold, Green Accepted			2021-06-18	
J	Honda, M; Ichibayashi, R; Yokomuro, H; Yoshihara, K; Masuda, H; Haga, D; Seiki, Y; Kudoh, C; Kishi, T				Honda, Mitsuru; Ichibayashi, Ryo; Yokomuro, Hiroki; Yoshihara, Katsunori; Masuda, Hiroyuki; Haga, Daisuke; Seiki, Yoshikatsu; Kudoh, Chiaki; Kishi, Taichi			Early Cerebral Circulation Disturbance in Patients Suffering from Severe Traumatic Brain Injury (TBI): A Xenon CT and Perfusion CT Study	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						severe traumatic brain injury; early cerebral circulation disturbance; a xenon CT; a perfusion CT	ACUTE HEAD-INJURY; BLOOD-FLOW; SUBARACHNOID HEMORRHAGE; COMPUTED-TOMOGRAPHY; INTRACRANIAL-PRESSURE; OUTCOME PREDICTION; VASOSPASM; ISCHEMIA; TIME; METABOLISM	Traumatic brain injury (TBI) is widely known to cause dynamic changes in cerebral blood flow (CBF). Ischemia is a common and deleterious secondary injury following TBI. Detecting early ischemia in TBI patients is important to prevent further advancement and deterioration of the brain tissue. The purpose of this study was to clarify the cerebral circulatory disturbance during the early phase and whether it can be used to predict patient outcome. A total of 90 patients with TBI underwent a xenon-computed tomography (Xe-CT) and subsequently perfusion CT to evaluate the cerebral circulation on days 1-3. We measured CBF using Xe-CT and mean transit time (MTT: the width between two inflection points [maximum upward slope and maximum downward slope from inflow to outflow of the contrast agent]) using perfusion CT and calculated the cerebral blood volume (CBV) using the AZ-7000W98 computer system. The relationships of the hemodynamic parameters CBF, MTT, and CBV to the Glasgow Coma Scale (GCS) score and the Glasgow Outcome Scale (GOS) score were examined. There were no significant differences in CBF, MTT, and CBV among GCS3-4, GCS5-6, and GCS7-8 groups. The patients with a favorable outcome (GR and MD) had significantly higher CBF and lower MTT than those with an unfavorable one (SD, VS, or D). The discriminant analysis of these parameters could predict patient outcome with a probability of 70.6%. During the early phase, CBF reduction and MTT prolongation might influence the clinical outcome of TBI. These parameters are helpful for evaluating the severity of cerebral circulatory disturbance and predicting the outcome of TBI patients.	[Honda, Mitsuru; Ichibayashi, Ryo; Yokomuro, Hiroki; Yoshihara, Katsunori] Toho Univ, Med Ctr, Omori Hosp, Dept Crit Care Ctr, Tokyo, Japan; [Masuda, Hiroyuki; Haga, Daisuke; Seiki, Yoshikatsu] Toho Univ, Med Ctr, Omori Hosp, Neurosurg, Tokyo, Japan; [Kudoh, Chiaki] KUDOH Clin Neurosurg & Neurol, Tokyo, Japan; [Kishi, Taichi] Toho Univ, Fac Med, Sch Med, Dept Educ Planning & Dev, Tokyo, Japan	Honda, M (corresponding author), Toho Univ, Med Ctr, Omori Hosp, Dept Crit Care Ctr,Ota Ku, 6-11-1 Omori Nishi, Tokyo 1438541, Japan.	mhonda@med.toho-u.ac.jp					ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; Anagisawa M, 1988, NATURE, V332, P411; Araki Yuzo, 2002, No To Shinkei, V54, P581; Bendinelli C, 2013, INJURY, V44, P1208, DOI 10.1016/j.injury.2013.03.039; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BOUMA GJ, 1993, ACTA NEUROCHIR, P34; Chai WN, 2011, ACTA NEUROCHIR SUPPL, V110, P225, DOI 10.1007/978-3-7091-0353-1_39; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; GOBIET W, 1975, ACTA NEUROCHIR, V32, P13, DOI 10.1007/BF01405899; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Hoeffner EG, 2004, RADIOLOGY, V231, P632, DOI 10.1148/radiol.2313021488; Honda Mitsuru, 2013, Acta Neurochir Suppl, V118, P259, DOI 10.1007/978-3-7091-1434-6_49; Honda M, 2012, NEUROL MED-CHIR, V52, P488, DOI 10.2176/nmc.52.488; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; *JAP SOC NEUR, 2001, GUID MAN SEV HEAD IN, P1; JENNETT B, 1975, LANCET, V1, P480; Kaloostian P, 2012, J NEUROTRAUM, V29, P727, DOI 10.1089/neu.2011.2147; Kanazawa R, 2007, SURG NEUROL, V67, P604, DOI 10.1016/j.surneu.2006.09.026; Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191; Laslo AM, 2008, AM J NEURORADIOL, V29, P79, DOI 10.3174/ajnr.A0747; Lefournier V, 2010, J NEURORADIOLOGY, V37, P284, DOI 10.1016/j.neurad.2010.03.003; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MILLER JD, 1992, J NEUROTRAUM, V9, pS317; Muizelaar JP, 1997, STROKE, V28, P1998, DOI 10.1161/01.STR.28.10.1998; Mustonen T, 2008, J NEUROL NEUROSUR PS, V79, P1128, DOI 10.1136/jnnp.2007.142851; OLDENDORF WH, 1967, J NUCL MED, V8, P570; Orbist WD, 1979, J NEUROSURG, V51, P292; OVERGAARD J, 1981, J NEUROSURG, V55, P63, DOI 10.3171/jns.1981.55.1.0063; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; PFENNINGER EG, 1989, J NEUROSURG, V70, P774, DOI 10.3171/jns.1989.70.5.0774; POWERS WJ, 1984, ANN NEUROL, V16, P546, DOI 10.1002/ana.410160504; Robertson CS, 2011, J NEUROTRAUM, V28, P727, DOI 10.1089/neu.2010.1476; ROBERTSON CS, 1992, J NEUROTRAUM, V9, pS349; Sase S, 2005, J COMPUT ASSIST TOMO, V29, P270, DOI 10.1097/01.rct.0000156400.40836.68; Sase S, 2002, J COMPUT ASSIST TOMO, V26, P471, DOI [10.1097/00004728-200205000-00028, 10.1097/01.RCT.0000014442.08104.F7]; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Soustiel JF, 2008, NEURORADIOLOGY, V50, P189, DOI 10.1007/s00234-007-0337-7; Sviri GE, 2006, NEUROSURGERY, V59, P319, DOI 10.1227/01.NEU.0000222819.18834.33; White R P, 1990, Neurosurg Clin N Am, V1, P401; Wintermark M, 2006, AM J NEURORADIOL, V27, P26; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824; Yoshimoto Y, 2004, SURG NEUROL, V62, P115, DOI 10.1016/j.surneu.2003.08.035	47	12	13	1	1	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.		2016	56	8					501	509		10.2176/nmc.oa.2015-0341			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DW6SY	WOS:000383782700007	27356957	Green Published, Bronze			2021-06-18	
J	Jurick, SM; Twamley, EW; Crocker, LD; Hays, CC; Orff, HJ; Golshan, S; Jak, AJ				Jurick, Sarah M.; Twamley, Elizabeth W.; Crocker, Laura D.; Hays, Chelsea C.; Orff, Henry J.; Golshan, Shahrokh; Jak, Amy J.			Postconcussive symptom overreporting in Iraq/Afghanistan Veterans with mild traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						concussion; depression; mild traumatic brain injury; neurobehavioral symptoms; neuropsychology; Operation Enduring Freedom/Operation Iraqi Freedom; performance validity test; postconcussive symptoms; posttraumatic stress disorder; symptom validity test	POSTTRAUMATIC-STRESS-DISORDER; VALIDITY SCALES; TASK-FORCE; PERFORMANCE VALIDITY; SERVICE MEMBERS; MMPI-2 VALIDITY; RESPONSE BIAS; PERSISTENT; TBI; CONCUSSION	A comprehensive evaluation, including the assessment of neurobehavioral symptoms, has been instituted at the Department of Veterans Affairs (VA) healthcare system to address the large number of Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) Veterans returning with mild traumatic brain injuries (mTBIs). The Validity-10 is a measure of symptom overreporting embedded within the Neurobehavioral Symptom Inventory, a component of the comprehensive evaluation that assesses postconcussive symptom severity. The Validity-10 is composed of 10 unlikely/low-frequency items and a validated cutoff score to identify postconcussive symptom overreporting. We examined the items and cutoff used in the initial development and validation study of the Validity-10 through retrospective chart reviews of 331 treatment-seeking Veterans who sustained an mTBI. The Validity-10 exhibited significant relationships with psychiatric variables, VA service connection, and neuropsychological performance validity (all p<0.01), but nonsignificant relationships with demographic and injury variables (all p>0.05). Furthermore, the Validity-10 modestly predicted neuropsychological performance validity test failure over and above psychiatric comorbidities and VA service connection. The present study supports the use of the Validity-10 to assess symptom validity in treatment-seeking OIF/OEF Veterans with a history of mTBI.	[Jurick, Sarah M.; Hays, Chelsea C.] San Diego State Univ Univ Calif San Diego Joint D, San Diego, CA USA; [Jurick, Sarah M.; Hays, Chelsea C.; Golshan, Shahrokh] Vet Med Res Fdn, San Diego, CA USA; [Twamley, Elizabeth W.; Orff, Henry J.; Jak, Amy J.] Dept Vet Affairs VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Twamley, Elizabeth W.; Orff, Henry J.; Golshan, Shahrokh] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Crocker, Laura D.; Jak, Amy J.] VA San Diego Healthcare Syst, Psychol Serv, San Diego, CA USA	Jak, AJ (corresponding author), VA San Diego Healthcare Syst, 3350 La Jolla Village Dr 151B, San Diego, CA 92161 USA.	ajak@ucsd.edu			VA Office of Academic Affiliations Interprofessional Polytrauma and Traumatic Brain Injury Rehabilitation Fellowship	This material was unfunded at the time of manuscript preparation. Laura D. Crocker was supported by the VA Office of Academic Affiliations Interprofessional Polytrauma and Traumatic Brain Injury Rehabilitation Fellowship.	Armistead-Jehle P, 2011, APPL NEUROPSYCHOL, V18, P284, DOI 10.1080/09084282.2011.595455; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Baker R, 2000, Appl Neuropsychol, V7, P111, DOI 10.1207/S15324826AN0702_8; Beck A. T., 1996, BECK DEPRESSION INVE, VII; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Butcher JN, 1989, MANUAL ADM SCORING M; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cernich AN, 2012, J HEAD TRAUMA REHAB, V27, P253, DOI 10.1097/HTR.0b013e3182585cd5; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen J., 1988, STAT POWER SOCIAL SC; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Delis D.C., 1999, CALIFORNIA VERBAL LE; Green P., 2004, MED SYMPTOM VALIDITY; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Jak AJ, 2015, J CLIN EXP NEUROPSYC, V37, P379, DOI 10.1080/13803395.2015.1020769; Jones A, 2011, CLIN NEUROPSYCHOL, V25, P1207, DOI 10.1080/13854046.2011.600726; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Logan BW, 2013, BEHAV SCI LAW, V31, P803, DOI 10.1002/bsl.2092; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McCrea M, 2008, MILD TRAUMATIC BRAIN; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Miskey HM, 2015, BRAIN IMAGING BEHAV, V9, P461, DOI 10.1007/s11682-015-9391-7; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Morey LC, 2014, ENCY CLIN PSYCHOL; Nelson NW, 2011, CLIN NEUROPSYCHOL, V25, P716, DOI 10.1080/13854046.2011.579174; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Ross SR, 2004, J CLIN EXP NEUROPSYC, V26, P115, DOI 10.1076/jcen.26.1.115.23933; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Thomas ML, 2009, CLIN NEUROPSYCHOL, V23, P1067, DOI 10.1080/13854040902795000; Tombaugh TN, 1996, TEST MEMORY MALINGER; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Weathers F. W., 1993, P INT SOC TRAUM STRE; Whiteside DM, 2012, J CLIN EXP NEUROPSYC, V34, P172, DOI 10.1080/13803395.2011.630648; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME, V4th	60	12	12	0	1	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2016	53	5					571	583		10.1682/JRRD.2015.05.0094			13	Rehabilitation	Rehabilitation	EB7TH	WOS:000387593000006	27898153	Bronze			2021-06-18	
J	Lippa, SM; Lange, RT; Bailie, JM; Kennedy, JE; Brickell, TA; French, LM				Lippa, Sara M.; Lange, Rael T.; Bailie, Jason M.; Kennedy, Jan E.; Brickell, Tracey A.; French, Louis M.			Utility of the Validity-10 scale across the recovery trajectory following traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						military; Neurobehavioral Symptom Inventory; postconcussion symptoms; symptom exaggeration; symptom report; symptom validity; TBI; time since injury; traumatic brain injury; Validity-10 scale	POSTTRAUMATIC-STRESS-DISORDER; SYMPTOM EXAGGERATION; EVALUATION CONTEXT; ENDURING FREEDOM; TEST-PERFORMANCE; RISK-FACTORS; HEAD-INJURY; VETERANS; POSTCONCUSSION; COMPENSATION	The Validity -10 scale was recently developed to screen for symptom exaggeration in patients following traumatic brain injury (TBI). However, it has only been validated on patients with TBI largely in the chronic phase of recovery. The influence of time since injury on the Validity -10 scale was investigated in 2,661 male servicemembers with TBI presenting to six U.S. Defense and Veterans Brain Injury Centers. Participants completed the Neurobehavioral Symptom Inventory (NSI). The Validity -10 scale and NSI total score were both weakly statistically significantly (1) positively correlated with time since injury, (2) negatively correlated with bodily injury severity, and (3) higher in participants undergoing medical board evaluations than in participants who returned to duty or were still hospitalized. Participants were statistically more likely to screen positive for possible symptom exaggeration on the Validity-10 scale as time since injury increased. However, the Validity-10 scale was only weakly related to time since injury, TBI severity, bodily injury severity, disposition, age, and return to duty status. That false positives are not increased in the acute phase of recovery and that the Validity -10 scale is not strongly related to clinical factors support the use of the Validity-10 scale in the acute recovery phase and across the TBI recovery trajectory.	[Lippa, Sara M.; Lange, Rael T.; Bailie, Jason M.; Kennedy, Jan E.; Brickell, Tracey A.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bldg 19,Room 6003,8901 Wisconsin Ave, Bethesda, MD 20889 USA; [Lippa, Sara M.; Lange, Rael T.; Brickell, Tracey A.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Bailie, Jason M.] Naval Med Ctr, San Diego, CA USA; [Kennedy, Jan E.] San Antonio Mil Med Ctr, San Antonio, TX USA; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA	Lippa, SM (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bldg 19,Room 6003,8901 Wisconsin Ave, Bethesda, MD 20889 USA.	sara.lippa.ctr@mail.mil	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604			Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Butcher JN, 1989, MANUAL ADM SCORING M; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Cook J B, 1972, Scand J Rehabil Med, V4, P27; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; French LM, 2012, J HEAD TRAUMA REHAB, V27, P63, DOI 10.1097/HTR.0b013e3182248344; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P663, DOI 10.1007/978-0-387-76978-3_21; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Kaplan DA, 2014, INFORM PAPER NEUROBE; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kelly JP, 1997, NEUROLOGY, V48, P581; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; Lippa SM, 2014, ARCH CLIN NEUROPSYCH, V29, P236, DOI 10.1093/arclin/acu002; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Management of Concussion/mTBI Working Group, 2009, J REHABIL RES DEV, V46, pCP1; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCormick CL, 2013, ARCH CLIN NEUROPSYCH, V28, P808, DOI 10.1093/arclin/act050; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea MA, 2008, INFLUENCE ACUTE INJU, P123; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; MOREY LC, 1990, PERSONALITY ASSESSME; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Reynolds S, 2003, J HEAD TRAUMA REHAB, V18, P139, DOI 10.1097/00001199-200303000-00005; ROGERS R, 1992, J CLIN PSYCHOL, V48, P643; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; U.S. Air Force, 1968, FLIGHT SURG GUID; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Whitney KA, 2010, APPL NEUROPSYCHOL, V17, P196, DOI 10.1080/09084282.2010.499787; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Widows M. R., 2005, STRUCTURED INVENTORY; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	54	12	12	0	4	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2016	53	3					379	390					12	Rehabilitation	Rehabilitation	DL6EF	WOS:000375731700008	27273336	Bronze			2021-06-18	
J	Lynch, CE; Crynen, G; Ferguson, S; Mouzon, B; Paris, D; Ojo, J; Leary, P; Crawford, F; Bachmeier, C				Lynch, Cillian E.; Crynen, Gogce; Ferguson, Scott; Mouzon, Benoit; Paris, Daniel; Ojo, Joseph; Leary, Paige; Crawford, Fiona; Bachmeier, Corbin			Chronic cerebrovascular abnormalities in a mouse model of repetitive mild traumatic brain injury	BRAIN INJURY			English	Article						Repetitive mild traumatic brain injury; cerebrovascular	CEREBRAL-BLOOD-FLOW; FOOTBALL-LEAGUE PLAYER; SMOOTH-MUSCLE-CELL; ALZHEIMERS-DISEASE; CAPILLARY PERICYTES; ENCEPHALOPATHY; HYPOPERFUSION; IMPAIRMENT; SPORT; ENDOTHELIN-1	Primary objective: To investigate the status of the cerebrovasculature following repetitive mild traumatic brain injury (r-mTBI).Research design: TBI is a risk factor for development of various neurodegenerative disorders. A common feature of neurodegenerative disease is cerebrovascular dysfunction which includes alterations in cerebral blood flow (CBF). TBI can result in transient reductions in CBF, with severe injuries often accompanied by varying degrees of vascular pathology post-mortem. However, at this stage, few studies have investigated the cerebrovasculature at chronic time points following repetitive mild brain trauma.Methods and procedures: r-mTBI was delivered to wild-type mice (12 months old) twice per week for 3 months and tested for spatial memory deficits (Barnes Maze task) at 1 and 6 months post-injury. At 7 months post-injury CBF was assessed via Laser Doppler Imaging and, following euthanasia, the brain was probed for markers of cerebrovascular dysfunction and inflammation.Main outcomes and results: Memory impairment was identified at 1 month post-injury and persisted as late as 6 months post-injury. Furthermore, significant immunopathological insult, reductions in global CBF and down-regulation of cerebrovascular-associated markers were observed.Conclusions: These results demonstrate impaired cognitive behaviour alongside chronic cerebrovascular dysfunction in a mouse model of repetitive mild brain trauma.	[Lynch, Cillian E.; Crynen, Gogce; Ferguson, Scott; Mouzon, Benoit; Paris, Daniel; Ojo, Joseph; Leary, Paige; Crawford, Fiona; Bachmeier, Corbin] Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA; [Lynch, Cillian E.; Crynen, Gogce; Ferguson, Scott; Mouzon, Benoit; Paris, Daniel; Ojo, Joseph; Crawford, Fiona; Bachmeier, Corbin] Open Univ, Dept Life Sci, Milton Keynes, Bucks, England; [Lynch, Cillian E.; Crynen, Gogce; Ferguson, Scott; Mouzon, Benoit; Paris, Daniel; Ojo, Joseph; Crawford, Fiona; Bachmeier, Corbin] James A Haley Vet Adm Ctr, Tampa, FL USA	Lynch, CE (corresponding author), Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA.	clynch@roskampinstitute.net			Roskamp Foundation; Chronic Effects of Neurotrauma Consortium [CENC - VA I01 RX001774, DoD W81XWH-13-2-0095]	The authors report no conflicts of interest. This research was supported by the Roskamp Foundation and by the Chronic Effects of Neurotrauma Consortium (CENC - VA I01 RX001774 and DoD W81XWH-13-2-0095). Dr. Crawford is a VA Research Career Scientist.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Amen DG, 2016, J ALZHEIMERS DIS, V53, P237, DOI 10.3233/JAD-160207; Armstead WM, 2013, J NEUROTRAUM, V30, P1898, DOI 10.1089/neu.2013.2962; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Castejon OJ, 2011, FOLIA NEUROPATHOL, V49, P162; DeGracia DJ, 2007, NEUROL RES, V29, P356, DOI 10.1179/016164107X204666; Dore-Duffy P, 2011, NEUROL RES, V33, P176, DOI 10.1179/016164111X12881719352372; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Halfter W, 2000, DEV BIOL, V220, P111, DOI 10.1006/dbio.2000.9649; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Hill RA, 2015, NEURON, V87, P95, DOI 10.1016/j.neuron.2015.06.001; Hirao K, 2005, NEUROIMAGE, V28, P1014, DOI 10.1016/j.neuroimage.2005.06.066; Castejon OJ, 2014, FOLIA NEUROPATHOL, V52, P10, DOI 10.5114/fn.2014.41740; Kenney K, 2015, EXPT NEUROLOGY, V87, P95; Kornfield TE, 2014, J NEUROSCI, V34, P11504, DOI 10.1523/JNEUROSCI.1971-14.2014; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Merlini M, 2016, ACTA NEUROPATHOL, V131, P737, DOI 10.1007/s00401-016-1560-2; Millspaugh JA, 1937, US NAVAL MED B, V35, P261; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; O'Farrell FM, 2014, NAT REV CARDIOL, V11, P427, DOI 10.1038/nrcardio.2014.58; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Ostergaard L, 2014, J CEREBR BLOOD F MET, V34, P1585, DOI 10.1038/jcbfm.2014.131; Paris D, 2004, BRAIN RES, V999, P53, DOI 10.1016/j.brainres.2003.11.061; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Petrov T, 2009, CAN J PHYSIOL PHARM, V87, P379, DOI [10.1139/y09-022, 10.1139/Y09-022]; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ponto LLB, 2016, J NEUROPSYCH CLIN N, V28, P89, DOI 10.1176/appi.neuropsych.15050106; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Ruitenberg A, 2005, ANN NEUROL, V57, P789, DOI 10.1002/ana.20493; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Salonia R, 2010, J NEUROTRAUM, V27, P1819, DOI 10.1089/neu.2010.1402; Schofield PW, 1997, NEUROLOGY, V49, P30, DOI 10.1212/WNL.49.1.30; Searcy JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089970; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Torres-Platas SG, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-12; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yamin R, 2012, J PHYSIOL-LONDON, V590, P4145, DOI 10.1113/jphysiol.2012.232306; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Yezhuvath US, 2009, NMR BIOMED, V22, P779, DOI 10.1002/nbm.1392; NEUROSURGERY	54	12	14	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	12					1414	1427		10.1080/02699052.2016.1219060			14	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	ED1IO	WOS:000388599100003	27834539				2021-06-18	
J	Mans, S; Folmer, ER; de Jongh, MAC; Lansink, KWW				Mans, Stefan; Folmer, Eline Reinders; de Jongh, Mariska A. C.; Lansink, Koen W. W.			Direct transport versus inter hospital transfer of severely injured trauma patients	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Trauma centre; Triage; Mortality; Trauma; Severely injured patients; Pre-hospital transport; Pre-hospital care; Trauma systems; Multi trauma; Inter hospital transfer	CENTER CARE; OUTCOMES	Introduction: Several studies have suggested that severely injured patients should be transported directly to a trauma centre bypassing the nearest hospital. However, the evidence remains inconclusive. The purpose of this study was to examine the benefits in terms of mortality of direct transport to a trauma centre versus primary treatment in a level II or III centre followed by inter hospital transfer to a trauma centre for severely injured patients without Traumatic Brain Injury (TBI). Patients and methods: We used the regional trauma registry and included all patients with an Injury Severity Score (ISS) > 15 and an Abbreviated Injury Score <4 for head injury. We adjusted for survival bias by including "potential transfers'': patients who died at the nearest hospitals before transportation to a trauma centre. Results: A total of 439 patients was included. The majority of patients (349/439, 79%) was transported directly to the level I trauma centre (direct group). The transferred group was formed by the remaining 90 patients, of whom 81 were transferred to the level I trauma centre after initial stabilisation elsewhere and 9 patients died in the emergency room before transfer to a level 1 trauma centre could occur. There were no significant differences in baseline and injury characteristics between the groups. Overall, 60 patients died in-hospital including 41 of the 349 patients (12%) in the direct group and 19 of the 90 patients (21%) in the transferred group. Nine of the 19 deaths in the transferred group were ascribed to potential transfers. After adjusting for prehospital Revised Trauma Score (RTS) and ISS, the odds ratio of death was 2.40 (95% CI: 1.07-5.40) for patients in the transfer group. When potential transfer patients were excluded from the analysis, the adjusted odds ratio of death was 1.14 (95% CI: 0.43-3.01). Conclusions: After adjusting for survivor bias by including potential transfers, the results of this study suggest a lower risk of death for patients who are directly transported to a level I trauma centre than for patients who receive primary treatment in a level II or III centre and are transferred to a trauma centre. However, this finding was only significant when adjusting for survival bias and therefore we conclude that it is still uncertain if there is a lower risk of death for patients who are transported directly to a level I trauma centre. (C) 2015 Elsevier Ltd. All rights reserved.	[Mans, Stefan; de Jongh, Mariska A. C.; Lansink, Koen W. W.] Elisabeth Tweesteden Hosp, Trauma Ctr Brabant, Tilburg, Netherlands; [Folmer, Eline Reinders; Lansink, Koen W. W.] Elisabeth Tweesteden Hosp, Dept Surg, Tilburg, Netherlands	Mans, S (corresponding author), Elisabeth Tweesteden Hosp, Trauma Ctr Brabant, Tilburg, Netherlands.	s.mans@students.uu.nl					BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Cummings P, 2013, JAMA PEDIATR, V167, P656, DOI 10.1001/jamapediatrics.2013.1329; de Jongh MAC, 2008, INJURY, V39, P1007, DOI 10.1016/j.injury.2008.03.026; Fatovich DM, 2011, RESUSCITATION, V82, P886, DOI 10.1016/j.resuscitation.2011.02.040; Fatovich DM, 2011, RESUSCITATION, V82, P560, DOI 10.1016/j.resuscitation.2011.01.016; Haas B, 2010, J AM COLL SURGEONS, V211, P804, DOI 10.1016/j.jamcollsurg.2010.08.014; Haas B, 2009, J AM COLL SURGEONS, V208, P28, DOI 10.1016/j.jamcollsurg.2008.09.004; Hill AD, 2011, J TRAUMA, V71, P1885, DOI 10.1097/TA.0b013e31823ac642; Janssen KJM, 2010, J CLIN EPIDEMIOL, V63, P721, DOI 10.1016/j.jclinepi.2009.12.008; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Williams T, 2013, PREHOSP EMERG CARE, V17, P442, DOI 10.3109/10903127.2013.804137	13	12	12	1	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2016	47	1					26	31		10.1016/j.injury.2015.09.020			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	CZ8HD	WOS:000367339900006	26510409				2021-06-18	
J	Meng, XE; Zhang, Y; Li, N; Fan, DF; Yang, C; Li, H; Guo, DZ; Pan, SY				Meng, X. E.; Zhang, Y.; Li, N.; Fan, D. F.; Yang, C.; Li, H.; Guo, D. Z.; Pan, S. Y.			Effects of hyperbaric oxygen on the Nrf2 signaling pathway in secondary injury following traumatic brain injury	GENETICS AND MOLECULAR RESEARCH			English	Article						Traumatic brain injury; Hyperbaric oxygen; Nrf2	OXIDATIVE STRESS; ENZYMES; MICE	We investigated the effects of hyperbaric oxygen treatment on the Nrf2 signaling pathway in secondary injury following traumatic brain injury, using a rat model. An improved Feeney freefall method was used to establish the rat traumatic brain injury model. Sixty rats were randomly divided into three groups: a sham surgery group, a traumatic brain injury group, and a group receiving hyperbaric oxygen treatment after traumatic brain injury. Neurological function scores were assessed at 12 and 24 h after injury. The expression levels of Nrf2, heme oxygenase 1 (HO-1), and quinine oxidoreductase 1 (NQO-1) in the cortex surrounding the brain lesion were detected by western blotting 24 h after the injury. Additionally, the TUNEL method was used to detect apoptosis of nerve cells 24 h after traumatic injury and Nissl staining was used to detect the number of whole neurons. Hyperbaric oxygen treatment significantly increased the expression of nuclear Nrf2 protein (P < 0.05), HO-1, and NQO-1 in the brain tissues surrounding the lesion after a traumatic brain injury (P < 0.05) and also significantly reduced the number of apoptotic and injured nerve cells. The neurological function scores also improved with hyperbaric oxygen treatment (P < 0.05). Therefore, hyperbaric oxygen has a neuroprotective role in traumatic brain injury, which is mediated by up-regulation of the Nrf2 signaling pathway.	[Meng, X. E.; Zhang, Y.; Li, N.; Fan, D. F.; Yang, C.; Li, H.; Guo, D. Z.; Pan, S. Y.] Navy Gen Hosp, Dept Hyperbar Oxygen, Beijing, Peoples R China	Pan, SY (corresponding author), Navy Gen Hosp, Dept Hyperbar Oxygen, Beijing, Peoples R China.	shuyipan_oooo@126.com					Cheng ZG, 2013, ASIAN PAC J TROP MED, V6, P305, DOI 10.1016/S1995-7645(13)60061-9; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Hong YA, 2010, ACTA PHARMACOL SIN, V31, P1421, DOI 10.1038/aps.2010.101; Lannin NA, 2014, NEUROREHABILITATION, V35, P635, DOI 10.3233/NRE-141161; Miller DM, 2014, J NEUROTRAUM, V31, P1194, DOI 10.1089/neu.2013.3218; Sandberg M, 2014, NEUROPHARMACOLOGY, V79, P298, DOI 10.1016/j.neuropharm.2013.11.004; Schwab JM, 2014, EXP NEUROL, V258, P121, DOI 10.1016/j.expneurol.2014.04.023; Si DW, 2014, EXP THER MED, V8, P1010, DOI 10.3892/etm.2014.1840; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; Xie Y, 2014, PHARMACOL BIOCHEM BE, V126, P181, DOI 10.1016/j.pbb.2014.08.005; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Zhuang Z, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-47	12	12	12	0	2	FUNPEC-EDITORA	RIBEIRAO PRETO	RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000, BRAZIL	1676-5680			GENET MOL RES	Genet. Mol. Res.		2016	15	1							15016933	10.4238/gmr.15016933			7	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	DJ0GM	WOS:000373879900011	26909929	Bronze			2021-06-18	
J	Murry, JS; Hoang, DM; Barmparas, G; Harada, MY; Bukur, M; Bloom, MB; Inaba, K; Margulies, DR; Salim, A; Ley, EJ				Murry, Jason S.; Hoang, David M.; Barmparas, Galinos; Harada, Megan Y.; Bukur, Marko; Bloom, Matthew B.; Inaba, Kenji; Margulies, Daniel R.; Salim, Ali; Ley, Eric J.			Prospective evaluation of early propranolol after traumatic brain injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Propranolol; Beta blockers; Bradycardia	BETA-BLOCKER EXPOSURE; CEREBRAL-BLOOD-FLOW; HEART-RATE; RATS; CHILDREN; IMPACT; MOUSE; DEATH; TRIAL	Background: Although beta-adrenergic receptor blockade may improve outcomes after traumatic brain injury (TBI), its early use is not routine. We hypothesize that judicious early low-dose propranolol after TBI (EPAT) will improve outcomes without altering bradycardia or hypotensive events. Methods: We conducted a prospective, observational study on all patients who presented with moderate-to-severe TBI from March 2010-August 2013. Ten initial patients did not receive propranolol (control). Subsequent patients received propranolol at 1-mg intravenous every 6 h starting within 12 h of intensive care unit (ICU) admission (EPAT) for a minimum of 48 h. Heart rate and blood pressure were recorded hourly for the first 72 h. Bradycardia and hypotensive events, mortality, and length of stay (LOS) were compared between cohorts to determine significant differences. Results: Thirty-eight patients were enrolled; 10 control and 28 EPAT. The two cohorts were similar when compared by gender, emergency department (ED) systolic blood pressure, ED heart rate, and mortality. ED Glasgow coma scale was lower (4.2 versus 10.7, P < 0.01) and injury severity score higher in control. EPAT patients received a mean of 10 +/- 14 doses of propranolol. Hypotensive events were similar between cohorts, whereas bradycardia events were higher in control (5.8 versus 1.6, P = 0.05). ICU LOS (15.4 versus 30.4 d, P = 0.02) and hospital LOS (10 versus 19.1 d, P = 0.05) were lower in EPAT. Mortality rates were similar between groups (10% versus 10.7%, P = 0.9). The administration of propranolol led to no recorded complications. Conclusions: Although bradycardia and hypotensive events occur early after TBI, low-dose intravenous propranolol does not increase their number or severity. Early use of propranolol after TBI appears to be safe and may be associated with decreased ICU and hospital LOS. (C) 2016 Elsevier Inc. All rights reserved.	[Murry, Jason S.; Hoang, David M.; Barmparas, Galinos; Harada, Megan Y.; Bloom, Matthew B.; Margulies, Daniel R.; Ley, Eric J.] Cedars Sinai Med Ctr, Div Trauma & Crit Care, Dept Surg, Los Angeles, CA 90048 USA; [Bukur, Marko] Delray Med Ctr, Dept Trauma & Crit Care, Delray Beach, FL USA; [Bukur, Marko] Broward Gen Med Ctr, Ft Lauderdale, FL USA; [Inaba, Kenji] Univ So Calif, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA USA; [Salim, Ali] Brigham & Womens Hosp, Dept Surg, Div Trauma Burn & Surg Crit Care, Boston, MA 02115 USA	Ley, EJ (corresponding author), Cedars Sinai Med Ctr, Div Trauma & Crit Care, Dept Surg, 8700 Beverly Blvd,Suite 8215N, Los Angeles, CA 90048 USA.	eric.ley@cshs.org	Barmparas, Galinos/L-6530-2019; INABA, KENJI/AAC-8532-2020; Bloom, Matthew/E-5660-2013	Bloom, Matthew/0000-0001-8102-4394; Bukur, Marko/0000-0002-1850-7147			Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; [Anonymous], SURV BEN BET BLOCK S; [Anonymous], TBI GUID; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Bible LE, 2014, J TRAUMA ACUTE CARE, V77, P54, DOI 10.1097/TA.0000000000000264; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; Chi OZ, 1999, ANESTH ANALG, V89, P690, DOI 10.1097/00000539-199909000-00030; CLIFTON G L, 1989, Neurosurgical Review, V12, P465, DOI 10.1007/BF01790692; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; EDVINSSON L, 1979, ACTA PHYSIOL SCAND, V107, P289, DOI 10.1111/j.1748-1716.1979.tb06478.x; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P228, DOI 10.1097/00003246-199302000-00014; Goldstein B, 1996, CRIT CARE MED, V24, P234, DOI 10.1097/00003246-199602000-00009; GREENDYKE RM, 1986, J NERV MENT DIS, V174, P290, DOI 10.1097/00005053-198605000-00005; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; HEMMINGSEN R, 1979, ACTA PHYSIOL SCAND, V105, P274, DOI 10.1111/j.1748-1716.1979.tb06342.x; Herndon DN, 2001, NEW ENGL J MED, V345, P1223, DOI 10.1056/NEJMoa010342; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Kato H, 2009, ANESTH ANALG, V108, P288, DOI 10.1213/ane.0b013e318187bb93; LASBENNES F, 1986, EXP BRAIN RES, V63, P169; Ley EJ, 2012, J TRAUMA ACUTE CARE, V72, P943, DOI 10.1097/TA.0b013e3182465527; Ley EJ, 2010, J TRAUMA, V68, P353, DOI 10.1097/TA.0b013e3181c8269a; LIU MY, 1995, J FORMOS MED ASSOC, V94, P386; LOWENSOHN RI, 1977, LANCET, V1, P626; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; NEILDWYER G, 1981, BRIT J CLIN PHARMACO, V11, P549, DOI 10.1111/j.1365-2125.1981.tb01169.x; Riordan WP, 2007, J TRAUMA, V63, P503, DOI 10.1097/TA.0b013e3181271c34; Sasaki M, 2001, J NEUROTRAUM, V18, P1241, DOI 10.1089/089771501317095278; Schroeppel TJ, 2014, J TRAUMA ACUTE CARE, V76, P504, DOI 10.1097/TA.0000000000000104; Sheng P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081802	32	12	12	1	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JAN	2016	200	1					221	226		10.1016/j.jss.2015.06.045			6	Surgery	Surgery	CZ1BM	WOS:000366840700032	26188959				2021-06-18	
J	Pagnozzi, AM; Dowson, N; Doecke, J; Fiori, S; Bradley, AP; Boyd, RN; Rose, S				Pagnozzi, Alex M.; Dowson, Nicholas; Doecke, James; Fiori, Simona; Bradley, Andrew P.; Boyd, Roslyn N.; Rose, Stephen			Automated, quantitative measures of grey and white matter lesion burden correlates with motor and cognitive function in children with unilateral cerebral palsy	NEUROIMAGE-CLINICAL			English	Article						Cerebral palsy; Magnetic resonance imaging; Brain lesion	TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; BASAL GANGLIA; MRI; SEGMENTATION; INTEGRITY; VALIDITY; DAMAGE	White and grey matter lesions are the most prevalent type of injury observable in the Magnetic Resonance Images (MRIs) of children with cerebral palsy (CP). Previous studies investigating the impact of lesions in children with CP have been qualitative, limited by the lack of automated segmentation approaches in this setting. As a result, the quantitative relationship between lesion burden has yet to be established. In this study, we perform automatic lesion segmentation on a large cohort of data (107 children with unilateral CP and 18 healthy children) with a new, validated method for segmenting both white matter (WM) and grey matter (GM) lesions. The method has better accuracy (94%) than the best current methods (73%), and only requires standard structural MRI sequences. Anatomical lesion burdens most predictive of clinical scores of motor, cognitive, visual and communicative function were identified using the Least Absolute Shrinkage and Selection operator (LASSO). The improved segmentations enabled identification of significant correlations between regional lesion burden and clinical performance, which conform to known structure-function relationships. Model performance was validated in an independent test set, with significant correlations observed for both WM and GM regional lesion burden with motor function (p < 0.008), and between WM and GM lesions alone with cognitive and visual function respectively (p < 0.008). The significant correlation of GM lesions with functional outcome highlights the serious implications GM lesions, in addition to WM lesions, have for prognosis, and the utility of structural MRI alone for quantifying lesion burden and planning therapy interventions. (C) 2016 Commonwealth Scientific and Industrial Research Organisation. Published by Elsevier Inc.	[Pagnozzi, Alex M.; Dowson, Nicholas; Doecke, James; Rose, Stephen] CSIRO Hlth & Biosecur, Australian E Hlth Res Ctr, Brisbane, Qld, Australia; [Pagnozzi, Alex M.; Bradley, Andrew P.] Univ Queensland, Sch Informat Technol & Elect Engn, Brisbane, Qld, Australia; [Fiori, Simona] IRCCS Stella Maris Fdn, Pisa, Italy; [Boyd, Roslyn N.] Univ Queensland, Queensland Cerebral Palsy & Rehabil Res Ctr, Ctr Childrens Hlth Res, Fac Med & Sci, Brisbane, Qld, Australia	Pagnozzi, AM (corresponding author), Royal Brisbane & Womens Hosp, Australian E Hlth Res Ctr, Level 5,UQ Hlth Sci Bldg, Herston, Qld 4029, Australia.	Alex.Pagnozzi@csiro.au	fiori, simona/K-7515-2016; Rose, Stephen/C-8044-2009; Boyd, Roslyn N/A-4498-2011; Dowson, Nicholas D H/B-7621-2017; Bradley, Andrew P./O-8516-2019; Bradley, Andrew P/C-5685-2009; Pagnozzi, Alex Michael/C-4777-2014	fiori, simona/0000-0002-0933-6120; Boyd, Roslyn N/0000-0002-4919-5975; Dowson, Nicholas D H/0000-0003-4694-5459; Bradley, Andrew P./0000-0003-0109-6844; Bradley, Andrew P/0000-0003-0109-6844; Pagnozzi, Alex Michael/0000-0001-7931-1204	University of QueenslandUniversity of Queensland; Commonwealth Scientific Industrial and Research Organisation (CSIRO)Commonwealth Scientific & Industrial Research Organisation (CSIRO); Foundation for Children Grant; NHMRCNational Health and Medical Research Council of Australia [1003887]; Smart Futures Co-Investment Program Grant; ARCAustralian Research Council [FT110100623]	Alex M. Pagnozzi is supported by the Australian Postgraduate Award (APA) from The University of Queensland, and the Commonwealth Scientific Industrial and Research Organisation (CSIRO). Roslyn N. Boyd is supported by a Foundation for Children Grant, NHMRC Research Fellowship (2015-2020) and a NHMRC Project Grant COMBIT (1003887). Roslyn N. Boyd and Stephen Rose are supported by the by the Smart Futures Co-Investment Program Grant. Andrew Bradley is supported by an ARC Future fellowship (FT110100623). The funding bodies have not contributed to the study design, the collection, management, analysis and interpretation of data, the writing of final reports or the decision to submit findings for publication. No other authors have potential conflicts of interest to declare.	Bax M, 2006, JAMA-J AM MED ASSOC, V296, P1602, DOI 10.1001/jama.296.13.1602; Bernal B, 2010, MAGN RESON IMAGING, V28, P217, DOI 10.1016/j.mri.2009.07.008; Bourdon KH, 2005, J AM ACAD CHILD PSY, V44, P557, DOI 10.1097/01.chi.0000159157.57075.c8; Boyd R. N., 2013, BMJ OPEN, P3, DOI [DOI 10.1136/BMJOPEN-2013-002853, 10.1136/bmjopen-2013-002853]; Cho SH, 2007, NEUROSCI LETT, V426, P123, DOI 10.1016/j.neulet.2007.08.049; Cioni G, 2011, PROG BRAIN RES, V189, P139, DOI 10.1016/B978-0-444-53884-0.00022-1; Fazio P, 2009, BRAIN, V132, P1980, DOI 10.1093/brain/awp118; Fiori S, 2015, NEUROIMAGE-CLIN, V8, P104, DOI 10.1016/j.nicl.2015.04.005; Frostig M, 2016, PERCEPT MOTOR SKILL, V12, P383, DOI [DOI 10.2466/PMS.1961.12.3.383, 10.2466/pms.1961.12.3.383.]; Garcia-Lorenzo D, 2013, MED IMAGE ANAL, V17, P1, DOI 10.1016/j.media.2012.09.004; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P249, DOI 10.1076/chin.8.4.249.13513; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Himmelmann K, 2011, DEV MED CHILD NEUROL, V53, P516, DOI 10.1111/j.1469-8749.2011.03932.x; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Krageloh-Mann I, 2007, DEV MED CHILD NEUROL, V49, P144; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Krumlinde-Sundholm L, 2007, DEV MED CHILD NEUROL, V49, P259, DOI 10.1111/j.1469-8749.2007.00259.x; Llado X, 2012, INFORM SCIENCES, V186, P164, DOI 10.1016/j.ins.2011.10.011; Martinez-Biarge M, 2010, EARLY HUM DEV, V86, P675, DOI 10.1016/j.earlhumdev.2010.08.013; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Modat M, 2010, COMPUT METH PROG BIO, V98, P278, DOI 10.1016/j.cmpb.2009.09.002; Pagnozzi A. M., 2015, DIGITAL IMAGE COMPUT; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; Reid SM, 2014, DEV MED CHILD NEUROL, V56, P178, DOI 10.1111/dmcn.12331; Rivest-Henault D., 2015, MED IMAGE ANAL; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Wechsler D., 1967, WECHSLER PRESCHOOL P	30	12	12	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2016	11						751	759		10.1016/j.nicl.2016.05.018			9	Neuroimaging	Neurosciences & Neurology	DQ9BD	WOS:000379504500082	27330975	DOAJ Gold, Green Published			2021-06-18	
J	Uteshev, VV				Uteshev, Victor V.			Allosteric Modulation of Nicotinic Acetylcholine Receptors: The Concept and Therapeutic Trends	CURRENT PHARMACEUTICAL DESIGN			English	Article						Allosteric; cognitive; nociceptive; inflammatory; protection; ischemic; stroke; traumatic; choline; nicotinic; PNU-120596; PNU120596	TRAUMATIC BRAIN-INJURY; VAGUS NERVE-STIMULATION; CULTURED CORTICAL-NEURONS; TIME-DEPENDENT CHANGES; PROOF-OF-CONCEPT; BINDING-SITES; COGNITIVE DEFICITS; PARTIAL AGONIST; ACH RECEPTORS; RAT-BRAIN	Expressing functional nicotinic acetylcholine receptors (nAChRs) may be beneficial to central neurons and neuronal networks because activation of nAChRs enhances neuronal resistance to injury, improves attention, cognitive performance, and produces robust anti-inflammatory and analgesic effects in mammals. Although exogenous orthosteric nAChR ligands present valuable tools in treatment of age-and trauma-related neurological deficits, therapeutic approaches that could amplify the brain's innate ability to maintain cholinergic homeostasis and resist injury may serve as intriguing and promising alternatives and have not been fully explored. One of these novel approaches utilizes positive allosteric modulators (PAMs) of nAChRs. Because of the ubiquitous expression of nAChRs in neuronal, glial and immune tissues, highly selective PAMs could amplify multiple endogenous neuroprotective, pro-cognitive, anti-inflammatory and anti-nociceptive cholinergic pathways to offset cholinergic hypofunction and generate therapeutic efficacy by targeting only a single player: i.e., nAChRs activated by endogenous cholinergic tone. In this article, I review the concept of allosteric modulation and current trends in therapeutic applications of nicotinic PAMs.	[Uteshev, Victor V.] Univ N Texas, Hlth Sci Ctr, Inst Hlth Aging, Ctr Neurosci Discovery, Ft Worth, TX 76107 USA	Uteshev, VV (corresponding author), Univ N Texas, Hlth Sci Ctr, Inst Hlth Aging, Ctr Neurosci Discovery, Ft Worth, TX 76107 USA.	Victor.Uteshev@unthsc.edu					AKAIKE A, 1994, BRAIN RES, V644, P181, DOI 10.1016/0006-8993(94)91678-0; Akaike A, 2010, J MOL NEUROSCI, V40, P211, DOI 10.1007/s12031-009-9236-1; Albuquerque EX, 2001, ALZ DIS ASSOC DIS, V15, pS19, DOI 10.1097/00002093-200108001-00004; Alkondon M, 2000, NEUROPHARMACOLOGY, V39, P2726, DOI 10.1016/S0028-3908(00)00156-8; Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; Alkondon M, 1999, J NEUROSCI, V19, P2693; AlSharari SD, 2013, BIOCHEM PHARMACOL, V86, P1201, DOI 10.1016/j.bcp.2013.06.018; Alvarez B, 2011, CURR OPIN PULM MED, V17, P172, DOI 10.1097/MCP.0b013e3283455c0b; ARENDASH GW, 1995, BRAIN RES, V674, P252, DOI 10.1016/0006-8993(94)01449-R; Arias HR, 2010, ADV PROTEIN CHEM STR, V80, P153, DOI [10.1016/S1876-1623(10)80005-7, 10.1016/B978-0-12-381264-3.00005-9]; Azzopardi E, 2013, GENES BRAIN BEHAV, V12, P414, DOI 10.1111/gbb.12038; BADIO B, 1994, MOL PHARMACOL, V45, P563; Baez-Pagan CA, 2015, J NEUROIMMUNE PHARM, V10, P468, DOI 10.1007/s11481-015-9601-5; Baldini AV, 2012, PRIM CARE COMPANION, V14; Banerjee C, 2000, NEUROBIOL DIS, V7, P666, DOI 10.1006/nbdi.2000.0317; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bencherif M, 2011, CELL MOL LIFE SCI, V68, P931, DOI 10.1007/s00018-010-0525-1; BERTRAND D, 1993, P NATL ACAD SCI USA, V90, P6971, DOI 10.1073/pnas.90.15.6971; Bertrand N, 1996, NEUROCHEM INT, V28, P293, DOI 10.1016/0197-0186(95)00086-0; Bitner RS, 2010, J PHARMACOL EXP THER, V334, P875, DOI 10.1124/jpet.110.167213; Bitner RS, 2007, J NEUROSCI, V27, P10578, DOI 10.1523/JNEUROSCI.2444-07.2007; Blair LAC, 1999, J NEUROSCI, V19, P1940; Bloem B, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00017; Boess FG, 2007, J PHARMACOL EXP THER, V321, P716, DOI 10.1124/jpet.106.118976; Bok J, 2007, MOL CELL NEUROSCI, V36, P13, DOI 10.1016/j.mcn.2007.05.008; Borovikova LV, 2000, NATURE, V405, P458; Boyce S, 2000, PAIN, V85, P443, DOI 10.1016/S0304-3959(99)00303-6; BRAESTRUP C, 1982, SCIENCE, V216, P1241, DOI 10.1126/science.6281892; Breese CR, 1997, J COMP NEUROL, V387, P385, DOI 10.1002/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X; Briggs CA, 1997, PHARMACOL BIOCHEM BE, V57, P231, DOI 10.1016/S0091-3057(96)00354-1; Briggs CA, 2009, BRIT J PHARMACOL, V158, P1486, DOI 10.1111/j.1476-5381.2009.00426.x; Brown KL, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00166; Brunzell DH, 2012, NEUROPSYCHOPHARMACOL, V37, P1134, DOI 10.1038/npp.2011.299; Buccafusco JJ, 2007, BIOCHEM PHARMACOL, V74, P1202, DOI 10.1016/j.bcp.2007.07.010; Buccafusco JJ, 2005, TRENDS PHARMACOL SCI, V26, P352, DOI 10.1016/j.tips.2005.05.007; BURGEN ASV, 1981, FED PROC, V40, P2723; Burghaus L, 2000, MOL BRAIN RES, V76, P385; Cabrera SM, 2006, BEHAV NEUROSCI, V120, P298, DOI 10.1037/0735-7044.120.2.298; Callahan PM, 2013, NEUROPHARMACOLOGY, V67, P201, DOI 10.1016/j.neuropharm.2012.10.019; CASTRO NG, 1995, BIOPHYS J, V68, P516, DOI 10.1016/S0006-3495(95)80213-4; CHANGEUX JP, 1990, TRENDS PHARMACOL SCI, V11, P485, DOI 10.1016/0165-6147(90)90049-E; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; CLARKE PBS, 1993, PROG BRAIN RES, V98, P77; Clough RW, 2007, NEUROSCIENCE, V147, P286, DOI 10.1016/j.neuroscience.2007.04.043; COLLINS F, 1991, J NEUROSCI, V11, P2582; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Curzon P, 2006, NEUROSCI LETT, V410, P15, DOI 10.1016/j.neulet.2006.09.061; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; Daly JW, 2000, NAT PROD REP, V17, P131, DOI 10.1039/a900728h; Damaj MI, 2000, NEUROPHARMACOLOGY, V39, P2785, DOI 10.1016/S0028-3908(00)00139-8; Damaj MI, 1998, J PHARMACOL EXP THER, V284, P1058; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Decker MW, 2004, CURR TOP MED CHEM, V4, P369, DOI 10.2174/1568026043451447; del Barrio L, 2011, TOXICOL SCI, V123, P193, DOI 10.1093/toxsci/kfr163; Demuro A, 2001, NEUROPHARMACOLOGY, V41, P854, DOI 10.1016/S0028-3908(01)00137-X; Dineley KT, 2015, TRENDS PHARMACOL SCI, V36, P96, DOI 10.1016/j.tips.2014.12.002; Dinklo T, 2011, J PHARMACOL EXP THER, V336, P560, DOI 10.1124/jpet.110.173245; DJURICIC B, 1991, J CEREBR BLOOD F MET, V11, P308, DOI 10.1038/jcbfm.1991.63; Dziewczapolski G, 2009, J NEUROSCI, V29, P8805, DOI 10.1523/JNEUROSCI.6159-08.2009; Egea J, 2007, NEUROSCIENCE, V145, P866, DOI 10.1016/j.neuroscience.2006.12.036; Egea J, 2015, BIOCHEM PHARMACOL, V97, P463, DOI 10.1016/j.bcp.2015.07.032; Ehlert FJ, 2013, PROG MOL BIOL TRANSL, V115, P291, DOI 10.1016/B978-0-12-394587-7.00007-5; Engel O, 2015, STROKE, V46, P3232, DOI 10.1161/STROKEAHA.115.008989; Faghih R, 2009, J MED CHEM, V52, P3377, DOI 10.1021/jm9003818; Fastrez J, 2009, CHEMBIOCHEM, V10, P2824, DOI 10.1002/cbic.200900590; Felix R, 1997, NEUROSCIENCE, V81, P1009, DOI 10.1016/S0306-4522(97)00224-8; Ferchmin PA, 2003, J PHARMACOL EXP THER, V305, P1071, DOI 10.1124/jpet.102.048173; Fernandes C, 2006, GENES BRAIN BEHAV, V5, P433, DOI 10.1111/j.1601-183X.2005.00176.x; FREEDMAN R, 1995, BIOL PSYCHIAT, V38, P22, DOI 10.1016/0006-3223(94)00252-X; Freedman R, 2000, J CHEM NEUROANAT, V20, P299, DOI 10.1016/S0891-0618(00)00109-5; Freitas K, 2013, BRIT J PHARMACOL, V169, P567, DOI 10.1111/j.1476-5381.2012.02226.x; Freitas K, 2013, J PHARMACOL EXP THER, V344, P264, DOI 10.1124/jpet.112.197871; Freitas K, 2013, NEUROPHARMACOLOGY, V65, P156, DOI 10.1016/j.neuropharm.2012.08.022; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Fucile S, 2004, CELL CALCIUM, V35, P1, DOI 10.1016/j.ceca.2003.08.006; Fujii S, 2000, NEUROSCI LETT, V286, P134, DOI 10.1016/S0304-3940(00)01076-4; Gasull T, 2000, J BIOL CHEM, V275, P18350, DOI 10.1074/jbc.M910468199; Gatson JW, 2015, BRAIN RES BULL, V112, P35, DOI 10.1016/j.brainresbull.2015.01.008; GERZANICH V, 1995, MOL PHARMACOL, V48, P774; GHONEIM MM, 1977, PSYCHOPHARMACOLOGY, V52, P1, DOI 10.1007/BF00426592; Gonzalez-Cestari TF, 2009, J PHARMACOL EXP THER, V328, P504, DOI 10.1124/jpet.108.144576; Grupe M, 2013, BRIT J PHARMACOL, V168, P2000; Guan YZ, 2015, MOL NEUROBIOL, V51, P1480, DOI 10.1007/s12035-014-8825-3; Guan ZZ, 2000, J NEUROCHEM, V74, P237, DOI 10.1046/j.1471-4159.2000.0740237.x; Gusev AG, 2010, J PHARMACOL EXP THER, V332, P588, DOI 10.1124/jpet.109.162099; Guseva MV, 2008, J NEUROTRAUM, V25, P975, DOI 10.1089/neu.2008.0516; Hao JW, 2011, EXP NEUROL, V227, P110, DOI 10.1016/j.expneurol.2010.09.020; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Harris JG, 2004, NEUROPSYCHOPHARMACOL, V29, P1378, DOI 10.1038/sj.npp.1300450; Hays SA, 2013, PROG BRAIN RES, V207, P275, DOI 10.1016/B978-0-444-63327-9.00010-2; Hellstrom-Lindahl E, 1999, MOL BRAIN RES, V66, P94, DOI 10.1016/S0169-328X(99)00030-3; Hernandez CM, 2010, J NEUROSCI, V30, P2442, DOI 10.1523/JNEUROSCI.5038-09.2010; Hogg RC, 2003, REV PHYSIOL BIOCH P, V147, P1, DOI 10.1007/s10254-003-0005-1; Hoyle E, 2006, PSYCHOPHARMACOLOGY, V189, P211, DOI 10.1007/s00213-006-0549-2; Hu M, 2009, BRIT J PHARMACOL, V158, P1857, DOI 10.1111/j.1476-5381.2009.00474.x; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Jamison RN, 2011, PAIN RES TREAT, V2011, DOI 10.1155/2011/941808; JANOWSKY DS, 1974, PSYCHOSOM MED, V36, P248, DOI 10.1097/00006842-197405000-00008; De Rosa MJ, 2009, LIFE SCI, V85, P444, DOI 10.1016/j.lfs.2009.07.010; Kalappa BI, 2013, EUR J PHARMACOL, V718, P226, DOI 10.1016/j.ejphar.2013.08.027; Kalappa BI, 2013, BRIT J PHARMACOL, V169, P1862, DOI 10.1111/bph.12247; Kalappa BI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013964; Kaneko S, 1997, BRAIN RES, V765, P135, DOI 10.1016/S0006-8993(97)00556-8; Kawashima K, 2004, FRONT BIOSCI-LANDMRK, V9, P2063, DOI 10.2741/1390; Kawashima K, 2003, LIFE SCI, V74, P675, DOI 10.1016/j.lfs.2003.09.037; Kelso ML, 2012, CURR DRUG TARGETS, V13, P631, DOI 10.2174/138945012800398964; Kenakin T, 2005, NAT REV DRUG DISCOV, V4, P919, DOI 10.1038/nrd1875; Kenakin T, 2007, J RECEPT SIG TRANSD, V27, P247, DOI 10.1080/10799890701509000; Kiewert C, 2010, BRAIN RES, V1312, P101, DOI 10.1016/j.brainres.2009.11.068; Kihara T, 1997, ANN NEUROL, V42, P159, DOI 10.1002/ana.410420205; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Kitagawa H, 2003, NEUROPSYCHOPHARMACOL, V28, P542, DOI 10.1038/sj.npp.1300028; Klein J, 1998, NEUROCHEM INT, V32, P479, DOI 10.1016/S0197-0186(97)00127-7; KLEIN J, 1991, J NEUROCHEM, V57, P370, DOI 10.1111/j.1471-4159.1991.tb03762.x; KOIKE T, 1989, P NATL ACAD SCI USA, V86, P6421, DOI 10.1073/pnas.86.16.6421; Koval L, 2011, INT J BIOCHEM CELL B, V43, P516, DOI 10.1016/j.biocel.2010.12.003; Kox M, 2008, NEUROLOGY, V70, P480, DOI 10.1212/01.wnl.0000279479.69502.3e; Lee CH, 2011, BIOCHEM PHARMACOL, V82, P959, DOI 10.1016/j.bcp.2011.06.044; Leiser SC, 2009, PHARMACOL THERAPEUT, V122, P302, DOI 10.1016/j.pharmthera.2009.03.009; Lendvai B, 2013, BRAIN RES BULL, V93, P86, DOI 10.1016/j.brainresbull.2012.11.003; Leonard S, 2000, EUR J PHARMACOL, V393, P237, DOI 10.1016/S0014-2999(00)00035-2; LeonS FE, 1997, J CLIN NEUROPHYSIOL, V14, P144, DOI 10.1097/00004691-199703000-00007; Levin ED, 2006, PSYCHOPHARMACOLOGY, V184, P523, DOI 10.1007/s00213-005-0164-7; Levin ED, 2009, BEHAV BRAIN RES, V196, P207, DOI 10.1016/j.bbr.2008.08.048; Li YX, 2002, J NEUROCHEM, V81, P853, DOI 10.1046/j.1471-4159.2002.00891.x; Li YX, 1999, BRAIN RES, V830, P218, DOI 10.1016/S0006-8993(99)01372-4; Liu Y, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-98; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; LONDON ED, 1989, NEUROCHEM RES, V14, P745, DOI 10.1007/BF00964952; Lopez-Hernandez GY, 2009, NEUROPHARMACOLOGY, V56, P821, DOI 10.1016/j.neuropharm.2009.01.011; Martelli D, 2014, AUTON NEUROSCI-BASIC, V182, P65, DOI 10.1016/j.autneu.2013.12.007; Martin LF, 2007, INT REV NEUROBIOL, V78, P225, DOI 10.1016/S0074-7742(06)78008-4; Marubio LM, 1999, NATURE, V398, P805; Mathew SV, 2007, HUM MOL GENET, V16, P2921, DOI 10.1093/hmg/ddm253; McGaughy J, 1999, PSYCHOPHARMACOLOGY, V144, P175, DOI 10.1007/s002130050991; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; McLean SL, 2012, J PSYCHOPHARMACOL, V26, P1265, DOI 10.1177/0269881111431747; McLean SL, 2011, EUR NEUROPSYCHOPHARM, V21, P333, DOI 10.1016/j.euroneuro.2010.06.003; McNicol ED, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006146.pub2; Medeiros R, 2014, AM J PATHOL, V184, P520, DOI 10.1016/j.ajpath.2013.10.010; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Meyer EM, 1997, BRAIN RES, V768, P49, DOI 10.1016/S0006-8993(97)00536-2; Meyer EM, 1998, J PHARMACOL EXP THER, V284, P1026; Meyer EM, 1998, BRAIN RES, V786, P252, DOI 10.1016/S0006-8993(97)00300-4; Mineur YS, 2013, P NATL ACAD SCI USA, V110, P3573, DOI 10.1073/pnas.1219731110; Mohler EG, 2010, PHARMACOL BIOCHEM BE, V95, P146, DOI 10.1016/j.pbb.2009.12.019; MUIR JL, 1993, BEHAV BRAIN RES, V57, P123, DOI 10.1016/0166-4328(93)90128-D; MUIR JL, 1994, J NEUROSCI, V14, P2313; Munro G, 2012, BRIT J PHARMACOL, V167, P421, DOI 10.1111/j.1476-5381.2012.02003.x; Neese SL, 2007, BRAIN RES, V1128, P157, DOI 10.1016/j.brainres.2006.09.073; Neren D, 2015, NEUROCRIT CARE; NEWHOUSE PA, 1992, PSYCHOPHARMACOLOGY, V108, P480, DOI 10.1007/BF02247425; Newhouse PA, 2004, CURR OPIN PHARMACOL, V4, P36, DOI 10.1016/j.coph.2003.11.001; Nordberg A, 2001, BIOL PSYCHIAT, V49, P200, DOI 10.1016/S0006-3223(00)01125-2; NORDBERG A, 1986, NEUROSCI LETT, V72, P115, DOI 10.1016/0304-3940(86)90629-4; NUTTER TJ, 1995, J GEN PHYSIOL, V105, P701, DOI 10.1085/jgp.105.6.701; Olincy A, 2007, BIOCHEM PHARMACOL, V74, P1192, DOI 10.1016/j.bcp.2007.07.015; Olincy A, 2006, ARCH GEN PSYCHIAT, V63, P630, DOI 10.1001/archpsyc.63.6.630; Olofsson PS, 2012, MOL MED, V18, P539, DOI 10.2119/molmed.2011.00405; Pandya AA, 2013, BIOCHEM PHARMACOL, V86, P1054, DOI 10.1016/j.bcp.2013.05.018; Panjkovich A, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-9; Papadia S, 2007, NEUROSCIENTIST, V13, P572, DOI 10.1177/1073858407305833; Papke RL, 1996, NEUROSCI LETT, V213, P201; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; Parada E, 2013, ANTIOXID REDOX SIGN, V19, P1135, DOI 10.1089/ars.2012.4671; Pavlov VA, 2005, BRAIN BEHAV IMMUN, V19, P493, DOI 10.1016/j.bbi.2005.03.015; Pavlov VA, 2015, IMMUNOL RES, V63, P38, DOI 10.1007/s12026-015-8718-1; PERRY EK, 1995, NEUROSCIENCE, V64, P385, DOI 10.1016/0306-4522(94)00410-7; PETERSEN RC, 1977, PSYCHOPHARMACOLOGY, V52, P283, DOI 10.1007/BF00426713; Pichat P, 2007, NEUROPSYCHOPHARMACOL, V32, P17, DOI 10.1038/sj.npp.1301188; Prada I, 2013, GLIA, V61, P1003, DOI 10.1002/glia.22497; Preskorn SH, 2014, J PSYCHIATR PRACT, V20, P12, DOI 10.1097/01.pra.0000442935.15833.c5; Prickaerts J, 2012, NEUROPHARMACOLOGY, V62, P1099, DOI 10.1016/j.neuropharm.2011.10.024; QIAN CG, 1993, EUR J PHARMACOL, V250, pR13; Quik M, 2015, BIOCHEM PHARMACOL, V97, P399, DOI 10.1016/j.bcp.2015.06.014; Rao AM, 2000, J NEUROCHEM, V75, P2528, DOI 10.1046/j.1471-4159.2000.0752528.x; Razani-Boroujerdi S, 2004, CELL IMMUNOL, V230, P1, DOI 10.1016/j.cellimm.2004.07.007; Ren K, 2007, NEUROSCIENCE, V148, P230, DOI 10.1016/j.neuroscience.2007.05.013; Ren K, 2007, NEUROSCIENCE, V145, P314, DOI 10.1016/j.neuroscience.2006.11.023; Rode F, 2012, BRAIN RES, V1458, P67, DOI 10.1016/j.brainres.2012.03.064; Role LW, 1996, NEURON, V16, P1077, DOI 10.1016/S0896-6273(00)80134-8; Roncarati R, 2009, J PHARMACOL EXP THER, V329, P459, DOI 10.1124/jpet.108.150094; Rowbotham MC, 2009, PAIN, V146, P245, DOI 10.1016/j.pain.2009.06.013; RUPNIAK NMJ, 1994, BRIT J PHARMACOL, V113, P1487, DOI 10.1111/j.1476-5381.1994.tb17164.x; SANDS SB, 1993, BIOPHYS J, V65, P2614, DOI 10.1016/S0006-3495(93)81296-7; Saricicek A, 2012, AM J PSYCHIAT, V169, P851, DOI 10.1176/appi.ajp.2012.11101546; Sarter M, 2005, NAT REV NEUROSCI, V6, P48, DOI 10.1038/nrn1588; Schwartz TW, 2006, J RECEPT SIG TRANSD, V26, P107, DOI 10.1080/10799890600567570; SCREMIN OU, 1991, STROKE, V22, P643, DOI 10.1161/01.STR.22.5.643; SEGUELA P, 1993, J NEUROSCI, V13, P596; Sharma G, 2001, P NATL ACAD SCI USA, V98, P4148, DOI 10.1073/pnas.071540198; Shaw S, 2002, J BIOL CHEM, V277, P44920, DOI 10.1074/jbc.M204610200; Shen JX, 2012, J MOL NEUROSCI, V48, P14, DOI 10.1007/s12031-012-9719-3; Shimohama S, 1998, BRAIN RES, V779, P359, DOI 10.1016/S0006-8993(97)00194-7; SHIMOHAMA S, 1986, J NEUROCHEM, V46, P288, DOI 10.1111/j.1471-4159.1986.tb12960.x; Shimohama S, 2001, BIOL PSYCHIAT, V49, P233, DOI 10.1016/S0006-3223(00)01100-8; Shimohama S, 2009, BIOL PHARM BULL, V32, P332, DOI 10.1248/bpb.32.332; Shytle RD, 2004, J NEUROCHEM, V89, P337, DOI 10.1046/j.1471-4159.2004.02347.x; Shytle RD, 2002, MOL PSYCHIATR, V7, P525, DOI 10.1038/sj.mp.4001035; Si ML, 2002, CIRC RES, V91, P62, DOI 10.1161/01.RES.0000024417.79275.23; Si ML, 2001, J PHARMACOL EXP THER, V298, P122; SPANDE TF, 1992, J AM CHEM SOC, V114, P3475, DOI 10.1021/ja00035a048; St Peters M, 2011, J NEUROSCI, V31, P9760, DOI 10.1523/JNEUROSCI.1902-11.2011; Stevens KE, 1996, NEUROPSYCHOPHARMACOL, V15, P152, DOI 10.1016/0893-133X(95)00178-G; SULLIVAN JP, 1994, J PHARMACOL EXP THER, V271, P624; Sun F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073581; SUNDERLAND T, 1986, PROG NEURO-PSYCHOPH, V10, P599, DOI 10.1016/0278-5846(86)90030-8; Takada-Takatori Y, 2009, BIOL PHARM BULL, V32, P318, DOI 10.1248/bpb.32.318; Takeuchi H, 2009, J NEUROSCI RES, V87, P576, DOI 10.1002/jnr.21869; Tatsumi R, 2006, J MED CHEM, V49, P4374, DOI 10.1021/jm060249c; Teaktong T, 2003, GLIA, V41, P207, DOI 10.1002/glia.10132; Thomsen MS, 2012, J NEUROIMMUNOL, V251, P65, DOI 10.1016/j.jneuroim.2012.07.006; Thomsen MS, 2010, CURR PHARM DESIGN, V16, P323, DOI 10.2174/138161210790170094; Timmermann DB, 2012, BRIT J PHARMACOL, V167, P164, DOI 10.1111/j.1476-5381.2012.01989.x; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436; Tischkau S, 2014, NEUROSCI LETT, V563, P107, DOI 10.1016/j.neulet.2014.01.047; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Umana IC, 2013, BIOCHEM PHARMACOL, V86, P1208, DOI 10.1016/j.bcp.2013.08.001; Uteshev V, 2016, J NEUROCHEM, V136, P217, DOI 10.1111/jnc.13236; Uteshev VV, 2014, EUR J PHARMACOL, V727, P181, DOI 10.1016/j.ejphar.2014.01.072; Uteshev VV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032951; Uteshev VV, 2012, ADV EXP MED BIOL, V740, P603, DOI 10.1007/978-94-007-2888-2_27; Uteshev VV, 2010, ACTA BIOCH BIOPH SIN, V42, P8, DOI 10.1093/abbs/gmp101; Uteshev VV, 2003, J NEUROPHYSIOL, V89, P1797, DOI 10.1152/jn.00943.2002; Uteshev VV, 2002, BRAIN RES, V948, P33, DOI 10.1016/S0006-8993(02)02946-3; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Valant C, 2012, MOL PHARMACOL, V81, P41, DOI 10.1124/mol.111.074872; van der Zanden EP, 2009, GASTROENTEROLOGY, V137, P1029, DOI 10.1053/j.gastro.2009.04.057; van Goethem NP, 2015, BEHAV PHARMACOL, V26, P403, DOI 10.1097/FBP.0000000000000134; van Kampen M, 2004, PSYCHOPHARMACOLOGY, V172, P375, DOI 10.1007/s00213-003-1668-7; Verbois SL, 2000, J NEUROTRAUM, V17, P1001, DOI 10.1089/neu.2000.17.1001; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238; Verbois SL, 2003, NEUROSCIENCE, V119, P1199, DOI 10.1016/S0306-4522(03)00206-9; VERNINO S, 1992, NEURON, V8, P127, DOI 10.1016/0896-6273(92)90114-S; Vida G, 2011, J IMMUNOL, V186, P4340, DOI 10.4049/jimmunol.1003722; Wallace TL, 2013, BIOCHEM PHARMACOL, V85, P1713, DOI 10.1016/j.bcp.2013.04.001; Wallace TL, 2013, EXPERT OPIN THER TAR, V17, P139, DOI 10.1517/14728222.2013.736498; Wallace TL, 2011, J PHARMACOL EXP THER, V336, P242, DOI 10.1124/jpet.110.171892; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang Y, 2005, NEUROSCIENCE, V132, P49, DOI 10.1016/j.neuroscience.2004.12.026; White SH, 2012, J NEUROPHYSIOL, V107, P2083, DOI 10.1152/jn.00701.2011; Whiteaker P, 1999, EUR J NEUROSCI, V11, P2689, DOI 10.1046/j.1460-9568.1999.00685.x; Williams DK, 2011, MOL PHARMACOL, V80, P1013, DOI 10.1124/mol.111.074302; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Wishka DG, 2006, J MED CHEM, V49, P4425, DOI 10.1021/jm0602413; Woodruff-Pak DS, 2000, EXP AGING RES, V26, P323, DOI 10.1080/036107300750015723; Woodruff-Pak DS, 2003, BEHAV BRAIN RES, V143, P159, DOI 10.1016/S0166-4328(03)00039-1; WOODRUFFPAK DS, 1994, BRAIN RES, V645, P309, DOI 10.1016/0006-8993(94)91665-9; Wootten D, 2013, NAT REV DRUG DISCOV, V12, P630, DOI 10.1038/nrd4052; Yang JS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002612; Young JW, 2007, EUR NEUROPSYCHOPHARM, V17, P145, DOI 10.1016/j.euroneuro.2006.03.008; Zhu CZ, 2011, BIOCHEM PHARMACOL, V82, P967, DOI 10.1016/j.bcp.2011.05.007; Zurkovsky L, 2013, BIOCHEM PHARMACOL, V86, P1133, DOI 10.1016/j.bcp.2013.07.032	255	12	12	2	17	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1381-6128	1873-4286		CURR PHARM DESIGN	Curr. Pharm. Design		2016	22	14					1986	1997		10.2174/1381612822666160201115341			12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	DK7ZV	WOS:000375146900003	26831463				2021-06-18	
J	Wu, E; Graham, DP				Wu, Emily; Graham, David P.			Association of Chronic Pain and Community Integration of Returning Veterans With and Without Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Brief Pain Inventory; community integration; traumatic brain injury; veterans	POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; SPINAL-CORD-INJURY; IDENTIFICATION TEST AUDIT; FEMALE VETERANS; PTSD CHECKLIST; COMBAT VETERANS; MENTAL-HEALTH; PRIMARY-CARE; DEPRESSION	Objective: To evaluate the association between community integration and pain in veterans with and without mild blast-related traumatic brain injury (TBI). Design and Participants: A cross-sectional study of 198 Operation Enduring Freedom/Operation Iraqi Freedom veterans, 135 with mild TBI and 63 without TBI exposure. Main Measures: Community Integration Questionnaire (CIQ), Community Reintegration of Injured Service Members Instrument, Brief Pain Inventory. Results: Pain interference was significantly associated with CIQ social integration (P=.037), and pain severity was significantly associated with CIQ home integration (P=.038) and CIQ social integration (P=.044). Pain interference and pain severity had a significant interaction as related to the CIQ total score (P=.046), CIQ job score (P=.034), and CIQ productivity score (P=.034). Pain interference (P=.042) and pain severity (P=.015) were associated with community participation, but not perceived limitations (P>.05) or satisfaction (P>.05) as measures by the Community Reintegration of Injured Service Members Instrument. There was a significant interaction between TBI status and pain severity (P=.021) with community participation. Conclusions: Chronic pain has a negative association with the community integration of returning veterans. Although TBI status was associated with overall community integration ratings, depression had a stronger association with impairments. These findings suggest, above and beyond the treatment of depression, the importance of effectively managing TBI-related pain to foster improved social functioning and to promote the psychological and social well-being of returning veterans.	[Wu, Emily; Graham, David P.] Michael E DeBakey Vet Affairs VA Med Ctr, Neurorehabil Neurons Networks Traumat Brain Injur, Houston, TX USA; [Graham, David P.] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Graham, David P.] South Cent Mental Illness Res Educ & Clin Ctr MIR, Dept Vet Affairs, Houston, TX USA	Graham, DP (corresponding author), Michael E DeBakey VA Med Ctr, Neurorehabil Neurons Networks Traumat Brain Injur, 2002 Holcombe Blvd,153 TBI,Bldg 100,STE 2B-126A, Houston, TX 77030 USA.	david.graham@va.gov			VA Medical Centers Research and Development Services, Rehabilitation Research and Development Service Career Development Award-2 [B7496W]; Neurorehabilitation: Neurons to Networks TBI Center of Excellence [B6812C]	The views expressed in this article are those of the author(s) and do not necessarily reflect the views, position, or policy of the Department of Veterans Affairs, the South Central MIRECC, the United States government, or Baylor College of Medicine. This material is based upon work supported (or supported in part) by the VA Medical Centers Research and Development Services, Rehabilitation Research and Development Service Career Development Award-2 (Grant # B7496W), and by the Neurorehabilitation: Neurons to Networks TBI Center of Excellence (Grant # B6812C).	Andersen J, 2010, PSYCHOSOM MED, V72, P498, DOI 10.1097/PSY.0b013e3181d969a1; Asnaani A, 2014, J ANXIETY DISORD, V28, P310, DOI 10.1016/j.janxdis.2014.01.005; Beckham JC, 1997, J PSYCHOSOM RES, V43, P379, DOI 10.1016/S0022-3999(97)00129-3; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Brown FL, 2013, BRAIN INJURY, V27, P1570, DOI 10.3109/02699052.2013.841996; Bryant RA, 1999, J HEAD TRAUMA REHAB, V14, P588, DOI 10.1097/00001199-199912000-00007; Cerda M, 2013, DEPRESS ANXIETY, V30, P413, DOI 10.1002/da.22007; Chopra MP, 2014, AM J GERIAT PSYCHIAT, V22, P86, DOI 10.1016/j.jagp.2013.01.064; Cleeland CS, 1989, ADV PAIN RES THER, V12, P391, DOI DOI 10.1093/BRAIN/113.5.1589; Cleeland CS, 2009, BRIEF PAIN INVENTORY; Daggett VS, 2013, J REHABIL RES DEV, V50, P327, DOI 10.1682/JRRD.2011.09.0168; Dobie DJ, 2002, GEN HOSP PSYCHIAT, V24, P367, DOI 10.1016/S0163-8343(02)00207-4; Gill J, 2014, PSYCHIAT RES, V216, P116, DOI 10.1016/j.psychres.2014.01.046; Graham DP, 2013, J PSYCHIATR RES, V47, P835, DOI 10.1016/j.jpsychires.2013.02.006; Gubata ME, 2014, J HEAD TRAUMA REHAB, V29, P65, DOI 10.1097/HTR.0b013e318295f590; Gubata ME, 2012, TRISERVICE DISABILIT; Herman D., 1993, ANN CONV INT SOC TRA; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jensen MP, 2005, SPINAL CORD, V43, P704, DOI 10.1038/sj.sc.3101777; Karatzias T, 2013, J MENT HEALTH, V22, P501, DOI 10.3109/09638237.2013.819418; Kelsall HL, 2014, PAIN, V155, P685, DOI 10.1016/j.pain.2013.12.025; Kennedy P, 2006, SPINAL CORD, V44, P95, DOI 10.1038/sj.sc.3101787; Khalili Narjes, 2013, Iran J Nurs Midwifery Res, V18, P105; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kratz AL, 2013, REHABIL PSYCHOL, V58, P1, DOI 10.1037/a0031727; Kukihara H, 2014, PSYCHIAT CLIN NEUROS, V68, P524, DOI 10.1111/pcn.12159; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Lang AJ, 2003, J TRAUMA STRESS, V16, P257, DOI 10.1023/A:1023796007788; Leibach GG, 2014, NEUROREHABILITATION, V34, P167, DOI 10.3233/NRE-131013; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Putzke JD, 2002, PAIN, V100, P231, DOI 10.1016/S0304-3959(02)00069-6; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Resnik L, 2011, J REHABIL RES DEV, V48, P89, DOI 10.1682/JRRD.2010.04.0070; Resnik L, 2009, J REHABIL RES DEV, V46, P469, DOI 10.1682/JRRD.2008.07.0082; Resnik LJ, 2007, J REHABIL RES DEV, V44, P991, DOI 10.1682/JRRD.2007.05.0071; Roberts RE, 1983, AM J PSYCHIAT, V140, P1; Saberi HR, 2013, INT J OCCUP ENV MED, V4, P185; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sullivan-Singh SJ, 2014, ARCH PHYS MED REHAB, V95, P1100, DOI 10.1016/j.apmr.2014.02.001; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Vardy J, 2014, J CLIN ONCOL, V32, P1677, DOI 10.1200/JCO.2013.52.8356; Walker EA, 2002, GEN HOSP PSYCHIAT, V24, P375, DOI 10.1016/S0163-8343(02)00203-7; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Willer B, 1993, J HEAD TRAUMA REHAB, V3, P75, DOI DOI 10.1097/00001199-199308020-00009	49	12	12	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2016	31	1					E1	E12		10.1097/HTR.0000000000000152			12	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DK9CN	WOS:000375228000001	26098259				2021-06-18	
J	Yan, H; Feng, YQ; Wang, Q				Yan, Hao; Feng, Yanqin; Wang, Qian			Altered Effective Connectivity of Hippocampus-Dependent Episodic Memory Network in mTBI Survivors	NEURAL PLASTICITY			English	Article							TRAUMATIC BRAIN-INJURY; MEDIAL TEMPORAL-LOBE; DEFAULT MODE NETWORK; COGNITIVE NEUROSCIENCE; ATROPHY; BINDING; FUTURE; INFORMATION; RECOGNITION; RETRIEVAL	Traumatic brain injuries (TBIs) are generally recognized to affect episodic memory. However, less is known regarding how external force altered the way functionally connected brain structures of the episodic memory system interact. To address this issue, we adopted an effective connectivity based analysis, namely, multivariate Granger causality approach, to explore causal interactions within the brain network of interest. Results presented that TBI induced increased bilateral and decreased ipsilateral effective connectivity in the episodic memory network in comparison with that of normal controls. Moreover, the left anterior superior temporal gyrus (aSTG, the concept forming hub), left hippocampus (the personal experience binding hub), and left parahippocampal gyrus (the contextual association hub) were no longer network hubs in TBI survivors, who compensated for hippocampal deficits by relying more on the right hippocampus (underlying perceptual memory) and the right medial frontal gyrus (MeFG) in the anterior prefrontal cortex (PFC). We postulated that the overrecruitment of the right anterior PFC caused dysfunction of the strategic component of episodic memory, which caused deteriorating episodic memory in mTBI survivors. Our findings also suggested that the pattern of brain network changes in TBI survivors presented similar functional consequences to normal aging.	[Yan, Hao] Shenzhen Univ, Sch Biomed Engn, Neuroimaging Lab, Hlth Sci Ctr, Shenzhen 518060, Peoples R China; [Yan, Hao] Shenzhen Univ, Coll Optoelect Engn, Minist Educ & Guangdong Prov, Key Lab Optoelect Devices & Syst, Shenzhen 518060, Peoples R China; [Yan, Hao; Feng, Yanqin] Xidian Univ, Dept Linguist, Xian 710071, Peoples R China; [Yan, Hao; Feng, Yanqin] Xidian Univ, Dept Psychol, Xian 710071, Peoples R China; [Wang, Qian] Northwestern Polytech Univ, Sch Foreign Languages, Xian 710029, Peoples R China	Yan, H (corresponding author), Shenzhen Univ, Sch Biomed Engn, Neuroimaging Lab, Hlth Sci Ctr, Shenzhen 518060, Peoples R China.; Yan, H (corresponding author), Shenzhen Univ, Coll Optoelect Engn, Minist Educ & Guangdong Prov, Key Lab Optoelect Devices & Syst, Shenzhen 518060, Peoples R China.; Yan, H (corresponding author), Xidian Univ, Dept Linguist, Xian 710071, Peoples R China.; Yan, H (corresponding author), Xidian Univ, Dept Psychol, Xian 710071, Peoples R China.	yanhao@xidian.edu.cn		Yan, Hao/0000-0002-1854-786X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31400962, 81371201, 31371026]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2015M582400]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [RW150401]	This paper is supported by the National Natural Science Foundation of China (31400962, 81371201, and 31371026), China Postdoctoral Science Foundation (2015M582400), and the Fundamental Research Funds for the Central Universities (RW150401).	Aminoff EM, 2013, TRENDS COGN SCI, V17, P379, DOI 10.1016/j.tics.2013.06.009; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Behrendt RP, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00304; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Carlomagno S, 2011, BRAIN INJURY, V25, P1010, DOI 10.3109/02699052.2011.605097; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen G., 2009, P INT SOC MAGN RESON, V17, P1718; Corrigan JD, 2001, CLIN J WOMENS HLTH, V1, P184; Coste C, 2015, NEUROPSYCHOLOGIA, V71, P133, DOI 10.1016/j.neuropsychologia.2015.03.014; Demirci O, 2009, NEUROIMAGE, V46, P419, DOI 10.1016/j.neuroimage.2009.02.014; Deshpande G, 2010, NEUROIMAGE, V52, P884, DOI 10.1016/j.neuroimage.2009.11.060; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Dischinger P, 2003, Annu Proc Assoc Adv Automot Med, V47, P577; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eustache F, 2016, NEUROPSYCHOLOGIA, V87, P96, DOI 10.1016/j.neuropsychologia.2016.05.006; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Friston KJ, 2009, PLOS BIOL, V7, P220, DOI 10.1371/journal.pbio.1000033; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Gilboa A, 2006, BRAIN, V129, P1399, DOI 10.1093/brain/awl093; Gottlieb LJ, 2012, LEARN MEMORY, V19, P605, DOI 10.1101/lm.027631.112; Grady C, 2012, NAT REV NEUROSCI, V13, P491, DOI 10.1038/nrn3256; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gutchess AH, 2005, J COGNITIVE NEUROSCI, V17, P84, DOI 10.1162/0898929052880048; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kessels RPC, 2007, INT J NEUROSCI, V117, P795, DOI 10.1080/00207450600910218; Knight RG, 2009, J CLIN EXP NEUROPSYC, V31, P575, DOI 10.1080/13803390802363710; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Lekeu F, 2002, NEUROPSYCHOLOGIA, V40, P131, DOI 10.1016/S0028-3932(01)00088-4; Leshikar ED, 2010, CORTEX, V46, P507, DOI 10.1016/j.cortex.2009.07.011; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Liao W, 2011, NEUROIMAGE, V54, P2683, DOI 10.1016/j.neuroimage.2010.11.007; Liu ZY, 2012, NMR BIOMED, V25, P1311, DOI 10.1002/nbm.2803; Maguire EA, 2013, J EXP PSYCHOL GEN, V142, P1180, DOI 10.1037/a0033650; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; Morgan VL, 2011, EPILEPSIA, V52, P1741, DOI 10.1111/j.1528-1167.2011.03196.x; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; OSHAUGHNESSY EJ, 1984, J FAM PRACTICE, V18, P391; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Piolino P, 2007, CORTEX, V43, P176, DOI 10.1016/S0010-9452(08)70474-X; Race E, 2011, J NEUROSCI, V31, P10262, DOI 10.1523/JNEUROSCI.1145-11.2011; Ralph M. A. Lambon, 2014, PHILOS T R SOC B, V369; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Rogers TT, 2004, PSYCHOL REV, V111, P205, DOI 10.1037/0033-295X.111.1.205; Rosenbaum RS, 2014, ANN NY ACAD SCI, V1316, P105, DOI 10.1111/nyas.12467; Rubin DC, 2015, PSYCHOL REV, V122, P1, DOI 10.1037/a0037907; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Shapira-Lichter I, 2013, P NATL ACAD SCI USA, V110, P4950, DOI 10.1073/pnas.1209888110; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sporns O, 2014, NAT NEUROSCI, V17, P652, DOI 10.1038/nn.3690; Squire LR, 2010, P NATL ACAD SCI USA, V107, P19044, DOI 10.1073/pnas.1014391107; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; St-Laurent M, 2016, CORTEX, V84, P15, DOI 10.1016/j.cortex.2016.08.010; Stevens MC, 2009, HUM BRAIN MAPP, V30, P2356, DOI 10.1002/hbm.20673; Stilla R, 2007, J NEUROSCI, V27, P11091, DOI 10.1523/JNEUROSCI.1808-07.2007; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Talati A, 2005, J COGNITIVE NEUROSCI, V17, P981, DOI 10.1162/0898929054475226; Tromp D, 2015, AGEING RES REV, V24, P232, DOI 10.1016/j.arr.2015.08.006; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; TULVING E, 1988, BRAIN COGNITION, V8, P3, DOI 10.1016/0278-2626(88)90035-8; Tulving E, 2001, PHILOS T R SOC B, V356, P1505, DOI 10.1098/rstb.2001.0937; Tulving E, 1983, ELEMENTS EPISODIC ME; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Winocur G, 2010, NEUROPSYCHOLOGIA, V48, P2339, DOI 10.1016/j.neuropsychologia.2010.04.016; Yonelinas AP, 2013, BEHAV BRAIN RES, V254, P34, DOI 10.1016/j.bbr.2013.05.030	84	12	12	0	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-5904	1687-5443		NEURAL PLAST	Neural. Plast.		2016	2016								6353845	10.1155/2016/6353845			12	Neurosciences	Neurosciences & Neurology	EF9VY	WOS:000390680300001	28074162	DOAJ Gold, Green Published			2021-06-18	
J	Zhou, HX; Liu, ZG; Liu, XJ; Chen, QX				Zhou, Hai-xiao; Liu, Zhi-gang; Liu, Xiao-jiao; Chen, Qian-xue			Umbilical cord-derived mesenchymal stem cell transplantation combined with hyperbaric oxygen treatment for repair of traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; traumatic brain injury; umbilical cord mesenchymal stem cells; transplantation; hyperbaric oxygen; rats; craniocerebral trauma; neurological function; neural regeneration	CEREBRAL PERFUSION-PRESSURE; DIFFERENTIATION	Transplantation of umbilical cord-derived mesenchymal stem cells (UC-MSCs) for repair of traumatic brain injury has been used in the clinic. Hyperbaric oxygen (HBO) treatment has long been widely used as an adjunctive therapy for treating traumatic brain injury. UC-MSC transplantation combined with HBO treatment is expected to yield better therapeutic effects on traumatic brain injury. In this study, we established rat models of severe traumatic brain injury by pressurized fluid (2.5-3.0 atm impact force). The injured rats were then administered UC-MSC transplantation via the tail vein in combination with HBO treatment. Compared with monotherapy, aquaporin 4 expression decreased in the injured rat brain, but growth-associated protein-43 expression, calaxon-like structures, and CM-Dil-positive cell number increased. Following combination therapy, however, rat cognitive and neurological function significantly improved. UC-MSC transplantation combined with HBO therapyfor repair of traumatic brain injury shows better therapeutic effects than monotherapy and significantly promotes recovery of neurological functions.	[Zhou, Hai-xiao] Wuhan Univ, Dept Plast Surg, Renmin Hosp, Wuhan 430072, Hubei Province, Peoples R China; [Liu, Zhi-gang] Wuhan Univ, Dept Anesthesiol, Renmin Hosp, Wuhan 430072, Hubei Province, Peoples R China; [Liu, Xiao-jiao; Chen, Qian-xue] Wuhan Univ, Dept Neurosurg, Renmin Hosp, Wuhan 430072, Hubei Province, Peoples R China	Zhou, HX (corresponding author), Wuhan Univ, Dept Plast Surg, Renmin Hosp, Wuhan 430072, Hubei Province, Peoples R China.	zhxiaoo@163.com					Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Chang DJ, 2011, BIOORG MED CHEM LETT, V21, P7050, DOI 10.1016/j.bmcl.2011.09.099; Chuang Sung-Kiang, 2011, J Evid Based Dent Pract, V11, P129, DOI 10.1016/j.jebdp.2011.06.008; Fuentes-Raspall R, 2012, CLIN ONCOL-UK, V24, pE126, DOI 10.1016/j.clon.2012.03.014; Guo BF, 2009, OTOLARYNG HEAD NECK, V140, P159, DOI 10.1016/j.otohns.2008.10.039; Guo JJ, 2013, STEM CELL RES, V11, P874, DOI 10.1016/j.scr.2013.05.004; Jasaitis A, 2012, CHEM PHYS, V396, P10, DOI 10.1016/j.chemphys.2011.04.003; Kunke D, 2009, BIOCHEM BIOPH RES CO, V386, P628, DOI 10.1016/j.bbrc.2009.06.084; Li L, 2011, BEHAV BRAIN RES, V217, P244, DOI 10.1016/j.bbr.2010.10.032; Lin SS, 2011, BONE, V48, pS143, DOI 10.1016/j.bone.2011.03.300; Qian J, 2013, INT J DEV NEUROSCI, V31, P280; Rocha FS, 2015, OR SURG OR MED OR PA, V120, P581, DOI 10.1016/j.oooo.2015.06.039; Tong L, 2010, BIOCHEM BIOPH RES CO, V401, P592, DOI 10.1016/j.bbrc.2010.09.107; Wang QH, 2000, CHUANGSHANG WAIKE ZA, V2, P42; Xiong Z, 2014, STEM CELL RES, V12, P387, DOI 10.1016/j.scr.2013.11.003; Yang YJ, 2008, UNDERSEA HYPERBAR M, V35, P113; Yu M, 2014, J NUTR BIOCHEM, V25, P227, DOI 10.1016/j.jnutbio.2013.10.011	19	12	15	0	7	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JAN	2016	11	1					107	113		10.4103/1673-5374.175054			7	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	DD7ZF	WOS:000370142800031	26981097	DOAJ Gold, Green Published			2021-06-18	
J	Hwang, BW; Kim, SJ; Park, KM; Kim, H; Yeom, J; Yang, JA; Jeong, H; Jung, H; Kim, K; Sung, YC; Hahn, SK				Hwang, Byung Woo; Kim, Su Jin; Park, Kyeng Min; Kim, Hyemin; Yeom, Junseok; Yang, Jeong-A; Jeong, Hyeonseon; Jung, Hyuntae; Kim, Kimoon; Sung, Young Chul; Hahn, Sei Kwang			Genetically engineered mesenchymal stem cell therapy using self-assembling supramolecular hydrogels	JOURNAL OF CONTROLLED RELEASE			English	Article						Hydrogel; Stem cell; Transgene expression; Cell therapy; Tissue regeneration	UMBILICAL-CORD BLOOD; HUMAN BONE-MARROW; BASEMENT-MEMBRANE MATRIX; TRAUMATIC BRAIN-INJURY; GENE-THERAPY; IN-VITRO; GROWTH-FACTOR; ADIPOSE-TISSUE; STROMAL CELLS; MYOCARDIAL-INFARCTION	Stem cell therapy has attracted a great deal of attention for treating intractable diseases such as cancer, stroke, liver cirrhosis, and ischemia. Especially, mesenchymal stemcells (MSCs) have been widely investigated for therapeutic applications due to the advantageous characteristics of long life-span, facile isolation, rapid proliferation, prolonged transgene expression, hypo-immunogenicity, and tumor tropism. MSCs can exert their therapeutic effects by releasing stress-induced therapeutic molecules after their rapid migration to damaged tissues. Recently, to improve the therapeutic efficacy, genetically engineered MSCs have been developed for therapeutic transgene expression by viral gene transduction and non-viral gene transfection. In general, the number of therapeutic cells for injection should be more than several millions for effective cell therapy. Adequate carriers for the controlled delivery of MSCs can reduce the required cell numbers and extend the duration of therapeutic effect, which provide great benefits for chronic disease patients. In this review, we describe genetic engineering of MSCs, recent progress of self-assembling supramolecular hydrogels, and their applications to cell therapy for intractable diseases and tissue regeneration. (C) 2015 Elsevier B.V. All rights reserved.	[Hwang, Byung Woo; Kim, Hyemin; Yeom, Junseok; Yang, Jeong-A; Jeong, Hyeonseon; Hahn, Sei Kwang] Dept Mat Sci & Engn, Pohang 790784, Gyeongbuk, South Korea; [Kim, Su Jin; Sung, Young Chul] Dept Life Sci, Pohang 790784, Gyeongbuk, South Korea; [Park, Kyeng Min; Kim, Kimoon] Inst for Basic Sci Korea, Dept Chem, Div Adv Mat Sci, Ctr Self Assembly & Complex, Pohang 790784, Gyeongbuk, South Korea; [Jung, Hyuntae; Kim, Kimoon; Sung, Young Chul; Hahn, Sei Kwang] Pohang Univ Sci & Technol POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, Gyeongbuk, South Korea; [Park, Kyeng Min] UST, Dept Nanomat Sci & Engn, Daejeon 305333, South Korea	Kim, K (corresponding author), Inst for Basic Sci Korea, Dept Chem, Div Adv Mat Sci, Ctr Self Assembly & Complex, 77 Cheongam Ro, Pohang 790784, Gyeongbuk, South Korea.	kkim@postech.ac.kr; ycsung@postech.ac.kr; skhanb@postech.ac.kr	Kim, Kimoon/B-7181-2008; Park, Kyeng Min/U-1370-2017; Park, Kyeng Min/I-5815-2019; Hahn, Sei Kwang/L-6037-2019; Kim, Hyemin/AAP-1700-2020; Kim, Hyemin/I-1547-2018	Park, Kyeng Min/0000-0001-6089-6169; Park, Kyeng Min/0000-0001-6089-6169; Kim, Hyemin/0000-0001-8534-3886; Yeom, Junseok/0000-0003-3556-2911; Hahn, Sei Kwang/0000-0002-7718-6259	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI14C1658]; Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean Government (MEST) [2012M3A9C6049791]; Institute for Basic Science [IBS-R007-D1]	This research was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI14C1658) and the Bio & Medical Technology Development Program (No. 2012M3A9C6049791) of the National Research Foundation (NRF) funded by the Korean Government (MEST). This work was supported by Institute for Basic Science [IBS-R007-D1].	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Ahmed TAE, 2008, TISSUE ENG PART B-RE, V14, P199, DOI 10.1089/ten.teb.2007.0435; Akiyama K, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt131; Ankrum J, 2010, TRENDS MOL MED, V16, P203, DOI 10.1016/j.molmed.2010.02.005; [Anonymous], 2012, NAT BIOTECHNOL, V30, P805, DOI 10.1038/nbt.2363; Appel EA, 2014, ANGEW CHEM INT EDIT, V53, P10038, DOI 10.1002/anie.201403192; Appel EA, 2010, J AM CHEM SOC, V132, P14251, DOI 10.1021/ja106362w; Aquino JB, 2010, GENE THER, V17, P692, DOI 10.1038/gt.2010.10; Ayhan MM, 2015, J AM CHEM SOC, V137, P10238, DOI 10.1021/jacs.5b04553; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Beggs KJ, 2006, CELL TRANSPLANT, V15, P711, DOI 10.3727/000000006783981503; Benoit DSW, 2007, BIOMATERIALS, V28, P66, DOI 10.1016/j.biomaterials.2006.08.033; Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Blow N, 2009, NAT METHODS, V6, P619, DOI 10.1038/nmeth0809-619; Bouard D, 2009, BRIT J PHARMACOL, V157, P153, DOI 10.1038/bjp.2008.349; Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963; Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen Q, 2009, BIOCHEM BIOPH RES CO, V381, P192, DOI 10.1016/j.bbrc.2009.02.040; Cheng XJ, 2013, ANGEW CHEM INT EDIT, V52, P7252, DOI 10.1002/anie.201210267; Connors KA, 1997, CHEM REV, V97, P1325, DOI 10.1021/cr960371r; Corsten MF, 2008, LANCET ONCOL, V9, P376, DOI 10.1016/S1470-2045(08)70099-8; Day A, 2001, J ORG CHEM, V66, P8094, DOI 10.1021/jo015897c; Devine SM, 2002, J CELL BIOCHEM, P73, DOI 10.1002/jcb.10046; Elzaouk L, 2006, EXP DERMATOL, V15, P865, DOI 10.1111/j.1600-0625.2006.00479.x; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Foo CTSWP, 2009, P NATL ACAD SCI USA, V106, P22067, DOI 10.1073/pnas.0904851106; Gomes CMF, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt189; Fridman R, 2012, NAT PROTOC, V7, P1138, DOI 10.1038/nprot.2012.053; Gafni Y, 2004, MOL THER, V9, P587, DOI 10.1016/j.ymthe.2003.12.009; Gage FH, 1998, NATURE, V392, P18; Gao ZB, 2013, NANOMED-NANOTECHNOL, V9, P174, DOI 10.1016/j.nano.2012.06.003; Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119; Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959; Griffin MD, 2010, HUM GENE THER, V21, P1641, DOI 10.1089/hum.2010.156; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Ha SJ, 2002, NAT BIOTECHNOL, V20, P381, DOI 10.1038/nbt0402-381; HARADA A, 1992, NATURE, V356, P325, DOI 10.1038/356325a0; Hirst AR, 2008, ANGEW CHEM INT EDIT, V47, P8002, DOI 10.1002/anie.200800022; HOMMINGA GN, 1993, ACTA ORTHOP SCAND, V64, P441, DOI 10.3109/17453679308993663; Hosseinkhani H, 2006, J BIOACT COMPAT POL, V21, P277, DOI 10.1177/0883911506066934; Hou L, 2011, CARBOHYD POLYM, V86, P1157, DOI 10.1016/j.carbpol.2011.06.008; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/nmat2732, 10.1038/NMAT2732]; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106; Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327; Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8; Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157; Jung H, 2014, BIOMACROMOLECULES, V15, P707, DOI 10.1021/bm401123m; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kedziorek DA, 2012, STEM CELLS, V30, P1286, DOI 10.1002/stem.1096; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kim J, 2000, J AM CHEM SOC, V122, P540, DOI 10.1021/ja993376p; Kim K, 2004, CHEM COMMUN, P848, DOI 10.1039/b400783b; Kim SW, 2013, CLIN CANCER RES, V19, P415, DOI 10.1158/1078-0432.CCR-12-1568; Kim SM, 2008, CANCER RES, V68, P9614, DOI 10.1158/0008-5472.CAN-08-0451; Kim Y, 2009, CHEM-EUR J, V15, P6143, DOI 10.1002/chem.200900305; Kimura Y, 2002, TISSUE ENG, V8, P603, DOI 10.1089/107632702760240526; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Ko YH, 2004, J AM CHEM SOC, V126, P1932, DOI 10.1021/ja031567t; Kraehenbuehl TP, 2011, NAT METHODS, V8, P731, DOI 10.1038/nmeth.1671; Kraitchman DL, 2005, CIRCULATION, V112, P1451, DOI 10.1161/CIRCULATIONAHA.105.537480; Kretschmann O, 2006, ANGEW CHEM INT EDIT, V45, P4361, DOI 10.1002/anie.200504539; Kumar S, 2008, GENE THER, V15, P711, DOI 10.1038/gt.2008.35; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Lee JW, 2003, ACCOUNTS CHEM RES, V36, P621, DOI 10.1021/ar020254k; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; Li L, 2011, J CELL PHYSIOL, V226, P1860, DOI 10.1002/jcp.22511; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Lim SH, 2009, ADV DRUG DELIVER REV, V61, P1084, DOI 10.1016/j.addr.2009.07.011; Liu SM, 2005, J AM CHEM SOC, V127, P16798, DOI 10.1021/ja056287n; Locatelli F, 2009, CELL MOL LIFE SCI, V66, P757, DOI 10.1007/s00018-008-8346-1; Loebinger MR, 2010, THORAX, V65, P362, DOI 10.1136/thx.2009.128025; Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Madeira C, 2015, TRENDS BIOTECHNOL, V33, P35, DOI 10.1016/j.tibtech.2014.11.003; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Masson E, 2012, RSC ADV, V2, P1213, DOI 10.1039/c1ra00768h; Mishra A, 2011, NANO TODAY, V6, P232, DOI 10.1016/j.nantod.2011.05.001; Mol A, 2005, BIOMATERIALS, V26, P3113, DOI 10.1016/j.biomaterials.2004.08.007; Moon HH, 2014, BIOMATERIALS, V35, P1744, DOI 10.1016/j.biomaterials.2013.11.019; Moutsatsos IK, 2001, MOL THER, V3, P449, DOI 10.1006/mthe.2001.0291; Nafea EH, 2011, J CONTROL RELEASE, V154, P110, DOI 10.1016/j.jconrel.2011.04.022; Nakahata M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1521; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100; Nowakowski A, 2013, ACTA NEUROBIOL EXP, V73, P1; Oh HJ, 2012, CELL PROLIFERAT, V45, P438, DOI 10.1111/j.1365-2184.2012.00838.x; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Parisi-Amon A, 2013, ADV HEALTHC MATER, V2, P428, DOI 10.1002/adhm.201200293; Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030; Park H, 2010, TISSUE ENG PT A, V16, P535, DOI [10.1089/ten.tea.2009.0029, 10.1089/ten.TEA.2009.0029]; Park KM, 2012, ACS NANO, V6, P2960, DOI 10.1021/nn204123p; Peterson B, 2005, TISSUE ENG, V11, P120, DOI 10.1089/ten.2005.11.120; Philip D, 2005, STEM CELLS, V23, P288, DOI 10.1634/stemcells.2002-0109; Rauwald U, 2010, J PHYS CHEM B, V114, P8606, DOI 10.1021/jp102933h; Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009; Rekharsky MV, 1998, CHEM REV, V98, P1875, DOI 10.1021/cr970015o; Rodrigues M, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt32; Rodrigues M, 2013, STEM CELLS, V31, P104, DOI 10.1002/stem.1215; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009; Rubin H, 2002, NAT BIOTECHNOL, V20, P675, DOI 10.1038/nbt0702-675; Salem AK, 2003, ADV MATER, V15, P210, DOI 10.1002/adma.200390047; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769; Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shah K, 2012, ADV DRUG DELIVER REV, V64, P739, DOI 10.1016/j.addr.2011.06.010; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Studeny M, 2002, CANCER RES, V62, P3603; Sun B, 2010, CANCER LETT, V296, P178, DOI 10.1016/j.canlet.2010.04.007; Sun Xu-Yong, 2011, World J Stem Cells, V3, P96, DOI 10.4252/wjsc.v3.i11.96; Sung JH, 2008, TRANSPL P, V40, P2649, DOI 10.1016/j.transproceed.2008.08.009; Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c; Tabata Y, 2003, TISSUE ENG, V9, pS5, DOI 10.1089/10763270360696941; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Tomanin R, 2004, CURR GENE THER, V4, P357; Tondreau T., MESENCHYMAL STEM CEL, P1105; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]; Tseng TC, 2014, BIOMATERIALS, V35, P2630, DOI 10.1016/j.biomaterials.2013.12.021; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Uchibori R, 2009, J GENE MED, V11, P373, DOI 10.1002/jgm.1313; Vanderbyl S, 2004, STEM CELLS, V22, P324, DOI 10.1634/stemcells.22-3-324; Wang T, 2009, ACTA BIOMATER, V5, P2939, DOI 10.1016/j.actbio.2009.04.040; Wang Z, 2015, STEM CELLS, V33, P456, DOI 10.1002/stem.1878; WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722; Wei X, 2013, ACTA PHARMACOL SIN, V34, P747, DOI 10.1038/aps.2013.50; Wenz G, 2006, CHEM REV, V106, P782, DOI 10.1021/cr970027+; Wong T, 2008, J INVEST DERMATOL, V128, P2179, DOI 10.1038/jid.2008.78; Wu DQ, 2008, LANGMUIR, V24, P10306, DOI 10.1021/la8006876; Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037; Yeom J, 2015, ADV HEALTHC MATER, V4, P237, DOI 10.1002/adhm.201400304; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Yu Y, 2007, MOL THER, V15, P1382, DOI 10.1038/sj.mt.6300202; Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014	150	12	13	2	80	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-3659	1873-4995		J CONTROL RELEASE	J. Control. Release	DEC 28	2015	220		A				119	129		10.1016/j.jconrel.2015.10.034			11	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	CY0TN	WOS:000366119100014	26485045				2021-06-18	
J	Ruiz, JRL; Carrasco, LPO; Valenzuela, CLL; Rodriguez, NEF; Valdovinos, BDLT; Estrada, IJ; Jimenez, JMD; Jimenez, SHD				Lopez Ruiz, J. R.; Osuna Carrasco, L. P.; Lopez Valenzuela, C. L.; Franco Rodriguez, N. E.; De La Torre Valdovinos, B.; Jimenez Estrada, I.; Duenas Jimenez, J. M.; Duenas Jimenez, S. H.			THE HIPPOCAMPUS PARTICIPATES IN THE CONTROL OF LOCOMOTION SPEED	NEUROSCIENCE			English	Article						hippocampus; traumatic brain injury; locomotion; tamoxifen; neuroprotection	SPINAL-CORD-INJURY; ESTROGEN-RECEPTOR MODULATORS; SENSORIMOTOR INTEGRATION; BRAIN-INJURY; HYPOTHALAMIC STIMULATION; THETA ACTIVITY; IN-VITRO; RAT; TAMOXIFEN; NEURONS	The hippocampus role in sensory-motor integration remains unclear. In these experiments we study its function in the locomotor control. To establish the connection between the hippocampus and the locomotor system, electrical stimulation in the CA1 region was applied and EMG recordings were obtained. We also evaluated the hindlimbs and forelimbs kinematic patterns in rats with a penetrating injury (PI) in the hippocampus as well as in a cortex-injured group (CI), which served as control. After the PI, tamoxifen a selective estrogen receptor modulator (SERM) that has been described as a neuroprotector and antiinflammatory drug, or vehicle was administered. Electrical stimulation in the hippocampus produces muscle contractions in the contralateral triceps, when 6 Hz or 8 Hz pulse trains were applied. The penetrating injury in the hippocampus reduced the EMG amplitude after the electrical stimulation. At 7DPI (days post-injury) we observed an increase in the strides speed in all four limbs of the non-treated group, decreasing the correlation percentage of the studied joints. After 15DPI the strides speed in the non-treated returned to normal. These changes did not occur in the tamoxifen group nor in cortex-injured group. After 30 days, the nontreated group presented a reduction in the number of pyramidal cell layer neurons at the injury site, in comparison to the tam-treated group. The loss of neurons, may cause the interruption of the trisynaptic circuit and changes in the locomotion speed. Tamoxifen preserves the pyramidal neurons after the injury, probably resulting in the strides speed recovery. (C) 2015 IBRO. Published by Elsevier Ltd. All rights reserved.	[Lopez Ruiz, J. R.; Osuna Carrasco, L. P.; Lopez Valenzuela, C. L.; Franco Rodriguez, N. E.; De La Torre Valdovinos, B.; Duenas Jimenez, S. H.] Univ Guadalajara, Dept Neurosci, Ctr Univ Ciencias Salud, Guadalajara 44340, Jalisco, Mexico; [Duenas Jimenez, J. M.] Univ Guadalajara, Dept Physiol, Ctr Univ Ciencias Salud, Guadalajara 44340, Jalisco, Mexico; [Jimenez Estrada, I.] IPN, CINVESTAV, Dept Physiol Biophys & Neurosci, Mexico City 07360, DF, Mexico	Jimenez, SHD (corresponding author), Univ Guadalajara, Dept Neurosci, Ctr Univ Ciencias Salud, Sierra Mojada 950,Col Independencia, Guadalajara 44340, Jalisco, Mexico.	ingb0b@hotmail.com; laupaucarrasco@hotmail.com; lucii.a@live.com.mx; lizzafranco@gmail.com; brandalff@gmail.com; ijimenez@fisio.cinvestav.mx; mduenas@cucs.udg.mx; sduenas@cucs.udg.mx	Franco Rodriguez, Nancy Elizabeth/B-5879-2014; Osuna Carrasco, Laura Paulina/H-1400-2017	Franco Rodriguez, Nancy Elizabeth/0000-0001-9195-8289; Lopez Ruiz, Jose Roberto/0000-0001-5305-9223; Osuna Carrasco, Laura Paulina/0000-0002-2230-1088			Arevalo MA, 2011, J NEUROENDOCRINOL; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; BLAND BH, 1972, BRAIN RES, V43, P67, DOI 10.1016/0006-8993(72)90275-2; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; Bland BH, 2009, INFORMATION PROCESSING BY NEURONAL POPULATIONS, P283; Cerciat M, 2010, GLIA, V58, P93, DOI 10.1002/glia.20904; Colom LV, 2005, SYNAPSE, V58, P151, DOI 10.1002/syn.20184; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; Dubal DB, 1999, J NEUROSCI, V19, P6385; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.041483198; Dypvik AT, 2004, J NEUROPHYSIOL, V92, P2040, DOI 10.1152/jn.01081.2003; Rodriguez NEF, 2013, BRAIN RES BULL, V98, P64, DOI 10.1016/j.brainresbull.2013.07.007; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; FROTSCHER M, 1985, J COMP NEUROL, V239, P237, DOI 10.1002/cne.902390210; Fuhrmann F, 2015, NEURON; Guptarak J, 2014, J NEUROTRAUM, V31, P268, DOI 10.1089/neu.2013.3108; Hallworth NE, 2004, EXP NEUROL, V188, P430, DOI 10.1016/j.expneurol.2004.04.014; Hines DJ, 2009, GLIA, V57, P1610, DOI 10.1002/glia.20874; Lee Rodgers J, 1988, AM STAT, V42, P59, DOI DOI 10.1080/00031305.1988.10475524; Lu CB, 2010, NEUROSCIENCE, V166, P84, DOI 10.1016/j.neuroscience.2009.11.072; Mosquera L, 2014, BRAIN RES, V1561, P11, DOI 10.1016/j.brainres.2014.03.002; Murphy DD, 1996, J NEUROSCI, V16, P4059; Natsume K, 1999, HIPPOCAMPUS, V9, P500, DOI 10.1002/(SICI)1098-1063(1999)9:5<500::AID-HIPO3>3.3.CO;2-6; Oddie SD, 1996, J NEUROSCI, V16, P1948; ROBINSON TE, 1974, J COMP PHYSIOL PSYCH, V86, P768, DOI 10.1037/h0036397; Salgado IK, 2015, NEURAL REGEN RES, V10, P385, DOI 10.4103/1673-5374.153685; Shen A Y, 1995, Chin J Physiol, V38, P111; Sinnamon HM, 2000, BEHAV BRAIN RES, V107, P93, DOI 10.1016/S0166-4328(99)00112-6; Sinnamon HM, 2000, NEUROSCIENCE, V98, P459, DOI 10.1016/S0306-4522(00)00145-7; SLAWINSKA U, 1995, BRAIN RES, V678, P117, DOI 10.1016/0006-8993(95)00174-O; Tan AM, 2005, J ANAT, V207, P717, DOI 10.1111/j.1469-7580.2005.00452.x; Tian DS, 2009, J NEUROCHEM, V109, P1658, DOI 10.1111/j.1471-4159.2009.06077.x; Velazquez-Zamora DA, 2012, HORM BEHAV, V61, P512, DOI 10.1016/j.yhbeh.2012.01.010; VERTES RP, 1994, NEUROSCIENCE, V60, P441, DOI 10.1016/0306-4522(94)90255-0; Young CK, 2011, NEUROSCIENCE, V192, P452, DOI 10.1016/j.neuroscience.2011.06.039; Zhang HQ, 2009, BRAIN RES, V1247, P196, DOI 10.1016/j.brainres.2008.10.015	36	12	12	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	DEC 17	2015	311						207	215		10.1016/j.neuroscience.2015.10.034			9	Neurosciences	Neurosciences & Neurology	CY1CJ	WOS:000366144000019	26597762				2021-06-18	
J	Prasad, GL; Gupta, DK; Mahapatra, AK; Sharma, BS				Prasad, G. Lakshmi; Gupta, Deepak Kumar; Mahapatra, Ashok Kumar; Sharma, Bhawani Shankar			Surgical results of decompressive craniectomy in very young children: A level one trauma centre experience from India	BRAIN INJURY			English	Article						Decompressive craniectomy; intracranial hypertension; intracranial pressure monitoring; paediatric; traumatic; young children	REFRACTORY INTRACRANIAL HYPERTENSION; BRAIN-INJURY; PEDIATRIC-PATIENTS; SINGLE-CENTER; HEAD-INJURY; INTENSIVE-CARE; PRESSURE; COMPLICATIONS; MANAGEMENT; MULTICENTER	Introduction: Literature remains sparse regarding decompressive craniectomy (DC) in traumatic brain injury (TBI) in very young children. This study analysed the indications, complications and outcome of young children undergoing DC for TBI at our institute.Study design: Retrospective.Observations: The total number of patients was 71. Mean age was 1.6 years. Mean duration from injury to surgery was 11.9 hours (range=3-80 hours). Around 50% had severe head injury. Intracranial pressure (ICP) monitoring was done in 33 patients. Mean ICP was 22.2mm Hg (range=9-50mm Hg). The threshold ICP for surgery was 15mm Hg. Perioperative mortality was 50% each for severe TBI (18/36) and diffuse cerebral edema (7/14), and 58% for infants (4/7). Ninety per cent of expired patients had ICP>20mm Hg. Mean follow-up duration was 19.6 months (range=2-42 months). Except one, all survivors had good-to-excellent outcomes (Glasgow outcome scale extended; GOS-E=7-8).Conclusions: Decompressive craniectomy offers a survival advantage in almost 50% of young children with severe TBI and should be used judiciously. The highest mortality was within the 1st week of surgery. The cut-off limit of 20mm Hg for surgical decompression might not be applicable to young children and a low threshold ICP needs to be considered. Factors associated with increased mortality are high opening ICP (>20mm Hg), GCS <8, diffuse cerebral oedema and infant age group. Timing of DC remains crucial. Further prospective studies are necessary to optimize the timing and ICP limit for surgical decompression.	[Prasad, G. Lakshmi; Gupta, Deepak Kumar; Mahapatra, Ashok Kumar; Sharma, Bhawani Shankar] All India Inst Med Sci, Jai Prakash Narayan Apex Trauma Ctr, Dept Neurosurg, New Delhi 110029, India	Gupta, DK (corresponding author), All India Inst Med Sci, JPNATC, Dept Neurosurg, Room 306, New Delhi 110029, India.	drdeepakgupta@gmail.com		Prasad, G Lakshmi/0000-0002-9264-5943			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Adamo MA, 2009, J NEUROSURG-PEDIATR, V3, P334, DOI 10.3171/2008.12.PEDS08310; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Akins PT, 2008, NEUROCRIT CARE, V9, P269, DOI 10.1007/s12028-007-9033-z; Appelboom G, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11177; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; Berger S, 2002, J TRAUMA, V53, P558, DOI 10.1097/00005373-200209000-00027; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Csokay A, 2012, CHILD NERV SYST, V28, P441, DOI 10.1007/s00381-011-1661-0; Cushing H, 1908, ANN SURG, V47, P641, DOI 10.1097/00000658-190805000-00001; Duhaime AC, 1997, PEDIAT NEUROSURGICAL, P125; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Guresir E, 2012, NEUROSURGERY, V70, P881, DOI 10.1227/NEU.0b013e318237a6a6; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Khan SA, 2014, CHILD NERV SYST, V30, P277, DOI 10.1007/s00381-013-2225-2; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lane PL, 2000, CAN J SURG, V43, P442; Lindvall P, 2004, CLIN INFECT DIS, V38, P384, DOI 10.1086/380970; Marcoux KK, 2005, AACN ADV CRIT CARE, V16, P212, DOI 10.1097/00044067-200504000-00012; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; PFENNINGER J, 1983, INTENS CARE MED, V9, P13, DOI 10.1007/BF01693699; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; REBAUD P, 1988, INTENS CARE MED, V14, P522, DOI 10.1007/BF00263524; Rosin D, 2001, Int J Surg Investig, V2, P335; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Rutigliano D, 2006, J PEDIATR SURG, V41, P83, DOI 10.1016/j.jpedsurg.2005.10.010; Sahuquillo J, 2013, CURR OPIN CRIT CARE, V19, P101, DOI 10.1097/MCC.0b013e32835eba1a; Society of Critical Care Medicine, 2003, Crit Care Med, V31, pS407; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Valentin A, 2003, CRIT CARE MED, V31, P1539, DOI 10.1097/01.CCM.0000065270.53951.9E; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	46	12	12	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1717	1724		10.3109/02699052.2015.1075146			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800025	26399723				2021-06-18	
J	Esquenazi, A; Moon, D; Wikoff, A; Sale, P				Esquenazi, Alberto; Moon, Daniel; Wikoff, Amanda; Sale, Patricio			Hemiparetic gait and changes in functional performance due to OnabotulinumtoxinA injection to lower limb muscles	TOXICON			English	Article; Proceedings Paper	TOXINS 2015 Basic Science and Clinical Aspects of Botulinum and Other Neurotoxins	JAN 14-17, 2015	Lisbon, PORTUGAL	Intl Neurotoxin Assoc (INA)		Gait analysis; Hemiparesis; OnabotulinumtoxinA; Spasticity	BOTULINUM-TOXIN-A; TRAUMATIC BRAIN-INJURY; DOUBLE-BLIND; STROKE; SPASTICITY; LOCOMOTION; VELOCITY; ADULTS; FOOT; HIP	Objective: To review gait alterations and evaluate the effects of OnabotulinumtoxinA on spatiotemporal walking parameters of patients with hemiparetic gait. Design: Retrospective pre- and post-intervention analysis. Setting: Gait analysis laboratory in a tertiary level rehabilitation hospital. Participants: 42 patients with hemiparesis. 19 males and 23 females, age 18-78 years were included. Intervention: Spatiotemporal parameters collected before and within 4-10 weeks after OnabotA injection to the ankle muscles. Data was recorded at self-selected velocity on a 12 m instrumented walkway. The most common muscles injected were medial and lateral gastrocnemius, soleus and tibialis posterior. Average total OnabotulinumtoxinA dose was 320 +/- 107 units. Main outcome: Spatiotemporal parameters of walking assessed before (T-0) and within 4-10 weeks post injection (T-1). Paired t-test was used to compare pre- and post-intervention data. A sequential Holm-Bonferroni procedure was used to adjust for multiple comparisons and minimize the risk of type I error. Statistical significance was set at p < 0.05. Results: Statistically significant increases were seen for walking velocity (20%) (T-0 = 0.40 +/- 0.26 m/s and T-1 = 0.48 +/- 0.29 m/s; p = 0.006), and increased cadence (T-0 = 63.48 +/- 23.93 steps/min, and T-1 = 70.88 +/- 23.65 steps/min; p = 0.006) following OnabotulinumtoxinA injections. Conclusion: This study demonstrates that injection of OnabotulinumtoxinA 320 units to ankle muscles selected with the aid of dynamic electromyography can significantly increase gait velocity and enhance functional ambulation in adults with hemiparesis due to upper motor neuron syndrome. (C) 2015 Elsevier Ltd. All rights reserved.	[Esquenazi, Alberto] MossRehab Gait & Mot Anal Lab, Elkins Pk, PA 19027 USA; Dept PM&R MossRehab, Elkins Pk, PA USA	Esquenazi, A (corresponding author), MossRehab Gait & Mot Anal Lab, Elkins Pk, PA 19027 USA.	aesquena@einstein.edu	Sale, Patrizio/K-8757-2016	Sale, Patrizio/0000-0002-4850-3673			Barker S, 2006, MED ENG PHYS, V28, P460, DOI 10.1016/j.medengphy.2005.07.017; Beaman CB, 2010, GAIT POSTURE, V31, P311, DOI 10.1016/j.gaitpost.2009.11.011; Bohannon RW, 1989, CLIN REHABIL, V3, P47; BRANDSTATER ME, 1983, ARCH PHYS MED REHAB, V64, P583; Cioni M, 2006, AM J PHYS MED REHAB, V85, P600, DOI 10.1097/01.phm.0000223216.50068.bc; Den Otter AR, 2007, GAIT POSTURE, V25, P342, DOI 10.1016/j.gaitpost.2006.04.007; Dietz V, 2000, GAIT POSTURE, V11, P102, DOI 10.1016/S0966-6362(99)00052-1; Dietz V, 1997, ELECTROEN CLIN NEURO, V103, P333, DOI 10.1016/S0013-4694(97)00047-7; Duysens J, 1998, GAIT POSTURE, V7, P131, DOI 10.1016/S0966-6362(97)00042-8; Esquenazi A, 2004, Eura Medicophys, V40, P111; Esquenazi A., 2001, PHYS MED REHABILITAT, P93; Esquenazi A, 2012, AM J PHYS MED REHAB, V91, P729, DOI 10.1097/PHM.0b013e31824fa9ca; Fock J, 2004, BRAIN INJURY, V18, P57, DOI 10.1080/0269905031000149498; Hesse S, 1996, STROKE, V27, P455, DOI 10.1161/01.STR.27.3.455; Hsu AL, 2003, ARCH PHYS MED REHAB, V84, P1185, DOI 10.1016/S0003-9993(03)00030-3; Jonkers I, 2009, GAIT POSTURE, V29, P129, DOI 10.1016/j.gaitpost.2008.07.010; Kaji R, 2010, J NEUROL, V257, P1330, DOI 10.1007/s00415-010-5526-3; Lamontagne A, 2002, GAIT POSTURE, V15, P244, DOI 10.1016/S0966-6362(01)00190-4; Mancini F, 2005, NEUROL SCI, V26, P26, DOI 10.1007/s10072-005-0378-9; Mayer M, 2002, Bratisl Lek Listy, V103, P3; Mayer N. H., 2010, OPEN REHABILITATION, V3, P143; Mayer NH, 2001, ADV NEUROL, V87, P311; Nadeau S, 1999, AM J PHYS MED REHAB, V78, P123, DOI 10.1097/00002060-199903000-00007; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; ODwyer NJ, 1996, BRAIN, V119, P1737, DOI 10.1093/brain/119.5.1737; Pang MYC, 2000, J PHYSIOL-LONDON, V528, P389, DOI 10.1111/j.1469-7793.2000.00389.x; Pierson SH, 1996, ARCH PHYS MED REHAB, V77, P717, DOI 10.1016/S0003-9993(96)90015-5; Pittock SJ, 2003, CEREBROVASC DIS, V15, P289, DOI 10.1159/000069495; Richards C, 1996, GAIT POSTURE, V4, P12, DOI 10.1016/0966-6362(96)01063-6; SCHNEIDER RJ, 1977, J NEUROL NEUROSUR PS, V40, P417, DOI 10.1136/jnnp.40.5.417; Taylor D.R, 1980, P INT C REHABILITATI, P278; WALL JC, 1986, ARCH PHYS MED REHAB, V67, P550	32	12	13	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0041-0101			TOXICON	Toxicon	DEC 1	2015	107		A		SI		109	113		10.1016/j.toxicon.2015.08.004			5	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CY6SP	WOS:000366539400018	26272707				2021-06-18	
J	Milleville-Pennel, I; Charron, C				Milleville-Pennel, Isabelle; Charron, Camilo			Driving for Real or on a Fixed-Base Simulator: Is It so Different? An Explorative Study	PRESENCE-VIRTUAL AND AUGMENTED REALITY			English	Article							TRAUMATIC BRAIN-INJURY; ON-ROAD; VIRTUAL ENVIRONMENTS; WORKLOAD; DRIVERS; PERFORMANCE; CONCURRENT; BEHAVIOR	The use of driving simulators to assess driving abilities is often controversial because of their artificiality. Our aim is thus to tackle this question by estimating and comparing new indicators such as the mental workload, the psychological feeling (e.g., stress, anxiety, pleasure, and mastery), and feeling of presence when driving a simulator and a real vehicle (either one's own or one that belongs to a driving school). We are most interested in a particular sort of real-world driving: the driving school. This situation has two advantages: It matches our own particular interest in the evaluation of driving abilities and, to some extent, it is as artificial as driving in a simulator. Fourteen expert drivers participated in this study. Each driver was invited to complete two questionnaires (i.e., the NASA-TLX and Questionnaire of Psychological Feeling) that relate to the various driving conditions (i.e., simulator, driving school vehicle, and personal vehicle). The heart rate of drivers was also recorded at rest and during some of the driving conditions. Our results indicate that the feeling of presence was, for some of its component parts, identical in both the simulator and in a real car. Moreover, in both the simulator and real car, none of the assessments of presence revealed values that were close to 100%; indeed, sometimes they were considerably lower. This result leads us to believe that presence may often be underestimated in virtual environments because of the lack of an objective value of reference in the real world. Moreover, results obtained for mental workload and affective feeling indicate that a simulator can be a useful tool for the initial resumption of driving after a period off the road. In particular, a simulator can help to avoid the sort of stress that can lead to task failure or a deterioration in performance.	[Milleville-Pennel, Isabelle; Charron, Camilo] CNRS, IRCCyN, F-44321 Nantes 03, France; [Charron, Camilo] Univ Rennes 2, F-35043 Rennes, France	Milleville-Pennel, I (corresponding author), CNRS, IRCCyN, BP 92101, F-44321 Nantes 03, France.	isabelle.milleville-pennel@irccyn.ec-nantes.fr					Abdi H, 2013, WILEY INTERDISCIP RE, V5, P149, DOI 10.1002/wics.1246; Anderson S. W., 2005, P 3 INT DRIV S HUM F, P286; Bella F, 2008, ACCIDENT ANAL PREV, V40, P1078, DOI 10.1016/j.aap.2007.10.015; Bittner AC, 2002, TRANSPORT RES REC, P38; BLAAUW GJ, 1982, HUM FACTORS, V24, P473, DOI 10.1177/001872088202400408; Brookhuis KA, 2010, ACCIDENT ANAL PREV, V42, P898, DOI 10.1016/j.aap.2009.06.001; Cegarra J., 2009, COMM PRES CINQ ED C; Gerhard M., 2001, Intelligent Virtual Agents. Third International Workshop, IVA 2001. Proceedings (Lecture Notes in Artificial Intelligence Vol.2190), P137; Gopher D., 1986, HDB PERCEPTION HUMAN, V2, P41; HART S G, 1988, P139; Herve A, 2007, ENCY MEASUREMENT STA, P849; Heuer H, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00032; Jahn G, 2005, TRANSPORT RES F-TRAF, V8, P255, DOI 10.1016/j.trf.2005.04.009; Johnson MJ, 2011, INT J PSYCHOPHYSIOL, V81, P203, DOI 10.1016/j.ijpsycho.2011.06.012; Kaptein N. A., 1996, TRANSPORT RES REC, V1550, P30; Lechner D., 1997, C SIA LYON AVR; Lecuyer A, 2009, PRESENCE-TELEOP VIRT, V18, P39, DOI 10.1162/pres.18.1.39; Lew HL, 2005, BRAIN INJURY, V19, P177, DOI 10.1080/02699050400017171; Matthews R, 2003, ACCIDENT ANAL PREV, V35, P451, DOI 10.1016/S0001-4575(02)00023-4; Mayhew DR, 2011, J SAFETY RES, V42, P267, DOI 10.1016/j.jsr.2011.06.004; Meehan M, 2005, APPL PSYCHOPHYS BIOF, V30, P239, DOI 10.1007/s10484-005-6381-3; MEEHAN M, 2001, THESIS U N CAROLINA; Mehler B., 2010, P 54 ANN M HUM FACT, V54, P2062; Mehler B, 2009, TRANSPORT RES REC, P6, DOI 10.3141/2138-02; Milleville-Pennel I, 2010, BRAIN INJURY, V24, P678, DOI 10.3109/02699051003692159; Otmani S, 2005, ACCIDENT ANAL PREV, V37, P930, DOI 10.1016/j.aap.2005.04.011; Patomella AH, 2006, J REHABIL MED, V38, P273, DOI 10.1080/16501970600632594; Pennel I, 2002, TRAV HUMAIN, V65, P29, DOI 10.3917/th.651.0029; Regenbrecht H, 2002, PRESENCE-TELEOP VIRT, V11, P425, DOI 10.1162/105474602760204318; Reimer B, 2011, ERGONOMICS, V54, P932, DOI 10.1080/00140139.2011.604431; ROBERT P, 1976, ROY STAT SOC C-APP, V25, P257; Robillard G, 2003, CYBERPSYCHOL BEHAV, V6, P467, DOI 10.1089/109493103769710497; Schubert T., 1999, VISUAL REPRESENTATIO, P269, DOI DOI 10.1007/978-1-4471-0563-3_30; Slater M., 1995, ACM T COMPUTER HUMAN, V2, P201, DOI 10.1145/210079.210084; Slater M, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1778765.1778829; Slater M, 2009, PHILOS T R SOC B, V364, P3549, DOI 10.1098/rstb.2009.0138; Stern E. B., 2004, 6 NAT WORKSH DRIV RE; Tornros J, 1998, ACCIDENT ANAL PREV, V30, P497, DOI 10.1016/S0001-4575(97)00099-7; Villani D, 2012, INTERACT COMPUT, V24, P265, DOI 10.1016/j.intcom.2012.04.008; Vuadens P, 2001, Rev Med Suisse Romande, V121, P453; Walshe D, 2005, CYBERPSYCHOL BEHAV, V8, P532, DOI 10.1089/cpb.2005.8.532	41	12	12	0	107	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA		1531-3263		PRESENCE-VIRTUAL AUG	PRESENCE-Virtual Augmented Reality	WIN	2015	24	1					74	91		10.1162/PRES_a_00216			18	Computer Science, Cybernetics; Computer Science, Software Engineering	Computer Science	CI1EN	WOS:000354485200005					2021-06-18	
J	Tackla, R; Hinzman, JM; Foreman, B; Magner, M; Andaluz, N; Hartings, JA				Tackla, Ryan; Hinzman, Jason M.; Foreman, Brandon; Magner, Mark; Andaluz, Norberto; Hartings, Jed A.			Assessment of Cerebrovascular Autoregulation Using Regional Cerebral Blood Flow in Surgically Managed Brain Trauma Patients	NEUROCRITICAL CARE			English	Article						Pressure reactivity index (PRx); Oxygen reactivity index (ORx); Blood flow velocity index (Mx); Traumatic brain injury; Neurocritical care	PERFUSION-PRESSURE; INTRACRANIAL-PRESSURE; TISSUE OXYGEN; REACTIVITY; VALIDATION; INJURY	Impairment of cerebrovascular autoregulation is a risk factor for ischemic damage following severe brain injury. Autoregulation can be assessed indirectly using intracranial pressure monitoring as a surrogate of cerebral blood volume, but this measure may not be applicable to patients following decompressive craniectomy. Here, we describe assessment of autoregulation using regional cerebral blood flow (rCBF). In seven patients with severe brain trauma who underwent neurological surgery, a Hemedex(A (R)) rCBF probe was placed intraoperatively in peri-lesional tissue. Autoregulation was assessed as a moving Pearson correlation between CPP and rCBF (rCBFx). Composite data from all patients showed relatively constant perfusion over a wide CPP range (50-90 mmHg) and a U-shaped autoregulation curve with maximal autoregulation (CPPopt) at 55-60 mmHg. All rCBF values fell below the ischemic threshold (< 18 ml/100 g/min) when CPPs were < 50 mmHg compared with 11 % ischemia when CPPs > 50 mmHg (P < 0.05). We examined the percent time during which both autoregulation was intact and rCBF exceeded the ischemic threshold. In the composite data, this variable was maximal in the CPP range of 75-80 mmHg (CPPideal). In individual patients, the range of CPPs with intact autoregulation varied widely. Individual CPPopt values ranged between 60 and 100 mmHg and CPPideal ranged between 65 and 105 mmHg. Assessment of autoregulation with Hemedex(A (R)) rCBF monitor is feasible and could be used to guide CPP management strategies to optimize both autoregulation and perfusion. Autoregulatory impairment and CPPopt vary considerably between patients, and the addition of rCBF monitoring could help guide CPP targeting decisions.	[Tackla, Ryan; Hinzman, Jason M.; Magner, Mark; Andaluz, Norberto; Hartings, Jed A.] Univ Cincinnati, Coll Med, Neurotrauma Ctr, Dept Neurosurg,UC Neurosci Inst, Cincinnati, OH 45267 USA; [Tackla, Ryan; Magner, Mark; Andaluz, Norberto; Hartings, Jed A.] Mayfield Clin, Cincinnati, OH USA; [Foreman, Brandon] Univ Cincinnati, Coll Med, Dept Neurol & Rehabil Med, Neurotrauma Ctr,UC Neurosci Inst, Cincinnati, OH 45267 USA	Hinzman, JM (corresponding author), Univ Cincinnati, Coll Med, Neurotrauma Ctr, Dept Neurosurg,UC Neurosci Inst, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	jmhinz2@gmail.com		Hartings, Jed/0000-0001-8583-3471; Foreman, Brandon/0000-0002-5418-674X	Mayfield Education and Research Foundation	This work was funded by the Mayfield Education and Research Foundation and thermal diffusion probes were donated by Hemedex, Inc.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1998, ACT NEUR S, V71, P74; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Czosnyka M, 2014, NEUROCRIT CARE; DEWEY RC, 1974, J NEUROSURG, V41, P597, DOI 10.3171/jns.1974.41.5.0597; Dias C., 2015, NEUROCRIT CARE; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Lang EW, 2002, J NEUROL NEUROSUR PS, V72, P583, DOI 10.1136/jnnp.72.5.583; Naqvi J, 2013, INT J VASC MED, V2013, DOI 10.1155/2013/629378; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Radolovich DK, 2009, NEUROCRIT CARE, V10, P274, DOI 10.1007/s12028-009-9190-3; Reinert M, 2007, NEUROL RES, V29, P455, DOI 10.1179/016164107X164175; Soehle M, 2003, NEUROL RES, V25, P411, DOI 10.1179/016164103101201580; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Vajkoczy P, 2000, J NEUROSURG, V93, P265, DOI 10.3171/jns.2000.93.2.0265; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilson JA, 2013, ACTA NEUROCHIR SUPPL, V115, P67, DOI 10.1007/978-3-7091-1192-5_15; Zweifel C, 2010, J NEUROTRAUM, V27, P1951, DOI 10.1089/neu.2010.1388; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	27	12	12	0	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2015	23	3					339	346		10.1007/s12028-015-0146-5			8	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	CV8WN	WOS:000364569000006	25948537				2021-06-18	
J	Webster, DL; Fei, L; Falcone, RA; Kaplan, J				Webster, Danielle L.; Fei, Lin; Falcone, Richard A.; Kaplan, JenniferM.			Higher-volume hypertonic saline and increased thrombotic risk in pediatric traumatic brain injury	JOURNAL OF CRITICAL CARE			English	Article						TBI; Pediatrics; Hypertonic saline solution; Sodium; Venous thromboembolism	DEEP VENOUS THROMBOSIS; GLASGOW OUTCOME SCALE; SEVERE HEAD-INJURY; DIABETIC-KETOACIDOSIS; INTRACRANIAL-PRESSURE; UNITED-STATES; CHILDREN; THROMBOEMBOLISM; MANAGEMENT; CATHETERS	Purpose: Hyperosmolar therapy is a mainstay in the acute medical management of traumatic brain injury (TBI). Emerging literature suggests that a hyperosmolar state may lead to thrombotic complications. The primary objective of this study was to investigate associations between hypertonic saline (HTS) and the outcome of deep venous thrombosis (DVT) in pediatric patients with severe TBI. Materials and methods: This is a single-center retrospective cohort study of 58 patients admitted to the intensive care unit at a Level 1 pediatric trauma center between January 2010 and June 2013. Main measurements included volume of HTS administration, serum sodium levels, DVT confirmed with ultrasonography, survival at 30 days postinjury, and Glasgow Outcome Scale. Results: The cumulative total bolus volume of HTS (mL/kg) given to each subject was associated with DVT (P = .01). Peak sodium level and 72-hour sustained sodium levels were associated with DVT (P = .05). A sustained sodium level of at least 160 mmol/L was associated with DVT (P = .02). Conclusion: In children with severe TBI, the total bolus volume of 3% HTS and sustained sodium levels greater than 160 mmol/L are independently associated with DVT. (C) 2015 Elsevier Inc. All rights reserved.	[Webster, Danielle L.; Fei, Lin; Falcone, Richard A.; Kaplan, JenniferM.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Webster, Danielle L.; Falcone, Richard A.; Kaplan, JenniferM.] Univ Cincinnati, Coll Med, Cincinnati, OH USA	Webster, DL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Pediat Crit Care Med MLC 2005, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Danielle.Webster@cchmc.org	Fei, Lin/N-8299-2015		NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001425] Funding Source: NIH RePORTER		Adelson P David, 2003, Pediatr Crit Care Med, V4, pS40; Agbeko RS, 2012, PEDIATR CRIT CARE ME, V13, pE39, DOI 10.1097/PCC.0b013e31820ac2ad; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Candrilli SD, 2009, PEDIATR CRIT CARE ME, V10, P554, DOI 10.1097/PCC.0b013e3181a705d3; Faustino EVS, 2013, J PEDIATR-US, V162, P387, DOI 10.1016/j.jpeds.2012.06.059; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; GRANT PJ, 1985, THROMB RES, V40, P393, DOI 10.1016/0049-3848(85)90274-9; Gutierrez JA, 2003, CRIT CARE MED, V31, P80, DOI 10.1097/00003246-200301000-00012; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Huh Jimmy W, 2009, Anesthesiol Clin, V27, P213, DOI 10.1016/j.anclin.2009.05.006; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kanin M, 2013, THROMB RES, V132, P527, DOI 10.1016/j.thromres.2013.08.018; Keenan CR, 2007, J THROMB HAEMOST, V5, P1185, DOI 10.1111/j.1538-7836.2007.02553.x; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Mannucci PM, 1997, BLOOD, V90, P2515, DOI 10.1182/blood.V90.7.2515.2515_2515_2521; Maxwell WL, 2012, INT J DEV NEUROSCI, V30, P167, DOI 10.1016/j.ijdevneu.2011.12.008; McCrory MC, 2011, PEDIATR CRIT CARE ME, V12, P80, DOI 10.1097/PCC.0b013e3181ce7644; Monagle P, 2012, CHEST, V141, pE737S, DOI 10.1378/chest.11-2308; Morrow SE, 2010, SEMIN PEDIATR SURG, V19, P279, DOI 10.1053/j.sempedsurg.2010.07.001; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Raffini L, 2009, PEDIATRICS, V124, P1001, DOI 10.1542/peds.2009-0768; Setty BA, 2012, PEDIATR BLOOD CANCER, V59, P258, DOI 10.1002/pbc.23388; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Takemoto CM, 2014, J PEDIATR-US, V164, P332, DOI 10.1016/j.jpeds.2013.10.025; Vidal E, 2014, J THROMB HAEMOST, V12, P1096, DOI 10.1111/jth.12598; Wakefield TW, 2009, J VASC SURG, V49, P1620, DOI 10.1016/j.jvs.2009.01.058; Worly JM, 2004, PEDIATRICS, V113, pE57, DOI 10.1542/peds.113.1.e57	30	12	13	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	DEC	2015	30	6					1267	1271		10.1016/j.jcrc.2015.07.022			5	Critical Care Medicine	General & Internal Medicine	CV0MX	WOS:000363945900022	26307005				2021-06-18	
J	Zhong, ZQ; Tao, Y; Yang, H				Zhong, Zeqi; Tao, Yuan; Yang, Hui			Treatment with harmine ameliorates functional impairment and neuronal death following traumatic brain injury	MOLECULAR MEDICINE REPORTS			English	Article						traumatic brain injury; harmine; glutamate transporter 1; inflammatory; neuronal death; functional recovery	GLUTAMATE TRANSPORTER GLT-1; BETA-CARBOLINE ALKALOIDS; FOCAL CEREBRAL-ISCHEMIA; ANTISENSE KNOCKDOWN; RAT-BRAIN; MODEL; EXCITOTOXICITY; EPILEPSY; DAMAGE; MICE	Traumatic brain injury (TBI) is a leading cause of mortality in young individuals, and results in motor and cognitive deficiency. Excitotoxicity is an important process during neuronal cell death, which is caused by excessive release of glutamate following TBI. Astrocytic glutamate transporters have a predominant role in maintaining extracellular glutamate concentrations below excitotoxic levels, and glutamate transporter 1 (GLT-1) may account for >90% of glutamate uptake in the brain. The -carboline alkaloid harmine has been demonstrated to exert neuroprotective actions in vivo, and the beneficial effects were specifically due to elevation of GLT-1. However, whether harmine provides neuroprotection following TBI remains to be elucidated. The present study performed intraperitoneal harmine injections in rats (30 mg/kg per day for up to 5 days), in order to investigate whether harmine treatment attenuates brain edema and improves functional recovery in a rat model of TBI. The neuronal survival ratio and the protein expression of apoptosis-associated caspase 3 were also assessed in the hippocampus of the rat brain. Furthermore, the expression levels of GLT-1 and inflammatory cytokines were detected, in order to determine the underlying mechanisms. The results of the present study demonstrated that administration of harmine significantly attenuated cerebral edema, and improved learning and memory ability. In addition, harmine significantly increased the protein expression of GLT-1, and markedly attenuated the expression levels of interleukin-1 and tumor necrosis factor-, thereby attenuating apoptotic neuronal death in the hippocampus. These results provided in vivo evidence that harmine may exert neuroprotective effects by synergistically reducing excitotoxicity and inflammation following TBI.	[Zhong, Zeqi; Yang, Hui] Third Mil Med Univ, Xinqiao Hosp, Dept Neurosurg, Chongqing 400037, Peoples R China; [Tao, Yuan] Third Mil Med Univ, Res Inst Field Surg, Daping Hosp, Dept Neurol, Chongqing 400042, Peoples R China	Yang, H (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Neurosurg, 183 Xinqiao Rd, Chongqing 400037, Peoples R China.	huiyang24k@163.com					Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; Astulla A, 2008, J NAT MED-TOKYO, V62, P470, DOI 10.1007/s11418-008-0259-7; Cao RH, 2007, CURR MED CHEM, V14, P479, DOI 10.2174/092986707779940998; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chu K, 2007, STROKE, V38, P177, DOI 10.1161/01.STR.0000252091.36912.65; Cui CM, 2014, NEUROL SCI, V35, P695, DOI 10.1007/s10072-013-1585-4; Fortunato JJ, 2010, BRAIN RES BULL, V81, P491, DOI 10.1016/j.brainresbull.2009.09.008; Han F, 2008, NEUROSCI LETT, V430, P275, DOI 10.1016/j.neulet.2007.11.021; Johnston MV, 2005, BRAIN PATHOL, V15, P234; Lai AY, 2006, J NEUROIMMUNOL, V175, P97, DOI 10.1016/j.jneuroim.2006.03.001; Lauderback CM, 2001, J NEUROCHEM, V78, P413, DOI 10.1046/j.1471-4159.2001.00451.x; Li Y, 2011, NEUROPHARMACOLOGY, V60, P1168, DOI 10.1016/j.neuropharm.2010.10.016; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Moura DJ, 2007, MUTAGENESIS, V22, P293, DOI 10.1093/mutage/gem016; Namura S, 2002, NEUROSCI LETT, V324, P117, DOI 10.1016/S0304-3940(02)00193-3; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Pickering M, 2005, EXP PHYSIOL, V90, P663, DOI 10.1113/expphysiol.2005.030734; Rao VLR, 2001, EUR J NEUROSCI, V13, P119, DOI 10.1046/j.1460-9568.2001.01367.x; Rao VLR, 2001, J NEUROSCI, V21, P1876, DOI 10.1523/JNEUROSCI.21-06-01876.2001; RAUEN T, 1994, NEUROSCI LETT, V169, P137, DOI 10.1016/0304-3940(94)90375-1; Reus GZ, 2010, OXID MED CELL LONGEV, V3, P325, DOI 10.4161/oxim.3.5.13109; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Samuelsson C, 2000, NEUROSCI LETT, V289, P185, DOI 10.1016/S0304-3940(00)01284-2; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; TAUBER MG, 1985, J INFECT DIS, V151, P528, DOI 10.1093/infdis/151.3.528; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803	27	12	13	0	8	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	DEC	2015	12	6					7985	7991		10.3892/mmr.2015.4437			7	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CZ6CT	WOS:000367189500022	26496827	Other Gold, Green Published			2021-06-18	
J	Kiefer, AW; Foss, KB; Reches, A; Gadd, B; Gordon, M; Rushford, K; Laufer, I; Weiss, M; Myer, GD				Kiefer, Adam W.; Foss, Kim Barber; Reches, Amit; Gadd, Brooke; Gordon, Michael; Rushford, Ken; Laufer, Ilan; Weiss, Michal; Myer, Gregory D.			Brain Network activation as a Novel Biomarker for the Return-to-play pathway Following sport-Related Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						brain network activation; EEG; concussion; hockey; return to play	CONCUSSION; MATURATION; DIAGNOSIS; POTENTIALS; ATTENTION; CHILDREN	Children and adolescent athletes are at a higher risk for concussion than adults, and also experience longer recovery times and increased associated symptoms. It has also recently been demonstrated that multiple, seemingly mild concussions may result in exacerbated and prolonged neurological deficits. Objective assessments and return-to-play criteria are needed to reduce risk and morbidity associated with concussive events in these populations. Recent research has pushed to study the use of electroencephalography as an objective measure of brain injury. In the present case study, we present a novel approach that examines event-related potentials via a brain network activation (BNA) analysis as a biomarker of concussion and recovery. Specifically, changes in BNA scores, as indexed through this approach, offer a potential indicator of neurological health as the BNA assessment qualitatively and quantitatively indexes the network dynamics associated with brain injury. Objective tools, such as these support accurate and efficient assessment of brain injury and may offer a useful step in categorizing the temporal and spatial changes in brain activity following concussive blows, as well as the functional connectivity of brain networks, associated with concussion.	[Kiefer, Adam W.; Foss, Kim Barber; Gadd, Brooke; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, Cincinnati, OH 45229 USA; [Kiefer, Adam W.; Myer, Gregory D.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Kiefer, Adam W.] Univ Cincinnati, Dept Psychol, Ctr Cognit Act & Percept, Cincinnati, OH 45221 USA; [Reches, Amit; Laufer, Ilan; Weiss, Michal] ElMindA Ltd, Herzliyya, Israel; [Gordon, Michael; Rushford, Ken] St Xavier High Sch, Cincinnati, OH USA; [Myer, Gregory D.] Univ Cincinnati, Dept Orthopaed Surg, Cincinnati, OH USA; [Myer, Gregory D.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Myer, Gregory D.] Ohio State Univ, Sports Hlth & Performance Inst, Columbus, OH 43210 USA	Kiefer, AW (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Sports Med, Cincinnati, OH 45229 USA.	adam.kiefer@cchmc.org	Kiefer, Adam/F-1756-2018; Meijer, Anna/K-5118-2016; Myer, Gregory/H-6572-2016	Myer, Gregory/0000-0002-9983-8422	Cincinnati Children's Research Foundation; Q30 Sports Science, LLC; Heidt Foundation; ElMindA, Ltd.	This research was funded, in part, by Cincinnati Children's Research Foundation; Q30 Sports Science, LLC; The Heidt Foundation; ElMindA, Ltd.	Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Daniel JC, 1999, NEUROPSY NEUROPSY BE, V12, P167; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Grubenhoff JA, 2011, BRAIN INJURY, V25, P943, DOI 10.3109/02699052.2011.597043; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Huettel SA, 2004, NEUROPSYCHOLOGIA, V42, P379, DOI 10.1016/j.neuropsychologia.2003.07.009; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Keightley ML, 2012, CURR OPIN PEDIATR, V24, P709, DOI 10.1097/MOP.0b013e3283599a55; Kutcher JS, 2013, BRIT J SPORT MED, V47, P299, DOI 10.1136/bjsports-2013-092257; Luna B, 2004, CHILD DEV, V75, P1357, DOI 10.1111/j.1467-8624.2004.00745.x; Mahajan Y, 2012, HEARING RES, V294, P82, DOI 10.1016/j.heares.2012.10.005; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; Mez J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0407-7; MIZRAHI EM, 1984, PEDIATRICS, V73, P419; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Moore RD, 2014, J ATHL TRAINING, V49, P36, DOI 10.4085/1062-6050-49.1.02; Pointinger H, 2002, BRAIN INJURY, V16, P799, DOI 10.1080/02699050210131911; Polich J., 1999, ELECTROENCEPHALOGRAP, P1073; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Reches A, 2016, EUR J PAIN, V20, P250, DOI 10.1002/ejp.716; Reches A, 2014, NEUROIMAGE, V88, P228, DOI 10.1016/j.neuroimage.2013.11.020; Reches A., 2013, FUNCT NEUROL REHABIL, V3, P295; Reches A, 2014, J MOL NEUROSCI, V54, P59, DOI 10.1007/s12031-014-0250-6; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Semple BD, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00069; Shahaf G, 2012, CLIN NEUROPHYSIOL, V123, P1568, DOI 10.1016/j.clinph.2011.12.010; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Sussman E, 2008, HEARING RES, V236, P61, DOI 10.1016/j.heares.2007.12.001; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Virji-Babul N, 2014, J NEUROTRAUM, V31, P1914, DOI 10.1089/neu.2014.3450; Whitford TJ, 2007, HUM BRAIN MAPP, V28, P228, DOI 10.1002/hbm.20273	35	12	13	2	10	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 20	2015	6								243	10.3389/fneur.2015.00243			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	DA9AE	WOS:000368097800001	26635720	DOAJ Gold, Green Published			2021-06-18	
J	Semple, BD; Noble-Haeusslein, LJ; Gooyit, M; Tercovich, KG; Peng, ZH; Nguyen, TT; Schroeder, VA; Suckow, MA; Chang, M; Raber, J; Trivedi, A				Semple, Bridgette D.; Noble-Haeusslein, Linda J.; Gooyit, Major; Tercovich, Kayleen G.; Peng, Zhihong; Nguyen, Trung T.; Schroeder, Valerie A.; Suckow, Mark A.; Chang, Mayland; Raber, Jacob; Trivedi, Alpa			Early Gelatinase Activity Is Not a Determinant of Long-Term Recovery after Traumatic Brain Injury in the Immature Mouse	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; HIGHLY SPECIFIC INHIBITOR; CENTRAL-NERVOUS-SYSTEM; GENE KNOCK-OUT; MATRIX METALLOPROTEINASES; CEREBROSPINAL-FLUID; HYPOXIA-ISCHEMIA; HEMORRHAGIC TRANSFORMATION; TISSUE INHIBITOR; MESSENGER-RNA	The gelatinases, matrix metalloproteinases (MMP)-2 and MMP-9, are thought to be key mediators of secondary damage in adult animal models of brain injury. Moreover, an acute increase in these proteases in plasma and brain extracellular fluid of adult patients with moderate-to-severe traumatic brain injuries (TBIs) is associated with poorer clinical outcomes and mortality. Nonetheless, their involvement after TBI in the pediatric brain remains understudied. Using a murine model of TBI at postnatal day 21 (p21), approximating a toddler-aged child, we saw upregulation of active and pro-MMP-9 and MMP-2 by gelatin zymography at 48 h post-injury. We therefore investigated the role of gelatinases on long-term structural and behavioral outcomes after injury after acute inhibition with a selective gelatinase inhibitor, p-OH SB-3CT. After systemic administration, p-OH SB-3CT crossed the blood-brain barrier at therapeutically-relevant concentrations. TBI at p21 induced hyperactivity, deficits in spatial learning and memory, and reduced sociability when mice were assessed at adulthood, alongside pronounced tissue loss in key neuroanatomical regions. Acute and short-term post-injury treatment with p-OH SB-3CT did not ameliorate these long-term behavioral, cognitive, or neuropathological deficits as compared to vehicle-treated controls, suggesting that these deficits were independent of MMP-9 and MMP-2 upregulation. These findings emphasize the vulnerability of the immature brain to the consequences of traumatic injuries. However, early upregulation of gelatinases do not appear to be key determinants of long-term recovery after an early-life injury.	[Semple, Bridgette D.; Noble-Haeusslein, Linda J.; Tercovich, Kayleen G.; Trivedi, Alpa] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94117 USA; [Semple, Bridgette D.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Melbourne Brain Ctr, Parkville, Vic 3052, Australia; [Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Phys Therapy & Rehabil, San Francisco, CA 94143 USA; [Gooyit, Major; Peng, Zhihong; Nguyen, Trung T.; Chang, Mayland] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Schroeder, Valerie A.; Suckow, Mark A.] Univ Notre Dame, Freimann Life Sci Ctr, Notre Dame, IN 46556 USA; [Schroeder, Valerie A.; Suckow, Mark A.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Div Neurosci, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Neurol, Div Neurosci, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Radiat Med, Div Neurosci, Portland, OR 97201 USA	Trivedi, A (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94117 USA.	alpa.mahuvakar@ucsf.edu	Tercovich, Kayleen/I-8941-2018; Peng, Zhihong/T-1359-2019	Tercovich, Kayleen/0000-0003-0450-8912; Peng, Zhihong/0000-0002-2764-4645; Suckow, Mark/0000-0001-7317-697X	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1NS077767, RO1NS050159]; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1052505]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM075762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS050159, R01NS077767] Funding Source: NIH RePORTER	LJN received two grants from the National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov/) with grant numbers RO1NS077767 and RO1NS050159. BDS received a CJ Martin Early Career Fellowship from the Australian National Health and Medical Research Council with award number 1052505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal SM, 2008, SEMIN CELL DEV BIOL, V19, P42, DOI 10.1016/j.semcdb.2007.06.003; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Asahi M, 2001, NEUROREPORT, V12, P3003, DOI 10.1097/00001756-200109170-00050; Bednarek N, 2012, PEDIATR RES, V71, P63, DOI 10.1038/pr.2011.3; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Brown S, 2000, J AM CHEM SOC, V122, P6799, DOI 10.1021/ja001461n; Chen CY, 2013, DEV NEUROSCI-BASEL, V35, P474, DOI 10.1159/000355874; Chen WQ, 2009, J NEUROCHEM, V111, P726, DOI 10.1111/j.1471-4159.2009.06362.x; Chou SHY, 2011, TRANSL STROKE RES, V2, P600, DOI 10.1007/s12975-011-0117-x; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; Copin JC, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-83; Cui J, 2012, MOL NEURODEGENER, V7, P1750; Davis MJ, 2012, BEHAV BRAIN RES, V229, P21, DOI 10.1016/j.bbr.2011.12.037; Demestre M, 2005, J NEUROIMMUNOL, V159, P146, DOI 10.1016/j.jneuroim.2004.09.015; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dragun P, 2008, J PHYSIOL PHARMACOL, V59, P441; Esparza J, 2004, FASEB J, V18, P1682, DOI 10.1096/fj.04-2445com; Fager N, 2000, MECH DEVELOP, V98, P105, DOI 10.1016/S0925-4773(00)00437-8; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Fernandez Eva, 2011, Pharmaceutics, V3, P53, DOI 10.3390/pharmaceutics3010053; Gooyit M, 2013, J MED CHEM, V56, P8139, DOI 10.1021/jm401217d; Gooyit M, 2012, ACS CHEM NEUROSCI, V3, P730, DOI 10.1021/cn300062w; Gould TD, 2009, NEUROMETHODS, V42, P1, DOI 10.1007/978-1-60761-303-9_1; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hsu JYC, 2006, J NEUROSCI, V26, P9841, DOI 10.1523/JNEUROSCI.1993-06.2006; Hsu JYC, 2008, J NEUROSCI, V28, P13467, DOI 10.1523/JNEUROSCI.2287-08.2008; Jia F, 2014, J NEUROTRAUM, V24, P24; Jiang XF, 2001, NEUROSCI LETT, V305, P41, DOI 10.1016/S0304-3940(01)01800-6; Kaplan A, 2014, NEURON, V81, P333, DOI 10.1016/j.neuron.2013.12.009; Kawai N, 2003, J NEUROTRAUM, V20, P649, DOI 10.1089/089771503322144563; Kim HJ, 2005, EXP NEUROL, V192, P60, DOI 10.1016/j.expneurol.2004.10.014; Konrad K, 2003, COGNITIVE BRAIN RES, V16, P425, DOI 10.1016/S0926-6410(03)00057-0; Lazarov O, 2006, J NEUROSCI, V26, P429, DOI 10.1523/JNEUROSCI.3961-05.2006; Lee M, 2005, ORG LETT, V7, P4463, DOI 10.1021/ol0517269; Lee M, 2007, CHEM BIOL DRUG DES, V70, P371, DOI 10.1111/j.1747-0285.2007.00577.x; Liu CL, 2014, TURK NEUROSURG, V24, P363, DOI 10.5137/1019-5149.JTN.8551-13.0; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Lorente L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094370; Lu A, 2013, NEUROSCIENCE, V253, P361, DOI 10.1016/j.neuroscience.2013.08.068; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Muradashvili N, 2014, METAB BRAIN DIS, V29, P29; Muradashvili N, 2015, METAB BRAIN DIS, V30, P411, DOI 10.1007/s11011-014-9550-3; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Oh LYS, 1999, J NEUROSCI, V19, P8464; Omouendze PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071263; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Pardridge William M, 2005, NeuroRx, V2, P1, DOI 10.1602/neurorx.2.1.1; Pastrana E, 2006, J NEUROSCI, V26, P5347, DOI 10.1523/JNEUROSCI.1111-06.2006; Potts Mathew B, 2006, NeuroRx, V3, P143; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Py NA, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/tnagi.2014.00247, 10.3389/fnagi.2014.00247]; Ranasinghe HS, 2012, DEV NEUROSCI-BASEL, V34, P417, DOI 10.1159/000343257; Roberts DJ, 2013, J NEUROTRAUM, V30, P1727, DOI 10.1089/neu.2012.2842; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Rosell A, 2008, STROKE, V39, P1121, DOI 10.1161/STROKEAHA.107.500868; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; ROSENBERG GA, 1995, J NEUROTRAUM, V12, P833, DOI 10.1089/neu.1995.12.833; Semple BD, 2015, NEUROBIOL DIS, P74; Semple BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103386; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Sifringer M, 2007, NEUROBIOL DIS, V25, P526, DOI 10.1016/j.nbd.2006.10.019; Silverman JL, 2011, BRAIN RES, V1380, P120, DOI 10.1016/j.brainres.2010.09.026; Strolin Benedetti M, 2005, Expert Opin Drug Metab Toxicol, V1, P447; Svedin P, 2007, J NEUROSCI, V27, P1511, DOI 10.1523/JNEUROSCI.4391-06.2007; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Toth M, 2001, Methods Mol Med, V57, P163, DOI 10.1385/1-59259-136-1:163; Vaillant C, 1999, J NEUROSCI, V19, P4994; Verslegers M, 2015, BRAIN STRUCT FUNCT, V220, P1601, DOI 10.1007/s00429-014-0747-3; Verslegers M, 2013, PROG NEUROBIOL, V105, P60, DOI 10.1016/j.pneurobio.2013.03.004; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; von Gertten C, 2003, J NEUROSCI RES, V73, P803, DOI 10.1002/jnr.10729; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang XY, 2013, EXP THER MED, V6, P263, DOI 10.3892/etm.2013.1116; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yang M, 2011, CURR PROT NEUROSCI, V8; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zhang HQ, 2010, NEUROSCIENTIST, V16, P156, DOI 10.1177/1073858409355830; Zheng KB, 2013, NEUROL INDIA, V61, P606, DOI 10.4103/0028-3886.125258	89	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143386	10.1371/journal.pone.0143386			25	Multidisciplinary Sciences	Science & Technology - Other Topics	CW8LQ	WOS:000365251500056	26588471	DOAJ Gold, Green Published			2021-06-18	
J	Hilz, MJ; Aurnhammer, F; Flanagan, SR; Intravooth, T; Wang, RH; Hosl, KM; Pauli, E; Koehn, J				Hilz, Max J.; Aurnhammer, Felix; Flanagan, Steven R.; Intravooth, Tassanai; Wang, Ruihao; Hoesl, Katharina M.; Pauli, Elisabeth; Koehn, Julia			Eyeball Pressure Stimulation Unveils Subtle Autonomic Cardiovascular Dysfunction in Persons with a History of Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						autonomic dysfunction; eyeball pressure stimulation; mild traumatic brain injury; parasympathetic tone	GUILLAIN-BARRE-SYNDROME; HEART-RATE-VARIABILITY; CEREBROGENIC CARDIAC-ARRHYTHMIAS; BAROREFLEX SENSITIVITY; SUDDEN-DEATH; TRIGEMINOCARDIAC REFLEX; HYPERTENSIVE PATIENTS; MORTALITY; MODULATION; RESPONSES	After mild traumatic brain injury (mTBI), patients have increased long-term mortality rates, persisting even beyond 13 years. Pathophysiology is unclear. Yet, central autonomic network dysfunction may contribute to cardiovascular dysregulation and increased mortality. Purely parasympathetic cardiovascular challenge by eyeball pressure stimulation (EP), might unveil subtle autonomic dysfunction in post-mTBI patients. We investigated whether mild EP shows autonomic cardiovascular dysregulation in post-mTBI patients. In 24 patients (34 +/- 12 years; 5-86 months post-injury) and 27 controls (30 +/- 11 years), we monitored respiration, electrocardiographic RR intervals (RRI), systolic and diastolic blood pressure (BPsys, BPdia) before and during 2min of 30mm Hg EP, applied by an ophthalmologic ocular pressure device (Okulopressor((R))). We calculated spectral powers of RRI in the mainly sympathetic low frequency (LF; 0.04-0.15Hz) and parasympathetic high frequency (HF; 0.15-0.5Hz) ranges, and of BP in the sympathetic LF range, the RRI-LF/HF ratio as index of the sympathetic-parasympathetic balance, normalized (nu) RRI-LF- and HF-powers, and LF- and HF-powers after natural logarithmic transformation (ln). Parameters before and during EP in post-mTBI patients and controls were compared by repeated measurement analysis of variance with post hoc analysis (p<0.05). During EP, BPsys and BPdia increased in post-mTBI patients. Only in controls but not in post-mTBI patients, EP increased RRI-HFnu-powers and decreased RRI-LF-powers, RRI-LFnu-powers, BPsys-LF-powers, BPsys-lnLF-powers and BPdia-lnLF-powers. RRI-LF/HF ratios slightly increased in post-mTBI patients but slightly decreased in controls upon EP. Even with only mild EP, our controls showed normal EP responses and shifted sympathetic-parasympathetic balance towards parasympathetic predominance. In contrast, our post-mTBI patients could not increase parasympathetic heart rate modulation but increased BP upon EP, indicating a paradox sympathetic activation. The findings support the hypothesis that central autonomic dysfunction might contribute to an increased cardiovascular risk, even years after mTBI.	[Hilz, Max J.; Aurnhammer, Felix; Intravooth, Tassanai; Wang, Ruihao; Pauli, Elisabeth; Koehn, Julia] Univ Erlangen Nurnberg, Dept Neurol, D-91054 Erlangen, Germany; [Flanagan, Steven R.] NYU, Sch Med, Dept Rehabil Med, New York, NY USA; [Hoesl, Katharina M.] Klinikum Europakanal Erlangen, Dept Psychiat Addict Psychiat Psychotherapy & Psy, Erlangen, Germany	Hilz, MJ (corresponding author), Univ Erlangen Nurnberg, Dept Neurol, Schwabachanlage 6, D-91054 Erlangen, Germany.	max.hilz@uk-erlangen.de		Flanagan, Steven/0000-0001-9005-5897; Wang, Ruihao/0000-0003-4792-5572; Intravooth, Tassanai/0000-0002-6188-4503	International Brain Research Foundation (IBRF), Flanders, NJ	The study was partially funded by the International Brain Research Foundation (IBRF), Flanders, NJ.	ALBENTOSA M, 1994, AQUACULTURE, V126, P315, DOI 10.1016/0044-8486(94)90048-5; ARNOLD RW, 1994, OPHTHALMOLOGY, V101, P1347; Arnold RW, 1999, YALE J BIOL MED, V72, P237; Ashman TA, 2006, MT SINAI J MED, V73, P999; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; BENARROCH EE, 1997, CENTRAL AUTONOMIC NE; BERNARDI L, 1995, CIRCULATION, V92, P2895, DOI 10.1161/01.CIR.92.10.2895; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Black M, 2002, J CLIN PATHOL, V55, P44, DOI 10.1136/jcp.55.1.44; Bowman R, 1996, BRIT J OPHTHALMOL, V80, P394, DOI 10.1136/bjo.80.5.394; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Brown CM, 2008, DIABETOLOGIA, V51, P756, DOI 10.1007/s00125-008-0958-3; Brown CM, 2002, CLIN SCI, V102, P623, DOI 10.1042/CS20010242; Dutsch M, 2007, NEUROLOGY, V69, P2249, DOI 10.1212/01.wnl.0000286946.06639.a7; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Flachenecker P, 1998, MUSCLE NERVE, V21, P680; Flachenecker P, 2001, NERVENARZT, V72, P610, DOI 10.1007/s001150170060; Flachenecker P, 1996, NEUROLOGY, V47, P102, DOI 10.1212/WNL.47.1.102; Flachenecker P, 2007, J NEUROL, V254, P96, DOI 10.1007/s00415-007-2024-3; GANDEVIA SC, 1978, J PHYSIOL-LONDON, V276, P383, DOI 10.1113/jphysiol.1978.sp012241; HACHINSKI VC, 1986, STROKE, V17, P387, DOI 10.1161/01.STR.17.3.387; Hemmer LB, 2010, J CLIN ANESTH, V22, P205, DOI 10.1016/j.jclinane.2009.03.017; Hilz MJ, 2008, STROKE, V39, P2421, DOI 10.1161/STROKEAHA.108.518613; Hilz MJ, 2006, BRAIN, V129, P3343, DOI 10.1093/brain/awl299; Hilz MJ, 2011, J HYPERTENS, V29, P2387, DOI 10.1097/HJH.0b013e32834c31db; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Hilz MJ, 2006, MUSCLE NERVE, V33, P6, DOI 10.1002/mus.20365; Hilz MJ, 2001, ANN NEUROL, V49, P575, DOI 10.1002/ana.1006; Hilz MJ, 2002, NEUROMUSCULAR FUNCTI, P1899; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Honzikova N, 2000, PHYSIOL RES, V49, P643; Huang M., 2009, J NEUROTRAUMA; Johansson M, 2007, J HYPERTENS, V25, P163, DOI 10.1097/01.hjh.0000254377.18983.eb; Kallio H, 2011, ANAESTHESIA, V66, P278, DOI 10.1111/j.1365-2044.2011.06627.x; La Rovere MT, 2001, CIRCULATION, V103, P2072; La Rovere MT, 1998, LANCET, V351, P478; Lanfranchi PA, 2002, AM J PHYSIOL-REG I, V283, pR815, DOI 10.1152/ajpregu.00051.2002; LANG S, 1991, CAN J ANAESTH, V38, P757, DOI 10.1007/BF03008454; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; LICHTENFELD P, 1971, AM J MED, V50, P772, DOI 10.1016/0002-9343(71)90185-9; LOKEN RG, 1994, CAN J ANAESTH, V41, P802, DOI 10.1007/BF03011587; Low P.A., 1997, CLIN AUTONOMIC DISOR; Marr A, 2002, CENTRAL NERVOUS SYST; Marthol H, 2007, J NEUROL SCI, V252, P99, DOI 10.1016/j.jns.2006.10.003; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Minahan RE, 1996, NEUROLOGY, V47, P1239, DOI 10.1212/WNL.47.5.1239; NATELSON BH, 1993, NEUROL CLIN, V11, P293; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Oppenheimer S, 2006, CLIN AUTON RES, V16, P6, DOI 10.1007/s10286-006-0276-0; OPPENHEIMER SM, 1991, BRAIN RES, V550, P115, DOI 10.1016/0006-8993(91)90412-O; OPPENHEIMER SM, 1990, ARCH NEUROL-CHICAGO, V47, P513, DOI 10.1001/archneur.1990.00530050029008; Orlandi G, 2000, ACTA NEUROL SCAND, V102, P317, DOI 10.1034/j.1600-0404.2000.102005317.x; Ormezzano O, 2008, J HYPERTENS, V26, P1373, DOI 10.1097/HJH.0b013e3283015e5a; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Parati G, 2001, ANN NY ACAD SCI, V940, P469; Paton JFR, 2005, BRAIN RES REV, V49, P555, DOI 10.1016/j.brainresrev.2005.02.005; Ponikowski P, 1997, AM J CARDIOL, V79, P1645, DOI 10.1016/S0002-9149(97)00215-4; Rosengard-Barlund M, 2009, DIABETOLOGIA, V52, P1164, DOI 10.1007/s00125-009-1340-9; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Schaller B, 2004, J NEUROL, V251, P658, DOI 10.1007/s00415-004-0458-4; Schini-Kerth VB, 1999, TRANSFUS CLIN BIOL, V6, P355, DOI 10.1016/S1246-7820(00)88980-6; Soros P, 2012, LANCET NEUROL, V11, P179, DOI 10.1016/S1474-4422(11)70291-5; Sykora M, 2008, CRIT CARE MED, V36, P3074, DOI 10.1097/CCM.0b013e31818b306d; Sykora M, 2009, STROKE, V40, P737, DOI 10.1161/STROKEAHA.108.519967; Tokgozoglu SL, 1999, STROKE, V30, P1307, DOI 10.1161/01.STR.30.7.1307; VANBROCKLIN MD, 1982, J AM OPTOM ASSOC, V53, P407; Xiong KL, 2014, BRAIN IMAGING BEHAV, V8, P487, DOI 10.1007/s11682-013-9288-2; ZOCHODNE DW, 1994, MUSCLE NERVE, V17, P1145, DOI 10.1002/mus.880171004	71	12	15	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2015	32	22					1796	1804		10.1089/neu.2014.3842			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CV6ST	WOS:000364401500010	26192266				2021-06-18	
J	Kim, SG; Lee, EH; Hwang, ST; Park, K; Chey, J; Hong, SH; Kim, JH				Kim, Sung-Geon; Lee, Eun-Ho; Hwang, Soon-Taeg; Park, Kwangbai; Chey, Jeanyung; Hong, Sang-Hwang; Kim, Ji-Hae			Estimation of K-WAIS-IV Premorbid Intelligence in South Korea: Development of the KPIE-IV	CLINICAL NEUROPSYCHOLOGIST			English	Article						Estimated intelligence; OPIE; KPIE.; Premorbid intelligence; WAIS-IV	TRAUMATIC BRAIN-INJURY; CLINICAL UTILITY; NEUROCOGNITIVE DEFICITS; DEMOGRAPHIC-VARIABLES; COMBINED PERFORMANCE; SCALE-4TH EDITION; OPIE-3; INDEX; IQ	Objective: The accurate estimation of premorbid intellectual functioning in patients with known or suspected cognitive impairment is crucial for clinicians. However, there is no reliable method for estimating premorbid intelligence in South Korea. The purpose of this study was to develop the Korea Premorbid Intelligence Estimate (KPIE) as an estimate of the premorbid intellectual functioning. Method: Data from the Korean WAIS-IV standardization sample were used to generate several Full Scale Intelligence Quotient (FSIQ) estimation formulas using demographic variables and current WAIS-IV subtest performance. The standardization sample (N=1216) was randomly divided into two groups: the first group was used to develop the formulas and the second group was used to validate the prediction equations. Age, education, gender, region of the country, and select subtest raw scores (Vocabulary, Information, Matrix Reasoning, and Visual Puzzle) were used as predictor variables. Results: Five KPIE-4 equations were generated. Estimated FSIQ derived from the KPIE-4 equation is highly correlated with K-WAIS-IV FSIQ. Conclusions: The resulting formulas for estimating premorbid FSIQ were highly significant and precise in predicting FSIQ scores of participants in the K-WAIS-IV normative sample. These equations provide a means for clinicians to estimate intellectual functioning in adults, and can be utilized as a method of estimating individuals premorbid functioning.	[Kim, Sung-Geon; Kim, Ji-Hae] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Psychiat, 50 Irwon Dong, Seoul 137710, South Korea; [Lee, Eun-Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Psychiat,Depress Ctr, Seoul 137710, South Korea; [Hwang, Soon-Taeg; Park, Kwangbai] Chungbuk Natl Univ, Dept Psychol, Chungju, South Korea; [Chey, Jeanyung] Seoul Natl Univ, Dept Psychol, Seoul, South Korea; [Hong, Sang-Hwang] Chinju Natl Univ Educ, Dept Educ, Chinju, South Korea	Kim, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Psychiat, 50 Irwon Dong, Seoul 137710, South Korea.	jihae0931.kim@samsung.com		Lee, Eun-ho/0000-0003-2550-8225			Baxendale S, 2014, J CLIN EXP NEUROPSYC, V36, P137, DOI 10.1080/13803395.2013.870535; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; EPPINGER MG, 1987, J CONSULT CLIN PSYCH, V55, P86, DOI 10.1037/0022-006X.55.1.86; Fallows RR, 2012, CLIN NEUROPSYCHOL, V26, P942, DOI 10.1080/13854046.2012.697193; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Groth-Marnat G., 2009, HDB PSYCHOL ASSESSME, V5th; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Jaeger J, 2006, PSYCHIAT RES, V145, P39, DOI 10.1016/j.psychres.2005.11.011; Kim HK, 2001, KOREAN J CLIN PSYCHO, V20, P155; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; Kurtz MM, 2009, NEUROPSYCHOLOGY, V23, P551, DOI 10.1037/a0016277; Schoenberg MR, 2003, CLIN NEUROPSYCHOL, V17, P308, DOI 10.1076/clin.17.3.308.18088; Schoenberg MR, 2002, CLIN NEUROPSYCHOL, V16, P426, DOI 10.1076/clin.16.4.426.13913; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wechsler D., 2012, KOREAN WECHSLER ADUL; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wechsler D., 1955, MANUAL WECHSLER ADUL; Weiss LG, 2010, PRACT RESOUR MENT, P1; WILSON RS, 1978, J CONSULT CLIN PSYCH, V46, P1554, DOI 10.1037/0022-006X.46.6.1554; Woodberry KA, 2008, AM J PSYCHIAT, V165, P579, DOI 10.1176/appi.ajp.2008.07081242	21	12	12	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV 10	2015	29			1			19	29		10.1080/13854046.2015.1072248			11	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	DG5HK	WOS:000372107700002	26247852				2021-06-18	
J	Lee, JEC; Garber, B; Zamorski, MA				Lee, Jennifer E. C.; Garber, Bryan; Zamorski, Mark A.			Prospective Analysis of Premilitary Mental Health, Somatic Symptoms, and Postdeployment Postconcussive Symptoms	PSYCHOSOMATIC MEDICINE			English	Article						military; traumatic brain injury; mental health; deployment; persistent postconcussive symptoms; prospective analysis	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; GULF-WAR; SERVICE MEMBERS; PTSD CHECKLIST; NATIONAL-GUARD; PRIMARY-CARE; IRAQ; DEPRESSION; ASSOCIATION	Objectives Many recent studies of service members returning from deployment have focused on the health impacts of mild traumatic brain injury (mTBI), including persistent postconcussive symptoms (PCS). However, cross-sectional study designs have made it difficult to understand the role of mental health in the etiology of persistent PCS. Methods Participants were 3319 military personnel (primarily men [90%] of 25-34 years [54%]) who had completed health surveys at basic training and after deployment, on average, 4.6 years later. Negative binomial regression was used to assess the association of PCS with demographic covariates, premilitary mental health and somatic symptoms, combat experiences and mTBI during deployment, in addition to postdeployment mental health and non-PCS somatic symptoms. Results Premilitary mental health and somatic symptoms predicted PCS even when adjusting for other variables, yielding an elevated incidence rate ratio (IRR) for posttraumatic stress disorder (PTSD; IRR = 1.23, 95% confidence interval [CI] = 1.06-1.41) and somatic symptoms (mild versus minimal somatic symptoms: IRR = 1.43, 95% CI = 1.31-1.55; moderate/severe versus minimal somatic symptoms: IRR = 1.69, 95% CI = 1.43-2.06), but not for depressive symptoms. When postdeployment mental health and somatic symptom measures were added to the model, the effect of premilitary somatic symptoms remained significant. Conclusions Findings point to potential etiological contributions of premilitary characteristics, particularly a tendency to experience somatic symptoms and PTSD, as well as mTBI and combat experiences, to the development of PCS. PCS were also strongly related to concurrent postdeployment mental health.	[Lee, Jennifer E. C.] Dept Natl Def, Mil Personnel Res & Anal, Ottawa, ON, Canada; [Garber, Bryan; Zamorski, Mark A.] Dept Natl Def, Directorate Mental Hlth, Ottawa, ON, Canada	Lee, JEC (corresponding author), Natl Def Hdq, Mil Personnel Res & Anal, 101 Colonel Dr, Ottawa, ON K1A 0K2, Canada.	jennifer.lee@forces.gc.ca			Canadian Department of National Defence	This project was funded by the Canadian Department of National Defence. No conflicts of interests are declared.	Arroll B, 2010, ANN FAM MED, V8, P348, DOI 10.1370/afm.1139; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Eaton W., 2011, TXB PSYCHIAT EPIDEMI; Edge HJM, 2012, MIL PSYCHOL, V24, P71, DOI 10.1080/08995605.2012.642292; Garber BG, 2012, MILD TRAUMATIC BRAIN; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hotopf M, 2005, INT J EPIDEMIOL, V34, P791, DOI 10.1093/ije/dyi102; Hyams KC, 1996, ANN INTERN MED, V125, P398, DOI 10.7326/0003-4819-125-5-199609010-00007; Iversen A, 2007, CLIN PSYCHOL REV, V27, P842, DOI 10.1016/j.cpr.2007.07.006; Keane T., 1994, PTSD CHECKLIST CIVIL; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K., 2003, PRIMARY CARE COMPANI, V5, P11; Lang AJ, 2005, BEHAV RES THER, V43, P585, DOI 10.1016/j.brat.2004.04.005; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Lee JEC, 2013, 2013006 DGMPRA TM DE; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; Miller KJ, 2013, J HEAD TRAUMA REHAB, V28, P31, DOI 10.1097/HTR.0b013e318255ceae; Olson CB, 2004, MIL PSYCHOL, V16, P53, DOI 10.1207/s15327876mp1601_4; Polusny MA, 2011, PSYCHOL MED, V41, P687, DOI 10.1017/S0033291710002047; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rona RJ, 2012, J PSYCHIATR RES, V46, P1191, DOI 10.1016/j.jpsychires.2012.05.009; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604	35	12	12	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0033-3174	1534-7796		PSYCHOSOM MED	Psychosom. Med.	NOV-DEC	2015	77	9					1006	1017		10.1097/PSY.0000000000000250			12	Psychiatry; Psychology; Psychology, Multidisciplinary	Psychiatry; Psychology	CV7ZU	WOS:000364497100006	26458235				2021-06-18	
J	Thaler, HW; Schmidsfeld, J; Pusch, M; Pienaar, S; Wunderer, J; Pittermann, P; Valenta, R; Gleiss, A; Fialka, C; Mousavi, M				Thaler, Heinrich Wolfgang; Schmidsfeld, Johen; Pusch, Michael; Pienaar, Simon; Wunderer, Joerg; Pittermann, Paul; Valenta, Rosmarie; Gleiss, Andreas; Fialka, Christian; Mousavi, Mehdi			Evaluation of S100B in the diagnosis of suspected intracranial hemorrhage after minor head injury in patients who are receiving platelet aggregation inhibitors and in patients 65 years of age and older	JOURNAL OF NEUROSURGERY			English	Article						minor head injury; intracranial hemorrhage; S100B; platelet aggregation inhibitors; older patients; traumatic brain injury	TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; PROTEIN S-100B; SERUM-LEVELS; MILD; ADULTS; CT; MULTICENTER; RISK; METAANALYSIS	OBJECT Cranial CT (CCT) scans and hospital admission are increasingly performed to rule out intracranial hemorrhage in patients after minor head injury (MHI), particularly in older patients and in those receiving antiplatelet therapy. This leads to high radiation exposure and a growing financial burden. The aim of this study was to determine whether the astroglial-derived protein S100B that is released into blood can be used as a reliable negative predictive tool for intracranial bleeding in patients after MHI, when they are older than 65 years or being treated with antiplatelet drugs (low-dose aspirin, clopidogrel). METHODS The authors conducted a prospective observational study in 2 trauma hospitals. A total of 782 patients with MHI (Glasgow Coma Scale Score 13-15) who were on medication with platelet aggregation inhibitors (PAIs) or were age 65 years and older, independent of antiplatelet therapy, were included. Clinical examination, bloodwork, observation, and CCT were performed in the traumatology emergency departments. When necessary, patients were admitted and observation took place on the ward; in these patients, CCT was performed during their hospital stay. Patients with severe trauma, focal neurological deficits, posttraumatic seizures, anticoagulant therapy, alcohol intoxication, coagulation disorder, blood sampling more than 3 hours after trauma, and unknown time of the trauma were excluded from the study. The median age of the patients was 83 years, and 69% were female. Sensitivity, specificity, and positive and negative predictive values of S100B with reference to CCT findings were calculated. The cutoff of S100B was set at 0.105 mu g/L. RESULTS Of the 782 patients, 50 (6.4%) had intracranial bleeding. One patient with positive results on CCT scan showed an S100B level below 0.105 mu g/L. Of all patients, 33.1% were below the cutoff. S100B showed a sensitivity of 98.0% (CI 89.5%-99.7%), a negative predictive value of 99.6% (CI 97.9%-99.9%), a specificity of 35.3% (CI 31.9% -38.8%), and a positive predictive value of 9.4% (CI 7.2%-12.2%). CONCLUSIONS Levels of S100B below 0.105 mu g/L can accurately predict normal CCT findings after MHI in older patients and in those treated with PAIs. Combining conventional decision criteria with measurement of S100B can reduce the CCT scan and hospital admission rates by approximately 30%.	[Thaler, Heinrich Wolfgang; Pusch, Michael; Pienaar, Simon; Wunderer, Joerg; Pittermann, Paul; Fialka, Christian] Med Univ Vienna, Trauma Hosp Meidling, Vienna, Austria; [Schmidsfeld, Johen; Mousavi, Mehdi] Med Univ Vienna, Donauspital, Dept Traumatol, Vienna, Austria; [Valenta, Rosmarie] Med Univ Vienna, Kaiser Franz Josef Spital, Dept Radiol, Vienna, Austria; [Gleiss, Andreas] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria	Thaler, HW (corresponding author), Trauma Hosp Meidling, Kundratstr 37, A-1120 Vienna, Austria.	heinrich.thaler@auva.at			Allgemeine Unfallversicherungsanstalt (AUVA-the Austrian Workers' Compensation Board); Medical Head Office, AUVA [FK 19/12]	This study was supported by a grant from the scientific fund of the Allgemeine Unfallversicherungsanstalt (AUVA-the Austrian Workers' Compensation Board); research account Nr FK 19/12, Medical Head Office, AUVA.	Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Davis PC, 2007, AM J NEURORADIOL, V28, P1619; Fabbri A, 2013, CRIT CARE, V17, DOI 10.1186/cc12575; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Harnan SE, 2011, J TRAUMA, V71, P245, DOI 10.1097/TA.0b013e31820d090f; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; He H, 2012, BIOSTATISTICS, V13, P32, DOI 10.1093/biostatistics/kxr020; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Laribi S, 2014, CLIN CHEM LAB MED, V52, P527, DOI 10.1515/cclm-2013-0621; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Morton MJ, 2012, ANN EMERG MED, V60, P361, DOI 10.1016/j.annemergmed.2011.12.026; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Patrono C, 2008, CHEST, V133, p199S, DOI 10.1378/chest.08-0672; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Rothoerl RD, 1998, J TRAUMA, V45, P765, DOI 10.1097/00005373-199810000-00025; Roudsari B, 2012, AM J ROENTGENOL, V198, P985, DOI 10.2214/AJR.11.6976; Ruan S, 2009, J NEUROTRAUM, V26, P1655, DOI [10.1089/neu.2009.0928, 10.1089/neu.2009-0928]; Smith-Bindman R, 2010, NEW ENGL J MED, V363, P1, DOI 10.1056/NEJMp1002530; Spektor S, 2003, J NEUROSURG, V99, P661, DOI 10.3171/jns.2003.99.4.0661; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tauber M, 2009, J TRAUMA, V67, P521, DOI 10.1097/TA.0b013e3181a7c184; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tibshirani, 1994, INTRO BOOTSTRAP, DOI 10.1201/9780429246593; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Townend WJ, 2002, J NEUROL NEUROSUR PS, V73, P542, DOI 10.1136/jnnp.73.5.542; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Vaturi M, 2013, AM J CARDIOL, V112, P212, DOI 10.1016/j.amjcard.2013.03.022; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yuan MK, 2013, AM J ROENTGENOL, V201, P626, DOI 10.2214/AJR.12.9652; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	38	12	12	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2015	123	5					1202	1208		10.3171/2014.12.JNS142276			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CU3QL	WOS:000363439800014	26148794	Bronze			2021-06-18	
J	Lei, J; Wang, L; Gao, GY; Cooper, E; Jiang, JY				Lei, Jin; Wang, Lei; Gao, Guoyi; Cooper, Edwin; Jiang, Jiyao			Right Median Nerve Electrical Stimulation for Acute Traumatic Coma Patients	JOURNAL OF NEUROTRAUMA			English	Article						coma; efficacy; right median nerve stimulation; severe traumatic brain injury	ACQUIRED BRAIN-INJURY; VEGETATIVE STATE; CONSCIOUSNESS; DISORDERS; AROUSAL	The right median nerve as a peripheral portal to the central nervous system can be electrically stimulated to help coma arousal after traumatic brain injury (TBI). The present study set out to examine the efficacy and safety of right median nerve electrical stimulation (RMNS) in a cohort of 437 comatose patients after severe TBI from August 2005 to December 2011. The patients were enrolled 2 weeks after their injury and assigned to the RMNS group (n=221) receiving electrical stimulation for 2 weeks or the control group (n=216) treated by standard management according to the date of birth in the month. The baseline data were similar. After the 2-week treatment, the RMNS-treated patients demonstrated a more rapid increase of the mean Glasgow Coma Score, although statistical significance was not reached (8.43 +/- 4.98 vs. 7.47 +/- 5.37, p=0.0532). The follow-up data at 6-month post-injury showed a significantly higher proportion of patients who regained consciousness (59.8% vs. 46.2%, p=0.0073). There was a lower proportion of vegetative persons in the RMNS group than in the control group (17.6% vs. 22.0%, p=0.0012). For persons regaining consciousness, the functional independence measurement (FIM) score was higher among the RMNS group patients (91.45 +/- 8.65 vs. 76.23 +/- 11.02, p<0.001). There were no unique complications associated with the RMNS treatment. The current study, although with some limitations, showed that RMNS may serve as an easy, effective, and noninvasive technique to promote the recovery of traumatic coma in the early phase.	[Lei, Jin; Wang, Lei; Gao, Guoyi; Jiang, Jiyao] Shanghai Jiao Tong Univ, Sch Med, Dept Neurosurg, Renji Hosp, Shanghai 200127, Peoples R China; [Lei, Jin; Wang, Lei; Gao, Guoyi; Jiang, Jiyao] Shanghai Inst Head Trauma, Shanghai, Peoples R China; [Cooper, Edwin] Univ Virginia Hlth Syst, Dept Neurol Surg, Charlottesville, VA USA	Gao, GY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Neurosurg, Renji Hosp, 1630 Dongfang Rd, Shanghai 200127, Peoples R China.	guoyigao@gmail.com			National Key Basic Research ProjectNational Basic Research Program of China [2012CB518100]; National Natural Scientific grants [81271381]; Program for Shanghai Outstanding Medical Academic Leader	This work was supported by grants from National Key Basic Research Project (No. 2012CB518100), National Natural Scientific grants (No. 81271381), and Program for Shanghai Outstanding Medical Academic Leader.	ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bagnato S, 2013, NEUROSCI BIOBEHAV R, V37, P2721, DOI 10.1016/j.neubiorev.2013.09.007; Bagnato S, 2011, J PERIPHER NERV SYST, V16, P315, DOI 10.1111/j.1529-8027.2011.00363.x; Bennett MH, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD004609.PUB3; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; BRICOLO A, 1980, J NEUROSURG, V52, P625, DOI 10.3171/jns.1980.52.5.0625; Buitrago MM, 2004, EXP BRAIN RES, V158, P336, DOI 10.1007/s00221-004-1906-1; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cooper EB, 2005, NEUROPSYCHOL REHABIL, V15, P389, DOI 10.1080/09602010443000317; Cooper EB, 2003, ACT NEUR S, V87, P7; Cooper EB, 1988, P AM INP OUTP SYST A; Cooper JB, 1999, BRAIN INJURY, V13, P261, DOI 10.1080/026990599121638; Cossu G, 2014, BRIT J NEUROSURG, V28, P187, DOI 10.3109/02688697.2013.841845; DeMarchi R, 2005, CAN J NEUROL SCI, V32, P4, DOI 10.1017/S0317167100016826; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Georgiopoulos M, 2010, STEREOT FUNCT NEUROS, V88, P199, DOI 10.1159/000314354; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Gobbo OL, 2004, BEHAV BRAIN RES, V152, P231, DOI 10.1016/j.bbr.2003.10.017; Hayashi N., 1997, SOC TREAT COMA, V6, P133; Kayama Y, 1998, EUR UROL, V33, P12, DOI 10.1159/000052235; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Kwan CL, 2000, PAIN, V85, P359, DOI 10.1016/S0304-3959(99)00287-0; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Liu JT, 2003, ACTA NEUROCHIR SUPPL, V87, P11; LYLE DM, 1986, J NEUROSURG, V65, P15, DOI 10.3171/jns.1986.65.1.0015; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Meyer MJ, 2010, BRAIN INJURY, V24, P722, DOI 10.3109/02699051003692134; Oppel L, 2003, BRAIN INJURY, V17, P225, DOI 10.1080/0269905021000030814; Peri CV, 2001, BRAIN INJURY, V15, P903, DOI 10.1080/02699050110065709; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; Yokoyama T, 1996, SOC TREAT COMA, V5, P117	33	12	23	3	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2015	32	20					1584	1589		10.1089/neu.2014.3768			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CS6VH	WOS:000362220500006	25664378				2021-06-18	
J	Chen, XM; Liu, Y; Zhang, L; Zhu, P; Zhu, HB; Yang, Y; Guan, P				Chen, Xiameng; Liu, Yuan; Zhang, Lin; Zhu, Peng; Zhu, Haibiao; Yang, Yu; Guan, Peng			Long-term neuroglobin expression of human astrocytes following brain trauma	NEUROSCIENCE LETTERS			English	Article						Neuroglobin; Astrocyte; TBI; Sub-acute; Chronic	PROTECTS PC12 CELLS; CEREBRAL-ISCHEMIA; GLOBIN GENE; 14-3-3 PROTEINS; MOUSE-BRAIN; INJURY; OVEREXPRESSION; HEMOGLOBIN; CYTOGLOBIN; OUTCOMES	Neuroglobin (Ngb), a 17 kDa monomeric protein, was initially described as a vertebrate oxygen-binding heme protein in 2000 and detected in metabolically active organs or cells, like the brain, peripheral nervous system as well as certain endocrine cells. A large array of initial experimental work reported that Ngb displayed a neuron restricted expression pattern in mammalian brains. However, growing evidence indicated astrocytes may also express Ngb under pathological conditions. To address the question whether human astrocytes express Ngb under traumatic insults, we investigated Ngb immuno-reactivity in post-mortem human brain tissues that died of acute, sub-acute and chronic brain trauma, respectively. We observed astrocytic Ngb expression in sub-acute and chronic traumatic brains rather than acute traumatic brains. Strikingly, the Ngb immuno-reactive astrocytes were still strongly detectable in groups that died 12 months after brain trauma. Our findings may imply an unexplored role of Ngb in astrocytes and the involved mechanisms were suggested to be further characterized. Also, therapeutic application of Ngb or Ngb-inducible chemical compounds in neuro-genesis or astrocytic scar forming can be expected. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Chen, Xiameng; Liu, Yuan; Zhu, Haibiao; Yang, Yu; Guan, Peng] Sichuan Univ, West China Sch Preclin & Forens Med, Dept Forens Pathol, Chengdu 610041, Sichuan, Peoples R China; [Zhang, Lin] Sichuan Univ, West China Univ Hosp 2, West China Inst Women & Childrens Hlth,Minist Edu, Lab Mol Translat Med,Key Lab Obstet & Gynecol & P, Chengdu 610041, Sichuan, Peoples R China; [Zhu, Peng] Peoples Procuratorate Chengdu, Chengdu, Sichuan, Peoples R China	Guan, P (corresponding author), Sichuan Univ, West China Sch Preclin & Forens Med, Dept Forens Pathol, Chengdu 610041, Sichuan, Peoples R China.	guanpengcn@hotmail.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [30470660]; Natural Science Foundation of Sichuan Province [05JY029-020, 2011JY0007]	This study was supported by National Natural Science Foundation of China (NSFC, No.30470660) and the Natural Science Foundation of Sichuan Province (No.05JY029-020, No.2011JY0007).	Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Butler PJ, 2004, RESP PHYSIOL NEUROBI, V141, P297, DOI 10.1016/j.resp.2004.01.010; Chen XQ, 2005, GLIA, V50, P182, DOI 10.1002/glia.20147; Chen XQ, 2002, BIOCHEM BIOPH RES CO, V296, P657; Chuang PY, 2010, J NEUROTRAUM, V27, P999, DOI 10.1089/neu.2009.1129; De Marinis E, 2010, NEUROSIGNALS, V18, P223, DOI 10.1159/000323906; Dellavalle B, 2010, GLIA, V58, P1220, DOI 10.1002/glia.21002; Dewilde S, 1996, J BIOL CHEM, V271, P19865, DOI 10.1074/jbc.271.33.19865; Emara M, 2009, MOL ONCOL, V3, P45, DOI 10.1016/j.molonc.2008.11.002; Fuchs C, 2006, CYTOGENET GENOME RES, V112, P296, DOI 10.1159/000089884; Geuens E, 2003, J BIOL CHEM, V278, P30417, DOI 10.1074/jbc.C300203200; Haines B, 2013, NEUROSCI LETT, V549, P3, DOI 10.1016/j.neulet.2013.04.039; Hoogewijs D, 2012, MOL BIOL EVOL, V29, P1105, DOI 10.1093/molbev/msr246; Hota KB, 2012, J CEREBR BLOOD F MET, V32, P1046, DOI 10.1038/jcbfm.2012.21; Hundahl CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034462; Hundahl CA, 2010, BRAIN RES, V1331, P58, DOI 10.1016/j.brainres.2010.03.056; Jang SW, 2009, J BIOL CHEM, V284, P24512, DOI 10.1074/jbc.M109.026237; Jin KL, 2011, PHARMACOLOGY, V87, P81, DOI 10.1159/000322998; Jin KL, 2010, STROKE, V41, P557, DOI 10.1161/STROKEAHA.109.567149; Kugelstadt D, 2004, BIOCHEM BIOPH RES CO, V325, P719, DOI 10.1016/j.bbrc.2004.10.080; Laufs TL, 2004, NEUROSCI LETT, V362, P83, DOI 10.1016/j.neulet.2004.02.072; Lechauve C, 2013, BBA-PROTEINS PROTEOM, V1834, P1772, DOI 10.1016/j.bbapap.2013.04.014; Li RC, 2008, NEUROBIOL AGING, V29, P1815, DOI 10.1016/j.neurobiolaging.2007.05.001; Li RC, 2008, BRAIN RES, V1190, P159, DOI 10.1016/j.brainres.2007.11.022; Li WG, 2011, PROTEINS, V79, P115, DOI 10.1002/prot.22863; Liu M, 2005, J CEREBR BLOOD F MET, V25, P939, DOI 10.1038/sj.jcbfm.9600085; Meir JU, 2009, J EXP BIOL, V212, P3330, DOI 10.1242/jeb.033761; Nedergaard M, 2005, GLIA, V50, P281, DOI 10.1002/glia.20205; Pellerin L, 2005, MOL NEUROBIOL, V32, P59, DOI 10.1385/MN:32:1:059; Pirim I, 1998, INT J NEUROSCI, V95, P101, DOI 10.3109/00207459809000653; Qin HJ, 2012, BRAIN TUMOR PATHOL, V29, P10, DOI 10.1007/s10014-011-0066-9; QVIST J, 1986, J APPL PHYSIOL, V61, P1560; Raida Zindy, 2012, Exp Transl Stroke Med, V4, P15, DOI 10.1186/2040-7378-4-15; Ramirez JM, 2007, ANNU REV PHYSIOL, V69, P113, DOI 10.1146/annurev.physiol.69.031905.163111; Roesner A, 2005, MOL BIOL EVOL, V22, P12, DOI 10.1093/molbev/msh258; Schneuer M, 2012, NEUROSCIENCE, V223, P35, DOI 10.1016/j.neuroscience.2012.07.052; Shang AJ, 2012, NEUROL SCI, V33, P551, DOI 10.1007/s10072-011-0772-4; Taylor JM, 2014, NEUROSCI LETT, V577, P125, DOI 10.1016/j.neulet.2014.03.012; Trendelenburg G, 2005, GLIA, V50, P307, DOI 10.1002/glia.20204; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; Vandergon TL, 1998, J BIOL CHEM, V273, P16998, DOI 10.1074/jbc.273.27.16998; Verratti V, 2009, ADV EXP MED BIOL, V648, P191, DOI 10.1007/978-90-481-2259-2_22; Wang XY, 2008, STROKE, V39, P1869, DOI 10.1161/STROKEAHA.107.506022; Wystub S, 2003, NEUROSCI LETT, V346, P114, DOI 10.1016/S0304-3940(03)00563-9; Zhang CG, 2002, BIOCHEM BIOPH RES CO, V290, P1411, DOI 10.1006/bbrc.2002.6360; Zhao J, 2011, SEMIN CELL DEV BIOL, V22, P705, DOI 10.1016/j.semcdb.2011.09.012; Zhao S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-67	48	12	15	0	13	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	OCT 8	2015	606						194	199		10.1016/j.neulet.2015.09.002			6	Neurosciences	Neurosciences & Neurology	CU2IJ	WOS:000363346900035	26362813				2021-06-18	
J	Henry, LC; Sandel, N				Henry, Luke C.; Sandel, Natalie			Adolescent Subtest Norms for the ImPACT Neurocognitive Battery	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						adolescent; concussion; neuropsychology; normative data	SPORTS-RELATED CONCUSSION; TENSOR IMAGING FINDINGS; TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; ONLINE VERSION; SYMPTOMS; RECOVERY; PERFORMANCE	The neurocognitive testing of sports concussion for injury management and return-to-play decisions has long been considered the gold standard in evaluation of the injury. Computerized testing batteries are frequently employed, with the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) being the most used of all the current testing platforms to evaluate concussion. ImPACT's clinical report yields four normed composite scores (Verbal Memory, Visual Memory, Visual Motor Speed, and Reaction Time) and another composite score that is not normed but is used as a validity measure (Impulse Control), as well as their corresponding subtest scores, which are not normed. The current study provides normative data on each of the subtests used to calculate the composite scores. Normative data are separated by gender for athletes aged 13 to 21 years old and are stratified by the norm age brackets already employed by the ImPACT. These norms may be helpful in the interpretation of the ImPACT clinical report and further delineation of areas of neurocognitive dysfunction.	[Henry, Luke C.] Univ Pittsburgh, Med Ctr, Orthopaed Surg, Pittsburgh, PA 15203 USA; [Sandel, Natalie] Widener Univ, Inst Grad Clin Psychol, Chester, PA 19013 USA	Henry, LC (corresponding author), Univ Pittsburgh, Med Ctr, Orthopaed Surg, 3200 S Water St, Pittsburgh, PA 15203 USA.	henryl@upmc.edu	Meijer, Anna/K-5118-2016				Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; BARTH J, 1989, J COGNITIVE NEUROREH, V26, P451; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Cohen R, 2006, CLIN NEUROPSYCHOLOGY, P572; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Henry L. C., 2010, HDB SPORT NEUROPSYCH, V1, P153; Ikeda Y, 2013, RES DEV DISABIL, V34, P2391, DOI 10.1016/j.ridd.2013.04.019; ImPACT Applications, 2011, IMM POST CONC ASS TE; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; National Academy of Neuropsychology, 2013, CONC LEG; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Sandel NK, 2013, APPL NEUROPSYCH-CHIL, V2, P64, DOI 10.1080/21622965.2012.670580; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839; Yurgelun-Todd D, 2007, CURR OPIN NEUROBIOL, V17, P251, DOI 10.1016/j.conb.2007.03.009; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	39	12	12	0	15	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	OCT 2	2015	4	4					266	276		10.1080/21622965.2014.911094			11	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	CT2QT	WOS:000362649000006	25412432				2021-06-18	
J	Harrison, DA; Griggs, KA; Prabhu, G; Gomes, M; Lecky, FE; Hutchinson, PJA; Menon, DK; Rowan, KM				Harrison, David A.; Griggs, Kathryn A.; Prabhu, Gita; Gomes, Manuel; Lecky, Fiona E.; Hutchinson, Peter J. A.; Menon, David K.; Rowan, Kathryn M.		Risk Adjustment Neurocritical Care	External Validation and Recalibration of Risk Prediction Models for Acute Traumatic Brain Injury among Critically Ill Adult Patients in the United Kingdom	JOURNAL OF NEUROTRAUMA			English	Article						outcome measures; prospective study; traumatic brain injury	LONG-TERM OUTCOMES; HEAD-INJURY; PROGNOSTIC-FACTORS; CARE; MORTALITY; MODERATE; IMPACT; RECOVERY; CLASSIFICATION; EPIDEMIOLOGY	This study validates risk prediction models for acute traumatic brain injury (TBI) in critical care units in the United Kingdom and recalibrates the models to this population. The Risk Adjustment In Neurocritical care (RAIN) Study was a prospective, observational cohort study in 67 adult critical care units. Adult patients admitted to critical care following acute TBI with a last pre-sedation Glasgow Coma Scale score of less than 15 were recruited. The primary outcomes were mortality and unfavorable outcome (death or severe disability, assessed using the Extended Glasgow Outcome Scale) at six months following TBI. Of 3626 critical care unit admissions, 2975 were analyzed. Following imputation of missing outcomes, mortality at six months was 25.7% and unfavorable outcome 57.4%. Ten risk prediction models were validated from Hukkelhoven and colleagues, the Medical Research Council (MRC) Corticosteroid Randomisation After Significant Head Injury (CRASH) Trial Collaborators, and the International Mission for Prognosis and Analysis of Clinical Trials in TBI (IMPACT) group. The model with the best discrimination was the IMPACT Lab model (C index, 0.779 for mortality and 0.713 for unfavorable outcome). This model was well calibrated for mortality at six months but substantially under-predicted the risk of unfavorable outcome. Recalibration of the models resulted in small improvements in discrimination and excellent calibration for all models. The risk prediction models demonstrated sufficient statistical performance to support their use in research and audit but fell below the level required to guide individual patient decision-making. The published models for unfavorable outcome at six months had poor calibration in the UK critical care setting and the models recalibrated to this setting should be used in future research.	[Harrison, David A.; Griggs, Kathryn A.; Prabhu, Gita; Rowan, Kathryn M.] Intens Care Natl Audit & Res Ctr, Clin Trials Unit, London WC1V 6AZ, England; [Gomes, Manuel] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England; [Lecky, Fiona E.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Hutchinson, Peter J. A.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Menon, David K.] Univ Cambridge, Div Anaesthesia, Cambridge, England	Harrison, DA (corresponding author), Intens Care Natl Audit & Res Ctr, Clin Trials Unit, Napier House,24 High Holborn, London WC1V 6AZ, England.	david.harrison@icnarc.org	Harrison, David A/O-4355-2018	Harrison, David A/0000-0002-9002-9098; Gomes, Manuel/0000-0002-1428-1232; Hutchinson, Peter/0000-0002-2796-1835; Grieve, Richard/0000-0001-8899-1301	National Institute for Health Research Health Technology Assessment (NIHR HTA) ProgrammeNational Institute for Health Research (NIHR) [07/37/29]; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); Neurocritical Care Network; National Institute for Health ResearchNational Institute for Health Research (NIHR) [07/37/29, NF-SI-0512-10090, NIHR-RP-R3-12-013] Funding Source: researchfish	This project was funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) Programme (project number 07/37/29) and has been published in full in Health Technology Assessment. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, NHS or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PJAH was supported by the NIHR Cambridge Biomedical Research Centre.; The authors wish to thank all the participants for taking part in the study, GPs and health care professionals for their assistance in patient follow-up, the Scottish Intensive Care Society Audit Group for providing access to their database, the Trauma Audit and Research Network for providing data for verification of recruitment, and the Neurocritical Care Network for adopting and supporting the study.	Brier G.W., 1950, MONTHLY WEATHER REV, V78, P1, DOI 2.0.CO;2; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P418, DOI 10.1016/j.apmr.2007.01.010; COX DR, 1958, BIOMETRIKA, V45, P562, DOI 10.1093/biomet/45.3-4.562; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Feiz-Erfan I, 2007, J NEUROSURG, V107, P364, DOI 10.3171/JNS-07/08/0364; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hayes J A, 2000, Health Technol Assess, V4, P1; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Hsiao KY, 2008, EMERG MED J, V25, P670, DOI 10.1136/emj.2007.053405; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hyam JA, 2006, CRIT CARE, V10, DOI 10.1186/cc5066; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Johnson P, 2006, BRAIN COGNITION, V60, P205; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; LI KH, 1991, STAT SINICA, V1, P65; Liao CC, 2007, J TRAUMA, V63, P827, DOI 10.1097/TA.0b013e31814b9466; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Oh Hyun Soo, 2006, Taehan Kanho Hakhoe Chi, V36, P621; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Pang BC, 2007, J NEUROTRAUM, V24, P136, DOI 10.1089/neu.2006.0113; Pape TLB, 2006, BRAIN INJURY, V20, P743, DOI 10.1080/02699050600676933; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Rocker GM, 2006, CAN J ANAESTH, V53, P814, DOI 10.1007/BF03022799; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Rubin DB., 1987, MULTIPLE IMPUTATION; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Salorio CF, 2008, PEDIATR CRIT CARE ME, V9, P47, DOI 10.1097/01.PCC.0000298638.66240.0E; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Skrobik Y, 2006, CAN J ANAESTH, V53, P432, DOI 10.1007/BF03022613; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Spiegelhalter D, 2011, SCIENCE, V333, P1393, DOI 10.1126/science.1191181; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; The CRASH trial management group, 2001, BMC Emerg Med, V1, P1; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Tibshirani, 1994, INTRO BOOTSTRAP, DOI 10.1201/9780429246593; van Buuren S, 2011, J STAT SOFTW, V45, P1; Xu XY, 2007, BRAIN INJURY, V21, P575, DOI 10.1080/02699050701426881; Yeoman P, 2011, J TRAUMA, V71, P387, DOI 10.1097/TA.0b013e31820ceadd; Zheng WB, 2007, NEURORADIOLOGY, V49, P271, DOI 10.1007/s00234-006-0187-8	56	12	13	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2015	32	19					1522	1537		10.1089/neu.2014.3628			16	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CR8NC	WOS:000361609500010	25898072	Green Published			2021-06-18	
J	Jennings, D; Sells, P; Allison, J; Boyd, K; Frommert, D; Kessler, C; Merryman, L; Muchmore, J; Odom, TJ; Salmon, R; Robinson, K				Jennings, David; Sells, Pat; Allison, Jenni; Boyd, Kasey; Frommert, Dave; Kessler, Chelsea; Merryman, Lindsey; Muchmore, Joe; Odom, T. J.; Salmon, Ryan; Robinson, Kevin			EFFECTS OF A SEASON OF SUBCONCUSSIVE CONTACT ON CHILD- SCAT3 SCORES IN 8-12 YEAR-OLD MALE ATHLETES	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						Child-Scat3; football; subconcussive contact		Background: Each year, over 173,000 children and adolescents visit emergency departments due to sports and recreation related concussions, an increase of 60% over the last decade due to the rise in the number of children participating in sport. While numerous authors have sought to address the epidemiology of concussions across multiple age groups who participate in contact sports, a recent review of literature did not reveal a substantial amount of published articles that addressed the issue of subconcussive contact. Multiple tools have been developed to assess acute episodes of concussion. Among the assessment protocols many include an assessment of balance, short and long term memory recall, and balance. The Child-SCAT3 was designed specifically to evaluate concussions in children 5-12 years of age. Objective: The purpose of this study was to determine the effect of a season of subconcussive contact on Child-SCAT3 scores in 8-12 year old males compared to their age matched peers who participated in non-contact sports. A secondary purpose was to evaluate how scores of the sub-components of the Child-SCAT3 compare between contact and non-contact athletes. Design: A prospective cohort study was performed of 71 male athletes (58 football, 13 baseball) ages 8-12 (contact mean age 10.30 years, SD 1.20; non-contact mean age 10.03 years, SD 1.26) over the course of a season. Methods: Portions of The Child-SCAT3 were administered and scored in pre-adolescent athletes prior to and following a season of participation in football (contact sport group) and baseball (non-contact sport group). The outcome measures of interest included the portions related to Cognitive ability, Balance, and Coordination. Results: No statistically significant differences were found in group, time or time and group interaction for any of the utilized portions of the Child-SCAT3. Statistically significant differences were found between groups for preseason cognitive orientation and postseason immediate memory. Cognitive orientation and coordination were also found to be statistically significantly improved across both groups over the course of the season. Limitations: This study was potentially limited by the number of control subjects tested. Conclusions: A season of subconcussive contact in football was not detrimental to cognitive and balance scores on the Child-SCAT3.	[Jennings, David; Sells, Pat; Allison, Jenni; Boyd, Kasey; Frommert, Dave; Kessler, Chelsea; Merryman, Lindsey; Muchmore, Joe; Odom, T. J.; Salmon, Ryan; Robinson, Kevin] Belmont Univ, Sch Phys Therapy, 1900 Belmont Blvd, Nashville, TN 37212 USA	Jennings, D (corresponding author), Belmont Univ, Sch Phys Therapy, 1900 Belmont Blvd, Nashville, TN 37212 USA.	David.L.Jennings1@gmail.com					Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Glaviano N, 2014, CLIN J SPORT MED, P1; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; IBM Corp, 2012, SPSS STAT WIND VERS; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; McCrory P, 2005, PHYSICIAN SPORTSMED, V33, P29, DOI 10.3810/psm.2005.04.76; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Merkel DL, 2012, INT J SPORTS PHYS TH, V7, P242; Moore RD, 2014, J ATHL TRAINING, V49, P36, DOI 10.4085/1062-6050-49.1.02; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Schneiders AG, 2008, BRIT J SPORT MED, V42, P1011, DOI 10.1136/bjsm.2007.041665; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Stern RA, 2015, NEUROLOGY, V85, P1008; SWAINE BR, 1993, PHYS THER, V73, P71, DOI 10.1093/ptj/73.2.71; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055	26	12	12	0	8	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	OCT	2015	10	5					667	675					9	Sport Sciences	Sport Sciences	VA2EZ	WOS:000409721600010	26491617				2021-06-18	
J	Kuechler, JN; Abusamha, A; Ziemann, S; Tronnier, VM; Gliemroth, J				Kuechler, Jan Nils; Abusamha, Abdulkareem; Ziemann, Sandra; Tronnier, Volker Martin; Gliemroth, Jan			Impact of percutaneous dilatational tracheostomy in brain injured patients	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Percutaneously dilatative tracheostomy; Brain tissue oxygen tension; Intracranial pressure; Cerebral perfusion pressure	INTRACRANIAL-PRESSURE; SURGICAL TRACHEOTOMY; PERFUSION-PRESSURE; MORTALITY; TRIAL	Objective: Tracheostomy is an established method in the airway management of critically ill patients with traumatic and non-traumatic brain injuries. High priority in the treatment of those patients is to protect vulnerable brain tissue. While bedside percutaneously dilatative tracheostomy (PDT) technique is increasingly used, there is disagreement about the harms of this intervention for the damaged brain. Therefore, discussions about the safety of tracheostomy in those patients must consider direct and indirect cerebral parameters. Methods: We examined a series of 289 tracheostomies regarding vital signs, respiratory and intracranial parameters in a retrospective study. Complications were recorded and risk factors for a complicated scenario statistically determined. Results: Severe complications were rare (1/289). Arterial hypotension occurred in 3 of 289 cases with a systolic blood pressure below 90 mmHg. We had two patients (0.5%) with transient hypoxia, but 43 cases (15%) of severe hypercapnia during PDT. Invasive measurement of brain tissue oxygen tension (PBrO2) ruled out any cerebral hypoxia during the procedure in 39 available cases. Intracranial pressure (ICP) rose temporarily in 24% of the cases. Cerebral perfusion pressure (CPP) however remained unaffected. Surgery time and hypercapnia are capable risk factors for intraoperative ICP elevation. There is no significant difference in intraoperative ICP rises between disease entities. Conclusion: PDT is a safe procedure for the most common neurosurgical diseases, even for patients with respiratory insufficiency. Shortening surgical time seems to be the most important factor to avoid ICP increase. (C) 2015 Elsevier B.V. All rights reserved.	[Kuechler, Jan Nils; Abusamha, Abdulkareem; Ziemann, Sandra; Tronnier, Volker Martin; Gliemroth, Jan] Med Univ Lubeck, Dept Neurosurg, D-23538 Lubeck, Germany	Gliemroth, J (corresponding author), Med Univ Lubeck, Dept Neurosurg, Ratzeburger Allee 160, D-23538 Lubeck, Germany.	jan.gliemroth@t-online.de		Kuchler, Jan/0000-0002-2587-3129			Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Borm W, 2003, NEUROSURG REV, V26, P188, DOI 10.1007/s10143-002-0248-3; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Byhahn C, 2000, ANAESTHESIST, V49, P202, DOI 10.1007/s001010050815; Cerejo A, 2012, NEUROL RES, V34, P181, DOI 10.1179/1743132811Y.0000000064; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Durbin CG, 2010, RESP CARE, V55, P1056; Esteban A, 2000, AM J RESP CRIT CARE, V161, P1450, DOI 10.1164/ajrccm.161.5.9902018; Fikkers BG, 2011, INTENS CARE MED, V37, P1103, DOI 10.1007/s00134-011-2222-4; HAZARD P, 1991, CRIT CARE MED, V19, P1018, DOI 10.1097/00003246-199108000-00008; Heuer GG, 2004, J NEUROSURG, V101, P408, DOI 10.3171/jns.2004.101.3.0408; Higgins KM, 2007, LARYNGOSCOPE, V117, P447, DOI 10.1097/01.mlg.0000251585.31778.c9; Imperiale C, 2009, ANESTH ANALG, V108, P588, DOI 10.1213/ane.0b013e31818f601b; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kleffmann J, 2012, NEUROCRIT CARE, V17, P85, DOI 10.1007/s12028-012-9709-x; Kocaeli H, 2008, ACTA NEUROCHIR, V150, P1263, DOI 10.1007/s00701-008-0153-9; Milanchi S, 2008, J TRAUMA, V65, P73, DOI 10.1097/TA.0b013e31814693f2; Oggiano M, 2014, Pneumologie, V68, P322, DOI 10.1055/s-0034-1365198; Oliver ER, 2007, LARYNGOSCOPE, V117, P1570, DOI 10.1097/MLG.0b013e318093edae; Simon M, 2013, CRIT CARE, V17, DOI 10.1186/cc13085; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stocchetti N, 2000, J NEUROSURG ANESTH, V12, P307, DOI 10.1097/00008506-200010000-00002; Weissbrod PA, 2012, LARYNGOSCOPE, V122, P1423, DOI 10.1002/lary.23289	24	12	12	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	OCT	2015	137						137	141		10.1016/j.clineuro.2015.07.007			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CS2SD	WOS:000361921000028	26189073				2021-06-18	
J	Lee, M; Chen, ZZ; Tomlinson, BN; Gooyit, M; Hesek, D; Juarez, MR; Nizam, R; Boggess, B; Lastochkin, E; Schroeder, VA; Wolter, WR; Suckow, MA; Cui, JC; Mobashery, S; Gu, ZZ; Chang, M				Lee, Mijoon; Chen, Zhenzhou; Tomlinson, Brittany N.; Gooyit, Major; Hesek, Dusan; Juarez, Maria Raquel; Nizam, Rasheeq; Boggess, Bill; Lastochkin, Elena; Schroeder, Valerie A.; Wolter, William R.; Suckow, Mark A.; Cui, Jiancun; Mobashery, Shahriar; Gu, Zezong; Chang, Mayland			Water-Soluble MMP-9 Inhibitor Reduces Lesion Volume after Severe Traumatic Brain Injury	ACS CHEMICAL NEUROSCIENCE			English	Article						MMP-9; prodrug; brain distribution; traumatic brain injury	GELATINASE INHIBITOR; MATRIX METALLOPROTEINASES; POTENT; BLOOD; MATRIX-METALLOPROTEINASE-9; BARRIER; BINDING	SB-3CT is a potent and selective inhibitor of matrix metalloproteinase (MMP)-2 and -9, which has shown efficacy in an animal model of severe traumatic brain injury (TBI). However, SB-3CT is poorly water-soluble and is metabolized primarily to p-hydroxy SB-3CT (2), a more potent inhibitor than SB-3CT. We synthesized the O-phosphate prodrug (3) of compound 2 to enhance its water solubility by more than 2000-fold. The prodrug 3 was a poor MMP inhibitor, but readily hydrolyzed to the active 2 in human blood. Pharmacokinetics and brain distribution studies in mice showed that 2 crossed the blood-brain barrier (BBB) and achieved therapeutic concentrations in the brain. The prodrug 3/compound 2 was evaluated in a mouse model of severe TBI and found to significantly decrease the brain lesion volume and improve neurological outcomes. MMP-9 inhibition by a water-soluble thiirane inhibitor is a promising therapy for treatment of TBI.	[Lee, Mijoon; Gooyit, Major; Hesek, Dusan; Boggess, Bill; Lastochkin, Elena; Mobashery, Shahriar; Chang, Mayland] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Schroeder, Valerie A.; Wolter, William R.; Suckow, Mark A.] Univ Notre Dame, Freimann Life Sci Ctr, Notre Dame, IN 46556 USA; [Schroeder, Valerie A.; Wolter, William R.; Suckow, Mark A.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Chen, Zhenzhou; Tomlinson, Brittany N.; Juarez, Maria Raquel; Nizam, Rasheeq; Cui, Jiancun; Gu, Zezong] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65212 USA; [Chen, Zhenzhou; Tomlinson, Brittany N.; Juarez, Maria Raquel; Nizam, Rasheeq; Cui, Jiancun; Gu, Zezong] Univ Missouri, Sch Med, Ctr Translat Neurosci, Columbia, MO 65212 USA	Gu, ZZ (corresponding author), Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65212 USA.	guze@health.missouri.edu; mchang@nd.edu		Suckow, Mark/0000-0001-7317-697X; Lee, Mijoon/0000-0001-7432-0427	Indiana Department of Health Spinal Cord and Brain Injury Fund; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM075762]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM075762] Funding Source: NIH RePORTER	This work was supported by a grant from the Indiana Department of Health Spinal Cord and Brain Injury Fund. M.G. is a Fellow of the Chemistry-Biochemistry-Biology Interface Program, supported by a training grant GM075762 from the National Institutes of Health.	Brown S, 2000, J AM CHEM SOC, V122, P6799, DOI 10.1021/ja001461n; Chen ZZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092133; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Forbes C, 2009, CHEM BIOL DRUG DES, V74, P527, DOI 10.1111/j.1747-0285.2009.00881.x; Gooyit M, 2012, ACS CHEM NEUROSCI, V3, P730, DOI 10.1021/cn300062w; Gooyit M, 2011, J MED CHEM, V54, P6676, DOI 10.1021/jm200566e; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Ikejiri M, 2005, J BIOL CHEM, V280, P33992, DOI 10.1074/jbc.M504303200; Jia F, 2014, J NEUROTRAUM, V31, P1225, DOI 10.1089/neu.2013.3230; Lee M, 2007, CHEM BIOL DRUG DES, V70, P371, DOI 10.1111/j.1747-0285.2007.00577.x; Lee M, 2009, CHEM BIOL DRUG DES, V73, P189, DOI 10.1111/j.1747-0285.2008.00750.x; O'Daniel PI, 2014, J AM CHEM SOC, V136, P3664, DOI 10.1021/ja500053x; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; Pardridge William M, 2005, NeuroRx, V2, P3; Shelton SB, 2008, J NEUROSCI METH, V168, P431, DOI 10.1016/j.jneumeth.2007.11.003; Testero SA, 2011, ACS MED CHEM LETT, V2, P177, DOI 10.1021/ml100254e; Walker JM, 2011, BEHAV BRAIN RES, V222, P169, DOI 10.1016/j.bbr.2011.03.049; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000	20	12	12	0	12	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	OCT	2015	6	10					1658	1664		10.1021/acschemneuro.5b00140			7	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	CU3OS	WOS:000363435300001	26241578	Green Accepted			2021-06-18	
J	Pan, T; Liao, K; Roenigk, K; Daly, JJ; Walker, MF				Pan, Tao; Liao, Ke; Roenigk, Kristen; Daly, Janis J.; Walker, Mark F.			Static and dynamic postural stability in veterans with combat-related mild traumatic brain injury	GAIT & POSTURE			English	Article						Concussion; Post-concussive; Balance; Posture; Blast exposure	CONCUSSION; IRAQ; DISORDERS; SYMPTOMS	Persistent post-concussive symptoms are reported by 10-15% of individuals who suffer mild traumatic brain injury (mTBI), but their basis is often uncertain. One such symptom is disequilibrium, a sensation of impaired balance during standing and walking. The hypothesis for this study was that this subjective symptom is associated with objective and measurable deficits in static and dynamic postural stability. An infrared motion tracking system was used to record body motion during quiet standing and in response to waist perturbations in fourteen veterans (age 22-40 years, 13 male) of the Operations Enduring Freedom (OEF) and Iraqi Freedom (OIF), who had a history of mTBI that occurred 7 months to 7 years prior to testing. We compared body sway between veterans with mTBI reporting persistent disequilibrium (T-D, n = 8) and those with no vestibular symptoms (n = 6), as well as to a group of non-veterans with no balance symptoms (n = 10). Static postural stability was reduced in T-D veterans in comparison to each of the other two groups (p < 0.0002), most notably on a compliant surface with eyes closed. The T-D group also had decreased dynamic stability of the upper trunk (p < 0.05) and enhanced postural oscillations (p < 0.02) following waist perturbations. Our findings support a physiological basis for persistent disequilibrium after mTBI and are consistent with impaired vestibular processing. Disruption of semicircular canal inputs is unlikely to be the cause, as head impulse responses were normal in all groups. The unexpected finding of dynamic postural oscillations requires further study but may indicate enhanced instability in sensorimotor networks responsible for postural control. Published by Elsevier B.V.	[Pan, Tao; Liao, Ke; Daly, Janis J.; Walker, Mark F.] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; [Pan, Tao; Liao, Ke; Roenigk, Kristen; Daly, Janis J.; Walker, Mark F.] Louis Stokes Cleveland VA Med Ctr, Cleveland, OH USA; [Pan, Tao; Liao, Ke; Roenigk, Kristen; Daly, Janis J.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Walker, Mark F.] Case Western Reserve Univ, Adv Platform Technol Ctr, Cleveland, OH 44106 USA; [Roenigk, Kristen; Daly, Janis J.; Walker, Mark F.] Case Western Reserve Univ, Funct Elect Stimulat Ctr, Cleveland, OH 44106 USA	Walker, MF (corresponding author), Cleveland VAMC, Dept Neurol, 10701 East Blvd,127W, Cleveland, OH 44106 USA.	mark.walker@case.edu			Department of DefenseUnited States Department of Defense [CDMRP W81XWH-08-2-0188]; Department of Veterans AffairsUS Department of Veterans Affairs; Armington Fund (University Hospitals of Cleveland)	This study was supported by the Department of Defense (CDMRP W81XWH-08-2-0188), by the Department of Veterans Affairs, and by the Armington Fund (University Hospitals of Cleveland).	Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Baloh RW, 1998, ARCH NEUROL-CHICAGO, V55, P649, DOI 10.1001/archneur.55.5.649; Basta D, 2005, HUM MOVEMENT SCI, V24, P268, DOI 10.1016/j.humov.2005.04.002; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Dichgans J, 1983, Adv Neurol, V39, P633; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Geurts ACH, 1999, ARCH PHYS MED REHAB, V80, P144, DOI 10.1016/S0003-9993(99)90111-9; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Peterka RJ, 2004, J NEUROPHYSIOL, V91, P410, DOI 10.1152/jn.00516.2003; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Scherer M, 2007, MIL MED, V172, P731, DOI 10.7205/MILMED.172.7.731; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604	31	12	12	0	12	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	OCT	2015	42	4					550	557		10.1016/j.gaitpost.2015.08.012			8	Neurosciences; Orthopedics; Sport Sciences	Neurosciences & Neurology; Orthopedics; Sport Sciences	CY0BP	WOS:000366071500025	26374930	Bronze			2021-06-18	
J	Rezapour, T; Hatami, J; Farhoudian, A; Sofuoglu, M; Noroozi, A; Daneshmand, R; Samiei, A; Ekhtiari, H				Rezapour, Tara; Hatami, Javad; Farhoudian, Ali; Sofuoglu, Mehmet; Noroozi, Alireza; Daneshmand, Reza; Samiei, Ahmadreza; Ekhtiari, Hamed			NEuro COgnitive REhabilitation for Disease of Addiction (NECOREDA) Program: From Development to Trial	BASIC AND CLINICAL NEUROSCIENCE			English	Article						Cognitive enhancers; Drug addiction; NECOREDA; Treatment	STROKE	Despite extensive evidence for cognitive deficits associated with drug use and multiple publications supporting the efficacy of cognitive rehabilitation treatment (CRT) services for drug addictions, there are a few well-structured tools and organized programs to improve cognitive abilities in substance users. Most published studies on cognitive rehabilitation for drug dependent patients used rehabilitation tools, which have been previously designed for other types of brain injuries such as schizophrenia or traumatic brain injuries and not specifically designed for drug dependent patients. These studies also suffer from small sample size, lack of follow-up period assessments and or comprehensive treatment outcome measures. To address these limitations, we decided to develop and investigate the efficacy of a paper and pencil cognitive rehabilitation package called NECOREDA (Neurocognitive Rehabilitation for Disease of Addiction) to improve neurocognitive deficits associated with drug dependence particularly caused by stimulants (e.g. amphetamine type stimulants and cocaine) and opiates. To evaluate the feasibility of NECOREDA program, we conducted a pilot study with 10 opiate and methamphetamine dependent patients for 3 months in outpatient setting. NECOREDA was revised based on qualitative comments received from clients and treatment providers. Final version of NECOREDA is composed of brain training exercises called "Brain Gym" and psychoeducational modules called "Brain Treasures" which is implemented in 16 training sessions interleaved with 16 review and practice sessions. NECOREDA will be evaluated as an add-on intervention to methadone maintenance treatment in a randomized clinical trial among opiate dependent patients starting from August 2015. We discuss methodological features of NECOREDA development and evaluation in this article.	[Rezapour, Tara; Hatami, Javad; Ekhtiari, Hamed] Inst Cognit Sci Studies, Translat Neurosci Program, Tehran, Iran; [Rezapour, Tara; Noroozi, Alireza; Ekhtiari, Hamed] Univ Tehran Med Sci, Iranian Inst Reduct High Risk Behav, Iranian Natl Ctr Addict Studies, Neurocognit Lab, Tehran 1336616357, Iran; [Hatami, Javad] Univ Tehran, Fac Psychol & Educ, Dept Psychol, Tehran, Iran; [Farhoudian, Ali; Daneshmand, Reza] Univ Social Welf & Rehabil Sci, Subst Abuse & Dependence Res Ctr, Tehran, Iran; [Sofuoglu, Mehmet] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Sofuoglu, Mehmet] VA Connecticut Healthcare Syst, West Haven, CT USA; [Noroozi, Alireza] Minist Hlth & Med Educ, Mental Hlth Social Hlth & Addict Dept MEHSHAD, Subst Abuse Prevent & Treatment Off SAPTO, Tehran, Iran; [Samiei, Ahmadreza] Arak Univ Med Sci, Sch Med, Clin Dept, Arak, Iran; [Ekhtiari, Hamed] Univ Tehran Med Sci, Res Ctr Mol & Cellular Imaging, Tehran 1336616357, Iran	Ekhtiari, H (corresponding author), Univ Tehran Med Sci, Iranian Natl Ctr Addict Studies, Neurocognit Lab, Tehran 1336616357, Iran.	H_Ekhtiari@razi.tums.ac.ir	Farhoudian, Ali/M-4188-2017; Ekhtiari, Hamed/L-3639-2013; Hatami, Javad/L-4750-2019; Rezapour, Tara/S-2976-2018; Noroozi, Alireza/M-7119-2019	Ekhtiari, Hamed/0000-0001-6902-8798; Noroozi, Alireza/0000-0002-5838-4348; Daneshmand, Reza/0000-0002-0988-678X			Ahmadi-Soleimani A., 2016, PROGR BRAIN RES, DOI [10.1177/0268355513518912, DOI 10.1177/0268355513518912]; Chen P, 2002, P NATL ACAD SCI USA, V99, P9031, DOI 10.1073/pnas.132076299; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Davis PE, 2002, DRUG ALCOHOL DEPEN, V67, P105, DOI 10.1016/S0376-8716(02)00012-1; Eack S. M., 2013, SOC WORK, V57, P235; Ekhtiari H., 2014, ASIA PACIFIC J MED T, V3, P7; Fals-Stewart W, 2010, EXP CLIN PSYCHOPHARM, V18, P87, DOI 10.1037/a0018058; Gould Thomas J, 2010, Addict Sci Clin Pract, V5, P4; Green Joseph B, 2003, Top Stroke Rehabil, V10, P1; Grefkes C, 2008, ANN NEUROL, V63, P236, DOI 10.1002/ana.21228; HEWER RL, 1990, Q J MED, V76, P659; Fernandez-Serrano MJ, 2012, PSYCHOPHARMACOLOGY, V219, P673, DOI 10.1007/s00213-011-2485-z; Kaneko Yoshio, 2012, Clin Psychopharmacol Neurosci, V10, P125, DOI 10.9758/cpn.2012.10.3.125; Landau WM, 2005, ANN NEUROL, V57, P465, DOI 10.1002/ana.20411; Mehrjerdi ZA, 2012, BASIC CLIN NEUROSCI, V3, P5; Milot M. H., 2012, CURRENT OPINION NEUR, V29, P997, DOI [10.1016/j.biotechadv.2011.08.021, DOI 10.1016/J.BIOTECHADV.2011.08.021.]; Nordahl TE, 2003, J NEUROPSYCH CLIN N, V15, P317, DOI 10.1176/appi.neuropsych.15.3.317; Prosser J, 2006, DRUG ALCOHOL DEPEN, V84, P240, DOI 10.1016/j.drugalcdep.2006.02.006; Rezapour T., 2016, PROGR BRAIN RE UNPUB, P1; Sofuoglu M, 2013, NEUROPHARMACOLOGY, V64, P452, DOI 10.1016/j.neuropharm.2012.06.021; Twamley EW, 2008, AM J PSYCHIATR REHAB, V11, P144, DOI 10.1080/15487760801963678	22	12	13	0	7	NEGAH INST SCIENTIFIC COMMUNICATION	TEHRAN	UNIT 2, NO 108, SOUTHERN JAMALZADEH ST, ENGHELAB SQ, TEHRAN, 00000, IRAN	2008-126X	2228-7442		BASIC CLIN NEUROSCI	Basic Clin. Neurosci.	OCT	2015	6	4					291	298					8	Neurosciences	Neurosciences & Neurology	DU9XY	WOS:000382572700009	26649167	DOAJ Gold			2021-06-18	
J	Auxemery, Y				Auxemery, Y.			Clinical forms of post-traumatic depression	ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE			French	Article						Psychic trauma; Traumatic depression; Posttraumatic depression; Post-concussive syndrome; Traumatic grief; Posttraumatic grief; Psychopathology; Psychopharmacology	TRAUMATIC BRAIN-INJURY; POSTCONCUSSION-LIKE SYMPTOMS; STRESS-DISORDER; PSYCHOTIC FEATURES; MAJOR DEPRESSION; COMBAT VETERANS; SEVERITY; POLYMORPHISM; COMORBIDITY; PTSD	Introduction. - As a result of determinants specific to the psychopathological structure of the psychological trauma, psycho-traumatised patients very rarely solicit the health care system directly with a request for treatment centred on their trauma. The medical profession is consulted for non-specific symptoms and complications, which are mainly somatoform, addictions and depressive disorders. After a few epidemiological reminders followed by a discussion concerning contemporary depressive and post-traumatic nosographic features, we define, through our clinical experience collated with the data in the literature, different clinical and etiopathogenic contexts of post-traumatic depression in order to control their therapeutic treatment. Clinical findings. - Burnout post-traumatic depression in response to re-experiencing is the most common: it is a reactive psycho-physiological burnout in response to the emotional distress re-experienced during flashbacks, insomnia, a constant feeling of insecurity and the deleterious consequences of this symptomatology in terms of social adaptation. A common genetic predisposition affecting serotoninergic regulation seems to be a vulnerability marker of both depressive and psychotraumatic symptoms. In this case, SSRI will be effective on sadness. In addition, these antidepressants have been widely prescribed for the first-line treatment of depressive and psychotraumatic symptoms. However, this pharmacological class is often insufficient in relieving autonomic hyperactivity such as re-experiencing which are mediated more by noradrenergic hyperactivity. SNRI such as venlafaxine can be used as a first-line treatment. Post-traumatic depression with psychotic features congruent with mood is dominated by a feeling of incurability; the subject blames himself and feels guilty about the traumatic event and its consequences. Symptoms of denial of identity are sometimes observed: confined by an intense depersonalization, the psycho-traumatised subject evokes that he is "no longer himself" and that his mind "is disconnected". Confronted with the psychological emptiness of the traumatic scene, the psycho-traumatised subject remains devoid of thought as if their mind has left him. In addition to antidepressant therapy, an atypical antipsychotic drug must be prescribed to relieve the melancholic symptoms as well as the concomitant psychotraumatic symptoms. Post-traumatic depression masked by peripheral physical injuries is the result of accidents combining psychological and physical impairment. The physical pain resulting from the accident regularly recalls the drama in the same way as traumatic re-experiencing. Depression masked by this somatic suffering is difficult to diagnose, but the repeated somatic complaints at the forefront of the request for treatment, the breakdown of self-esteem as well as the level of subjective strain due to pain and dysesthesia are all indications. The psychotherapy will focus on the symbolic reconstruction of the organs that have been damaged or destroyed, with the aim of healing the extensive narcissistic impairment. Post-concussive depression is diagnosed following a head trauma, however severe. It is sometimes assigned to neurological lesions and at other times recognised as the expression of a purely psychological reaction. Antidepressant therapy, or possibly trial therapy, is often indicated. The terms traumatic grief and post-traumatic grief are often used synonymously in publications: a conceptual opposition must however been recalled. If the traumatic grief is the result of the loss of an object that holds much psychological importance for the individual, the subject has not however been traumatised by this event and is not suffering and will not suffer from re-experiencing. The therapy will include methods used in the psychotherapeutic treatment of grief; antidepressants are often insufficient. Differently, post-traumatic grief takes shape when the toss of another is concomitant with the confrontation with the reality of the death witnessed in a moment of peri-traumatic dissociation. This grief is often observed following the discovery of the body of a close friend or family member who has committed suicide, or when part of a family has been decimated by an accident whilst the survivors watch their close relations die pending the arrival of the emergency services, or when a military comrade is wounded in combat in front of his partner. The mourning process cannot really begin until the flashbacks cease. Conclusions. - Clinical depression or even melancholia, possibly masked by somatic or post concussive complaints, is often the initial mode of contact with the health care system for the psycho-traumatised subject. The different clinical and etiopathogenic contexts of post traumatic depression that we have developed in this work use specific therapies which need to be clarified by further research based on this nosography. (C) L'Encephale, Paris, 2014.	[Auxemery, Y.] Hop Instruct Armees Percy, Serv Med Psychol Clin Appl Aeronaut, 101 Ave Henri Barbusse,BP406, F-92141 Clamart, France	Auxemery, Y (corresponding author), Hop Instruct Armees Percy, Serv Med Psychol Clin Appl Aeronaut, 101 Ave Henri Barbusse,BP406, F-92141 Clamart, France.	yann.auxemery@hotmail.fr					Alarcon RD, 1999, PSYCHIATRY, V62, P114, DOI 10.1080/00332747.1999.11024860; American Psychiatric Association, 2000, DSM 4 TR MAN DIAGN S; Auxemery Y, 2012, ENCEPHALE, V38, P329, DOI 10.1016/j.encep.2011.07.003; Auxemery Y, 2011, ENCEPHALE, V37, P433, DOI 10.1016/j.encep.2010.12.001; Beckham JC, 1998, AM J PSYCHIAT, V155, P1565, DOI 10.1176/ajp.155.11.1565; Bleich A, 1997, BRIT J PSYCHIAT, V170, P479, DOI 10.1192/bjp.170.5.479; BOURGEOIS ML, 2003, DEUIL NORMAL DEUIL P; Braakman MH, 2009, ACTA PSYCHIAT SCAND, V119, P15, DOI 10.1111/j.1600-0447.2008.01252.x; Breslau N, 2002, CAN J PSYCHIAT, V47, P923; BRIOLE G, 1994, C PSYCH NEUR LANG FR; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chen YW, 1996, BIOL PSYCHIAT, V39, P896, DOI 10.1016/0006-3223(95)00295-2; Clervoy P., 2013, MED ARMEES, V41, P1; Croon KF, 2009, CNS DRUGS, V23, P427, DOI 10.2165/00023210-200923050-00006; Davidson JRT, 1998, J PSYCHIAT RES, V32, P301, DOI 10.1016/S0022-3956(98)00016-8; Deb S, 1999, AM J PSYCHIAT, V156, P374; Ducrocq F, 2005, ENCEPHALE, V31, P212; Ducrocq F, 2001, ENCEPHALE, V27, P159; *ESEMED MHEDEA, 2004, ACTA PSYCHIAT SCAND, V420, P28; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Ferreri M, 1996, LENCEPHALE SP, Vsp7, P7; Hamner MB, 1999, BIOL PSYCHIAT, V45, P846, DOI 10.1016/S0006-3223(98)00301-1; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hirschfeld Robert M A, 2012, J Clin Psychiatry, V73 Suppl 1, P5, DOI 10.4088/JCP.11096su1c.01; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Kendler KS, 2005, ARCH GEN PSYCHIAT, V62, P529, DOI 10.1001/archpsyc.62.5.529; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kolassa IT, 2010, J CLIN PSYCHIAT, V71, P543, DOI 10.4088/JCP.08m04787blu; Lebigot F, 2011, TRAITER TRAUMATISMES; Lebigot F, 2003, MALADIES DEPRESSIVES, P306; Lee HJ, 2005, DEPRESS ANXIETY, V21, P135, DOI 10.1002/da.20064; Marshall RD, 2001, AM J PSYCHIAT, V158, P1467, DOI 10.1176/appi.ajp.158.9.1467; MCFARLANE AC, 1992, J NERV MENT DIS, V180, P498, DOI 10.1097/00005053-199208000-00004; MCGORRY PD, 1995, AUST NZ J PSYCHIAT, V29, P385, DOI 10.3109/00048679509064945; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; North CS, 1997, AM J PSYCHIAT, V154, P1696, DOI 10.1176/ajp.154.12.1696; Oquendo M, 2005, AM J PSYCHIAT, V162, P560, DOI 10.1176/appi.ajp.162.3.560; Pae CU, 2008, INT CLIN PSYCHOPHARM, V23, P1, DOI 10.1097/YIC.0b013e32825ea324; Petrakis IL, 2012, NEUROPSYCHOPHARMACOL, V37, P996, DOI 10.1038/npp.2011.283; ROCA RP, 1992, AM J PSYCHIAT, V149, P1234; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shad MU, 2011, HUM PSYCHOPHARM CLIN, V26, P4, DOI 10.1002/hup.1171; Sher L, 2005, MED HYPOTHESES, V65, P205, DOI 10.1016/j.mehy.2005.03.014; Stroebe M, 2001, ISR J PSYCHIATR REL, V38, P185; Tagay S, 2005, J PSYCHOSOM RES, V58, P439, DOI 10.1016/j.jpsychores.2004.09.007; Vaiva G., 2007, STRESS TRAUMA, V7, P69; Waddington A, 2003, ENCEPHALE, V29, P20; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Weathers F.W., 1993, PTSD CHECKLIST RELIA; Yao SN, 2003, ENCEPHALE, V29, P232; YEHUDA R, 1992, J NERV MENT DIS, V180, P321, DOI 10.1097/00005053-199205000-00006	51	12	12	0	18	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0013-7006			ENCEPHALE	Enceph.-Rev. Psychiatr. Clin. Biol. Ther.	SEP	2015	41	4					346	354		10.1016/j.encep.2014.07.005			9	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	DE4EE	WOS:000370581200010	25238908				2021-06-18	
J	Hayashi, T; Ago, K; Nakamae, T; Higo, E; Ogata, M				Hayashi, Takahito; Ago, Kazutoshi; Nakamae, Takuma; Higo, Eri; Ogata, Mamoru			Two different immunostaining patterns of beta-amyloid precursor protein (APP) may distinguish traumatic from nontraumatic axonal injury	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Traumatic axonal injury; Beta-amyloid precursor protein (APP); Hypoxia; Immunostaining patterns	CLOSED-HEAD INJURY; BRAIN-INJURY; DAMAGE; IMMUNOHISTOCHEMISTRY; DIAGNOSIS; MARKER; ADULTS	Immunostaining for beta-amyloid precursor protein (APP) is recognized as an effective tool for detecting traumatic axonal injury, but it also detects axonal injury due to ischemic or other metabolic causes. Previously, we reported two different patterns of APP staining: labeled axons oriented along with white matter bundles (pattern 1) and labeled axons scattered irregularly (pattern 2) (Hayashi et al. (Leg Med (Tokyo) 11:S171-173, 2009). In this study, we investigated whether these two patterns are consistent with patterns of trauma and hypoxic brain damage, respectively. Sections of the corpus callosum from 44 cases of blunt head injury and equivalent control tissue were immunostained for APP. APP was detected in injured axons such as axonal bulbs and varicose axons in 24 of the 44 cases of head injuries that also survived for three or more hours after injury. In 21 of the 24 APP-positive cases, pattern 1 alone was observed in 14 cases, pattern 2 alone was not observed in any cases, and both patterns 1 and 2 were detected in 7 cases. APP-labeled injured axons were detected in 3 of the 44 control cases, all of which were pattern 2. These results suggest that pattern 1 indicates traumatic axonal injury, while pattern 2 results from hypoxic insult. These patterns may be useful to differentiate between traumatic and nontraumatic axonal injuries.	[Hayashi, Takahito; Ago, Kazutoshi; Nakamae, Takuma; Higo, Eri; Ogata, Mamoru] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Legal Med, Kagoshima 8908544, Japan	Hayashi, T (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Legal Med, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	takahito@m2.kufm.kagoshima-u.ac.jp			Ministry of Education, Culture, Science, and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [19590677, 22790599]	This study was financially supported by Grants-in-Aids for Scientific Research (C) (grant no. 19590677 to M. Ogata) and for Young Scientists (B) (grant no. 22790599 to T. Hayashi) from the Ministry of Education, Culture, Science, and Technology of Japan.	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Davceva N, 2012, J FORENSIC LEG MED, V19, P413, DOI 10.1016/j.jflm.2012.04.011; Field AS, 2003, AM J NEURORADIOL, V24, P1461; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Graham DI, 2004, FORENSIC SCI INT, V146, P89, DOI 10.1016/S0379-0738(03)00274-3; Harrington D, 2000, J CLIN FORENSIC MED, V7, P19; Hayashi Takahito, 2009, Leg Med (Tokyo), V11 Suppl 1, pS171, DOI 10.1016/j.legalmed.2009.01.076; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Kaur B, 1999, J CLIN PATHOL, V52, P203, DOI 10.1136/jcp.52.3.203; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Oehmichen M, 1999, INT J LEGAL MED, V112, P261, DOI 10.1007/s004140050246; Oehmichen M, 1998, FORENSIC SCI INT, V95, P67, DOI 10.1016/S0379-0738(98)00075-9; Oehmichen Manfred, 2003, Leg Med (Tokyo), V5, P190, DOI 10.1016/S1344-6223(03)00077-4; Ogata M, 1999, INT J LEGAL MED, V113, P19, DOI 10.1007/s004140050273; Ogata Mamoru, 2007, Legal Medicine, V9, P105, DOI 10.1016/j.legalmed.2006.11.013; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.ne.17.030194.002421; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x	25	12	15	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	SEP	2015	129	5					1085	1090		10.1007/s00414-015-1245-8			6	Medicine, Legal	Legal Medicine	CQ0VM	WOS:000360315900021	26249371				2021-06-18	
J	Liu, WH; Zhu, JZ; Liu, J; Guo, Q				Liu, Weihua; Zhu, Jianzhong; Liu, Jing; Guo, Qing			Psychological state and needs of family member caregivers for victims of traumatic brain injury: A cross-sectional descriptive study	INTERNATIONAL JOURNAL OF NURSING SCIENCES			English	Article						Caregivers; Family member; Stress; Traumatic brain injury		Objective: Here we evaluated the impact of varying severity of traumatic brain injury on the psychological state and demands of family caregivers. Further, we determined the most significant and least significant daily needs among family caregivers. Methods: We performed a cross-sectional descriptive study in three public hospitals in Tai'an, China. Three hundred caregivers related to traumatic brain injury victims were randomly selected. Patients had varying degrees of injuries (mild to severe). The Symptom Checklist-90 (SCL-90) was used to assess family caregivers' psychological statuses. The Critical Care Family Needs Inventory (CCFNI) was used to determine family caregivers' needs. Finally, the Glasgow Coma Scale (GCS) was employed to define patients' level of traumatic brain injury. Results: SCL-90 scores for each psychological dimension were significantly higher with increasing TBI severity (p < 0.05). Similarly, CCFNI scores were significantly higher with increasing TBI severity (p < 0.05) for information, reassurance, and accessibility. These same dimensions were found to be the most important needs for family members of TBI injury victims, while support and comfort were the least important dimensions. Conclusions: The more severe pathogenic condition of the patient, the heavier the psychological pressure is on their family member caregivers. Medical staff should therefore pay close attention to the psychological health of family caregivers of TBI patients, especially family caregivers of critical cases. Interventions should be accordingly designed and conducted to meet the needs of family caregivers. Copyright (C) 2015, Chinese Nursing Association. Production and hosting by Elsevier (Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND license	[Liu, Weihua; Liu, Jing; Guo, Qing] Taishan Med Univ, Sch Nursing, Tai An 271016, Shandong, Peoples R China; [Zhu, Jianzhong] Hosp Taishan Med Univ, Dept Med Imaging, Tai An 271000, Shandong, Peoples R China	Zhu, JZ (corresponding author), Hosp Taishan Med Univ, Dept Med Imaging, Tai An 271000, Shandong, Peoples R China.	mri1964@outlook.com			National Social Science Fund of China [15BRK023]	The labor costs of the graduate students is supported by the National Social Science Fund of China (No. 15BRK023).	Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Chien WT, 2005, RES NURS HEALTH, V28, P474, DOI 10.1002/nur.20103; De Silva MJ, 2008, INT J EPIDEMIOL, V38, P1; Duff Diane, 2002, Axone, V24, P14; Ennis N, 2013, NEUROPSYCHOL REHABIL, V23, P1, DOI 10.1080/09602011.2012.712871; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Freitas KS, 2007, REV LAT-AM ENFERM, V15, P84, DOI 10.1590/S0104-11692007000100013; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Keenan Alanna, 2010, Can J Neurosci Nurs, V32, P25; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Liu H, 2006, J NURS CHINA, V13, P84; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Moller-Leimkuhler AM, 2011, EUR ARCH PSY CLIN N, V261, P165, DOI 10.1007/s00406-010-0155-5; Nonterah CW, 2013, BRAIN INJURY, V27, P1287, DOI 10.3109/02699052.2013.812243; Noor Siah A A, 2012, Clin Ter, V163, P63; Riley GA, 2007, CLIN REHABIL, V21, P82, DOI 10.1177/0269215506071279; Ruis C, 2014, J CLIN EXP NEUROPSYC, V36, P170, DOI 10.1080/13803395.2013.875519; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Watanabe Y, 2001, DISABIL REHABIL, V23, P370	20	12	12	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2352-0132			Int J Nurs Sci	INT. J. NURS. SCI.	SEP	2015	2	3					231	236		10.1016/j.ijnss.2015.07.001			6	Nursing	Nursing	V3Z2H	WOS:000218721400002		DOAJ Gold			2021-06-18	
J	Thiam, DW; Yap, SH; Chong, SL				Thiam, Desmond Wei; Yap, Si Hui; Chong, Shu Ling			Clinical Decision Rules for Paediatric Minor Head Injury: Are CT Scans a Necessary Evil?	ANNALS ACADEMY OF MEDICINE SINGAPORE			English	Article						Brain injuries; Children; Prediction rules; Traumatic brain injury	COMPUTED-TOMOGRAPHY SCANS; CHILDREN; PREDICTION; CHILDHOOD; ALGORITHM; EVENTS; CANCER; TRAUMA; RISK	Introduction: High performing clinical decision rules (CDRs) have been derived to predict which head-injured child requires a computed tomography (CT) of the brain. We set out to evaluate the performance of these rules in the Singapore population. Materials and Methods: This is a prospective observational cohort study of children aged less than 16 who presented to the emergency department (ED) from April 2014 to June 2014 with a history of head injury. Predictor variables used in the Canadian Assessment of Tomography for Childhood Head Injury (CATCH), Children's Head Injury Algorithm for the Prediction of Important Clinical Events (CHALICE) and Pediatric Emergency Care Applied Research Network (PECARN) CDRs were collected. Decisions on CT imaging and disposition were made at the physician's discretion. The performance of the CDRs were assessed and compared to current practices. Results: A total of 1179 children were included in this study. Twelve (1%) CT scans were ordered; 6(0.5%) of them had positive findings. The application of the CDRs would have resulted in a significant increase in the number of children being subjected to CT (as follows): CATCH 237 (20.1%), CHALICE 282 (23.9%), PECARN high- and intermediate-risk 456 (38.7%), PECARN high-risk only 45 (3.8%). The CDRs demonstrated sensitivities of: CATCH 100% (54.1 to 100), CHALICE 83.3% (35.9 to 99.6), PECARN 100% (54.1 to 100), and specificities of: CATCH 80.3% (77.9 to 82.5), CHALICE 76.4% (73.8 to 78.8), PECARN high- and intermediate-risk 61.6% (58.8 to 64.4) and PECARN high-risk only 96.7% (95.5 to 97.6). Conclusion: The CDRs demonstrated high accuracy in detecting children with positive CT findings but direct application in areas with low rates of significant traumatic brain injury (TBI) is likely to increase unnecessary CT scans ordered. Clinical observation in most cases may be a better alternative.	[Thiam, Desmond Wei; Yap, Si Hui] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Chong, Shu Ling] KK Womens & Childrens Hosp, Dept Emergency Med, Singapore 229899, Singapore; [Chong, Shu Ling] Duke NUS, Grad Sch Med, Singapore, Singapore	Chong, SL (corresponding author), KK Womens & Childrens Hosp, Dept Emergency Med, 100 Bukit Timah Rd, Singapore 229899, Singapore.	Chong.Shu-Ling@kkh.com.sg			Paediatrics Academic Clinical Program (Paeds ACP) Young Researcher Pilot Grant	The ongoing prospective head injury surveillance is supported by the Paediatrics Academic Clinical Program (Paeds ACP) Young Researcher Pilot Grant. The authors would like to thank Ms Dianna Sri for her contribution towards the data collection.	Beaudin M, 2007, J PEDIATR SURG, V42, P849, DOI 10.1016/j.jpedsurg.2006.12.038; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Crowe L, 2010, ARCH DIS CHILD, V95, P1017, DOI 10.1136/adc.2009.174854; DAVIS RL, 1994, ANN EMERG MED, V24, P640, DOI 10.1016/S0196-0644(94)70273-X; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Griffin ES, 2014, J EMERG NURS, V40, P98, DOI 10.1016/j.jen.2013.07.001; Hamilton M, 2010, PEDIATRICS, V126, pE33, DOI 10.1542/peds.2009-0692; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Matsumoto JH, 2013, EPILEPSY BEHAV, V27, P233, DOI 10.1016/j.yebeh.2013.01.024; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Rohacek M, 2012, INJURY, V43, P1415, DOI 10.1016/j.injury.2012.01.001; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Schonfeld D, 2013, ANN EMERG MED, V62, P597, DOI 10.1016/j.annemergmed.2013.06.020; Simon B, 2001, J TRAUMA, V51, P231, DOI 10.1097/00005373-200108000-00004	23	12	14	0	0	ACAD MEDICINE SINGAPORE	REPUBLIC SINGAPORE	142 NEIL RD, REPUBLIC SINGAPORE 088871, SINGAPORE	0304-4602			ANN ACAD MED SINGAP	Ann. Acad. Med. Singap.	SEP	2015	44	9					335	341					7	Medicine, General & Internal	General & Internal Medicine	CV4US	WOS:000364262600004	26584662				2021-06-18	
J	Zhuo, JC; Keledjian, K; Xu, S; Pampori, A; Gerzanich, V; Simard, JM; Gullapalli, RP				Zhuo, Jiachen; Keledjian, Kaspar; Xu, Su; Pampori, Adam; Gerzanich, Volodymyr; Simard, J. Marc; Gullapalli, Rao P.			Changes in Diffusion Kurtosis Imaging and Magnetic Resonance Spectroscopy in a Direct Cranial Blast Traumatic Brain Injury (dc-bTBI) Model	PLOS ONE			English	Article							TRANSIENT FOCAL ISCHEMIA; PATTERN SEPARATION; HIGH-RESOLUTION; DENTATE GYRUS; PROTON MRS; MODERATE; RATS; CA3; NEUROPATHOLOGY; SENSORIMOTOR	Explosive blast-related injuries are one of the hallmark injuries of veterans returning from recent wars, but the effects of a blast overpressure on the brain are poorly understood. In this study, we used in vivo diffusion kurtosis imaging (DKI) and proton magnetic resonance spectroscopy (MRS) to investigate tissue microstructure and metabolic changes in a novel, direct cranial blast traumatic brain injury (dc-bTBI) rat model. Imaging was performed on rats before injury and 1, 7, 14 and 28 days after blast exposure (similar to 517 kPa peak overpressure to the dorsum of the head). No brain parenchyma abnormalities were visible on conventional T2-weighted MRI, but microstructural and metabolic changes were observed with DKI and proton MRS, respectively. Increased mean kurtosis, which peaked at 21 days post injury, was observed in the hippocampus and the internal capsule. Concomitant increases in myo-Inositol (Ins) and Taurine (Tau) were also observed in the hippocampus, while early changes at 1 day in the Glutamine (Gln) were observed in the internal capsule, all indicating glial abnormality in these regions. Neurofunctional testing on a separate but similarly treated group of rats showed early disturbances in vestibulomotor functions (days 1-14), which were associated with imaging changes in the internal capsule. Delayed impairments in spatial memory and in rapid learning, as assessed by Morris Water Maze paradigms (days 14-19), were associated with delayed changes in the hippocampus. Significant microglial activation and neurodegeneration were observed at 28 days in the hippocampus. Overall, our findings indicate delayed neurofunctional and pathological abnormalities following dc-bTBI that are silent on conventional T2-weighted imaging, but are detectable using DKI and proton MRS.	[Zhuo, Jiachen; Xu, Su; Gullapalli, Rao P.] Univ Maryland, Sch Med, Dept Diagnost Radiol, Baltimore, MD 21201 USA; [Zhuo, Jiachen; Xu, Su; Gullapalli, Rao P.] Univ Maryland, Sch Med, Dept Nucl Med, Baltimore, MD 21201 USA; [Keledjian, Kaspar; Pampori, Adam; Gerzanich, Volodymyr; Simard, J. Marc] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	Gullapalli, RP (corresponding author), Univ Maryland, Sch Med, Dept Diagnost Radiol, Baltimore, MD 21201 USA.	msimard@smail.umaryland.edu; rgullapalli@umm.edu			Department of the Army [W81XWH-12-1-0098, W81XWH-08-1-0725, W81XWH 10-1-0898]; Baltimore Veterans Affairs Medical Center [1I01BX001629]; Veterans AffairsUS Department of Veterans Affairs [I01BX001629] Funding Source: NIH RePORTER	This work was supported by the Department of the Army (W81XWH-12-1-0098 and W81XWH-08-1-0725 to RPG, W81XWH 10-1-0898 to JMS, http://cdmrp.army.mil/funding/), and the Baltimore Veterans Affairs Medical Center (1I01BX001629 to JMS, http://www.maryland.va.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2006, HEPATOLOGY, V44, P788, DOI 10.1002/hep.21357; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bland ST, 2000, STROKE, V31, P1144, DOI 10.1161/01.STR.31.5.1144; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Cheung JS, 2012, STROKE, V43, P2252, DOI 10.1161/STROKEAHA.112.661926; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; George EO, 2014, J NEUROTRAUM, V31, P1018, DOI 10.1089/neu.2013.3224; Gerzanich V, 2003, CIRC RES, V93, P805, DOI 10.1161/01.RES.0000097872.69043.A0; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Helpern JA, 2011, J MAGN RESON IMAGING, V33, P17, DOI 10.1002/jmri.22397; Holshouser BA, 2006, J MAGN RESON IMAGING, V24, P33, DOI 10.1002/jmri.20607; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Lee I, 2004, NEURON, V42, P803, DOI 10.1016/j.neuron.2004.05.010; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Marino S, 2011, NEUROCRIT CARE, V14, P127, DOI 10.1007/s12028-010-9406-6; MARKGRAF CG, 1992, BRAIN RES, V575, P238, DOI 10.1016/0006-8993(92)90085-N; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Mellor S G, 1988, Br J Hosp Med, V39, P536; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Petullo D, 1999, LIFE SCI, V64, P1099, DOI 10.1016/S0024-3205(99)00038-7; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Salzman SK, 1994, NEUROBIOLOGY CENTRAL; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schiemanck SK, 2008, J REHABIL MED, V40, P96, DOI 10.2340/16501977-0130; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Shanmuganathan K, 2004, AM J NEURORADIOL, V25, P539; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Simard JM, 2014, J NEUROTRAUM, V31, P1292, DOI 10.1089/neu.2013.3016; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Tosun C, 2013, BRAIN SCI, V3, P215, DOI 10.3390/brainsci3010215; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Van Cauter S, 2012, RADIOLOGY, V263, P492, DOI 10.1148/radiol.12110927; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Xu S, 2006, J MAGN RESON, V182, P221, DOI 10.1016/j.jmr.2006.07.003; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050; Zwingmann C, 2000, DEV NEUROSCI-BASEL, V22, P463, DOI 10.1159/000017476	61	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136151	10.1371/journal.pone.0136151			18	Multidisciplinary Sciences	Science & Technology - Other Topics	CP5VA	WOS:000359951900044	26301778	DOAJ Gold, Green Published			2021-06-18	
J	Bernhard, M; Bein, B; Bottiger, BW; Bohn, A; Fischer, M; Grasner, JT; Hinkelbein, J; Kill, C; Lott, C; Popp, E; Roessler, M; Schaumberg, A; Wenzel, V; Hossfeld, B				Bernhard, M.; Bein, B.; Boettiger, B. W.; Bohn, A.; Fischer, M.; Graesner, J. T.; Hinkelbein, J.; Kill, C.; Lott, C.; Popp, E.; Roessler, M.; Schaumberg, A.; Wenzel, V.; Hossfeld, B.			Practice management guideline on prehospital emergency anaesthesia. Working group "Prehospital emergency anaesthesia" of the scientific working group on emergency medicine of the German Society of Anaesthesiology and Intensive Care Medicine	NOTFALL & RETTUNGSMEDIZIN			German	Article						Guideline; Emergency medicine; Emergency anaesthesia; Management; Complications	RAPID-SEQUENCE INTUBATION; TRAUMATIC BRAIN-INJURY; AIRWAY-MANAGEMENT; TRACHEAL INTUBATION; SUCCESS RATES; ADRENAL INSUFFICIENCY; VIDEO LARYNGOSCOPES; ETOMIDATE; MULTICENTER; INDUCTION	Inducing anaesthesia outside the hospital is an important therapeutic intervention in emergency medicine; it is much more difficult to accomplish than inside the hospital. Its primary goals include hypnosis and analgesia which enable airway management to achieve mechanical ventilation and adequate oxygenation. Secondary goals of emergency anaesthesia include amnesia, anxiolysis, reduced oxygen consumption and work of breathing, and thus protection of vital organs and avoidance of secondary myocardial injury or cerebral injuries. Prior to prehospital induction of anaesthesia, patient-, scene- and operator-specific factors need to be considered. The rapid sequence induction includes basic monitoring, pre-oxygenation, standardized preparation of drugs and equipment, administration of drugs, removal of the cervical collar and manual in-line stabilization during intubation attempt (if needed), intubation and confirmation of endotracheal intubation. Every spontaneously breathing emergency patient should receive pre-oxygenation for at least 3-4 min with 12-15 l oxygen per min and a tight-sealing facemask, or a demand valve. The standardized preparation process includes preparation and labeling drugs/syringes, checking the bag-valve mask, preparing the endotracheal tube with a stylet and blocking syringe, as well as having a stethoscope and material to secure the tube at hand, as well as alternative airway devices. It also includes immediate access to alternative means of airway management, as well as a suction unit, ventilator and monitoring devices including capnography. Basic monitoring for prehospital emergency anaesthesia includes ECG, an automatic/manual blood pressure cuff, and pulse oximetry. Continuous capnography is used without exception to confirm ventilation, to detect possible disconnections/dislocations, and for indirect monitoring of hemodynamics. Prior to induction of prehospital emergency anaesthesia, two peripheral intravenous catheters should be placed if possible.	[Bernhard, M.] Univ Klinikum Leipzig AoR, Zentrale Notaufnahme, D-04103 Leipzig, Germany; [Bein, B.] Asklepios Klin St Georg, Klin Anasthesiol & Operat Intens Med, Hamburg, Germany; [Boettiger, B. W.; Hinkelbein, J.] Univ Klinikum Koln AoR, Klin Anasthesiol & Operat Intens Med, Cologne, Germany; [Bohn, A.] Feuerwehr Munster, Munster, Germany; [Fischer, M.] ALB FILS KLINIKEN GmbH, Klin Anasthesiol & Operat Intens Med, Klin Eichert, Goppingen, Germany; [Graesner, J. T.] Univ Klinikum Kiel, Klin Anasthesiol & Operat Intens Med, Kiel, Germany; [Kill, C.] Univ Klinikum Giessen & Marburg GmbH, Zentrum Notfallmed, Marburg, Germany; [Lott, C.] Johannes Gutenberg Univ Mainz, Klin Anasthesiol Univ Med, D-55122 Mainz, Germany; [Popp, E.] Univ Klinikum Heidelberg, Anasthesiol Klin, Sekt Notfallmed, Heidelberg, Germany; [Roessler, M.] Univ Gottingen, Anasthesiol Klin, Zentrum Anasthesiol Rettungs & Intens Med, D-37073 Gottingen, Germany; [Schaumberg, A.] Standort Giessen Justus Liebig Univ Giessen, Univ Klinikum Giessen & Marburg, Klin Anasthesiol & Operat Intens Med, Giessen, Germany; [Wenzel, V.] Med Univ Innsbruck, Univ Klin Anasthesie & Intens Med, A-6020 Innsbruck, Austria; [Hossfeld, B.] Bundeswehrkrankenhaus, Klin Anasthesiol & Intens Med, Ulm, Germany	Bernhard, M (corresponding author), Univ Klinikum Leipzig AoR, Zentrale Notaufnahme, Liebigstr 26, D-04103 Leipzig, Germany.	michael.bernhard@medizin.uni-leipig.de	Roessler, Markus Soeren/I-7834-2013; Grasner, Jan-Thorsten/G-1934-2014	Grasner, Jan-Thorsten/0000-0001-8143-0376			Adams HP, 2003, STROKE, V34, P1056, DOI 10.1161/01.STR.0000064841.47697.22; [Anonymous], 2009, ANASTH INTENSIVMED, V50, pS489; Barnard EBG, 2015, EMERG MED J, V32, P449, DOI 10.1136/emermed-2014-203740; Benumof JL, 1997, ANESTHESIOLOGY, V87, P979, DOI 10.1097/00000542-199710000-00034; Bergen Joseph M., 1997, Journal of Emergency Medicine, V15, P221, DOI 10.1016/S0736-4679(96)00350-2; Bernhard M, 2006, ANAESTHESIST, V55, P1157, DOI 10.1007/s00101-006-1106-4; Bernhard M, 2014, ANAESTHESIST, V63, P589, DOI 10.1007/s00101-014-2348-1; Bernhard M, 2011, NOTFALL RETTUNGSMED, V14, P554, DOI 10.1007/s10049-010-1402-z; Bernhard M, 2010, ANASTH INTENSIVMED, V51, pS615; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS7, DOI DOI 10.1089/NEU.2007.9995; Braun P, 2010, CURR OPIN ANESTHESIO, V23, P500, DOI 10.1097/ACO.0b013e32833bc135; Breckwoldt J, 2012, RESUSCITATION, V83, P434, DOI 10.1016/j.resuscitation.2011.10.011; Bretschneider I, 2011, NOTARZT, V27, P270, DOI 10.1055/s-0031-1276960; Cavus E, 2011, EMERG MED J, V28, P650, DOI 10.1136/emj.2010.098707; Chan CM, 2012, CRIT CARE MED, V40, P2945, DOI 10.1097/CCM.0b013e31825fec26; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Christ M, 2011, INTENSIVMED, V47, P83; Connor CW, 2014, ANESTH ANALG, V118, P419, DOI 10.1213/ANE.0000000000000012; Cook T, 2012, CURR OPIN ANESTHESIO, V25, P461, DOI 10.1097/ACO.0b013e32835528b1; Cotton BA, 2008, ARCH SURG-CHICAGO, V143, P62, DOI 10.1001/archsurg.143.1.62; Cowan GM, 2012, EMERG MED J, V29, P136, DOI 10.1136/emj.2010.105304; Deutsche_Interdisziplinare_Vereinigung_Fur_Intensiv- Und Notfallmedizin (Divi), 2012, EMPF KENNZ SPRITZ IN; Easby J, 2004, J TRAUMA, V6, P217; Edlow JA, 2014, LANCET, V384, P2064, DOI 10.1016/S0140-6736(13)62184-4; Eich C, 2009, RESUSCITATION, V80, P1371, DOI 10.1016/j.resuscitation.2009.09.004; El-Orbany M, 2010, ANESTH ANALG, V110, P1318, DOI 10.1213/ANE.0b013e3181d5ae47; ELBEHEIRY H, 1995, CAN J ANAESTH, V42, P875, DOI 10.1007/BF03011034; Genzwurker HV, 2010, ANASTH INTENSIVMED, V51, P202; Grasner JT, 2007, NOTFALLMEDIZIN UP2DA, V2, P197; Gries A, 2006, ANAESTHESIST, V55, P1080, DOI 10.1007/s00101-006-1051-2; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Hasler RM, 2012, RESUSCITATION, V83, P476, DOI 10.1016/j.resuscitation.2011.10.018; Hedenstierna G, 2005, INTENS CARE MED, V31, P1327, DOI 10.1007/s00134-005-2761-7; Helm M, 2006, BRIT J ANAESTH, V96, P67, DOI 10.1093/bja/aei275; Helm M, 2013, ACTA ANAESTH SCAND, V57, P199, DOI 10.1111/aas.12032; Helm M, 2010, ANAESTHESIST, V59, P896, DOI 10.1007/s00101-010-1759-x; Helm M, 2005, BEST PRACT RES-CLIN, V19, P623, DOI 10.1016/j.bpa.2005.06.002; Henderson JJ, 2004, ANAESTHESIA, V59, P675, DOI 10.1111/j.1365-2044.2004.03831.x; Herff H, 2009, ANESTH ANALG, V109, P303, DOI 10.1213/ane.0b013e3181ad8a1e; Heuer JF, 2012, ANAESTH INTENS CARE, V40, P120, DOI 10.1177/0310057X1204000113; Hossfeld B, 2011, NOTFALL RETTUNGSMED, V14, P15, DOI 10.1007/s10049-010-1355-2; Hossfeld B, 2011, NOTFALL RETTUNGSMED, V14, P10, DOI 10.1007/s10049-010-1354-3; HUGG CJ, 1993, ANESTH ANALG       S, V25, P77; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; Jacoby J, 2006, ANN EMERG MED, V47, P525, DOI 10.1016/j.annemergmed.2005.12.009; Kheterpal S, 2013, ANESTHESIOLOGY, V119, P1360, DOI 10.1097/ALN.0000435832.39353.20; Koenig SJ, 2014, J INTENSIVE CARE MED; Kuhnigk H, 2007, NARKOSE NOTFALLMEDIZ; Liccardi G, 2009, CURR MED RES OPIN, V25, P1621, DOI 10.1185/03007990903010474; Lockey D, AAGBI SAFETY GUIDELI; Lossius HM, 2012, CRIT CARE, V16, DOI 10.1186/cc11189; Luxen J, 2014, ANAESTHESIST, V63, P331, DOI 10.1007/s00101-014-2303-1; Mayglothling J, 2012, J TRAUMA ACUTE CARE, V73, pS333, DOI 10.1097/TA.0b013e31827018a5; Messelken M, 2010, DTSCH ARZTEBL INT, V107, P523, DOI 10.3238/arztebl.2010.0523; MOULTON C, 1994, LANCET, V343, P1261, DOI 10.1016/S0140-6736(94)92155-5; MRUGALLA H, 2003, NOTFALL RETTUNGSMED, V6, P233; Neumayr A, 2014, NOTFALL RETTUNGSMED, V17, P25, DOI 10.1007/s10049-013-1816-5; Newton A, 2008, J TRAUMA, V64, P487, DOI 10.1097/TA.0b013e31802e7476; Niven AS, 2013, CURR OPIN CRIT CARE, V19, P9, DOI 10.1097/MCC.0b013e32835c6014; Paal P, 2010, RESUSCITATION, V81, P148, DOI 10.1016/j.resuscitation.2009.10.023; Patanwala AE, 2014, ACAD EMERG MED, V21, P87, DOI 10.1111/acem.12292; Pehbock D, 2010, ANESTHESIOLOGY, V113, P593, DOI 10.1097/ALN.0b013e3181e73f07; PERRY JJ, 2008, COCHRANE DB SYST REV, V2; Reinhart K, 2010, ANAESTHESIST, V59, P347, DOI 10.1007/s00101-010-1719-5; Rortgen D, 2011, ANAESTHESIST, V60, P312, DOI 10.1007/s00101-010-1812-9; Rognas L, 2014, EUR J EMERG MED, V21, P418, DOI 10.1097/MEJ.0000000000000103; Rognas L, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-58; Sakles JC, 2013, ACAD EMERG MED, V20, P71, DOI 10.1111/acem.12055; Schlechtriemen T, 2004, NOTFALL RETTUNGSMED, V7, P231; Schmidt J, 2007, ANASTH INTENSIVMED, V48, pS88; Sefrin P, 2014, NOTARZT, V30, P73, DOI 10.1055/s-0034-1369910; SITZWOHL C, 2010, BMJ-BRIT MED J, V341, P5943; Sorensen MK, 2012, BRIT J ANAESTH, V108, P682, DOI 10.1093/bja/aer503; Steinmann D, 2009, ANAESTHESIST, V58, P695, DOI 10.1007/s00101-009-1548-6; Stollings JL, 2014, ANN PHARMACOTHER, V48, P62, DOI 10.1177/1060028013510488; Swanson Eric R, 2004, Prehosp Emerg Care, V8, P273; Thierbach A, 2004, ANAESTHESIST, V53, P543, DOI 10.1007/s00101-004-0679-z; Timmermann A, 2012, ANASTH INTENSIVMED, V53, P294; Timmermann A, 2009, ANAESTHESIST, V58, P663, DOI 10.1007/s00101-009-1570-8; van den Heuvel I, 2013, CURR OPIN ANESTHESIO, V26, P404, DOI 10.1097/ACO.0b013e328362a84c; VANDERWALT J, 1995, PAEDIATR ANAESTH, V5, P257; Voelckel WG, 2004, ANAESTHESIST, V53, P1151, DOI 10.1007/s00101-004-0771-4; von Goedecke A, 2007, ANESTH ANALG, V104, P481, DOI 10.1213/01.ane.0000255964.86086.63; Weingart SD, 2012, ANN EMERG MED, V59, P165, DOI 10.1016/j.annemergmed.2011.10.002; Weller D, 2006, AKTUEL NEUROL, V33, pP532; Werdan K, 2011, KARDIOLOGE, V5, P166, DOI 10.1007/s12181-011-0349-8; Wetsch WA, 2013, EUR J ANAESTH, V30, P537, DOI 10.1097/EJA.0b013e3283614119; Wetsch WA, 2011, EUR J ANAESTH, V28, P849, DOI 10.1097/EJA.0b013e32834c7c7f; Wilbur K, 2001, CJEM, V3, P302; Zollinger A, 2012, DIE ANASTHESIOLOGIE	90	12	12	1	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1434-6222	1436-0578		NOTFALL RETTUNGSMED	Notfall Rettungsmed.	AUG	2015	18	5					395	+		10.1007/s10049-015-0041-9			17	Emergency Medicine	Emergency Medicine	CN7HF	WOS:000358604300011					2021-06-18	
J	Fricia, M; Passanisi, M; Salamanna, F; Parrilli, A; Giavaresi, G; Fini, M				Fricia, Marco; Passanisi, Maurizio; Salamanna, Francesca; Parrilli, Annapaola; Giavaresi, Gianluca; Fini, Milena			Osteointegration in Custom-made Porous Hydroxyapatite Cranial Implants: From Reconstructive Surgery to Regenerative Medicine	WORLD NEUROSURGERY			English	Article						Cranioplasty; Hydroxyapatite; Osteointegration; Regenerative medicine; Traumatic brain injury	BONE; SCAFFOLDS	BACKGROUND: Custom-made porous hydroxyapatite (HA) implant (Fin-Ceramica Faenza S.p.A., Italy) is a biomimetic, osteoconductive material. Margin fusion at the bone-implant edge, cell proliferation within implant pores, and osteointegration in an animal model have already been described. CASE DESCRIPTION: Radiological, microtomographical, and histological analyses were performed on two patients who underwent surgical explantation of cranial implants after postoperative complication. Primary devices explanted after 2 years showed areas of newly formed bone strictly osteointegrated with pores of the prosthesis. These prostheses showed a focal zone of resorption in correspondence of the newly formed bone, and no signs of inflammation or cytotoxicity were observed. A back-up prosthesis, explanted from the same patient after 6 months because of an infection, did not show presence of newly formed bone both on the surface and in the internal part of the prosthesis. CONCLUSIONS: Custom-made porous HA implant is an osteoconductive material able to promote osteogenesis, osteointegrate with bone tissue, provide an effective cranial reconstruction, and restore functional features of the skull. However, complete bone healing is still a complex and long process.	[Fricia, Marco; Passanisi, Maurizio] Cannizzaro Univ Hosp, Dept Neurosurg, Catania, Italy; [Salamanna, Francesca; Parrilli, Annapaola; Giavaresi, Gianluca; Fini, Milena] Rizzoli Orthopaed Inst, Dept RIT Rizzoli, Lab Biocompatibil Technol Innovat & Adv Therapies, Bologna, Italy; [Giavaresi, Gianluca; Fini, Milena] Rizzoli Orthopaed Inst, Lab Preclin & Surg Studies, Bologna, Italy	Fricia, M (corresponding author), Cannizzaro Univ Hosp, Dept Neurosurg, Catania, Italy.	marco.fricia@aoec.it	Parrilli, Annapaola/C-7008-2019; Giavaresi, Gianluca/J-5583-2016; Fini, Milena/J-4808-2016; Salamanna, Francesca/J-6032-2016	Parrilli, Annapaola/0000-0003-0251-5094; Giavaresi, Gianluca/0000-0001-7843-5969; Fini, Milena/0000-0002-3732-3570; Salamanna, Francesca/0000-0001-7402-4054			Babis GC, 2005, INJURY, V36, pS38, DOI 10.1016/j.injury.2005.10.009; Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1; Fernandez-Yague MA, 2015, ADV DRUG DELIVER REV, V84, P1, DOI 10.1016/j.addr.2014.09.005; Fini M, 2011, J BONE MINER METAB, V29, P633, DOI 10.1007/s00774-011-0309-1; Frassanito P, 2013, CLIN NEUROL NEUROSUR, V115, P1496, DOI 10.1016/j.clineuro.2012.11.032; Hardy H, 2012, NEUROCHIRURGIE, V58, P25, DOI 10.1016/j.neuchi.2011.09.006; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Khojasteh A, 2013, OR SURG OR MED OR PA, V116, pE405, DOI 10.1016/j.oooo.2012.01.044; Gonzalez AL, 2015, CHILD NERV SYST, V31, P333, DOI 10.1007/s00381-014-2493-5; Martini L, 2012, PLAST RECONSTR SURG, V129, p625E, DOI 10.1097/PRS.0b013e318244220d; Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031; Messina G, 2011, ACTA NEUROCHIR, V153, P1717, DOI 10.1007/s00701-011-1014-5; Polo-Corrales L, 2014, J NANOSCI NANOTECHNO, V14, P15, DOI 10.1166/jnn.2014.9127; Shepherd JH, 2012, J MATER SCI-MATER M, V23, P2335, DOI 10.1007/s10856-012-4598-2; Sprio S, 2011, J BIOTECHNOL, V156, P347, DOI 10.1016/j.jbiotec.2011.07.034; Staffa G, 2012, J CRANIO MAXILL SURG, V40, pE65, DOI 10.1016/j.jcms.2011.04.014; Tevlin R, 2014, J DENT RES, V93, P1187, DOI 10.1177/0022034514547271	17	12	12	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2015	84	2							591.e11	10.1016/j.wneu.2015.03.027			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CO7FL	WOS:000359324900068	25819529				2021-06-18	
J	Hammond, FM; Barrett, R; Dijkers, MP; Zanca, JM; Horn, SD; Smout, RJ; Guerrier, T; Hauser, E; Dunning, MR				Hammond, Flora M.; Barrett, Ryan; Dijkers, Marcel. P.; Zanca, Jeanne M.; Horn, Susan D.; Smout, Randall J.; Guerrier, Tami; Hauser, Elizabeth; Dunning, Megan R.			Group Therapy Use and Its Impact on the Outcomes of Inpatient Rehabilitation After Traumatic Brain Injury: Data From Traumatic Brain Injury-Practice Based Evidence Project	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Health services; Health services research; Occupational therapy; Physical therapy specialty; Psychology; Recreation therapy; Rehabilitation; Speech therapy; Therapeutics	OCCUPATIONAL-THERAPY; PHYSIOTHERAPY	Objectives: To describe the amount and content of group therapies provided during inpatient rehabilitation for traumatic brain injury (TBI), and to assess the relations of group therapy with patient, injury, and treatment factors and outcomes. Design: Prospective observational cohort. Setting: Inpatient rehabilitation. Participants: Consecutive admissions (N=2130) for initial TBI rehabilitation at 10 inpatient rehabilitation facilities (9 in the United States, 1 in Canada) from October 2008 to September 2011. Interventions: Not applicable. Main Outcome Measures: Proportion of sessions that were group therapy (>= 2 patients were treated simultaneously by >= 1 clinician); proportion of patients receiving group therapy; type of activity performed and amount of time spent in group therapy, by discipline; rehabilitation length of stay; discharge location; and FIM cognitive and motor scores at discharge. Results: Of the patients, 79% received at least 1 session of group therapy, with group therapy accounting for 13.7% of all therapy sessions and 15.8% of therapy hours. On average, patients spent 2.9h/wk in group therapy. The greatest proportion of treatment time in group format was in therapeutic recreation (25.6%), followed by speech therapy (16.2%), occupational therapy (10.4%), psychology (8.1%), and physical therapy (7.9%). Group therapy time and type of treatment activities varied among admission FIM cognitive subgroups and treatment sites. Several factors appear to be predictive of receiving group therapy, with the treatment site being a major influence. However, group therapy as a whole offered little explanation of differences in the outcomes studied. Conclusions: Group therapy is commonly used in TBI rehabilitation, to varying degrees among disciplines, sites, and cognitive impairment subgroups. Various therapeutic activities take place in group therapy, indicating its perceived value in addressing many domains of functioning. Variation in outcomes is not explained well by overall percentage of therapy time delivered in groups. (C) 2015 by the American Congress of Rehabilitation Medicine	[Hammond, Flora M.; Guerrier, Tami; Hauser, Elizabeth] Carolinas Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Barrett, Ryan; Horn, Susan D.; Smout, Randall J.] Inst Clin Outcomes Res, Salt Lake City, UT USA; [Dijkers, Marcel. P.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Zanca, Jeanne M.] Kessler Fdn, New York, NY USA; [Dunning, Megan R.] Rush Univ, Med Ctr, Chicago, IL 60612 USA	Hammond, FM (corresponding author), 4141 Shore Dr, Indianapolis, IN 46254 USA.	flora.hammond@rhin.com			National Institutes of Health, National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD050439-01]; National Institute on Disability and Rehabilitation Research [H133A080023]; Ontario Neurotrauma Foundation [2007-ABI-ISIS-525]; American Congress of Rehabilitation Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD050439] Funding Source: NIH RePORTER	Supported by the National Institutes of Health, National Center for Medical Rehabilitation Research (grant no. 1R01HD050439-01), National Institute on Disability and Rehabilitation Research (grant no. H133A080023), and Ontario Neurotrauma Foundation (grant no. 2007-ABI-ISIS-525).; Publication of this article was supported by the American Congress of Rehabilitation Medicine.	[Anonymous], 2012, INP REH THER SERV CO; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Corrigan JD, 2015, ARCH PHYS MED REHAB, V96, pS209, DOI 10.1016/j.apmr.2015.03.026; Coulter CL, 2009, ARCH PHYS MED REHAB, V90, P1727, DOI 10.1016/j.apmr.2009.04.019; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; De Weerdt W, 2001, AUST J PHYSIOTHER, V47, P53, DOI 10.1016/S0004-9514(14)60298-1; Dobrez DG, 2004, ARCH PHYS MED REHAB, V85, P1909, DOI 10.1016/j.apmr.2004.06.064; DUNCOMBE LW, 1995, AM J OCCUP THER, V49, P199, DOI 10.5014/ajot.49.3.199; Fuller PR, 2013, J PSYCHOSOC NURS MEN, V51, P22, DOI 10.3928/02793692-20130314-01; Gage B, 2007, LONG TERM CARE HOSP; GAUTHIER L, 1987, AM J OCCUP THER, V41, P360, DOI 10.5014/ajot.41.6.360; Heinemann AW, 1994, TOP STROKE REHABIL, V1, P1; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS304, DOI 10.1016/j.apmr.2014.11.030; KURASIK S, 1967, J AM GERIATR SOC, V15, P852, DOI 10.1111/j.1532-5415.1967.tb02443.x; LUNDGREN CC, 1986, AM J OCCUP THER, V40, P397, DOI 10.5014/ajot.40.6.397; Oouchida Y, 2013, INT J PHYS MED REHAB, V1, P146, DOI [10.4172/2329-9096.1000146, DOI 10.4172/2329-9096.1000146]; TRAHEY PJ, 1991, AM J OCCUP THER, V45, P397, DOI 10.5014/ajot.45.5.397; van Langeveld SA, 2011, PHYS THER, V91, P210, DOI 10.2522/ptj.20090417; Vestri A, 2014, BRAIN INJURY, V28, P1102, DOI 10.3109/02699052.2014.910698; Zanca JM, 2013, ARCH PHYS MED REHAB, V94, pS145, DOI 10.1016/j.apmr.2012.11.049; Zanca JM, 2011, PHYS THER, V91, P1877, DOI 10.2522/ptj.20100392	22	12	12	0	19	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2015	96	8		3			S282	S292		10.1016/j.apmr.2014.11.029			11	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CO3CV	WOS:000359035100010	26212404	Bronze, Green Accepted			2021-06-18	
J	Heyanka, DJ; Thaler, NS; Linck, JF; Pastorek, NJ; Miller, B; Romesser, J; Sim, AH				Heyanka, Daniel J.; Thaler, Nicholas S.; Linck, John F.; Pastorek, Nicholas J.; Miller, Brian; Romesser, Jennifer; Sim, Anita H.			A Factor Analytic Approach to the Validation of the Word Memory Test and Test of Memory Malingering as Measures of Effort and Not Memory	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Forensic neuropsychology; Head injury; traumatic brain injury; Malingering/symptom validity testing; Learning and Memory	TRAUMATIC BRAIN-INJURY; PSYCHOGENIC NONEPILEPTIC SEIZURES; SYMPTOM VALIDITY TEST; DISABILITY INCENTIVES; COGNITIVE IMPAIRMENT; EXTERNAL INCENTIVES; HEAD-INJURY; TEST-SCORES; FAILURE; TOMM	Research has demonstrated the utility of performance validity tests (PVTs) as a method of determining adequate effort during a neuropsychological evaluation. Although some studies affirm that forced-choice PVTs measure effort rather than memory, doubts remain in the literature. The purpose of the current study was to evaluate the relationship between effort and memory variables in a mild traumatic brain injury (TBI) sample (n = 160) by separating memory and effort as distinct factors while statistically controlling for the shared covariance between the variables. A two-factor solution was extracted such that the five PVT variables loaded on Factor 1 and the four memory variables loaded on Factor 2. The pattern matrix, which controls for the covariance between variables, provided clear support of two highly distinct factors with minimal cross-loadings. Our findings support assertions that PVTs measure effort independent of memory in veterans with mild TBI.	[Heyanka, Daniel J.] Bay Pines Dept Vet Affairs Med Ctr, Bay Pines, FL USA; [Thaler, Nicholas S.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Linck, John F.] Oklahoma City Dept Vet Affairs Med Ctr, Oklahoma City, OK USA; [Pastorek, Nicholas J.; Miller, Brian] Michael E DeBakey Dept Vet Affairs Med Ctr, Houston, TX USA; [Romesser, Jennifer] George E Wahlen Dept Vet Affairs Med Ctr, Salt Lake City, UT USA; [Sim, Anita H.] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA	Heyanka, DJ (corresponding author), Bay Pines Dept Vet Affairs Med Ctr, Dept Mental Hlth & Behav Sci, Bay Pines, FL 33744 USA.	dhneuropsych@gmail.com					Allen MD, 2007, BRAIN INJURY, V21, P1425, DOI 10.1080/02699050701769819; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Bowden SC, 2006, CLIN NEUROPSYCHOL, V20, P858, DOI 10.1080/13854040500246935; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Courville T, 2001, EDUC PSYCHOL MEAS, V61, P229, DOI 10.1177/00131640121971211; Delis DC, 2000, CALIFORNIA VERBAL LE; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Drane DL, 2006, EPILEPSIA, V47, P1879, DOI 10.1111/j.1528-1167.2006.00611.x; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Gervais R, 2000, ARCH CLIN NEUROPSYCH, V15, P841, DOI 10.1016/S0887-6177(00)80347-9; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Gervais RO, 2001, J RHEUMATOL, V28, P1892; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2003, MANUAL WORD MEMORY T; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Henson RK, 2006, EDUC PSYCHOL MEAS, V66, P393, DOI 10.1177/0013164405282485; Hilsabeck RC, 2011, CLIN NEUROPSYCHOL, V25, P1228, DOI 10.1080/13854046.2011.589409; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Rohling ML, 2010, CLIN NEUROPSYCHOL, V24, P119, DOI 10.1080/13854040903307243; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sullivan BK, 2007, APPL NEUROPSYCHOL, V14, P189, DOI 10.1080/09084280701509083; Tabachnick BG, 2007, USING MULTIVARIATE S; Thompson B., 2004, EXPLORATORY CONFIRMA; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tombaugh TN, 1996, TEST MEMORY MALINGER; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Williamson David J., 2003, Epilepsia, V44, P13; Williamson DJ, 2004, EPILEPSIA, V45, P179; Willis PF, 2011, MIL MED, V176, P1426, DOI 10.7205/MILMED-D-11-00168	32	12	12	0	14	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2015	30	5					369	376		10.1093/arclin/acv025			8	Psychology, Clinical; Psychology	Psychology	CO3PS	WOS:000359071300002	25964105	Bronze			2021-06-18	
J	Horn, SD; Kinikini, M; Moore, LW; Hammond, FM; Brandstater, ME; Smout, RJ; Barrett, RS				Horn, Susan D.; Kinikini, Merin; Moore, Linda W.; Hammond, Flora M.; Brandstater, Murray E.; Smout, Randall J.; Barrett, Ryan S.			Enteral Nutrition for Patients With Traumatic Brain Injury in the Rehabilitation Setting: Associations With Patient Preinjury and Injury Characteristics and Outcomes	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Comparative effectiveness research; Enteral nutrition; Propensity score; Rehabilitation	METABOLIC-RESPONSE; INTOLERANCE; SUPPORT; CARE	Objective: To determine the association of enteral nutrition (EN) with patient preinjury and injury characteristics and outcomes for patients receiving inpatient rehabilitation after traumatic brain injury (TBI). Design: Prospective observational study. Setting: Nine rehabilitation centers. Participants: Patients (N=1701) admitted for first full inpatient rehabilitation after TBI. Interventions: Not applicable. Main Outcome Measures: FIM at rehabilitation discharge, length of stay, weight loss, and various infections. Results: There were many significant differences in preinjury and injury characteristics between patients who received EN and patients who did not. After matching patients with a propensity score of >40% for the likely use of EN, patients receiving EN with either a standard or a high-protein formula (>20% of calories coming from protein) for >25% of their rehabilitation stay had higher HMI motor and cognitive scores at rehabilitation discharge and less weight loss than did patients with similar characteristics not receiving EN. Conclusions: For patients receiving inpatient rehabilitation after TBI and matched on a propensity score of >40% for the likely use of EN, clinicians should strongly consider, when possible, EN for >25% of the rehabilitation stay and especially with a formula that contains at least 20% protein rather than a standard formula. (C) 2015 by the American Congress of Rehabilitation Medicine	[Horn, Susan D.; Smout, Randall J.; Barrett, Ryan S.] Int Sever Informat Syst Inc, Inst Clin Outcomes Res, Salt Lake City, UT USA; [Kinikini, Merin] Intermt Med Ctr, Neuro Specialty Rehabil Unit, Salt Lake City, UT USA; [Moore, Linda W.] Houston Methodist Hosp, Houston, TX USA; [Hammond, Flora M.] Carolinas Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ, Indianapolis, IN 46204 USA; [Brandstater, Murray E.] Loma Linda Univ, Med Ctr, Loma Linda, CA USA	Horn, SD (corresponding author), Univ Utah, Sch Med, Dept Populat Hlth Sci, Hlth Syst Innovat & Res Program, Williams Bldg,Rm 1N491,295 Chipeta Way, Salt Lake City, UT 84108 USA.	susan.horn@hsc.utah.edu		Moore, Linda W/0000-0003-2519-5150	National Institutes of Health, National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD050439-01]; National Institute on Disability and Rehabilitation Research [H133A080023]; Ontario Neurotrauma Foundation [2007-ABI-ISIS-525]; American Congress of Rehabilitation Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD050439] Funding Source: NIH RePORTER	Supported by the National Institutes of Health, National Center for Medical Rehabilitation Research (grant no. 1R01HD050439-01), the National Institute on Disability and Rehabilitation Research (grant no. H133A080023), and the Ontario Neurotrauma Foundation (grant no. 2007-ABI-ISIS-525).; Publication of this article was supported by the American Congress of Rehabilitation Medicine.	Acosta-Escribano J, 2010, INTENS CARE MED, V36, P1532, DOI 10.1007/s00134-010-1908-3; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bistrian BR, 2011, JPEN-PARENTER ENTER, V35, P556, DOI 10.1177/0148607111416122; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chourdakis M, 2012, JPEN-PARENTER ENTER, V36, P108, DOI 10.1177/0148607110397878; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; Dickerson RN, 2012, J TRAUMA ACUTE CARE, V73, P549, DOI 10.1097/TA.0b013e318256de1b; Dickerson RN, 2009, JPEN-PARENTER ENTER, V33, P646, DOI 10.1177/0148607109335307; Doig GS, 2011, INJURY, V42, P50, DOI 10.1016/j.injury.2010.06.008; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hansen TS, 2008, ARCH PHYS MED REHAB, V89, P2114, DOI 10.1016/j.apmr.2008.04.013; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; James R, 2005, ARCH PHYS MED REHAB, V86, pS82, DOI 10.1016/j.apmr.2005.07.314; JUSTO MCM, 2011, NUTR HOSP, V26, P1120, DOI DOI 10.3305/NH.2011.26.5.5133; Kennedy RE, 2006, J HEAD TRAUMA REHAB, V21, P260, DOI 10.1097/00001199-200605000-00006; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; McEvoy CT, 2009, CLIN NUTR, V28, P526, DOI 10.1016/j.clnu.2009.04.009; Parks J, 2013, AM J CRIT CARE, V22, P136, DOI 10.4037/ajcc2013105; Pepe JL, 1999, J HEAD TRAUMA REHAB, V14, P462, DOI 10.1097/00001199-199910000-00007; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; Tan M, 2011, BRIT J NEUROSURG, V25, P2, DOI 10.3109/02688697.2010.522745; Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033; Vizzini A, 2011, NUTRITION, V27, P129, DOI 10.1016/j.nut.2010.05.004; Wang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053938; YOUNG B, 1987, J NEUROSURG, V67, P668, DOI 10.3171/jns.1987.67.5.0668; Zampolini M, 2011, AM J PHYS MED REHAB, V90, P79, DOI 10.1097/PHM.0b013e318206c695	30	12	12	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2015	96	8		3			S245	S255		10.1016/j.apmr.2014.06.024			11	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CO3CV	WOS:000359035100007	26212401	Green Accepted			2021-06-18	
J	Hu, SL; Huang, YX; Hu, R; Li, F; Feng, H				Hu, Sheng-Li; Huang, Yu-Xing; Hu, Rong; Li, Fei; Feng, Hua			Osteopontin Mediates Hyperbaric Oxygen Preconditioning-Induced Neuroprotection Against Ischemic Stroke	MOLECULAR NEUROBIOLOGY			English	Article						Akt; Hyperbaric oxygen preconditioning; IL-1 beta; Middle cerebral artery occlusion; Neuroprotection; Osteopontin	CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; RECOMBINANT OSTEOPONTIN; DEFICIENT MICE; HIGH-ALTITUDE; RAT-BRAIN; RECOVERY; ACTIVATION	Neurosurgical operations may result in surgical injury which would lead to postoperative neurological deficits. Hyperbaric oxygen preconditioning (HBO-PC) may be beneficial for such people. However, the exact mechanism underlying HBO-PC is not well known yet. The aim of this study is to explore the role of osteopontin (OPN) in HBO-PC-induced neuroprotection. The study consisted of two experiments. In experiment 1, Sprague Dawley (SD) rats were divided into four groups: sham group, HBO-PC sham group, stroke group, and HBO-PC group (HBO-PC + stroke). The animals in the second experiment were randomly assigned to one of two groups: OPN small interfering (siRNA) group (HBO-PC + stroke + OPN siRNA) and control siRNA group (HBO-PC + stroke + negative control siRNA). Neurological outcome in HBO-PC group was better than that of stroke group. After OPN siRNA was administered, neurological function aggravated compared with control siRNA group. Brain morphology and structure seen by light microscopy was diminished in stroke group and OPN siRNA group, while fewer pathological injuries occurred in HBO-PC and control siRNA group. The infarct volume in HBO-PC group was the lowest, followed by OPN siRNA group and stroke group, respectively. Preconditioning with HBO promoted expression of OPN, which reduced the expression of interleukin (IL)-1 beta/nuclear factor-kappa-gene binding (NF kappa B) and augmented protein kinase B (Akt). OPN siRNA reversed these changes. OPN plays an important role in the neuroprotection elicited by HBO-PC. Pretreatment with HBO may be beneficial for people going to undertake brain surgery.	[Hu, Sheng-Li; Huang, Yu-Xing; Hu, Rong; Li, Fei; Feng, Hua] Third Mil Med Univ, Dept Neurosurg, Southwest Hosp, Chongqing 400038, Peoples R China; [Huang, Yu-Xing] Chengdu Univ Tradit Chinese Med, Teaching Hosp, Dept Neurosurg, Chengdu 610075, Sichuang Provin, Peoples R China	Feng, H (corresponding author), Third Mil Med Univ, Dept Neurosurg, Southwest Hosp, Gaotanyan 29, Chongqing 400038, Peoples R China.	fenghua8888@vip.163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81000532, 81471261]; National Key Basic Research Program of China (973 Program)National Basic Research Program of China [2014CB541600]	This work was supported by grants from the National Natural Science Foundation of China (No. 81000532, 81471261) and National Key Basic Research Program of China (973 Program, 2014CB541600).	Alex J, 2005, J THORAC CARDIOV SUR, V130, P1623, DOI 10.1016/j.jtcvs.2005.08.018; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Cheng OM, 2011, STROKE, V42, P484, DOI 10.1161/STROKEAHA.110.604421; Choi JS, 2007, BRAIN RES, V1151, P195, DOI 10.1016/j.brainres.2007.03.016; Doyle KP, 2008, J CEREBR BLOOD F MET, V28, P1235, DOI 10.1038/jcbfm.2008.17; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Han QQ, 2011, BIOMATERIALS, V32, P5077, DOI 10.1016/j.biomaterials.2011.03.072; Hashimoto M, 2007, J NEUROSCI, V27, P3603, DOI 10.1523/JNEUROSCI.4805-06.2007; Hu SL, 2008, ACTA NEUROCHIR SUPPL, V105, P191; Hu SL, 2010, NEUROL RES, V32, P173, DOI 10.1179/174313209X414524; Jadhav V, 2008, FRONT BIOSCI, V13, P3793, DOI 10.2741/2968; Lu PG, 2012, NEUROL RES, V34, P944, DOI 10.1179/1743132812Y.0000000096; Matula C, 2000, STEREOT FUNCT NEUROS, V75, P142, DOI 10.1159/000048396; Meller R, 2005, J CEREBR BLOOD F MET, V25, P217, DOI 10.1038/sj.jcbfm.9600022; Ostrowski RP, 2010, ACTA NEUROCHIR SUPPL, V106, P47, DOI 10.1007/978-3-211-98811-4_7; Plantman S, 2012, NEUROREPORT, V23, P647, DOI 10.1097/WNR.0b013e328355380e; Schroeter M, 2006, BRAIN, V129, P1426, DOI 10.1093/brain/awl094; SHAPIRA Y, 1994, STROKE, V25, P1637, DOI 10.1161/01.STR.25.8.1637; Suzuki H, 2010, ANN NEUROL, V68, P650, DOI 10.1002/ana.22102; Suzuki H, 2010, STROKE, V41, P1783, DOI 10.1161/STROKEAHA.110.586537; Suzuki H, 2010, CRIT CARE MED, V38, P612, DOI 10.1097/CCM.0b013e3181c027ae; van Velthoven CTJ, 2011, STROKE, V42, P2294, DOI 10.1161/STROKEAHA.110.608315; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Wu CY, 2004, J NEUROCHEM, V90, P1477, DOI 10.1111/j.1471-4159.2004.02682.x; Xie ZL, 2003, J BIOL CHEM, V278, P48546, DOI 10.1074/jbc.M302727200; Yan WJ, 2013, J CEREBR BLOOD F MET, V33, P396, DOI 10.1038/jcbfm.2012.179; Yan YP, 2009, NEUROCHEM INT, V55, P826, DOI 10.1016/j.neuint.2009.08.007; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yogaratnam JZ, 2010, CARDIOVASC REVASCULA, V11, P8, DOI 10.1016/j.carrev.2009.03.004; Zheng DQ, 2000, J BIOL CHEM, V275, P24565, DOI 10.1074/jbc.M002646200	31	12	13	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	AUG	2015	52	1					236	243		10.1007/s12035-014-8859-6			8	Neurosciences	Neurosciences & Neurology	CN3QO	WOS:000358341600022	25146847				2021-06-18	
J	Metzger, A; Rees, J; Kwon, Y; Matsuura, T; McKnite, S; Lurie, KG				Metzger, Anja; Rees, Jennifer; Kwon, Young; Matsuura, Timothy; McKnite, Scott; Lurie, Keith G.			INTRATHORACIC PRESSURE REGULATION IMPROVES CEREBRAL PERFUSION AND CEREBRAL BLOOD FLOW IN A PORCINE MODEL OF BRAIN INJURY	SHOCK			English	Article						Traumatic brain injury; intracranial pressure; intrathoracic pressure; intrathoracic pressure regulation; cerebral perfusion pressure; intracranial hypertension	STANDARD CARDIOPULMONARY-RESUSCITATION; IMPEDANCE THRESHOLD DEVICE; INSPIRATORY IMPEDANCE; INTRACRANIAL-PRESSURE; VALVE; SURVIVAL; PIGS	Brain injury is a leading cause of death and disability in children and adults in their most productive years. Use of intrathoracic pressure regulation (IPR) to generate negative intrathoracic pressure during the expiratory phase of positive pressure ventilation improves mean arterial pressure and 24-h survival in porcine models of hemorrhagic shock and cardiac arrest and has been demonstrated to decrease intracranial pressure (ICP) and cerebral perfusion pressure (CPP) in these models. Application of IPR for 240 min in a porcine model of intracranial hypertension (ICH) will increase CPP when compared with controls. Twenty-three female pigs were subjected to focal brain injury by insertion of an epidural Foley catheter inflated with 3 mL of saline. Animals were randomized to treatment for 240 min with IPR set to a negative expiratory phase pressure of -12 cmH(2)O or no IPR therapy. Intracranial pressure, mean arterial pressure, CPP, and cerebral blood flow (CBF) were evaluated. Intrathoracic pressure regulation significantly improved mean CPP and CBF. Specifically, mean CPP after 90, 120, 180, and 240 min of IPR use was 43.7 +/- 2.8 mmHg, 44.0 +/- 2.7 mmHg, 44.5 +/- 2.8 mmHg, and 43.1 +/- 1.9 mmHg, respectively; a significant increase from ICH study baseline (39.5 +/- 1.7 mmHg) compared with control animals in which mean CPP was 36.7 +/- 1.4 mmHg (ICH study baseline) and then 35.9 +/- 2.1 mmHg, 33.7 +/- 2.8 mmHg, 33.9 +/- 3.0 mmHg, and 36.0 +/- 2.7 mmHg at 90, 120, 180, and 240 min, respectively (P < 0.05 for all time points). Cerebral blood flow, as measured by an invasive CBF probe, increased in the IPR group (34 +/- 4 mL/100 g-min to 49 +/- 7 mL/100 g-min at 90 min) but not in controls (27 +/- 1 mL/100 g-min to 25 +/- 5 mL/100 g-min at 90 min) (P = 0.01). Arterial pH remained unchanged during the entire period of IPR compared with baseline values and control values. In this anesthetized pig model of ICH, treatment with IPR significantly improved CPP and CBF. This therapy may be of clinical value by noninvasively improving cerebral perfusion in states of compromised cerebral perfusion.	[Metzger, Anja; Lurie, Keith G.] Univ Minnesota, Dept Emergency Med, Minneapolis, MN USA; [Metzger, Anja; Lurie, Keith G.] Adv Circulatory Syst Inc, Roseville, MN USA; [Rees, Jennifer; Kwon, Young; Matsuura, Timothy] Univ Minnesota, Dept Cardiol, Minneapolis, MN USA; [McKnite, Scott] Minneapolis Med Res Fdn Inc, Minneapolis, MN USA	Metzger, A (corresponding author), 1905 Cty Rd C West, Roseville, MN 55113 USA.	ametzger@advancedcirculatory.com			Department of Defense Medical Research and Development Program Award: Regulation of Cerebral and Systemic Perfusion Following Traumatic Brain Injury grant [W81XWH-11-2-0094]	This study was supported by the Department of Defense Medical Research and Development Program Award: Regulation of Cerebral and Systemic Perfusion Following Traumatic Brain Injury (grant no. W81XWH-11-2-0094).	Bauer R, 1999, EXP TOXICOL PATHOL, V51, P143, DOI 10.1016/S0940-2993(99)80088-8; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS32, DOI 10.1089/neu.2007.9991; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS21; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS87; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS71; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS91; Convertino VA, 2005, AVIAT SPACE ENVIR MD, V76, P319; Convertino VA, 2004, CLIN AUTON RES, V14, P240, DOI 10.1007/s10286-004-0180-4; Convertino VA, 2005, EUR J APPL PHYSIOL, V94, P392, DOI 10.1007/s00421-005-1344-1; Convertino Victor A, 2004, Crit Care Med, V32, pS381, DOI 10.1097/01.CCM.0000134348.69165.15; GUERCI AD, 1985, CIRC RES, V56, P20, DOI 10.1161/01.RES.56.1.20; Kiehna EN, 2013, J NEUROSURG, V119, P756, DOI 10.3171/2013.4.JNS122489; Kroppenstedt SN, 1999, J NEUROTRAUM, V16, P629, DOI 10.1089/neu.1999.16.629; LEFFLER CW, 1989, AM J PHYSIOL, V257, pH266; Lurie K, 2000, CRIT CARE MED, V28, pN207, DOI 10.1097/00003246-200011001-00009; Lurie K, 2000, RESUSCITATION, V44, P219, DOI 10.1016/S0300-9572(00)00160-X; Lurie Keith G, 2003, Respir Care, V48, P52; Lurie KG, 2004, CRIT CARE MED, V32, P1555, DOI 10.1097/01.CCM.0000131207.29081.A2; Lurie KG, 2003, CRIT CARE MED, V31, pA10; Lurie KG, 2002, CIRCULATION, V105, P124, DOI 10.1161/hc0102.101391; Lurie KG, 2001, ANESTH ANALG, V93, P649, DOI 10.1097/00000539-200109000-00024; Lurie KG, 1998, CHEST, V113, P1084, DOI 10.1378/chest.113.4.1084; LURIE KG, 1995, CIRCULATION, V91, P1629, DOI 10.1161/01.CIR.91.6.1629; Marino Bradley S, 2004, Crit Care Med, V32, pS398, DOI 10.1097/01.CCM.0000139950.39972.68; Yannopoulos D, 2006, CRIT CARE MED, V34, pS495, DOI 10.1097/01.CCM.0000246082.10422.7E; Yannopoulos D, 2006, RESUSCITATION, V70, P445, DOI 10.1016/j.resuscitation.2006.02.005; Yannopoulos D, 2006, RESUSCITATION, V69, P487, DOI 10.1016/j.resuscitation.2005.11.005; Yannopoulos D, 2007, ANESTH ANALG, V104, P157, DOI 10.1213/01.ane.0000249047.80184.5a	30	12	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	AUG	2015	44			1			96	102		10.1097/SHK.0000000000000314			7	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	DO3NA	WOS:000377687100015	25692250				2021-06-18	
J	Yue, L; Humayun, MS				Yue, Lan; Humayun, Mark S.			Monte Carlo analysis of the enhanced transcranial penetration using distributed near-infrared emitter array	JOURNAL OF BIOMEDICAL OPTICS			English	Article						Monte Carlo; near infrared; emitter array; transcranial propagation; scatter; tissues	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; LASER THERAPY; LIGHT THERAPY; NEUROTHERA EFFECTIVENESS; PHOTON MIGRATION; ADULT HEAD; MODEL; PROPAGATION; SAFETY	Transcranial near-infrared (NIR) treatment of neurological diseases has gained recent momentum. However, the low NIR dose available to the brain, which shows severe scattering and absorption of the photons by human tissues, largely limits its effectiveness in clinical use. Hereby, we propose to take advantage of the strong scattering effect of the cranial tissues by applying an evenly distributed multiunit emitter array on the scalp to enhance the cerebral photon density while maintaining each single emitter operating under the safe thermal limit. By employing the Monte Carlo method, we simulated the transcranial propagation of the array emitted light and demonstrated markedly enhanced intracranial photon flux as well as improved uniformity of the photon distribution. These enhancements are correlated with the source location, density, and wavelength of light. To the best of our knowledge, we present the first systematic analysis of the intracranial light field established by the scalp-applied multisource array and reveal a strategy for the optimization of the therapeutic effects of the NIR radiation. (C) 2015 Society of Photo-Optical Instrumentation Engineers (SPIE)	[Yue, Lan; Humayun, Mark S.] Univ So Calif, Inst Biomed Therapeut, USC Eye Inst, Los Angeles, CA 90033 USA	Yue, L (corresponding author), Univ So Calif, Inst Biomed Therapeut, USC Eye Inst, 1441 Eastlake Ave,NTT Room 4463, Los Angeles, CA 90033 USA.	lyue@usc.edu; humayun@med.usc.edu			W. M. Keck FoundationW.M. Keck Foundation; National Science Foundation (NSF) grantNational Science Foundation (NSF) [CBET-1404089]; Guangdong Innovative and Entrepreneurial Research Team Program [2013S046]; Shenzhen Peacock Plan, China	This work is supported by the W. M. Keck Foundation, the National Science Foundation (NSF) grant (Award No.: CBET-1404089), the Guangdong Innovative and Entrepreneurial Research Team Program (No. 2013S046), and Shenzhen Peacock Plan, China.	Barker JW, 2014, BIOMED OPT EXPRESS, V5, P4300, DOI 10.1364/BOE.5.004300; Boas DA, 2002, OPT EXPRESS, V10, P159, DOI 10.1364/OE.10.000159; Bozkurt A, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-9; De Taboada L, 2011, J ALZHEIMERS DIS, V23, P521, DOI 10.3233/JAD-2010-100894; Dehghani H, 2003, PHYS MED BIOL, V48, P2713, DOI 10.1088/0031-9155/48/16/310; Eells JT, 2003, P NATL ACAD SCI USA, V100, P3439, DOI 10.1073/pnas.0534746100; Fang QQ, 2009, OPT EXPRESS, V17, P20178, DOI 10.1364/OE.17.020178; Hacke W, 2014, STROKE, V45, P3187, DOI 10.1161/STROKEAHA.114.005795; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Huang YY, 2012, J BIOPHOTONICS, V5, P827, DOI 10.1002/jbio.201200077; Ito Y, 2000, J BIOMED OPT, V5, P383, DOI 10.1117/1.1287730; Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37; Jagdeo JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047460; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lapchak PA, 2007, NEUROSCIENCE, V148, P907, DOI 10.1016/j.neuroscience.2007.07.002; Lapchak PA, 2010, ANN MED, V42, P576, DOI 10.3109/07853890.2010.532811; Lapchak PA, 2010, BRAIN RES, V1306, P100, DOI 10.1016/j.brainres.2009.10.022; Moges H, 2009, LASER SURG MED, V41, P52, DOI 10.1002/lsm.20732; Moreira MS, 2009, J PHOTOCH PHOTOBIO B, V97, P145, DOI 10.1016/j.jphotobiol.2009.09.002; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P443, DOI 10.1089/pho.2011.9908; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Okada E, 2003, APPL OPTICS, V42, P2906, DOI 10.1364/AO.42.002906; Okada E, 1997, APPL OPTICS, V36, P21, DOI 10.1364/AO.36.000021; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; SCHWEIGER M, 1995, MED PHYS, V22, P1779, DOI 10.1118/1.597634; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Xuan WJ, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.108003; Yue L, 2015, PROC SPIE, V9321, DOI 10.1117/12.2077019; Zhang L, 2008, CELL PHYSIOL BIOCHEM, V22, P215, DOI 10.1159/000149799; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547	32	12	12	1	7	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	1083-3668	1560-2281		J BIOMED OPT	J. Biomed. Opt.	AUG	2015	20	8							088001	10.1117/1.JBO.20.8.088001			9	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	CT0VV	WOS:000362516700026	26252627				2021-06-18	
J	Shijo, K; Ghavim, S; Harris, NG; Hovda, DA; Sutton, RL				Shijo, Katsunori; Ghavim, Sima; Harris, Neil G.; Hovda, David A.; Sutton, Richard L.			Glucose administration after traumatic brain injury exerts some benefits and no adverse effects on behavioral and histological outcomes	BRAIN RESEARCH			English	Article						Beam-walking; Cognition; Controlled cortical impact; Contusion volume; Hippocampus; Hyperglycemia; Neurological exam; Rat; Spatial working memory	CORTICAL IMPACT INJURY; POSITRON-EMISSION-TOMOGRAPHY; PENTOSE-PHOSPHATE PATHWAY; INTENSIVE INSULIN THERAPY; FLUID-PERCUSSION INJURY; TIGHT GLYCEMIC CONTROL; CLOSED-HEAD TRAUMA; 5-PERCENT DEXTROSE; 0.9-PERCENT SALINE; CONTUSION VOLUME	The impact of hyperglycemia after traumatic brain injury (TBI), and even the administration of glucose-containing solutions to head injured patients, remains controversial. In the current study adult male Sprague-Dawley rats were tested on behavioral tasks and then underwent surgery to induce sham injury or unilateral controlled cortical impact (CCI) injury followed by injections (i.p.) with either a 50% glucose solution (Glc; 2 g/kg) or an equivalent volume of either 0.9% or 8% saline (Sal) at 0, 1, 3 and 6 h post-injury. The type of saline treatment did not significantly affect any outcome measures, so these data were combined. Rats with CCI had significant deficits in beam-walking traversal time and rating scores (p's < 0.001 versus sham) that recovered over test sessions from 1 to 13 days post-injury (p's < 0.001), but these beam-walking deficits were not affected by Glc versus Sal treatments. Persistent post-CCI deficits in forelimb contraflexion scores and forelimb tactile placing ability were also not differentially affected by Glc or Sal treatments. However, deficits in latency to retract the right hind limb after limb extension were significantly attenuated in the CCI-Glc group (p < 0.05 versus CCI-Sal). Both CCI groups were significantly impaired in a plus maze test of spatial working memory on days 4, 9 and 14 post-surgery (p < 0.001 versus sham), and there was no effect of Glc versus Sal on this cognitive outcome measure. At 15 days post-surgery the loss of cortical tissue volume (p < 0.001 versus sham) was significantly less in the CCI-Glc group (30.0%; p<0.05) compared to the CCI-Sal group (35.7%). Counts of surviving hippocampal hilar neurons revealed a significant (similar to 40%) loss ipsilateral to CCI (p<0.001 versus sham), but neuronal loss in the hippocampus was not different in the CCI-Sal and CCI-Glc groups. Taken together, these results indicate that an early elevation of blood glucose may improve some neurological outcomes and, importantly, the induction of hyperglycemia after isolated TBI did not adversely affect any sensorimotor, cognitive or histological outcomes. (C) 2015 Elsevier B.V. All rights reserved.	[Shijo, Katsunori; Ghavim, Sima; Harris, Neil G.; Hovda, David A.; Sutton, Richard L.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Shijo, Katsunori; Ghavim, Sima; Harris, Neil G.; Hovda, David A.; Sutton, Richard L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Hovda, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Sutton, RL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, 300 Stein Plaza,Ste 562,Box 956901, Los Angeles, CA 90095 USA.	shijou-nsu@umin.ac.jp; sghavim@mednet.ucla.edu; ngharris@mednet.ucla.edu; dhovda@mednet.ucla.edu; rsutton@mednet.ucla.edu		Harris, Neil/0000-0002-1965-6750	UCLA Brain Injury Research Center; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [PO1NS058489]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489] Funding Source: NIH RePORTER	This work was supported by the UCLA Brain Injury Research Center and award PO1NS058489 from the National Institute of Neurological Disorders and Stroke (NINDS). The content is the sole responsibility of the authors and does not necessarily represent official views of the NINDS or the National Institutes of Health.	Alessandri B, 2000, ACTA NEUROCHIR SUPPL, V76, P425; Alessandri B, 2012, J NEUROTRAUM, V29, P2181, DOI 10.1089/neu.2011.2067; Alves OL, 2005, J NEUROTRAUM, V22, P733, DOI 10.1089/neu.2005.22.733; Appelberg KS, 2009, J NEUROTRAUM, V26, P497, DOI 10.1089/neu.2008.0664; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Bartnik BL, 2007, J NEUROTRAUM, V24, P1079, DOI 10.1089/neu.2006.0210; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Chen T, 2000, J NEUROTRAUM, V17, P135, DOI 10.1089/neu.2000.17.135; Cherian L, 1997, CRIT CARE MED, V25, P1378, DOI 10.1097/00003246-199708000-00027; Cherian L, 1998, J NEUROTRAUM, V15, P307, DOI 10.1089/neu.1998.15.307; Cherian L, 1998, J NEUROTRAUM, V15, P1059, DOI 10.1089/neu.1998.15.1059; Cinotti R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0498-9; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Deng-Bryant Y, 2011, J NEUROTRAUM, V28, P1813, DOI 10.1089/neu.2011.1822; Diaz-Parejo P, 2003, INTENS CARE MED, V29, P544, DOI 10.1007/s00134-003-1669-3; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; Fanne Rami Abu, 2011, J Neurosurg, V114, P85, DOI 10.3171/2010.4.JNS10263; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FELDMAN Z, 1995, J NEUROSURG, V83, P1060, DOI 10.3171/jns.1995.83.6.1060; Fukushima M, 2009, J NEUROTRAUM, V26, P1095, DOI 10.1089/neu.2008.0771; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; Gurevich B, 1997, ANESTH ANALG, V84, P554, DOI 10.1097/00000539-199703000-00016; Harris NG, 2012, J NEUROTRAUM, V29, P1469, DOI 10.1089/neu.2011.2161; Hill J, 2010, J NEUROTRAUM, V27, P1439, DOI 10.1089/neu.2010.1328; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Jiang XB, 2000, NEUROL MED-CHIR, V40, P16, DOI 10.2176/nmc.40.16; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kinoshita K, 2002, J NEUROTRAUM, V19, P681, DOI 10.1089/08977150260139075; Kokiko-Cochran ON, 2008, NEUROSCI LETT, V436, P27, DOI 10.1016/j.neulet.2008.02.046; Krishnappa IK, 1999, J NEUROTRAUM, V16, P213, DOI 10.1089/neu.1999.16.213; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; McNay EC, 2000, P NATL ACAD SCI USA, V97, P2881, DOI 10.1073/pnas.050583697; Moro N, 2013, BRAIN RES, V1535, P124, DOI 10.1016/j.brainres.2013.08.044; Moro N, 2011, NEUROSCI LETT, V491, P158, DOI 10.1016/j.neulet.2011.01.029; Moro N, 2010, EXP NEUROL, V225, P391, DOI 10.1016/j.expneurol.2010.07.013; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI [10.1089/neu.2008.0769, 10.1089/neu.2008-0769]; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; SHAPIRA Y, 1992, ANESTHESIOLOGY, V77, P79, DOI 10.1097/00000542-199207000-00012; Shi H, 2015, CNS NEUROSCI THER, V21, P374, DOI 10.1111/cns.12366; Shimamura M, 2005, NEUROSCIENCE, V131, P87, DOI 10.1016/j.neuroscience.2004.10.041; Statler KD, 2003, BRAIN RES, V994, P37, DOI 10.1016/j.brainres.2003.09.042; Stover JF, 2002, INTENS CARE MED, V28, P1491, DOI 10.1007/s00134-002-1431-2; Su XF, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/807142; Sugimori H, 1996, BRAIN RES BULL, V40, P263, DOI 10.1016/0361-9230(96)00052-4; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; SUTTON RL, 1994, ACTA NEUROCHIR, P446; SUTTON RL, 1992, RESTOR NEUROL NEUROS, V4, P1, DOI 10.3233/RNN-1992-4101; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Takahashi S, 2012, ASN NEURO, V4, P71, DOI 10.1042/AN20120002; Talmor D, 1998, ANESTH ANALG, V86, P1225, DOI 10.1097/00000539-199806000-00017; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor AN, 2010, J NEUROTRAUM, V27, P1081, DOI 10.1089/neu.2009.1252; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Vink R, 1997, J CEREBR BLOOD F MET, V17, P50, DOI 10.1097/00004647-199701000-00007; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2012, ANESTHESIOLOGY, V116, P73, DOI 10.1097/ALN.0b013e31823d7731	77	12	14	1	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 21	2015	1614						94	104		10.1016/j.brainres.2015.04.022			11	Neurosciences	Neurosciences & Neurology	CL0MW	WOS:000356637800010	25911580	Green Accepted			2021-06-18	
J	Divani, AA; Murphy, AJ; Meints, J; Sadeghi-Bazargani, H; Nordberg, J; Monga, M; Low, WC; Bhatia, PM; Beilman, GJ; SantaCruz, KS				Divani, Afshin A.; Murphy, Amanda J.; Meints, Joyce; Sadeghi-Bazargani, Homayoun; Nordberg, Jessica; Monga, Manoj; Low, Walter C.; Bhatia, Prerana M.; Beilman, Greg J.; SantaCruz, Karen S.			A Novel Preclinical Model of Moderate Primary Blast-Induced Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						axonal damage; blast traumatic brain injury; brain injury; functional outcomes; lithotripsy; vasospasm	SHOCK-WAVE LITHOTRIPSY; POSTTRAUMATIC-STRESS-DISORDER; RAT MODEL; INTRACRANIAL-PRESSURE; EXPLOSIVE BLAST; ANIMAL-MODEL; BLOOD-FLOW; IN-VITRO; EXPOSURE; NEUROTRAUMA	Blast-induced traumatic brain injury (bTBI) is the signature injury of the recent Iraq and Afghanistan wars. Here, we present a novel method to induce bTBI using shock wave (SW) lithotripsy. Using a lithotripsy machine, Wistar rats (N=70; 408.3 +/- 93g) received five SW pulses to the right side of the frontal cortex at 24kV and a frequency of 60Hz. Animals were then randomly divided into three study endpoints: 24h (n=25), 72h (n=19) and 168h (n=26). Neurological and behavioral assessments (Garcia's test, beam walking, Rotarod, and elevated plus maze) were performed at the baseline, and further assessments followed at 3, 6, 24, 72, and 168h post-injury, if applicable. We performed digital subtraction angiography (DSA) to assess presence of cerebral vasospasm due to induced bTBI. Damage to brain tissue was assessed by an overall histological severity (OHS) score based on depth of injury, area of hemorrhage, and extent of axonal injury. Except for beam walking, OHS was significantly correlated with the other three outcome measures with at least one of their assessments during the first 6h after the experiment. OHS manifested the highest absolute correlation coefficients with anxiety at the baseline and 6h post-injury (r(baseline)=-0.75, r(6hrs)=0.85; p<0.05). Median hemispheric differences for contrast peak values (obtained from DSA studies) for 24, 72, and 168h endpoints were 3.45%, 3.05% and 0.2%, respectively, with statistically significant differences at 1 versus 7d (p<0.05) and 3 versus 7d (p<0.01). In this study, we successfully established a preclinical rat model of bTBI with characteristics similar to those observed in clinical cases. This new method may be useful for future investigations aimed at understanding bTBI pathophysiology.	[Divani, Afshin A.; Murphy, Amanda J.; Nordberg, Jessica; Bhatia, Prerana M.] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; [Divani, Afshin A.; Low, Walter C.] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA; [Divani, Afshin A.; Bhatia, Prerana M.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Murphy, Amanda J.; Meints, Joyce] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Beilman, Greg J.] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Sadeghi-Bazargani, Homayoun] Tabriz Univ Med Sci, Neurosci Res Ctr, Tabriz, Iran; [Sadeghi-Bazargani, Homayoun] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Monga, Manoj] Cleveland Clin, Dept Urol, Cleveland, OH 44106 USA; [SantaCruz, Karen S.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA	Divani, AA (corresponding author), Univ Minnesota, Dept Neurol, 420 Delaware St SE,MMC 295, Minneapolis, MN 55455 USA.	divani@umn.edu	Sadeghi-Bazargani, Homayoun/M-5522-2017	Sadeghi-Bazargani, Homayoun/0000-0002-0396-8709; Beilman, Gregory/0000-0001-5036-3027	Stroke Research Center, University of Minnesota; HealthEZ (Bloomington, MN); Lake Region Medical (Chaska, MN); Covidien (Mansfield, MA); American Heart Association's Stroke Council; University of Minnesota's Undergraduate Research Opportunities Program (UROP); Lake Region Medical	The study was supported in part by the Summer Student Fellowship program at the Stroke Research Center, University of Minnesota that has been established by a generous support from HealthEZ (Bloomington, MN), Lake Region Medical (Chaska, MN), and Covidien (Mansfield, MA). Amanda J. Murphy has received a Medical Student Scholarship in Cerebrovascular Disease and Stroke sponsored by the American Heart Association's Stroke Council. Prerana M. Bhatia was supported by the University of Minnesota's Undergraduate Research Opportunities Program (UROP). Dr. Divani has received research support from Lake Region Medical.	Agoston DV, 2009, J NEUROTRAUM, V26, P901, DOI 10.1089/neu.2008.0724; Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Albala DM, 2005, BJU INT, V96, P603, DOI 10.1111/j.1464-410X.2005.05692.x; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Auge Brian K, 2002, Curr Opin Urol, V12, P287, DOI 10.1097/00042307-200207000-00005; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI 10.1089/neu.2009-0898; Bhatia PM, 2012, TRANSL STROKE RES, V3, P428, DOI 10.1007/s12975-012-0199-0; Bir C, 2012, MAGN RESON IMAGING, V30, P527, DOI 10.1016/j.mri.2011.12.003; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Cleveland RO, 2000, J ACOUST SOC AM, V107, P1745, DOI 10.1121/1.428572; Cohen H, 2008, BIOL PSYCHIAT, V64, P708, DOI 10.1016/j.biopsych.2008.05.025; Colombel C, 2002, BRAIN RES, V950, P231, DOI 10.1016/S0006-8993(02)03043-3; Divani AA, 2006, J NEUROIMAGING, V16, P139, DOI 10.1111/j.1552-6569.2006.00024.x; Divani AA, 2009, ANN BIOMED ENG, V37, P2428, DOI 10.1007/s10439-009-9782-2; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Eriksson L., 2006, MULTI MEGAVARIATE DA; Faridar Alireza, 2011, Front Neurol, V2, P80, DOI 10.3389/fneur.2011.00080; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Howard D, 1997, ULTRASOUND MED BIOL, V23, P1107, DOI 10.1016/S0301-5629(97)00081-1; Januszkiewicz AJ, 1997, TOXICOLOGY, V121, P51, DOI 10.1016/S0300-483X(97)03655-X; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Martin EM, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000315260.92070.3f; Nakagawa A, 2008, ACTA NEUROCHIR SUPPL, V102, P421, DOI 10.1007/978-3-211-85578-2_82; Nakagawa Y, 2011, ENDOSCOPY, V43, pE310, DOI 10.1055/s-0030-1256642; Ogden JA, 2001, CLIN ORTHOP RELAT R, P8; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Ropper A, 2011, NEW ENGL J MED, V364, P2156, DOI 10.1056/NEJMe1102187; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Sadeghi-Bazargani H, 2011, Ann Burns Fire Disasters, V24, P191; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Sweis BM, 2013, NEUROSCIENCE, V246, P142, DOI 10.1016/j.neuroscience.2013.04.052; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006	47	12	13	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2015	32	14					1109	1116		10.1089/neu.2014.3686			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CV0TB	WOS:000363965000010	25585201				2021-06-18	
J	Wang, Z; Peng, WJ; Zhang, CH; Sheng, CX; Huang, W; Wang, Y; Fan, R				Wang, Zhe; Peng, Weijun; Zhang, Chunhu; Sheng, Chenxia; Huang, Wei; Wang, Yang; Fan, Rong			Effects of stem cell transplantation on cognitive decline in animal models of Alzheimer's disease: A systematic review and meta-analysis	SCIENTIFIC REPORTS			English	Article							AMYLOID-BETA DEPOSITION; TRAUMATIC BRAIN-INJURY; IMPROVE MEMORY DYSFUNCTION; NEURAL PRECURSOR CELLS; MOUSE MODEL; TRANSGENIC MICE; INTRACEREBRAL TRANSPLANTATION; RESTORE COGNITION; CONTROLLED-TRIALS; RESCUES MEMORY	Alzheimer's disease (AD), an irreversible progressive neurodegenerative disease, causes characteristic cognitive impairment, and no curative treatments are currently available. Stem cell transplantation offers a powerful tool for the treatment of AD. We conducted a systematic review and meta-analysis of data from controlled studies to study the impact of stem cell biology and experimental design on learning and memory function following stem cell transplantation in animal models of AD. A total of 58 eligible controlled studies were included by searching PubMed, EMBASE, and Web of Science up to April 13, 2015. Meta-analysis showed that stem cell transplantation could promote both learning and memory recovery. Stratified meta-analysis was used to explore the influence of the potential factors on the estimated effect size, and meta-regression analyses were undertaken to explore the sources of heterogeneity for learning and memory function. Publication bias was assessed using funnel plots and Egger's test. The present review reinforces the evidence supporting stem cell transplantation in experimental AD. However, it highlights areas that require well-designed and well-reported animal studies.	[Wang, Zhe; Peng, Weijun; Sheng, Chenxia; Huang, Wei] Cent S Univ, Xiangya Hosp 2, Dept Integrated Chinese & Western Med, Changsha 410011, Hunan, Peoples R China; [Zhang, Chunhu; Wang, Yang; Fan, Rong] Cent S Univ, Xiangya Hosp, Inst Integrated Med, Changsha 410008, Hunan, Peoples R China	Peng, WJ (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Integrated Chinese & Western Med, Changsha 410011, Hunan, Peoples R China.	pengweijun1987@gmail.com	Peng, Weijun/M-5131-2014	Peng, Weijun/0000-0002-4506-0942	Young Scientists Fund of the National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81303074, 81403259]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [8137370]; Natural Science Foundation of Hunan ProvinceNatural Science Foundation of Hunan Province [13JJ3030]; special project of high-tech industrial development of Hunan Province [2012SK3212]	This work was financially supported by the Young Scientists Fund of the National Natural Science Foundation of China (Grant No. 81303074, 81403259), the National Natural Science Foundation of China (Grant No.8137370), Natural Science Foundation of Hunan Province (Grant No. 13JJ3030) and the special project of high-tech industrial development of Hunan Province (Grant No. 2012SK3212).	Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; [Anonymous], 2008, CRTER; [Anonymous], 2009, CRTER; [Anonymous], 2010, CRTER; [Anonymous], 2013, NEUROSCI LETT; [Anonymous], 2010, CRTER; [Anonymous], 2011, PROGR ANATOMICAL SCI; Antonic A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001738; Babaei P, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/369417; Ben Menachem-Zidon O, 2014, NEUROPSYCHOPHARMACOL, V39, P401, DOI 10.1038/npp.2013.208; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Bobkova NV, 2013, B EXP BIOL MED+, V156, P119, DOI 10.1007/s10517-013-2293-z; Chen SQ, 2014, AM J ALZHEIMERS DIS, V29, P142, DOI 10.1177/1533317513506776; Choi Sung S, 2014, Exp Neurobiol, V23, P45, DOI 10.5607/en.2014.23.1.45; Danos O, 2010, J GENE MED, V12, P559, DOI 10.1002/jgm.1472; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Esmaeilzade Banafshe, 2012, Iranian Biomedical Journal, V16, P1, DOI 10.6091/IBJ.1029.2012; Garcia KO, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00030; Garcia-Bonilla L, 2012, J NEUROCHEM, V122, P233, DOI 10.1111/j.1471-4159.2012.07773.x; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Glat MJ, 2013, STEM CELLS DEV, V22, P1490, DOI 10.1089/scd.2012.0633; Gu G, 2015, NEUROSCIENCE, V291, P81, DOI 10.1016/j.neuroscience.2015.01.073; [谷海刚 Gu Haigang], 2008, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V12, P2235; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Karran E, 2014, NEW ENGL J MED, V370, P377, DOI 10.1056/NEJMe1313943; Ker K, 2009, CNS NEUROSCI THER, V15, P52, DOI 10.1111/j.1755-5949.2008.00069.x; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim KS, 2013, NEUROBIOL AGING, V34, P2408, DOI 10.1016/j.neurobiolaging.2013.03.029; Lee HJ, 2012, CELL TRANSPLANT, V21, P2487, DOI 10.3727/096368912X638964; Lee HJ, 2012, NEUROBIOL AGING, V33, P588, DOI 10.1016/j.neurobiolaging.2010.03.024; Lee HJ, 2010, NEUROSCI LETT, V481, P30, DOI 10.1016/j.neulet.2010.06.045; Lee JK, 2010, CURR ALZHEIMER RES, V7, P540; Lee JK, 2012, STEM CELLS, V30, P1544, DOI 10.1002/stem.1125; Lee JK, 2010, STEM CELLS, V28, P329, DOI 10.1002/stem.277; Lees JS, 2012, INT J STROKE, V7, P582, DOI 10.1111/j.1747-4949.2012.00797.x; Li M, 2014, INT J MOL SCI, V15, P19226, DOI 10.3390/ijms151019226; Li Wen-yu, 2012, Zhejiang Da Xue Xue Bao Yi Xue Ban, V41, P659; Li ZF, 2010, J ALZHEIMERS DIS, V21, P1233, DOI 10.3233/JAD-2010-100003; [李志方 LI Zhifang], 2008, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V30, P595; Liao Y, 2014, BRIT J CLIN PHARMACO, V78, P718, DOI 10.1111/bcp.12382; Liu JB, 2007, J EUR ACAD DERMATOL, V21, P205, DOI 10.1111/j.1468-3083.2006.01899.x; Liu YH, 2013, DRUG DISCOV TODAY, V18, P1212, DOI 10.1016/j.drudis.2013.07.020; Ma T, 2013, CELL TRANSPLANT, V22, pS113, DOI 10.3727/096368913X672181; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Moghadam FH, 2009, DIFFERENTIATION, V78, P59, DOI 10.1016/j.diff.2009.06.005; O'Collins VE, 2006, ANN NEUROL, V59, P467, DOI 10.1002/ana.20741; Park D, 2013, NEUROBIOL AGING, V34, P2639, DOI 10.1016/j.neurobiolaging.2013.04.026; Park D, 2012, EXP NEUROL, V234, P521, DOI 10.1016/j.expneurol.2011.12.040; Park D, 2012, CELL TRANSPLANT, V21, P365, DOI 10.3727/096368911X586765; Peng WJ, 2014, J NEUROSURG, V121, P653, DOI 10.3171/2014.6.JNS132577; Peng WJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/261409; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; SACKS HS, 1987, NEW ENGL J MED, V316, P450, DOI 10.1056/NEJM198702193160806; Stygelbout V, 2014, BRAIN, V137, P537, DOI 10.1093/brain/awt344; Tang J, 2008, NEUROSCI RES, V62, P86, DOI 10.1016/j.neures.2008.06.005; Tsai LH, 2014, NATURE, V507, P439, DOI 10.1038/nature13214; Wang QH, 2006, J MED INVESTIG, V53, P61, DOI 10.2152/jmi.53.61; [王卓 Wang Zhuo], 2014, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V18, P8130; Wardlaw JM, 2000, LANCET, V356, P597, DOI 10.1016/S0140-6736(05)73980-5; Wheaton P, 2011, J PSYCHOPHARMACOL, V25, P1581, DOI 10.1177/0269881110388331; Wimo A, 2010, ALZHEIMERS DEMENT, V6, P98, DOI 10.1016/j.jalz.2010.01.010; Wu QY, 2007, NEUROSCI LETT, V417, P281, DOI 10.1016/j.neulet.2007.02.092; Wu S, 2008, PATHOBIOLOGY, V75, P186, DOI 10.1159/000124979; Xuan AG, 2009, NEUROSCI LETT, V450, P167, DOI 10.1016/j.neulet.2008.12.001; Xue SR, 2011, CHINESE MED J-PEKING, V124, P2642, DOI 10.3760/cma.j.issn.0366-6999.2011.17.014; Xue SR, 2012, SCI CHINA LIFE SCI, V55, P132, DOI 10.1007/s11427-012-4283-1; Yan YF, 2014, NEURAL REGEN RES, V9, P798, DOI 10.4103/1673-5374.131596; Yang Chun, 2007, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V23, P159; Yang HN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069129; Yang H, 2013, NEUROCHEM RES, V38, P2474, DOI 10.1007/s11064-013-1161-6; Yang H, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt227; Yun HM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.490; Zhang P, 2012, NEURAL REGEN RES, V7, P245, DOI 10.3969/j.issn.1673-5374.2012.04.001; Zhang W, 2014, J NEUROSCI RES, V92, P185, DOI 10.1002/jnr.23299; Zhang W, 2015, NEUROBIOL AGING, V36, P1282, DOI 10.1016/j.neurobiolaging.2014.10.040; Zhang W, 2014, MOL NEUROBIOL, V50, P423, DOI 10.1007/s12035-014-8640-x; Zhao Zhiying, 2005, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V19, P331	77	12	12	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 10	2015	5								12134	10.1038/srep12134			10	Multidisciplinary Sciences	Science & Technology - Other Topics	CM5HM	WOS:000357717900001	26159750	DOAJ Gold, Green Published			2021-06-18	
J	Cao, Y; Walker, EA; Krause, JS				Cao, Yue; Walker, Elizabeth A.; Krause, James S.			Environmental barriers and subjective health among people with chronic spinal cord injury: A cohort study	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Spinal cord injuries; Health; Environment	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; PHYSICAL-DISABILITIES; ACTIVITY PARTICIPATION; PERCEIVED HEALTH; YOUNG-ADULTS; COMMUNITY; MORTALITY; CHILDREN; SATISFACTION	Objective: Although previous studies have found environmental barriers to be associated with social participation and life satisfaction after spinal cord injury (SCI), few studies exist reporting their effects on subjective health after SCI. Our purpose was to identify the prevalence of perceived environmental barriers and their effects on subjective health in persons with chronic SCI who completed two repeated measurements during a 5-year longitudinal study. Design: This is a prospective cohort study. Environmental barriers were measured at baseline by the Craig Hospital Inventory of Environmental Factors-Short Form. Subjective health was measured at baseline and 5-year follow-up by days of physical and mental health not good. Other control variables included sex, race, age at injury, years since injury, and injury severity at baseline. Setting: Data were collected at a specialty hospital and analyzed at a medical university in the Southeastern USA. Participants: A total of 1635 participants completed both baseline and follow-up surveys. Results: Twenty per cent of participants reported at least one policy barrier, 46% at least one physical and structural barrier, 22% at least one attitudinal and support barrier, 26% at least one barrier to services and assistance, and 13% at least one barrier at work or school. After controlling for sex, race, age at injury, years since injury, and injury severity, the physical and structural barriers, and services and assistance barriers measured at baseline significantly predicted subjective physical and mental health measured at follow-up. Conclusion: Environmental barriers are prevalent among people with chronic SCI. They are important predictors for future subjective health.	[Cao, Yue; Walker, Elizabeth A.; Krause, James S.] Med Univ S Carolina, Coll Hlth Profess, Charleston, SC 29425 USA	Cao, Y (corresponding author), Med Univ S Carolina, Coll Hlth Profess, 77 President St,Suite C101A,MSC 700, Charleston, SC 29425 USA.	caoyu@musc.edu			Department of Education, NIDRR [H133B090005]; South Carolina Spinal Cord Injury Research Fund [11-006]	This study was developed under a grant from the Department of Education, NIDRR grant numbers H133B090005, and grant SCIRF 11-006 from the South Carolina Spinal Cord Injury Research Fund.	Barf HA, 2009, DISABIL REHABIL, V31, P921, DOI 10.1080/09638280802358282; BULLARD RD, 1993, TOXICOL IND HEALTH, V9, P821, DOI 10.1177/074823379300900508; Cardol M, 2002, CLIN REHABIL, V16, P27, DOI 10.1191/0269215502cr464oa; *CDCP, 2006, BEH RISK FACT SURV S; Cockerham W.C., 2013, SOCIAL CAUSES HLTH D; Craig Hospital Research Department, 2001, CRAIG HOSP INV ENV F; Farmer MM, 1997, J HEALTH SOC BEHAV, V38, P298, DOI 10.2307/2955372; Fougeyrollas P., 2002, TOP SPINAL CORD INJ, V7, P1, DOI DOI 10.1310/QDNN-8FN0-NJMG-TVWB; Frohlich KL, 2001, SOCIOL HEALTH ILL, V23, P776, DOI 10.1111/1467-9566.00275; George LK, 1980, QUALITY LIFE OLDER P, Vxii, P238; Gray DB, 2003, J ARCHIT PLAN RES, V20, P29; Hays JC, 1996, J CLIN EPIDEMIOL, V49, P969, DOI 10.1016/0895-4356(96)00138-2; Houtrow A, 2012, ACAD PEDIATR, V12, P326, DOI 10.1016/j.acap.2012.03.004; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Johnson D, 2005, J MARRIAGE FAM, V67, P1061, DOI 10.1111/j.1741-3737.2005.00194.x; JOHNSON RJ, 1993, J HEALTH SOC BEHAV, V34, P105, DOI 10.2307/2137238; Kawachi I., 2003, NEIGHBORHOODS HLTH; Krause JS, 2009, SPINAL CORD, V47, P592, DOI 10.1038/sc.2009.15; Krause James S, 2010, Top Spinal Cord Inj Rehabil, V16, P53; Law M, 2007, ARCH PHYS MED REHAB, V88, P1636, DOI 10.1016/j.apmr.2007.07.035; Lynch SM, 2003, DEMOGRAPHY, V40, P309, DOI 10.1353/dem.2003.0016; Macintyre S, 2002, SOC SCI MED, V55, P125, DOI 10.1016/S0277-9536(01)00214-3; MADDOX GL, 1964, J CHRON DIS, V17, P449, DOI 10.1016/0021-9681(64)90105-5; MADDOX GL, 1962, J GERONTOL, V17, P180, DOI 10.1093/geronj/17.2.180; Mihaylov SI, 2004, DEV MED CHILD NEUROL, V46, P299; MOHAI P, 1992, RACE INCIDENCE ENV H; Noreau L., 2002, TOPICS SPINAL CORD I, V7, P56, DOI DOI 10.1310/1UGA-EY2T-N6XP-1PHE; Putzke JD, 2002, ARCH PHYS MED REHAB, V83, P555, DOI 10.1053/apmr.2002.31173; Rimmer JH, 2004, AM J PREV MED, V26, P419, DOI 10.1016/j.amepre.2004.02.002; Rimmer JH, 2000, ARCH PHYS MED REHAB, V81, P182; US Department of Education OoSEaRS National Institute on Disability and Rehabiliation Research, 2000, LONG RANG PLAN 2013; Viemero V, 1998, PSYCHOTHER PSYCHOSOM, V67, P317, DOI 10.1159/000012297; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, P1793, DOI 10.1016/j.apmr.2004.04.024; Whiteneck GG, 2004, ARCH PHYS MED REHAB, V85, P1324, DOI 10.1016/j.apmr.2003.09.027; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009; World Health Organization, 2001, INT CLASS FUNCT DIS; Yeung P, 2014, DISABIL REHABIL, V36, P63, DOI 10.3109/09638288.2013.777808	38	12	12	0	12	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	JUL	2015	38	4					557	562		10.1179/2045772314Y.0000000275			6	Clinical Neurology	Neurosciences & Neurology	CL4RS	WOS:000356941800022	25329423	Green Published			2021-06-18	
J	Khanna, NK; Baumgartner, K; LaBella, CR				Khanna, Neil K.; Baumgartner, Katherine; LaBella, Cynthia R.			Balance Error Scoring System Performance in Children and Adolescents With No History of Concussion	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; traumatic brain injury; pediatrics; balance; postural stability	MILD HEAD-INJURY; POSTURAL STABILITY; BRAIN-INJURY	Background: The Balance Error Scoring System (BESS) is a useful means of measuring postural stability, which frequently exhibits deficits after a concussion. However, it has limited applicability for children since there is insufficient normative data available for the BESS in the pediatric population. The purposes of this study were to report scores for the BESS in children 10 to 17 years old with no history of concussion and to identify whether BESS score is correlated with age, sex, sports participation, height, weight, or body mass index. Hypothesis: Baseline BESS scores will be related to age and sports participation. Study Design: Descriptive laboratory study. Level of Evidence: Level 3. Methods: One examiner recruited 100 participants 10 to 17 years old over a period of 4 months; performed all of the BESS tests; surveyed participants regarding age, sex, and sports participation; recorded participants' heights and weights; and calculated body mass indices. Intrarater reliability was measured. The main outcome measures were total, firm, and foam surface BESS scores. We assessed data for normality using the Shapiro-Wilk test and used the Spearman rank test to determine whether BESS scores correlated with sex, age, sports participation, height, weight, or body mass index. Results: There was no correlation between the BESS firm surface (5.37 +/- 4.4), BESS foam surface (12.28 +/- 4.43), or total surface scores (17.64 +/- 7.52) and age, anthropometrics, or sports participation. Male and female subjects had similar scores except in the 10-to 13-year-old age group on the foam surface, where girls performed better than boys (10.42 +/- 4.53 vs 13.07 +/- 4.23; P = 0.02). Conclusion: Baseline BESS scores in children aged 10 to 17 years were normally distributed and were not related to age, sex, height, weight, body mass index, or sports participation.	[Khanna, Neil K.; LaBella, Cynthia R.] Northwestern Univ Feinberg Sch Med, Chicago, IL USA; [Khanna, Neil K.; Baumgartner, Katherine; LaBella, Cynthia R.] Ann Robert H Lurie Childrens Hosp Chicago, 225 East Chicago Ave,Box 69, Chicago, IL 60611 USA	Khanna, NK (corresponding author), Ann Robert H Lurie Childrens Hosp Chicago, 225 East Chicago Ave,Box 69, Chicago, IL 60611 USA.	khanna@fsm.northwestern.edu			Northwestern University Feinberg School of Medicine	The authors reported the following potential conflicts of interest: Funding was provided by Northwestern University's Feinberg School of Medicine.	Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; HIRABAYASHI S, 1995, BRAIN DEV-JPN, V17, P111, DOI 10.1016/0387-7604(95)00009-Z; HYTONEN M, 1993, ACTA OTO-LARYNGOL, V113, P119, DOI 10.3109/00016489309135778; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; Iverson GL, 2013, REHABIL RES PRACT, V2013, DOI 10.1155/2013/846418; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; RIACH CL, 1987, DEV MED CHILD NEUROL, V29, P650; Riemann BL, 2000, J ATHL TRAINING, V35, P19	17	12	12	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JUL-AUG	2015	7	4					341	345		10.1177/1941738115571508			5	Sport Sciences	Sport Sciences	V20NJ	WOS:000214893000009	26137180	Green Published			2021-06-18	
J	Stelmaschuk, S; Will, MC; Meyers, T				Stelmaschuk, Stephanie; Will, Mary Colleen; Meyers, Tamara			Amantadine to Treat Cognitive Dysfunction in Moderate to Severe Traumatic Brain Injury	JOURNAL OF TRAUMA NURSING			English	Article							GLASGOW COMA SCALE; HEAD-INJURIES; RELIABILITY; HYDROCHLORIDE; DISABILITY; SYMPTOMS; EFFICACY	Traumatic brain injury (TBI) is a leading cause of injury, disability, and death in the United States. Amantadine is an established dopamine agonist that supports neurological function. The purpose of this literature review was to determine whether amantadine improves cognitive function post-TBI. PubMed and CINAHL were used to search the literature for articles using amantadine to treat TBI from 1994 to 2004. Outcomes were summarized and the evidence was appraised. Although earlier studies from 1994 to 2003 were lower-level studies and recommended further research on treatment of cognitive dysfunction in TBI, the literature from 2004 to present generally concluded that amantadine improved cognitive function related to arousal, memory, and aggression. It can be started days to months postinjury and still produces benefits.	[Stelmaschuk, Stephanie] Grant Med Ctr, Inpatient Trauma Serv, Columbus, OH 43215 USA; [Will, Mary Colleen] Cent Ohio Primary Care, Columbus, OH USA; [Meyers, Tamara] Grant Med Ctr, Outpatient Trauma & Acute Care Surg Off, Columbus, OH 43215 USA	Stelmaschuk, S (corresponding author), Grant Med Ctr, Inpatient Trauma Serv, 111 S Grant Ave,Ste 350, Columbus, OH 43215 USA.	Stephanie.Stelmaschuk@ohiohealth.com					Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chen JJ, 2007, PHARMACOTHERAPY, V27, p161S, DOI 10.1592/phco.27.12part2.161S; Colorado Division of Workers' Compensation, 2012, TRAUM BRAIN INJ MED, P1; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; Hannay HJ, 1996, J HEAD TRAUMA REHAB, V11, P41, DOI 10.1097/00001199-199612000-00007; Huang EY, 2014, PLOS ONE, V9, P1; Hughes S, 2005, BRAIN INJURY, V19, P1197, DOI 10.1080/02699050500309296; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kraus MF, 1997, BRAIN INJURY, V11, P455, DOI 10.1080/026990597123430; Kraus MF, 2005, BRAIN INJURY, V19, P471, DOI 10.1080/02699050400025059; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Reddy CC, 2013, J HEAD TRAUMA REHAB, V28, P260, DOI 10.1097/HTR.0b013e318257fbc6; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; Saniova B, 2004, J NEURAL TRANSM, V111, P511, DOI 10.1007/s00702-004-0112-4; Schneider WN, 1999, BRAIN INJURY, V13, P863; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wheaton P, 2009, J CLIN PSYCHOPHARM, V29, P468, DOI 10.1097/JCP.0b013e3181b66f04; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016	29	12	13	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-7496	1932-3883		J TRAUMA NURS	J. Trauma Nurs.	JUL-AUG	2015	22	4					194	203		10.1097/JTN.0000000000000138			10	Critical Care Medicine; Nursing	General & Internal Medicine; Nursing	CM8HV	WOS:000357941000005	26165872				2021-06-18	
J	Walker, WC; Ketchum, JS; Marwitz, JH; Kolakowsky-Hayner, SA; McClish, DK; Bushnik, T				Walker, William C.; Ketchum, James S., III; Marwitz, Jennifer H.; Kolakowsky-Hayner, Stephanie A.; McClish, Donna K.; Bushnik, Tamara			Global Outcome and Late Seizures After Penetrating Versus Closed Traumatic Brain Injury: A NIDRR TBI Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							POSTTRAUMATIC EPILEPSY; RISK-FACTORS; HEAD-INJURY; RECOVERY; PREDICTION; MULTICENTER; POPULATION; PREVENTION; SCALE; BLUNT	Background: If and how much dural penetration influences long-term outcome after traumatic brain injury (TBI) is understudied, especially within the civilian population. Objectives: Using the large TBI Model Systems cohort, this study assessed and compared penetrating TBI (PTBI) and closed TBI with respect to global outcome and late seizures 2 years after injury. Methods: After performing unadjusted PTBI versus closed TBI comparisons, multivariate regression models were built and analyzed for both outcomes by including the following additional predictors: length of unconsciousness, posttraumatic amnesia duration, hospital length of stay, age, gender, race, marital status, education level, problem substance abuse, and preinjury employment status. Results: The collapsed Glasgow Outcome Scale model (n = 6111) showed significant secondary effects of PTBI with employment status. When employed before injury, individuals with PTBI were 2.62 times more likely (95% confidence interval, 1.92-3.57) to have a lower Glasgow Outcome Scale category. The final model for late seizures (n = 6737) showed a significant main effect for PTBI. Adjusting for other predictors, individuals with PTBI were 2.78 times more likely (95% confidence interval, 1.93-3.99) than those with closed TBI to be rehospitalized for a seizure. Conclusion: This study empirically demonstrates that penetrating injury mechanism has important prognostic implications.	[Walker, William C.; Marwitz, Jennifer H.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; [Ketchum, James S., III; McClish, Donna K.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA; [Kolakowsky-Hayner, Stephanie A.] Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA 95128 USA; [Bushnik, Tamara] NYU, Rusk Rehabil, Langone Sch Med, New York, NY USA	Walker, WC (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, 1223 E Marshall St,4th Fl, Richmond, VA 23298 USA.	wwalker@mcvh-vcu.edu	Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909; Bushnik, Tamara/0000-0003-3328-257X	US Department of Education, National Institute on Disability and Rehabilitation Research (NIDRR)US Department of Education; TBI Model Systems Centers (VCU) [H133A120031, H133A070038, H133A120100]	The TBI Model Systems National Database is supported by the US Department of Education, National Institute on Disability and Rehabilitation Research (NIDRR) in collaboration with the TBI Model Systems Centers (VCU, no. H133A120031; Santa Clara, no. H133A070038; and Rusk, no. H133A120100). However, these contents do not necessarily reflect the opinions or views of the TBI Model Systems Centers, NIDRR or the US Department of Education.	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Beghi E, 2003, EPILEPSIA, V44, P21, DOI 10.1046/j.1528-1157.44.s10.1.x; Black KL, 2002, J HEAD TRAUMA REHAB, V17, P489, DOI 10.1097/00001199-200212000-00001; Bush BA, 2003, ARCH PHYS MED REHAB, V84, P1803, DOI 10.1016/S0003-9993(03)00367-8; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; CLARK WC, 1986, J NEUROSURG, V65, P9, DOI 10.3171/jns.1986.65.1.0009; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; DASILVA AM, 1990, ACT NEUR S, V50, P48; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; JENNETT WB, 1960, J NEUROL NEUROSUR PS, V23, P295, DOI 10.1136/jnnp.23.4.295; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Konigs M, 2012, J NEUROL NEUROSUR PS, V83, P1048, DOI 10.1136/jnnp-2012-302635; LEVIN HS, 1995, J NEUROTRAUM, V12, P913, DOI 10.1089/neu.1995.12.913; LEVY ML, 1994, NEUROSURGERY, V35, P77, DOI 10.1227/00006123-199407000-00012; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Perrin PB, 2014, J HEAD TRAUMA REHABI; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Thais MERD, 2014, J NEUROPSYCHOL, V8, P125, DOI 10.1111/jnp.12000; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Sherer M, 2014, ARCH PHYS MED REHAB, V95, P1162, DOI [10.1016/j.apmr.2014.02.006, 10.1016/j.apmr.2013.06.004]; Smith JE, 2014, INJURY, V45, P874, DOI 10.1016/j.injury.2013.12.004; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Willmore LJ, 2009, NEUROCHEM RES, V34, P688, DOI 10.1007/s11064-008-9841-3; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zafonte RD, 1997, BRAIN INJURY, V11, P403	40	12	12	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2015	30	4					231	240		10.1097/HTR.0000000000000127			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CM8JA	WOS:000357944700001	25931183				2021-06-18	
J	Mantua, J; Mahan, KM; Henry, OS; Spencer, RMC				Mantua, Janna; Mahan, Keenan M.; Henry, Owen S.; Spencer, Rebecca M. C.			Altered sleep composition after traumatic brain injury does not affect declarative sleep-dependent memory consolidation	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						sleep; memory consolidation; TBI; traumatic brain injury; NREM	MINOR HEAD-INJURY; SLOW-WAVE SLEEP; PROCEDURAL MEMORY; DISTURBANCES; ADOLESCENTS; SPINDLES; QUALITY; CYCLES; RECALL; NEED	Individuals with a history of traumatic brain injury (TBI) often report sleep disturbances, which may be caused by changes in sleep architecture or reduced sleep quality (greater time awake after sleep onset, poorer sleep efficiency, and sleep stage proportion alterations). Sleep is beneficial for memory formation, and herein we examine whether altered sleep physiology following TBI has deleterious effects on sleep-dependent declarative memory consolidation. Participants learned a list of word pairs in the morning or evening, and recall was assessed 12-h later, following an interval awake or with overnight sleep. Young adult participants (18-22 years) were assigned to one of four experimental groups: TBI Sleep (n = 14), TBI Wake (n = 12), non-TBI Sleep (n = 15), non-TBI Wake (n = 15). Each TBI participant was >1 year post injury. Sleep physiology was measured with polysomnography. Memory consolidation was assessed by comparing change in word-pair recall over 12-h intersession intervals. The TBI group spent a significantly greater proportion of the night in SWS than the non-TBI group at the expense of NREM1. The TBI group also had marginally lower EEG delta power during SVVS in the central region. Intersession changes in recall were greater for intervals with sleep than without sleep in both groups. However, despite abnormal sleep stage proportions for individuals with a TBI history, there was no difference in the intersession change in recall following sleep for the TBI and non-TBI groups. In both Sleep groups combined, there was a positive correlation between Intersession Change and the proportion of the night in NREM2 + SWS. Overall, sleep composition is altered following TBI but such deficits do not yield insufficiencies in sleep-dependent memory consolidation.	[Mantua, Janna; Spencer, Rebecca M. C.] Univ Massachusetts, Neurosci & Behav Program, Amherst, MA 01003 USA; [Mahan, Keenan M.; Henry, Owen S.] Univ Massachusetts, Commonwealth Honors Coll, Amherst, MA 01003 USA; [Spencer, Rebecca M. C.] Univ Massachusetts, Dept Psychol & Brain Sci, Amherst, MA 01003 USA	Spencer, RMC (corresponding author), Univ Massachusetts, Dept Psychol & Brain Sci, 135 Hicks Way,Tobin 419, Amherst, MA 01003 USA.	rspencer@psych.umass.edu		Henry, Owen/0000-0002-2266-7768	Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [26381308] Funding Source: KAKEN		Ackermann S., 2014, SLEEP; Ackermann S, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-013-0430-8; Armed Forces Health Surveillance Center (AFHSC), 2013, MSMR, V20, P9; Baran B, 2012, J NEUROSCI, V32, P1035, DOI 10.1523/JNEUROSCI.2532-11.2012; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Bhalerao U, 2013, BRAIN INJURY, V27, P767, DOI 10.3109/02699052.2013.793396; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Clemens Z, 2005, NEUROSCIENCE, V132, P529, DOI 10.1016/j.neuroscience.2005.01.011; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Crowley K, 2002, CLIN NEUROPHYSIOL, V113, P1615, DOI 10.1016/S1388-2457(02)00237-7; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Feld GB, 2013, SLEEP, V36, P1317, DOI 10.5665/sleep.2954; Ficca G, 2000, BEHAV BRAIN RES, V112, P159, DOI 10.1016/S0166-4328(00)00177-7; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Gao B, 2010, SLEEP, V33, P879, DOI 10.1093/sleep/33.7.879; Genzel L, 2009, SLEEP, V32, P302, DOI 10.1093/sleep/32.3.302; Goder R, 2007, SLEEP MED, V8, P503, DOI 10.1016/j.sleep.2006.11.014; Hershner SD, 2014, NAT SCI SLEEP, V6, P73, DOI 10.2147/NSS.S62907; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Holz J, 2012, J SLEEP RES, V21, P612, DOI 10.1111/j.1365-2869.2012.01017.x; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; JOHNS MW, 1994, SLEEP, V17, P703, DOI 10.1093/sleep/17.8.703; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Martin SE, 1997, AM J RESP CRIT CARE, V155, P1596, DOI 10.1164/ajrccm.155.5.9154863; Mazzoni G, 1999, J SLEEP RES, V8, P185, DOI 10.1046/j.1365-2869.1999.00154.x; Mednick SC, 2013, J NEUROSCI, V33, P4494, DOI 10.1523/JNEUROSCI.3127-12.2013; Nudo RJ, 2011, J COMMUN DISORD, V44, P515, DOI 10.1016/j.jcomdis.2011.04.004; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Pillar G, 2003, PEDIATR NEUROL, V29, P131, DOI 10.1016/S0887-8994(03)00149-8; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Ruch S, 2012, NEUROPSYCHOLOGIA, V50, P2389, DOI 10.1016/j.neuropsychologia.2012.06.008; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Sommerauer M, 2013, J SLEEP RES, V22, P634, DOI 10.1111/jsr.12068; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Toki S, 2014, J AFFECT DISORDERS, V152, P462, DOI 10.1016/j.jad.2013.07.021; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilson JK, 2012, NEUROBIOL AGING, V33, P991, DOI 10.1016/j.neurobiolaging.2011.06.029	51	12	12	0	9	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	JUN 5	2015	9								328	10.3389/fnhum.2015.00328			9	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	CK3EZ	WOS:000356100700001	26097451	DOAJ Gold, Green Published			2021-06-18	
J	Cheng, OM; Li, R; Zhao, L; Yu, LJ; Yang, B; Wang, J; Chen, BB; Yang, JQ				Cheng, Oumei; Li, Rong; Zhao, Lei; Yu, Lijuan; Yang, Bin; Wang, Jia; Chen, Beibei; Yang, Junqing			Short-Term Sleep Deprivation Stimulates Hippocampal Neurogenesis in Rats Following Global Cerebral Ischemia/Reperfusion	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; NEUROTROPHIC FACTOR; FOREBRAIN ISCHEMIA; ADULT HIPPOCAMPUS; DENTATE GYRUS; MEMORY; BDNF; RESTRICTION; MECHANISMS; EXPRESSION	Background Sleep deprivation (SD) plays a complex role in central nervous system (CNS) diseases. Recent studies indicate that short-term SD can affect the extent of ischemic damage. The aim of this study was to investigate whether short-term SD could stimulate hippocampal neurogenesis in a rat model of global cerebral ischemia/reperfusion (GCIR). Methods One hundred Sprague-Dawley rats were randomly divided into Sham, GCIR and short-term SD groups based on different durations of SD; the short-term SD group was randomly divided into three subgroups: the GCIR+6hSD*3d-treated, GCIR+12hSD-treated and GCIR +12hSD*3d-treated groups. The GCIR rat model was induced via the bilateral occlusion of the common carotid arteries and hemorrhagic hypotension. The rats were sleep-deprived starting at 48 h following GCIR. A Morris water maze test was used to assess learning and memory ability; cell proliferation and differentiation were analyzed via 5-bromodeoxyuridine (BrdU) and neuron-specific enolase (NSE), respectively, at 14 and 28 d; the expression of hippocampal BDNF was measured after 7 d. Results The different durations of short-term SD designed in our experiment exhibited improvement in cognitive function as well as increased hippocampal BDNF expression. Additionally, the short-term SD groups also showed an increased number of BrdU-and BrdU/NSE-positive cells compared with the GCIR group. Of the three short-term SD groups, the GCIR +12hSD*3d-treated group experienced the most substantial beneficial effects. Conclusions Short-term SD, especially the GCIR+ 12hSD*3d-treated method, stimulates neurogenesis in the hippocampal dentate gyrus (DG) of rats that undergo GCIR, and BDNF may be an underlying mechanism in this process.	[Cheng, Oumei; Li, Rong; Chen, Beibei] Chongqing Med Univ, Dept Neurol, Affiliated Hosp 1, Chongqing 400016, Peoples R China; [Zhao, Lei; Yu, Lijuan; Yang, Bin; Wang, Jia; Yang, Junqing] Chongqing Med Univ, Dept Pharmacol, Key Lab Biochem & Mol Pharmacol, Chongqing 400016, Peoples R China	Yang, JQ (corresponding author), Chongqing Med Univ, Dept Pharmacol, Key Lab Biochem & Mol Pharmacol, Chongqing 400016, Peoples R China.	1139627371@qq.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81100981, 81471334]; National Key Clinical Specialties Construction Program of China	This research was supported by the National Natural Science Foundation of China (No. 81100981, 81471334) and the National Key Clinical Specialties Construction Program of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANO M, 1993, JPN J PHARMACOL, V63, P469, DOI 10.1254/jjp.63.469; Bachmann V, 2012, SLEEP, V35, P335, DOI 10.5665/sleep.1690; Chen J, 1998, J NEUROSCI, V18, P4914; Cheng OM, 2012, BRAIN RES, V1470, P111, DOI 10.1016/j.brainres.2012.06.026; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Faraguna U, 2008, J NEUROSCI, V28, P4088, DOI 10.1523/JNEUROSCI.5510-07.2008; Fujihara H, 2003, J MOL NEUROSCI, V21, P223, DOI 10.1385/JMN:21:3:223; Gao B, 2010, SLEEP, V33, P879, DOI 10.1093/sleep/33.7.879; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; Hairston IS, 2005, J NEUROPHYSIOL, V94, P4224, DOI 10.1152/jn.00218.2005; Hairston IS, 2004, J NEUROPHYSIOL, V91, P1586, DOI 10.1152/jn.00894.2003; Harukuni I, 2006, NEUROL CLIN, V24, P1, DOI 10.1016/j.ncl.2005.10.004; Hsu JC, 2003, BRAIN RES, V984, P170, DOI 10.1016/S0006-8993(03)03128-7; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Junek A, 2010, NEUROSCIENCE, V170, P1140, DOI 10.1016/j.neuroscience.2010.08.018; Kawai T, 2004, J CEREBR BLOOD F MET, V24, P548, DOI 10.1097/00004647-200405000-00009; Kee NJ, 2001, EXP BRAIN RES, V136, P313, DOI 10.1007/s002210000591; Kuang G, 2012, PPAR RES, V2012, DOI [10.1155/2012/209794, DOI 10.1155/2012/209794]; Kushikata T, 1999, AM J PHYSIOL-REG I, V276, pR1334; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Liu JL, 1998, J NEUROSCI, V18, P7768; LONGSTRETH WT, 1993, ANN EMERG MED, V22, P64, DOI 10.1016/S0196-0644(05)80252-5; Martinez-Vargas M, 2012, NEUROSCI LETT, V529, P118, DOI 10.1016/j.neulet.2012.09.037; Medeiros R, 1998, BRAZ J MED BIOL RES, V31, P675, DOI 10.1590/S0100-879X1998000500012; Mirescu C, 2006, P NATL ACAD SCI USA, V103, P19170, DOI 10.1073/pnas.0608644103; Moldovan M, 2010, EXP NEUROL, V222, P135, DOI 10.1016/j.expneurol.2009.12.023; Murray Patrick S, 2011, Int J Pept, V2011, P654085, DOI 10.1155/2011/654085; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Peskine A, 2010, BRAIN INJURY, V24, P755, DOI 10.3109/02699051003709581; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Quintard H, 2014, NEUROSCIENCE, V277, P72, DOI 10.1016/j.neuroscience.2014.06.047; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385, DOI 10.1111/j.1600-0404.1984.tb07822.x; Taliaz D, 2010, MOL PSYCHIATR, V15, P80, DOI 10.1038/mp.2009.67; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Weil ZM, 2009, EXP NEUROL, V218, P129, DOI 10.1016/j.expneurol.2009.04.018; Yagita Y, 2001, STROKE, V32, P1890, DOI 10.1161/01.STR.32.8.1890; Zhou YL, 2013, J MOL HISTOL, V44, P291, DOI 10.1007/s10735-012-9466-3; Zucconi GG, 2006, BRAIN RES BULL, V69, P375, DOI 10.1016/j.brainresbull.2006.01.009; Zunzunegui C, 2011, SLEEP, V34, P1261, DOI 10.5665/SLEEP.1252	42	12	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0125877	10.1371/journal.pone.0125877			13	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ7ST	WOS:000355700700016	26039740	DOAJ Gold, Green Published			2021-06-18	
J	Phillips, S; Woessner, D				Phillips, Shawn; Woessner, Derek			Sports-Related Traumatic Brain Injury	PRIMARY CARE			English	Article						Sports-related; Mild traumatic brain injury; MTBI; Mild TBI guidelines; Sideline Concussion Assessment Tool 3 (SCAT3); Postconcussive syndrome	CONCUSSION; EDUCATION	Concussions have garnered more attention in the medical literature, media, and social media. As such, in the nomenclature according to the Centers for Disease Control and Prevention, the term concussion has been supplanted by the term mild traumatic brain injury. Current numbers indicate that 1.7 million TBIs are documented annually, with estimates around 3 million annually (173,285 sports- and recreation-related TBIs among children and adolescents). The Sideline Concussion Assessment Tool 3 and the NFL Sideline Concussion Assessment Tool are commonly used sideline tools.	[Woessner, Derek] Lancaster Gen Hosp, Lancaster, PA 17602 USA	Woessner, D (corresponding author), Lancaster Gen Hosp, 555 North Duke St, Lancaster, PA 17602 USA.	dwoessner2@lghealth.org	Meijer, Anna/K-5118-2016				Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2007, HEADS BRAIN INJ YOUR, P2; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Gravel J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-63; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sedney CL, 2011, CLIN SPORT MED, V30, P189, DOI 10.1016/j.csm.2010.08.005; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Wrightson P, 2000, J CLIN NEUROSCI, V7, P384, DOI 10.1054/jocn.1999.0678	12	12	12	0	23	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0095-4543	1558-299X		PRIMARY CARE	Primary Care	JUN	2015	42	2					243	+		10.1016/j.pop.2015.01.010			7	Primary Health Care; Medicine, General & Internal	General & Internal Medicine	CI1ZC	WOS:000354542900010	25979585				2021-06-18	
J	Sun, LQ; Gao, JL; Cui, Y; Zhao, MM; Bin Jing, X; Li, R; Tian, YX; Cui, JZ; Wu, ZX				Sun, Li Qian; Gao, Jun Ling; Cui, Ying; Zhao, Man Man; Bin Jing, Xiao; Li, Ran; Tian, Yan Xia; Cui, Jian Zhong; Wu, Zhong-Xue			Neuronic autophagy contributes to p-connexin 43 degradation in hippocampal astrocytes following traumatic brain injury in rats	MOLECULAR MEDICINE REPORTS			English	Article						autophagy; gap junction; microtubule-associated protein 1 light chain 3; p-connexin-43; traumatic brain injury	ANNULAR GAP-JUNCTIONS; COMMUNICATION; REDUCTION; DEFICITS; DEATH; CELLS; MODEL	Connexins, gap junction proteins, have short half-lives of only a few hours; therefore, degradation of these proteins can rapidly modulate their function. Autophagy is a type of degradation pathway that has been implicated in several diseases and was reported to be induced following traumatic brain injury (TBI). The aim of the present study was to investigate the involvement of neuronic autophagy in proteolysis of phosphorylated connexin 43 (p-Cx43) in hippocampal astrocytes following TBI in rats. Western blot analysis and immunofluorescence showed a TBI-induced increase in levels of astrocytic p-Cx43 following treatment with 3-methyladenine, an inhibitor of autophagy, in the hippocampus. Internalized gap junctions were observed in the neuronic cytoplasm using transmission electron microscopy. These results demonstrated that neuronic autophagy may regulate cellular levels of p-Cx43 in hippocampal astrocytes following TBI. This therefore indicated that the persistence of p-Cx43 accumulation was due to insufficient degradation capacity of constitutive autophagy.	[Sun, Li Qian; Wu, Zhong-Xue] Capital Med Univ, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, Beijing 100050, Peoples R China; [Sun, Li Qian; Wu, Zhong-Xue] Capital Med Univ, Beijing Tiantan Hosp, Beijing 100050, Peoples R China; [Gao, Jun Ling; Cui, Ying; Zhao, Man Man; Li, Ran; Tian, Yan Xia] Hebei United Univ, Sch Basic Med Sci, Dept Histol & Embryol, Tangshan 063000, Hebei, Peoples R China; [Bin Jing, Xiao] Tangshan Ophthalmol Hosp, Dept Ophthalmol, Tangshan 063000, Hebei, Peoples R China; [Cui, Jian Zhong] Tangshan Gongren Hosp, Dept Neurosurg, Tangshan 063000, Hebei, Peoples R China	Wu, ZX (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, 6 Tiantan Xili, Beijing 100050, Peoples R China.	zhongxuewu@yeah.net			Natural Science Foundation of Hebei ProvinceNatural Science Foundation of Hebei Province [H2012401071]	The present study was supported by a grant from the Natural Science Foundation of Hebei Province (no. H2012401071).	Cottrell GT, 2003, AM J PHYSIOL-CELL PH, V284, pC511, DOI 10.1152/ajpcell.00214.2002; De Bock M, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00120; De Maio A, 2002, J CELL PHYSIOL, V191, P269, DOI 10.1002/jcp.10108; LEACH DH, 1984, ACTA ANAT, V120, P214, DOI 10.1159/000145923; Lichtenstein A, 2011, J CELL SCI, V124, P910, DOI 10.1242/jcs.073072; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Meijer AJ, 2009, CRIT REV CL LAB SCI, V46, P210, DOI 10.1080/10408360903044068; Milad MR, 2004, BEHAV NEUROSCI, V118, P389, DOI 10.1037/0735-7044.118.2.389; Ohsumi A, 2010, J NEUROTRAUM, V27, P1255, DOI 10.1089/neu.2009.1234; Pozuelo-Rubio M, 2011, CELL DEATH DIFFER, V18, P479, DOI 10.1038/cdd.2010.118; Rami A, 2000, EXP NEUROL, V170, P297, DOI 10.1006/exnr.2001.7712; Rash JE, 2001, J NEUROSCI, V21, P1983, DOI 10.1523/JNEUROSCI.21-06-01983.2001; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; SASAKI T, 1986, CELL TISSUE RES, V246, P523, DOI 10.1007/BF00215192; Song SX, 2013, MOL MED REP, V7, P327, DOI 10.3892/mmr.2012.1147; Sun LQ, 2014, MOL MED REP, V9, P77, DOI 10.3892/mmr.2013.1787; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	19	12	12	0	9	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	JUN	2015	11	6					4419	4423		10.3892/mmr.2015.3264			5	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CJ4ZL	WOS:000355497100059	25626126	Bronze			2021-06-18	
J	Wang, IK; Cheng, YK; Lin, CL; Peng, CL; Chou, CY; Chang, CT; Yen, TH; Huang, CC; Sung, FC; Hsu, CY				Wang, I-Kuan; Cheng, Yu-Kai; Lin, Cheng-Li; Peng, Chiao-Ling; Chou, Che-Yi; Chang, Chiz-Tzung; Yen, Tzung-Hai; Huang, Chiu-Ching; Sung, Fung-Chang; Hsu, Chung Y.			Comparison of Subdural Hematoma Risk between Hemodialysis and Peritoneal Dialysis Patients with ESRD	CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							STAGE RENAL-DISEASE; TRAUMATIC BRAIN-INJURY; CHRONIC KIDNEY-DISEASE; OLDER-ADULTS; FALLS; COMPLICATIONS; MORTALITY; MODALITY; FAILURE; IMPACT	Background and objectives This study compared the risk of subdural hematoma (SDH) and subsequent mortality in hemodialysis (HD) and peritoneal dialysis (PD) patients with ESRD. Design, setting, participants, & measurements Claims data were obtained from the National Health Insurance Administration Research Database in Taiwan. This retrospective cohort study comprised 10,136 PD patients and 10,136 HD patients with newly diagnosed ESRD from 1998 to 2010. Patients were matched by propensity score and year of dialysis initiation. Incidence rates and hazard ratios of SDH as well as odds ratios of subsequent 30-day deaths from SDH were evaluated from the date of the first dialysis session to the date when SDH was diagnosed, or the date of renal transplantation, death, withdraw from insurance, or the end of the follow-up period (December 31, 2011). Results Median (25th percentile, 75th percentile) follow-up times for SDH events were 3.61 years (1.91, 6.33) and 3.33 years (1.83, 5.66) in the HD and PD cohorts, respectively. The overall SDH incidence rate (95% confidence interval [95% CID was 61.4% higher in the HD cohort than in the PD cohort (34.7 [95% CI, 31.4 to 35.4] versus 21.5 [95% CI, 20.2 to 22.9] per 10,000 person-years, with an adjusted hazard ratio of 1.62 [95% CI, 1.17 to 2.33]). Approximately 152 of 253 (60%) of SDH events were associated with trauma. Subsequent 30-day SDH-related mortality was not statistically higher in HD patients than in PD patients (29.1% versus 25.3%; adjusted odds ratio, 1.30; 95% CI, 0.70 to 2.41). Conclusions HD patients have a higher risk of developing SDH than PD patients. Both patient groups have a high risk of mortality. Routine education on fall prevention is needed for dialysis patients.	[Wang, I-Kuan] China Med Univ, Coll Med, Dept Internal Med, Taichung 404, Taiwan; [Wang, I-Kuan; Sung, Fung-Chang; Hsu, Chung Y.] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung 404, Taiwan; [Wang, I-Kuan; Chou, Che-Yi; Chang, Chiz-Tzung; Huang, Chiu-Ching] China Med Univ Hosp, Div Nephrol, Taichung, Taiwan; [Cheng, Yu-Kai] China Med Univ Hosp, Div Neurosurg, Taichung, Taiwan; [Hsu, Chung Y.] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Lin, Cheng-Li; Sung, Fung-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Peng, Chiao-Ling] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Yen, Tzung-Hai] Chang Gung Mem Hosp, Div Nephrol, Taipei 10591, Taiwan; [Yen, Tzung-Hai] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Sung, FC (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, 91 Hsueh Shih Rd, Taichung 404, Taiwan.	fcsung1008@yahoo.com	Yen, Tzung-Hai/AAQ-4525-2020; Chou, Che-Yi/N-8887-2015	Yen, Tzung-Hai/0000-0002-0907-1505; Chou, Che-Yi/0000-0003-4029-9097; Hsu, Chung Y./0000-0002-5632-2733	National Sciences Council, Executive Yuan [NSC 100-2621-M-039-001]; China Medical University Hospital [1MS1, DMR-100-101, DMR-101-016, DMR-103-013, DMR-104-015]; Research Laboratory of Pediatrics, Children's Hospital of China Medical University; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; Academia Sinica Taiwan Biobank; Academia Sinica Taiwan Biobank, Stroke Biosignature Project [BM103010096]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325-B-039 -006]; Tseng-Lien Lin Foundation; Taiwan Brain Disease Foundation; Katsuzo Aoshima Memorial Fund; Kiyo Aoshima Memorial Fund	This study was supported by grants from the National Sciences Council, Executive Yuan (NSC 100-2621-M-039-001), China Medical University Hospital (1MS1, DMR-100-101, DMR-101-016, DMR-103-013, and DMR-104-015), Research Laboratory of Pediatrics, Children's Hospital of China Medical University, Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002), Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM103010096), NRPB Stroke Clinical Trial Consortium (MOST 103-2325-B-039 -006), Tseng-Lien Lin Foundation, Taiwan Brain Disease Foundation, and Katsuzo and Kiyo Aoshima Memorial Funds.	Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; Brouns R, 2004, CLIN NEUROL NEUROSUR, V107, P1, DOI 10.1016/j.clineuro.2004.07.012; Buoncristiani U, 1993, Perit Dial Int, V13 Suppl 2, pS202; Burn DJ, 1998, J NEUROL NEUROSUR PS, V65, P810, DOI 10.1136/jnnp.65.6.810; Chen YJ, 2014, OSTEOPOROSIS INT, V25, P1513, DOI 10.1007/s00198-014-2632-6; Cook WL, 2006, CLIN J AM SOC NEPHRO, V1, P1197, DOI 10.2215/CJN.01650506; Desmet C, 2005, AM J KIDNEY DIS, V45, P148, DOI 10.1053/j.ajkd.2004.09.027; Farragher J, 2014, CLIN J AM SOC NEPHRO, V9, P1248, DOI 10.2215/CJN.11001013; Gottesman RF, 2003, INT REV PSYCHIATR, V15, P302, DOI 10.1080/09540260310001606683; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Huang KW, 2014, DIGEST DIS SCI, V59, P807, DOI 10.1007/s10620-013-2973-6; Jacobsson LJ, 2007, ACTA NEUROL SCAND, V116, P300, DOI 10.1111/j.1600-0404.2007.00896.x; Kimmel PL, 1998, AM J MED, V105, P214, DOI 10.1016/S0002-9343(98)00245-9; Kopitnik Jr TA, 1989, SURG NEUROL, V32, P289; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Maxeiner H, 2002, NEUROSURGERY, V50, P503, DOI 10.1097/00006123-200203000-00013; Mehrotra R, 2011, ARCH INTERN MED, V171, P110, DOI 10.1001/archinternmed.2010.352; Mizumasa T, 2004, NEPHRON CLIN PRACT, V97, pC23, DOI 10.1159/000077592; Nordstrom A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001151; Power A, 2010, NEPHROL DIAL TRANSPL, V25, P2272, DOI 10.1093/ndt/gfq013; Prohovnik I, 2007, J CEREBR BLOOD F MET, V27, P1861, DOI 10.1038/sj.jcbfm.9600478; RODBY RA, 1994, AM J KIDNEY DIS, V23, P401, DOI 10.1016/S0272-6386(12)81003-1; Rossier A, 2012, NEPHROL DIAL TRANSPL, V27, P352, DOI 10.1093/ndt/gfr326; Savazzi GM, 2001, NEPHRON, V89, P31, DOI 10.1159/000046040; Sood P, 2007, CLIN J AM SOC NEPHRO, V2, P956, DOI 10.2215/CJN.03781106; Stefanidis I, 2005, CLIN NEPHROL, V64, P129; Takeda K, 1997, NEPHROL DIAL TRANSPL, V12, P952, DOI 10.1093/ndt/12.5.952; Tamura MK, 2011, KIDNEY INT, V79, P14, DOI 10.1038/ki.2010.336; Vonesh EF, 2004, KIDNEY INT, V66, P2389, DOI 10.1111/j.1523-1755.2004.66028.x; Wang HH, 2014, AM J KIDNEY DIS, V63, P604, DOI 10.1053/j.ajkd.2013.10.013; Wang IK, 2014, EUR J NEUROL, V21, P894, DOI 10.1111/ene.12406; Wang IK, 2013, J NEPHROL, V26, P331, DOI 10.5301/jn.5000149; WOLCOTT DL, 1988, AM J KIDNEY DIS, V12, P275, DOI 10.1016/S0272-6386(88)80220-8	33	12	12	0	2	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1555-9041	1555-905X		CLIN J AM SOC NEPHRO	Clin. J. Am. Soc. Nephrol.	JUN	2015	10	6					994	1001		10.2215/CJN.08140814			8	Urology & Nephrology	Urology & Nephrology	CJ8XV	WOS:000355787700014	25825482	Green Published, Bronze			2021-06-18	
J	Young, J; Pionk, T; Hiatt, I; Geeck, K; Smith, JS				Young, Jennica; Pionk, Timothy; Hiatt, Ivy; Geeck, Katalin; Smith, Jeffrey S.			Environmental enrichment aides in functional recovery following unilateral controlled cortical impact of the forelimb sensorimotor area however intranasal administration of nerve growth factor does not	BRAIN RESEARCH BULLETIN			English	Article						Traumatic brain injury; NGF; Intranasal administration; Enriched environment; FL-SMC CCI	TRAUMATIC BRAIN-INJURY; DENDRITIC STRUCTURAL PLASTICITY; COGNITIVE FUNCTION; CONTUSION INJURY; MOTOR CORTEX; ADULT RATS; TRANSPLANTATION; EXPRESSION; EXERCISE; DEFICITS	Purpose: An injury to the forelimb sensorimotor cortex results in the impairment of motor function in animals. Recent research has suggested that intranasal administration of nerve growth factor (NGF), a protein naturally found in the brain, and placement into enriched environments (EE) improves motor and cognitive function after traumatic brain injury (TBI). The purpose of this study was to determine whether NGF, EE, or the combination of both was beneficial in the recovery of motor function following TBI. Results: Uninjured animals had fewer foot faults than injured animals, displaying a lesion effect. Injured animals housed in EE were shown to have fewer foot faults whether or not they received NGF. Injured animals also displayed an increased reliance on the non-impaired limb further validating a lesion effect. Conclusion: EE is an effective treatment on the recovery of motor function after a TBI. Intranasal administration of NGF was found to not be an effective treatment for functional motor recovery after a TBI. (C) 2015 Elsevier Inc. All rights reserved.	[Young, Jennica; Pionk, Timothy; Hiatt, Ivy; Geeck, Katalin; Smith, Jeffrey S.] Saginaw Valley State Univ, Brain Res Lab, University Ctr, MI 48710 USA	Smith, JS (corresponding author), Saginaw Valley State Univ, Crystal M Lange Coll Hlth & Human Serv, Dept Hlth Sci, Malcolm & Lois Field Endowed Chair Hlth Sci, 7400 Bay Rd, University Ctr, MI 48710 USA.	jennicay@siu.edu; tdpionk@svsu.edu; ijhiatt@svsu.edu; kjgeeck@svsu.edu; jsmith12@svsu.edu		Smith, Jeffrey/0000-0001-5499-4475	Dow Student Research and Creativity Institute	Funding was provided by the Dow Student Research and Creativity Institute to Jennica Young. The authors would also like to thank Evan Nudi, Jacob Dunkerson, Kim Meerschaert, Justin Jacqmain, Garrick Salois, Kelsey Dubbs, and Madeleine Searles of The Brain Research Laboratory at Saginaw Valley State University.	Allred RP, 2004, EXP NEUROL, V190, P433, DOI 10.1016/j.expneurol.2004.08.005; Angelucci F, 2009, CEREBELLUM, V8, P499, DOI 10.1007/s12311-009-0129-1; Bayona Nestor A, 2005, Top Stroke Rehabil, V12, P1; Bonini S, 2000, OPHTHALMOLOGY, V107, P1347, DOI 10.1016/S0161-6420(00)00163-9; Branchi I, 2006, BIOL PSYCHIAT, V60, P690, DOI 10.1016/j.biopsych.2006.01.005; Bury SD, 2002, J NEUROSCI, V22, P8597; De Rosa R, 2005, P NATL ACAD SCI USA, V102, P3811, DOI 10.1073/pnas.0500195102; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; GAROFALO L, 1994, EXP NEUROL, V125, P195, DOI 10.1006/exnr.1994.1024; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; HELD JM, 1985, BEHAV NEUROSCI, V99, P678, DOI 10.1037/0735-7044.99.4.678; Hicks AU, 2007, NEUROSCIENCE, V146, P31, DOI 10.1016/j.neuroscience.2007.01.020; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hoane MR, 2008, MAGNESIUM RES, V21, P29; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Humm JL, 1999, EXP NEUROL, V157, P349, DOI 10.1006/exnr.1999.7061; Jones TA, 1999, J NEUROSCI, V19, P10153; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Kawamata T, 1997, P NATL ACAD SCI USA, V94, P8179, DOI 10.1073/pnas.94.15.8179; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; Kuypers NJ, 2010, J NEUROTRAUM, V27, P1275, DOI 10.1089/neu.2010.1327; Lv QS, 2013, BRAIN RES, V1493, P80, DOI 10.1016/j.brainres.2012.11.028; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Peruzzaro ST, 2013, RESTOR NEUROL NEUROS, V31, P431, DOI 10.3233/RNN-120299; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; SLAVIN MD, 1988, BRAIN INJURY RECOVER, P165; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Tian LL, 2012, BRAIN RES, V1440, P47, DOI 10.1016/j.brainres.2011.12.059; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; WILL B, 1992, ADV EXP MED BIOL, V325, P79; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001	35	12	14	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	JUN	2015	115						17	22		10.1016/j.brainresbull.2015.04.003			6	Neurosciences	Neurosciences & Neurology	CL2AG	WOS:000356745400003	25889001				2021-06-18	
J	Woods, DL; Yund, EW; Wyma, JM; Ruff, R; Herron, TJ				Woods, David L.; Yund, E. William; Wyma, John M.; Ruff, Ron; Herron, Timothy J.			Measuring executive function in control subjects and TBI patients with question completion time (QCT)	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						aging; gender; reaction time; executive function; head injury; reading	COGNITIVE FAILURES QUESTIONNAIRE; CHECKLIST-CIVILIAN VERSION; TRAUMATIC BRAIN-INJURY; PSYCHOMETRIC PROPERTIES; PROCESSING SPEED; WORKING-MEMORY; NORMATIVE DATA; PTSD; SCALE; AGE	Questionnaire completion is a complex task that places demands on cognitive functions subserving reading, introspective memory, decision-making, and motor control. Although computerized questionnaires and surveys are used with increasing frequency in clinical practice, few studies have examined question completion time (QCT), the time required to complete each question. Here, we analyzed QCTs in 172 control subjects and 31 patients with traumatic brain injury (TBI) who completed two computerized questionnaires, the 17-question Post-Traumatic Stress Disorder (PTSD) Checklist (PCL) and the 25-question Cognitive Failures Questionnaire (CFQ). In control subjects, robust correlations were found between self paced QCTs on the PCL and CFQ (r = 0.82). QCTs on individual questions correlated strongly with the number of words in the question, indicating the critical role of reading speed. QCTs increased significantly with age, and were reduced in females and in subjects with increased education and computer experience. QCT z-scores, corrected for age, education, computer use, and sex, correlated more strongly with each other than with the results of other cognitive tests. Patients with a history of severe TBI showed significantly delayed QCTs, but QCTs fell within the normal range in patients with a history of mild TBI. When questionnaires are used to gather relevant patient information, simultaneous QCT measures provide reliable and clinically sensitive measures of processing speed and executive function.	[Woods, David L.; Yund, E. William; Wyma, John M.; Herron, Timothy J.] VANCHCS, Human Cognit Neurophysiol Lab, Martinez, CA 95553 USA; [Woods, David L.] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [Woods, David L.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Woods, David L.] UC Davis Ctr Mind & Brain, Davis, CA USA; [Ruff, Ron] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA	Woods, DL (corresponding author), VANCHCS, Human Cognit Neurophysiol Lab, Neurol Serv 127E, 150 Muir Rd, Martinez, CA 95553 USA.	dlwoods@ucdavis.edu		Herron, Timothy/0000-0002-4297-014X; Woods, David/0000-0002-8804-3587	CSRD VA [I01 CX001000] Funding Source: Medline; Veterans AffairsUS Department of Veterans Affairs [I01CX001000] Funding Source: NIH RePORTER		Allenby A, 2002, EUR J CANCER CARE, V11, P245, DOI 10.1046/j.1365-2354.2002.00310.x; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Borella E, 2011, J GERONTOL B-PSYCHOL, V66, P311, DOI 10.1093/geronb/gbr002; Brand M, 2010, GERONTOLOGY, V56, P319, DOI 10.1159/000248829; Bridger RS, 2013, ERGONOMICS, V56, P1515, DOI 10.1080/00140139.2013.821172; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Caplan D, 2011, PSYCHOL AGING, V26, P439, DOI 10.1037/a0021837; Christopher ME, 2012, J EXP PSYCHOL GEN, V141, P470, DOI 10.1037/a0027375; Commodari E, 2008, AGING CLIN EXP RES, V20, P578; CONIGRAVE KM, 1995, ADDICTION, V90, P1349, DOI 10.1111/j.1360-0443.1995.tb03552.x; Conybeare D, 2012, J CLIN PSYCHOL, V68, P699, DOI 10.1002/jclp.21845; Foa EB, 2000, J TRAUMA STRESS, V13, P181, DOI 10.1023/A:1007781909213; Hubel KA, 2013, J CLIN EXP NEUROPSYC, V35, P745, DOI 10.1080/13803395.2013.824070; Karstoft KI, 2014, PSYCHOL ASSESSMENT, V26, P321, DOI 10.1037/a0034889; Lamberts KF, 2010, J CLIN EXP NEUROPSYC, V32, P56, DOI 10.1080/13803390902806550; Lynn R, 2009, TRAMES-J HUMANIT SOC, V13, P3, DOI 10.3176/tr.2009.1.01; Malhotra N, 2008, PUBLIC OPIN QUART, V72, P914, DOI 10.1093/poq/nfn050; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Novakovic-Agopian T, 2014, J HEAD TRAUMA REHAB, V29, P136, DOI 10.1097/HTR.0b013e3182691b15; POLLINA LK, 1992, BRIT J PSYCHOL, V83, P305, DOI 10.1111/j.2044-8295.1992.tb02443.x; REASON J, 1984, BRIT J CLIN PSYCHOL, V23, P121, DOI 10.1111/j.2044-8260.1984.tb00635.x; Reitan RM, 2000, ARCH CLIN NEUROPSYCH, V15, P443, DOI 10.1016/S0887-6177(99)00043-8; Reitan RM, 2005, ARCH CLIN NEUROPSYCH, V20, P957, DOI 10.1016/j.acn.2005.07.010; Richter P, 1998, PSYCHOPATHOLOGY, V31, P160, DOI 10.1159/000066239; Salthouse TA, 2000, BIOL PSYCHOL, V54, P35, DOI 10.1016/S0301-0511(00)00052-1; Schneider ALC, 2015, ALZ DIS ASSOC DIS, V29, P32, DOI 10.1097/WAD.0000000000000042; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Sullivan K, 2011, J HEAD TRAUMA REHAB, V26, P170, DOI 10.1097/HTR.0b013e3181e47f95; Tiu RD, 2003, J LEARN DISABIL-US, V36, P424, DOI 10.1177/00222194030360050401; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Verma A, 2007, J CLIN SLEEP MED, V3, P357; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Wallace JC, 2002, J GEN PSYCHOL, V129, P238, DOI 10.1080/00221300209602098; Weathers F. W., 1993, ANN M INT SOC TRAUM; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Woods D. L., 2015, PLOS ONE IN PRESS; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3339/fnhum.2015.00131, 10.3389/fnhum.2015.00131]; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P721, DOI 10.1080/13803395.2010.550602; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P101, DOI 10.1080/13803395.2010.493149; Yarnold PR, 1996, PERCEPT MOTOR SKILL, V82, P689, DOI 10.2466/pms.1996.82.2.689	41	12	12	0	10	FRONTIERS RESEARCH FOUNDATION	LAUSANNE	PO BOX 110, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	MAY 19	2015	9								288	10.3389/fnhum.2015.00288			9	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	CK2SW	WOS:000356063600002	26042021	DOAJ Gold, Green Published			2021-06-18	
J	Bache, S; Rasmussen, R; Rossing, M; Hammer, NR; Juhler, M; Friis-Hansen, L; Nielsen, FC; Moller, K				Bache, Soren; Rasmussen, Rune; Rossing, Maria; Hammer, Niels Risor; Juhler, Marianne; Friis-Hansen, Lennart; Nielsen, Finn Cilius; Moller, Kirsten			Detection and quantification of microRNA in cerebral microdialysate	JOURNAL OF TRANSLATIONAL MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; ISCHEMIA	Background: Secondary brain injury accounts for a major part of the morbidity and mortality in patients with spontaneous aneurysmal subarachnoid hemorrhage (SAH), but the pathogenesis and pathophysiology remain controversial. MicroRNAs (miRNAs) are important posttranscriptional regulators of complementary mRNA targets and have been implicated in the pathophysiology of other types of acute brain injury. Cerebral microdialysis is a promising tool to investigate these mechanisms. We hypothesized that miRNAs would be present in human cerebral microdialysate. Methods: RNA was extracted and miRNA profiles were established using high throughput real-time quantification PCR on the following material: 1) Microdialysate sampled in vitro from A) a solution of total RNA extracted from human brain, B) cerebrospinal fluid (CSF) from a neurologically healthy patient, and C) a patient with SAH; and 2) cerebral microdialysate and CSF sampled in vivo from two patients with SAH. MiRNAs were categorized according to their relative recovery (RR) and a pathway analysis was performed for miRNAs exhibiting a high RR in vivo. Results: Seventy-one of the 160 miRNAs detected in CSF were also found in in vivo microdialysate from SAH patients. Furthermore specific miRNAs consistently exhibited either a high or low RR in both in vitro and in vivo microdialysate. Analysis of repeatability showed lower analytical variation in microdialysate than in CSF. Conclusions: MiRNAs are detectable in cerebral microdialysate; a large group of miRNAs consistently showed a high RR in cerebral microdialysate. Measurement of cerebral interstitial miRNA concentrations may aid in the investigation of secondary brain injury in neurocritical conditions.	[Bache, Soren; Hammer, Niels Risor; Moller, Kirsten] Univ Copenhagen Hosp, Ctr Neurosci, Dept Neuroanaesthesiol, DK-2100 Copenhagen, Denmark; [Bache, Soren; Rossing, Maria; Friis-Hansen, Lennart; Nielsen, Finn Cilius] Univ Copenhagen Hosp, Ctr Diagnost, Rigshosp, Ctr Genom Med, DK-2100 Copenhagen, Denmark; [Rasmussen, Rune; Juhler, Marianne] Univ Copenhagen Hosp, Dept Neurosurg, Ctr Neurosci, Rigshosp, DK-2100 Copenhagen, Denmark	Bache, S (corresponding author), Univ Copenhagen Hosp, Ctr Neurosci, Dept Neuroanaesthesiol, DK-2100 Copenhagen, Denmark.	bache@dadlnet.dk	Moller, Kirsten/A-4751-2009; Nielsen, Finn Cilius/AAA-4926-2020	Moller, Kirsten/0000-0003-3058-1072; Nielsen, Finn Cilius/0000-0002-9829-1031; Friis-Hansen, Lennart/0000-0002-7222-0163	Rigshospitalet's Board of Research; Lundbeck FoundationLundbeckfonden; Brodrene Hartmanns Fond; Grosserer Jakob Ehrenreich & Hustru Grethe Ehrenreichs Fond	Ms. Ewa Futoma from Centre for Genomic Medicine is gratefully acknowledged for her thorough teaching and supervision of SB in the necessary laboratory skills regarding RNA isolation and qRT-PCR. Dr. Soren Nielsen from Centre of Inflammation and Metabolism is gratefully acknowledged for his qualified introduction of SB to pre-processing and normalization of qRT-PCR data. Rigshospitalet's Board of Research, the Lundbeck Foundation, Brodrene Hartmanns Fond and Grosserer Jakob Ehrenreich & Hustru Grethe Ehrenreichs Fond funded this study.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Baraniskin A, 2011, BLOOD, V117, P3140, DOI 10.1182/blood-2010-09-308684; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Cui H, 2013, J CRANIOFAC SURG, V24, P2147, DOI 10.1097/SCS.0b013e3182a243f3; Freilich RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079416; Hillman J, 2005, NEUROSURGERY, V56, P1264, DOI 10.1227/01.NEU.0000159711.93592.8D; Kim JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097946; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Ronald Zielke H, 2009, J NEUROCHEM, V109, P24, DOI 10.1111/j.1471-4159.2009.05941.x; Rosell A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016750; Samuelsson C, 2007, J CEREBR BLOOD F MET, V27, P1309, DOI 10.1038/sj.jcbfm.9600433; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Shi GD, 2012, EXP BRAIN RES, V216, P225, DOI 10.1007/s00221-011-2925-3; Su W, 2014, J IMMUNOL, V192, P358, DOI 10.4049/jimmunol.1301397; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	19	12	12	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1479-5876		J TRANSL MED	J. Transl. Med.	MAY 7	2015	13								149	10.1186/s12967-015-0505-1			10	Medicine, Research & Experimental	Research & Experimental Medicine	DD2YL	WOS:000369788000003	25947950	DOAJ Gold, Green Published			2021-06-18	
J	Svoboda, E; Richards, B; Yao, C; Leach, L				Svoboda, Eva; Richards, Brian; Yao, Christie; Leach, Larry			Long-term maintenance of smartphone and PDA use in individuals with moderate to severe memory impairment	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY; OF-THE-LITERATURE; FOLLOW-UP; COGNITIVE REHABILITATION; PLANNING PROBLEMS; SELF-AWARENESS; N-OF-1 TRIALS; PAGING SYSTEM; THERAPY GOALS; HEAD-INJURY	In an earlier paper we described a structured, theory-driven training programme which was administered to 10 individuals with moderate-to-severe memory impairment. All individuals received an errorless-fading-of-cues protocol in the use of personal digital assistants (PDAs) or smartphones (Svoboda, Richards, Leach, & Mertens, 2012) and demonstrated generalisation of acquired skills to day-to-day memory challenges. Maintenance of intervention gains over the long-term is another indicator of successful generalisation. Here we present the maintenance of device use in the same group of individuals 12 to 19 months after programme completion. A within-subject, ABABB multi-case experimental design was used to evaluate the impact of PDA or smartphone use on day-to-day memory functioning at baseline, immediately post-intervention, at return to baseline, and at short-term and long-term follow-up. Results presented here focus predominantly on long-term follow-up. All 10 individuals showed maintenance of gains in day-to-day functioning as quantified across several ecologically valid questionnaire and task-based measures. This was corroborated by family members with whom six of the participants resided. This study further demonstrates the programme's clinical effectiveness in enabling individuals with moderate-to-severe memory impairment to function more independently and with greater confidence up to 19 months following programme completion.	[Svoboda, Eva; Richards, Brian; Yao, Christie; Leach, Larry] Baycrest Hlth Sci, Neuropsychol & Cognit Hlth Program, Toronto, ON M6A 2E1, Canada	Svoboda, E (corresponding author), Baycrest Hlth Sci, Neuropsychol & Cognit Hlth Program, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.	esvoboda@baycrest.org		Yao, Christie/0000-0002-0507-4717			ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Chelune GJ, 1993, NEUROPSYCHOLOGY, V7, P41, DOI DOI 10.1037/0894-4105.7.1.41; Cicerone K. D., 2005, EFFECTIVENESS REHABI; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cullen C. N., 1976, NURS TIMES, V72, P45; Culley C, 2010, NEUROPSYCHOL REHABIL, V20, P103, DOI 10.1080/09602010902906926; DePompei R, 2008, NEUROREHABILITATION, V23, P487; Donaghy S, 1998, BRAIN INJURY, V12, P1061, DOI 10.1080/026990598121963; Fish J, 2008, J NEUROL NEUROSUR PS, V79, P930, DOI 10.1136/jnnp.2007.125203; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; Gentry T, 2008, AM J OCCUP THER, V62, P18, DOI 10.5014/ajot.62.1.18; GILES GM, 1989, AM J OCCUP THER, V43, P409, DOI 10.5014/ajot.43.6.409; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P824, DOI 10.1080/09602010902995945; Hudak AM, 2012, J HEAD TRAUMA REHAB, V27, P87, DOI 10.1097/HTR.0b013e3182114efd; Kim HJ, 1999, BRAIN INJURY, V13, P147, DOI 10.1080/026990599121818; Kim HJ, 2000, BRAIN INJURY, V14, P187, DOI 10.1080/026990500120844; Lemoncello R, 2011, NEUROPSYCHOL REHABIL, V21, P825, DOI 10.1080/09602011.2011.618661; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Martin-Saez M, 2011, NEUROPSYCHOL REHABIL, V21, P769, DOI 10.1080/09602011.2011.614378; MAYLOR EA, 1990, Q J EXP PSYCHOL-A, V42, P471, DOI 10.1080/14640749008401233; McDonald A, 2011, NEUROPSYCHOL REHABIL, V21, P784, DOI 10.1080/09602011.2011.598405; Moscovitch M., 1982, AGING COGNITIVE PROC, P55; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Savage KR, 2013, CLIN REHABIL, V27, P521, DOI 10.1177/0269215512464230; Schacter D. L., 1994, MEMORY SYSTEMS 1994, P1; Schmitter-Edgecombe M, 2004, BRAIN INJURY, V18, P997, DOI 10.1080/02699050410001719934; SIDMAN M, 1967, J EXP ANAL BEHAV, V10, P3, DOI 10.1901/jeab.1967.10-3; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; SOHLBERG MM, 2001, COGNITIVE REHABILITA, P194; Stapleton S, 2007, BRAIN INJURY, V21, P401, DOI 10.1080/02699050701252030; Svoboda E, 2012, NEUROPSYCHOL REHABIL, V22, P408, DOI 10.1080/09602011.2011.652498; Svoboda E, 2010, NEUROPSYCHOL REHABIL, V20, P562, DOI 10.1080/09602011003669918; Svoboda E, 2009, J INT NEUROPSYCH SOC, V15, P629, DOI 10.1017/S1355617709090791; Tate RL, 2008, NEUROPSYCHOL REHABIL, V18, P385, DOI 10.1080/09602010802009201; Tate RL, 2013, NEUROPSYCHOL REHABIL, V23, P619, DOI 10.1080/09602011.2013.824383; Teasdale TW, 2009, J NEUROL NEUROSUR PS, V80, P781, DOI 10.1136/jnnp.2008.162966; Troyer A. K., 2002, J GERONTOL B-PSYCHOL, V57B, P19, DOI [10.1093/geronb/57.1.P19, DOI 10.1093/GERONB/57.1.P19]; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Wilson BA, 2003, NEUROREHABILITATION, V18, P3; Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wilson BA, 1997, NEUROPSYCHOL REHABIL, V7, P43, DOI 10.1080/713755518; Yasuda K, 2002, NEUROPSYCHOL REHABIL, V12, P155, DOI 10.1080/09602010143000239	52	12	12	1	23	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAY 4	2015	25	3					353	373		10.1080/09602011.2014.927368			21	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	CF1QL	WOS:000352322600002	24945553				2021-06-18	
J	Meares, S; Shores, EA; Smyth, T; Batchelor, J; Murphy, M; Vukasovic, M				Meares, Susanne; Shores, E. Arthur; Smyth, Tracy; Batchelor, Jennifer; Murphy, Margaret; Vukasovic, Matthew			Identifying Posttraumatic Amnesia in Individuals With a Glasgow Coma Scale of 15 After Mild Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Amnesia; anterograde; Brain injuries; Rehabilitation	COGNITIVE IMPAIRMENT; RECOMMENDATIONS; MANAGEMENT; ACCURACY	Objective: To examine the utility of the Abbreviated Westmead Post-traumatic Amnesia Scale, which includes the Glasgow Coma Scale (GCS) and 3 picture cards used to measure amnesia, in identifying the presence or absence of posttraumatic amnesia in individuals with mild traumatic brain injury (mTBI). Design: Prospective study using data from the Abbreviated Westmead Post-traumatic Amnesia Scale. Setting: Trauma hospital. Participants: Individuals with possible mTBI who presented between April and September 2011 (N=252; age range, 18-65y; mean age, 37.4 +/- 13.9y; 77% men). Intervention: Administration of the Abbreviated Westmead Post-traumatic Amnesia Scale. Main Outcome Measures: GCS and Abbreviated Westmead Post-traumatic Amnesia Scale pass/fail rates. Results: Of the individuals, 169 (mean age, 35.1 +/- 13.6y; 77% men) received the scale. A pass/fail performance was achieved a median 121 minutes (interquartile range, 89-205min) after triage. Of the 45 who failed, 31(69%) had a GCS score of 15. The likelihood of failing was associated with being older (odds ratio [On 1.03; 95% confidence interval [CI], 1.02-1.06; P<.05), having consumed alcohol (OR, 3.09; 95% CI, 1.42-6.74; P<01), and the scale being administered closer to the time of the injury (OR, 0.99; 95% CI, 0.99-1.00; P<.05). Nineteen (42%) of those who failed had consumed alcohol, 11 had a GCS score of 15, and 8 had a GCS score of 14. Conclusions: A GCS score of 15 does not always signify return to normative cognitive function. Individuals with a GCS score of 15 who are acutely cognitively impaired are at risk of not being accurately identified. The addition of an amnesia score to the GCS in the Abbreviated Westmead Post-traumatic Amnesia Scale will assist in making a diagnosis of mTBI. (C) 2015 by the American Congress of Rehabilitation Medicine	[Meares, Susanne; Shores, E. Arthur; Smyth, Tracy; Batchelor, Jennifer] Macquarie Univ, Dept Psychol, N Ryde, NSW 2109, Australia; [Meares, Susanne] Westmead Hosp, Dept Rehabil Med, Westmead, NSW 2145, Australia; [Smyth, Tracy; Murphy, Margaret; Vukasovic, Matthew] Westmead Hosp, Dept Emergency Serv, Westmead, NSW 2145, Australia	Meares, S (corresponding author), Macquarie Univ, Dept Psychol, N Ryde, NSW 2109, Australia.	sue.meares@mq.edu.au		Batchelor, Jennifer/0000-0003-4438-4993; Shores, Edwin A/0000-0003-1553-5131; Meares, Susanne/0000-0002-3859-9974	Motor Accidents Authority of New South Wales [09/915]	Supported by the Motor Accidents Authority of New South Wales (grant no. 09/915).	Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Meares S, 2011, BRAIN INJURY, V25, P1198, DOI 10.3109/02699052.2011.608213; Nell V, 2000, ARCH PHYS MED REHAB, V81, P614, DOI 10.1053/mr.2000.3877; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Tate RL, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.074989; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x	10	12	13	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2015	96	5					956	959		10.1016/j.apmr.2014.12.014			4	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CH6JL	WOS:000354142800024	25576643				2021-06-18	
J	Quartana, PJ; Wilk, JE; Balkin, TJ; Hoge, CW				Quartana, Phillip J.; Wilk, Joshua E.; Balkin, Thomas J.; Hoge, Charles W.			Indirect associations of combat exposure with post-deployment physical symptoms in US soldiers: Roles of post-traumatic stress disorder, depression and insomnia	JOURNAL OF PSYCHOSOMATIC RESEARCH			English	Article						Combat exposure; Physical symptoms; PTSD; Insomnia; Depression; Pain; Military	TRAUMATIC BRAIN-INJURY; COGNITIVE-BEHAVIORAL THERAPY; MENTAL-HEALTH PROBLEMS; SEVERITY INDEX; SLEEP DURATION; SOMATIC SYMPTOMS; WAR VETERANS; CHRONIC PAIN; IRAQ; PTSD	Objective: To characterize the indirect associations of combat exposure with post-deployment physical symptoms through shared associations with post-traumatic stress disorder (PTSD), depression and insomnia symptoms. Methods: Surveys were administered to a sample of U.S. soldiers (N = 587) three months after a 15-month deployment to Iraq. A multiple indirect effects model was used to characterize direct and indirect associations between combat exposure and physical symptoms. Results: Despite a zero-order correlation between combat exposure and physical symptoms, the multiple indirect effects analysis did not provide evidence of a direct association between these variables. Evidence for a significant indirect association of combat exposure and physical symptoms was observed through PTSD, depression, and insomnia symptoms. In fact, 92% of the total effect of combat exposure on physical symptoms scores was indirect. These findings were evident even after adjusting for the physical injury and relevant demographics. Conclusion: This is the first empirical study to suggest that PTSD, depression and insomnia collectively and independently contribute to the association between combat exposure and post-deployment physical symptoms. Limitations, future research directions, and potential policy implications are discussed. Published by Elsevier Inc.	[Quartana, Phillip J.; Wilk, Joshua E.; Balkin, Thomas J.; Hoge, Charles W.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA	Quartana, PJ (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	phillip.j.quartana2.civ@mail.mil			U.S. Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC)	The authors have no conflicts of interest to report. The U.S. Army Medical Research and Materiel Command (USAMRMC) provides intramural funding that supports enhancing the psychological resilience of the warfighter.	Abad VC, 2008, SLEEP MED REV, V12, P211, DOI 10.1016/j.smrv.2007.09.001; Adler AB, 2009, J CONSULT CLIN PSYCH, V77, P928, DOI 10.1037/a0016877; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Benyamini Y, 2005, SOC SCI MED, V61, P1267, DOI 10.1016/j.socscimed.2005.01.023; Bisson JI, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003388.pub4; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bliese PD, 2007, PSYCHOL SERV, V4, P141, DOI DOI 10.1037/1541-1559.4.3.141; Britt TW, 2013, J TRAUMA STRESS, V26, P94, DOI 10.1002/jts.21775; Cuijpers P, 2013, CAN J PSYCHIAT, V58, P376, DOI 10.1177/070674371305800702; Edwards RR, 2008, PAIN, V137, P202, DOI 10.1016/j.pain.2008.01.025; Elder GJ, 2014, SLEEP MED REV, V18, P215, DOI 10.1016/j.smrv.2013.05.001; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Ferrie JE, 2007, SLEEP, V30, P1659, DOI 10.1093/sleep/30.12.1659; Finan PH, 2013, J PAIN, V14, P1539, DOI 10.1016/j.jpain.2013.08.007; Gagnon C, 2013, J AM BOARD FAM MED, V26, P701, DOI 10.3122/jabfm.2013.06.130064; Germain A, 2013, AM J PSYCHIAT, V170, P372, DOI 10.1176/appi.ajp.2012.12040432; Goodin BR, 2012, BIOL PSYCHOL, V91, P36, DOI 10.1016/j.biopsycho.2012.02.020; Gupta MA, 2013, INT REV PSYCHIATR, V25, P86, DOI 10.3109/09540261.2012.736367; Harvey AG, 2003, CLIN PSYCHOL REV, V23, P377, DOI 10.1016/S0272-7358(03)00032-1; Harvey AG, 2011, ANNU REV CLIN PSYCHO, V7, P297, DOI 10.1146/annurev-clinpsy-032210-104550; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Jones E, 2002, BMJ-BRIT MED J, V324, P321, DOI 10.1136/bmj.324.7333.321; Killgore WDS, 2006, J PSYCHOSOM RES, V60, P379, DOI 10.1016/j.jpsychores.2006.02.012; Kline A, 2010, AM J PUBLIC HEALTH, V100, P276, DOI 10.2105/AJPH.2009.162925; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lindqvist D, 2014, BRAIN BEHAV IMMUN, V42, P81, DOI 10.1016/j.bbi.2014.06.003; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; Luyster FS, 2012, SLEEP, V35, P727, DOI 10.5665/sleep.1846; MACKINNON DP, 1995, MULTIVAR BEHAV RES, V30, P41, DOI 10.1207/s15327906mbr3001_3; Maia A, 2011, ANXIETY STRESS COPIN, V24, P309, DOI 10.1080/10615806.2010.521238; McCurry SM, 2014, SLEEP, V37, P299, DOI 10.5665/sleep.3402; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CM, 2009, JAMA-J AM MED ASSOC, V301, P2005, DOI 10.1001/jama.2009.682; Motivala SJ, 2011, ANN BEHAV MED, V42, P141, DOI 10.1007/s12160-011-9280-2; Nissen LR, 2011, MIL MED, V176, P1138, DOI 10.7205/MILMED-D-11-00094; Plumb TR, 2014, PSYCHOL SERV, V11, P209, DOI 10.1037/a0034958; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Purvis Dianna L, 2013, US Army Med Dep J, P66; Quartana PJ, 2010, PAIN, V149, P325, DOI 10.1016/j.pain.2010.02.029; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Shah AJ, 2013, BIOL PSYCHIAT, V73, P1103, DOI 10.1016/j.biopsych.2013.01.019; Sipos ML, 2014, DEPRESS ANXIETY, V31, P124, DOI 10.1002/da.22157; Slavich GM, 2014, PSYCHOL BULL, V140, P774, DOI 10.1037/a0035302; Smith MT, 2007, SLEEP, V30, P494, DOI 10.1093/sleep/30.4.494; Smith TJ, 2013, J ACAD NUTR DIET, V113, P907, DOI 10.1016/j.jand.2013.03.002; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Tang NKY, 2012, SLEEP, V35, P675, DOI 10.5665/sleep.1830; Taylor DJ, 2014, INT REV PSYCHIATR, V26, P205, DOI 10.3109/09540261.2014.902808; Terhakopian A, 2008, J TRAUMA STRESS, V21, P290, DOI 10.1002/jts.20341; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Toblin RL, 2014, JAMA INTERN MED, V174, P1400, DOI 10.1001/jamainternmed.2014.2726; Toblin RL, 2012, J AFFECT DISORDERS, V136, P469, DOI 10.1016/j.jad.2011.10.048; Valkanova V, 2013, J AFFECT DISORDERS, V150, P736, DOI 10.1016/j.jad.2013.06.004; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vasterling JJ, 2008, J REHABIL RES DEV, V45, P347, DOI 10.1682/JRRD.2007.05.0077; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wilson ALG, 2010, ANN EPIDEMIOL, V20, P939, DOI 10.1016/j.annepidem.2010.08.007; Wright KM, 2011, J CLIN PSYCHOL, V67, P1240, DOI 10.1002/jclp.20845; Xia L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071065; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	67	12	13	0	16	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3999	1879-1360		J PSYCHOSOM RES	J. Psychosomat. Res.	MAY	2015	78	5					478	483		10.1016/j.jpsychores.2014.11.017			6	Psychiatry	Psychiatry	CF9ZO	WOS:000352926600011	25499887				2021-06-18	
J	Zhang, J; Niu, F; Dong, HM; Liu, L; Li, J; Li, SX				Zhang, Ji; Niu, Fei; Dong, Hongmei; Liu, Liang; Li, Jie; Li, Shangxun			Characterization of Protein Alterations in Damaged Axons in the Brainstem Following Traumatic Brain Injury Using Fourier Transform Infrared Microspectroscopy: A Preliminary Study	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; forensic pathology; traumatic brain injury; axonal injury; Fourier transform infrared microspectroscopy; protein conformation	FT-IR SPECTROSCOPY; RAT-BRAIN; COMBINATION; TISSUE	Axonal injury contributes greatly to neurological dysfunction following traumatic brain injury (TBI), but current histological diagnostic methods are limited in identifying the pathological profiles of injured axons and unable to provide an objective and accurate quantification. Fourier transform infrared microspectroscopy (FTIRM) has the ability to offer macromolecular bioinformatics of the tissues including biochemical composition and structure by calculating band absorption intensity. In this study, axonal injury in the brainstem of rats with traumatic brain injury at 72h post-trauma, which was confirmed with beta-amyloid precursor protein (-APP) immunostaining, was detected with FTIRM technique. The lower intensity of infrared absorbance under the amide I band corresponds strongly to the area of axonal injury, and further analysis of amide I band shows significant differences in protein conformation between injured and normal axons. The findings indicate that using FTIRM technique, the amide I band has potentials to be a infrared spectral marker of axonal injury.	[Zhang, Ji; Dong, Hongmei; Liu, Liang] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Forens Med, Wuhan 430030, Hubei, Peoples R China; [Niu, Fei] Wuhan Univ, Dept Chem & Mol Sci, Inst Anal, Wuhan 430072, Hubei, Peoples R China; [Li, Jie] Wuhan Publ Secur Bur, Dept Chem & Phys, Inst Forens Sci, Wuhan 430015, Hubei, Peoples R China; [Li, Shangxun] Dept Publ Secur Hubei Prov, Dept Chem & Phys, Wuhan 430064, Hubei, Peoples R China	Dong, HM (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll Huazhong, Dept Forens Med, 13 Hangkong Rd, Wuhan 430030, Hubei, Peoples R China.	hongmeidong1@hotmail.com			National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81102298]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [2012TS002]	Supported by a grant from the National Nature Science Foundation of China (No. 81102298) and the Fundamental Research Funds for the Central Universities (No. 2012TS002).	Adekoya N., 2002, SURVEILLANCE TRAUMAT; Ali K, 2008, INT J MOL MED, V21, P297; Beekes M, 2007, VET MICROBIOL, V123, P305, DOI 10.1016/j.vetmic.2007.04.010; CHOO LP, 1995, BIOSPECTROSCOPY, V1, P141, DOI 10.1002/bspy.350010208; Davceva N, 2012, J FORENSIC LEG MED, V19, P413, DOI 10.1016/j.jflm.2012.04.011; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Kneipp J, 2000, BBA-MOL BASIS DIS, V1501, P189, DOI 10.1016/S0925-4439(00)00021-1; Kretlow A, 2008, BBA-MOL BASIS DIS, V1782, P559, DOI 10.1016/j.bbadis.2008.06.004; LeVine SM, 1998, FREE RADICAL BIO MED, V25, P33, DOI 10.1016/S0891-5849(98)00019-7; Richter T, 2002, VIB SPECTROSC, V28, P103, DOI 10.1016/S0924-2031(01)00149-7; Sivakumar S, 2013, SPECTROCHIM ACTA A, V110, P241, DOI 10.1016/j.saa.2013.03.056; Toyran N, 2004, EUR BIOPHYS J BIOPHY, V33, P549, DOI 10.1007/s00249-004-0396-1; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Wang HC, 2010, J NEUROTRAUM, V27, P707, DOI 10.1089/neu.2009.1071; Whiteman S C, 2008, Ther Adv Respir Dis, V2, P23, DOI 10.1177/1753465807087972; Yang TAT, 2011, FORENSIC SCI INT, V207, pE34, DOI 10.1016/j.forsciint.2010.12.005	18	12	12	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	MAY	2015	60	3					759	763		10.1111/1556-4029.12743			5	Medicine, Legal	Legal Medicine	CH4HI	WOS:000353994200031	25773901				2021-06-18	
J	Connolly, M; Vespa, P; Pouratian, N; Gonzalez, NR; Hu, X				Connolly, Mark; Vespa, Paul; Pouratian, Nader; Gonzalez, Nestor R.; Hu, Xiao			Characterization of the Relationship Between Intracranial Pressure and Electroencephalographic Monitoring in Burst-Suppressed Patients	NEUROCRITICAL CARE			English	Article						Neurovascular coupling; Intracranial pressure; Electroencephalogram; Multi-modality monitoring; Acute brain injury	CEREBRAL-BLOOD-FLOW; CORTICAL SPREADING DEPRESSION; TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; HEAD-INJURY; DEPOLARIZATION; ISCHEMIA; SEIZURES; CORTEX; FLUCTUATIONS	The objective of this study is to characterize the relationship between ICP and EEG Simultaneous ICP and EEG data were obtained from burst-suppressed patients and segmented by EEG bursts. Segments were categorized as increasing/decreasing and peak/valley to investigate relationship between ICP changes and EEG burst duration. A generalized ICP response was obtained by averaging all segments time-aligned at burst onsets. A vasodilatation index (VDI) was derived from the ICP pulse waveform and calculated on a sliding interval to investigate cerebrovascular changes post-burst. Data from two patients contained 309 bursts. 246 ICP segments initially increased, of which 154 peaked. 63 ICP segments decreased, and zero reached a valley. The change in ICP (0.54 +/- A 0.85 mmHg) was significantly correlated with the burst duration (p < 0.001). Characterization of the ICP segments showed a peak at 8.1 s and a return to baseline at 14.7 s. The VDI for increasing segments was significantly elevated (median 0.56, IQR 0.31, p < 0.001) and correlated with burst duration (p < 0.001). Changes in the ICP and pulse waveform shape after EEG burst suggest that these signals can be related within the context of neurovascular coupling. Existence of a physiological relationship between ICP and EEG may allow the study of neurovascular coupling in acute brain injury patients.	[Connolly, Mark; Vespa, Paul; Pouratian, Nader; Gonzalez, Nestor R.; Hu, Xiao] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Hu, Xiao] Univ Calif San Francisco, Dept Physiol Nursing, Inst Computat Hlth Sci, San Francisco, CA 94143 USA; [Hu, Xiao] Univ Calif San Francisco, Dept Neurosurg, Inst Computat Hlth Sci, San Francisco, CA 94143 USA; [Hu, Xiao] Univ Calif San Francisco, Inst Computat Hlth Sci, San Francisco, CA 94143 USA	Hu, X (corresponding author), Univ Calif San Francisco, Dept Physiol Nursing, Inst Computat Hlth Sci, San Francisco, CA 94143 USA.	XHu@mednet.ucla.edu		Pouratian, Nader/0000-0002-0426-3241; Gonzalez, Nestor/0000-0002-8277-6317	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS076738]; University of California, San Francisco Institute of Computational Health Sciences; National Institute of neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS079477]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [K23EB014326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS079477, R01NS076738] Funding Source: NIH RePORTER	XH support from the National Institutes of Health Award Number NS076738 and the University of California, San Francisco Institute of Computational Health Sciences. NRG support from National Institute of neurological Disorders and Stroke of the National Institutes of Health under Award Number K23NS079477.	Asgari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050795; Asgari S, 2011, NEUROCRIT CARE, V15, P55, DOI 10.1007/s12028-010-9463-x; Ayata C, 2013, STROKE, V44, pS87, DOI 10.1161/STROKEAHA.112.680264; Baumgartner C, 1998, J NUCL MED, V39, P978; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Fuchtemeier M, 2010, NEUROIMAGE, V52, P445, DOI 10.1016/j.neuroimage.2010.04.237; GOLANOV EV, 1994, AM J PHYSIOL, V266, pR204; HART RG, 1981, NEUROSURGERY, V8, P417, DOI 10.1227/00006123-198104000-00002; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hu X, 2010, PHYSIOL MEAS, V31, P679, DOI 10.1088/0967-3334/31/5/006; Hu X, 2009, IEEE T BIO-MED ENG, V56, P696, DOI 10.1109/TBME.2008.2008636; Koide M, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/819340; LAURITZEN M, 1982, ANN NEUROL, V12, P469, DOI 10.1002/ana.410120510; Leao AAP, 1944, J NEUROPHYSIOL, V7, P391, DOI 10.1152/jn.1944.7.6.391; Lescot T, 2005, ACTA NEUROCHIR, V147, P125, DOI 10.1007/s00701-004-0355-8; Liu XA, 2011, CEREB CORTEX, V21, P374, DOI 10.1093/cercor/bhq105; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; MAYEVSKY A, 1991, J CEREBR BLOOD F MET, V11, P829, DOI 10.1038/jcbfm.1991.142; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Roche-Labarbe N, 2007, NEUROIMAGE, V36, P718, DOI 10.1016/j.neuroimage.2007.04.002; Shin HK, 2006, J CEREBR BLOOD F MET, V26, P1018, DOI 10.1038/sj.jcbfm.9600252; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Stover JF, 1999, CRIT CARE MED, V27, P1351, DOI 10.1097/00003246-199907000-00028; Strong AJ, 2007, BRAIN, V130, P995, DOI 10.1093/brain/awl392; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Westbrook LE, 1998, EPILEPSIA, V39, P978, DOI 10.1111/j.1528-1157.1998.tb01447.x; WINER JW, 1991, NEUROSURGERY, V29, P739, DOI 10.1227/00006123-199111000-00016; Winer JW, 1991, NEUROSURGERY, V29, P741; Winkler MKL, 2012, EPILEPSIA, V53, P22, DOI 10.1111/j.1528-1167.2012.03699.x; Woitzik J, 2012, J CEREBR BLOOD F MET, V32, P203, DOI 10.1038/jcbfm.2011.169	31	12	12	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2015	22	2					212	220		10.1007/s12028-014-0059-8			9	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	CD9VK	WOS:000351447100006	25142827	Green Accepted			2021-06-18	
J	Feng, T; Aono, K; Covassin, T; Chakrabartty, S				Feng, Tao; Aono, Kenji; Covassin, Tracey; Chakrabartty, Shantanu			Self-Powered Monitoring of Repeated Head Impacts Using Time-Dilation Energy Measurement Circuit	IEEE TRANSACTIONS ON BIOMEDICAL CIRCUITS AND SYSTEMS			English	Article; Proceedings Paper	IEEE International Symposium on Circuits and Systems (ISCAS)	JUN 01-05, 2014	Melbourne, AUSTRALIA	IEEE		Biomechanics; concussion monitoring; energy harvesting; helmet sensors; piezo-floating-gate (PFG) sensors; self-powered sensors	KINEMATICS	Due to the current epidemic levels of sport-related concussions (SRC) in the U.S., there is a pressing need for technologies that can facilitate long-term and continuous monitoring of head impacts. Existing helmet-sensor technology is inconsistent, inaccurate, and is not economically or logistically practical for large-scale human studies. In this paper, we present the design of a miniature, battery-less, self-powered sensor that can be embedded inside sport helmets and can continuously monitor and store different spatial and temporal statistics of the helmet impacts. At the core of the proposed sensor is a novel time-dilation circuit that allows measurement of a wide-range of impact energies. In this paper an array of linear piezo-floating-gate (PFG) injectors has been used for self-powered sensing and storage of linear and rotational head-impact statistics. The stored statistics are then retrieved using a plug-and-play reader and has been used for offline data analysis. We report simulation and measurement results validating the functionality of the time-dilation circuit for different levels of impact energies. Also, using prototypes of linear PFG integrated circuits fabricated in a 0.5 mu m CMOS process, we demonstrate the functionality of the proposed helmet-sensors using controlled drop tests.	[Feng, Tao; Aono, Kenji; Chakrabartty, Shantanu] Michigan State Univ, Dept Elect & Comp Engn, E Lansing, MI 48824 USA; [Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA	Feng, T (corresponding author), Michigan State Univ, Dept Elect & Comp Engn, E Lansing, MI 48824 USA.	fengtao@egr.msu.edu; aonokenj@egr.msu.edu; covassin@ath.msu.edu; shantanu@egr.msu.edu	Aono, Kenji/P-7033-2018; Aono, Kenji/O-8498-2019	Aono, Kenji/0000-0002-7192-0061; Aono, Kenji/0000-0002-7192-0061	National Science FoundationNational Science Foundation (NSF) [CAREER: 0954752, GRFP: DGE-0802267]; National Science Foundation Graduate Research Fellowship ProgramNational Science Foundation (NSF) [2013136776]	This work was supported by research grants from the National Science Foundation (CAREER: 0954752 and GRFP: DGE-0802267). This material is based upon work supported in part by the National Science Foundation Graduate Research Fellowship Program under Fellow No. 2013136776. This paper was recommended by Associate Editor V. Gruev.	Aono K, 2014, IEEE INT SYMP CIRC S, P1620, DOI 10.1109/ISCAS.2014.6865461; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Huang C, 2011, ELECTRON LETT, V47, P277, DOI 10.1049/el.2010.3430; Huang CL, 2012, IEEE J SOLID-ST CIRC, V47, P476, DOI 10.1109/JSSC.2011.2172159; Institute of Medicine (IOM) and National Research Council (NRC), 2013, SPORT REL CONC YOUTH; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Sarkar P, 2013, IEEE T CIRCUITS-I, V60, P2311, DOI 10.1109/TCSI.2013.2245472; Sarkar P, 2013, IEEE T BIOMED CIRC S, V7, P437, DOI 10.1109/TBCAS.2012.2220764; Yang YW, 2009, J INTEL MAT SYST STR, V20, P2223, DOI 10.1177/1045389X09351757	18	12	12	0	14	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1932-4545	1940-9990		IEEE T BIOMED CIRC S	IEEE Trans. Biomed. Circuits Syst.	APR	2015	9	2			SI		217	226		10.1109/TBCAS.2015.2403864			10	Engineering, Biomedical; Engineering, Electrical & Electronic	Engineering	CH3BJ	WOS:000353900400008	25838527				2021-06-18	
J	Hua, CA; Merchant, TE; Li, XY; Li, YM; Shulkin, BL				Hua, Chiaho; Merchant, Thomas E.; Li, Xingyu; Li, Yimei; Shulkin, Barry L.			Establishing Age-Associated Normative Ranges of the Cerebral F-18-FDG Uptake Ratio in Children	JOURNAL OF NUCLEAR MEDICINE			English	Article						PET; F-18-FDG; children; brain	POSITRON-EMISSION-TOMOGRAPHY; CROSSED CEREBELLAR DIASCHISIS; GLUCOSE-METABOLISM; HUMAN-BRAIN; FRONTAL-LOBE; FDG UPTAKE; CHILDHOOD; SPECT; ADOLESCENTS; NETWORKS	In this study, we reported age-associated ranges of the regional cerebral F-18-FDG uptake ratio in pediatric patients as a surrogate to normative data from healthy children. Methods: F-18-FDG PET scans of 132 children and adolescents (age, 1-20 y) with non-central nervous system-related diseases and normal-appearing tracer distributions in the brain were retrospectively analyzed. PET images of individual patients were warped to a 3-dimensional reference template. Uptake ratio was calculated for 63 anatomic regions by normalizing the regional count per voxel with the average count per voxel in all regions. Models of regional uptake ratio as a function of age and sex were developed to calculate the 95% prediction interval. Results: The paracentral lobule and cuneus had the highest resting metabolic state among all gray matter regions, whereas the brain stem, uncus, and hippocampus had the lowest uptake. A large left-right asymmetry was present in the angular gyrus and inferior occipital gyrus. Quantitative data of the regression, 95% confidence interval, and 95% prediction interval for each age were summarized for the 63 regions. In 52 of 63 regions, the F-18-FDG uptake ratio had a significant age effect. The linear model was optimal for 12 regions, whereas the spline model with 1 age knot was a better fit for 40 regions. In children younger than 5 y, frontal and temporal lobes had a lower uptake than parietal and occipital lobes in general. However, uptake in the frontal lobe continued to increase with age but it decreased in the parietal and occipital lobes. Conclusion: Anatomic regions of the brain in children and adolescents exhibited uniquely different F-18-FDG uptake trends with age. Our results may be useful for studying childhood development and possibly regional metabolic defects in children with traumatic brain injury or central nervous system disorders or children receiving cancer treatment.	[Hua, Chiaho; Merchant, Thomas E.; Shulkin, Barry L.] St Jude Childrens Res Hosp, Dept Radiol Sci, Memphis, TN 38105 USA; [Li, Xingyu; Li, Yimei] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA	Hua, CA (corresponding author), St Jude Childrens Res Hosp, Dept Radiol Sci, Mail Stop 220,262 Danny Thomas Pl, Memphis, TN 38105 USA.	chia-ho.hua@stjude.org	Hua, Chia-ho/D-4220-2018; shulkin, barry l/J-6268-2018; Merchant, Thomas E/N-3344-2018	shulkin, barry l/0000-0003-4784-7914; Merchant, Thomas E/0000-0002-0412-6255			Boellaard R, 2009, J NUCL MED, V50, p11S, DOI 10.2967/jnumed.108.057182; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Cleveland W.S., 1996, STAT THEORY COMPUTAT, P10, DOI 10.1007/978- 3- 642- 48425-4_ 2.; Conklin HM, 2007, DEV NEUROPSYCHOL, V31, P103, DOI 10.1207/s15326942dn3101_6; Craddock RC, 2013, NAT METHODS, V10, P524, DOI [10.1038/NMETH.2482, 10.1038/nmeth.2482]; Devous MD, 2006, J SPEECH LANG HEAR R, V49, P856, DOI 10.1044/1092-4388(2006/061); Di X, 2012, BRAIN CONNECT, V2, P275, DOI 10.1089/brain.2012.0086; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; Garibotto V, 2013, CLIN NUCL MED, V38, pE112, DOI 10.1097/RLU.0b013e318279b991; Giedd JN, 2013, PRINCIPLES FRONTAL L, P135; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Kang EJ, 2004, NEUROIMAGE, V22, P1543, DOI 10.1016/j.neuroimage.2004.04.010; KUSHNER M, 1987, J NUCL MED, V28, P1667; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; London K, 2015, NEUROIMAGE, V106, P264, DOI 10.1016/j.neuroimage.2014.11.047; London K, 2014, EUR J NUCL MED MOL I, V41, P723, DOI 10.1007/s00259-013-2639-9; Montandon ML, 2007, COMPUT MED IMAG GRAP, V31, P28, DOI 10.1016/j.compmedimag.2006.09.017; Moore JK, 2002, ANN OTO RHINOL LARYN, V111, P7; Muzik O, 1999, PROG NEURO-PSYCHOPH, V23, P589, DOI 10.1016/S0278-5846(99)00018-4; Otte A, 1998, J NEUROL SCI, V156, P73, DOI 10.1016/S0022-510X(98)00019-7; R Project, R LANG ENV STAT COMP; Radau PE, 2001, MED PHYS, V28, P1660, DOI 10.1118/1.1388894; Riedl V, 2014, J NEUROSCI, V34, P6260, DOI 10.1523/JNEUROSCI.0492-14.2014; Shamoto H, 1997, J CHILD NEUROL, V12, P407, DOI 10.1177/088307389701200701; Shan ZYY, 2014, HUM BRAIN MAPP, V35, P2297, DOI 10.1002/hbm.22328; Shiee N, 2011, LECT NOTES COMPUT SC, V6801, P1, DOI 10.1007/978-3-642-22092-0_1; Slomka PJ, 2001, COMPUT MED IMAG GRAP, V25, P153, DOI 10.1016/S0895-6111(00)00044-6; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Studholme C, 1999, PATTERN RECOGN, V32, P71, DOI 10.1016/S0031-3203(98)00091-0; Uddin LQ, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00021; Van Bogaert P, 1998, NEUROIMAGE, V8, P62, DOI 10.1006/nimg.1998.0346; Van Laere K, 2001, J NUCL MED, V42, P361	33	12	12	0	1	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	APR	2015	56	4					575	579		10.2967/jnumed.114.146993			5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CE9NL	WOS:000352170600041	25745092	Bronze			2021-06-18	
J	Mioni, G; Rendell, PG; Terrett, G; Stablum, F				Mioni, Giovanna; Rendell, Peter G.; Terrett, Gill; Stablum, Franca			Prospective Memory Performance in Traumatic Brain Injury Patients: A Study of Implementation Intentions	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Traumatic brain injury; Implementation intentions; Prospective memory; Event-based; Time-based; Virtual Week	CLOSED-HEAD-INJURY; EXECUTIVE FUNCTIONS; OLDER-ADULTS; REHABILITATION; INVOLVEMENT; DISORDERS; STRATEGY; PEOPLE; COMA	Traumatic brain injury (TBI) patients often present with prospective memory (PM) dysfunction. Forgetting to complete tasks may result in a loss of independence, limited employment prospects and anxiety, therefore, it is important to develop programs to improve PM performance in TBI patients. A strategy which may improve PM performance is implementation intentions. It involves making explicit plans specifying when, where and how one will perform a task in the future. In the present study, a group of 36 TBI patients and a group of 34 controls performed Virtual Week using either implementation intentions or no strategy. The results showed that the PM performance of TBI patients was less accurate than controls, in particular when the PM cue was time-based. No effect of implementation intentions was observed for TBI patients, however, controls improved their PM performance when the task was time-based. The findings suggest that strategies to improve PM in this clinical group are likely to be more complex than those that benefit healthy adults and may involve targeting phases of the PM process other than, or in addition to, the intention formation phase.	[Mioni, Giovanna; Stablum, Franca] Univ Padua, Dept Gen Psychol, I-35131 Padua, Italy; [Rendell, Peter G.; Terrett, Gill] Australian Catholic Univ, Sch Psychol, Melbourne, Vic, Australia	Mioni, G (corresponding author), Univ Padua, Dept Gen Psychol, Via Venezia 12, I-35131 Padua, Italy.	mioni.giovanna@gmail.com	Rendell, Peter/E-7539-2010; Terrett, Gill/D-7165-2019	Rendell, Peter/0000-0002-4829-4322; Terrett, Gill/0000-0003-2500-6428; Stablum, Franca/0000-0003-0123-5090; mioni, Giovanna/0000-0002-1212-4591			BELLEZZA FS, 1981, REV EDUC RES, V51, P247, DOI 10.3102/00346543051002247; Carlesimo GA, 2009, BEHAV NEUROL, V22, P101, DOI [10.3233/ben-2009-0251, 10.3233/BEN-2009-0251]; Chasteen AL, 2001, PSYCHOL SCI, V12, P457, DOI 10.1111/1467-9280.00385; Cohen A. L., 2008, PROSPECTIVE MEMORY C, P367; Einstein G., 1996, PROSPECTIVE MEMORY T, P115; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Ellis JA., 1996, PROSPECTIVE MEMORY T, P1; Fish J, 2010, NEUROPSYCHOL REHABIL, V20, P161, DOI 10.1080/09602010903126029; Fleming J, 2008, J INT NEUROPSYCH SOC, V14, P823, DOI 10.1017/S1355617708080971; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Gollwitzer PM, 1999, AM PSYCHOL, V54, P493, DOI 10.1037//0003-066X.54.7.493; Gollwitzer PM, 1997, J PERS SOC PSYCHOL, V73, P186, DOI 10.1037/0022-3514.73.1.186; HAGAN C, 1979, REHABILITATION HEAD; Kardiasmenos KS, 2008, NEUROPSYCHOLOGY, V22, P746, DOI 10.1037/a0013211; Kinch J., 2001, BRAIN IMPAIR, V2, P119, DOI [10.1375/brim.2.2.119, DOI 10.1375/BRIM.2.2.119]; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kliegel M., 2008, PROSPECTIVE MEMORY C; Kliegel M, 2002, PSYCHOL BEITR, V44, P303, DOI DOI 10.1037/0012-1649.44.2.612; Lengfelder A, 2001, NEUROPSYCHOLOGY, V15, P80, DOI 10.1037//0894-4105.15.1.80; Liu LL, 2004, PSYCHOL AGING, V19, P318, DOI 10.1037/0882-7974.19.2.318; Martin M, 2003, INT J PSYCHOL, V38, P195, DOI 10.1080/00207590344000123; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; Maujean A., 2003, BRAIN IMPAIR, V4, P135, DOI DOI 10.1375/BRIM.4.2.135.27024; McDaniel M A, 1993, Memory, V1, P23, DOI 10.1080/09658219308258223; McDaniel MA, 1999, NEUROPSYCHOLOGY, V13, P103, DOI 10.1037/0894-4105.13.1.103; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel MA, 2008, MEM COGNITION, V36, P716, DOI 10.3758/MC.36.4.716; McDaniel MA, 2010, MEM COGNITION, V38, P221, DOI 10.3758/MC.38.2.221; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McFarland C, 2012, MEM COGNITION, V40, P62, DOI 10.3758/s13421-011-0126-8; McFarland CP, 2011, AGING NEUROPSYCHOL C, V18, P633, DOI 10.1080/13825585.2011.613449; McFarland CP, 2009, NEUROPSYCHOLOGIA, V47, P1660, DOI 10.1016/j.neuropsychologia.2009.02.023; Meeks JT, 2010, PSYCHOL RES-PSYCH FO, V74, P82, DOI 10.1007/s00426-008-0223-x; Mioni G., 2014, TRAUMATIC BRAIN INJU, DOI [DOI 10.5772/57307, 10.5772/57307]; Mioni G, 2015, NEUROPSYCHOL REHABIL, V25, P419, DOI 10.1080/09602011.2014.941295; Mioni G, 2013, J CLIN EXP NEUROPSYC, V35, P90, DOI 10.1080/13803395.2012.755151; Mioni G, 2012, J INT NEUROPSYCH SOC, V18, P697, DOI 10.1017/S1355617712000306; Paivio A., 1971, IMAGERY VERBAL PROCE; Potvin MJ, 2011, NEUROPSYCHOL REHABIL, V21, P899, DOI 10.1080/09602011.2011.630882; Rendell PG, 2000, APPL COGNITIVE PSYCH, V14, pS43, DOI 10.1002/acp.770; Gouveia PAR, 2007, BRAIN COGNITION, V63, P240, DOI 10.1016/j.bandc.2006.09.001; Schmidt IW, 2001, PERCEPT MOTOR SKILL, V93, P761, DOI 10.2466/PMS.93.7.761-776; Schnitzspahn KM, 2009, EUR J AGEING, V6, P147, DOI 10.1007/s10433-009-0116-x; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; TEASDALE G, 1974, LANCET, V2, P81; Thone-Otto A.I., 2008, PROSPECTIVE MEMORY C, P321; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Webb TL, 2007, J EXP SOC PSYCHOL, V43, P295, DOI 10.1016/j.jesp.2006.02.001; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012	50	12	16	0	8	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	APR	2015	21	4					305	313		10.1017/S1355617715000211			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	CK2EI	WOS:000356023000005	26028246				2021-06-18	
J	Stricker, NH; Keller, JE; Castillo, DT; Haaland, KY				Stricker, Nikki H.; Keller, Jenna E.; Castillo, Diane T.; Haaland, Kathleen Y.			The Neurocognitive Performance of Female Veterans With Posttraumatic Stress Disorder	JOURNAL OF TRAUMATIC STRESS			English	Article							INTIMATE PARTNER VIOLENCE; MEMORY MALINGERING TOMM; PSYCHOMETRIC PROPERTIES; PTSD; ATTENTION; DYSFUNCTION; DEFICITS; INHIBITION; VICTIMS; ABUSE	Neurocognitive problems are common with posttraumatic stress disorder (PTSD) and are important to understand because of their association with the success of PTSD treatment and its potential neural correlates. To our knowledge, this is the first neurocognitive study in an all-female U.S. veteran sample, some of whom had PTSD. We examined neurocognitive performance and assessed whether learning deficits, common in PTSD, were associated with executive functioning. Veterans with PTSD (n = 56) and without (n = 53) were evaluated for psychiatric and neurocognitive status. The PTSD group had a lower estimated IQ (d = 0.53) and performed more poorly on all neurocognitive domains (d range = 0.57-0.88), except verbal retention (d = 0.04). A subset of the 2 groups that were matched on IQ and demographics similarly demonstrated poorer performance for the PTSD group on all neurocognitive domains (d range = 0.52-0.79), except verbal retention (d = 0.15). Within the PTSD group, executive functioning accounted for significant variance in verbal learning over and above IQ and processing speed (R-2 = .06), as well as depression (R-2 = .07) and PTSD severity (R-2 = .06). This study demonstrated that female veterans with PTSD performed more poorly than females without PTSD on several neurocognitive domains, including verbal learning, processing speed, and executive functioning. Replication of these results using a control group of veterans with more similar trauma exposure, history of mild traumatic brain injury, and psychiatric comorbidities would solidify these findings. Resumen Los problemas neurocognitivos son comunes en el trastorno por estres postraumatico (TEPT) y es importante entenderlos debido a su asociacion con el exito del tratamiento de TEPT y sus potenciales correlatos neurales. Hasta donde sabemos, es este el primer estudio neurocognitivo en una muestra solamente compuesta por mujeres veteranas, algunas de las cuales tenian TEPT. Examinamos el rendimiento neurocognitivo y evaluamos si los problemas de aprendizaje, comunes en TEPT, estaban asociados con el funcionamiento ejecutivo. Las veteranas con (56) y sin (53) TEPT fueron evaluadas en su estado psiquiatrico y neurocognitivo. El grupo TEPT tenia un CI estimado menor (d = 0.53) y rindieron mas pobremente en todos los dominios neurocognitivos (rango d = 0.57-0.88), excepto en la retencion verbal (d = 0.04). Un subconjunto de los 2 grupos, que tenian CI y datos demograficos comparables, demostraron rendimientos bajos similares en todos los dominios neurocognitivos (rango d = 0.52-0.79), excepto por la retencion verbal (d = 0.15). Dentro del grupo TEPT, el funcionamiento ejecutivo explica la varianza significativa en aprendizaje verbal por encima del CI y la velocidad de procesamiento (R2 = .06), como tambien la depresion (R2 = .07), y la gravedad del TEPT (R2 = .06). Este estudio demostro que las mujeres veteranas con TEPT rindieron peor que las mujeres sin TEPT en varios dominios neurocognitivos, incluyendo el aprendizaje verbal, la velocidad de procesamiento y el funcionamiento ejecutivo. La replicacion de estos resultados usando un grupo control de veteranos con exposicion similar al trauma, historia de leve LTC (lesion traumatica cerebral) y comorbilidades psiquiatricas podrian darle mayor solidez a estos hallazgos. Traditional and Simplified Chinese Abstracts by AsianSTSS ??: ?????????????????????? ??: ?????????????(PTSD)????????????PTSD?????????????????,??????????????????????,????????PTSD????????????????????????????????????PTSD?????????????????????PTSD?????(56)???PTSD?????(53)?????????????????PTSD??????IQ??? (d = 0.53),??????????????(d?? = 0.57-0.88),??????????(d = 0.04)? ?IQ???????????????,????????????????????(d?? = 0.52-0.79),??????????(d = 0.15)?PTSD??,????????IQ?????????????(R2 = .06)????(R2 = .07)?PTSD???(R2 = .06)???????????,??PTSD??????????PTSD???????????????????,????????????????????????????????????????????????????????????????,??????????? ??: ????????????????????? ??: ????????????(PTSD)???????????PTSD????????????????,?????????????????????,????????PTSD??????????????????????????????????PTSD?????????????????????PTSD?????(56)???PTSD?????(53)????????????????PTSD??????IQ??? (d = 0.53),??????????????(d?? = 0.57-0.88),??????????(d = 0.04)? ?IQ???????????????,???????????????????(d?? = 0.52-0.79),??????????(d = 0.15)?PTSD??,????????IQ?????????????(R2 = .06)????(R2 = .07)?PTSD???(R2 = .06)???????????,??PTSD??????????PTSD??????????????????,???????????????????????????????????????????????????????????????,???????????	[Stricker, Nikki H.] VA Boston Healthcare Syst, Psychol Serv, Boston, MA USA; [Stricker, Nikki H.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Keller, Jenna E.] Biomed Res Inst New Mexico, Albuquerque, NM USA; [Keller, Jenna E.; Castillo, Diane T.] New Mexico VA Healthcare Syst, Psychol Serv, Albuquerque, NM USA; [Castillo, Diane T.; Haaland, Kathleen Y.] New Mexico VA Healthcare Syst, Res Serv, Albuquerque, NM USA; [Castillo, Diane T.; Haaland, Kathleen Y.] Univ New Mexico, Sch Med, Dept Psychiat & Behav Sci, Albuquerque, NM 87131 USA; [Haaland, Kathleen Y.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA	Haaland, KY (corresponding author), Univ New Mexico, Psychiat & Behav Sci, Sch Med, Family Practice & Psychiat & Behav Sci Bldg, Albuquerque, NM 87131 USA.	khaaland@unm.edu		Haaland, Kathleen/0000-0002-8712-676X	Department of DefenseUnited States Department of Defense [PT074309, W81XWH-08-2-0022]; Department of Veterans Affairs Research Career Scientist AwardUS Department of Veterans Affairs; Research Service at the NM-VAHCS; Department of Veterans Affairs VISN 1 Career Development Award-MentoredUS Department of Veterans Affairs	Portions of this manuscript were previously featured in a paper entitled "Neuropsychological Deficits in Female Veterans with PTSD: Preliminary Findings" presented at the 26 Annual Meeting of the International Society for Traumatic Stress Studies, Montreal, Quebec, Canada, November 4-6, 2010. This study was supported by the Department of Defense (Grant #PT074309, Award Number W81XWH-08-2-0022 to DC), Department of Veterans Affairs Research Career Scientist Award (KYH), a grant from the Research Service at the NM-VAHCS (KYH), and Department of Veterans Affairs VISN 1 Career Development Award-Mentored (NHS).	Allen JP, 1997, ALCOHOL CLIN EXP RES, V21, P613, DOI 10.1097/00000374-199706000-00008; Amir N, 2009, J CONSULT CLIN PSYCH, V77, P961, DOI 10.1037/a0016685; Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Andreano JM, 2009, LEARN MEMORY, V16, P248, DOI 10.1101/lm.918309; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Beck A. T., 1996, BECK DEPRESSION INVE, VII; Beebe DW, 2000, J CLIN EXP NEUROPSYC, V22, P779, DOI 10.1076/jcen.22.6.779.950; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bremner JD, 2004, J NERV MENT DIS, V192, P643, DOI 10.1097/01.nmd.0000142027.52893.c8; BREMNER JD, 1993, AM J PSYCHIAT, V150, P235; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Corbo V, 2014, PSYCHIAT RES-NEUROIM, V223, P53, DOI 10.1016/j.pscychresns.2014.04.013; Crowell TA, 2002, CLIN NEUROPSYCHOL, V16, P310, DOI 10.1076/clin.16.3.310.13851; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Delis D. C., 2000, CVLT II MANUAL; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Fennema-Notestine C, 2002, BIOL PSYCHIAT, V52, P1089, DOI 10.1016/S0006-3223(02)01413-0; First M.B., 2002, STRUCTURED CLINICAL; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Geuze E, 2008, NEUROIMAGE, V41, P675, DOI 10.1016/j.neuroimage.2008.03.007; Gilbertson MW, 2006, J ABNORM PSYCHOL, V115, P484, DOI 10.1037/0021-843X.115.3.484; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Hill BD, 2012, APPL NEUROPSYCH-ADUL, V19, P198, DOI 10.1080/09084282.2011.643960; Hilsabeck RC, 2011, CLIN NEUROPSYCHOL, V25, P1228, DOI 10.1080/13854046.2011.589409; Jenkins MA, 2000, CLIN NEUROPSYCHOL, V14, P7, DOI 10.1076/1385-4046(200002)14:1;1-8;FT007; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; Parslow RA, 2007, AM J PSYCHIAT, V164, P509, DOI 10.1176/appi.ajp.164.3.509; Qureshi SU, 2011, J NEUROPSYCH CLIN N, V23, P16, DOI 10.1176/appi.neuropsych.23.1.16; Samuelson KW, 2006, NEUROPSYCHOLOGY, V20, P716, DOI 10.1037/0894-4105.20.6.716; Shimamura A. P., 2008, HDB METAMEM MEM, V11, P373; Shucard JL, 2008, BIOL PSYCHOL, V79, P223, DOI 10.1016/j.biopsycho.2008.05.005; Soble JR, 2013, J CLIN EXP NEUROPSYC, V35, P551, DOI 10.1080/13803395.2013.798398; Southwick S., 2010, HANDBOOK OF PTSD SCI, P166; Stein MB, 2002, BIOL PSYCHIAT, V52, P1079, DOI 10.1016/S0006-3223(02)01414-2; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tremont G, 2000, CLIN NEUROPSYCHOL, V14, P295, DOI 10.1076/1385-4046(200008)14:3;1-P;FT295; Vanderploeg R., 2013, NEUROPSYCHOLOGY SCIE, VI, P114; Vasterling J.J., 2005, NEUROPSYCHOLOGY PTSD, P178; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Wechsler D., 2001, WECHSLER TEST OF ADU; Wild J, 2008, BRIT J PSYCHIAT, V193, P254, DOI 10.1192/bjp.bp.107.045922; Zinzow HM, 2007, TRAUMA VIOLENCE ABUS, V8, P384, DOI 10.1177/1524838007307295	54	12	12	1	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	APR	2015	28	2					102	109		10.1002/jts.22000			8	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	CF8NJ	WOS:000352818300003	25847622				2021-06-18	
J	Tatla, SK; Jarus, T; Virji-Babul, N; Holsti, L				Tatla, Sandy K.; Jarus, Tal; Virji-Babul, Naznin; Holsti, Liisa			The development of the Pediatric Motivation Scale for rehabilitation	CANADIAN JOURNAL OF OCCUPATIONAL THERAPY-REVUE CANADIENNE D ERGOTHERAPIE			English	Article						Acquired brain injury; Child health services; Developmental disabilities; Pediatrics; Psychometric properties	SELF-DETERMINATION THEORY; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; INTRINSIC MOTIVATION; CEREBRAL-PALSY; CHILDREN; INTERVENTIONS; PERCEPTIONS; OUTCOMES; ENVIRONMENT	Background. Clinicians recognize that client motivation is key to optimizing rehabilitation; however, they are limited in its assessment by a paucity of motivation measures. Purpose. This paper presents the preliminary psychometrics of the Pediatric Motivation Scale (PMOT) designed to measure motivation from a child's perspective. Method. Content validity of the PMOT was measured through expert feedback (n = 12), and field testing ocurred with 41 children, 21 in rehabilitation and 20 healthy. Pearson product-moment correlations were used to analyze subscale correlations, test-retest reliability, and convergent validity with the Pediatric Volitional Questionnaire (PVQ). Internal consistency was measured using Cronbach's alpha. Findings. Preliminary psychometric evaluation indicates strong internal consistency for PMOT total ( = .96) and subscales ( = .79-.91). The PMOT and PVQ moderately correlated in the rehabilitation subsample (r = .71, p < .01); no correlation was found in the healthy subsample (p > .05). Test-retest reliability was excellent (r = .97). Implications. This study provides preliminary psychometric evidence of the PMOT for children undergoing rehabilitation. These pilot findings warrant ongoing scale development. Description. Les cliniciens reconnaissent que la motivation des clients est un facteur-cle pour optimiser la readaptation. Toutefois, leur habilete a evaluer la motivation est limitee par l'absence d'outils de mesure. But. Cet article presente les mesures psychometriques preliminaires de la << Pediatric Motivation Scale >> (PMOT) concue pour mesurer la motivation selon le point de vue de l'enfant. Methodologie. La validite du contenu de la PMOT a ete mesuree selon la retroaction d'experts (n = 12) et des essais sur le terrain realises aupres de 41 enfants, dont 21 d'entre eux etaient en readaptation et 20 en sante. Des coefficients de correlation de Pearson ont servi a analyser les correlations entre les sous-echelles, la fiabilite test-retest, et de la validite convergente avec le << Pediatric Volitional Questionnaire >> (PVQ). La coherence interne a ete mesuree a l'aide de l'alpha de Cronbach. Resultats. L'evaluation psychometrique preliminaire indique une forte coherence interne pour le total de la PMOT ( = .96) et les sous-echelles ( = .79-.91). La PMOT et le PVQ etaient moderement correles pour l'echantillon d'enfants en readaptation (r = .71, p < .01); aucune correlation n'a ete trouvee pour l'echantillon d'enfants en sante (p > .05). La fiabilite du test-retest etait excellente (r = .97). Consequences. Cette etude fournit l'evidence psychometrique preliminaire de la PMOT pour les enfants qui sont actuellement en readaptation. Ces resultats pilotes justifient la poursuite de l'elaboration de l'echelle de mesure.	[Tatla, Sandy K.] Univ British Columbia, Sunny Hill Hlth Ctr Children, Acute Rehabil Team, Vancouver, BC V5Z 1M9, Canada; [Tatla, Sandy K.; Jarus, Tal; Holsti, Liisa] Univ British Columbia, Dept Occupat Sci & Occupat Therapy, Vancouver, BC V5Z 1M9, Canada; [Virji-Babul, Naznin] Univ British Columbia, Fac Med, Dept Phys Therapy, Vancouver, BC, Canada	Tatla, SK (corresponding author), Sunny Hill Hlth Ctr Children, Therapy Dept, 3644 Slocan Ave, Vancouver, BC V5M 3E8, Canada.	statla2@cw.bc.ca	Tatla, Sandy/V-6805-2019	Virji-Babul, Naznin/0000-0002-8984-5848; Tatla, Sandy/0000-0001-5708-2666; Jarus, Tal/0000-0003-4124-7782; Holsti, Liisa/0000-0003-0315-0330	Child and Family Research Institute; University of British Columbia, Vancouver, BC, Canada	Sandy Tatla was supported by the Child and Family Research Institute, an agency working in close partnerships with the British Columbia Provincial Health Services Authority and the University of British Columbia, Vancouver, BC, Canada.	Andersen Susan, 2005, Phys Occup Ther Pediatr, V25, P39, DOI 10.1300/J006v25n01_04; BARRY J R, 1965, Cleft Palate J, V45, P62; Bartlett DJ, 2002, PHYS THER, V82, P237, DOI 10.1093/ptj/82.3.237; Basu S., 2008, USERS MANUAL PEDIAT, V2; Boosman H, 2013, BRAIN INJURY, V27, P685, DOI 10.3109/02699052.2013.775504; Choi J, 2010, SCHIZOPHRENIA BULL, V36, P966, DOI 10.1093/schbul/sbp030; Cicerone KD, 2012, ARCH PHYS MED REHAB, V93, P188, DOI 10.1016/j.apmr.2011.12.003; Deci E., 1985, INTRINSIC MOTIVATION, DOI DOI 10.1007/978-1-4899-2271-7; Deci EL, 2008, CAN PSYCHOL, V49, P182, DOI 10.1037/a0012801; Deci EL, 2008, CAN PSYCHOL, V49, P14, DOI 10.1037/0708-5591.49.1.14; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dunn W, 2013, ART SCI MOTIVATION T, P225; Fonteyn M. E., 1993, QUAL HEALTH RES, V3, P430, DOI DOI 10.1177/104973239300300403; Furr M.R., 2008, PSYCHOMETRICS INTRO; Gilmore L, 2009, RES DEV DISABIL, V30, P1023, DOI 10.1016/j.ridd.2009.02.005; Gilmore R, 2010, DEV NEUROREHABIL, V13, P88, DOI 10.3109/17518420903386161; Goverover Y, 2014, BRAIN INJURY, V28, P174, DOI 10.3109/02699052.2013.860474; Greber C., 2013, ART SCI MOTIVATION T, P123; Hagen C, 1998, RANCHOS LEVELS COGNI; Haley S.M., 1992, PEDIAT EVALUATION DI; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Katartzi ES, 2011, RES DEV DISABIL, V32, P2674, DOI 10.1016/j.ridd.2011.06.005; Kim SI, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00098; King G, 2014, CHILD ADOL MENT H-UK, V19, P2, DOI 10.1111/camh.12015; Koka A, 2003, PSYCHOL SPORT EXERC, V4, P333, DOI 10.1016/S1469-0292(02)00012-2; Leng E.Y., 2010, EURASIA J MATH SCI T, V6, P215, DOI [10.12973/ejmste/75242, DOI 10.12973/EJMSTE/75242]; Lundgren-Laine H, 2010, QUAL HEALTH RES, V20, P565, DOI 10.1177/1049732309354278; Maclean N, 2000, SOC SCI MED, V50, P495; Maclean N, 2000, BMJ-BRIT MED J, V321, P1051, DOI 10.1136/bmj.321.7268.1051; Majnemer A, 2011, PHYS OCCUP THER PEDI, V31, P1, DOI 10.3109/01942638.2011.541747; Markland D, 1997, RES Q EXERCISE SPORT, V68, P20, DOI 10.1080/02701367.1997.10608863; MCAULEY E, 1989, RES Q EXERCISE SPORT, V60, P48, DOI 10.1080/02701367.1989.10607413; MCAULEY E, 1991, J APPL SOC PSYCHOL, V21, P139, DOI 10.1111/j.1559-1816.1991.tb00493.x; Miller L, 2014, PHYS OCCUP THER PEDI, V34, P90, DOI 10.3109/01942638.2013.771720; Morgan GA, 2009, DIMENSIONS MASTERY Q; Nichols D.S., 1996, PEDIATR PHYS THER, V8, DOI [https://doi.org/10.1097/00001577-199600810-00004, DOI 10.1097/00001577-199600810-00004]; Oddy M, 2008, J CLIN EXP NEUROPSYC, V30, P568, DOI 10.1080/13803390701555598; Portney LG, 2009, FDN CLIN RES APPL PR; Reid D, 2005, EARLY CHILD DEV CARE, V175, P153, DOI 10.1080/0300443042000230366; Ronen GM, 2011, DEV MED CHILD NEUROL, V53, P305, DOI 10.1111/j.1469-8749.2011.03919.x; Ryan RM, 2006, MOTIV EMOTION, V30, P347, DOI 10.1007/s11031-006-9051-8; Self-Determination Theory Research Group, INTR MOT INV; Tatla S. K., 2014, THESIS U BRIT COLUMB; Tatla SK, 2014, BRAIN INJURY, V28, P1022, DOI 10.3109/02699052.2014.890747; Tatla SK, 2013, DEV MED CHILD NEUROL, V55, P593, DOI 10.1111/dmcn.12147; Tokcan Gul, 2003, Pediatr Phys Ther, V15, P16, DOI 10.1097/01.PEP.0000050765.71924.6C; Wright FV, 2014, J CHILD NEUROL, V29, P1055, DOI 10.1177/0883073814533423; Ziviani J, 2013, DEV MED CHILD NEUROL, V55, P965, DOI 10.1111/dmcn.12179; Ziviani Jenny, 2001, Physical and Occupational Therapy in Pediatrics, V21, P91, DOI 10.1080/J006v21n02_08	50	12	12	0	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0008-4174	1911-9828		CAN J OCCUP THER	Can. J. Occup. Ther.	APR	2015	82	2					93	105		10.1177/0008417414556884			13	Rehabilitation	Rehabilitation	CE0ZS	WOS:000351541400004	26281433				2021-06-18	
J	Yu, ZY; Liu, N; Zhao, JH; Li, YD; McCarthy, TJ; Tedford, CE; Lo, EH; Wang, XY				Yu, Zhanyang; Liu, Ning; Zhao, Jianhua; Li, Yadan; McCarthy, Thomas J.; Tedford, Clark E.; Lo, Eng H.; Wang, Xiaoying			Near infrared radiation rescues mitochondrial dysfunction in cortical neurons after oxygen-glucose deprivation	METABOLIC BRAIN DISEASE			English	Article						Near infrared radiation; Oxygen-glucose deprivation; Primary cortical neurons; MTT reduction; Mitochondrial membrane potential; ATP	LEVEL LASER THERAPY; TERM NEUROLOGICAL DEFICITS; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; PROMOTES REGENERATION; FUNCTIONAL RECOVERY; LIGHT; MICE; PHOTOBIOMODULATION; ACTIVATION	Near infrared radiation (NIR) is known to penetrate and affect biological systems in multiple ways. Recently, a series of experimental studies suggested that low intensity NIR may protect neuronal cells against a wide range of insults that mimic diseases such as stroke, brain trauma and neurodegeneration. However, the potential molecular mechanisms of neuroprotection with NIR remain poorly defined. In this study, we tested the hypothesis that low intensity NIR may attenuate hypoxia/ischemia-induced mitochondrial dysfunction in neurons. Primary cortical mouse neuronal cultures were subjected to 4 h oxygen-glucose deprivation followed by reoxygenation for 2 h, neurons were then treated with a 2 min exposure to 810-nm NIR. Mitochondrial function markers including MTT reduction and mitochondria membrane potential were measured at 2 h after treatment. Neurotoxicity was quantified 20 h later. Our results showed that 4 h oxygen-glucose deprivation plus 20 h reoxygenation caused 33.8 +/- 3.4 % of neuron death, while NIR exposure significantly reduced neuronal death to 23.6 +/- 2.9 %. MTT reduction rate was reduced to 75.9 +/- 2.7 % by oxygen-glucose deprivation compared to normoxic controls, but NIR exposure significantly rescued MTT reduction to 87.6 +/- 4.5 %. Furthermore, after oxygen-glucose deprivation, mitochondria membrane potential was reduced to 48.9 +/- 4.39 % of normoxic control, while NIR exposure significantly ameliorated this reduction to 89.6 +/- 13.9 % of normoxic control. Finally, NIR significantly rescued OGD-induced ATP production decline at 20 min after NIR. These findings suggest that low intensity NIR can protect neurons against oxygen-glucose deprivation by rescuing mitochondrial function and restoring neuronal energetics.	[Yu, Zhanyang; Liu, Ning; Zhao, Jianhua; Li, Yadan; Lo, Eng H.; Wang, Xiaoying] Massachusetts Gen Hosp, Neuroprotect Res Lab, Dept Neurol, Charlestown, MA 02129 USA; [Yu, Zhanyang; Liu, Ning; Zhao, Jianhua; Li, Yadan; Lo, Eng H.; Wang, Xiaoying] Massachusetts Gen Hosp, Neuroprotect Res Lab, Dept Radiol, Charlestown, MA 02129 USA; [Yu, Zhanyang; Liu, Ning; Zhao, Jianhua; Li, Yadan; Lo, Eng H.; Wang, Xiaoying] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [McCarthy, Thomas J.] Sequent Med Inc, Aliso Viejo, CA 92656 USA; [Tedford, Clark E.] Solentix Biosci Inc, Poulsbo, WA 98370 USA	Yu, ZY (corresponding author), Massachusetts Gen Hosp, Neuroprotect Res Lab, Dept Neurol, Charlestown, MA 02129 USA.	Yu.Zhanyang@mgh.harvard.edu; wangxi@helix.mgh.harvard.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS076694, P01NS055104, R01NS065998, R37NS037074] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS076694, R01 NS065998, P01 NS055104, R37 NS037074] Funding Source: Medline		Anders JJ, 2004, NEUROL RES, V26, P233, DOI 10.1179/016164104225013914; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Brosseau L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002049.pub2; Byrnes KR, 2005, LASER SURG MED, V36, P171, DOI 10.1002/lsm.20143; Cavalier-Smith T, 2006, P ROY SOC B-BIOL SCI, V273, P1943, DOI 10.1098/rspb.2006.3531; CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cb.04.110188.001103; De Taboada L, 2011, J ALZHEIMERS DIS, V23, P521, DOI 10.3233/JAD-2010-100894; Duan R, 2001, LASER SURG MED, V29, P174, DOI 10.1002/lsm.1106; Eells JT, 2003, P NATL ACAD SCI USA, V100, P3439, DOI 10.1073/pnas.0534746100; FRIEDMANN H, 1991, J PHOTOCH PHOTOBIO B, V11, P87, DOI 10.1016/1011-1344(91)80271-I; Huang Y. Y., 2013, J BIOPHOTONICS; Huang YY, 2013, J BIOPHOTONICS, V6, P829, DOI 10.1002/jbio.201200157; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Khuman J, 2012, J NEUROTRAUM, V29, P408, DOI 10.1089/neu.2010.1745; Lapchak PA, 2004, STROKE, V35, P1985, DOI 10.1161/01.STR.0000131808.69640.b7; Leung MCP, 2002, LASER SURG MED, V31, P283, DOI 10.1002/lsm.10096; Liu JX, 2009, J NEUROSCI RES, V87, P164, DOI 10.1002/jnr.21826; Majem M, 2006, LARYNGOSCOPE, V116, P1651, DOI 10.1097/01.mlg.0000231736.08477.47; Morimoto Yusuke, 2013, Laser Ther, V22, P17; Moriyama Y, 2005, PHOTOCHEM PHOTOBIOL, V81, P1351, DOI 10.1562/2005-02-28-RA-450; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Peplow PV, 2010, PHOTOMED LASER SURG, V28, P291, DOI 10.1089/pho.2008.2446; Plaetzer K, 2002, PHOTOCH PHOTOBIO SCI, V1, P172, DOI 10.1039/b108816e; Sharma SK, 2011, LASER SURG MED, V43, P851, DOI 10.1002/lsm.21100; Wang X. Y., 2013, LASERS MED SCI; Wang XY, 2002, STROKE, V33, P1882, DOI 10.1161/01.STR.0000020121.41527.5D; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Xavier M, 2010, LASER SURG MED, V42, P553, DOI 10.1002/lsm.20896; Xuan WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053454; Yu Z, 2009, NEUROSCIENCE, V162, P396, DOI 10.1016/j.neuroscience.2009.04.055	31	12	12	0	7	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7490	1573-7365		METAB BRAIN DIS	Metab. Brain Dis.	APR	2015	30	2					491	496		10.1007/s11011-014-9515-6			6	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	CD2HA	WOS:000350894800015	24599760	Green Accepted			2021-06-18	
J	Newman, AJ; Hayes, SH; Rao, AS; Allman, BL; Manohar, S; Ding, DL; Stolzberg, D; Lobarinas, E; Mollendorf, JC; Salvi, R				Newman, Andrew J.; Hayes, Sarah H.; Rao, Abhiram S.; Allman, Brian L.; Manohar, Senthilvelan; Ding, Dalian; Stolzberg, Daniel; Lobarinas, Edward; Mollendorf, Joseph C.; Salvi, Richard			Low-cost blast wave generator for studies of hearing loss and brain injury: Blast wave effects in closed spaces	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Blast wave generator; Low cost; Cochlear hair cells; Hippocampal neurogenesis; Traumatic brain injury; Hearing loss	OUTER HAIR CELL; MICROTUBULE-ASSOCIATED PROTEIN; INDUCED NEUROTRAUMA; DOUBLECORTIN; OVERPRESSURE; EXPRESSION; MEMORY; INNER; RATS; NEUROGENESIS	Background: Military personnel and civilians living in areas of armed conflict have increased risk of exposure to blast overpressures that can cause significant hearing loss and/or brain injury. The equipment used to simulate comparable blast overpressures in animal models within laboratory settings is typically very large and prohibitively expensive. New method: To overcome the fiscal and space limitations introduced by previously reported blast wave generators, we developed a compact, low-cost blast wave generator to investigate the effects of blast exposures on the auditory system and brain. Results: The blast wave generator was constructed largely from off the shelf components, and reliably produced blasts with peak sound pressures of up to 198 dB SPL (159.3 kPa) that were qualitatively similar to those produced from muzzle blasts or explosions. Exposure of adult rats to 3 blasts of 188 dB peak SPL (50.4 kPa) resulted in significant loss of cochlear hair cells, reduced outer hair cell function and a decrease in neurogenesis in the hippocampus. Comparison to existing methods: Existing blast wave generators are typically large, expensive, and are not commercially available. The blast wave generator reported here provides a low-cost method of generating blast waves in a typical laboratory setting. Conclusions: This compact blast wave generator provides scientists with a low cost device for investigating the biological mechanisms involved in blast wave injury to the rodent cochlea and brain that may model many of the damaging effects sustained by military personnel and civilians exposed to intense blasts. (C) 2015 Elsevier B.V. All rights reserved.	[Newman, Andrew J.; Rao, Abhiram S.; Mollendorf, Joseph C.] SUNY Buffalo, Dept Mech & Aerosp Engn, Buffalo, NY 14214 USA; [Hayes, Sarah H.; Allman, Brian L.; Manohar, Senthilvelan; Ding, Dalian; Stolzberg, Daniel; Lobarinas, Edward; Salvi, Richard] SUNY Buffalo, Ctr Hearing & Deafness, Dept Communicat Disorders & Sci, Buffalo, NY 14214 USA	Hayes, SH (corresponding author), SUNY Buffalo, Ctr Hearing & Deafness, 137 Cary Hall,3435 Main St, Buffalo, NY 14214 USA.	ajnewman@ara.com; shhayes@buffalo.edu; abhirams@buffalo.edu; brian.allman@schulich.uwo.ca; smanohar@buffalo.edu; dding@buffalo.edu; dstolzbe@uwo.ca; elobarinas@ufl.edu; molendrf@buffalo.edu; salvi@buffalo.edu	Stolzberg, Daniel/H-8930-2019; mollendorf, joseph/AAR-7207-2020	Stolzberg, Daniel/0000-0001-6100-9891; 	NIH National Institute on Deafness and Other Communicative DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC011808]; Office of Naval ResearchOffice of Naval Research [N000141210731]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC011808] Funding Source: NIH RePORTER	Research supported in part by part by NIH National Institute on Deafness and Other Communicative Disorders (R01DC011808, RS) and the Office of Naval Research (N000141210731, RS).	Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bass CR, 2008, J TRAUMA, V65, P604, DOI 10.1097/TA.0b013e3181454ab4; Birch RS, 2003, APPL ACOUST, V64, P269, DOI 10.1016/S0003-682X(02)00088-9; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chen GD, 2010, HEARING RES, V265, P63, DOI 10.1016/j.heares.2010.02.010; Cho SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067618; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; FREIWALD DA, 1972, J APPL PHYS, V43, P2224, DOI 10.1063/1.1661479; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Goodman T, 2010, NEUROSCIENCE, V171, P769, DOI 10.1016/j.neuroscience.2010.09.047; Gould E, 1993, Curr Opin Neurobiol, V3, P676, DOI 10.1016/0959-4388(93)90138-O; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; HAMERNIK RP, 1984, HEARING RES, V16, P143, DOI 10.1016/0378-5955(84)90004-2; HAMERNIK RP, 1984, HEARING RES, V13, P229, DOI 10.1016/0378-5955(84)90077-7; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hoffer ME, 2011, NEUROREHABILITATION, V29, P125, DOI 10.3233/NRE-2011-0686; Hofstetter P, 1997, AUDIOLOGY, V36, P301; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jamesdaniel S, 2009, J PROTEOME RES, V8, P3520, DOI 10.1021/pr900222c; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Kinney G.F., 1985, EXPLOSIVE SHOCKS AIR; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Kraus KS, 2010, NEUROSCIENCE, V167, P1216, DOI 10.1016/j.neuroscience.2010.02.071; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Li YQ, 2011, NEUROTOX RES, V20, P307, DOI 10.1007/s12640-011-9244-0; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lucca JJD, 2012, J NEUROL SCI, V318, P146, DOI 10.1016/j.jns.2012.02.002; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Manohar S, 2012, NEUROSCIENCE, V202, P169, DOI 10.1016/j.neuroscience.2011.12.013; Martin EM, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000315260.92070.3f; Mediavilla Varas Jesus, 2011, Front Neurol, V2, P58, DOI 10.3389/fneur.2011.00058; MILLS DM, 1994, HEARING RES, V77, P183, DOI 10.1016/0378-5955(94)90266-6; MISHKIN M, 1982, PHILOS T R SOC B, V298, P85, DOI 10.1098/rstb.1982.0074; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Newman AJ, 2010, J FLUID ENG-T ASME, V132, DOI 10.1115/1.4002183; Newman AJ., 2010, PEAK OVERPRESSURE FI; Patterson JH, 1997, TOXICOLOGY, V121, P29, DOI 10.1016/S0300-483X(97)03653-6; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Reyes S, 2001, HEARING RES, V158, P139, DOI 10.1016/S0378-5955(01)00309-4; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Roberto M, 1989, Ann Otol Rhinol Laryngol Suppl, V140, P23; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Van der Gucht E, 2006, ANAT REC PART A, V288A, P753, DOI 10.1002/ar.a.20350; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; WHITE C S, 1959, ORNL, VTID-5764, P1; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9	68	12	14	1	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	MAR 15	2015	242						82	92		10.1016/j.jneumeth.2015.01.009			11	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CD2PQ	WOS:000350921900009	25597910	Green Accepted			2021-06-18	
J	Vaagenes, IC; Tsai, SY; Ton, ST; Husak, VA; McGuire, SO; O'Brien, TE; Kartje, GL				Vaagenes, Ian C.; Tsai, Shih-Yen; Ton, Son T.; Husak, Vicki A.; McGuire, Susan O.; O'Brien, Timothy E.; Kartje, Gwendolyn L.			Binge Ethanol Prior to Traumatic Brain Injury Worsens Sensorimotor Functional Recovery in Rats	PLOS ONE			English	Article							COGNITIVE RECOVERY; ADULT-RATS; STROKE; NEUROGENESIS; PREVALENCE; PLASTICITY; DRINKING; THERAPY; TRENDS; DAMAGE	A significant number of patients suffering from traumatic brain injury (TBI) have a high blood alcohol level at the time of injury. Furthermore, drinking alcohol in a binge-like pattern is now recognized as a national problem, leading to a greater likelihood of being injured. Our objective was to determine the consequences of a binge paradigm of alcohol intoxication at the time of TBI on long-term functional outcome using a sensitive test of sensorimotor function. We trained adult, male, Sprague Dawley rats on the skilled forelimb reaching task and then administered a single binge dose of ethanol (2g/kg, i.p.) or saline for three consecutive days (for a total of 3 doses). One hour after the final ethanol dose, rats underwent a TBI to the sensorimotor cortex corresponding to the preferred reaching forelimb. Animals were then tested for seven weeks on the skilled forelimb reaching task to assess the profile of recovery. We found that the group given ethanol prior to TBI displayed a slower recovery curve with a lower recovery plateau as compared to the control group. Therefore, even a relatively short (3 day) episode of binge alcohol exposure can negatively impact long-term recovery from a TBI, underscoring this significant public health problem.	[Vaagenes, Ian C.; Tsai, Shih-Yen; Ton, Son T.; Husak, Vicki A.; McGuire, Susan O.; Kartje, Gwendolyn L.] Edward Hines Jr VA Hosp, Res Serv, Hines, IL 60141 USA; [Kartje, Gwendolyn L.] Loyola Univ, Med Ctr, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Ton, Son T.; Kartje, Gwendolyn L.] Loyola Univ, Med Ctr, Neurosci Res Inst, Maywood, IL 60153 USA; [O'Brien, Timothy E.] Loyola Univ, Dept Math & Stat, Chicago, IL 60611 USA; [McGuire, Susan O.] Univ Illinois, Coll Med, Dept Anesthesiol, Chicago, IL 60680 USA	Vaagenes, IC (corresponding author), Edward Hines Jr VA Hosp, Res Serv, Hines, IL 60141 USA.	Ian.Vaagenes@va.gov	McGuire, Susan O/AAD-8582-2020		National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 AA020951]; National Institute on Alcohol Abuse and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [T32 AA013526]; Department of Veterans AffairsUS Department of Veterans Affairs; Office of Academic AffiliationsUS Department of Veterans Affairs; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R21AA020951, T32AA013526, T32AA013527] Funding Source: NIH RePORTER	Funding: This research was supported by a grant from the National Institute of Health R21 AA020951, an National Institute on Alcohol Abuse and Alcoholism training grant T32 AA013526, the Department of Veterans Affairs and the Office of Academic Affiliations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews EM, 2008, EXP NEUROL, V211, P588, DOI 10.1016/j.expneurol.2008.02.027; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Gillani RL, 2010, BEHAV BRAIN RES, V208, P415, DOI 10.1016/j.bbr.2009.12.015; Hansson AC, 2010, INT J NEUROPSYCHOPH, V13, P583, DOI 10.1017/S1461145710000246; Hayes DM, 2013, ALCOHOL CLIN EXP RES, V37, P425, DOI 10.1111/j.1530-0277.2012.01955.x; Hingson RW, 2009, J STUD ALCOHOL DRUGS, P12, DOI 10.15288/jsads.2009.s16.12; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; Kanny Dafna, 2012, Morbidity and Mortality Weekly Report, V61, P14; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Klein A, 2012, NEUROSCI BIOBEHAV R, V36, P1030, DOI 10.1016/j.neubiorev.2011.12.010; Morales D, 2006, J NEUROTRAUM, V23, P976, DOI 10.1089/neu.2006.23.976; ODONOGHUE DL, 1986, BRAIN RES, V385, P311, DOI 10.1016/0006-8993(86)91078-4; Olthuis JV, 2011, J AM COLL HEALTH, V59, P239, DOI 10.1080/07448481.2010.497523; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Ostrovskaya O, 2011, J PHARMACOL EXP THER, V337, P171, DOI 10.1124/jpet.110.176990; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Prasad RM, 2001, J NEUROTRAUM, V18, P1019, DOI 10.1089/08977150152693719; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Seymour AB, 2005, J CEREBR BLOOD F MET, V25, P1366, DOI 10.1038/sj.jcbfm.9600134; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Thurman V DJC, 2007, BRAIN INJURY MED; Tsai SY, 2011, STROKE, V42, P186, DOI 10.1161/STROKEAHA.110.590083; Wainwright PE, 2007, DEV PSYCHOBIOL, V49, P664, DOI 10.1002/dev.20245; Wolf WA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108031; YAMAKAMI I, 1995, J NEUROSURG, V82, P813, DOI 10.3171/jns.1995.82.5.0813; Young ME, 2009, LEARN MOTIV, V40, P160, DOI 10.1016/j.lmot.2008.10.004; Zhang LX, 1999, J NEUROTRAUM, V16, P243, DOI 10.1089/neu.1999.16.243	32	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120356	10.1371/journal.pone.0120356			8	Multidisciplinary Sciences	Science & Technology - Other Topics	CD7NO	WOS:000351277500121	25768795	DOAJ Gold, Green Published			2021-06-18	
J	Ashforda, S; Jackson, D; Turner-Stokes, L				Ashforda, Stephen; Jackson, Diana; Turner-Stokes, Lynne			Goal setting, using goal attainment scaling, as a method to identify patient selected items for measuring arm function	PHYSIOTHERAPY			English	Article						Function; Upper limb; Outcome measurement; Goals	UPPER-LIMB SPASTICITY; BOTULINUM-TOXIN-A; QUALITY-OF-LIFE; DOUBLE-BLIND; OUTCOME MEASURES; STROKE; MULTICENTER; MANAGEMENT; REHABILITATION	Objective Following stroke or brain injury, goals for rehabilitation of the hemiparetic upper limb include restoring active function if there is return of motor control or, if none is possible, improving passive function, and facilitating care for the limb. To inform development of a new patient reported outcome measure (PROM) of active and passive function in the hemiparetic upper limb, the Arm Activity measure, we examined functional goals for the upper limb, identified during goal setting for spasticity intervention (physical therapy and concomitant botulinum toxin A interventions). Design Using secondary analysis of a prospective observational cohort study, functional goals determined between patients, their carers and the clinical team were assigned into categories by two raters. Goal category identification, followed by assignment of goals to a category, was undertaken and then confirmed by a second reviewer. Participants Participants comprised nine males and seven females of mean (SD) age 54.5 (15.7) years and their carers. Fifteen had sustained a stroke and one a traumatic brain injury. Results Goals were used to identify five categories: passive function, active function, symptoms, cosmesis and impairment. Two passive function items not previously identified by a previous systematic review were identified. Conclusions Analysis of goals important to patients and carers revealed items for inclusion in a new measure of arm function and provide a useful alternative method to involve patients and carers in standardised measure development. (C) 2014 Chartered Society of Physiotherapy. Published by Elsevier Ltd. All rights reserved.	[Ashforda, Stephen; Turner-Stokes, Lynne] Northwick Pk Hosp & Clin Res Ctr, Reg Rehabil Unit, Harrow, Middx, England; [Ashforda, Stephen; Jackson, Diana; Turner-Stokes, Lynne] Kings Coll London, Sch Med, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England	Ashforda, S (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Reg Rehabil Unit, Harrow, Middx, England.	Stephen.Ashford@nhs.net	Turner-Stokes, Lynne/F-4418-2012; Ashford, Stephen/D-6653-2013	Turner-Stokes, Lynne/0000-0002-3302-9462; Ashford, Stephen/0000-0001-5541-7063	Department of HealthEuropean Commission [RP-PG-0407-10185, CAT-CL-03-2012-010] Funding Source: Medline; National Institute for Health ResearchNational Institute for Health Research (NIHR) [CAT-CL-03-2012-010, RP-PG-0407-10185] Funding Source: researchfish		Ashford S, 2006, PHYSIOTHER RES INT, V11, P24, DOI 10.1002/pri.36; Ashford S, 2013, PHYSIOTHER RES INT, V18, P178, DOI 10.1002/pri.1554; Ashford S, 2013, DISABIL REHABIL, V35, P1513, DOI 10.3109/09638288.2012.743602; Ashford S, 2013, CLIN REHABIL, V27, P728, DOI 10.1177/0269215512474942; Ashford S, 2009, DISABIL REHABIL, V31, P220, DOI 10.1080/09638280801906388; Ashford S, 2008, J REHABIL MED, V40, P787, DOI 10.2340/16501977-0276; Bakheit AMO, 2004, J NEUROL NEUROSUR PS, V75, P665, DOI 10.1136/jnnp.2003.026096; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Bergfeldt U, 2006, J REHABIL MED, V38, P166, DOI 10.1080/16501970500415348; Bhakta BB, 2000, J NEUROL NEUROSUR PS, V69, P217, DOI 10.1136/jnnp.69.2.217; Borg J, 2011, J REHABIL MED, V43, P15, DOI 10.2340/16501977-0663; CALSYN RJ, 1978, COMMUNITY MENT HLT J, V14, P300, DOI 10.1007/BF00778605; Giordano A, 2009, J NEUROL NEUROSUR PS, V80, P1023, DOI 10.1136/jnnp.2008.171181; Hurn J, 2006, CLIN REHABIL, V20, P756, DOI 10.1177/0269215506070793; INVOLVE, 2009, PAT PUBL INV RES RES; Jones F, 2011, DISABIL REHABIL, V33, P797, DOI 10.3109/09638288.2010.511415; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; Latham GP, 2007, EUR PSYCHOL, V12, P290, DOI 10.1027/1016-9040.12.4.290; Locke E.A., 1990, THEORY GOAL SETTING; Locke EA, 2002, AM PSYCHOL, V57, P705, DOI 10.1037//0003-066X.57.9.705; LOMAS J, 1987, MED CARE, V25, P764, DOI 10.1097/00005650-198708000-00009; McCrory P, 2009, J REHABIL MED, V41, P536, DOI 10.2340/16501977-0366; Penta M, 1998, ARCH PHYS MED REHAB, V79, P1038, DOI 10.1016/S0003-9993(98)90167-8; Playford D, 2008, CURR OPIN NEUROL, V21, P649, DOI 10.1097/WCO.0b013e328318ecca; Playford ED, 2009, CLIN REHABIL, V23, P334, DOI 10.1177/0269215509103506; Reed J, 1997, J ADV NURS, V26, P765, DOI 10.1046/j.1365-2648.1997.00395.x; Royal College of Physicians, 2009, SPAST AD MAN US BOT; Rushton PW, 2002, ARCH PHYS MED REHAB, V83, P771, DOI 10.1053/apmr.2002.32636; Shaw L, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14260; STOLEE P, 1992, J AM GERIATR SOC, V40, P574, DOI 10.1111/j.1532-5415.1992.tb02105.x; Streiner DL., 2003, HLTH MEASUREMENT SCA, V3rd; Turner-Stokes L, 2014, REHABILITATION GOAL, P119; Turner-Stokes L., 2013, BMJ OPEN; Turner-Stokes L, 2010, J REHABIL MED, V42, P81, DOI 10.2340/16501977-0474; Turner-Stokes L, 2009, J REHABIL MED, V41, P528, DOI 10.2340/16501977-0383; van der Lee JH, 2004, STROKE, V35, P1410, DOI 10.1161/01.STR.0000126900.24964.7e; Wade DT, 2009, CLIN REHABIL, V23, P291, DOI 10.1177/0269215509103551; WADE DT, 1992, SCAND J REHABIL MED, P97; Wade DT, 1992, MEASUREMENT NEUROLOG; World Health Organization, 2002, INT CLASS FUNCT DIS	40	12	12	1	30	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0031-9406	1873-1465		PHYSIOTHERAPY	Physiotherapy	MAR	2015	101	1					88	94		10.1016/j.physio.2014.04.001			7	Rehabilitation	Rehabilitation	AZ5XW	WOS:000348292800012	24954806				2021-06-18	
J	Cui, T; Zhu, GY				Cui, Tao; Zhu, Gangyi			Ulinastatin Attenuates Brain Edema After Traumatic Brain Injury in Rats	CELL BIOCHEMISTRY AND BIOPHYSICS			English	Article						TBI; Brain edema; UTI; AQP-4	URINARY TRYPSIN-INHIBITOR; SEVERE HEAD-INJURY; NF-KAPPA-B; OXIDATIVE STRESS; PROTEASE INHIBITORS; REACTIVE ASTROCYTES; AQUAPORIN-4; EXPRESSION; MICE; ACTIVATION	Traumatic brain injury (TBI) remains the leading cause of injury-related death and disability. Brain edema, one of the most major complications of TBI, contributes to elevated intracranial pressure, and poor prognosis following TBI. The objective of this study was to evaluate whether Ulinastatin (UTI), a serine protease inhibitor, attenuates brain edema following TBI. Our results showed that treatment with UTI at a dose of 50,000 U/kg attenuated the brain edema, as assayed by water content 24 h after TBI induction. This attenuation was associated with a significant decrease of the expression level of aquaporin-4. In addition, we showed that UTI treatment also markedly inhibited the expression of pro-inflammatory cytokines including IL-1 beta and TNF-alpha as well as activity of NF-kappa B. Collectively, our findings suggested that UTI may be a promising strategy to treat brain edema following TBI.	[Cui, Tao; Zhu, Gangyi] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Neurosurg, Luoyang 471003, Henan, Peoples R China	Cui, T (corresponding author), Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Neurosurg, Luoyang 471003, Henan, Peoples R China.	drtaocui@163.com					Alexander JJ, 2008, NEUROCHEM INT, V52, P447, DOI 10.1016/j.neuint.2007.08.006; Bloch Orin, 2007, Neurosurg Focus, V22, pE3; Collins MA, 2012, NEUROTOX RES, V21, P70, DOI 10.1007/s12640-011-9276-5; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Duris K, 2011, TRANSL STROKE RES, V2, P232, DOI 10.1007/s12975-010-0063-z; ENDO S, 1993, RES COMMUN CHEM PATH, V82, P27; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hirashima Y, 2001, J BIOL CHEM, V276, P13650, DOI 10.1074/jbc.M009906200; Iseri SO, 2008, REGUL PEPTIDES, V146, P73, DOI 10.1016/j.regpep.2007.08.014; Ito H, 2006, J NEUROCHEM, V99, P107, DOI 10.1111/j.1471-4159.2006.04036.x; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; KATAYAMA Y, 1990, ACT NEUR S, V51, P308; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; KIMELBERG HK, 1992, J NEUROTRAUM, V9, pS71; Koga Y, 2010, NEUROL RES, V32, P925, DOI 10.1179/016164110X12645013515133; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Lopez NE, 2012, J NEUROTRAUM, V29, P385, DOI 10.1089/neu.2011.2053; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Nakatani K, 2001, J LEUKOCYTE BIOL, V69, P241; Nielsen S, 1997, J NEUROSCI, V17, P171; NIETOSAMPEDRO M, 1987, J NEUROSCI RES, V17, P214, DOI 10.1002/jnr.490170303; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Park S, 2004, STROKE, V35, P2412, DOI 10.1161/01.STR.0000141162.29864.e9; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Sanz O, 2002, J NEUROSCI RES, V67, P772, DOI 10.1002/jnr.10140; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Vizuete ML, 1999, NEUROBIOL DIS, V6, P245, DOI 10.1006/nbdi.1999.0246; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Yano T, 2003, ANESTHESIOLOGY, V98, P465, DOI 10.1097/00000542-200302000-00028	37	12	20	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1085-9195	1559-0283		CELL BIOCHEM BIOPHYS	Cell Biochem. Biophys.	MAR	2015	71	2					595	600		10.1007/s12013-014-0239-3			6	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CA9KF	WOS:000349241400012	25209743				2021-06-18	
J	Harvey, HH; Koller, DL; Lowrey, KM				Harvey, Hosea H.; Koller, Dionne L.; Lowrey, Kerri M.			The Four Stages of Youth Sports TBI Policymaking: Engagement, Enactment, Research, and Reform	JOURNAL OF LAW MEDICINE & ETHICS			English	Article; Proceedings Paper	National Public Health Law Conference - Intersection of Law, Policy and Prevention	OCT, 2014	Atlanta, GA	Network Public Hlth Law, Ame Soc Law, Med & Eth			TRAUMATIC BRAIN-INJURY; STATE LAWS; EDUCATION; IMPACT	Drawing from research on a variety of public health law interventions, this article frames such interventions as developing in four key stages: engagement, enactment, research, and reform. Here, we apply this four-stage framework to youth sports TBI laws, while postulating connections to past interventions and predicting future outcomes.	[Harvey, Hosea H.] Temple Univ, Beasley Sch Law, Law, Philadelphia, PA 19122 USA; [Koller, Dionne L.] Univ Baltimore, Sch Law, Law, Baltimore, MD 21201 USA; [Koller, Dionne L.] Univ Baltimore, Sch Law, Ctr Sport & Law, Baltimore, MD 21201 USA; [Lowrey, Kerri M.] Network Publ Hlth Law, Baltimore, MD USA; [Lowrey, Kerri M.] Univ Maryland, Francis King Carey Sch Law, Baltimore, MD 21201 USA	Harvey, HH (corresponding author), Temple Univ, Beasley Sch Law, Law, Philadelphia, PA 19122 USA.						[Anonymous], 2014, J LAW MED ETHICS, V42; Brownson RC, 2009, AM J PUBLIC HEALTH, V99, P1576, DOI 10.2105/AJPH.2008.156224; Cantu R., 2012, CONCUSSIONS OUR KIDS; Carter W. Burlette, 1999, VA J SPORTS L, V1, p[235, 244]; Carter W. Burlette, 1999, VA J SPORTS L, V1, p[235, 235]; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Davis, 2001, MARQUETTE SPORTS LAW, V11, P211; Davis CS, 2005, AM J PUBLIC HEALTH, V95, P233, DOI 10.2105/AJPH.2003.031310; Davis T., 2001, MARQUETTE SPORTS LAW, V11, p[211, 234]; Davis T., 2001, MARQUETTE SPORTS LAW, V11, p[211, 212]; Harper S, 2014, J POLICY ANAL MANAG, V33, P141, DOI 10.1002/pam.21735; Harvey Hosea H, 2014, Yale J Health Policy Law Ethics, V14, P66; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Ibrahim JK, 2011, AM J PREV MED, V40, P659, DOI 10.1016/j.amepre.2011.02.024; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lowrey K. M., 2014, J BUSINESS TECHNOLOG, V10, P61; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; National Federation of State High School Associations, 2013, NFHS HDB 2013 2014; Rivara F. P., 2014, AM J SPORTS MED, V1187, p[1197, 1202]; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Williams J, 2014, J HEALTH ECON, V36, P20, DOI 10.1016/j.jhealeco.2014.03.006	21	12	12	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1105	1748-720X		J LAW MED ETHICS	J. Law Med. Ethics	SPR	2015	43			1	SI		87	90		10.1111/jlme.12225			4	Ethics; Law; Medical Ethics; Medicine, Legal	Social Sciences - Other Topics; Government & Law; Medical Ethics; Legal Medicine	CF5CS	WOS:000352573600021	25846174				2021-06-18	
J	Li, YH; Zhang, CL; Zhang, XY; Zhou, HX; Meng, LL				Li, Yue-Hong; Zhang, Chun-Lai; Zhang, Xiao-Yan; Zhou, Hong-Xia; Meng, Ling-Li			Effects of mild induced hypothermia on hippocampal connexin 43 and glutamate transporter 1 expression following traumatic brain injury in rats	MOLECULAR MEDICINE REPORTS			English	Article						traumatic brain injury; mild induced hypothermia; brain edema; connexin 43; glutamate transporter 1	THERAPEUTIC HYPOTHERMIA; MECHANISMS; DEATH; MODEL	Traumatic brain injury (TBI) is a common cause of worldwide disability and mortality. Currently, the incidence and prevalence of TBI is markedly increasing and an effective therapy is lacking. Therapeutic hypothermia (32-35 degrees C) has been reported to reduce intracranial pressure and induce putative neuroprotective effects. However, the underlying molecular mechanisms remain to be elucidated. The aim of the present study was to investigate the effects of mild induced hypothermia (MIH) on the expression of connexin 43 (Cx43) and glutamate transporter 1 (GLT-1) in the hippocampus following TBI in rats. A rat model of TBI was created using a modified weight-drop device, followed by 4 h of hypothermia (33 degrees C) or normothermia (37 degrees C). A wet-dry weight method was used to assess brain edema and spatial learning ability was evaluated using a Morris water maze The levels of Cx43 and GLT-1 were detected by immunohistochemical and western blot analysis, respectively. The results demonstrated that MIH treatment improved TBI-induced brain edema and neurological function deficits. In addition, therapeutic MIH significantly downregulated Cx43 expression and upregulated the levels of GLT-1 in the hippocampus post-TBI. These findings suggested that treatment with MIH may provide a novel neuroprotective therapeutic strategy for TBI through reversing the increase in Cx43 protein and the decrease in GLT-1.	[Li, Yue-Hong] Tangshan Gongren Hosp, Dept Obstetr & Gynecol, Tangshan 063000, Hebei, Peoples R China; [Zhang, Chun-Lai] Tangshan Gongren Hosp, Dept Cardiol, Tangshan 063000, Hebei, Peoples R China; [Zhang, Xiao-Yan; Zhou, Hong-Xia; Meng, Ling-Li] Hebei United Univ, Sch Basic Med Sci, Tangshan 063000, Hebei, Peoples R China	Zhang, CL (corresponding author), Tangshan Gongren Hosp, Dept Cardiol, 27 Wenhua Rd, Tangshan 063000, Hebei, Peoples R China.	zhangchunlai1970@yeah.net			Science and Technology Development Project of Tangshan City [12140209A-31]	The present study was supported by a grant from the Science and Technology Development Project of Tangshan City (no. 12140209A-31).	Andrews PJD, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-277; Broessner G, 2012, CRITICAL CARE, V16, pA1, DOI DOI 10.1186/CC11259; Cheng SX, 2013, THER HYPOTHERMIA TEM, V3, P132, DOI 10.1089/ther.2013.0005; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; FAY T, 1943, ASS RES NERV MENT DI, V24, P611; Feng JF, 2010, NEUROSURGERY, V67, P730, DOI 10.1227/01.NEU.0000378023.81727.6E; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; Jiang S, 2014, NEUROCHEM RES, V39, P833, DOI 10.1007/s11064-014-1277-3; Kramer C, 2012, NEUROLOGIST, V18, P173, DOI 10.1097/NRL.0b013e318253f8ef; Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001; Liu HG, 2010, SLEEP MED, V11, P205, DOI 10.1016/j.sleep.2009.05.015; Liu LP, 2007, FRONT BIOSCI-LANDMRK, V12, P816, DOI 10.2741/2104; Marion D, 2009, J NEUROTRAUM, V26, P455, DOI 10.1089/neu.2008.0582; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marquez-Rosado L, 2012, BBA-BIOMEMBRANES, V1818, P1985, DOI 10.1016/j.bbamem.2011.07.028; Mroue RM, 2011, INTEGR BIOL-UK, V3, P255, DOI 10.1039/c0ib00158a; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Ohsumi A, 2010, J NEUROTRAUM, V27, P1255, DOI 10.1089/neu.2009.1234; Ongstad EL, 2013, ADV WOUND CARE, V2, P55, DOI 10.1089/wound.2011.0341; Rami A, 2000, EXP NEUROL, V170, P297, DOI 10.1006/exnr.2001.7712; Sun LQ, 2014, MOL MED REP, V9, P77, DOI 10.3892/mmr.2013.1787; Tang JP, 2004, J CEREBR BLOOD F MET, V24, P1133, DOI 10.1097/01.WCB.0000135593.05952.DE; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Wang XY, 2013, CELL MOL NEUROBIOL, V33, P401, DOI 10.1007/s10571-013-9906-y; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yu ML, 2014, ONCOL REP, V31, P2751, DOI 10.3892/or.2014.3163	28	12	13	0	9	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	MAR	2015	11	3					1991	1996		10.3892/mmr.2014.2928			6	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CD2OA	WOS:000350917700062	25394735	Bronze			2021-06-18	
J	Webster, J; Taylor, A; Balchin, R				Webster, J.; Taylor, A.; Balchin, R.			Traumatic brain injury, the hidden pandemic: A focused response to family and patient experiences and needs	SAMJ SOUTH AFRICAN MEDICAL JOURNAL			English	Article							EXECUTIVE DYSFUNCTION	Introduction. Traumatic brain injury (TB!) has many potential cognitive, behavioural and psychological consequences, and contributes significantly to the national burden of disease and to ongoing violent behaviour. Few resources are available for the rehabilitation of patients with TBI in South Africa, and access to rehabilitation facilities in the public sector is limited. Consequently, it is the families impacted on by TBI that ultimately carry the care and rehabilitation burden once survivors are discharged from hospital. Families are generally ill equipped to cope with the complex and potentially long-term disabilities that accompany brain injury. Methods. Reviewing interviews with 175 family members and 354 patients recovering from TBI helped identify the key challenges that the survivors of TBI and their families face. Results. Nine problem areas were identified that formed the basis for development of a discharge resource, the S-Plan, which serves to inform patients and carers and provide practical solutions for the problems they face. Conclusion. The experiences of TBI survivors and their family members served to inform the development of simple, integrated coping strategies, namely two S-Plan tools, one for survivors and their families/caregivers and the other for care workers, in conjunction with counselling and support group processes. The S-Plan constitutes a discharge resource to inform patients and carers and provide practical solutions for the problems they face in caring for family members who have suffered TBI.	[Webster, J.] Groote Schuur Hosp, ComaCARE Trust, ZA-7925 Cape Town, South Africa; [Taylor, A.] Univ Cape Town, Fac Hlth Sci, Div Neurosurg, ZA-7925 Cape Town, South Africa; [Taylor, A.] Groote Schuur Hosp, ZA-7925 Cape Town, South Africa; [Balchin, R.] Univ Cape Town, Fac Humanities, Dept Psychol, ZA-7925 Cape Town, South Africa	Taylor, A (corresponding author), Univ Cape Town, Fac Hlth Sci, Div Neurosurg, ZA-7925 Cape Town, South Africa.	allan.taylor@uct.ac.za			Nussbaum Foundation; Norwegian Centre for Human Rights; Western Cape Department of Social Development; Claude Leon Foundation	JW thanks the Nussbaum Foundation, the Norwegian Centre for Human Rights and the Western Cape Department of Social Development for their support of this research. RB sincerely thanks the Claude Leon Foundation for their funding and support of this research.	Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Carney N, 1999, REHABILITATION TRAUM; Chesnut RM, 1998, EVIDENCE REPORT REHA; Darby D., 1999, NEUROPSYCHOLOGY CLIN; de Villiers L, 2011, SAMJ S AFR MED J, V101, P345, DOI 10.7196/SAMJ.4588; Groenewald P., 2012, W CAPE MORTALITY PRO; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hassan STS, 2011, J NEPAL MED ASSOC, V50, P53; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Kolb B., 2003, FUNDAMENTALS HUMAN N; Luukkainen S, 2012, PSYCHIAT RES, V200, P767, DOI 10.1016/j.psychres.2012.04.018; Matzopoulos R, 2010, HEALTH POLICY, V97, P62, DOI 10.1016/j.healthpol.2010.03.003; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613	16	12	13	0	9	SA MEDICAL ASSOC	PRETORIA	BLOCK F CASTLE WALK CORPORATE PARK, NOSSOB STREET, ERASMUSKLOOF EXT3, PRETORIA, 0002, SOUTH AFRICA	0256-9574	2078-5135		SAMJ S AFR MED J	SAMJ S. Afr. Med. J.	MAR	2015	105	3					195	198		10.7196/SAMJ.9014			4	Medicine, General & Internal	General & Internal Medicine	CD8IA	WOS:000351337200018	26294826	DOAJ Gold			2021-06-18	
J	Whitney, KA; Davis, JJ				Whitney, Kriscinda A.; Davis, Jeremy J.			The Non-Credible Score of the Rey Auditory Verbal Learning Test: Is It Better at Predicting Non-Credible Neuropsychological Test Performance Than the RAVLT Recognition Score?	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Test validity; Neuropsychology; Malingering; Military veterans; Memory	RESPONSE BIAS SCALE; SYMPTOM VALIDITY TESTS; TRAUMATIC BRAIN-INJURY; MEMORY PERFORMANCE; TEST FAILURE; HEAD-INJURY; VALIDATION; MMPI-2; INDEX	The ability of both the non-credible score of the Rey Auditory Verbal Learning Test (RAVLT NC) and the recognition score of the RAVLT (RAVLTRecog) to predict credible versus non-credible neuropsychological test performance was examined. Credible versus non-credible group membership was determined according to diagnostic criteria with consideration of performance on two stand-alone performance validity tests. Findings from this retrospective data analysis of outpatients seen for neuropsychological testing within a Veterans Affairs Medical Center (N = 175) showed that RAVLT Recog demonstrated better classification accuracy than RAVLT NC in predicting credible versus non-credible neuropsychological test performance. Specifically, an RAVLT Recog cutoff of <= 9 resulted in reasonable sensitivity (48%) and acceptable specificity (91%) in predicting non-credible neuropsychological test performance. Implications for clinical practice are discussed. Note: The views contained here within are those of the authors and not representative of the institutions with which they are associated.	[Whitney, Kriscinda A.] Richard L Roudebush Vet Affairs Med Ctr, Dept Psychiat, Indianapolis, IN 46202 USA; [Whitney, Kriscinda A.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Davis, Jeremy J.] Univ Utah, Sch Med, Div Phys Med & Rehabil, Salt Lake City, UT 84132 USA	Whitney, KA (corresponding author), Richard L Roudebush Vet Affairs Med Ctr 116P, 1481 W 10th St, Indianapolis, IN 46202 USA.	kamarks@iupui.edu					Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Axelrod BN, 2014, CLIN NEUROPSYCHOL, V28, P876, DOI 10.1080/13854046.2014.907583; Barrash J, 2004, J CLIN EXP NEUROPSYC, V26, P125, DOI 10.1076/jcen.26.1.125.23928; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bernard L C, 1991, Arch Clin Neuropsychol, V6, P81, DOI 10.1016/0887-6177(91)90024-4; BERNARD LC, 1993, J CLIN PSYCHOL, V49, P45, DOI 10.1002/1097-4679(199301)49:1<45::AID-JCLP2270490107>3.0.CO;2-7; Binder LM, 2003, J CLIN EXP NEUROPSYC, V25, P420, DOI 10.1076/jcen.25.3.420.13806; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Delis DC, 2000, CALIFORNIA VERBAL LE; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; GLAROS AG, 1988, J CLIN PSYCHOL, V44, P1013, DOI 10.1002/1097-4679(198811)44:6<1013::AID-JCLP2270440627>3.0.CO;2-Z; Green P., 1996, MANUAL COMPUTARIZED; Green P., 2004, GREENS MED SYMPTON V; Green P., 2009, ADV INTERPRETATION P; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Haines ME, 2001, CLIN NEUROPSYCHOL, V15, P171, DOI 10.1076/clin.15.2.171.1891; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hosmer D. W., 2000, APPL LOGISTIC REGRES; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; MCCAFFREY RJ, 2003, PRACTITIONERS GUIDE; Meyers J E, 2001, Appl Neuropsychol, V8, P234, DOI 10.1207/S15324826AN0804_6; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; O'Bryant SE, 2006, CLIN NEUROPSYCHOL, V20, P533, DOI 10.1080/13854040590967568; Schmidt M., 1996, REY AUDITORY VERBAL; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Suhr J. A., 2007, ASSESSMENT MALINGERE; Suhr JA, 2002, ARCH CLIN NEUROPSYCH, V17, P69, DOI 10.1016/S0887-6177(00)00102-5; Tombaugh TN, 1996, TEST MEMORY MALINGER; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Whitney KA, 2013, ARCH CLIN NEUROPSYCH, V28, P222, DOI 10.1093/arclin/act012; Young JC, 2011, ARCH CLIN NEUROPSYCH, V26, P194, DOI 10.1093/arclin/acr015	37	12	12	1	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2015	30	2					130	138		10.1093/arclin/acu094			9	Psychology, Clinical; Psychology	Psychology	CF0JP	WOS:000352230000005	25599723				2021-06-18	
J	Baltazar, GA; Pate, AJ; Panigrahi, B; LaBoy, S; Prosniak, R; Mody, A; Chendrasekhar, A				Baltazar, Gerard A.; Pate, Amy J.; Panigrahi, Benita; LaBoy, Shannon; Prosniak, Roman; Mody, Armaiti; Chendrasekhar, Akella			Malnutrition as Measured by Albumin and Prealbumin on Admission Is Associated with Poor Outcomes after Severe Traumatic Brain Injury	AMERICAN SURGEON			English	Article									[Baltazar, Gerard A.; Pate, Amy J.; Panigrahi, Benita; Chendrasekhar, Akella] Univ Richmond, Med Ctr, Staten Isl, NY USA; [Panigrahi, Benita; LaBoy, Shannon; Prosniak, Roman; Mody, Armaiti] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA	Baltazar, GA (corresponding author), Univ Richmond, Med Ctr, Surg, 220 Manhattan Ave,Suite 3J, New York, NY 10025 USA.	gerardbaltazar@gmail.com		Baltazar, Gerard/0000-0001-6109-3843			Chhabra Gaurav, 2013, J Emerg Trauma Shock, V6, P180, DOI 10.4103/0974-2700.115332; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Tohme S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-1	4	12	12	0	2	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	FEB	2015	81	2					E61	E63					3	Surgery	Surgery	CI6TK	WOS:000354894700008	25642858				2021-06-18	
J	Davies, SW; Leonard, KL; Falls, RK; Mageau, RP; Efird, JT; Hollowell, JP; Trainor, WE; Kanaan, HA; Hickner, RC; Sawyer, RG; Poulin, NR; Waibel, BH; Toschlog, EA				Davies, Stephen W.; Leonard, Kenji L.; Falls, Randall K., Jr.; Mageau, Ronald P.; Efird, Jimmy T.; Hollowell, Joseph P.; Trainor, Wayne E., II; Kanaan, Hilal A.; Hickner, Robert C.; Sawyer, Robert G.; Poulin, Nathaniel R.; Waibel, Brett H.; Toschlog, Eric A.			Lung protective ventilation (ARDSNet) versus airway pressure release ventilation: Ventilatory management in a combined model of acute lung and brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Lung protective ventilation (ARDSNet); airway pressure release ventilation (APRV); adult respiratory distress syndrome (ARDS); traumatic brain injury (TBI); swine	FREQUENCY OSCILLATORY VENTILATION; RESPIRATORY-DISTRESS-SYNDROME; RECRUITMENT	BACKGROUND: Concomitant lung/brain traumatic injury results in significant morbidity and mortality. Lung protective ventilation (Acute Respiratory Distress Syndrome Network [ARDSNet]) has become the standard for managing adult respiratory distress syndrome; however, the resulting permissive hypercapnea may compound traumatic brain injury. Airway pressure release ventilation (APRV) offers an alternative strategy for the management of this patient population. APRV was hypothesized to retard the progression of acute lung/brain injury to a degree greater than ARDSNet in a swine model. METHODS: Yorkshire swine were randomized to ARDSNet, APRV, or sham. Ventilatory settings and pulmonary parameters, vitals, blood gases, quantitative histopathology, and cerebral microdialysis were compared between groups using chi(2), Fisher's exact, Student's t test, Wilcoxon rank-sum, and mixed-effects repeated-measures modeling. RESULTS: Twenty-two swine (17 male, 5 female), weighing a mean (SD) of 25 (6.0) kg, were randomized to APRV (n = 9), ARDSNet (n = 12), or sham (n = 1). PaO2/FIO2 ratio dropped significantly, while intracranial pressure increased significantly for all three groups immediately following lung and brain injury. Over time, peak inspiratory pressure, mean airway pressure, and PaO2/FIO2 ratio significantly increased, while total respiratory rate significantly decreased within the APRV group compared with the ARDSNet group. Histopathology did not show significant differences between groups in overall brain or lung tissue injury; however, cerebral microdialysis trends suggested increased ischemia within the APRV group compared with ARDSNet over time. CONCLUSION: Previous studies have not evaluated the effects of APRV in this population. While our macroscopic parameters and histopathology did not observe a significant difference between groups, microdialysis data suggest a trend toward increased cerebral ischemia associated with APRV over time. Additional and future studies should focus on extending the time interval for observation to further delineate differences between groups. (Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.)	[Davies, Stephen W.; Sawyer, Robert G.] Univ Virginia, Sch Med, Dept Surg, Charlottesville, VA 22908 USA; [Leonard, Kenji L.; Poulin, Nathaniel R.; Waibel, Brett H.; Toschlog, Eric A.] E Carolina Univ, Div Trauma & Acute Care Surg, Brody Sch Med, Greenville, NC USA; [Falls, Randall K., Jr.; Mageau, Ronald P.] E Carolina Univ, Dept Surg, Brody Sch Med, Dept Pathol, Greenville, NC USA; [Hickner, Robert C.] E Carolina Univ, Dept Physiol, Brody Sch Med, Greenville, NC USA; [Efird, Jimmy T.] E Carolina Univ, Biostat Unit, Brody Sch Med, Greenville, NC USA; [Kanaan, Hilal A.] E Carolina Univ, Ctr Hlth Dispar, Brody Sch Med, Greenville, NC USA; [Kanaan, Hilal A.] E Carolina Univ, Div Neurosurg, Brody Sch Med, Greenville, NC USA; [Hollowell, Joseph P.; Trainor, Wayne E., II] Vidant Med Ctr, Greenville, NC USA	Davies, SW (corresponding author), Univ Virginia, Sch Med, Dept Surg, POB 800679, Charlottesville, VA 22908 USA.	sd2wf@virginia.edu		Sawyer, Robert/0000-0002-8155-2661; hickner, Robert/0000-0002-2683-1617; Leonard, Kenji/0000-0002-3580-1516	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T32AI078875-05]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [T32AI078875] Funding Source: NIH RePORTER	This study was supported by NIH 5T32AI078875-05 (to S.W.D. and R.G.S.).	Albert S, 2011, J SURG RES, V166, pE71, DOI 10.1016/j.jss.2010.10.022; Ambrosio AM, 2012, ANESTHESIOLOGY, V117, P1322, DOI 10.1097/ALN.0b013e31827542aa; American Veterinary Medical Association, 2013, AM VET MED ASS GUID; ARDSnet, 2010, NIH NHLBI ARDS CLIN; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Daoud EG, 2012, RESP CARE, V57, P282, DOI 10.4187/respcare.01238; David M, 2006, BRIT J ANAESTH, V97, P525, DOI 10.1093/bja/ael215; Dries DJ, 2009, J BURN CARE RES, V30, P929, DOI 10.1097/BCR.0b013e3181bfb84c; Erickson SE, 2009, CRIT CARE MED, V37, P1574, DOI 10.1097/CCM.0b013e31819fefdf; Goodman JC, 2009, CURR OPIN CRIT CARE, V15, P110, DOI 10.1097/MCC.0b013e328325d142; Guldner A, 2014, ANESTHESIOLOGY, V120, P673, DOI 10.1097/ALN.0000000000000124; Heuer JF, 2012, NEUROCRIT CARE, V17, P281, DOI 10.1007/s12028-011-9566-z; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Kreyer S, 2010, J NEUROSURG ANESTH, V22, P323, DOI 10.1097/ANA.0b013e3181e775f1; Lopez-Aguilar J, 2005, CRIT CARE MED, V33, P1077, DOI 10.1097/01.CCM.0000162913.72479.F7; Lowe GJ, 2006, CURR OPIN CRIT CARE, V12, P3, DOI 10.1097/01.ccx.0000198055.29600.4b; Mascia L, 2009, NEUROCRIT CARE, V11, P417, DOI 10.1007/s12028-009-9242-8; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; O'Rourke J, 2007, EUR J ANAESTH, V24, P454, DOI 10.1017/S0265021506002006; Pan ZY, 2005, BIOMETRICS, V61, P1000, DOI 10.1111/j.1541-0420.2005.00365.x; Purins K, 2012, NEUROCRIT CARE, V16, P462, DOI 10.1007/s12028-012-9675-3; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Roy S, 2013, SHOCK, V39, P28, DOI 10.1097/SHK.0b013e31827b47bb; Roy S, 2012, J TRAUMA ACUTE CARE, V73, P391, DOI 10.1097/TA.0b013e31825c7a82; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sasidhar M, 2012, RESP CARE, V57, P1325, DOI 10.4187/respcare.01394; STOCK MC, 1987, CRIT CARE MED, V15, P462, DOI 10.1097/00003246-198705000-00002; Veeravagu A, 2014, WORLD NEUROSURG, V82, pE235, DOI 10.1016/j.wneu.2014.02.030; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Young N, 2010, CURR OPIN CRIT CARE, V16, P45, DOI 10.1097/MCC.0b013e32833546fa; Young NH, 2011, NEUROCRIT CARE, V15, P623, DOI 10.1007/s12028-011-9550-7	38	12	13	1	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2015	78	2					240	249		10.1097/TA.0000000000000518			10	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	CA3TF	WOS:000348828300004	25757107	Green Accepted			2021-06-18	
J	Rike, PO; Johansen, HJ; Ulleberg, P; Lundqvist, A; Schanke, AK				Rike, Per-Ola; Johansen, Hans J.; Ulleberg, Pal; Lundqvist, Anna; Schanke, Anne-Kristine			Exploring associations between self-reported executive functions, impulsive personality traits, driving self-efficacy, and functional abilities in driver behaviour after brain injury	TRANSPORTATION RESEARCH PART F-TRAFFIC PSYCHOLOGY AND BEHAVIOUR			English	Article						Stroke; Traumatic brain injuries; Driving self-efficacy; Self-awareness; Executive function; Personality	INDIVIDUAL-DIFFERENCES; COMMUNITY INTEGRATION; OLDER-ADULTS; AWARENESS; MODEL; RISK; PREDICTORS; DEFICITS; DYSFUNCTION; ACCIDENTS	Objective: The assessment of self-awareness and self-efficacy as they relate to driving after stroke and TBI is lacking in the literature where the focus has tended to be on neuropsychological testing of underlying component of cognition in predicting driving outcome. Therefore, this study aims to investigate the associations between self-rating of higher-level functions and post-injury driving behaviour. Methods: The present one-year follow-up study included twenty-four adults with stroke and ten adults with traumatic brain injury (TBI) deemed suitable for driving after a comprehensive driving evaluation according to Norwegian regulations. In addition, but not part of the decision making, baseline measurements included self-rating of executive functions (Behaviour Rating of Executive Function (BRIEF-A)), impulsive personality traits (UPPS Impulsive Behaviour Scale), driving self-efficacy (Adelaide Driving Self-Efficacy Scale (ADSES)), and functional abilities (Awareness Questionnaire (AQ)). Follow-up measurements twelve months after baseline were collected, the ADSES, AQ and Swedish Driver Behaviour Questionnaire (Swedish DBQ). Results: Perceived driving self-efficacy and functional abilities did not change from baseline to follow-up. Baseline perceived executive functions and impulsive personality traits were significantly associated with driving self-efficacy at follow-up. Lower self-efficacy and functional abilities were associated with lower driving mileage and increased use of compensatory driving strategies, whereas lower self-efficacy beliefs were associated with driver mistakes and inattention. Driver violations and inattention were associated with minor accidents. Conclusion: The present study demonstrates that higher-level functions such as executive functions, impulsive personality traits, driving self-efficacy and functional abilities, influence post-injury accident involvement mediated through proximal driving factors such as driver inattention. Further evidence is warranted to explore self-rating measures compared to performance-based methods as predictors of risky driver behaviour, crashes, and near misses. (C) 2015 Elsevier Ltd. All rights reserved.	[Rike, Per-Ola; Schanke, Anne-Kristine] Sunnaas Rehabil Hosp, Nesodden, Norway; [Johansen, Hans J.] Stavern Rehabil Hosp, Stavern, Norway; [Ulleberg, Pal; Schanke, Anne-Kristine] Univ Oslo, Dept Psychol, N-0316 Oslo, Norway; [Lundqvist, Anna] Linkoping Univ Hosp, Dept Rehabil Med, S-58185 Linkoping, Sweden	Rike, PO (corresponding author), Sunnaas Rehabil Hosp, N-1450 Nesoddtangen, Norway.	perola.rike@sunnaas.no			Extrastiftelsen [2008/2/0113]	The authors thank all persons for their participation and Frank Becker, M.D. for the medical data quality assurance. The study was supported by grants from Extrastiftelsen (Grant Number 2008/2/0113). The authors declare that there are no conflicts of interest.	Aberg L, 1998, ERGONOMICS, V41, P39, DOI 10.1080/001401398187314; Adrian J, 2011, ACCIDENT ANAL PREV, V43, P1652, DOI 10.1016/j.aap.2011.03.023; Af Wahlberg A, 2011, THEOR ISS ERGON SCI, V12, P66, DOI 10.1080/14639220903023376; af Wahlberg AE, 2010, J SAFETY RES, V41, P99, DOI 10.1016/j.jsr.2010.02.005; Amado S, 2014, ACCIDENT ANAL PREV, V63, P65, DOI 10.1016/j.aap.2013.10.022; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Baldock MRJ, 2006, ACCIDENT ANAL PREV, V38, P1038, DOI 10.1016/j.aap.2006.04.016; Bandura A., 1997, SELF EFFICACY EXERCI; Banfield J., 2004, HDB SELF REGULATION, P62; Baumeister R. F., 2011, HDB SELF REGULATION; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bjornskau T., 2003, ROAD TRAFFIC RISK NO; Cellar DF, 2000, PSYCHOL REP, V86, P454, DOI 10.2466/PR0.86.2.454-456; Chiou KS, 2011, J INT NEUROPSYCH SOC, V17, P720, DOI 10.1017/S1355617711000658; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Coleman BR., 2005, DRIVER REHABILITATIO, P165; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Constantinou E, 2011, ACCIDENT ANAL PREV, V43, P1323, DOI 10.1016/j.aap.2011.02.002; Costa P., 1992, REVISED NEO PERSONAL; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [10.1097/00001199-198909000-00008, DOI 10.1097/00001199-198909000-00008]; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; Daigneault G, 2002, J CLIN EXP NEUROPSYC, V24, P221, DOI 10.1076/jcen.24.2.221.993; de Winter JCF, 2010, J SAFETY RES, V41, P463, DOI 10.1016/j.jsr.2010.10.007; Dolan SL, 2008, BEHAV SCI LAW, V26, P799, DOI 10.1002/bsl.845; ELANDER J, 1993, PSYCHOL BULL, V113, P279, DOI 10.1037/0033-2909.113.2.279; Ellekjaer Hanne, 2007, Tidsskr Nor Laegeforen, V127, P740; GALSKI T, 1992, AM J OCCUP THER, V46, P324, DOI 10.5014/ajot.46.4.324; George S., 2013, AUSTRALASIAN J AGEIN; George S, 2007, CLIN REHABIL, V21, P56, DOI 10.1177/0269215506071284; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Griffen JA, 2011, CLIN NEUROPSYCHOL, V25, P1158, DOI 10.1080/13854046.2011.609841; Hargrave DD, 2012, NEUROPSYCHOL REHABIL, V22, P489, DOI 10.1080/09602011.2012.662333; Hatakka M., 2002, TRANSPORTATION RES F, V5, P201, DOI [10.1016/S1369-8478(02)00018-9., 10.1016/S1369-8478]; Hofmann W, 2012, TRENDS COGN SCI, V16, P174, DOI 10.1016/j.tics.2012.01.006; Hunt AW, 2013, NEUROPSYCHOL REHABIL, V23, P914, DOI 10.1080/09602011.2013.835739; Kay LG, 2009, ARCH PHYS MED REHAB, V90, P1514, DOI 10.1016/j.apmr.2009.03.011; Lajunen T., 2003, TRANSPORTATION RES F, V6, P97, DOI [DOI 10.1016/S1369-8478(03)00008-1, 10.1016/S1369-8478(03)00008-1]; Ledesma RD, 2010, TRAFFIC INJ PREV, V11, P142, DOI 10.1080/15389580903497139; Lundqvist A, 2007, BRAIN INJURY, V21, P1109, DOI 10.1080/02699050701651660; Marottoli RA, 1998, ACCIDENT ANAL PREV, V30, P331, DOI 10.1016/S0001-4575(97)00100-0; Marshall SC, 2007, TOP STROKE REHABIL, V14, P98, DOI 10.1310/tsr1401-98; Michon J.A., 1985, HUMAN BEHAV TRAFFIC, P485, DOI [10.1007/978-1-4613-2173-6 19, DOI 10.1007/978-1-4613-2173-619]; Morisset N, 2010, SWISS J PSYCHOL, V69, P233, DOI 10.1024/1421-0185/a000027; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Ortoleva C., 2011, J HEAD TRAUMA REHABI; Parker D, 2000, ACCIDENT ANAL PREV, V32, P751, DOI 10.1016/S0001-4575(99)00125-6; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; PRIGATANO GP, 1991, AWARENESS DEFICITS B; Radford KA, 2004, BRAIN INJURY, V18, P775, DOI 10.1080/02699050310001657394; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; REASON J, 1990, ERGONOMICS, V33, P1315, DOI 10.1080/00140139008925335; Rike P. O., 2014, EXPLORING ASS UNPUB; Rike P. O., 2014, BRAIN INJURY, P1; Rimmo P.-A., 2014, TRANSPORT RES F-TRAF, V2, P151; Roca J, 2013, TRANSPORT RES F-TRAF, V17, P98, DOI 10.1016/j.trf.2012.10.005; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Roth R.M., 2005, BEHAV RATING INVENTO; Sakai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045920; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Schanke AK, 2008, J REHABIL MED, V40, P733, DOI 10.2340/16501977-0256; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; Scialfa C, 2010, J GERONTOL B-PSYCHOL, V65, P434, DOI 10.1093/geronb/gbq032; Scott CA, 2009, J CLIN EXP NEUROPSYC, V31, P353, DOI 10.1080/13803390802169067; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sommer M, 2010, ARCH CLIN NEUROPSYCH, V25, P99, DOI 10.1093/arclin/acp109; Stapleton T, 2012, AUST OCCUP THER J, V59, P63, DOI 10.1111/j.1440-1630.2011.00980.x; Stuss D. T., 2007, HUMAN FRONTAL LOBES, P292; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Sumer N, 2003, ACCIDENT ANAL PREV, V35, P949, DOI 10.1016/S0001-4575(02)00103-3; Sundstrom A, 2011, EUR J PSYCHOL ASSESS, V27, P164, DOI 10.1027/1015-5759/a000063; Tamietto M, 2006, NEUROREHABILITATION, V21, P81; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Verdejo-Garcia A, 2010, PSYCHOPHARMACOLOGY, V210, P377, DOI 10.1007/s00213-010-1833-8; Weaver B, 2009, ACCIDENT ANAL PREV, V41, P76, DOI 10.1016/j.aap.2008.09.006; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Wood JM, 2013, J GERONTOL A-BIOL, V68, P559, DOI 10.1093/gerona/gls150; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU; ZUCKERMAN M, 1978, J CONSULT CLIN PSYCH, V46, P139, DOI 10.1037/0022-006X.46.1.139	81	12	12	1	17	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1369-8478	1873-5517		TRANSPORT RES F-TRAF	Transp. Res. Pt. F-Traffic Psychol. Behav.	FEB	2015	29						34	47		10.1016/j.trf.2015.01.004			14	Psychology, Applied; Transportation	Psychology; Transportation	CE6VV	WOS:000351977200004					2021-06-18	
J	Stubberud, J; Langenbahn, D; Levine, B; Stanghelle, J; Schanke, AK				Stubberud, Jan; Langenbahn, Donna; Levine, Brian; Stanghelle, Johan; Schanke, Anne-Kristine			Emotional Health and Coping in Spina Bifida After Goal Management Training: A Randomized Controlled Trial	REHABILITATION PSYCHOLOGY			English	Article						executive functioning; cognitive rehabilitation; brain injury; goal management; evidence-based	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; EXECUTIVE FUNCTIONS; YOUNG-ADULTS; COGNITIVE REHABILITATION; RHEUMATOID-ARTHRITIS; ATTENTION; CHILDREN; ADOLESCENTS; DYSFUNCTION	Objective: Executive function impairments are common after spina bifida (SB) and potentially have a detrimental effect on the individual's emotional health and coping. Goal management training (GMT) is a cognitive rehabilitation method for improving executive function. The purpose of this study was to determine the efficacy of GMT on aspects of perceived emotional health and coping in individuals with SB. Method: Thirty-eight adult subjects with SB were included in this randomized controlled trial. Inclusion was based upon the presence of executive functioning complaints. Experimental subjects (n = 24) received 21 hr of GMT, with efficacy of GMT being compared with results of subjects in a wait-list condition (n = 14). Four self-report questionnaires assessing emotional health and coping were utilized as outcome measures. All subjects were assessed at baseline, postintervention, and at 6-month follow-up. Results: Findings indicated positive effects of GMT relative to the control group on measures of emotional health. Of note, the GMT group showed significant improvement, compared with control subjects, on a self-report inventory of depressive and anxiety symptoms after training, lasting at least 6 months posttreatment. Furthermore, both groups showed improvements after training on mental health components of health-related quality of life. Finally, the GMT group showed a significant increase in task-focused coping and a decrease in avoidant coping after training compared with pretreatment baseline assessment scores. Conclusions: Overall, findings indicate that by us a compensatory intervention to manage executive dysfunction, effective and lasting benefits can be achieved with regard to aspects of perceived emotional health and coping.	[Stubberud, Jan] Sunnaas Rehabil Hosp, N-1450 Nesoddtangen, Aker, Norway; [Langenbahn, Donna] NYU, Sch Med, Rusk Inst Rehabil Med, New York, NY 10003 USA; [Levine, Brian] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada; [Levine, Brian] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Levine, Brian] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada; [Stanghelle, Johan; Schanke, Anne-Kristine] Univ Oslo, Sunnaas Rehabil Hosp, N-0316 Oslo, Norway; [Stanghelle, Johan; Schanke, Anne-Kristine] Univ Oslo, Fac Med, N-0316 Oslo, Norway	Stubberud, J (corresponding author), Sunnaas Rehabil Hosp, Bjoemnemyrveien 11, N-1450 Nesoddtangen, Aker, Norway.	jan.stubberud@sunnaas.no	Levine, Brian/O-2725-2019; Levine, Brian/G-4328-2010	Levine, Brian/0000-0003-4343-811X; Levine, Brian/0000-0003-4343-811X; Stubberud, Jan/0000-0001-9592-8589	South-Eastern Norway Regional Health Authority [2011041]	This work was supported by the South-Eastern Norway Regional Health Authority (Grant Number 2011041). We thank all patients, caregivers, and staff, especially Astri Andersen, Lisbeth Brondberg, Gunnar Riemer, Lena Haugen, Karen Grimsrud, Brede Dammann, Pal-Erik Plaum, Helene Barder, Per Frydenborg, and Solveig Skou, who helped to carry out the study. We also thank Marianne Lovstad and Jan Egil Nordvik for discussions concerning this study.	Abresch RT, 2007, J SPINAL CORD MED, V30, pS112; Ammerman R. T., 2006, NEURAL TUBE DEFECTS, P61; Ammerman RT, 1998, J CLIN PSYCHOL MED S, V5, P449, DOI 10.1023/A:1026211028595; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Appleton PL, 1997, J PEDIATR PSYCHOL, V22, P707, DOI 10.1093/jpepsy/22.5.707; Barf HA, 2010, J REHABIL MED, V42, P56, DOI 10.2340/16501977-0481; Bellin MH, 2010, J PEDIATR PSYCHOL, V35, P778, DOI 10.1093/jpepsy/jsp094; Ben-Yishay Y., 2011, HDB HOLISTIC NEUROPS; Burgess P.W., 1996, BADS BEHAV ASSESSMEN, P18; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Campbell LK, 2009, J PEDIATR PSYCHOL, V34, P317, DOI 10.1093/jpepsy/jsn080; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Compas BE, 2001, PSYCHOL BULL, V127, P87, DOI 10.1037//0033-2909.127.1.87; Compas BE, 2001, J DEV BEHAV PEDIATR, V22, P323, DOI 10.1097/00004703-200110000-00007; CONNERS CK, 2000, CONNERS CPT 2 CONTIN; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; D'Zurilla TJ, 2001, HANDBOOK OF COGNITIVE-BEHAVIORAL THERAPIES, SECOND EDITION, P211; Dams-O'Connor K, 2013, BRAIN IMPAIR, V14, P51, DOI 10.1017/BrImp.2013.9; Davidson RJ, 2003, PSYCHOSOM MED, V65, P564, DOI 10.1097/01.PSY.0000077505.67574.E3; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Dennis M, 2010, DEV DISABIL RES REV, V16, P31, DOI 10.1002/ddrr.89; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Detrait ER, 2005, NEUROTOXICOL TERATOL, V27, P515, DOI 10.1016/j.ntt.2004.12.007; Donker T, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-79; Dumville JC, 2006, CONTEMP CLIN TRIALS, V27, P1, DOI 10.1016/j.cct.2005.08.003; DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360; Eid J, 1999, SCAND J PSYCHOL, V40, P101, DOI 10.1111/1467-9450.00105; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Finset A, 2000, BRAIN INJURY, V14, P887; Fletcher JM, 2010, DEV DISABIL RES REV, V16, P1, DOI 10.1002/ddrr.101; Fletcher JM, 1996, DEV NEUROPSYCHOL, V12, P53, DOI 10.1080/87565649609540640; Gioia G.A., 2000, BEHAV RATING INVENTO; Haidt J., 1999, REV GEN PSYCHOL, V3, P317, DOI [10.1037/1089-2680.3.4.317, DOI 10.1037/1089-2680.3.4.317]; Heffelfinger AK, 2008, J INT NEUROPSYCH SOC, V14, P793, DOI 10.1017/S1355617708081022; Hellemans KGC, 2010, NEUROSCI BIOBEHAV R, V34, P791, DOI 10.1016/j.neubiorev.2009.06.004; Iddon JL, 2004, J NEUROL NEUROSUR PS, V75, P1112, DOI 10.1136/jnnp.2003.029058; In de Braek D. M., 2012, J ATTENTION DISORDER; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JOSEPH S, 1992, PERS INDIV DIFFER, V13, P1249, DOI 10.1016/0191-8869(92)90262-N; Kabat-Zinn J, 1990, FULL CATASTROPHE LIV; Kalfoss MH, 2006, FLUIDS BARRIERS CNS, V3, pS31, DOI [10.1186/1743-8454-3-S1-S31., DOI 10.1186/1743-8454-3-S1-S31]; Kelly NC, 2012, CHILD NEUROPSYCHOL, V18, P417, DOI 10.1080/09297049.2011.613814; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Kvien TK, 1998, J CLIN EPIDEMIOL, V51, P1077, DOI 10.1016/S0895-4356(98)00099-7; Lazarus R.S., 1984, STRESS APPRAISAL COP; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lewis HA, 1996, J PEDIATR PSYCHOL, V21, P25, DOI 10.1093/jpepsy/21.1.25; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Loge JH, 1998, J CLIN EPIDEMIOL, V51, P1069, DOI 10.1016/S0895-4356(98)00098-5; Loge JH, 1998, SCAND J SOC MED, V26, P250; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Mathias JL, 2003, APPL NEUROPSYCHOL, V10, P57, DOI 10.1207/S15324826AN1002_01; Matthews G., 1996, HDB COPING THEORY RE, P573; Miotto EC, 2009, NEUROPSYCHOL REHABIL, V19, P517, DOI 10.1080/09602010802332108; Mitchell LE, 2004, LANCET, V364, P1885, DOI 10.1016/S0140-6736(04)17445-X; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; Perry GS, 2010, AM J PUBLIC HEALTH, V100, P2337, DOI 10.2105/AJPH.2010.205146; Ponsford J. L., 2013, J CLIN EXPT NEUROPSY; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Posner Michael I., 1995, P615; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Prigatano GP., 1999, PRINCIPLES NEUROPSYC; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P1; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Ravndal E, 2010, DRUG ALCOHOL DEPEN, V108, P65, DOI 10.1016/j.drugalcdep.2009.11.008; Robertson I. H., 2013, PRINCIPLES FRONTAL L, P742; Robertson IH, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P631; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Robertson IH, 1996, GOAL MANAGEMENT TRAI; Roebroeck ME, 2006, DISABIL REHABIL, V28, P1237, DOI 10.1080/09638280600551716; Rose BM, 2007, J PEDIATR PSYCHOL, V32, P983, DOI 10.1093/jpepsy/jsm042; Rueda M. R., 2004, HDB SELF REGULATION, P401; Ruff HA, 1996, ATTENTION EARLY DEV; Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332; Shapiro SL., 2000, HDB SELF REGULATION, P253, DOI DOI 10.1016/B978-012109890-2/50037-8; Simblett SK, 2011, NEUROPSYCHOL REHABIL, V21, P1, DOI 10.1080/09602011.2011.592099; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Stubberud J, 2014, NEUROPSYCHOL REHABIL, V24, P26, DOI 10.1080/09602011.2013.847847; Stubberud J, 2013, J INT NEUROPSYCH SOC, V19, P672, DOI 10.1017/S1355617713000209; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Tang YY, 2007, P NATL ACAD SCI USA, V104, P17152, DOI 10.1073/pnas.0707678104; Tarazi RA, 2008, CLIN NEUROPSYCHOL, V22, P585, DOI 10.1080/13854040701425940; TEASDALE JD, 1995, BEHAV RES THER, V33, P25, DOI 10.1016/0005-7967(94)E0011-7; Tuminello ER, 2012, CHILD NEUROPSYCHOL, V18, P105, DOI 10.1080/09297049.2011.590470; van Hooren SAH, 2007, PATIENT EDUC COUNS, V65, P205, DOI 10.1016/j.pec.2006.07.010; Verhoef M, 2007, DEV MED CHILD NEUROL, V49, P192, DOI 10.1111/j.1469-8749.2007.00192.x; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Ware JE., 2000, SCORE VERSION 2 SF 3; Wechsler D., 1999, MANUAL WECHSLER ABBR; Wilson BA, 1996, BEHAV ASSESSMENT DYS; Winocur G, 2007, J INT NEUROPSYCH SOC, V13, P153, DOI 10.1017/S135561770707018X; Zukerman JM, 2011, J PEDIATR PSYCHOL, V36, P265, DOI 10.1093/jpepsy/jsq075	99	12	12	0	8	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2015	60	1					1	16		10.1037/rep0000018			16	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	CC4VV	WOS:000350353600001	25496433				2021-06-18	
J	Fraisier, C; Papa, A; Almeras, L				Fraisier, Christophe; Papa, Anna; Almeras, Lionel			High-mobility group box-1, promising serological biomarker for the distinction of human WNV disease severity	VIRUS RESEARCH			English	Article						West Nile virus; Encephalitis; Neuroinvasive disease; Serum biomarkers; ELISA	TRAUMATIC BRAIN-INJURY; NILE VIRUS-INFECTION; 1 HMGB1 PROTEIN; CEREBROSPINAL-FLUID; POSTISCHEMIC INFLAMMATION; WEST; SERUM; MARKERS; CELLS	The recent increase of West Nile neuroinvasive disease (WNND) incidence in southern Europe made this change in epidemiology a major concern for public health. The lack of a vaccine or specific treatment against human WNV infection imposes the need to discover biological markers associated with disease severity for diagnostic and/or therapeutic purposes. Recently, using a brain proteomic study from a mouse model of West Nile virus (WNV) infection with neuronal involvement, we reported the kinetic up-regulation of high-mobility group box-1 (HMGB1) and peroxiredoxin-6 (PRDX6), before and after onset of clinical symptoms, respectively. To evaluate whether these proteins could be useful biomarkers for the distinction of WNV disease severity in humans, HMBG1 and PRDX6 concentrations in serum from WNV-infected patients (n = 49) diagnosed for either WNF (n = 22) or WNND (n = 27), were measured by ELISA and compared to concentrations in serum from uninfected healthy individuals (n = 30). HMGB1 concentrations were significantly higher in WNND than in either WNF patients (p <0.05) or healthy individuals (p <0.001). In contrast, PRDX6 levels were significantly higher in healthy individuals compared with WNV-infected patients (p <0.001), regardless of clinical symptoms. The present study highlighted the deregulation of HMGB1 and PRDX6 serum level in WNV-infected patients and provided HMGB1 as candidate biomarker distinguishing disease severity. Further investigation in larger cohorts could confirm HMGB1 and PRDX6 as auxiliary biomarkers in confirmed cases of WNV infection and validate the usefulness of measuring HMBG1 for prediction of detrimental clinical outcome. (C) 2014 Elsevier B.V. All rights reserved.	[Fraisier, Christophe; Almeras, Lionel] Aix Marseille Univ, INSERM 1095, IRD 198,UM63, CNRS 7278,Unite Rech Maladies Infect & Trop Emerg, Marseille, France; [Papa, Anna] Aristotle Univ Thessaloniki, Sch Med, Dept Microbiol, GR-54006 Thessaloniki, Greece	Almeras, L (corresponding author), Aix Marseille Univ, INSERM 1095, IRD 198,UM63, CNRS 7278,Unite Rech Maladies Infect & Trop Emerg, Marseille, France.	almeras.lionel@gmail.com		ALMERAS, Lionel/0000-0003-0490-5774			Allonso D, 2012, J CLIN VIROL, V55, P214, DOI 10.1016/j.jcv.2012.07.010; Au AK, 2012, J NEUROTRAUM, V29, P2013, DOI 10.1089/neu.2011.2171; Fang P, 2012, MOL NEUROBIOL, V45, P499, DOI 10.1007/s12035-012-8264-y; Fossati S, 2007, INT REV NEUROBIOL, V82, P137, DOI 10.1016/S0074-7742(07)82007-1; Fraisier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068318; Hattori Fumiyuki, 2007, V44, P357; Higgins SJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-105; Kapoor H, 2004, J CLIN VIROL, V31, P289, DOI 10.1016/j.jcv.2004.05.017; Kumar M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-73; Leis AA, 2012, MUSCLE NERVE, V45, P826, DOI 10.1002/mus.23241; Miyake Y, 2012, ADV EXP MED BIOL, V738, P144, DOI 10.1007/978-1-4614-1680-7_9; Momonaka H., 2013, BRAIN DEV; Neghina AM, 2011, VECTOR-BORNE ZOONOT, V11, P1289, DOI 10.1089/vbz.2010.0206; Nixon ML, 2006, J CLIN VIROL, V37, P174, DOI 10.1016/j.jcv.2006.07.005; Papa A, 2012, EXPERT REV ANTI-INFE, V10, P743, DOI [10.1586/eri.12.59, 10.1586/ERI.12.59]; Passali D, 2012, ACTA OTORHINOLARYNGO, V32, P46; Paz S, 2013, INT J ENV RES PUB HE, V10, P3543, DOI 10.3390/ijerph10083543; Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042; Petzold A, 2010, MUSCLE NERVE, V41, P42, DOI 10.1002/mus.21448; Power JHT, 2008, ACTA NEUROPATHOL, V115, P611, DOI 10.1007/s00401-008-0373-3; Rizzo C, 2012, EURO SURVEILL, V17; Shichita T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00132; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Tang HY, 2012, J PROTEOME RES, V11, P678, DOI 10.1021/pr200603h; Wang HC, 2006, VIRAL IMMUNOL, V19, P3, DOI 10.1089/vim.2006.19.3; Wang KY, 2012, CLIN CHIM ACTA, V413, P1737, DOI 10.1016/j.cca.2012.07.002; Zhang XZ, 2009, CANCER SCI, V100, P2396, DOI 10.1111/j.1349-7006.2009.01314.x	27	12	12	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-1702	1872-7492		VIRUS RES	Virus Res.	JAN 2	2015	195						9	12		10.1016/j.virusres.2014.08.017			4	Virology	Virology	AY5EM	WOS:000347595900002	25197038				2021-06-18	
J	Azouvi, P; Vallat-Azouvi, C; Millox, V; Darnoux, E; Ghout, I; Azerad, S; Ruet, A; Bayen, E; Pradat-Diehl, P; Aegerter, P; Weiss, JJ; Jourdan, C				Azouvi, Philippe; Vallat-Azouvi, Claire; Millox, Valerie; Darnoux, Emmanuelle; Ghout, Idir; Azerad, Sylvie; Ruet, Alexis; Bayen, Eleonore; Pradat-Diehl, Pascale; Aegerter, Philippe; Weiss, Jean-Jacques; Jourdan, Claire			Ecological validity of the Dysexecutive Questionnaire: Results from the PariS-TBI study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Everyday function; Assessment; Executive functions; Rehabilitation	TRAUMATIC BRAIN-INJURY; EXECUTIVE DYSFUNCTION; RASCH ANALYSIS; HEAD-INJURY; SCALE; REHABILITATION; RATINGS; SAMPLE; SELF; DEX	The Dysexecutive Questionnaire (DEX; Wilson, Pettigrew, & Teasdale, 1998) has been designed to assess executive dysfunctions in daily life. However, its relationships with cognitive testing, mood, and the ability to fulfil daily life demands, have not yet been systematically addressed. The objective of this study was to address these issues in a prospective four-year follow-up study of patients with severe traumatic brain injury (TBI) (PariS-TBI study). One hundred and forty seven patients were included. The DEX (self-version) showed a good internal consistency. The total DEX score was significantly inversely correlated with years of education, but did not significantly correlate with any initial injury severity measure. The DEX was significantly and positively related to cognitive deficits, as assessed with the Neurobehavioral Rating Scale-Revised (NRS-R); with mood disorders, as assessed with the Hospital Anxiety and Depression Scale (HADS); with dependency in elementary and extended activities of daily living; and with non-return to work. In multivariate analyses, cognitive and mood impairments were significantly and independently related to the total DEX score. These results suggest that the DEX is a multidetermined sensitive questionnaire to detect everyday life difficulties in patients with severe TBI at a chronic stage.	[Azouvi, Philippe; Ruet, Alexis; Jourdan, Claire] Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, Garches, France; [Azouvi, Philippe; Vallat-Azouvi, Claire; Ruet, Alexis; Jourdan, Claire] Univ Versailles St Quentin, EA 4047, HANDIReSP, Versailles, France; [Vallat-Azouvi, Claire; Millox, Valerie] Hop Raymond Poincare, Antenne UEROS UGECAMIF SAMSAH92, Garches, France; [Darnoux, Emmanuelle; Azerad, Sylvie; Weiss, Jean-Jacques] CRFTC, Paris, France; [Darnoux, Emmanuelle; Ghout, Idir; Azerad, Sylvie; Aegerter, Philippe] Hop Ambroise Pare, AP HP, URC, Boulogne, France; [Bayen, Eleonore; Pradat-Diehl, Pascale] Grp Hosp Pitie Salpetriere, AP HP, Serv Med Phys & Readaptat, F-75634 Paris, France; [Pradat-Diehl, Pascale] Univ Paris 06, Paris, France	Azouvi, P (corresponding author), Hop Raymond Poincare, Serv Med Phys & Readaptat, 104 Bd Raymond Poincare, F-92380 Garches, France.	philippe.azouvi@rpc.aphp.fr	RUET, Alexis/L-8726-2015	RUET, Alexis/0000-0002-5080-5734; AEGERTER, Philippe/0000-0002-9156-5028	French Ministry of Health [AOM04084]; AP-HP (Departement de la Recherche Clinique et du Developpement); Institut de Recherche en Sante Publique (IRESP)	The first part of this study (first year follow-up) was funded by a grant from the French Ministry of Health [Programme Hospitalier de Recherche Clinique 2004, AOM04084] and supported by AP-HP (Departement de la Recherche Clinique et du Developpement). The second part of this study (4-year follow-up) was funded by a grant from the Institut de Recherche en Sante Publique (IRESP).	Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P376, DOI 10.1017/S1355617705050423; Bodenburg S, 2008, J NERV MENT DIS, V196, P75, DOI 10.1097/NMD.0b013e31815faa2b; Boelen DHE, 2009, NEUROPSYCHOL REHABIL, V19, P625, DOI 10.1080/09602010802613853; BOYD TM, 1993, APPL COGNITIVE PSYCH, V7, P171, DOI 10.1002/acp.2350070208; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Cazalis F, 2001, J INT NEUROPSYCH SOC, V7, P795, DOI 10.1017/S1355617701777028; Chan RCK, 2008, J NEUROL NEUROSUR PS, V79, P86, DOI 10.1136/jnnp.2007.117184; Chan RCK, 2001, BRIT J PSYCHOL, V92, P551, DOI 10.1348/000712601162338; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chaytor N, 2007, J INT NEUROPSYCH SOC, V13, P377, DOI 10.1017/S1355617707070592; Chaytor N, 2007, BRAIN INJURY, V21, P615, DOI 10.1080/02699050701426949; Chevignard M, 2000, CORTEX, V36, P649, DOI 10.1016/S0010-9452(08)70543-4; Chevignard MP, 2008, NEUROPSYCHOL REHABIL, V18, P461, DOI 10.1080/09602010701643472; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Gerstorf D, 2008, AGING NEUROPSYCHOL C, V15, P424, DOI 10.1080/13825580701640374; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; JENNETT B, 1975, LANCET, V1, P480; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; MAHONEY F I, 1965, Md State Med J, V14, P61; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; Mooney B, 2006, APPL NEUROPSYCHOL, V13, P12, DOI 10.1207/s15324826an1301_2; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; PONSFORD J, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Simblett SK, 2012, NEUROPSYCHOL REHABIL, V22, P874, DOI 10.1080/09602011.2012.703956; Simblett SK, 2011, NEUROPSYCHOL REHABIL, V21, P1, DOI 10.1080/09602011.2011.592099; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Stuss D. T., 2007, HUMAN FRONTAL LOBES, P292; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; TRUELLE JL, 1992, SCAND J REHABIL MED, P115; Vallat-Azouvi C, 2012, NEUROPSYCHOL REHABIL, V22, P634, DOI 10.1080/09602011.2012.681110; Vanier M, 2000, ARCH PHYS MED REHAB, V81, P796, DOI 10.1053/apmr.2000.4436; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; Wilson BA, 1996, BEHAV ASSESSMENT DYS; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	43	12	12	0	16	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2015	25	6					864	878		10.1080/09602011.2014.990907			15	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	DP1TC	WOS:000378271300004	25523796				2021-06-18	
J	Behfar, MH; Bjorninen, T; Moradi, E; Sydanheimo, L; Ukkonen, L				Behfar, Mohammad H.; Bjorninen, Toni; Moradi, Elham; Sydanheimo, Lauri; Ukkonen, Leena			Biotelemetric Wireless Intracranial Pressure Monitoring: An In Vitro Study	INTERNATIONAL JOURNAL OF ANTENNAS AND PROPAGATION			English	Article							CHILDREN	Assessment of intracranial pressure (ICP) is of great importance in management of traumatic brain injuries (TBIs). The existing clinically established ICP measurement methods require catheter insertion in the cranial cavity. This increases the risk of infection and hemorrhage. Thus, noninvasive but accurate techniques are attractive. In this paper, we present two wireless, batteryless, and minimally invasive implantable sensors for continuous ICP monitoring. The implants comprise ultrathin (50 mu m) flexible spiral coils connected in parallel to a capacitive microelectromechanical systems (MEMS) pressure sensor. The implantable sensors are inductively coupled to an external on-body reader antenna. The ICP variation can be detected wirelessly through measuring the reader antenna's input impedance. This paper also proposes novel implant placement to improve the efficiency of the inductive link. In this study, the performance of the proposed telemetry system was evaluated in a hydrostatic pressure measurement setup. The impact of the human tissues on the inductive link was simulated using a 5mm layer of pig skin. The results from the in vitro measurement proved the capability of our developed sensors to detect ICP variations ranging from 0 to 70 mm Hg at 2.5 mm Hg intervals.	[Behfar, Mohammad H.; Bjorninen, Toni; Moradi, Elham; Sydanheimo, Lauri; Ukkonen, Leena] Tampere Univ Technol, Dept Elect & Commun Engn, Tampere 33720, Finland	Behfar, MH (corresponding author), Tampere Univ Technol, Dept Elect & Commun Engn, Tampere 33720, Finland.	mohammadhossein.behfar@tut.fi	Bjorninen, Toni/AAN-6987-2021; Sydanheimo, Lauri/AAL-8784-2021	Bjorninen, Toni/0000-0001-9335-7196; Sydanheimo, Lauri/0000-0003-3069-8887; Behfar, Mohammadhossein/0000-0002-9108-569X	Academy of FinlandAcademy of FinlandEuropean Commission [265768, 258460, 264947]; Jane and Aatos Erkko Foundation; Finnish Funding Agency for Technology and Innovation (TEKES)Finnish Funding Agency for Technology & Innovation (TEKES)	This work was supported by the Academy of Finland (Funding Decisions 265768, 258460, and 264947), Jane and Aatos Erkko Foundation, and the Finnish Funding Agency for Technology and Innovation (TEKES). The authors thank Nazanin Zanjanizadeh Ezazi for her contribution to the graphical illustration of the brain tissue.	Chen LY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6028; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; Ellison WJ, 1996, J MOL LIQ, V68, P171, DOI 10.1016/0167-7322(96)00926-9; Huixin Z., 2013, J SEMICONDUCTORS, V34; Kawoos U, 2008, IEEE T MICROW THEORY, V56, P2356, DOI 10.1109/TMTT.2008.2004253; Kristiansson H, 2013, J NEUROSURG ANESTH, V25, P372, DOI 10.1097/ANA.0b013e31829795ce; Meng X, 2012, ELECTRON LETT, V48, P363, DOI 10.1049/el.2012.0281; Moradi E, 2014, 2014 IEEE RFID TECHNOLOGY AND APPLICATIONS CONFERENCE (RFID-TA), P145, DOI 10.1109/RFID-TA.2014.6934217; Moreira-Gonzalez A, 2006, PLAST RECONSTR SURG, V117, P1964, DOI 10.1097/01.prs.0000209933.78532.a7; O'Reilly MA, 2011, ULTRASOUND MED BIOL, V37, P1930, DOI 10.1016/j.ultrasmedbio.2011.08.001; Peyman A, 2009, PHYS MED BIOL, V54, P227, DOI 10.1088/0031-9155/54/2/004; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; Wiegand C, 2007, DEV MED CHILD NEUROL, V49, P935, DOI 10.1111/j.1469-8749.2007.00935.x	15	12	12	0	20	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-5869	1687-5877		INT J ANTENN PROPAG	Int. J. Antennas Propag.		2015	2015								918698	10.1155/2015/918698			10	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CZ6YM	WOS:000367247100001		DOAJ Gold			2021-06-18	
J	Bennett, TD; Dean, JM; Keenan, HT; McGlincy, MH; Thomas, AM; Cook, LJ				Bennett, T. D.; Dean, J. M.; Keenan, H. T.; McGlincy, M. H.; Thomas, A. M.; Cook, L. J.			Linked Records of Children with Traumatic Brain Injury Probabilistic Linkage without Use of Protected Health Information	METHODS OF INFORMATION IN MEDICINE			English	Article						Medical record linkage; pediatrics; brain injuries	CLINICAL REGISTRY DATA; IDENTIFIERS	Objective: Record linkage may create powerful datasets with which investigators can conduct comparative effectiveness studies evaluating the impact of tests or interventions on health. All linkages of health care data files to date have used protected health information (PHI) in their linkage variables. A technique to link datasets without using PHI would be advantageous both to preserve privacy and to increase the number of potential linkages. Methods: We applied probabilistic linkage to records of injured children in the National Trauma Data Bank (NTDB, N = 156,357) and the Pediatric Health Information Systems (PHIS, N = 104,049) databases from 2007 to 2010. 49 match variables without PHI were used, many of them administrative variables and indicators for procedures recorded as International Classification of Diseases, 9th revision, Clinical Modification codes. We validated the accuracy of the linkage using identified data from a single center that submits to both databases. Results: We accurately linked the PHIS and NTDB records for 69% of children with any injury, and 88010 of those with severe traumatic brain injury eligible for a study of intervention effectiveness (positive predictive value of 98%, specificity of 99.99%). Accurate linkage was associated with longer lengths of stay, more severe injuries, and multiple injuries. Conclusion: In populations with substantial illness or injury severity, accurate record linkage may be possible in the absence of PHI. This methodology may enable linkages and, in turn, comparative effectiveness studies that would be unlikely or impossible otherwise.	[Bennett, T. D.; Dean, J. M.; Keenan, H. T.; Thomas, A. M.; Cook, L. J.] Univ Utah, Sch Med, Salt Lake City, UT USA; [McGlincy, M. H.] Strateg Matching Inc, Morrisonville, NY USA	Bennett, TD (corresponding author), Univ Colorado, Sch Med, Pediat Crit Care, Childrens Hosp Colorado,ACCORDS, 13199 E Montview Blvd,Suite 300,Campus Mail F443, Aurora, CO 80045 USA.	tell.bennett@ucdenver.edu		Bennett, Tellen/0000-0003-1483-4236	Eunice Kennedy Shriver National Institute for Child Health and Human Development at the National Institutes of Health [K23HD074620]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074620] Funding Source: NIH RePORTER	This work was supported by the Eunice Kennedy Shriver National Institute for Child Health and Human Development at the National Institutes of Health (Grant K23HD074620 to TB). We are indebted to David Bertoch and Matthew Hall at the Children's Hospital Association and to Melanie Neal and her team at the American College of Surgeons.	American College of Surgeons Committee on Trauma, 2010, NAT TRAUM DAT BANK R; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Belin TR, 2004, APPL BAYESIAN MODELI; *CDCP, 1997, MMWR, V46; Conway PH, 2009, J PEDIATR-US, V154, P789, DOI 10.1016/j.jpeds.2009.01.010; Cook LJ, 2001, METHOD INFORM MED, V40, P196; Deans KJ, 2014, J PEDIATR SURG, V49, P207, DOI 10.1016/j.jpedsurg.2013.09.058; FELLEGI IP, 1969, J AM STAT ASSOC, V64, P1183, DOI 10.2307/2286061; Gelman A., 2004, BAYESIAN DATA ANAL; Gerber JS, 2010, PEDIATRICS, V126, P1067, DOI 10.1542/peds.2010-1275; Hammill BG, 2009, AM HEART J, V157, P995, DOI 10.1016/j.ahj.2009.04.002; Herzog Thomas N., 2007, DATA QUALITY RECORD; JARO MA, 1995, STAT MED, V14, P491, DOI 10.1002/sim.4780140510; Kuzu M, 2013, J AM MED INFORM ASSN, V20, P285, DOI 10.1136/amiajnl-2012-000917; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Larsen MD., JOINT STAT M P SURV, P1995; Mason CA, 2008, BIRTH DEFECTS RES A, V82, P812, DOI 10.1002/bdra.20510; McGlincy MH, 2004, BAYESIAN RECORD LINK, P4001; McGlincy MH, 2006, USING TEST DATABASES, P3404; Navathe AS, 2011, JAMA-J AM MED ASSOC, V306, P1254, DOI 10.1001/jama.2011.1341; NEWCOMBE HB, 1959, SCIENCE, V130, P954, DOI 10.1126/science.130.3381.954; NEWCOMBE HB, 1962, COMMUN ACM, V5, P563, DOI 10.1145/368996.369026; Pasquali SK, 2010, AM HEART J, V160, P1099, DOI 10.1016/j.ahj.2010.08.010; Quantin C, 1998, METHOD INFORM MED, V37, P271; Randall SM, 2013, J BIOMEDICAL INFORM; ROOS LL, 1991, METHOD INFORM MED, V30, P117; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schneider TD, 2013, INFORM THEORY PRIMER; Schnell R, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-41; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Slonim AD, 2010, PEDIATRICS, V125, P1208, DOI 10.1542/peds.2009-1451; Tri-Analytics Inc. and The Johns Hopkins University, 1997, ICDMAP 90 SOFTW US G; United States Department of Health and Human Services, 2014, UND HLTH INF PRIV 20; Weber SC, 2012, J AM MED INFORM ASSN, V19, pE157, DOI 10.1136/amiajnl-2011-000329; Weiss NS, 2011, EPIDEMIOLOGY, V22, P292, DOI 10.1097/EDE.0b013e318210aca5; Weiss PF, 2009, J PEDIATR-US, V155, P812, DOI 10.1016/j.jpeds.2009.05.030; WINKLER W. E., 1993, IMPROVED DECISION RU; Winkler W.E, 2006, OVERVIEW RECORD LINK; Winkler W. E., 1994, ADV METHODS RECORD L	40	12	12	0	3	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0026-1270	2511-705X		METHOD INFORM MED	Methods Inf. Med.		2015	54	4					328	337		10.3414/ME14-01-0093			10	Computer Science, Information Systems; Health Care Sciences & Services; Medical Informatics	Computer Science; Health Care Sciences & Services; Medical Informatics	CP6XQ	WOS:000360031900006	26021580	Green Accepted, Bronze			2021-06-18	
J	Cao, L; Tian, Y; Jiang, Y; Zhang, GJ; Lei, H; Di, ZL				Cao, Lei; Tian, Ye; Jiang, Yi; Zhang, Ge-Juan; Lei, Hui; Di, Zheng-Li			Down-Regulation of Homer1b/c Protects Against Chemically Induced Seizures Through Inhibition of mTOR Signaling	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Epilepsy; Homer; mGluRs; mTOR	TRAUMATIC BRAIN-INJURY; ANTIEPILEPTIC DRUGS; IN-VITRO; EPILEPSY; ACTIVATION; MECHANISMS; PATHWAY; MODEL	Background: Homer is a family of post synaptic density proteins functionally and physically attached to target proteins at proline-rich sequences. Reducing Homer1b/c expression has been shown in previous studies to be protective against excitotoxic insults, implicating Homer1b/c in the physiological regulation of aberrant neuronal excitability. Methods: To test the efficacy of a Homer1b/c reducing therapy for disorders with a detrimental hyperexcitability profile in mice, we used small interfere RNA (siRNA) to decrease endogenous Homer1b/c expression in mouse hippocampus. The baseline motor and cognitive behavior was measured by sensorimotor tests, Morris water maze and elevated plus maze tasks. The anti-epileptic effects of Homer1b/c knockdown were determined in two chemically induced seizure models induced by Picrotoxin (PTX) or pentylenetetrazole (PTZ) administration. Results: The results of sensorimotor tests, Morris water maze and elevated plus maze tasks showed that Homer1b/c reduction had no effect on baseline motor or cognitive behavior. In two chemically induced seizure models, mice with reduced Homerb/c protein had less severe seizures than control mice. Total Homer1b/c protein levels and seizure severity were highly correlated, such that those mice with the most severe seizures also had the highest levels of Homer1b/c. In addition, the phosphorylation of mammalian target of rapamycin (mTOR) and its target protein 56 was significantly inhibited in Homer1b/c down-regulated mice. Homer1b/c knockdown-induced inhibition of mTOR pathway was partially ablated by the metabotropic glutamate receptor 5 (mGluR5) agonist CHPG. Conclusion: Our results demonstrate that endogenous Homer1b/c is integral for regulating neuronal hyperexcitability in adult animals and suggest that reduction of Homer1b/c could protect against chemically induced seizures through inhibition mTOR pathway. Copyright (C) 2015 S Karger AG, Basel	[Cao, Lei; Tian, Ye; Jiang, Yi; Zhang, Ge-Juan; Lei, Hui; Di, Zheng-Li] Xi An Jiao Tong Univ, Xian Cent Hosp, Dept Neurol Dis, Xian 710032, Shaanxi Provinc, Peoples R China; [Cao, Lei] Capital Med Univ, Xuanwu Hosp, Dept Rehabil, Beijing, Peoples R China	Tian, Y (corresponding author), Xi An Jiao Tong Univ, Xian Cent Hosp, Dept Neurol Dis, Xian 710032, Shaanxi Provinc, Peoples R China.	tianye_xjtu@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81201004]	This work was supported by the National Natural Science Foundation of China (No. 81201004).	Avedissian M, 2007, HIPPOCAMPUS, V17, P130, DOI 10.1002/hipo.20248; Chen T, 2013, CELL SIGNAL, V25, P2863, DOI 10.1016/j.cellsig.2013.09.004; Chen T, 2012, NEUROCHEM RES, V37, P983, DOI 10.1007/s11064-011-0691-z; Chen T, 2012, INT J MOL MED, V29, P630, DOI 10.3892/ijmm.2011.870; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Devos SL, 2013, J NEUROSCI, V33, P12887, DOI 10.1523/JNEUROSCI.2107-13.2013; Dhir A., 2012, CURR PROTOC NEUROSCI, V58, P9, DOI [10.1002/0471142301.ns0937s58, DOI 10.1002/0471142301.NS0937S58, DOI 10.1002/0471142301.ns0937s58]; Elger CE, 2008, EPILEPSY BEHAV, V12, P501, DOI 10.1016/j.yebeh.2008.01.003; Fei F, 2014, NEUROSCIENCE, V267, P187, DOI 10.1016/j.neuroscience.2014.02.037; Ghazizadeh V, 2014, METAB BRAIN DIS, V29, P787, DOI 10.1007/s11011-014-9549-9; Kemp A, 2004, P NATL ACAD SCI USA, V101, P8192, DOI 10.1073/pnas.0402650101; LaSarge CL, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmo1.2014.00018, 10.3389/fnmol.2014.00018]; Luo P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.116; Luo P, 2012, NEUROCHEM INT, V61, P731, DOI 10.1016/j.neuint.2012.06.014; Maret S, 2007, P NATL ACAD SCI USA, V104, P20090, DOI 10.1073/pnas.0710131104; Pitkanen A, 2011, BIOMARK MED, V5, P629, DOI [10.2217/bmm.11.67, 10.2217/BMM.11.67]; Rogawski MA, 2006, EPILEPSY RES, V69, P273, DOI 10.1016/j.eplepsyres.2006.02.004; Russo E, 2012, MOL NEUROBIOL, V46, P662, DOI 10.1007/s12035-012-8314-5; Shandra AA, 1996, EPILEPSIA, V37, P269, DOI 10.1111/j.1528-1157.1996.tb00024.x; Shiraishi-Yamaguchi Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-206; Sutton G, 2002, J NEUROCHEM, V82, P1097, DOI 10.1046/j.1471-4159.2002.01031.x; Szumlinski KK, 2004, NEURON, V43, P401, DOI 10.1016/j.neuron.2004.07.019; Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331	27	12	12	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-8987	1421-9778		CELL PHYSIOL BIOCHEM	Cell. Physiol. Biochem.		2015	35	4					1633	1642		10.1159/000373977			10	Cell Biology; Physiology	Cell Biology; Physiology	CF3OC	WOS:000352457400030	25824461	DOAJ Gold			2021-06-18	
J	De La Pena, I; Sanberg, PR; Acosta, S; Lin, SZ; Borlongan, CV				De La Pena, Ike; Sanberg, Paul R.; Acosta, Sandra; Lin, Shinn-Zong; Borlongan, Cesar V.			G-CSF as an Adjunctive Therapy With Umbilical Cord Blood Cell Transplantation for Traumatic Brain Injury	CELL TRANSPLANTATION			English	Article; Proceedings Paper	7th Pan Pacific Sympsosium on Stem Cells and Cancer Research	APR 12-14, 2014	Taichung, TAIWAN			Traumatic brain injury (TBI); Stem cells; Granulocyte-colony-stimulating factor (G-CSF); Neuroinflammation	COLONY-STIMULATING FACTOR; MESENCHYMAL STEM-CELLS; BONE-MARROW-TRANSPLANTATION; HIGH-DOSE CHEMOTHERAPY; FUNCTIONAL RECOVERY; PERIPHERAL-BLOOD; PROGENITOR CELLS; ISCHEMIC-STROKE; HEMATOPOIETIC CYTOKINES; MYOCARDIAL-INFARCTION	Traumatic brain injury (TBI), a major contributor to deaths and permanent disability worldwide, has been recently described as a progressive cell death process rather than an acute event. TBI pathophysiology is complicated and can be distinguished by the initial primary injury and the subsequent secondary injury that ensues days after the trauma. Therapeutic opportunities for TBI remain very limited with patients subjected to surgery or rehabilitation therapy. The efficacy of stem cell-based interventions, as well as neuroprotective agents in other neurological disorders of which pathologies overlap with TBI, indicates their potential as alternative TBI treatments. Furthermore, their therapeutic limitations may be augmented when combination therapy is pursued instead of using a single agent. Indeed, we demonstrated remarkable combined efficacy of human umbilical cord blood (hUCB) cell therapy and granulocyte-colony-stimulating factor (G-CSF) treatment in TBI models, providing essential evidence for the translation of this approach to treat TBI. Further studies are warranted to determine the mechanisms underlying therapeutic benefits exerted by hUCB + G-CSF in order to enhance its safety and efficacy in the clinic.	[De La Pena, Ike; Sanberg, Paul R.; Acosta, Sandra; Borlongan, Cesar V.] Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL USA; [Lin, Shinn-Zong] China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan; [Lin, Shinn-Zong] China Med Univ, Beigan Hosp, Dept Neurosurg, Yunlin, Taiwan; [Lin, Shinn-Zong] China Med Univ, An Nan Hosp, Dept Neurosurg, Tainan, Taiwan; [Lin, Shinn-Zong] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	Borlongan, CV (corresponding author), 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	cborlong@health.usf.edu	Lin, Shinn-Zong/AAX-2379-2020	dela Pena, Ike/0000-0003-2046-522X	Department of DefenseUnited States Department of Defense [W81XWH-11-1-0634]; University of South Florida Signature Interdisciplinary Program in Neuroscience Funds; University of South Florida; Veterans Administration Reintegration Funds; University of South Florida Neuroscience Collaborative Program; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01NS071956-01A1]; James and Esther King Biomedical Research Foundation [1KG01-33966]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS071956] Funding Source: NIH RePORTER	This study was funded by the Department of Defense W81XWH-11-1-0634, the University of South Florida Signature Interdisciplinary Program in Neuroscience Funds, the University of South Florida and Veterans Administration Reintegration Funds, and the University of South Florida Neuroscience Collaborative Program. P. R. Sanberg and C. V. Borlongan serve as consultant and founder, respectively, of Saneron CCEL Therapeutics, Inc. C. V. Borlongan is funded by the National Institutes of Health 1R01NS071956-01A1 and James and Esther King Biomedical Research Foundation 1KG01-33966. The funders had no role in the decision to publish or prepare this manuscript.	Acosta S. A., 2013, J STEM CELL RES T S4, V1, pS004; Acosta SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090953; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Balseanu AT, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/fnagi.2014.00130, 10.3389/fnagi.2014.00044]; Beekman R, 2012, BLOOD, V119, P5071, DOI 10.1182/blood-2012-01-406116; BENSINGER W, 1993, BLOOD, V81, P3158; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BODINE DM, 1994, BLOOD, V84, P1482; Boltze J, 2012, CELL TRANSPLANT, V21, P723, DOI 10.3727/096368911X586783; Borlongan CV, 2011, LEUKEMIA, V25, P1674, DOI 10.1038/leu.2011.167; Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons; Joint Section on Neurotrauma and Critical Care AANS/CNS Carney, 2007, METHODS J NEUROTR S1, V24, pS3; Brasure M, 2013, ARCH PHYS MED REHAB, V94, P1398, DOI 10.1016/j.apmr.2012.12.019; BRONCHUD MH, 1987, BRIT J CANCER, V56, P809, DOI 10.1038/bjc.1987.295; Chen SJ, 2010, STEM CELLS DEV, V19, P1757, DOI 10.1089/scd.2009.0452; Copeland N, 2009, CLIN MED, V9, P342, DOI 10.7861/clinmedicine.9-4-342; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; CRAWFORD J, 1991, NEW ENGL J MED, V325, P164, DOI 10.1056/NEJM199107183250305; DALE DC, 1993, BLOOD, V81, P2496; Dawn B., 2012, 20 YEARS G CSF MILES, P435; Dela Pena I, 2014, J NEUROSURG SCI, V58, P145; DELUCA E, 1992, BRIT J CANCER, V66, P893, DOI 10.1038/bjc.1992.381; DEMETRI GD, 1991, BLOOD, V78, P2791; Diederich K, 2009, J NEUROSCI, V29, P11572, DOI 10.1523/JNEUROSCI.0453-09.2009; Dong F, 2000, BLOOD, V95, P1656, DOI 10.1182/blood.V95.5.1656.005k29_1656_1662; DUHRSEN U, 1988, BLOOD, V72, P2074; England TJ, 2012, STROKE, V43, P405, DOI 10.1161/STROKEAHA.111.636449; Fabrizio KS, 2010, NURS CLIN N AM, V45, P569, DOI 10.1016/j.cnur.2010.06.003; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fesli A, 2014, J PLAST RECONSTR AES, V67, P837, DOI 10.1016/j.bjps.2014.02.011; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Giustini Alessandro, 2013, Handb Clin Neurol, V110, P401, DOI 10.1016/B978-0-444-52901-5.00034-4; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Gorin NC, 2013, EUR J HAEMATOL, V91, P315, DOI 10.1111/ejh.12154; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Guo XH, 2012, TURK NEUROSURG, V22, P732, DOI 10.5137/1019-5149.JTN.6177-12.1; Han JL, 2008, NEUROSCI LETT, V432, P167, DOI 10.1016/j.neulet.2007.07.056; HANAZONO Y, 1990, EXP HEMATOL, V18, P1097; Harris OA, 2009, J NEUROSURG, V110, P1256, DOI 10.3171/2009.1.JNS081320; Henning RJ, 2008, STEM CELLS DEV, V17, P1207, DOI 10.1089/scd.2008.0023; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Huang HY, 2012, CELL TRANSPLANT, V21, pS3, DOI 10.3727/096368912X633725; Hunter MG, 1998, J IMMUNOL, V160, P4979; Ilic D, 2012, BRIT MED BULL, V102, P43, DOI 10.1093/bmb/lds008; Iskander A, 2013, STEM CELL TRANSL MED, V2, P703, DOI 10.5966/sctm.2013-0066; Kadota R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050391; Kaneko Y, 2012, CELL MED, V4, P55, DOI 10.3727/215517912X639306; Kawada H, 2006, CIRCULATION, V113, P701, DOI 10.1161/CIRCULATIONAHA.105.563668; Kokjohn TA, 2013, J NEUROTRAUM, V30, P981, DOI 10.1089/neu.2012.2699; Komine-Kobayashi M, 2006, J CEREBR BLOOD F MET, V26, P402, DOI 10.1038/sj.jcbfm.9600195; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee EJ, 2012, MOL THER, V20, P155, DOI 10.1038/mt.2011.202; Lemoli RM, 1996, J CLIN ONCOL, V14, P3018, DOI 10.1200/JCO.1996.14.11.3018; Li T, 2014, MOL CELL BIOCHEM, V387, P91, DOI 10.1007/s11010-013-1874-5; LIESCHKE GJ, 1994, BLOOD, V84, P1737; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; Liu YP, 2009, ACTA NEUROPATHOL, V117, P469, DOI 10.1007/s00401-009-0516-1; Lu J, 2012, BRAIN INJURY, V26, P1523, DOI 10.3109/02699052.2012.722257; Luo J, 2009, ACTA NEUROCHIR, V151, P1483, DOI 10.1007/s00701-009-0402-6; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McIntosh TK, 1996, EUR J ANAESTH, V13, P291, DOI 10.1046/j.1365-2346.1996.00981.x; Metcalf D, 2010, NAT REV CANCER, V10, P425, DOI 10.1038/nrc2843; Meuer K, 2006, J NEUROCHEM, V97, P675, DOI 10.1111/j.1471-4159.2006.03727.x; Minnerup Jens, 2009, Exp Transl Stroke Med, V1, P2, DOI 10.1186/2040-7378-1-2; Morikawa K, 2002, BRIT J HAEMATOL, V118, P296, DOI 10.1046/j.1365-2141.2002.03574.x; Mueller BK, 2009, BRIT J PHARMACOL, V157, P675, DOI 10.1111/j.1476-5381.2009.00220.x; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Newman MB, 2003, NEUROTOX RES, V5, P355, DOI 10.1007/BF03033155; Newman MB, 2005, STEM CELLS DEV, V14, P29, DOI 10.1089/scd.2005.14.29; Nishio Y, 2007, J NEUROPATH EXP NEUR, V66, P724, DOI 10.1097/nen.0b013e3181257176; Piao CS, 2012, DIFFERENTIATION, V83, P17, DOI 10.1016/j.diff.2011.08.006; Pimentel-Coelho PM, 2012, PEDIATR RES, V71, P464, DOI 10.1038/pr.2011.59; PLATZER E, 1985, J EXP MED, V162, P1788, DOI 10.1084/jem.162.6.1788; Popa-Wagner A, 2010, STROKE, V41, P1027, DOI 10.1161/STROKEAHA.109.575621; Prakash A, 2013, PHARMACOL BIOCHEM BE, V110, P46, DOI 10.1016/j.pbb.2013.05.015; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; Sakowitz OW, 2006, ACTA NEUROCHIR SUPPL, V96, P139; Sanberg PR, 2012, PROG BRAIN RES, V201, P99, DOI 10.1016/B978-0-444-59544-7.00006-8; Sanberg PR, 2012, BRIT MED BULL, V101, P163, DOI 10.1093/bmb/lds001; Sanberg PR, 2005, ANN NY ACAD SCI, V1049, P67, DOI 10.1196/annals.1334.008; Sanchez-Ramos J, 2009, NEUROSCIENCE, V163, P55, DOI 10.1016/j.neuroscience.2009.05.071; Sanchez-Ramos J, 2012, J ALZHEIMERS DIS, V31, P843, DOI 10.3233/JAD-2012-120196; Sandestig A, 2014, THER HYPOTHERMIA TEM, V4, P10, DOI 10.1089/ther.2013.0024; Sandoe J, 2013, NAT NEUROSCI, V16, P780, DOI 10.1038/nn.3425; Sanganalmath SK, 2011, BASIC RES CARDIOL, V106, P709, DOI 10.1007/s00395-011-0183-y; Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17; Schabitz WR, 2010, STROKE, V41, P2545, DOI 10.1161/STROKEAHA.110.579508; Schneider A, 2005, CELL CYCLE, V4, P1753, DOI 10.4161/cc.4.12.2213; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Shahaduzzaman M, 2013, AGE, V35, P2071, DOI 10.1007/s11357-012-9496-5; Shao CX, 2006, FREE RADICAL BIO MED, V41, P77, DOI 10.1016/j.freeradbiomed.2006.03.007; SHERIDAN WP, 1992, LANCET, V339, P640, DOI 10.1016/0140-6736(92)90795-5; SHERIDAN WP, 1989, LANCET, V2, P891; Shim W, 2011, CARDIOVASC RES, V89, P20, DOI 10.1093/cvr/cvq301; SHIMODA K, 1993, J CLIN INVEST, V91, P1310, DOI 10.1172/JCI116330; Shimoda K, 1997, BLOOD, V90, P597, DOI 10.1182/blood.V90.2.597.597_597_604; Shyu WC, 2006, CAN MED ASSOC J, V174, P927, DOI 10.1503/cmaj.051322; Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66; Solaroglu I, 2006, NEUROSCIENCE, V143, P965, DOI 10.1016/j.neuroscience.2006.09.014; Solaroglu I, 2009, NEUROL RES, V31, P167, DOI 10.1179/174313209X393582; Sprigg N, 2006, STROKE, V37, P2979, DOI 10.1161/01.STR.0000248763.49831.c3; Stachura DL, 2013, BLOOD, V122, P3918, DOI 10.1182/blood-2012-12-475392; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Takahashi H, 2012, EUR SPINE J, V21, P2580, DOI 10.1007/s00586-012-2213-3; TAYLOR KM, 1989, J CLIN ONCOL, V7, P1791, DOI 10.1200/JCO.1989.7.12.1791; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; TIAN SS, 1994, BLOOD, V84, P1760; Toth ZE, 2008, BLOOD, V111, P5544, DOI 10.1182/blood-2007-10-119073; Tsuji T, 1999, GROWTH FACTORS, V16, P225, DOI 10.3109/08977199909002132; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Urdzikova L, 2011, CYTOTHERAPY, V13, P1090, DOI 10.3109/14653249.2011.575355; Verina T, 2013, PEDIATR NEUROL, V48, P346, DOI 10.1016/j.pediatrneurol.2012.10.010; Walker PA, 2012, SURGERY, V152, P790, DOI 10.1016/j.surg.2012.06.006; Walker PA, 2009, J TRAUMA, V67, pS120, DOI 10.1097/TA.0b013e3181ad323a; Ward AC, 2000, LEUKEMIA, V14, P973, DOI 10.1038/sj.leu.2401808; Welte K., 2012, 20 YEARS G CSF MILES, P15; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Willing AE, 2003, CELL TRANSPLANT, V12, P449, DOI 10.3727/000000003108746885; Wong D, 2013, BRAIN INJURY, V27, P1377, DOI 10.3109/02699052.2013.823662; Wong JC, 2013, CRIT REV CL LAB SCI, V50, P103, DOI 10.3109/10408363.2013.844678; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xiao BG, 2007, J CELL MOL MED, V11, P1272, DOI 10.1111/j.1582-4934.2007.00101.x; Yang DY, 2010, NEUROL RES, V32, P1041, DOI 10.1179/016164110X12807570510013; Yang M, 2010, CELL TRANSPLANT, V19, P1073, DOI 10.3727/096368910X503415; Yu GL, 2008, MED SCI MONITOR, V14, pRA163; Zhang XM, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-61; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0; Zhao Li R, 2013, Recent Pat CNS Drug Discov, V8, P2	134	12	12	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.		2015	24	3			SI		447	457		10.3727/096368915X686913			11	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Cell Biology; Research & Experimental Medicine; Transplantation	CF7RQ	WOS:000352754400012	25646620				2021-06-18	
J	Doig, E; Prescott, S; Fleming, J; Cornwell, P; Kuipers, P				Doig, Emmah; Prescott, Sarah; Fleming, Jennifer; Cornwell, Petrea; Kuipers, Pim			Development and construct validation of the Client-Centredness of Goal Setting (C-COGS) scale	SCANDINAVIAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						rehabilitation; goal planning; brain injury	TRAUMATIC BRAIN-INJURY; SELF-AWARENESS; REHABILITATION QUESTIONNAIRE; NEUROLOGICAL REHABILITATION; OCCUPATIONAL-THERAPY; PERSPECTIVES; ADULTS; HOME; RELIABILITY; OUTCOMES	Background: Client-centred philosophy is integral to occupational therapy practice and client-centred goal planning is considered fundamental to rehabilitation. Evaluation of whether goal-planning practices are client-centred requires an understanding of the client's perspective about goal-planning processes and practices. The Client-Centredness of Goal Setting (C-COGS) was developed for use by practitioners who seek to be more client-centred and who require a scale to guide and evaluate individually orientated practice, especially with adults with cognitive impairment related to acquired brain injury. Aims: To describe development of the C-COGS scale and examine its construct validity. Material and methods: The C-COGS was administered to 42 participants with acquired brain injury after multidisciplinary goal planning. C-COGS scores were correlated with the Canadian Occupational Performance Measure (COPM) importance scores, and measures of therapeutic alliance, motivation, and global functioning to establish construct validity. Results: The C-COGS scale has three subscales evaluating goal alignment, goal planning participation, and client-centredness of goals. The C-COGS subscale items demonstrated moderately significant correlations with scales measuring similar constructs. Conclusion: Findings provide preliminary evidence to support the construct validity of the C-COGS scale, which is intended to be used to evaluate and reflect on client-centred goal planning in clinical practice, and to highlight factors contributing to best practice rehabilitation.	[Doig, Emmah; Prescott, Sarah; Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Woolloongabba, Qld 4102, Australia; [Fleming, Jennifer; Kuipers, Pim] Queensland Hlth, Metro South Hlth Dist, Ctr Functioning & Hlth Res, Buranda, Qld, Australia; [Cornwell, Petrea] Metro North Hosp, Herston, Qld, Australia; [Cornwell, Petrea] Queensland Hlth, Hlth Serv, Herston, Qld, Australia; [Cornwell, Petrea] Griffith Univ, Sch Appl Psychol & Behav Basis Hlth, Griffith Hlth Inst, Nathan, Qld 4111, Australia; [Kuipers, Pim] Griffith Univ, GHI, CONROD, Nathan, Qld 4111, Australia	Doig, E (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia Campus, Brisbane, Qld, Australia.	e.doig@uq.edu.au	Cornwell, Petrea/AAE-5547-2019; Doig, Emmah/AAG-6674-2021	Doig, Emmah/0000-0002-7020-053X; Kuipers, Pim/0000-0003-0340-2286	Division of Rehabilitation at Princess Alexandra Hospital	This research was conducted with the assistance of a Community Rehabilitation Workforce Project Grant from the Division of Rehabilitation at Princess Alexandra Hospital.	Barnes M, 2000, TXB REHABILITATION M; Bright FAS, 2012, DISABIL REHABIL, V34, P997, DOI 10.3109/09638288.2011.629712; *CAN ASS OCC THER, 1997, EN OCC OCC THER PERS; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; Cott CA, 2004, DISABIL REHABIL, V26, P1411, DOI 10.1080/09638280400000237; Cott CA, 2006, DISABIL REHABIL, V28, P1387, DOI 10.1080/09638280600638398; Doig E., 2014, REHABILITATION GOAL, P181; Doig EJ, 2008, BR J OCCUP THER, V71, P360, DOI DOI 10.1177/030802260807100902; Doig E, 2014, AM J OCCUP THER, V68, P578, DOI 10.5014/ajot.2014.010785; Doig E, 2011, BRAIN INJURY, V25, P1114, DOI 10.3109/02699052.2011.607788; Doig E, 2010, DISABIL REHABIL, V32, P2061, DOI 10.3109/09638281003797356; Doig E, 2009, AM J OCCUP THER, V63, P559, DOI 10.5014/ajot.63.5.559; Fleming JM, 1996, BRAIN INJURY, V10, P1; Hale LA, 2010, EUR J PHYSIOTHER, V12, P142, DOI 10.3109/14038196.2010.486040; Hammell KRW, 2013, CAN J OCCUP THER, V80, P141, DOI 10.1177/0008417413497906; Holliday RC, 2007, DISABIL REHABIL, V29, P389, DOI 10.1080/09638280600841117; Holliday RC, 2007, J NEUROL NEUROSUR PS, V78, P576, DOI 10.1136/jnnp.2006.102509; Kiresuk T., 1994, GOAL ATTAINMENT SCAL; Law M, 1995, Can J Occup Ther, V62, P250; Law M, 1998, CANADIAN OCCUPATIONA; Law MJS, 1998, CLIENT CTR OCCUPATIO; Leach E, 2010, DISABIL REHABIL, V32, P159, DOI 10.3109/09638280903036605; Levack WMM, 2011, PATIENT EDUC COUNS, V85, P206, DOI 10.1016/j.pec.2011.01.011; Levack WMM, 2009, BRAIN INJURY, V23, P192, DOI 10.1080/02699050802695582; Luborsky L, 1996, J Psychother Pract Res, V5, P260; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; Malec JF., 2005, The Mayo-Portland Adaptability Inventory; Mew MM, 1996, AUST OCCUP THER J, V43, P155; Palmadottir G., 2006, BR J OCCUP THER, V69, P394, DOI DOI 10.1177/030802260606900902; Patton M.Q., 2002, QUALITATIVE RES EVAL; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Sherer M., 2014, HDB NEUROPSYCHOLOGY, P233, DOI [10.1007/978-1-4939-0784-7_12, DOI 10.1007/978-1-4939-0784-7_12]; Sumison T., 1999, CLIENT CTR PRACTICE; Townsend E. A., 2013, ENABLING OCCUPATION, P87; Van De Weyer RC, 2010, DISABIL REHABIL, V32, P1419, DOI 10.3109/09638280903574345; Von Koch L, 1998, DISABIL REHABIL, V20, P367, DOI 10.3109/09638289809166095; Wade DT, 1998, CLIN REHABIL, V12, P273, DOI 10.1191/026921598678166365; WEBB PM, 1994, REHABIL PSYCHOL, V39, P179, DOI 10.1037/h0080321; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832	39	12	12	0	10	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1103-8128	1651-2014		SCAND J OCCUP THER	Scand. J. Occup. Ther.		2015	22	4			SI		302	310		10.3109/11038128.2015.1017530			9	Rehabilitation	Rehabilitation	CR4RY	WOS:000361326800010	25699472				2021-06-18	
J	Gatto, R; Chauhan, M; Chauhan, N				Gatto, Rodolfo; Chauhan, Mihir; Chauhan, Neelima			Anti-edema effects of rhEpo in experimental traumatic brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Traumatic brain injury; controlled cortical impact injury; recombinant human erythropoietin; magnetic resonance imaging; edema; AQP4	RECOMBINANT-HUMAN-ERYTHROPOIETIN; NRF2 SIGNALING PATHWAY; AGED GARLIC EXTRACT; SPINAL-CORD-INJURY; AQP4 EXPRESSION; RAT MODEL; AQUAPORIN-4 EXPRESSION; CULTURED ASTROCYTES; CEREBRAL PROTECTION; RECEPTOR ANTAGONIST	Purpose: Traumatic brain injury (TBI) is one of the leading causes of disability and death which begins with the formation of edema as the persistent primary causative factor in TBI. Although medical management of cerebral edema by hypothermia, ventriculostomy, mannitol or hypertonic saline have been effective in treating edema, many of these therapies end up with some neurologic deficits, necessitating novel treatment options for treating post-TBI edema. This study investigated edema reducing effects of recombinant human Erythropoietin (rhEPO) in reducing acute brain edema in the CCI mouse model of TBI. Methods: Anti-edema effects of rhEpo in reducing acute brain edema after injury in the CCI mouse model of TBI were assessed by T2 weighted magnetic resonance imaging (T2wMRI) as the accurate detector of brain edema in correlation with Western blot analysis of cerebral aquaporin 4 (AQP4) index as the critical marker of edema. Results: Results show that rhEpo treatment significantly reduced brain edema with concomitant reduction in AQP4 immuno-expression in the CCI mouse model of TBI. Conclusion: Current results emphasize clinical utility of rhEpo in treating post-TBI edema.	[Gatto, Rodolfo] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL USA; [Chauhan, Mihir] Med Univ Lublin, Lublin, Poland; [Chauhan, Neelima] Jesse Brown VA Med Ctr, R&D, Neurosci Res, Chicago, IL 60612 USA; [Chauhan, Neelima] Univ Illinois, Dept Pediat, Chicago, IL USA	Chauhan, N (corresponding author), Jesse Brown VA Med Ctr, R&D 151, 820 South Damen Ave, Chicago, IL 60612 USA.	nchauhan@uic.edu	Gatto, Rodolfo Gabriel/R-7155-2018	Gatto, Rodolfo Gabriel/0000-0003-2170-6662	VA MERIT Grants (Rehab R&D, Department of Veterans Affairs, Jesse Brown VA Medical Center) [B6285R/NBC, I008880/NBC]; Westside Institute for Science & Education, Chicago, IL; Department of Pediatrics, University of Illinois at Chicago; Department of BioEngineering, University of Illinois at Chicago	This work was supported by VA MERIT Grants (#B6285R/NBC and #I008880/NBC, Rehab R&D, Department of Veterans Affairs, Jesse Brown VA Medical Center); Westside Institute for Science & Education, Chicago, IL; Departments of Pediatrics and Department of BioEngineering, University of Illinois at Chicago. Authors are thankful for the support provided by Dr. Robert Kleps (Research Resource Center, University of Illinois at Chicago) in collecting MRI data. Authors specially wish to thank Jesse Brown VA-Veterinary Medical Unit staff (Robin McWherter, Tyler Ridgeway, Nicholas Cronk and Carl Miller) for their valuable help and support in providing excellent environment and resources to conduct all animal procedures.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bernaudin M, 2000, GLIA, V30, P271, DOI 10.1002/(SICI)1098-1136(200005)30:3<271::AID-GLIA6>3.3.CO;2-8; Bian XX, 2010, NEUROL MED-CHIR, V50, P361, DOI 10.2176/nmc.50.361; Brissaud O, 2010, PEDIATR RES, V68, P123, DOI 10.1203/00006450-201011001-00237; Byts Nadiya, 2009, Exp Transl Stroke Med, V1, P4, DOI 10.1186/2040-7378-1-4; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Chauhan NB, 2005, NEUROPHARMACOLOGY, V48, P93, DOI 10.1016/j.neuropharm.2004.09.014; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chauhan NB, 2010, BRAIN RES, V1360, P177, DOI 10.1016/j.brainres.2010.09.010; Chauhan NB, 2010, J NEUROSCI METH, V190, P1, DOI 10.1016/j.jneumeth.2010.04.004; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Emir M, 2004, TRANSPLANT P, V36, P2935, DOI 10.1016/j.transproceed.2004.11.101; FRANKLIN KBJ, 1998, MOUSE BRAIN STEREOTA; Gaddam Samson Kumar, 2013, Methods Mol Biol, V982, P141, DOI 10.1007/978-1-62703-308-4_9; Grasso G, 2005, NEUROSURGERY, V56, P821, DOI 10.1227/01.NEU.0000156493.00904.7E; Grasso G, 2007, BRAIN RES, V1182, P99, DOI 10.1016/j.brainres.2007.08.078; Gunnarson E, 2009, P NATL ACAD SCI USA, V106, P1602, DOI 10.1073/pnas.0812708106; Hartley CE, 2008, J NEUROSURG, V109, P708, DOI 10.3171/JNS/2008/109/10/0708; Hellewell SC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-156; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hutchinson Peter, 2007, Neurosurg Focus, V22, pE14; Jin W, 2011, J TRAUMA, V71, P680, DOI 10.1097/TA.0b013e3181f6b984; Jin W, 2011, ANN CLIN LAB SCI, V41, P25; Kabadi SV, 2010, ANN NY ACAD SCI, V1199, P105, DOI 10.1111/j.1749-6632.2009.05352.x; Kalinin S, 2006, ANTIOXID REDOX SIGN, V8, P873, DOI 10.1089/ars.2006.8.873; Kapoor S, 2013, J NEUROSCI, V33, P17398, DOI 10.1523/JNEUROSCI.2756-13.2013; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Kimelberg HK, 2010, NEUROSCIENTIST, V16, P79, DOI 10.1177/1073858409342593; Knapp JM, 2005, AACN ADV CRIT CARE, V16, P199, DOI 10.1097/00044067-200504000-00011; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; Li LA, 2011, J NEUROTRAUM, V28, P535, DOI 10.1089/neu.2010.1619; Liao ZB, 2008, EUR J NEUROL, V15, P140, DOI 10.1111/j.1468-1331.2007.02013.x; Liao ZB, 2009, NEUROL INDIA, V57, P722, DOI 10.4103/0028-3886.59466; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Marmarou CR, 2014, BRAIN RES, V1581, P89, DOI 10.1016/j.brainres.2014.06.005; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Moore EM, 2011, ANAESTH INTENS CARE, V39, P356, DOI 10.1177/0310057X1103900306; Ning RZ, 2011, BRAIN RES, V1384, P140, DOI 10.1016/j.brainres.2011.01.099; Odri A, 2009, ANN FR ANESTH, V28, P352, DOI 10.1016/j.annfar.2009.02.023; Ogden AT, 2005, NEUROSURGERY, V57, P207, DOI 10.1227/01.NEU.0000166533.79031.D8; Ozisik K, 2006, TRANSPLANT P, V38, P2784, DOI 10.1016/j.transproceed.2006.08.100; Ozisik PA, 2007, SURG NEUROL, V68, P547, DOI 10.1016/j.surneu.2007.01.030; Pearse D, 2010, CURR OPIN INVEST DR, V11, P1207; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Ray B, 2011, CURR MED CHEM, V18, P3306, DOI 10.2174/092986711796504664; Ray B, 2011, J NEUROCHEM, V117, P388, DOI 10.1111/j.1471-4159.2010.07145.x; Romeiro RR, 2007, NEUROSCI LETT, V426, P133, DOI 10.1016/j.neulet.2007.09.004; Schober ME, 2014, J NEUROTRAUM, V31, P358, DOI 10.1089/neu.2013.2922; Shi ZF, 2015, BIOMED ENVIRON SCI, V28, P199, DOI 10.3967/bes2015.026; Sims JR, 2009, NEUROLOGY, V72, P2104, DOI 10.1212/WNL.0b013e3181aa5329; Siren AL, 2009, NEUROTHERAPEUTICS, V6, P108, DOI 10.1016/j.nurt.2008.10.041; Tang ZH, 2013, NEUROPHARMACOLOGY, V67, P8, DOI 10.1016/j.neuropharm.2012.10.017; Tang ZH, 2012, NEUROSCI LETT, V530, P23, DOI 10.1016/j.neulet.2012.09.029; Taya K, 2008, ACTA NEUROCHIR SUPPL, V102, P425, DOI 10.1007/978-3-211-85578-2_83; Tomura S, 2011, J NEUROTRAUM, V28, P237, DOI 10.1089/neu.2010.1443; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Valable S, 2010, J CEREBR BLOOD F MET, V30, P361, DOI 10.1038/jcbfm.2009.222; Velly L, 2010, PHARMACOL THERAPEUT, V128, P445, DOI 10.1016/j.pharmthera.2010.08.002; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Vitellaro-Zuccarello L, 2008, NEUROSCIENCE, V151, P452, DOI 10.1016/j.neuroscience.2007.11.004; Wang L, 2015, TRANSL STROKE RES, V6, P50, DOI 10.1007/s12975-014-0362-x; Weiss N, 2007, CRIT CARE, V11, DOI 10.1186/cc6107; Xiong Y, 2008, BRAIN RES, V1230, P247, DOI 10.1016/j.brainres.2008.06.127; Xiong Y, 2011, J NEUROSURG, V114, P549, DOI 10.3171/2010.10.JNS10925; Zhang YL, 2010, BRAIN RES, V1353, P249, DOI 10.1016/j.brainres.2010.07.046; Zhao JB, 2011, CYTOKINE, V56, P343, DOI 10.1016/j.cyto.2011.07.018; Zhu L, 2009, J TRAUMA, V66, P730, DOI 10.1097/TA.0b013e318184b4db	75	12	17	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2015	33	6					927	941		10.3233/RNN-150577			15	Neurosciences	Neurosciences & Neurology	DA1MU	WOS:000367560700011	26484701				2021-06-18	
J	Kalpakis, K; Yang, SM; Hu, PF; Mackenzie, CF; Stansbury, LG; Stein, DM; Scalea, TM				Kalpakis, Konstantinos; Yang, Shiming; Hu, Peter F.; Mackenzie, Colin F.; Stansbury, Lynn G.; Stein, Deborah M.; Scalea, Thomas M.			Permutation entropy analysis of vital signs data for outcome prediction of patients with severe traumatic brain injury	COMPUTERS IN BIOLOGY AND MEDICINE			English	Article						Permutation entropy; Ordinal pattern; Traumatic brain injury; Vital signs; Prediction	INTRACRANIAL HYPERTENSION; EEG; MORTALITY	Permutation entropy is computationally efficient, robust to outliers, and effective to measure complexity of time series. We used this technique to quantify the complexity of continuous vital signs recorded from patients with traumatic brain injury (TBI). Using permutation entropy calculated from early vital signs (initial 10-20% of patient hospital stay time), we built classifiers to predict in-hospital mortality and mobility, measured by 3-month Extended Glasgow Outcome Score (GOSE). Sixty patients with severe TBI produced a skewed dataset that we evaluated for accuracy, sensitivity and specificity. The overall prediction accuracy achieved 91.67% for mortality, and 76.67% for 3-month GOSE in testing datasets, using the leave-one-out cross validation. We also applied Receiver Operating Characteristic analysis to compare classifiers built from different learning methods. Those results support the applicability of permutation entropy in analyzing the dynamic behavior of TBI vital signs for early prediction of mortality and long-term patient outcomes. (C) 2014 Elsevier Ltd. All rights reserved.	[Kalpakis, Konstantinos] Univ Maryland, Dept Comp Sci & Elect Engn, Baltimore, MD 21250 USA; [Yang, Shiming; Hu, Peter F.; Mackenzie, Colin F.; Stansbury, Lynn G.; Stein, Deborah M.; Scalea, Thomas M.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA	Kalpakis, K (corresponding author), Univ Maryland, Dept Comp Sci & Elect Engn, Baltimore, MD 21250 USA.	kalpakis@umbc.edu	Yang, Shiming/I-3695-2015	Yang, Shiming/0000-0003-0338-4268; Stein, Deborah/0000-0003-3683-3963	 [W81XWH-07-2-0118];  [FA8650-11-2-6D01]	This research was funded in part by the grants W81XWH-07-2-0118 (Early Support of Intracranial Perfusion) and FA8650-11-2-6D01 (Continuing Non-Invasive Monitoring and the Development of Predictive Triage Indices for Outcomes Following Trauma). The authors thank Karen Murdoch, RPT; Melissa Binder, BS; Betsy Kramer RN, MS; and the ONPOINT investigators group for their support.	Bandt C, 2005, ECOL MODEL, V182, P229, DOI 10.1016/j.ecolmodel.2004.04.003; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Berg S., 2010, P BIOS BERL GERM; Bezerianos A, 2003, ANN BIOMED ENG, V31, P221, DOI 10.1114/1.1541013; Bian C., 2012, PHYS REV E, V85, P7; Bruzzo AA, 2008, NEUROL SCI, V29, P3, DOI 10.1007/s10072-008-0851-3; Cai YY, 2006, MED ENG PHYS, V28, P297, DOI 10.1016/j.medengphy.2005.05.002; Cao YH, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.046217; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Fawcelt T., HPL20034 INT ENT TEC; Fulcher BD, 2014, IEEE T KNOWL DATA EN, V26, P3026, DOI 10.1109/TKDE.2014.2316504; Guo DS, 2010, INT J GEOGR INF SCI, V24, P1367, DOI 10.1080/13658811003619143; Japkowicz Nathalie, 2011, EVALUATING LEARNING; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kahraman S., CLIN INVEST, V22; Kahraman S, 2011, J TRAUMA, V70, P547, DOI 10.1097/TA.0b013e31820c768a; Kantz H., 2003, NONLINEAR TIME SERIE; Li XL, 2008, ANESTHESIOLOGY, V109, P448, DOI 10.1097/ALN.0b013e318182a91b; Li XL, 2007, EPILEPSY RES, V77, P70, DOI 10.1016/j.eplepsyres.2007.08.002; Lopes FM, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-61; MacKay D.J., 2003, INFORM THEORY INFERE; Nicolaou N, 2011, CLIN EEG NEUROSCI, V42, P24, DOI 10.1177/155005941104200107; Olofsen E, 2008, BRIT J ANAESTH, V101, P810, DOI 10.1093/bja/aen290; Ouyang GX, 2010, CLIN NEUROPHYSIOL, V121, P694, DOI 10.1016/j.clinph.2009.12.030; Platt JC, 2000, ADV NEUR IN, P61; Provost F., 2000, WELL TRAINED PETS IM; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Simon N., 2011, SCIENCE         1216; Sinai Y.G., 2007, METRIC ENTROPY DYNAM; Stein DM, 2013, NEUROCRIT CARE, V18, P332, DOI 10.1007/s12028-013-9832-3; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; Sun XL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-607; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505; Szekely GJ, 2009, ANN APPL STAT, V3, P1236, DOI 10.1214/09-AOAS312; Veisi I, 2007, PROCEEDINGS OF THE 7TH IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, VOLS I AND II, P200; Zanin M., 2008, CHAOS, V18; Zanin M, 2012, ENTROPY-SWITZ, V14, P1553, DOI 10.3390/e14081553	38	12	13	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825	1879-0534		COMPUT BIOL MED	Comput. Biol. Med.	JAN 1	2015	56						167	174		10.1016/j.compbiomed.2014.11.007			8	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	AZ5MQ	WOS:000348265400016	25464358				2021-06-18	
J	Karic, T; Sorteberg, A; Nordenmark, TH; Becker, F; Roe, C				Karic, Tanja; Sorteberg, Angelika; Nordenmark, Tonje Haug; Becker, Frank; Roe, Cecilie			Early rehabilitation in patients with acute aneurysmal subarachnoid hemorrhage	DISABILITY AND REHABILITATION			English	Article						Brain injury; early rehabilitation; intracranial aneurysm; mobilization; stroke; subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; EARLY MOBILIZATION; PHASE-II; INTRACRANIAL-PRESSURE; STROKE; MANAGEMENT; VASOSPASM; MORTALITY; SAFETY; RETURN	Purpose: The aim of this study was to describe and quantify the content of early rehabilitation adapted to patients with acute aneurysmal subarachnoid hemorrhage (aSAH) and to assess its feasibility. Methods: This was a prospective, observational study including 37 aSAH patients. Early rehabilitation was applied according to a mobilization algorithm. Clinical parameters, the time that rehabilitation team used on early rehabilitation and progression in mobilization were recorded. The patients' clinical conditions were graded according to the World Federation of Neurological Surgeons scale (WFNS). Results: Poor-grade patients (WFNS 3, 4, 5) (n = 12) received more rehabilitation (median 412 min) than did good-grade patients (WFNS 1, 2) (median 240 min). Mobilization to 600 of head elevation in good-grade patients began on day one after securing the aneurysm. Out-of-bed mobilization was possible on day three. Poor-grade patients were mobilized to 60 after two days and were out of bed on day seven. At discharge, 67% of poor-grade patients were mobilized to walking versus 78% of good-grade patients. No serious adverse effects to early rehabilitation were observed. Conclusions: Early rehabilitation in aSAH patients is feasible from the first day after securing the aneurysm. The rehabilitation content varied according to the patient's clinical grade.	[Karic, Tanja; Nordenmark, Tonje Haug; Roe, Cecilie] Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0424 Oslo, Norway; [Karic, Tanja; Sorteberg, Angelika] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Neurosurg, N-0027 Oslo, Norway; [Becker, Frank] Sunnaas Rehabil Hosp, Nesoddtangen, Norway; [Becker, Frank; Roe, Cecilie] Univ Oslo, Inst Clin Med, Oslo, Norway	Karic, T (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, PB 4950 Nydalen, N-0424 Oslo, Norway.	tanja.karic@gmail.com		Becker, Frank/0000-0002-0857-0628			Albano C, 2005, CRIT CARE NURS Q, V28, P135, DOI 10.1097/00002727-200504000-00006; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; [Anonymous], 2005, CLIN REHABIL, V19, P811, DOI 10.1191/0269215505cr923ed; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Bernhardt J, 2008, STROKE, V39, P390, DOI 10.1161/STROKEAHA.107.492363; Bernhardt J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006187.pub2; Blissitt PA, 2006, AM J CRIT CARE, V15, P206; Brimioulle S, 1997, PHYS THER, V77, P1682, DOI 10.1093/ptj/77.12.1682; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, pS35, DOI 10.1016/S0003-9993(99)90101-6; Cumming TB, 2011, STROKE, V42, P153, DOI 10.1161/STROKEAHA.110.594598; Diserens K, 2006, CEREBROVASC DIS, V22, P183, DOI 10.1159/000093453; Diserens K, 2012, CLIN REHABIL, V26, P451, DOI 10.1177/0269215511425541; DRAKE CG, 1988, J NEUROSURG, V68, P985; Engberg AW, 2006, ACTA NEUROL SCAND, V113, P178, DOI 10.1111/j.1600-0404.2005.00570.x; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Haug T, 2007, NEUROSURGERY, V60, P649, DOI 10.1227/01.NEU.0000255414.70807.A0; Hellawell DJ, 2001, DISABIL REHABIL, V23, P300, DOI 10.1080/769979114; HEROS RC, 1983, ANN NEUROL, V14, P599, DOI 10.1002/ana.410140602; Indredavik B, 1999, STROKE, V30, P917, DOI 10.1161/01.STR.30.5.917; Jessup RL, 2007, AUST HEALTH REV, V31, P330, DOI 10.1071/AH070330; Koch SM, 1996, J CRIT CARE, V11, P176, DOI 10.1016/S0883-9441(96)90028-3; Kwakkel G, 1997, STROKE, V28, P1550, DOI 10.1161/01.STR.28.8.1550; Langhorne P, 1996, Physiother Res Int, V1, P75; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; Lindekleiv HM, 2011, ACTA NEUROL SCAND, V123, P34, DOI 10.1111/j.1600-0404.2010.01336.x; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Olkowski BF, 2013, PHYS THER, V93, P208, DOI 10.2522/ptj.20110334; Passier PECA, 2011, J STROKE CEREBROVASC, V20, P324, DOI 10.1016/j.jstrokecerebrovasdis.2010.02.001; Rosen DS, 2005, NEUROCRIT CARE, V2, P110, DOI 10.1385/NCC:2:2:110; Ryu CW, 2011, J KOREAN NEUROSURG S, V49, P112, DOI 10.3340/jkns.2011.49.2.112; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Sandvei MS, 2011, NEUROLOGY, V77, P1833, DOI 10.1212/WNL.0b013e3182377de3; Sorbo A, 2005, BRAIN INJURY, V19, P493, DOI 10.1080/02699050400013709; Sorteberg A, 2013, CURR PEDIATR REV, V9, P343, DOI 10.2174/221155281120100005; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099; Sveinsson OA, 2011, LAEKNABLADID, V97, P355, DOI 10.17992/lbl.2011.06.377; Titsworth WL, 2012, J NEUROSURG, V116, P1379, DOI 10.3171/2012.2.JNS111881; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; van Wijk R, 2012, NEUROREHAB NEURAL RE, V26, P20, DOI 10.1177/1545968311407779; Whyte J, 2006, J HEAD TRAUMA REHAB, V21, P99, DOI 10.1097/00001199-200603000-00003; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Whyte J, 2012, ARCH PHYS MED REHAB, V93, pS101, DOI 10.1016/j.apmr.2011.11.040; Whyte J, 2009, NEUROPSYCHOL REHABIL, V19, P807, DOI 10.1080/09602010903031146	43	12	13	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2015	37	16-17					1446	1454		10.3109/09638288.2014.966162			9	Rehabilitation	Rehabilitation	CN7RC	WOS:000358630700007	25264735				2021-06-18	
J	Kim, SH; Saver, JL				Kim, Seo Hyun; Saver, Jeffrey L.			Initial Body Temperature in Ischemic Stroke Nonpotentiation of Tissue-Type Plasminogen Activator Benefit and Inverse Association With Severity	STROKE			English	Article						body temperature; outcome measures; stroke; tissue-type plasminogen activator	TRAUMATIC BRAIN-INJURY; THROMBOLYSIS; HYPOTHERMIA; TPA; ALTEPLASE; OUTCOMES; TRIALS; SIZE	Background and Purpose-Body temperature (BT) is an important physiological factor in acute ischemic stroke. However, the relationship of initial BT to stroke severity and degree of benefit from thrombolytic therapy has been delineated incompletely. Methods-We analyzed the public data set of the 2 National Institute of Neurological Disorders and Stroke Tissue-Type Plasminogen Activator (tPA) stroke trials, comparing patients with lower (<37.0 degrees C) and higher (=37.0 degrees C) presenting BT. Results-Among 595 patients (297 placebo and 298 tPA treated) with documented initial BT, 77.1% had initial BT <37.0 degrees C and 22.9% >= 37.0 degrees C. Patients with higher initial BT had lower baseline stroke severity in both tPA-treated patients (the National Institute of Health Stroke Scale median, 11 versus 15; P=0.05) and placebo-treated patients (median, 13 versus 16; P<0.01). Patients with higher initial BT also had lower infarction volume on computed tomography at 3 months in both tPA-treated patients (median, 9.6 versus 16.7 cm(3); P=0.08) and placebo-treated patients (median, 13.1 versus 28.1 cm(3); P=0.02), but no clinical outcome differences. Analysis of lytic treatment effect found no heterogeneity in the degree of tPA benefit in both higher and lower BT groups (>= 37.0 degrees C: odds ratio for the modified Rankin Scale 0-1 outcome, 2.55; 95% confidence interval, 1.05-6.21 and <37.0 degrees C: odds ratio, 2.30; 95% confidence interval, 1.38-3.84; heterogeneity P=0.83). Conclusions-In patients with hyperacute stroke, higher presenting temperatures are associated with less severe neurological deficits and reduced final infarct volumes. Presenting temperature does not modify the benefit of tPA on 3-month favorable outcome.	[Kim, Seo Hyun] Yonsei Univ, Wonju Coll Med, Dept Neurol, Wonju, South Korea; [Saver, Jeffrey L.] Univ Calif Los Angeles, David Geffen Sch Med, Comprehens Stroke Ctr, Dept Neurol, Los Angeles, CA 90095 USA	Saver, JL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Comprehens Stroke Ctr, Dept Neurol, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	jsaver@mednet.ucla.edu		Saver, Jeffrey/0000-0001-9141-2251	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS044364, U01 NS44364] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS044364] Funding Source: NIH RePORTER		Boysen G, 2001, STROKE, V32, P413, DOI 10.1161/01.STR.32.2.413; Bukur M, 2012, J SURG RES, V175, P24, DOI 10.1016/j.jss.2011.07.003; Dabzl D, 2012, HARRISONS PRINCIPLES; de Ridder I, 2013, CEREBROVASC DIS, V35, P60, DOI 10.1159/000345335; de Ridder IR, 2013, INT J STROKE; Ernon L, 2006, ACTA NEUROL SCAND, V114, P23, DOI 10.1111/j.1600-0404.2006.00596.x; Hilz MJ, 2011, STROKE, V42, P1528, DOI 10.1161/STROKEAHA.110.607721; Idicula Titto T, 2008, J Stroke Cerebrovasc Dis, V17, P141, DOI 10.1016/j.jstrokecerebrovasdis.2008.01.010; Karaszewski B, 2013, J CEREBR BLOOD F MET, V33, P1083, DOI 10.1038/jcbfm.2013.52; Karaszewski B, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-123; Konstantinidis A, 2011, J TRAUMA, V71, P1627, DOI 10.1097/TA.0b013e3182159e31; Kvistad CE, 2014, ACTA NEUROL SCAND, V129, P325, DOI 10.1111/ane.12184; Kvistad CE, 2012, VASC HEALTH RISK MAN, V8, P333, DOI 10.2147/VHRM.S31614; Kvistad CE, 2014, VASC HEALTH RISK MAN, V10, P49, DOI 10.2147/VHRM.S55423; Kvistad CE, 2013, VASC HEALTH RISK MAN, V9, P297, DOI 10.2147/VHRM.S44570; Lees JS, 2011, STROKE, V42, P2618, DOI 10.1161/STROKEAHA.110.611210; Levine SR, 2000, STROKE, V31, P2912; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Middleton S, 2011, LANCET, V378, P1699, DOI 10.1016/S0140-6736(11)61485-2; Millan M, 2008, EUR J NEUROL, V15, P1384, DOI 10.1111/j.1468-1331.2008.02321.x; Naess H, 2010, ACTA NEUROL SCAND, V122, P414, DOI 10.1111/j.1600-0404.2010.01331.x; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Saini M, 2009, STROKE, V40, P3051, DOI 10.1161/STROKEAHA.109.556134; Saver JL, 2007, STROKE, V38, P414, DOI 10.1161/01.STR.0000254580.39297.3c; Shaw GJ, 2007, PHYS MED BIOL, V52, P2953, DOI 10.1088/0031-9155/52/11/002; Shaw GJ, 2006, THROMB RES, V117, P603, DOI 10.1016/j.thromres.2005.05.005; Steiner AA, 2002, ANNU REV PHYSIOL, V64, P263, DOI 10.1146/annurev.physiol.64.081501.155856; Takagi K, 2003, J NEUROSURG, V98, P50, DOI 10.3171/jns.2003.98.1.0050; van der Worp HB, 2010, J CEREBR BLOOD F MET, V30, P1079, DOI 10.1038/jcbfm.2010.44; YENARI MA, 1995, THROMB RES, V77, P475, DOI 10.1016/0049-3848(95)93883-2	30	12	13	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	JAN	2015	46	1					132	136		10.1161/STROKEAHA.114.006107			5	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	AX1XB	WOS:000346735800036	25424482	Green Accepted, Bronze			2021-06-18	
J	Lauterbach, MD; Notarangelo, PL; Nichols, SJ; Lane, KS; Koliatsos, VE				Lauterbach, Margo D.; Notarangelo, Paula L.; Nichols, Stephen J.; Lane, Kristy S.; Koliatsos, Vassilis E.			Diagnostic and treatment challenges in traumatic brain injury patients with severe neuropsychiatric symptoms: insights into psychiatric practice	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						traumatic brain injury; neurobehavioral; treatment	FOLLOW-UP; AXIS-I; DEPRESSION; DISORDERS; AGGRESSION; MOOD	Traumatic brain injury (TBI) causes a variety of neuropsychiatric problems that pose diagnostic and treatment challenges for providers. In this report, we share our experience as a referral neuropsychiatry program to assist the general psychiatrist when adult TBI patients with psychiatric symptoms present for evaluation and treatment. We completed a retrospective study of patients with moderate-to-severe TBI and severe neuropsychiatric impairments. We collected information on demographics, nature of injury, symptomatology, diagnoses, and treatments. Data analysis indicates that mood stabilization was a key concern, often requiring aggressive pharmacological management. Cognitive dysfunction was a problem for the majority of patients, but was only medicated in a third, due to poor efficacy or behavioral side effects. The co-occurrence of multiple TBI-related symptoms and diagnoses in this patient cohort emphasizes the need for individualized psychopharmacological approaches and interventions.	[Lauterbach, Margo D.; Notarangelo, Paula L.; Lane, Kristy S.; Koliatsos, Vassilis E.] Sheppard Pratt Hlth Syst, Neuropsychiat Program Sheppard Pratt, Baltimore, MD 21285 USA; [Nichols, Stephen J.] Univ Tennessee, Coll Med Chattanooga, Dept Emergency Med, Chattanooga, TN USA	Lauterbach, MD (corresponding author), Sheppard Pratt Hlth Syst, Neuropsychiat Program Sheppard Pratt, 6501 North Charles St,POB 6815, Baltimore, MD 21285 USA.	mlauterbach@sheppardpratt.org			Leonard and Helen R. Stulman Charitable Foundation; Women's Hospital Foundation, Inc.	The authors are supported by the Leonard and Helen R. Stulman Charitable Foundation and the Women's Hospital Foundation, Inc. Dr Lauterbach is a one-third owner of Brain Educators, LLC, publishers of The Brain Card (R). The authors report no other conflicts of interest in this work.	Arciniegas DB, 2003, INT REV PSYCHIATR, V15, P328, DOI 10.1080/09540260310001606719; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Deb S, 1999, AM J PSYCHIAT, V156, P374; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Guerreiro DF, 2009, BRAIN INJURY, V23, P358, DOI 10.1080/02699050902800918; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Himanen L, 2009, BRAIN INJURY, V23, P220, DOI 10.1080/02699050902748323; Hurley Robin A., 2002, Curr Treat Options Neurol, V4, P59, DOI 10.1007/s11940-002-0005-5; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Perino C, 2001, BRAIN INJURY, V15, P139, DOI 10.1080/026990501458371; Rao V, 2015, SEMIN NEUROL, V35, P64, DOI 10.1055/s-0035-1544241; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P231, DOI 10.1176/appi.neuropsych.22.2.231; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Silver JM, 2011, TXB TRAUMATIC BRAIN, P234; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Yasseen B, 2008, BRAIN INJURY, V22, P752, DOI 10.1080/02699050802320132	32	12	12	0	9	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND		1178-2021		NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2015	11						1601	1607		10.2147/NDT.S80457			7	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	CM3KL	WOS:000357580800001	26170672	DOAJ Gold, Green Published			2021-06-18	
J	Lefebvre, G; Tremblay, S; Theoret, H				Lefebvre, Genevieve; Tremblay, Sara; Theoret, Hugo			Probing the effects of mild traumatic brain injury with transcranial magnetic stimulation of the primary motor cortex	BRAIN INJURY			English	Article						Concussion; cortical excitability; Inhibition; primary motor cortex	SPORT-RELATED CONCUSSION; INTRACORTICAL INHIBITION; CORTICAL EXCITABILITY; FOOTBALL PLAYERS; HEAD-INJURIES; LONG-TERM; GABA; PLASTICITY; GLUTAMATE; TMS	Primary objective: The present paper systematically reviews studies using transcranial magnetic stimulation (TMS) over the primary motor cortex (M1) to assess cortical excitability, intra-cortical inhibition/facilitation and synaptic plasticity following mild traumatic brain injury (mTBI). Methods: Articles using TMS over M1 in patients with mTBI or sport-related concussion indexed in PubMed and published between 1998 and September 2014 were included in the present review. Main outcomes and results: From the 17 articles that matched search criteria, results from various TMS paradigms were summarized and divided in three main areas of interest: motor cortical excitability/facilitation, motor cortical inhibition and cortical plasticity. Although studies suggest a trend of abnormal intra-cortical inhibition following mTBI, no clear and specific pattern emerges from the surveyed data. Conclusions: At this time and with the possible exception of intra-cortical inhibitory measures, TMS cannot reliably detect changes in M1 excitability in individuals with mTBI or a concussion at both the acute and chronic stages of injury. This may be explained by the small number of studies and large variety of stimulation parameters. Additional longitudinal and multimodal studies are needed to better understand the nature of the excitability changes that may occur within M1 following mTBI.	[Lefebvre, Genevieve; Tremblay, Sara; Theoret, Hugo] Univ Montreal, Psychol, Montreal, PQ H3C 3J7, Canada; [Lefebvre, Genevieve; Tremblay, Sara; Theoret, Hugo] Ste Justine Hosp Res Ctr, Montreal, PQ, Canada	Theoret, H (corresponding author), Univ Montreal, Dept Psychol, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	hugo.theoret@umontreal.ca	Tremblay, Sara/X-5471-2019	Theoret, Hugo/0000-0002-7458-8797	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Fonds de Recherche du Quebec-SanteFonds de la Recherche en Sante du Quebec; Vanier Canada Graduate scholarship from the Canadian Institutes of Health Research	This work was supported by grants from the Canadian Institutes of Health Research and the Fonds de Recherche du Quebec-Sante. ST was supported by a Vanier Canada Graduate scholarship from the Canadian Institutes of Health Research. The authors report no conflicts of interest.	Abbruzzese G, 2002, J CLIN NEUROPHYSIOL, V19, P307, DOI 10.1097/00004691-200208000-00005; Ashwal S, 2004, J NEUROTRAUM, V21, P1539, DOI 10.1089/neu.2004.21.1539; BARKER AT, 1985, LANCET, V1, P1106; Bashir S, 2012, RESTOR NEUROL NEUROS, V30, P277, DOI 10.3233/RNN-2012-110207; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen R, 2008, CLIN NEUROPHYSIOL, V119, P504, DOI 10.1016/j.clinph.2007.10.014; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; Chistyakov AV, 1998, ACTA NEUROCHIR, V140, P467, DOI 10.1007/s007010050126; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Di Lazzaro V, 2007, CLIN NEUROPHYSIOL, V118, P2207, DOI 10.1016/j.clinph.2007.07.005; Di Lazzaro V, 2000, CLIN NEUROPHYSIOL, V111, P794, DOI 10.1016/S1388-2457(99)00314-4; Di Lazzaro V, 2003, J PHYSIOL-LONDON, V547, P485, DOI 10.1113/jphysiol.2002.030486; Di Lazzaro V, 2000, EXP BRAIN RES, V135, P455, DOI 10.1007/s002210000543; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Giza CC, 2001, J ATHL TRAINING, V36, P228; Green Robin, 2010, Neuropsychol Rehabil, V20, P471, DOI 10.1080/09602011003693298; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Holshouser BA, 2006, J MAGN RESON IMAGING, V24, P33, DOI 10.1002/jmri.20607; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Ilic TV, 2002, J PHYSIOL-LONDON, V545, P153, DOI 10.1113/jphysiol.2002.030122; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Liepert J, 1997, J NEURAL TRANSM, V104, P1207, DOI 10.1007/BF01294721; Livingston SC, 2012, J CLIN NEUROPHYSIOL, V29, P23, DOI 10.1097/WNP.0b013e318246ae46; Livingston SC, 2010, BRAIN INJURY, V24, P904, DOI 10.3109/02699051003789245; Lovell M, 2008, NEUROL CLIN, V26, P45, DOI 10.1016/j.ncl.2007.12.001; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McDonnell MN, 2006, EXP BRAIN RES, V173, P86, DOI 10.1007/s00221-006-0365-2; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mendez CV, 2005, J NEUROPSYCH CLIN N, V17, P297, DOI 10.1176/appi.neuropsych.17.3.297; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Miller NR, 2014, BRAIN INJURY, V28, P1270, DOI 10.3109/02699052.2014.915987; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Paulus W, 2008, BRAIN STIMUL, V1, P151, DOI 10.1016/j.brs.2008.06.002; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Putukian M, 2009, BRIT J SPORT MED, V43, pI28, DOI 10.1136/bjsm.2009.058230; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; Reddy CC, 2009, CURR SPORT MED REP, V8, P10, DOI 10.1249/JSR.0b013e31819539ca; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Stagg CJ, 2011, J PHYSIOL-LONDON, V589, P5845, DOI 10.1113/jphysiol.2011.216978; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Tallus J, 2012, ACTA NEUROL SCAND, V126, P178, DOI 10.1111/j.1600-0404.2011.01623.x; Tallus J, 2013, J NEUROTRAUM, V30, P1270, DOI 10.1089/neu.2012.2760; Tokimura H, 2000, J PHYSIOL-LONDON, V523, P503, DOI 10.1111/j.1469-7793.2000.t01-1-00503.x; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2013, J NEUROPHYSIOL, V109, P1343, DOI 10.1152/jn.00704.2012; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Udupa K, 2009, EXP BRAIN RES, V199, P177, DOI 10.1007/s00221-009-1997-9; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x; Ziemann U, 2004, CLIN NEUROPHYSIOL, V115, P1717, DOI 10.1016/j.clinph.2004.03.006	64	12	12	0	15	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	9					1032	1043		10.3109/02699052.2015.1028447			12	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CR1UG	WOS:000361110000003	25996466				2021-06-18	
J	Liang, ZY; Luo, YH				Liang, Zhaoyang; Luo, Yunhua			A QCT-Based Nonsegmentation Finite Element Head Model for Studying Traumatic Brain Injury	APPLIED BIONICS AND BIOMECHANICS			English	Article							BONE-DENSITY; CT NUMBERS	In the existing finite element head models (FEHMs) that are constructed from medical images, head tissues are usually segmented into a number of components according to the interior anatomical structure of the head. Each component is represented by a homogenous material model. There are a number of disadvantages in the segmentation-based finite element head models. Therefore, we developed a nonsegmentation finite element head model with pointwise-heterogeneous material properties and corroborated it by available experiment data. Fromthe obtained results, it was found that although intracranial pressures predicted by the existing (piecewise-homogeneous) and the proposed (pointwise-heterogeneous) FEHM are very similar to each other, strain/stress levels in the head tissues are very different. The maximum peak strains/stresses predicted by the proposed FEHM are much higher than those by the existing FEHM, indicating that piecewise-homogeneous FEHM may have underestimated the stress/strain level induced by impact and thus may be inaccurate in predicting traumatic brain injuries.	[Liang, Zhaoyang; Luo, Yunhua] Univ Manitoba, Dept Mech Engn, Winnipeg, MB R3T 5V6, Canada	Luo, YH (corresponding author), Univ Manitoba, Dept Mech Engn, Winnipeg, MB R3T 5V6, Canada.	yunhua.luo@ad.umanitoba.ca			Manitoba Health Research Council (Canada)	The reported research has been supported by the Manitoba Health Research Council (Canada), which is gratefully acknowledged.	Adams JE, 2009, EUR J RADIOL, V71, P415, DOI 10.1016/j.ejrad.2009.04.074; [Anonymous], 2012, BIOM SOL ENG AN; Chen Y, 2010, ACTA MECH, V213, P155, DOI 10.1007/s00707-009-0274-0; du Plessis FCP, 1998, MED PHYS, V25, P1195, DOI 10.1118/1.598297; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Goldsmith W, 2001, CRIT REV BIOMED ENG, V29, P441, DOI 10.1615/CritRevBiomedEng.v29.i56.10; Goldsmith Werner, 2005, Critical Reviews in Biomedical Engineering, V33, P105, DOI 10.1615/CritRevBiomedEng.v33.i2.20; Helgason B, 2008, CLIN BIOMECH, V23, P135, DOI 10.1016/j.clinbiomech.2007.08.024; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Luo Y, 2008, ADV THEORETICAL APPL, V1, P225; Luo YH, 2012, P I MECH ENG H, V226, P499, DOI 10.1177/0954411912445729; Nahum A. M., 1977, P 21 STAPP CAR CRASH; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; Schileo E, 2008, J BIOMECH, V41, P2483, DOI 10.1016/j.jbiomech.2008.05.017; Schneider W, 2000, PHYS MED BIOL, V45, P459, DOI 10.1088/0031-9155/45/2/314; Simpleware, 2012, FAST EAS ROB WAY CON; Voo L, 1996, MED BIOL ENG COMPUT, V34, P375, DOI 10.1007/BF02520009; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165	18	12	12	0	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1176-2322	1754-2103		APPL BIONICS BIOMECH	Appl. Bionics Biomech.		2015	2015						1	8	837585	10.1155/2015/837585			8	Engineering, Biomedical; Robotics	Engineering; Robotics	CC5XP	WOS:000350438600001	27019594	DOAJ Gold, Green Published			2021-06-18	
J	Linton, KF				Linton, Kristen Faye			Interpersonal violence and traumatic brain injuries among Native Americans and women	BRAIN INJURY			English	Article						Brain injury; interpersonal violence; Native American; rural	OUTCOMES; HEALTH	Objectives: This study aimed to assess the odds of experiencing a traumatic brain injury (TBI) as a result of interpersonal violence (IPV) among Native Americans compared to other races controlling for gender, age, socioeconomic status, rurality and intoxication at the time of the injury. Methods: A secondary data analysis of the Arizona Trauma Database consisting of 18 944 cases of TBI between 2008-2010 throughout the state of Arizona was conducted. There were 312 patients who experienced injuries caused by IPV in the sample. Descriptive statistics, cross-tabulations, bivariate analyses and a logistic regression model were used for analyses. Results: The logistic regression model found that Native Americans (OR = 1.15), patients from the other race category (OR = 1.18), females (OR = 1.35) and those who were insured (OR = 1.26) had higher odds of experiencing a TBI as a result of IPV. Rurality and intoxication were mediators of the correlation between Native American race and TBI as a result of IPV. Conclusions: Native Americans are more likely than Whites and females are more likely than males to experience TBIs as a result of IPV.	[Linton, Kristen Faye] Univ Hawaii Manoa, Sch Social Work, Honolulu, HI 96822 USA	Linton, KF (corresponding author), Univ Nevada, Sch Social Work, 4505 S Maryland Pkwy, Las Vegas, NV 89154 USA.	kristen.linton@unlv.edu					Banks ME, 2007, TRAUMA VIOLENCE ABUS, V8, P290, DOI 10.1177/1524838007303503; Centers for Disease Control and Prevention, 2010, TRAUM BRAIN INJ US R; Evans-Campbell T, 2006, AM J PUBLIC HEALTH, V96, P1416, DOI 10.2105/AJPH.2004.054213; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Jones L, 2008, J FAM VIOLENCE, V23, P113, DOI 10.1007/s10896-007-9132-9; Kim H, 2013, CAN J OCCUP THER, V80, P49, DOI 10.1177/0008417412473262; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Linton KF, 2014, BRAIN INJURY, V28, P1076, DOI 10.3109/02699052.2014.901558; Malcoe LH, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-20; National Institute of Justice, 2002, IMP EV STOP GRANT PR; POLISSAR L, 1982, MED CARE, V20, P959, DOI 10.1097/00005650-198209000-00008; Saler Mihaela, 2011, Curr Treat Options Cardiovasc Med, V13, P215, DOI 10.1007/s11936-011-0124-y; Somers SA, 2010, COVERING LOW INCOME; U.S. Department of Health and Human Services, 2012, NAT AM TRAUM BRAIN I; Yuan NP, 2006, J INTERPERS VIOLENCE, V21, P1566, DOI 10.1177/0886260506294239	15	12	12	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	5					639	643		10.3109/02699052.2014.989406			5	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CH3GL	WOS:000353917000014	25517042				2021-06-18	
J	Malpas, CB; Saling, MM; Velakoulis, D; Desmond, P; O'Brien, TJ				Malpas, Charles B.; Saling, Michael M.; Velakoulis, Dennis; Desmond, Patricia; O'Brien, Terence J.		Alzheimer's Disease Neuroimaging I	Tau and Amyloid-beta Cerebrospinal Fluid Biomarkers have Differential Relationships with Cognition in Mild Cognitive Impairment	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Amyloid-beta; cerebrospinal fluid; cognition; mild cognitive impairment; tau	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; ALZHEIMERS-DISEASE; CSF BIOMARKERS; EPISODIC MEMORY; OLDER-ADULTS; PHOSPHO-TAU; DEFICITS; DEPOSITION; PATHOLOGY	Alzheimer's disease (AD) is characterized by two primary pathologies: tau-related neurofibrillary tangles and the extracellular accumulation of amyloid-beta (A beta). The development of these pathologies is topologically distinct early in the disease, with A beta beginning to accumulate as a diffuse, neocortical pathology, while tau-related pathology begins to form in mesial temporal regions. This study investigated the hypothesis that, by virtue of this distinction, there exist preferential associations between the primary pathologies and aspects of the cognitive phenotype. We investigated the relationship between cerebrospinal fluid (CSF) biomarkers for tau and A beta pathologies with neurocognitive measures in 191 patients with mild cognitive impairment (MCI). Participants completed cognitive tests of new learning, information processing speed, and working memory. Separate regression models were computed and then followed up with mediation analyses to examine the predictive status of CSF biomarkers. The effect of A beta on learning was mediated by phospho-tau (p = 0.008). In contrast, A beta had a direct effect on information processing speed that was not mediated by phospho-tau (p = 0.59). No predictors were significant for working memory. This study provided evidence for a differential relationship of A beta and phospho-tau pathologies on the neurocognitive phenotype of MCI. This supports the proposition that these primary AD pathologies maximally affect different aspects of cognition, and has potential implications for cognitive assessments and the use of biomarkers in disease-modifying therapeutic trials.	[Malpas, Charles B.; Velakoulis, Dennis; Desmond, Patricia; O'Brien, Terence J.] Univ Melbourne, Dept Med Royal Melbourne Hosp, Melbourne Brain Ctr, Melbourne, Vic 3010, Australia; [Malpas, Charles B.; Saling, Michael M.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia; [Saling, Michael M.] Austin Hlth, Dept Neuropsychol, Victoria, Australia; [Saling, Michael M.] Austin Hosp, Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic, Australia; [Velakoulis, Dennis] Royal Melbourne Hosp, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia; [Velakoulis, Dennis] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia; [Desmond, Patricia] Univ Melbourne, Dept Radiol, Melbourne, Vic, Australia; [Desmond, Patricia] Royal Melbourne Hosp, Dept Med Imaging, Melbourne, Vic, Australia; [O'Brien, Terence J.] Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic, Australia	Malpas, CB (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.	charles.malpas@unimelb.edu.au	Malpas, Charles/L-4741-2019; Pasternak, Stephen H/A-3136-2011; Preda, Adrian/K-8889-2013; Desmond, Patricia/D-1966-2014	Pasternak, Stephen H/0000-0002-0204-0255; Hsiung, Ging-Yuek/0000-0002-8017-0856; Preda, Adrian/0000-0003-3373-2438; Ponto, Laura/0000-0003-1197-6714; O'Brien, Terence/0000-0002-7198-8621; Desmond, Patricia/0000-0002-4803-6323	Alzheimer's Australia Dementia Research Foundation Viertel postgraduate research scholarship; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging, the National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Alzheimer's AssociationAlzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; Bio Clinica, Inc.; Biogen Idec Inc.Biogen; Bristol-Myers Squibb CompanyBristol-Myers Squibb; Eisai Inc.Eisai Co Ltd; Elan Pharmaceuticals, Inc.; Eli Lilly and CompanyEli Lilly; Euro Immun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE HealthcareGE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research and Development, LLC.; Johnson and Johnson Pharmaceutical Research and Development LLC.Johnson & JohnsonJohnson & Johnson USA; Medpace, Inc.; Merck and Co., Inc.Merck & Company; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals CorporationNovartis; Pfizer Inc.Pfizer; Piramal Imaging; ServierServier; Synarc Inc.; Takeda Pharmaceutical CompanyTakeda Pharmaceutical Company Ltd; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01AG024904] Funding Source: NIH RePORTER	Charles Malpas is the recipient of an Alzheimer's Australia Dementia Research Foundation Viertel postgraduate research scholarship.; Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; Bio Clinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; Euro Immun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research and Development, LLC.; Johnson and Johnson Pharmaceutical Research and Development LLC.; Medpace, Inc.; Merck and Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (http://www.fnih.org). The grantee organization is the California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.	Andreasen N, 2003, WORLD J BIOL PSYCHIA, V4, P147, DOI 10.1080/15622970310029912; Apostolova LG, 2008, BRAIN LANG, V104, P33, DOI 10.1016/j.bandl.2007.03.008; Battistone M, 2008, APPL NEUROPSYCHOL, V15, P69, DOI 10.1080/09084280801917863; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bennett DA, 2004, ARCH NEUROL-CHICAGO, V61, P378, DOI 10.1001/archneur.61.3.378; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Fripp J, 2008, NEUROIMAGE, V43, P430, DOI 10.1016/j.neuroimage.2008.07.053; Galton CJ, 2000, BRAIN, V123, P484, DOI 10.1093/brain/123.3.484; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; Gold G, 2001, J NEUROPATH EXP NEUR, V60, P946, DOI 10.1093/jnen/60.10.946; GROBER E, 1991, J CLIN EXP NEUROPSYC, V13, P933, DOI 10.1080/01688639108405109; Grober E, 1999, NEUROBIOL AGING, V20, P573, DOI 10.1016/S0197-4580(99)00063-9; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Hampel H, 2004, ARCH GEN PSYCHIAT, V61, P95, DOI 10.1001/archpsyc.61.1.95; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hayes A.F., 2018, INTRO MEDIATION MODE, V2nd ed.; Hedden T, 2012, J NEUROSCI, V32, P16233, DOI 10.1523/JNEUROSCI.2462-12.2012; Hesse C, 2001, NEUROSCI LETT, V297, P187, DOI 10.1016/S0304-3940(00)01697-9; Hodges JR, 2006, BRAIN, V129, P2811, DOI 10.1093/brain/awl275; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jolliffe I. T., 2002, PRINCIPAL COMPONENTS; Kemppainen NM, 2007, NEUROLOGY, V68, P1603, DOI 10.1212/01.wnl.0000260969.94695.56; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Kohnken R, 2000, NEUROSCI LETT, V287, P187, DOI 10.1016/S0304-3940(00)01178-2; Koopman K, 2009, NEUROCHEM INT, V55, P214, DOI 10.1016/j.neuint.2009.02.017; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LAMBERTY GJ, 1994, NEUROPSY NEUROPSY BE, V7, P230; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Lim YY, 2013, NEUROPSYCHOLOGY, V27, P322, DOI 10.1037/a0032321; Lublin AL, 2010, MT SINAI J MED, V77, P43, DOI 10.1002/msj.20160; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Markesbery WR, 2010, J ALZHEIMERS DIS, V19, P221, DOI 10.3233/JAD-2010-1220; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mormino EC, 2009, BRAIN, V132, P1310, DOI 10.1093/brain/awn320; Nagy Z, 1999, DEMENT GERIATR COGN, V10, P115, DOI 10.1159/000017111; Nelson HE, 1982, NATL ADULT READING T; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P1, DOI 10.1097/NEN.0b013e3181919a48; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Nordlund A, 2008, J INT NEUROPSYCH SOC, V14, P582, DOI 10.1017/S135561770808079X; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Palmqvist S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038639; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Rey A., 1958, LEXAMEN CLINIQUE PSY; Riemenschneider M, 2003, MOL PSYCHIATR, V8, P343, DOI 10.1038/sj.mp.4001220; Rolstad S, 2011, J ALZHEIMERS DIS, V26, P135, DOI 10.3233/JAD-2011-110038; Rosenmann H, 2012, J MOL NEUROSCI, V47, P1, DOI 10.1007/s12031-011-9665-5; Rowe CC, 2007, NEUROLOGY, V68, P1718, DOI 10.1212/01.wnl.0000261919.22630.ea; Schmitter-Edgecombe M., 1993, NEUROPSYCHOLOGY, V7, P136, DOI DOI 10.1037/0894-4105.7.2.136; Seppala TT, 2012, NEUROLOGY, V78, P1568, DOI 10.1212/WNL.0b013e3182563bd0; Seppala TT, 2011, J ALZHEIMERS DIS, V25, P583, DOI 10.3233/JAD-2011-101911; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sobel M. E., 1986, SOCIOL METHODOL, V16, p159 , DOI DOI 10.2307/270922; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Tosun D, 2010, NEUROBIOL AGING, V31, P1340, DOI 10.1016/j.neurobiolaging.2010.04.030; Van Broeck B, 2007, NEURODEGENER DIS, V4, P349, DOI 10.1159/000105156; Vanmechelen E, 2000, NEUROSCI LETT, V285, P49, DOI 10.1016/S0304-3940(00)01036-3; Visser PJ, 2009, LANCET NEUROL, V8, P619, DOI 10.1016/S1474-4422(09)70139-5; Wallin AK, 2006, DEMENT GERIATR COGN, V21, P131, DOI 10.1159/000090631; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277	74	12	13	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2015	47	4					965	975		10.3233/JAD-142643			11	Neurosciences	Neurosciences & Neurology	CQ9JS	WOS:000360931300015	26401775	Green Accepted			2021-06-18	
J	Mao, X; Hao, SY; Zhu, ZD; Zhang, H; Wu, WC; Xu, FF; Liu, BY				Mao, Xiang; Hao, Shuyu; Zhu, Zhendan; Zhang, Hao; Wu, Weichuan; Xu, Feifan; Liu, Baiyun			Procyanidins protects against oxidative damage and cognitive deficits after traumatic brain injury	BRAIN INJURY			English	Article						Antioxidant; CREB; hippocampus; oxidative stress; procyanidins; TBI	LONG-TERM-MEMORY; ELEMENT-BINDING PROTEIN; CAMP RESPONSE; CREB; HIPPOCAMPUS; ACTIVATION; ANTIOXIDANTS; EXPRESSION; PLASTICITY; PHOSPHORYLATION	Primary objective: Oxidative stress is the principal factor in traumatic brain injury (TBI) that initiates the events that result in protracted neuronal dysfunction and remodeling. Importantly, antioxidants can protect the brain against oxidative damage and modulate the capacity of the brain to cope with synaptic dysfunction and cognitive impairment. Research design: To date, however, no studies have investigated the effects of procyanidins (PC) on cognitive deficits after TBI. Methods and Procedures: In the present study, rats with controlled cortical impact (CCI) were used to investigate the protective effects of procyanidins. Main outcomes and results: The results showed that procyanidins reduced the level of malondialdehyde (MDA) and elevated the level of glutathione (GSH) and the activity of superoxide dismutase (SOD). In addition, treatment with procyanidins, which elevated the levels of brain-derived neurotropic factor (BDNF), phosphorylation-cAMP-response element binding protein (pCREB), total CREB, and cyclic AMP (cAMP), improved cognitive performance in the Morris water maze after TBI. Conclusions: These results suggest that procyanidins appear to counteract oxidative damage and behavioral dysfunction after TBI through antioxidant activity and the up-regulation of cAMP/CREB signaling.	[Mao, Xiang; Zhang, Hao] Anhui Med Univ, Affiliated Hosp 1, Dept Neurosurg, Hefei, Anhui, Peoples R China; [Hao, Shuyu; Xu, Feifan; Liu, Baiyun] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Mao, Xiang; Zhu, Zhendan; Zhang, Hao; Liu, Baiyun] Capital Med Univ, Beijing Neurosurg Inst, Neurotrauma Lab, Beijing, Peoples R China; [Mao, Xiang; Liu, Baiyun] Armed Police Forces, Gen Hosp, Dept Neurotrauma, Beijing, Peoples R China; [Mao, Xiang; Hao, Shuyu; Zhu, Zhendan; Zhang, Hao; Xu, Feifan; Liu, Baiyun] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Mao, Xiang; Hao, Shuyu; Zhu, Zhendan; Zhang, Hao; Xu, Feifan; Liu, Baiyun] Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China; [Zhu, Zhendan] Anhui Med Univ, Armed Police Forces Clin Coll, Gen Hosp, Hefei, Anhui, Peoples R China; [Wu, Weichuan] Guangdong Med Coll, Affiliated Hosp, Dept Neurosurg, Zhanjiang, Peoples R China	Liu, BY (corresponding author), Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, 6 Tiantan Xili, Beijing, Peoples R China.	liubaiyun1212@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171144]; Beijing Nova programBeijing Municipal Science & Technology Commission [XX2012033]; National Key Technology Research and Development Program of the Ministry of Science and Technology of ChinaNational Key Technology R&D Program [2013BAI09B03]	The authors report no conflict of interests related to this study or the findings specified in this paper. This study was supported by National Natural Science Foundation of China (No. 81171144), Beijing Nova program (No. XX2012033) and National Key Technology Research and Development Program of the Ministry of Science and Technology of China(2013BAI09B03).	Alonso M, 2002, HIPPOCAMPUS, V12, P551, DOI 10.1002/hipo.10035; Ashman TA, 2006, MT SINAI J MED, V73, P999; Bagchi D, 1998, GEN PHARMACOL, V30, P771, DOI 10.1016/S0306-3623(97)00332-7; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brightwell JJ, 2007, LEARN MEMORY, V14, P195, DOI 10.1101/lm.395407; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Himanen L, 2005, BRAIN INJURY, V19, P93, DOI 10.1080/02699050410001720031; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Koleckar V, 2008, MINI-REV MED CHEM, V8, P436, DOI 10.2174/138955708784223486; Li YF, 2009, NEUROPSYCHOPHARMACOL, V34, P2404, DOI 10.1038/npp.2009.66; [刘虓虓 Liu Xiaoxiao], 2013, [中国兽医学报, Chinese Journal of Veterinary Science], V33, P1426; Merenda A, 2008, J NEUROTRAUM, V25, P527, DOI 10.1089/neu.2007.0359; Mizuno M, 2002, BEHAV BRAIN RES, V133, P135, DOI 10.1016/S0166-4328(01)00470-3; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Rosenegger D, 2008, NEUROBIOL LEARN MEM, V90, P544, DOI 10.1016/j.nlm.2008.06.005; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S; SCHNEIDER HH, 1984, BIOCHEM PHARMACOL, V33, P1690, DOI 10.1016/0006-2952(84)90295-8; Segal M, 1998, NEURAL PLAST, V6, P1, DOI 10.1155/NP.1998.1; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Trifilieff P, 2006, LEARN MEMORY, V13, P349, DOI 10.1101/lm.80206; Ustun ME, 2001, J NEUROSURG ANESTH, V13, P227; Wu AG, 2004, EUR J NEUROSCI, V19, P1699, DOI 10.1111/j.1460-9568.2004.03246.x; Wu AG, 2010, NEUROREHAB NEURAL RE, V24, P290, DOI 10.1177/1545968309348318; Xu JQ, 2010, J GERONTOL A-BIOL, V65, P236, DOI 10.1093/gerona/glp211; Yamashima T, 2012, PROG LIPID RES, V51, P221, DOI 10.1016/j.plipres.2012.02.001; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5	36	12	15	0	18	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	1					86	92		10.3109/02699052.2014.968621			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AW1WC	WOS:000346078000011	25279568				2021-06-18	
J	Padula, WV; Subramanian, P; Spurling, A; Jenness, J				Padula, William V.; Subramanian, Prem; Spurling, April; Jenness, Jonathan			Risk of fall (RoF) intervention by affecting visual egocenter through gait analysis and yoked prisms	NEUROREHABILITATION			English	Article						Visual midline shift syndrome; yoked prisms; balance; spatial visual process; visual egocenter	ADAPTATION; NEGLECT; VISION	BACKGROUND: Following a neurologic event such as traumatic brain injury (TBI), cerebrovascular accident (CVA), and chronic neurological conditions including Parkinson's disease, multiple sclerosis, and cerebral palsy a shift in the visual midline (egocenter) can directly affect posture, balance and spatial orientation. As a consequence, this increases the risk of fall (RoF) and injury that imposes a major financial burden on the public health system. OBJECTIVE: To determine if there is a statistically significant change in balance with the intervention of yoked prisms to reduce the risk of fall in subjects with neurological impairments. METHODS: Ambulation of thirty-six subjects was evaluated on a pressure sensitive mat before and after intervention with yoked prisms. Changes in gait and balance were analyzed in the anterior-posterior (AP) and medial-lateral (ML) axes during ambulation. RESULTS: T-tests for each measure comparing the difference-of-differences to a zero change at baseline returned statistically significant reductions in both AP (p < 0.0001; 95% CI: 1.368-2.976) and ML (p = 0.0002; 95% CI: 1.472-4.173) imbalances using specifically directed yoked prisms to correct the visual midline deviation. CONCLUSION: These findings demonstrate that yoked prisms have the potential to provide a cost-effective means to restore the visual midline thereby improving balance, reduce RoF and subsequent injury.	[Padula, William V.; Spurling, April; Jenness, Jonathan] Padula Inst Vis Rehabil, Guilford, CT 06437 USA; [Subramanian, Prem] Univ Colorado, Dept Ophthalmol, Sch Med, Aurora, CO USA; [Padula, William V.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Padula, WV (corresponding author), Padula Inst Vis Rehabil, 37 Soundview Rd, Guilford, CT 06437 USA.	wpadula@padulainstitute.com					Adams G., 1963, LANCET, V282, P533; Benabib R, 1993, OCCUPATIONAL THERAPY, P57; Bron A. J., 1997, WOLFFS ANATOMY EYE O, VEighth; *CDCP, 2004, WEB BAS INJ STAT QUE; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Eubank T., 2001, J AM OPTOMETRY ASS, V72, P217; FIFE D, 1985, ANN EMERG MED, V14, P244, DOI 10.1016/S0196-0644(85)80448-0; Himmelbach M., 2007, BMC NEUROSCI, V8, P1471; Johannsen L., 2006, BMC NEUROLOGY, V6, P1471; Milner A., 2003, PROGR BRAIN RES, P225; MOORE J, 1993, BRAIN ATLAS FUNCTION; NASHOLD BS, 1972, ARCH OPHTHALMOL-CHIC, V88, P245; National Hospital Ambulatory Medical Care Survey, 2015, AMB HLTH CAR DAT; Padula WV, 2009, BRAIN INJURY, V23, P566, DOI 10.1080/02699050902926283; PADULA WV, 1994, BRAIN INJURY, V8, P125, DOI 10.3109/02699059409150964; Padula WV, 2012, NEUROVISUAL PROCESSI; Perennou D, 2006, RESTOR NEUROL NEUROS, V24, P319; Rode G, 2006, NEUROPSYCHOLOGIA, V44, P2487, DOI 10.1016/j.neuropsychologia.2006.04.002; Rolfs M, 2011, J NEUROPHYSIOL, V105, P1, DOI 10.1152/jn.00862.2010; Rossetti Y, 1998, NATURE, V395, P166, DOI 10.1038/25988; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Tilikete C, 2001, CURR BIOL, V11, P524, DOI 10.1016/S0960-9822(01)00151-8; TREVARTHEN CB, 1968, PSYCHOL FORSCH, V31, P299, DOI 10.1007/BF00422717; Tromp AM, 2001, J CLIN EPIDEMIOL, V54, P837, DOI 10.1016/S0895-4356(01)00349-3; Zasler ND, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1	25	12	12	1	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2015	37	2					305	314		10.3233/NRE-151263			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CV9HB	WOS:000364597200015	26484522	Bronze			2021-06-18	
J	Pham, N; Sawyer, TW; Wang, YS; Jazii, FR; Vair, C; Taghibiglou, C				Pham, Nam; Sawyer, Thomas W.; Wang, Yushan; Jazii, Ferdous Rastgar; Vair, Cory; Taghibiglou, Changiz			Primary Blast-Induced Traumatic Brain Injury in Rats Leads to Increased Prion Protein in Plasma: A Potential Biomarker for Blast-Induced Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						ELISA; brain injury; blood plasma; PrPC; blast exposure	SERUM S100B LEVELS; ENDOTHELIAL-CELLS; EXPRESSION; AFGHANISTAN; DEFINITION; DEATH; MICE; PRPC; ACCUMULATION; INFLAMMATION	Traumatic brain injury (TBI) is deemed the "signature injury" of recent military conflicts in Afghanistan and Iraq, largely because of increased blast exposure. Injuries to the brain can often be misdiagnosed, leading to further complications in the future. Therefore, the use of protein biomarkers for the screening and diagnosis of TBI is urgently needed. In the present study, we have investigated the plasma levels of soluble cellular prion protein (PrPC) as a novel biomarker for the diagnosis of primary blast-induced TBI (bTBI). We hypothesize that the primary blast wave can disrupt the brain and dislodge extracellular localized PrPC, leading to a rise in concentration within the systemic circulation. Adult male Sprague-Dawley rats were exposed to single pulse shockwave overpressures of varying intensities (15-30 psi or 103.4-206.8 kPa] using an advanced blast simulator. Blood plasma was collected 24 h after insult, and PrPC concentration was determined with a modified commercial enzyme-linked immunosorbent assay (ELISA) specific for PrPC. We provide the first report that mean PrPC concentration in primary blast exposed rats (3.97 ng/mL +/- 0.13 SE) is significantly increased compared with controls (2.46 ng/mL +/- 0.14 SE; two tailed test p<0.0001). Furthermore, we report a mild positive rank correlation between PrPC concentration and increasing blast intensity (psi) reflecting a plateaued response at higher pressure magnitudes, which may have implications for all military service members exposed to blast events. In conclusion, it appears that plasma levels of PrPC may be a novel biomarker for the detection of primary bTBI.	[Pham, Nam; Jazii, Ferdous Rastgar; Taghibiglou, Changiz] Univ Saskatchewan, Dept Pharmacol, Coll Med, Saskatoon S7N 5E5, SK, Canada; [Sawyer, Thomas W.; Wang, Yushan; Vair, Cory] Suffield Res Ctr, Def Res & Dev Canada, Ralston, AB, Canada	Taghibiglou, C (corresponding author), Univ Saskatchewan, Dept Pharmacol, Saskatoon S7N 5E5, SK, Canada.	changiz.taghibiglou@usask.ca	Taghibiglou, Changiz/H-4590-2019		DRDC [W7702-145664]	This research is supported by DRDC Contract W7702-145664. The authors thank the following individuals: Drs. Venkat Gopalakrishnan and John Mikler for their useful critical reviewing of our manuscript; Stephen Bjarnason at the DRDC for his managerial support for this project; Tracy Weiss, Peggy Nelson, Grant Hennes, and Julia Barnes for their excellent technical help during the blast exposure and blood collection processes; and Bing Yan and Dr. June Lim for their valuable assistance and consultation regarding statistical analysis.	Agoston D. V., 2012, FRONT NEUROL, V3, P1; Agoston DV, 2009, J NEUROTRAUM, V26, P901, DOI 10.1089/neu.2008.0724; Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; BENDHEIM PE, 1992, NEUROLOGY, V42, P149, DOI 10.1212/WNL.42.1.149; Biasini E, 2012, TRENDS NEUROSCI, V35, P92, DOI 10.1016/j.tins.2011.10.002; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Carnini Anna, 2010, Prion, V4, P80; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Coulpier M, 2006, NEUROSCIENCE, V141, P1827, DOI 10.1016/j.neuroscience.2006.05.037; Defense and Veterans Brain Injury Center, 2014, DOD WORLDW NUMB TBI; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Didonna A, 2013, CELL MOL BIOL LETT, V18, P209, DOI 10.2478/s11658-013-0085-0; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Ford MJ, 2002, NEUROSCIENCE, V111, P533, DOI 10.1016/S0306-4522(01)00603-0; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Graner J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00016; GREINER M, 1995, J IMMUNOL METHODS, V185, P123, DOI 10.1016/0022-1759(95)00121-P; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Hatpio R, 2004, CLIN BIOCHEM, V37, P512, DOI 10.1016/j.clinbiochem.2004.05.012; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoshino S, 2003, ACT NEUR S, V86, P297; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Krupinski J, 2008, ACTA NEUROPATHOL, V116, P537, DOI 10.1007/s00401-008-0427-6; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Martins VR, 2002, NEUROCHEM INT, V41, P353, DOI 10.1016/S0197-0186(02)00054-2; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Milhavet O, 2000, P NATL ACAD SCI USA, V97, P13937, DOI 10.1073/pnas.250289197; Mitsios N, 2007, J NEUROSCI RES, V85, P602, DOI 10.1002/jnr.21142; Mitteregger G, 2007, BRAIN PATHOL, V17, P174, DOI 10.1111/j.1750-3639.2007.00061.x; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Ramasamy A, 2009, J R Army Med Corps, V155, P258; Rangel A, 2007, J NEUROSCI RES, V85, P2741, DOI 10.1002/jnr.21215; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Ritzel D. V., 2011, NATO HFM, V207; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Sales N, 1998, EUR J NEUROSCI, V10, P2464, DOI 10.1046/j.1460-9568.1998.00258.x; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schardin H, 1950, WORLD WAR, VII; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Shyu WC, 2005, J NEUROSCI, V25, P8967, DOI 10.1523/JNEUROSCI.1115-05.2005; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Simak J, 2002, TRANSFUSION, V42, P334, DOI 10.1046/j.1537-2995.2002.00072.x; Singh A., 2009, PLOS ONE, V4, P1; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Spudich A, 2005, NEUROBIOL DIS, V20, P442, DOI 10.1016/j.nbd.2005.04.002; Starke R, 2002, BRIT J HAEMATOL, V119, P863, DOI 10.1046/j.1365-2141.2002.03847.x; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Taghibiglou C, 2011, BIOCHEM BIOPH RES CO, V413, P159, DOI 10.1016/j.bbrc.2011.08.011; Tanielian T., 2008, 720CCF MG RAND CORP; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Volkel D, 2001, TRANSFUSION, V41, P441, DOI 10.1046/j.1537-2995.2001.41040441.x; Walz R, 1999, EPILEPSIA, V40, P1679, DOI 10.1111/j.1528-1157.1999.tb01583.x; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Watt NT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2135; Weise J, 2006, STROKE, V37, P1296, DOI 10.1161/01.STR.0000217262.03192.d4; Weise J, 2004, NEUROSCI LETT, V372, P146, DOI 10.1016/j.neulet.2004.09.030; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109	76	12	14	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2015	32	1					58	65		10.1089/neu.2014.3471			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AX4JX	WOS:000346900100008	25058115	Green Published			2021-06-18	
J	Raj, R; Brinck, T; Skrifvars, MB; Kivisaari, R; Siironen, J; Lefering, R; Handolin, L				Raj, Rahul; Brinck, Tuomas; Skrifvars, Markus B.; Kivisaari, Riku; Siironen, Jari; Lefering, Rolf; Handolin, Lauri			Validation of the revised injury severity classification score in patients with moderate-to-severe traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Prognostic model; External validation; Revised injury severity classification score; TR-DGU; TR-THEL; Trauma register	RETROSPECTIVE ANALYSIS; PREDICTION MODELS; PROGNOSTIC VALUE; MORTALITY; CARE; EPIDEMIOLOGY; PERFORMANCE	Introduction: By analysing risk-adjusted mortality ratios, weaknesses in the process of care might be identified. Traumatic brain injury (TBI) is the main cause of death in trauma, and thus it is crucial that trauma prediction models are valid for TBI patients. Accordingly, we assessed the validity of the RISC score in TBI patients by internal and external validation analyses. Methods: Patients with moderate-to-severe TBI admitted to the TraumaRegister DGU (R) (TR-DGU) and the trauma registry of Helsinki University Hospital (TR-THEL) in 2006-2011 were included in this retrospective open cohort study. Definition of moderate-to-severe TBI was head abbreviated injury scale of 3 or higher. Subgroup analysis for patients with isolated and polytrauma TBI was performed. The performance of the RISC score was evaluated by assessing its discrimination (area under the curve, AUC) and calibration (Hosmer-Lemeshow [H-L] test). Results: Among the 9106 and 809 patients with moderate-to-severe TBI admitted to TR-DGU and TR-THEL, unadjusted mortality was 26% and 23%, respectively. Internal and external validation of the RISC score showed good discrimination (TR-DGU AUC 0.89, 95% confidence interval [CI] 0.88-0.90 and TR-THEL AUC 0.84, 95% CI 0.81-0.87), but poor calibration (p < 0.001) in patients with moderate-to-severe TBI. Subgroup analysis found the discrimination only to be modest in isolated TBI (AUC 0.76) and calibration to be particularly poor in polytrauma TBI (TR-DGU H-L = 4356, p < 0.001; TR-THEL H-L 112, p < 0.001). Conclusion: The RISC score was found to be of limited predictive value in patients with moderate-to-severe TBI. A new general trauma scoring system that includes TBI specific prognostic factors is warranted. (C) 2014 Elsevier Ltd. All rights reserved.	[Raj, Rahul; Kivisaari, Riku; Siironen, Jari] Helsinki Univ Hosp, Dept Neurosurg, Toolo Hosp, FI-00029 Helsinki, Finland; [Brinck, Tuomas; Handolin, Lauri] Helsinki Univ Hosp, Toolo Hosp, Dept Orthoped & Traumatol, FI-00029 Helsinki, Finland; [Skrifvars, Markus B.] Helsinki Univ Hosp, Meilahti Hosp, Dept Intens Care, FI-00029 Helsinki, Finland; [Lefering, Rolf] Univ Witten Herdecke, Fac Hlth, Inst Res Operat Med IFOM, Cologne Merheim Med Ctr, D-51109 Cologne, Germany	Raj, R (corresponding author), Topeliuksenkatu 5,PB-266, Helsinki 00029, Finland.	rahul.br.raj@icloud.com; tuomas.brinck@hus.fi; markus.skrifvars@hus.fi; riku.kivisaari@hus.fi; jari.siironen@hus.fi; rolf.lefering@uni-wh.de; lauri.handolin@hus.fi	Raj, Rahul/K-7693-2012	Raj, Rahul/0000-0003-4243-9591	Helsinki University Hospital EVO grant [TYH2012142]	The authors have no personal conflict of interest to declare. This study was funded by a Helsinki University Hospital EVO grant (TYH2012142).	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Association for the Advancement of Automotive Medicine, 2008, ABBR INJ SCAL 2005 U; Bertolini G, 2000, J Epidemiol Biostat, V5, P251; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; David W, 2013, APPL LOGISTIC REGRES, V3rd; Demetriades D, 1998, BRIT J SURG, V85, P379; Finazzi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016110; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; Hosmer DW, 1997, STAT MED, V16, P965; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; Jarman B, 2010, QUAL SAF HEALTH CARE, V19, P9, DOI 10.1136/qshc.2009.032953; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; Lefering R, 2009, EUR J TRAUMA EMERG S, V35, P437, DOI 10.1007/s00068-009-9122-0; Lesko MM, 2013, J NEUROTRAUM, V30, P17, DOI 10.1089/neu.2012.2438; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Maegele M, 2009, TRANSFUSION MED, V19, P117, DOI 10.1111/j.1365-3148.2009.00920.x; Moreno R, 1998, CRIT CARE MED, V26, P50, DOI 10.1097/00003246-199801000-00016; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nathens AB, 2008, J TRAUMA, V65, P628, DOI 10.1097/TA.0b013e3181837994; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Pouw ME, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5913; Raj R, 2014, CRIT CARE, V18, DOI 10.1186/cc13814; Raj R, 2013, NEUROSURGERY, V73, P305, DOI 10.1227/01.neu.0000430326.40763.ec; Ringdal KG, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-7; Shafi S, 2008, J TRAUMA, V64, P599, DOI 10.1097/TA.0b013e31816533f9; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Wafaisade A, 2012, J TRAUMA ACUTE CARE, V72, P936, DOI 10.1097/TA.0b013e31823dca70; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	35	12	13	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2015	46	1					86	93		10.1016/j.injury.2014.08.026			8	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	AX1YJ	WOS:000346739600017	25195181				2021-06-18	
J	Rogers, JM; Fox, AM; Donnelly, J				Rogers, Jeffrey M.; Fox, Allison M.; Donnelly, James			Impaired practice effects following mild traumatic brain injury: An event-related potential investigation	BRAIN INJURY			English	Article						Attention; event-related potentials; mild TBI; PASAT; practice effects	CLOSED-HEAD INJURY; ATTENTION; RECOVERY; SYMPTOMS; VALIDITY; DEFICITS; TBI; IDENTIFICATION; PARADIGM; STRESS	Background: The negative effects of mild traumatic brain injury (mTBI) on attention are well established. Effects of practice on neuropsychological test performance have also been long recognized and more recently linked to electrophysiological indices of information processing. Objective: The current study examined the behavioural and electrophysiological impact of mTBI on consistent practice of a neuropsychological test of attention. Research design: Prospective cohort study. Methods: Adult participants with a history of mild TBI (n = 10; time since injury > 2 months, mean = 15.2 months) and healthy matched controls (n = 10) completed the Paced Auditory Serial Addition Task (PASAT) at four separate sessions. Event-related potentials (ERPs) were simultaneously recorded. Results: Accuracy of PASAT performance in both groups improved significantly with practice. In healthy controls behavioural improvements were associated with significant attenuation of a frontally distributed ERP component marker of executive attention. These executive attention demands did not appear to ease with consistent practice in the mTBI group, who also endorsed more concussion-related symptoms. Conclusions: These preliminary results suggest sustained mental effort is required to achieve 'normal' performance levels following mTBI and support the use of practice-related, ERP indices of recovery from mTBI as a sensitive correlate of persistent post-concussion symptoms.	[Rogers, Jeffrey M.] Australian Catholic Univ, Sch Psychol, Strathfield, NSW 2135, Australia; [Fox, Allison M.] Univ Western Australia, Sch Psychol, Crawley, WA, Australia; [Donnelly, James] So Cross Univ, Sch Hlth & Human Sci Psychol, Coffs Harbour, NSW, Australia	Rogers, JM (corresponding author), Australian Catholic Univ, Sch Psychol, Locked Bag 2002, Strathfield, NSW 2135, Australia.	jeffrey.rogers@acu.edu.au	Donnelly, James F/P-5932-2015; Fox, Allison M/H-9218-2014	Donnelly, James F/0000-0002-2052-7948; Fox, Allison M/0000-0001-5189-6271; Rogers, Jeffrey M/0000-0002-0320-969X	University of Western Australia	The authors report no conflicts of interest. This work was supported by a University of Western Australia International Postgraduate Research Scholarship awarded to the first author.	Alexander M.P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI DOI 10.1097/00001199-199206000-00009; Andreassi J., 1995, PSYCHOPHYSIOLOGY HUM; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Baddeley A., 1974, PSYCHOL LEARN MOTIV, P47, DOI [10.1016/s0079-7421(08)60452-1, DOI 10.1016/S0079-7421(08)60452-1]; Beglinger LJ, 2005, ARCH CLIN NEUROPSYCH, V20, P517, DOI 10.1016/j.acn.2004.12.003; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Cicerone KD, 1997, CLIN NEUROPSYCHOL, V11, P266, DOI 10.1080/13854049708400455; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Diehr MC, 1998, ASSESSMENT, V5, P375, DOI 10.1177/107319119800500407; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FEINSTEIN A, 1994, J CLIN EXP NEUROPSYC, V16, P436, DOI 10.1080/01688639408402654; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D.M., 1974, PSYCHOL EFFECTS CONC; HANSEN JC, 1980, ELECTROEN CLIN NEURO, V49, P277, DOI 10.1016/0013-4694(80)90222-9; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Jennett B, 1989, MILD HEAD INJURY, P23; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Keller M, 2000, J NEUROL NEUROSUR PS, V68, P761, DOI 10.1136/jnnp.68.6.761; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; LOGAN GD, 1991, J EXP PSYCHOL LEARN, V17, P179, DOI 10.1037/0278-7393.17.2.179; Lovibond S.H., 1995, MANUAL DEPRESSION AN; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Naatanen R, 1985, ATTENTION PERFORM, VXI, P355; NORMAN DA, 1986, CONSCIOUSNESS SELF R, P1, DOI DOI 10.1007/978-1-4757-0629-1_1; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; Potter DD, 2002, J INT NEUROPSYCH SOC, V8, P828, DOI 10.1017/S1355617702860118; Potter DD, 1999, J PSYCHOPHYSIOL, V13, P173, DOI 10.1027//0269-8803.13.3.173; Prigatano G., 2010, STUDY ANOSOGNOSIA, P229; *PSYCH CORP, 2001, WECHSL IND ACH TEST; Psychological Corporation, 2001, WECHSL TEST AD READ; Rey A, 1964, EXAMEN CLIN PSYCHOL; Richardson J, 2000, CLIN NEUROPSYHOLOGIC; Rogers JM, 2012, ADV COGN PSYCHOL, V8, P281, DOI [10.5709/acp-0123-z, 10.2478/v10053-008-0123-z]; Roman DD, 1991, CLIN NEUROPSYCHOL, V5, P33; Royan J, 2004, ARCH CLIN NEUROPSYCH, V19, P131, DOI 10.1016/S0887-6177(02)00216-0; Ryan L M, 1996, Appl Neuropsychol, V3, P49, DOI 10.1207/s15324826an0302_1; SchmitterEdgecombe M, 1997, NEUROPSYCHOLOGY, V11, P296, DOI 10.1037/0894-4105.11.2.296; SCHNEIDER W, 1987, BEHAV RES METH INSTR, V19, P73, DOI 10.3758/BF03203762; Schneider W, 2003, COGNITIVE SCI, V27, P525, DOI 10.1016/S0364-0213(03)00011-9; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Shallice T, 1993, ATTENTION SELECTION, P171; SHELLEY AM, 1991, PSYCHOPHYSIOLOGY, V28, P496, DOI 10.1111/j.1469-8986.1991.tb01987.x; Sherman EMS, 1997, CLIN NEUROPSYCHOL, V11, P34, DOI 10.1080/13854049708407027; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Solbakk AK, 1999, PSYCHOPHYSIOLOGY, V36, P802; Spikman JM, 2001, BRAIN COGNITION, V47, P446, DOI 10.1006/brcg.2001.1320; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; Spreen O., 1998, COMPENDIUM NEUROPSYC; Stablum F, 1996, CORTEX, V32, P261, DOI 10.1016/S0010-9452(96)80050-5; The Psychological Corporation, 1998, PAC AUD SER ADD TEST; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Woods DL., 1990, EVENT RELATED BRAIN, P178; Zasler N, 2000, NEUROPSYCHOLOGICAL M, P23	74	12	12	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	3					343	351		10.3109/02699052.2014.976273			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CB0HQ	WOS:000349307000009	25436891				2021-06-18	
J	Spritzer, SD; Kinney, CL; Condie, J; Wellik, KE; Hoffman-Snyder, CR; Wingerchuk, DM; Demaerschalk, BM				Spritzer, Scott D.; Kinney, Carolyn L.; Condie, John; Wellik, Kay E.; Hoffman-Snyder, Charlene R.; Wingerchuk, Dean M.; Demaerschalk, Bart M.			Amantadine for Patients With Severe Traumatic Brain Injury A Critically Appraised Topic	NEUROLOGIST			English	Article						amantadine; traumatic brain injury; therapy; evidence-based medicine	TRIAL; SCALE; COMA	Background: Research into traumatic brain injury (TBI) has increased significantly. Diagnostic testing and therapeutics for patients with severe TBI are 2 areas on which there is increasing focus. Amantadine hydrochloride is one treatment considered to have potential therapeutic value in this patient population. Objective: The objective was addressed through the development of a structured critically appraised topic. This included a clinical scenario, structured question, literature search strategy, critical appraisal, results, evidence summary, commentary, and bottom-line conclusions. Participants included consultant and resident neurologists, a medical librarian, clinical epidemiologists, and content experts in the disciplines of neurocritical care and physical medicine and rehabilitation. Results: A multicenter, placebo-controlled, double-blind, randomized controlled trial was selected for review. The trial compared the rate of recovery, as determined by the overall Disability Rating Scale score, in a total of 184 patients with severe TBI. Patients were randomized to either receive amantadine (87) or visually identical placebo (97) over the 4-week study interval. The rate of recovery, as measured by the Disability Rating Scale, was found to be greater in the treatment arm as compared with the placebo arm (difference in slope -0.24 points/wk, P = 0.007) over the 4-week treatment interval. Conclusions: The results from this study demonstrated that amantadine hydrochloride accelerates recovery in patients with severe TBI.	[Spritzer, Scott D.; Hoffman-Snyder, Charlene R.; Wingerchuk, Dean M.; Demaerschalk, Bart M.] Mayo Clin, Dept Neurol, Phoenix, AZ 85054 USA; [Kinney, Carolyn L.] Mayo Clin, Dept Phys Med & Rehabil, Phoenix, AZ 85054 USA; [Wellik, Kay E.] Mayo Clin, Dept Lib Serv, Div Educ Adm, Phoenix, AZ 85054 USA; [Condie, John] Phoenix Childrens Hosp, Dept Pediat Neurol, Phoenix, AZ USA	Demaerschalk, BM (corresponding author), Mayo Clin, Dept Neurol, 5777 E Mayo Blvd, Phoenix, AZ 85054 USA.	demaerschalk.bart@mayo.edu			Clinician Educator grants from the Mayo Clinic College of Medicine	B.M.D. and D.M.W., Co-Directors of Mayo Clinic Evidence Based Clinical Practice, Research, Informatics, and Training (MERIT) Center, were supported by Clinician Educator grants from the Mayo Clinic College of Medicine.	Faul M., 2002, TRAUMATIC BRAIN INJU; Forsyth RJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003984.pub2; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Matsuda W, 2005, NEUROPSYCHOL REHABIL, V20, P111; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Schneider WN, 1999, BRAIN INJURY, V13, P863; Siddall ORM, 2005, ANN PHARMACOTHER, V39, P1309, DOI 10.1345/aph.1E637	10	12	13	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1074-7931			NEUROLOGIST	Neurologist	JAN	2015	19	2					61	64		10.1097/NRL.0000000000000001			4	Clinical Neurology	Neurosciences & Neurology	CA0FY	WOS:000348593500008	25607336				2021-06-18	
J	Turner-Stokes, L; Bassett, P; Rose, H; Ashford, S; Thu, A				Turner-Stokes, Lynne; Bassett, Paul; Rose, Hilary; Ashford, Stephen; Thu, Aung			Serial measurement of Wessex Head Injury Matrix in the diagnosis of patients in vegetative and minimally conscious states: a cohort analysis	BMJ OPEN			English	Article							MEDICAL ASPECTS; RECOVERY; SCALE; DISORDERS; VALIDATION; ACCURACY	Objective: To evaluate serial application of the Wessex Head Injury Matrix (WHIM) in diagnosis of prolonged disorders of consciousness (PDOC). Specifically, to determine whether the trajectory of change predicts outcome status, and whether the current hierarchical order of WHIM items is correct for this context. Design: Analysis of prospectively gathered clinical cohort data. Setting: Consecutive admissions to a tertiary inpatient neurorehabilitation service for evaluation of PDOC in real-life clinical practice, over a 10-year period (2004-2014). Participants: Patients (n=65) presenting in sudden-onset vegetative (VS) or minimally conscious states (MCS). Mean age 38.4 (sd14.1) years; male: female ratio 66%: 33%. Aetiology of brain injury: 40(62%) traumatic; 12(19%) vascular; 11(17%) hypoxic; 3(3%) other. Primary outcome measure: WHIM alongside detailed clinical evaluation. Methods: The WHIM was administered serially by the multidisciplinary team throughout an in-patient evaluation programme (mean length 74 (sd42) days). Patients were divided into four groups, according to PDOC status on discharge (VS, MCS-Minus, MCS-Plus or Emerged). Results: WHIM hierarchical scores (Most Advanced Behaviour (MAB)) correlated with PDOC status at discharge (Pearson r=0.49, p<0.001). In the original order, the MAB distinguished the 'VS', 'MCS' and 'Emerged' categories (analysis of variance (ANOVA) post hoc p<0.001), but not the subgroups of MCS-Minus and MCS-Plus. In stepwise regression analysis, MAB-Ex (excluding two items) accounted for 68% of the variance in PDOC status at discharge. On multilevel statistical modelling, trajectory of change in MAB separated the four PDOC groups, both at individual and at group level (p<0.001). After reordering of items, the new-order MAB accounted for more (73%) of the variance in PDOC status, and also distinguished significantly between MCS-Minus and MCS-Plus groups at discharge (p<0.002). Conclusions: The WHIM is a useful diagnostic tool in PDOC, and trajectory of change is an important predictor of outcome. The proposed new hierarchical order requires further evaluation in future multicentre analyses.	[Turner-Stokes, Lynne; Ashford, Stephen] Kings Coll London, Sch Med, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England; [Turner-Stokes, Lynne; Rose, Hilary; Ashford, Stephen; Thu, Aung] Northwick Pk Hosp & Clin Res Ctr, Reg Rehabil Unit, London, England; [Bassett, Paul] Statsconsultancy Ltd, London, England	Turner-Stokes, L (corresponding author), Kings Coll London, Sch Med, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England.	Lynne.turner-stokes@dial.pipex.com	Turner-Stokes, Lynne/F-4418-2012; Ashford, Stephen/D-6653-2013	Turner-Stokes, Lynne/0000-0002-3302-9462; Bassett, Paul/0000-0001-7830-4563; Ashford, Stephen/0000-0001-5541-7063	National Institute for Health Research in England (NIHR)National Institute for Health Research (NIHR) [RP-PG-0407-10185]; Dunhill Medical TrustDunhill Medical Trust; National Institute for Health ResearchNational Institute for Health Research (NIHR) [RP-PG-0407-10185] Funding Source: researchfish	This manuscript presents independent research funded by the National Institute for Health Research in England (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0407-10185). Financial support for the preparation of this manuscript was also provided by the Dunhill Medical Trust.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; [Anonymous], 2013, PROL DIS CONSC NAT C; [Anonymous], 2003, THE VEG STAT; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Delargy M., 2013, REV PROLONGED DISORD; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gill-Thwaites H, 2004, BRAIN INJURY, V18, P1255, DOI 10.1080/02699050410001719952; Majerus S, 2000, NEUROPSYCHOL REHABIL, V10, P167, DOI 10.1080/096020100389237; Majerus S, 2009, PROG BRAIN RES, V177, P49, DOI 10.1016/S0079-6123(09)17705-1; Schnakers C, 2008, BRAIN INJURY, V22, P786, DOI 10.1080/02699050802403557; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; Shiel A, 2000, WHIM WESSEX HEAD INJ; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; Wilson FC, 2009, NEUROPSYCHOL REHABIL, V19, P754, DOI 10.1080/09602010902805318; Wilson FC, 2005, NEUROPSYCHOL REHABIL, V15, P431, DOI 10.1080/09602010543000091	25	12	12	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2015	5	4							e006051	10.1136/bmjopen-2014-006051			12	Medicine, General & Internal	General & Internal Medicine	CI4GB	WOS:000354705000007	25900459	DOAJ Gold, Green Published			2021-06-18	
J	Wang, H; Wang, B; Jackson, K; Miller, CM; Hasadsri, L; Llano, D; Rubin, R; Zimmerman, J; Johnson, C; Sutton, B				Wang, Huan; Wang, Bonnie; Jackson, Kevin; Miller, Claire M.; Hasadsri, Linda; Llano, Daniel; Rubin, Rachael; Zimmerman, Jarred; Johnson, Curtis; Sutton, Brad			A NOVEL HEAD-NECK COOLING DEVICE FOR CONCUSSION INJURY IN CONTACT SPORTS	TRANSLATIONAL NEUROSCIENCE			English	Article						Head-neck cooling; Mild traumatic brain injury; Brain hypothermia; Brain temperature; Sports	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; RANDOMIZED CONTROLLED-TRIAL; PROLONGED EXERCISE; HYPERTHERMIC EXERCISE; PROLACTIN RESPONSE; BODY HYPERTHERMIA; FOOTBALL LINEMEN; FIBER TRACKING; DIFFUSION	Emerging research on the long-term impact of concussions on athletes has allowed public recognition of the potentially devastating effects of these and other mild head injuries. Mild traumatic brain injury (mTBI) is a multifaceted disease for which management remains a clinical challenge. Recent pre-clinical and clinical data strongly suggest a destructive synergism between brain temperature elevation and mTBI; conversely, brain hypothermia, with its broader, pleiotropic effects, represents the most potent neuro-protectant in laboratory studies to date. Although well-established in selected clinical conditions, a systemic approach to accomplish regional hypothermia has failed to yield an effective treatment strategy in traumatic brain injury (TBI). Furthermore, although systemic hypothermia remains a potentially valid treatment strategy for moderate to severe TBIs, it is neither practical nor safe for mTBIs. Therefore, selective head-neck cooling may represent an ideal strategy to provide therapeutic benefits to the brain. Optimizing brain temperature management using a National Aeronautics and Space Administration (NASA) spacesuit spinoff head-neck cooling technology before and/or after mTBI in contact sports may represent a sensible, practical, and effective method to potentially enhance recover and minimize post-injury deficits. In this paper, we discuss and summarize the anatomical, physiological, preclinical, and clinical data concerning NASA spinoff head-neck cooling technology as a potential treatment for mTBIs, particularly in the context of contact sports.	[Wang, Huan] Univ Illinois Coll Med Urbana Champaign, Dept Neurosurg, Carle Fdn Hosp, Urbana, IL 61820 USA; [Wang, Huan; Jackson, Kevin] Univ Illinois, Beckman Inst, Thermal Neurosci Lab, Urbana, IL USA; [Wang, Bonnie] Univ Illinois Coll Med Urbana Champaign, Dept Internal Med, Carle Fdn Hosp, Urbana, IL USA; [Miller, Claire M.] Univ Illinois, Neurosci Program, Urbana, IL USA; [Hasadsri, Linda] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Llano, Daniel] Univ Illinois Coll Med Urbana Champaign, Dept Mol & Integrat Physiol, Carle Fdn Hosp, Urbana, IL USA; [Llano, Daniel; Rubin, Rachael; Johnson, Curtis; Sutton, Brad] Univ Illinois, Beckman Inst, Urbana, IL USA; [Zimmerman, Jarred] Carle Fdn Hosp, Dept Sports Med, Urbana, IL USA; [Johnson, Curtis] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL USA; [Sutton, Brad] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL USA	Wang, H (corresponding author), Univ Illinois Coll Med Urbana Champaign, Dept Neurosurg, Carle Fdn Hosp, Urbana, IL 61820 USA.	huanwang@illinois.edu	Llano, Daniel/X-8184-2019; Sutton, Bradley P./A-4801-2008; Johnson, Curtis/U-8372-2019	Llano, Daniel/0000-0003-0933-1837; Sutton, Bradley P./0000-0002-8443-0408; 			Artal-Sanz M, 2005, FEBS LETT, V579, P3287, DOI 10.1016/j.febslet.2005.03.052; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Bales James W, 2010, Open Drug Discov J, V2, P119; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bazan NG, 2011, MOL NEUROBIOL, V44, P216, DOI 10.1007/s12035-011-8200-6; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BOMALASKI JS, 1995, J IMMUNOL, V154, P4027; Bridge MW, 2003, EUR J APPL PHYSIOL, V89, P451, DOI 10.1007/s00421-003-0800-z; BRISSON GR, 1989, EUR J APPL PHYSIOL O, V58, P816, DOI 10.1007/BF02332212; BROOKS VB, 1982, REV PHYSIOL BIOCH P, V95, P1; Butler PJ, 1997, PHYSIOL REV, V77, P837; CARLSSON C, 1976, J NEUROCHEM, V26, P1001, DOI 10.1111/j.1471-4159.1976.tb06484.x; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; COLESHAW SRK, 1983, J APPL PHYSIOL, V55, P27; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Connor NP, 1998, J COMMUN DISORD, V31, P535, DOI 10.1016/S0021-9924(98)00024-0; Coris EE, 2009, SOUTH MED J, V102, P569, DOI 10.1097/SMJ.0b013e3181a4f389; Covaciu L, 2011, INTENS CARE MED, V37, P1277, DOI 10.1007/s00134-011-2264-7; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; DIESEL DA, 1990, J APPL PHYSIOL, V69, P1946; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Ducreux D, 2005, NEURORADIOLOGY, V47, P604, DOI 10.1007/s00234-005-1389-1; Ducreux D, 2005, AM J NEURORADIOL, V26, P1840; EKBLOM B, 1986, SPORTS MED, V3, P50, DOI 10.2165/00007256-198603010-00005; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Giza C. C., 2001, J ATHL TRAINING, P36228; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Godek SF, 2006, J ATHL TRAINING, V41, P8; Godek SF, 2005, AM J SPORT MED, V33, P843, DOI 10.1177/0363546504270999; Godek SF, 2005, BRIT J SPORT MED, V39, P205, DOI 10.1136/bjsm.2004.011767; Godek SF, 2004, J ATHL TRAINING, V39, P235; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Guest S, 2007, PHYSIOL BEHAV, V92, P975, DOI 10.1016/j.physbeh.2007.07.004; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hajat C, 2000, STROKE, V31, P410, DOI 10.1161/01.STR.31.2.410; Harris OA, 2009, J NEUROSURG, V110, P1256, DOI 10.3171/2009.1.JNS081320; HAYWARD JN, 1969, BRAIN RES, V16, P417, DOI 10.1016/0006-8993(69)90236-4; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hootman JM, 2007, J ATHL TRAINING, V42, P311; HORI T, 1976, PFLUG ARCH EUR J PHY, V364, P205, DOI 10.1007/BF00585193; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Ide K, 2000, PROG NEUROBIOL, V61, P397, DOI 10.1016/S0301-0082(99)00057-X; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KATSUMURA H, 1995, ACTA NEUROCHIR, V135, P62, DOI 10.1007/BF02307416; Kawakami T, 2001, J DERMATOL, V28, P63, DOI 10.1111/j.1346-8138.2001.tb00091.x; KAWAKAMI Y, 1967, J APPL PHYSIOL, V23, P964; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KHURANA RK, 1980, ANN NEUROL, V7, P144, DOI 10.1002/ana.410070209; Kiang JG, 1996, J INVEST MED, V44, P53; KMIECIAKKOLADA K, 1987, POL J PHARMACOL PHAR, V39, P47; Koehn J, 2012, STROKE, V43, P2142, DOI 10.1161/STROKEAHA.112.652248; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Le TH, 2005, NEUROSURGERY, V56, P189, DOI 10.1227/01.NEU.0000144846.00569.3A; Lee JW, 2006, J HEAD TRAUMA REHAB, V21, P272, DOI 10.1097/00001199-200605000-00007; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lovell M, 2009, CLIN SPORT MED, V28, P95, DOI 10.1016/j.csm.2008.08.008; Low D, 2005, EXP PHYSIOL, V90, P909, DOI 10.1113/expphysiol.2005.031294; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; MADSEN PL, 1993, J APPL PHYSIOL, V74, P245; Markianos M, 1996, ACTA NEUROCHIR, V138, P57, DOI 10.1007/BF01411725; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2011, J NEUROPSYCH CLIN N, V23, P277, DOI 10.1176/appi.neuropsych.23.3.277; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MCMURTRY IF, 1975, EXPERIENTIA, V31, P1303, DOI 10.1007/BF01945793; Miyazawa T, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00308; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Mundel T, 2007, EXP PHYSIOL, V92, P187, DOI 10.1113/expphysiol.2006.034934; Mundel T, 2006, EXP PHYSIOL, V91, P1007, DOI 10.1113/expphysiol.2006.034629; NORTHOFF H, 1994, INT J SPORTS MED, V15, pS167, DOI 10.1055/s-2007-1021132; Nybo L, 2002, J PHYSIOL-LONDON, V545, P697, DOI 10.1113/jphysiol.2002.030023; Nybo L, 2002, J APPL PHYSIOL, V93, P58, DOI 10.1152/japplphysiol.00049.2002; Nybo L, 2001, J PHYSIOL-LONDON, V534, P279, DOI 10.1111/j.1469-7793.2001.t01-1-00279.x; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Ogoh S, 2009, J APPL PHYSIOL, V107, P1370, DOI 10.1152/japplphysiol.00573.2009; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Ozgunen KT, 2010, SCAND J MED SCI SPOR, V20, P140, DOI 10.1111/j.1600-0838.2010.01219.x; Pitsiladis YP, 2002, EXP PHYSIOL, V87, P215, DOI 10.1113/eph8702342; Pratico D, 2002, J NEUROCHEM, V80, P894, DOI 10.1046/j.0022-3042.2002.00777.x; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Rasmussen P, 2006, EUR J APPL PHYSIOL, V96, P299, DOI 10.1007/s00421-005-0079-3; Rasmussen P, 2010, ACTA PHYSIOL, V199, P63, DOI 10.1111/j.1748-1716.2010.02084.x; Rolls ET, 2008, NEUROIMAGE, V41, P1504, DOI 10.1016/j.neuroimage.2008.03.005; Sakurai A, 2012, J NEUROTRAUM, V29, P313, DOI 10.1089/neu.2011.2152; SALTIN B, 1972, J APPL PHYSIOL, V32, P635; Secher NH, 2008, J APPL PHYSIOL, V104, P306, DOI 10.1152/japplphysiol.00853.2007; Selkirk GA, 2004, J OCCUP ENVIRON HYG, V1, P521, DOI 10.1080/15459620490475216; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Sharma HS, 2012, INT REV NEUROBIOL, V102, P249, DOI 10.1016/B978-0-12-386986-9.00010-7; Sharma HS, 2006, J NEURAL TRANSM, V113, P497, DOI 10.1007/s00702-005-0406-1; Sharma HS, 2003, INT J HYPERTHER, V19, P325, DOI 10.1080/0265673021000054621; Shen H, 2011, BRAIN RES, V1368, P248, DOI 10.1016/j.brainres.2010.10.014; Shirreffs SM, 2006, J SPORT SCI, V24, P699, DOI 10.1080/02640410500482677; Solomon GS, 2011, CLIN SPORT MED, V30, P165, DOI 10.1016/j.csm.2010.09.002; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Strebel S, 1997, SURG NEUROL, V47, P128, DOI 10.1016/S0090-3019(96)00459-4; Suzuki T, 2004, J NEUROTRAUM, V21, P842, DOI 10.1089/0897715041526186; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TIPTON MJ, 1994, UNDERSEA HYPERBAR M, V21, P305; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Wang H, 2006, ACTA NEUROCHIR, V148, P681, DOI 10.1007/s00701-006-0748-y; Wang H, 2004, J NEUROSURG, V100, P272, DOI 10.3171/jns.2004.100.2.0272; Wang H, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00307; Wang H, 2012, J NEUROSURG, V116, P1159, DOI 10.3171/2009.8.JNS09929; Wegmann M, 2012, SPORTS MED, V42, P545, DOI 10.2165/11630550-000000000-00000; White MD, 1996, J APPL PHYSIOL, V81, P1249; WIERENGA PK, 1994, EUR J CELL BIOL, V63, P68; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Williamson JW, 1999, J APPL PHYSIOL, V87, P1213; Wilson TE, 2006, AM J PHYSIOL-REG I, V291, pR1443, DOI 10.1152/ajpregu.00712.2005; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	133	12	12	0	20	SCIENDO	WARSAW	DE GRUYTER POLAND SP Z O O, BOGUMILA ZUGA 32A STR, 01-811 WARSAW, POLAND	2081-3856	2081-6936		TRANSL NEUROSCI	Transl. Neurosci.	JAN	2015	6	1					20	31		10.1515/tnsci-2015-0004			12	Neurosciences	Neurosciences & Neurology	CC8VE	WOS:000350645900004	28123788	DOAJ Gold, Green Published			2021-06-18	
J	Worni, A; Gholami, H; Marchand, L; Katsoulis, J; Mericske-Stern, R; Enkling, N				Worni, Andreas; Gholami, Hadi; Marchand, Laurent; Katsoulis, Joannis; Mericske-Stern, Regina; Enkling, Norbert			Retrievability of Implant-Supported Crowns When Using Three Different Cements: A Controlled Clinical Trial	INTERNATIONAL JOURNAL OF PROSTHODONTICS			English	Article							FIXED PARTIAL DENTURES; RETAINED CROWNS; DENTAL ANXIETY; IN-VITRO; RESTORATIONS; COMPLICATIONS; DENTISTRY; SURVIVAL; REMOVER	Purpose: The purpose of this study was to analyze the removal of implant-supported crowns retained by three different cements using an air-accelerated crown remover and to evaluate the patients' response to the procedure. Materials and Methods: This controlled clinical trial was conducted with 21 patients (10 women, 11 men; mean age: 51 +/- 10.2 years) who had received a total of 74 implants (all placed in the posterior zone of the mandible). Four months after implant surgery, the crowns were cemented on standard titanium abutments of different heights. Three different cements (two temporary: Harvard TEMP and Improv; and one definitive: Durelon) were used and randomly assigned to the patients. Eight months later, one blinded investigator removed all crowns. The number of activations of the instrument (CORONAflex, KaVo) required for crown removal was recorded. The patients completed a questionnaire retrospectively to determine the impact of the procedure and to gauge their subjective perception. A linear regression model and descriptive statistics were used for data analysis. Results: All crowns could be retrieved without any technical complications or damage. Both abutment height (P = .019) and cement type (P = .004) had a significant effect on the number of activations, but the type of cement was more important. An increased total number of activations had no or only a weak correlation to the patients' perception of concussion, noise, pain, and unwillingness to use the device. Conclusions: Cemented implant crowns can be removed, and the application of an air-accelerated device is a practicable method. A type of cement with appropriate retention force has to be selected. The impact on the patients' subjective perception should be taken into account.	[Worni, Andreas; Gholami, Hadi; Marchand, Laurent; Katsoulis, Joannis; Mericske-Stern, Regina] Univ Bern, Dept Prosthodont, CH-3010 Bern, Switzerland; [Enkling, Norbert] Univ Bonn, Dept Prosthodont, Bonn, Germany	Mericske-Stern, R (corresponding author), Univ Bern, Sch Dent Med, Dept Prosthodont, Freiburgstr 7, CH-3010 Bern, Switzerland.	regina.mericske@zmk.unibe.ch					Akca K, 2002, INT J ORAL MAX IMPL, V17, P536; Al Hamad KQ, 2011, CLIN ORAL IMPLAN RES, V22, P638, DOI 10.1111/j.1600-0501.2010.02011.x; Bertold M, 2006, FOGORV SZ, V99, P237; BROCKHURST PJ, 1983, OPER DENT, V8, P130; Chaar MS, 2011, J ORAL REHABIL, V38, P697, DOI 10.1111/j.1365-2842.2011.02209.x; Chee W W, 1998, J Prosthodont, V7, P120; de Jongh A, 2006, EUR J ORAL SCI, V114, P286, DOI 10.1111/j.1600-0722.2006.00384.x; DEDMON HW, 1982, OPER DENT, V7, P97; Diserens V, 2006, INT J PERIODONT REST, V26, P151; Ekfeldt A, 1994, Int J Oral Maxillofac Implants, V9, P179; Enkling N, 2013, J DENT RES, V92, p139S, DOI 10.1177/0022034513504953; Enkling N, 2013, QUINTESSENCE INT, V44, P363, DOI 10.3290/j.qi.a29148; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Hebel KS, 1997, J PROSTHET DENT, V77, P28, DOI 10.1016/S0022-3913(97)70203-8; Ichikawa Tetsuo, 2008, J Prosthodont, V17, P487, DOI 10.1111/j.1532-849X.2008.00329.x; Jung RE, 2012, CLIN ORAL IMPLAN RES, V23, P2, DOI 10.1111/j.1600-0501.2012.02547.x; Karl M, 2004, INT J ORAL MAX IMPL, V19, P30; Karl M, 2008, INT J ORAL MAX IMPL, V23, P648; Karl M, 2006, INT J ORAL MAX IMPL, V21, P756; LANG NP, 1983, J CLIN PERIODONTOL, V10, P563, DOI 10.1111/j.1600-051X.1983.tb01295.x; Mansour A, 2002, CLIN ORAL IMPLAN RES, V13, P343, DOI 10.1034/j.1600-0501.2002.130401.x; Mehl C, 2008, CLIN ORAL IMPLAN RES, V19, P1304, DOI 10.1111/j.1600-0501.2008.01587.x; Mehl C, 2012, CLIN ORAL IMPLAN RES, V23, P930, DOI 10.1111/j.1600-0501.2011.02236.x; Mericske-Stern R, 2001, CLIN ORAL IMPLAN RES, V12, P309, DOI 10.1034/j.1600-0501.2001.012004309.x; Michalakis KX, 2000, INT J ORAL MAX IMPL, V15, P545; Michalakis KX, 2003, INT J ORAL MAX IMPL, V18, P719; OLIVA RA, 1980, J PROSTHET DENT, V44, P267, DOI 10.1016/0022-3913(80)90008-6; Palmer RM, 2000, CLIN ORAL IMPLAN RES, V11, P179, DOI 10.1111/j.1600-0501.2000.tb00012.x; Ramp MH, 1999, J PROSTHET DENT, V81, P510, DOI 10.1016/S0022-3913(99)70203-9; Sailer I, 2012, CLIN ORAL IMPLAN RES, V23, P163, DOI 10.1111/j.1600-0501.2012.02538.x; Shapoff Cary A, 2012, Compend Contin Educ Dent, V33, P94; Vermaire JH, 2008, COMMUNITY DENT ORAL, V36, P409, DOI 10.1111/j.1600-0528.2007.00416.x; Vigolo P, 2004, INT J ORAL MAX IMPL, V19, P260; WALTON JN, 1994, J PROSTHET DENT, V71, P283, DOI 10.1016/0022-3913(94)90468-5; Wang JS, 1997, CHIN DENT J, V16, P218; Weber HP, 2006, CLIN ORAL IMPLAN RES, V17, P375, DOI 10.1111/j.1600-0501.2005.01232.x; WILLIAMSON RT, 1993, J PROSTHET DENT, V69, P634, DOI 10.1016/0022-3913(93)90297-2	37	12	12	0	6	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0893-2174	1942-4426		INT J PROSTHODONT	Int. J. Prosthodont.	JAN-FEB	2015	28	1					22	29		10.11607/ijp.4119			8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AZ8UE	WOS:000348489100005	25588168				2021-06-18	
J	Wu, X; Lu, X; Lu, XQ; Yu, J; Sun, YR; Du, ZY; Wu, XH; Mao, Y; Zhou, LF; Wu, SR; Hu, J				Wu, Xing; Lu, Xin; Lu, Xiangqiong; Yu, Jian; Sun, Yirui; Du, Zhuoying; Wu, Xuehai; Mao, Ying; Zhou, Liangfu; Wu, Sirong; Hu, Jin			Prevalence of severe hypokalaemia in patients with traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Hypokalaemia; Hypophosphataemia; Hypernatraemia; Mortality	HYPOPHOSPHATEMIA; POTASSIUM; HYPOMAGNESEMIA; HYPERNATREMIA; THERAPY	Introduction: Patients with traumatic brain injury (TBI) are more vulnerable to develop hypokalaemia, we sought to investigate the prevalence, and the relationship between severe hypokalaemia and the mortality of traumatic brain injury patients. Methods: Isolated traumatic brain patients who had hypokalaemia (serum potassium <3.5 mmol/L) and age >= 14 yrs were recruited into the study between January 2008 and March 2013. Hypokalaemia was defined as potassium level in the blood <3.5 mmol/L during the hospitalisation, which was classified by severity: mild (3.0 mmol/L <= K < 3.5 mmol/L), moderate (2.5 mmol/L <= K < 3.0 mmol/L) and severe (K < 2.5 mmol/L). Multivariable logistic regression was performed to find the impact of hypokalaemia on mortality. Results: A total 375 cases were included in analysis. The peak incidence of severe hypokalaemia occurred in the first 24-96 h. TBI patients with severe hypokalaemia had significantly higher serum sodium and lower serum phosphorus than those patients with mild or moderate hypokalaemia (p < 0.001). Compare to other groups, the severe hypokalaemia group had the worst outcome. Moreover, the patients (n = 15) who had severe hypokalaemia, hypernatraemia (Na > 160 mmol/L), and hypophosphataemia (P < 0.3 mmol/L) all died in hospital. Multiple logistic regression analysis resulted in decrease of GCS (OR = 1.27; 95% CI = 1.15-1.41; p < 0.001) and potassium (OR = 4.35; 95% CI = 2.04-9.26; p < 0.001) being associated with significant increased risk of mortality. Conclusions: The peak incidence of severe hypokalaemia occurred in the first 24-96 h. TBI patients with severe hypokalaemia are more vulnerable to develop hypophosphataemia and hypernatraemia than patients with mild and moderate hypokalaemia. Severe hypokalaemia are the independent risk factors for mortality in TBI patients. (C) 2014 Elsevier Ltd. All rights reserved.	[Wu, Xing; Yu, Jian; Sun, Yirui; Du, Zhuoying; Wu, Xuehai; Mao, Ying; Zhou, Liangfu; Hu, Jin] Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai 200433, Peoples R China; [Lu, Xin; Lu, Xiangqiong; Wu, Sirong] Soochow Univ, Dept Emergency Med, Affiliated Hosp 1, Suzhou, Jiangsu, Peoples R China	Hu, J (corresponding author), Fudan Univ, Dept Neurosurg, Huashan Hosp, Wulumuqizhong Rd 12, Shanghai 200433, Peoples R China.	bttnirvina@gmail.com; 87luxin@gmail.com; 809451680@qq.com; lance2002@hotmail.com; yirui.sun@live.cn; duzhuoying@gmail.com; 170529860@qq.com; yinmao.neuro@gmail.com; neuro.lfzhou@gmail.com; wusirongmd@163.com; tgzy125@gmail.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [30870805, 81271003, 90919002, 30770824, 81000518, 81171133, 81271375, 08djl400503]; National Basic Research ProgrammeNational Basic Research Program of China [2009CB941100, 2010CB945500, 2012CB966300]; Science and Technology Commission of Shanghai Municipality ProjectScience & Technology Commission of Shanghai Municipality (STCSM) [10JC1402300]; Shanghai Nature Science Foundation [08411952000]	This work is supported, in part, by funds from National Natural Science Foundation of China (NSFC Grants 30870805, 81271003, 90919002, 30770824, 81000518, 81171133, 81271375 and 08djl400503), National Basic Research Programme (2009CB941100, 2010CB945500, 2012CB966300), The Science and Technology Commission of Shanghai Municipality Project (10JC1402300), Shanghai Nature Science Foundation (08411952000). The funders had no involvement in the study design; collection, analysis and interpretation of the study data; the writing of the manuscript; or the decision to submit the manuscript for publication.	Aibiki M, 2001, CRIT CARE MED, V29, P1726, DOI 10.1097/00003246-200109000-00012; AUBIER M, 1985, NEW ENGL J MED, V313, P420, DOI 10.1056/NEJM198508153130705; Beal AL, 2002, SHOCK, V18, P107, DOI 10.1097/00024382-200208000-00002; Bilotta F, 2012, NEUROCRIT CARE, V16, P280, DOI 10.1007/s12028-011-9652-2; BOLLAERT PE, 1995, CHEST, V107, P1698, DOI 10.1378/chest.107.6.1698; BROWN MJ, 1983, NEW ENGL J MED, V309, P1414, DOI 10.1056/NEJM198312083092303; Buckley MS, 2010, CRIT CARE MED, V38, pS253, DOI 10.1097/CCM.0b013e3181dda0be; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CRONIN D, 2012, BMJ CASE REP, V10, P2012; EPSTEIN FH, 1983, NEW ENGL J MED, V309, P1450, DOI 10.1056/NEJM198312083092308; Fauci A.S.B.E., 2008, HARRISONS PRINCIPLES; FISHER J, 1983, CHEST, V83, P504, DOI 10.1378/chest.83.3.504; Fofi L, 2012, J CLIN NEUROSCI, V19, P513, DOI 10.1016/j.jocn.2011.07.041; GABOW PA, 1992, KIDNEY INT, V41, P1311, DOI 10.1038/ki.1992.195; GRAVELYN TR, 1988, AM J MED, V84, P870, DOI 10.1016/0002-9343(88)90065-4; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; Lazar L, 1997, J PEDIATR SURG, V32, P88, DOI 10.1016/S0022-3468(97)90102-0; Li M, 2013, INJURY, V44, P1213, DOI 10.1016/j.injury.2012.05.021; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; Paltiel O, 2001, ARCH INTERN MED, V161, P1089, DOI 10.1001/archinte.161.8.1089; Polderman KH, 2008, INTENS CARE MED, V34, P1738, DOI 10.1007/s00134-008-1132-6; Polderman KH, 2000, CRIT CARE MED, V28, P2022, DOI 10.1097/00003246-200006000-00057; Polderman KH, 2001, J NEUROSURG, V94, P697, DOI 10.3171/jns.2001.94.5.0697; POMERANZ S, 1989, ACTA NEUROCHIR, V97, P62, DOI 10.1007/BF01577741; Schaefer FC, 2007, J TRAUMA STRESS, V20, P529, DOI 10.1002/jts.20240; Seo W, 2010, J NEUROSCI NURS, V42, P201, DOI 10.1097/JNN.0b013e3181e26b4a; SHIN B, 1986, ANESTHESIOLOGY, V65, P90, DOI 10.1097/00000542-198607000-00018; Ng Y, 2011, INTENS CARE MED, V37, P1285, DOI 10.1007/s00134-011-2240-2; Suzuki S, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.10.011; TROUWBORST A, 1984, INJURY, V15, P293, DOI 10.1016/0020-1383(84)90048-2; Tse HF, 2000, AM J MED, V109, P599, DOI 10.1016/S0002-9343(00)00590-8; VANEK VW, 1994, SOUTHERN MED J, V87, P41, DOI 10.1097/00007611-199401000-00010; Ybanez N, 2014, AM J KIDNEY DIS, V63, P530, DOI 10.1053/j.ajkd.2013.07.005	34	12	12	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2015	46	1					35	41		10.1016/j.injury.2014.08.002			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	AX1YJ	WOS:000346739600007	25195182				2021-06-18	
J	Yadav, NK; Ciuffreda, KJ				Yadav, Naveen K.; Ciuffreda, Kenneth J.			Objective assessment of visual attention in mild traumatic brain injury (mTBI) using visual-evoked potentials (VEP)	BRAIN INJURY			English	Article						Alpha band power; attenuation ratio (AR); attention deficit; mild traumatic brain injury (mTBI); primary visual cortex (V1); visual attention; visual-evoked potential (VEP)	REPORT SCALE ASRS; ADULT ADHD; EEG ALPHA; DEFICITS; PERFORMANCE; CONCUSSION; VALIDITY	Purpose: To quantify visual attention objectively using the visual-evoked potential (VEP) in those having mild traumatic brain injury (mTBI) with and without a self-reported attentional deficit. Research design and methods: Subjects were comprised of 16 adults with mTBI: 11 with an attentional deficit and five without. Three test conditions were used to assess the visual attentional state to quantify objectively the VEP alpha band attenuation ratio (AR) related to attention: (1) pattern VEP; (2) eyes-closed; and (3) eyes-closed number counting. The AR was calculated for both the individual and combined alpha frequencies (8-13 Hz). The objective results were compared to two subjective tests of visual and general attention (i.e. the VSAT and ASRS, respectively). Results: The AR for both the individual and combined alpha frequencies was found to be abnormal in those with mTBI having an attentional deficit. In contrast, the AR was normal in those with mTBI but without an attentional deficit. The AR correlated with the ASRS, but not with the VSAT, test scores. Conclusions: The objective and subjective tests were able to differentiate between those having mTBI with and without an attentional deficit. The proposed VEP protocol can be used in the clinic to detect and assess objectively and reliably a visual attentional deficit in the mTBI population.	[Yadav, Naveen K.; Ciuffreda, Kenneth J.] SUNY Coll Optometry, Dept Biol & Vis Sci, New York, NY 10036 USA	Yadav, NK (corresponding author), SUNY Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA.	nyadav@sunyopt.edu			College of Optometrists in Vision Development (COVD)	We thank DIOPSYS Inc., Pine Brook, NJ for providing the VEP system for the study. We also thank Dr Kevin Willeford for his helpful comments on the manuscript. This work was supported by the College of Optometrists in Vision Development (COVD).	Abdi H., 2010, ENCY RES DESIGN, V1, P1, DOI DOI 10.4135/9781412961288; American Clinical Neurophysiology Society, 2006, J Clin Neurophysiol, V23, P107; Babiloni C, 2004, COGNITIVE BRAIN RES, V19, P259, DOI 10.1016/j.cogbrainres.2003.12.010; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; BERNAL J, 1992, INT J NEUROSCI, V66, P45, DOI 10.3109/00207459208999788; Chan RCK, 2002, J CLIN EXP NEUROPSYC, V24, P1081, DOI 10.1076/jcen.24.8.1081.8371; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Ciuffreda K. J., 2011, J BEHAV OPTOMETRY, V22, P10; Ciuffreda KJ, 2013, BRAIN INJURY, V27, P41, DOI 10.3109/02699052.2012.700088; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Ciuffreda Kenneth J, 2002, Optometry, V73, P735; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; DUMERMUTH G, 1987, NEUROPSYCHOBIOLOGY, V17, P85, DOI 10.1159/000118345; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FULLER PW, 1978, J LEARN DISABIL-US, V11, P303, DOI 10.1177/002221947801100507; Garson GD, 2013, CORRELATION STAT ASS; Gomarus HK, 2009, CLIN NEUROPHYSIOL, V120, P73, DOI 10.1016/j.clinph.2008.10.017; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hale TS, 2009, NEUROPSYCHOLOGIA, V47, P2082, DOI 10.1016/j.neuropsychologia.2009.03.021; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Hansen C., 2001, UNDERSTANDING ACTIVE; Helvie R, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P45, DOI 10.1201/b10524-4; Hopf JM, 2000, CLIN NEUROPHYSIOL, V111, P1241, DOI 10.1016/S1388-2457(00)00313-8; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kim JH, 2013, PSYCHIAT INVEST, V10, P41, DOI 10.4306/pi.2013.10.1.41; Kirschfeld K, 2008, NEUROREPORT, V19, P907, DOI 10.1097/WNR.0b013e328302c545; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; LEGEWIE H, 1969, ELECTROEN CLIN NEURO, V27, P470, DOI 10.1016/0013-4694(69)90187-4; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; LUDLAM WM, 1979, J AM OPTOM ASSOC, V50, P111; Luria A. R., 1966, HIGHER CORTICAL FUNC; MACKIE RT, 1995, BRIT J OPHTHALMOL, V79, P290, DOI 10.1136/bjo.79.3.290; Marr AL., 2004, CENTRAL NERVOUS SYST; MCCULLOCH DL, 1991, INVEST OPHTH VIS SCI, V32, P2372; Nazhvani AD, 2013, CLIN NEUROL NEUROSUR, V115, P2329, DOI 10.1016/j.clineuro.2013.08.009; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Scheiman M., 2008, CLIN MANAGEMENT BINO, V3rd; Schnabel R, 2012, CLIN NEUROPSYCHOL, V26, P769, DOI 10.1080/13854046.2012.693541; SMITH A, 1967, ARCH NEUROL-CHICAGO, V17, P78, DOI 10.1001/archneur.1967.00470250082008; Solan HA, 2003, J LEARN DISABIL-US, V36, P556, DOI 10.1177/00222194030360060601; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Suchoff IB, 2001, VISUAL VESTIBULAR CO; Suter PS, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P1, DOI 10.1201/b10524; Thiabault LE, 1990, 34 ANN P ASS ADV AUT, V34, P337; Trenerry MR, 1989, PROFESSIONAL MANUAL; van de Glind G, 2013, DRUG ALCOHOL DEPEN, V132, P587, DOI 10.1016/j.drugalcdep.2013.04.010; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Willeford KT, 2013, DOC OPHTHALMOL, V126, P105, DOI 10.1007/s10633-012-9363-9; Willeford KT, 2013, DOC OPHTHALMOL, V126, P29, DOI 10.1007/s10633-012-9357-7; Yadav NK, 2013, BRAIN INJURY, V27, P1631, DOI 10.3109/02699052.2013.844856; Yadav NK, 2012, DOC OPHTHALMOL, V124, P177, DOI 10.1007/s10633-012-9319-0; Yadav NK, 2014, BRAIN INJURY, V28, P1; Ylvisaker M., 2003, BRAIN IMPAIR, V4, P1, DOI [10.1375/brim.4.1.1.27031, DOI 10.1375/brim.4.1.1.27031]; Zasler N, 2007, BRAIN INJURY MED PRI	65	12	13	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	3					352	365		10.3109/02699052.2014.979229			14	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CB0HQ	WOS:000349307000010	25415539				2021-06-18	
J	Mallick, S; D'Mello, SR				Mallick, Sathi; D'Mello, Santosh R.			JAZ (Znf346), a SIRT1-interacting Protein, Protects Neurons by Stimulating p21 (WAF/CIP1) Protein Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Huntington Disease; Neurodegeneration; Neuroprotection; Sirtuin 1 (SIRT1)	TRAUMATIC BRAIN-INJURY; ZINC-FINGER PROTEIN; CELL-CYCLE ARREST; PROVIDES NEUROPROTECTION; DEACETYLASE ACTIVITY; OXIDATIVE STRESS; CORTICAL-NEURONS; SIRT1; P21(WAF1/CIP1); APOPTOSIS	SIRT1, a class III histone deacetylase, protects neurons in various models of neurodegenerative diseases. We previously described that neuroprotection by SIRT1 is independent of its catalytic activity. To elucidate how SIRT1 protects neurons, we performed a mass spectrometric screen to find SIRT1-interacting proteins. One of the proteins identified was JAZ (Znf346), a member of a new class of Cys-2-His-2 zinc finger proteins. To investigate the significance of JAZ in the regulation of neuronal survival, we overexpressed it in neurons. We found that JAZ protects cerebellar granule neurons against potassium deprivation-induced death and cortical neurons from death resulting from oxidative stress. JAZ also protects neurons against toxicity induced by mutant huntingtin and mutant ataxin-1 expression. Although expression of endogenous JAZ does not change in neurons primed to die, knockdown of its expression promotes death of otherwise healthy neurons. In contrast to its protective effect in neurons, overexpression of JAZ in different cell lines promotes death. We find that JAZ suppresses cell cycle progression, thereby explaining its contrasting effect in postmitotic neurons versus proliferating cell lines. Although not affecting the expression of several cyclins, overexpression of JAZ stimulates expression of p21 (WAF1/CIP1), a cell cycle inhibitor known to have neuroprotective effects. Results of chromatin immunoprecipitation and transcriptional assays indicate that the stimulatory effect of JAZ on p21 expression is mediated at the transcriptional level. Furthermore, knockdown of p21 expression inhibits the neuroprotective effect of JAZ. Together, our results suggest that JAZ protects neurons by inhibiting cell cycle re-entry through the transcriptional stimulation of p21 expression.	[Mallick, Sathi] Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75080 USA; [Mallick, Sathi; D'Mello, Santosh R.] So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA	D'Mello, SR (corresponding author), So Methodist Univ, Dept Biol Sci, Dedman Life Sci Bldg,6501 Airline Rd, Dallas, TX 75275 USA.	sdmello@smu.edu	D'Mello, Santosh/AAM-3644-2020; D'Mello, Santosh/AAO-7192-2020	D'Mello, Santosh/0000-0002-7652-1334	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS040408, NS066404]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS066404, R01NS040408] Funding Source: NIH RePORTER	This work was supported, in whole or in part, by National Institutes of Health Grants NS040408 and NS066404.	Bardai FH, 2011, J NEUROSCI, V31, P1746, DOI 10.1523/JNEUROSCI.5704-10.2011; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Burge RG, 2014, BIOCHEMISTRY-US, V53, P1495, DOI 10.1021/bi401675h; Chen T, 2004, MOL CELL BIOL, V24, P6608, DOI 10.1128/mcb.24.15.6608-6619.2004; Copani A, 2001, TRENDS NEUROSCI, V24, P25, DOI 10.1016/S0166-2236(00)01663-5; Cox LS, 1997, J PATHOL, V183, P134, DOI 10.1002/(SICI)1096-9896(199710)183:2<134::AID-PATH960>3.0.CO;2-D; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Dastidar SG, 2011, J NEUROSCI, V31, P402, DOI 10.1523/JNEUROSCI.2897-10.2011; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Dobbin MM, 2013, NAT NEUROSCI, V16, P1008, DOI 10.1038/nn.3460; Donmez G, 2013, EMBO MOL MED, V5, P344, DOI 10.1002/emmm.201302451; Donmez G, 2012, TRENDS PHARMACOL SCI, V33, P494, DOI 10.1016/j.tips.2012.05.007; Duan WZ, 2013, CNS DRUGS, V27, P345, DOI 10.1007/s40263-013-0055-0; Finerty PJ, 1997, J MOL BIOL, V271, P195, DOI 10.1006/jmbi.1997.1177; Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138; Harms C, 2007, J NEUROSCI, V27, P4562, DOI 10.1523/JNEUROSCI.5110-06.2007; Haskew-Layton RE, 2010, P NATL ACAD SCI USA, V107, P17385, DOI 10.1073/pnas.1003996107; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Kabadi SV, 2012, NEUROTHERAPEUTICS, V9, P405, DOI 10.1007/s13311-011-0095-4; Kang H, 2011, MOL CELL, V44, P203, DOI 10.1016/j.molcel.2011.07.038; Langley B, 2008, J NEUROSCI, V28, P163, DOI 10.1523/JNEUROSCI.3200-07.2008; Ma TC, 2013, NEUROBIOL DIS, V49, P13, DOI 10.1016/j.nbd.2012.08.016; Majdzadeh N, 2008, DEV NEUROBIOL, V68, P1076, DOI 10.1002/dneu.20637; Mergenthaler P, 2013, J CEREBR BLOOD F MET, V33, P351, DOI 10.1038/jcbfm.2012.213; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Poluha W, 1996, MOL CELL BIOL, V16, P1335; RATAN RR, 1994, J NEUROSCI, V14, P4385; Schaefer JS, 2010, J BIOL CHEM, V285, P11258, DOI 10.1074/jbc.M109.073932; Tang BL, 2008, MOL ASPECTS MED, V29, P187, DOI 10.1016/j.mam.2007.02.001; Tomita K, 2006, BRAIN RES, V1081, P44, DOI 10.1016/j.brainres.2006.01.120; Verma P, 2014, J NEUROSCI, V34, P1599, DOI 10.1523/JNEUROSCI.3039-13.2014; Yang ML, 2006, BLOOD, V108, P4136, DOI 10.1182/blood-2006-06-029645; Yang ML, 2011, CELL CYCLE, V10, P2390, DOI 10.4161/cc.10.14.16587; Yang ML, 1999, J BIOL CHEM, V274, P27399, DOI 10.1074/jbc.274.39.27399	35	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35409	35420		10.1074/jbc.M114.597575			12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AX0RT	WOS:000346660200031	25331946	Green Published, Other Gold			2021-06-18	
J	Beijer, LJ; Rietveld, ACM; Ruiter, MB; Geurts, ACH				Beijer, L. J.; Rietveld, A. C. M.; Ruiter, M. B.; Geurts, A. C. H.			Preparing an E-learning-based Speech Therapy (EST) efficacy study: Identifying suitable outcome measures to detect within-subject changes of speech intelligibility in dysarthric speakers	CLINICAL LINGUISTICS & PHONETICS			English	Article						Clinical outcome research; dysarthria; outcome measures; speech intelligibility; web-based training	PARKINSONS-DISEASE; WEB APPLICATION; DISCRIMINATION; INTENSITY; DEFICITS; STROKE; IMPACT; MODEL; SUS	We explored the suitability of perceptual and acoustic outcome measures to prepare E-learning based Speech Therapy (EST) efficacy tests regarding speech intelligibility in dysarthric speakers. Eight speakers with stroke (n = 3), Parkinson's disease (n = 4) and traumatic brain injury (n = 1) participated in a 4 weeks EST trial. A repeated measures design was employed. Perceptual measures were (a) scale ratings for "ease of intelligibility'' and "pleasantness'' in continuous speech and (b) orthographic transcription scores of semantically unpredictable sentences. Acoustic measures were (c) "intensity during closure'' (Delta IDC) in the occlusion phase of voiceless plosives, (d) changes in the vowel space of /a/, /e/ and /o/ and (e) the F0 variability in semantically unpredictable sentences. The only consistent finding concerned an increased (instead of the expected decreased) Delta IDC after EST, possibly caused by increased speech intensity without articulatory adjustments. The importance of suitable perceptual and acoustic measures for efficacy research is discussed.	[Beijer, L. J.; Rietveld, A. C. M.; Ruiter, M. B.; Geurts, A. C. H.] Sint Maartensklin Res, Nijmegen, Netherlands; [Rietveld, A. C. M.; Ruiter, M. B.] Radboud Univ Nijmegen, Fac Arts, Dept Linguist, NL-6525 ED Nijmegen, Netherlands; [Geurts, A. C. H.] Radboud Univ Nijmegen, Med Ctr, Dept Rehabil, NL-6525 ED Nijmegen, Netherlands	Beijer, LJ (corresponding author), Sint Maartensklin, POB 9011, NL-6500 GM Nijmegen, Netherlands.	L.Beijer@maartenskliniek.nl	Geurts, Alexander/H-8032-2014; Ruiter, Marina B./J-3128-2016	Geurts, Alexander/0000-0001-7478-1119; Ruiter, Marina B./0000-0001-6147-5235			Abdi H., 2007, ENCY MEASUREMENT STA; ACKERMANN H, 1991, J NEUROL NEUROSUR PS, V54, P1093, DOI 10.1136/jnnp.54.12.1093; Basso A, 2005, APHASIOLOGY, V19, P975, DOI 10.1080/02687030544000182; Beijer LJ, 2012, J MED SPEECH-LANG PA, V20, P17; Beijer LJ, 2011, J COMMUN DISORD, V44, P701, DOI 10.1016/j.jcomdis.2011.05.002; Beijer LJ, 2010, TELEMED J E-HEALTH, V16, P732, DOI 10.1089/tmj.2009.0183; Beijer LJ, 2010, TELEMED J E-HEALTH, V16, P178, DOI 10.1089/tmj.2009.0104; Benoit C, 1996, SPEECH COMMUN, V18, P381, DOI 10.1016/0167-6393(96)00026-X; Bhogal SK, 2003, STROKE, V34, P987, DOI 10.1161/01.STR.0000062343.64383.D0; Blaney B, 2000, CLIN LINGUIST PHONET, V14, P307; Boersma P., 2009, PRAAT DOING PHONETIC; BOERSMA P, 1998, THESIS U AMSTERDAM N; Boves L., 1984, PHONETIC BASIS PERCE; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246, DOI 10.1044/jshr.1202.246; De Bodt MS, 2002, J COMMUN DISORD, V35, P283, DOI 10.1016/S0021-9924(02)00065-5; de Rue N. P. W. D., 2012, THESIS RADBOUD U NIJ; de Swart BJM, 2003, NEUROLOGY, V60, P498, DOI 10.1212/01.WNL.0000044480.95458.56; Hill A., 2008, THESIS U QUEENSLAND; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Kent RD, 1999, J MED SPEECH-LANG PA, V7, P83; Kent RD, 2003, CLIN LINGUIST PHONET, V17, P427, DOI 10.1080/0269920031000086248; Kim Y, 2011, J SPEECH LANG HEAR R, V54, P417, DOI 10.1044/1092-4388(2010/10-0020); Kwakkel G, 2006, DISABIL REHABIL, V28, P823, DOI 10.1080/09638280500534861; Laures J. S., 2012, J COMMUN DISORD, V36, P449; Laures JS, 1999, J SPEECH LANG HEAR R, V42, P1148, DOI 10.1044/jslhr.4205.1148; Maas E, 2008, AM J SPEECH-LANG PAT, V17, P277, DOI 10.1044/1058-0360(2008/025); Martens H., 2010, LOGOPEDIE, P31; Neger T., 2010, THESIS RADBOUD U NIJ; Palmer R, 2004, J MED SPEECH-LANG PA, V12, P183; Palmer R., 2007, INT J SPEECH LANGUAG, P140; Ramig LO, 2001, J NEUROL NEUROSUR PS, V71, P493, DOI 10.1136/jnnp.71.4.493; Rietveld T., 2009, ALGEMENE FONETIEK; Robey RR, 2004, J COMMUN DISORD, V37, P401, DOI 10.1016/j.jcomdis.2004.04.003; Rvachew S., 2004, J SPEECH HEAR RES, V37, P347; SCHEFFE H, 1952, J AM STAT ASSOC, V47, P381, DOI 10.2307/2281310; Schneider W., 2007, E PRIME VERSION 2 0; Troche J, 2012, AM J SPEECH-LANG PAT, V21, P258, DOI 10.1044/1058-0360(2012/11-0007); Van de Weijer J., 1991, LOGOPEDIE FONIATRIE, V63, P97; van Doremalen J., 2009, P INTERSPEECH, P592; VANBERGEM DR, 1993, SPEECH COMMUN, V12, P1, DOI 10.1016/0167-6393(93)90015-D; Wang YT, 2005, J COMMUN DISORD, V38, P231, DOI 10.1016/j.jcomdis.2004.12.001; Winters JM, 2004, TELEMED J E-HEALTH, V10, P200, DOI 10.1089/1530562041641255	42	12	12	0	20	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9206	1464-5076		CLIN LINGUIST PHONET	Clin. Linguist. Phon.	DEC	2014	28	12					927	950		10.3109/02699206.2014.936627			24	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	AT2YI	WOS:000344800100004	25025268				2021-06-18	
J	Casaletto, KB; Doyle, KL; Weber, E; Woods, SP				Casaletto, Kaitlin Blackstone; Doyle, Katie L.; Weber, Erica; Woods, Steven Paul		HIV Neurobehav Res Program HNRP	Self-Predictions of Prospective Memory in HIV-Associated Neurocognitive Disorders: Evidence of a Metamemory Deficit	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Executive functions; Metacognition; Everyday functioning	TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; OLDER-ADULTS; INFECTION; AWARENESS; IMPAIRMENT; TIME; DISSOCIATIONS; RELIABILITY; PERFORMANCE	HIV-associated neurocognitive disorders (HAND) are associated with deficits in prospective memory (PM; "remembering to remember"), conferring risk of daily functioning declines. However, self-perceptions of PM functioning are not reliably associated with PM performance in HIV, suggesting a possible deficit in awareness of PM abilities (meta-PM). Our study examined meta-PM in HAND and its correlates using self-predictions of laboratory-based PM performance. Performance-based PM abilities, self-reported prediction of PM performance, and PM complaints in everyday life were assessed in 49 individuals with HAND, 93 HIV+ without HAND (HIV+ noHAND), and 121 seronegative adults (HIV-). After controlling for group-level differences, HAND was associated with a greater number of PM symptoms in everyday life and worse PM performance when compared with both HIV+ noHAND and HIV- samples. Although HAND individuals reported somewhat lower predictions regarding their laboratory PM performance relative to the other study groups, they nevertheless exhibited significantly greater inaccurate overconfidence in time-based PM abilities. Within the HAND group, overconfidence in time-based meta-PM was associated with executive dysfunction and antiretroviral (ARV) nonadherence. HAND individuals evidenced a moderate deficit in awareness of PM functioning characterized by overconfidence in time-based PM abilities. Overconfidence in PM may result in absence of compensatory strategy use, and lead to increased errors in daily functioning (e.g., ARV nonadherence).	[Casaletto, Kaitlin Blackstone; Doyle, Katie L.; Weber, Erica] SDSU UCSD Joint Doctoral Program Clin Psychol, San Diego, CA 92103 USA; [Woods, Steven Paul] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Woods, Steven Paul] Univ Houston, Dept Psychol, Houston, TX 77204 USA	Woods, SP (corresponding author), Univ Houston, Dept Psychol, 126 Heyne Bldg, Houston, TX 77204 USA.	spwoods@uh.edu		Woods, Steven Paul/0000-0003-0776-4233	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-MH073419, P30-MH62512, T32-DA31098, F31-DA035708, F31-DA034510]; Foundation for Rehabilitation Psychology; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P30MH062512, R01MH073419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [T32DA031098, F31DA035708, F31DA034510] Funding Source: NIH RePORTER	This research was supported by National Institutes of Health grants R01-MH073419, P30-MH62512, T32-DA31098, F31-DA035708, and F31-DA034510. This study was also supported (in part) by a Foundation for Rehabilitation Psychology Dissertation Award.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Carey CL, 2006, J CLIN EXP NEUROPSYC, V28, P536, DOI 10.1080/13803390590949494; Chiao S, 2013, AIDS RES HUM RETROV, V29, P949, DOI [10.1089/aid.2012.0229, 10.1089/AID.2012.0229]; Contardo C, 2009, ARCH CLIN NEUROPSYCH, V24, P547, DOI 10.1093/arclin/acp046; Culbertson W, 2001, TOL DX TOWER LONDON; Delis DC, 2001, CALIFORNIA VERBAL LE; DEVOLDER PA, 1990, PSYCHOL AGING, V5, P291, DOI 10.1037/0882-7974.5.2.291; Doyle KL, 2013, J CLIN EXP NEUROPSYC, V35, P359, DOI 10.1080/13803395.2013.776010; Fernandez-Duque D, 2000, CONSCIOUS COGN, V9, P288, DOI 10.1006/ccog.2000.0447; Gupta S, 2010, J CLIN EXP NEUROPSYC, V32, P898, DOI 10.1080/13803391003596470; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Hinkin CH, 1996, J CLIN EXP NEUROPSYC, V18, P431, DOI 10.1080/01688639608408999; Juengst S, 2012, DISABIL REHABIL, V34, P19, DOI 10.3109/09638288.2011.587088; Karantzoulis S, 2009, J INT NEUROPSYCH SOC, V15, P407, DOI 10.1017/S1355617709090596; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Loft S, 2014, J CLIN EXP NEUROPSYC, V36, P761, DOI 10.1080/13803395.2014.942255; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McNair D.M., 1981, MANUAL PROFILE MOOD; Morgan EE, 2012, J CLIN EXP NEUROPSYC, V34, P416, DOI 10.1080/13803395.2012.654764; Oksanen KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092123; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Pirogovsky E, 2012, J INT NEUROPSYCH SOC, V18, P986, DOI 10.1017/S1355617712000781; Psychological Corporation, 1997, WAIS 3 WMS 3 TECHN M; Psychological Corporation, 2001, WECHSLER TEST ADULT; Raskin S., 2010, MEMORY INTENTIONS TE; Raskin SA, 2011, NEUROPSYCHOLOGY, V25, P201, DOI 10.1037/a0020999; Reitan RM., 1985, HALSTEAD REITAN NEUR; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Rourke SB, 1999, J CLIN EXP NEUROPSYC, V21, P757, DOI 10.1076/jcen.21.6.757.852; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; Smith SJ, 2011, NEUROPSYCHOLOGY, V25, P734, DOI 10.1037/a0025475; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Woods S. P., 2014, J INT NEUROPSYCH SOC, V20, P1; Woods SP, 2004, J CLIN EXP NEUROPSYC, V26, P759, DOI 10.1080/13803390490509565; Woods SP, 2005, J INT NEUROPSYCH SOC, V11, P408, DOI 10.1017/S1355617705050460; Woods SP, 2008, CLIN NEUROPSYCHOL, V22, P864, DOI 10.1080/13854040701595999; Woods SP, 2006, COGN BEHAV NEUROL, V19, P217, DOI 10.1097/01.wnn.0000213916.10514.57; Woods SP, 2007, SCHIZOPHR RES, V90, P344, DOI 10.1016/j.schres.2006.11.005; Woods SP, 2012, J INT NEUROPSYCH SOC, V18, P134, DOI 10.1017/S1355617711001263; Woods SP, 2011, REHABIL PSYCHOL, V56, P77, DOI 10.1037/a0022753; Woods SP, 2009, J INT NEUROPSYCH SOC, V15, P42, DOI 10.1017/S1355617708090012; World Health Organization, 1998, COMP INT DIAGN INT C; Zogg JB, 2011, ARCH CLIN NEUROPSYCH, V26, P250, DOI 10.1093/arclin/acr020	46	12	12	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2014	29	8					818	827		10.1093/arclin/acu061			10	Psychology, Clinical; Psychology	Psychology	AU9DD	WOS:000345890900009	25404005	Bronze, Green Published			2021-06-18	
J	Kong, XD; Bai, S; Chen, X; Wei, HJ; Jin, WN; Li, MS; Yan, YP; Shi, FD				Kong, Xiao-Dong; Bai, Sheng; Chen, Xin; Wei, Hui-Jie; Jin, Wei-Na; Li, Min-Shu; Yan, Yaping; Shi, Fu-Dong			Alterations of natural killer cells in traumatic brain injury	NEUROSCIENCE BULLETIN			English	Article						natural killer cells; traumatic brain injury; central nervous system; immunity	ANEURYSMAL SUBARACHNOID HEMORRHAGE; HEAD-INJURY; SYSTEM; CYTOTOXICITY; RECEPTORS; PROLACTIN; CORTISOL; FEATURES; MODERATE	To investigate the relationship between natural killer (NK) cells and traumatic brain injury (TBI), we tracked an established phenotype of circulating NK cells at several time points in patients with different grades of TBI. In serial peripheral blood samples, NK cells were prospectively measured by flow cytometry of CD3(-) CD56(+) lymphocytes. Compared to healthy controls, TBI patients had reductions in both the percentage and the absolute number of NK cells. Furthermore, the magnitude of NK cell reduction correlated with the degree of TBI severity at several time points. That is, NK cell population size was independently associated with lower Glasgow Coma Scale scores. In addition, at some time points, a positive correlation was found between the NK cell counts and Glasgow Outcome Scale scores. Our results indicate that TBI induces a reduction in the number of NK cells, and the magnitude of the reduction appears to parallel the severity of TBI.	[Kong, Xiao-Dong; Bai, Sheng; Chen, Xin; Wei, Hui-Jie; Jin, Wei-Na; Li, Min-Shu; Yan, Yaping; Shi, Fu-Dong] Tianjin Med Univ, Gen Hosp, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin Neurol Inst,Minist Educ,Dept Neurol, Tianjin 300052, Peoples R China; [Kong, Xiao-Dong; Bai, Sheng; Chen, Xin; Wei, Hui-Jie; Jin, Wei-Na; Li, Min-Shu; Yan, Yaping; Shi, Fu-Dong] Tianjin Med Univ, Gen Hosp, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin Neurol Inst,Minist Educ,Dept Neurosurg, Tianjin 300052, Peoples R China; [Kong, Xiao-Dong] Tianjin Med Univ, Gen Hosp, Dept Geriatr, Tianjin Geriatr Inst, Tianjin 300052, Peoples R China; [Shi, Fu-Dong] St Josephs Hosp, Dept Neurol, Barrow Neurol Inst, Phoenix, AZ USA	Shi, FD (corresponding author), Tianjin Med Univ, Gen Hosp, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin Neurol Inst,Minist Educ,Dept Neurol, Tianjin 300052, Peoples R China.	fshi@tijmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81370029, 81200907]; Tianjin Research Program of Application Foundation and Advanced Technology [12JCQNJC6800]; National Key Clinical Specialty Construction Project of China [12ZCDZSY17400]; National Clinical Key subject Construction Project of the NHFPC Fund	We thank Drs. J. Hao, L Liu and F. Chen for helpful advice, and Ms. P. Minick for editorial assistance. This work was supported in part by the National Natural Science Foundation of China (81370029 and 81200907); the Tianjin Research Program of Application Foundation and Advanced Technology (12JCQNJC6800); a National Key Clinical Specialty Construction Project of China (12ZCDZSY17400); and a National Clinical Key subject Construction Project of the NHFPC Fund.	Annane D, 2008, EUR RESPIR J, V31, P1150, DOI 10.1183/09031936.00040908; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Fabregas N, 2002, Minerva Anestesiol, V68, P285; Forel JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050446; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hao JW, 2011, ANN NEUROL, V69, P721, DOI 10.1002/ana.22339; Hao JW, 2010, J EXP MED, V207, P1907, DOI 10.1084/jem.20092749; Hsueh CM, 2002, J NEUROIMMUNOL, V123, P102, DOI 10.1016/S0165-5728(01)00488-X; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jurkowski M, 2001, BRAIN BEHAV IMMUN, V15, P93, DOI 10.1006/brbi.2000.0602; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Liu RL, 2006, J IMMUNOL, V176, P5247, DOI 10.4049/jimmunol.176.9.5247; Lunemann A, 2008, J IMMUNOL, V181, P6170, DOI 10.4049/jimmunol.181.9.6170; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MASERA R, 1989, IMMUNOPHARMACOLOGY, V18, P11, DOI 10.1016/0162-3109(89)90026-X; Mavoungou E, 2005, CLIN EXP IMMUNOL, V139, P287, DOI 10.1111/j.1365-2249.2004.02686.x; Mavoungou E, 2006, CLIN MED RES, V4, P33, DOI 10.3121/cmr.4.1.33; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Mrakovcic-Sutic I, 2010, SCAND J IMMUNOL, V72, P57, DOI 10.1111/j.1365-3083.2010.02407.x; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Shi FD, 2000, NAT IMMUNOL, V1, P245, DOI 10.1038/79792; Shi FD, 2001, TRENDS IMMUNOL, V22, P97, DOI 10.1016/S1471-4906(00)01821-4; Shi FD, 2011, NAT REV IMMUNOL, V11, P658, DOI 10.1038/nri3065; Shi FD, 2011, AUTOIMMUNITY, V44, P3, DOI 10.3109/08916931003782122; Shi FD, 2010, NATURAL KILLER CELLS: BASIC SCIENCE AND CLINICAL APPLICATION, P373, DOI 10.1016/B978-0-12-370454-2.00028-4; Shi FD, 2009, J IMMUNOL, V182, P1730, DOI 10.4049/jimmunol.182.3.1730; Shi QG, 2012, NEUROSCI BULL, V28, P469, DOI 10.1007/s12264-012-1256-0; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; TEASDALE G, 1974, LANCET, V2, P81; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Wang SY, 2008, LANCET, V372, P1765, DOI 10.1016/S0140-6736(08)61367-7; Wolach B, 2001, J NEUROSURG, V94, P706, DOI 10.3171/jns.2001.94.5.0706; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Yu JH, 2010, BLOOD, V115, P274, DOI 10.1182/blood-2009-04-215491	41	12	12	1	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1673-7067	1995-8218		NEUROSCI BULL	Neurosci. Bull.	DEC	2014	30	6					903	912		10.1007/s12264-014-1481-9			10	Neurosciences	Neurosciences & Neurology	AU6ZO	WOS:000345750500002	25446874	Green Published			2021-06-18	
J	Kumasaka, K; Marks, JA; Eisenstadt, R; Murcy, MA; Samadi, D; Li, SJ; Johnson, V; Browne, KD; Smith, DH; Schwab, CW; Pascual, JL				Kumasaka, Kenichiro; Marks, Joshua A.; Eisenstadt, Rachel; Murcy, Mohammad A.; Samadi, Davoud; Li, Shengjie; Johnson, Victoria; Browne, Kevin D.; Smith, Douglas H.; Schwab, C. William; Pascual, Jose L.			In vivo leukocyte-mediated brain microcirculatory inflammation: a comparison of osmotherapies and progesterone in severe traumatic brain injury	AMERICAN JOURNAL OF SURGERY			English	Article; Proceedings Paper	66th Annual Meeting of the Southwestern-Surgical-Congress	APR 13-16, 2014	Scottsdale, AZ	SW Surg Congress		Intravital microscopy; Neuroinflammation; Traumatic brain injury; Osmotherapy; Progesterone; Polymorphonuclear neutrophil	HYPERTONIC SALINE; HEMORRHAGIC-SHOCK; CEREBRAL MICROCIRCULATION; NEUTROPHIL ACTIVATION; MANNITOL; RESUSCITATION; NEUROPROTECTION; THERAPY; BARRIER; IMPACT	BACKGROUND: Mannitol, hypertonic saline, and progesterone may blunt leukocyte recruitment after traumatic brain injury (TBI). We hypothesized that progesterone reduces pericontusional recruitment of leukocytes to a greater extent than either osmotherapy a day after TBI. METHODS: CD1 mice underwent controlled cortical impact and were treated with osmotherapy (mannitol and hypertonic saline) or progesterone. Thirty-two hours after TBI, live pial microscopy was used to evaluate leukocyte-endothelial interactions and immunohistochemistry was used for the detection of pericontusional tissue polymorphonuclear neutrophils. Neurologic recovery was assessed before sacrifice. RESULTS: Mannitol resulted in the lowest in vivo leukocyte recruitment compared with progesterone (795 +/- 282 vs 1,636 +/- 434 LEU/100 mm/minutes, P < .05). Mannitol also displayed lower tissue accumulation of leukocytes as compared with progesterone (5.7 +/- 1.7 vs 15.2 +/- .1 LEU/mm(2), P -.03). However, progesterone resulted in better neurologic recovery than either osmotherapy. CONCLUSIONS: Leukocyte recruitment to injured brain is lowest with mannitol administration. How different agents alter progression of secondary brain injury will require further evaluation in humans. (C) 2014 Elsevier Inc. All rights reserved.	[Kumasaka, Kenichiro; Marks, Joshua A.; Eisenstadt, Rachel; Murcy, Mohammad A.; Samadi, Davoud; Li, Shengjie; Schwab, C. William; Pascual, Jose L.] Univ Penn, Dept Surg, Div Traumatol Surg Crit Care & Emergency Surg, Philadelphia, PA 19104 USA; [Johnson, Victoria; Browne, Kevin D.; Smith, Douglas H.] Univ Penn, Perelman Sch Med, Ctr Brain Injury & Repair, Dept Neurosurg, Philadelphia, PA 19104 USA	Pascual, JL (corresponding author), Univ Penn, Dept Surg, Div Traumatol Surg Crit Care & Emergency Surg, Philadelphia, PA 19104 USA.	jose.pascual@uphs.upenn.edu	Pascual, Jose/ABI-2291-2020	Pascual, Jose/0000-0002-1613-7912	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS092398] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS092398] Funding Source: Medline		Alvarez B, 1998, FREE RADICAL BIO MED, V24, P1331, DOI 10.1016/S0891-5849(98)00005-7; Angle N, 2000, SHOCK, V14, P503, DOI 10.1097/00024382-200014050-00002; Antonenko D, 2013, AM J SURG, V206, P845; Barone M, 1997, ACT NEUR S, V70, P267; BURKE AM, 1981, J NEUROSURG, V55, P550, DOI 10.3171/jns.1981.55.4.0550; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; David Wasserman OM, GLUCOSE CLAMPING CON; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Gando S, 2002, THROMB HAEMOSTASIS, V88, P943; Hinson HE, 2013, J INTENSIVE CARE MED, V28, P3, DOI 10.1177/0885066611400688; Li S, 2011, CRIT CARE MED, V39, P1493, DOI 10.1097/CCM.0b013e31821201d3; Lukaszewicz AC, 2011, CURR OPIN ANESTHESIO, V24, P138, DOI 10.1097/ACO.0b013e32834458af; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Nilsen J, 2002, ENDOCRINOLOGY, V143, P205, DOI 10.1210/en.143.1.205; NOLTE D, 1992, AM J PHYSIOL, V263, pH1411; Pascual JL, 2003, J TRAUMA, V54, pS133, DOI 10.1097/01.TA.0000064526.33647.63; Pascual JL, 2002, ANN SURG, V236, P634, DOI 10.1097/00000658-200211000-00014; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Rizoli SB, 1998, J IMMUNOL, V161, P6288; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; ROSNER MJ, 1987, NEUROSURGERY, V21, P147, DOI 10.1227/00006123-198708000-00003; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Schumacher M, 2007, ENDOCR REV, V28, P387, DOI 10.1210/er.2006-0050; Soustiel JF, 2006, BRAIN RES, V1101, P136, DOI 10.1016/j.brainres.2006.05.045; Vachharajani V, 2007, MICROCIRCULATION, V14, P223, DOI 10.1080/10739680601139153; Wong CH, 2006, FOOD CHEM TOXICOL, V44, P1399, DOI 10.1016/j.fct.2006.03.004; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yada-Langui MM, 2004, EXP BIOL MED, V229, P684	30	12	13	0	4	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	DEC	2014	208	6					961	967		10.1016/j.amjsurg.2014.08.004			7	Surgery	Surgery	AW2LU	WOS:000346120300025	25305798	Green Accepted			2021-06-18	
J	Takeda, Y; Kawashima, T; Kiyota, K; Oda, S; Morimoto, N; Kobata, H; Isobe, H; Honda, M; Fujimi, S; Ondaj, J; Seishi, I; Sakamoto, T; Ishikawa, M; Nakano, H; Kishikawa, M; Sadamitsu, D; Kinoshita, K; Yokoyama, T; Harada, M; Kitaura, M; Ichihara, K; Hashimoto, H; Tsuji, H; Yorifuji, T; Nagano, O; Katayama, H; Ujike, Y; Morita, K				Takeda, Yoshimasa; Kawashima, Takahisa; Kiyota, Kazuya; Oda, Shigeto; Morimoto, Naoki; Kobata, Hitoshi; Isobe, Hisashi; Honda, Mitsuru; Fujimi, Satoshi; Ondaj, Jun; Seishi, I; Sakamoto, Tetsuya; Ishikawa, Masami; Nakano, Hiroshi; Kishikawa, Masanobu; Sadamitsu, Daikai; Kinoshita, Kosaku; Yokoyama, Tomoharu; Harada, Masahiro; Kitaura, Michio; Ichihara, Kiyoshi; Hashimoto, Hiroshi; Tsuji, Hidekazu; Yorifuji, Takashi; Nagano, Osamu; Katayama, Hiroshi; Ujike, Yoshihito; Morita, Kiyoshi			Feasibility study of immediate pharyngeal cooling initiation in cardiac arrest patients after arrival at the emergency room	RESUSCITATION			English	Article						Cardiac arrest; Brain ischaemia; Therapeutic hypothermia	BRAIN TEMPERATURE; HYPOTHERMIA	Aim: Cooling the pharynx and upper oesophagus would be more advantageous for rapid induction of therapeutic hypothermia since the carotid arteries run in their vicinity. The aim of this study was to determine the effects of pharyngeal cooling on brain temperature and the safety and feasibility for patients under resuscitation. Methods: Witnessed non-traumatic cardiac arrest patients (n = 108) were randomized to receive standard care with (n = 53) or without pharyngeal cooling (n = 55). In the emergency room, pharyngeal cooling was initiated before or shortly after return of spontaneous circulation by perfusing physiological saline (5 degrees C) into a pharyngeal cuff for 120 min. Results: There was a significant decrease in tympanic temperature at 40 min after arrival (P = 0.02) with a maximum difference between the groups at 120 min (32.9 +/- 1.2 degrees C, pharyngeal cooling group vs. 34.1 +/- 1.3 degrees C, control group; P < 0.001). The return of spontaneous circulation (70% vs. 65%, P = 0.63) and rearrest (38% vs. 47%, P = 0.45) rates were not significantly different based on the initiation of pharyngeal cooling. No post-treatment mechanical or cold-related injury was observed on the pharyngeal epithelium by macroscopic observation. The thrombocytopaenia incidence was lower in the pharyngeal cooling group (P = 0.001) during the 3-day period after arrival. The cumulative survival rate at 1 month was not significantly different between the two groups. Conclusions: Initiation of pharyngeal cooling before or immediately after the return of spontaneous circulation is safe and feasible. Pharyngeal cooling can rapidly decrease tympanic temperature without adverse effects on circulation or the pharyngeal epithelium. (C) 2014 The Authors. Published by Elsevier Ireland Ltd.	[Takeda, Yoshimasa] Okayama Univ, Sch Med, Dept Anesthesiol, Kita Ku, Okayama 7008558, Japan; [Kawashima, Takahisa] Iseikai Hosp, Dept Emergency & Crit Care Med, Higashiyodogawa Ku, Osaka 5330022, Japan; [Kiyota, Kazuya] Saitama Red Cross Hosp, Tertiary Emergency Med Ctr, Chuo Ku, Saitama 3380001, Japan; [Oda, Shigeto] Chiba Univ, Grad Sch Med, Dept Emergency & Crit Care Med, Chuo Ku, Chiba 2600856, Japan; [Morimoto, Naoki] Osaka Mishima Emergency Crit Care Ctr, Okayama 7080841, Japan; [Kobata, Hitoshi] Osaka Mishima Emergency Crit Care Ctr, Osaka 5691124, Japan; [Isobe, Hisashi] Himeji Med Ctr, Dept Emergency Diag & Treatment, Himeji, Hyogo 6700012, Japan; [Honda, Mitsuru] Toho Univ, Fac Med, Emergency & Crit Care Ctr, Ota Ku, Tokyo 1430015, Japan; [Fujimi, Satoshi] Osaka Gen Med Ctr, Crit Care & Trauma Ctr, Sumiyoshi Ku, Osaka 5580056, Japan; [Ondaj, Jun] Kitakyushu Yugawa Hosp, Dept Neurosurg, Kokuraminami Ku, Fukuoka 8000251, Japan; [Seishi, I] Japanese Red Cross Kumamoto Hosp, Dept Emergency Med, Higashi Ku, Kumamoto 8618039, Japan; [Sakamoto, Tetsuya] Teikyo Univ, Trauma & Resuscitat Ctr, Sch Med, Itabashi Ku, Tokyo 1730003, Japan; [Ishikawa, Masami] Kure Kyosai Hosp, Emergency Dept, Hiroshima 7370811, Japan; [Nakano, Hiroshi] Okazaki City Hosp, Emergency Dept, Okazaki, Aichi 4440002, Japan; [Kishikawa, Masanobu] Osaka Med Ctr, Emergency & Crit Care Ctr, Chuo Ku, Osaka 5400006, Japan; [Sadamitsu, Daikai] Saiseikai Fukuoka Gen Hosp, Emergency & Crit Care Ctr, Chuo Ku, Fukuoka 8100001, Japan; [Kinoshita, Kosaku] Nihon Univ, Itabashi Hosp, Emergency & Crit Care Ctr, Itabashi Ku, Tokyo 1730032, Japan; [Yokoyama, Tomoharu] Tokyo Med Univ, Hachioji Med Ctr, Hachioji, Tokyo 1930944, Japan; [Harada, Masahiro] Kumamoto Med Ctr, Emergency & Crit Care Ctr, Chuo Ku, Kumamoto 8600008, Japan; [Kitaura, Michio] Kagawa Rosai Hosp, Dept Emergency & Crit Care Med, Kagawa 7630013, Japan; [Ichihara, Kiyoshi] Yamaguchi Univ, Grad Sch Med, Dept Clin Lab Sci, Yamaguchi 7550046, Japan; [Hashimoto, Hiroshi; Tsuji, Hidekazu] Daiken Med Co, Chuo Ku, Osaka 5410045, Japan; [Yorifuji, Takashi] Okayama Univ, Grad Sch Environm & Life Sci, Dept Human Ecol, Kita Ku, Okayama 7008558, Japan; [Nagano, Osamu] Kochi Univ, Sch Med, Dept Disaster & Emergency Med, Kochi 7838505, Japan; [Katayama, Hiroshi] Kawasaki Med Sch, Dept Anesthesiol & Intens Care Med, Kita Ku, Okayama 7000821, Japan; [Ujike, Yoshihito] Okayama Univ, Sch Med, Dept Emergency & Crit Care Med, Kita Ku, Okayama 7008558, Japan; [Morita, Kiyoshi] Okayama Univ, Kita Ku, Okayama 7000082, Japan	Takeda, Y (corresponding author), Okayama Univ, Sch Med, Dept Anesthesiol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	yoshit@cc.okayama-u.ac.jp	Harada, Masahiro/S-8719-2018; Hashimoto, Hiroshi/AAD-3667-2020	Harada, Masahiro/0000-0002-0162-5390; Kiyota, Kazuya/0000-0003-4423-4434	Ministry of Health, Labour and Welfare of JapanMinistry of Health, Labour and Welfare, Japan [H19-trans-005]; Daiken Medical Co	The research was supported by a grant from the Ministry of Health, Labour and Welfare of Japan (H19-trans-005) and by a grant from Daiken Medical Co. No sources of funding were involved in the study design; in the collection, analysis, and interpretation of the data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	ASTRUP T, 1965, THROMB DIATH HAEMOST, V14, P401; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Castren M, 2010, CIRCULATION, V122, P729, DOI 10.1161/CIRCULATIONAHA.109.931691; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Endo K, 2007, AM J OTOLARYNG, V28, P126, DOI 10.1016/j.amjoto.2006.07.001; Hagioka S, 2003, CRIT CARE MED, V31, P2502, DOI 10.1097/01.CCM.0000084845.76762.F4; Holzer M, 2002, NEW ENGL J MED, V346, P549; Keller C, 1997, ANAESTHESIA, V52, P592; Kim F, 2014, JAMA-J AM MED ASSOC, V311, P45, DOI 10.1001/jama.2013.282173; MCCAFFREY TV, 1975, J APPL PHYSIOL, V39, P114; Murphy JV, 2000, J TRAUMA, V48, P171, DOI 10.1097/00005373-200001000-00036; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; PATEL PM, 1994, BRAIN RES, V650, P205, DOI 10.1016/0006-8993(94)91783-3; Sakamoto T, 2014, RESUSCITATION, V85, P762, DOI 10.1016/j.resuscitation.2014.01.031; Takata K, 2005, CRIT CARE MED, V33, P1340, DOI 10.1097/01.CCM.0000166351.19369.D3; Takeda Y, 2012, ANESTHESIOLOGY, V117, P117, DOI 10.1097/ALN.0b013e3182580536; Wadelek J, 2012, ANAESTH INTENSIVE TH, V44, P31; Wolff B, 2009, INT J CARDIOL, V133, P223, DOI 10.1016/j.ijcard.2007.12.039; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	19	12	12	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572	1873-1570		RESUSCITATION	Resuscitation	DEC	2014	85	12					1647	1653		10.1016/j.resuscitation.2014.09.014			7	Critical Care Medicine; Emergency Medicine	General & Internal Medicine; Emergency Medicine	AW9UQ	WOS:000346603700009	25263513	Green Published, Other Gold			2021-06-18	
J	Fuller, G; Lawrence, T; Woodford, M; Lecky, F				Fuller, Gordon; Lawrence, Thomas; Woodford, Maralyn; Lecky, Fiona			The accuracy of alternative triage rules for identification of significant traumatic brain injury: a diagnostic cohort study	EMERGENCY MEDICINE JOURNAL			English	Article							HEAD-INJURY; CARE	Introduction Traumatic brain injury (TBI) is a leading cause of death and disability in young adults. Reorganisation of trauma services with direct triage of suspected head injury patients to trauma centres may improve outcomes following TBI. This study aimed to determine the sensitivity of principal English triage tools for identifying significant TBI. Methods We performed a diagnostic cohort study using data prospectively collated from the Trauma Audit and Research Network database between 2005 and 2011. Adult head injury patients were retrospectively classified according to London Ambulance Service (LAS) and Head Injury Transportation Straight to Neurosurgery study (HITS-NS) triage criteria. Sensitivity and specificity were then calculated against a reference standard of significant TBI, comprising head region abbreviated injury score (AIS) >= 3 or neurosurgical operation. Results 6559 patients were included in complete case analyses. The LAS and HITS-NS triage tools demonstrated sensitivities of 44.5% (95% CI 43.2 to 45.9) and 32.6% (95% CI 31.4 to 33.9), respectively, for identifying significant TBI patients. False negative significant TBI cases were relatively older, more likely to be female, more frequently secondary to low-level falls, and were less likely to have very severe AIS five or six head injuries, p<0.01. Conclusions A considerable proportion of significant head injury patients may not be triaged directly to trauma centres. Investment is therefore necessary to improve the accuracy of existing triage rules and maintain expertise in TBI diagnosis and management in non-specialist emergency departments.	[Fuller, Gordon; Lawrence, Thomas; Woodford, Maralyn] Salford Royal Hosp, Manchester Acad Hlth Sci Ctr, Hlth Sci Res Grp, Trauma Audit & Res Network, Salford M6 8HD, Lancs, England; [Lecky, Fiona] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England	Fuller, G (corresponding author), Salford Royal Hosp, Manchester Acad Hlth Sci Ctr, Hlth Sci Res Grp, Trauma Audit & Res Network, Mayo Bldg,Eccles Old Rd, Salford M6 8HD, Lancs, England.	gordonwfuller@doctors.org.uk		Lawrence, Thomas/0000-0003-3648-7634; Fuller, Gordon Ward/0000-0001-8532-3500			Allison P.D., 2001, MISSING DATA; American College of Surgeons Committee on Trauma, 2006, RES OPT CAR INJ PAT; Campbell FM, 1996, THESIS U MANCHESTER; Committee on Injury Scaling, 2005, ABBR INJ SCAL 2005 R; Cox S, 2012, INJURY, V43, P573, DOI 10.1016/j.injury.2010.10.003; *DEP HLTH, HOSP EP STAT; Edmonds ZV, 2002, ANN EMERG MED, V39, P233, DOI 10.1067/mem.2002.122017; Fuller G, 2011, J NEUROSURG ANESTH, V23, P198, DOI 10.1097/ANA.0b013e3182161816; Gage AM, 2012, J AM COLL SURGEONS, V215, P148, DOI 10.1016/j.jamcollsurg.2012.02.025; Harrison DA, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17230; Hedges JR, 2009, J EMERG MED, V37, P115, DOI 10.1016/j.jemermed.2008.07.001; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Kann SH, 2007, ACTA ANAESTH SCAND, V51, P1172, DOI 10.1111/j.1399-6576.2007.01354.x; Lossius Hans Morten, 2012, J Trauma Manag Outcomes, V6, P9, DOI 10.1186/1752-2897-6-9; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; National Institute for Clinical Excellence, 2007, CLIN GUID 56 HEAD IN; O'Reilly GM, 2012, INJURY, V43, P1917, DOI 10.1016/j.injury.2012.07.185; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Sleat G, 2011, INJURY, V42, P838, DOI 10.1016/j.injury.2011.05.014; WILBERGER JE, 1990, J TRAUMA, V30, P733, DOI 10.1097/00005373-199006000-00014	22	12	14	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	NOV	2014	31	11					914	919		10.1136/emermed-2013-202575			6	Emergency Medicine	Emergency Medicine	AQ8YO	WOS:000343126800015	23939945				2021-06-18	
J	Kessel, B; Dagan, J; Swaid, F; Ashkenazi, I; Olsha, O; Peleg, K; Givon, A; Alfici, R				Kessel, Boris; Dagan, Jasmin; Swaid, Forat; Ashkenazi, Itamar; Olsha, Oded; Peleg, Kobi; Givon, Adi; Alfici, Ricardo		Israel Trauma Grp	Rib fractures: comparison of associated injuries between pediatric and adult population	AMERICAN JOURNAL OF SURGERY			English	Article						Blunt trauma; Rib fractures; Associated injuries; Pattern of injury	THORACIC TRAUMA; CHILDREN; MORTALITY; MORBIDITY	BACKGROUND: Rib fractures are considered a marker of exposure to significant traumatic energy. In children, because of high elasticity of the chest wall, higher energy levels are necessary for ribs to fracture. The purpose of this study was to analyze patterns of associated injuries in children as compared with adults, all of whom presented with rib fractures. METHODS: A retrospective cohort study involving blunt trauma patients with rib fractures registered in the National Trauma Registry was conducted. RESULTS: Of 6,995 trauma victims who were found to suffer from rib fractures, 328 were children and 6,627 were adults. Isolated rib fractures without associated injuries occurred in 19 children (5.8%) and 731 adults (11%). More adults had 4 or more fractured ribs compared with children (P < .001). Children suffered from higher rates of associated brain injuries (P = .003), hemothorax/pneumothorax (P = .006), spleen, and liver injury (P < .001). Mortality rate was 5% in both groups. CONCLUSIONS: The incidence of associated head, thoracic, and abdominal solid organ injuries in children was significantly higher than in adults suffering from rib fractures. In spite of a higher Injury Severity Score and incidence of associated injuries, mortality rate was similar. Mortality of rib fracture patients was mostly affected by the presence of extrathoracic injuries. (C) 2014 Elsevier Inc. All rights reserved.	[Kessel, Boris] Hillel Yaffe Med Ctr, Trauma Unit, Hadera, Israel; [Dagan, Jasmin; Ashkenazi, Itamar; Alfici, Ricardo] Hillel Yaffe Med Ctr, Div Surg, Hadera, Israel; [Swaid, Forat] Bnai Zion Med Ctr, Dept Gen Surg, Haifa, Israel; [Olsha, Oded] Shaare Zedek Med Ctr, Dept Surg, Jerusalem, Israel; [Peleg, Kobi; Givon, Adi] Gertner Inst Epidemiol & Hlth Policy Res, Natl Ctr Trauma & Emergency Med Res, Tel Hashomer, Israel	Swaid, F (corresponding author), Bnai Zion Med Ctr, Dept Gen Surg, Haifa, Israel.	foratola@gmail.com	, ita/AAG-5879-2020	, ita/0000-0002-6305-4159			Al-Hassani A, 2010, AM SURGEON, V76, P888; Balci AE, 2004, EUR J CARDIO-THORAC, V26, P387, DOI 10.1016/j.ejcts.2004.04.024; Bergeron E, 2003, J TRAUMA, V54, P478, DOI 10.1097/01.TA.0000037095.83469.4C; Black TL, 1996, SOUTHERN MED J, V89, P494, DOI 10.1097/00007611-199605000-00009; Bulger EM, 2000, J TRAUMA, V48, P1040, DOI 10.1097/00005373-200006000-00007; Ceran S, 2002, EUR J CARDIO-THORAC, V21, P57, DOI 10.1016/S1010-7940(01)01056-9; Flagel BT, 2005, SURGERY, V138, P717, DOI 10.1016/j.surg.2005.07.022; GARCIA VF, 1990, J TRAUMA, V30, P695, DOI 10.1097/00005373-199006000-00007; Jones KM, 2011, AM J SURG, V202, P598, DOI 10.1016/j.amjsurg.2010.09.029; Liman ST, 2003, EUR J CARDIO-THORAC, V23, P374, DOI 10.1016/S1010-7940(02)00813-8; NAKAYAMA DK, 1989, ANN SURG, V210, P770, DOI 10.1097/00000658-198912000-00013; PECLET MH, 1990, J PEDIATR SURG, V25, P961, DOI 10.1016/0022-3468(90)90238-5; Sirmali M, 2003, EUR J CARDIO-THORAC, V24, P133, DOI 10.1016/S1010-7940(03)00256-2; ZIEGLER DW, 1994, J TRAUMA, V37, P975, DOI 10.1097/00005373-199412000-00018	14	12	12	0	5	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	NOV	2014	208	5					831	834		10.1016/j.amjsurg.2013.10.033			4	Surgery	Surgery	AT4TO	WOS:000344935500023	24832239				2021-06-18	
J	Pachatouridis, D; Alexiou, GA; Zigouris, A; Michos, E; Drosos, D; Fotakopoulos, G; Voulgaris, S				Pachatouridis, Dimitrios; Alexiou, George A.; Zigouris, Andreas; Michos, Evaggelos; Drosos, Dimitrios; Fotakopoulos, George; Voulgaris, Spyridon			Management of Hydrocephalus After Decompressive Craniectomy	TURKISH NEUROSURGERY			English	Article						Cranioplasty; Decompressive craniectomy; Hydrocephalus	POSTTRAUMATIC HYDROCEPHALUS	AIM: We set out to investigate the optimal timing for shunt placement in patients with hydrocephalus after decompressive craniectomy (DC). MATERIAL and METHODS: We studied 63 consecutive patients that underwent DC because of traumatic brain injury, middle cerebral artery infarct or intracerebral hemorrhage. Hydrocephalus was diagnosed in 23/63 patients. The 23 patients were divided into two groups. The first group (A) consisted of 11 patients in whom a ventriculoperitoneal shunt was placed simultaneously or before cranioplasty. In the second group (B) of 12 patients, we performed cranioplasty and a ventriculostomy with monitoring of intracranial pressure was placed simultaneously. After 3 to 5 days, a ventriculoperitoneal shunt was placed with the most appropriate opening pressure. RESULTS: In group A, nine out of the eleven patients experienced complications, mainly hygromas or hematomas that required reoperation. In group B, none of the patients was reoperated. The use of programmable valves allowed for non-invasive revision of the opening pressure when required. CONCLUSION: Cranioplasty and ventriculostomy followed by a second stage placement of a ventriculoperitoneal shunt are associated with fewer complications in the treatment of hydrocephalus after DC.	[Pachatouridis, Dimitrios; Alexiou, George A.; Zigouris, Andreas; Michos, Evaggelos; Drosos, Dimitrios; Fotakopoulos, George; Voulgaris, Spyridon] Univ Hosp Ioannina, Dept Neurosurg, Ioannina, Greece	Alexiou, GA (corresponding author), Univ Hosp Ioannina, Dept Neurosurg, Ioannina, Greece.	alexiougrg@yahoo.gr		Alexiou, George/0000-0003-0257-4481; fotakopoulos, george/0000-0002-2491-2886			Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; Clarke Michelle J, 2007, Neurosurg Focus, V22, pE3, DOI 10.3171/foc.2007.22.4.4; Czosnyka M, 2000, J NEUROL NEUROSUR PS, V68, P246; Dandy WE, 1914, AM J DIS CHILD, V8, P406; FOROGLOU G, 1972, Acta Radiologica Diagnosis, V13, P524; GREITZ D, 1993, ACTA RADIOL, V34, P1; Oh CH, 2008, J KOREAN NEUROSURG S, V44, P211, DOI 10.3340/jkns.2008.44.4.211; Pollack IF, 1999, NEUROSURGERY, V45, P1399, DOI 10.1097/00006123-199912000-00026; PORTNOY HD, 1982, J NEUROSURG, V56, P666, DOI 10.3171/jns.1982.56.5.0666; RAIMONDI AJ, 1994, CHILD NERV SYST, V10, P2, DOI 10.1007/BF00313578; Rekate HL, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-2; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Wen L, 2007, J CRANIOFAC SURG, V18, P526; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	15	12	13	0	3	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	NOV	2014	24	6					855	858		10.5137/1019-5149.JTN.8871-13.1			4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AY0EI	WOS:000347270100009	25448200				2021-06-18	
J	Walsh, KP; Kuhn, TB; Bamburg, JR				Walsh, Keifer P.; Kuhn, Thomas B.; Bamburg, James R.			Cellular prion protein: A co-receptor mediating neuronal cofilin-actin rod formation induced by beta-amyloid and proinflammatory cytokines	PRION			English	Article						actin; Alzheimer disease; cofilin; caveolin-1; cellular prion protein; lipid rafts; oxidative stress; NADPH oxidase; proinflammatory cytokines	NADPH-OXIDASE; ALZHEIMERS-DISEASE; SYNAPTIC LOSS; LIPID RAFTS; NEURODEGENERATION; ACTIVATION; CELLS; TRAFFICKING; MECHANISM; BINDING	Increasing evidence suggests that proteins exhibiting prion-like behavior cause distinct neurodegenerative diseases, including inherited, sporadic and acquired types. The conversion of cellular prion protein (PrPC) to its infectious protease resistant counterpart (PrPRes) is the essential feature of prion diseases. However, PrPC also performs important functions in transmembrane signaling, especially in neurodegenerative processes. Beta-amyloid (A) synaptotoxicity and cognitive dysfunction in mouse models of Alzheimer disease are mediated by a PrPC-dependent pathway. Here we review how this pathway converges with proinflammatory cytokine signaling to activate membrane NADPH oxidase (NOX) and generate reactive oxygen species (ROS) leading to dynamic remodeling of the actin cytoskeleton. The NOX signaling pathway may also be integrated with those of other transmembrane receptors clustered in PrPC-enriched membrane domains. Such a signal convergence along the PrPC-NOX axis could explain the relevance of PrPC in a broad spectrum of neurodegenerative disorders, including neuroinflammatory-mediated alterations in synaptic function following traumatic brain injury. PrPC overexpression alone activates NOX and generates a local increase in ROS that initiates cofilin activation and formation of cofilin-saturated actin bundles (rods). Rods sequester cofilin from synaptic regions where it is required for plasticity associated with learning and memory. Rods can also interrupt vesicular transport by occluding the neurite within which they form. Through either or both mechanisms, rods may directly mediate the synaptic dysfunction that accompanies various neurodegenerative disorders.	[Walsh, Keifer P.; Bamburg, James R.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Kuhn, Thomas B.] Univ Alaska, Dept Chem & Biochem, Fairbanks, AK 99701 USA	Bamburg, JR (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	James.Bamburg@ColoState.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG044812]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21AG044812] Funding Source: NIH RePORTER	Supported in part by a grant from National Institutes of Health (AG044812 to JRB).	Ansari MA, 2011, FREE RADICAL BIO MED, V51, P171, DOI 10.1016/j.freeradbiomed.2011.03.025; Barmada S, 2004, NEUROBIOL DIS, V16, P527, DOI 10.1016/j.nbd.2004.05.005; Barth BM, 2012, CELL SIGNAL, V24, P1126, DOI 10.1016/j.cellsig.2011.12.020; Bate C, 2012, PRION, V6, P350, DOI 10.4161/pri.21751; Bernstein BW, 2012, J NEUROSCI, V32, P6670, DOI 10.1523/JNEUROSCI.6020-11.2012; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cichon J, 2012, J BIOL CHEM, V287, P3919, DOI 10.1074/jbc.M111.301911; Clarke CJ, 2011, ADV ENZYME REGUL, V51, P51, DOI 10.1016/j.advenzreg.2010.09.016; Davis RC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-10; Ermonval M, 2003, BIOCHIMIE, V85, P33, DOI 10.1016/S0300-9084(03)00040-3; Fantini J, 2009, BBA-BIOMEMBRANES, V1788, P2345, DOI 10.1016/j.bbamem.2009.08.016; Haughey NJ, 2010, BBA-MOL CELL BIOL L, V1801, P878, DOI 10.1016/j.bbalip.2010.05.003; Head BP, 2014, BBA-BIOMEMBRANES, V1838, P532, DOI 10.1016/j.bbamem.2013.07.018; Hernandez F, 2007, CELL MOL LIFE SCI, V64, P2219, DOI 10.1007/s00018-007-7220-x; Hernandez-Rapp J, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00025; Huang TY, 2008, DEV CELL, V15, P691, DOI 10.1016/j.devcel.2008.09.017; Jackson GS, 2001, P NATL ACAD SCI USA, V98, P8531, DOI 10.1073/pnas.151038498; Lin Y, 2013, INT J MED SCI, V10, P515, DOI 10.7150/ijms.5423; Maloney MT, 2005, J NEUROSCI, V25, P11313, DOI 10.1523/JNEUROSCI.3711-05.2005; Masters CL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006262; McDonald JM, 2012, BRAIN RES, V1450, P138, DOI 10.1016/j.brainres.2012.02.041; Mi JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083609; Michel V, 2007, BIOL CELL, V99, P129, DOI 10.1042/BC20060051; Minamide LS, 2000, NAT CELL BIOL, V2, P628; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Pradines E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.195; Prusiner SB, 2013, ANNU REV GENET, V47, P601, DOI 10.1146/annurev-genet-110711-155524; Renner M, 2014, PATHOL BIOL, VS0369-8114, P33; Sanghera N, 2011, CHEM BIOL, V18, P1422, DOI 10.1016/j.chembiol.2011.08.016; Scheff SW, 2014, BIOCHEM PHARMACOL, V88, P517, DOI 10.1016/j.bcp.2013.12.028; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Schonhofen P, 2014, MINI-REV MED CHEM, V14, P393, DOI 10.2174/1389557514666140506161458; Shi Q, 2013, MED MICROBIOL IMMUN, V202, P215, DOI 10.1007/s00430-012-0284-8; Sultana R, 2013, FREE RADICAL BIO MED, V62, P157, DOI 10.1016/j.freeradbiomed.2012.09.027; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Um JW, 2013, PRION, V7, P37, DOI 10.4161/pri.22212; Walsh KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095995; Wolf M., 2014, CEREB CORTEX, V1991; Yang BH, 2007, AM J PHYSIOL-HEART C, V292, pH954, DOI 10.1152/ajpheart.00758.2006	40	12	13	0	14	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1933-6896	1933-690X		PRION	Prion	NOV-DEC	2014	8	6					375	380		10.4161/pri.35504			6	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AZ7DD	WOS:000348377600001	25426519	Green Published, Bronze			2021-06-18	
J	Keilhoff, G; Lucas, B; Pinkernelle, J; Steiner, M; Fansa, H				Keilhoff, Gerburg; Lucas, Benjamin; Pinkernelle, Josephine; Steiner, Michael; Fansa, Hisham			Effects of cerebrolysin on motor-neuron-like NSC-34 cells	EXPERIMENTAL CELL RESEARCH			English	Article						BrdU; Calpain; Cerebrolysin; NSC-34 cells; Organotypic spinal cord culture; Spectrin; Src	TRAUMATIC BRAIN-INJURY; ALPHA-II-SPECTRIN; GLUCOSE DEPRIVATION; SCHWANN-CELLS; IN-VITRO; MECHANICAL HYPERSENSITIVITY; TYROSINE PHOSPHORYLATION; PEPTIDE PREPARATION; SPINAL MICROGLIA; TRANSGENIC MODEL	Although the peripheral nervous system is capable of regeneration, this capability is limited. As a potential means of augmenting nerve regeneration, the effects of cerebrolysin (CL) - a proteolytic peptide fraction - were tested in vitro on the motor-neuron-like NSC-34 cell line and organotypic spinal cord cultures. Therefore, NSC-34 cells were subjected to mechanical stress by changing media and metabolic stress by oxygen glucose deprivation. Afterwards, cell survival/proliferation using MTT and BrdU-labeling (FACS) and neurite sprouting using ImageJ analysis were evaluated. Calpain-1, Src and alpha-spectrin protein expression were analyzed by Western blot. In organotypic cultures, the effect of CL on motor neuron survival and neurite sprouting was tested by immunohistochemistry. CL had a temporary anti-proliferative but initially neuroprotective effect on OGD-stressed NSC-34 cells. High-dosed or repeatedly applied CL was deleterious for cell survival. CL amplified neurite reconstruction to limited extent, affected calpain-1 protein expression and influenced calpain-mediated spectrin cleavage as a function of Src expression. In organotypic spinal cord slice cultures, CL was not able to support motor neuron survival/neurite sprouting. Moreover, it hampered astroglia and microglia activities. The data suggest that CL may have only isolated positive effects on injured spinal motor neurons. High-dosed or accumulated CL seemed to have adverse effects in treatment of spinal cord injury. Further experiments are required to optimize the conditions for a safe clinical administration of CL in spinal cord injuries. (C) 2014 Elsevier Inc. All rights reserved.	[Keilhoff, Gerburg; Lucas, Benjamin; Pinkernelle, Josephine; Steiner, Michael] Otto Von Guericke Univ, Inst Biochem & Cell Biol, D-39120 Magdeburg, Germany; [Fansa, Hisham] Klinikum Bielefeld, Dept Plast Reconstruct & Aesthet Surg Hand Surg, D-33604 Bielefeld, Germany	Keilhoff, G (corresponding author), Otto Von Guericke Univ, Inst Biochem & Cell Biol, Leipziger Str 44, D-39120 Magdeburg, Germany.	Gerburg.keilhoff@med.ovgu.de			DFGGerman Research Foundation (DFG)European Commission [KE 488/15-1]	This work was supported by a DFG grant (KE 488/15-1). We are grateful to Leona Buck and Susanne Bonifatius for their excellent technical help and advice.	Alvarez XA, 2011, EUR J NEUROL, V18, P59, DOI 10.1111/j.1468-1331.2010.03092.x; Alvarez XA, 2000, J NEURAL TRANSM-SUPP, P281; Vazquez-Roque RA, 2012, J NEUROSCI RES, V90, P288, DOI 10.1002/jnr.22753; Bevers MB, 2008, J CEREBR BLOOD F MET, V28, P655, DOI 10.1038/sj.jcbfm.9600595; BJELFMAN C, 1990, MOL CELL BIOL, V10, P361, DOI 10.1128/MCB.10.1.361; Blomgren K, 1999, J BIOL CHEM, V274, P14046, DOI 10.1074/jbc.274.20.14046; Bralic M, 2012, MED HYPOTHESES, V79, P358, DOI 10.1016/j.mehy.2012.05.034; Cali T, 2012, CELL CALCIUM, V52, P73, DOI 10.1016/j.ceca.2012.04.015; Campbell RL, 2012, BIOCHEM J, V447, P335, DOI 10.1042/BJ20120921; Cao X, 2010, NEUROSCI LETT, V479, P118, DOI 10.1016/j.neulet.2010.05.040; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chen HH, 2007, NEUROBIOL AGING, V28, P1148, DOI 10.1016/j.neurobiolaging.2006.05.036; Chen ZP, 2001, J VIROL, V75, P3613, DOI 10.1128/JVI.75.8.3613-3625.2001; Chou HC, 2010, FREE RADICAL BIO MED, V49, P96, DOI 10.1016/j.freeradbiomed.2010.04.001; Deng LX, 2013, J NEUROSCI, V33, P5655, DOI 10.1523/JNEUROSCI.2973-12.2013; Du BY, 2012, CHEMOTHERAPY, V58, P44, DOI 10.1159/000335603; Ebewe Arzneimittel, 1998, Patent, Patent No. [DE69126563T2, 69126563]; FOX JEB, 1993, J BIOL CHEM, V268, P25973; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gumy LF, 2010, EXP NEUROL, V223, P28, DOI 10.1016/j.expneurol.2009.06.004; Guo G, 2007, NEUROCHEM RES, V32, P2160, DOI 10.1007/s11064-007-9408-8; Haninec P, 2003, ANN ANAT, V185, P233, DOI 10.1016/S0940-9602(03)80030-4; Hartbauer M, 2001, J NEURAL TRANSM, V108, P459, DOI 10.1007/s007020170067; Hishiki T, 2011, PEDIATR SURG INT, V27, P225, DOI 10.1007/s00383-010-2775-2; HONG SC, 1994, BRAIN RES, V661, P43, DOI 10.1016/0006-8993(94)91178-9; Hutter-Paier B, 1998, J NEURAL TRANSM-SUPP, P363; Hutter-Paier B, 1998, J NEURAL TRANSM-SUPP, P351; Isonaka R, 2012, BRAIN RES, V1470, P11, DOI 10.1016/j.brainres.2012.06.014; Juarez I, 2011, SYNAPSE, V65, P1128, DOI 10.1002/syn.20950; Kalluri HSG, 2007, NEUROSCI LETT, V426, P145, DOI 10.1016/j.neulet.2007.08.047; KANJE M, 1991, BRAIN RES, V550, P340, DOI 10.1016/0006-8993(91)91338-2; Katsura H, 2006, J NEUROSCI, V26, P8680, DOI 10.1523/JNEUROSCI.1771-06.2006; Kieran D, 2004, NEUROSCIENCE, V125, P427, DOI 10.1016/j.neuroscience.2004.01.046; Ladurner G, 2005, J NEURAL TRANSM, V112, P415, DOI 10.1007/s00702-004-0248-2; Li N, 2011, BIOMATERIALS, V32, P9374, DOI 10.1016/j.biomaterials.2011.08.065; Lluis JM, 2007, CANCER RES, V67, P7368, DOI 10.1158/0008-5472.CAN-07-0515; Lombardi VRM, 1999, METHOD FIND EXP CLIN, V21, P331, DOI 10.1358/mf.1999.21.5.541910; Lucas B, 2014, ACTA HISTOCHEM, V116, P820, DOI 10.1016/j.acthis.2014.01.013; Ma M, 2013, NEUROBIOL DIS, V60, P61, DOI 10.1016/j.nbd.2013.08.010; Ma M, 2013, NEUROBIOL DIS, V56, P34, DOI 10.1016/j.nbd.2013.03.009; MacFarlane SN, 2000, J NEUROSCI, V20, P5245, DOI 10.1523/JNEUROSCI.20-14-05245.2000; Machnicka B, 2012, CELL MOL LIFE SCI, V69, P191, DOI 10.1007/s00018-011-0804-5; Mahmood T, 2012, N AM J MED SCI, V4, P429, DOI 10.4103/1947-2714.100998; Maier O, 2013, NEUROCHEM INT, V62, P1029, DOI 10.1016/j.neuint.2013.03.008; Masliah E, 2012, DRUG TODAY, V48, P3, DOI 10.1358/dot.2012.48(Suppl.A).1739716; Matsunaga T, 1998, INT J CANCER, V79, P226, DOI 10.1002/(SICI)1097-0215(19980619)79:3<226::AID-IJC3>3.3.CO;2-N; MATSUNAGA T, 1993, CANCER RES, V53, P3179; Matusica D, 2008, J NEUROSCI RES, V86, P553, DOI 10.1002/jnr.21507; Meloni BP, 2011, J NEUROSCI METH, V195, P67, DOI 10.1016/j.jneumeth.2010.11.023; Mingorance-Le Meur A, 2009, EMBO J, V28, P248, DOI 10.1038/emboj.2008.265; Montero M, 2007, EXP NEUROL, V204, P106, DOI 10.1016/j.expneurol.2006.09.026; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Navarro X, 2009, INT REV NEUROBIOL, V87, P483, DOI 10.1016/S0074-7742(09)87027-X; Nedrelow JH, 2003, J BIOL CHEM, V278, P7735, DOI 10.1074/jbc.M210988200; Nicolas G, 2002, MOL CELL BIOL, V22, P3527, DOI 10.1128/MCB.22.10.3527-3536.2002; Ohno H, 2007, BIOCHEM BIOPH RES CO, V353, P547, DOI 10.1016/j.bbrc.2006.12.061; OSHIMA M, 1989, J BIOL CHEM, V264, P20811; Paramo B, 2013, INT J BIOCHEM CELL B, V45, P2596, DOI 10.1016/j.biocel.2013.08.013; Pham NA, 2009, INT J CANCER, V124, P280, DOI 10.1002/ijc.23912; Pietsch M, 2010, CURR TOP MED CHEM, V10, P270, DOI 10.2174/156802610790725489; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pinkernelle J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073422; Pinkernelle J, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-32; Radi M, 2011, BIOORG MED CHEM LETT, V21, P5928, DOI 10.1016/j.bmcl.2011.07.079; Rao MV, 2008, J NEUROSCI, V28, P12241, DOI 10.1523/JNEUROSCI.4119-08.2008; Rasband W. S, 2012, IMAGEJ; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; Riley C, 2006, J NEURAL TRANSM, V113, P103, DOI 10.1007/s00702-005-0302-8; ROBERTSLEWIS JM, 1993, ANN NY ACAD SCI, V679, P78; Rockenstein E, 2007, ACTA NEUROPATHOL, V113, P265, DOI 10.1007/s00401-006-0166-5; Rockenstein E, 2006, J NEUROSCI RES, V83, P1252, DOI 10.1002/jnr.20818; Sahly I, 2006, J COMP NEUROL, V494, P705, DOI 10.1002/cne.20690; Salomoni P, 2010, TRENDS CELL BIOL, V20, P233, DOI 10.1016/j.tcb.2010.01.006; Salotti J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072582; Samantaray S, 2008, CNS NEUROL DISORD-DR, V7, P305, DOI 10.2174/187152708784936680; Santos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033468; Sato K, 2008, J NEUROSCI RES, V86, P2179, DOI 10.1002/jnr.21668; Schauer E, 2006, J NEURAL TRANSM, V113, P855, DOI 10.1007/s00702-005-0384-3; Schwab M, 1998, J NEURAL TRANSM-SUPP, P299; Sheridan RE, 2006, LIFE SCI, V79, P591, DOI 10.1016/j.lfs.2006.02.002; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Simon CM, 2010, HUM MOL GENET, V19, P973, DOI 10.1093/hmg/ddp562; Spira ME, 2001, CELL MOL NEUROBIOL, V21, P591, DOI 10.1023/A:1015135617557; Stys PK, 2002, NEUROSCI LETT, V328, P150, DOI 10.1016/S0304-3940(02)00469-X; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vaisid T, 2005, BBA-MOL CELL RES, V1743, P223, DOI 10.1016/j.bbamcr.2005.01.001; Vyas A, 2010, EXP NEUROL, V223, P112, DOI 10.1016/j.expneurol.2009.05.022; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wronski R, 2000, J NEURAL TRANSM, V107, P145, DOI 10.1007/s007020050013; Xu P, 2013, GLIA, V61, P1029, DOI 10.1002/glia.22491; Xu XH, 2009, DIFFERENTIATION, V77, P38, DOI 10.1016/j.diff.2008.09.006; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zhang CL, 2010, J NEUROSCI RES, V88, P3275, DOI 10.1002/jnr.22495; Zhou LJ, 2011, BRAIN BEHAV IMMUN, V25, P322, DOI 10.1016/j.bbi.2010.09.025	96	12	12	0	11	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4827	1090-2422		EXP CELL RES	Exp. Cell Res.	OCT 1	2014	327	2					234	255		10.1016/j.yexcr.2014.06.020			22	Oncology; Cell Biology	Oncology; Cell Biology	AP3EU	WOS:000341959200006	24997385				2021-06-18	
J	Perez-Barcena, J; Llompart-Pou, JA; O'Phelan, KH				Perez-Barcena, Jon; Antonio Llompart-Pou, Juan; O'Phelan, Kristine H.			Intracranial Pressure Monitoring and Management of Intracranial Hypertension	CRITICAL CARE CLINICS			English	Article						Intracranial pressure; Intracranial hypertension; Head injury	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; INTENSIVE INSULIN THERAPY; VENTRICULOSTOMY-RELATED INFECTIONS; POSTTRAUMATIC SEIZURE PROPHYLAXIS; WAKE-UP TEST; DECOMPRESSIVE CRANIECTOMY; MODERATE HYPOTHERMIA; HYPERTONIC SALINE	Intracranial pressure (ICP) monitoring is considered the standard of care in the majority of neurosurgical centers in North America and Europe. ICP is a reflection of the relationship between alterations in craniospinal volume and the ability of the craniospinal axis to accommodate added volume. ICP cannot be reliably estimated from any specific clinical feature or CT finding and must be directly measured. This review describes methods of monitoring ICP and how monitoring technique can provide additional information and provides key points regarding the treatment of intracranial hypertension in the neuro-ICU.	[Perez-Barcena, Jon; O'Phelan, Kristine H.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Antonio Llompart-Pou, Juan] Son Espases Hosp, Dept Intens Care, Palma De Mallorca 07010, Balearic Island, Spain	Perez-Barcena, J (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, 1120 Northwest 14th St, Miami, FL 33136 USA.	jperezbarcena@med.miami.edu	Viani, Rafael/V-1196-2018				Albeck MJ, 1998, J NEUROSURG, V89, P275, DOI 10.3171/jns.1998.89.2.0275; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS87; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS71; Brain Trauma Foundation, 2007, J NEUROTRAUM, V24, pS55, DOI DOI 10.1089/NEU.2007.9988; Brain Trauma Foundation, 2007, NUTR J NEUROTRAUMA, V24, pS77; Bratton SL, 2007, J NEUROTRAUMA, V24, pS7; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS45; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Choi PTL, 1999, CRIT CARE MED, V27, P200, DOI 10.1097/00003246-199901000-00053; Citerio G, 2004, INTENS CARE MED, V30, P1882, DOI 10.1007/s00134-004-2377-3; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cormio M, 1999, J NEUROTRAUM, V16, P927, DOI 10.1089/neu.1999.16.927; CRUZ J, 1990, J NEUROSURG, V73, P725, DOI 10.3171/jns.1990.73.5.0725; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; DONATO T, 1994, ANESTH ANALG, V78, P58; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; Foundation Brain Trauma, 2007, CEREBRAL PERFUSION T, V24, pS59; Frontera JA, 2006, STROKE, V37, P199, DOI 10.1161/01.STR.0000194960.73883.0f; Hartl R, 2013, WORLD NEUROSURG, V79, P599, DOI 10.1016/j.wneu.2013.03.046; Helbok R, 2012, CRIT CARE, V16, DOI 10.1186/cc11880; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; Hutchinson PJ, 2005, ACTA NEUROCHIR, V147, P1, DOI 10.1007/s00701-004-0400-7; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; Johnston AJ, 2004, INTENS CARE MED, V30, P791, DOI 10.1007/s00134-003-2155-7; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kellie George, 1824, Trans Med Chir Soc Edinb, V1, P84; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; Kerr M E, 2001, Neurosurg Focus, V11, pE1; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; Lane PL, 2000, CAN J SURG, V43, P442; Latorre JGS, 2009, NEUROLOGIST, V15, P193, DOI 10.1097/NRL.0b013e31819f956a; Lavinio A, 2011, CURR OPIN ANESTHESIO, V24, P117, DOI 10.1097/ACO.0b013e32834458c5; LEE MW, 1994, J NEUROTRAUM, V11, P325, DOI 10.1089/neu.1994.11.325; Lescot T, 2008, CURR OPIN CRIT CARE, V14, P129, DOI 10.1097/MCC.0b013e3282f63c51; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Maitinez-Manas RM, 2000, J NEUROL NEUROSUR PS, V69, P82, DOI 10.1136/jnnp.69.1.82; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; Mindermann T, 1998, ACT NEUR S, V71, P56; Monro A., 1823, OBSERVATIONS STRUCTU, P5; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; Oddo M, 2012, CURR OPIN CRIT CARE, V18, P111, DOI 10.1097/MCC.0b013e32835132a5; Patel N, 2013, J TRAUMA ACUTE CARE, V74, P771; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Qureshi AI, 2000, CRIT CARE MED, V28, P1556, DOI 10.1097/00003246-200005000-00049; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; Sahuquillo J, 2004, CURR PHARM DESIGN, V10, P2193, DOI 10.2174/1381612043384051; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sahuquillo J, 2009, INTENS CARE MED, V35, P890, DOI 10.1007/s00134-008-1357-4; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Skoglund K, 2014, NEUROCRIT CARE, V20, P413, DOI 10.1007/s12028-013-9876-4; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Suarez Jose I, 2004, Cleve Clin J Med, V71 Suppl 1, pS9; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Warner DS, 1996, ANESTHESIOLOGY, V84, P1475, DOI 10.1097/00000542-199606000-00024; Whitcomb BW, 2005, CRIT CARE MED, V33, P2772, DOI 10.1097/01.CCM.0000189741.44071.25; Wolfla CE, 1997, J NEUROSURG, V86, P505, DOI 10.3171/jns.1997.86.3.0505; Zhong J, 2003, NEUROL RES, V25, P339, DOI 10.1179/016164103101201661; Zornow M H, 1995, New Horiz, V3, P488	80	12	16	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0704	1557-8232		CRIT CARE CLIN	Crit. Care Clin.	OCT	2014	30	4					735	+		10.1016/j.ccc.2014.06.005			17	Critical Care Medicine	General & Internal Medicine	AR5IY	WOS:000343619800007	25257738				2021-06-18	
J	Scheyerer, MJ; Dutschler, J; Billeter, A; Zimmermann, SM; Sprengel, K; Werner, CML; Simmen, HP; Wanner, GA				Scheyerer, Max J.; Duetschler, Joel; Billeter, Adrian; Zimmermann, Stefan M.; Sprengel, Kai; Werner, Clement M. L.; Simmen, Hans-Peter; Wanner, Guido A.			Effect of elevated serum alcohol level on the outcome of severely injured patients	EMERGENCY MEDICINE JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; GLASGOW COMA SCALE; ETHANOL LEVELS; INTOXICATION; PREVALENCE; CONSUMPTION; SEVERITY; MODERATE; ABUSE; MODEL	Background The influence of high blood alcohol level (BAL) on the outcome of severely injured patients and the corresponding pathophysiological changes is a controversial issue. Objective To carry out a prognostic study to compare the physiological values and short-term outcome of severely injured patients depending on their serum alcohol level. Methods A total of 383 severely injured patients with an Injury Severity Score (ISS) >= 17 were admitted to the trauma division between October 2008 and December 2009 and enrolled into this study. Patients were grouped according to their BAL (>0.5 parts per thousand, 'BAL positive' vs <0.5 parts per thousand, 'BAL negative'). Trauma mechanism, pattern of injury and its treatment, and a course of intensive care treatment, physiological parameters and outcome with respect to mortality were analysed. Results Both groups had similar ISS. In comparison with the BAL-negative group, patients in the BAL-positive group had a significantly lower Glasgow Coma Scale score (9.64 vs 12 points; p=0.005) and, although not significant, a trend towards higher values of the Abbreviated Injury Score for the head (3.29 vs 2.81 points; p=0.146). Furthermore, significantly higher lactate (3.11 mmol/L vs 2.02 mmol/L; p<0.001) levels and lower median arterial pressure values (87.9 mm Hg vs 99.4 mm Hg; p=0.006) were seen in the BAL-positive group at day of admission. However, the overall in-hospital mortality was comparable to that in BAL-negative patients (19.6% vs 21.5%). Similarly, hospital stay (15.29 vs 17.55 days) and duration of intensive care unit treatment (8.53 vs 8.36 days) were not significantly affected by a high BAL upon admission. Conclusions Severely injured patients with a raised BAL have a higher incidence of severe traumatic brain injury and worse initial physiological parameters. However, the survival rate and in-hospital stay is not influenced. This supports the theory of a neuroprotective role of alcohol.	[Scheyerer, Max J.; Duetschler, Joel; Billeter, Adrian; Zimmermann, Stefan M.; Sprengel, Kai; Werner, Clement M. L.; Simmen, Hans-Peter; Wanner, Guido A.] Univ Zurich Hosp, Div Trauma Surg, Dept Surg, CH-8091 Zurich, Switzerland	Scheyerer, MJ (corresponding author), Univ Zurich Hosp, Div Trauma Surg, Dept Surg, Raemistr 100, CH-8091 Zurich, Switzerland.	maxjscheyerer@gmx.ch	Billeter, Adrian/O-2185-2019; Sprengel, Kai/G-4780-2014	Billeter, Adrian/0000-0001-8724-4793; Simmen, Hans-Peter/0000-0002-5201-4549; Sprengel, Kai/0000-0001-5921-8272			ANDERSEN JA, 1990, J TRAUMA, V30, P415, DOI 10.1097/00005373-199030040-00007; Berry C, 2010, AM SURGEON, V76, P1067; Blondell RD, 2002, J STUD ALCOHOL, V63, P380, DOI 10.15288/jsa.2002.63.380; Borges G, 2004, SOC SCI MED, V58, P1191, DOI 10.1016/S0277-9536(03)00290-9; Chen SC, 1999, J TRAUMA, V47, P881, DOI 10.1097/00005373-199911000-00011; Cherpitel CJ, 2004, ALCOHOL CLIN EXP RES, V28, p18S, DOI 10.1097/01.ALC.0000127411.61634.14; Cornwell EE, 1998, AM SURGEON, V64, P461; DAUGHTERS K, 1995, AM SURGEON, V61, P896; Demetriades D, 2004, J AM COLL SURGEONS, V199, P687, DOI 10.1016/j.jamcollsurg.2004.07.017; Dunne JR, 2005, J TRAUMA, V58, P959, DOI 10.1097/01.TA.0000158508.84009.49; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Hadjizacharia P, 2011, EUR J TRAUMA EMERG S, V37, P169, DOI 10.1007/s00068-010-0038-5; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; Mukamal KJ, 2003, JAMA-J AM MED ASSOC, V289, P1405, DOI 10.1001/jama.289.11.1405; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Ogden E J D, 2004, Traffic Inj Prev, V5, P185; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; Porter RS, 2000, PEDIATR EMERG CARE, V16, P316, DOI 10.1097/00006565-200010000-00003; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Sall JM, 1996, EXP NEUROL, V139, P257, DOI 10.1006/exnr.1996.0099; SLOAN EP, 1989, J TRAUMA, V29, P1647, DOI 10.1097/00005373-198912000-00011; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; STEIN PD, 1988, J TRAUMA, V28, P465, DOI 10.1097/00005373-198804000-00008; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Taylor AN, 2002, J NEUROTRAUM, V19, P1597, DOI 10.1089/089771502762300256; TULLOH BR, 1994, INJURY, V25, P539, DOI 10.1016/0020-1383(94)90097-3; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P205, DOI 10.1111/j.1530-0277.1990.tb00473.x; Yaghoubian A, 2009, AM SURGEON, V75, P950	30	12	12	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	OCT	2014	31	10					813	817		10.1136/emermed-2013-202804			5	Emergency Medicine	Emergency Medicine	AP9EE	WOS:000342380600006	23850886				2021-06-18	
J	Van Straten, AF; Fesler, JR; Hakimi, R; Sheng, TY; Thompson, DM; Hakimi, AS				Van Straten, Amanda F.; Fesler, Jessica R.; Hakimi, Ryan; Sheng, Tianyun; Thompson, David M.; Hakimi, Andrea S.			SIRPIDs: Prevalence and Outcome in Critically Ill Patients	JOURNAL OF CLINICAL NEUROPHYSIOLOGY			English	Article						SIRPID; EEG; Critical illness; Video EEG; Long-term monitoring; Critical care monitoring	ICTAL DISCHARGES SIRPIDS; PERIODIC EEG PATTERNS; CLINICAL-SIGNIFICANCE	Purpose:To determine the prevalence, associated factors, and outcomes of critically ill patients with stimulus-induced rhythmic, periodic, or ictal discharges (SIRPIDs) on long-term video-EEG (VEEG).Methods:After IRB approval, we retrospectively reviewed patient characteristics and VEEG findings of all consecutive critical care unit patients who underwent VEEG monitoring between January 2012 and September 2012.Results:The prevalence of SIRPIDs was 12.1% (4 of 33 patients; exact 95% confidence interval, 3.4%-28.2%). Factors associated with SIRPIDs versus non-SIRPIDs patients included a higher prevalence of subclinical status epilepticus (100% vs. 17.2%, P = 0.003), longer total VEEG recording time (286 vs. 56.9 hours, P = 0.0004), and acute traumatic brain injury (75.0% vs. 17.2%, P = 0.036). Sex, age, a history of epilepsy, nonstatus epileptic seizures, other EEG periodic patterns, and background rhythm reactivity on VEEG did not correlate with the presence of SIRPIDs. The presence or absence of SIRPIDs had no bearing on outcome; however, the population studied was very small.Conclusions:This small series suggests that the presence of subclinical status epilepticus and traumatic brain injury correlated with the presence of SIRPIDs signifying that SIRPIDs may be due to a more focal etiology and may represent a more ictal pattern than previously thought. Longer recording times in those patient populations may yield more cases of SIRPIDs in which to base further studies.	[Van Straten, Amanda F.; Fesler, Jessica R.; Hakimi, Ryan; Hakimi, Andrea S.] Univ Oklahoma, Hlth Sci Ctr, Dept Neurol, Oklahoma City, OK 73104 USA; [Sheng, Tianyun; Thompson, David M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK 73104 USA	Van Straten, AF (corresponding author), Univ Oklahoma, Hlth Sci Ctr, 920 Stanton L Young Blvd,Suite 2040, Oklahoma City, OK 73104 USA.	afvanstraten@gmail.com		Fesler, Jessica/0000-0003-4969-5600			Alvarez V, 2013, CLIN NEUROPHYSIOL, V124, P204, DOI 10.1016/j.clinph.2012.06.017; BRENNER RP, 1990, J CLIN NEUROPHYSIOL, V7, P249, DOI 10.1097/00004691-199004000-00007; Andraus MEC, 2012, ARQ NEURO-PSIQUIAT, V70, P145, DOI 10.1590/S0004-282X2012000200014; GLOOR P, 1968, EPILEPSIA, V9, P249, DOI 10.1111/j.1528-1157.1968.tb04624.x; GUTLING E, 1995, NEUROLOGY, V45, P915, DOI 10.1212/WNL.45.5.915; Hirsch LJ, 2008, EPILEPSIA, V49, P968, DOI 10.1111/j.1528-1167.2007.01481.x; Hirsch Lawrence J., 2002, Epilepsia, V43, P283; Hirsch LJ, 2004, EPILEPSIA, V45, P109, DOI 10.1111/j.0013-9580.2004.38103.x; Kaplan PW, 2011, EPILEPTIC DISORD, V13, P291, DOI 10.1684/epd.2011.0463; KUROIWA Y, 1980, ARCH NEUROL-CHICAGO, V37, P15, DOI 10.1001/archneur.1980.00500500045005; Lin JH, 2012, CLIN NEUROL NEUROSUR, V114, P1283, DOI 10.1016/j.clineuro.2012.03.006; Logi F, 2011, BRAIN INJURY, V25, P972, DOI 10.3109/02699052.2011.589795; Rossetti AO, 2007, CLIN NEUROPHYSIOL, V118, P2533, DOI 10.1016/j.clinph.2007.08.002; SNODGRASS SM, 1989, J CLIN NEUROPHYSIOL, V6, P159, DOI 10.1097/00004691-198904000-00003; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; Steriade M, 1996, SCIENCE, V272, P225, DOI 10.1126/science.272.5259.225; Zeiler SR, 2011, J CLIN NEUROPHYSIOL, V28, P493, DOI 10.1097/WNP.0b013e318231c00a	17	12	12	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0736-0258	1537-1603		J CLIN NEUROPHYSIOL	J. Clin. Neurophysiol.	OCT	2014	31	5					418	421		10.1097/WNP.0000000000000094			4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AQ6CC	WOS:000342894400006	25271679				2021-06-18	
J	Selvarajah, S; Schneider, EB; Becker, D; Sadowsky, CL; Haider, AH; Hammond, ER				Selvarajah, Shalini; Schneider, Eric B.; Becker, Daniel; Sadowsky, Cristina L.; Haider, Adil H.; Hammond, Edward R.			The Epidemiology of Childhood and Adolescent Traumatic Spinal Cord Injury in the United States: 2007-2010	JOURNAL OF NEUROTRAUMA			English	Article						adolescents; burden; children; epidemiology; Nationwide Emergency Department Sample; traumatic spinal cord injury	PEDIATRIC POPULATION; NEUROLOGICAL CLASSIFICATION; INTERNATIONAL STANDARDS; SEVERITY SCORE; MANAGEMENT; FEATURES; BURDEN; TRENDS; MOTOR; AGE	The burden of acute traumatic spinal cord injury (TSCI) among U. S. children and adolescents was last described over a decade ago using inpatient data. We describe cumulative incidence, mortality, discharge disposition, and inflation-adjusted charges of childhood and adolescent TSCI in the U. S. using emergency department (ED) data from the Nationwide Emergency Department Sample (2007-2010). Patients ages 17 years and younger with a diagnosis of acute TSCI were identified using the International Classification of Diseases, Ninth Revision (ICD-9) diagnosis codes 806.* and 952.* (N = 6132). The cumulative incidence of childhood and adolescent TSCI averaged 17.5 per million population per year. The median age at presentation was 15 years (interquartile range [IQR] = 12-16) and the majority of patients were male (72.5%). The overall median new injury severity score (NISS) was 16 (IQR = 9-27), remaining unchanged during the study duration (p = 0.703). Children 5 years and younger were more likely to be injured from a road traffic accident (RTA; 50.9%), sustain C1-C4 injuries (47.4%), have more severe injury (median NISS = 22; IQR = 13-29), and concurrent brain injury (24%) compared to older children and adolescents, p < 0.001. Firearms were implicated in 8.3% of injuries, of which 94.7% were among adolescents ages 13-17 years. Of the 35 TSCI-related ED deaths, 40% occurred among children ages 5 years and younger. 62.4% of patients required inpatient admission. Despite stable cumulative incidence and overall injury severity, ED treatment charge per visit increased on average $1394 from $3495 in 2007 to $4889 in 2010 (p = 0.008). RTA-related TSCI disproportionately affects young children, while firearm-related TSCI is most common among adolescents. These findings inform TSCI prevention strategies. Prevention may be key in mitigating rising healthcare cost.	[Selvarajah, Shalini; Schneider, Eric B.; Haider, Adil H.] Johns Hopkins Univ, Sch Med, Ctr Surg Trials & Outcomes Res, Baltimore, MD USA; [Haider, Adil H.] Johns Hopkins Univ, Sch Med, Div Acute Care Surg, Baltimore, MD USA; [Becker, Daniel] Johns Hopkins Univ Hosp, Dept Neurol, Baltimore, MD 21287 USA; [Becker, Daniel] Int Neurorehabil Inst, Lutherville Timonium, MD USA; [Sadowsky, Cristina L.; Hammond, Edward R.] Kennedy Krieger Inst, Hugo W Moser Res Inst, Int Ctr Spinal Cord Injury, Baltimore, MD USA; [Hammond, Edward R.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Selvarajah, S (corresponding author), Johns Hopkins Sch Med, Dept Surg, Ctr Surg Trials & Outcomes Res, 600 N Wolfe St,Blalock 611, Baltimore, MD 21287 USA.	sselvar2@jhmi.edu					Alabama B, 2013, SPIN CORD INJ FACTS; Augutis M, 2003, SPINAL CORD, V41, P328, DOI 10.1038/sj.sc.3101478; BRACKEN MB, 1981, AM J EPIDEMIOL, V113, P615, DOI 10.1093/oxfordjournals.aje.a113140; Burke D C, 1971, Paraplegia, V9, P1; BURNEY RE, 1993, ARCH SURG-CHICAGO, V128, P596; Centers for Disease Control and Prevention, 2013, WEB BAS INJ STAT QUE; Chafetz RS, 2009, J SPINAL CORD MED, V32, P157, DOI 10.1080/10790268.2009.11760767; Charyk Stewart T., J TRAUMA ACUTE CARE, V74, P628; Clark D. E., 2012, ICDPIC STATA MODULE; Clarke EC, 2012, SPINAL CORD INJURIES, P251; Consortium for Spinal Cord Medicine :, 2008, EARL AC MAN AD SPIN; Costacurta MLG, 2010, SPINAL CORD, V48, P118, DOI 10.1038/sc.2009.130; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; DeVivo MJ, 2011, ARCH PHYS MED REHAB, V92, P332, DOI 10.1016/j.apmr.2010.08.031; Fehlings MG, 1996, AM FAM PHYSICIAN, V54, P155; FENSTERMAKER RA, 1993, UROL CLIN N AM, V20, P413; Fine P.R., 1976, J MED SCI, V13, P173; Furlan JC, 2013, CAN J NEUROL SCI, V40, P456, DOI 10.1017/S0317167100014530; Haut ER, 2012, JAMA-J AM MED ASSOC, V307, P2589, DOI 10.1001/jama.2012.6626; Healthcare Cost and Utilization Project Agency for Healthcare Research and Quality, 2011, INTR HCUP NAT EM DEP; Healthcare Cost and Utilization Project Agency for Healthcare Research and Quality. The Nationwide Emergency Department Sample (NEDS), 2013, OV NAT EM DEP SAMPL; KEWALRAMANI LS, 1980, PARAPLEGIA, V18, P206, DOI 10.1038/sc.1980.36; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Lavoie A, 2004, J TRAUMA, V56, P1312, DOI 10.1097/01.TA.0000075342.36072.EF; Martins F, 1998, SPINAL CORD, V36, P574, DOI 10.1038/sj.sc.3100657; McKenna MT, 2005, AM J PREV MED, V28, P415, DOI 10.1016/j.amepre.2005.02.009; Mulcahey M.J., 2010, J NURSE LIFE CARE PL, V10, P204; National Spinal Cord Injury Statistical Center, 2011, ANN REP SPIN CORD IN; ORENSTEIN JB, 1994, PEDIATR EMERG CARE, V10, P132, DOI 10.1097/00006565-199406000-00003; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Parent S, 2011, J NEUROTRAUM, V28, P1515, DOI 10.1089/neu.2009.1153; Parent S, 2010, SPINE, V35, pS202, DOI 10.1097/BRS.0b013e3181f35acb; Retting RA, 2003, J SAFETY RES, V34, P485, DOI 10.1016/j.jsr.2003.05.001; Sahr RC, 2013, CONSUMER PRICE INDEX; Schottler J, 2012, DEV MED CHILD NEUROL, V54, P1138, DOI 10.1111/j.1469-8749.2012.04411.x; Selvarajah S, 2014, J NEUROTRAUM, V31, P228, DOI 10.1089/neu.2013.3098; Shavelle RM, 2007, J SPINAL CORD MED, V30, pS48, DOI 10.1080/10790268.2007.11753969; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; U. S Census Bureau, 2010, PROJ TOT RES POP 5 Y; Vitale MG, 2006, J PEDIATR ORTHOPED, V26, P745, DOI 10.1097/01.bpo.0000235400.49536.83; Vogel Lawrence C, 2012, Handb Clin Neurol, V109, P131, DOI 10.1016/B978-0-444-52137-8.00008-5	41	12	14	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 15	2014	31	18					1548	1560		10.1089/neu.2014.3332			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AP5UH	WOS:000342143700003	24811704				2021-06-18	
J	Bergsland, M; Covacu, R; Estrada, CP; Svensson, M; Brundin, L				Bergsland, Maria; Covacu, Ruxandra; Estrada, Cynthia Perez; Svensson, Mikael; Brundin, Lou			Nitric Oxide-Induced Neuronal to Glial Lineage Fate-Change Depends on NRSF/REST Function in Neural Progenitor Cells	STEM CELLS			English	Article						Stem cell-microenvironment interactions; Transcription factors; Oligodendrocytes; Neural stem cells; Differentiation	ADULT HUMAN BRAIN; MULTIPLE-SCLEROSIS; SUBVENTRICULAR ZONE; STEM-CELLS; TRANSCRIPTION FACTORS; CEREBROSPINAL-FLUID; NEUROGENESIS; REST; OLIGODENDROCYTES; INFLAMMATION	Degeneration of central nervous system tissue commonly occurs during neuroinflammatory conditions, such as multiple sclerosis and neurotrauma. During such conditions, neural stem/progenitor cell (NPC) populations have been suggested to provide new cells to degenerated areas. In the normal brain, NPCs from the subventricular zone generate neurons that settle in the olfactory bulb or striatum. However, during neuroinflammatory conditions NPCs migrate toward the site of injury to form oligodendrocytes and astrocytes, whereas newly formed neurons are less abundant. Thus, the specific NPC lineage fate decisions appear to respond to signals from the local environment. The instructive signals from inflammation have been suggested to rely on excessive levels of the free radical nitric oxide (NO), which is an essential component of the innate immune response, as NO promotes neuronal to glial cell fate conversion of differentiating rat NPCs in vitro. Here, we demonstrate that the NO-induced neuronal to glial fate conversion is dependent on the transcription factor neuron-restrictive silencing factor-1 (NRSF)/repressor element-1 silencing transcription (REST). Chromatin modification status of a number of neuronal and glial lineage restricted genes was altered upon NO-exposure. These changes coincided with gene expression alterations, demonstrating a global shift toward glial potential. Interestingly, by blocking the function of NRSF/REST, alterations in chromatin modifications were lost and the NO-induced neuronal to glial switch was suppressed. This implicates NRSF/REST as a key factor in the NPC-specific response to innate immunity and suggests a novel mechanism by which signaling from inflamed tissue promotes the formation of glial cells.	[Bergsland, Maria; Covacu, Ruxandra; Estrada, Cynthia Perez; Brundin, Lou] Karolinska Inst, Dept Clin Neurosci, Karolinska Univ Hosp, Div Neurol, SE-17176 Stockholm, Sweden; [Bergsland, Maria; Svensson, Mikael] Karolinska Inst, Dept Clin Neurosci, Karolinska Univ Hosp, Div Neurosurg, SE-17176 Stockholm, Sweden	Bergsland, M (corresponding author), Karolinska Inst, Dept Clin Neurosci, SE-17176 Stockholm, Sweden.	maria.bergsland@ki.se	Svensson, Mikael/F-8662-2012	Svensson, Mikael/0000-0003-1179-7003; Covacu, Ruxandra/0000-0003-3183-2988; Brundin, Lou/0000-0003-4408-7817	Swedish Research CouncilSwedish Research CouncilEuropean Commission [K2013-62X-20724-06-3]; Torsten and Ragnar Soderberg Foundation; The Swedish Neuro Association; Karolinska Institutet Theme-center for Regenerative Medicine	We are grateful to Britt Meijer for assistance with human NPC culturing. This work is supported by the Swedish Research Council (K2013-62X-20724-06-3); Torsten and Ragnar Soderberg Foundation; The Swedish Neuro Association; and Karolinska Institutet Theme-center for Regenerative Medicine.	AMBER IJ, 1988, J LEUKOCYTE BIOL, V43, P187; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Bergsland M, 2006, GENE DEV, V20, P3475, DOI 10.1101/gad.403406; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; BO L, 1994, ANN NEUROL, V36, P778, DOI 10.1002/ana.410360515; Bolli R, 2003, TRENDS CARDIOVAS MED, V13, P72, DOI 10.1016/S1050-1738(02)00230-X; Brundin L, 1998, ANN NEUROL, V44, P704, DOI 10.1002/ana.410440421; Brundin L, 1999, EUR J NEUROL, V6, P585, DOI 10.1046/j.1468-1331.1999.650585.x; CHAO CC, 1994, DEV NEUROSCI-BASEL, V16, P172, DOI 10.1159/000112104; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Covacu R, 2006, STEM CELLS, V24, P2792, DOI 10.1634/stemcells.2005-0640; Covey MV, 2012, DEVELOPMENT, V139, P2878, DOI 10.1242/dev.074765; Curtis MA, 2012, DEV NEUROBIOL, V72, P990, DOI 10.1002/dneu.22028; Danilov AI, 2003, J NEUROIMMUNOL, V136, P112, DOI 10.1016/S0165-5728(02)00464-2; DeWald LE, 2011, J NEUROSCI, V31, P3470, DOI 10.1523/JNEUROSCI.2768-10.2011; Dietrich N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002494; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Forstermann U, 1998, FASEB J, V12, P773; Gahm C, 2005, NEUROSURGERY, V57, P1272, DOI 10.1227/01.NEU.0000187317.32529.06; Gao ZL, 2011, J NEUROSCI, V31, P9772, DOI 10.1523/JNEUROSCI.1604-11.2011; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; Hawkins RD, 2011, CELL RES, V21, P1393, DOI 10.1038/cr.2011.146; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Kohman RA, 2013, BRAIN BEHAV IMMUN, V27, P22, DOI 10.1016/j.bbi.2012.09.003; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; Mecha M, 2013, EXP NEUROL, V250, P348, DOI 10.1016/j.expneurol.2013.10.011; Mehler Mark F, 2002, Results Probl Cell Differ, V39, P27; MERRILL JE, 1993, J IMMUNOL, V151, P2132; Moll NM, 2013, GLIA, V61, P1659, DOI 10.1002/glia.22547; MONCADA S, 1991, PHARMACOL REV, V43, P109; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Nait-Oumesmar B, 2008, J NEUROL SCI, V265, P26, DOI 10.1016/j.jns.2007.09.032; NATHAN CF, 1991, CURR OPIN IMMUNOL, V3, P65, DOI 10.1016/0952-7915(91)90079-G; Packer MA, 2003, P NATL ACAD SCI USA, V100, P9566, DOI 10.1073/pnas.1633579100; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pfeifenbring S, 2013, GLIA, V61, P1250, DOI 10.1002/glia.22512; RAINE CS, 1989, LAB INVEST, V60, P714; Roybon L, 2009, EUR J NEUROSCI, V29, P232, DOI 10.1111/j.1460-9568.2008.06595.x; Sabelstrom H, 2013, SCIENCE, V342, P637, DOI 10.1126/science.1242576; SALTER M, 1991, FEBS LETT, V291, P145, DOI 10.1016/0014-5793(91)81123-P; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Sequerra EB, 2013, DEVELOPMENT, V140, P3303, DOI 10.1242/dev.093096; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Sugimori M, 2007, DEVELOPMENT, V134, P1617, DOI 10.1242/dev.001255; Svenningsson A, 1999, NEUROLOGY, V53, P1880, DOI 10.1212/WNL.53.8.1880; Taskiran D, 2000, INT J NEUROSCI, V101, P65, DOI 10.3109/00207450008986493; Tepavcevic V, 2011, J CLIN INVEST, V121, P4722, DOI 10.1172/JCI59145; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; VISSER JJ, 1994, ANN INTERN MED, V120, P345, DOI 10.7326/0003-4819-120-4-199402150-00023; Westerlund U, 2003, EXP CELL RES, V289, P378, DOI 10.1016/S0014-4827(03)00291-X; Zheng DY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r9	55	12	14	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	SEP	2014	32	9					2539	2549		10.1002/stem.1749			11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	AO4GM	WOS:000341294500022	24807147	Other Gold			2021-06-18	
J	Enicker, B; Madiba, TE				Enicker, Basil; Madiba, Thandinkosi E.			Cranial injuries secondary to assault with a machete	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Machete; Compound depressed skull fracture; Intra-cranial haematoma	DEPRESSED SKULL FRACTURES; MANAGEMENT; EXPERIENCE; INFECTION	Background: Assaults with a machete cause compound skull fractures which present as a neurosurgical emergency. We aimed to profile cranial injuries caused by a machete over a 10 year period in a single neurosurgical unit. Materials and methods: Retrospective data analysis of cranial injuries following assault with a machete, admitted to the neurosurgery ward, from January 2003 to December 2012 was performed. Medical records were analyzed for demographics, clinical presentation, CT scan findings, surgical treatment and Glasgow Outcome Scale (GOS) at discharge. Management involved wound debridement with antibiotic cover. Results: Of 185 patients treated 172 (93%) were male. Mean age was 31 +/- 11.4 years. Mean GCS on admission was 13 +/- 2. Presenting features were focal neurological deficit (48%), brain matter oozing from wounds (20%), and post traumatic seizures (12%). Depressed skull fractures were found in 162 (88%) patients. Findings on CT brain scan were intra-cranial haematoma (88%), pneumocephalus (39%) and features of raised intra-cranial pressure (37%). Thirty-one patients (17%) presented with septic head wounds. One hundred and fifty seven patients (85%) were treated surgically. The median hospital stay was 8 days (range 1-145). The median GOS at discharge was 5 (range 1-5). Twelve patients died within the same admission (6.5%). Conclusion: Machetes cause complex cranial injuries with associated neurological deficit and should be treated as neurosurgical emergency. Timeous intervention and good surgical principles are advocated to prevent secondary infection and further neurological deterioration. (C) 2014 Elsevier Ltd. All rights reserved.	[Enicker, Basil] Univ KwaZulu Natal, Dept Neurosurg, Durban, South Africa; [Enicker, Basil; Madiba, Thandinkosi E.] Inkosi Albert Luthuli Cent Hosp, Durban, South Africa; [Madiba, Thandinkosi E.] Univ KwaZulu Natal, Durban, South Africa	Enicker, B (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Inkosi Albert Luthuli Cent Hosp, Dept Neurosurg, Private Bag X03, ZA-4058 Mayville, South Africa.	basilenicker@yahoo.com	Madiba, T E/N-6069-2013; Madiba, T E/ABI-8313-2020	Madiba, T E/0000-0002-0155-9143; Madiba, T E/0000-0002-0155-9143			[Anonymous], 2012, CENS 2011 STAT REL P; Borkar SA, 2009, TURK NEUROSURG, V19, P103; BRAAKMAN R, 1972, J NEUROL NEUROSUR PS, V35, P395, DOI 10.1136/jnnp.35.3.395; Crandon IW, 2011, INT J INJ CONTROL SA, V18, P293, DOI 10.1080/17457300.2011.569890; Irmay F, 2000, LANCET, V356, P1072, DOI 10.1016/S0140-6736(00)02731-8; JENNETT B, 1972, J NEUROSURG, V36, P333, DOI 10.3171/jns.1972.36.3.0333; LeFeuvre D, 2004, SURG NEUROL, V62, P121, DOI 10.1016/j.surneu.2003.10.048; Marion DW, 2006, NEUROSURGERY, V58, P655; Nathoo N, 2011, WORLD NEUROSURG, V75, P716, DOI 10.1016/j.wneu.2010.11.043; Omoke NI, 2010, INJURY, V41, P120, DOI 10.1016/j.injury.2009.08.023; Omoke NI, 2012, INT ORTHOP, V36, P613, DOI 10.1007/s00264-011-1322-7; VANDENHEEVER CM, 1989, J NEUROSURG, V71, P186, DOI 10.3171/jns.1989.71.2.0186; Wiedeman JE, 2001, MIL MED, V166, P1023; Wylen EL, 1999, SURG NEUROL, V51, P452, DOI 10.1016/S0090-3019(98)00040-8	14	12	12	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2014	45	9					1355	1358		10.1016/j.injury.2014.04.036			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	AN0NI	WOS:000340280900013	24933443				2021-06-18	
J	Foy, CML				Foy, Catherine M. L.			Long Term Efficacy of an Integrated Neurological and Vocational Rehabilitation Programme for Young Adults with Acquired Brain Injury	JOURNAL OF OCCUPATIONAL REHABILITATION			English	Article						Brain injuries; Traumatic brain injury; Rehabilitation; vocational; Return to work	PSYCHOSOCIAL ADJUSTMENT; COMMUNITY INTEGRATION; FOLLOW-UP; WORK; RETURN; EMPLOYMENT; PREDICTION; POPULATION; DISABILITY; STABILITY	Purpose To characterise and determine the pre-injury, injury and post-injury factors associated with vocational outcome 1-9 years post-discharge from a mixed therapy/educational/vocational rehabilitation (VR) residential programme. Methods 119 clients of working age when they acquired their brain injury and who had attended the centre between 2002 and 2011 were followed up at least 1 year post-discharge to determine their vocational outcome as part of an ongoing review/audit of the service. All clients had had a severe/very severe brain injury. Clients were classified as having a positive vocational outcome (working-paid/voluntary, full/part-time or undertaking full or part-time vocationally related education) or negative vocational outcome (undertaking neither work nor education). Results Over half of the clients attained a positive vocational outcome. Length of time since discharge did not differ between those clients with a positive or negative vocational outcome. Vocational outcome was predicted by cognitive and motor ability at discharge, and gender. Together these variables correctly classified the vocational outcome of 76 % of the clients. Conclusion Clients with severe/very severe brain injury can attain a positive vocational outcome following intensive neurorehabilitation consisting of traditional therapies in addition to educational and VR.	QEF Neuro Rehabil Serv, Banstead SM7 3EE, Surrey, England	Foy, CML (corresponding author), QEF Neuro Rehabil Serv, Banstead Pl,Pk Rd, Banstead SM7 3EE, Surrey, England.	Catherine.Foy@QEF.org.uk					Ashley MJ, 1997, BRAIN INJURY, V11, P677; Asikainen I, 1996, BRAIN INJURY, V10, P883, DOI 10.1080/026990596123864; BENYISHAY Y, 1987, J HEAD TRAUMA REHAB, V2, P35, DOI DOI 10.1097/00001199-198703000-00007; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Fleming J, 1999, BRAIN INJURY, V13, P417; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Johansson U, 2006, AM J OCCUP THER, V60, P60, DOI 10.5014/ajot.60.1.60; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kreutzer J S, 1988, Brain Inj, V2, P205, DOI 10.3109/02699058809150945; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; Murphy L, 2006, BRAIN INJURY, V20, P1119, DOI 10.1080/02699050600664335; Nightingale EJ, 2007, BRAIN IMPAIR, V8, P101, DOI [10.1375/brim.8.2.101, DOI 10.1375/BRIM.8.2.101]; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2009, J HEAD TRAUMA REHAB, V24, P262, DOI 10.1097/HTR.0b013e3181a68b73; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Sach T, 2011, CLIN REHABIL, V25, P957; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 1999, BRAIN INJURY, V13, P973; The Neurological Alliance, 2003, NEUR ALL NEUR NUMB B; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Treger I, 2007, DISABIL REHABIL, V29, P1397, DOI 10.1080/09638280701314923; Tyerman A, 2012, NEUROREHABILITATION, V31, P51, DOI 10.3233/NRE-2012-0774; UK National Institute for Health and Clinical Excellence, 2003, HEAD INJ TRIAG ASS I, P4; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Waddell G., 2006, IS WORK GOOD YOUR HL; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wehman P, 2003, ARCH PHYS MED REHAB, V84, P192, DOI 10.1053/apmr.2003.50027; Wilson FC, 2009, NEUROREHABILITATION, V24, P377, DOI 10.3233/NRE-2009-0492; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	44	12	12	0	18	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1053-0487	1573-3688		J OCCUP REHABIL	J. Occup. Rehabil.	SEP	2014	24	3					533	542		10.1007/s10926-013-9488-z			10	Rehabilitation; Social Issues	Rehabilitation; Social Issues	AN3KX	WOS:000340487900015	24347006				2021-06-18	
J	Goldin, Y; Cantor, JB; Tsaousides, T; Spielman, L; Gordon, WA				Goldin, Yelena; Cantor, Joshua B.; Tsaousides, Theodore; Spielman, Lisa; Gordon, Wayne A.			Sexual Functioning and the Effect of Fatigue in Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						depression; fatigue; sex; health; sexual functioning; traumatic brain injury	QUALITY-OF-LIFE; GENDER-DIFFERENCES; MILD; TBI; FREQUENCY; VALIDITY; MODERATE; NEUROENDOCRINE; PARTICIPATION; ASSOCIATION	Objectives: The primary objective was to examine specific aspects of sexual functioning (frequency, desired frequency, importance, and satisfaction) and their relationship to fatigue in individuals with traumatic brain injury (TBI) compared with those without brain injury. The relationship of demographic variables, emotional well-being, and health-related quality of life to sexual functioning was also explored. Participants: 200 community-dwelling adults with self-reported mild-to-severe TBI and 83 individuals without brain injury. Measures: Participation Objective, Participation Subjective, Fatigue Assessment Instrument, Global Fatigue Index, Beck Depression Inventory, and SF-36 Health Survey. Methods: Data were collected through administration of self-report measures and interviews as part of a larger study of post-TBI fatigue. Results: Several aspects of sexual activity (frequency, desired frequency, and importance) were closely related to specific features of fatigue among individuals with TBI. Women with TBI reported lower frequency and lower importance of sex than men. In individuals without brain injury, the impact of fatigue was limited to the frequency of sexual activity with no sex differences observed. Conclusions: Fatigue plays a different role in the subjective experience of sexual activity for men and women with TBI than for those without brain injuries. Fatigue and sex should be taken into account in future research and interventions focused on sexual function after TBI.	[Goldin, Yelena] JFK Johnson Rehabil Inst, Cognit Rehabil Dept, Edison, NJ 08820 USA; [Cantor, Joshua B.; Tsaousides, Theodore; Spielman, Lisa; Gordon, Wayne A.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA	Goldin, Y (corresponding author), JFK Johnson Rehabil Inst, Cognit Rehabil Dept, 2048 Oak Tree Rd, Edison, NJ 08820 USA.	ygoldinlauretta@jfkhealth.org			National Institute on Disability and Rehabilitation Research, United States Department of EducationUS Department of Education [H133A020501]	This study was supported by grant H133A020501 from the National Institute on Disability and Rehabilitation Research, United States Department of Education.	Agha Amar, 2005, Pituitary, V8, P245, DOI 10.1007/s11102-005-3463-4; Aloni A, 1999, BRAIN INJURY, V13, P89, DOI 10.1080/026990599121755; [Anonymous], 2001, MAN US VERS 1; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Bay E, 2009, WESTERN J NURS RES, V31, P731, DOI 10.1177/0193945909334856; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Beck A. T., 1996, BECK DEPRESSION INVE, VII; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; BELZA BL, 1995, J RHEUMATOL, V22, P639; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bormann J, 2001, J Assoc Nurses AIDS Care, V12, P75, DOI 10.1016/S1055-3290(06)60146-5; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; CALL V, 1995, J MARRIAGE FAM, V57, P639, DOI 10.2307/353919; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; de Groot MH, 2003, ARCH PHYS MED REHAB, V84, P1714, DOI 10.1053/S0003-9993(03)00346-0; DeLuca J, 2005, ISS CLIN COGN NEUROP, P319; Dijkers MPJM, 2008, J HEAD TRAUMA REHAB, V23, P3, DOI 10.1097/01.HTR.0000308716.80590.6b; Dittner AJ, 2004, J PSYCHOSOM RES, V56, P157, DOI 10.1016/S0022-3999(03)00371-4; Elliott ML, 1996, BRAIN INJURY, V10, P703, DOI 10.1080/026990596123972; Elovic EP, 2005, ISS CLIN COGN NEUROP, P89; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Gaudet L, 2001, SEX DISABIL, V19, P111, DOI 10.1023/A:1010673722429; GORDON WA, 2003, PARTICIPATION OBJECT; Grady C, 1998, NURS RES, V47, P227, DOI 10.1097/00006199-199807000-00008; Griffith ER, 1990, REHABILITATION ADULT, P206; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Horn LJ, 1990, J HEAD TRAUMA REHAB, V5, P1; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; KRUPP LB, 1995, NEUROLOGY, V45, P1956, DOI 10.1212/WNL.45.11.1956; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Laumann E.O., 1994, SOCIAL ORG SEXUALITY; Lawton MP, 1999, J AGING HEALTH, V11, P169, DOI 10.1177/089826439901100203; Levine J, 2009, PHYS MED REH CLIN N, V20, P347, DOI 10.1016/j.pmr.2008.12.006; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Meek PM, 2000, NURS RES, V49, P181, DOI 10.1097/00006199-200007000-00001; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Ripley DL, 2008, ARCH PHYS MED REHAB, V89, P1090, DOI 10.1016/j.apmr.2007.10.038; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; Schwartz CE, 1996, ARCH PHYS MED REHAB, V77, P165, DOI 10.1016/S0003-9993(96)90162-8; SCHWARTZ JE, 1993, J PSYCHOSOM RES, V37, P753, DOI 10.1016/0022-3999(93)90104-N; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; VANZOMEREN AH, 1984, CLOSED HEAD INJURY P; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Winstead-Fry P, 1998, J Nurs Meas, V6, P111	60	12	12	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2014	29	5					418	426		10.1097/HTR.0b013e31829cf76d			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AP2GW	WOS:000341891700010	23867995				2021-06-18	
J	Ko, AL; Nerva, JD; Chang, JJJ; Chesnut, RM				Ko, Andrew L.; Nerva, John D.; Chang, Jason J. J.; Chesnut, Randall M.			Traumatic Fracture of a Polymethyl Methacrylate Patient-Specific Cranioplasty Implant	WORLD NEUROSURGERY			English	Article						Cranioplasty fracture; Patient-specific implants; Pediatric neurosurgery; Synthetic cranioplasty; Traumatic brain injury		OBJECTIVE: To present a case of a traumatic fracture of a polymethyl methacrylate (PMMA) patient-specific implant (PSI) for cranioplasty. METHODS: A 14-year-old boy with a history of right decompressive hemicraniectomy and reconstructive cranioplasty with a PMMA PSI presented after an unhelmeted bicycle accident with somnolence, confusion, seizures, left hemiparesis, and an obviously deformed cranium. RESULTS: Computed tomography scan showed a comminuted, depressed fracture of the implant and cerebral contusions. The implant was seen to be shattered, resulting in displaced, overriding fragments and significant damage to underlying brain. The patient remained neurologically stable. To minimize the number of operations, intervention was delayed while a polyetheretherketone PSI was fabricated. During surgery, it was noted that the fractured pieces of the implant had caused dural lacerations, and some pieces were embedded in brain parenchyma. The fractured PMMA was removed, and the new implant was placed. The patient remained hemiparetic and was later transferred to an inpatient rehabilitation facility. CONCLUSIONS: PMMA PSIs are commonly used for large defects and generally have good outcomes with low rates of revision. The case report described involves a shattered PMMA PSI after a traumatic impact, which resulted in hemiparesis. The question arises if this type of complication can be easily avoided with the addition of titanium onlay to restrict displacement in the event of fracture. This onlay represents a minor change of technique that could prevent migration of fracture fragments.	[Ko, Andrew L.; Nerva, John D.; Chang, Jason J. J.; Chesnut, Randall M.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA	Nerva, JD (corresponding author), Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA.	jdnerva@uw.edu		Ko, Andrew/0000-0002-6253-9891			Eppley BL, 2005, J CRANIOFAC SURG, V16, P140, DOI 10.1097/00001665-200501000-00028; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Matic DB, 2004, J CRANIOFAC SURG, V15, P415, DOI 10.1097/00001665-200405000-00012; Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003; Petridis AK, 2009, J CLIN NEUROSCI, V16, P1089, DOI 10.1016/j.jocn.2008.08.006; VANGOOL AV, 1985, J MAXILLOFAC SURG, V13, P2, DOI 10.1016/S0301-0503(85)80005-9	6	12	12	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP-OCT	2014	82	3-4							53600000000000	10.1016/j.wneu.2013.09.025			3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AQ6HV	WOS:000342912300111	24056094				2021-06-18	
J	Medina-Torres, CE; Pollitt, CC; Underwood, C; Castro-Olivera, EM; Collins, SN; Allavena, RE; Richardson, DW; van Eps, AW				Medina-Torres, C. E.; Pollitt, C. C.; Underwood, C.; Castro-Olivera, E. M.; Collins, S. N.; Allavena, R. E.; Richardson, D. W.; van Eps, A. W.			Equine lamellar energy metabolism studied using tissue microdialysis	VETERINARY JOURNAL			English	Article						Horse; Laminitis; Lamellae; Bioenergetics; Urea clearance	TRAUMATIC BRAIN-INJURY; HUMAN SKELETAL-MUSCLE; IN-VIVO MICRODIALYSIS; CEREBRAL MICRODIALYSIS; SUBARACHNOID HEMORRHAGE; CEREBROSPINAL-FLUID; LACTATE METABOLISM; ADIPOSE-TISSUE; GLUCOSE; BLOOD	Failure of lamellar energy metabolism may contribute to the pathophysiology of equine laminitis. Tissue microdialysis has the potential to dynamically monitor lamellar energy balance over time. The objectives of this study were to develop a minimally invasive lamellar microdialysis technique and use it to measure normal lamellar energy metabolite concentrations over 24 h. Microdialysis probes were placed (through the white line) into either the lamellar dermis (LAM) (n = 6) or the sublamellar dermis (SUBLAM) (n = 6) and perfused continuously over a 24 h study period. Probes were placed in the skin dermis (SKIN) for simultaneous comparison to LAM (n = 6). Samples were collected every 2 h and analysed for glucose, lactate, pyruvate, urea and glycerol concentrations. LAM was further compared with SUBLAM by simultaneous placement and sampling in four feet from two horses over 4 h. Horses were monitored for lameness, and either clinically evaluated for 1 month after probe removal (n = 4) or subjected to histological evaluation of the probe site (n = 10). There were no deleterious clinical effects of probe placement and the histological response was mild. Sample fluid recovery and metabolite concentrations were stable for 24 h. Glucose was lower (and lactate:glucose ratio higher) in LAM compared with SUBLAM and SKIN (P < 0.05). Pyruvate was lower in SUBLAM than SKIN and urea was lower in LAM than SKIN (P < 0.05). These differences suggest lower perfusion and increased glucose consumption in LAM compared with SUBLAM and SKIN. In conclusion, lamellar tissue microdialysis was well tolerated and may be useful for determining the contribution of energy failure in laminitis pathogenesis. (C) 2014 Elsevier Ltd. All rights reserved.	[Medina-Torres, C. E.; Pollitt, C. C.; Underwood, C.; Castro-Olivera, E. M.; Collins, S. N.; Allavena, R. E.; van Eps, A. W.] Univ Queensland, Fac Sci, Sch Vet Sci, Australian Equine Laminitis Res Unit, Gatton, Qld 4343, Australia; [Richardson, D. W.] Univ Penn, Sch Vet Med, New Bolton Ctr, Kennett Sq, PA 19348 USA	van Eps, AW (corresponding author), Univ Queensland, Fac Sci, Sch Vet Sci, Australian Equine Laminitis Res Unit, Gatton Campus, Gatton, Qld 4343, Australia.	a.vaneps@uq.edu.au	van Eps, Andrew William/B-3633-2013; Pollitt, Christopher/L-3964-2019; Allavena, Rachel/F-5720-2012; Medina-Torres, Carlos E./V-7880-2019	van Eps, Andrew William/0000-0001-6108-2503; Allavena, Rachel/0000-0001-5126-7125; Medina-Torres, Carlos E./0000-0003-2048-8165	Grayson Jockey Club Research Foundation Grant	Supported by a Grayson Jockey Club Research Foundation Grant. This material has been presented in part as an abstract at the American College of Veterinary Internal Medicine Forum, Seattle, 12-15 June, 2013.	Belknap JK, 2009, VET IMMUNOL IMMUNOP, V129, P155, DOI 10.1016/j.vetimm.2008.11.013; BENVENISTE H, 1990, PROG NEUROBIOL, V35, P195, DOI 10.1016/0301-0082(90)90027-E; BENVENISTE H, 1989, J NEUROCHEM, V52, P1741, DOI 10.1111/j.1471-4159.1989.tb07252.x; Chou CC, 2001, J VET PHARMACOL THER, V24, P405, DOI 10.1046/j.1365-2885.2001.00364.x; de Lange E.C.M., 2013, AAPS ADV PHARM SCI S, V4, P13; Diczfalusy E, 2011, MED BIOL ENG COMPUT, V49, P1459, DOI 10.1007/s11517-011-0841-0; Edner A, 2005, J VET MED A, V52, P99, DOI 10.1111/j.1439-0442.2004.00685.x; Edner AH, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-10; Farnebo S, 2010, CLIN PHYSIOL FUNCT I, V30, P57, DOI 10.1111/j.1475-097X.2009.00904.x; French KR, 2004, EQUINE VET J, V36, P261, DOI 10.2746/0425164044877170; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; GLICK JH, 1969, AM J CLIN PATHOL, V52, P320; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Hall J. E., 2011, GUYTON HALL TXB MED; Hamrin K, 2002, J APPL PHYSIOL, V92, P385; Heller A., 2013, APPL ELECTROCHEMISTR, V108, P2482; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; INGVASTLARSSON C, 1992, J VET PHARMACOL THER, V15, P386, DOI 10.1111/j.1365-2885.1992.tb01030.x; Klaus S, 2004, CRIT CARE, V8, P363, DOI 10.1186/cc2882; Langemann H, 2001, NEUROL RES, V23, P531, DOI 10.1179/016164101101198785; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Meierhans R, 2010, CRIT CARE, V14, DOI 10.1186/cc8869; Murchie TA, 2006, EQUINE VET J, V38, P520, DOI 10.2746/042516406X156136; Nichols SP, 2011, ANAL CHEM, V83, P1180, DOI 10.1021/ac103070t; Nourian AR, 2010, VET J, V183, P273, DOI 10.1016/j.tvjl.2009.05.008; Nourian AR, 2010, VET J, V183, P22, DOI 10.1016/j.tvjl.2009.01.003; Oddo M, 2012, STROKE, V43, P1418, DOI 10.1161/STROKEAHA.111.648568; Oddo M, 2012, CURR OPIN CRIT CARE, V18, P111, DOI 10.1097/MCC.0b013e32835132a5; Pass M A, 1998, Equine Vet J Suppl, P133; Pawlak EA, 2014, EQUINE VET J, V46, P203, DOI 10.1111/evj.12092; Pollitt CC, 1996, EQUINE VET J, V28, P38, DOI 10.1111/j.2042-3306.1996.tb01588.x; Redden R.F., 2003, AAEP P, V49, P57; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Ronquist G, 2003, EXP DERMATOL, V12, P572, DOI 10.1034/j.1600-0625.2003.00018.x; Rosdahl H, 1997, ACTA PHYSIOL SCAND, V159, P261, DOI 10.1046/j.1365-201X.1997.123358000.x; Rosdahl H, 1998, AM J PHYSIOL-ENDOC M, V274, pE936; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Setala LP, 2004, MICROSURG, V24, P223, DOI 10.1002/micr.20045; Sorg Brian S., 2005, Journal of Pharmacological and Toxicological Methods, V52, P341, DOI 10.1016/j.vascn.2005.05.004; van Eps A, 2010, VET CLIN N AM-EQUINE, V26, P287, DOI 10.1016/j.cveq.2010.06.007; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vickroy TW, 2008, J VET PHARMACOL THER, V31, P156, DOI 10.1111/j.1365-2885.2008.00942.x; Waelgaard L, 2012, ACTA ANAESTH SCAND, V56, P200, DOI 10.1111/j.1399-6576.2011.02572.x; Wattle O., 2004, Clinical Techniques in Equine Practice, V3, P22, DOI 10.1053/j.ctep.2004.07.002; Zhang WM, 2013, CLIN BIOCHEM, V46, P694, DOI 10.1016/j.clinbiochem.2012.11.008	45	12	12	0	14	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-0233	1532-2971		VET J	Vet. J.	SEP	2014	201	3					275	282		10.1016/j.tvjl.2014.05.030			8	Veterinary Sciences	Veterinary Sciences	AQ3RQ	WOS:000342711600009	24947715	Green Accepted			2021-06-18	
J	Mihindu, E; Bhullar, I; Tepas, J; Kerwin, A				Mihindu, Esther; Bhullar, Indermeet; Tepas, Joseph; Kerwin, Andrew			Computed Tomography of the Head in Children with Mild Traumatic Brain Injury	AMERICAN SURGEON			English	Article							CT	Pediatric Emergency Care Applied Research Network (PECARN) guidelines have a near 100 per cent negative predictive value for clinically important traumatic brain injury (ciTBI) in children with mild head injury (Glasgow Coma Score [GCS] 14 or 15). Our goal was to retrospectively apply their criteria to our database to determine the potential impact on the rates of unnecessary head computed tomography (CT) and ciTBI detection. The records of pediatric patients with GCS 14 to 15 that had a head CT for suspected TBI after blunt trauma from 2008 to 2010 were reviewed. Of 493 children, CT was negative in 447 (91%), but findings were present in 46 (9%). Applying PECARN recommendations, 178 (36%) met all six criteria but still underwent head CT; all were negative. The remaining 315 (64%) missed one or more PECARN criteria and underwent CT; only 46 (15%) had findings, and two (0.6%) required surgery. There were no false-negatives. The negative predictive value for ciTBI was 100 per cent. Observance of PECARN guidelines identifies children who do not require CT, increasing the yield of finding a ciTBI among those who cannot satisfy all six criteria.	[Mihindu, Esther; Bhullar, Indermeet; Tepas, Joseph; Kerwin, Andrew] Univ Florida, Coll Med Jacksonville, Dept Surg, Jacksonville, FL 32209 USA	Mihindu, E (corresponding author), Univ Florida, Coll Med Jacksonville, Dept Surg, 655 West Eight St, Jacksonville, FL 32209 USA.	Esther.Mihindu@jax.ufl.edu					Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Linton OW, 2003, AM J ROENTGENOL, V181, P321, DOI 10.2214/ajr.181.2.1810321; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Mettler Fred A. Jr., 2000, Journal of Radiological Protection, V20, P353, DOI 10.1088/0952-4746/20/4/301	7	12	12	0	0	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	SEP	2014	80	9					841	843					3	Surgery	Surgery	AQ2KS	WOS:000342615200012	25197865				2021-06-18	
J	Xiong, GX; Elkind, JA; Kundu, S; Smith, CJ; Antunes, MB; Tamashiro, E; Kofonow, JM; Mitala, CM; Stein, SC; Grady, MS; Einhorn, E; Cohen, NA; Cohen, AS				Xiong, Guoxiang; Elkind, Jaclynn A.; Kundu, Suhali; Smith, Colin J.; Antunes, Marcelo B.; Tamashiro, Edwin; Kofonow, Jennifer M.; Mitala, Christina. M.; Stein, Sherman C.; Grady, M. Sean; Einhorn, Eugene; Cohen, Noam A.; Cohen, Akiva S.			Traumatic Brain Injury-Induced Ependymal Ciliary Loss Decreases Cerebral Spinal Fluid Flow	JOURNAL OF NEUROTRAUMA			English	Article						beta-tubulin; basal body; hydrocephalus; lateral fluid percussion; particle tracking	CEREBROSPINAL-FLUID; BEAT FREQUENCY; HYDROCEPHALUS; DYSKINESIA; MOTILITY; SLEEP; DYSFUNCTION; MOVEMENT; REVEALS; SYSTEM	Traumatic brain injury (TBI) afflicts up to 2 million people annually in the United States and is the primary cause of death and disability in young adults and children. Previous TBI studies have focused predominantly on the morphological, biochemical, and functional alterations of gray matter structures, such as the hippocampus. However, little attention has been given to the brain ventricular system, despite the fact that altered ventricular function is known to occur in brain pathologies. In the present study, we investigated anatomical and functional alterations to mouse ventricular cilia that result from mild TBI. We demonstrate that TBI causes a dramatic decrease in cilia. Further, using a particle tracking technique, we demonstrate that cerebrospinal fluid flow is diminished, thus potentially negatively affecting waste and nutrient exchange. Interestingly, injury-induced ventricular system pathology resolves completely by 30 days after injury as ependymal cell ciliogenesis restores cilia density to uninjured levels in the affected lateral ventricle.	[Xiong, Guoxiang; Elkind, Jaclynn A.; Kundu, Suhali; Smith, Colin J.; Mitala, Christina. M.; Cohen, Akiva S.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Antunes, Marcelo B.; Tamashiro, Edwin; Kofonow, Jennifer M.; Cohen, Noam A.] Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA; [Stein, Sherman C.; Grady, M. Sean] Univ Penn, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Cohen, Akiva S.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Einhorn, Eugene; Cohen, Noam A.] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA	Cohen, AS (corresponding author), Univ Penn, Perelman Sch Med, Dept Pediat, 3615 Civ Ctr Blvd,816-H ARC, Philadelphia, PA 19104 USA.	cohena@email.chop.edu	Tamashiro, Edwin/C-5062-2012	Tamashiro, Edwin/0000-0002-3153-6292	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD059288, R01NS069629]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD059288, R37HD059288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069629] Funding Source: NIH RePORTER	The authors thank Michael Schell for critiquing an earlier draft of the manuscript and Kathleen Joy Propert for statistical guidance. This study was supported in part by National Institutes of Health grants (R01HD059288 and R01NS069629; to A.S.C.).	Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Al-Shroof M, 2001, MAYO CLIN PROC, V76, P1219, DOI 10.4065/76.12.1219; Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; Antunes MB, 2007, BIOTECHNIQUES, V43, P195, DOI 10.2144/000112531; Antunes MB, 2009, IMMUNOL ALLERGY CLIN, V29, P631, DOI 10.1016/j.iac.2009.07.004; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; BANNISTER CM, 1980, DEV MED CHILD NEUROL, V22, P725; BEYERL B, 1984, NEUROSURGERY, V15, P257, DOI 10.1227/00006123-198408000-00020; Bolt BA., 1993, EARTHQUAKES; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Bush A, 2007, ARCH DIS CHILD, V92, P1136, DOI 10.1136/adc.2006.096958; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Feng CY, 2011, J NEUROSCI, V31, P9147, DOI 10.1523/JNEUROSCI.5018-10.2011; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gudis DA, 2010, OTOLARYNG CLIN N AM, V43, P461, DOI 10.1016/j.otc.2010.02.007; Guyot LL, 2000, NEUROL RES, V22, P25; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kiefer M, 1998, CHILD NERV SYST, V14, P263, DOI 10.1007/s003810050222; Kosaki K, 2004, AM J MED GENET A, V129A, P308, DOI 10.1002/ajmg.a.30177; Krueger JM, 1998, ANN NY ACAD SCI, V856, P148, DOI 10.1111/j.1749-6632.1998.tb08323.x; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Lehman M, 2000, PROG BRAIN RES, V125, P415; Linderholm KR, 2012, SCHIZOPHRENIA BULL, V38, P426, DOI 10.1093/schbul/sbq086; Monkkonen KS, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-26; NAKAMURA Y, 1993, CHILD NERV SYST, V9, P65, DOI 10.1007/BF00305310; Noback C. R., 2005, HUMAN NERVOUS SYSTEM; OPP MR, 1991, AM J PHYSIOL, V260, pR453; OPP MR, 1991, AM J PHYSIOL, V260, pR52; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Regenold WT, 2009, BIOL PSYCHIAT, V65, P489, DOI 10.1016/j.biopsych.2008.11.010; Reichler IM, 2001, J SMALL ANIM PRACT, V42, P345, DOI 10.1111/j.1748-5827.2001.tb02471.x; Rios M, 2007, REPROD FERT DEVELOP, V19, P634, DOI 10.1071/RD06146; ROTH Y, 1985, BRAIN RES, V330, P291, DOI 10.1016/0006-8993(85)90688-2; Rothermundt M, 2004, MOL PSYCHIATR, V9, P897, DOI 10.1038/sj.mp.4001548; Rubenstein E, 1998, LANCET, V351, P283, DOI 10.1016/S0140-6736(97)09234-9; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SANTANDER RG, 1984, ACTA ANAT, V118, P82; Sapiro R, 2002, MOL CELL BIOL, V22, P6298, DOI 10.1128/MCB.22.17.6298-6305.2002; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; Skinner DC, 1999, ENDOCRINOLOGY, V140, P4399, DOI 10.1210/endo.140.10.7074; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stadlbauer A, 2010, NEUROIMAGE, V51, P42, DOI 10.1016/j.neuroimage.2010.01.110; Sutto Z, 2004, J PHYSIOL-LONDON, V560, P519, DOI 10.1113/jphysiol.2004.068171; Takaki E, 2007, J BIOL CHEM, V282, P37285, DOI 10.1074/jbc.M704562200; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Toth Z, 1997, J NEUROSCI, V17, P8106; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Winters SL, 2007, AM J PHYSIOL-LUNG C, V292, pL614, DOI 10.1152/ajplung.00288.2005; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Zhang ZB, 2007, CELL MOTIL CYTOSKEL, V64, P360, DOI 10.1002/cm.20189	59	12	12	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2014	31	16					1396	1404		10.1089/neu.2013.3110			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AN4DB	WOS:000340536700003	24749541	Green Published			2021-06-18	
J	Hyatt, K; Davis, LL; Barroso, J				Hyatt, Kyong; Davis, Linda L.; Barroso, Julie			Chasing the Care: Soldiers Experience Following Combat-Related Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article							HEAD-INJURY; VETERANS; BARRIERS; IRAQ	Objective: One of the most common, yet most difficult to detect injuries sustained by U.S. soldiers in Iraq and Afghanistan is mild traumatic brain injury (mTBI). Left untreated, mTBI can negatively impact soldiers' postdeployment adjustment. This research describes the rehabilitation experiences of soldiers with a history of mTBI and their spouses. Method: Nine soldiers with mTBI and their spouses participated in the study. A total of 27 interviews were conducted exploring couples' post-mTBI rehabilitation experiences. Participants consisted of active duty soldiers with mTBI who had returned from deployment within 2 years, and their civilian spouses. Strauss and Corbin's grounded theory methodology was used to collect and analyze the data. Findings: The majority of the soldiers and spouses who participated (16/18) indicated that uncertain prognosis and symptom management were the greatest challenges of post-mTBI. Other challenges, such as delayed diagnosis, limited access to mental health care, and difficulty navigating an unfamiliar military health care system was also reported. Conclusions: Because of mTBI's lack of visible manifestation, soldiers may confuse their mTBI symptoms with those of other deployment-related injuries and this leads to a delay in treatment. Future research should explore the standardization of post-mTBI rehabilitation programs and the effectiveness of soldier education to promote early detection and treatment.	[Hyatt, Kyong] Walter Reed Natl Mil Med Ctr, Bethesda, MD 20889 USA; [Davis, Linda L.; Barroso, Julie] Duke Univ, Durham, NC 27710 USA	Hyatt, K (corresponding author), Walter Reed Natl Mil Med Ctr, 8901 Wisconsin Ave Bldg 17B,Suite 3E, Bethesda, MD 20889 USA.		Davis, Linda Lindsey/T-7351-2019		TriService Nursing Research Program [HU0001-11-1-TS14 (N11-C17)]	The authors thank Dr Charles Vacchiano, Dr. Susan Silva, Dr. Paul Lewis, and LCDR Billy Collins for their support. This study was funded by grant HU0001-11-1-TS14 (N11-C17) from the TriService Nursing Research Program.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bradshaw D., 2008, TRAUMATIC BRAIN INJU; Carlson K, 2009, ASSESSMENT TREATMENT; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CDC, 2003, REP C MILD TRAUM BRA; CDC, 2010, TRAUMATIC BRAIN INJU; Charmaz K, 2006, CONSTRUCTING GROUNDE; Daggett V, 2009, J NEUROSCI NURS, V41, P59, DOI 10.1097/JNN.0b013e31819a7133; Department of Defense Personnel & Procurement Statistics, 2008, DEF MANP DAT 2008; *DVBIC, 2006, DEF VET BRAIN INJ CT; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Pandit N.R., 1996, QUALITATIVE REPORT, V2, P1; Pietrzak RH, 2009, PSYCHIAT SERV, V60, P1118, DOI 10.1176/ps.2009.60.8.1118; Resnik L, 2009, J REHABIL RES DEV, V46, P469, DOI 10.1682/JRRD.2008.07.0082; Ruff RM, 2009, PSYCHOL INJ LAW, V2, P34, DOI 10.1007/s12207-009-9029-4; Rutherford WH, 1989, BRAIN INJURY, V10, P225; Sosin DM, 1996, BRAIN INJURY, V10, P47; Strauss A., 1990, BASICS QUALITATIVE R; Strauss A., 1998, BASICS QUALITATIVE R; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; ZOROYA G, 2006, CTR WAR RELATED BRAI	28	12	12	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	AUG	2014	179	8					849	855		10.7205/MILMED-D-13-00526			7	Medicine, General & Internal	General & Internal Medicine	AN7UO	WOS:000340806700006	25102527	Bronze			2021-06-18	
J	Yang, DB; Yu, WH; Dong, XQ; Du, Q; Shen, YF; Zhang, ZY; Zhu, Q; Che, ZH; Liu, QJ; Wang, H; Jiang, L; Du, YF				Yang, Ding-Bo; Yu, Wen-Hua; Dong, Xiao-Qiao; Du, Quan; Shen, Yong-Feng; Zhang, Zu-Yong; Zhu, Qiang; Che, Zhi-Hao; Liu, Qun-Jie; Wang, Hao; Jiang, Li; Du, Yuan-Feng			Plasma copeptin level predicts acute traumatic coagulopathy and progressive hemorrhagic injury after traumatic brain injury	PEPTIDES			English	Article						Copeptin; Traumatic brain injury; Acute traumatic coagulopathy; Progressive hemorrhagic injury; Biomarker	BIOMARKER; DISEASE	Higher plasma copeptin levels correlate with poor clinical outcomes after traumatic brain injury. Nevertheless, their links with acute traumatic coagulopathy and progressive hemorrhagic injury are unknown. Therefore, we aimed to investigate the relationship between plasma copeptin levels, acute traumatic coagulopathy and progressive hemorrhagic injury in patients with severe traumatic brain injury. We prospectively studied 100 consecutive patients presenting within 6 h from head trauma. Progressive hemorrhagic injury was present when the follow-up computerized tomography scan reported any increase in size or number of the hemorrhagic lesion, including newly developed ones. Acute traumatic coagulopathy was defined as an activated partial thromboplastic time greater than 40s and/or international normalized ratio greater than 1.2 and/or a platelet count less than 120 x 10(9)/L. We measured plasma copeptin levels on admission using an enzyme-linked immunosorbent assay in a blinded fashion. In multivariate logistic regression analysis, plasma copeptin level emerged as an independent predictor of progressive hemorrhagic injury and acute traumatic coagulopathy. Using receiver operating characteristic curves, we calculated areas under the curve for progressive hemorrhagic injury and acute traumatic coagulopathy. The predictive performance of copeptin was similar to that of Glasgow Coma Scale score. However, copeptin did not obviously improve the predictive value of Glasgow Coma Scale score. Thus, copeptin may help in the prediction of progressive hemorrhagic injury and acute traumatic coagulopathy after traumatic brain injury. (C) 2014 Elsevier Inc. All rights reserved.	[Yang, Ding-Bo; Yu, Wen-Hua; Dong, Xiao-Qiao; Du, Quan; Shen, Yong-Feng; Zhang, Zu-Yong; Zhu, Qiang; Che, Zhi-Hao; Liu, Qun-Jie; Wang, Hao; Jiang, Li; Du, Yuan-Feng] Nanjing Med Univ, Affiliated Hangzhou Hosp, Hangzhou Peoples Hosp 1, Dept Neurosurg, Hangzhou 310006, Zhejiang, Peoples R China	Dong, XQ (corresponding author), Nanjing Med Univ, Affiliated Hangzhou Hosp, Hangzhou Peoples Hosp 1, Dept Neurosurg, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China.	dxqhyy@163.com			Zhejiang Province Medical and Health Project [2014KYA177]	This study was supported by a grant from Zhejiang Province Medical and Health Project (No. 2014KYA177).	Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Anand T, 2012, J SURG RES, V178, P321, DOI 10.1016/j.jss.2012.02.062; Cohen MJ, 2014, THROMB RES, V133, pS25, DOI 10.1016/j.thromres.2014.03.013; Dobsa L, 2013, BIOCHEM MEDICA, V23, P172, DOI 10.11613/BM.2013.021; Dong XQ, 2011, J TRAUMA, V71, P1194, DOI 10.1097/TA.0b013e31821283f2; Dong XQ, 2011, PEPTIDES, V32, P253, DOI 10.1016/j.peptides.2010.11.021; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Giannopoulos G, 2013, CURR TOP MED CHEM, V13, P231, DOI 10.2174/15680266113139990088; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Kleindienst A, 2010, ACTA NEUROCHIR SUPPL, V106, P221, DOI 10.1007/978-3-211-98811-4_41; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lin C, 2013, PEPTIDES, V42, P43, DOI 10.1016/j.peptides.2013.01.015; Nickel CH, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-7; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Stocchetti N, 2014, LANCET NEUROL, V13, P14, DOI 10.1016/S1474-4422(13)70280-1; Tong WS, 2011, NEURORADIOLOGY, V53, P305, DOI 10.1007/s00234-010-0659-8; Wu X, 2014, J TRAUMA ACUTE CARE, V76, P114, DOI 10.1097/TA.0b013e3182a8fe48; Yalta K, 2013, INT J CARDIOL, V167, P1750, DOI 10.1016/j.ijcard.2012.12.039; Yu GF, 2012, PEPTIDES, V33, P164, DOI 10.1016/j.peptides.2011.11.017; Yu WH, 2014, CLIN CHIM ACTA, V433, P174, DOI 10.1016/j.cca.2014.03.014; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233	25	12	17	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	AUG	2014	58						26	29		10.1016/j.peptides.2014.05.015			4	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	AN0XR	WOS:000340307800005	24905622				2021-06-18	
J	Koizumi, H; Ideguchi, M; Iwanaga, H; Shirao, S; Sadahiro, H; Oka, F; Suehiro, E; Yoneda, H; Ishihara, H; Nomura, S; Suzuki, M				Koizumi, Hiroyasu; Ideguchi, Makoto; Iwanaga, Hideyuki; Shirao, Satoshi; Sadahiro, Hirokazu; Oka, Fumiaki; Suehiro, Eiichi; Yoneda, Hiroshi; Ishihara, Hideyuki; Nomura, Sadahiro; Suzuki, Michiyasu			Cognitive dysfunction might be improved in association with recovered neuronal viability after intracranial meningioma resection	BRAIN RESEARCH			English	Article						Neurocognitive function; Cerebral cortical neuron; Radioligans	CEREBRAL-BLOOD-FLOW; POSITRON-EMISSION-TOMOGRAPHY; STATISTICAL IMAGING ANALYSIS; TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; IODINE-123-IOMAZENIL SPECT; ALZHEIMERS-DISEASE; I-123-IOMAZENIL SPECT; RECEPTOR-BINDING; CORTICAL DAMAGE	Intracranial meningiomas are the most common types of neoplasms that cause mental disorders. Although higher brain function can be restored and even improved in some patients after tumor resection, the mechanisms remain unclear. We investigated changes in the brains of patients after resection of an intracranial meningioma using I-123-Iomazenil (IMZ)-single photon emission computed tomography (SPECT). Ten patients underwent IMZ-SPECT within 4 weeks before and 3 months after intracranial meningioma resection. Changes in IMZ accumulation in brain parenchyma were assessed as ratios of counts in the lesion-to-contralateral hemisphere (L/C ratios). Mean Mini-Mental State Examination scores before and after resection of 19.9 +/- 11.4 vs. 26.5 +/- 3.8, respectively (p =0.03) indicated that the cognitive function of these patients was significantly improved after tumor resection. The average WC ratios calculated from image counts of IMZ were 0.92 +/- 0.05 and 0.98 +/- 0.02 before and after surgery, respectively. The L/C ratio of IMZ accumulation was significantly decreased after tumor resection (p=0.0003). In contrast, regional cerebral blood flow calculated from I-123-Iodoamphetamine-SPECT images did not significantly differ after tumor resection. The recovered binding potential of IMZ in brain parenchyma surrounding the tumor bulk after resection indicates that the viability of central benzodiazepine receptors was reversibly depressed and recoverable after release from compression by the tumor. The recovered neuronal viability revealed by IMZ-SPECT might be responsible for the improved cognitive function after intracranial meningioma resection. (C) 2014 Published by Elsevier B.V.	[Koizumi, Hiroyasu; Ideguchi, Makoto; Shirao, Satoshi; Sadahiro, Hirokazu; Oka, Fumiaki; Suehiro, Eiichi; Yoneda, Hiroshi; Ishihara, Hideyuki; Nomura, Sadahiro; Suzuki, Michiyasu] Yamaguchi Univ, Sch Med, Dept Neurosurg, Ube, Yamaguchi 7558505, Japan; [Iwanaga, Hideyuki] Yamaguchi Univ, Sch Med, Dept Radiol, Ube, Yamaguchi 7558505, Japan	Koizumi, H (corresponding author), Yamaguchi Univ, Sch Med, Dept Neurosurg, Ube, Yamaguchi 7558505, Japan.	hiroyasu@yamaguchi-u.ac.jp	Suehiro, Eiichi/I-5852-2019				ANDY OJ, 1981, SOUTHERN MED J, V74, P968, DOI 10.1097/00007611-198108000-00022; Ball S, 1998, BIOL PSYCHIAT, V43, P107, DOI 10.1016/S0006-3223(97)00300-4; Bugnicourt JM, 2013, J NEUROL, V260, P1324, DOI 10.1007/s00415-012-6799-5; Caminiti G, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/218928; Carlsson G, 2010, CHILD NERV SYST, V26, P105, DOI 10.1007/s00381-009-0984-6; Chida K, 2011, J NUCL MED, V52, P511, DOI 10.2967/jnumed.110.084186; Chida K, 2009, STROKE, V40, P448, DOI 10.1161/STROKEAHA.108.515775; Dijkstra M, 2009, J NEUROL NEUROSUR PS, V80, P910, DOI 10.1136/jnnp.2007.138925; Dong YH, 2012, J NEUROL NEUROSUR PS, V83, P580, DOI 10.1136/jnnp-2011-302070; Feder M., 1989, J NEURO REHAB, V3, P15; Fukuchi K, 1997, J NUCL MED, V38, P467; Gazzeri R, 2008, ACTA NEUROCHIR, V150, P1117, DOI 10.1007/s00701-008-0142-z; Goto H, 2003, J CLIN NEUROSCI, V10, P375, DOI 10.1016/S0967-5868(03)00023-7; Hanyu H, 2012, J NEUROL SCI, V323, P71, DOI 10.1016/j.jns.2012.08.013; HATAZAWA J, 1995, J NUCL MED, V36, P2154; Heiss WD, 2000, STROKE, V31, P366, DOI 10.1161/01.STR.31.2.366; Heiss WD, 1997, STROKE, V28, P2045, DOI 10.1161/01.STR.28.10.2045; Heiss WD, 1998, STROKE, V29, P454, DOI 10.1161/01.STR.29.2.454; Hosoda K, 2003, STROKE, V34, P1187, DOI 10.1161/01.STR.0000068781.31429.BE; IIDA H, 1994, J NUCL MED, V35, P2019; Iida H, 2010, J NUCL MED, V51, P1624, DOI 10.2967/jnumed.110.078352; Kaneko K, 2006, NUCL MED COMMUN, V27, P893, DOI 10.1097/01.mnm.0000243380.79872.32; Kasama S, 2005, DEMENT GERIATR COGN, V19, P266, DOI 10.1159/000084551; Koizumi H, 2010, J CEREBR BLOOD F MET, V30, P1673, DOI 10.1038/jcbfm.2010.75; Krupp W, 2009, NEUROSURGERY, V64, P40, DOI 10.1227/01.NEU.0000336330.75381.39; LAMPL Y, 1995, PSYCHIAT RES, V58, P177, DOI 10.1016/0165-1781(95)02586-L; LEIMKUHLER ME, 1985, ANN NEUROL, V18, P617, DOI 10.1002/ana.410180518; Louis DN, 2000, PATHOLOGY GENETICS T, P176; MAURICEWILLIAMS RS, 1988, BMJ-BRIT MED J, V296, P1785, DOI 10.1136/bmj.296.6639.1785; MINOSHIMA S, 1994, J NUCL MED, V35, P1528; Morimoto N, 2012, J NEUROL SCI, V319, P96, DOI 10.1016/j.jns.2012.04.020; Nakagawara J, 1997, STROKE, V28, P124, DOI 10.1161/01.STR.28.1.124; Nakagawara J, 2012, NEUROL MED-CHIR, V52, P318, DOI 10.2176/nmc.52.318; Nishimura T, 2007, ANN NUCL MED, V21, P15, DOI 10.1007/BF03033995; Ogura T, 2009, ANN NUCL MED, V23, P33, DOI 10.1007/s12149-008-0203-7; Pappata S, 2010, EUR J NUCL MED MOL I, V37, P1156, DOI 10.1007/s00259-010-1409-1; Prohovnik I, 1998, J NUCL MED, V39, P927; Rudolf J, 2000, LANCET, V355, P115, DOI 10.1016/S0140-6736(99)04280-4; SCHAG CC, 1984, J CLIN ONCOL, V2, P187, DOI 10.1200/JCO.1984.2.3.187; SELECKI B R, 1965, Med J Aust, V1, P383; Sergides I, 2009, NEUROL RES, V31, P84, DOI 10.1179/174313208X331563; Shiga T, 2006, EUR J NUCL MED MOL I, V33, P817, DOI 10.1007/s00259-005-0033-y; Simoca I, 1994, Rom J Neurol Psychiatry, V32, P237; Takahashi K, 2005, AM J NEURORADIOL, V26, P2005; Tallet AV, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-77; Tucha O, 2000, NEUROSURGERY, V47, P324, DOI 10.1097/00006123-200008000-00011; Tucha O, 2003, J NEUROSURG, V98, P21, DOI 10.3171/jns.2003.98.1.0021; Umeoka S, 2007, J NEUROSURG, V107, P352, DOI 10.3171/JNS-07/08/0352; Uruma G, 2013, ANN NUCL MED, V27, P187, DOI 10.1007/s12149-012-0674-4; Varrone A, 1999, CLIN NUCL MED, V24, P660, DOI 10.1097/00003072-199909000-00004; Yamashita T, 2012, CLIN NUCL MED, V37, P128, DOI 10.1097/RLU.0b013e31823e9a9a	51	12	12	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 29	2014	1574						50	59		10.1016/j.brainres.2014.05.047			10	Neurosciences	Neurosciences & Neurology	AM6ZM	WOS:000340014500006	24928615				2021-06-18	
J	Zhu, KJ; Huang, H; Chu, H; Yu, H; Zhang, SM				Zhu, Ke-Jun; Huang, Hong; Chu, Hui; Yu, Hang; Zhang, Shi-Ming			Alterations in enterocyte mitochondrial respiratory function and enzyme activities in gastrointestinal dysfunction following brain injury	WORLD JOURNAL OF GASTROENTEROLOGY			English	Article						Mitochondria; Brain injury; Enterocyte; Rats; Malate dehydrogenase	INCREASED INTESTINAL PERMEABILITY; PYRUVATE-DEHYDROGENASE; ORGAN DYSFUNCTION; RATS; SEPSIS; MUCOSA; NEURODEGENERATION; SEVERITY; MOTILITY; BARRIER	AIM: To determine the alterations in rat enterocyte mitochondrial respiratory function and enzyme activities following traumatic brain injury (TBI). METHODS: Fifty-six male SD rats were randomly divided into seven groups (8 rats in each group): a control group (rats with sham operation) and traumatic brain injury groups at 6, 12, 24 h, days 2, 3, and 7 after operation. TBI models were induced by Feendy' s free-falling method. Mitochondrial respiratory function (respiratory control ratio and ADP/O ratio) was measured with a Clark oxygen electrode. The activities of respiratory chain complex I-IV and related enzymes were determined by spectrophotometry. RESULTS: Compared with the control group, the mitochondrial respiratory control ratio (RCR) declined at 6 h and remained at a low level until day 7 after TBI (control, 5.42 +/- 0.46; 6 h, 5.20 +/- 0.18; 12 h, 4.55 +/- 0.35; 24 h, 3.75 +/- 0.22; 2 d, 4.12 +/- 0.53; 3 d, 3.45 +/- 0.41; 7 d, 5.23 +/- 0.24, P < 0.01). The value of phosphate-to-oxygen (P/O) significantly decreased at 12, 24 h, day 2 and day 3, respectively (12 h, 3.30 +/- 0.10; 24 h, 2.61 +/- 0.21; 2 d, 2.95 +/- 0.18; 3 d, 2.76 +/- 0.09, P < 0.01) compared with the control group (3.46 +/- 0.12). Two troughs of mitochondrial respiratory function were seen at 24 h and day 3 after TBI. The activities of mitochondrial complex. (6 h: 110 +/- 10, 12 h: 115 +/- 12, 24 h: 85 +/- 9, day 2: 80 +/- 15, day 3: 65 +/- 16, P < 0.01) and complex. (6 h: 105 +/- 8, 12 h: 110 +/- 92, 24 h: 80 +/- 10, day 2: 76 +/- 8, day 3: 68 +/- 12, P < 0.01) were increased at 6 h and 12 h following TBI, and then significantly decreased at 24 h, day 2 and day 3, respectively. However, there were no differences in complex. and. activities between the control and TBI groups. Furthermore, pyruvate dehydrogenase (PDH) activity was significantly decreased at 6 h and continued up to 7 d after TBI compared with the control group (6 h: 90 +/- 8, 12 h: 85 +/- 10, 24 h: 65 +/- 12, day 2: 60 +/- 9, day 3: 55 +/- 6, day 7: 88 +/- 11, P < 0.01). The changes in alpha-ketoglutaric dehydrogenase (KGDH) activity were similar to PDH, except that the decrease in KGDH activity began at 12 h after TBI (12 h: 90 +/- 12, 24 h: 80 +/- 9, day 2: 76 +/- 15, day 3: 68 +/- 7, day 7: 90 +/- 13, P < 0.01). No significant change in malate dehydrogenase (MDH) activity was observed. CONCLUSION: Rat enterocyte mitochondrial respiratory function and enzyme activities are inhibited following TBI. Mitochondrial dysfunction may play an important role in TBI-induced gastrointestinal dysfunction. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.	[Zhu, Ke-Jun; Zhang, Shi-Ming] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou 215006, Jiangsu, Peoples R China; [Zhu, Ke-Jun; Huang, Hong; Chu, Hui; Yu, Hang] PLA, Hosp 100, Dept Trauma Surg, Suzhou 215007, Jiangsu, Peoples R China	Zhang, SM (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, 188 Shizi Jie, Suzhou 215006, Jiangsu, Peoples R China.	mmboyzkj@hotmail.com	Zhu, Ren-Yuan/V-8966-2019	Zhu, Ren-Yuan/0000-0003-3091-7461	Scientific Research Foundation of the Chinese PLA Medical Programs [ms031]	Supported by The Scientific Research Foundation of the Chinese PLA Medical Programs, No. ms031	Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI 10.1089/neu.2008-0858; BROWN GC, 1992, BIOCHEM J, V284, P1; Dervenis Christos, 2003, J Hepatobiliary Pancreat Surg, V10, P415, DOI 10.1007/s00534-002-0727-5; Doig CJ, 1998, AM J RESP CRIT CARE, V158, P444, DOI 10.1164/ajrccm.158.2.9710092; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; Faries PL, 1998, J TRAUMA, V44, P1031, DOI 10.1097/00005373-199806000-00016; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Feighery L, 2008, J TRAUMA, V64, P131, DOI 10.1097/TA.0b013e3181568d9f; GARDESTROM P, 1995, J BIOENERG BIOMEMBR, V27, P415, DOI 10.1007/BF02110004; Grivennikova VG, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1490, DOI 10.1134/S0006297913130087; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hang CH, 2005, WORLD J GASTROENTERO, V11, P1149, DOI 10.3748/wjg.v11.i8.1149; Hinkle PC, 2005, BBA-BIOENERGETICS, V1706, P1, DOI 10.1016/j.bbabio.2004.09.004; HINMAN LM, 1981, J BIOL CHEM, V256, P6583; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h; Jin W, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/502564; Kasturi BS, 2009, J NEUROTRAUM, V26, P1315, DOI [10.1089/neu.2008.0751, 10.1089/neu.2008-0751]; Kemp CD, 2008, AM SURGEON, V74, P866; Kowald A, 2011, P NATL ACAD SCI USA, V108, P10237, DOI 10.1073/pnas.1101604108; LAWRENCE CB, 1986, BIOCHIM BIOPHYS ACTA, V848, P35, DOI 10.1016/0005-2728(86)90157-X; Long JG, 2006, LIFE SCI, V79, P1466, DOI 10.1016/j.lfs.2006.04.024; Mei QA, 2011, ACTA PHARMACOL SIN, V32, P495, DOI 10.1038/aps.2010.225; Moran M, 2012, FREE RADICAL BIO MED, V53, P595, DOI 10.1016/j.freeradbiomed.2012.05.009; Overhaus M, 2009, SHOCK, V31, P382, DOI 10.1097/SHK.0b013e3181862ea4; Pilitsis JG, 2001, NEUROL RES, V23, P227, DOI 10.1179/016164101101198389; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; Rocha Milagros, 2012, Infectious Disorders - Drug Targets, V12, P161; Rowlands BJ, 1999, BRIT MED BULL, V55, P196, DOI 10.1258/0007142991902213; Smith Katherine, 2013, Nat Rev Gastroenterol Hepatol, V10, P260, DOI 10.1038/nrgastro.2013.68; Tan M, 2011, BRIT J NEUROSURG, V25, P2, DOI 10.3109/02688697.2010.522745; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2007, BRAIN INJURY, V21, P433, DOI 10.1080/02699050701311083; Wang YB, 2011, WORLD J GASTROENTERO, V17, P657, DOI 10.3748/wjg.v17.i5.657; Wang Yan-bin, 2010, Zhonghua Yi Xue Za Zhi, V90, P1716; WANG YB, 2007, ZHONGHUA XIAOHUA ZAZ, V27, P103, DOI DOI 10.3760/J.ISSN:0254-1432.2007.02.008; Xiao SC, 2008, WORLD J GASTROENTERO, V14, P3231, DOI 10.3748/wjg.14.3231; Zhang XN, 2008, J ZHEJIANG UNIV-SC B, V9, P90, DOI 10.1631/jzus.B0710621	38	12	16	0	10	BAISHIDENG PUBLISHING GROUP INC	PLEASANTON	8226 REGENCY DR, PLEASANTON, CA 94588 USA	1007-9327	2219-2840		WORLD J GASTROENTERO	World J. Gastroenterol.	JUL 28	2014	20	28					9585	9591		10.3748/wjg.v20.i28.9585			7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AL8LI	WOS:000339389800043	25071356	Green Published, Other Gold			2021-06-18	
J	Kim, SC; Park, SW; Ryoo, I; Jung, SC; Yun, TJ; Choi, SH; Kim, JH; Sohn, CH				Kim, Soo Chin; Park, Sun-Won; Ryoo, Inseon; Jung, Seung Chai; Yun, Tae Jin; Choi, Seung Hong; Kim, Ji-Hoon; Sohn, Chul-Ho			Contrast-Enhanced FLAIR (Fluid-Attenuated Inversion Recovery) for Evaluating Mild Traumatic Brain Injury	PLOS ONE			English	Article							DIFFUSE AXONAL INJURY; HEAD-INJURY; SUBDURAL-HEMATOMA; MR; MENINGES; SEQUELAE; RESECTION; SPACE; SITE	Purpose: To evaluate whether adding a contrast-enhanced fluid-attenuated inversion recovery (FLAIR) sequence to routine magnetic resonance imaging (MRI) can detect additional abnormalities in the brains of symptomatic patients with mild traumatic brain injury. Materials and Methods: Fifty-four patients with persistent symptoms following mild closed head injury were included in our retrospective study (M:F = 32: 22, mean age: 59.8 +/- 16.4, age range: 26-84 years). All MRI examinations were obtained within 14 days after head trauma (mean: 3.2 +/- 4.1 days, range: 0.2-14 days). Two neuroradiologists recorded (1) the presence of traumatic brain lesions on MR images with and without contrast-enhanced FLAIR images and (2) the pattern and location of meningeal enhancement depicted on contrast-enhanced FLAIR images. The number of additional traumatic brain lesions diagnosed with contrast-enhanced FLAIR was recorded. Correlations between meningeal enhancement and clinical findings were also evaluated. Results: Traumatic brain lesions were detected on routine image sequences in 25 patients. Three additional cases of brain abnormality were detected with the contrast-enhanced FLAIR images. Meningeal enhancement was identified on contrast-enhanced FLAIR images in 9 cases while the other routine image sequences showed no findings of traumatic brain injury. Overall, the additional contrast-enhanced FLAIR images revealed more extensive abnormalities than routine imaging in 37 cases (p<0.001). In multivariate logistic regression analysis, subdural hematoma and posttraumatic loss of consciousness showed a significant association with meningeal enhancement on contrast-enhanced FLAIR images, with odds ratios 13.068 (95% confidence interval 2.037 to 83.852), and 15.487 (95% confidence interval 2.545 to 94.228), respectively. Conclusion: Meningeal enhancement on contrast-enhanced FLAIR images can help detect traumatic brain lesions as well as additional abnormalities not identified on routine unenhanced MRI. Therefore contrast-enhanced FLAIR MR imaging is recommended when a contrast MR study is indicated in a patient with a symptomatic prior closed mild head injury.	[Kim, Soo Chin; Park, Sun-Won] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Radiol, Seoul, South Korea; [Kim, Soo Chin; Park, Sun-Won; Ryoo, Inseon; Jung, Seung Chai; Yun, Tae Jin; Choi, Seung Hong; Kim, Ji-Hoon; Sohn, Chul-Ho] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Ryoo, Inseon] Korea Univ, Guro Hosp, Dept Radiol, Seoul, South Korea; [Jung, Seung Chai] Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Yun, Tae Jin; Choi, Seung Hong; Kim, Ji-Hoon; Sohn, Chul-Ho] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea	Park, SW (corresponding author), Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Radiol, Seoul, South Korea.	swpark8802@gmail.com		Choi, Seung Hong/0000-0002-0412-2270			Akiyama Y, 2009, NEUROL MED-CHIR, V49, P97, DOI 10.2176/nmc.49.97; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Atkinson JLD, 2003, J MAGN RESON IMAGING, V17, P484, DOI 10.1002/jmri.10275; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; BURKE JW, 1990, RADIOLOGY, V174, P99, DOI 10.1148/radiology.174.1.2294579; Dolinskas CA, 1998, AM J NEURORADIOL, V19, P419; Domenicucci M, 1998, NEUROSURGERY, V42, P51, DOI 10.1097/00006123-199801000-00010; ELSTER AD, 1990, RADIOLOGY, V174, P93, DOI 10.1148/radiology.174.1.2294578; Ercan N, 2004, AM J NEURORADIOL, V25, P761; EVANS RW, 1992, NEUROL CLIN, V10, P815; Fukuoka H, 2010, AM J NEURORADIOL, V31, P868, DOI 10.3174/ajnr.A1937; Gasparotti R, 2011, INSIGHTS IMAGING, V2, P335, DOI 10.1007/s13244-011-0086-3; Goo HW, 2003, PEDIATR RADIOL, V33, P843, DOI 10.1007/s00247-003-1057-8; HAINES DE, 1991, ANAT RECORD, V230, P3, DOI 10.1002/ar.1092300103; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; Henegar MM, 1996, J NEUROSURG, V84, P174, DOI 10.3171/jns.1996.84.2.0174; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Masutani Y, 2003, EUR J RADIOL, V46, P53, DOI 10.1016/S0720-048X(02)00328-5; Mathews VP, 1999, RADIOLOGY, V211, P257, DOI 10.1148/radiology.211.1.r99mr25257; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Rapana A, 1997, CLIN NEUROL NEUROSUR, V99, P124, DOI 10.1016/S0303-8467(96)00585-9; Romano Valerie A., 1994, Journal of Emergency Medicine, V12, P369, DOI 10.1016/0736-4679(94)90280-1; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Sato N, 1997, RADIOLOGY, V204, P839, DOI 10.1148/radiology.204.3.9280269; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Smirniotopoulos JG, 2007, RADIOGRAPHICS, V27, P525, DOI 10.1148/rg.272065155; Soman S, 2013, AM J NEURORADIOL, V34, P2092, DOI 10.3174/ajnr.A3595; SZE G, 1993, AM J ROENTGENOL, V160, P727, DOI 10.2214/ajr.160.4.8456653; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	33	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102229	10.1371/journal.pone.0102229			10	Multidisciplinary Sciences	Science & Technology - Other Topics	AO4KM	WOS:000341306600049	25028975	DOAJ Gold, Green Published			2021-06-18	
J	Brewer-Smyth, K				Brewer-Smyth, Kathleen			Obesity, Traumatic Brain Injury, Childhood Abuse, and Suicide Attempts in Females at Risk	REHABILITATION NURSING			English	Article						Brain injury; child; child abuse sexual; traumatic brain injury; trauma; suicide; obesity; female	ALL-CAUSE MORTALITY; SEXUAL-ABUSE; SALIVARY CORTISOL; PHYSICAL ABUSE; BEHAVIOR; HEALTH; CONSEQUENCES; ASSOCIATION; OVERWEIGHT; NEGLECT	Purpose: This study tested the hypothesis that obesity is related to history of traumatic brain injury (TBI), severity and frequency of childhood physical (CPA) and sexual abuse (CSA), and suicide attempts, adjusting for related variables in a high risk female population. Design: This cross-sectional study of 81 females compared obese to non-obese. Methods: All variables were verified by private interviews, physical examination, and documented evidence, then statistically analyzed with logistic regression. Findings: Obesity at the time of interview was related to history of a decreased number of TBIs per person, greater CSA, suicide attempts, and decreased CPA, adjusting for current smoking, depression, currently using selective serotonin reuptake inhibitors, and age. Conclusions: Number of TBIs per person and CPA were inversely related to obesity, adjusting for related variables. Greater CSA frequency and severity, and having attempted suicide were significantly related to greater risk of obesity, adjusting for related variables. Though causes of obesity cannot be determined by this design, and findings should be viewed with caution, this study provides new insight into the obesity epidemic that requires further investigation. Clinical Relevance: Rehabilitation nurses are in ideal settings when patient's conditions are less acute, providing opportunities to address complex serious underlying etiologies of obesity. Obesity has not been alleviated by teaching about diet and exercise because obesity may be the result of dietary self-medication of pain from previous experiences. CSA is a very serious problem that could precipitate suicide attempts, obesity, and multifaceted poor health outcomes throughout the life span; subsequently placing individuals at greater risk of requiring rehabilitation services.	Univ Delaware, Coll Hlth Sci, Newark, DE 19716 USA	Brewer-Smyth, K (corresponding author), Univ Delaware, Coll Hlth Sci, McDowell Hall, Newark, DE 19716 USA.	kbsmyth@udel.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [20RR016472-04, T32 NR07036]; Sigma Theta Tau International Honor Society; Rehabilitation Nursing Foundation; Baxter Foundation; University of Delaware General University Research Fund; University of Delaware Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR016472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32NR007036] Funding Source: NIH RePORTER	Data collection for this study was funded in part by the National Institutes of Health 20RR016472-04, T32 NR07036, Sigma Theta Tau International Honor Society, Rehabilitation Nursing Foundation, The Baxter Foundation, University of Delaware General University Research Fund, and University of Delaware Research Foundation. Barry Milcarek is also acknowledged posthumously for his statistical assistance.	Amitai M, 2012, INT J ENV RES PUB HE, V9, P985, DOI 10.3390/ijerph9030985; Anderson WL, 2013, OBESITY, V21, pE798, DOI 10.1002/oby.20531; Ashrafian H, 2012, ENDOCRINE, V42, P218, DOI 10.1007/s12020-011-9581-z; BANDURA A, 1978, J COMMUN, V28, P12, DOI 10.1111/j.1460-2466.1978.tb01621.x; Bandura A., 1977, SOCIAL LEARNING THEO; Beck A. T., 1996, BECK DEPRESSION INVE, VII; Bentley T, 2009, OBESITY, V17, P1900, DOI 10.1038/oby.2009.160; Berthoud HR, 2012, P NUTR SOC, V71, P478, DOI 10.1017/S0029665112000602; Brewer-Smyth K, 2004, BIOL PSYCHIAT, V55, P21, DOI 10.1016/S0006-3223(03)00705-4; Brewer-Smyth K., 2001, NEUROLOGIC NEUROENDO; Brewer-Smyth K, 2008, ADV NURS SCI, V31, P119, DOI 10.1097/01.ANS.0000319562.84007.22; Brewer-Smyth Kathleen, 2007, J Neurosci Nurs, V39, P361; Brewer-Smyth K, 2008, NURS RES, V57, P166, DOI 10.1097/01.NNR.0000319501.97864.d5; Brewer-Smyth Kathleen, 2004, Rehabil Nurs, V29, P75; Capodaglio P, 2013, EUR J PHYS REHAB MED, V49, P399; CDC, 2011, HLTH WEIGHT; CDC, 2012, OV OB; Cooper Gregory D, 2011, Issues Ment Health Nurs, V32, P696, DOI 10.3109/01612840.2011.597911; De Bellis MD, 2001, DEV PSYCHOPATHOL, V13, P539, DOI 10.1017/S0954579401003078; De Bellis MD, 2011, J CHILD SEX ABUS, V20, P548, DOI 10.1080/10538712.2011.607753; Dumont DM, 2012, ANNU REV PUBL HEALTH, V33, P325, DOI 10.1146/annurev-publhealth-031811-124614; Felitti VJ, 2009, ACAD PEDIATR, V9, P131, DOI 10.1016/j.acap.2009.03.001; FELITTI VJ, 1993, SOUTHERN MED J, V86, P732, DOI 10.1097/00007611-199307000-00002; FELITTI VJ, 1991, SOUTHERN MED J, V84, P328, DOI 10.1097/00007611-199103000-00008; Fergusson DM, 2008, CHILD ABUSE NEGLECT, V32, P607, DOI 10.1016/j.chiabu.2006.12.018; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P1681, DOI 10.1001/jama.2013.3101; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Fuller-Thomson E, 2013, PUBLIC HEALTH, V127, P449, DOI 10.1016/j.puhe.2013.01.006; Hollingsworth K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051868; Jourdan C, 2012, DEV MED CHILD NEUROL, V54, P624, DOI 10.1111/j.1469-8749.2012.04291.x; Klinitzke G, 2013, J AFFECT DISORDERS, V145, P277, DOI 10.1016/j.jad.2012.07.010; Meyer IH, 1996, CHILD ABUSE NEGLECT, V20, P213, DOI 10.1016/S0145-2134(95)00137-9; MUENZENMAIER K, 1993, HOSP COMMUNITY PSYCH, V44, P666; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; da Silva SSP, 2013, J INTERPERS VIOLENCE, V28, P1989, DOI 10.1177/0886260512471077; Pervanidou P, 2012, METABOLISM, V61, P611, DOI 10.1016/j.metabol.2011.10.005; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Shin SH, 2012, CHILD ABUSE NEGLECT, V36, P84, DOI 10.1016/j.chiabu.2011.08.007; Smeets PAM, 2012, P NUTR SOC, V71, P511, DOI 10.1017/S0029665112000808; Tagliaferri F, 2009, J TRAUMA, V66, P727, DOI 10.1097/TA.0b013e31815edefd; VanHoy S. N., 2009, CRITICAL CARE NURSIN, V21, pvi; VanHoy Sherry N, 2009, Crit Care Nurs Clin North Am, V21, P377, DOI 10.1016/j.ccell.2009.07.004; Wegman HL, 2009, PSYCHOSOM MED, V71, P805, DOI 10.1097/PSY.0b013e3181bb2b46; Williamson DF, 2002, INT J OBESITY, V26, P1075, DOI 10.1038/sj.ijo.0802038	45	12	13	1	27	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0278-4807	2048-7940		REHABIL NURS	Rehabil. Nurs.	JUL-AUG	2014	39	4					183	191		10.1002/rnj.150			9	Nursing; Rehabilitation	Nursing; Rehabilitation	AM0OR	WOS:000339545400004	24668743	Green Accepted			2021-06-18	
J	Hinkewich, C; Green, R				Hinkewich, Chris; Green, Robert			The impact of etomidate on mortality in trauma patients	CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE			English	Article							RAPID-SEQUENCE INTUBATION; SINGLE-DOSE ETOMIDATE; ADRENAL INSUFFICIENCY; EMERGENCY-DEPARTMENT; BRAIN-INJURY; INDUCTION	Etomidate has a neutral hemodynamic profile which has made it an attractive medication for emergent intubation. Despite theoretical advantages of etomidate administration in the trauma patient, there are incomplete data to support its use. This study examined the association of etomidate use for emergent intubation in traumatic illness with patient mortality. This is a historical cohort study using the Nova Scotia Trauma Registry. It included all major adult trauma patients who required tracheal intubation at the Queen Elizabeth II Health Sciences Centre in Halifax, Canada from January 23, 2000 to March 25, 2012. Prospectively recorded data were analyzed, including patient demographics, presence of comorbidities, trauma specific variables, admission and discharge vitals, length of stay in the intensive care unit (ICU) and hospital, mechanical ventilation-free days, and mortality. Associations between the use of etomidate and 28-day mortality are presented as odds ratios. Multivariable logistic regression models were created adjusting for age, injury severity score (ISS), sex, comorbidities, presence of traumatic brain injury, and injury type. The effects of etomidate on other relevant outcome variables were assessed using unpaired Student's t-tests. Three hundred eight patients were included in the study, and there were 42 deaths. Patients receiving etomidate were similar to those who did not, including ISS and pre-intubation blood pressure. The 28-day mortality was 18.7% in the etomidate group and 11.1% in the non-etomidate group (odds ratio = 1.85; 95% confidence interval [CI] 0.96 to 3.57; P = 0.07). After adjustment for age, female sex, ISS, and comorbidity, the odds ratio was 1.94 (95% CI 0.87 to 4.37; P = 0.11). There were no differences between the two groups in ICU length of stay, hospital length of stay, or number of ventilation-free days. The association between use of a single dose of etomidate for emergency tracheal intubation in the trauma patient and mortality is inconclusive. Etomidate administration should be used with caution in trauma patients requiring tracheal intubation. Further data are required to determine the safety and risk-benefit of etomidate use in this patient population.	[Hinkewich, Chris; Green, Robert] Dalhousie Univ, Dept Anesthesia, Div Crit Care, Halifax, NS, Canada	Green, R (corresponding author), Room 377 Bethune Bldg,1276 South Pk St, Halifax, NS B3H 2Y9, Canada.	research.rsg@cdha.nshealth.ca					Asehnoune K, 2012, INTENS CARE MED, V38, P1673, DOI 10.1007/s00134-012-2619-8; Banh KV, 2012, J EMERG MED, V43, pE277, DOI 10.1016/j.jemermed.2012.02.027; Chan CM, 2012, CRIT CARE MED, V40, P2945, DOI 10.1097/CCM.0b013e31825fec26; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cuthbertson BH, 2009, INTENS CARE MED, V35, P1868, DOI 10.1007/s00134-009-1603-4; Green RS, 2012, CAN J EMERG MED, V14, P74, DOI 10.2310/8000.2012.110548; Heffner AC, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.08.011; Hildreth AN, 2008, J TRAUMA, V65, P573, DOI 10.1097/TA.0b013e31818255e8; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; LEDINGHAM IM, 1983, LANCET, V1, P1270; Mohammad Z, 2006, CRIT CARE, V10, DOI 10.1186/cc4979; Schenarts CL, 2001, ACAD EMERG MED, V8, P1, DOI 10.1111/j.1553-2712.2001.tb00537.x; Sivilotti Marco L A, 2006, CJEM, V8, P351; Sivilotti MLA, 1998, ANN EMERG MED, V31, P313, DOI 10.1016/S0196-0644(98)70341-5; Vinclair M, 2008, INTENS CARE MED, V34, P714, DOI 10.1007/s00134-007-0970-y; Warner KJ, 2009, J TRAUMA, V67, P45, DOI 10.1097/TA.0b013e3181a92a70; Zed PJ, 2006, ACAD EMERG MED, V13, P378, DOI 10.1197/j.aem.2005.11.076	18	12	12	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0832-610X	1496-8975		CAN J ANESTH	Can. J. Anesth.	JUL	2014	61	7					650	655		10.1007/s12630-014-0161-6			6	Anesthesiology	Anesthesiology	AI7OW	WOS:000337084200007	24723214				2021-06-18	
J	Kartal, AG; Yilmaz, S; Yaka, E; Pekdemir, M; Sarisoy, HT; Cekmen, MB; Yuksel, M				Kartal, Asli Gulfer; Yilmaz, Serkan; Yaka, Elif; Pekdemir, Murat; Sarisoy, Hasan Tahsin; Cekmen, Mustafa Baki; Yuksel, Melih			Diagnostic Value of S100B Protein in the Differential Diagnosis of Acute Vertigo in the Emergency Department	ACADEMIC EMERGENCY MEDICINE			English	Article							NEURON-SPECIFIC ENOLASE; S-100 PROTEIN; BRAIN-DAMAGE; DIZZINESS; SERUM; MARKERS; STROKE	Objectives: Vertigo is a common presenting complaint resulting from central or peripheral etiologies. Because central causes may be life-threatening, ascertaining the nature of the vertigo is crucial in the emergency department (ED). With a broad range of potential etiologies, distinguishing central causes from benign peripheral causes is a diagnostic challenge. Cranial magnetic resonance imaging (MRI) is the recommended neuroimaging method when clinical findings are ambiguous. However, MRI scanning for every patient with an uncertain diagnosis may not be efficient or possible. Therefore, to improve ED resource utilization for patients with vertigo, there is a need to identify the subset most likely to have MRI abnormalities. It has previously been shown that S100B protein provides a useful serum marker of stroke, subarachnoid hemorrhage, and traumatic brain injury. This study evaluated whether S100B levels could predict central causes of vertigo as identified by cranial MRI in the ED. Methods: This prospective, observational study was conducted with adult patients with acute-onset vertigo (within 6 hours) in the ED of a teaching hospital in Kocaeli, Turkey. Patients with nausea or dizziness complaints without previously known vertigo or cranial pathology, and who agreed to participate in the study, were included. Patients with trauma or with neurologic findings that developed concurrent with their symptoms were excluded. Serum levels of S100B were measured with an electrochemiluminescence immunoassay kit. All subjects underwent cranial MRI. The predictors of positive MRI results were evaluated using logistic regression analysis. Sensitivity and specificity of S100B levels for identifying subjects with central causes of vertigo on MRI were calculated with receiver operating characteristic (ROC) curve. Results: Of the 82 subjects included in the study, 48 (58.5%) were female, and the mean (+/- SD) age was 51 (+/- 16) years. Thirty-one (37.8%) subjects had positive MRI results. Median (with interquartile range [IQR]) serum S100B levels were significantly different between MRI-negative and MRI-positive groups (median = 27.00 pg/mL, IQR = 10.00 to 44.60 vs. median = 60.94 pg/mL, IQR = 38.25 to 77.95, respectively; p = 0.04). In logistic regression analysis, subjective "he or she is spinning" (p = 0.030, odds ratio [OR] = 1.63, 95% confidence interval [CI] = 1.38 to 2.49), systolic blood pressure (sBP; p = 0.045, OR = 1.044, 95% CI = 1.021 to 1.080), and serum S100B level (p = 0.042, OR = 1.22, 95% CI = 1.018 to 1.445) were found to be independent predictors of MRI abnormalities. In the ROC analysis, S100B > 30 pg/mL predicted the clinical outcome with 83.9% sensitivity (95% CI = 66.3% to 94.5%) and 51.0% specificity (95% CI = 36.6% to 65.2%). The area under the ROC curve was 0.774 (95% CI = 0.666 to 0.881). Conclusions: To the best of our knowledge this is the first study assessing the utility of serum S100B levels for diagnosis of acute-onset vertigo. Serum S100B levels are associated with the presence of central causes of vertigo on cranial MRI. However, serum S100B levels are not sufficiently sensitive to exclude candidates from cranial MRI. (C) 2014 by the Society for Academic Emergency Medicine	[Kartal, Asli Gulfer; Yilmaz, Serkan; Yaka, Elif; Pekdemir, Murat; Yuksel, Melih] Kocaeli Univ, Fac Med, Dept Emergency Med, Kocaeli, Turkey; [Sarisoy, Hasan Tahsin] Kocaeli Univ, Fac Med, Dept Radiol, Kocaeli, Turkey; [Cekmen, Mustafa Baki] Kocaeli Univ, Fac Med, Dept Biochem, Kocaeli, Turkey	Yilmaz, S (corresponding author), Kocaeli Univ, Fac Med, Dept Emergency Med, Kocaeli, Turkey.	serkanyilmaz@kocaeli.edu.tr	Sarisoy, Hasan Tahsin/Q-8399-2019; YILMAZ, Serkan/G-2746-2018; Yaka, Elif/F-8511-2018; Yuksel, Melih/ABI-1074-2020; Pekdemir, Murat/F-9741-2018	YILMAZ, Serkan/0000-0003-1496-6976; Pekdemir, Murat/0000-0002-3917-0192			Abraha HD, 1997, ANN CLIN BIOCHEM, V34, P546, DOI 10.1177/000456329703400510; Akinci E, 2007, ADV THER, V24, P1068, DOI 10.1007/BF02877713; Bruzzone MG, 2004, NEUROL SCI, V1, P20; Cloutier JF, 2008, J OTOLARYNGOL-HEAD N, V37, P331, DOI 10.2310/7070.2008.0067; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Heath CL, 2013, EMERG RADIOL, V20, P45; Heinzmann CW, 2002, FRONT BIOSCI ZURICH, V7, P1356; Herr D, 1989, ANN EMERG MED, V18, P664; Kerber KA, 2008, ACAD EMERG MED, V15, P744, DOI 10.1111/j.1553-2712.2008.00189.x; Marzo SJ, 2000, SKULL BASE SURG, V10, P171, DOI 10.1055/s-2000-9334; Navi BB, 2012, MAYO CLIN PROC, V87, P1080, DOI 10.1016/j.mayocp.2012.05.023; Newman-Toker DE, 2008, MAYO CLIN PROC, V83, P765, DOI 10.4065/83.7.765; NORRVING B, 1995, ACTA NEUROL SCAND, V91, P43; Ozono Y, 2014, ACTA OTO-LARYNGOL, V134, P140, DOI 10.3109/00016489.2013.832377; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Wunderlich MT, 2004, J NEUROL SCI, V227, P49, DOI 10.1016/j.jns.2004.08.005; Yardan T, 2009, AM J EMERG MED, V27, P838, DOI 10.1016/j.ajem.2008.04.016; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	19	12	13	0	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	JUL	2014	21	7					736	741		10.1111/acem.12420			6	Emergency Medicine	Emergency Medicine	AN5AA	WOS:000340600200003	25125270	Bronze			2021-06-18	
J	Kazemi, P; Villar, G; Flexman, AM				Kazemi, Pooya; Villar, Giselle; Flexman, Alana M.			Anesthetic Management of Neurosurgical Procedures During Pregnancy: A Case Series	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						pregnancy; neurosurgery; craniotomy; complications; outcomes; anesthesia	HEMORRHAGE; NEOPLASMS; WOMEN	Introduction: Neurosurgical disorders are rare during pregnancy and challenge the anesthesiologist with conflicting anesthetic considerations and little evidence to guide decision-making. Our objective was to review the anesthetic management of pregnant patients undergoing intracranial neurosurgery at our institution and to describe the perioperative complications and outcomes. Methods: We used our institutional Discharge Abstract Database to identify patients assigned both neurological and obstetrical International Classification of Disease 10-A codes between April 1, 2001 and March 1, 2012. Pregnant patients who underwent intracranial neurosurgical procedures underwent a detailed chart review to extract demographic data and details about their anesthetic management and outcome. Results: Nine patients underwent full chart review with a median age of 28 (range, 17 to 35) years and a gestational age of 23 (range, 7 to 30) weeks. Patients underwent a craniotomy for vascular lesions (4), neoplasms (3), and traumatic brain injuries (2). One patient was hyperventilated (PaCO2 28 mmHg), and mannitol and furosemide were used in 6 and 3 patients, respectively, without complication. Maternal neurological outcomes were good in 5 patients (Glasgow Outcome Scale of > 3), poor in 3 patients (Glasgow Outcome Scale 3), and 1 patient died. Fetal outcomes were good in 5 patients and poor in 4 patients (1 therapeutic abortion, 3 intrauterine fetal demises). All cases of fetal distress or demise were either remote or occurred before the anesthetic management. Conclusions: Pregnant patients undergoing neurosurgery experience a high rate of morbidity and mortality. There were no adverse outcomes directly attributed to the use of osmotic diuretics and hyperventilation in our series.	[Kazemi, Pooya; Villar, Giselle; Flexman, Alana M.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Villar, Giselle] British Columbias Womens Hosp, Dept Anesthesia, Vancouver, BC, Canada; [Flexman, Alana M.] Vancouver Gen Hosp, Dept Anesthesiol & Perioperat Care, Vancouver, BC V5Z 1M9, Canada	Flexman, AM (corresponding author), Vancouver Gen Hosp, Dept Anesthesiol & Perioperat Care, Room 2449,899 West 12th Ave, Vancouver, BC V5Z 1M9, Canada.	alana.flexman@vch.ca					Allen G, 2006, NEUROCRIT CARE, V4, P18, DOI 10.1385/NCC:4:1:018; [Anonymous], 2011, OBSTET GYNECOL, V117, P420, DOI 10.1097/AOG.0b013e31820eede9; Bader AP, 2009, OBSTET ANESTHESIA PR, P1053; Bateman BT, 2006, NEUROLOGY, V67, P424, DOI 10.1212/01.wnl.0000228277.84760.a2; Bateman BT, 2012, ANESTHESIOLOGY, V116, P324, DOI 10.1097/ALN.0b013e3182410b22; Bharti N, 2002, INT J OBSTET ANESTH, V11, P219, DOI 10.1054/ijoa.2001.0941; BRUNS PD, 1963, AM J OBSTET GYNECOL, V86, P160; Cohen-Gadol AA, 2009, J NEUROSURG, V111, P2009, DOI 10.3171/2009.3.JNS081160; Curley G, 2010, CRIT CARE MED, V38, P1348, DOI 10.1097/CCM.0b013e3181d8cf2b; Czeizel AE, 1999, CLIN DRUG INVEST, V18, P307, DOI 10.2165/00044011-199918040-00007; Elwatidy S, 2011, BRIT J NEUROSURG, V25, P478, DOI 10.3109/02688697.2010.550345; Flemming KD, 2003, SURG NEUROL, V60, P545, DOI 10.1016/S0090-3019(03)00251-9; Goldschlager Tony, 2009, J Trauma, V66, pE50, DOI 10.1097/TA.0b013e318031cc98; Gross BA, 2012, NEUROSURGERY, V71, P349, DOI 10.1227/NEU.0b013e318256c34b; HAAS JF, 1986, J NEUROL NEUROSUR PS, V49, P874, DOI 10.1136/jnnp.49.8.874; Hayasaka IU, 1984, CONGENIT ANOM, V24, P111; JENNETT B, 1975, LANCET, V1, P480; LOW JA, 1970, AM J OBSTET GYNECOL, V106, P1032, DOI 10.1016/S0002-9378(16)34089-3; LUMBERS ER, 1983, J PHYSIOL-LONDON, V343, P439, DOI 10.1113/jphysiol.1983.sp014902; Lynch JC, 2011, BRIT J NEUROSURG, V25, P225, DOI 10.3109/02688697.2010.508846; Muench MV, 2007, OBSTET GYN CLIN N AM, V34, P555, DOI 10.1016/j.ogc.2007.06.001; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NAKATSUKA T, 1993, TERATOLOGY, V48, P139, DOI 10.1002/tera.1420480208; Ng J, 2008, J NEUROL NEUROSUR PS, V79, P745, DOI 10.1136/jnnp.2007.117002; Nossek E, 2011, ACTA NEUROCHIR, V153, P1727, DOI 10.1007/s00701-011-1061-y; PLISKOW S, 1995, J REPROD MED, V40, P154; Qaiser R, 2007, SEMIN NEUROL, V27, P476, DOI 10.1055/s-2007-991129; ROSS MG, 1986, PEDIATR PULM, V2, P40, DOI 10.1002/ppul.1950020111; Sharma JB, 2003, INT J GYNECOL OBSTET, V80, P321, DOI 10.1016/S0020-7292(02)00342-9; Terry AR, 2012, NEURO-ONCOLOGY, V14, P768, DOI 10.1093/neuonc/nos078; Tewari KS, 2000, AM J OBSTET GYNECOL, V182, P1215, DOI 10.1016/S0002-9378(00)70188-8; Tuncali Bahattin, 2006, J Anesth, V20, P40, DOI 10.1007/s00540-005-0359-4; Wang LP, 2008, ANESTH ANALG, V107, P193, DOI 10.1213/ane.0b013e31816c8888	33	12	13	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2014	26	3					234	240					7	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	AJ0FN	WOS:000337325500008	24296540				2021-06-18	
J	Thomsen, GM; Le Belle, JE; Harnisch, JA; Mc Donald, WS; Hovda, DA; Sofroniew, MV; Kornblum, HI; Harris, NG				Thomsen, Gretchen M.; Le Belle, Janel E.; Harnisch, Jessica A.; Mc Donald, Whitney S.; Hovda, David A.; Sofroniew, Michael V.; Kornblum, Harley I.; Harris, Neil G.			Traumatic brain injury reveals novel cell lineage relationships within the subventricular zone	STEM CELL RESEARCH			English	Article							NEURAL STEM-CELLS; ADULT BRAIN; FOREBRAIN NEUROGENESIS; NEURONAL PROGENITORS; PROLIFERATION; ISCHEMIA; PRECURSORS; REGENERATION; REPLACEMENT; ASTROCYTES	The acute response of the rodent subventricular zone (SVZ) to traumatic brain injury (TBI) involves a physical expansion through increased cell proliferation. However, the cellular underpinnings of these changes are not well understood. Our analyses have revealed that there are two distinct transit-amplifying cell populations that respond in opposite ways to injury. Mash1+ transit-amplifying cells are the primary SVZ cell type that is stimulated to divide following TBI. In contrast, the EGFR+ population, which has been considered to be a functionally equivalent progenitor population to Mash1+ cells in the uninjured brain, becomes significantly less proliferative after injury. Although normally quiescent GFAP+ stem cells are stimulated to divide in SVZ ablation models, we found that the GFAP+ stem cells do not divide more after TBI. We found, instead, that TBI results in increased numbers of GFAP+/EGFR+ stem cells via non-proliferative means-potentially through the dedifferentiation of progenitor cells. EGFR+ progenitors from injured brains only were competent to revert to a stem cell state following brief exposure to growth factors. Thus, our results demonstrate previously unknown changes in lineage relationships that differ from conventional models and likely reflect an adaptive response of the SVZ to maintain endogenous brain repair after TBI. (C) 2014 The Authors. Published by Elsevier B.V.	[Thomsen, Gretchen M.; Harnisch, Jessica A.; Mc Donald, Whitney S.; Hovda, David A.; Harris, Neil G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, UCLA Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Le Belle, Janel E.; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, NPI Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Hovda, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Sofroniew, Michael V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	Kornblum, HI (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Neurosci Res Bldg,Suite 379, Los Angeles, CA 90095 USA.	hkornblum@mednet.ucla.edu; ngharris@mednet.ucla.edu	Sofroniew, Michael/ABE-8857-2020	Harris, Neil/0000-0002-1965-6750	UCLA Brain Injury Research Center; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS055910, NRSA 5F31NS064697-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS064697, R01NS055910] Funding Source: NIH RePORTER	We wish to thank Dr. David McArthur for helpful discussion about the statistics. This work was supported by the UCLA Brain Injury Research Center, and Award Number R01 NS055910 and NRSA 5F31NS064697-02 from the National Institute of Neurological Disorders and Stroke (NINDS).	Alagappan D, 2009, ASN NEURO, V1, DOI 10.1042/AN20090002; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Blizzard CA, 2011, CEREB CORTEX, V21, P281, DOI 10.1093/cercor/bhq091; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Cesetti T, 2009, STEM CELLS, V27, P1443, DOI 10.1002/stem.74; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Ciccolini F, 2005, DEV BIOL, V284, P112, DOI 10.1016/j.ydbio.2005.05.007; Craig G, 1996, J NEUROSCI, V16, P2649; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; Gregorian C, 2009, J NEUROSCI, V29, P1874, DOI 10.1523/JNEUROSCI.3095-08.2009; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Imura T, 2003, J NEUROSCI, V23, P2824; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kim Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008122; Kreuzberg M, 2010, EXP NEUROL, V226, P90, DOI 10.1016/j.expneurol.2010.08.006; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Leker RR, 2007, STROKE, V38, P153, DOI 10.1161/01.STR.0000252156.65953.a9; Magavi SS, 2000, NATURE, V405, P951; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Ninomiya M, 2006, NEUROSCI LETT, V403, P63, DOI 10.1016/j.neulet.2006.04.039; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; R Development Core Team, 2008, R LANGUAGE ENV STAT; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Rasband W.S., 2008, IMAGEJ; Sundholm-Peters NL, 2005, J NEUROPATH EXP NEUR, V64, P1089, DOI 10.1097/01.jnen.0000190066.13312.8f; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Tonchev AB, 2003, MOL CELL NEUROSCI, V23, P292, DOI 10.1016/S1044-7431(03)00058-7; Tsai YW, 2013, J CEREBR BLOOD F MET, V33, P764, DOI 10.1038/jcbfm.2013.15; Yagita Y, 2001, STROKE, V32, P1890, DOI 10.1161/01.STR.32.8.1890; Yamamoto S, 2001, EXP NEUROL, V172, P115, DOI 10.1006/exnr.2001.7798	42	12	12	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1873-5061	1876-7753		STEM CELL RES	Stem Cell Res.	JUL	2014	13	1					48	60		10.1016/j.scr.2014.04.013			13	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AP7VY	WOS:000342287000005	24835668	DOAJ Gold, Green Accepted			2021-06-18	
J	Tylicka, M; Matuszczak, E; Debek, W; Hermanowicz, A; Ostrowska, H				Tylicka, Marzena; Matuszczak, Ewa; Debek, Wojciech; Hermanowicz, Adam; Ostrowska, Halina			Circulating proteasome activity following mild head injury in children	CHILDS NERVOUS SYSTEM			English	Article						Mild head injury; Concussion; Head injury; Children; Circulating proteasome activity; Plasma	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; REDUCES INFARCTION; 20S PROTEASOME; LEUKOCYTE INFILTRATION; OXIDIZED PROTEINS; GENE-EXPRESSION; RAT MODEL; KAPPA-B; UBIQUITIN	The aim of the study is to characterize changes in circulating proteasome (c-proteasome) activity following mild traumatic brain injury in children. Fifty children managed at the Department of Pediatric Surgery because of concussion-mild head injury was randomly included into the study. The children were aged 11 months to 17 years (median = 10.07 + -1.91 years). Plasma proteasome activity was assessed using Suc-Leu-Leu-Val-Tyr-AMC peptide substrate, 2-6 h, 12-16 h, and 2 days after injury. Twenty healthy children admitted for planned inguinal hernia repair served as controls. Statistically significant elevation of plasma c-proteasome activity was noted in children with mild head injury 2-6 h, 12-16 h, and 2 days after the injury. Authors observed a statistically significant upward trend in the c-proteasome activity between 2-6 and 12-16 h after the mild head injury, consistent with the onset of the symptoms of cerebral concussion and a downward trend in the c-proteasome activity in the plasma of children with mild head injury between 12-16 h and on the second day after the injury, consistent with the resolving of the symptoms of cerebral concussion. Further studies are needed to demonstrate that the proteasome activity could be a prognostic factor, which can help in further diagnostic and therapeutic decisions in patients with head injury.	[Matuszczak, Ewa; Debek, Wojciech; Hermanowicz, Adam; Ostrowska, Halina] Med Univ Bialystok, Dept Pediat Surg, PL-15274 Bialystok, Poland; [Tylicka, Marzena] Med Univ Bialystok, Dept Biophys, PL-15089 Bialystok, Poland	Matuszczak, E (corresponding author), Med Univ Bialystok, Dept Pediat Surg, PL-15274 Bialystok, Poland.	ewamat@tlen.pl	Ostrowska, Halina/X-1832-2018; Debek, Wojciech/S-8168-2018; Hermanowicz, ahermanowicz/T-3500-2018; Tylicka, Marzena/AAV-7088-2020; Matuszczak, Ewa/T-3497-2018	Ostrowska, Halina/0000-0003-0706-8270; Debek, Wojciech/0000-0001-6023-8510; Hermanowicz, ahermanowicz/0000-0002-5723-6941; Tylicka, Marzena/0000-0002-9594-8173; Matuszczak, Ewa/0000-0003-2425-9589			Chambellan A, 2006, AM J RESP CELL MOL, V35, P424, DOI 10.1165/rcmb.2005-0251OC; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; Dutaud D, 2002, J IMMUNOL METHODS, V260, P183, DOI 10.1016/S0022-1759(01)00555-5; Egerer K, 2002, J RHEUMATOL, V29, P2045; Halliwell B, 2002, ANN NY ACAD SCI, V962, P182, DOI 10.1111/j.1749-6632.2002.tb04067.x; Henninger N, 2006, NEUROSCI LETT, V398, P300, DOI 10.1016/j.neulet.2006.01.015; Herrmann J, 2007, CIRC RES, V100, P1276, DOI 10.1161/01.RES.0000264500.11888.f0; Marcin JP, 2002, CRIT CARE MED, V30, pS457, DOI 10.1097/00003246-200211001-00011; Martin S, 2004, NEUROSCI LETT, V357, P76, DOI 10.1016/j.neulet.2003.10.085; Meller R, 2006, J BIOL CHEM, V281, P7429, DOI 10.1074/jbc.M512138200; Meller R, 2008, J NEUROSCI, V28, P50, DOI 10.1523/JNEUROSCI.3474-07.2008; Mengual E, 1996, J NEUROSCI, V16; Mishto M, 2006, NEUROBIOL AGING, V27, P54, DOI 10.1016/j.neurobiolaging.2004.12.004; Ostrowska H, 2008, CLIN BIOCHEM, V41, P1377, DOI 10.1016/j.clinbiochem.2008.08.063; Piccinini M, 2003, J NEUROIMMUNOL, V135, P135, DOI 10.1016/S0165-5728(02)00439-3; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; Rehni AK, 2010, BIOL PHARM BULL, V33, P1953, DOI 10.1248/bpb.33.1953; Royo NC, 2007, NEUROSCIENCE, V148, P359, DOI 10.1016/j.neuroscience.2007.06.014; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Szabo Z, 2010, BRAIN RES, V1341, P25, DOI 10.1016/j.brainres.2009.01.035; Verma R, 2000, CELL, V101, P341, DOI 10.1016/S0092-8674(00)80843-0; Weih M, 2001, J CEREBR BLOOD F MET, V21, P1090, DOI 10.1097/00004647-200109000-00006; Williams AJ, 2006, NEUROCHEM INT, V49, P106, DOI 10.1016/j.neuint.2006.03.018; Williams AJ, 2003, J CEREBR BLOOD F MET, V23, P75, DOI 10.1097/01.WCB.0000039285.37737.C2; Yao XL, 2008, J NEUROCHEM, V104, P353, DOI 10.1111/j.1471-4159.2007.04970.x; Zhang L, 2001, STROKE, V32, P2926, DOI 10.1161/hs1201.100207	29	12	12	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUL	2014	30	7					1191	1196		10.1007/s00381-014-2409-4			6	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	AK7TR	WOS:000338631100008	24700339	Green Published, Other Gold			2021-06-18	
J	Kumar, A; Rinwa, P; Dhar, H				Kumar, Anil; Rinwa, Puneet; Dhar, Hitesh			Microglial inhibitory effect of ginseng ameliorates cognitive deficits and neuroinflammation following traumatic head injury in rats	INFLAMMOPHARMACOLOGY			English	Article						Head trauma; Memory impairment; Microglia; Neuroinflammation; Oxidative stress	INDUCED HIPPOCAMPAL DAMAGE; BRAIN-INJURY; OXIDATIVE STRESS; IMMATURE RATS; MINOCYCLINE; GINSENOSIDES; CELLS; MODEL; NEURODEGENERATION; PATHOPHYSIOLOGY	Traumatic brain injury produces several neuropathological alterations, some of them are analogous to patients suffering from memory disorders. Role of neuroinflammation and oxidative stress has been suggested in the pathophysiology of brain injury-induced cognitive dysfunction. Therefore, the present study was designed to explore the possible role of ginseng and its interaction with minocycline (microglial inhibitor) against experimental brain trauma-induced behavioral, biochemical and molecular alterations. Wistar rats were exposed to brain traumatic injury using weight-drop method. Following injury and a post-injury rehabilitation period of 2 weeks, animals were administered vehicle/drugs for another 2 weeks. Brain injury caused significant memory impairment in Morris water maze task as evident from increase in escape latency and total distance travelled to reach the hidden platform. This was followed by a significant decrease in time spent in target quadrant and frequency of appearance in target quadrant. Further, there was a significant increase in oxidative stress markers, neuroinflammation (TNF-alpha and IL-6) and acetylcholinesterase levels in both cortex and hippocampal regions of traumatized rat brain. Ginseng (100 and 200 mg/kg) and minocycline (50 mg/kg) treatment for 2 weeks significantly attenuated all these behavioral, biochemical and molecular alterations. Further, combination of sub-effective doses of ginseng (50 and 100 mg/kg) and minocycline (25 mg/kg) potentiated their protective effects which was significant as compared to their effects alone. The results of the present study suggest that the therapeutic effects of ginseng might involve inhibition of microglial pathway against head trauma-induced cognitive impairment and neuroinflammation in rats.	[Kumar, Anil; Rinwa, Puneet; Dhar, Hitesh] Panjab Univ, UGC Ctr Adv Study, Univ Inst Pharmaceut Sci, Div Pharmacol, Chandigarh 160014, India	Kumar, A (corresponding author), Panjab Univ, UGC Ctr Adv Study, Univ Inst Pharmaceut Sci, Div Pharmacol, Chandigarh 160014, India.	kumaruips@yahoo.com	KUMAR, ANIL -/D-7471-2011	KUMAR, ANIL -/0000-0002-9506-6197	Council of Scientific and Industrial Research (CSIR), New DelhiCouncil of Scientific & Industrial Research (CSIR) - India	Authors gratefully acknowledge the financial support of Council of Scientific and Industrial Research (CSIR), New Delhi for carrying out this work. Authors would also like to thank Dr. Thirunavukkarasu Angappan, Deputy General Manager at Panacea Biotec Ltd, Lalru for supplying Wistar rats for our experimental studies.	Abdel Baki S.G., 2010, PLOS ONE, V5; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Al-Hazmi MA, 2013, TOXICOL IND HLTH; Banishin CG, 1989, RECENT ADV GINSENG S, P139; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Dean OM, 2012, CNS DRUGS, V26, P391, DOI 10.2165/11632000-000000000-00000; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Freire MAM, 2012, W INDIAN MED J, V61, P751; GORNALL AG, 1949, J BIOL CHEM, V177, P751; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kelso ML, 2011, NEUROSCI LETT, V488, P60, DOI 10.1016/j.neulet.2010.11.003; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Kraus RL, 2005, J NEUROCHEM, V94, P819, DOI 10.1111/j.1471-4159.2005.03219.x; Lam TI, 2013, NEUROREHABIL NEURAL; Lee JH, 2004, J BIOL CHEM, V279, P9912, DOI 10.1074/jbc.M310824200; Lee KW, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-196; Lenzlinger PM, 2001, J NEUROTRAUM, V18, P479, DOI 10.1089/089771501300227288; Lim JH, 1997, NEUROSCI RES, V28, P191, DOI 10.1016/S0168-0102(97)00041-2; Lin E, 2008, AM J CHINESE MED, V36, P981, DOI 10.1142/S0192415X08006399; Liu QA, 2011, NEUROCHEM INT, V58, P119, DOI 10.1016/j.neuint.2010.11.004; Luck H., 1971, METHOD ENZYMAT AN, P885; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Miller CS, 1999, TOXICOL IND HEALTH, V15, P284, DOI 10.1191/074823399678846871; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nah SY, 2009, BRAIN RES, V1248, P184, DOI 10.1016/j.brainres.2008.10.064; Nah SY, 2007, CNS DRUG REV, V13, P381; Lopez MVN, 2007, BBA-GEN SUBJECTS, V1770, P1308, DOI 10.1016/j.bbagen.2007.06.008; Ozdemir D, 2005, NEUROSCI LETT, V385, P234, DOI 10.1016/j.neulet.2005.05.055; Ozdemir D, 2012, NEUROSCI LETT, V507, P84, DOI 10.1016/j.neulet.2011.11.059; Pall ML, 2001, ANN NY ACAD SCI, V933, P323; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Qian Y. N., 2013, NEUROREPORT; Samukawa K, 2008, BIORHEOLOGY, V45, P689, DOI 10.3233/BIR-2008-0516; Schaible EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071056; Scremin OU, 2006, BRAIN RES, V1124, P155, DOI 10.1016/j.brainres.2006.09.062; Seabrook TJ, 2006, GLIA, V53, P776, DOI 10.1002/glia.20338; Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004; Su Zhang-jie, 2008, Zhonghua Yi Xue Za Zhi, V88, P3003; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Wang T, 2013, J NEUROTRAUMA; Wang YL, 2011, NEUROSCI LETT, V487, P70, DOI 10.1016/j.neulet.2010.09.076; WILLS ED, 1966, BIOCHEM J, V99, P667, DOI 10.1042/bj0990667; Wu CF, 2007, INT IMMUNOPHARMACOL, V7, P313, DOI 10.1016/j.intimp.2006.04.021; Xia L, 2012, J NEUROSCI RES, V90, P1424, DOI 10.1002/jnr.22811; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; Zhang RH, 2009, AM J CHINESE MED, V37, P657, DOI 10.1142/S0192415X09007144	53	12	12	0	12	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0925-4692	1568-5608		INFLAMMOPHARMACOLOGY	Inflammopharmacology	JUN	2014	22	3					155	167		10.1007/s10787-013-0187-3			13	Immunology; Pharmacology & Pharmacy; Toxicology	Immunology; Pharmacology & Pharmacy; Toxicology	AH8NH	WOS:000336394200002	24052247				2021-06-18	
J	Micieli, JA; Zurakowski, D; Ahmed, IIK				Micieli, Jonathan A.; Zurakowski, David; Ahmed, Iqbal Ike K.			Impact of visors on eye and orbital injuries in the National Hockey League	CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE			English	Article							ICE HOCKEY; CONCUSSIONS; HEAD	Objective: Eye and orbital injuries are a significant risk to professional hockey league players and have resulted in career-ending injuries. The goal of this study was to determine the incidence, value lost, mechanism, and effect of visors on eye and orbital injuries over the last 10 National Hockey League (NHL) seasons: 2002-2003 to 2012-2013. Design: Retrospective case control study. Participants: Participants were 8741 NHL players who had played at least 1 game during the last 10 seasons. Methods: Using The Sports Network (TSN), ProSports Transactions, and the Sporting News Hockey Register, NHL players were searched to identify eye and orbital injuries. The mechanism of injury was obtained from media reports and direct observation from online videos. The number of players wearing visors each year was obtained from The Hockey News annual visor survey. Results: A total of 149 eye or orbital injuries over the last 10 seasons resulted in an overall incidence of 2.48 per 10 000 athlete exposures. A total of 1120 missed games led to a lost financial value of more than $33 million. Visor use among players grew from 32% in 2002-2003 to 73% in 2012-2013, and there was a significantly increased risk for having an eye or orbital injury when a visor was not worn (OR 4.23, 95% CI 2.84-6.30). Most injuries were a result of being hit by a deflected or direct puck (37%) followed by being struck by a high stick (28%). Players who did not wear a visor were found to be involved in more fights, hits, and penalty minutes (p < 0.001). Conclusions: Eye and orbital injuries are mostly accidental in nature and represent a significant risk and cost to the NHL and its players. Eye and orbital injuries are significantly more likely in players who do not wear visors.	[Micieli, Jonathan A.; Ahmed, Iqbal Ike K.] Univ Toronto, Dept Ophthalmol, Toronto, ON M5S 1A1, Canada; [Zurakowski, David] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Anesthesiol, Boston, MA USA; [Zurakowski, David] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Surg, Boston, MA USA; [Ahmed, Iqbal Ike K.] Trillium Hlth Partners, Mississauga, ON, Canada; [Ahmed, Iqbal Ike K.] Credit Valley EyeCare, Mississauga, ON, Canada	Micieli, JA (corresponding author), Dept Ophthalmol & Vis Sci, 340 Coll St,Suite 400, Toronto, ON M5T 3A9, Canada.	jonathanmicieli@gmail.com					Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Bernstein R., 2006, CODE UNWRITTEN RULES; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Brophy M., 2013, NHL NHLPA AGREE MAND; Campbell K, 2011, THN POLL NHL VISOR U; Cole C., 2013, NATL POST; McGran K., 2013, PLACE TRIVIA HIST AW; Morris DS, 2009, BMJ CASE REP; Orchard J, 2002, BRIT J SPORT MED, V36, P16, DOI 10.1136/bjsm.36.1.16; Stevens ST, 2006, J SCI MED SPORT, V9, P238, DOI 10.1016/j.jsams.2006.03.025; Stevens ST, 2008, SOUTH MED J, V101, P979, DOI 10.1097/SMJ.0b013e3181818107; The Canadian Press, 2013, COMP COMM TOUTS VIS; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X; Woods SE, 2008, SOUTH MED J, V101, P991, DOI 10.1097/SMJ.0b013e3181830d42	16	12	13	0	9	CANADIAN OPHTHAL SOC	OTTAWA	1525 CARLING AVE SUITE 610, OTTAWA, ONTARIO K1Z 8R9, CANADA	0008-4182	1715-3360		CAN J OPHTHALMOL	Can. J. Opthalmol.-J. Can. Opthalmol.	JUN	2014	49	3					243	248		10.1016/j.jcjo.2014.03.008			6	Ophthalmology	Ophthalmology	AI0GE	WOS:000336523400013	24862769				2021-06-18	
J	Wang, Q; Wei, X; Gao, H; Li, J; Liao, J; Liu, X; Qin, B; Yu, Y; Deng, C; Tang, B; Huang, XF				Wang, Q.; Wei, X.; Gao, H.; Li, J.; Liao, J.; Liu, X.; Qin, B.; Yu, Y.; Deng, C.; Tang, B.; Huang, X. -F.			SIMVASTATIN REVERSES THE DOWNREGULATION OF M1/4 RECEPTOR BINDING IN 6-HYDROXYDOPAMINE-INDUCED PARKINSONIAN RATS: THE ASSOCIATION WITH IMPROVEMENTS IN LONG-TERM MEMORY	NEUROSCIENCE			English	Article						Parkinson's disease; simvastatin; M1/4 receptors; memory	TRAUMATIC BRAIN-INJURY; MEDIAL FOREBRAIN-BUNDLE; ALZHEIMERS-DISEASE; STRIATAL DOPAMINE; DIFFERENTIAL RESPONSE; COGNITIVE DYSFUNCTION; PREFRONTAL CORTEX; SUBSTANTIA-NIGRA; UP-REGULATION; RISK-FACTORS	Background: It is believed that muscarinic M1/4 receptors are closely correlated to the dopaminergic system and are strongly involved in the pathogenesis of Parkinson's disease (PD). In addition to regulating lipid metabolism and protection from stroke, statins have been used to regulate the declined cognition. We aimed to explore the regional changes in M1/4 receptors in the 6-hydroxydopamine (6-OHDA)-lesioned rat brain. Methods: PD rat model was set up by injecting 6-OHDA into the unilateral medial forebrain bundle; while simvastatin (10 mg/kg/day) or saline was orally administrated for 3 weeks, respectively. Long-term memory was measured using the Morris water maze. [H-3] pirenzepine binding autoradiography was applied to investigate the alterations of M1/4 receptors in the PD rat brains. Results: 6-OHDA induced long-term memory deficits along with downregulation of M1/4 receptors in the hippocampus, the medial amygdala, the posteromedial cortical and the piriform cortex; simvastatin administration significantly ameliorated the impaired memory and reversed the downregulation of M1/4 receptors in the examined brain regions. Profound positive correlations were verified between the decline in long-term memory activity and the restoration of M1/4 receptors in different brain regions after simvastatin treatment. Conclusions/significance: Our results provide strong evidence that M1/4 receptor modulation after simvastatin administration did, at least partially, contribute to the improvement in the long-term memory in 6-OHDA-induced PD rats. These results provide a possible mechanism for simvastatin treatment in psycho-neurological diseases such as PD via M1/4 receptors. (C) 2014 IBRO. Published by Elsevier Ltd. All rights reserved.	[Wang, Q.; Wei, X.; Gao, H.; Li, J.; Liao, J.; Liu, X.; Qin, B.] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou 510630, Guangdong, Peoples R China; [Wang, Q.; Yu, Y.; Deng, C.; Huang, X. -F.] Univ Wollongong, Sch Hlth Sci, Ctr Translat Neurosci, Wollongong, NSW 2522, Australia; [Tang, B.] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China	Wang, Q (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Neurol Res Lab, 600 Tianhe Rd, Guangzhou 510630, Guangdong, Peoples R China.	denniswq@yahoo.com	Deng, Chao/F-4417-2016; Huang, Xu-Feng/H-7408-2015	Deng, Chao/0000-0003-1147-5741; Huang, Xu-Feng/0000-0002-5895-2253; Wang, Qing/0000-0002-3882-6540; Yu, Yinghua/0000-0003-2508-7512	973 ProjectNational Basic Research Program of China [2011CB510000]; National Natural Science Foundations of ChinaNational Natural Science Foundation of China (NSFC) [81071031, 81271427]; 985 project grant [820003281901]; Australia National Health and Medical Research Council Grant (NHMRC)National Health and Medical Research Council of Australia [514640]	This work was supported by the 973 Project (2011CB510000), National Natural Science Foundations of China (Grant No. 81071031, 81271427), 985 project grant (820003281901), and Australia National Health and Medical Research Council Grant (NHMRC, ID: 514640) from Q. W. The authors thank Mr. Nikolce Mackovski for preparation on the 6-OHDA-induced PD rat model. The study utilized the Schizophrenia Research Institute funded beta imager.	Anagnostaras SG, 2003, NAT NEUROSCI, V6, P51, DOI 10.1038/nn992; Andersson DR, 2010, EXP NEUROL, V221, P251, DOI 10.1016/j.expneurol.2009.11.011; Andringa G, 2000, EUR J NEUROSCI, V12, P3033, DOI 10.1046/j.1460-9568.2000.00181.x; Araki T, 2000, J NEURAL TRANSM, V107, P873, DOI 10.1007/s007020070039; Auld DS, 2002, PROG NEUROBIOL, V68, P209, DOI 10.1016/S0301-0082(02)00079-5; Ayer RE, 2013, ACTA NEUROCHIR SUPPL, V115, P259, DOI 10.1007/978-3-7091-1192-5_46; Becker C, 2008, DRUG SAFETY, V31, P399, DOI 10.2165/00002018-200831050-00004; Bymaster FP, 2003, PROG NEURO-PSYCHOPH, V27, P1125, DOI 10.1016/j.pnpbp.2003.09.008; Caviness JN, 2011, CNS NEUROSCI THER, V17, P32, DOI 10.1111/j.1755-5949.2010.00216.x; Da Cunha C, 2002, CELL MOL NEUROBIOL, V22, P227, DOI 10.1023/A:1020736131907; Dean B, 1999, NEUROCHEM INT, V34, P109, DOI 10.1016/S0197-0186(98)00074-6; Digby GJ, 2012, J NEUROSCI, V32, P8532, DOI 10.1523/JNEUROSCI.0337-12.2012; Dolga AM, 2011, EXP NEUROL, V228, P1, DOI 10.1016/j.expneurol.2010.11.013; Doralp S, 2008, NEUROBIOL LEARN MEM, V90, P382, DOI 10.1016/j.nlm.2008.05.013; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; FLYNN DD, 1993, SYNAPSE, V14, P283, DOI 10.1002/syn.890140406; Gao X, 2012, ARCH NEUROL-CHICAGO, V69, P380, DOI 10.1001/archneurol.2011.1060; Gubellini P, 2004, PROG NEUROBIOL, V74, P271, DOI 10.1016/j.pneurobio.2004.09.005; HOWARDJONES N, 1985, WHO CHRON, V39, P51; Hu Y, 2005, BRAIN RES, V1060, P26, DOI 10.1016/j.brainres.2005.08.019; Hu Y, 2010, NEUROBIOL AGING, V31, P1010, DOI 10.1016/j.neurobiolaging.2008.06.008; JOYCE JN, 1991, EXP NEUROL, V113, P277, DOI 10.1016/0014-4886(91)90017-7; JOYCE JN, 1991, EXP NEUROL, V113, P261, DOI 10.1016/0014-4886(91)90016-6; Keener A, 2008, CNS NEUROSCI THER, V14, P287, DOI 10.1111/j.1755-5949.2008.00055.x; Lee YC, 2013, NEUROLOGY, V81, P410, DOI 10.1212/WNL.0b013e31829d873c; Lester DB, 2010, CNS NEUROSCI THER, V16, P137, DOI 10.1111/j.1755-5949.2010.00142.x; Li L, 2006, ANN NEUROL, V60, P729, DOI 10.1002/ana.21053; Li Y, 2010, SYNAPSE, V64, P224, DOI 10.1002/syn.20722; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Muma NA, 2001, EXP NEUROL, V168, P135, DOI 10.1006/exnr.2000.7582; Mutez E, 2009, PHARMACOL RES, V60, P41, DOI 10.1016/j.phrs.2009.03.010; Newell KA, 2007, PROG NEURO-PSYCHOPH, V31, P225, DOI 10.1016/j.pnpbp.2006.07.004; Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687; Pakrasi S, 2007, J NEUROL, V254, P907, DOI 10.1007/s00415-006-0473-8; PAXINOS G, 1997, RAT BRAIN STEREOTAXI; Reiss AB, 2007, DRUGS, V67, P2111, DOI 10.2165/00003495-200767150-00001; Rezvani AH, 2008, NEUROSCIENCE, V154, P885, DOI 10.1016/j.neuroscience.2008.04.020; RodriguezPuertas R, 1997, SYNAPSE, V26, P341, DOI 10.1002/(SICI)1098-2396(199708)26:4<341::AID-SYN2>3.0.CO;2-6; Selley ML, 2005, BRAIN RES, V1037, P1, DOI 10.1016/j.brainres.2004.02.083; Solomon A, 2009, NEUROBIOL AGING, V30, P1006, DOI 10.1016/j.neurobiolaging.2007.09.012; SUGAWARA T, 2011, ACTA NEUROCHIR SUPPL, V2, P9, DOI DOI 10.1007/978-3-7091-0356-2_2; Tayebati SK, 2006, MECH AGEING DEV, V127, P115, DOI 10.1016/j.mad.2005.09.024; Uc EY, 2009, NEUROLOGY, V73, P1469, DOI 10.1212/WNL.0b013e3181bf992f; van der Most PJ, 2009, PROG NEUROBIOL, V88, P64, DOI 10.1016/j.pneurobio.2009.02.002; Wahner AD, 2008, NEUROLOGY, V70, P1418, DOI 10.1212/01.wnl.0000286942.14552.51; Wang G, 2009, CLIN NEUROL NEUROSUR, V111, P523, DOI 10.1016/j.clineuro.2009.02.005; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wang Q, 2008, NEUROSCIENCE, V154, P1100, DOI 10.1016/j.neuroscience.2008.04.026; Wang Q, 2005, BRIT J PHARMACOL, V144, P933, DOI 10.1038/sj.bjp.0706106; Wang Q, 2011, EXP NEUROL, V230, P27, DOI 10.1016/j.expneurol.2010.04.006; Wang Q, 2009, EXP NEUROL, V216, P132, DOI 10.1016/j.expneurol.2008.11.016; Wisman LAB, 2008, J NEUROSCI, V28, P7797, DOI 10.1523/JNEUROSCI.1885-08.2008; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xu YQ, 2013, CNS NEUROSCI THER, V19, P170, DOI 10.1111/cns.12053; Xu YQ, 2012, PROG NEUROBIOL, V97, P1, DOI 10.1016/j.pneurobio.2012.02.002; Yan JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020945; Yang J, 2004, PHARMACOL BIOCHEM BE, V78, P179, DOI 10.1016/j.pbb.2004.03.007; Young Anne B., 1994, P293; Yuan H, 2005, J NEUROSCI METH, V144, P35, DOI 10.1016/j.jneumeth.2004.10.004; Zhang QJ, 2008, BRAIN RES, V1243, P152, DOI 10.1016/j.brainres.2008.09.028	60	12	12	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	MAY 16	2014	267						57	66		10.1016/j.neuroscience.2014.02.031			10	Neurosciences	Neurosciences & Neurology	AF0KM	WOS:000334402700006	24613723				2021-06-18	
J	Cunningham, C; Chen, WC; Shorten, A; McClurkin, M; Choezom, T; Schmidt, CP; Chu, V; Bozik, A; Best, C; Chapman, M; Furman, M; Detyniecki, K; Giacino, JT; Blumenfeld, H				Cunningham, Courtney; Chen, William C.; Shorten, Andrew; McClurkin, Michael; Choezom, Tenzin; Schmidt, Christian P.; Chu, Victoria; Bozik, Anne; Best, Cameron; Chapman, Melissa; Furman, Moran; Detyniecki, Kamil; Giacino, Joseph T.; Blumenfeld, Hal			Impaired consciousness in partial seizures is bimodally distributed	NEUROLOGY			English	Article							TEMPORAL-LOBE EPILEPSY; COMA RECOVERY SCALE; ICTAL CONSCIOUSNESS; VEGETATIVE STATE; CLASSIFICATION; COMPLEX; RESPONSIVENESS; RES	Objective:To investigate whether impaired consciousness in partial seizures can usually be attributed to specific deficits in the content of consciousness or to a more general decrease in the overall level of consciousness.Methods:Prospective testing during partial seizures was performed in patients with epilepsy using the Responsiveness in Epilepsy Scale (n = 83 partial seizures, 30 patients). Results were compared with responsiveness scores in a cohort of patients with severe traumatic brain injury evaluated with the JFK Coma Recovery Scale-Revised (n = 552 test administrations, 184 patients).Results:Standardized testing during partial seizures reveals a bimodal scoring distribution, such that most patients were either fully impaired or relatively spared in their ability to respond on multiple cognitive tests. Seizures with impaired performance on initial test items remained consistently impaired on subsequent items, while other seizures showed spared performance throughout. In the comparison group, we found that scores of patients with brain injury were more evenly distributed across the full range in severity of impairment.Conclusions:Partial seizures can often be cleanly separated into those with vs without overall impaired responsiveness. Results from similar testing in a comparison group of patients with brain injury suggest that the bimodal nature of Responsiveness in Epilepsy Scale scores is not a result of scale bias but may be a finding unique to partial seizures. These findings support a model in which seizures either propagate or do not propagate to key structures that regulate overall arousal and thalamocortical function. Future investigations are needed to relate these behavioral findings to the physiology underlying impaired consciousness in partial seizures.	[Cunningham, Courtney; Chen, William C.; Shorten, Andrew; McClurkin, Michael; Choezom, Tenzin; Schmidt, Christian P.; Chu, Victoria; Bozik, Anne; Best, Cameron; Chapman, Melissa; Furman, Moran; Detyniecki, Kamil; Blumenfeld, Hal] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Blumenfeld, Hal] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Blumenfeld, Hal] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06510 USA; [Giacino, Joseph T.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Boston, MA USA	Blumenfeld, H (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.	hal.blumenfeld@yale.edu	Chapman, Melissa/AAA-8332-2021; Giacino, Joseph/AAF-1952-2021	Chapman, Melissa/0000-0002-1377-1539; Giacino, Joseph/0000-0002-7916-9698; Chen, William/0000-0001-8924-5853	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS055829]; Clinical and Translational Science Award (CTSA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 RR0249139]; National Institute on Disability and Rehabilitation Research (NIDRR) [H133A031713]; Patrick and Catherine Weldon Donaghue Medical Research Foundation; Betsy and Jonathan Blattmachr Family; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055829] Funding Source: NIH RePORTER	Supported by NIH R01 NS055829, Clinical and Translational Science Award (CTSA) UL1 RR0249139, National Institute on Disability and Rehabilitation Research (NIDRR) H133A031713, the Patrick and Catherine Weldon Donaghue Medical Research Foundation, and by the Betsy and Jonathan Blattmachr Family.	Ali F, 2012, EPILEPSY BEHAV, V23, P98, DOI 10.1016/j.yebeh.2011.11.021; Arthuis M, 2009, BRAIN, V132, P2091, DOI 10.1093/brain/awp086; BANCAUD J, 1981, EPILEPSIA, V22, P489, DOI 10.1111/j.1528-1157.1981.tb06159.x; Bauerschmidt A, 2013, EPILEPSY BEHAV, V26, P25, DOI 10.1016/j.yebeh.2012.10.022; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Blume Warren T., 2001, Epilepsia, V42, P1212, DOI 10.1046/j.1528-1157.2001.22001.x; Blumenfeld H, 2004, NEUROLOGY, V63, P1015, DOI 10.1212/01.WNL.0000141086.91077.CD; Blumenfeld H, 2004, CEREB CORTEX, V14, P892, DOI 10.1093/cercor/bhh048; Blumenfeld H, 2013, EPILEPSIA, V54, P1125, DOI 10.1111/epi.12157; Blumenfeld H, 2012, LANCET NEUROL, V11, P814, DOI 10.1016/S1474-4422(12)70188-6; Blumenfeld H, 2011, NEUROL CLIN, V29, P801, DOI 10.1016/j.ncl.2011.07.014; Cavanna AE, 2008, EPILEPSY BEHAV, V13, P184, DOI 10.1016/j.yebeh.2008.01.009; Cavanna AE, 2011, EPILEPSY BEHAV, V22, P651, DOI 10.1016/j.yebeh.2011.10.003; Englot DJ, 2008, J NEUROSCI, V28, P9066, DOI 10.1523/JNEUROSCI.2014-08.2008; Englot DJ, 2010, BRAIN, V133, P3764, DOI 10.1093/brain/awq316; Englot DJ, 2009, J NEUROSCI, V29, P13006, DOI 10.1523/JNEUROSCI.3846-09.2009; ESCUETA AVD, 1982, ANN NEUROL, V11, P292, DOI 10.1002/ana.410110310; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Guye M, 2006, BRAIN, V129, P1917, DOI 10.1093/brain/awl151; Herskovitz M, 2012, J CLIN NEUROSCI, V19, P1605, DOI 10.1016/j.jocn.2012.04.004; Johanson M, 2011, BEHAV NEUROL, V24, P11, DOI [10.1155/2011/874295, 10.3233/BEN-2011-0316]; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Laff R, 2003, NEUROLOGY, V61, P1262, DOI 10.1212/01.WNL.0000090464.03392.9B; Lambert I, 2012, EPILEPSIA, V53, P2104, DOI 10.1111/j.1528-1167.2012.03690.x; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2009, NEUROLOGY OF CONSCIOUSNESS: COGNITIVE NEUROSCIENCE AND NEUROPATHOLOGY, P1; Laureys S, 2009, ANN NEW YORK ACAD SC; Lee KH, 2002, NEUROLOGY, V59, P841, DOI 10.1212/WNL.59.6.841; Lovstad M, 2010, J HEAD TRAUMA REHAB, V25, P349, DOI 10.1097/HTR.0b013e3181cec841; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; McPherson A, 2012, EPILEPSIA, V53, pe180, DOI 10.1111/j.1528-1167.2012.03657.x; Motelow JE, 2012, SOC NEUR ABS; Norden AD, 2002, EPILEPSY BEHAV, V3, P219, DOI 10.1016/S1525-5050(02)00029-X; Plum F, 1982, DIAGNOSIS STUPOR COM; Yang L, 2012, EPILEPSIA, V53, P437, DOI 10.1111/j.1528-1167.2011.03341.x	37	12	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	MAY 13	2014	82	19					1736	1744		10.1212/WNL.0000000000000404			9	Clinical Neurology	Neurosciences & Neurology	AH9XO	WOS:000336499000017	24727311	Green Published			2021-06-18	
J	Kumar, A; Rinwa, P; Dhar, H				Kumar, Anil; Rinwa, Puneet; Dhar, Hitesh			Possible nitric oxide modulation in the protective effects of rutin against experimental head trauma-induced cognitive deficits: behavioral, biochemical, and molecular correlates	JOURNAL OF SURGICAL RESEARCH			English	Article						Apoptosis; Cognitive dysfunction; Head trauma; Neuroinflammation; Nitric oxide	BRAIN-INJURY; OXIDATIVE STRESS; MEMORY IMPAIRMENT; NERVOUS-SYSTEM; IMMATURE RATS; PLUS-MAZE; DAMAGE; MECHANISMS; MODEL; QUERCETIN	Background: Traumatic head injury is turning out to be a major cause of disability and death. Nitric oxide (NO), an intercellular messenger plays a crucial role in the pathophysiology of several neurologic disorders. Therefore, the present study was designed to investigate the effects of rutin, a well-known flavonoid against cognitive deficits and neuroinflammation associated with traumatic head injury and the probable role of NO pathway in this effect. Materials and methods: Wistar rats were exposed to head trauma using weight drop method and kept for a postsurgical rehabilitation period of 2 wk. Later, animals were administered with rutin (20, 40, and 80 mg/kg; per oral) alone and in combination with NO modulators such as NG-nitro-L-arginine methyl ester and L-arginine, daily for another 2 wk. Results: Head injury caused impaired spatial navigation in Morris water maze test and poor retention in elevated plus maze task. Furthermore, there was a significant rise in acetylcholinesterase activity, oxidative stress, neuroinflammation (tumor necrosis factor a), and neuronal apoptosis (caspase-3) in both cortex and hippocampal regions of traumatized rat brain. Rutin significantly attenuated these behavioral, biochemical, and molecular alterations associated with head trauma. Furthermore, pretreatment of NG-nitro-L-arginine methyl ester (10 mg/kg, intraperitoneally), a nonspecific nitric oxide synthase inhibitor, with subeffective dose of rutin (40 mg/kg) potentiated the protective effects; however, pretreatment of L-arginine (100 mg/kg; intraperitoneally), an NO donor, reversed the effects of rutin. Conclusions: The present study suggests that NO modulation could possibly be involved in the neuroprotective effects of rutin against head trauma-induced cognitive deficits, neuroinflammation, and apoptotic signaling cascade. (C) 2014 Elsevier Inc. All rights reserved.	[Kumar, Anil; Rinwa, Puneet; Dhar, Hitesh] Panjab Univ, Div Pharmacol, Univ Inst Pharmaceut Sci, UGC Ctr Adv Study, Chandigarh 160014, India	Kumar, A (corresponding author), Panjab Univ, Pharmacol Res Lab, Univ Inst Pharmaceut Sci, UGC Ctr Adv Study, Chandigarh 160014, India.	kumaruips@rediffmail.com	KUMAR, ANIL -/D-7471-2011	KUMAR, ANIL -/0000-0002-9506-6197	Council of Scientific and Industrial Research (CSIR), New DelhiCouncil of Scientific & Industrial Research (CSIR) - India	The authors gratefully acknowledge the financial support of Council of Scientific and Industrial Research (CSIR), New Delhi for carrying out this work. Authors would like to thank Dr Thirunavukkarasu Angappan, Deputy General Manager, Panacea Biotec Ltd, Lalru for the supply of experimental animals.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; Cahuana GM, 2004, EXP CELL RES, V293, P22, DOI 10.1016/j.yexcr.2003.10.004; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Contestabile A, 2000, BRAIN RES REV, V32, P476, DOI 10.1016/S0165-0173(00)00018-7; Da Cunha IC, 2005, PHYSIOL BEHAV, V84, P351, DOI 10.1016/j.physbeh.2004.12.005; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; GORNALL AG, 1949, J BIOL CHEM, V177, P751; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Gupta R, 2003, PHARMACOL RES, V48, P209, DOI 10.1016/S1043-6618(03)00102-6; Javadi-Paydar M, 2013, BEHAV PHARMACOL, V24, P195, DOI 10.1097/FBP.0b013e3283618a8c; Javed H, 2012, NEUROSCIENCE, V210, P340, DOI 10.1016/j.neuroscience.2012.02.046; Ji XT, 2012, J SURG RES, V178, pE9, DOI 10.1016/j.jss.2011.12.038; Kamalakkannan N, 2006, MOL CELL BIOCHEM, V293, P211, DOI 10.1007/s11010-006-9244-1; Kanbak G, 2013, GENE, V512, P492, DOI 10.1016/j.gene.2012.10.012; Khan MM, 2009, BRAIN RES, V1292, P123, DOI 10.1016/j.brainres.2009.07.026; Kim H, 2005, PHARM RES-DORDR, V22, P1499, DOI 10.1007/s11095-005-6250-z; Koda T, 2009, CELL MOL NEUROBIOL, V29, P523, DOI 10.1007/s10571-008-9344-4; Koppal T, 1999, J NEUROCHEM, V72, P310, DOI 10.1046/j.1471-4159.1999.0720310.x; Kumar A, 2007, J MED FOOD, V10, P486, DOI 10.1089/jmf.2006.076; La Casa C, 2000, J ETHNOPHARMACOL, V71, P45, DOI 10.1016/S0378-8741(99)00174-9; Lenzlinger PM, 2001, J NEUROTRAUM, V18, P479, DOI 10.1089/089771501300227288; Lopez-Revuelta A, 2006, CHEM-BIOL INTERACT, V161, P79, DOI 10.1016/j.cbi.2006.03.004; Luck H., 1971, METHOD ENZYMAT AN, P885; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marzouk MS, 2007, NAT PROD RES, V21, P436, DOI 10.1080/14786410600943288; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Mellou F, 2006, PROCESS BIOCHEM, V41, P2029, DOI 10.1016/j.procbio.2006.05.002; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nassiri-Asl M, 2008, PROG NEURO-PSYCHOPH, V32, P989, DOI 10.1016/j.pnpbp.2008.01.011; Nassiri-Asl M, 2010, PROG NEURO-PSYCHOPH, V34, P204, DOI 10.1016/j.pnpbp.2009.11.006; Ozdemir D, 2012, NEUROSCI LETT, V507, P84, DOI 10.1016/j.neulet.2011.11.059; Pall ML, 2000, MED HYPOTHESES, V54, P115, DOI 10.1054/mehy.1998.0825; Palumbo A, 2000, J BIOL CHEM, V275, P16885, DOI 10.1074/jbc.M909509199; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; Pu FL, 2005, J HEALTH SCI, V51, P636, DOI 10.1248/jhs.51.636; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Scremin OU, 2006, BRAIN RES, V1124, P155, DOI 10.1016/j.brainres.2006.09.062; SHARMA AC, 1992, PROG NEURO-PSYCHOPH, V16, P117, DOI 10.1016/0278-5846(92)90014-6; Sheu JR, 2004, J AGR FOOD CHEM, V52, P4414, DOI 10.1021/jf040059f; Skelton RW, 2000, J CLIN EXP NEUROPSYC, V22, P157, DOI 10.1076/1380-3395(200004)22:2;1-1;FT157; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Uysal N, 2013, TURK NEUROSURG, V23, P129, DOI 10.5137/1019-5149.JTN.5582-11.1; Virarkar M, 2013, CRIT REV FOOD SCI, V53, P1157, DOI 10.1080/10408398.2011.573885; WILLS ED, 1966, BIOCHEM J, V99, P667, DOI 10.1042/bj0990667; Yamada K, 1996, NEUROSCIENCE, V74, P365, DOI 10.1016/0306-4522(96)00161-3; Yang YC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/980276; ZHANG J, 1995, ANNU REV PHARMACOL, V35, P213; Zhou L, 2009, NITRIC OXIDE-BIOL CH, V20, P223, DOI 10.1016/j.niox.2009.03.001	57	12	12	0	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	MAY	2014	188	1					268	279		10.1016/j.jss.2013.12.028			12	Surgery	Surgery	AE4RS	WOS:000333971300034	24484907				2021-06-18	
J	Pajoohesh-Ganji, A; Burns, MP; Pal-Ghosh, S; Tadvalkar, G; Hokenbury, NG; Stepp, MA; Faden, AI				Pajoohesh-Ganji, Ahdeah; Burns, Mark P.; Pal-Ghosh, Sonali; Tadvalkar, Gauri; Hokenbury, Nicole G.; Stepp, Mary Ann; Faden, Alan I.			Inhibition of amyloid precursor protein secretases reduces recovery after spinal cord injury	BRAIN RESEARCH			English	Article						Spinal cord injury; Amyloid precursor protein; gamma-Secretase; Bace1; Amyloid-beta	TRANSGENIC MOUSE MODEL; LONG-TERM ACCUMULATION; ALZHEIMERS-DISEASE; BETA-SECRETASE; BRAIN TRAUMA; A-BETA; INFLAMMATORY RESPONSES; BACE1; AXONS; EXPRESSION	Amyloid-beta (A beta) is produced through the enzymatic cleavage of amyloid precursor protein (APP) by beta (Bace1) and gamma-secretases. The accumulation and aggregation of A beta as amyloid plaques is the hallmark pathology of Alzheimer's disease and has been found in other neurological disorders, such as traumatic brain injury and multiple sclerosis. Although the role of A beta after injury is not well understood, several studies have reported a negative correlation between A beta formation and functional outcome. In this study we show that levels of APP, the enzymes cleaving APP (Bace1 and gamma-secretase), and A beta are significantly increased from 1 to 3 days after impact spinal cord injury (SCI) in mice. To determine the role of All after SCI, we reduced or inhibited A beta in vivo through pharmacological (using DAFT) or genetic (Bace1 knockout mice) approaches. We found that these interventions significantly impaired functional recovery as evaluated by white matter sparing and behavioral testing. These data are consistent with a beneficial role for A beta after SCI. (C) 2014 Elsevier B.V. All rights reserved.	[Pajoohesh-Ganji, Ahdeah; Pal-Ghosh, Sonali; Tadvalkar, Gauri; Hokenbury, Nicole G.; Stepp, Mary Ann] George Washington Univ, Washington, DC 20037 USA; [Burns, Mark P.; Hokenbury, Nicole G.] Georgetown Univ, Washington, DC USA; [Hokenbury, Nicole G.; Faden, Alan I.] Univ Maryland, Baltimore, MD 21201 USA	Pajoohesh-Ganji, A (corresponding author), George Washington Univ, Dept Anat & Regenerat Biol, Ross Hall,Room 226C,2300 1 St NW, Washington, DC 20037 USA.	andeah@gwu.edu	Stepp, Mary Ann/ABF-2702-2020	Burns, Mark P/0000-0003-4750-2000; Faden, Alan I./0000-0003-0128-2348; Stepp, Mary Ann/0000-0001-5623-2538; Pajoohesh-Ganji, Ahdeah/0000-0002-1542-029X	Paralyzed Veterans of America [PVA2685]; NIH SIG [F10 RR025565]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR025565] Funding Source: NIH RePORTER	We would like to thank the valuable technical assistance of Qing Shu and Dr. Anastas Popratiloff, Director of GWU Center for Microscopy and Image Analysis. Also, we would like to thank Dr. Samuel Simmens and Gill Brooks from the Department of Epidemiology and Biostatistics for their valuable advice with statistical analysis. This work was supported by Paralyzed Veterans of America (PVA2685) and NIH SIG Grants (F10 RR025565).	Ahlgren S, 1996, ACTA NEUROPATHOL, V92, P49, DOI 10.1007/s004010050488; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Batchelor PE, 2008, J NEUROTRAUM, V25, P1217, DOI 10.1089/neu.2007.0308; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Brosnan CF, 2009, J CLIN INVEST, V119, P10, DOI 10.1172/JCI37786; Bryson JB, 2012, HUM MOL GENET, V21, P3871, DOI 10.1093/hmg/dds215; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Choo AM, 2008, EXP NEUROL, V212, P490, DOI 10.1016/j.expneurol.2008.04.038; Cornish R, 2000, SPINE, V25, P1227, DOI 10.1097/00007632-200005150-00005; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; De Strooper B, 1999, NATURE, V402, P471, DOI 10.1038/44973; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Donnelly DJ, 2009, J NEUROSCI METH, V181, P36, DOI 10.1016/j.jneumeth.2009.04.010; Farah MH, 2011, J NEUROSCI, V31, P5744, DOI 10.1523/JNEUROSCI.6810-10.2011; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; GEHRMANN J, 1995, GLIA, V15, P141, DOI 10.1002/glia.440150206; Grant JL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004145; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Hu XY, 2008, FASEB J, V22, P2970, DOI 10.1096/fj.08-106666; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Hu XY, 2013, FASEB J, V27, P1868, DOI 10.1096/fj.12-224212; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Iwata A, 2002, J NEUROPATH EXP NEUR, V61, P1056, DOI 10.1093/jnen/61.12.1056; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kobayashi S, 2010, NEUROCHEM INT, V56, P387, DOI 10.1016/j.neuint.2009.11.005; LI GL, 1995, J NEUROTRAUM, V12, P269, DOI 10.1089/neu.1995.12.269; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Lu JK, 2000, SPINE, V25, P1859, DOI 10.1097/00007632-200007150-00022; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Mannix Rebekah C, 2012, Int J Alzheimers Dis, V2012, P608732, DOI 10.1155/2012/608732; Mannix RC, 2011, J NEUROTRAUM, V28, P1855, DOI 10.1089/neu.2011.1759; Matsuoka Y, 2001, AM J PATHOL, V158, P1345, DOI 10.1016/S0002-9440(10)64085-0; Nadler Y, 2008, GLIA, V56, P552, DOI 10.1002/glia.20638; Pajoohesh-Ganji A, 2012, BRAIN RES, V1475, P96, DOI 10.1016/j.brainres.2012.07.058; Pajoohesh-Ganji A, 2011, NEUROTHERAPEUTICS, V8, P195, DOI 10.1007/s13311-011-0036-2; Pajoohesh-Ganji A, 2010, NEUROSCI RES, V67, P117, DOI 10.1016/j.neures.2010.02.009; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Saeidi H., 2013, Journal of Isfahan Medical School, V30, P1942; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Schnell L, 1999, J NEUROPATH EXP NEUR, V58, P245, DOI 10.1097/00005072-199903000-00004; Selkoe DJ, 2004, ANN INTERN MED, V140, P627, DOI 10.7326/0003-4819-140-8-200404200-00047; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Velanac V, 2012, GLIA, V60, P203, DOI 10.1002/glia.21255; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8	52	12	12	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	APR 29	2014	1560						73	82		10.1016/j.brainres.2014.02.049			10	Neurosciences	Neurosciences & Neurology	AH1IV	WOS:000335874700008	24630972	Green Accepted			2021-06-18	
J	Kurinsky, RM; Rochette, LM; Smith, GA				Kurinsky, Rachel M.; Rochette, Lynne M.; Smith, Gary A.			Pediatric Injuries Associated With High Chairs and Chairs in the United States, 2003-2010	CLINICAL PEDIATRICS			English	Article						injury; high chair; booster seat; chair; fall; child; infant		This study describes the epidemiology of injuries among children 3 years old associated with high chairs compared with chairs by retrospectively analyzing data from the National Electronic Injury Surveillance System from 2003 to 2010. An estimated 402 479 (95% confidence interval = 335 116-469 842) injuries associated with high chairs and chairs were treated in United States emergency departments, with an average of 9421 high chair-related injuries and 40 889 chair-related injuries annually. The number of high chair-related injuries significantly increased by 22.4% from 8926 injuries in 2003 to 10 930 injuries in 2010. Falling was the most common injury mechanism associated with high chairs (92.8%) and chairs (87.3%). Closed head injury was the most common diagnosis associated with high chairs (37.3%), and increased in number (P = .005) and rate (P = .006) from 2003 to 2010. Child caregivers should properly engage high chair safety restraint systems and encourage appropriate behaviors by young children when using chairs.	[Kurinsky, Rachel M.; Rochette, Lynne M.; Smith, Gary A.] Nationwide Childrens Hosp, Res Inst, Columbus, OH 43205 USA; [Kurinsky, Rachel M.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Rochette, Lynne M.] US Army Res Inst Behav & Social Sci, Ft Belvoir, VA USA; [Smith, Gary A.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Smith, Gary A.] Child Injury Prevent Alliance, Columbus, OH USA	Smith, GA (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	gary.smith@nationwidechildrens.org			National Medical Student Injury Research Training Program of the Center for Injury Research and Policy; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [1R49CE001172]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001172] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: A student research scholarship was provided by the National Medical Student Injury Research Training Program of the Center for Injury Research and Policy and funded by the Centers for Disease Control and Prevention (grant# 1R49CE001172) to RMK while she worked on this study.	American Society for Testing and Materials International, 2010, F264010 ASTM INT; American Society for Testing and Materials International, 2010, F40410 ASTM INT; Drago DA, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.5.e59; Mayr JM, 1999, ACTA PAEDIATR, V88, P319, DOI 10.1080/08035259950170105; Ozanne-Smith J, 12 MON U ACC RES CTR; Powell EC, 2002, AMBUL PEDIATR, V2, P276, DOI 10.1367/1539-4409(2002)002<0276:IADOHC>2.0.CO;2; Schalamon J, 2006, EUR J PEDIATR, V165, P732, DOI 10.1007/s00431-006-0130-3; Souheil M, 2011, J FORENSIC SCI, V56, P534, DOI 10.1111/j.1556-4029.2010.01656.x; Watson W, 1998, VICTORIAN INJURY SUR, V37, P1; WATSON WL, 1993, J PAEDIATR CHILD H, V29, P228, DOI 10.1111/j.1440-1754.1993.tb00493.x	10	12	13	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	APR	2014	53	4					372	379		10.1177/0009922813510599			8	Pediatrics	Pediatrics	AC0SU	WOS:000332205900011	24322954				2021-06-18	
J	Matsui, T; Yoshida, Y; Yanagihara, M; Suenaga, H				Matsui, Tomohiro; Yoshida, Yusuke; Yanagihara, Masashi; Suenaga, Hiromi			Hypothermia at 35 A degrees C Reduces the Time-Dependent Microglial Production of Pro-inflammatory and Anti-inflammatory Factors that Mediate Neuronal Cell Death	NEUROCRITICAL CARE			English	Article						Microglia; Hypothermia at 35 degrees C; Tumor necrosis factor-alpha; Interleukin-10; Neuronal cell death; Nitric oxide; Temporal change; Optimum temperature; PC12 cells	TRAUMATIC BRAIN-INJURY; HOSPITAL CARDIAC-ARREST; MODERATE HYPOTHERMIA; NITRIC-OXIDE; THERAPEUTIC HYPOTHERMIA; INTRACRANIAL-PRESSURE; CEREBROSPINAL-FLUID; HEAD-INJURY; INTERLEUKIN-10; TEMPERATURE	Therapeutic hypothermia protects neurons after severe brain damage. This effect has been mainly achieved at the core temperatures of 32-34 A degrees C; however, the optimum temperature of therapeutic hypothermia is not fully defined. Here we studied whether hypothermic culture at 35 A degrees C had the same effects on the decrease of time-dependent expression of tumor necrosis factor (TNF)-alpha, interleukin (IL)-10, and nitric oxide (NO) by stimuli-activated microglia as that at 33 A degrees C, as determined in our previous reports, and whether these factors directly induced neuronal cell death. We determined the levels of cytokines and NO produced by microglia cultured with adenosine triphosphate (ATP), a toll-like receptor (TLR)2 agonist (N-palmitoyl-S-(2,3-bis(palmitoyloxy)-(2R,S)-propyl)-(R)-cysteinyl-seryl-(lysyl)3-lysine, Pam(3)CSK(4)), or a TLR4 agonist (lipopolysaccharide) under mild hypothermic (33 A degrees C), minimal hypothermic (35 A degrees C), and normothermic (37 A degrees C) conditions. We also determined the viability of rat neuronal pheochromocytoma PC12 cells treated with recombinant TNF-alpha or IL-10 or (+/-)-(E)-4-ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexenamide (NOR3, an NO donor). Production of TNF-alpha, as well as that of IL-10 and NO were decreased by minimal hypothermia at 1.5-6, and 24-48 h, respectively, compared with normothermia, although some effects were diminished as compared with those by mild hypothermia. Exposure to TNF-alpha, IL-10, and NOR3 caused the death of PC12 cells in a concentration-dependent manner after 24 h. Hypothermic culture at 35 A degrees C decreased the production of early-phase TNF-alpha and late-phase IL-10 and NO from ATP- and TLR-activated microglia as observed at 33 A degrees C, albeit with diminished effects. Moreover, these factors caused the death of neuronal cells in a concentration-dependent manner. These results suggest that the attenuation of microglial production of TNF-alpha, IL-10, and NO by therapeutic hypothermia leads to the inhibition of neuronal cell death. Minimal hypothermia at 35 A degrees C may be sufficient to elicit neuroprotective effect.	[Matsui, Tomohiro; Yanagihara, Masashi; Suenaga, Hiromi] Yamaguchi Univ, Dept Lab Sci, Grad Sch Med, Ube, Yamaguchi 7558505, Japan; [Yoshida, Yusuke] ACEL Inc, Dept Res & Dev, Midori Ku, Sagamihara, Kanagawa 2520131, Japan	Matsui, T (corresponding author), Yamaguchi Univ, Dept Lab Sci, Grad Sch Med, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	giants@yamaguchi-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [22791435]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [25462403] Funding Source: KAKEN	This research was supported in part by Grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant-in-Aid for Young Scientists (B), No. 22791435 to T. M.	Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; Blanco M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030700; BUSTO R, 1989, NEUROSCI LETT, V101, P299, DOI 10.1016/0304-3940(89)90549-1; Ceulemans AG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-60; CHADD MA, 1972, ARCH DIS CHILD, V47, P819, DOI 10.1136/adc.47.255.819; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dedoni S, 2010, J NEUROCHEM, V115, P1421, DOI 10.1111/j.1471-4159.2010.07046.x; DIETRICH WD, 1990, STROKE, V21, P1318, DOI 10.1161/01.STR.21.9.1318; Gal R, 2009, BRATISL MED J, V110, P222; Gibbons H, 2003, MOL BRAIN RES, V110, P63, DOI 10.1016/S0169-328X(02)00585-5; Gunn AJ, 2000, CURR OPIN PEDIATR, V12, P111, DOI 10.1097/00008480-200004000-00004; Holzer M, 2002, NEW ENGL J MED, V346, P549; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kline AE, 2002, BRAIN RES, V937, P22, DOI 10.1016/S0006-8993(02)02458-7; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lehnardt S, 2007, J NEUROIMMUNOL, V190, P28, DOI 10.1016/j.jneuroim.2007.07.023; Logue ES, 2007, ACAD EMERG MED, V14, P293, DOI 10.1197/j.aem.2006.10.097; Loidl CF, 1998, BRAIN RES, V791, P303, DOI 10.1016/S0006-8993(98)00195-4; Maekawa S, 2002, CRIT CARE MED, V30, P2700, DOI 10.1097/00003246-200212000-00014; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Matsui T, 2008, J NEUROTRAUM, V25, P709, DOI 10.1089/neu.2007.0482; Matsui T, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/436263; Matsui T, 2012, NEUROCRIT CARE, V17, P293, DOI 10.1007/s12028-011-9639-z; Matsui T, 2012, INTENS CARE MED, V38, P1392, DOI 10.1007/s00134-012-2591-3; MINAMISAWA H, 1990, ANN NEUROL, V28, P26, DOI 10.1002/ana.410280107; Minghetti L, 1998, PROG NEUROBIOL, V54, P99, DOI 10.1016/S0301-0082(97)00052-X; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; PALMER AM, 1993, J NEUROTRAUM, V10, P363, DOI 10.1089/neu.1993.10.363; Pappas TC, 2003, AGING CELL, V2, P83, DOI 10.1046/j.1474-9728.2003.00039.x; SCHUBERT A, 1995, J NEUROSURG ANESTH, V7, P139, DOI 10.1097/00008506-199504000-00021; Si QS, 1997, NEUROSCIENCE, V81, P223, DOI 10.1016/S0306-4522(97)00172-3; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Tokutomi T, 2009, J TRAUMA, V66, P166, DOI 10.1097/TA.0b013e318157dbec; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Yamaguchi S, 2000, NEUROL RES, V22, P657; Yamamoto T, 2000, EUR J PHARMACOL, V397, P25, DOI 10.1016/S0014-2999(00)00244-2; Zhou ZG, 2009, J NEUROCHEM, V110, P1617, DOI 10.1111/j.1471-4159.2009.06263.x	47	12	13	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2014	20	2					301	310		10.1007/s12028-013-9911-5			10	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	AD0XA	WOS:000332956400018	24072458				2021-06-18	
J	Meltzer, CC; Sze, G; Rommelfanger, KS; Kinlaw, K; Banja, JD; Wolpe, PR				Meltzer, C. C.; Sze, G.; Rommelfanger, K. S.; Kinlaw, K.; Banja, J. D.; Wolpe, P. R.			Guidelines for the Ethical Use of Neuroimages in Medical Testimony: Report of a Multidisciplinary Consensus Conference	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; EXPERT WITNESS; INCIDENTAL FINDINGS; LITIGATION; DISORDER; QUALIFICATIONS; FAVORITISM; PHYSICIANS; TRUTH; FMRI	With rapid advances in neuroimaging technology, there is growing concern over potential misuse of neuroradiologic imaging data in legal matters. On December 7 and 8, 2012, a multidisciplinary consensus conference, Use and Abuse of Neuroimaging in the Courtroom, was held at Emory University in Atlanta, Georgia. Through this interactive forum, a highly select group of experts-including neuroradiologists, neurologists, forensic psychiatrists, neuropsychologists, neuroscientists, legal scholars, imaging statisticians, judges, practicing attorneys, and neuroethicists-discussed the complex issues involved in the use of neuroimaging data entered into legal evidence and for associated expert testimony. The specific contexts of criminal cases, child abuse, and head trauma were especially considered. The purpose of the conference was to inform the development of guidelines on expert testimony for the American Society of Neuroradiology and to provide principles for courts on the ethical use of neuroimaging data as evidence. This report summarizes the conference and resulting recommendations.	[Meltzer, C. C.] Emory Univ, Dept Radiol & Imaging Sci, Atlanta, GA USA; [Meltzer, C. C.; Rommelfanger, K. S.] Emory Univ, Dept Neurol, Atlanta, GA USA; [Meltzer, C. C.; Wolpe, P. R.] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA USA; [Banja, J. D.] Emory Univ, Dept Rehabil Med, Atlanta, GA USA; [Kinlaw, K.; Wolpe, P. R.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Wolpe, P. R.] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Wolpe, P. R.] Emory Univ, Dept Sociol, Atlanta, GA USA; [Sze, G.] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA	Meltzer, CC (corresponding author), Emory Univ, Sch Med, Emory Univ Hosp, D-112,1364 Clifton Rd NE, Atlanta, GA 30322 USA.	cmeltze@emory.edu			American Society of Neuroradiology; American College of Radiology; Emory Neuroscience Initiative; Emory Center for Ethics; Atlanta Clinical and Translational Institute; ASNR; Atlanta Clinical and Translational Science Institute [NIH U54 UL1RR02500]; Emory University Neuroscience Initiative; Atlanta Clinical and Translational Science Institute; National Center for Advancing Translational Science (of the National Institutes of Health)	Carolyn C. Meltzer-RELATED: Grant: American Society of Neuroradiology,* UNRELATED: Board Membership: Image Matrix of the American College of Radiology,* General Electric-Association of University Radiologists Award Board,* Association of University Radiologists,* ASNR executive committee,* Comments: travel reimbursement only; Consultancy: Thomas Jefferson University, University of Arizona, Comments: review of radiology department. Gordon Sze-RELATED: Support for Travel to Meetings for the Study or Other Purposes: ASNR, American College of Radiology, Emory Neuroscience Initiative, Emory Center for Ethics, Atlanta Clinical and Translational Institute, Comments: Plane flights and ground transportation were provided to all participants outside of Atlanta to attend the symposium, UNRELATED: Board Membership: Guerbet Advisory Board, Expert Testimony: scattered law firms, Grants/Grants Pending: National Institutes of Health,* Remedy Pharmaceuticals,* Travel/Accommodations/Meeting Expenses Unrelated to Activities Listed: ASNR. Kathy Kinlaw-RELATED: Grant: Support for the conference was provided by the ASNR, the Atlanta Clinical and Translational Science Institute (NIH U54 UL1RR02500), and the Emory University Neuroscience Initiative. This support was for the consensus conference overall, not to support my direct participation in the project or writing. John D. Banja-RELATED: Grant: ASNR,* Atlanta Clinical and Translational Science Institute,* American College of Radiology,* Comments: These entities supported a consensus conference from which the article was derived; UNRELATED: Board Membership: American Society of Cataract and Refractive Surgery, Comments: I amthe public member of the governing board. That affiliation has nothing to do, however, with issues in forensic neuroradiology, Other: Atlanta Clinical and Translational Science Institute,* Comments: I direct the ethics program of the Atlanta Clinical and Translational Science Institute, which is made possible by a grant from the National Center for Advancing Translational Science (of the National Institutes of Health). This speaks to the (dual) use of translational technologies. However, I do not see how that role would suggest a "conflict" bearing on this article. Paul R. Wolpe-RELATED: GRANT: ASNR,* Comments: They helped fund the consensus conference on which the article was based. * Money paid to the institution.	Anderson JS, 2011, AM J NEURORADIOL, V32, P548, DOI 10.3174/ajnr.A2330; [Anonymous], 1996, J NUCL MED, V37, P1256; [Anonymous], 2009, SCIENCEINSIDER; [Anonymous], 2002, PEDIATRICS, V109, P974; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Barnes Patrick D, 2002, Top Magn Reson Imaging, V13, P85, DOI 10.1097/00002142-200204000-00004; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Berlin L, 2000, AM J ROENTGENOL, V174, P1215, DOI 10.2214/ajr.174.5.1741215; Berlin Leonard, 2006, J Am Coll Radiol, V3, P252, DOI 10.1016/j.jacr.2005.12.013; Brown T, 2010, STANFORD LAW REV, V62, P1119; BRUCE DA, 1989, PEDIATR ANN, V18, P482, DOI 10.3928/0090-4481-19890801-07; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Feigl GC, 2013, WORLD NEUROSURG; Feld AD, 2005, AM J GASTROENTEROL, V100, P991, DOI 10.1111/j.1572-0241.2005.50180.x; Field A, 2012, ASFNR GUIDELINES CLI, P5; Findley KA, 2012, HOUSTON J HLTH POLIC; Ganis G, 2011, NEUROIMAGE, V55, P312, DOI 10.1016/j.neuroimage.2010.11.025; Hugh TB, 2009, J LAW MED, V16, P846; Janower Murray L, 2005, J Am Coll Radiol, V2, P424, DOI 10.1016/j.jacr.2004.09.003; Johnson SB, 2009, J ADOLESCENT HEALTH, V45, P216, DOI 10.1016/j.jadohealth.2009.05.016; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Jukuri T, 2013, SCHIZOPHR RES, V143, P239, DOI 10.1016/j.schres.2012.11.020; Karim AA, 2010, CEREB CORTEX, V20, P205, DOI 10.1093/cercor/bhp090; Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001/jama.282.1.36; Kesselheim AS, 2006, OBSTET GYNECOL, V108, P273, DOI 10.1097/01.AOG.0000225969.08432.75; Konrad KA, 2012, J THEOR BIOL, V306, P61, DOI 10.1016/j.jtbi.2012.04.013; Korgaonkar MS, 2013, NEUROPSYCHOPHARMACOL, V38, P863, DOI 10.1038/npp.2012.252; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kulich R, 2009, PAIN MED, V10, P373, DOI 10.1111/j.1526-4637.2009.00567.x; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lindberg DM, 2008, PEDIATRICS, V121, pE945, DOI 10.1542/peds.2007-2485; Maggiore WA, 2011, PREHOSP EMERG CARE, V15, P426, DOI 10.3109/10903127.2011.561413; McCabe DP, 2008, COGNITION, V107, P343, DOI 10.1016/j.cognition.2007.07.017; Mohamed FB, 2006, RADIOLOGY, V238, P679, DOI 10.1148/radiol.2382050237; Moriarty JC, 2008, BEHAV SCI LAW, V26, P29, DOI 10.1002/bsl.795; Morse S.J., 2006, OHIO STATE J CRIMINA, V3, P397; Morse SJ, 2011, FUTURE EVIDENCE SCI, P137; Nakamura M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-213; Sato JR, 2012, J PSYCHIATR RES, V46, P1126, DOI 10.1016/j.jpsychires.2012.05.008; Shore S, 1971, Med Trial Tech Q, V18, P121; Sieswerda-Hoogendoorn T, 2012, EUR J PEDIATR, V171, P617, DOI 10.1007/s00431-011-1611-6; Snead OC, 2007, NEW YORK U LAW REV, V82, P1265; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Vohs KD, 2006, SCIENCE, V314, P1154, DOI 10.1126/science.1132491; Weisberg DS, 2008, J COGNITIVE NEUROSCI, V20, P470, DOI 10.1162/jocn.2008.20.3.470; White Tonya, 2008, Top Magn Reson Imaging, V19, P97, DOI 10.1097/RMR.0b013e3181809f1e; Williams MA, 2006, NEUROLOGY, V66, P13, DOI 10.1212/01.wnl.0000190568.69950.11; Woodward ND, 2012, AM J PSYCHIAT, V169, P1092, DOI 10.1176/appi.ajp.2012.12010056	49	12	12	0	9	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	APR	2014	35	4					632	637		10.3174/ajnr.A3711			6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AG3TP	WOS:000335343000005	23988754	Other Gold, Green Published			2021-06-18	
J	Moore, M; Winkelman, A; Kwong, S; Segal, SP; Manley, GT; Shumway, M				Moore, Megan; Winkelman, Amy; Kwong, Sharon; Segal, Steven P.; Manley, Geoffrey T.; Shumway, Martha			The emergency department social work intervention for mild traumatic brain injury (SWIFT-Acute): A pilot study	BRAIN INJURY			English	Article						Brain injury; implementation; intervention study; treatment outcome	HEAD-INJURY; RANDOMIZED-TRIAL; RISK-FACTORS; SYMPTOMS; RECOMMENDATIONS; MANAGEMENT	Objective: To determine acceptability and preliminary effectiveness of Emergency Department (ED) Social Work Intervention for Mild Traumatic Brain Injury (SWIFT-Acute) on alcohol use, community functioning, depression, anxiety, post-concussive symptoms, post-traumatic stress disorder and service use. Methods: This study enrolled 64 patients who received head CT after mild traumatic brain injury (mTBI) and were discharged <24 hours from a Level 1 trauma centre ED. The cohort study compared outcomes for SWIFT-Acute (n = 32) and Usual Care (n = 32) 3 months post-injury. SWIFT-Acute includes education about symptoms and decreasing alcohol use, coping strategies, reassurance and education about recovery process and follow-up guidelines and resources. Measures: Alcohol Use Disorders Identification Test (AUDIT), Community Integration Questionnaire (CIQ), Patient Health Questionnaire-4, Rivermead Post-concussion Symptoms Questionnaire, PTSD Checklist-Civilian, acceptability and service use surveys. Results: Paired t-test revealed SWIFT-Acute group maintained pre-injury community functioning; Usual Care significantly declined in functioning on the CIQ. Both groups reported 'hazardous' pre-injury drinking on AUDIT. Wilcoxon Signed Rank test showed the SWIFT-Acute group significantly reduced alcohol use; the Usual Care group did not. Both groups significantly increased medical service use. No statistically significant differences were found on other measures. Acceptability ratings were extremely high. Conclusions: SWIFT-Acute was acceptable to patients. There is preliminary evidence of effectiveness for reducing alcohol use and preventing functional decline. Future randomized studies are needed.	[Moore, Megan] Univ Washington, Sch Social Work, Seattle, WA 98195 USA; [Winkelman, Amy; Manley, Geoffrey T.] Univ Calif San Francisco, Brain & Spinal Cord Injury Ctr, San Francisco, CA 94143 USA; [Winkelman, Amy; Manley, Geoffrey T.] San Francisco Gen Hosp & Trauma Ctr, Dept Neurosurg, San Francisco, CA USA; [Kwong, Sharon] San Francisco Gen Hosp & Trauma Ctr, Dept Social Serv 4, San Francisco, CA USA; [Segal, Steven P.] Univ Calif Berkeley, Sch Social Welf, Berkeley, CA 94720 USA; [Shumway, Martha] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA	Moore, M (corresponding author), Univ Washington, Sch Social Work, 4101 15th Ave NE,Box 354900, Seattle, WA 98195 USA.	mm99@uw.edu	Segal, Steven/AAY-6932-2020	Segal, Steven/0000-0001-6204-6950	San Francisco Hearts and Heroes Foundation	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. The production of the patient educational materials was supported by a grant from the San Francisco Hearts and Heroes Foundation.	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI 10.1089/neu.2008-0849; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, TRAUM BRAIN INJ CONC; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Corrigan JD, 2008, JAMA-J AM MED ASSOC, V300, P720, DOI 10.1001/jama.300.6.720; Dijkers M, 2000, COMMUNITY INTEGRATIO; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Gronwall D, 1986, J HEAD TRAUMA REHAB, V1, P53, DOI DOI 10.1097/00001199-198606000-00009; Hinkle J L, 1986, J Neurosci Nurs, V18, P268; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P74, DOI DOI 10.1097/00001199-199309000-00009; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Moore M, 2012, SOC WORK HEALTH CARE, V51, P140, DOI 10.1080/00981389.2011.610872; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Paniak C, 2000, BRAIN INJURY, V14, P219; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Ruff RM, 2009, PSYCHOL INJ LAW, V2, P34, DOI 10.1007/s12207-009-9029-4; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Soo C, 2007, COCHRANE DB SYST REV, V3; Stranjalis G, 2008, J TRAUMA, V65, P789, DOI 10.1097/TA.0b013e3181469e26; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Weathers F.W., 1993, 9 ANN C ISTSS SAN AN; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI DOI 10.1097/00001199-199308020-00009; Wilson R, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-68; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	47	12	13	0	22	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2014	28	4					448	455		10.3109/02699052.2014.890746			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AF5GL	WOS:000334741900008	24702522				2021-06-18	
J	Oyetunji, TA; Haider, AH; Obirieze, AC; Fisher, M; Cornwell, EE; Qureshi, FG; Abdullah, F; Nwomeh, BC				Oyetunji, Tolulope A.; Haider, Adil H.; Obirieze, Augustine C.; Fisher, Michael; Cornwell, Edward E., III; Qureshi, Faisal G.; Abdullah, Fizan; Nwomeh, Benedict C.			Epidemiology of 577 Pediatric Firearm Fatalities: A 2-year Review of the National Trauma Data Bank	AMERICAN SURGEON			English	Article; Proceedings Paper	43rd Annual Meeting of the American-Pediatric-Surgical-Association (APSA)	MAY 20-23, 2012	San Antonio, TX	Amer Pediat Surg Assoc			INJURY-RELATED MORTALITY; TEACHING SAFETY SKILLS; AFRICAN-AMERICAN MEN; PREVENT GUN PLAY; STORAGE PRACTICES; CHILDREN; ASSOCIATION; CARE; ADOLESCENTS; OWNERSHIP	The purpose of this study was to delineate the epidemiology of pediatric firearm injuries, including ethno-demographic patterns with impact on years of potential life lost (YPLL). A 2-year review of the National Trauma Data Bank (2007 to 2008) was conducted. Firearm fatalities in records of patients younger than 18 years were identified. Data were analyzed by demographic and injury characteristics and YPLL was calculated by ethnicity. A total of 577 deaths were identified in the pediatric group. Blacks accounted for 49.7 per cent of the fatalities; Hispanics, 19.2 per cent; whites, 17.7 per cent, and other ethnicity, 13.4 per cent. Median Injury Severity Score was 25 with a median Glasgow Coma Scale score of 3. Traumatic brain injury was present in 84.2 per cent of the records. Assault accounted for 72.8 per cent, self-inflicted injury 12.7 per cent, and unintentional injuries were 8.2 per cent. Most firearm fatalities occurred at home (33.6%). By emergency department (ED) disposition, 29.3 per cent died in the ED, 32.9 per cent were admitted to the intensive care unit, and 30.0 per cent taken to the operating room. Blacks had a total of 17,446 YPLL, Hispanics 6,776 YPLL, and whites 6,718 YPLL. Pediatric firearm fatalities still remain an important public health concern. Inclusive gun control policies focused on primary prevention of accidental injuries may be more effective in mitigating its impact.	[Oyetunji, Tolulope A.; Obirieze, Augustine C.; Fisher, Michael; Cornwell, Edward E., III] Howard Univ, Coll Med, Dept Surg, Washington, DC 20060 USA; [Haider, Adil H.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Abdullah, Fizan] Johns Hopkins Univ, Sch Med, Div Pediat Surg, Baltimore, MD 21205 USA; [Qureshi, Faisal G.] Childrens Natl Med Ctr, Dept Gen & Thorac Surg, Washington, DC 20010 USA; [Nwomeh, Benedict C.] Ohio State Univ, Coll Med, Div Pediat Surg, Columbus, OH 43210 USA	Oyetunji, TA (corresponding author), Howard Univ, Coll Med, Dept Surg, 2041 Georgia Ave NW, Washington, DC 20060 USA.	toyetunji@howard.edu	Nwomeh, Benedict/E-3771-2011	Nwomeh, Benedict/0000-0001-6665-2077; Oyetunji, Tolulope/0000-0003-3039-7195			Baxley F, 2006, ARCH PEDIAT ADOL MED, V160, P542, DOI 10.1001/archpedi.160.5.542; BEAVER BL, 1990, J PEDIATR SURG, V25, P97, DOI 10.1016/S0022-3468(05)80171-X; Bryant WW, 2011, J BLACK STUD, V42, P690, DOI 10.1177/0021934710393243; CHRISTOFFEL KK, 1991, PEDIATRICS, V88, P294; Connor SM, 2005, PEDIATRICS, V115, pE38, DOI 10.1542/peds.2004-1105; Coyne-Beasley T, 2002, ARCH PEDIAT ADOL MED, V156, P763, DOI 10.1001/archpedi.156.8.763; Coyne-Beasley T, 2001, ARCH PEDIAT ADOL MED, V155, P659, DOI 10.1001/archpedi.155.6.659; Cummings P, 1997, JAMA-J AM MED ASSOC, V278, P1084, DOI 10.1001/jama.278.13.1084; Darras Kyle M, 2002, Adv Nurse Pract, V10, P51; Earls F, 1991, J Health Care Poor Underserved, V2, P156; Earls F., 1991, J HEALTH CARE POOR U, V2, P165; Everett SA, 1997, J COMMUN HEALTH, V22, P313, DOI 10.1023/A:1025172903135; Farah MM, 1999, PEDIATRICS, V104, P1059, DOI 10.1542/peds.104.5.1059; Freed LH, 1998, PEDIATR CLIN N AM, V45, P427, DOI 10.1016/S0031-3955(05)70017-1; Garbarino J, 2002, FUTURE CHILD, V12, P73; Gatheridge BJ, 2004, PEDIATRICS, V114, pE294, DOI 10.1542/peds.2003-0635-L; Glatt Kathleen, 2005, J Pediatr Nurs, V20, P448, DOI 10.1016/j.pedn.2005.08.006; Grossman DC, 1999, ARCH PEDIAT ADOL MED, V153, P875, DOI 10.1001/archpedi.153.8.875; Grossman DC, 2000, PEDIATRICS, V106, P22, DOI 10.1542/peds.106.1.22; HAMMOND WR, 1993, AM PSYCHOL, V48, P142, DOI 10.1037/0003-066X.48.2.142; Hardy MS, 2002, FUTURE CHILD, V12, P101, DOI 10.2307/1602741; Hepburn L, 2006, J TRAUMA, V61, P423, DOI 10.1097/01.ta.0000226396.51850.fc; Himle MB, 2004, J APPL BEHAV ANAL, V37, P1, DOI 10.1901/jaba.2004.37-1; Jostad CM, 2008, J APPL BEHAV ANAL, V41, P117, DOI 10.1901/jaba.2008.41-117; Katcher M L, 1994, Wis Med J, V93, P511; Kunz Howard P, 2001, J Emerg Nurs, V27, P485, DOI 10.1067/men.2001.118613; Li GH, 1996, ARCH PEDIAT ADOL MED, V150, P1160, DOI 10.1001/archpedi.1996.02170360050008; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MARTIN JR, 1991, ANN EMERG MED, V20, P58, DOI 10.1016/S0196-0644(05)81120-5; MAY JP, 1993, J GEN INTERN MED, V8, P380, DOI 10.1007/BF02600078; McGee Z T, 2001, J Cult Divers, V8, P94; Miltenberger RG, 2005, J APPL BEHAV ANAL, V38, P395, DOI 10.1901/jaba.2005.130-04; Nathens AB, 2000, J TRAUMA, V48, P25, DOI 10.1097/00005373-200001000-00005; NAURECKAS SM, 1995, ARCH PEDIAT ADOL MED, V149, P1318, DOI 10.1001/archpedi.1995.02170250024003; ORNATO JP, 1985, J TRAUMA, V25, P575, DOI 10.1097/00005373-198507000-00001; Schwab W, 2000, J TRAUMA, V48, P30; Senturia YD, 1996, ARCH PEDIAT ADOL MED, V150, P265, DOI 10.1001/archpedi.1996.02170280035006; Solomon BS, 2002, ARCH PEDIAT ADOL MED, V156, P769, DOI 10.1001/archpedi.156.8.769; Teret SP, 2002, FUTURE CHILD, V12, P119, DOI 10.2307/1602742; Tongren JE, 2009, JAMA-J AM MED ASSOC, V301, P2213, DOI 10.1001/jama.2009.746; United States Census Bureau, THE 2012 STATISTICAL; WINTEMUTE GJ, 1987, JAMA-J AM MED ASSOC, V257, P3107, DOI 10.1001/jama.257.22.3107; ZAVOSKI RW, 1995, PEDIATRICS, V96, P278	43	12	12	0	8	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	APR	2014	80	4					366	371					6	Surgery	Surgery	AJ5RL	WOS:000337744400018	24887667				2021-06-18	
J	Zhu, HP; Gao, Q; Xia, X; Xiang, J; Yao, HL; Shao, JB				Zhu, Huiping; Gao, Qi; Xia, Xin; Xiang, Joe; Yao, Hongli; Shao, Jianbo			Clinically-Important Brain Injury and CT Findings in Pediatric Mild Traumatic Brain Injuries: A Prospective Study in a Chinese Reference Hospital	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						mild traumatic brain injury; children; emergency department; CT scan; clinically-important brain injury	HEAD-INJURY; COMPUTED-TOMOGRAPHY; UNITED-STATES; CHILDREN; POPULATION; EMERGENCY; OUTCOMES; TERM; EPIDEMIOLOGY; CONCUSSION	This study investigated injury patterns and the use of computed tomography (CT) among Chinese children with mild traumatic brain injury (MTBI). We enrolled children with MTBI who were treated within 24 hours of head trauma in the emergency department of Wuhan Medical Care Center for Women and Children in Wuhan, China. Characteristics of MTBIs were analyzed by age and gender. Results of cranial CT scan and clinically-important brain injury (ciTBI) for children were obtained. The definition of ciTBI was: death from TBI, intubation for more than 24 h for TBI, neurosurgery, or hospital admission of 2 nights or more. Of 455 eligible patients with MTBI, ciTBI occurred in two, and no one underwent neurosurgical intervention. CT scans were performed for 441 TBI patients (96.9%), and abnormal findings were reported for 147 patients (33.3%, 95% CI 29.0-37.8). Falls were the leading cause of MTBI (61.5%), followed by blows (18.9%) and traffic collisions (14.1%) for children in the 0-2 group and 10-14 group. For children aged between 3 and 9, the top three causes of TBI were falls, traffic collisions and blows. Leisure activity was the most reported activity when injuries occurred for all age groups. Sleeping/resting and walking ranked in the second and third place for children between 0 and 2 years of age, and walking and riding for the other two groups. The places where the majority injuries occurred were the home for the 0-2 and 3-9 years of age groups, and school for the 10-14 years of age group. There was no statistical difference between boys and girls with regard to the activity that caused the MTBI. This study highlights the important roles that parents and school administrators in the development of preventive measures to reduce the risk of traumatic brain injury in children. Also, identifying children who had a head trauma at very low risk of clinically important TBI for whom CT might be unnecessary is a priority area of research in China.	[Zhu, Huiping; Gao, Qi] Capital Med Univ, Sch Publ Hlth, Beijing 100069, Peoples R China; [Zhu, Huiping; Gao, Qi] Beijing Municipal Key Lab Clin Epidemiol, Beijing 100069, Peoples R China; [Xia, Xin] Hubei Prov Ctr Dis Control & Prevent, Wuhan 430079, Peoples R China; [Xiang, Joe] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Yao, Hongli; Shao, Jianbo] Wuhan Childrens Hosp, Wuhan 430016, Peoples R China	Shao, JB (corresponding author), Capital Med Univ, Sch Publ Hlth, 10 Xitoutiao, Beijing 100069, Peoples R China.	zhuhuiping@ccmu.edu.cn; gaoqi@ccmu.edu.cn; xiaxin84@163.com; yxx125@case.edu; yhl778@sina.com; shaojb2002@sina.com	Gao, Qi/N-8721-2019	Gao, Qi/0000-0002-5370-5536			Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Andersson EE, 2012, DEV NEUROREHABIL, V15, P26, DOI 10.3109/17518423.2011.633570; [Anonymous], 2007, NEUR DIS PUBL HLTH C, P164; Bartlett SN, 2002, HEALTH POLICY PLANN, V17, P1, DOI 10.1093/heapol/17.1.1; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; Dorfman AL, 2011, ARCH PEDIAT ADOL MED, V165, P458, DOI 10.1001/archpediatrics.2010.270; Eisele JA, 2006, J HEAD TRAUMA REHAB, V21, P537, DOI 10.1097/00001199-200611000-00008; Ellingson KD, 2008, AM J PREV MED, V34, pS157, DOI 10.1016/j.amepre.2007.12.021; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; Frush DP, 2008, PEDIATR RADIOL, V38, pS629, DOI 10.1007/s00247-008-1006-7; Kozlowski KF, 2007, NEUROREHABILITATION, V22, P191; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; Murgio A, 2001, CHILD NERV SYST, V17, P257, DOI 10.1007/s003810000403; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Numminen HJ, 2011, EUR J NEUROL, V18, P460, DOI 10.1111/j.1468-1331.2010.03179.x; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Runyan CW, 2005, AM J PREV MED, V28, P73, DOI 10.1016/j.amepre.2004.09.010; Shang Y. Q., 2002, CHIN J RADIOL HLTH, V11, P232; Shao JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051634; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thiruppathy SP, 2004, ACTA NEUROCHIR, V146, P1075, DOI 10.1007/s00701-004-0335-z; Willer B, 2004, INJURY PREV, V10, P144, DOI 10.1136/ip.2003.005017; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zhong H. P., 2010, MED INNOVATION CHINA, V7, P166	35	12	14	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	APR	2014	11	4					3493	3506		10.3390/ijerph110403493			14	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	AG9TM	WOS:000335762700002	24675642	DOAJ Gold, Green Published			2021-06-18	
J	Sun, L; Qiang, R; Yang, Y; Jiang, ZL; Wang, GH; Zhao, GW; Ren, TJ; Jiang, R; Xu, LH				Sun, Li; Qiang, Ren; Yang, Yao; Jiang, Zheng-Lin; Wang, Guo-Hua; Zhao, Guang-Wei; Ren, Tao-Jie; Jiang, Rui; Xu, Li-Hua			L-Serine Treatment May Improve Neurorestoration of Rats after Permanent Focal Cerebral Ischemia Potentially Through Improvement of Neurorepair	PLOS ONE			English	Article							NEURAL STEM-CELLS; PROMOTES NEURITE OUTGROWTH; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; TENASCIN-C; NEURONAL MIGRATION; NOGO-A; STROKE; MECHANISMS; GDNF	The present study was conducted to clarify whether treatment with L-serine can improve the brain repair and neurorestoration of rats after permanent middle cerebral artery occlusion (pMCAO). After pMCAO, the neurological functions, brain lesion volume, and cortical injury were determined. GDNF, NGF, NCAM L1, tenascin-C, and Nogo-A levels were measured. Proliferation and differentiation of the neural stem cells (NSCs) and proliferation of the microvessels in the ischemic boundary zone of the cortex were evaluated. Treatment with L-serine (168 mg/kg body weight, i.p.) began 3 h after pMCAO and was repeated every 12 h for 7 days or until the end of the experiment. L-Serine treatment: 1) reduced the lesion volume and neuronal loss; 2) improved the recovery of neurological functions; 3) elevated the expression of nerve growth-related factors; and 4) facilitated the proliferation of endogenous NSCs and microvessels activated after pMCAO and increased the number of new-born neurons. 5) D-cycloserine, an inhibitor of serine hydroxymethyltransferase, blunted the effects of L-serine on NSC proliferation, differentiation, microvascular proliferation. In conclusions, L-serine treatment in pMCAO rats can reduce brain injury and facilitate neurorestoration which is partly associated with the improvement of proliferation of NSCs and microvessels, reconstruction of neurovascular units and resultant neurorepair. The effects of L-serine on endogenous NSC proliferation and microvascular proliferation are partly mediated by the action of L-serine as a substrate for the production of one-carbon groups used for purine and pyrimidine synthesis and modulation of the expression of some nerve growth-related factors.	[Sun, Li; Yang, Yao; Jiang, Zheng-Lin; Wang, Guo-Hua; Zhao, Guang-Wei; Ren, Tao-Jie; Jiang, Rui; Xu, Li-Hua] Nantong Univ, Dept Neuropharmacol, Inst Naut Med, Nantong, Jiangsu, Peoples R China; [Qiang, Ren] Third Peoples Hosp Nantong, Dept Infect Dis, Nantong, Jiangsu, Peoples R China; [Jiang, Zheng-Lin; Zhao, Guang-Wei; Ren, Tao-Jie] Nantong Univ, Dept Neurol, Affiliated Hosp, Nantong, Jiangsu, Peoples R China	Yang, Y (corresponding author), Nantong Univ, Dept Neuropharmacol, Inst Naut Med, Nantong, Jiangsu, Peoples R China.	jsyangyao@126.com; jiangzl@ntu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81000497, 81071614, 81372131]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Nantong University	This work was supported partly by grants from the National Natural Science Foundation of China (81000497, 81071614 and 81372131), by project funding from the Priority Academic Program Development of Jiangsu Higher Education Institutions, and by the Project for Innovation Development of Graduate Student of Nantong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaskharoun M, 2010, ASN NEURO, V2, DOI 10.1042/AN20100001; Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Andrews MR, 2009, J NEUROSCI, V29, P5546, DOI 10.1523/JNEUROSCI.0759-09.2009; Bednar MM, 2012, NEUROL RES, V34, P129, DOI 10.1179/1743132811Y.0000000069; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Chen B, 2009, BRAIN RES, V1284, P1, DOI 10.1016/j.brainres.2009.05.100; Chen J, 2005, J NEUROTRAUM, V22, P896, DOI 10.1089/neu.2005.22.896; Chen JA, 2010, MOL THER, V18, P1769, DOI 10.1038/mt.2010.133; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chiu SC, 2009, J MOL MED, V87, P1179, DOI 10.1007/s00109-009-0528-2; Cui YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017126; de Koning TJ, 2004, CURR OPIN NEUROL, V17, P197, DOI 10.1097/00019052-200404000-00019; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; Duan SR, 2010, NEUROL RES, V32, P835, DOI 10.1179/016164109X12581096870159; Duarte EP, 2012, GROWTH FACTORS, V30, P242, DOI 10.3109/08977194.2012.691478; GERMANO AF, 1994, J NEUROTRAUM, V11, P345, DOI 10.1089/neu.1994.11.345; Gogel S, 2011, GENE THER, V18, P1, DOI 10.1038/gt.2010.130; He XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046223; Ichim G, 2012, EXP CELL RES, V318, P1221, DOI 10.1016/j.yexcr.2012.03.006; Jablonska A, 2011, ACTA NEUROBIOL EXP, V71, P74; Joester A, 2001, MATRIX BIOL, V20, P13, DOI 10.1016/S0945-053X(00)00136-0; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; Joshi CN, 2004, BRAIN RES PROTOC, V13, P11, DOI 10.1016/j.brainresprot.2003.12.001; Kameda M, 2007, EUR J NEUROSCI, V26, P1462, DOI 10.1111/j.1460-9568.2007.05776.x; Kramer M, 2010, J NEUROSCI METH, V187, P84, DOI 10.1016/j.jneumeth.2009.12.020; Leker RR, 2009, EXPERT OPIN BIOL TH, V9, P1117, DOI 10.1517/14712590903130558; Macrae IM, 2011, BRIT J PHARMACOL, V164, P1062, DOI 10.1111/j.1476-5381.2011.01398.x; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; MANOHAR R, 1984, BIOCHEMISTRY-US, V23, P4116, DOI 10.1021/bi00313a016; Meiners S, 1999, J NEUROSCI, V19, P8443; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Pandya Rachna S., 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P81; Pernet V, 2012, CELL DEATH DIFFER, V19, P1096, DOI 10.1038/cdd.2011.191; Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; RAMESH KS, 1980, BIOCHEM J, V187, P623, DOI 10.1042/bj1870623; Ren TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067044; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Rigato F, 2002, J NEUROSCI, V22, P6596; Sahota P, 2011, NEUROTHERAPEUTICS, V8, P434, DOI 10.1007/s13311-011-0040-6; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Schulz F, 2013, NANOSCALE, V5, P10605, DOI 10.1039/c3nr02707d; Seo JH, 2012, YONSEI MED J, V53, P1059, DOI 10.3349/ymj.2012.53.6.1059; Shear DA, 2011, RESTOR NEUROL NEUROS, V29, P215, DOI 10.3233/RNN-2011-0593; Stout RW, 2001, COMPARATIVE MED, V51, P524; Sun CR, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-77; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Vaquero J, 2011, PROG NEUROBIOL, V93, P341, DOI 10.1016/j.pneurobio.2010.12.002; Wang GH, 2010, J NEUROSCI RES, V88, P2035, DOI 10.1002/jnr.22365; Wang T, 2012, BRAIN RES BULL, V87, P499, DOI 10.1016/j.brainresbull.2012.02.011; Wang XK, 2004, MOL PHARMACOL, V65, P890, DOI 10.1124/mol.65.4.890; Xiong Y, 2010, DISCOV MED, V10, P434; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yoneyama M, 2011, J PHARMACOL SCI, V115, P425, DOI 10.1254/jphs.11R02CP	54	12	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93405	10.1371/journal.pone.0093405			12	Multidisciplinary Sciences	Science & Technology - Other Topics	AE0SR	WOS:000333677000140	24671106	DOAJ Gold, Green Published			2021-06-18	
J	Ghorbani, P; Falken, M; Riddez, L; Sundelof, M; Oldner, A; Strommer, L				Ghorbani, Poya; Falken, Magnus; Riddez, Louis; Sundelof, Martin; Oldner, Anders; Strommer, Lovisa			Clinical review is essential to evaluate 30-day mortality after trauma	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Mortality; Trauma deaths; Clinical review; Dead on arrival	PERFORMANCE IMPROVEMENT; DEATHS; TIME; EPIDEMIOLOGY; DEFINITIONS; INJURIES; PATTERNS; SERVICE; IMPACT	Background: Securing high-quality mortality statistics requires systematic evaluation of all trauma deaths. We examined the proportion of trauma patients dying within 30 days from causes not related to the injury and the impact of exclusion of patients dead on arrival on 30-day trauma mortality. We also defined the demographics, injury characteristics, cause of death and time to death in patients admitted to our trauma center who died within 30 days, between 2007-2011. Methods: Demographics, injury characteristics, status alive/dead on arrival, cause of death and time to death of all patients were reviewed. Deaths were analyzed based on injury mechanism (penetrating, blunt trauma and low energy blunt trauma) and cause of death (traumatic brain injury (TBI), hemorrhage, organ dysfunction and other/unknown). Results: Of the 7422 admissions, 343 deaths were identified of which 36 (10.5%) involved causes not related to the injury. The overall age was 71 years, Injury Severity Score (ISS) 29 and time to death 24 hours (all medians). Fifty-four patients (17.6%) were dead on arrival. Exclusion of patients dead on arrival reduced the overall mortality rate (P < 0.05) and median ISS (P < 0.05) and increased median age (P < 0.01) and time to death (P < 0.001). Injury mechanism was penetrating trauma in 7.5%, blunt trauma in 56.0%, and low energy blunt trauma in 36.5%. TBI accounted for 58.6%; hemorrhage 16.3%, organ dysfunction 15.0%, and other/unknown for 10.1% of the deaths. Patients who died after low energy blunt trauma were older, had lower ISS and longer time to death compared to those who died after penetrating and blunt trauma (all P < 0.01). Conclusions: Clinical review of all trauma deaths was essential to interpret mortality. Thirty-day trauma mortality included 10.5% deaths not directly related to the injury and the exclusion of patients dead on arrival significantly affected the unadjusted mortality rate, ISS, median age and time to death.	[Ghorbani, Poya; Strommer, Lovisa] Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Div Surg, Stockholm, Sweden; [Falken, Magnus; Riddez, Louis; Sundelof, Martin] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Oldner, Anders] Karolinska Inst, Dept Physiol & Pharmacol, Div Anesthesiol & Intens Care, Stockholm, Sweden; [Strommer, Lovisa] Karolinska Univ Hosp, Dept Surg Gastroenterol, S-17176 Stockholm, Sweden	Strommer, L (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Div Surg, Stockholm, Sweden.	Lovisa.Strommer@karolinska.se	Oldner, Anders/Q-4353-2018	Oldner, Anders/0000-0003-1600-9221; Strommer, Lisa/0000-0001-5424-7111	Swedish Society of Medicine	We would like to thank Olof Brattstrom for his continuous efforts at the Trauma Registry at Karolinska University Hospital. We also would like to thank Lisbet Bergendal, Lena A Jansson and Tina Friberg for their hard work and invaluable contribution, which allows for our scholarly activities. The study was supported by funding from the Swedish Society of Medicine.	Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; American College of Surgeons Committee on Trauma, 2006, RES OPT CAR INJ PAT; Brattstrom O, 2012, EUR J EPIDEMIOL, V27, P233, DOI 10.1007/s10654-012-9651-4; CAYTEN CG, 1991, ANN SURG, V214, P510, DOI 10.1097/00000658-199110000-00015; Cayten CG, 1991, ANN SURG, V214, P520; Chalkley D, 2011, EMERG MED J, V28, P305, DOI 10.1136/emj.2009.085613; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Esposito TJ, 2012, J TRAUMA ACUTE CARE, V73, P587, DOI 10.1097/TA.0b013e318265ce05; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; Groven S, 2011, J TRAUMA, V70, P569, DOI 10.1097/TA.0b013e31820d1a9b; Kahl JE, 2013, J TRAUMA ACUTE CARE, V75, P195, DOI 10.1097/TA.0b013e3182997865; Newgard CD, 2013, J AM COLL SURGEONS, V216, P147, DOI 10.1016/j.jamcollsurg.2012.08.017; Pasquale MD, 1996, J TRAUMA, V41, P726, DOI 10.1097/00005373-199610000-00022; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; Powell DW, 2004, J AM COLL SURGEONS, V199, P211, DOI 10.1016/j.jamcollsurg.2004.04.004; Ringdal KG, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-7; ROMANO PS, 1992, AM J EPIDEMIOL, V136, P863, DOI 10.1093/aje/136.7.863; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Skaga NO, 2008, INJURY, V39, P612, DOI 10.1016/j.injury.2007.11.426; Soreide K, 2007, WORLD J SURG, V31, P2092, DOI 10.1007/s00268-007-9226-9; Staudenmayer KL, 2013, J AM COLL SURGEONS, V217, P569, DOI 10.1016/j.jamcollsurg.2013.06.017; Van Haren RM, 2012, J TRAUMA ACUTE CARE, V73, P1512, DOI 10.1097/TA.0b013e318270d40f; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	24	12	12	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	MAR 13	2014	22								18	10.1186/1757-7241-22-18			7	Emergency Medicine	Emergency Medicine	AF5ZT	WOS:000334794800001	24625137	DOAJ Gold, Green Published			2021-06-18	
J	Amara, J; Iverson, KM; Krengel, M; Pogoda, TK; Hendricks, A				Amara, Jomana; Iverson, Katherine M.; Krengel, Maxine; Pogoda, Terri K.; Hendricks, Ann			Anticipating the Traumatic Brain Injury-Related Health Care Needs of Women Veterans After the Department of Defense Change in Combat Assignment Policy	WOMENS HEALTH ISSUES			English	Article							POSTTRAUMATIC-STRESS-DISORDER; IRAQI FREEDOM; MILITARY	Background: Female service members' presence in combat zones during Operation Enduring Freedom and Operation Iraqi Freedom is unprecedented both in terms of the number of women deployed and the nature of their involvement. In light of changing Department of Defense policy governing the deployment of women in combat zones, this article intends to set the groundwork for estimating future combat-related injuries and subsequent Veterans Health Administration (VHA) utilization while focusing on traumatic brain injury (TBI). Methods: The article summarizes and presents the results of a study that examines veterans who present to VHA for TBI evaluation. For a national sample of veterans, a dataset including information on post-screening utilization, diagnoses, and location of care was constructed. The dataset included self-reported health symptoms and other information obtained from a standardized national VHA post-screening clinical evaluation, the comprehensive TBI evaluation (CTBIE). Findings: Both women and men utilize high levels of VHA health care after a CTBIE. However, there are gender differences in the volume and types of services used, with women utilizing different services than their male counterparts and incurring higher costs, including higher overall and outpatient costs. Conclusion: As women veterans seek more of their health care from the VHA, there will be a need for more coordinated care to identify and manage deployment-related TBI and common comorbidities such as posttraumatic stress disorder, depression, and chronic pain. Deployment-connected injuries are likely to rise because of the rescinding of the ban on women in combat. This in turn has critical implications for VHA strategic planning and budgeting. Published by Elsevier Inc.	[Amara, Jomana] Naval Postgrad Sch, DRMI, Monterey, CA 93943 USA; [Iverson, Katherine M.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [Iverson, Katherine M.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Krengel, Maxine] VA Boston Healthcare Syst, Boston, MA USA; [Krengel, Maxine] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Pogoda, Terri K.] VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Boston, MA USA; [Pogoda, Terri K.] Boston Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Hendricks, Ann] VA Boston Healthcare Syst, Hlth Care Financing & Econ Ctr, Boston, MA USA	Amara, J (corresponding author), Naval Postgrad Sch, DRMI Code 64, 699 Dyer Rd,Bldg 234, Monterey, CA 93943 USA.	jhamara@nps.edu	Pogoda, Terri/F-6243-2012	Pogoda, Terri/0000-0003-1397-8780			Amara J., 2011, DETERMINANTS OF UTIL; Bass C. R., 2012, ANNALS OF BIOMEDICAL, V40, P1185; Beckett M. K., 2002, STATUS OF GENDER INT; Bumiller E., 2013, THE NEWYORK TIMES; Burrelli D. F., 2013, WOMEN IN COMBAT ISSU; Congressional Budget Office, 2010, POTENTIAL COSTS OF V; Department of Veterans Affairs, 2009, COMPREHENSIVE TBI EV; Department of Veterans Affairs, 2010, NATIONAL SURVEY OF V; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLINICAL PRAC; Fontana A, 2006, PSYCHIAT QUART, V77, P55, DOI 10.1007/s11126-006-7961-y; Frayne S., 2010, SOURCEBOOK WOMEN VET, V1; Frayne SM, 2006, J GEN INTERN MED, V21, pS40, DOI 10.1111/j.1525-1497.2006.00373.x; Frayne SM, 2012, SOURCEBOOK WOMEN VET, V2; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Harrell M. C., 2007, MONOGRAPH REPORTS; Harrell M. C., 2002, THE STATUS OF GENDER; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Iverson KM, 2013, J WOMENS HEALTH, V22, P267, DOI 10.1089/jwh.2012.3755; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Kaur S, 2007, J GEN INTERN MED, V22, P228, DOI 10.1007/s11606-006-0048-5; Kimerling R, 2011, WOMEN HEALTH ISS, V21, pS145, DOI 10.1016/j.whi.2011.04.007; Krengel M., 2011, VA HEALTH CARE UTILI; Lehavot K, 2012, AM J PREV MED, V42, P473, DOI 10.1016/j.amepre.2012.01.006; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Mengeling MA, 2011, WOMEN HEALTH ISS, V21, pS120, DOI 10.1016/j.whi.2011.04.021; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pellerin C., 2013, DEFENSE GOV NEWS ART; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Street AE, 2013, J GEN INTERN MED, V28, pS556, DOI 10.1007/s11606-013-2333-4; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vogt D., 2011, JOURNAL OF ABNORMAL, V120, P786; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Washington DL, 2007, MIL MED, V172, P812, DOI 10.7205/MILMED.172.8.812; Washington DL, 2013, J GEN INTERN MED, V28, pS571, DOI 10.1007/s11606-012-2323-y	37	12	12	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1049-3867	1878-4321		WOMEN HEALTH ISS	Womens Health Iss.	MAR-APR	2014	24	2					E171	E176		10.1016/j.whi.2013.12.004			6	Public, Environmental & Occupational Health; Women's Studies	Public, Environmental & Occupational Health; Women's Studies	AO1ZG	WOS:000341113500003	24630421				2021-06-18	
J	Cossman, JP; Morrison, CS; Taylor, HO; Salter, AB; Klinge, PM; Sullivan, SR				Cossman, Jack P.; Morrison, Clinton S.; Taylor, Helena O.; Salter, Amanda B.; Klinge, Petra M.; Sullivan, Stephen R.			Traumatic Orbital Roof Fractures: Interdisciplinary Evaluation and Management	PLASTIC AND RECONSTRUCTIVE SURGERY			English	Article							GROWING SKULL FRACTURES; REPEATED COMPUTED-TOMOGRAPHY; CERVICAL-SPINE INJURY; SURGICAL-MANAGEMENT; HEAD-INJURY; RECONSTRUCTION	Background: The orbital roof forms part of the anterior skull base and is positioned for potential concomitant ophthalmologic and neurologic injury. Despite potential morbidity and mortality, orbital roof fractures have garnered little attention compared with orbital floor fractures. The authors' purpose is to review and describe key points when treating these fractures. Methods: The authors reviewed 1171 consecutive patient at a trauma center with orbital or skull base fractures from 2009 to 2011. Patient demographics, mechanism of injury, associated injuries, treatment, outcomes, and complications were recorded. Results: Among the 1171 patients, the authors identified 60 with an orbital roof fracture (5 percent). All were evaluated by plastic surgery, neurosurgery, and ophthalmology. Average age was 38.1 years, and the male-to-female ratio was 4:1. Frequent mechanisms of injury were fall (33 percent), followed by assault (25 percent). Concomitant craniofacial skeletal fractures were common (87 percent), as were ophthalmologic injuries (47 percent), and traumatic brain injury with intracranial hemorrhage (65 percent). Six patients (10 percent) required operative repair of the orbital roof, all of whom had a dural laceration and cerebrospinal fluid leak. Most patients (90 percent) had minimal displacement and no clinically evident cerebrospinal fluid leak and were treated with observation without complications. Conclusions: Orbital roof fractures are a less common but potentially serious craniofacial injury. Most can be safely observed; however, intracranial or intraorbital injury may warrant surgical intervention to remove impinging bony fragments, repair dura, or reconstruct the orbital roof. An interdisciplinary approach with plastic surgery, ophthalmology, and neurosurgery is crucial to providing comprehensive care. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.	Brown Univ, Warren Alpert Med Sch, Div Plast Surg, Providence, RI 02905 USA; Brown Univ, Warren Alpert Med Sch, Dept Plast Surg, Providence, RI 02905 USA; Brown Univ, Warren Alpert Med Sch, Dept Pediat, Providence, RI 02905 USA; Brown Univ, Warren Alpert Med Sch, Dept Ophthalmol, Providence, RI 02905 USA; Brown Univ, Warren Alpert Med Sch, Dept Neurosurg, Providence, RI 02905 USA; Rhode Isl Hosp, Providence, RI USA; [Sullivan, Stephen R.] Hasbro Childrens Hosp, Providence, RI 02905 USA	Sullivan, SR (corresponding author), Brown Univ, Warren Alpert Med Sch, Div Plast & Reconstruct Surg,Rhode Isl Hosp, Dept Pediat,Dept Plast & Reconstruct Surg, 2 Dudley St,MOC 180, Providence, RI 02905 USA.	stephen.sullivan@brown.edu					ANTONYSHYN O, 1989, PLAST RECONSTR SURG, V84, P10, DOI 10.1097/00006534-198907000-00002; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Bullock M Ross, 2006, Neurosurgery, V58, pS47; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clauser L, 2004, CHILD NERV SYST, V20, P168, DOI 10.1007/s00381-003-0868-0; Cobb ARM, 2013, BRIT J ORAL MAX SURG, V51, P41, DOI 10.1016/j.bjoms.2012.03.006; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Connon FF, 2011, ANN SURG, V254, P1028, DOI 10.1097/SLA.0b013e318219727f; Donahue DJ, 1997, PEDIATR NEUROSURG, V26, P261, DOI 10.1159/000121201; Ersahin Y, 2000, NEUROSURG REV, V23, P139, DOI 10.1007/PL00011945; Fattahi T, 2009, INT J ORAL MAX SURG, V38, P1263, DOI 10.1016/j.ijom.2009.09.006; FLANAGAN JC, 1980, OPHTHALMOLOGY, V87, P325; Foster JA, 2004, AM ORTHOPT J, V54, P13; Fulcher TP, 2003, OPHTHALMIC PLAST REC, V19, P359, DOI 10.1097/01.IOP.0000083646.20672.6B; Gaziolu N, 2008, ULUS TRAVMA ACIL CER, V14, P247; GREENWALD MJ, 1989, OPHTHALMOLOGY, V96, P491; Gupta SK, 1997, ACTA NEUROCHIR, V139, P928, DOI 10.1007/BF01411301; Haug RH, 2002, ORAL SURG ORAL MED O, V93, P238, DOI 10.1067/moe.2002.120975; HAVLIK RJ, 1995, J CRANIOFAC SURG, V6, P103, DOI 10.1097/00001665-199503000-00003; Hoffman JR, 1998, ANN EMERG MED, V32, P461, DOI 10.1016/S0196-0644(98)70176-3; Karabekir HS, 2012, J CRANIO MAXILL SURG, V40, pE189, DOI 10.1016/j.jcms.2011.10.006; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Kim JW, 2012, ARCH PLAST SURG-APS, V39, P31, DOI 10.5999/aps.2012.39.1.31; KOLTAI PJ, 1995, ARCH OTOLARYNGOL, V121, P1375; Manson PN, 2009, PLAST RECONSTR SURG, V124, P2096, DOI 10.1097/PRS.0b013e3181bf8394; Marion DW, 2006, NEUROSURGERY, V58, P655; MESSINGER A, 1989, PLAST RECONSTR SURG, V84, P213, DOI 10.1097/00006534-198908000-00003; Mithani SK, 2009, PLAST RECONSTR SURG, V123, P1293, DOI 10.1097/PRS.0b013e31819e26f2; Mulligan RP, 2010, PLAST RECONSTR SURG, V126, P1648, DOI 10.1097/PRS.0b013e3181ef90e4; OLEE TJ, 2008, OPER TECH OTOLARYNGO, V19, P98; PENFOLD CN, 1992, BRIT J ORAL MAX SURG, V30, P97, DOI 10.1016/0266-4356(92)90078-W; PIOTROWSKI WP, 1995, J CRANIO MAXILL SURG, V23, P6, DOI 10.1016/S1010-5182(05)80247-1; RYALL RG, 1992, J NEUROSURG, V77, P737, DOI 10.3171/jns.1992.77.5.0737; Scholsem M, 2008, NEUROSURGERY, V62, P463, DOI [10.1227/01.NEU.0000297037.51609.07, 10.1227/01.neu.0000316014.97926.82, 10.1227/01.neu.0000325884.05871.aa]; Shah AD, 2011, INDIAN J OPHTHALMOL, V59, P501, DOI 10.4103/0301-4738.86325; Stahel PF, 2005, ORTHOPADE, V34, P823, DOI 10.1007/s00132-005-0842-5; SULLIVAN WG, 1991, PLAST RECONSTR SURG, V87, P657, DOI 10.1097/00006534-199104000-00008; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039	40	12	12	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0032-1052	1529-4242		PLAST RECONSTR SURG	Plast. Reconstr. Surg.	MAR	2014	133	3					335E	343E		10.1097/01.prs.0000438051.36881.e0			9	Surgery	Surgery	AD4TN	WOS:000333243600013	24572878				2021-06-18	
J	Gordon, KE; Do, MT; Thompson, W; McFaull, S				Gordon, Kevin E.; Do, Minh T.; Thompson, Wendy; McFaull, Steven		Canadian Paediat Surveillance Prog	Concussion management by paediatricians: A national survey of Canadian paediatricians	BRAIN INJURY			English	Article						Brain concussion; child; clinical medicine; physicians practice patterns; guideline adherence	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; INTERNATIONAL-CONFERENCE; AGREEMENT STATEMENT; CONSENSUS STATEMENT; KNOWLEDGE TRANSFER; CHILDREN; ADOLESCENTS; EDUCATION; MILD	Objective: To assess the use of concussion/mild traumatic brain injury (mTBI) guidelines, criteria used in the initiation of return-to-play (RTP) and management of RTP for brain injured children and youth by Canadian paediatricians. Methods: A cross-sectional survey was mailed through the Canadian Paediatric Surveillance Program to similar to 2600 paediatric specialists and sub-specialists. Results: Of 809 respondents (31%), 503 encountered newly diagnosed paediatric concussion/mTBI within the past 12 months, reporting similar to 6900 cases. Of the respondents, 96.7% (95% CI = 94.7-98.6%) reported using one or more of the presented concussion/mTBI guidelines in the management of their patients. The most frequently reported criteria (> 50%) used to determine asymptomatic status were: free from all concussion symptoms, by patient report (92%), by proxy report (76%), normal physical examination (65%), in school full-time, with usual school performance (53%). Most respondents (84.9%) did not initiate RTP immediately after their patients became asymptomatic. The median time waiting before initiating RTP was 7 days. The median duration of the RTP sequence was 7 days, with considerable variation reported. Conclusions: Canadian paediatricians frequently encounter patients with concussion/mTBI. Their concussion/mTBI care appears to be consistent with current guidelines,	[Gordon, Kevin E.] Canadian Paediat Soc, Ottawa, ON, Canada; [Gordon, Kevin E.] Dalhousie Univ, Dept Pediat, Div Pediat Neurol, Halifax, NS B3K 6R8, Canada; [Do, Minh T.; Thompson, Wendy; McFaull, Steven] Publ Hlth Agcy Canada, Ottawa, ON, Canada	Gordon, KE (corresponding author), Dalhousie Univ, IWK Hlth Ctr, Div Pediat Neurol, 5850 Univ Ave, Halifax, NS B3K 6R8, Canada.	kegor@dal.ca			Public Health Agency of Canada	Funding Source: Public Health Agency of Canada.	Alla S, 2012, BRIT J SPORT MED, V46, P562, DOI 10.1136/bjsm.2010.081299; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Aubry M., 2002, BRIT J SPORT MED, V36, P3, DOI [DOI 10.1136/BJSM.36.1.6, 10.1136/bjsm.36.1.6]; Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; Bergman DA, 1999, PEDIATRICS, V104, P1407; Broshek DK, 2012, J CHILD NEUROLOGY; *CAN PED SOC, 2006, PEDIAT CHILD HLTH, V11, P420; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gordon KE, 2006, PEDIATR NEUROL, V34, P376, DOI 10.1016/j.pediatrneurol.2005.09.007; Grenier D, 2004, Paediatr Child Health, V9, P379; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Johnston KM, 2000, CLIN J SPORT MED, V10, P209; Kaye AJ, 2010, J TRAUMA, V68, P1396, DOI 10.1097/TA.0b013e3181cf7d1b; Kelly JP, 1997, NEUROLOGY, V48, P581; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Patel DR, 2010, PEDIATR CLIN N AM, V57, P649, DOI 10.1016/j.pcl.2010.03.006; Pleacher MD, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2005.019067; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Purcell L, 2008, CLIN PEDIATR, V47, P106, DOI 10.1177/0009922807306053; Purcell LK, 2012, PAED CHILD HEALT-CAN, V17, P36; Sosin DM, 1996, BRAIN INJURY, V10, P47; Standaert CJ, 2007, ARCH PHYS MED REHAB, V88, P1077, DOI 10.1016/j.apmr.2007.06.002; StataCorp, 2011, STAT STAT SOFTW REL; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	38	12	12	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2014	28	3					311	317		10.3109/02699052.2013.862740			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AC0RI	WOS:000332202100007	24354430				2021-06-18	
J	King, PR; Wade, MJ; Beehler, GP				King, Paul R.; Wade, Michael J.; Beehler, Gregory P.			Health Service and Medication Use Among Veterans With Persistent Postconcussive Symptoms	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article						Chronic pain; health service utilization; persistent postconcussive symptoms; posttraumatic stress disorder; veterans	TRAUMATIC BRAIN-INJURY; POST-CONCUSSION SYNDROME; POSTTRAUMATIC-STRESS-DISORDER; COMORBIDITY SURVEY REPLICATION; MILD HEAD-INJURY; LOW-BACK-PAIN; CARE UTILIZATION; UNITED-STATES; IRAQ WAR; DEPRESSION	Persistent postconcussive symptoms (PPCS) are noted when a series of cognitive, emotional, and somatosensory complaints persist for months after a concussion. Clinical management of PPCS can be challenging in the veteran population because of the nonspecific nature of symptoms and co-occurrence with affective disturbances such as posttraumatic stress disorder (PTSD) and chronic pain. In this study, we compared health service and medication use patterns in a sample of 421 veterans with PPCS with an age-matched cohort of case controls. The results suggest that the veterans with PPCS showed high rates of medical and mental health service utilization during a mean treatment period of 2 years. Although chronic pain commonly co-occurs with PPCS in veterans, service use and medication prescribing trends seem to have been influenced more by the presence of PTSD than chronic pain. Our findings reinforce the overlap among PPCS, PTSD, and chronic pain and demonstrate the complexity inherent in treating these conditions in veterans.	[King, Paul R.; Beehler, Gregory P.] VA Western New York Healthcare Syst, Ctr Integrated Healthcare, Buffalo, NY 14215 USA; [Wade, Michael J.] Syracuse VA Med Ctr, Ctr Integrated Healthcare, Syracuse, NY USA; [Beehler, Gregory P.] SUNY Buffalo, Buffalo, NY 14260 USA	King, PR (corresponding author), VA Western New York Healthcare Syst, Ctr Integrated Healthcare 116N, 3495 Bailey Ave, Buffalo, NY 14215 USA.	Paul.King2@va.gov			Department of Veterans Affairs Office of Academic AffiliationsUS Department of Veterans Affairs; Department of Veterans Affairs Center for Integrated Healthcare, VA Western New York Healthcare System at Buffalo	This study was supported by the Department of Veterans Affairs Office of Academic Affiliations, Advanced Fellowship Program in Mental Illness Research and Treatment, and the Department of Veterans Affairs Center for Integrated Healthcare, VA Western New York Healthcare System at Buffalo.	Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arnow BA, 2009, PSYCHIAT SERV, V60, P344, DOI 10.1176/appi.ps.60.3.344; Axelrod BN, 1996, PSYCHOL ASSESSMENT, V8, P422, DOI 10.1037/1040-3590.8.4.422; Beehler GP, 2013, PAIN MED, V14, P1021, DOI 10.1111/pme.12126; Bernardy NC, 2012, J CLIN PSYCHIAT, V73, P297, DOI 10.4088/JCP.11m07311; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Department of Veterans Affairs/ Department of Defense ( VA/ DoD), 2009, VA DOD CLIN PRACT GU; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Engel CC, 1996, PAIN, V65, P197, DOI 10.1016/0304-3959(95)00164-6; EVANS RW, 1994, HEADACHE, V34, P268, DOI 10.1111/j.1526-4610.1994.hed3405268.x; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gore M, 2012, SPINE, V37, pE668, DOI 10.1097/BRS.0b013e318241e5de; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Lund BC, 2013, PSYCHIAT SERV, V64, P21, DOI 10.1176/appi.ps.201100544; Luo XM, 2004, SPINE, V29, P79, DOI 10.1097/01.BRS.0000105527.13866.0F; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Nestvold K, 2009, BRAIN INJURY, V23, P15, DOI 10.1080/02699050802530540; Outcalt SD, PAIN MED; Parsons L, 2001, P 26 ANN SAS US GROU, P214; Possemato K, 2010, PSYCHOL TRAUMA-US, V2, P218, DOI 10.1037/a0019236; Ravindran LN, 2009, BRAIN RES, V1293, P24, DOI 10.1016/j.brainres.2009.03.037; Ritzwoller DP, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-72; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stalnacke BM, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/528265; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Tamcan O, 2010, PAIN, V150, P451, DOI 10.1016/j.pain.2010.05.019; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; VA/DoD, 2010, VA DOD CLIN PRACT GU; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Von Korff M, 2005, PAIN, V113, P331, DOI 10.1016/j.pain.2004.11.010; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; World Health Organization, 1992, ICD 10 INT STAT CLAS	49	12	12	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3018	1539-736X		J NERV MENT DIS	J. Nerv. Ment. Dis.	MAR	2014	202	3					231	238		10.1097/NMD.0000000000000103			8	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	AD7OK	WOS:000333453300008	24566509				2021-06-18	
J	Albuquerque, CEL; Arcanjo, FPN; Cristino, G; Lopes, AM; de Almeida, PC; Prado, R; Pereira-Stabile, CL				Lopes Albuquerque, Carlos Eduardo; Nogueira Arcanjo, Francisco Placido; Cristino-Filho, Gerardo; Lopes-Filho, Antonio Mont'Alverne; de Almeida, Paulo Cesar; Prado, Roberto; Pereira-Stabile, Cecilia Luiz			How Safe Is Your Motorcycle Helmet?	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							DEATH; SEVERITY; SOCIETY; BURDEN; IMPACT; LAWS	Purpose: Motorcycle crash helmets do not totally prevent head and facial trauma. The aim of this study was to investigate if protection offered by helmets differs according to helmet type. Materials and Methods: In this retrospective cohort study, outpatient records of motorcyclists were analyzed for the Facial Injury Severity Scale (FISS), traumatic brain injury (TBI), facial fractures, and helmet use. Statistical analysis was conducted using the Fisher and Bonferroni tests, bivariate regression analysis, and 1-way analysis of variance. Results: There were 253 motorcyclists who sustained craniomaxillofacial injuries and were referred for outpatient treatment (men, 88.9%; mean age, 29.64 +/- 11.6 yr); 60.1% had up to 9 years of formal education; 156 patients reported not using crash helmets, 51 were using open-face helmets, and 46 were using full-face helmets. The mean FISS score was significantly higher for unhelmeted riders compared with full-face helmet riders (P = .047), with no difference between unhelmeted riders and open-face helmet users (P = 1.00). Results for TBI were statistically greater for those wearing open-face helmets compared with full-face helmets (P = .035). Conclusion: In this study, a large percentage of motorcyclists had facial fractures and TBI, and crash helmets did not always offer adequate protection against craniomaxillofacial injury, especially open-face helmets. Thus, further investigation into helmet types and quality of protection offered is recommended. (C) 2014 American Association of Oral and Maxillofacial Surgeons		Albuquerque, CEL (corresponding author), Rua Finlandia 35, Sobral, CE, Brazil.	petergilmara2@gmail.com			Research Initiative Grant from Santa Casa de Misericordia de Sobral Hospital	This project was funded by a Research Initiative Grant from Santa Casa de Misericordia de Sobral Hospital.	Abbas AK, 2012, ACCIDENT ANAL PREV, V49, P249, DOI 10.1016/j.aap.2011.09.033; Bagheri SC, 2006, J ORAL MAXIL SURG, V64, P408, DOI 10.1016/j.joms.2005.11.013; Branas CC, 2001, ACCIDENT ANAL PREV, V33, P641, DOI 10.1016/S0001-4575(00)00078-6; Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; Cook LJ, 2009, 811208 DOT HS NAT HI; Croce MA, 2009, ANN SURG, V250, P390, DOI 10.1097/SLA.0b013e3181b365a2; Eastridge BJ, 2006, J TRAUMA, V60, P978, DOI 10.1097/01.ta.0000215582.86115.01; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Houston DJ, 2008, ACCIDENT ANAL PREV, V40, P200, DOI 10.1016/j.aap.2007.05.005; Hundley JC, 2004, J TRAUMA, V57, P944, DOI 10.1097/01.TA.0000149497.20065.F4; Instituto Sangari, 2012, MAP VIOL 2012; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Majdan M, 2012, EUR J PUBLIC HEALTH, V10, P1; Mayrose J, 2008, J SAFETY RES, V39, P429, DOI 10.1016/j.jsr.2008.07.001; Norvell DC, 2002, AM J EPIDEMIOL, V156, P483, DOI 10.1093/aje/kwf081; Oginni FO, 2009, TRAFFIC INJ PREV, V10, P70, DOI 10.1080/15389580802496968; Ouellet James V, 2006, Traffic Inj Prev, V7, P49, DOI 10.1080/15389580500338652; Servadei F, 2003, INJURY PREV, V9, P257, DOI 10.1136/ip.9.3.257; TSAI YJ, 1995, AM J EPIDEMIOL, V142, P974, DOI 10.1093/oxfordjournals.aje.a117746; WAISELFISZ Julio Jacobo, 2012, MAPA VIOLENCIA 2012; World Health Organization, 2006, HELM ROAD SAF MAN DE; World Health Organization, 2009, GLOB STAT REP ROAD S; Yu WY, 2011, INT J EPIDEMIOL, V40, P794, DOI 10.1093/ije/dyr040	24	12	12	0	24	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	MAR	2014	72	3					542	549		10.1016/j.joms.2013.10.017			8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AA5OZ	WOS:000331150800014	24326016				2021-06-18	
J	Yan, HQ; Shin, SS; Ma, XC; Li, YM; Dixon, CE				Yan, Hong Q.; Shin, Samuel S.; Ma, Xiecheng; Li, Youming; Dixon, C. Edward			Differential effect of traumatic brain injury on the nuclear factor of activated T Cells C3 and C4 isoforms in the rat hippocampus	BRAIN RESEARCH			English	Article						Nuclear factor of activated T cells (NFAT); Immunohistochemistry; Rat; Traumatic brain injury (TBI); Calcineurin	FLUID PERCUSSION INJURY; DELAYED NEURONAL DEATH; GENE-EXPRESSION; TRANSCRIPTION FACTORS; TYROSINE-HYDROXYLASE; CALCINEURIN SUBUNIT; REACTIVE ASTROCYTES; FRONTAL-CORTEX; NFAT; APOPTOSIS	The interaction between the phosphatase calcineurin and transcription factor nuclear factor of activated T cells (NFAT) plays an important role numerous signaling and the regulatory events. Although NFAT is mostly known for its transcription function in the immune system, NFAT also has essential functions even in the central nervous system (CNS). The effects of traumatic brain injury (TBI) on NFAT are currently unknown. To determine if there is an alteration in NFAT after TBI, we examined NFATc3 and c4 levels at 6 h, 1 day, 1 week, 2 weeks and 4 weeks post injury. Rats were anesthetized and surgically prepared for controlled cortical impact (CCI) injury or sham surgery. Semi-quantitative measurements of NFATc3 and c4 in the hippocampal homogenates from injured and sham rats sacrificed at the appropriate time after injury were assessed using Western blot analysis. After TBI insult, in the hippocampus ipsilateral to the injury, NFATc3 expression levels were decreased both in the cytoplasmic and nuclear fractions. However, NFATc4 expression levels were increased in the cytoplasmic fraction but decreased in the nuclear fraction. Double labeling (with NeuN and GFAP) immunohistochemistry revealed that NFATc3 was expressed in subset of astrocytes and NFATc4 was expressed primarily in neurons. These differential responses in NFATc3 and c4 expression after TBI insult may indicate long-term changes in hippocampal excitability and may contribute to behavioral deficits. Further study is warranted to illustrate the role of NFATc3 and c4 in the setting of TBI. Published by Elsevier B.V.	[Yan, Hong Q.; Shin, Samuel S.; Ma, Xiecheng; Li, Youming; Dixon, C. Edward] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Dixon, C. Edward] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15240 USA	Dixon, CE (corresponding author), Univ Pittsburgh, Dept Neurol Surg, Safar Ctr, 201 Hill Bldg,3434 Fifth Ave, Pittsburgh, PA 15260 USA.	dixonec@upmc.edu			NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS33150, NS060672, NS079061]; Veterans Affairs grantUS Department of Veterans Affairs [B6761R]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS079061, R01NS033150, P01NS030318, R01NS060672] Funding Source: NIH RePORTER	This work was supported by NIH/NINDS grants NS33150, NS060672 and NS079061; and the Veterans Affairs grant B6761R.	Abdul HM, 2009, J NEUROSCI, V29, P12957, DOI 10.1523/JNEUROSCI.1064-09.2009; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Asai A, 1999, J BIOL CHEM, V274, P34450, DOI 10.1074/jbc.274.48.34450; Bales JW, 2011, EXP NEUROL, V229, P300, DOI 10.1016/j.expneurol.2011.02.013; Bales JW, 2010, BRAIN RES, V1358, P211, DOI 10.1016/j.brainres.2010.08.029; Bales JW, 2010, J NEUROTRAUM, V27, P109, DOI 10.1089/neu.2009.1072; Benedito AB, 2005, J BIOL CHEM, V280, P2818, DOI 10.1074/jbc.M408741200; Bodor J, 2000, J LEUKOCYTE BIOL, V67, P774; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fernandez AM, 2007, J NEUROSCI, V27, P8745, DOI 10.1523/JNEUROSCI.1002-07.2007; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 2001, CURR OPIN GENET DEV, V11, P505, DOI 10.1016/S0959-437X(00)00225-2; Graef IA, 2001, P NATL ACAD SCI USA, V98, P5740, DOI 10.1073/pnas.101602398; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Groth RD, 2007, J NEUROCHEM, V102, P1162, DOI 10.1111/j.1471-4159.2007.04632.x; Groth RD, 2003, J NEUROSCI, V23, P8125; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Horsley V, 2002, J CELL BIOL, V156, P771, DOI 10.1083/jcb.200111073; Im SH, 2004, MOL CELLS, V18, P1; Jayanthi S, 2005, P NATL ACAD SCI USA, V102, P868, DOI 10.1073/pnas.0404990102; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Kurz JE, 2005, BRAIN RES, V1048, P153, DOI 10.1016/j.brainres.2005.04.062; Kurz JE, 2005, J NEUROTRAUM, V22, P476, DOI 10.1089/neu.2005.22.476; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Luoma JI, 2008, J NEUROSCI, V28, P3159, DOI 10.1523/JNEUROSCI.5227-07.2008; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Minematsu H, 2011, CELL SIGNAL, V23, P1785, DOI 10.1016/j.cellsig.2011.06.013; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Neal JW, 2001, J BIOL CHEM, V276, P3666, DOI 10.1074/jbc.M004888200; Neria F, 2013, GLIA, V61, P1052, DOI 10.1002/glia.22494; Nguyen T, 2008, INT J DEV NEUROSCI, V26, P141, DOI 10.1016/j.ijdevneu.2007.10.004; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Quadrato G, 2012, P NATL ACAD SCI USA, V109, pE1499, DOI 10.1073/pnas.1202068109; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Reeves TM, 2007, BRAIN RES, V1154, P225, DOI 10.1016/j.brainres.2007.04.002; Serfling E, 2000, BBA-MOL CELL RES, V1498, P1, DOI 10.1016/S0167-4889(00)00082-3; Serrano-Perez MC, 2011, GLIA, V59, P94, DOI 10.1002/glia.21079; Shioda N, 2007, J NEUROCHEM, V102, P1506, DOI 10.1111/j.1471-4159.2007.04600.x; Shioda N, 2006, J NEUROCHEM, V98, P310, DOI 10.1111/j.1471-4159.2006.03874.x; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Ulrich JD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.365197; Vashishta A, 2009, J NEUROSCI, V29, P15331, DOI 10.1523/JNEUROSCI.4873-09.2009; Wallace TL, 2011, BIOCHEM PHARMACOL, V82, P891, DOI 10.1016/j.bcp.2011.06.034; Yan HQ, 2007, BRAIN RES, V1134, P171, DOI 10.1016/j.brainres.2006.11.087; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	50	12	14	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 22	2014	1548						63	72		10.1016/j.brainres.2013.12.028			10	Neurosciences	Neurosciences & Neurology	AB6UM	WOS:000331925000006	24389074	Green Accepted			2021-06-18	
J	Nikles, CJ; McKinlay, L; Mitchell, GK; Carmont, SAS; Senior, HE; Waugh, MCA; Epps, A; Schluter, PJ; Lloyd, OT				Nikles, Catherine J.; McKinlay, Lynne; Mitchell, Geoffrey K.; Carmont, Sue-Ann S.; Senior, Hugh E.; Waugh, Mary-Clare A.; Epps, Adrienne; Schluter, Philip J.; Lloyd, Owen T.			Aggregated n-of-1 trials of central nervous system stimulants versus placebo for paediatric traumatic brain injury - a pilot study	TRIALS			English	Article						Traumatic brain injury; Children; Methylphenidate; Dexamphetamine; n-of-1 trials	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CHILDREN; METHYLPHENIDATE; INVENTORY; SECONDARY; PREDICTORS; VALIDITY; ADHD; CARE	Background: In 2006 there were 432,700 people in Australia who had acquired brain injury (ABI) with some limitation of activities; 90% of these were traumatic brain injuries (TBIs) and nearly a third sustained injury below age 15 years. One to four years post injury, 20% to 46% of children with traumatic brain injury (TBI) have clinically significant disorders of attention. There is controversy as to whether central nervous system (CNS) stimulants can be an effective method of treating these. Objectives were to determine the efficacy of CNS stimulants for children with TBI, and to calculate the sample size for a larger trial using the Conners' 3 Parent Rating Scales Score as the primary endpoint. Methods: Pilot series of aggregated prospective randomised, double-blind, n-of-1 trials of stimulant versus placebo within individual patients. Setting: tertiary children's public hospital. Participants: ten children aged 6 to 16 years more than 12 months post TBI with attention, concentration and behavioral difficulties on stimulants. Interventions: Three cycles of methylphenidate or dexamphetamine orally at doses titrated by physician compared to placebo. Main Outcome Measures: Conners 3 Parent (Conners 3-P) and Teacher (Conners 3-T) Rating Scales (Global Index), Behaviour Rating Inventory of Executive Function (BRIEF) and Eyberg Child Behaviour Inventory (ECBI). Results: Five of ten patients completed the study. Data from 18 completed cycles from seven patients were analysed. The posterior mean difference between stimulant and placebo scores for the Conners 3-PS (Global Index) was 2.3 (SD 6.2; 95% credible region -1.0 to 6.1; posterior probability that this mean difference was greater than zero was 0.92), and for the Conners 3-T (Global Index) the posterior mean difference was 5.9 (SD 4.5; 95% credible region -3.1 to 14.9; posterior probability 0.93). Posterior mean differences suggest improvement in behaviour and executive function and a decrease in number and intensity of child behaviour problems when taking stimulants compared to placebo. Taken together these data are suggestive of a small benefit at group level. Conclusions: In this pilot study, there was sufficient evidence that stimulants may be useful in management of behavioral and cognitive sequelae following TBI, to warrant a larger trial.	[Nikles, Catherine J.; Mitchell, Geoffrey K.; Carmont, Sue-Ann S.; Senior, Hugh E.] Univ Queensland, Sch Med, Ipswich, Qld 4305, Australia; [McKinlay, Lynne; Lloyd, Owen T.] Royal Childrens Hosp, Queensland Paediat Rehabil Serv, Herston, Qld 4029, Australia; [Waugh, Mary-Clare A.] Childrens Hosp, Westmead, NSW 2145, Australia; [Epps, Adrienne] Sydney Childrens Hosp, Rehabil Dept, Randwick, NSW 2031, Australia; [Schluter, Philip J.] Univ Canterbury, Sch Hlth Sci, Christchurch 8020, New Zealand	Nikles, CJ (corresponding author), Univ Queensland, Sch Med, Ipswich Campus,Bldg 12,Salisbury Rd, Ipswich, Qld 4305, Australia.	uqjnikle@uq.edu.au	Nikles, Jane/F-4572-2010; Carmont, Sue-Ann S/G-4769-2011; Senior, Hugh/H-1579-2011; Mitchell, Geoffrey/F-1489-2010	Nikles, Jane/0000-0001-5356-2291; Carmont, Sue-Ann S/0000-0001-6266-7757; McKinlay, Lynne/0000-0002-6677-0628; Schluter, Philip/0000-0001-6799-6779; Senior, Hugh/0000-0002-7081-2499; Mitchell, Geoffrey/0000-0001-7817-6821	Royal Children's Hospital Foundation; Motor Accident Insurance Commission of Queensland; NHMRCNational Health and Medical Research Council of Australia [401780]	We thank Ms Carla Rogers, Ms Anne Bucetti and Mr Peter Mulvey, Research Assistants, for help with data collection. Funding was provided by the Royal Children's Hospital Foundation (Research project seed research, new investigator) and the Motor Accident Insurance Commission of Queensland. Jane Nikles was funded by an NHMRC post-doctoral research fellowship 401780.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Australian Government, 2007, BULLETIN, V55; Bakker K., 2008, EFFICACY STIMULANT M; Bakker K., 2000, BRAIN IMPAIR, V1, P29; BOGGS SR, 1990, J CLIN CHILD PSYCHOL, V19, P75, DOI 10.1207/s15374424jccp1901_9; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Brown RT, 2005, PEDIATRICS, V115, pE749, DOI 10.1542/peds.2004-2560; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Catroppa C, 2009, DEV NEUROREHABIL, V12, P53, DOI 10.1080/17518420802634476; Clarke E, 1990, SCHOOL PSYCHOL INT, V11, P227; Conners C. K., 2008, CONNORS; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P279, DOI 10.1023/A:1022606501530; Eyberg S., 1999, EYBERG CHILD BEHAV I; EYBERG SM, 1978, J CLIN CHILD PSYCHOL, V7, P113, DOI 10.1080/15374417809532835; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Guyatt GH, 2000, JAMA-J AM MED ASSOC, V284, P1290, DOI 10.1001/jama.284.10.1290; Harvey DW, 2012, ARCH DIS CHILD, V97, P755, DOI 10.1136/archdischild-2012-302250; Hornyak J E, 1997, Pediatr Rehabil, V1, P15; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; Lee PM., 1997, BAYESIAN STAT INTRO, V3; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mahalick DM, 1998, PEDIATR NEUROSURG, V29, P121, DOI 10.1159/000028705; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Nikles CJ, 2007, EUR J CLIN PHARMACOL, V63, P985, DOI 10.1007/s00228-007-0361-x; Nikles CJ, 2006, PEDIATRICS, V117, P2040, DOI 10.1542/peds.2005-1328; Nikles J, 2011, J CLIN EPIDEMIOL, V64, P471, DOI 10.1016/j.jclinepi.2010.05.009; Schluter PJ, 2005, STAT MED, V24, P2625, DOI 10.1002/sim.2132; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Swanson JM, 2003, NEUROSCI BIOBEHAV R, V27, P615, DOI 10.1016/j.neubiorev.2003.08.013; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Williams SE, 1998, J HEAD TRAUMA REHAB, V13, P73, DOI 10.1097/00001199-199806000-00007; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Zucker DR, 1997, J CLIN EPIDEMIOL, V50, P401, DOI 10.1016/S0895-4356(96)00429-5	37	12	13	0	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-6215			TRIALS	Trials	FEB 13	2014	15								54	10.1186/1745-6215-15-54			11	Medicine, Research & Experimental	Research & Experimental Medicine	AD7TL	WOS:000333469600001	24524676	DOAJ Gold, Green Published			2021-06-18	
J	Ruis, C; van den Berg, E; van Stralen, HE; Wajer, IMCH; Biessels, GJ; Kappelle, LJ; Postma, A; van Zandvoort, MJE				Ruis, Carla; van den Berg, Esther; van Stralen, Haike E.; Wajer, Irene M. C. Huenges; Biessels, Geert Jan; Kappelle, L. Jaap; Postma, Albert; van Zandvoort, Martine J. E.			Symptom Checklist 90-Revised in neurological outpatients	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Symptom Checklist 90-Revised; Complaints; Neurology; Psychopathology.; Questionnaire	TRAUMATIC BRAIN-INJURY; SCL 90-R; AFFECTIVE-DISORDERS; TUMOR; HEADACHE	The Symptom Checklist 90-Revised (SCL-90-R) is an international, widely used, self-report questionnaire of multidimensional complaints with normative data for healthy control subjects and psychiatric patients. The questionnaire is also often used in neurological patients. Little is known about the amount and pattern of complaints in this group, and normative data are lacking. We therefore analyzed self-reported symptoms on the SCL-90-R of a neurological population (N = 600). Moreover, we compared the answer patterns of five subgroups: neurodegenerative disease, cerebrovascular disease, epilepsy, brain tumor, and traumatic brain injury. Neurological outpatients scored significantly higher in comparison with normative data from healthy control subjects, with most pronounced scores on Inadequacy of Thinking and Acting, Depression, and Somatization (p < .01, effect sizes 1.69, 0.83, and 0.83). No differences between the various pathologies were found. Although it is difficult to determine whether the complaints arise directly from the neurological disease or more indirectly from psychiatric disturbances accompanying the disease, simply comparing a neurological patient to normative data for healthy control subjects can lead to inappropriate classifications. Complaints of our patients should not be directly interpreted as psychopathology. A two-step procedure in which scores on the SCL-90-R are first compared to healthy control subjects and secondly to neurological patients can be helpful in the interpretation.	[Ruis, Carla; van den Berg, Esther; Wajer, Irene M. C. Huenges; Biessels, Geert Jan; Kappelle, L. Jaap; van Zandvoort, Martine J. E.] Univ Med Ctr Utrecht, Dept Neurol, Rudolf Magnus Inst Neurosci, NL-3508 GA Utrecht, Netherlands; [Ruis, Carla; van den Berg, Esther; van Stralen, Haike E.; Postma, Albert; van Zandvoort, Martine J. E.] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands; [van Stralen, Haike E.] Univ Med Ctr Utrecht, Dept Rehabil Med, Rudolf Magnus Inst Neurosci, NL-3508 GA Utrecht, Netherlands	Ruis, C (corresponding author), Univ Med Ctr Utrecht, Dept Neurol, G03-228,POB 85500, NL-3508 GA Utrecht, Netherlands.	c.ruis@umcutrecht.nl	van den Berg, Esther/ABD-8026-2020	van den Berg, Esther/0000-0002-8120-7366			Alfano Dennis P, 1990, Clin Neuropsychol, V4, P69, DOI 10.1080/13854049008401498; ALFANO DP, 1993, NEUROPSY NEUROPSY BE, V6, P111; Arrindell W, 1986, SYMPTOM CHECKLIST HA; Arrindell WA., 2005, SYMPTOM CHECKLIST HA; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bornstein R. A., 1990, COGN BEHAV NEUROL, V3, P200; Caplan B., 1992, J CLIN EXPT NEUROPSY, V14, P78; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; Derogatis L.R., 1994, SCL 90 R ADM SCORING, V3rd; Derogatis LR, 1977, SCL 90 ADM SCORING P; FORSYTH PA, 1993, NEUROLOGY, V43, P1678, DOI 10.1212/WNL.43.9.1678; Gass C. S., 2009, OXFORD HDB PERSONALI, P432; Gass CS, 1997, ARCH CLIN NEUROPSYCH, V12, P199, DOI 10.1016/S0887-6177(96)00032-7; Glassmire DM, 2003, ASSESSMENT, V10, P299, DOI 10.1177/1073191103256129; Kaplan CP, 1998, J HEAD TRAUMA REHAB, V13, P94, DOI 10.1097/00001199-199806000-00009; Kaplan CP, 1998, BRAIN INJURY, V12, P977, DOI 10.1080/026990598122025; Kaplan CP, 1998, BRAIN INJURY, V12, P199, DOI 10.1080/026990598122674; Leathem JM, 2000, J HEAD TRAUMA REHAB, V15, P1246, DOI 10.1097/00001199-200012000-00005; Leon-Carrion J, 2006, STUD NEUROPSYCH DEV, P275; Lezak M. D., 2012, NEUROPSYCHOLOGICAL A, P804; PIOTROWSKI C, 1990, PROF PSYCHOL-RES PR, V21, P99, DOI 10.1037/0735-7028.21.2.99; Schankin CJ, 2007, CEPHALALGIA, V27, P904, DOI 10.1111/j.1468-2982.2007.01368.x; Stang PE, 2005, NEUROLOGY, V64, P1573, DOI 10.1212/01.WNL.0000158326.31368.04; TATE DG, 1990, REHABIL PSYCHOL, V35, P211, DOI 10.1037/h0079062; Warlow C.P., 2011, STROKE PRACTICAL MAN; WEINGARTNER H, 1981, ARCH GEN PSYCHIAT, V38, P42; WOESSNER R, 1995, J HEAD TRAUMA REHAB, V10, P78, DOI 10.1097/00001199-199504000-00009; Woessner R., 1996, ASSESSMENT, V3, P291	29	12	13	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	520 CHESTNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	FEB 7	2014	36	2					170	177		10.1080/13803395.2013.875519			8	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	AB2CN	WOS:000331600700006	24479727				2021-06-18	
J	Castel-Lacanal, E; Tarri, M; Loubinoux, I; Gasq, D; de Boissezon, X; Marque, P; Simonetta-Moreau, M				Castel-Lacanal, E.; Tarri, M.; Loubinoux, I.; Gasq, D.; de Boissezon, X. .; Marque, P.; Simonetta-Moreau, M.			Transcranial magnetic stimulation in brain injury	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			English	Article						Stroke; Traumatic brain injury; Transcranial magnetic stimulation	MOTOR-EVOKED-POTENTIALS; THETA-BURST STIMULATION; TRANSCALLOSAL INHIBITION; UNAFFECTED HEMISPHERE; CORTEX EXCITABILITY; FOLLOW-UP; STROKE; RECOVERY; RTMS; REORGANIZATION	Objectives. - Transcranial magnetic stimulations (TMS) have been used for many years as a diagnostic tool to explore changes in cortical excitability, and more recently as a tool for therapeutic neuromodulation. We are interested in their applications following brain injury: stroke, traumatic and anoxic brain injury. Data synthesis. - Following brain injury, there is decreased cortical excitability and changes in interhemispheric interactions depending on the type, the severity, and the time-lapse between the injury and the treatment implemented. rTMS (repetitive TMS) is a therapeutic neuromodulation tool which restores the interhemispheric interactions following stroke by inhibiting the healthy cortex with frequencies <= 1 Hz, or by exciting the lesioned cortex with frequencies between 3 and 50 Hz. Results in motor recovery are promising and those in improving aphasia or visuospatial neglect are also encouraging. Finally, the use of TMS is mainly limited by the risk of seizure, and is therefore contraindicated for many patients. Conclusion. - TMS is a useful non-invasive brain stimulation tool to diagnose the effects of brain injury, to study the mechanisms of recovery and a non-invasive neuromodulation promising tool to influence the post-lesional recovery. (C) 2013 Societe francaise d'anesthesie et de reanimation (Sfar). Published by Elsevier Masson SAS. All rights reserved.	[Castel-Lacanal, E.; Gasq, D.; de Boissezon, X. .; Marque, P.] CHU Rangueil, Serv Med Phys & Readaptat, F-31059 Toulouse 9, France; [Castel-Lacanal, E.; Tarri, M.; Loubinoux, I.; Gasq, D.; de Boissezon, X. .; Marque, P.; Simonetta-Moreau, M.] CHU Purpan, INSERM U 825, F-31024 Toulouse 3, France; [Simonetta-Moreau, M.] CHU Purpan, Serv Neurol, F-31024 Toulouse 3, France	Castel-Lacanal, E (corresponding author), CHU Rangueil, Serv Med Phys & Readaptat, 1 Ave Jean Poulhes,TSA 50032, F-31059 Toulouse 9, France.	castel-lacanal.e@chu-toulouse.fr	Loubinoux, Isabelle/E-5537-2016; MARQUE, Philippe/AAC-4798-2019	Loubinoux, Isabelle/0000-0003-4461-0890; GASQ, David/0000-0002-1339-370X			Adeyemo Bamidele O, 2012, Front Psychiatry, V3, P88, DOI 10.3389/fpsyt.2012.00088; Baeumer T, 2006, J PHYSIOL-LONDON, V572, P857, DOI 10.1113/jphysiol.2006.104901; Bagnato S, 2012, CLIN NEUROPHYSIOL, V123, P1937, DOI 10.1016/j.clinph.2012.03.014; Barba C, 2006, NEUROCASE, V12, P232, DOI 10.1080/13554790600878879; BARKER AT, 1985, LANCET, V1, P1106; Barwood CHS, 2011, EUR J NEUROL, V18, P935, DOI 10.1111/j.1468-1331.2010.03284.x; Barwood CHS, 2011, NEUROREHABILITATION, V28, P113, DOI 10.3233/NRE-2011-0640; Bembenek JP, 2012, FUNCT NEUROL, V27, P79; BERARDELLI A, 1990, NEUROSCI LETT, V112, P54, DOI 10.1016/0304-3940(90)90321-Y; Bernabeu M, 2009, J NEUROTRAUM, V26, P2185, DOI 10.1089/neu.2008.0859; Centonze D, 2005, J PSYCHIATR NEUROSCI, V30, P127; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Chistyakov AV, 1998, ACTA NEUROCHIR, V140, P467, DOI 10.1007/s007010050126; Chistyakov AV, 1999, CLIN NEUROPHYSIOL, V110, P1080, DOI 10.1016/S1388-2457(99)00029-2; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; Cruccu G, 2007, EUR J NEUROL, V14, P952, DOI 10.1111/j.1468-1331.2007.01916.x; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Duque J, 2005, NEUROIMAGE, V28, P940, DOI 10.1016/j.neuroimage.2005.06.033; Edwardson MA, 2013, EXP BRAIN RES, V224, P335, DOI 10.1007/s00221-012-3315-1; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Fitzgerald PB, 2002, CLIN NEUROPHYSIOL, V113, P1136, DOI 10.1016/S1388-2457(02)00145-1; Fujiki M, 2006, NEUROSCI LETT, V405, P226, DOI 10.1016/j.neulet.2006.07.005; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Hanajima R, 2001, J PHYSIOL-LONDON, V531, P849, DOI 10.1111/j.1469-7793.2001.0849h.x; Hsu WY, 2012, STROKE, V43, P1849, DOI 10.1161/STROKEAHA.111.649756; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lefaucheur JP, 2011, NEUROPHYSIOL CLIN, V41, P221, DOI 10.1016/j.neucli.2011.10.062; Leo RJ, 2007, J PAIN, V8, P453, DOI 10.1016/j.jpain.2007.01.009; Leung A, 2009, J PAIN, V10, P1205, DOI 10.1016/j.jpain.2009.03.010; Liepert J, 2000, MUSCLE NERVE, V23, P1761, DOI 10.1002/1097-4598(200011)23:11<1761::AID-MUS14>3.0.CO;2-M; Lim JY, 2010, J REHABIL MED, V42, P447, DOI 10.2340/16501977-0553; Loubinoux I, 2003, NEUROIMAGE, V20, P2166, DOI 10.1016/j.neuroimage.2003.08.017; Martin Paula I., 2004, Seminars in Speech and Language, V25, P181; MEYER BU, 1995, BRAIN, V118, P429, DOI 10.1093/brain/118.2.429; Modugno N, 2001, EXP BRAIN RES, V140, P453, DOI 10.1007/s002210100843; Moosavi SH, 1999, J NEUROL SCI, V164, P179, DOI 10.1016/S0022-510X(99)00065-9; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Naeser MA, 2005, BRAIN LANG, V93, P95, DOI 10.1016/j.bandl.2004.08.004; Nyffeler T, 2009, STROKE, V40, P2791, DOI 10.1161/STROKEAHA.109.552323; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Schulz R, 2013, NEUROPHARMACOLOGY, V64, P579, DOI 10.1016/j.neuropharm.2012.05.016; Shimizu T, 2002, BRAIN, V125, P1896, DOI 10.1093/brain/awf183; Siebner HR, 2003, EXP BRAIN RES, V148, P1, DOI 10.1007/s00221-002-1234-2; Song WQ, 2009, J REHABIL MED, V41, P162, DOI 10.2340/16501977-0302; Stinear CM, 2012, BRAIN, V135, P2527, DOI 10.1093/brain/aws146; Swayne OBC, 2008, CEREB CORTEX, V18, P1909, DOI 10.1093/cercor/bhm218; Szaflarski JP, 2011, MED SCI MONITOR, V17, pCR132, DOI 10.12659/MSM.881446; Takeuchi N, 2006, BRAIN INJURY, V20, P991, DOI 10.1080/02699050600909771; Tallus J, 2012, ACTA NEUROL SCAND, V126, P178, DOI 10.1111/j.1600-0404.2011.01623.x; Tombari D, 2004, NEUROIMAGE, V23, P827, DOI 10.1016/j.neuroimage.2004.07.058; Traversa R, 1998, BRAIN RES, V803, P1, DOI 10.1016/S0006-8993(98)00505-8; Traversa R, 2000, CLIN NEUROPHYSIOL, V111, P1695, DOI 10.1016/S1388-2457(00)00373-4; Wang RY, 2012, NEUROREHAB NEURAL RE, V26, P222, DOI 10.1177/1545968311423265; WEILLER C, 1992, ANN NEUROL, V31, P463, DOI 10.1002/ana.410310502	57	12	13	0	30	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	FEB	2014	33	2					83	87		10.1016/j.annfar.2013.11.006			5	Anesthesiology	Anesthesiology	AD8IS	WOS:000333510300004	24378049				2021-06-18	
J	Mahmood, A; Wu, HT; Qu, CS; Mahmood, S; Xiong, Y; Kaplan, D; Chopp, M				Mahmood, Asim; Wu, Hongtao; Qu, Changsheng; Mahmood, Selina; Xiong, Ye; Kaplan, David; Chopp, Michael			Down-regulation of Nogo-A by collagen scaffolds impregnated with bone marrow stromal cell treatment after traumatic brain injury promotes axonal regeneration in rats	BRAIN RESEARCH			English	Article						Bone marrow stromal cells; Nogo-A; Axonal regeneration; Traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; FUNCTIONAL RECOVERY; NEURITE GROWTH; ADULT-RATS; NEONATAL LESIONS; EXPRESSION; TRANSPLANTATION; MYELIN; PROTEOGLYCANS; INHIBITION	Nogo-A is a major form of growth inhibitory molecule (growth-IM) which inhibits axonal regeneration and neurite regrowth after neural injury. Bone marrow stromal cells (MSCs) have been shown to inhibit Nogo-A expression in vitro and in cerebral ischemic animal models. The present study was designed to investigate the effects of treatment with human MSCs (hMSCs) impregnated into collagen scaffolds on the expression of Nogo-A and axonal plasticity after traumatic brain injury (TBI). Adult male Wistar rats were injured with controlled cortical impact and treated either with saline, hMSCs-alone or hMSCs impregnated into collagen scaffolds (scaffold+hMSC) transplanted into the lesion cavity 7 days after TBI. Rats were sacrificed 14 days after TBI and brain tissues were harvested for immunohistochemical studies, Western blot analysis, laser capture microdissections and qRT-PCR to evaluate axonal density and Nogo-A protein and gene expressions. Our data showed that treatment of TBI with scaffold+hMSC significantly decreased TBI-induced Nogo-A protdin expression and increased axonal density compared to saline and hMSCalone treatments. In addition, scaffold+hMSC transplantation decreased Nogo-A transcription in oligodendrocytes after TBI. Scaffold+hMSC treatment was superior to hMSC-alone treatment in suppressing Nogo-A expression and enhancing axonal regeneration after TBI. Our data suggest that transplanting hMSCs with scaffolds down-regulates Nogo-A transcription and protein expression which may partially contribute to the enhanced axonal regeneration after TBI. (C) 2013 Elsevier B.V. All rights reserved.	[Mahmood, Asim; Wu, Hongtao; Qu, Changsheng; Mahmood, Selina; Xiong, Ye] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Chopp, Michael] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI 48309 USA; [Kaplan, David] Tufts Univ, Ctr Sci & Technol, Dept Biomed Engn, Boston, MA 02155 USA	Mahmood, A (corresponding author), Henry Ford Hosp, Dept Neurosurg, 2799W Grand Blvd, Detroit, MI 48202 USA.	amahmoo1@hfhs.org; hwu1@hfhs.org; cqu1@hfhs.org; selina_117@hotmail.com; yxiong1@hfhs.org; david.kaplan@tufts.edu; mchopp1@hfhs.org		Xiong, Ye/0000-0001-9770-6031			Al Halabiah H, 2005, GENE EXPR PATTERNS, V5, P561, DOI 10.1016/j.modgep.2004.10.010; Bonilla C, 2012, J TRAUMA ACUTE CARE, V72, P1203, DOI 10.1097/TA.0b013e318248bdcf; Bovolenta P, 2000, PROG NEUROBIOL, V61, P113, DOI 10.1016/S0301-0082(99)00044-1; Buchli AD, 2005, ANN MED, V37, P556, DOI 10.1080/07853890500407520; Calza L, 2001, P NATL ACAD SCI USA, V98, P4160, DOI 10.1073/pnas.051626998; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Condic ML, 2002, NEUROREPORT, V13, pA37, DOI 10.1097/00001756-200203040-00002; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dodd DA, 2005, J BIOL CHEM, V280, P12494, DOI 10.1074/jbc.M411827200; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; Huber AB, 2002, J NEUROSCI, V22, P3553; KARTJETILLOTSON G, 1986, J COMP NEUROL, V250, P206, DOI 10.1002/cne.902500207; KOLB H, 1992, J COMP NEUROL, V318, P147, DOI 10.1002/cne.903180204; Lee DHS, 2003, NAT REV DRUG DISCOV, V2, P872, DOI 10.1038/nrd1228; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; LEONG SK, 1973, BRAIN RES, V62, P218, DOI 10.1016/0006-8993(73)90630-6; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Lu DY, 2003, J HEAD TRAUMA REHAB, V18, P357, DOI 10.1097/00001199-200307000-00006; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Mahrnood A., 2013, J NEUROSURG, V118, P381; Merkler D, 2001, J NEUROSCI, V21, P3665, DOI 10.1523/JNEUROSCI.21-10-03665.2001; Mihailoff G.A., 1981, NEUROSCI LETT, V21; MURAKAMI F, 1988, BRAIN RES, V447, P98, DOI 10.1016/0006-8993(88)90969-9; NAH SH, 1976, BRAIN RES, V107, P433, DOI 10.1016/0006-8993(76)90242-0; Ordway GA, 2009, J NEUROSCI RES, V87, P2430, DOI 10.1002/jnr.22078; Papadopoulos CM, 2002, ANN NEUROL, V51, P433, DOI 10.1002/ana.10144; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Properzi F, 2003, BIOCHEM SOC T, V31, P335, DOI 10.1042/BST0310335; Qu CS, 2011, BRAIN RES, V1371, P129, DOI 10.1016/j.brainres.2010.10.088; Shen LH, 2008, GLIA, V56, P1747, DOI 10.1002/glia.20722; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Wang XX, 2002, J NEUROSCI, V22, P5505; Wang YL, 2012, LIFE SCI J, V9, P733; Wang ZT, 2013, J MOL NEUROSCI, V49, P409, DOI 10.1007/s12031-012-9908-0; Wright KT, 2007, BIOCHEM BIOPH RES CO, V354, P559, DOI 10.1016/j.bbrc.2007.01.013; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Z'Graggen WJ, 2000, J NEUROSCI, V20, P6561, DOI 10.1523/JNEUROSCI.20-17-06561.2000	46	12	17	0	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 13	2014	1542						41	48		10.1016/j.brainres.2013.10.045			8	Neurosciences	Neurosciences & Neurology	299UF	WOS:000330420500005	24177046				2021-06-18	
J	Stubberud, J; Langenbahn, D; Levine, B; Stanghelle, J; Schanke, AK				Stubberud, Jan; Langenbahn, Donna; Levine, Brian; Stanghelle, Johan; Schanke, Anne-Kristine			Goal Management Training improves everyday executive functioning for persons with spina bifida: Self-and informant reports six months post-training	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Executive functioning; Cognitive rehabilitation; Brain injury; Goal management; Evidence-based	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; YOUNG-ADULTS; COGNITIVE REHABILITATION; FRONTAL-LOBE; ECOLOGICAL VALIDITY; CLINICAL NEUROPSYCHOLOGY; DYSEXECUTIVE SYNDROME; STRATEGY APPLICATION; DIRECTED BEHAVIOR	Executive dysfunction accounts for significant disability for many patients with spina bifida (SB), thus indicating the need for effective interventions aimed at improving executive functioning in this population. Goal Management Training (GMT) is a cognitive rehabilitation approach that targets disorganised behaviour resulting from executive dysfunction, and has received empirical support in studies of other patient groups. The purpose of this study was to determine if GMT would lead to perceived improved executive functioning in the daily lives of patients with SB, as evidenced by reduced report of dysexecutive problems in daily life on self- and informant questionnaires. Thirty-eight adults with SB were included in this randomised controlled trial (RCT). Inclusion was based upon the presence of executive functioning complaints. Experimental subjects (n = 24) received 21 hours of GMT, with efficacy of GMT being compared to results of subjects in a wait-list condition (n = 14). All subjects were assessed at baseline, post-intervention, and at six-month follow-up. Self-report measures indicated that the GMT group's everyday executive functioning improved significantly after training, lasting at least 6 months post-treatment.There were no significant effects on informant-report questionnaires. Overall, these findings indicate that executive difficulties in everyday life can be ameliorated for individuals with congenital brain dysfunction.	[Stubberud, Jan; Stanghelle, Johan; Schanke, Anne-Kristine] Sunnaas Rehabil Hosp, N-1450 Nesoddtangen, Norway; [Langenbahn, Donna] NYU, Sch Med, Rusk Inst Rehabil Med, New York, NY USA; [Levine, Brian] Rotman Res Inst, Baycrest Ctr, Toronto, ON, Canada; [Levine, Brian] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Levine, Brian] Univ Toronto, Dept Med, Toronto, ON, Canada; [Stanghelle, Johan] Univ Oslo, Dept Med, Oslo, Norway; [Schanke, Anne-Kristine] Univ Oslo, Dept Psychol, Oslo, Norway	Stubberud, J (corresponding author), Sunnaas Rehabil Hosp, Bjornemyrveien 11, N-1450 Nesoddtangen, Norway.	Jan.stubberud@sunnaas.no	Levine, Brian/G-4328-2010; Levine, Brian/O-2725-2019	Levine, Brian/0000-0003-4343-811X; Levine, Brian/0000-0003-4343-811X; Stubberud, Jan/0000-0001-9592-8589	South-Eastern Norway Regional Health Authority [2011041]	This work was supported by the South-Eastern Norway Regional Health Authority (grant number 2011041).	Alfonso JP, 2011, DRUG ALCOHOL DEPEN, V117, P78, DOI 10.1016/j.drugalcdep.2010.12.025; Barf HA, 2009, DISABIL REHABIL, V31, P921, DOI 10.1080/09638280802358282; Barf HA, 2010, J REHABIL MED, V42, P56, DOI 10.2340/16501977-0481; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; BROADBENT DE, 1986, BRIT J CLIN PSYCHOL, V25, P285, DOI 10.1111/j.2044-8260.1986.tb00708.x; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Burgess P. W., 1996, BEHAV ASSESSMENT DYS; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Burgess PW., 2005, EFFECTIVENESS REHABI; Burmeister R, 2005, CHILD NEUROPSYCHOL, V11, P265, DOI 10.1080/092970490911324; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Charney Edward B., 1992, P471; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; Chevignard M, 2000, CORTEX, V36, P649, DOI 10.1016/S0010-9452(08)70543-4; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cicerone KD, 2012, ARCH PHYS MED REHAB, V93, P188, DOI 10.1016/j.apmr.2011.12.003; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; CONNERS CK, 2000, CONNERS CPT 2 CONTIN; Coull J. T., 1995, THESIS CAMBRIDGE U; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Dennis M, 2006, J INT NEUROPSYCH SOC, V12, P285, DOI 10.1017/S1355617706060371; Dennis M, 2010, DEV DISABIL RES REV, V16, P31, DOI 10.1002/ddrr.89; Dumville JC, 2006, CONTEMP CLIN TRIALS, V27, P1, DOI 10.1016/j.cct.2005.08.003; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360; Evans J, 2005, EFFECTIVENESS REHABI, P247; Evans JJ, 1997, PSYCHOL MED, V27, P635, DOI 10.1017/S0033291797004790; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Fleming JM, 1996, BRAIN INJURY, V10, P1; Fletcher JM, 1996, DEV NEUROPSYCHOL, V12, P53, DOI 10.1080/87565649609540640; Franzen M.D., 1996, ECOLOGICAL VALIDITY, P91; Friedman D, 2009, REHABIL PSYCHOL, V54, P16, DOI 10.1037/a0014279; Gioia G.A., 2000, BEHAV RATING INVENTO; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Grant M, 2012, NEUROPSYCHOL REHABIL, V22, P852, DOI 10.1080/09602011.2012.693455; Greene CM, 2009, NEUROPSYCHOLOGIA, V47, P591, DOI 10.1016/j.neuropsychologia.2008.10.003; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Heffelfinger AK, 2008, J INT NEUROPSYCH SOC, V14, P793, DOI 10.1017/S1355617708081022; Hetherington R, 2006, CHILD NERV SYST, V22, P117, DOI 10.1007/s00381-005-1231-4; Holmbeck GN, 2010, J CONSULT CLIN PSYCH, V78, P511, DOI 10.1037/a0019599; Iddon JL, 2004, J NEUROL NEUROSUR PS, V75, P1112, DOI 10.1136/jnnp.2003.029058; In de Braek D. M., 2012, J ATTENTION DISORDER, DOI 10.1177/1087054712468052; Jackson J., 2011, CRITICAL CARE MED, DOI 10.1097/CCM.0b013e3182373115; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kabat-Zinn J, 1990, FULL CATASTROPHE LIV; Kelly NC, 2012, CHILD NEUROPSYCHOL, V18, P417, DOI 10.1080/09297049.2011.613814; LANDRY SH, 1993, J PEDIATR PSYCHOL, V18, P389, DOI 10.1093/jpepsy/18.3.389; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Levaux M.N., 2012, CASE REPORTS PSYCHIA, V2012; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Levine B, 2008, COGNITIVE NEUROREHAB, P464; Levine B, 2007, J INT NEUROPSYCH SOC, V13, P143, DOI 10.1017/S1355617707070178; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lewis MW, 2011, NEUROPSYCHOL REHABIL, V21, P145, DOI 10.1080/09602011.2010.543867; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Lovstad M, 2012, BRAIN INJURY, V26, P1586, DOI 10.3109/02699052.2012.698787; Mahone EM, 2002, CHILD NEUROPSYCHOL, V8, P258, DOI 10.1076/chin.8.4.258.13510; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; Mataro M, 2001, NEUROPSYCHOL REV, V11, P169, DOI 10.1023/A:1012904907249; Mathias JL, 2003, APPL NEUROPSYCHOL, V10, P57, DOI 10.1207/S15324826AN1002_01; McCambridge J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039116; McPherson KM, 2009, CLIN REHABIL, V23, P296, DOI 10.1177/0269215509102980; Merckelbach H, 1999, PERS INDIV DIFFER, V26, P961, DOI 10.1016/S0191-8869(98)00193-7; Mesulam M.-M., 2002, HUMAN FRONTAL LOBES, P8; Metzler-Baddeley C, 2010, APPL NEUROPSYCHOL, V17, P299, DOI 10.1080/09084282.2010.523394; Miotto EC, 2009, NEUROPSYCHOL REHABIL, V19, P517, DOI 10.1080/09602010802332108; Mitchell LE, 2004, LANCET, V364, P1885, DOI 10.1016/S0140-6736(04)17445-X; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; ORNE MT, 1962, AM PSYCHOL, V17, P776, DOI 10.1037/h0043424; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Raz A, 2006, NAT REV NEUROSCI, V7, P367, DOI 10.1038/nrn1903; Raz N, 2009, NEUROPSYCHOL REV, V19, P411, DOI 10.1007/s11065-009-9122-1; Robertson IH, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P631; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Robertson IH, 1996, GOAL MANAGEMENT TRAI; Rose BM, 2007, J PEDIATR PSYCHOL, V32, P983, DOI 10.1093/jpepsy/jsm042; Roth R., 2005, BRIEF A BEHAV RATING; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332; Schweizer TA, 2008, NEUROREHAB NEURAL RE, V22, P72, DOI 10.1177/1545968307305303; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Simblett SK, 2012, NEUROPSYCHOL REHABIL, V22, P874, DOI 10.1080/09602011.2012.703956; Simblett SK, 2011, NEUROPSYCHOL REHABIL, V21, P1, DOI 10.1080/09602011.2011.592099; Smith A, 1996, NATURE, V380, P291, DOI 10.1038/380291a0; SNOW JH, 1994, ARCH CLIN NEUROPSYCH, V9, P277, DOI 10.1016/0887-6177(94)90033-7; Sohlberg MM, 1998, J HEAD TRAUMA REHAB, V13, P62, DOI 10.1097/00001199-199810000-00008; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Stubberud J, 2013, J INT NEUROPSYCH SOC, V19, P672, DOI 10.1017/S1355617713000209; Stubberud J, 2012, DISABIL REHABIL, V34, P740, DOI 10.3109/09638288.2011.619617; Stuss DT, 2007, J INT NEUROPSYCH SOC, V13, P120, DOI 10.1017/S1355617707070154; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Tarazi RA, 2008, CLIN NEUROPSYCHOL, V22, P585, DOI 10.1080/13854040701425940; TIPPER SP, 1987, PERS INDIV DIFFER, V8, P667, DOI 10.1016/0191-8869(87)90064-X; Tuminello ER, 2012, CHILD NEUROPSYCHOL, V18, P105, DOI 10.1080/09297049.2011.590470; Turner-Stokes L, 2002, DISABIL REHABIL, V24, P383, DOI 10.1080/096382801101550; Vinck A, 2006, J NEUROL NEUROSUR PS, V77, P1083, DOI 10.1136/jnnp.2005.075887; Vogel A, 2004, DEMENT GERIATR COGN, V17, P181, DOI 10.1159/000076354; Waid-Ebbs JK, 2012, BRAIN INJURY, V26, P1646, DOI 10.3109/02699052.2012.700087; Wechsler D., 1999, MANUAL WECHSLER ABBR; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P1, DOI 10.1017/CBO9780511581083; Wilson BA, 1996, BEHAV ASSESSMENT DYS; Wilson BA, 2008, ANNU REV CLIN PSYCHO, V4, P141, DOI 10.1146/annurev.clinpsy.4.022007.141212; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014; World Health Organization, 2001, INT CLASS FUNCT DIS; Worthington A. D., 2005, HDB CLIN NEUROPSYCHO; Zald DH, 2010, NEUROPSYCHOLOGIA, V48, P3377, DOI 10.1016/j.neuropsychologia.2010.08.012; Zukerman JM, 2011, J PEDIATR PSYCHOL, V36, P265, DOI 10.1093/jpepsy/jsq075	120	12	12	0	20	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN 2	2014	24	1					26	60		10.1080/09602011.2013.847847			35	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	295GJ	WOS:000330104300002	24168074				2021-06-18	
J	Bottari, C; Shun, PLW; Le Dorze, G; Gosselin, N; Dawson, D				Bottari, Carolina; Shun, Priscilla Lam Wai; Le Dorze, Guylaine; Gosselin, Nadia; Dawson, Deirdre			Self-Generated Strategic Behavior in an Ecological Shopping Task	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						activities of daily living; brain injuries; cognition; decision making; executive function	EXECUTIVE DYSFUNCTION; IADL PROFILE; BRAIN-INJURY; VALIDATION; VALIDITY	OBJECTIVES. The use of cognitive strategies optimizes performance in complex everyday tasks such as shopping. This exploratory study examined the cognitive strategies people with traumatic brain injury (TBI) effectively use in an unstructured, real-world situation. METHOD. A behavioral analysis of the self-generated strategic behaviors of 5 people with severe TBI using videotaped sessions of an ecological shopping task (Instrumental Activities of Daily Living Profile) was performed. RESULTS. All participants used some form of cognitive strategy in an unstructured real-world shopping task, although the number, type, and degree of effectiveness of the strategies in leading to goal attainment varied. The most independent person used the largest number and a broader repertoire of self-generated strategies. CONCLUSION. These results provide initial evidence that occupational therapists should examine the use of self-generated cognitive strategies in real-world contexts as a potential means of guiding therapy aimed at improving independence in everyday activities for people with TBI.	[Bottari, Carolina; Shun, Priscilla Lam Wai] Univ Montreal, Occupat Therapy Program, Sch Rehabil, Montreal, PQ H3C 3J7, Canada; [Bottari, Carolina; Shun, Priscilla Lam Wai; Le Dorze, Guylaine] Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada; [Shun, Priscilla Lam Wai] McGill Univ, Montreal Neurol Inst, Occupat Therapy Dept, Montreal, PQ, Canada; [Le Dorze, Guylaine] Univ Montreal, Sch Speech Language Therapy & Audiol, Montreal, PQ H3C 3J7, Canada; [Gosselin, Nadia] Hop Sacre Coeur, Res Ctr, Montreal, PQ H4J 1C5, Canada; [Gosselin, Nadia] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Dawson, Deirdre] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Dawson, Deirdre] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Dawson, Deirdre] Rotman Res Inst, Toronto, ON, Canada	Bottari, C (corresponding author), Univ Montreal, Occupat Therapy Program, Sch Rehabil, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	carolina.bottari@umontreal.ca	Le Dorze, Guylaine/A-1790-2014; Dawson, Deirdre R/I-8882-2014	Dawson, Deirdre R/0000-0001-7517-6121			Alexander PA, 1998, EDUC PSYCHOL REV, V10, P129, DOI 10.1023/A:1022185502996; Bottari C, 2011, BRAIN INJURY, V25, P1306, DOI 10.3109/02699052.2011.624570; Bottari C, 2010, ARCH PHYS MED REHAB, V91, P734, DOI 10.1016/j.apmr.2009.12.023; Bottari C, 2009, NEUROPSYCHOL REHABIL, V19, P177, DOI 10.1080/09602010802188435; Bottari C, 2009, BRAIN INJURY, V23, P322, DOI 10.1080/02699050902788436; Bottari CL, 2010, CAN J OCCUP THER, V77, P90, DOI 10.2182/cjot.2010.77.2.5; Bouazzaoui B, 2010, ACTA PSYCHOL, V135, P59, DOI 10.1016/j.actpsy.2010.05.007; BURKE W H, 1991, Brain Injury, V5, P241, DOI 10.3109/02699059109008095; Cicerone K. D., 2005, REHABILITATION TRAUM, P71; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; Draucker CB, 2007, QUAL HEALTH RES, V17, P1137, DOI 10.1177/1049732307308450; Fertherlin J. M., 1989, OCCUPATIONAAL THERAP, V1, P75; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; Haskins EC, 2012, COGNITIVE REHABILITA; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Mateer C A, 1999, Semin Clin Neuropsychiatry, V4, P50; Norman D. A., 1986, COGNITIVE NEUROSCIEN, P376; Patton M., 1990, QUALITATIVE EVALUATI, V2, DOI [DOI 10.1002/NUR.4770140111, 10.1002/nur.4770140111]; QSR International, 2012, NVIVO COMP SOFTW; Schneidert M, 2003, DISABIL REHABIL, V25, P588, DOI 10.1080/0963828031000137090; SOHLBERG MM, 1993, J HEAD TRAUMA REHAB, V8, P45, DOI DOI 10.1097/00001199-199303000-00006; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; STUSS DT, 1991, SELF : INTERDISCIPLINARY APPROACHES, P255; TEASDALE G, 1974, LANCET, V2, P81; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474; Toglia JP, 2012, CAN J OCCUP THER, V79, P225, DOI 10.2182/cjot.2012.79.4.4; Walsh MM, 2009, COGNITIVE PSYCHOL, V58, P416, DOI 10.1016/j.cogpsych.2008.09.003; Wilson BA, 2000, NEUROPSYCHOL REV, V10, P233, DOI 10.1023/A:1026464827874; Woods D. K., 2008, TRANSANA VERSION 2 2	29	12	12	0	11	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	JAN-FEB	2014	68	1					67	76		10.5014/ajot.2014.008987			10	Rehabilitation	Rehabilitation	296CA	WOS:000330161500010	24367957	Bronze			2021-06-18	
J	Broshek, DK; Samples, H; Beard, J; Goodkin, HP				Broshek, Donna K.; Samples, Hillary; Beard, Jennifer; Goodkin, Howard P.			Current Practices of the Child Neurologist in Managing Sports Concussion	JOURNAL OF CHILD NEUROLOGY			English	Article						concussion; mild traumatic brain injury; head trauma; return to play; sports	TRAUMATIC BRAIN-INJURY; EXERCISE; SYMPTOMS	Given the 2010 position statement issued by the American Academy of Neurology that neurologists be consulted on return-to-play decisions following a concussion, we surveyed members of the Child Neurology Society to asses clinical practice management of concussion among child neurologists. Among the 239 respondents, the majority continued to rely on the American Academy of Neurology's 1997 Practice Parameter to guide their decision-making process. Although the 2008 consensus statement from the Third International Conference on Concussion in Sport (Zurich Guidelines) is currently considered the most up-to-date guideline, few respondents relied exclusively on this guideline. More respondents who completed continuing medical education on concussion reported making clinical decisions based on the Zurich guidelines. The finding that child neurologists who completed continuing medical education had a greater familiarity with the more recently proposed consensus-based concussion guidelines supports the development of additional education in sports concussion at all levels of child neurology training.	[Broshek, Donna K.; Samples, Hillary; Beard, Jennifer] Univ Virginia Hlth Syst, Brain Injury & Sports Concuss Inst, Dept Psychiat & Neurobehav Sci, Charlottesville, VA USA; [Goodkin, Howard P.] Univ Virginia Hlth Syst, Brain Injury & Sports Concuss Inst, Dept Neurol, Charlottesville, VA USA; [Goodkin, Howard P.] Univ Virginia Hlth Syst, Brain Injury & Sports Concuss Inst, Dept Pediat, Charlottesville, VA USA	Goodkin, HP (corresponding author), Univ Virginia, Dept Neurol, POB 800394, Charlottesville, VA 22908 USA.	hpg9v@virginia.edu		Goodkin, Howard/0000-0003-0528-4949			American Academy of Neurology, 2010, POS STAT SPORTS CONC; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Ferriero Donna M, 2010, Ann Neurol, V67, pA5, DOI 10.1002/ana.22047; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Goodkin HP, 2011, SEMIN PEDIATR NEUROL, V18, P142, DOI 10.1016/j.spen.2011.05.013; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Kaye AJ, 2010, J TRAUMA, V68, P1396, DOI 10.1097/TA.0b013e3181cf7d1b; Kelly JP, 1997, NEUROLOGY, V48, P581; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McCrory Paul, 2009, J Athl Train, V44, P434, DOI 10.4085/1062-6050-44.4.434; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Schwarz A, 2010, NY TIMES; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082	18	12	12	0	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JAN	2014	29	1					17	22		10.1177/0883073812464525			6	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	282UY	WOS:000329200300002	23143716				2021-06-18	
J	Clark-Wilson, J; Giles, GM; Baxter, DM				Clark-Wilson, Jo; Giles, Gordon Muir; Baxter, Doreen M.			Revisiting the neurofunctional approach: Conceptualizing the core components for the rehabilitation of everyday living skills	BRAIN INJURY			English	Article						Brain injury; cognition; learning; neurofunctional approach	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; TOTAL TASK PRESENTATION; COGNITIVE REHABILITATION; HEAD-INJURY; MULTIDISCIPLINARY REHABILITATION; THERAPEUTIC ALLIANCE; IMPAIRED AWARENESS; FUNCTIONAL SKILLS; WORKING ALLIANCE	Background: Introduced in the 1980s, the neurofunctional approach (NFA) is one of the few interventions designed primarily for clients with severe deficits following traumatic brain injury (TBI). Specifically the NFA was intended for those individuals who were limited in their ability to solve novel problems or generalize skills from one setting to another and whose lack of insight limited their engagement in the rehabilitative process. Description of the approach: The NFA is a client-centred, goal-driven approach that incorporates the principles of skill learning and promotes the development of routines and competencies in practical activities required for everyday living. Programmes based on the NFA are developed specifically to meet each client's unique needs, using a range of evidence-based interventions. Recent evidence: Recently the NFA has been found to be more effective than cognitive-retraining for some individuals with moderate-to-severe TBI who have deficits in activities of daily living. This paper aims to define the core features of the NFA, outline the theoretical basis on which it is founded and consider implications of the findings for rehabilitation after TBI in general. The NFA is highly relevant for clients living in the community who require a case manager to direct an integrated, rehabilitation programme or provide structured input for the long-term maintenance of skills.	[Clark-Wilson, Jo; Baxter, Doreen M.] Head First, Hawkhurst, Kent, England; [Giles, Gordon Muir] Crestwood Treatment Ctr, Neurobehav Serv, Fremont, CA USA; [Giles, Gordon Muir] Samuel Merritt Univ, Dept Occupat Therapy, Oakland, CA USA	Giles, GM (corresponding author), Crestwood Treatment Ctr, 2171 Mowry Ave, Fremont, CA 94538 USA.	jo.clarkwilson@head-first.org					ANDERSON JR, 1982, PSYCHOL REV, V89, P369, DOI 10.1037/0033-295X.89.4.369; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Bandura A., 1977, SOCIAL LEARNING THEO; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bombardier CH, 1999, REHABIL PSYCHOL, V44, P52, DOI 10.1037/0090-5550.44.1.52; Brasure M, 2013, ARCH PHYS MED REHAB, V94, P1398, DOI 10.1016/j.apmr.2012.12.019; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Campbell C H, 1988, Rehabil Nurs, V13, P320; Carkhuff R.R., 1977, COUNSELING THERAPY; Castonguay LG, 1996, J CONSULT CLIN PSYCH, V64, P497, DOI 10.1037/0022-006X.64.3.497; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Clare L, 2010, AM J GERIAT PSYCHIAT, V18, P928, DOI 10.1097/JGP.0b013e3181d5792a; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [10.1097/00001199-198909000-00008, DOI 10.1097/00001199-198909000-00008]; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; Draganski D, 2004, NATURE, V427, P311; DRISKELL JE, 1992, J APPL PSYCHOL, V77, P615, DOI 10.1037/0021-9010.77.5.615; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Evans J. J., 2010, HDB CLIN NEUROPSYCHO, DOI [10.1093/acprof:oso/9780199 234110.003.02, DOI 10.1093/ACPROF:OSO/9780199234110.003.02]; Finfgeld-Connett D, 2009, CLIN NURS RES, V18, P272, DOI 10.1177/1054773809337577; Follette WC, 1996, BEHAV THER, V27, P623, DOI 10.1016/S0005-7894(96)80047-5; Geurtsen GJ, 2010, J REHABIL MED, V42, P97, DOI 10.2340/16501977-0508; Giles G. M., 2011, COGNITION OCCUPATION, P351; Giles GM, 2006, J HEAD TRAUMA REHAB, V21, P168, DOI 10.1097/00001199-200603000-00009; Giles GM, 2005, BRAIN INJURY, V19, P753, DOI 10.1080/02699050500110108; Giles GM, 1997, AM J OCCUP THER, V51, P256, DOI 10.5014/ajot.51.4.256; GILES GM, 1988, AM J OCCUP THER, V42, P658, DOI 10.5014/ajot.42.10.658; Giles GM, 2005, COGNITION OCCUPATION, P139; GILES GM, 1993, BRAIN INJURY REHABIL; Giles GM, 2010, AM J OCCUP THER, V64, P182, DOI 10.5014/ajot.64.1.182; Giles GM, 2009, ARCH PHYS MED REHAB, V90, P530, DOI 10.1016/j.apmr.2009.01.004; Giuffrida CG, 2009, AM J OCCUP THER, V63, P398, DOI 10.5014/ajot.63.4.398; Goldenberg G, 1998, NEUROPSYCHOL REHABIL, V8, P123; Goldenberg G, 2001, NEUROPSYCHOL REHABIL, V11, P147, DOI 10.1080/09602010042000204; Goverover Y, 2010, AM J OCCUP THER, V64, P540, DOI 10.5014/ajot.2010.09020; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; HAYESROTH B, 1977, PSYCHOL REV, V84, P260, DOI 10.1037/0033-295X.84.3.260; High WM, 2006, ARCH PHYS MED REHAB, V87, P334, DOI 10.1016/j.apmr.2005.11.028; Holliday RC, 2007, DISABIL REHABIL, V29, P389, DOI 10.1080/09638280600841117; Holloway M, 2012, SOCIAL CARE NEURODIS, V3, P122, DOI DOI 10.1108/20420911211268740; HORVATH AO, 1991, J COUNS PSYCHOL, V38, P139, DOI 10.1037/0022-0167.38.2.139; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P563, DOI 10.1080/09602011.2012.676284; Hsieh MY, 2012, DISABIL REHABIL, V34, P408, DOI 10.3109/09638288.2011.607219; JR Anderson., 1981, COGNITIVE SKILLS THE, P1; Kazdin A. E., 1994, BEHAV MODIFICATION A; Klonoff PS, 1998, ARCH PHYS MED REHAB, V79, P684, DOI 10.1016/S0003-9993(98)90045-4; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; KOSCIULEK JF, 1994, REHABIL PSYCHOL, V39, P215, DOI 10.1037/0090-5550.39.4.215; KOSCIULEK JF, 1996, J APPL REHABILITATIO, V27, P8; KRAMER AF, 1990, J EXP PSYCHOL HUMAN, V16, P505; LATHAM GP, 1988, J APPL PSYCHOL, V73, P753, DOI 10.1037/0021-9010.73.4.753; LATHAM GP, 1994, J ORGAN BEHAV, V15, P49, DOI 10.1002/job.4030150106; Liao B, 2013, J EXP PSYCHOPATHOL, V4, P148, DOI 10.5127/jep.026612; LLOYD LF, 1994, BRAIN INJURY, V8, P529, DOI 10.3109/02699059409151005; Locke EA, 1997, RES PERS H, V15, P293; Lovden M, 2013, NEUROSCI BIOBEHAV R, V37, P2296, DOI 10.1016/j.neubiorev.2013.02.014; LUBORSKY L, 1985, ARCH GEN PSYCHIAT, V42, P602; Manchester D, 2001, BRAIN DAM B, P157; Manchester D, 1997, BRAIN INJURY, V11, P605, DOI 10.1080/026990597123296; Martelli MF, 2008, NEUROREHABILITATION, V23, P115; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; MARTIN G, 1981, BEHAV RES SEVERE DEV, V2, P117; Mastos M, 2007, CLIN REHABIL, V21, P47, DOI 10.1177/0269215506073494; MCDONNELL J, 1989, EDUC TRAIN MENT RET, V24, P230; McEwen SE, 2009, BRAIN INJURY, V23, P1041, DOI 10.3109/02699050903421107; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Mehrabian A, 1972, NONVERBAL COMMUNICAT; Miller W. R., 2002, MOTIVATIONAL INTERVI; Morrison MT, 2013, AM J OCCUP THER, V67, P460, DOI 10.5014/ajot.2013.007880; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Nudo RJ, 2007, STROKE, V38, P840, DOI 10.1161/01.STR.0000247943.12887.d2; Parish L, 2007, NEUROPSYCHOL REHABIL, V17, P230, DOI 10.1080/09602010600750675; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; Polatajko H. J., 2005, COGNITION OCCUPATION, P237; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Rauch RJ, 2001, NEUROREHABILITATION, V16, P11; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; ROGERS CR, 1957, J CONSULT PSYCHOL, V21, P95, DOI 10.1037/0022-006X.60.6.827; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Rotenberg-Shpigelman S, 2012, NEUROPSYCHOL REHABIL, V22, P532, DOI 10.1080/09602011.2012.665610; Rothwell NA, 1999, BRAIN INJURY, V13, P521; SALOMON G, 1989, EDUC PSYCHOL-US, V24, P113, DOI 10.1207/s15326985ep2402_1; Sander AM, 2007, NEUROREHABILITATION, V22, P9; Schefft BK, 2008, APPL NEUROPSYCHOL, V15, P61, DOI 10.1080/09084280801917806; Schmitter-Edgecombe M, 2006, J HEAD TRAUMA REHAB, V21, P131, DOI 10.1097/00001199-200603000-00006; Schmitter-Edgecombe M, 2000, NEUROPSYCHOLOGY, V14, P559; SchmitterEdgecombe M, 1997, NEUROPSYCHOLOGY, V11, P296, DOI 10.1037/0894-4105.11.2.296; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Shiffrin RM, 1981, COGNITIVE SKILLS THE, P111, DOI 10.4324/9780203728178; Sohlberg M, 1987, APT ATTENTION PROCES; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Sohlberg MM., 2011, OPTIMIZING COGNITIVE; SPOONER F, 1984, EDUC TRAIN MENT RET, V19, P15; Trahan E, 2006, J HEAD TRAUMA REHAB, V21, P226, DOI 10.1097/00001199-200605000-00003; Truax C., 1967, EFFECTIVE COUNSELING; Turner-Stokes L, 2005, COCHRANE DB SYST REV, V20; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; van Heugten C, 2012, NEUROPSYCHOL REHABIL, V22, P653, DOI 10.1080/09602011.2012.680891; Vanderploeg RD, 2006, J HEAD TRAUMA REHAB, V21, P179, DOI 10.1097/00001199-200603000-00010; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P47, DOI 10.1017/CBO9780511581083.006; Woody SR, 2002, BEHAV THER, V33, P5, DOI 10.1016/S0005-7894(02)80003-X; Wulf G, 2002, PSYCHON B REV, V9, P185, DOI 10.3758/BF03196276; Wulf G, 2013, INT REV SPORT EXER P, V6, P77, DOI 10.1080/1750984X.2012.723728; Yuen HK, 1994, OCCUPATIONAL THERAPY, V12, P31; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zencius A H, 1989, Brain Inj, V3, P199, DOI 10.3109/02699058909004553	115	12	12	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	13-14					1646	1656		10.3109/02699052.2014.946449			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AT1LY	WOS:000344696600003	25153760	Green Published			2021-06-18	
J	Kim, DR; Yang, SH; Sung, JH; Lee, SW; Son, BC				Kim, Deok-ryeong; Yang, Seung-Ho; Sung, Jae-hoon; Lee, Sang-won; Son, Byung-chul			Significance of Intracranial Pressure Monitoring after Early Decompressive Craniectomy in Patients with Severe Traumatic Brain Injury	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Brain injuries; Intracranial pressure monitoring; Decompressive craniectomy; Mortality	SEVERE HEAD-INJURY; MANAGEMENT; CLASSIFICATION; GUIDELINES; PROGNOSIS; OUTCOMES; IMPACT; DEATH	Objective : Early decompressive craniectomy (DC) has been used as the first stage treatment to prevent secondary injuries in cases of severe traumatic brain injury (TBI). Postoperative management is the major factor that influences outcome. The aim of this study is to investigate the effect of postoperative management, using intracranial pressure (ICP) monitoring and including consecutive DC on the other side, on the two-week mortality in severe TBI patients treated with early DC. Methods : Seventy-eight patients with severe TBI [Glasgow Coma Scale (GCS) score <9] underwent early DC were retrospectively investigated. Among 78 patients with early DC, 53 patients were managed by conventional medical treatments and the other, 25 patients were treated under the guidance of ICP monitoring, placed during early DC. In the ICP monitoring group, consecutive DC on the other side were performed on 11 patients due to a high ICP of greater than 30 mm Hg and failure to respond to any other medical treatments. Results : The two-week mortality rate was significantly different between two groups [50.9% (27 patients) and 24% (6 patients), respectively, p=0.025]. After adjusting for confounding factors, including sex, low GCS score, and pupillary abnormalities, ICP monitoring was associated with a 78% lower likelihood of 2-week mortality (p=0.021). Conclusion : ICP monitoring in conjunction with postoperative treatment, after early DC, is associated with a significantly reduced risk of death.	[Kim, Deok-ryeong] Eulji Univ, Sch Med, Eulji Gen Hosp, Dept Neurosurg, Seoul, South Korea; [Yang, Seung-Ho; Sung, Jae-hoon; Lee, Sang-won] Catholic Univ Korea, St Vincents Hosp, Dept Neurosurg, Coll Med, Suwon, South Korea; [Son, Byung-chul] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Neurosurg, Seoul 137701, South Korea	Son, BC (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Neurosurg, 222 Banpo Daero, Seoul 137701, South Korea.	sbc@catholic.ac.kr					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Akyuz M, 2010, TURK NEUROSURG, V20, P382, DOI 10.5137/1019-5149.JTN.2785-09.1; Bao YH, 2010, J NEUROTRAUM, V27, P341, DOI 10.1089/neu.2009.1040; Bratton SL, 2007, J NEUROTRAUMA, V24, pS7; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; GERL A, 1980, Zentralblatt fuer Neurochirurgie, V41, P125; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; McKinely BA, 1999, J TRAUMA, V46, P271, DOI 10.1097/00005373-199902000-00013; Miyazaki Y, 1966, Shujutsu, V20, P845; MORGALLA MH, 1995, SURG NEUROL, V43, P583, DOI 10.1016/0090-3019(95)00034-8; Munch E, 2000, NEUROSURGERY, V47, P315; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Plesnila N, 2007, PROG BRAIN RES, V161, P393, DOI 10.1016/S0079-6123(06)61028-5; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Roberts Susan R, 2004, Crit Care Nurs Clin North Am, V16, P537, DOI 10.1016/j.ccell.2004.06.008; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430; Wolfla CE, 1997, J NEUROSURG, V86, P505, DOI 10.3171/jns.1997.86.3.0505; Wolfla CE, 1996, J NEUROSURG, V84, P642, DOI 10.3171/jns.1996.84.4.0642; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	37	12	12	0	8	KOREAN NEUROSURGICAL SOC	SEOUL	BLDG B, #402, 27, CHILPAE-RO, JUNG-GU, SEOUL, 04511, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	JAN	2014	55	1					26	31		10.3340/jkns.2014.55.1.26			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AB1ZN	WOS:000331592900005	24570814	DOAJ Gold, Green Published			2021-06-18	
J	Ma, HP; Ou, JC; Yeh, CT; Wu, D; Tsai, SH; Chiu, WT; Hu, CJ				Ma, Hon-Ping; Ou, Ju-Chi; Yeh, Chun-Ting; Wu, Dean; Tsai, Shin-Han; Chiu, Wen-Ta; Hu, Chaur-Jong			Recovery from sleep disturbance precedes that of depression and anxiety following mild traumatic brain injury: a 6-week follow-up study	BMJ OPEN			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CHINESE VERSION; QUALITY INDEX; INVENTORY; SEQUELAE; SCALE	Objectives: The detailed course of mental disorders at the acute and subacute stages of mild traumatic brain injury (mTBI), especially with regard to recovery from sleep disturbances, has not been well characterised. The aim of this study was to determine the course of depression, anxiety and sleep disturbance, following an mTBI. Setting: We recruited patients with mTBI from three university hospitals in Taipei and healthy participants as control group for this study. Participants: 100 patients with mTBI (35 men) who were older than 20 years, with a Glasgow Coma Scale score of 13-15 and loss of consciousness for <30 min, completed the baseline and 6-week follow-up assessments. 137 controls (47 men) without TBI were recruited in the study. None of the participants had a history of cerebrovascular disease, mental retardation, previous TBI, epilepsy or severe systemic medical illness. Primary outcome measures: The Beck Anxiety Inventory (BAI), the Beck Depression Inventory II (BDI), the Epworth Sleepiness Scale (ESS) and the Pittsburgh Sleep Quality Index (PSQI) were assessed for the patients with mTBI at baseline and 6 weeks after mTBI and for the controls. Results: The ESS scores were not significantly different between the mTBI at baseline or at 6 weeks after mTBI and controls. Although the BAI, BDI and PSQI scores of the mTBI group were significantly different than those of the control group at baseline, all had improved significantly 6 weeks later. However, only the PSQI score improved to a level that was not significantly different from that of the control group. Conclusions: Daytime sleepiness is not affected by mTBI. However, mTBI causes depression and anxiety and diminished sleep quality. Although all these conditions improve significantly within 6 weeks post-mTBI, only sleep quality improves to a pre-mTBI level. Thus, recovery from mTBI-induced sleep disturbance occurs more rapidly than that of mTBI-induced depression and anxiety.	[Ma, Hon-Ping; Ou, Ju-Chi; Yeh, Chun-Ting; Tsai, Shin-Han] Taipei Med Univ, Shuang Ho Hosp, Dept Emergency Med, New Taipei City, Taiwan; [Ma, Hon-Ping; Yeh, Chun-Ting; Tsai, Shin-Han] Taipei Med Univ, Sch Med, Dept Emergency Med, Taipei, Taiwan; [Wu, Dean; Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei City, Taiwan; [Wu, Dean; Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Sleep Ctr, New Taipei City, Taiwan; [Tsai, Shin-Han] Taipei Med Univ, Coll Publ Hlth & Nutr, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Chiu, Wen-Ta] Minist Hlth & Welf, Taipei, Taiwan; [Hu, Chaur-Jong] Taipei Med Univ, Sch Med, Dept Neurol, Taipei, Taiwan; [Hu, Chaur-Jong] Natl Def Med Ctr, Dept Neurol, Taipei, Taiwan	Hu, CJ (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei City, Taiwan.	chaurjongh@s.tmu.edu.tw			National Science Council, TaiwanMinistry of Science and Technology, Taiwan [NSC 98-2321-B-038-005-MY3, NSC 101-2321-B-038-005, DOH 101-TD-B-111-003]	This study was supported by grants from the National Science Council, Taiwan (NSC 98-2321-B-038-005-MY3, NSC 101-2321-B-038-005, DOH 101-TD-B-111-003).	Access Economics Pty Limited, 2009, THE ECONOMIC COST OF; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beck A. T., 1996, MANUAL FOR THE BECK; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chen NH, 2002, QUAL LIFE RES, V11, P817, DOI 10.1023/A:1020818417949; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; MCFARLANE AC, 1992, J NERV MENT DIS, V180, P498, DOI 10.1097/00005053-199208000-00004; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; O'Donnell ML, 2003, CLIN PSYCHOL REV, V23, P587, DOI 10.1016/S0272-7358(03)00036-9; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Palagini L, 2013, SLEEP MED REV, P1; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; RUTHERFORD WH, 1977, LANCET, V1, P1; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; U. S. Department of Veterans Affairs, 2009, VA DOD CLINICAL PRAC; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; ZHENG YP, 1988, COMPR PSYCHIAT, V29, P484, DOI 10.1016/0010-440X(88)90063-6	29	12	12	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2014	4	1							e004205	10.1136/bmjopen-2013-004205			6	Medicine, General & Internal	General & Internal Medicine	AJ0RP	WOS:000337363700039	24459040	DOAJ Gold, Green Published			2021-06-18	
J	Possin, KL; LaMarre, AK; Wood, KA; Mungas, DM; Kramer, JH				Possin, Katherine L.; LaMarre, Amanda K.; Wood, Kristie A.; Mungas, Dan M.; Kramer, Joel H.			Ecological Validity and Neuroanatomical Correlates of the NIH EXAMINER Executive Composite Score	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article							TRAUMATIC BRAIN-INJURY; SYSTEMS BEHAVIOR SCALE; MULTIPLE-SCLEROSIS; FRONTOTEMPORAL DEMENTIA; COGNITIVE IMPAIRMENT; DIAGNOSTIC-CRITERIA; PREFRONTAL CORTEX; CLINICAL-RESEARCH; DECISION-MAKING; DYSFUNCTION		[Possin, Katherine L.; LaMarre, Amanda K.; Wood, Kristie A.; Kramer, Joel H.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Mungas, Dan M.] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA	Possin, KL (corresponding author), 675 Nelson Rising Lane,Ste 190,MC 1207, San Francisco, CA 94158 USA.	kpossin@memory.ucsf.edu			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [HHSN271200623661C]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG037566, P01AG019724, P50AG023501]; Hellman Family Foundation; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG010129, R01AG010220, P50AG023501, P01AG019724, K23AG037566] Funding Source: NIH RePORTER	This work was supported by NINDS (J.K., HHSN271200623661C); NIA (K.P., K23AG037566), (J.K., P01AG019724 and P50AG023501); and by the Hellman Family Foundation (K.P.). We thank Stephen Wilson, Ph.D., for his guidance on the voxel-based morphometry methods, and our research participants for their generous time and efforts. We have no conflicts of interest to report.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Basso MR, 2008, J CLIN EXP NEUROPSYC, V30, P920, DOI 10.1080/13803390801888733; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Bondi MW, 2008, NEUROPSYCHOL REV, V18, P73, DOI 10.1007/s11065-008-9054-1; Boyle PA, 2004, CLIN NEUROPSYCHOL, V18, P75, DOI 10.1080/13854040490507172; Brown PD, 2003, J CLIN ONCOL, V21, P2519, DOI 10.1200/JCO.2003.04.172; Caeyenberghs K, 2012, BRAIN STRUCTURE FUNC; Cahn-Weiner DA, 2007, J INT NEUROPSYCH SOC, V13, P747, DOI 10.1017/S1355617707070853; Champod AS, 2010, J NEUROSCI, V30, P3849, DOI 10.1523/JNEUROSCI.0097-10.2010; Chiaravalloti ND, 2003, COGN BEHAV NEUROL, V16, P54, DOI 10.1097/00146965-200303000-00007; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; Coles AJ, 2012, LANCET, V380, P1829, DOI 10.1016/S0140-6736(12)61768-1; Correa DD, 2010, CURR NEUROL NEUROSCI, V10, P232, DOI 10.1007/s11910-010-0108-4; Cummings J.L., 2007, HUMAN FRONTAL LOBES, V2nd ed, P12; Diamond A., 2002, PRINCIPLES FRONTAL L, P466, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0029; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Hayes S, 2013, PHYSIOTHERAPY, V99, P165, DOI 10.1016/j.physio.2012.05.002; Hellmuth J, 2012, NEUROLOGY, V78, P1824, DOI 10.1212/WNL.0b013e318258f785; Kramer J. H., 2013, J INT NEUROPSYCHOLOG, V19; Kramer Joel H, 2003, Cogn Behav Neurol, V16, P211, DOI 10.1097/00146965-200312000-00002; Lane-Brown AT, 2009, BRAIN INJURY, V23, P999, DOI 10.3109/02699050903379347; Lezak M., 2012, NEUROPSYCHOLOGICAL A, V5th; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Malloy P, 2005, COGN BEHAV NEUROL, V18, P18, DOI 10.1097/01.wnn.0000152232.47901.88; Malloy P, 2007, ALZHEIMERS DEMENT, V3, P200, DOI 10.1016/j.jalz.2007.04.374; Malloy PF, 2001, FRONTAL SYSTEMS BEHA; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; Parmenter BA, 2007, J INT NEUROPSYCH SOC, V13, P417, DOI 10.1017/S1355617707070580; Peinemann A, 2005, J NEUROL SCI, V239, P11, DOI 10.1016/j.jns.2005.07.007; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Possin K. L., 2013, NEUROLOGY; Provost JS, 2010, EUR J NEUROSCI, V32, P873, DOI 10.1111/j.1460-9568.2010.07333.x; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Robinson H., 2013, J INT NEUROPSYCHOLOG, V19; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Sachdev PS, 2004, NEUROLOGY, V62, P912, DOI 10.1212/01.WNL.0000115108.65264.4B; Salthouse TA, 2005, NEUROPSYCHOLOGY, V19, P532, DOI 10.1037/0894-4105.19.4.532; Schmahmann JD, 2008, CORTEX, V44, P1037, DOI 10.1016/j.cortex.2008.04.004; Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Tomaszewski S, 2009, CLIN NEUROPSYCHOL, V23, P446, DOI 10.1080/13854040802360558; Torralva T, 2007, NEUROPSYCHOLOGIA, V45, P342, DOI 10.1016/j.neuropsychologia.2006.05.031; Van der Werf YD, 2003, NEUROPSYCHOLOGIA, V41, P1330, DOI 10.1016/S0028-3932(03)00059-9; Velligan DI, 2002, PSYCHIAT RES, V113, P227, DOI 10.1016/S0165-1781(02)00264-0; Vercelletto M, 2011, J ALZHEIMERS DIS, V23, P749, DOI 10.3233/JAD-2010-101632; Whitwell J. L., 2012, EUROPEAN J NEUROLOGY, V20, P629; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Wilson SM, 2010, BRAIN, V133, P2069, DOI 10.1093/brain/awq129; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Yin XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050590	58	12	12	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2014	20	1					20	28		10.1017/S1355617713000611			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	AC2VC	WOS:000332373400005	23764015	Green Accepted			2021-06-18	
J	Shao, S; Huang, XT; Wang, YC; He, S; Xu, XH; Zhu, XH; Yang, XJ; Ding, ZM; Yao, L; Huang, YJ; Wang, C				Shao, Shan; Huang, Xianting; Wang, Yuchan; He, Song; Xu, Xiaohong; Zhu, Xinghua; Yang, Xiaojing; Ding, Zongmei; Yao, Li; Huang, Yuejiao; Wang, Chun			A role for activator of G-protein signaling 3 (AGS3) in multiple myeloma	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						AGS3; MM; Apoptosis; CAM-DR	MEDIATED DRUG-RESISTANCE; RECEPTOR-INDEPENDENT ACTIVATORS; TRAUMATIC BRAIN-INJURY; CELL-ADHESION; CAM-DR; BCL-2 EXPRESSION; REGULATOR AGS3; IN-VITRO; ALPHA; CREB	Previous studies have demonstrated that activator of G-protein signaling 3 (AGS3; also known as GPSM1), a member of the AGS family, plays an important anti-apoptotic role through enhancing the phosphorylation of cyclic AMP response element-binding protein (p-CREB). In this report, we delineate the anti-apoptotic role of AGS3 in multiple myeloma (MM). To do this, we developed a cell apoptotic model induced by doxorubicin in MM. Our data indicate that decreased expression of AGS3 is correlated with reduced levels of p-CREB in the apoptotic model. The negative role of AGS3 in cell apoptosis was further confirmed by knocking down AGS3. The microenvironment has been shown to influence tumor cell phenotype in response to chemotherapy. Since cell adhesion-mediated drug resistance remains a major obstacle for successful treatment of MM, we constructed a cell adhesion model in MM and detected the changing of AGS3 protein expression. AGS3 siRNA reversed the high rate of MM cell adhesion to either fibronectin or HS-5 cells. Consistent with the reduced adhesion rate, the cells also exhibited reduced drug resistance to doxorubicin, mitoxantrone, and dexamethasone. Collectively, these data indicate that AGS3 may be represented as a good candidate for pursuing clinical trials in MM. Moreover, our data provide a clinical therapeutic target for MM and potentially other tumors that home and/or metastasize to the bone.	[Shao, Shan; Wang, Chun] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Hematol, Shanghai 200080, Peoples R China; [Huang, Xianting; Wang, Yuchan; Yang, Xiaojing; Ding, Zongmei; Yao, Li; Huang, Yuejiao] Nantong Univ, Coll Med, Dept Immunol, Nantong 226001, Jiangsu, Peoples R China; [He, Song; Xu, Xiaohong] Nantong Univ, Canc Hosp, Dept Pathol, Nantong 226001, Jiangsu, Peoples R China; [Xu, Xiaohong] Nantong Univ, Canc Hosp, Dept Hematol, Nantong 226001, Jiangsu, Peoples R China	Wang, C (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Hematol, Shanghai 200080, Peoples R China.	wangchunmd@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81201858]; Natural Science Foundation of Jiangsu provinceNatural Science Foundation of Jiangsu Province [BK2012231]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (No. 81201858) and Natural Science Foundation of Jiangsu province Grant (BK2012231); A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Anderson Kenneth C., 2000, Hematology Am Soc Hematol Educ Program, P147; Balakumaran A, 2010, EXPERT REV MOL DIAGN, V10, P465, DOI 10.1586/ERM.10.31; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Blumer JB, 2005, TRENDS PHARMACOL SCI, V26, P470, DOI 10.1016/j.tips.2005.07.003; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Clark RSB, 1997, J NEUROSCI, V17, P9172; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; Emmons MF, 2011, MOL CANCER THER, V10, P2257, DOI 10.1158/1535-7163.MCT-11-0149; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Gauduchon J, 2005, CLIN CANCER RES, V11, P2345, DOI 10.1158/1078-0432.CCR-04-1668; Groves B, 2007, P NATL ACAD SCI USA, V104, P18103, DOI 10.1073/pnas.0709282104; Hazlehurst LA, 2006, CANCER RES, V66, P2338, DOI 10.1158/0008-5472.CAN-05-3256; Hazlehurst LA, 2001, CANCER METAST REV, V20, P43, DOI 10.1023/A:1013156407224; Kobune M, 2007, MOL CANCER THER, V6, P1774, DOI 10.1158/1535-7163.MCT-06-0684; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Landowski TH, 2003, ONCOGENE, V22, P2417, DOI 10.1038/sj.onc.1206315; Lee SW, 2012, IMMUNOL LETT, V144, P41, DOI 10.1016/j.imlet.2012.03.005; Li B, 2013, LEUKEMIA RES, V37, P50, DOI 10.1016/j.leukres.2012.08.027; Lin J, 2013, ONCOL REP, V30, P731, DOI 10.3892/or.2013.2489; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Pattingre S, 2004, METHOD ENZYMOL, V390, P17; Pattingre S, 2003, J BIOL CHEM, V278, P20995, DOI 10.1074/jbc.M300917200; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Pizzinat N, 2001, J BIOL CHEM, V276, P16601, DOI 10.1074/jbc.M007573200; Raghupathi R, 2003, J NEUROTRAUM, V20, P421, DOI 10.1089/089771503765355504; Reed JC, 1998, BBA-BIOENERGETICS, V1366, P127, DOI 10.1016/S0005-2728(98)00108-X; Sakamoto KM, 2009, CLIN CANCER RES, V15, P2583, DOI 10.1158/1078-0432.CCR-08-1137; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tohnya TM, 2004, CANCER BIOL THER, V3, P1060, DOI 10.4161/cbt.3.11.1303; Wang W, 2013, J NEUROSCI RES, V91, P726, DOI 10.1002/jnr.23195; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; Yanamandra N, 2006, CLIN CANCER RES, V12, P591, DOI 10.1158/1078-0432.CCR-05-1792; Zheng Y, 2013, LEUKEMIA, V27, P702, DOI 10.1038/leu.2012.272	40	12	13	0	7	SPRINGER JAPAN KK	TOKYO	SHIROYAMA TRUST TOWER 5F, 4-3-1 TORANOMON, MINATO-KU, TOKYO, 105-6005, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	JAN	2014	99	1					57	68		10.1007/s12185-013-1484-8			12	Hematology	Hematology	AA3KE	WOS:000330990500008	24307516				2021-06-18	
J	Shen, LJ; Yang, SB; Lv, QW; Zhang, GH; Zhou, J; Guo, M; Huang, HB; Li, Z; Yang, CS				Shen, Liang-Jun; Yang, Song-Bin; Lv, Qing-Wei; Zhang, Guo-Hai; Zhou, Jing; Guo, Mi; Huang, Hang-Bin; Li, Zhao; Yang, Chun-Song			High plasma adiponectin levels in patients with severe traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; Adiponectin; Prognosis; Biomarker	CORONARY-HEART-DISEASE; SERUM ADIPONECTIN; MYOCARDIAL-INFARCTION; INDEPENDENT PREDICTOR; MORTALITY; LEPTIN; MEN; ASSOCIATION; RESISTIN; DECREASE	Background: Adiponectin plays an important role in the regulation of tissue inflammation. There is a paucity of data on circulating plasma adiponectin concentrations in human traumatic brain injury. This study is designed to investigate the potential associations between plasma adiponectin levels and clinical outcomes after traumatic brain injury. Methods: Plasma adiponectin levels of 86 patients with severe traumatic brain injury and 86 healthy subjects were determined. Clinical outcomes included in-hospital mortality, 6-month mortality and 6-month unfavorable outcome (Glasgow Outcome Scale score of 1-3). Results: Plasma adiponectin levels were significantly higher in patients compared to controls (20.5 +/- 5.9 vs. 7.7 +/- 2.0 mu g/ml; P< 0.001) and emerged as an independent predictor of in-hospital mortality [odds ratio (OR), 1318; 95% confidence interval (CI), 1.049-1.629; P = 0.0081, 6-month mortality (OR, 1328; 95% CI, 1.082-1.657; P = 0.007) and 6-month unfavorable outcome (OR, 1240; 95% CI, 1.066-1.443; P = 0.005) in a multivariate analysis. For predicting these clinical outcomes, areas under receiver operating characteristic curve of plasma adiponectin level were similar to those of Glasgow Coma scale scores (all P> 0.05). However, adiponectin did not improve predictive values of Glasgow Coma scale scores (all P> 0.05). Conclusion: Plasma adiponectin level may represent a novel biomarker for predicting clinical outcomes of traumatic brain injury. (C) 2013 Elsevier B.V. All rights reserved.	[Shen, Liang-Jun; Yang, Song-Bin; Lv, Qing-Wei; Zhang, Guo-Hai; Zhou, Jing; Guo, Mi; Huang, Hang-Bin; Li, Zhao; Yang, Chun-Song] Shengzhou Peoples Hosp, Dept Neurosurg, Shenzhou 312400, Peoples R China	Shen, LJ (corresponding author), Shengzhou Peoples Hosp, Dept Neurosurg, 208 Yiyuan Rd, Shenzhou 312400, Peoples R China.	shengzhoushenlj@163.com			Shaoxing Science and Technology Research Fund Project [2012D10002]	The authors thank all staffs in the Department of Neurosurgery, Shengzhou People's Hospital (Shengzhou, China) for their technical support. This study was supported by a grant from the Shaoxing Science and Technology Research Fund Project (No. 2012D10002).	Blaslov K, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/535906; Cavusoglu E, 2006, EUR HEART J, V27, P2300, DOI 10.1093/eurheartj/ehl153; Chen B, 2009, BRAIN RES, V1273, P129, DOI 10.1016/j.brainres.2009.04.002; Chen MP, 2005, ARTERIOSCL THROM VAS, V25, P821, DOI 10.1161/01.ATV.0000157784.25920.a7; Dekker JM, 2008, J CLIN ENDOCR METAB, V93, P1489, DOI 10.1210/jc.2007-1436; Frystyk J, 2007, J CLIN ENDOCR METAB, V92, P571, DOI 10.1210/jc.2006-1067; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Karmiris K, 2006, INFLAMM BOWEL DIS, V12, P100, DOI 10.1097/01.MIB.0000200345.38837.46; Kizer JR, 2008, J CLIN ENDOCR METAB, V93, P3357, DOI 10.1210/jc.2008-0640; Marousi S, 2010, ACTA NEUROL SCAND, V121, P277, DOI 10.1111/j.1600-0404.2009.01231.x; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McEntegart MB, 2007, EUR HEART J, V28, P829, DOI 10.1093/eurheartj/ehm033; Nagasawa H, 2011, J NEUROL SCI, V304, P102, DOI 10.1016/j.jns.2011.02.002; Nishimura M, 2008, CIRCULATION, V117, P216, DOI 10.1161/CIRCULATIONAHA.107.725044; Ohashi K, 2012, BIOCHIMIE, V94, P2137, DOI 10.1016/j.biochi.2012.06.008; Otero M, 2006, ANN RHEUM DIS, V65, P1198, DOI 10.1136/ard.2005.046540; Pilz S, 2006, J CLIN ENDOCR METAB, V91, P4277, DOI 10.1210/jc.2006-0836; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Sada KE, 2006, J RHEUMATOL, V33, P1545; Schnabel R, 2008, EUR HEART J, V29, P649, DOI 10.1093/eurheartj/ehn009; Takeuchi S, 2013, TURK NEUROSURG, V23, P349, DOI 10.5137/1019-5149.JTN.7023-12.1; Tietge UJF, 2004, AM J PHYSIOL-ENDOC M, V287, pE82, DOI 10.1152/ajpendo.00494.2003; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; Venkatesh B, 2009, CRIT CARE, V13, DOI 10.1186/cc7941; Wang KY, 2012, CLIN CHIM ACTA, V413, P1737, DOI 10.1016/j.cca.2012.07.002; Wang WH, 2011, CLIN CHIM ACTA, V412, P1626, DOI 10.1016/j.cca.2011.05.016; Yatomi K, 2009, BRAIN RES, V1297, P169, DOI 10.1016/j.brainres.2009.08.039	28	12	12	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	JAN 1	2014	427				SI		37	41		10.1016/j.cca.2013.09.047			5	Medical Laboratory Technology	Medical Laboratory Technology	AA0WX	WOS:000330819200010	24099881				2021-06-18	
J	Xing, GQ; Janis, C; Jiang, XL; Wen, JL; Jia, M; Li, H				Xing, Guoqiang; Carlton, Janis; Jiang, Xiaolong; Wen, Jillian; Jia, Min; Li, He			Differential expression of brain cannabinoid receptors between repeatedly stressed males and females may play a role in age and gender-related difference in traumatic brain injury: implications from animal studies	FRONTIERS IN NEUROLOGY			English	Article						stress; anxiety; brain cannabinoid receptors; sex dimoiphism; TBI outcome		Inconsistent gender differences in the outcome of TBI have been reported.The mechanism is unknown. In a recent male animal study, repeated stress followed by TBI had synergistic effects on brain gene expression and caused greater behavioral deficits. Because females are more likely to develop anxiety after stress and because anxiety is mediated by cannabinoid receptors (CBRs) (CB1 and CB2), there is a need to compare CB1 and CB2 expression in stressed males and females. CB1 and CB2 mRNA expression was determined in the amygdala, hippocampus, prefrontal cortex (PFC), and hypothalamus of adolescent male and female rats after 3 days of repeated tail-shock stress using qPCR. PFC CB1 and CB2 protein levels were determined using Western blot techniques. Both gender and stress had significant effects on brain CB1 mRNA expression levels. Overall, females showed significantly higher CB1 and CB2 mRNA levels in all brain regions than males (p < 0.01). Repeated stress reduced CB1 mRNA levels in the amygdala, hippocampus, and PFC (p < 0.01, each). A gender x stress interaction was found in CB1 mRNA level in the hippocampus (p < 0.05), hypothalamus (p < 0.01), and PFC (p < 0.01). Within-sex one-way ANOVA analysis showed decreased CB1 mRNA in the hippocampus, hypothalamus, and PFC of stressed females (p < 0.01, each) but increased CB1 mRNA levels in the hypothalamus of stressed males (p < 01). There was a gender and stress interaction in prefrontal CB1 receptor protein levels (p < 0.05), which were decreased in stressed females only (p < 0.05). Prefrontal CB2 protein levels were decreased in both male and female animals after repeated stress (p < 0.05, each). High basal levels of CBR expression in young naive females could protect against TBI damage whereas stress-induced CBR deficits could predict a poor outcome of TBI in repeatedly stressed females. Further animal studies could help evaluate this possibility.	[Xing, Guoqiang; Carlton, Janis; Jiang, Xiaolong; Wen, Jillian; Jia, Min; Li, He] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA	Xing, GQ (corresponding author), Johns Hopkins Univ MCC, 9601 Med Ctr Dr,Suite 227, Rockville, MD 20850 USA.	gxing99@yahoo.com; he.li@usuhs.edu	Xing, Guoqiang/ABA-8450-2020		Lotus Biotech.com; Center for the Study of Traumatic Stress, Uniformed Services University of the Health Sciences	This work was supported, in part, by Lotus Biotech.com and the Center for the Study of Traumatic Stress, Uniformed Services University of the Health Sciences. Daniel Xing proofread this manuscript.	Aguado T, 2005, FASEB J, V19, P1704, DOI 10.1096/fj.05-3995fje; Aguado T, 2006, J NEUROSCI, V26, P1551, DOI 10.1523/JNEUROSCI.3101-05.2006; Alvares LD, 2008, NEUROBIOL LEARN MEM, V90, P1, DOI 10.1016/j.nlm.2008.01.009; Amenta PS, 2012, J NEUROSCI RES, V90, P2293, DOI 10.1002/jnr.23114; Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Bajzer M, 2011, DIABETOLOGIA, V54, P3121, DOI 10.1007/s00125-011-2302-6; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bolognini D, 2010, BRIT J PHARMACOL, V160, P677, DOI 10.1111/j.1476-5381.2010.00756.x; Bradshaw HB, 2006, AM J PHYSIOL-REG I, V291, pR349, DOI 10.1152/ajpregu.00933.2005; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Broomhall LGJ, 2009, J NERV MENT DIS, V197, P178, DOI 10.1097/NMD.0b013e318199fe7f; Brown SB, 2012, HEALTH CARE WOMEN IN, V33, P896, DOI 10.1080/07399332.2012.673654; Bulstrode H, 2014, ANN NEUROL, V75, P186, DOI 10.1002/ana.24116; Busch L, 2006, CLIN EXP PHARMACOL P, V33, P258, DOI 10.1111/j.1440-1681.2006.04355.x; Butkevich I, 2009, HORM BEHAV, V55, P149, DOI 10.1016/j.yhbeh.2008.09.008; Canli T, 2002, P NATL ACAD SCI USA, V99, P10789, DOI 10.1073/pnas.162356599; Cardenas VA, 2011, PSYCHIAT RES-NEUROIM, V193, P93, DOI 10.1016/j.pscychresns.2011.01.013; Carlson KF, 2013, BRAIN INJURY, V27, P640, DOI 10.3109/02699052.2013.771795; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; CAUDELL KA, 1995, WESTERN J NURS RES, V17, P672, DOI 10.1177/019394599501700607; Chhatwal JP, 2005, NEUROPSYCHOPHARMACOL, V30, P516, DOI 10.1038/sj.npp.1300655; Choi K, 2012, J PSYCHIATR RES, V46, P882, DOI 10.1016/j.jpsychires.2012.03.021; Cohen-Yeshurun A, 2013, J CEREBR BLOOD F MET, V33, P1242, DOI 10.1038/jcbfm.2013.75; Conley YP, 2014, J NEUROTRAUM, V31, P34, DOI 10.1089/neu.2013.2855; Craft RM, 2005, LIFE SCI, V77, P2471, DOI 10.1016/j.lfs.2005.04.019; Czeh B, 2007, NEUROPSYCHOPHARMACOL, V32, P1490, DOI 10.1038/sj.npp.1301275; De Bellis MD, 2006, BIOL PSYCHIAT, V60, P697, DOI 10.1016/j.biopsych.2006.04.035; DEFONSECA FR, 1994, LIFE SCI, V54, P159, DOI 10.1016/0024-3205(94)00585-0; Di Marzo V, 2008, BRIT J PHARMACOL, V153, P1272, DOI 10.1038/sj.bjp.0707682; Egertova M, 2000, J COMP NEUROL, V422, P159, DOI 10.1002/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1; Fan F, 1996, BRAIN RES, V706, P13, DOI 10.1016/0006-8993(95)01113-7; Fattore L, 2010, BRIT J PHARMACOL, V160, P544, DOI 10.1111/j.1476-5381.2010.00776.x; FELDER CC, 1995, MOL PHARMACOL, V48, P443; Felmingham K, 2009, NEUROREPORT, V20, P1402, DOI 10.1097/WNR.0b013e3283300fbc; Gallily R, 2000, EUR J PHARMACOL, V406, pR5, DOI 10.1016/S0014-2999(00)00653-1; Golech SA, 2004, MOL BRAIN RES, V132, P87, DOI 10.1016/j.molbrainres.2004.08.025; Gonzalez S, 2000, BIOCHEM BIOPH RES CO, V270, P260, DOI 10.1006/bbrc.2000.2406; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Gudsnuk KMA, 2011, CLIN PERINATOL, V38, P703, DOI 10.1016/j.clp.2011.08.005; Haller J, 2002, EUR J NEUROSCI, V16, P1395, DOI 10.1046/j.1460-9568.2002.02192.x; Hedges DW, 2010, COGN BEHAV NEUROL, V23, P124, DOI 10.1097/WNN.0b013e3181e1cbe1; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; HILL JO, 1986, J NUTR, V116, P2000; Hill MN, 2008, HIPPOCAMPUS, V18, P221, DOI 10.1002/hipo.20386; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iverson KM, 2013, J WOMENS HEALTH, V22, P267, DOI 10.1089/jwh.2012.3755; Jiang XL, 2009, NEUROPSYCHOPHARMACOL, V34, P410, DOI 10.1038/npp.2008.71; Jonsson CA, 2013, BRAIN INJURY, V27, P831, DOI 10.3109/02699052.2013.775493; Jonsson CA, 2013, J NEUROTRAUM, V30, P76, DOI 10.1089/neu.2012.2592; Karsten Carley A, 2013, Front Psychiatry, V4, P89, DOI 10.3389/fpsyt.2013.00089; King N, 2014, NEUROREHABILITATION, V34, P741, DOI 10.3233/NRE-141072; Lee TTY, 2013, NEUROSCIENCE, V249, P106, DOI 10.1016/j.neuroscience.2012.11.017; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Li CSR, 2008, NEUROSCI BIOBEHAV R, V32, P581, DOI 10.1016/j.neubiorev.2007.10.003; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039025; Mackie K, 2005, HANDB EXP PHARMACOL, V168, P299; Malcher-Lopes R, 2008, EUR J PHARMACOL, V583, P322, DOI 10.1016/j.ejphar.2007.12.033; Malcher-Lopes R, 2006, J NEUROSCI, V26, P6643, DOI 10.1523/JNEUROSCI.5126-05.2006; Marchalant Y, 2009, NEUROBIOL DIS, V34, P300, DOI 10.1016/j.nbd.2009.01.014; Maren S, 2007, LEARN MEMORY, V14, P318, DOI 10.1101/lm.477007; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Martin M, 2002, PSYCHOPHARMACOLOGY, V159, P379, DOI 10.1007/s00213-001-0946-5; Martinez-Vargas M, 2013, INT J MOL SCI, V14, P23341, DOI 10.3390/ijms141223341; Marumo K, 2009, NEUROSCI RES, V63, P89, DOI 10.1016/j.neures.2008.10.012; Mauler F, 2003, CNS DRUG REV, V9, P343; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; McLaughlin C R, 1993, Brain Res Dev Brain Res, V76, P75; Meulders A, 2012, PAIN, V153, P1030, DOI 10.1016/j.pain.2012.02.005; Mittendorfer B, 2001, AM J PHYSIOL-ENDOC M, V281, pE1333; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Ng I, 2006, BRIT J NEUROSURG, V20, P73, DOI 10.1080/02688690600682259; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Nong L, 2002, J NEUROIMMUNOL, V127, P169, DOI 10.1016/S0165-5728(02)00113-3; Onaivi ES, 1999, PROG NEURO-PSYCHOPH, V23, P1063, DOI 10.1016/S0278-5846(99)00052-4; OVIEDO A, 1993, BRAIN RES, V616, P293, DOI 10.1016/0006-8993(93)90220-H; Palazuelos J, 2012, J BIOL CHEM, V287, P1198, DOI 10.1074/jbc.M111.291294; Pamplona FA, 2008, NEUROBIOL LEARN MEM, V90, P290, DOI 10.1016/j.nlm.2008.04.003; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Patel S, 2006, J PHARMACOL EXP THER, V318, P304, DOI 10.1124/jpet.106.101287; Pertwee RG, 2008, ADDICT BIOL, V13, P147, DOI 10.1111/j.1369-1600.2008.00108.x; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Pratchett LC, 2010, PSYCHIAT CLIN N AM, V33, P465, DOI 10.1016/j.psc.2010.01.010; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Reich CG, 2009, BEHAV BRAIN RES, V203, P264, DOI 10.1016/j.bbr.2009.05.013; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Ribeiro R, 2013, PROSTAG OTH LIPID M, V100, P1, DOI 10.1016/j.prostaglandins.2012.11.003; Richard D, 2009, BEST PRACT RES CL EN, V23, P17, DOI 10.1016/j.beem.2008.10.007; Roche M, 2007, EUR J NEUROSCI, V26, P2643, DOI 10.1111/j.1460-9568.2007.05861.x; Rogers MA, 2009, PSYCHIAT RES-NEUROIM, V174, P210, DOI 10.1016/j.pscychresns.2009.06.001; Romeo RD, 2010, FRONT NEUROENDOCRIN, V31, P232, DOI 10.1016/j.yfrne.2010.02.004; Romero J, 1997, MOL BRAIN RES, V46, P100, DOI 10.1016/S0169-328X(96)00277-X; Schmidt AT, 2012, INT J DEV NEUROSCI, V30, P225, DOI 10.1016/j.ijdevneu.2011.11.003; Schmidt W, 2012, NEUROSCIENCE, V227, P313, DOI 10.1016/j.neuroscience.2012.09.080; Schmitt A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00019; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Silvestri C, 2013, CELL METAB, V17, P475, DOI 10.1016/j.cmet.2013.03.001; Silvestri C, 2011, REV ENDOCR METAB DIS, V12, P153, DOI 10.1007/s11154-011-9167-3; Stein DG, 2011, NEUROSCIENCE, V191, P101, DOI 10.1016/j.neuroscience.2011.04.013; Stevens JS, 2012, NEUROPSYCHOLOGIA, V50, P1578, DOI 10.1016/j.neuropsychologia.2012.03.011; Tang SL, 2005, J NEUROPHYSIOL, V94, P2983, DOI 10.1152/jn.01187.2004; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Thomaes K, 2010, J CLIN PSYCHIAT, V71, P1636, DOI 10.4088/JCP.08m04754blu; Tishkina A O, 2009, Dokl Biol Sci, V428, P403; Uriguen L, 2004, NEUROPHARMACOLOGY, V46, P966, DOI 10.1016/j.neuropharm.2004.01.003; van der Stelt M, 2001, J NEUROSCI, V21, P8765, DOI 10.1523/JNEUROSCI.21-22-08765.2001; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Vettor R, 2009, BEST PRACT RES CL EN, V23, P51, DOI 10.1016/j.beem.2008.10.002; Villarreal G, 2002, BIOL PSYCHIAT, V52, P119, DOI 10.1016/S0006-3223(02)01359-8; Vlachos I, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001104; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Wainwright NWJ, 2002, J AFFECT DISORDERS, V72, P33, DOI 10.1016/S0165-0327(01)00420-7; Weber K, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-63; Westenbroek C, 2005, HORM BEHAV, V47, P620, DOI 10.1016/j.yhbeh.2005.01.004; Widom CS, 2008, CHILD ABUSE NEGLECT, V32, P785, DOI 10.1016/j.chiabu.2007.12.006; Woodward SH, 2009, ARCH GEN PSYCHIAT, V66, P1373, DOI 10.1001/archgenpsychiatry.2009.160; Woon FL, 2010, PROG NEURO-PSYCHOPH, V34, P1181, DOI 10.1016/j.pnpbp.2010.06.016; Xing G, 2013, POSTTRAUMATIC STRESS, P83; Xing GQ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00196; Xing GQ, 2011, NEUROSCI LETT, V502, P5, DOI 10.1016/j.neulet.2011.05.013; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052; Yun J, 2010, J NEUROCHEM, V114, P1840, DOI 10.1111/j.1471-4159.2010.06893.x; Zhang J, 2011, PSYCHIAT RES-NEUROIM, V192, P84, DOI 10.1016/j.pscychresns.2010.09.001; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	130	12	12	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.		2014	5								161	10.3389/fneur.2014.00161			12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	V42QW	WOS:000209629300153	25221540	DOAJ Gold, Green Published			2021-06-18	
J	Yoo, JS; Kim, OL; Kim, SH; Kim, MS; Jang, SH				Yoo, Jin-Sun; Kim, Oh Lyong; Kim, Seong Ho; Kim, Min Su; Jang, Sung Ho			Relation between cognition and neural connection from injured cingulum to brainstem cholinergic nuclei in chronic patients with traumatic brain injury	BRAIN INJURY			English	Article						Brain injury; brainstem cholinergic nuclei; cingulum; cognition; traumatic diffusion tensor imaging	DIFFUSION TENSOR TRACTOGRAPHY; AXONAL INJURY; ANTERIOR; SYSTEM; BUNDLE; FORNIX; CORTEX	Background: This study investigated the relation between cognition and the neural connection from injured cingulum to brainstem cholinergic nuclei in patients with traumatic brain injury (TBI), using diffusion tensor tractography (DTT). Methods: Among 353 patients with TBI, 20 chronic patients who showed discontinuation of both anterior cingulums from the basal forebrain on DTT were recruited for this study. The Wechsler Intelligence Scale and the Memory Assessment Scale (MAS; short-term, verbal, visual and total memory) were used for assessment of cognition. Patients were divided into two groups according to the presence of a neural connection between injured cingulum and brainstem cholinergic nuclei. Results: Eight patients who had a neural connection between injured cingulum and brainstem cholinergic nuclei showed better short-term memory on MAS than 12 patients who did not (p<0.05). However, other results of neuropsychological testing showed no significant difference (p>0.05). Conclusions: Better short-term memory in patients who had the neural connection between injured cingulum and brainstem cholinergic nuclei appears to have been attributed to the presence of cholinergic innervation to the cerebral cortex through the neural connection instead of the injured anterior cingulum. The neural connection appears to compensate for the injured anterior cingulum in obtaining cholinergic innervation.	[Yoo, Jin-Sun; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea; [Kim, Oh Lyong; Kim, Seong Ho; Kim, Min Su] Yeungnam Univ, Coll Med, Dept Neurosurg, Taegu 705717, South Korea	Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea (NRF) - by the Ministry of Education, Science and Technology [2012R1A1A4A01001873]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A4A01001873).	Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Baek SO, 2013, NEUROREHABILITATION, V33, P465, DOI 10.3233/NRE-130979; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Concha L, 2005, AM J NEURORADIOL, V26, P2267; Gazzaniga M.S., 2009, COGNITIVE NEUROSCIEN, V3rd; Harding L., 1996, ASSESSMENT NEUROPSYC; Hong JH, 2010, J REHABIL MED, V42, P979, DOI 10.2340/16501977-0603; Hong JH, 2010, BRAIN RES, V1346, P190, DOI 10.1016/j.brainres.2010.05.088; Jackson O, 2004, NEUROIMAGE, V21, P456, DOI 10.1016/j.neuroimage.2003.09.050; Jang SH, 2013, NEUROSCI LETT, V543, P47, DOI 10.1016/j.neulet.2013.02.058; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Le TH, 2006, SEMIN ROENTGENOL, V41, P177, DOI 10.1053/j.ro.2006.04.003; Malykhin N, 2008, PSYCHIAT RES-NEUROIM, V164, P132, DOI 10.1016/j.pscychresns.2007.11.007; McCauley SR, 2011, J NEUROTRAUM, V28, P503, DOI 10.1089/neu.2010.1555; Miranda MI, 2003, NEUROBIOL LEARN MEM, V80, P211, DOI 10.1016/S1074-7427(03)00061-3; MUFSON EJ, 1984, J COMP NEUROL, V225, P31, DOI 10.1002/cne.902250105; Naidich TP, 2009, DUVERNOYS ATLAS HUMA; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Selden NR, 1998, BRAIN, V121, P2249, DOI 10.1093/brain/121.12.2249; Sugiyama K, 2009, J NEUROTRAUM, V26, P1879, DOI [10.1089/neu.2008.0839, 10.1089/neu.2008-0839]; van Huijzen, 2008, HUMAN CENTRAL NERVOU; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wechsler D., 1981, WAIS R MANUAL WECHSL; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Williams JM, 1991, MAS MEMORY ASSESSMEN; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yamada K, 2009, P NATL ACAD SCI USA, V106, pE14, DOI 10.1073/pnas.0812352106; Yeo SS, 2013, J REHABIL MED, V45, P595, DOI 10.2340/16501977-1145; Yeo SS, 2012, NEUROREHABILITATION, V31, P143, DOI 10.3233/NRE-2012-0783; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	36	12	12	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	10					1257	1261		10.3109/02699052.2014.901557			5	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AN2ZZ	WOS:000340455900004	24926814				2021-06-18	
J	Zupan, B; Babbage, D; Neumann, D; Willer, B				Zupan, Barbra; Babbage, Duncan; Neumann, Dawn; Willer, Barry			Recognition of facial and vocal affect following traumatic brain injury	BRAIN INJURY			English	Article						Affect; facial; intensity; vocal	EMOTION RECOGNITION; NONVERBAL-COMMUNICATION; DIFFERENT MEDIA; PERCEPTION; EXPRESSIONS; DEFICITS; IMPAIRMENT; PROSODY; VOICE; FACE	Objective: Studies of facial affect recognition by people with traumatic brain injury (TBI) have shown this to be a significant problem. Vocal affect recognition also appears to be challenging for this population, but little is known about the degree to which one modality is impaired compared to the other. This study compared facial and vocal affect recognition of high and low intensity emotion expressions in people with moderate-to-severe TBI. Methods: The Diagnostic Analysis of Nonverbal Accuracy-2 (Adult Faces; Voices) was administered to 203 participants with TBI. Results: Adults with TBI identified vocal emotion expressions with greater accuracy than facial emotion expressions. Facial affect recognition impairment was identified in 34% of participants, 22% were classified as having vocal affect recognition impairment and 15% showed impairment in both modalities. Participants were significantly less accurate at identifying low vs high intensity emotion expressions in both modalities. Happy facial expressions were significantly better identified than all other emotions. Errors were distributed across the emotion categories for vocal expressions. Conclusions: The degree of facial affect impairment was significantly greater than vocal affect impairment in this sample of people with moderate-to-severe TBI. Low intensity emotion expressions were particularly problematic and an advantage for positively valenced facial emotion expressions was indicated.	[Zupan, Barbra] Brock Univ, Dept Appl Linguist, St Catharines, ON L2S 3A1, Canada; [Babbage, Duncan] Auckland Univ Technol, Sch Rehabil & Occupat Studies, Ctr Person Centred Res, Auckland, New Zealand; [Neumann, Dawn] Indiana Sch Med, Dept Psychiat, Indianapolis, IN USA; [Willer, Barry] SUNY Buffalo, Dept Psychiat, Buffalo, NY 14260 USA	Zupan, B (corresponding author), Brock Univ, Dept Appl Linguist, 500 Glenridge Ave, St Catharines, ON L2S 3A1, Canada.	bzupan@brocku.ca		Barbra, Zupan/0000-0002-4603-333X; Babbage, Duncan/0000-0002-9259-9246	National Institute on Disability and Rehabilitation Research (NIDDR) [H133G080043]	This work was funded through the National Institute on Disability and Rehabilitation Research (NIDDR; Award #H133G080043).	Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; AMBADY N, 1992, PSYCHOL BULL, V111, P256, DOI 10.1037/0033-2909.111.2.256; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Batty M, 2006, DEVELOPMENTAL SCI, V9, P207, DOI 10.1111/j.1467-7687.2006.00480.x; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; BOWERS D, 1987, NEUROPSYCHOLOGIA, V25, P317, DOI 10.1016/0028-3932(87)90021-2; Bowers D, 1998, FLORIDA AFFECT BATTE; Collignon O, 2008, BRAIN RES, V1242, P126, DOI 10.1016/j.brainres.2008.04.023; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; de Gelder B, 2000, COGNITION EMOTION, V14, P289, DOI 10.1080/026999300378824; Dimoska A, 2010, J INT NEUROPSYCH SOC, V16, P369, DOI 10.1017/S1355617709991445; Ekman P., 1976, PICTURES FACIAL AFFE; Elfenbein HA, 2002, EMO SOC BEH, P37; Guercio JM, 2004, BRAIN INJURY, V18, P593, DOI 10.1080/02699050310001646116; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Keltner D., 2000, HDB EMOTIONS, V2nd ed., P236; Knapp M.L., 2010, NONVERBAL COMMUNICAT, V7th; Massaro DW, 1996, PSYCHON B REV, V3, P215, DOI 10.3758/BF03212421; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S., 2005, BRAIN IMPAIR, V6, P56, DOI DOI 10.1375/BRIM.6.1.56.65481; McDonald S., 2002, AWARENESS SOCIAL INF; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; Neumann D, 2014, J HEAD TRAUMA REHABI; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; NOWICKI S, 1993, J SOC PSYCHOL, V133, P749, DOI 10.1080/00224545.1993.9713934; NOWICKI S, 1994, J NONVERBAL BEHAV, V18, P9, DOI 10.1007/BF02169077; Nowicki S., 2008, MANUAL RECEPTIVE TES; Paulmann S, 2011, MOTIV EMOTION, V35, P192, DOI 10.1007/s11031-011-9206-0; Pell MD, 2011, COGNITION EMOTION, V25, P834, DOI 10.1080/02699931.2010.516915; Pell MD, 1997, BRAIN LANG, V57, P80, DOI 10.1006/brln.1997.1638; Pell MD, 2006, BRAIN LANG, V96, P221, DOI 10.1016/j.bandl.2005.04.007; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; Russell JA, 2003, ANNU REV PSYCHOL, V54, P329, DOI 10.1146/annurev.psych.54.101601.145102; Scherer KR, 2003, SPEECH COMMUN, V40, P227, DOI 10.1016/S0167-6393(02)00084-5; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; WALLBOTT HG, 1986, J PERS SOC PSYCHOL, V51, P690, DOI 10.1037/0022-3514.51.4.690; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P113, DOI 10.1080/13803390902806543; Yim J, 2013, BRAIN INJURY, V27, P1155, DOI 10.3109/02699052.2013.804203; Zupan B, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829dded6	47	12	12	1	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	8					1087	1095		10.3109/02699052.2014.901560			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AI6KP	WOS:000336983200010	24701988				2021-06-18	
J	Freppel, S; Bisdorff, A; Colnat-Coulbois, S; Ceyte, H; Cian, C; Gauchard, G; Auque, J; Perrin, P				Freppel, S.; Bisdorff, A.; Colnat-Coulbois, S.; Ceyte, H.; Cian, C.; Gauchard, G.; Auque, J.; Perrin, P.			VISUO-PROPRIOCEPTIVE INTERACTIONS IN DEGENERATIVE CERVICAL SPINE DISEASES REQUIRING SURGERY	NEUROSCIENCE			English	Article						cervical proprioception; degenerative cervical spine diseases; surgical treatment; static postural control; postural sensorimotor strategies	NECK MUSCLE VIBRATION; CERVICOCEPHALIC KINESTHETIC SENSIBILITY; EVOKED POSTURAL RESPONSES; PAIN; HEAD; POSITION; SPONDYLOSIS; VERTIGO; MOTION; RANGE	Cervical proprioception plays a key role in postural control, but its specific contribution is controversial. Postural impairment was shown in whiplash injuries without demonstrating the sole involvement of the cervical spine. The consequences of degenerative cervical spine diseases are underreported in posture-related scientific literature in spite of their high prevalence. No report has focused on the two different mechanisms underlying cervicobrachial pain: herniated discs and spondylosis. This study aimed to evaluate postural control of two groups of patients with degenerative cervical spine diseases with or without optokinetic stimulation before and after surgical treatment. Seventeen patients with radiculopathy were recruited and divided into two groups according to the spondylotic or discal origin of the nerve compression. All patients and a control population of 31 healthy individuals underwent a static posturographic test with 12 recordings; the first four recordings with the head in 0 degrees position: eyes closed, eyes open without optokinetic stimulation, with clockwise and counter clockwise optokinetic stimulations. These four sensorial situations were repeated with the head rotated 30 degrees to the left and to the right. Patients repeated these 12 recordings 6 weeks postoperatively. None of the patients reported vertigo or balance disorders before or after surgery. Prior to surgery, in the eyes closed condition, the herniated disc group was more stable than the spondylosis group. After surgery, the contribution of visual input to postural control in a dynamic visual environment was reduced in both cervical spine diseases whereas in a stable visual environment visual contribution was reduced only in the spondylosis group. The relative importance of visual and proprioceptive inputs to postural control varies according to the type of pathology and surgery tends to reduce visual contribution mostly in the spondylosis group. (C) 2013 IBRO. Published by Elsevier Ltd. All rights reserved.	[Freppel, S.; Bisdorff, A.; Colnat-Coulbois, S.; Ceyte, H.; Gauchard, G.; Perrin, P.] Univ Lorraine, EA DevAH Dev Adapt & Disadvantage 3450, Fac Med, Nancy, France; [Freppel, S.; Bisdorff, A.; Colnat-Coulbois, S.; Ceyte, H.; Gauchard, G.; Perrin, P.] Univ Lorraine, UFR STAPS, Nancy, France; [Freppel, S.] Univ Hosp, Grp Hosp Sud Reunion, Dept Neurosurg, St Pierre, Reunion, France; [Bisdorff, A.] Ctr Hosp Emile Mayrisch, Dept Neurol, Luxembourg, Luxembourg; [Colnat-Coulbois, S.; Auque, J.] Univ Hosp Nancy, Dept Neurosurg, Nancy, France; [Ceyte, H.; Cian, C.] Inst Rech Biomed Armees, La Tronche, France; [Perrin, P.] Univ Hosp, Dept Otorhinolaryngol, Vandoeuvre Les Nancy, France	Perrin, P (corresponding author), Univ Lorraine, EA DevAH Dev Adapt & Handicap 3450, UFR STAPS Nancy, 30 Rue Jardin Bot, F-54600 Villers Les Nancy, France.	philippe.perrin@univ-lorraine.fr		Ceyte, Hadrien/0000-0003-1746-5026			Bell KM, 2011, SPINE, V36, P263, DOI 10.1097/BRS.0b013e3181ccc552; Berencsi A, 2005, HUM MOVEMENT SCI, V24, P689, DOI 10.1016/j.humov.2005.10.014; BIGUER B, 1988, BRAIN, V111, P1405, DOI 10.1093/brain/111.6.1405; Bove M, 2002, J NEUROPHYSIOL, V88, P2232, DOI 10.1152/jn.00198.2002; Bove M, 2001, J APPL PHYSIOL, V91, P581; Brandt T, 2001, J NEUROL NEUROSUR PS, V71, P8, DOI 10.1136/jnnp.71.1.8; Cevik R, 2010, CLIN RHEUMATOL, V29, P541, DOI 10.1007/s10067-010-1385-7; Ceyte H, 2006, EXP BRAIN RES, V170, P136, DOI 10.1007/s00221-006-0389-7; CLOWARD RB, 1958, J NEUROSURG, V15, P602, DOI 10.3171/jns.1958.15.6.0602; Dumas G, 2013, J VESTIBUL RES-EQUIL, V23, P41, DOI 10.3233/VES-130468; Field S, 2008, MANUAL THER, V13, P183, DOI 10.1016/j.math.2006.12.005; Gangloff P, 2002, NEUROSCI LETT, V330, P179, DOI 10.1016/S0304-3940(02)00779-6; KARLBERG M, 1995, ACTA OTO-LARYNGOL, P440; Kristjansson E, 2003, CLIN REHABIL, V17, P768, DOI 10.1191/0269215503cr676oa; Lee HJ, 2005, SPINE, V30, pE60, DOI 10.1097/01.brs.0000152160.28052.a2; Machaly SA, 2011, CLIN RHEUMATOL, V30, P1527, DOI 10.1007/s10067-011-1770-x; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; McCormack BM, 1996, WESTERN J MED, V165, P43; Persson L, 1996, J VESTIBUL RES-EQUIL, V6, P439; Pinsault N, 2008, ARCH PHYS MED REHAB, V89, P2375, DOI 10.1016/j.apmr.2008.06.009; REVEL M, 1991, ARCH PHYS MED REHAB, V72, P288; REVEL M, 1994, ARCH PHYS MED REHAB, V75, P895, DOI 10.1016/0003-9993(94)90115-5; Rix GD, 2001, ARCH PHYS MED REHAB, V82, P911, DOI 10.1053/apmr.2001.23300; ROLL JP, 1988, INT CONGR SER, V812, P155; RYAN GMS, 1955, LANCET, V2, P1355; TAYLOR JL, 1991, BRAIN, V114, P755, DOI 10.1093/brain/114.2.755; Thurrell AEI, 2002, EXP BRAIN RES, V147, P558, DOI 10.1007/s00221-002-1296-1; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; Vitte E, 1992, POSTURE GAIT CONTROL, V2, P176; Wolsley CJ, 1996, EXP BRAIN RES, V111, P283	30	12	13	1	14	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	DEC 26	2013	255						226	232		10.1016/j.neuroscience.2013.09.060			7	Neurosciences	Neurosciences & Neurology	302GR	WOS:000330591500020	24120556				2021-06-18	
J	Jiang, Y; Rumble, JL; Gleixner, AM; Unnithan, AS; Pulugulla, SH; Posimo, JM; Choi, HJH; Crum, TS; Pant, DB; Leak, RK				Jiang, Y.; Rumble, J. L.; Gleixner, A. M.; Unnithan, A. S.; Pulugulla, S. H.; Posimo, J. M.; Choi, H. J. H.; Crum, T. S.; Pant, D. B.; Leak, R. K.			N-ACETYL CYSTEINE BLUNTS PROTEOTOXICITY IN A HEAT SHOCK PROTEIN-DEPENDENT MANNER	NEUROSCIENCE			English	Article						Parkinson's disease; Alzheimer's disease; heat shock protein 70; heat shock cognate 70; chaperone; N-acetylcysteine	UBIQUITIN-PROTEASOME PATHWAY; BULBAR MUSCULAR-ATROPHY; OXIDATIVE STRESS; MOLECULAR CHAPERONES; NEURODEGENERATIVE DISORDERS; PARKINSONS-DISEASE; INDUCED APOPTOSIS; CELL-DEATH; RHEUMATOID-ARTHRITIS; NEUROBLASTOMA-CELLS	N-Acetyl cysteine, a glutathione precursor, has been shown to benefit patients with Alzheimer's disease and reduce the symptoms of traumatic brain injury in soldiers. Parkinson's and Alzheimer's disease are both characterized by stress from protein misfolding, or proteotoxicity. We have developed a high-throughput model of proteotoxicity by treating neuroblastoma N2a cells with the proteasome inhibitor MG132 and performing three independent assays for viability. Our previous study showed that N-acetyl cysteine protects N2a cells against two sequential treatments of MG132 and raises glutathione levels in a two-hit model of synergistic neurodegeneration. In the present study, however, N-acetyl cysteine was found to reduce the toxicity of a single hit of MG132 independent of its effect on glutathione. All three viability assays confirmed this protection. We measured heat shock protein 70 (Hsp70) levels because Hsp70 is a protective chaperone that helps refold proteins or guides ubiquitinated proteins toward degradation by the proteasome. Hsp70 levels were higher in MG132-treated cells when N-acetyl cysteine was applied. No parallel change in heat shock cognate 70 (Hsc70) was elicited. Inhibition of Hsp70/Hsc70 activity with VER 155008 attenuated the protection afforded by N-acetyl cysteine in a dose-responsive manner. MG132 induced a large rise in ubiquitinated proteins and N-acetyl cysteine reduced this effect. Consistent with the chaperone functions of Hsp70, VER 155008 also prevented the reduction in ubiquitin-conjugated proteins by N-acetyl cysteine. These data reveal a new role for N-acetyl cysteine: this compound may reduce misfolded protein levels and ameliorate proteotoxicity through heat shock proteins. These findings broaden the potential mechanisms of action for this dietary supplement in neurodegenerative proteinopathies. (C) 2013 IBRO. Published by Elsevier Ltd. All rights reserved.	[Jiang, Y.; Rumble, J. L.; Gleixner, A. M.; Unnithan, A. S.; Pulugulla, S. H.; Posimo, J. M.; Choi, H. J. H.; Crum, T. S.; Pant, D. B.; Leak, R. K.] Duquesne Univ, Div Pharmaceut Sci, Mylan Sch Pharm, Pittsburgh, PA 15282 USA	Leak, RK (corresponding author), Duquesne Univ, Div Pharmaceut Sci, 600 Forbes Ave, Pittsburgh, PA 15282 USA.	leakr@duq.edu	Leak, Rehana K/I-2607-2019	Leak, Rehana K/0000-0003-2817-7417	Pennsylvania Department of Health (Commonwealth Universal Research Enhancement program); Mylan School of Pharmacy at the Duquesne University	R.K.L. designed the experiments and wrote the manuscript. Y.J., J.R., A.M.G., A.S.U., S.P., J.M.P., T.C., and D.P. performed the experiments, analyzed the data, provided technical support, and proofread the article. This work was supported by a Grant from the Pennsylvania Department of Health (Commonwealth Universal Research Enhancement program) and by a startup award to R.K.L. from the Mylan School of Pharmacy at the Duquesne University. We are especially grateful for the superb administrative assistance of Deb Wilson, Mary Caruso, and Jackie Farrer. None of the authors have any conflicts to disclose.	Adachi H, 2003, J NEUROSCI, V23, P2203; Adair JC, 2001, NEUROLOGY, V57, P1515, DOI 10.1212/WNL.57.8.1515; Anckar J, 2007, ADV EXP MED BIOL, V594, P78; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Beere HM, 2001, SCI STKE, V93, P1; Besche HC, 2009, CELL, V138, P25, DOI 10.1016/j.cell.2009.06.035; Breusing N, 2008, BIOL CHEM, V389, P203, DOI 10.1515/BC.2008.029; Calabrese EJ, 2010, HUM EXP TOXICOL, V29, P249, DOI 10.1177/0960327109363973; Calabrese EJ, 2005, ENVIRON POLLUT, V138, P378, DOI 10.1016/j.envpol.2004.10.001; Calabrese EJ, 2001, TOXICOL SCI, V62, P330, DOI 10.1093/toxsci/62.2.330; Chacko SK, 2010, EXP CLIN ENDOCR DIAB, V118, P64, DOI 10.1055/s-0029-1225647; Chao PL, 2007, ANN NY ACAD SCI, V1122, P276, DOI 10.1196/annals.1403.020; Chatterjee M, 2013, HAEMATOLOGICA, V98, P1132, DOI 10.3324/haematol.2012.066175; Clark J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012333; DAS KC, 1995, AM J PHYSIOL-LUNG C, V269, pL588; Farr SA, 2003, J NEUROCHEM, V84, P1173, DOI 10.1046/j.1471-4159.2003.01580.x; Fenteany G, 1996, CHEM BIOL, V3, P905, DOI 10.1016/S1074-5521(96)90179-9; Gabai VL, 2002, J APPL PHYSIOL, V92, P1743, DOI 10.1152/japplphysiol.01101.2001; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Giordano J, 2008, CRIT REV TOXICOL, V38, P623, DOI 10.1080/10408440802026356; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gusarova V, 2001, J BIOL CHEM, V276, P24891, DOI 10.1074/jbc.M100633200; Han YH, 2010, ANTICANCER RES, V30, P2107; Han YH, 2010, INT J MOL MED, V25, P657, DOI 10.3892/ijmm_00000389; Hineno A, 2011, NEUROCHEM RES, V36, P2127, DOI 10.1007/s11064-011-0537-8; Hoffer ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054163; Kalia SK, 2010, CNS NEUROL DISORD-DR, V9, P741; Kalia SK, 2004, NEURON, V44, P931, DOI 10.1016/j.neuron.2004.11.026; Kaneko K, 2008, NEUROSCI LETT, V446, P56, DOI 10.1016/j.neulet.2008.08.089; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Lanneau D, 2010, THESCIENTIFICWORLDJO, V10, P1543, DOI 10.1100/tsw.2010.152; Leak RK, 2008, J NEUROCHEM, V106, P860, DOI 10.1111/j.1471-4159.2008.05459.x; Leak RK, 2010, J NEUROSCI METH, V191, P234, DOI 10.1016/j.jneumeth.2010.06.023; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lee HZ, 2009, FOOD CHEM TOXICOL, V47, P561, DOI 10.1016/j.fct.2008.12.013; Loeffler DA, 1996, BRAIN RES, V738, P265, DOI 10.1016/S0006-8993(96)00782-2; Loeffler DA, 2001, FREE RADICAL RES, V35, P111, DOI 10.1080/10715760100300651; Louro MO, 2000, J TRACE ELEM MED BIO, V14, P174, DOI 10.1016/S0946-672X(00)80007-3; Luo WJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-24; Macias AT, 2011, J MED CHEM, V54, P4034, DOI 10.1021/jm101625x; Massey AJ, 2010, CANCER CHEMOTH PHARM, V66, P535, DOI 10.1007/s00280-009-1194-3; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; McNaught KS, 2003, EXP NEUROL, V179, P38, DOI 10.1006/exnr.2002.8050; McNaught KSP, 2004, INT REV NEUROBIOL, V62, P95, DOI 10.1016/S0074-7742(04)62003-4; Memisogullari R, 2004, J DIABETES COMPLICAT, V18, P193, DOI 10.1016/S1056-8727(03)00032-1; MEYER M, 1993, EMBO J, V12, P2005, DOI 10.1002/j.1460-2075.1993.tb05850.x; Mezzetti A, 1996, J AM GERIATR SOC, V44, P823, DOI 10.1111/j.1532-5415.1996.tb03741.x; Mezzetti A, 1998, FREE RADICAL BIO MED, V25, P676, DOI 10.1016/S0891-5849(98)00109-9; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Muller JM, 1997, EUR J BIOCHEM, V244, P45, DOI 10.1111/j.1432-1033.1997.00045.x; Mustafi SB, 2009, CELL STRESS CHAPERON, V14, P579, DOI 10.1007/s12192-009-0109-x; Needham PG, 2011, J BIOL CHEM, V286, P43611, DOI 10.1074/jbc.M111.288928; Nollen EAA, 2002, J CELL SCI, V115, P2809; Ohtsuka K, 2000, INT J HYPERTHER, V16, P231, DOI 10.1080/026567300285259; OMURA S, 1991, J ANTIBIOT, V44, P113, DOI 10.7164/antibiotics.44.113; Petersen AC, 2012, ACTA PHYSIOL, V204, P382, DOI 10.1111/j.1748-1716.2011.02344.x; Pocernich CB, 2000, NEUROCHEM INT, V36, P185, DOI 10.1016/S0197-0186(99)00126-6; Pocernich CB, 2012, BBA-MOL BASIS DIS, V1822, P625, DOI 10.1016/j.bbadis.2011.10.003; Posimo JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058596; Posimo JM, 2013, J VIS EXP IN PRESS; Putics A, 2008, ANTIOXID REDOX SIGN, V10, P65, DOI 10.1089/ars.2007.1866; Rideout HJ, 2002, MOL CELL NEUROSCI, V21, P223, DOI 10.1006/mcne.2002.1173; Rideout HJ, 2001, J NEUROCHEM, V78, P899, DOI 10.1046/j.1471-4159.2001.00474.x; Rideout HJ, 2005, J NEUROCHEM, V93, P1304, DOI 10.1111/j.1471-4159.2005.03124.x; Sawada H, 2004, J BIOL CHEM, V279, P10710, DOI 10.1074/jbc.M308434200; Saykally JN, 2012, NEUROSCIENCE, V223, P305, DOI 10.1016/j.neuroscience.2012.07.070; Seok SH, 2007, TOXICOL IN VITRO, V21, P870, DOI 10.1016/j.tiv.2007.02.011; Shang F, 2011, FREE RADICAL BIO MED, V51, P5, DOI 10.1016/j.freeradbiomed.2011.03.031; Sun F, 2006, NEUROTOXICOLOGY, V27, P807, DOI 10.1016/j.neuro.2006.06.006; Sun LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032503; Taysi S, 2002, RHEUMATOL INT, V21, P200, DOI 10.1007/s00296-001-0163-x; Texel SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025077; Texel SJ, 2008, BIOCHEM SOC T, V36, P1277, DOI 10.1042/BST0361277; Titler AM, 2013, CELL TISSUE RES, V352, P427, DOI 10.1007/s00441-013-1571-4; Tsai YC, 2003, J BIOL CHEM, V278, P22044, DOI 10.1074/jbc.M212235200; Tucker Stephanie, 2006, Current Alzheimer Research, V3, P221, DOI 10.2174/156720506777632835; Unnithan AS, 2012, NEUROCHEM INT, V61, P356, DOI 10.1016/j.neuint.2012.06.001; Xie WJ, 2010, J NEUROCHEM, V115, P188, DOI 10.1111/j.1471-4159.2010.06914.x; Yan CYI, 1998, J NEUROSCI, V18, P4042; Zhang FJ, 2011, TOXICOL SCI, V120, P87, DOI 10.1093/toxsci/kfq364; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303; Zhu YG, 2007, NEUROCHEM INT, V50, P671, DOI 10.1016/j.neuint.2006.12.013; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	84	12	12	0	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	DEC 26	2013	255						19	32		10.1016/j.neuroscience.2013.09.049			14	Neurosciences	Neurosciences & Neurology	302GR	WOS:000330591500002	24096134				2021-06-18	
J	Caminiti, F; Ciurleo, R; Bramanti, P; Marino, S				Caminiti, Fabrizia; Ciurleo, Rosella; Bramanti, Placido; Marino, Silvia			Persistent anosmia in a traumatic brain injury patient: Role of orbitofrontal cortex	BRAIN INJURY			English	Article						Anosmia; frontal lobe; orbitofrontal cortex; sniffin' sticks test; traumatic brain injury	ODOR DISCRIMINATION; OLFACTORY THRESHOLDS; IDENTIFICATION; TESTS	Background: The olfactory loss due to traumatic brain injury is a common clinical condition. The understanding of the cortical areas involved in ability to detect, discriminate and identify the odours is still limited. However, it has been shown that the orbitofrontal cortex (OFC) is involved in the discrimination and recognition of odours and in particular the right OFC has a dominant role in the central processing of smell. Method: This study used the Sniffin' Sticks Test to evaluate olfactory function of a 40-year-old female with persistent post-traumatic anosmia and to have a objective measure method for the follow-up. Results: A marked decrease in the ability to identify and discriminate odours was found. On the other hand the ability to perceive the odours was little compromised. A cerebral Magnetic Resonance Imaging, performed 10 months after the trauma, showed the presence of a post-traumatic scarring in the right frontal lobe involving the OFC. Conclusions: In this case of post-traumatic anosmia, the ability to perceive and recognize odours does not seem to be compromised in the same measure. It is postulated that the post-traumatic outcomes, involving areas of multisensory integration such as the OFC, have an important pathogenetic role in the loss of ability to recognize and discriminate odours.	[Caminiti, Fabrizia; Ciurleo, Rosella; Bramanti, Placido; Marino, Silvia] IRCCS Ctr Neurolesi Bonino Pulejo, I-98124 Messina, Italy	Marino, S (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, SS 113,Via Palermo, I-98124 Messina, Italy.	silvimarino@gmail.com	Bramanti, Placido/K-5117-2016; Ciurleo, Rosella/T-4590-2019	Ciurleo, Rosella/0000-0003-0709-5914; Caminiti, Fabrizia/0000-0002-2527-8063			Costanzo RM, 2006, ADV OTO-RHINO-LARYNG, V63, P99, DOI 10.1159/000093753; Eslinger P J, 1982, Brain Cogn, V1, P259, DOI 10.1016/0278-2626(82)90028-8; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Li W, 2010, PSYCHOL SCI, V21, P1454, DOI 10.1177/0956797610382121; Mueller Christian A, 2009, J Med Case Rep, V3, P9283, DOI 10.4076/1752-1947-3-9283; Welge-Lussen A, 2012, RHINOLOGY, V50, P67, DOI 10.4193/Rhino11.141; Wu AP, 2008, AM J RHINOL, V22, P606, DOI 10.2500/ajr.2008.22.3238; ZUSHO H, 1982, ARCH OTOLARYNGOL, V108, P90	12	12	12	0	5	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2013	27	13-14					1715	1718		10.3109/02699052.2013.823667			4	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	259BW	WOS:000327503400030	24088167				2021-06-18	
J	Elder, H				Elder, Hinemoa			Indigenous Theory Building for Maori Children and Adolescents with Traumatic Brain Injury and their Extended Family	BRAIN IMPAIRMENT			English	Article						indigenous; child and adolescent; traumatic brain injury; theory building; Maori	FUNCTIONAL OUTCOMES; ETHNIC DISPARITIES; MENTAL-HEALTH; HEAD-INJURY; NEW-ZEALAND; REHABILITATION; AMERICAN; CARE	Background: International research identifies indigeneity as a risk factor for traumatic brain injury (TBI). Aotearoa New Zealand studies show that mokopuna (grandchildren; used here to encompass the ages and stages of infant, child and adolescent development and those in young adulthood) are significantly overrepresented in TBI populations. The important role of whanau (family) is also well established in child and adolescent TBI scholarship. Despite awareness of these factors, no studies have been identified that explore whanau knowledge about mokopuna TBI. The aim of this study was to explore two questions: (1) What do Maori people say about mokopuna TBI in the context of the Maori cultural belief that the head is the most sacred part of the body? and (2) How could this information be used to build theory that could inform addressing the rehabilitation needs of this group? Method: Eighteen marae wananga (culture-specific fora in traditional meeting houses) were held. The wananga typically lasted approximately 2 hours. Footage and written transcripts were analysed using Rangahau Kaupapa Maori (Maori indigenous research methods). Results: The wairua theory of mokopuna TBI proposes that TBI not only injures brain anatomy and physiology but also injures wairua (defined here as a unique connection between Maori and all aspects of the universe). Injury to wairua means that culturally determined interventions are both indicated and expected. The wairua theory of mokopuna TBI thereby provides a guide to intervention. Conclusion: A Maori theory of mokopuna TBI has been identified which describes a culture-specific aspect of TBI. This theory proposes that pre-existing whanau knowledge salient to TBI is critical to optimising recovery. Further research is needed to test this theory not only in TBI but also in other areas such as in mental illness, neurodegenerative disease and addiction.	[Elder, Hinemoa] Whare Wananga Awanuiarangi, Oneroa, Waiheke Island, New Zealand	Elder, H (corresponding author), Whare Wananga Awanuiarangi, POB 334, Oneroa, Waiheke Island, New Zealand.	hinemoa@xtra.co.nz					Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; Barker-Collo S.L., 2012, WORLD C NEUR 16 19 M; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P32, DOI 10.1159/000170090; Blackmer J, 1999, BRAIN INJURY, V13, P627; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Burgess ES, 1999, J HEAD TRAUMA REHAB, V14, P394, DOI 10.1097/00001199-199908000-00008; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P303; Cheung M., 2010, CELLULAR CULTURAL ST; Durie M., 2001, MAURI ORA DYNAMICS M; Durie M., 1994, WHAIORA MAORI HLTH D; Durie M, 2011, TRANSCULT PSYCHIATRY, V48, P24, DOI 10.1177/1363461510383182; Elder H., 2013, BRAIN IMPAIRMENT; Faleafa Monique, 2009, Pac Health Dialog, V15, P28; Glavish N., 2007, TIKANGA BEST PRACTIC; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Jamieson LM, 2008, MED J AUSTRALIA, V188, P576, DOI 10.5694/j.1326-5377.2008.tb01793.x; Jansen P., 2008, RITNGA WHAKAARO MAOR; Keightley M, 2011, BRAIN INJURY, V25, P142, DOI 10.3109/02699052.2010.541898; Keightley ML, 2009, BRAIN INJURY, V23, P250, DOI 10.1080/02699050902748331; Kokiri Te Puni, 2007, TIROHANGA KI MAORI M; Kukutai T., 2004, SOC POLICY J N Z, V23, P86; Langlois J., 2003, MORBIDITY MORTALITY, V52, pSS; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; McClintock K, 2012, INT J SOC PSYCHIATR, V58, P96, DOI 10.1177/0020764010387067; Nelson LA, 2007, J HEAD TRAUMA REHAB, V22, P105, DOI 10.1097/01.HTR.0000265098.52306.a9; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ DIAG; Pomedli S., 2008, MATARIKI, V1, P91; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Robson B., 2001, EHTNICITY MATTERS RE; Saltapidas H, 2008, BRAIN IMPAIR, V9, P1, DOI 10.1375/brim.9.1.1; Saltapidas H, 2007, J HEAD TRAUMA REHAB, V22, P132, DOI 10.1097/01.HTR.0000265101.75177.8d; Sander AM, 2007, NEUROREHABILITATION, V22, P9; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Smith G.H., 2003, KAUP MAOR S NZARE AA; Statistics New Zealand, 2012, QUICKST MAOR; Statistics New Zealand & Ministry of Culture and Heritage, 2003, MEAS CULT CULT EXP C; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Taylor H.G., 1999, NEUROPSYCHOLOGY, V7, P755; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; TAYLOR HG, 1995, TRAUMATIC HEAD INJUR; Te Puni Kokiri, 2010, 2009 RANGAHAU NGA WA; Uomoto J.M., 2005, REHABILITATION TRAUM, P247; Wereta W., 2002, INT S CULT STAT 21 2; Woods DT, 2011, DEV NEUROREHABIL, V14, P274, DOI 10.3109/17518423.2011.586371; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393	47	12	12	0	10	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2013	14	3					406	414		10.1017/BrImp.2013.28			9	Clinical Neurology; Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	300MD	WOS:000330467100003					2021-06-18	
J	Gao, L; Wu, XH; Hu, J; Jin, Y; Han, X; Wu, X; Mao, Y; Zhou, LF				Gao, Liang; Wu, Xuehai; Hu, Jin; Jin, Yi; Han, Xi; Wu, Xing; Mao, Ying; Zhou, Liangfu			Intensive Management and Prognosis of 127 Cases with Traumatic Bilateral Frontal Contusions	WORLD NEUROSURGERY			English	Article						Bifrontal contusions; Intracranial pressure; Traumatic brain injury	BIFRONTAL DECOMPRESSIVE CRANIECTOMY; INJURY	BACKGROUND: With the development of edema and the possible enlargement of the hemorrhagic contusion, patients with a bifrontal contusion may deteriorate rapidly or even die as the result of central brain herniation. Therefore, close monitoring and in time treatment may be important to these patients. METHODS: A 127 patients with bifrontal contusions were reviewed retrospectively. Among them, 63 patients accepted operations, 39 cases underwent intracranial pressure (ICP) monitoring, and 24 cases did not. We compared the GlasgowOutcome Scale (GOS) for prognosis, length of osmolar therapy, and length in intensive care unit (ICU) and hospital stay between ICP and non-ICP groups. RESULTS: Compared with the non-ICP operation group, there was no significant difference in Glasgow Coma Scale score in the ICP group, both at admission (average 8.62 vs. 8.91, P = 0.711) and at discharge (average 11.32 vs. 10.45, P = 0.427). However, the length of stay in the ICU was much shorter in the ICP operation group than that of the non-ICP group (15.67 +/- 8.72 days vs. 25.32 +/- 18.78 days, P = 0.013). Hospital stay was also shortened significantly in the ICP operation group compared with the non-ICP operation group (18.94 +/- 8.92 days vs. 34.29 +/- 22.64 days, P = 0.001). The length of osmolar therapy with mannitol was also decreased in the ICP operation group compared with the non-ICP group (14.11 +/- 6.65 days vs. 21.84 +/- 12.02, P = 0.008). However, there was no difference in mortality between two groups (5/39 vs. 4/24). We followed up 29 ICP operation patients and nineteen non-ICP operation patients using GOS 6 months later. The average GOS was 4.21 and 3.32 for the ICP and non-ICP groups respectively (P = 0.025). CONCLUSION: ICP is one of the most important intensive types of monitoring for patients with moderate-to-severe bifrontal contusions and may be beneficial in creating a better prognosis. Intensive care and proper management are necessary to reduce stays in ICU, hospitalization, and mannitol osmolar therapy, and to improve GOS.	[Gao, Liang; Wu, Xuehai; Hu, Jin; Jin, Yi; Han, Xi; Wu, Xing; Mao, Ying; Zhou, Liangfu] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China	Mao, Y (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China.	yingmao168@hotmail.com			Shanghai Nature Science Foundation [08411952000, 10ZR1405400]; Shanghai Health Bureau [2008114]	This study was supported by grants (08411952000, 10ZR1405400) from Shanghai Nature Science Foundation, and the Shanghai Health Bureau (2008114).	Brain Trauma Foundation, 2007, GUID MAN SEV TRAUM B, P59; Hung KS, 2004, J CLIN NEUROSCI, V11, P849, DOI 10.1016/j.jocn.2003.06.009; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Pittella JEH, 1999, ARQ NEURO-PSIQUIAT, V57, P848, DOI 10.1590/S0004-282X1999000500018; Rehman Tausif, 2008, Cases J, V1, P203, DOI 10.1186/1757-1626-1-203; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327; VENES JL, 1975, J NEUROSURG, V42, P429, DOI 10.3171/jns.1975.42.4.0429; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110	8	12	14	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2013	80	6					879	888		10.1016/j.wneu.2013.01.020			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	290DL	WOS:000329733300088	23313235				2021-06-18	
J	Leonardi, AD; Keane, NJ; Hay, K; Ryan, AG; Bir, CA; VandeVord, PJ				Leonardi, Alessandra Dal Cengio; Keane, Nickolas J.; Hay, Kathryn; Ryan, Anne G.; Bir, Cynthia A.; VandeVord, Pamela J.			Methodology and Evaluation of Intracranial Pressure Response in Rats Exposed to Complex Shock Waves	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Blast; IED; TBI; Skull flexure; Complex wave environment	BLAST OVERPRESSURE; CORTICAL-NEURONS; INJURY; EPIDEMIOLOGY	Studies on blast neurotrauma have focused on investigating the effects of exposure to free-field blast representing the simplest form of blast threat scenario without considering any reflecting surfaces. However, in reality personnel are often located within enclosures or nearby reflecting walls causing a complex blast environment, that is, involving shock reflections and/or compound waves from different directions. The purpose of this study was to design a complex wave testing system and perform a preliminary investigation of the intracranial pressure (ICP) response of rats exposed to a complex blast wave environment (CBWE). The effects of head orientation in the same environment were also explored. Furthermore, since it is hypothesized that exposure to a CBWE would be more injurious as compared to a free-field blast wave environment (FFBWE), a histological comparison of hippocampal injury (cleaved caspase-3 and glial fibrillary acidic protein (GFAP)) was conducted in both environments. Results demonstrated that, regardless of orientation, peak ICP values were significantly elevated over the peak static air overpressure. Qualitative differences could be noticed compared to the ICP response in rats exposed to simulated FFBWE. In the CBWE scenario, after the initial loading the skull/brain system was not allowed to return to rest and was loaded again reaching high ICP values. Furthermore, results indicated consistent and distinct ICP-time profiles according to orientation, as well as distinctive values of impulse associated with each orientation. Histologically, cleaved caspase-3 positive cells were significantly increased in the CBWE as compared to the FFBWE. Overall, these findings suggest that the geometry of the skull and the way sutures are distributed in the rats are responsible for the difference in the stresses observed. Moreover, this increase stress contributes to correlation of increased injury in the CBWE.	[Leonardi, Alessandra Dal Cengio; Ryan, Anne G.; VandeVord, Pamela J.] Virginia Tech Univ, Blacksburg, VA USA; [Keane, Nickolas J.; Hay, Kathryn; Bir, Cynthia A.] Wayne State Univ, Detroit, MI USA	VandeVord, PJ (corresponding author), Virginia Tech Univ, Blacksburg, VA USA.	pvord@vt.edu		Bir, Cynthia/0000-0002-0777-0951	Department of DefenseUnited States Department of Defense [W81XWH-08-2-0207]; Office of Naval ResearchOffice of Naval Research [N000140810585]	We would like to thank the WSU Bioengineering Center Staff for assisting with this project, especially Sujith Sajja, Dr. Bin Wu for her indispensable contribution in surgery and Mr. Dave Ritzel for his blast physics expertise. This project was partially funded by the Department of Defense (Award no. W81XWH-08-2-0207) and the Office of Naval Research (Award Number N000140810585).	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI 10.1089/neu.2009-0898; Bolander R., 2012, THESIS WAYNE STATE U; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Bowen I. G., 1968, DASA2113, P1; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Ganpule S., 2012, BIOMECH MODEL MECHAN, P1, DOI 1007/s10237-012-0421-8; Leibovici D, 1996, J TRAUMA, V41, P1030, DOI 10.1097/00005373-199612000-00015; Leonardi A.D., 2011, THESIS WAYNE STATE U; Leonardi AD, 2012, J BIOMECH, V45, P2595, DOI 10.1016/j.jbiomech.2012.08.024; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Mackenzie IMJ, 2011, PHILOS T R SOC B, V366, P295, DOI 10.1098/rstb.2010.0252; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; Payette DJ, 2008, INT J CLIN EXP PATHO, V1, P44; Phillips Y. Y., 1991, CONVENTIONAL WARFARE, P221; Richmond D. R., 1968, ANN NY ACAD SCI, P103; Richmond D. R., 1985, 9 INT S MABS 9 OXF E, V9; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Smith JE, 2011, PHILOS T R SOC B, V366, P291, DOI 10.1098/rstb.2010.0251; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Stuhmiller JH, 1997, TOXICOLOGY, V121, P91, DOI 10.1016/S0300-483X(97)03658-5; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Warren MW, 2007, ACTA NEUROPATHOL, V114, P277, DOI 10.1007/s00401-007-0259-9; Yelverton J. T., 1993, BLAST OVERPRESSURE S	29	12	12	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	DEC	2013	41	12					2488	2500		10.1007/s10439-013-0850-2			13	Engineering, Biomedical	Engineering	249UN	WOS:000326803700003	23904049				2021-06-18	
J	Liegeois, FJ; Mahony, K; Connelly, A; Pigdon, L; Tournier, JD; Morgan, AT				Liegeois, Frederique J.; Mahony, Kate; Connelly, Alan; Pigdon, Lauren; Tournier, Jacques-Donald; Morgan, Angela T.			Pediatric traumatic brain injury: Language outcomes and their relationship to the arcuate fasciculus	BRAIN AND LANGUAGE			English	Article						Pediatric brain injury; Expressive language; Dysarthria; Tractography; Arcuate fasciculus	UNCINATE FASCICULUS; AXONAL INJURY; HEAD-INJURY; DIFFUSION; TRACTOGRAPHY; RECOVERY; SPEECH; LATERALIZATION; PREDICTORS; PATHWAYS	Pediatric traumatic brain injury (TBI) may result in long-lasting language impairments alongside dysarthria, a motor-speech disorder. Whether this co-morbidity is due to the functional links between speech and language networks, or to widespread damage affecting both motor and language tracts, remains unknown. Here we investigated language function and diffusion metrics (using diffusion-weighted tractography) within the arcuate fasciculus, the uncinate fasciculus, and the corpus callosum in 32 young people after TBI (approximately half with dysarthria) and age-matched healthy controls (n = 17). Only participants with dysarthria showed impairments in language, affecting sentence formulation and semantic association. In the whole TBI group, sentence formulation was best predicted by combined corpus callosum and left arcuate volumes, suggesting this "dual blow" seriously reduces the potential for functional reorganisation. Word comprehension was predicted by fractional anisotropy in the right arcuate. The co-morbidity between dysarthria and language deficits therefore seems to be the consequence of multiple tract damage. (C) 2013 Elsevier Inc. All rights reserved.	[Liegeois, Frederique J.] UCL, Inst Child Hlth, Dev Cognit Neurosci Unit, London WC1N 1EH, England; [Mahony, Kate] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Connelly, Alan; Tournier, Jacques-Donald] Florey Neurosci Inst, Brain Res Inst, Melbourne, Vic, Australia; [Pigdon, Lauren; Morgan, Angela T.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Morgan, Angela T.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia	Liegeois, FJ (corresponding author), UCL, Inst Child Hlth, Dev Cognit Neurosci Unit, 30 Guilford St, London WC1N 1EH, England.	f.liegeois@ucl.ac.uk	Connelly, Alan/A-9065-2013; Morgan, Angela/J-5235-2017	Connelly, Alan/0000-0001-7159-8079; Morgan, Angela/0000-0003-1147-7405; Liegeois, Frederique/0000-0002-8640-6217	Transport Accident Commission [D131]; Victorian neurotrauma initiative; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [607315, 1023043]	This study was supported by Grant D131 from the Transport Accident Commission: Victorian neurotrauma initiative, awarded to A.T.M., F.J.L., A.C., and J-D.T.; and National Health and Medical Research Council Grants nos. 607315 and 1023043 awarded to A.T.M.	Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Berry JG, 2010, INJURY PREV, V16, P198, DOI 10.1136/ip.2009.022442; Bigler ED, 2010, BRAIN IMAGING BEHAV, V4, P270, DOI 10.1007/s11682-010-9105-0; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Cahill LM, 2002, BRAIN INJURY, V16, P415, DOI 10.1080/02699050110119871; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Catani M., 2011, CORTEX J DEVOTED STU; Catani M, 2007, P NATL ACAD SCI USA, V104, P17163, DOI 10.1073/pnas.0702116104; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Ciccarelli O, 2008, LANCET NEUROL, V7, P715, DOI 10.1016/S1474-4422(08)70163-7; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; de la Plata CDM, 2011, J INT NEUROPSYCH SOC, V17, P24, DOI 10.1017/S1355617710001189; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M, 2000, APHASIOLOGY, V14, P391, DOI 10.1080/026870300401423; Duffau H, 2009, J NEUROL, V256, P382, DOI 10.1007/s00415-009-0053-9; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Feldman H. M., 2008, DEV BEHAV PEDIAT, P467; Fletcher PT, 2010, NEUROIMAGE, V51, P1117, DOI 10.1016/j.neuroimage.2010.01.083; Friederici AD, 2012, TRENDS COGN SCI, V16, P262, DOI 10.1016/j.tics.2012.04.001; Friederici AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020726; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Galantucci S, 2011, BRAIN, V134, P3011, DOI 10.1093/brain/awr099; Glasser MF, 2008, CEREB CORTEX, V18, P2471, DOI 10.1093/cercor/bhn011; Hinkley LBN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039804; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Johnson CP, 2011, J INT NEUROPSYCH SOC, V17, P663, DOI 10.1017/S1355617711000464; Jones D.K., 2012, NEUROIMAGE; JORDAN F M, 1990, Brain Injury, V4, P147, DOI 10.3109/02699059009026159; Josse G, 2008, J NEUROSCI, V28, P14132, DOI 10.1523/JNEUROSCI.4383-08.2008; Kim JN, 2006, NEUROREPORT, V17, P1279, DOI 10.1097/01.wnr.0000230516.86090.67; Kim SH, 2011, NEUROREHABILITATION, V29, P305, DOI 10.3233/NRE-2011-0706; Le K, 2012, AM J SPEECH-LANG PAT, V21, pS115, DOI 10.1044/1058-0360(2012/11-0114); Lebel C, 2009, HUM BRAIN MAPP, V30, P3563, DOI 10.1002/hbm.20779; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Liegeois F, 2013, NEUROLOGY, V80, P926, DOI 10.1212/WNL.0b013e3182840c6d; Lum JAG, 2012, CORTEX, V48, P1138, DOI 10.1016/j.cortex.2011.06.001; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mandalis A, 2007, DEV NEUROPSYCHOL, V32, P683, DOI 10.1080/87565640701376045; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; Moran C, 2004, BRAIN INJURY, V18, P273, DOI 10.1080/02699050310001617415; Morgan AT, 2010, CHILD CARE HLTH DEV, V36, P44, DOI 10.1111/j.1365-2214.2009.00961.x; Morgan AT, 2013, BRAIN, V136, P646, DOI 10.1093/brain/aws355; Northam GB, 2012, BRAIN, V135, P3781, DOI 10.1093/brain/aws276; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Papagno C, 2011, BRAIN, V134, P405, DOI 10.1093/brain/awq283; Parker GJM, 2005, NEUROIMAGE, V24, P656, DOI 10.1016/j.neuroimage.2004.08.047; Prescher A., 2011, BRAIN LANGUAGE; Saporta ASD, 2011, PEDIATR NEUROL, V44, P270, DOI 10.1016/j.pediatrneurol.2010.11.006; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Semel E, 2006, CLIN EVALUATION LANG; Seo JP, 2012, NEUROREHABILITATION, V30, P323, DOI 10.3233/NRE-2012-0762; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Sullivan JR, 2010, APPL NEUROPSYCHOL, V17, P93, DOI 10.1080/09084281003708852; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Tasker RC, 2010, DEV NEUROSCI-BASEL, V32, P374, DOI 10.1159/000316806; Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Trivedi R, 2009, PEDIATR RES, V66, P636, DOI 10.1203/PDR.0b013e3181bbc6b5; Verhoeven J. S., 2011, CEREBRAL CORTEX NEW; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wechsler D., 2011, WECHSLER ABBREVIATED; Weiller C, 2011, BRAIN LANG, V118, P29, DOI 10.1016/j.bandl.2011.01.005; Wilson BJ, 2011, PEDIATR NEUROL, V44, P350, DOI 10.1016/j.pediatrneurol.2010.12.002; Wilson SM, 2012, BRAIN LANG, V122, P190, DOI 10.1016/j.bandl.2012.04.005; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Yeatman JD, 2011, J COGNITIVE NEUROSCI, V23, P3304, DOI 10.1162/jocn_a_00061	75	12	12	0	26	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X	1090-2155		BRAIN LANG	Brain Lang.	DEC	2013	127	3					388	398		10.1016/j.bandl.2013.05.003			11	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	261PM	WOS:000327677100011	23756046	Green Published, Other Gold			2021-06-18	
J	Rostami, E; Davidsson, J; Gyorgy, A; Agoston, DV; Risling, M; Bellander, BM				Rostami, Elham; Davidsson, Johan; Gyorgy, Andrea; Agoston, Denes V.; Risling, Marten; Bellander, Bo-Michael			The Terminal Pathway of the Complement System Is Activated in Focal Penetrating But Not in Mild Diffuse Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						C1q; C3; C5b-9; complement; synaptic stripping; TBI	C-REACTIVE PROTEIN; AXONAL INJURY; WALLERIAN DEGENERATION; ALZHEIMERS-DISEASE; GLIAL-CELLS; RAT; INFLAMMATION; EXPRESSION; ABSENCE; NEURODEGENERATION	The complement system plays an important role in the inflammatory response activated by many central nervous system disorders. However, its significance in traumatic diffuse traumatic axonal injury (TAI) is not fully known. Here we analyze the complement activity in two rat models of traumatic brain injury (TBI); a focal penetration injury (pen-TBI) and a rotational acceleration injury (rot-TBI) that leads to a mild TAI. We used in situ hybridization to examine the distribution of mRNA for C1q and C3 and immunohistochemistry to examine the presence of the C3 protein and C5b-9 complex at 1-5 days after injury. We found a time-dependent complement activity in both models. However, the responses caused by the two models were different. We detected C5b-9 surrounding the cavity in pen-TBI, but C5b-9 was not found in the rot-TBI. Our findings suggest that the terminal complement pathway is progressed to the formation of the C5b-9 membrane attack complex only in the penetrating TBI but not in isolated TAI model. This indicates that the complement activation does not lead to membrane-damaging effects and a subsequent secondary axotomy in TAI by the terminal complex C5b-9. The role of complement activation in TAI is unclear, but might indicate an alternative function following rot-TBI, such as opsonizing the synapses for elimination.	[Rostami, Elham; Risling, Marten] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Bellander, Bo-Michael] Karolinska Inst, Dept Clin Neurosci, S-17177 Stockholm, Sweden; [Davidsson, Johan] Chalmers, Div Vehicle Safety, S-41296 Gothenburg, Sweden; [Gyorgy, Andrea; Agoston, Denes V.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD USA	Rostami, E (corresponding author), Karolinska Inst, Dept Neurosci, Retzius Vag 8, S-17177 Stockholm, Sweden.	Elham.rostami@ki.se	Davidsson, Johan/A-3229-2016	Davidsson, Johan/0000-0002-1717-1514	Karolinska InstitutetKarolinska Institutet; Swedish Armed Forces; Vinnova, SwedenVinnova	The study was funded by Karolinska Institutet and the Swedish Armed Forces and Vinnova, Sweden. We thank Viktoria Hammarstedt for editorial help and Dr Christine Mossinger for her generosity in contributing antibody GADPH.	Anderson AJ, 2004, J NEUROTRAUM, V21, P1831, DOI 10.1089/0897715042664894; Bellander BM, 1996, J NEUROSURG, V85, P468, DOI 10.3171/jns.1996.85.3.0468; Bellander BM, 2004, J NEUROTRAUM, V21, P605, DOI 10.1089/089771504774129937; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Berg A, 2012, EXP NEUROL, V237, P8, DOI 10.1016/j.expneurol.2012.06.008; Bonifati DM, 2007, MOL IMMUNOL, V44, P999, DOI 10.1016/j.molimm.2006.03.007; Bruck W, 1997, BRAIN PATHOL, V7, P741, DOI 10.1111/j.1750-3639.1997.tb01060.x; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; BURGER W, 1987, AGENTS ACTIONS, V21, P93; Dalle Lucca Jurandir J, 2012, J Neurol Sci, V318, P146, DOI 10.1016/j.jns.2012.02.002; Davidsson J, 2009, INT IRCOBI C BIOM IN, P43; Davidsson Johan, 2011, Front Neurol, V2, P41, DOI 10.3389/fneur.2011.00041; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; GASQUE P, 1995, J IMMUNOL, V154, P4726; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Graham D.I., 2002, GREENFIELDS NEUROPAT; Gyorgy AB, 2010, J NEUROSCI METH, V192, P96, DOI 10.1016/j.jneumeth.2010.07.029; Holbourn AHS, 1943, LANCET, V2, P438; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; KOSKI CL, 1985, J IMMUNOL, V134, P1810; Koski CL, 1996, J NEUROCHEM, V66, P303; Morgan BP, 1997, CLIN EXP IMMUNOL, V107, P1, DOI 10.1046/j.1365-2249.1997.d01-890.x; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Padilla ND, 2003, IMMUNOLOGY, V109, P564, DOI 10.1046/j.1365-2567.2003.01681.x; Pekny M, 2007, INT REV NEUROBIOL, V82, P95, DOI 10.1016/S0074-7742(07)82005-8; Plantman S, 2012, J NEUROTRAUM, V29, P1219, DOI 10.1089/neu.2011.2182; Qiao F, 2010, AM J PATHOL, V177, P3061, DOI 10.2353/ajpath.2010.100158; Rahpeymai Y, 2006, EMBO J, V25, P1364, DOI 10.1038/sj.emboj.7601004; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Stahel PF, 1997, MOL BRAIN RES, V50, P205, DOI 10.1016/S0169-328X(97)00189-7; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Stahel PF, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-2; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; SVENSSON M, 1995, MOL CHEM NEUROPATHOL, V24, P53, DOI 10.1007/BF03160112; Trouw LA, 2008, MOL IMMUNOL, V45, P1199, DOI 10.1016/j.molimm.2007.09.008; Van Beek J, 2003, ANN NY ACAD SCI, V992, P56; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Webster S, 1997, AM J PATHOL, V150, P1531; Yasojima K, 1999, AM J PATHOL, V154, P927, DOI 10.1016/S0002-9440(10)65340-0	47	12	13	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2013	30	23					1954	1965		10.1089/neu.2012.2583			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AI0FA	WOS:000336520400004	23808389				2021-06-18	
J	Taylor, SR; Smith, C; Harris, BT; Costine, BA; Duhaime, AC				Taylor, Sabrina R.; Smith, Colin; Harris, Brent T.; Costine, Beth A.; Duhaime, Ann-Christine			Maturation-dependent response of neurogenesis after traumatic brain injury in children	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						traumatic brain injury; neurogenesis; subventricular zone; hippocampus; subgranular zone; development; trauma	CONTROLLED CORTICAL IMPACT; SUBVENTRICULAR ZONE CELLS; ADULT HUMAN BRAIN; DENTATE GYRUS; ENHANCED NEUROGENESIS; NEURONAL MIGRATION; CEREBRAL-CORTEX; HEAD-INJURY; HIPPOCAMPAL NEUROGENESIS; DOUBLECORTIN EXPRESSION	Object. Traumatic brain injury (TBI) is the leading cause of acquired disability in children, yet innate repair mechanisms are incompletely understood. Given data from animal studies documenting neurogenesis in response to trauma and other insults, the authors investigated whether similar responses could be found in children of different ages after TBI. Methods. Immunohistochemistry was used to label doublecortin (DCX), a protein expressed by immature migrating neuroblasts (newborn neurons), in specimens from patients ranging in age from 3 weeks to 10 years who had died either after TBI or from other causes. Doublecortin-positive (DCX+) cells were examined in the subventricular zone (SVZ) and periventricular white matter (PWM) and were quantified within the granule cell layer (GCL) and subgranular zone (SGZ) of the dentate gyms to determine if age and/or injury affect the number of DCX+ cells in these regions. Results. The DCX+ cells decreased in the SVZ as patient age increased and were found in abundance around a focal subacute infarct in a 1-month-old non-TBI patient, but were scarce in all other patients regardless of age or history of trauma. The DCX+ cells in the PWM and dentate gyrus demonstrated a migratory morphology and did not co-localize with markers for astrocytes, microglia, or macrophages. In addition, there were significantly more DCX+ cells in the GCL and SGZ of the dentate gyms in children younger than 1 year old than in older children. The density of immature migrating neuroblasts in infants (under 1 year of age) was significantly greater than in young children (2-6 years of age, p = 0.006) and older children (7-10 years of age, p = 0.007). Conclusions. The main variable influencing the number of migrating neuroblasts observed in the SVZ, PWM, and hippocampus was patient age. Trauma had no discernible effect on the number of migrating neuroblasts in this cohort of patients in whom death typically occurred within hours to days after TBI.	[Taylor, Sabrina R.] Dartmouth Coll, Program Expt & Mol Med, Hanover, NH 03755 USA; [Taylor, Sabrina R.; Costine, Beth A.; Duhaime, Ann-Christine] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Taylor, Sabrina R.; Costine, Beth A.; Duhaime, Ann-Christine] Harvard Univ, Sch Med, Boston, MA USA; [Smith, Colin] Univ Edinburgh, Dept Neuropathol, Edinburgh EH8 9YL, Midlothian, Scotland; [Harris, Brent T.] Georgetown Univ, Med Ctr, Dept Pathol, Washington, DC 20007 USA; [Harris, Brent T.] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA	Taylor, SR (corresponding author), Massachusetts Gen Hosp, Dept Neurosurg, 149 13th St,3-328, Charlestown, MA 02129 USA.	srtaylor@partners.org		Costine-Bartell, Beth/0000-0001-7559-9378	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 NS 045776]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01HD083759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS045776] Funding Source: NIH RePORTER	We thank Igor Bageyev for his expertise and assistance in obtaining images, and Dr. Christian Waeber (Center for Neuroscience, Massachusetts General Hospital) for access to microscopy facilities, which are funded through NIH Grant No. P30 NS 045776.	ALTMAN J, 1966, J COMP NEUROL, V126, P337, DOI 10.1002/cne.901260302; Amrein I, 2004, HIPPOCAMPUS, V14, P1000, DOI 10.1002/hipo.20018; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Braun H, 2002, J NEUROTRAUM, V19, P975, DOI 10.1089/089771502320317122; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Cha BH, 2004, BRAIN DEV-JPN, V26, P394, DOI 10.1016/j.braindev.2003.12.006; Chiaretti A, 2009, NEUROLOGY, V72, P609, DOI 10.1212/01.wnl.0000342462.51073.06; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Covey MV, 2010, DEV NEUROSCI-BASEL, V32, P488, DOI 10.1159/000321607; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Duhaime AC, 2003, J NEUROSURG, V99, P542, DOI 10.3171/jns.2003.99.3.0542; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Eisch AJ, 2006, HIPPOCAMPUS, V16, P271, DOI 10.1002/hipo.20161; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Fahrner A, 2007, EXP NEUROL, V203, P320, DOI 10.1016/j.expneurol.2006.08.023; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FISHELL G, 1991, DEVELOPMENT, V113, P755; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Gerber J, 2009, NEUROLOGY, V73, P1026, DOI 10.1212/WNL.0b013e3181b9c892; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Goings GE, 2002, NEUROSCI LETT, V329, P161, DOI 10.1016/S0304-3940(02)00611-0; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Guidi S, 2011, BRAIN RES BULL, V85, P169, DOI 10.1016/j.brainresbull.2011.03.028; HAGER G, 1995, J NEUROSCI RES, V40, P207, DOI 10.1002/jnr.490400209; Hamilton BE, 2013, PEDIATRICS, V131, P548, DOI 10.1542/peds.2012-3769; Haynes RL, 2011, PEDIATR RES, V69, P62, DOI 10.1203/PDR.0b013e3181ff3792; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kempermann G, 2000, NOVART FDN SYMP, V231, P220, DOI 10.1002/0470870834.ch14; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Koketsu D, 2006, EXP NEUROL, V199, P92, DOI 10.1016/j.expneurol.2006.03.012; Koob AO, 2008, INT J DEV NEUROSCI, V26, P641, DOI 10.1016/j.ijdevneu.2008.04.001; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; KOTAPKA MJ, 1993, NEUROPATH APPL NEURO, V19, P128, DOI 10.1111/j.1365-2990.1993.tb00417.x; Kreuzberg M, 2010, EXP NEUROL, V226, P90, DOI 10.1016/j.expneurol.2010.08.006; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; Li Y, 2010, TRANSL STROKE RES, V1, P184, DOI 10.1007/s12975-010-0016-6; Liu YWJ, 2008, EUR J NEUROSCI, V28, P2254, DOI 10.1111/j.1460-9568.2008.06518.x; Lucassen PJ, 2010, EUR NEUROPSYCHOPHARM, V20, P1, DOI 10.1016/j.euroneuro.2009.08.003; Manganas LN, 2007, SCIENCE, V318, P980, DOI 10.1126/science.1147851; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; McCabe BK, 2001, J NEUROSCI, V21, P2094, DOI 10.1523/JNEUROSCI.21-06-02094.2001; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; NOWAKOWSKI RS, 1981, J COMP NEUROL, V196, P129, DOI 10.1002/cne.901960110; Panizzo RA, 2009, NEUROIMAGE, V44, P1239, DOI 10.1016/j.neuroimage.2008.10.062; Pekcec A, 2008, AGING CELL, V7, P368, DOI 10.1111/j.1474-9726.2008.00392.x; Qin J, 2000, BRAIN RES, V863, P225, DOI 10.1016/S0006-8993(00)02099-0; Qiu L, 2007, J CEREBR BLOOD F MET, V27, P785, DOI 10.1038/sj.jcbfm.9600385; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; RAKIC P, 1981, J COMP NEUROL, V196, P99, DOI 10.1002/cne.901960109; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Rao MS, 2006, AGING CELL, V5, P545, DOI 10.1111/j.1474-9726.2006.00243.x; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Sumner JP, 2009, NEUROIMAGE, V44, P671, DOI 10.1016/j.neuroimage.2008.07.050; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Taylor S, 2010, 40 ANN M SOC NEUR SA; Wang CM, 2011, CELL RES, V21, P1534, DOI 10.1038/cr.2011.83; Zhang RL, 2009, J CEREBR BLOOD F MET, V29, P1240, DOI 10.1038/jcbfm.2009.55	77	12	12	0	8	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	DEC	2013	12	6					545	554		10.3171/2013.8.PEDS13154			10	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	257EV	WOS:000327367300004	24053630				2021-06-18	
J	Villapol, S; Wang, Y; Adams, M; Symes, AJ				Villapol, Sonia; Wang, Yu; Adams, Matthew; Symes, Aviva J.			Smad3 deficiency increases cortical and hippocampal neuronal loss following traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						TGF-beta; T beta RII; Smad3; pSmad3; Neurodegeneration; Neuron; Astrocyte; Cell death; CA1; Caspase-3	GROWTH-FACTOR-BETA; MIDBRAIN DOPAMINERGIC-NEURONS; CENTRAL-NERVOUS-SYSTEM; FLUORO-JADE-B; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; SCAR FORMATION; NEUROTROPHIC FACTOR; ALZHEIMERS-DISEASE; CELL-DEATH	Transforming growth factor-beta (TGF-beta) signaling is involved in pathological processes following brain injury. TGF-beta signaling through Smad3 contributes significantly to the immune response and glial scar formation after brain injury. However, TGF-beta is also neuroprotective, suggesting that Smad3 signaling may also be involved in neuroprotection after injury. We found expression of the TGF-beta type II receptor (T beta RII) and Smad3 protein to be strongly and rapidly induced in neurons in the ipsilateral cortex and CA1 region of the hippocampus after stab wound injury. In contrast, astrocytic expression of T beta RII and Smad3 was induced more slowly. Comparison of the response of wild-type and Smad3 null mice to cortical stab wound injury showed a more pronounced loss of neuronal viability in Smad3 null mice. Neuronal density was more strongly reduced in Smad3 null mice than in wild-type mice at 1 and 3 days post lesion in both the ipsilateral cortex and hippocampal CA1 region. Fluoro-Jade B, TUNEL staining, and cleaved caspase-3 staining also demonstrated increased neuronal degeneration at early time points after injury in the ipsilateral hemisphere in Smad3 null mice. Taken together, our results suggest that TGF-beta cytokine family signaling through Smad3 protects neurons in the damaged cortex and hippocampus at early time points after injury. Published by Elsevier Inc.	[Villapol, Sonia; Wang, Yu; Adams, Matthew; Symes, Aviva J.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20814 USA; [Villapol, Sonia; Symes, Aviva J.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Wang, Yu] Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei 230022, Peoples R China	Symes, AJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pharmacol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	aviva.symes@usuhs.edu	Symes, Aviva J/S-7471-2016; Villapol, Sonia/D-1949-2014	Symes, Aviva J/0000-0003-2557-9939; Villapol, Sonia/0000-0002-6174-4113	Defense Brain and Spinal Cord Injury Program; Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30970997]	This work was supported by a translational research grant from the Defense Brain and Spinal Cord Injury Program (AJS), by a post-doctoral fellowship from the Center for Neuroscience and Regenerative Medicine (SV), and by a natural science grant (30970997) from the National Natural Science Foundation of China (YW). We would like to thank M. Balarezo for her technical help and D. McDaniel for the confocal microscopy assistance. The opinions and assertions contained herein are the private opinions of the authors and are not to be construed as reflecting the views of the Uniformed Services University of the Health Sciences or the US Department of Defense.	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Andersson O, 2006, EMBO REP, V7, P831, DOI 10.1038/sj.embor.7400752; Andrews ZB, 2006, NEUROBIOL DIS, V21, P568, DOI 10.1016/j.nbd.2005.09.001; Baig S, 2009, NEUROSCIENCE, V163, P561, DOI 10.1016/j.neuroscience.2009.06.045; Battaglia G, 2011, J CELL MOL MED, V15, P555, DOI 10.1111/j.1582-4934.2010.01011.x; Blottner D, 1996, EUR J NEUROSCI, V8, P202, DOI 10.1111/j.1460-9568.1996.tb01181.x; Bonner HP, 2010, J NEUROCHEM, V114, P606, DOI 10.1111/j.1471-4159.2010.06790.x; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Bruno V, 1998, J NEUROSCI, V18, P9594; Buckwalter MS, 2006, AM J PATHOL, V169, P154, DOI 10.2353/ajpath.2006.051272; Caraci F, 2011, CNS NEUROSCI THER, V17, P237, DOI 10.1111/j.1755-5949.2009.00115.x; CHALAZONITIS A, 1992, DEV BIOL, V152, P121, DOI 10.1016/0012-1606(92)90162-A; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Collombet JM, 2006, NEUROSCI LETT, V398, P337, DOI 10.1016/j.neulet.2006.01.029; Day WA, 2005, NEUROBIOL DIS, V19, P323, DOI 10.1016/j.nbd.2005.01.010; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Docagne F, 2002, MOL CELL NEUROSCI, V21, P634, DOI 10.1006/mcne.2002.1206; Dunker N, 2000, EUR J BIOCHEM, V267, P6982, DOI 10.1046/j.1432-1327.2000.01825.x; Farkas LM, 2003, J NEUROSCI, V23, P5178; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gao X, 2009, J NEUROTRAUM, V26, P1325, DOI 10.1089/neu.2008-0744; Gonzalez-Aparicio R, 2010, EXP NEUROL, V226, P136, DOI 10.1016/j.expneurol.2010.08.016; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; HOEPPNER TJ, 1986, EXP NEUROL, V94, P519, DOI 10.1016/0014-4886(86)90235-9; Konig HG, 2005, J CELL BIOL, V168, P1077, DOI 10.1083/jcb.200407027; KRIEGLSTEIN K, 1995, EMBO J, V14, P736, DOI 10.1002/j.1460-2075.1995.tb07052.x; Kumar A, 2001, J BIOL CHEM, V276, P656, DOI 10.1074/jbc.M004649200; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Li LY, 2013, J MOL NEUROSCI, V50, P109, DOI 10.1007/s12031-012-9879-1; Lin AH, 2005, J IMMUNOL, V175, P547, DOI 10.4049/jimmunol.175.1.547; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; LOGAN A, 1994, EUR J NEUROSCI, V6, P355, DOI 10.1111/j.1460-9568.1994.tb00278.x; Logan A, 1999, EXP NEUROL, V159, P504, DOI 10.1006/exnr.1999.7180; Logan A, 1999, EUR J NEUROSCI, V11, P2367, DOI 10.1046/j.1460-9568.1999.00654.x; MARTINOU JC, 1990, DEV BRAIN RES, V52, P175, DOI 10.1016/0165-3806(90)90233-O; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Mokin M, 2006, J NEUROSCI METH, V157, P218, DOI 10.1016/j.jneumeth.2006.04.016; Moreira T, 2007, NEUROSCIENCE, V144, P1169, DOI 10.1016/j.neuroscience.2006.10.054; POULSEN KT, 1994, NEURON, V13, P1245, DOI 10.1016/0896-6273(94)90062-0; PREHN JHM, 1993, J CEREBR BLOOD F MET, V13, P521, DOI 10.1038/jcbfm.1993.67; Riba-Bosch A, 2004, NEUROSCIENCE, V125, P803, DOI 10.1016/j.neuroscience.2004.02.017; Ruocco A, 1999, J CEREBR BLOOD F MET, V19, P1345, DOI 10.1097/00004647-199912000-00008; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Sofroniew M.V., 2009, TRENDS NEUROSCI, P1; Stoll G, 2004, BRAIN PATHOL, V14, P51, DOI 10.1111/j.1750-3639.2004.tb00497.x; Sulyok S, 2004, MOL CELL ENDOCRINOL, V225, P127, DOI 10.1016/j.mce.2004.07.011; Sun CS, 2007, J COMP NEUROL, V500, P876, DOI 10.1002/cne.21207; Susarla BTS, 2011, J NEUROCHEM, V119, P868, DOI 10.1111/j.1471-4159.2011.07470.x; Tapia-Gonzalez S, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-72; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Tsuchida K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-15; Tsuchiya T, 2011, EUR J NEUROSCI, V33, P401, DOI 10.1111/j.1460-9568.2010.07538.x; Ueberham U, 2006, EUR J NEUROSCI, V24, P2327, DOI 10.1111/j.1460-9568.2006.05109.x; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.brainres.2004.04.032; Vilar JMG, 2006, PLOS COMPUT BIOL, V2, P36, DOI 10.1371/journal.pcbi.0020003; Wachs FP, 2006, J NEUROPATH EXP NEUR, V65, P358, DOI 10.1097/01.jnen.0000218444.53405.f0; Walshe TE, 2011, NEUROSCIENCE, V189, P123, DOI 10.1016/j.neuroscience.2011.05.020; Wang Y, 2007, EXP NEUROL, V203, P168, DOI 10.1016/j.expneurol.2006.08.006; Wang Y, 2010, J MOL NEUROSCI, V41, P383, DOI 10.1007/s12031-010-9329-x; WINDLE WF, 1952, J COMP NEUROL, V96, P359, DOI 10.1002/cne.900960207; WyssCoray T, 1997, J NEUROIMMUNOL, V77, P45, DOI 10.1016/S0165-5728(97)00049-0; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; Zhu Y, 2002, J NEUROSCI, V22, P3898, DOI 10.1523/JNEUROSCI.22-10-03898.2002	73	12	12	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	2013	250						353	365		10.1016/j.expneurol.2013.10.008			13	Neurosciences	Neurosciences & Neurology	270FZ	WOS:000328305600038	24120438	Green Published			2021-06-18	
J	Xu, JH; Zhang, TZ; Peng, XF; Jin, CJ; Zhou, J; Zhang, YN				Xu, Ji-Hong; Zhang, Tie-Zheng; Peng, Xiao-Feng; Jin, Chun-Ji; Zhou, Jin; Zhang, Yi-Nan			Effects of sevoflurane before cardiopulmonary bypass on cerebral oxygen balance and early postoperative cognitive dysfunction	NEUROLOGICAL SCIENCES			English	Article						Sevoflurane; Cardiopulmonary bypass; Cerebral oxygen balance; Cognitive dysfunction	BLOOD-FLOW AUTOREGULATION; NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; CARDIAC-SURGERY; ANESTHESIA; PROTECTION; LACTATE; RATS	Postoperative cognitive dysfunction (POCD) is associated with cardiopulmonary bypass (CPB). We investigated the effect of different doses of inhaled sevoflurane administered prior to CPB on cerebral oxygen supply and demand, and the incidence of associated early POCD. One hundred and twenty patients were randomly allocated into four treatment groups (n = 30, each) and administered a high- [1.5 minimum alveolar concentration (MAC)], moderate- (1.0 MAC), low- (0.5 MAC), or no- sevoflurane dose prior to CPB. Standard blood gas parameters, serum S-100 protein, and neuron-specific enolase (NSE) were measured at different time points. The mini-mental state examination (MMSE) was administered 1 day before and 24 and 72 h after surgery. The jugular bulb venous oxygen saturation (SjvO(2)) in the moderate- and high-dose groups at a nasopharyngeal temperature of 25-28 A degrees C was significantly higher compared with the control group, while the arteriovenous oxygen content difference (AVDO(2)) and cerebral extraction of oxygen (CEO2) were significantly reduced. The serum S-100 protein and NSE concentrations of the moderate- and high-dose groups at 1 and 6 h after the cessation of CPB were significantly lower than that of the control group. The 24 h postoperative MMSE scores of the moderate- and high-dose groups were significantly higher than those of the low-dose and control groups. An inhaled optimal concentration of sevoflurane may be beneficial for cerebral oxygen balance during CPB, and may ameliorate cognitive damage. However, the effect is dose-dependent.	[Xu, Ji-Hong; Zhang, Tie-Zheng; Peng, Xiao-Feng; Jin, Chun-Ji; Zhou, Jin; Zhang, Yi-Nan] Gen Hosp Shenyang Mil Reg, Dept Anesthesiol, Shenyang 110016, Peoples R China	Zhang, TZ (corresponding author), Gen Hosp Shenyang Mil Reg, Dept Anesthesiol, 83 Wenhua Rd, Shenyang 110016, Peoples R China.	tzzhang@hotmail.com			Natural Science Fund of Liaoning Province of China [20102244]	This study was supported by the Natural Science Fund of Liaoning Province of China (20102244).	Alves OL, 2004, CURR PHARM DESIGN, V10, P2163, DOI 10.2174/1381612043384187; American Psychiatric Association, 1987, AM PSYCH ASS DIAGN S; Artru F, 2004, J NEUROSURG ANESTH, V16, P226, DOI 10.1097/00008506-200407000-00007; Chieregato A, 2007, J NEUROSURG ANESTH, V19, P222, DOI 10.1097/ANA.0b013e31806589f6; Cooper E. H., 1994, International Journal of Biological Markers, V9, P205; Fita G, 1999, Rev Esp Anestesiol Reanim, V46, P438; GRACE J, 1995, ARCH NEUROL-CHICAGO, V52, P477, DOI 10.1001/archneur.1995.00540290067019; Gupta AK, 1999, ANESTH ANALG, V88, P549, DOI 10.1097/00000539-199903000-00016; Hans P, 1998, AGRESSOLOGIE, V29, P233; Kadoi Y, 2007, J ANESTH, V21, P330, DOI 10.1007/s00540-007-0537-7; Kurth CD, 2001, ANESTHESIOLOGY, V95, P959; Li Shu, 2005, J Extra Corpor Technol, V37, P180; Lu H, 1998, ANESTH ANALG, V87, P854, DOI 10.1097/00000539-199810000-00020; McKeating EG, 1998, ACT NEUR S, V71, P117; MILLS SA, 1993, ANN THORAC SURG, V56, pS86, DOI 10.1016/0003-4975(93)91142-A; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; MURKIN JM, 1993, ANN THORAC SURG, V56, P1461, DOI 10.1016/0003-4975(93)90730-6; Nader ND, 2004, J CARDIOTHOR VASC AN, V18, P269, DOI 10.1053/j.jvca.2004.03.004; Nakamura Shunsuke, 2011, Nihon Rinsho, V69, P704; Ogawa Y, 2006, ANESTH ANALG, V102, P552, DOI 10.1213/01.ane.0000189056.96273.48; Parolari A, 2000, EUR J CARDIO-THORAC, V18, P575, DOI 10.1016/S1010-7940(00)00552-2; Reinsfelt B, 2011, ACTA ANAESTH SCAND, V55, P118, DOI 10.1111/j.1399-6576.2010.02324.x; Schoen J, 2011, BRIT J ANAESTH, V106, P840, DOI 10.1093/bja/aer091; SMITHIES MN, 1991, CRIT CARE MED, V19, P1401, DOI 10.1097/00003246-199111000-00017; Werner C, 2005, ANESTH ANALG, V101, P509, DOI 10.1213/01.ANE.0000160586.71403.A4	25	12	19	1	12	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	DEC	2013	34	12					2123	2129		10.1007/s10072-013-1347-3			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	268ZN	WOS:000328209500006	23525738				2021-06-18	
J	Ownsworth, T; Fleming, J; Tate, R; Shum, DHK; Griffin, J; Schmidt, J; Lane-Brown, A; Kendall, M; Chevignard, M				Ownsworth, Tamara; Fleming, Jennifer; Tate, Robyn; Shum, David H. K.; Griffin, Janelle; Schmidt, Julia; Lane-Brown, Amanda; Kendall, Melissa; Chevignard, Mathilde			Comparison of error-based and errorless learning for people with severe traumatic brain injury: study protocol for a randomized control trial	TRIALS			English	Article						Brain injury; Metacognition; Self-awareness; Rehabilitation; Functional activities; Randomized controlled trial	ASSESSING SUPPORT NEEDS; METACOGNITIVE SKILLS; TREATMENT FIDELITY; SELF-AWARENESS; COOKING TASK; SCALE; INDIVIDUALS; CARE; INTERVENTIONS; VALIDITY	Background: Poor skills generalization poses a major barrier to successful outcomes of rehabilitation after traumatic brain injury (TBI). Error-based learning (EBL) is a relatively new intervention approach that aims to promote skills generalization by teaching people internal self-regulation skills, or how to anticipate, monitor and correct their own errors. This paper describes the protocol of a study that aims to compare the efficacy of EBL and errorless learning (ELL) for improving error self-regulation, behavioral competency, awareness of deficits and long-term outcomes after TBI. Methods/Design: This randomized, controlled trial (RCT) has two arms (EBL and ELL); each arm entails 8 x 2 h training sessions conducted within the participants' homes. The first four sessions involve a meal preparation activity, and the final four sessions incorporate a multitasking errand activity. Based on a sample size estimate, 135 participants with severe TBI will be randomized into either the EBL or ELL condition. The primary outcome measure assesses error self-regulation skills on a task related to but distinct from training. Secondary outcomes include measures of self-monitoring and self-regulation, behavioral competency, awareness of deficits, role participation and supportive care needs. Assessments will be conducted at pre-intervention, post-intervention, and at 6-months post-intervention. Discussion: This study seeks to determine the efficacy and long-term impact of EBL for training internal self-regulation strategies following severe TBI. In doing so, the study will advance theoretical understanding of the role of errors in task learning and skills generalization. EBL has the potential to reduce the length and costs of rehabilitation and lifestyle support because the techniques could enhance generalization success and lifelong application of strategies after TBI.	[Ownsworth, Tamara; Shum, David H. K.] Griffith Univ, Griffith Hlth Inst, Sch Appl Psychol, Mt Gravatt, Qld 4122, Australia; [Ownsworth, Tamara; Shum, David H. K.] Griffith Univ, Griffith Hlth Inst, Behav Basis Hlth Program, Mt Gravatt, Qld 4122, Australia; [Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld, Australia; [Fleming, Jennifer; Griffin, Janelle] Princess Alexandra Hosp, Woolloongabba, Australia; [Tate, Robyn; Lane-Brown, Amanda] Univ Sydney, Rehabil Studies Unit, Sydney, NSW 2006, Australia; [Tate, Robyn] Royal Rehabil Ctr, Brain Injury Unit,Royal, Sydney, NSW, Australia; [Schmidt, Julia] Australian Catholic Univ Sydney, Brisbane, Qld, Australia; [Lane-Brown, Amanda] Liverpool Hosp, Brain Injury Rehabil Unit, Sydney, NSW, Australia; [Chevignard, Mathilde] Liverpool Hosp, Brain Injury Rehabil Unit, Sydney, NSW, Australia; [Kendall, Melissa] Acquired Brain Injury Outreach Serv, Brisbane, Qld, Australia; [Chevignard, Mathilde] Hop St Maurice, Rehabil Dept Children Acquired Brain Injury INR A, St Maurice, France; [Chevignard, Mathilde] Univ Paris 06, ER6, Paris, France	Ownsworth, T (corresponding author), Griffith Univ, Griffith Hlth Inst, Sch Appl Psychol, Mt Gravatt, Qld 4122, Australia.	t.ownsworth@griffith.edu.au	Shum, David/A-3914-2008	Shum, David/0000-0002-4810-9262; Schmidt, Julia/0000-0003-2004-4871; Ownsworth, Tamara/0000-0003-1835-7094	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [APP1043677]; NHMRC ProjectNational Health and Medical Research Council of Australia [APP1043677]	The project outlined in this study protocol is funded by the National Health and Medical Research Council (NHMRC; project grant APP1043677). The authors would like to acknowledge Dr Elizabeth Beadle who contributed to the preparation of this manuscript in her position as Project Coordinator funded the NHMRC Project Grant (APP1043677).	Access Economics, 2008, EC COST SPIN CORD IN; Borrelli B, 2005, J CONSULT CLIN PSYCH, V73, P852, DOI 10.1037/0022-006X.73.5.852; Borrelli B, 2011, J PUBLIC HEALTH DENT, V71, pS52, DOI 10.1111/j.1752-7325.2011.00233.x; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Chevignard MP, 2008, NEUROPSYCHOL REHABIL, V18, P461, DOI 10.1080/09602010701643472; Chevignard MP, 2010, BRAIN IMPAIR, V11, P125, DOI 10.1375/brim.11.2.125; Clare L, 2008, NEUROPSYCHOL REV, V18, P1, DOI 10.1007/s11065-008-9051-4; Domholdt E., 2005, REHABILITATION RES P; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; Pagulayan KF, 2007, J INT NEUROPSYCH SOC, V13, P561, DOI 10.1017/S1355617707070713; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; GLISKY EL, 1986, NEUROPSYCHOLOGIA, V24, P313, DOI 10.1016/0028-3932(86)90017-5; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Gupta Sandeep K, 2011, Perspect Clin Res, V2, P109, DOI 10.4103/2229-3485.83221; Hart T, 2008, NEUROPSYCHOL REHABIL, V18, P1, DOI 10.1080/09602010601082359; Kolakowsky-Hayner S, PATIENT COMPETENCY R; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P961, DOI 10.1017/S1355617707071305; Lee KJ, 2005, BRIT MED J, V330, P142, DOI 10.1136/bmj.330.7483.142; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Nalder E, 2012, J REHABIL MED, V44, P837, DOI 10.2340/16501977-1033; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; NOURBAKHSH MR, 1994, PHYS THER, V74, P768, DOI 10.1093/ptj/74.8.768; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; OWNSWORTH T, 2004, BRAIN IMPAIR, V5, P53, DOI DOI 10.1375/BRIM.5.1.53.35407; Ownsworth T, 2008, J REHABIL MED, V40, P81, DOI 10.2340/16501977-0124; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Prigatano G. P., 1986, NEUROPSYCHOLOGICAL R; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; SHERER M, AWARENESS QUESTIONNA; Soo C, 2007, J HEAD TRAUMA REHAB, V22, P288, DOI 10.1097/01.HTR.0000290973.01872.4c; Soo C, 2010, ARCH PHYS MED REHAB, V91, P905, DOI 10.1016/j.apmr.2009.11.033; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Tate RL, 2011, J REHABIL MED, V43, P609, DOI 10.2340/16501977-0829; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Toglia J. P., 2011, COGNITION OCCUPATION, P161; Wilson BA, 1996, BEHAV ASSESSMENT DYS	42	12	12	0	25	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-6215			TRIALS	Trials	NOV 5	2013	14								369	10.1186/1745-6215-14-369			9	Medicine, Research & Experimental	Research & Experimental Medicine	276KX	WOS:000328750300002	24192067	DOAJ Gold, Green Published			2021-06-18	
J	Abookasis, D; Volkov, B; Mathews, MS				Abookasis, David; Volkov, Boris; Mathews, Marlon S.			Closed head injury-induced changes in brain pathophysiology assessed with near-infrared structured illumination in a mouse model	JOURNAL OF BIOMEDICAL OPTICS			English	Article						closed head injury; structured illumination; optical properties; cerebral hemodynamics; scattering parameters	CEREBRAL-BLOOD-FLOW; TISSUE OPTICAL-PROPERTIES; PHASE-MEASURING-PROFILOMETRY; DIGITAL MICROMIRROR DEVICE; OXYGEN-SATURATION; LIGHT-PROPAGATION; SHAPE MEASUREMENT; COMPLEX OBJECT; SPECTROSCOPY; MICROSCOPY	Use of near-infrared (NIR) structured illumination technique has recently received great interest in biomedical research and clinical studies because of its ability to perform wide-field imaging and quantitatively map changes in tissue hemodynamic properties and morphological features in a noncontact and scan-free fashion. We report on the feasibility of using the same to quantitatively monitor and map changes in brain optical properties and physiological parameters pre-and post-closed head injury in a mouse model. Five anesthetized male mice underwent head injury by weight-drop model using a similar to 50-g cylindrical metal object falling from a height of 90 cm onto the intact scalp. During experiments, NIR structured illumination was projected on the mouse head at two spatial frequencies and six different NIR wavelengths. A CCD camera positioned perpendicular to the head recorded the diffuse-reflected light. Computer analysis performed off-line on the captured data reveals spatiotemporal changes in the distribution of brain tissue absorption and reduced scattering coefficients. Using Beer's law and Mie theory, hemodynamic (hemoglobin, oxygen saturation, and lipids) and morphological (scattering amplitude and power) changes up to 1-h post-trauma were observed in comparison with baseline measurements. Functional maps of different brain properties were also generated. Following injury, we found difference in both brain hemodynamic and morphologic properties with respect to baseline levels, where in some properties, this difference was considered statistically significant. Specifically, a t-test indicates a substantial decrease in oxyhemoglobin (HbO(2)) concentration and tissue oxygen saturation (StO(2)) post-injury (p < 0.01 and p < 0.001, respectively). Overall, our preliminary results demonstrate the potential application of NIR structured illumination technique to track and spatially map changes in intact mouse brain pathophysiological parameters following head injury. (C) 2013 Society of Photo-Optical Instrumentation Engineers (SPIE)	[Abookasis, David; Volkov, Boris] Ariel Univ, Dept Elect & Elect Engn, IL-40700 Ariel, Israel; [Mathews, Marlon S.] Univ Calif Irvine, Med Ctr, Dept Neurol Surg, Orange, CA 92868 USA	Abookasis, D (corresponding author), Ariel Univ, Dept Elect & Elect Engn, IL-40700 Ariel, Israel.	davida@ariel.ac.il					Abookasis D., 2008, P SOC PHOTO-OPT INS, V6842; Abookasis D, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.045003; Abookasis D, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3116709; Abrahamson EE, 2013, J CEREBR BLOOD F MET, V33, P826, DOI 10.1038/jcbfm.2013.24; Adibhatla RM, 2006, AAPS J, V8, pE314; Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Bednarkiewicz A, 2008, APPL OPTICS, V47, P1193, DOI 10.1364/AO.47.001193; Berryman F, 2008, EUR SPINE J, V17, P663, DOI 10.1007/s00586-007-0581-x; Bevilacqua F, 1999, APPL OPTICS, V38, P4939, DOI 10.1364/AO.38.004939; Boas DA, 2011, PHILOS T R SOC A, V369, P4407, DOI 10.1098/rsta.2011.0250; Bouma B. E., 2002, HDB OPTICAL COHERENC; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Broich K, 1994, J Stroke Cerebrovasc Dis, V4, P271, DOI 10.1016/S1052-3057(10)80106-5; Cao YP, 2003, PROC SPIE, V5254, P496, DOI 10.1117/12.546556; Carlton PM, 2008, CHROMOSOME RES, V16, P351, DOI 10.1007/s10577-008-1231-9; Chen JL, 2013, OPT EXPRESS, V21, P112, DOI 10.1364/OE.21.000112; Cheung C, 2001, PHYS MED BIOL, V46, P2053, DOI 10.1088/0031-9155/46/8/302; Choi J, 2004, J BIOMED OPT, V9, P221, DOI 10.1117/1.1628242; Cuccia D. J., 2009, IN VIVO OPTICAL IMAG; Cuccia DJ, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3088140; Cuccia DJ, 2005, OPT LETT, V30, P1354, DOI 10.1364/OL.30.001354; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Delica S, 2007, APPL OPTICS, V46, P7237, DOI 10.1364/AO.46.007237; DePiero F., 1996, ADV COMPUT, V43, P243, DOI DOI 10.1016/S0065-2458(08)60646-4; Dognitz N, 1998, LASER MED SCI, V13, P55, DOI 10.1007/BF00592960; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Doornbos RMP, 1999, PHYS MED BIOL, V44, P967, DOI 10.1088/0031-9155/44/4/012; Eker C., 1999, THESIS LUND I TECHNO; Fiolka R, 2008, OPT LETT, V33, P1629, DOI 10.1364/OL.33.001629; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fukano T, 2003, APPL OPTICS, V42, P4119, DOI 10.1364/AO.42.004119; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Gioux S, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3614566; Gonzalez-Quevedo A., 2012, BRAIN DAMAGE BRIDGIN; GRAAFF R, 1992, APPL OPTICS, V31, P1370, DOI 10.1364/AO.31.001370; Grossman R. G., 1990, NEUROBEHAVIORAL CONS; Hagen N, 2012, OPT EXPRESS, V20, P403, DOI 10.1364/OE.20.000403; HALE GM, 1973, APPL OPTICS, V12, P555, DOI 10.1364/AO.12.000555; Henry-Feugeas MC, 2000, BRAIN INJURY, V14, P597; Hoshi Y, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2142325; Huang PSS, 2003, OPT ENG, V42, P163, DOI 10.1117/1.1525272; Hull EL, 2001, J OPT SOC AM A, V18, P584, DOI 10.1364/JOSAA.18.000584; Ioroi T, 2002, EXP BRAIN RES, V144, P172, DOI 10.1007/s00221-002-1030-z; ITO U, 1986, ACTA NEUROCHIR, V79, P120, DOI 10.1007/BF01407455; Jacques SL, 2010, BIOMED OPT EXPRESS, V1, P157, DOI 10.1364/BOE.1.000157; Kakaboura A, 2007, J MATER SCI-MATER M, V18, P155, DOI 10.1007/s10856-006-0675-8; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Konecky SD, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.056008; Kristensson E, 2008, APPL OPTICS, V47, P3927, DOI 10.1364/AO.47.003927; Krzewina LG, 2006, OPT LETT, V31, P477, DOI 10.1364/OL.31.000477; Kurth CD, 2009, ANESTH ANALG, V108, P1268, DOI 10.1213/ane.0b013e318196ac8e; Lee CK, 2005, OPT EXPRESS, V13, P8339, DOI 10.1364/OPEX.13.008339; Lin AJ, 2011, ANN BIOMED ENG, V39, P1349, DOI 10.1007/s10439-011-0269-6; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mourant JR, 1997, APPL OPTICS, V36, P949, DOI 10.1364/AO.36.000949; Nachabe R, 2010, BIOMED OPT EXPRESS, V1, P1432, DOI 10.1364/BOE.1.001432; Neil MAA, 1997, OPT LETT, V22, P1905, DOI 10.1364/OL.22.001905; O'Sullivan TD, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.071311; Okada E, 2003, APPL OPTICS, V42, P2906, DOI 10.1364/AO.42.002906; PODBIELSKA H, 1991, OPT ENG, V30, P1981, DOI 10.1117/12.56009; Powell T. J., 2004, HEAD INJURY PRACTICA; Quan C, 2001, OPT COMMUN, V189, P21, DOI 10.1016/S0030-4018(01)01038-0; Reilly P., 1997, HEAD INJURY; Richardson JTE, 2001, CLIN NEUROPSYCHOLOGI; Shafer R, 2011, J NEUROINTERV SURG, V3, P395, DOI 10.1136/jnis.2010.004184; Shi ZZ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.067004; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; SRINIVASAN V, 1984, APPL OPTICS, V23, P3105, DOI 10.1364/AO.23.003105; Su XY, 2001, OPT LASER ENG, V35, P263, DOI 10.1016/S0143-8166(01)00023-9; Su XY, 1996, P SOC PHOTO-OPT INS, V2866, P460, DOI 10.1117/12.263022; SU XY, 1994, P SOC PHOTO-OPT INS, V2132, P484, DOI 10.1117/12.176592; Sviri G. E., 2010, OPEN NEUROSERG J, V3, P6; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; Ter Minassian A, 1999, ANESTHESIOLOGY, V91, P985; Tkaczyk TS, 2004, OPT EXPRESS, V12, P3745, DOI 10.1364/OPEX.12.003745; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Wang LV, 2009, OPT SCI ENG-CRC, V144, P1, DOI 10.1201/9781420059922; Wang LV, 2007, BIOMEDICAL OPTICS PR, P5; Wang X, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2098607; Weber JR, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3528628; Wilson JD, 2005, BIOPHYS J, V88, P2929, DOI 10.1529/biophysj.104.054528; WRAY S, 1988, BIOCHIM BIOPHYS ACTA, V933, P184, DOI 10.1016/0005-2728(88)90069-2; Xue L, 2001, APPL OPTICS, V40, P1207, DOI 10.1364/AO.40.001207; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; Yeganeh HZ, 2012, BIOMED OPT EXPRESS, V3, P2761, DOI 10.1364/BOE.3.002761; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003; Zhao J, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1891345; Zhou C, 2006, OPT EXPRESS, V14, P1125, DOI 10.1364/OE.14.001125; Zhou C, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3146814	95	12	12	1	10	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	1083-3668	1560-2281		J BIOMED OPT	J. Biomed. Opt.	NOV	2013	18	11							116007	10.1117/1.JBO.18.11.116007			15	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	278MT	WOS:000328895100034	24220698				2021-06-18	
J	Choy, DKS; Nga, VDW; Lim, J; Lu, J; Chou, N; Yeo, TT; Teoh, SH				Choy, David Kim Seng; Nga, Vincent Diong Weng; Lim, Jing; Lu, Jia; Chou, Ning; Yeo, Tseng Tsai; Teoh, Swee-Hin			Brain Tissue Interaction with Three-Dimensional, Honeycomb Polycaprolactone-Based Scaffolds Designed for Cranial Reconstruction Following Traumatic Brain Injury	TISSUE ENGINEERING PART A			English	Article							TRICALCIUM PHOSPHATE SCAFFOLDS; PLATELET-RICH PLASMA; MARROW STROMAL CELLS; PCL-TCP SCAFFOLDS; IN-VIVO; DRUG-DELIVERY; GROWTH-FACTOR; COMBINATION; DIFFERENTIATION; TRANSPLANTATION	Following traumatic brain injury (TBI), resultant voids are unable to support injections of suspension treatments, leading to ineffective healing. Moreover, without a structure to support the large defect, the defect site suffers from mechanical instability, which may impair the healing process. Therefore, having a delivery vehicle that can temporarily fill and provide mechanical support to the defect site may alleviate the healing process. In this work, we reported for the first time, the inflammatory response of brain tissue with polycaprolactone (PCL) and PCL-tricalcium phosphate (TCP) scaffolds designed and fabricated for cranial reconstruction. After cranial defects were created in Sprague-Dawley rats, PCL and PCL-TCP scaffolds were implanted for a period of 1 week and 1 month. Following histology and immunofluorescence staining with the ionized calcium binding adaptor molecule-1 (IBA-1), glial fibrillary acidic protein (GFAP), nestin, and neuronal nuclei (NeuN), results indicated that IBA-1-positive activated microglia were observed across all groups, and declined significantly by 1 month (p<0.05). Interestingly, IBA-1-positive microglia were significantly fewer in the PCL-TCP group (p<0.05), suggesting a relatively milder inflammatory response. A decrease in the number of GFAP-positive cells among all groups over time (>29%) was also observed. Initially, astrocyte hypertrophy was observed proximal to the TBI site (55% in PCL and PCL-TCP groups, 75% in control groups), but it subsided by 1 month. Proximal to the TBI site, nestin immunoreactivity was intense during week 1, and which reduced by 1 month across all groups. NeuN-positive neurons were shrunken proximal to the TBI site (<0.9mm), 32% smaller in the PCL-TCP group and 27% smaller in the PCL group. Based on above data indicating the comparatively milder, initial inflammatory response of brain tissue to PCL-TCP scaffolds, it is suggested that PCL-TCP scaffolds have notable clinical advantages as compared to PCL scaffolds.	[Choy, David Kim Seng; Nga, Vincent Diong Weng; Chou, Ning; Yeo, Tseng Tsai] Natl Univ Singapore Hosp, Div Neurosurg, Singapore, Singapore; [Lim, Jing; Teoh, Swee-Hin] Nanyang Technol Univ, Sch Chem & Biomed Engn, Div Bioengn, Singapore 637457, Singapore; [Lu, Jia] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore; [Lu, Jia] Def Med & Environm Res Inst, DSO Natl Labs DMERI DSO, Singapore, Singapore	Teoh, SH (corresponding author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Div Bioengn, 70 Nanyang Dr,N1-3, Singapore 637457, Singapore.	teohsh@ntu.edu.sg	Nga, Vincent Diong Weng/U-3308-2017; Yeo, Tseng Tsai/U-8864-2017; Chou, Ning/B-5314-2011	Nga, Vincent Diong Weng/0000-0001-5256-5669; 	National University Health System Clinician's Research Grant	This work was funded by the National University Health System Clinician's Research Grant. The authors would like to express their gratitude toward Mary Kan for her contribution to histopathology, Kian Chye for his involvement as a perfusionist, Dr. Enoka for her help in the IACUC application, and Dr. Yang Ming for helping out in the procedure.	Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1; Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.0.CO;2-7; Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6; Johann V, 2007, EXP BRAIN RES, V177, P458, DOI 10.1007/s00221-006-0689-y; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Lim HC, 2011, J BONE JOINT SURG BR, V93B, P120, DOI 10.1302/0301-620X.93B1.24767; LOGAN A, 1993, TRENDS PHARMACOL SCI, V14, P337, DOI 10.1016/0165-6147(93)90007-7; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0; Mourino V, 2010, J R SOC INTERFACE, V7, P209, DOI 10.1098/rsif.2009.0379; Ng K, 2001, BALLET REV, V29, P13; O'Keefe RJ, 2011, TISSUE ENG PART B-RE, V17, P389, DOI [10.1089/ten.teb.2011.0475, 10.1089/ten.TEB.2011.0475]; Rai B, 2005, BIOMATERIALS, V26, P3739, DOI 10.1016/j.biomaterials.2004.09.052; Rai B, 2007, J ORAL MAXIL SURG, V65, P2195, DOI 10.1016/j.joms.2006.11.026; Rai B, 2007, J BIOMED MATER RES A, V81A, P888, DOI 10.1002/jbm.a.31142; Schantz JT, 2005, J MATER SCI-MATER M, V16, P807, DOI 10.1007/s10856-005-3584-3; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019; Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3; Teo EY, 2011, BIOMATERIALS, V32, P279, DOI 10.1016/j.biomaterials.2010.08.089; Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513; Wells MR, 1997, EXP NEUROL, V146, P395, DOI 10.1006/exnr.1997.6543; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440; Xiong Y, 2008, J NEUROSURG, V109, P510, DOI 10.3171/JNS/2008/109/9/0510; Yasuda H, 2010, J NEUROSURG, V112, P336, DOI 10.3171/2009.2.JNS08495; Yeo A, 2008, J BIOMED MATER RES A, V84A, P208, DOI 10.1002/jbm.a.31454; Yeo A, 2010, J BIOMED MATER RES A, V92A, P311, DOI 10.1002/jbm.a.32366; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0; Zhang ZY, 2010, BIOMATERIALS, V31, P608, DOI 10.1016/j.biomaterials.2009.09.078	34	12	12	0	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	NOV 1	2013	19	21-22					2382	2389		10.1089/ten.tea.2012.0733			8	Cell & Tissue Engineering; Cell Biology; Engineering, Biomedical; Materials Science, Biomaterials	Cell Biology; Engineering; Materials Science	239PN	WOS:000326038000009	23691928	Green Published			2021-06-18	
J	Miyake, H; Inoue, A; Tanaka, M; Matsuki, N				Miyake, Hizuru; Inoue, Akiko; Tanaka, Miho; Matsuki, Naoaki			Serum Glial Fibrillary Acidic Protein as a Specific Marker for Necrotizing Meningoencephalitis in Pug Dogs	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						canine; glial fibrillary acidic protein; necrotizing meningoencephalitis; serum	TRAUMATIC BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; ISCHEMIC-STROKE; AUTOANTIBODY; GFAP	To evaluate the ability of serum glial fibrillary acidic protein (GFAP) concentration as a diagnostic marker for canine central nervous system (CNS) disorders, sera from dogs with various CNS (n=47) and non-CNS (n=56) disorders were measured for GFAP by using an ELISA kit. Healthy Beagles (n=15) and Pug dogs (n=12) were also examined as controls. Interestingly, only Pug dogs with necrotizing meningoencephalitis (NME) showed elevated serum GFAP concentrations (<0.01 to 1.14 ng/ml), while other breeds of dogs with NME did not. Among the Pug dogs with NME, serum GFAP concentrations did not correlate with their clinical features, such as ages or survival times. Our data indicate the usefulness of serum GFAP as a novel marker for Pug dogs with NME.	[Miyake, Hizuru; Inoue, Akiko; Tanaka, Miho; Matsuki, Naoaki] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Clin Pathobiol, Bunkyo Ku, Tokyo 1138657, Japan	Matsuki, N (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Clin Pathobiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amki@mail.ecc.u-tokyo.ac.jp					Dvorak F, 2009, CEREBROVASC DIS, V27, P37, DOI 10.1159/000172632; Foerch C, 2006, J NEUROL NEUROSUR PS, V77, P181, DOI 10.1136/jnnp.2005.074823; Fujiwara K, 2008, VET REC, V162, P592, DOI 10.1136/vr.162.18.592; Matsuki N, 2004, J VET MED SCI, V66, P295, DOI 10.1292/jvms.66.295; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Park ES, 2012, VET PATHOL, V49, P682, DOI 10.1177/0300985811429311; Talarico LR, 2010, J SMALL ANIM PRACT, V51, P138, DOI 10.1111/j.1748-5827.2009.00823.x; Toda Y, 2007, VET REC, V161, P261, DOI 10.1136/vr.161.8.261; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wunderlich MT, 2006, EUR J NEUROL, V13, P1118, DOI 10.1111/j.1468-1331.2006.01435.x	10	12	12	0	3	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	NOV	2013	75	11					1543	1545		10.1292/jvms.13-0252			3	Veterinary Sciences	Veterinary Sciences	AC3QW	WOS:000332437300023	23856761	Green Published, Bronze			2021-06-18	
J	Wan, CH; Jiang, JK; Mao, H; Cao, JH; Wu, XH; Cui, G				Wan, Chunhua; Jiang, Junkang; Mao, Hui; Cao, Jianhua; Wu, Xiaohong; Cui, Gang			Involvement of Upregulated P53-Induced Death Domain Protein (PIDD) in Neuronal Apoptosis after Rat Traumatic Brain Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						PIDD; Traumatic brain injury; Neuronal apoptosis; Rat	TUMOR-SUPPRESSOR GENE; ADULT BRAIN; ACTIVATION; P53; CASPASE-2; STRESS; PIDDOSOME; PATHWAYS; PRODEATH; COMPLEX	Traumatic brain injury (TBI) initiates a series of complicated pathological events that could eventually lead to neuronal apoptosis. Recent studies indicated that p53 played a crucial role in neuronal apoptosis and regeneration following TBI. However, the detailed mechanism of p53-induced neuronal apoptosis in TBI remains largely elusive. In this study, we identified that p53-induced death domain protein (PIDD), whose transcription could be rapidly induced by p53 activation, was significantly upregulated after TBI. Western blot and immunohistochemistrical analyses revealed that the expression of PIDD was gradually increased, reached a peak at 3 days, and then decreased gradually to basal level after brain trauma. Further, double immunofluorescent analysis showed that PIDD was distributed predominantly in neurons, and the number of PIDD-positive neurons was significantly elevated in injured brain cortex. In addition, we found that PIDD was mainly distributed in active caspase-3-positive neurons, implicating a possible involvement of PIDD in the regulation of neuronal apoptosis during TBI. Finally, we showed that the expressions of p53 and Bax were altered correlatively with PIDD after brain trauma, implying that the upregulation of PIDD after TBI might be a result of p53 activation. Taken together, these findings suggested that PIDD might be an important regulator and potential therapeutic target of TBI.	[Wan, Chunhua; Jiang, Junkang] Nantong Univ, Sch Publ Hlth, Nantong, Peoples R China; [Mao, Hui; Cao, Jianhua; Wu, Xiaohong; Cui, Gang] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou 215006, Peoples R China	Cui, G (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, 188 Shixin St, Suzhou 215006, Peoples R China.	cui_gang123@163.com	Yu, Hongwei/L-3754-2017	Yu, Hongwei/0000-0002-5607-0628	Administration of Science and Technology of Nantong [BK2012090]	This work was supported by a grant of the Administration of Science and Technology of Nantong (BK2012090).	Ando K, 2012, MOL CELL, V47, P681, DOI 10.1016/j.molcel.2012.06.024; Baptiste-Okoh N, 2008, P NATL ACAD SCI USA, V105, P1937, DOI 10.1073/pnas.0711800105; Berube C, 2005, P NATL ACAD SCI USA, V102, P14314, DOI 10.1073/pnas.0506475102; Chen JA, 2011, CELL MOL NEUROBIOL, V31, P269, DOI 10.1007/s10571-010-9617-6; Conti AC, 1998, J NEUROSCI, V18, P5663; Cregan SP, 1999, J NEUROSCI, V19, P7860; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; Kiryu-Seo S, 2005, J NEUROSCI, V25, P1442, DOI 10.1523/JNEUROSCI.4041-04.2005; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lin YP, 2000, NAT GENET, V26, P122, DOI 10.1038/79102; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; LOGAN A, 1992, J NEUROSCI, V12, P3828; Martin LJ, 2001, J COMP NEUROL, V433, P299, DOI 10.1002/cne.1141; Martin LJ, 2001, INT J MOL MED, V7, P455; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Napieralski JA, 1999, MOL BRAIN RES, V71, P78, DOI 10.1016/S0169-328X(99)00155-2; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Qiu JH, 2002, J NEUROSCI, V22, P3504; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tinel A, 2007, EMBO J, V26, P197, DOI 10.1038/sj.emboj.7601473; Tomasevic G, 2010, J NEUROSCI RES, V88, P3414, DOI 10.1002/jnr.22491; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	27	12	12	0	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	NOV	2013	51	3					695	702		10.1007/s12031-013-0050-4			8	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	235IH	WOS:000325710500008	23797734				2021-06-18	
J	Zeng, JS; Tong, WS; Zheng, P				Zeng, Jingsong; Tong, Wusong; Zheng, Ping			Decreased risk of acute kidney injury with intracranial pressure monitoring in patients with moderate or severe brain injury Clinical article	JOURNAL OF NEUROSURGERY			English	Article						intracranial pressure; traumatic brain injury; acute kidney injury; mannitol; cystatin C; creatinine	INTENSIVE-CARE; MANNITOL; COMPLICATIONS; THERAPY; FAILURE; TRAUMA; IMPACT	Object. The authors undertook this study to evaluate the effects of continuous intracranial pressure (ICP) monitoring directed mannitol treatment on kidney function in patients with moderate or severe traumatic brain injury (TBI). Methods. One hundred sixty-eight patients with TBI were prospectively assigned to an ICP monitoring group or a conventional treatment control group based on the Brain Trauma Foundation guidelines. Clinical data included the dynamic changes of patients' blood concentrations of cystatin C, creatinine (Cr), and blood urea nitrogen (BUN); mannitol use; and 6-month Glasgow Outcome Scale (GOS) scores. Results. There were no statistically significant differences with respect to hospitalized injury, age, or sex distribution between the 2 groups. The incidence of acute kidney injury (AKI) was higher in the control group than in the ICP monitoring group (p < 0.05). The mean mannitol dosage in the ICP monitoring group (443 133 g) was significantly lower than in the control group (820 412 g) (p < 0.01), and the period of mannitol use in the ICP monitoring group (3 3.8 days) was significantly shorter than in the control group (7 2.3 days) (p < 0.01). The 6-month GOS scores in the ICP monitoring group were significantly better than in the control group (p < 0.05). On the 7th, 14th, and 21st days after injury, the plasma cystatin C and Cr concentrations in the ICP-monitoring group were significantly higher than the control group (p < 0.05). Conclusions. In patients with moderate and severe TBI, ICP-directed mannitol treatment demonstrated a beneficial effect on reducing the incidence of AKI compared with treatment directed by neurological signs and physiological indicators.	[Zeng, Jingsong; Tong, Wusong] Pudong New Area Peoples Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Zheng, Ping] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia	Zheng, P (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia.	jojo_ras@hotmail.com					Anderson RCE, 2004, J NEUROSURG, V101, P53, DOI 10.3171/ped.2004.101.2.0053; Bagshaw SM, 2008, RENAL FAILURE, V30, P581, DOI 10.1080/08860220802134649; Bekar A, 2009, J CLIN NEUROSCI, V16, P236, DOI 10.1016/j.jocn.2008.02.008; Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Bilotta F, 2012, NEUROCRIT CARE, V16, P280, DOI 10.1007/s12028-011-9652-2; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Cremer OL, 2008, EUR J ANAESTH, V25, P87, DOI 10.1017/S0265021507003237; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Fang L, 2010, RENAL FAILURE, V32, P673, DOI 10.3109/0886022X.2010.486492; Forsyth RJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002043.pub2; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; GADALLAH MF, 1995, AM J MED SCI, V309, P219, DOI 10.1097/00000441-199504000-00006; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hirsch KG, 2012, NEUROCRIT CARE, V17, P388, DOI 10.1007/s12028-012-9676-2; Lane PL, 2000, CAN J SURG, V43, P442; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; Perez-Perez AJ, 2002, AM J NEPHROL, V22, P573, DOI 10.1159/000065279; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Tommasino C, 2007, BEST PRACT RES-CLIN, V21, P497, DOI 10.1016/j.bpa.2007.07.002; Tsai SF, 2010, CLIN NEPHROL, V74, P70; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356	28	12	14	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2013	119	5					1228	1232		10.3171/2013.7.JNS122131			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	238OB	WOS:000325956200025	23909252				2021-06-18	
J	Schwer, CI; Lehane, C; Guelzow, T; Zenker, S; Strosing, KM; Spassov, S; Erxleben, A; Heimrich, B; Buerkle, H; Humar, M				Schwer, Christian I.; Lehane, Cornelius; Guelzow, Timo; Zenker, Simone; Strosing, Karl M.; Spassov, Sashko; Erxleben, Anika; Heimrich, Bernd; Buerkle, Hartmut; Humar, Matjaz			Thiopental Inhibits Global Protein Synthesis by Repression of Eukaryotic Elongation Factor 2 and Protects from Hypoxic Neuronal Cell Death	PLOS ONE			English	Article							ISCHEMIC BRAIN-INJURY; NITRIC-OXIDE; CEREBRAL-ISCHEMIA; FACTOR-II; RAT HIPPOCAMPAL; NMDA RECEPTORS; KINASE PATHWAY; NUCLEAR-FACTOR; EEF2 KINASE; IN-VITRO	Ischemic and traumatic brain injury is associated with increased risk for death and disability. The inhibition of penumbral tissue damage has been recognized as a target for therapeutic intervention, because cellular injury evolves progressively upon ATP-depletion and loss of ion homeostasis. In patients, thiopental is used to treat refractory intracranial hypertension by reducing intracranial pressure and cerebral metabolic demands; however, therapeutic benefits of thiopental-treatment are controversially discussed. In the present study we identified fundamental neuroprotective molecular mechanisms mediated by thiopental. Here we show that thiopental inhibits global protein synthesis, which preserves the intracellular energy metabolite content in oxygen-deprived human neuronal SK-N-SH cells or primary mouse cortical neurons and thus ameliorates hypoxic cell damage. Sensitivity to hypoxic damage was restored by pharmacologic repression of eukaryotic elongation factor 2 kinase. Translational inhibition was mediated by calcium influx, activation of the AMP-activated protein kinase, and inhibitory phosphorylation of eukaryotic elongation factor 2. Our results explain the reduction of cerebral metabolic demands during thiopental treatment. Cycloheximide also protected neurons from hypoxic cell death, indicating that translational inhibitors may generally reduce secondary brain injury. In conclusion our study demonstrates that therapeutic inhibition of global protein synthesis protects neurons from hypoxic damage by preserving energy balance in oxygen-deprived cells. Molecular evidence for thiopental-mediated neuroprotection favours a positive clinical evaluation of barbiturate treatment. The chemical structure of thiopental could represent a pharmacologically relevant scaffold for the development of new organ-protective compounds to ameliorate tissue damage when oxygen availability is limited.	[Schwer, Christian I.; Lehane, Cornelius; Strosing, Karl M.; Spassov, Sashko; Buerkle, Hartmut; Humar, Matjaz] Univ Med Ctr Freiburg, Dept Anesthesiol & Crit Care Med, Freiburg, Germany; [Guelzow, Timo] Univ Med Ctr Freiburg, Dept Gen Neurosurg Cellular Neurophysiol, Freiburg, Germany; [Erxleben, Anika] Univ Freiburg, Inst Pharmaceut Sci, D-79106 Freiburg, Germany; [Zenker, Simone; Heimrich, Bernd] Univ Freiburg, Dept Anat & Cell Biol, D-79106 Freiburg, Germany	Humar, M (corresponding author), Univ Med Ctr Freiburg, Dept Anesthesiol & Crit Care Med, Freiburg, Germany.	matjaz.humar@uniklinik-freiburg.de	Buerkle, Hartmut/I-5785-2014; Spassov, Sashko/C-2105-2013	Spassov, Sashko/0000-0002-3585-3682; Lehane, Cornelius/0000-0001-5173-5216; Erxleben, Anika/0000-0002-7427-6478	Department of Anesthesiology and Critical Care Medicine, University Medical Center Freiburg, Germany	This work was funded by the Department of Anesthesiology and Critical Care Medicine, University Medical Center Freiburg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS49; ALDRIDGE WN, 1960, BIOCHEM J, V76, P47, DOI 10.1042/bj0760047; Almaas R, 2000, ANESTHESIOLOGY, V92, P764, DOI 10.1097/00000542-200003000-00020; Anderson CM, 2002, J NEUROSCI, V22, P9203; BECKER KE, 1976, ANESTHESIOLOGY, V45, P656, DOI 10.1097/00000542-197612000-00013; Bolanos JP, 1999, BBA-BIOENERGETICS, V1411, P415, DOI 10.1016/S0005-2728(99)00030-4; Bouaziz N, 2002, EUR J PHARMACOL, V441, P35, DOI 10.1016/S0014-2999(02)01490-5; Boutilier RG, 2000, COMP BIOCHEM PHYS A, V126, P481, DOI 10.1016/S1095-6433(00)00234-8; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS71; Browne GJ, 2004, J BIOL CHEM, V279, P12220, DOI 10.1074/jbc.M309773200; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Candelario-Jalil E, 2008, CURR PHARM DESIGN, V14, P1401, DOI 10.2174/138161208784480216; CARLBERG U, 1990, EUR J BIOCHEM, V191, P639, DOI 10.1111/j.1432-1033.1990.tb19169.x; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Chen Z, 2009, CIRC RES, V104, P496, DOI 10.1161/CIRCRESAHA.108.187567; Cole DJ, 2001, CAN J ANAESTH, V48, P807, DOI 10.1007/BF03016699; Cunningham LA, 2005, GLIA, V50, P329, DOI 10.1002/glia.20169; DESSI F, 1992, BRAIN RES, V581, P323, DOI 10.1016/0006-8993(92)90726-P; Diggle TA, 1998, BIOCHEM J, V336, P525, DOI 10.1042/bj3360525; Diggle TA, 2001, BIOCHEM J, V353, P621, DOI 10.1042/0264-6021:3530621; DOENICKE A, 1965, ACTA ANAESTH SCAND, P11; Du JH, 2008, BIOCHEM BIOPH RES CO, V368, P402, DOI 10.1016/j.bbrc.2008.01.099; Erecinska M, 2003, J CEREBR BLOOD F MET, V23, P513, DOI 10.1097/01.WCB.0000066287.21705.21; GOTO K, 1990, BRAIN RES, V534, P299, DOI 10.1016/0006-8993(90)90144-Z; Greco SJ, 2009, BIOCHEM BIOPH RES CO, V380, P98, DOI 10.1016/j.bbrc.2009.01.041; Hand SC, 1996, ANNU REV PHYSIOL, V58, P539, DOI 10.1146/annurev.ph.58.030196.002543; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hidaka Ikuhiro, 2009, Hiroshima Journal of Medical Sciences, V58, P9; Hizli AA, 2013, MOL CELL BIOL, V33, P596, DOI 10.1128/MCB.01270-12; Humar M, 2004, MOL PHARMACOL, V65, P350, DOI 10.1124/mol.65.2.350; Humar M, 2009, MOL PHARMACOL, V75, P667, DOI 10.1124/mol.108.052183; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Li J, 2010, J CEREBR BLOOD F MET, V30, P480, DOI 10.1038/jcbfm.2009.255; Lin CC, 2013, CELL MOL LIFE SCI; Loop T, 2003, ANESTHESIOLOGY, V99, P360, DOI 10.1097/00000542-200308000-00017; Michiels C, 2004, AM J PATHOL, V164, P1875, DOI 10.1016/S0002-9440(10)63747-9; MORIKAWA E, 1994, STROKE, V25, P429, DOI 10.1161/01.STR.25.2.429; Moro MA, 2004, CELL CALCIUM, V36, P265, DOI 10.1016/j.ceca.2004.02.011; NEUWELT EA, 1982, J NEUROSURG, V56, P254, DOI 10.3171/jns.1982.56.2.0254; NORDBY HK, 1984, ACTA NEUROCHIR, V72, P157, DOI 10.1007/BF01406868; Oakhill JS, 2012, TRENDS ENDOCRIN MET, V23, P125, DOI 10.1016/j.tem.2011.12.006; Park WS, 2006, J KOREAN MED SCI, V21, P337, DOI 10.3346/jkms.2006.21.2.337; Pizzi M, 2002, EUR J NEUROSCI, V16, P2342, DOI 10.1046/j.1460-9568.2002.02403.x; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Py BF, 2009, AUTOPHAGY, V5, P393, DOI 10.4161/auto.5.3.7762; ROBERTS I, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000033; Roesslein M, 2008, J PHARMACOL EXP THER, V325, P217, DOI 10.1124/jpet.107.133108; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; RYAZANOV AG, 1987, FEBS LETT, V214, P331, DOI 10.1016/0014-5793(87)80081-9; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Salminen A, 2011, J NEUROCHEM, V118, P460, DOI 10.1111/j.1471-4159.2011.07331.x; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Shibuta S, 1998, BRIT J PHARMACOL, V124, P804, DOI 10.1038/sj.bjp.0701884; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; SMITH DS, 1980, ACTA PHYSIOL SCAND, P129; STEEN PA, 1980, ANESTHESIOLOGY, V53, P183; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; Wilson JX, 2002, J NEUROSURG ANESTH, V14, P66, DOI 10.1097/00008506-200201000-00014; Won SJ, 2002, J BIOCHEM MOL BIOL, V35, P67, DOI 10.5483/BMBRep.2002.35.1.067; Wong AKF, 2009, CLIN SCI, V116, P607, DOI 10.1042/CS20080066; Wu H, 2006, CANCER RES, V66, P3015, DOI 10.1158/0008-5472.CAN-05-1554; YASUDA T, 1993, INT J LEGAL MED, V105, P239, DOI 10.1007/BF01642801; Ying WJ, 2007, FRONT BIOSCI-LANDMRK, V12, P2728, DOI 10.2741/2267; ZAGER EL, 1988, J NEUROSURG, V69, P568, DOI 10.3171/jns.1988.69.4.0568; Zhan RZ, 1998, BRIT J ANAESTH, V81, P932; Zhan RZ, 1998, ANESTHESIOLOGY, V89, P456, DOI 10.1097/00000542-199808000-00023; Zhang XL, 2010, NEUROCHEM RES, V35, P1281, DOI 10.1007/s11064-010-0186-3	69	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77258	10.1371/journal.pone.0077258			12	Multidisciplinary Sciences	Science & Technology - Other Topics	239OF	WOS:000326034500026	24167567	DOAJ Gold, Green Published			2021-06-18	
J	Gu, SJ; Xuan, HF; Lu, M; Chen, XZ; Dong, WF; Yan, XF; Si, Y; Gao, GL; Hu, DX; Miao, JQ				Gu, Shui-Jun; Xuan, Hong-Fei; Lu, Ming; Chen, Xin-Zhi; Dong, Wei-Feng; Yan, Xiao-Feng; Si, Yun; Gao, Guo-Liang; Hu, Dian-Xiang; Miao, Jian-Qing			Admission plasma visfatin level strongly correlates with hematoma growth and early neurologic deterioration in patients with acute spontaneous basal ganglia hemorrhage	CLINICA CHIMICA ACTA			English	Article						Intracerebral hemorrhage; Hematoma growth; Early neurologic deterioration; Visfatin; Biomarker	COLONY-ENHANCING FACTOR; SPONTANEOUS INTRACEREBRAL HEMORRHAGE; TRAUMATIC BRAIN-INJURY; PROGNOSTIC-SIGNIFICANCE; ISCHEMIC-STROKE; INFLAMMATION; PREDICTORS; MORTALITY; PROTEIN	Background: Visfatin, a proinflammatory mediator has been associated with poor clinical outcomes after acute brain injury. The present study is designed to investigate the potential association between plasma visfatin levels and the risk of hematoma growth (HG) and early neurologic deterioration (END) after intracerebral hemorrhage. Methods: There were 85 patients as cases who presented with first-time hemorrhagic stroke that were assessed within 6 h after the incident The control group consisted of 85 healthy volunteers. HG was defined as hematoma enlargement >33% at 24 h. END was defined as an increase of >= 4 points in National Institute of Health Stroke Scale score at 24 h from symptoms onset Plasma visfatin levels were determined using enzyme immunoassay. Results: Plasma visfatin levels were significantly higher in patients compared to controls. Plasma visfatin level emerged as an independent predictor of HG [odds ratio (OR), 1.154; 95% confidence interval (CI), 1.046-3.108; P = 0.009] and END (OR, 1.195; 95% CI, 1.073-3516; P = 0.005). For predicting HG, area under curve (AUC) of plasma visfatin level (0.814; 95% CI: 0.715-0.890) was similar to that of hematoma volume (0.839; 95% CI, 0.743-0.909) (P = 0.703). For predicting END, AUC of plasma visfatin level (0.828; 95% CI: 0.730-0.901) was similar to that of hematoma volume (0.863; 95% CI, 0.771-0.928) (P = 0.605). Visfatin did not improve AUC of hematoma volume for predicting HG and END (both P > 0.05). Conclusion: Plasma visfatin level represents a novel biomarker for predicting HG and END. (C) 2013 Elsevier B.V. All rights reserved.	[Gu, Shui-Jun; Xuan, Hong-Fei; Lu, Ming; Chen, Xin-Zhi; Dong, Wei-Feng; Yan, Xiao-Feng; Si, Yun; Gao, Guo-Liang; Hu, Dian-Xiang; Miao, Jian-Qing] First Peoples Hosp Xiaoshan Dist Hangzhou City, Dept Neurosurg, Hangzhou 311200, Zhejiang, Peoples R China	Lu, M (corresponding author), First Peoples Hosp Xiaoshan Dist Hangzhou City, Dept Neurosurg, 199 Shixin South Rd, Hangzhou 311200, Zhejiang, Peoples R China.	sjghxml@163.com			Hangzhou Science and Technology Research Fund Project [20120533Q43]	The authors thank all staffs in Department of Neurosurgery, The First People's Hospital of Xiaoshan District of Hangzhou City (Hangzhou, China) for their technical support. This study was supported by a grant from Hangzhou Science and Technology Research Fund Project (no. 20120533Q43).	Broderick JP, 2007, STROKE, V38, P1072, DOI 10.1161/01.STR.0000258078.35316.30; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Chen J, 2012, PEPTIDES, V38, P8, DOI 10.1016/j.peptides.2012.08.016; Chen WP, 2010, CLIN CHEM LAB MED, V48, P1141, DOI 10.1515/CCLM.2010.230; Dahl TB, 2012, ANNU REV NUTR, V32, P229, DOI 10.1146/annurev-nutr-071811-150746; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; Delcourt C, 2012, NEUROLOGY, V79, P314, DOI 10.1212/WNL.0b013e318260cbba; Fan JS, 2012, ACAD EMERG MED, V19, P133, DOI 10.1111/j.1553-2712.2011.01285.x; Flaherty ML, 2006, NEUROLOGY, V66, P1182, DOI 10.1212/01.wnl.0000208400.08722.7c; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Hu W, 2013, PEPTIDES, V43, P8, DOI 10.1016/j.peptides.2013.02.017; Huang Q, 2013, PEPTIDES, V39, P55, DOI 10.1016/j.peptides.2012.11.006; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Lee KA, 2011, CHEST, V140, P382, DOI 10.1378/chest.10-3100; Leira R, 2004, NEUROLOGY, V63, P461, DOI 10.1212/01.WNL.0000133204.81153.AC; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Lu LF, 2009, J STROKE CEREBROVASC, V18, P354, DOI 10.1016/j.jstrokecerebrovasdis.2009.01.003; Mazaherioun M, 2012, ARCH IRAN MED, V15, P688, DOI 0121511/AIM.008; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Rodriguez-Luna D, 2011, NEUROLOGY, V77, P1599, DOI 10.1212/WNL.0b013e3182343387; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Siegler JE, 2011, INT J STROKE, V6, P211, DOI 10.1111/j.1747-4949.2011.00596.x; Sonoli SS, 2011, EUR REV MED PHARMACO, V15, P9; Stofkova A, 2010, Endocr Regul, V44, P25; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Weng JF, 2013, PEPTIDES, V40, P8, DOI 10.1016/j.peptides.2012.12.017; Yin CG, 2013, PEPTIDES, V42, P101, DOI 10.1016/j.peptides.2013.01.005	31	12	13	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	OCT 21	2013	425						85	89		10.1016/j.cca.2013.07.025			5	Medical Laboratory Technology	Medical Laboratory Technology	270GE	WOS:000328306100015	23916712				2021-06-18	
J	Park, Y; Luo, TF; Zhang, F; Liu, CL; Bramlett, HM; Dietrich, WD; Hu, BR				Park, Yujung; Luo, Tianfei; Zhang, Fan; Liu, Chunli; Bramlett, Helen M.; Dietrich, W. Dalton; Hu, Bingren			Downregulation of Src-kinase and glutamate-receptor phosphorylation after traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						NMDA receptor; PSD93; Src family kinases; traumatic brain injury; tyrosine phosphorylation	D-ASPARTATE RECEPTORS; TRANSIENT CEREBRAL-ISCHEMIA; NMDA RECEPTORS; TYROSINE-PHOSPHORYLATION; POSTSYNAPTIC DENSITIES; SURFACE EXPRESSION; RATS; DAMAGE; RELEASE; COMPLEX	Phosphorylation of N-methyl-D-aspartate (NMDA) receptors is a major regulatory mechanism underlying synaptic plasticity. However, changes in NMDA receptors and phosphorylation after traumatic brain injury (TBI) remain incompletely understood. Using an animal TBI model, we observed that the protein level of NMDA receptor subunit NR2B was downregulated in synaptosomal fractions obtained from the ipsilateral neocortical injury region, whereas the levels of NR2A, NR1, and PSD93 were not significantly altered at 4 and 24 hours after TBI. Further investigation showed that tyrosine phosphorylations of NR2B Y1472 and PSD93 Y340 in synaptosomal fractions were significantly decreased relative to their total protein level after TBI. Correspondingly, phosphorylation of the Src-kinase-inhibitory site Y527 was increased, whereas phosphorylation of the activation site Y416 was decreased, indicating that the activity of Src kinase is significantly inhibited after TBI. In comparison, other Src family kinase substrates of NMDA receptor, NR2A Y1246, NR2A Y1325, and NR2B Y1070 were not obviously affected after TBI. The results suggest that TBI downregulates the Src-kinase-mediated phosphorylation of NR2 and PSD93 to destabilize the synaptic localization of NMDA receptors. Therefore, post-TBI loss of NMDA receptors may contribute to the depression of synaptic activity after TBI.	[Park, Yujung; Luo, Tianfei; Zhang, Fan; Liu, Chunli; Hu, Bingren] Univ Maryland, Sch Med, Dept Anesthesiol, Neurochem Lab Brain Injury, Baltimore, MD 21201 USA; [Park, Yujung; Luo, Tianfei; Zhang, Fan; Liu, Chunli; Hu, Bingren] Univ Maryland, Sch Med, Shock Trauma & Anesthesiol Res Ctr, Baltimore, MD 21201 USA; [Bramlett, Helen M.; Dietrich, W. Dalton] Univ Miami, Sch Med, Miami Project Cure Paralysis, Miami, FL USA	Hu, BR (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, Neurochem Lab Brain Injury, Baltimore, MD 21201 USA.	bhu@anes.umm.edu		Zhang, Fan/0000-0002-0744-673X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS040407, NS030291]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040407, P50NS030291] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health grants NS040407 and NS030291.	Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; BAETHMANN A, 1989, J NEUROSURG, V70, P578, DOI 10.3171/jns.1989.70.4.0578; Besshoh S, 2005, J NEUROCHEM, V93, P186, DOI 10.1111/j.1471-4159.2004.03009.x; Bigford GE, 2009, J NEUROTRAUM, V26, P703, DOI 10.1089/neu.2008.0783; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Cheung HH, 2001, J NEUROCHEM, V78, P524, DOI 10.1046/j.1471-4159.2001.00433.x; Delint-Ramirez I, 2010, J NEUROSCI, V30, P8162, DOI 10.1523/JNEUROSCI.1792-10.2010; Dietrich WD, 1996, J NEUROTRAUM, V13, P309, DOI 10.1089/neu.1996.13.309; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Groveman BR, 2012, FEBS J, V279, P20, DOI 10.1111/j.1742-4658.2011.08413.x; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hu BR, 1998, J NEUROSCI, V18, P625; Jiang XN, 2011, NEUROSCI LETT, V503, P215, DOI 10.1016/j.neulet.2011.08.039; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kumar A, 2002, J NEUROSCI RES, V67, P781, DOI 10.1002/jnr.10181; Lan JY, 2001, J NEUROSCI, V21, P6058; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Liu CL, 2005, NEUROSCIENCE, V134, P1273, DOI 10.1016/j.neuroscience.2005.05.015; Marklund N, 2006, NEUROCHEM RES, V31, P1085, DOI 10.1007/s11064-006-9120-0; Nada S, 2003, J BIOL CHEM, V278, P47610, DOI 10.1074/jbc.M303873200; O'Leary TJ, 2009, BIOTECH HISTOCHEM, V84, P217, DOI 10.1080/10520290903039086; Petralia RS, 2010, NEUROSCIENCE, V167, P68, DOI 10.1016/j.neuroscience.2010.01.022; PONTEN U, 1973, J NEUROCHEM, V21, P1121, DOI 10.1111/j.1471-4159.1973.tb07566.x; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Sato Y, 2008, NEUROSCIENCE, V153, P700, DOI 10.1016/j.neuroscience.2008.03.006; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhang F, 2013, STROKE, V44, P170, DOI 10.1161/STROKEAHA.112.667253	35	12	14	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2013	33	10					1642	1649		10.1038/jcbfm.2013.121			8	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	228PV	WOS:000325199600019	23838828	Green Published, Bronze			2021-06-18	
J	Salvador, E; Neuhaus, W; Foerster, C				Salvador, Ellaine; Neuhaus, Winfried; Foerster, Carola			Stretch in Brain Microvascular Endothelial Cells (cEND) as an In Vitro Traumatic Brain Injury Model of the Blood Brain Barrier	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Medicine; Issue 80; stretch injury; traumatic brain injury; blood-brain barrier; brain microvascular endothelial cells (cEND)	PERMEABILITY; BREAKDOWN; CULTURE; HYPOXIA; TARGET	Due to the high mortality incident brought about by traumatic brain injury (TBI), methods that would enable one to better understand the underlying mechanisms involved in it are useful for treatment. There are both in vivo and in vitro methods available for this purpose. In vivo models can mimic actual head injury as it occurs during TBI. However, in vivo techniques may not be exploited for studies at the cell physiology level. Hence, in vitro methods are more advantageous for this purpose since they provide easier access to the cells and the extracellular environment for manipulation. Our protocol presents an in vitro model of TBI using stretch injury in brain microvascular endothelial cells. It utilizes pressure applied to the cells cultured in flexible-bottomed wells. The pressure applied may easily be controlled and can produce injury that ranges from low to severe. The murine brain microvascular endothelial cells (cEND) generated in our laboratory is a well-suited model for the blood brain barrier (BBB) thus providing an advantage to other systems that employ a similar technique. In addition, due to the simplicity of the method, experimental set-ups are easily duplicated. Thus, this model can be used in studying the cellular and molecular mechanisms involved in TBI at the BBB.	[Salvador, Ellaine; Neuhaus, Winfried; Foerster, Carola] Univ Wurzburg, Zentrum Operat Med, Klin & Poliklin Anasthesiol, Wurzburg, Germany; [Neuhaus, Winfried] Univ Vienna, Fac Life Sci, Dept Med Chem, A-1010 Vienna, Austria	Foerster, C (corresponding author), Univ Wurzburg, Zentrum Operat Med, Klin & Poliklin Anasthesiol, Wurzburg, Germany.	Foerster_C@klinik.uni-wuerzburg.de		Neuhaus, Winfried/0000-0002-6552-7183	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)German Research Foundation (DFG) [FO 315/4-]; European UnionEuropean Commission [HEALTH-F2-2009- 241778]	This research was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under grant number FO 315/4- and the European Union Seventh Framework Programme (FP7/2007-2013) under Grant agreement No. HEALTH-F2-2009- 241778 to CF.	Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Berrout J, 2012, BRAIN RES, V1436, P1, DOI 10.1016/j.brainres.2011.11.044; Burek M, 2012, JOVE-J VIS EXP, DOI 10.3791/4022; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Forster C, 2005, J PHYSIOL-LONDON, V565, P475, DOI 10.1113/jphysiol.2005.084038; Geddes-Klein D., 2006, J NEUROTRAUM, V23, P93; Gidday JM, 1999, J NEUROTRAUM, V16, P27, DOI 10.1089/neu.1999.16.27; Gumbleton M, 2001, J PHARM SCI-US, V90, P1681, DOI 10.1002/jps.1119; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Omidi Y, 2003, BRAIN RES, V990, P95, DOI 10.1016/S0006-8993(03)03443-7; RAYCHAUDHURY A, 1994, J CELL SCI, V107, P39; RUBIN LL, 1991, J CELL BIOL, V115, P1725, DOI 10.1083/jcb.115.6.1725; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; Thal S. C., 2013, CRIT CARE M IN PRESS; Wanner IB, 2008, GLIA, V56, P1691, DOI 10.1002/glia.20721; Wanner IB, 2012, METHODS MOL BIOL, V814, P189, DOI 10.1007/978-1-61779-452-0_14; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	25	12	12	0	9	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	OCT	2013		80							e50928	10.3791/50928			6	Multidisciplinary Sciences	Science & Technology - Other Topics	V36RP	WOS:000209228800050	24193450	Green Published, Bronze			2021-06-18	
J	Xu, GZ; Wang, MD; Liu, KG; Bai, YA; Wu, W; Li, W				Xu, Gang-Zhu; Wang, Mao-De; Liu, Kai-Ge; Bai, Yin-An; Wu, Wei; Li, Wen			A meta-analysis of treating acute traumatic brain injury with calcium channel blockers	BRAIN RESEARCH BULLETIN			English	Article						Traumatic subarachnoid haemorrhage; Calcium channel blockers; Acute traumatic brain injury; Meta-analysis	SEVERE HEAD-INJURY; SUBARACHNOID HEMORRHAGE; OXYGEN-CONSUMPTION; FLOW VELOCITIES; DOUBLE-BLIND; HIT-I; NIMODIPINE; TRIAL; NEUROPROTECTION; INCREASES	The purpose of this systematic review was to evaluate and meta-analyse the current evidence for the use of calcium channel blockers (CCBs) in the treatment of acute traumatic brain injury (TBI) and traumatic subarachnoid haemorrhage (tSAH). A systematic search of clinical trials.gov, Cochrane library databases, EMBASE, MEDLINE, Web of science search and WHO trial registry, plus hand-searching of grey literature, was undertaken in March 2013. Two reviewers independently extracted the data using a pre-defined data extraction form. RevMan 5 software was used to synthesise data and calculate the risk ratio (RR) based on event rates as well as the 95% confidence interval (Cl). Finally, nine RCTs with a total of 2182 patients were included. Meta-analysis showed that there was no difference between CCBs and control groups for rates of mortality (n = 1337, 5 RCTs, RR 0.93 CI 0.77-1.12). In a subgroup tSAH analysis, the difference was not significant (n = 389, 2 RCTs, RR 0.73 CI 0.53-1.02). There were slightly fewer unfavourable outcomes in the treatment group, but the difference was not statistically significant (n = 2101, 8 RCTs, RR 0.90 CI 0.76-1.08). In the subgroup tSAH analysis, again, the difference did not reach statistical significance (n = 1074, 5 RCTs, RR 0.95 CI 0.73-1.24). It seems that larger, well-designed RCTs are necessary in order to ascertain any clinical benefit CCBs may or may not have for the treatment of acute TBI. Crown Copyright (C) 2013 Published by Elsevier Inc. All rights reserved.	[Xu, Gang-Zhu; Liu, Kai-Ge; Bai, Yin-An; Wu, Wei; Li, Wen] Xian Med Univ, Affiliated Hosp, Dept Neurosurg, Xian 710077, Shaanxi, Peoples R China; [Wang, Mao-De] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, Xian 710061, Peoples R China	Xu, GZ (corresponding author), Xian Med Univ, Affiliated Hosp, Dept Neurosurg, 48 Fenghao West Rd, Xian 710077, Shaanxi, Peoples R China.	xgz917@126.com; maodewang@163.com					[Anonymous], 2011, REV MAN REVMAN COMP; Asian A., 2009, PHARM RES, V59, P120; BAILEY I, 1991, ACTA NEUROCHIR, V110, P97, DOI 10.1007/BF01400674; Berman RF, 2000, J NEUROSURG, V93, P821, DOI 10.3171/jns.2000.93.5.0821; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; COMPTON J S, 1990, British Journal of Neurosurgery, V4, P9, DOI 10.3109/02688699009000676; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; European Study Group on Nimodipine in Severe Head Injury, 1994, J NEUROSURG, V80, P797; Farhoudi M, 2007, NEUROSCIENCES, V12, P285; Feng Dongxia, 2000, Chin J Traumatol, V3, P85; Fukuda T, 1998, NEUROSURGERY, V43, P1040, DOI 10.1097/00006123-199811000-00022; GENTLEMAN D, 1990, INJURY, V21, P305, DOI 10.1016/0020-1383(90)90047-X; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JENNETT B, 1975, LANCET, V7905, P480; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; Kostron H, 1985, Neurochirurgia (Stuttg), V28 Suppl 1, P103; Langham J., 2009, CDS REV, V1, DOI DOI 10.1002/14651858; Lee LL, 2004, EXP NEUROL, V190, P70, DOI 10.1016/j.expneurol.2004.07.003; Levasseur JE, 2000, J NEUROTRAUM, V17, P101, DOI 10.1089/neu.2000.17.101; MATTHEWS DSF, 1995, J NEUROL NEUROSUR PS, V59, P359, DOI 10.1136/jnnp.59.4.359; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; Muizelaar JP, 1996, NEUROTRAUMA, P553; Murray GD, 1996, ACTA NEUROCHIR, V138, P1163, DOI 10.1007/BF01809745; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nicholls DG, 2000, PHYSIOL REV, V80, P315; Patel HC, 1999, HOSP MED, V60, P497, DOI 10.12968/hosp.1999.60.7.1155; Pillai SV, 2003, NEUROL INDIA, V51, P361; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; RINKEL GJ, 2005, COCHRANE DB SYST REV, V1; Romner B, 1996, J NEUROSURG, V85, P90, DOI 10.3171/jns.1996.85.1.0090; Roos YBWEM, 2001, STROKE, V32, P1860, DOI 10.1161/01.STR.32.8.1860; Sahuquillo J, 2000, REV NEUROLOGIA, V30, P401, DOI 10.33588/rn.3005.99063; Sprenger K, 2003, EFFECT 3 WEEK UNPUB; STEIGER HJ, 1994, NEUROSURGERY, V34, P79; TEASDALE G, 1990, ACT NEUR S, V51, P315; TEASDALE G, 1992, J NEUROTRAUM, V9, pS545; Tse YH, 2005, SURG PRACT, V9, P122, DOI 10.1111/j.1744-1633.2005.00271.x; Vergouwen MDI, 2006, LANCET NEUROL, V5, P1029, DOI 10.1016/S1474-4422(06)70582-8; Zubkov AY, 2000, ACT NEUR S, V76, P223	42	12	12	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	OCT	2013	99						41	47		10.1016/j.brainresbull.2013.09.011			7	Neurosciences	Neurosciences & Neurology	285TX	WOS:000329419000008	24099981				2021-06-18	
J	Huang, E; Ngo, M; Yee, S; Held, L; Norman, K; Scremin, AME; Scremin, O				Huang, Emerald; Ngo, Mai; Yee, Stuart; Held, Laura; Norman, Keith; Scremin, A. M. Erika; Scremin, Oscar			Repeated blast exposure alters open field behavior recorded under low illumination	BRAIN RESEARCH			English	Article						Brain injury; Blast injury; Rat	TRAUMATIC BRAIN-INJURY; RAT; HEADACHE; MODELS; AGE	Blast-induced traumatic brain injury (bTBI) can have devastating behavioral consequences. This study was designed to evaluate the behavioral consequences of single or repeated bTBI, as evaluated by an open field (OF) test conducted in near-darkness to avoid confounding effects of illumination and photophobia. Sprague-Dawley rats under isoflurane anesthesia were exposed to a series of 3 sub-lethal blasts into a compressed air-driven blast chamber separated by 2 week intervals (n=11). Sham controls received anesthesia but without blast exposure (n=11). OF tests were performed 1 or 7 days after each blast using a computerized video tracking system in near-darkness to monitor spontaneous activity. Spatial and temporal variables calculated for both blast and sham groups were: Distance moved (cm) and time (s) spent in the center or periphery zones of the field, total distance traveled, speed in center and periphery zones, rearing events and non-linear regressions of distance moved and rearing events on time. Results showed that the sham group expressed the expected decrease (habituation) in total distance walked, and distance walked as well as speed in center and periphery in successive exposures to the OF while the blast group did not, a sign of impaired learning. The blast group also walked more and faster and demonstrated more rearing behavior, both considered OF signs of anxiety. These results indicate that OF outcomes of bTBI in animals have resemblance to alterations observed in human subjects with this condition and might be useful in evaluating the response of behavioral outcomes of bTBI to experimental treatments. Published by Elsevier B.V.	[Huang, Emerald; Ngo, Mai; Yee, Stuart] Univ Calif Los Angeles, VA Multicampus Residency Program, Los Angeles, CA USA; [Held, Laura; Scremin, A. M. Erika] Vet Affairs Greater Los Angeles Healthcare Syst, Res Serv, Los Angeles, CA 90073 USA; [Norman, Keith; Scremin, Oscar] Vet Affairs Greater Los Angeles Healthcare Syst, Res Serv, Los Angeles, CA USA; [Scremin, A. M. Erika] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Scremin, Oscar] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	Scremin, O (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Dept Res, 11301 Wilshire Blvd,Bldg 115,Room 319, Los Angeles, CA 90073 USA.	oscremin@ucla.edu			Department of Veterans Affairs Rehabilitation Research & Development Merit Review (VARRD)US Department of Veterans Affairs [B5089R]; VA RR&D Research Career Scientist award	This work was supported by Department of Veterans Affairs Rehabilitation Research & Development Merit Review (VARR&D) #B5089R, and a VA RR&D Research Career Scientist award (to O.U.S.).	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BIRCH D, 1975, VISION RES, V15, P687, DOI 10.1016/0042-6989(75)90285-0; BLIZARD DA, 1971, BRIT J PSYCHOL, V62, P245, DOI 10.1111/j.2044-8295.1971.tb02034.x; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Cryan JF, 2011, BRIT J PHARMACOL, V164, P1129, DOI 10.1111/j.1476-5381.2011.01362.x; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; DIXON LK, 1968, J COMP PHYSIOL PSYCH, V66, P803, DOI 10.1037/h0026533; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Li SH, 2006, J NEUROSCI RES, V83, P292, DOI 10.1002/jnr.20720; LIVESEY PJ, 1970, J COMP PHYSIOL PSYCH, V73, P93, DOI 10.1037/h0030018; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; RUSSELL RW, 1990, PHARMACOL BIOCHEM BE, V37, P811, DOI 10.1016/0091-3057(90)90567-2; RUSSELL RW, 1982, ANNU REV PHARMACOL, V22, P435, DOI 10.1146/annurev.pa.22.040182.002251; Sartori SB, 2011, FUTUR NEUROL, V6, P531, DOI 10.2217/FNL.11.34; Song C, 2005, NEUROSCI BIOBEHAV R, V29, P627, DOI 10.1016/j.neubiorev.2005.03.010; Spelman J.F., 2012, J GEN INTERN MED; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Tanielan T, 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; VALLE FP, 1970, AM J PSYCHOL, V83, P103, DOI 10.2307/1420860; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020	29	12	12	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 5	2013	1529						125	133		10.1016/j.brainres.2013.06.042			9	Neurosciences	Neurosciences & Neurology	221KQ	WOS:000324658200013	23850767				2021-06-18	
J	Erez, N; Weiss, PL; Kizony, R; Rand, D				Erez, Neta; Weiss, Patrice L.; Kizony, Rachel; Rand, Debbie			Comparing Performance Within a Virtual Supermarket of Children With Traumatic Brain Injury to Typically Developing Children: A Pilot Study	OTJR-OCCUPATION PARTICIPATION AND HEALTH			English	Article						virtual reality; executive function; traumatic brain injury	EXECUTIVE FUNCTION; REALITY; REHABILITATION; ENVIRONMENT; CHILDHOOD; VALIDITY; IMPACT; SKILLS; TASK	The purpose of this study was to determine the usability of a virtual reality environment for pediatric traumatic brain injury (TBI) by assessing the performance of a simple virtual shopping task and comparing their results to typically developing peers. Twenty children with TBI and 20 typically developing children, matched in age and sex, "shopped" for four items in a virtual supermarket (VMall). A short feedback questionnaire, Borg's scale of perceived exertion, and the Zoo Map subtest from the Behavioral Assessment of the Dysexecutive Syndrome for Children were also administered. All of the children were able to complete a four-item test within the VMall. Overall, good usability was obtained. A significant difference in shopping performance was found between the two groups; the mean shopping time and number of mistakes was higher for the children with TBL The use of a short shopping test within a functional virtual environment enabled detection of poorer performance of children with TBI that may be due to executive function deficits. Because the task was enjoyable and motivating, the VMall may also be used to enhance participation in instrumental activities of daily living and play for children with TBI.	[Erez, Neta] Safra Childrens Hosp, Sheba Med Ctr, Dept Occupat Therapy, Tel Hashomer, Israel; [Erez, Neta] Univ Haifa, Dept Occupat Therapy, Masters program, IL-31999 Haifa, Israel; [Weiss, Patrice L.; Kizony, Rachel] Univ Haifa, Dept Occupat Therapy, IL-31999 Haifa, Israel; [Kizony, Rachel] Sheba Med Ctr, Tel Hashomer, Israel; [Rand, Debbie] Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Dept Occupat Therapy, IL-69978 Tel Aviv, Israel	Rand, D (corresponding author), Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Dept Occupat Therapy, IL-69978 Tel Aviv, Israel.	drand@post.tau.ac.il					Bart O, 2008, OTJR-OCCUP PART HEAL, V28, P89, DOI 10.3928/15394492-20080301-01; Bart O, 2011, DISABIL REHABIL, V33, P1579, DOI 10.3109/09638288.2010.540291; BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burden V., 2003, BEHAV ASSESSMENT DYS; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; Chen MJ, 2002, J SPORT SCI, V20, P873, DOI 10.1080/026404102320761787; Chevignard MP, 2009, DEV NEUROREHABIL, V12, P76, DOI 10.1080/17518420902777019; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Engel-Yeger B, 2009, NEUROPSYCHOL REHABIL, V19, P662, DOI 10.1080/09602010802622730; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; GITLINWEINER K, 2000, PLAY DIAGNOSIS ASSES; Jacobs R, 2002, CHILD NEUROPSYCHOL, V8, P93, DOI 10.1076/chin.8.2.93.8726; Josman N, 2008, INT J DISABIL HUM DE, V7, P49; Josman N, 2010, AM J OCCUP THER, V64, P47, DOI 10.5014/ajot.64.1.47; Katz N, 2005, DISABIL REHABIL, V27, P1235, DOI 10.1080/09638280500076079; Kizony R., 2006, P 11 ANN CYB C VIRT; Klinger E, 2006, CYBERPSYCHOL BEHAV, V9, P342, DOI 10.1089/cpb.2006.9.342; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laufer Y, 2011, J PHYS THER ED, V25, P59, DOI DOI 10.1097/00001416-201110000-00011; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; Mateer C A, 1999, Semin Clin Neuropsychiatry, V4, P50; Mortenson Patricia A, 2006, Phys Occup Ther Pediatr, V26, P181, DOI 10.1300/J006v26n01_11; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Parsons TD, 2009, DEV NEUROREHABIL, V12, P224, DOI 10.1080/17518420902991719; Piaget Jean., 1962, PLAY DREAMS IMITATIO; Portney L., 2015, FDN CLIN RES APPL PR, V3rd ed.; Rand D, 2005, ANN REV CYBERTHERAPY, V3, P193; Rand D, 2007, DISABIL REHABIL, V29, P1710, DOI 10.1080/09638280601107450; Rand D, 2009, NEUROPSYCHOL REHABIL, V19, P583, DOI 10.1080/09602010802469074; Rand D, 2009, AM J OCCUP THER, V63, P535, DOI 10.5014/ajot.63.5.535; Rizzo A, 2005, PRESENCE-TELEOP VIRT, V14, P119, DOI 10.1162/1054746053967094; Rizzo AA, 1997, ST HEAL T, V44, P123; Rocke K, 2008, AM J OCCUP THER, V62, P528, DOI 10.5014/ajot.62.5.528; Sandlund M, 2009, DEV MED CHILD NEUROL, V51, P173, DOI 10.1111/j.1469-8749.2008.03184.x; Schultheis MT, 2001, REHABIL PSYCHOL, V46, P296, DOI 10.1037/0090-5550.46.3.296; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shimoni M, 2012, RES DEV DISABIL, V33, P858, DOI 10.1016/j.ridd.2011.12.014; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Weiss P, 2006, TXB NEURAL REPAIR RE, V51, P182; Weiss P L, 1998, Work, V11, P277, DOI 10.3233/WOR-1998-11305; Weiss PL, 2009, PHYS THER REV, V14, P307, DOI 10.1179/108331909X12488667117339; Weiss PL, 2003, CYBERPSYCHOL BEHAV, V6, P335, DOI 10.1089/109493103322011650; Weiss PL, 2004, J NEUROENG REHABIL, V1, P1, DOI DOI 10.1186/1743-0003-1-12; Whaley M H, 1997, J Cardiopulm Rehabil, V17, P37, DOI 10.1097/00008483-199701000-00005; White SJ, 2009, AUTISM RES, V2, P138, DOI 10.1002/aur.78; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU, P221; Ylvisaker Mark, 2002, Pediatr Rehabil, V5, P51, DOI 10.1080/1363849021000041891; Zhang L, 2003, ARCH PHYS MED REHAB, V84, P1118, DOI 10.1016/S0003-9993(03)00203-X	54	12	12	1	15	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1539-4492	1938-2383		OTJR-OCCUP PART HEAL	OTJR-Occup. Particip. Health	FAL	2013	33	4					218	227		10.3928/15394492-20130912-04			10	Rehabilitation	Rehabilitation	234WX	WOS:000325676100006	24652030				2021-06-18	
J	Franschman, G; Andriessen, TMJC; Boer, C; Van der Naalt, J; Horn, J; Haitsma, I; Vos, PE				Franschman, G.; Andriessen, T. M. J. C.; Boer, C.; Van der Naalt, J.; Horn, J.; Haitsma, I.; Vos, P. E.			Physician-based emergency medical service deployment characteristics in severe traumatic brain injury: A Dutch multicenter study	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Emergency medical service; Regional; Physician; Paramedic; Advanced life support	HELICOPTER; MANAGEMENT; IMPACT; HYPERVENTILATION; ASSOCIATION; VENTILATION; GUIDELINES; TRANSPORT; DISPATCH; SCORE	Introduction: Prehospital guidelines advise advanced life support in all patients with severe traumatic brain injury (TBI). In the Netherlands, it is recommended that prehospital advanced life support is particularly provided by a physician-based helicopter emergency medical service (P-HEMS) in addition to paramedic care (EMS). Previous studies have however shown that a substantial part of severe TBI patients is exclusively treated by an EMS team. In order to better understand this phenomenon, we evaluated P-HEMS deployment characteristics in severe TBI in a multicenter setting. Methods: The database included patient demographics, prehospital and injury severity parameters and determinants of EMS or EMS/P-HEMS dispatch in 334 patients with severe TBI admitted to level 1 trauma centres in the Netherlands. Results: P-HEMS was deployed in 62% of patients with severe TBI. Patients treated by the P-HEMS had a higher injury severity score (29 (20-38)) vs. (25 (16-30); P < 0.001), more frequently required blood product transfusions (41% vs. 29%; P = 0.03) and recurrently suffered from TBI with extracranial injuries (33% vs. 6%; P < 0.001) than patients solely treated by an EMS. The prehospital endotracheal intubation rate was higher in the P-HEMS group in isolated TBI (93% vs. 19%; P < 0.001) or TBI with extracranial injuries (96% vs. 43%; P < 0.001) compared to the EMS group. In the EMS group, more patients were secondary referred to a level 1 trauma centre (32% vs. 4%; P < 0.001 vs. P-HEMS). Despite higher injury severity levels in P-HEMS patients, 6-month mortality rates were similar among groups, irrespective of the presence of extracranial injuries in addition to TBI. Deployment of P-HEMS estimated 52% and 72% (P < 0.001) in urban and rural regions, respectively, with comparable endotracheal intubation rates among regions. Conclusions: This study shows that a physician-based HEMS was more frequently deployed in patients with severe TBI in the presence of extracranial injuries, and in rural trauma regions. Treatment of severe TBI patients by a paramedic EMS only was associated with a higher incidence of secondary referrals to a level I trauma centre. Our data support adjustment of local prehospital guidelines for patients with severe TBI to the geographical context. (C) 2013 Elsevier Ltd. All rights reserved.	[Franschman, G.; Boer, C.] Vrije Univ Amsterdam Med Ctr, Dept Anesthesiol, Inst Cardiovasc Res, NL-1081 HV Amsterdam, Netherlands; [Andriessen, T. M. J. C.; Vos, P. E.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Van der Naalt, J.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9713 AV Groningen, Netherlands; [Horn, J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, NL-1105 AZ Amsterdam, Netherlands; [Haitsma, I.] Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands	Franschman, G (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Anesthesiol, Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	g.franschman@vumc.nl		Boer, Christa/0000-0002-7781-6951	Netherlands Brain Foundation [HSN-07-01]	This study was financially supported by the Netherlands Brain Foundation (HSN-07-01).	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; [Anonymous], 2011, FDN NAT AMB EM ROOM; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bulger EM, 2012, J TRAUMA ACUTE CARE, V72, P567, DOI 10.1097/TA.0b013e31824baddf; Davis DP, 2011, PREHOSP EMERG CARE, V15, P184, DOI 10.3109/10903127.2010.545473; Davis DP, 2010, J TRAUMA, V69, P294, DOI 10.1097/TA.0b013e3181dc6c7f; Davis DP, 2005, J EMERG MED, V29, P391, DOI 10.1016/j.jemermed.2005.04.012; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; DEANE SA, 1990, AUST NZ J SURG, V60, P441, DOI 10.1111/j.1445-2197.1990.tb07399.x; di Bartolomeo S, 2003, EUR J EMERG MED, V10, P268, DOI 10.1097/01.mej.0000103466.32882.7b; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; Franschman G, 2012, INJURY, V43, P1838, DOI 10.1016/j.injury.2012.05.020; Franschman G, 2009, RESUSCITATION, V80, P1147, DOI 10.1016/j.resuscitation.2009.06.029; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Franschman G, 2011, J TRAUMA, V71, P826, DOI 10.1097/TA.0b013e31820cebf0; Galvagno SM, 2012, JAMA-J AM MED ASSOC, V307, P1602, DOI 10.1001/jama.2012.467; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hoogerwerf Nico, 2010, Ned Tijdschr Geneeskd, V154, pA2149; Joosse P, 2012, J TRAUMA ACUTE CARE, V72, P487, DOI 10.1097/TA.0b013e318226ed59; Lemson J, 2008, Ned Tijdschr Geneeskd, V152, P1106; Rose MK, 2012, AM SURGEON, V78, P794; ten Duis HJ, 2003, INJURY, V34, P722, DOI 10.1016/S0020-1383(03)00162-1; Thomas SH, 2002, J TRAUMA, V52, P47, DOI 10.1097/00005373-200201000-00010; Wigman LD, 2011, INJURY, V42, P525, DOI 10.1016/j.injury.2010.03.015	24	12	12	0	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2013	44	9					1232	1236		10.1016/j.injury.2013.06.002			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	211VX	WOS:000323940600017	23816167				2021-06-18	
J	Lannsjo, M; Raininko, R; Bustamante, M; von Seth, C; Borg, J				Lannsjo, Marianne; Raininko, Raili; Bustamante, Mariana; von Seth, Charlotta; Borg, Jorgen			BRAIN PATHOLOGY AFTER MILD TRAUMATIC BRAIN INJURY: AN EXPLORATORY STUDY BY REPEATED MAGNETIC RESONANCE EXAMINATION	JOURNAL OF REHABILITATION MEDICINE			English	Article						mild traumatic brain injury; brain concussion; magnetic resonance imaging; Rivermead Post-Concussion Symptoms Questionnaire; Glasgow Outcome Scale Extended	GLASGOW OUTCOME SCALE; CONCUSSION SYMPTOMS QUESTIONNAIRE; HEAD-INJURY; AXONAL INJURY; MRI; RECOVERY; CT; PREDICTION; VALIDITY; ATROPHY	Objective: To explore brain pathology after mild traumatic brain injury by repeated magnetic resonance examination. Design: A prospective follow-up study. Subjects: Nineteen patients with mild traumatic brain injury presenting with Glasgow Coma Scale (GCS) 14-15. Methods: The patients were examined on day 2 or 3 and 3-7 months after the injury. The magnetic resonance protocol comprised conventional T1- and T2-weighted sequences including fluid attenuated inversion recovery (FLAIR), two susceptibility-weighted sequences to. reveal haemorrhages, and diffusion-weighted sequences. Computer-aided volume comparison was performed. Clinical outcome was assessed by the Rivermead Post-Concussion Symptoms Questionnaire (RPQ), Hospital Anxiety and Depression Scale (HADS) and Glasgow Outcome Scale Extended (GOSE). Results: At follow-up, 7 patients (37%) reported >= 3 symptoms in RPQ, 5 reported some anxiety and 1 reported mild depression. Fifteen patients reported upper level of good recovery and 4 patients lower level of good recovery (GOSE 8 and 7, respectively). Magnetic resonance pathology was found in 1 patient at the first examination, but 4 patients (21%) showed volume loss at the second examination, at which 3 of them reported <3 symptoms and 1 >= 3 symptoms, all exhibiting GOSE scores of 8. Conclusion: Loss of brain volume, demonstrated by computer-aided magnetic resonance imaging volumetry, may be a feasible marker of brain pathology after mild traumatic brain injury.	[Lannsjo, Marianne; von Seth, Charlotta] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Lannsjo, Marianne] Uppsala Univ, Cty Council Gavleborg, Ctr Res & Dev, Uppsala, Sweden; [Raininko, Raili] Uppsala Univ, Dept Radiol, Uppsala, Sweden; [Bustamante, Mariana] Uppsala Univ, Ctr Image Anal, Uppsala, Sweden; [Borg, Jorgen] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Stockholm, Sweden	Lannsjo, M (corresponding author), Sandviken Hosp, SE-81189 Sandviken, Sweden.	marianne.lannsjo@lg.se		Borg, Jorgen/0000-0002-2372-7478; Bustamante, Mariana/0000-0002-1958-1672	Centre for Research & Development, Uppsala University/County Council of Gavleborg	This study was supported by grants from the Centre for Research & Development, Uppsala University/County Council of Gavleborg.	Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Gustafsson O, 1999, ACTA RADIOL, V40, P360, DOI 10.3109/02841859909177748; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Ibanez L, 2006, ITK SOFTWARE GUIDE; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Jacobsson LJ, 2007, ACTA NEUROL SCAND, V116, P300, DOI 10.1111/j.1600-0404.2007.00896.x; Johnson VE, 2012, EXP NEUROL; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lannsjo, 2012, EUR J NEUROL, DOI [10.1111/j.1468-1331.2012.03813.x, DOI 10.1111/J.1468-1331.2012.03813.X]; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Leibson CL, 2012, J NEUROTRAUM, V29, P1; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Pierpaoli C, 1996, J CEREBR BLOOD F MET, V16, P892, DOI 10.1097/00004647-199609000-00013; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ripoll MA, 2003, ACTA RADIOL, V44, P199, DOI 10.1034/j.1600-0455.2003.00038.x; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Schrader Harald, 2009, BMC Med Imaging, V9, P11, DOI 10.1186/1471-2342-9-11; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organisation, 1993, ICD 10 CLASSIFICATIO; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	42	12	12	0	11	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	SEP	2013	45	8					721	728		10.2340/16501977-1169			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	243ZS	WOS:000326357500005	24002306	DOAJ Gold			2021-06-18	
J	Rigby, J; Vela, L; Housman, J				Rigby, Justin; Vela, Luzita; Housman, Jeff			Understanding Athletic Trainers' Beliefs Toward a Multifacted Sport-Related Concussion Approach: Application of the Theory of Planned Behavior	JOURNAL OF ATHLETIC TRAINING			English	Article						concussion management; traumatic brain injuries; practice guidelines	HIGH-SCHOOL; MANAGEMENT; STATEMENT; WORKING; BURNOUT; IMPACT	Context: Practice guidelines recommend a multifaceted approach for managing concussions, but a relatively small percentage of athletic trainers (ATs) follow these recommendations. Understanding ATs' beliefs toward the recommended concussion practice guidelines is the first step in identifying interventions that could increase compliance. The theory of planned behavior (TPB) allows us to measure ATs' beliefs toward the recommended concussion practice guidelines. Objective: To examine the influence of ATs' beliefs toward the current recommended concussion guidelines on concussion- management practice through an application of the TPB. Design: Cross-sectional study. Setting: A Web link with a survey was e-mailed to 1000 randomly selected members of the National Athletic Trainers' Association (NATA). Patients or Other Participants: A total of 221 certified ATs working in secondary school/clinic, high school, and college/ university settings. Main Outcome Measure(s): A 66-item survey reflecting the current recommended concussion guidelines of the NATA and International Conference on Concussion in Sport was created to measure beliefs using the TPB constructs attitude toward the behavior (BA), subjective norms (SN), perceived behavioral control (PBC), and behavioral intention (BI) of ATs. We used a linear multiple regression to determine if the TPB constructs BA, SN, and PBC predicted BI and if PBC and BI predicted behavior according to the TPB model. Results: We found that BA, SN, and PBC predicted BI (R = 0.683, R-2 = 0.466, F-3,F-202 = 58.78, P < .001). The BA (t(202) = 5.53, P < .001) and PBC (t(202) = 9.64, P < .001) contributed to the model, whereas SN (t(202) = -0.84, P = .402) did not. The PBC and BI predicted behavior (R = 0.661, R-2 = 0.437, F-2,F-203 = 78.902, P < .001). Conclusions: In this sample, the TPB constructs predicted BI and behavior of ATs' compliance with recommended concussion-management guidelines. The BA and PBC were the most influential constructs, indicating that those with positive attitudes toward concussion-management recommendations are more likely to implement them, and ATs are less likely to implement them when they do not believe they have the power to do so. We theorize that interventions targeting ATs' attitudes and control perceptions will lead to improved compliance.	[Rigby, Justin] Brigham Young Univ, Dept Exercise Sci, Provo, UT 84602 USA; [Vela, Luzita; Housman, Jeff] Texas State Univ, Dept Hlth & Human Performance, San Marcos, TX USA	Rigby, J (corresponding author), Brigham Young Univ, Dept Exercise Sci, 106 SFH, Provo, UT 84602 USA.	justin.h.rigby@gmail.com					AIKEN LR, 1985, EDUC PSYCHOL MEAS, V45, P131, DOI 10.1177/0013164485451012; Ajzen I., 1980, UNDERSTANDING ATTITU, V278; Ajzen I., 1991, THEORY PLANNED BEHAV; AJZEN I, CONSTRUCTION THEORY; Ajzen I., 1988, ATTITUDES PERSONALIT; Ajzen I., 2007, PREDICTION CHANGE HL; Armitage CJ, 1999, J APPL SOC PSYCHOL, V29, P72, DOI 10.1111/j.1559-1816.1999.tb01375.x; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Conatser P, 2002, ADAPT PHYS ACT Q, V19, P172, DOI 10.1123/apaq.19.2.172; Conatser P, 2009, J ATHL TRAINING, V44, P279, DOI 10.4085/1062-6050-44.3.279; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Darker CD, 2010, PSYCHOL HEALTH, V25, P71, DOI 10.1080/08870440902893716; Dunn J. G. H., 1999, MEASUREMENT PHYS ED, V3, P15, DOI [DOI 10.1207/S15327841MPEE0301_2, 10.1207/s15327841mpee0301_2]; Ferrara MS, 2001, J ATHL TRAINING, V36, P145; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fishbein M., 1975, BELIEF ATTITUDE INTE; Fishbein M., 1987, HLTH ED RES, V2, P361, DOI [10.1093/her/2.4.361, DOI 10.1093/HER/2.4.361]; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Hales D, 2010, AM J HEALTH BEHAV, V34, P387; Hendrix AE, 2000, J ATHL TRAINING, V35, P139; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mazerolle SM, 2011, J ATHL TRAINING, V46, P194, DOI 10.4085/1062-6050-46.2.194; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory Paul, 2009, J Athl Train, V44, P434, DOI 10.4085/1062-6050-44.4.434; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Rigby J, 2011, J ATHL TRAIN S, V46, pS63; Scheid D., 2011, NATA NEWS        MAR, P10; Walter JM, 2009, J ATHL TRAINING, V44, P190, DOI 10.4085/1062-6050-44.2.190	32	12	12	0	17	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP-OCT	2013	48	5					636	644		10.4085/1062-6050-48.3.10			9	Sport Sciences	Sport Sciences	268AR	WOS:000328140600007	23848518	Green Published			2021-06-18	
J	Rowson, S; Daniel, RW; Duma, SM				Rowson, Steven; Daniel, Ray W.; Duma, Stefan M.			Biomechanical performance of leather and modern football helmets Technical note	JOURNAL OF NEUROSURGERY			English	Article						concussion; helmet; football; head acceleration; Summation of Tests for the Analysis of Risk (STAR) evaluation system; injury risk	CHRONIC TRAUMATIC ENCEPHALOPATHY; IMPACT PERFORMANCE; PROFESSIONAL FOOTBALL; BRAIN-INJURY; CONCUSSION	With the increased national concern about concussions in football, recent research has focused on evaluating the impact performance of modern football helmets. Specifically, this technical note offers a biomechanical analysis of classic leather helmets compared with modern helmets. Furthermore, modern helmets were examined to illustrate the performance differences between the better- and worse-performing ones. A total of 1224 drop tests were performed from a range of drop heights and impact locations on 11 different helmet types (10 modern and 1 leather helmet model). The resulting head acceleration was used to assess the risk of concussion for each drop test. The results of this analysis demonstrate that modern helmets are significantly and substantially superior to leather helmets in all impact scenarios, and that notable differences exist among modern helmets.	[Rowson, Steven; Daniel, Ray W.; Duma, Stefan M.] Virginia Polytech Inst & State Univ, Ctr Injury Biomech, Blacksburg, VA 24061 USA	Rowson, S (corresponding author), 440 ICTAS Bldg,Stanger St, Blacksburg, VA 24061 USA.	srowson@vt.edu	Duma, Stefan/A-8368-2012; Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596; Daniel, Ray/0000-0002-8666-0979			Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; Cantu R, 2012, J NEUROSURG, V117, P187, DOI 10.3171/2011.12.JNS112108; Cormier J, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003312; Cormier J, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004248; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Newman J A, 2000, Stapp Car Crash J, V44, P215; NOCSAE, STAND PERF SPEC NEWL; NOCSAE, STAND TEST METH EQ U; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2008, CLIN J SPORT MED, V18, P316, DOI 10.1097/JSM.0b013e31817f016a; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2010, CLIN J SPORT MED, V20, P344, DOI 10.1097/JSM.0b013e3181ed7e50; Shain KS, 2010, CLIN J SPORT MED, V20, P422, DOI 10.1097/JSM.0b013e3181f7db25; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Viano DC, 2012, ANN BIOMED ENG, V40, P175, DOI 10.1007/s10439-011-0395-1; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	24	12	13	0	38	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	2013	119	3					805	809		10.3171/2013.3.JNS121735			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	204IJ	WOS:000323358700037	23651012	Bronze			2021-06-18	
J	Sinha, S; Gunawat, P; Nehra, A; Sharma, BS				Sinha, Sumit; Gunawat, Prashant; Nehra, Ashima; Sharma, Bhawani S.			Cognitive, functional, and psychosocial outcome after severe traumatic brain injury: A cross-sectional study at a tertiary care trauma center	NEUROLOGY INDIA			English	Article						Cognitive outcome; functional outcome; glasgow outcome score; psychosocial outcome; traumatic brain injury	CLOSED-HEAD-INJURY; REHABILITATION; PLASTICITY; MORTALITY; RECOVERY; TESTS	Background: Traumatic brain injury (TBI) constitutes a significant public health problem. Objectives: To assess cognitive, functional, and psychosocial outcome in patients with severe TBI (STBI). Materials and Methods: A total of 77 survivors of STBI treated at our center were prospectively assessed in the outpatient department 1 year after the injury. These patients were assessed for cognitive, functional, and psychosocial outcome using cognitive outcome tests, dysfunctional analysis questionnaire, and personality trait inventory, respectively. Cognitive and functional outcome was graded as average and above average recovery (good recovery) or below average recovery (poor recovery). Psychosocial outcome was assessed as average recovery (good recovery) or mild impairment and severe impairment (poor to very poor recovery). Statistical analysis was done using Chi-square and Fisher's exact tests. Results: The ability to learn new things was most affected aspect of cognitive function and only 1% of patients had good recovery in this domain. However, 44% had good outcome for simple memory. A total of 61% showed good recovery in several aspects of functional status. At the end of 1 year, 62.5% patients still remained unemployed. 45.4% patients had good recovery, while 37% had severe impairment for various personality traits and 40% of patients had impaired emotional stability, while 57% patients showed impaired recovery in depressive tendency. Conclusion: In this study 61% patients with STBI had good recovery in functional outcome and 45.4% in psychosocial outcome at 1 year follow-up. However, improvement in cognitive outcome was not so optimistic with the ability to learn new things being most affected.	[Sinha, Sumit; Gunawat, Prashant; Sharma, Bhawani S.] All India Inst Med Sci, Ctr Neurosci, Dept Neurosurg, New Delhi 110029, India; [Nehra, Ashima] All India Inst Med Sci, Ctr Neurosci, Dept Clin Neuropsychol, New Delhi 110029, India	Sinha, S (corresponding author), All India Inst Med Sci, Ctr Neurosci, Dept Neurosurg, Room 713,7th Floor, New Delhi 110029, India.	sumitaiims@yahoo.com					Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Brooks D N, 1979, Int Rehabil Med, V1, P166; Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; Demery JA, 2010, CLIN NEUROPSYCHOL, V24, P1292, DOI 10.1080/13854046.2010.528452; Elwood RW, 1995, NEUROPSYCHOL REV, V5, P173, DOI 10.1007/BF02214761; Furlonger A J, 2000, Crit Care Resusc, V2, P246; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Gupta A, 2012, ANN INDIAN ACAD NEUR, V15, P120, DOI 10.4103/0972-2327.94995; HAMMELL KRW, 1994, INT J REHABIL RES, V17, P319; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jeon IC, 2008, J KOREAN NEUROSURG S, V44, P295, DOI 10.3340/jkns.2008.44.5.295; Kaufman AS, ASSESSING ADOLESCENT, V006, P7; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Lu J, 2005, ACT NEUR S, V95, P281; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; MAHAJAN A, 1990, J PERSONALITY CLIN S, V6, P134; Mahapatra AK, 2005, TXB HEAD INJURY, P197; Mahncke HW, 2006, PROG BRAIN RES, V157, P81, DOI 10.1016/S0079-6123(06)57006-2; Mammi P, 2006, Eura Medicophys, V42, P17; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Pershad D, 1976, Neurol India, V24, P86; PERSHAD D, 1985, MEASUREMENT DYSFUNCT; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; RUBIN H, 1948, J CONSULT PSYCHOL, V12, P251, DOI 10.1037/h0055299; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Sousa J, 2002, NEUROL INDIA, V50, P430; TEASDALE G, 1974, LANCET, V2, P81; Turner G. R., 2008, NEUROPSYCHOL REHABIL, V18, P372; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; WILSON B, 1991, Brain Injury, V5, P189, DOI 10.3109/02699059109008089; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	40	12	13	0	7	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	SEP-OCT	2013	61	5					501	506		10.4103/0028-3886.121920			6	Neurosciences	Neurosciences & Neurology	277KA	WOS:000328816300010	24262453				2021-06-18	
J	Stenberg, M; Koskinen, LO; Levi, R; Stalnacke, BM				Stenberg, Maud; Koskinen, Lars-Owe; Levi, Richard; Stalnacke, Britt-Marie			SEVERE TRAUMATIC BRAIN INJURIES IN NORTHERN SWEDEN: A PROSPECTIVE 2-YEAR STUDY	JOURNAL OF REHABILITATION MEDICINE			English	Article						traumatic brain injury; outcome; demographics; critical pathways	ALCOHOL; REHABILITATION; OUTCOMES; LEVEL; SCALE; COMA; INTOXICATION; POPULATION; PRINCIPLES; MORTALITY	Objective: To assess: (1) the clinical characteristics and injury descriptors of patients with severe traumatic brain injury in Northern Sweden admitted to the single Neurotrauma Center (NC) serving this region; (it) the care pathway of patients from injury to 3 months after discharge from the NC; and (iii) the outcomes at 3 months post-injury. Design: Population-based prospective 2-year cohort study. Patients: Patients age 17-65 years with acute severe traumatic brain injury, lowest non-sedated Glasgow Coma Scale (GCS) score of 3-8 within 24 h post-trauma. Methods: Patients were treated according to an intracranial pressure-oriented protocol based on the Lund concept at the NC. They were assessed at 3 weeks after injury with Rancho Los Amigos Cognitive Scale Revised (RLAS-R), Levels of Cognitive functioning, and at 3 months with RLAS-R and Glasgow Outcome Scale Extended (GOSE). Results: A total of 37 patients were included. Hospital deaths within 3 months post-injury occurred in 5 patients. After 3 months the RLAS-R scores were significantly improved (p<0.001). Eight patients had both "superior cognitive functioning" on the RLAS-R and "favourable outcome" on the GOSE. Thirty-four patients (92%) were directly admitted to the NC. By contrast, after discharge patients were transferred back to one of several county hospitals or to one of several local hospitals, and some had multiple transfers between different hospitals and departments. Conclusion: Overall outcomes were surprisingly good in this group of severely injured patients. The routines for transferring patients with severe traumatic brain injury from a geographically large, sparsely populated region to a regional NC to receive well-monitored neurosurgical care seem to work very well. The post-acute clinical pathways are less clearly reflecting an optimized medical and rehabilitative strategy.	[Stenberg, Maud; Levi, Richard; Stalnacke, Britt-Marie] Umea Univ, Dept Community Med & Rehabil, SE-90185 Umea, Sweden; [Koskinen, Lars-Owe] Umea Univ, Dept Pharmacol & Clin Neurosci, Div Neurosurg, SE-90185 Umea, Sweden	Stenberg, M (corresponding author), Umea Univ, Umea Univ Hosp, Dept Community Med & Rehabil, Bldg 9A, SE-90185 Umea, Sweden.	maud.stenberg@vll.se	Koskinen, Lars-Owe/AAQ-8957-2020	Koskinen, Lars-Owe/0000-0003-3528-8502	Vasterbotten County Council	The authors would like to thank the patients and their relatives, the clinical staff of our unit, especially psychologist Anna-Lisa Nilsson. The authors also thank neuroradiologist, senior consultant Per Jonasson for assessing the CT scans and colleagues at the NC for helping us to recruit patients, colleagues in the intensive care unit and colleagues in rehabilitation department in the NHR. This study was supported by grants from Vasterbotten County Council.	Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Borg J, 2011, AM J PHYS MED REHAB, V90, P65, DOI 10.1097/PHM.0b013e3181fc80e7; BRICKLEY MR, 1995, INJURY, V26, P311, DOI 10.1016/0020-1383(95)00034-7; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Eker C, 2000, BRAIN INJURY, V14, P605; Golan JD, 2007, J TRAUMA, V63, P365, DOI 10.1097/TA.0b013e31811ec178; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P929, DOI 10.1034/j.1399-6576.2002.460802.x; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; Hagen C, 1987, REHABILITATION HEAD; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; JENNETT B, 1975, LANCET, V1, P480; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Rootman DB, 2007, J TRAUMA, V63, P1370, DOI 10.1097/TA.0b013e31815b837a; Schootman M, 1999, BRAIN INJURY, V13, P995; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	32	12	15	0	4	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	SEP	2013	45	8					792	800		10.2340/16501977-1200			9	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	243ZS	WOS:000326357500015	24002316	DOAJ Gold, Green Published			2021-06-18	
J	Austin, CA; Slomine, BS; DeMatt, EJ; Salorio, CF; Suskauer, SJ				Austin, Cynthia A.; Slomine, Beth S.; DeMatt, Ellen J.; Salorio, Cynthia F.; Suskauer, Stacy J.			Time to follow commands remains the most useful injury severity variable for predicting WeeFIM (R) scores 1 year after paediatric TBI	BRAIN INJURY			English	Article						Child; coma; outcome; PTA; traumatic brain injury	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC AMNESIA DURATION; CLOSED-HEAD INJURY; FUNCTIONAL INDEPENDENCE; PRACTICAL SCALE; CHILDREN; REHABILITATION; RECOVERY; MULTICENTER; ORIENTATION	Objective: To investigate the relationship between injury severity variables, particularly time to follow commands (TFC) and long-term functional outcomes in paediatric traumatic brain injury (TBI). Methods and procedure: Participants included 40 children with moderate-to-severe TBI discharged from inpatient rehabilitation. Measures of severity were initial Glasgow Coma Scale score, TFC, duration of Post Traumatic Amnesia (PTA) and total duration of impaired consciousness (TFC + PTA). Functional outcome was measured by age-corrected Functional Independence Measure for Children (WeeFIM (R)) scores at 1-year after discharge. Results: Correlations indicated that injury severity variables (TFC, PTA and TFC + PTA) were all associated with functional outcome. Regression analyses revealed that TFC and TFC + PTA similarly accounted for 49% or 47% of the variance, respectively, in total WeeFIM (R) score. Thirty-seven of 40 children had good outcome; of the three children with TFC>26 days, two had poor outcome. Conclusion: PTA and TFC + PTA do not provide a benefit over TFC alone for prediction of long-term outcome and TFC is identified earlier in the recovery course. TFC remains an important predictor of functional outcome 1-year after discharge from inpatient rehabilitation after paediatric TBI.	[Austin, Cynthia A.; Slomine, Beth S.; DeMatt, Ellen J.; Salorio, Cynthia F.; Suskauer, Stacy J.] Kennedy Krieger Inst, Baltimore, MD 21205 USA; [Slomine, Beth S.; Salorio, Cynthia F.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Slomine, Beth S.; Salorio, Cynthia F.; Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Suskauer, SJ (corresponding author), Kennedy Krieger Inst, 707 North Broadway, Baltimore, MD 21205 USA.	suskauer@kennedykrieger.org	Austin, Cynthia/AAM-2814-2021		National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD061611]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD061611] Funding Source: NIH RePORTER	This work was supported by grant funding from the National Institute of Child Health and Human Development (K23HD061611).	Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; Brown AW, 2010, BRAIN INJURY, V24, P472, DOI 10.3109/02699051003610466; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Cohen J., 2003, APPL MULTIPLE CORREL; Eastvold AD, 2013, J HEAD TRAUMA REHAB, V28, P48, DOI 10.1097/HTR.0b013e31823c9317; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; Howard M, 1986, MEMORY ORIENTATION A; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; Kane RL, 1997, UNDERSTANDING HLTH C, P233; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Keith TZ, 2006, MULTIPLE REGRESSION; Kosch Y, 2010, BRAIN INJURY, V24, P479, DOI 10.3109/02699051003610417; Kramer ME, 2012, J HEAD TRAUMA REHABI; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MAHONEY WJ, 1983, PEDIATRICS, V71, P756; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; MSALL ME, 1994, CLIN PEDIATR, V33, P431, DOI 10.1177/000992289403300709; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Ottenbacher KJ, 1997, ARCH PHYS MED REHAB, V78, P1309, DOI 10.1016/S0003-9993(97)90302-6; Poon WS, 2005, ACT NEUR S, V93, P207; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; RUIJS MBM, 1992, DEV MED CHILD NEUROL, V34, P885; RUIJS MBM, 1993, EUR J PEDIATR, V152, P844, DOI 10.1007/BF02073384; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Sanders JO, 2006, J PEDIATR ORTHOPED, V26, P542, DOI 10.1097/01.bpo.0000226272.78330.bb; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Serghiou MH, 2008, DEV NEUROREHABIL, V11, P39, DOI 10.1080/17518420701520644; Suskauer SJ, 2009, J PEDIATR REHAB MED, V2, P297, DOI 10.3233/PRM-2009-0092; Tabachnick BG, 2013, USING MULTIVARIATE S; TEASDALE G, 1974, LANCET, V2, P81; Uniform Data System for Medical Rehabilitation, 2006, WEEFIM 2 CLIN GUID V; Uniform Data System for Medical Rehabilitation, 2009, FIM SYST CLIN GUID V; WAGSTYL J, 1987, J PEDIATR SURG, V22, P127, DOI 10.1016/S0022-3468(87)80427-X; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Whyte J, 2001, ARCH PHYS MED REHAB, V82, P1355, DOI 10.1053/apmr.2001.26091; Ziviani Jenny, 2001, Physical and Occupational Therapy in Pediatrics, V21, P91, DOI 10.1080/J006v21n02_08	41	12	13	0	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	AUG	2013	27	9					1056	1062		10.3109/02699052.2013.794964			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	180HZ	WOS:000321586100010	23781827	Green Accepted			2021-06-18	
J	Beer-Furlan, A; de Almeida, CC; Noleto, G; Paiva, W; Ferreira, AA; Teixeira, MJ				Beer-Furlan, Andre; de Almeida, Cesar Cimonari; Noleto, Gustavo; Paiva, Wellingson; Ferreira, Almir Andrade; Teixeira, Manoel Jacobsen			Dural sinus and internal jugular vein thrombosis complicating a blunt head injury in a pediatric patient	CHILDS NERVOUS SYSTEM			English	Article						Closed head injury; Cerebral venous sinus; Thrombosis; Blunt trauma	CEREBRAL VENOUS THROMBOSIS; SUPERIOR SAGITTAL SINUS; SINOVENOUS THROMBOSIS; TRAUMA PATIENTS; CT VENOGRAPHY; CHILDREN; OBSTRUCTION; CHILDHOOD	Cerebral venous sinus thrombosis (CVST) following a blunt head trauma is a rare condition, described in the literature along with the lack of consensus regarding diagnosis and management. We present a case of a pediatric patient with a blunt head injury and epidural hematoma, who developed dural sinus and internal jugular vein thrombosis with fatal outcome. Most of reports show good outcome and recovery, but CVST might be related to poor recovery and even lead to death. The diagnosis and management of this condition are discussed based on a literature review. It is important to keep a high degree of suspicion of CVST since early diagnosis may prevent potentially treatable catastrophic outcomes.	[Beer-Furlan, Andre; de Almeida, Cesar Cimonari; Noleto, Gustavo; Paiva, Wellingson; Ferreira, Almir Andrade; Teixeira, Manoel Jacobsen] Univ Sao Paulo Med Sch FMUSP, Dept Neurosurg, BR-05410001 Sao Paulo, Brazil	Beer-Furlan, A (corresponding author), Univ Sao Paulo Med Sch FMUSP, Dept Neurosurg, Rua Alves Guimaraes 643,Ap 132 Sao Paulo, BR-05410001 Sao Paulo, Brazil.	beerfurlan@uol.com.br	Paiva, Wellingson S/G-5517-2013	Paiva, Wellingson S/0000-0002-5165-7040; Cimonari de Almeida, Cesar/0000-0002-2073-4509			Akhtar W, 2010, RADIOLOGY, V256, P1014, DOI 10.1148/radiol.100960; Almandoz JED, 2010, RADIOLOGY, V255, P570, DOI 10.1148/radiol.10091565; Bagley C, 1934, SURG GYNECOL OBSTET, V58, P498; Bakar B, 2010, ULUS TRAVMA ACIL CER, V16, P98; Barbati G, 2003, Minerva Anestesiol, V69, P919; BARRON TF, 1992, PEDIATR NEUROL, V8, P112, DOI 10.1016/0887-8994(92)90030-3; Bishop FS, 2009, J NEUROSURG, V111, P17, DOI 10.3171/2009.2.JNS08491; BJORNEBRINK J, 1976, ANGIOLOGY, V27, P688, DOI 10.1177/000331977602701203; Bousser MG, 2007, LANCET NEUROL, V6, P162, DOI 10.1016/S1474-4422(07)70029-7; BOUSSER MG, 1985, STROKE, V16, P199, DOI 10.1161/01.STR.16.2.199; Brors M, 2001, NEURORADIOLOGY, V43, P144, DOI 10.1007/PL00006045; Caplan JM, 2008, EMERG MED J, V25, P777, DOI 10.1136/emj.2008.061952; CARRIE AW, 1954, J NEUROSURG, V11, P173, DOI 10.3171/jns.1954.11.2.0173; Carvalho KS, 2001, J CHILD NEUROL, V16, P574, DOI 10.2310/7010.2001.16834; D'Alise MD, 1998, SURG NEUROL, V49, P430, DOI 10.1016/S0090-3019(97)00182-1; Daligic A, 2008, TURK NEUROSURG, V18, P70; Dobbs TD, 2012, J CLIN NEUROSCI, V19, P1058, DOI 10.1016/j.jocn.2012.01.002; Erdogan B, 2004, CHILD NERV SYST, V20, P239, DOI 10.1007/s00381-003-0845-7; Ferrera PC, 1998, AM J EMERG MED, V16, P382, DOI 10.1016/S0735-6757(98)90134-6; Fujii Y, 2009, J TRAUMA, V66, P1002, DOI 10.1097/TA.0b013e31819a0277; Georgoulis G, 2014, WORLD NEUROSURG, V81, pE7, DOI 10.1016/j.wneu.2011.11.006; HESSELBROCK R, 1985, NEUROSURGERY, V16, P825, DOI 10.1227/00006123-198506000-00017; Holzmann D, 1999, LARYNGOSCOPE, V109, P645, DOI 10.1097/00005537-199904000-00024; Huisman TAGM, 2001, EUR RADIOL, V11, P1760, DOI 10.1007/s003300100822; Kuether TA, 1998, NEUROSURGERY, V42, P1163, DOI 10.1097/00006123-199805000-00129; Kumar GSS, 2004, NEUROL INDIA, V52, P123; Lee W T, 1995, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, V36, P425; MARTIN JP, 1955, BRIT MED J, V2, P467, DOI 10.1136/bmj.2.4937.467; Matsushige T, 2009, J TRAUMA, V66, P1599, DOI 10.1097/TA.0b013e3181a3a8e6; MEDLOCK MD, 1992, NEUROSURGERY, V31, P870, DOI 10.1227/00006123-199211000-00007; Meena AK, 2000, NEUROL INDIA, V48, P195; Muthukumar N, 2004, J CLIN NEUROSCI, V11, P924, DOI 10.1016/j.jocn.2003.10.032; Nehme J, 2009, INT J PEDIATR OTORHI, V73, P629, DOI 10.1016/j.ijporl.2008.10.025; Ochagavia AR, 1996, LANCET, V347, P1564, DOI 10.1016/S0140-6736(96)90721-7; Owler BK, 2005, CHILD NERV SYST, V21, P262, DOI 10.1007/s00381-004-1014-3; Peeters E, 2001, AM J NEURORADIOL, V22, P1949; Renowden S, 2004, EUR RADIOL, V14, P215, DOI 10.1007/s00330-003-2021-6; RICH C, 1993, STROKE, V24, P603, DOI 10.1161/01.STR.24.4.603; Rottger C, 2004, HEADACHE, V44, P812, DOI 10.1111/j.1526-4610.2004.04150.x; Saad DF, 2005, J TRAUMA, V58, P1066, DOI 10.1097/01.TA.0000162726.74081.F3; Saadatnia M, 2009, INT J STROKE, V4, P111, DOI 10.1111/j.1747-4949.2009.00260.x; Satoh H, 2000, NEUROL MED-CHIR, V40, P361, DOI 10.2176/nmc.40.361; Shigemori Y, 2007, SURG NEUROL, V68, P660, DOI 10.1016/j.surneu.2006.11.037; Stiefel D, 2000, EUR J PEDIATR SURG, V10, P41, DOI 10.1055/s-2008-1072321; TAHA JM, 1993, NEUROSURGERY, V32, P541, DOI 10.1227/00006123-199304000-00008; Yuen HW, 2005, ANN ACAD MED SINGAP, V34, P639; Zhao X, 2008, J NEUROTRAUM, V25, P104, DOI 10.1089/neu.2007.0351	47	12	12	0	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	AUG	2013	29	8					1231	1234		10.1007/s00381-013-2184-7			4	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	185FT	WOS:000321952500005	23748465				2021-06-18	
J	Blaine, H; Sullivan, KA; Edmed, SL				Blaine, Hannah; Sullivan, Karen A.; Edmed, Shannon L.			The Effect of Varied Test Instructions on Neuropsychological Performance following Mild Traumatic Brain Injury: An Investigation of "Diagnosis Threat"	JOURNAL OF NEUROTRAUMA			English	Article						diagnosis threat; mild traumatic brain injury; neurocognitive disorder; post-concussion syndrome	POST-CONCUSSION SYNDROME; WOMENS MATH PERFORMANCE; WORD-ASSOCIATION TEST; BLACK-AND-WHITE; STEREOTYPE THREAT; HEAD-INJURY; POSTCONCUSSION SYNDROME; COGNITIVE PERFORMANCE; MEMORY; SYMPTOMS	Diagnosis threat is a psychosocial factor that has been proposed to contribute to poor outcomes following mild traumatic brain injury (mTBI). This threat is thought to impair the cognitive test performance of individuals with mTBI because of negative injury stereotypes. University students (N = 45, 62.2% female) with a history of mTBI were randomly allocated to a diagnosis threat (DT; n = 15), reduced threat (DT-reduced; n = 15), or neutral (n = 15) group. The reduced threat condition invoked a positive stereotype (i.e., that people with mTBI can perform well on cognitive tests). All participants were given neutral instructions before they completed baseline tests of objective cognitive function across a number of domains, psychological symptoms, and PCS symptoms, including self-reported cognitive and emotional difficulties. Participants then received either neutral, DT, or DT-reduced instructions before repeating the tests. Results were analyzed using separate mixed model analysis of variances (ANOVAs); one for each dependent measure. The only significant result was for the 2 x 3 ANOVA on an objective test of attention/working memory, Digit Span (p < 0.05), such that the DT-reduced group performed better than the other groups, which were not different from each other. Although not consistent with predictions or earlier DT studies, the absence of group differences on most tests fits with several recent DT findings. The results of this study suggest that it is timely to reconsider the role of DT as a unique contributor to poor mTBI outcome.	[Blaine, Hannah; Sullivan, Karen A.; Edmed, Shannon L.] Queensland Univ Technol, Sch Psychol & Counseling, Brisbane, Qld 4001, Australia; [Sullivan, Karen A.; Edmed, Shannon L.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	Sullivan, KA (corresponding author), Queensland Univ Technol, O Block B Wing,Kelvin Grove Campus Victoria Pk Rd, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.au			School of Psychology and Counselling, Queensland University of Technology	The Human Research Ethics Committee of Queensland University of Technology (QUT-QUT-HREC # 1200000165) approved this research. This project was granted an occupational workplace health and safety clearance. Funding for this project was provided by the School of Psychology and Counselling, Queensland University of Technology. The authors acknowledge Chloe Kempe for assistance with randomization and cross scoring, Sherrie-Anne Kaye for advice on the pilot study, and Dr. April Thames whose correspondence with us influenced our writing of this paper.	Aronson J, 1999, J EXP SOC PSYCHOL, V35, P29, DOI 10.1006/jesp.1998.1371; Aronson J, 2002, J EXP SOC PSYCHOL, V38, P113, DOI 10.1006/jesp.2001.1491; Beilock SL, 2006, PERS SOC PSYCHOL B, V32, P1059, DOI 10.1177/0146167206288489; Ben-Zeev T, 2005, J EXP SOC PSYCHOL, V41, P174, DOI 10.1016/j.jesp.2003.11.007; BENTON AL, 1961, ARCH GEN PSYCHIAT, V4, P79; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; Brown RP, 2006, J APPL PSYCHOL, V91, P979, DOI 10.1037/0021-9010.91.4.979; CHARTER RA, 1987, INT J CLIN NEUROPSYC, V9, P28; Chong CS, 2008, HONG KONG J OCCUP TH, V18, P59, DOI 10.1016/S1569-1861(09)70004-X; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; DELANEY RC, 1992, ARCH CLIN NEUROPSYCH, V7, P523, DOI 10.1016/0887-6177(92)90142-A; Derogatis L. R., 2001, BSI 18 BRIEF SYMPTOM; Derogatis L.R., 1994, SCL 90 R ADM SCORING, V3rd; Frazen MD, 1996, CLIN NEUROPSYCHOL, V10, P125; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Iverson GL, 2001, ARCH CLIN NEUROPSYCH, V16, P183, DOI 10.1016/S0887-6177(00)00060-3; Johns M, 2005, PSYCHOL SCI, V16, P175, DOI 10.1111/j.0956-7976.2005.00799.x; Kellow JT, 2008, J BLACK PSYCHOL, V34, P94, DOI 10.1177/0095798407310537; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; King P.R., 2011, THESIS STATE U NEW Y; Kinkela J.H., 2008, THESIS OHIO U; Kit K.A., 2009, THESIS U VICTORIA; Krendl AC, 2008, PSYCHOL SCI, V19, P168, DOI 10.1111/j.1467-9280.2008.02063.x; Levy B, 1996, J PERS SOC PSYCHOL, V71, P1092, DOI 10.1037/0022-3514.71.6.1092; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; McMinn M. R., 1988, CLIN NEUROPSYCHOL, V2, P67, DOI [10.1080/13854048808520087, DOI 10.1080/13854048808520087]; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Silva M. A., 2008, GRAD J COUNS PSYCHOL, V1, P1; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Smith JL, 2004, EDUC PSYCHOL REV, V16, P177, DOI 10.1023/B:EDPR.0000034020.20317.89; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; Spitzer C, 2011, FORTSCHR NEUROL PSYC, V79, P517, DOI 10.1055/s-0031-1281602; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Sullivan K.A., 2013, J HEAD TRAUMA REHABI; Sumerall SW, 1997, J CLIN PSYCHOL, V53, P517, DOI 10.1002/(SICI)1097-4679(199708)53:5<517::AID-JCLP14>3.0.CO;2-H; Thames AD, 2013, J INT NEUROPSYCH SOC, V19, P583, DOI 10.1017/S1355617713000076; Tombaugh TN, 1996, TEST MEMORY MALINGER; Tulsky D., 1997, WAIS 3 WMS 3 TECHNIC; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Weber M, 2010, BRAIN INJURY, V24, P1364, DOI 10.3109/02699052.2010.507110; Wechsler D., 1997, WAIS 3 ADM SCORING M; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wisdom NM, 2012, ARCH CLIN NEUROPSYCH, V27, P208, DOI 10.1093/arclin/acr107; ZIMMERMAN DW, 1993, CAN J EXP PSYCHOL, V47, P523, DOI 10.1037/h0078850	57	12	12	1	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2013	30	16					1405	1414		10.1089/neu.2013.2865			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	199JB	WOS:000322989500004	23410235	Green Published			2021-06-18	
J	Easter, JS; Haukoos, JS; Claud, J; Wilbur, L; Hagstrom, MT; Cantrill, S; Mestek, M; Symonds, D; Bakes, K				Easter, Joshua S.; Haukoos, Jason S.; Claud, Jonathan; Wilbur, Lee; Hagstrom, Michelle Tartalgia; Cantrill, Stephen; Mestek, Michael; Symonds, David; Bakes, Katherine			Traumatic Intracranial Injury in Intoxicated Patients With Minor Head Trauma	ACADEMIC EMERGENCY MEDICINE			English	Article							GLASGOW COMA SCALE; COMPUTED-TOMOGRAPHY; BRAIN-INJURY; MANAGEMENT; GUIDELINES; ALCOHOL; ADULTS	Objectives Studies focusing on minor head injury in intoxicated patients report disparate prevalences of intracranial injury. It is unclear if the typical factors associated with intracranial injury in published clinical decision rules for computerized tomography (CT) acquisition are helpful in differentiating patients with and without intracranial injuries, as intoxication may obscure particular features of intracranial injury such as headache and mimic other signs of head injury such as altered mental status. This study aimed to estimate the prevalence of intracranial injury following minor head injury (Glasgow Coma Scale [GCS] score 14) in intoxicated patients and to assess the performance of established clinical decision rules in this population. Methods This was a prospective cohort study of consecutive intoxicated adults presenting to the emergency department (ED) following minor head injury. Historical and physical examination features included those from the Canadian CT Head Rule, National Emergency X-Radiography Utilization Study (NEXUS), and New Orleans Criteria. All patients underwent head CT. Results A total of 283 patients were enrolled, with a median age of 40years (interquartile range [IQR]=28 to 48years) and median alcohol concentration of 195mmol/L (IQR=154 to 256mmol/L). A total of 238 of 283 (84%) were male, and 225 (80%) had GCS scores of 15. Clinically important injuries (injuries requiring admission to the hospital or neurosurgical follow-up) were identified in 23 patients (8%; 95% confidence interval [CI]=5% to 12%); one required neurosurgical intervention (0.4%, 95% CI=0% to 2%). Loss of consciousness and headache were associated with clinically important intracranial injury on CT. The Canadian CT Head Rule had a sensitivity of 70% (95% CI=47% to 87%) and NEXUS criteria had a sensitivity of 83% (95% CI=61% to 95%) for clinically important injury in intoxicated patients. Conclusions In this study, the prevalence of clinically important injury in intoxicated patients with minor head injury was significant. While the presence of the common features associated with intracranial injury in nonintoxicated patients should raise clinical suspicion for intracranial injury in intoxicated patients, the Canadian CT Head Rule and NEXUS criteria do not have adequate sensitivity to be applied in intoxicated patients with minor head injury. (C) 2013 by the Society for Academic Emergency Medicine	[Easter, Joshua S.; Haukoos, Jason S.; Claud, Jonathan; Wilbur, Lee; Hagstrom, Michelle Tartalgia; Cantrill, Stephen; Bakes, Katherine] Denver Hlth Med Ctr, Dept Emergency Med, Denver, CO USA; [Easter, Joshua S.; Haukoos, Jason S.; Bakes, Katherine] Univ Colorado, Sch Med, Aurora, CO USA; [Haukoos, Jason S.] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Claud, Jonathan] Legacy Salmon Creek Hosp, Dept Emergency Med, Vancouver, WA USA; [Wilbur, Lee] Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA; [Hagstrom, Michelle Tartalgia] St Marys Hlth Ctr, Richmond Hts, MO USA; [Mestek, Michael; Symonds, David] Denver Hlth Med Ctr, Dept Radiol, Denver, CO USA	Bakes, K (corresponding author), Denver Hlth Med Ctr, Dept Emergency Med, Denver, CO USA.	Katherine.Bakes@dhha.org			Agency for Healthcare Research and Quality (AHRQ)United States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS019464-01]; AHRQUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K02 HS017526]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS019464, K02HS017526] Funding Source: NIH RePORTER	Supported, in part, by a Physician Scientist Award (K12HS019464-01) from the Agency for Healthcare Research and Quality (AHRQ) to Dr. Easter and an Independent Scientist Award (K02 HS017526) from the AHRQ to Dr. Haukoos. Dr. Wilbur, an associate editor of this journal, had no role in the peer review process and publication decision for this paper. The other authors have no conflicts of interest to declare.	Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Bracken ME, 2007, ANN EMERG MED, V49, P45, DOI 10.1016/j.annemergmed.2006.04.013; Cook L S, 1994, Acad Emerg Med, V1, P227; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Godbout BJ, 2011, EMERG RADIOL, V18, P381, DOI 10.1007/s10140-011-0966-3; Harnan SE, 2011, J TRAUMA, V71, P245, DOI 10.1097/TA.0b013e31820d090f; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; REINUS WR, 1994, ANN EMERG MED, V23, P1271, DOI 10.1016/S0196-0644(94)70351-5; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Shahin H, 2010, J TRAUMA, V69, P1176, DOI 10.1097/TA.0b013e3181edbd47; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Taylor TR, 2009, BRIT J NEUROSURG, V23, P622, DOI 10.3109/02688690903215666; Yates D, 2007, BMJ-BRIT MED J, V335, P719, DOI 10.1136/bmj.39331.702951.47	17	12	13	0	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563			ACAD EMERG MED	Acad. Emerg. Med.	AUG	2013	20	8					753	760		10.1111/acem.12184			8	Emergency Medicine	Emergency Medicine	201IQ	WOS:000323134300002	24033617				2021-06-18	
J	Sabre, L; Tomberg, T; Korv, J; Kepler, J; Kepler, K; Linnamagi, U; Asser, T				Sabre, L.; Tomberg, T.; Korv, J.; Kepler, J.; Kepler, K.; Linnamaegi, Ue; Asser, T.			Brain activation in the acute phase of traumatic spinal cord injury	SPINAL CORD			English	Article						traumatic spinal cord injury; functional magnetic resonance imaging; cortical reorganisation	MOTOR CORTEX; REORGANIZATION; SYSTEM; FMRI	Study design: Prospective clinical study. Background: The aim of the study was to investigate cortical reorganisation after traumatic spinal cord injury (TSCI) using functional magnetic resonance imaging (fMRI). Setting: Tartu University Hospital, Tartu, Estonia. Methods: We studied six right-handed tetraplegic TSCI patients at 1, 3 and 12 months after the injury and 12 age-and gender-matched healthy controls. Individuals performed simple test-rest cycles of flexion/extension of the right-hand fingers and flexion/extension of the right ankle during fMRI. The volumes of activation (VOA), maximum t-values, centres of gravity (COG) and weighted laterality indexes were calculated. Results: There was no recovery of neurologic function in three patients and, according to the American Spinal Injury Association (ASIA) Impairment Scale the remaining three recovered. A positive correlation between the VOA in the primary motor cortex and the ASIA Impairment Scale (1 month: r-0.82, P-0.002; 3 Month: r-0.63, P-0.03; 12 Month: r-0.23, P-0.52) was found. The study also revealed a pattern of cortical activation that was increased among the patients who recovered (in Brodmann area 4 (BA 4), P = 0.06; BA 1-2-3-5, P = 0.08; BA 6, P = 0.05). During the hand task there was an expansion of COG laterally, anteriorly and inferiorly among the patients who recovered. During the hand movement the cortical activation was less lateralised among the patients compared with the controls (P<0.05). Conclusion: Our study has found broadening of cortical activation and shift of COG during the first year after TSCI, depending on the recovery.	[Sabre, L.; Tomberg, T.; Korv, J.; Linnamaegi, Ue; Asser, T.] Univ Tartu, Dept Neurol & Neurosurg, EE-51014 Tartu, Estonia; [Tomberg, T.] Tartu Univ Hosp, Radiol Clin, Tartu, Estonia; [Kepler, J.] Parnu Hosp, Diagnost Serv, Parnu, Estonia; [Kepler, K.] Univ Tartu, Inst Phys, EE-51014 Tartu, Estonia	Sabre, L (corresponding author), Univ Tartu, Dept Neurol & Neurosurg, 8 L Puusepa St, EE-51014 Tartu, Estonia.	liis.sabre@ut.ee	Korv, Janika/I-4395-2015; Asser, Toomas/G-8446-2015; Sabre, Liis/D-7931-2014	Korv, Janika/0000-0002-6074-0727; Sabre, Liis/0000-0002-5727-8404	Estonian Science Foundation [7868]; Estonian Ministry of Education and ResearchMinistry of Education and Research, Estonia [SF0180064s07]	This study was supported by the Estonian Science Foundation research grant number 7868 and the targeted financing from the Estonian Ministry of Education and Research number SF0180064s07. We thank the nurses of the Radiology Clinic, Tartu University Hospital, for their kind help in performing the study.	Brett M., 2002, NEUROIMAGE, V16, P2, DOI [10.1016/S1053-8119(02)90010-8, DOI 10.1016/S1053-8119(02)90010-8]; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Curt A, 2002, J NEUROTRAUM, V19, P43, DOI 10.1089/089771502753460222; Curt A, 2002, BRAIN, V125, P2567, DOI 10.1093/brain/awf250; Freund P, 2013, NEUROSCIENTIST, V19, P116, DOI 10.1177/1073858412449192; Freund P, 2012, J NEUROL NEUROSUR PS, V83, P629, DOI 10.1136/jnnp-2011-301875; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Furkiewicz MT, 2007, NEUROREHAB NEURAL RE, V21, P527, DOI 10.1177/1545968307301872; Jurkiewicz MT, 2010, NEUROREHAB NEURAL RE, V24, P136, DOI 10.1177/1545968309347680; Kokotilo KJ, 2009, J NEUROL PHYS THER, V33, P45, DOI 10.1097/NPT.0b013e31819824f0; Kokotilo KJ, 2009, J NEUROTRAUM, V26, P2113, DOI 10.1089/neu.2008.0688; Lotze M, 1999, RESTOR NEUROL NEUROS, V14, P183; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Mikulis DJ, 2002, NEUROLOGY, V58, P794, DOI 10.1212/WNL.58.5.794; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Streletz Leopold J., 1995, Brain Topography, V7, P245, DOI 10.1007/BF01202383; Tomberg T, 2012, SPINAL CORD, V50, P885, DOI 10.1038/sc.2012.70; Wilke M, 2006, NEUROIMAGE, V33, P522, DOI 10.1016/j.neuroimage.2006.07.010	19	12	18	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	AUG	2013	51	8					623	629		10.1038/sc.2013.41			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	196LS	WOS:000322777600008	23689388	Bronze			2021-06-18	
J	Forsgren, E; Antonsson, M; Saldert, C				Forsgren, Emma; Antonsson, Malin; Saldert, Charlotta			Training conversation partners of persons with communication disorders related to Parkinson's disease-a protocol and a pilot study	LOGOPEDICS PHONIATRICS VOCOLOGY			English	Article						Cognition; communication; conversation partner training; Parkinson's disease; significant other	TRAUMATIC BRAIN-INJURY; CONTROLLED-TRIAL; APHASIA; PEOPLE; PERSPECTIVE; DYSARTHRIA; STROKE; ADULTS	This paper reports on the adaptation of a training programme for conversation partners of persons with Parkinson's disease, and a protocol for assessment of possible changes in conversational interaction as a result of intervention. We present data from an explorative multiple case study with three individuals with Parkinson's disease and their spouses. Repeated analysis of natural conversational interaction and measures of the participants' perception of communication as well as measures of different cognitive abilities were obtained. The results show that the communication in all three dyads was affected by both speech and language problems and that the conversation training model and the assessment protocol may work well after minor adjustments. Influence of different aspects of cognition on communication is discussed.	[Forsgren, Emma; Antonsson, Malin; Saldert, Charlotta] Univ Gothenburg, Inst Neurosci & Physiol, Div Speech & Language Pathol, Gothenburg, Sweden; [Forsgren, Emma; Saldert, Charlotta] Univ Gothenburg, GPCC, Gothenburg, Sweden	Saldert, C (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Div Speech & Language Pathol, Gothenburg, Sweden.	charlotta.saldert@neuro.gu.se	Saldert, Charlotta/ABH-1746-2020	Saldert, Charlotta/0000-0001-8808-3610; Forsgren, Emma/0000-0002-2402-0909			Altmann L, 2011, PARKINSONS DIS, P1, DOI DOI 10.4061/21011/238956; Apt P., 2008, TOKEN TEST; Berg E, 2003, CLIN LINGUIST PHONET, V17, P63, DOI 10.1080/0269920021000055540; Bloch S., 2004, AUGMENT ALTERN COMM, V20, P272, DOI [10.1080/07434610400005614, DOI 10.1080/07434610400005614]; Bloch S, 2009, INT J LANG COMM DIS, V44, P769, DOI 10.1080/13682820802546969; Bloch S, 2008, CLIN LINGUIST PHONET, V22, P974, DOI 10.1080/02699200802394831; Brown-Schmidt S, 2009, PSYCHON B REV, V16, P893, DOI 10.3758/PBR.16.5.893; Delis D.C., 2001, DELIS KAPLAN EXECUTI; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Friedman O, 2005, DEVELOPMENTAL SCI, V8, P218, DOI 10.1111/j.1467-7687.2005.00410.x; Griffiths S, 2011, INT J LANG COMM DIS, V46, P497, DOI 10.1111/j.1460-6984.2011.00012.x; HARTELIUS L, 1994, FOLIA PHONIATR LOGO, V46, P9, DOI 10.1159/000266286; Henry JD, 2004, J INT NEUROPSYCH SOC, V10, P608, DOI 10.1017/S1355617704104141; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Kagan Aura, 2004, Top Stroke Rehabil, V11, P67; Kent R.D., 1992, INTELLIGIBILITY SPEE; Legg C, 2005, APHASIOLOGY, V19, P559, DOI 10.1080/02687030544000029; LOCK S, 2001, SUPPORTING PARTNERS; Long AF, 2008, CLIN REHABIL, V22, P1083, DOI 10.1177/0269215508090091; Long A, 2009, CLIN REHABIL, V23, P846, DOI 10.1177/0269215509336055; Miller N, 2006, AGE AGEING, V35, P235, DOI 10.1093/ageing/afj053; Perkins L Whitworth A Lesser R, 1997, CONVERSATION ANAL PR; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Simmons-Mackie N, 2010, ARCH PHYS MED REHAB, V91, P1814, DOI 10.1016/j.apmr.2010.08.026; Sorin-Peters R, 2004, APHASIOLOGY, V18, P951, DOI 10.1080/02687030444000453; Tallberg IM, 2008, SCAND J PSYCHOL, V49, P479, DOI 10.1111/j.1467-9450.2008.00653.x; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Togher L, 2010, APHASIOLOGY, V24, P914, DOI 10.1080/02687030903422478; Whitworth A, 1999, APHASIOLOGY, V13, P407, DOI 10.1080/026870399402154; Wilkinson R, 1998, Int J Lang Commun Disord, V33 Suppl, P144; Wilkinson R, 2010, APHASIOLOGY, V24, P869, DOI 10.1080/02687030903501958; World Health Organization, 2001, INT CLASS FUNCT DIS; Yin R. K., 2017, CASE STUDY RES DESIG, V6th	34	12	12	0	26	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	1401-5439			LOGOP PHONIATR VOCO	Logop. Phoniatr. Vocology.	JUL	2013	38	2					82	90		10.3109/14015439.2012.731081			9	Audiology & Speech-Language Pathology; Otorhinolaryngology	Audiology & Speech-Language Pathology; Otorhinolaryngology	192ZC	WOS:000322525500007	23072445				2021-06-18	
J	Heath, CJ; Callahan, JL				Heath, Christopher J.; Callahan, Jennifer L.			Self-Reported Concussion Symptoms and Training Routines in Mixed Martial Arts Athletes	RESEARCH IN SPORTS MEDICINE			English	Article						athletic injuries; brain injury; concussion	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; AMATEUR; PERFORMANCE; COHORT; SCHOOL; RISK	Mixed martial arts (MMA) is a full-contact, fighting sport that has risen in popularity over recent years, resulting in an increase in both training facilities and sport participants. To date, little research has examined the complications and vulnerability to head trauma, or concussive symptomatology, in MMA athletes. In this study, we assessed relationships between training routines and concussive symptoms, as well as medical care, in MMA athletes. A sample (N=119) of MMA athletes reported concussive symptoms, training routines, and medical histories through an online survey. Nearly 15% of the MMA athletes reported history of a knockout, and nearly one-third reported a technical knockout. Subjective ratings of concussive symptoms were high for these athletes, with many of them waiting only a brief time after such incidents to return to competition. These findings have important implications for informing the medical treatment and safety decision for returning to participation for these athletes.	[Heath, Christopher J.; Callahan, Jennifer L.] Univ N Texas, Dept Psychol, Denton, TX 76203 USA	Heath, CJ (corresponding author), Univ N Texas, Dept Psychol, 1155 Union Circle 311280, Denton, TX 76203 USA.	christopher-heath@my.unt.edu		Callahan, Jennifer/0000-0001-9190-3886			Amtmann J. A., 2008, J STRENGTH COND RES, V18, P194; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailes JE, 2009, J INT NEUROPSYCH SOC, V15, P509, DOI 10.1017/S1355617709090936; Buse GJ, 2006, BRIT J SPORT MED, V40, P169, DOI 10.1136/bjsm.2005.021295; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jako P, 2002, BRIT J SPORT MED, V36, P394, DOI 10.1136/bjsm.36.6.394; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Loosemore M, 2008, BRIT J SPORT MED, V42, P864, DOI 10.1136/bmj.39342.690220.55; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrory Paul, 2009, J Athl Train, V44, P434, DOI 10.4085/1062-6050-44.4.434; Nevada Department of Business and Industry Nevada State Athletic Commission, 2011, 467427 NAC NEV DEP B; Nevada Department of Business and Industry Nevada State Athletic Commission, 2011, 4674748 NAC NEV DEP; New Jersey State Athletic Control Board, 2011, TYP BOUT RES; Ngai KM, 2008, BRIT J SPORT MED, V42, P686, DOI 10.1136/bjsm.2007.044891; Porter M, 1996, CLIN J SPORT MED, V6, P97, DOI 10.1097/00042752-199604000-00006; Ravdin LD, 2003, CLIN J SPORT MED, V13, P21, DOI 10.1097/00042752-200301000-00005; Shuttleworth-Rdwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P511, DOI 10.1016/j.acn.2008.05.002; Zazryn T, 2006, BRIT J SPORT MED, V40, P670, DOI 10.1136/bjsm.2006.025924	23	12	12	2	33	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.	JUL 1	2013	21	3					195	203		10.1080/15438627.2013.792082			9	Sport Sciences	Sport Sciences	166PT	WOS:000320570300001	23777375				2021-06-18	
J	Kleffelgaard, I; Roe, C; Sandvik, L; Hellstrom, T; Soberg, HL				Kleffelgaard, Ingerid; Roe, Cecile; Sandvik, Leiv; Hellstrom, Torgeir; Soberg, Helene L.			Measurement Properties of the High-Level Mobility Assessment Tool for Mild Traumatic Brain Injury	PHYSICAL THERAPY			English	Article							POST-CONCUSSION SYMPTOMS; INTERRATER RELIABILITY; CONCURRENT VALIDITY; WALKING SPEED; HEAD-INJURY; SELF-REPORT; HIMAT; QUALITY; PEOPLE; GAIT	Background. The High-Level Mobility Assessment Tool (HiMAT) was developed to quantify balance and mobility problems after traumatic brain injury (TBI). Measurement properties of the HiMAT have not been tested in the mild TBI (MTBI) population. Objective. The aim of this study was to examine the reliability, validity, and responsiveness of the HiMAT in a sample of the MTBI population. Design. A cohort, pretest-posttest, comparison study was conducted. Methods. Ninety-two patients (69% men, 31% women) with a mean age of 37.1 years (SD=13.8) and a mean Glasgow Coma Scale score of 14.7 (SD=0.7) were recruited from Oslo University Hospital. All patients were tested with the HiMAT (range of scores=0 [worst] to 54 [best]) at 3 months postinjury. Fifty-one patients were retested at 6 months. A subgroup of 25 patients was selected for the reliability testing. Balance function reported on the Rivermead Post Concussion Symptoms Questionnaire was chosen as a criterion and anchor. Criterion-related validity was studied with correlation analysis. Intraclass correlation coefficients (ICCs) were used for assessing interrater and intrarater reliability Minimal detectable change (MDC) for the HiMAT was estimated. Responsiveness was assessed with receiver operating characteristic curve analyses. Results. The mean HiMAT sum score was 46.2 (95% confidence interval=44.4 to 48.1). The HiMAT had a ceiling effect of 22.8%. The correlation between HiMAT scores and self-reported balance problems was large (r=-.63, P<.001). Interrater and intrarater reliability of the HiMAT sum score was high (interrater ICC=.99, intrarater ICC=.95). The MDC was -3 to +4 points. Responsiveness was good, and the HiMAT discriminated well between patients with self-perceived improved balance function versus unchanged balance function (area under the curve=0.86). Limitations. The small sample size, a ceiling effect, and lack of a gold standard were limitations of the study. Conclusions. The HiMAT demonstrated satisfactory measurement properties for patients with MTBI. The HiMAT can be used as an outcome measure of balance and mobility problems in patients with MTBI.	[Kleffelgaard, Ingerid; Roe, Cecile; Hellstrom, Torgeir; Soberg, Helene L.] Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0424 Oslo, Norway; [Kleffelgaard, Ingerid] Oslo & Akershus Univ, Coll Appl Sci, Fac Hlth Sci, Dept Physiotherapy, Oslo, Norway; [Roe, Cecile] Univ Oslo, Fac Med, N-0316 Oslo, Norway; [Sandvik, Leiv] Oslo Univ Hosp, Unit Biostat & Epidemiol, N-0424 Oslo, Norway	Kleffelgaard, I (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, POB 4956, N-0424 Oslo, Norway.	inff@live.no			Norwegian Fund for Postgraduate Training in Physiotherapy	This study was financially supported by the Norwegian Fund for Postgraduate Training in Physiotherapy.	Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Campbell M, 2005, BRAIN INJURY, V19, P1095, DOI 10.1080/02699050500188898; Collen F M, 1991, Int Disabil Stud, V13, P50; Coman L, 2006, CAN J AGING, V25, P253, DOI 10.1353/cja.2007.0001; Finch E, 2002, PHYS REHABILITATION, Vix, P320; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; HOSMER DW, 2000, WILEY PS TX, P1; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Mokkink LB, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-22; Quinn B, 2000, BRAIN INJURY, V14, P1063; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Rosner B., 2005, FUNDAMENTALS BIOSTAT; Shumway-Cook A, 2000, MOTOR CONTROL THEORY, p[x, 614]; Soberg HL, 2011, J TRAUMA, V71, P425, DOI 10.1097/TA.0b013e3181eff54f; Soberg HL, 2007, J TRAUMA, V62, P461, DOI 10.1097/01.ta.0000222916.30253.ea; Stauffer ME, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/231926; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; van Loo M, 2003, CLIN REHABIL, V17, P775, DOI 10.1191/0269215503cr677oa; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams G, 2004, HIGH LEVEL MOBILITY; Williams GP, 2009, INT J THER REHABIL, V16, P370, DOI 10.12968/ijtr.2009.16.7.43046; Williams G, 2010, BRAIN INJURY, V24, P1027, DOI 10.3109/02699052.2010.490517; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; Wrisley DM, 2003, ARCH PHYS MED REHAB, V84, P1528, DOI 10.1016/S0003-9993(03)00274-0	34	12	12	0	11	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	JUL	2013	93	7					900	910		10.2522/ptj.20120381			11	Orthopedics; Rehabilitation	Orthopedics; Rehabilitation	176QU	WOS:000321320000005	23504342	Green Published, Bronze			2021-06-18	
J	Ranson, C; Peirce, N; Young, M				Ranson, Craig; Peirce, Nicholas; Young, Mark			Batting head injury in professional cricket: a systematic video analysis of helmet safety characteristics	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							ICE HOCKEY; BASEBALL; IMPACT	Background Batters in cricket are continuing to sustain head and facial injuries despite wearing protective helmets. Objective To gain an understanding of the types and mechanisms of head injuries sustained by batters wearing a helmet. Methods Injury type, location and mechanism were categorised via analysis of 35 videos of National or International cricketers sustaining a head injury while batting. Results 53% of the injuries occurred following ball impact to either the helmet faceguard and peak, or the faceguard alone. Ten injuries (29%) resulted from the ball penetrating the gap between the helmet peak and faceguard. 29% of the injuries involved the ball contacting the face following penetration of the gap between the helmet peak and faceguard. Fractures, lacerations and contusions were the most common injuries associated with face or faceguard impacts while concussion was more commonly associated with impacts to the side or rear of the helmet shell. Many of the injuries described resulted in prolonged or permanent absence from cricket. Conclusions Significant head and facial injuries occur in cricket batters despite wearing of helmets. Cricket helmet design and associated National and International Safety Standards should be improved to provide increased protection against head injury related to ball impact to the faceguard and shell of the helmet.	[Ranson, Craig] Cardiff Metropolitan Univ UWIC, Cardiff Sch Sport, Cardiff CF23 6XD, S Glam, Wales; [Peirce, Nicholas; Young, Mark] England & Wales Cricket Board, Sci & Med Dept, Loughborough, Leics, England	Ranson, C (corresponding author), Cardiff Metropolitan Univ UWIC, Cardiff Sch Sport, Cardiff CF23 6XD, S Glam, Wales.	cranson@cardiffmet.ac.uk	Ranson, Craig/AAQ-5452-2020	peirce, nicholas/0000-0002-3272-5060; Ranson, Craig/0000-0002-3783-0505	ICC; ICC Medical Committee	The authors acknowledge the ICC and ICC Medical Committee for their support of the project. Thanks also go to project collaborators at the Loughborough Sports Technology Institute, Nikunj Velani, Dr Andy Harland and Will Sach.	Athiviraham A, 2012, AM J SPORT MED, V40, P2808, DOI 10.1177/0363546512461754; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Biasca N, 2002, BRIT J SPORT MED, V36, P410, DOI 10.1136/bjsm.36.6.410; British Standards Institute B, 1998, 7927 BS I; Caswell SV, 2012, AM J SPORTS MED; [Council for Standards Australia New New Zealand SS], 449913 ASNZS; DALY PJ, 1990, SPORTS MED, V10, P122, DOI 10.2165/00007256-199010020-00005; Dick R, 2007, J ATHL TRAINING, V42, P255; Echlin PS, 2005, BRIT J SPORT MED, V39, P254, DOI 10.1136/bjsm.2004.013128; McIntosh AS, 2011, BRIT J SPORT MED, V45, P1258, DOI 10.1136/bjsports-2011-090509; McIntosh AS, 2003, BRIT J SPORT MED, V37, P325, DOI 10.1136/bjsm.37.4.325; National Operating Committee on Standards for Athletic Equipment N, 2010, 024 NOCSAE; Orchard J, 2010, OPEN ACCESS J SPORTS, V1, P63; Orchard JW, 2006, J SCI MED SPORT, V9, P459, DOI 10.1016/j.jsams.2006.05.001; Shain KS, 2010, CLIN J SPORT MED, V20, P422, DOI 10.1097/JSM.0b013e3181f7db25	15	12	12	0	42	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	JUL	2013	47	10					644	648		10.1136/bjsports-2012-091898			5	Sport Sciences	Sport Sciences	161AP	WOS:000320162600014	23418269				2021-06-18	
J	Abrahamson, EE; Foley, LM; DeKosky, ST; Hitchens, TK; Ho, C; Kochanek, PM; Ikonomovic, MD				Abrahamson, Eric E.; Foley, Lesley M.; DeKosky, Steven T.; Hitchens, T. Kevin; Ho, Chien; Kochanek, Patrick M.; Ikonomovic, Milos D.			Cerebral blood flow changes after brain injury in human amyloid-beta knock-in mice	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Alzheimer's disease; amyloid; arterial spin-labeling MRI; blood flow; brain injury; statin	TRAUMA-INDUCED INCREASES; NITRIC-OXIDE SYNTHASE; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; A-BETA; FUNCTIONAL HYPEREMIA; REDUCTASE INHIBITORS; OXIDATIVE STRESS; SIMVASTATIN; ACTIVATION	Traumatic brain injury (TBI) is an environmental risk factor for Alzheimer's disease (AD). Increased brain concentrations of amyloid-beta (A beta) peptides and impaired cerebral blood flow (CBF) are shared pathologic features of TBI and AD and promising therapeutic targets. We used arterial spin-labeling magnetic resonance imaging to examine if CBF changes after TBI are influenced by human A beta and amenable to simvastatin therapy. CBF was measured 3 days and 3 weeks after controlled cortical impact (CCI) injury in transgenic human A beta-expressing APP(NLh/NLh) mice compared to murine A beta-expressing C57Bl/6J wild types. Compared to uninjured littermates, CBF was reduced in the cortex of the injured hemisphere in both A beta transgenics and wild types; deficits were more pronounced in the transgenic group, which exhibited injury-induced increased concentrations of human A beta. In the hemisphere contralateral to CCI, CBF levels were stable in A beta transgenic mice but increased in wild-type mice, both relative to uninjured littermates. Post-injury treatment of A beta transgenic mice with simvastatin lowered brain A beta concentrations, attenuated deficits in CBF ipsilateral to injury, restored hyperemia contralateral to injury, and reduced brain tissue loss. Future studies examining long-term effects of simvastatin therapy on CBF and chronic neurodegenerative changes after TBI are warranted.	[Abrahamson, Eric E.; Ikonomovic, Milos D.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15213 USA; [Abrahamson, Eric E.; Ikonomovic, Milos D.] VA Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA USA; [Foley, Lesley M.; Hitchens, T. Kevin; Ho, Chien] Carnegie Mellon Univ, Dept Biol Sci, VA Pittsburgh Healthcare Syst, Pittsburgh NMR Ctr Biomed Res, Pittsburgh, PA 15213 USA; [DeKosky, Steven T.] Univ Virginia, Sch Med, Off Dean, Charlottesville, VA 22908 USA; [DeKosky, Steven T.] Univ Virginia, Sch Med, Dept Neurol, Charlottesville, VA 22908 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Pittsburgh, PA 15213 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Ikonomovic, Milos D.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15213 USA	Ikonomovic, MD (corresponding author), Univ Pittsburgh, Dept Neurol, BSTWR S-521,200 Lothrop St, Pittsburgh, PA 15213 USA.	ikonomovicmd@upmc.edu	Ho, Chien/O-6112-2016; Kochanek, Patrick M/D-2371-2015	Ho, Chien/0000-0002-4094-9232; Kochanek, Patrick M/0000-0002-2627-913X; DeKosky, Steven/0000-0003-3743-2758	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P50 NS30318]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P41-EB001977]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB001977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318] Funding Source: NIH RePORTER	Supported by NIH P50 NS30318. The Pittsburgh NMR Center for Biomedical Research is supported by a grant from the National Institutes of Health (P41-EB001977). We acknowledge expert technical assistance provided by Mr. William Paljug, Mr. John Melick, and Ms. Lan Shao.	Abrahamson EE, 2006, EXP NEUROL, V197, P437, DOI 10.1016/j.expneurol.2005.10.011; Abrahamson EE, 2009, ANN NEUROL, V66, P407, DOI 10.1002/ana.21731; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P14; Crawford F, 1998, EXP NEUROL, V150, P159, DOI 10.1006/exnr.1997.6743; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Dietrich HH, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-15; Endres M, 1998, P NATL ACAD SCI USA, V95, P8880, DOI 10.1073/pnas.95.15.8880; Foley LM, 2008, J NEUROTRAUM, V25, P299, DOI 10.1089/neu.2007.0471; Franklin K. B. J., 1997, MOUSE BRAIN STEREOTA; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Iadecola C, 2003, CELL MOL NEUROBIOL, V23, P681, DOI 10.1023/A:1025092617651; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Laufs U, 2000, TRENDS CARDIOVAS MED, V10, P143, DOI 10.1016/S1050-1738(00)00044-X; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Loane DJ, 2011, J NEUROTRAUM, V28, P225, DOI 10.1089/neu.2010.1595; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Mannix Rebekah C, 2012, Int J Alzheimers Dis, V2012, P608732, DOI 10.1155/2012/608732; Nagaoka T, 2007, INVEST OPHTH VIS SCI, V48, P825, DOI 10.1167/iovs.06-0856; Niwa K, 2000, P NATL ACAD SCI USA, V97, P9735, DOI 10.1073/pnas.97.17.9735; Paris D, 2004, NEUROSCI LETT, V366, P80, DOI 10.1016/j.neulet.2004.05.017; Park L, 2004, J CEREBR BLOOD F MET, V24, P334, DOI 10.1097/01.WCB.0000105800.49957.1E; Reaume AG, 1996, J BIOL CHEM, V271, P23380, DOI 10.1074/jbc.271.38.23380; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; Suo ZM, 1998, NEUROSCI LETT, V257, P77, DOI 10.1016/S0304-3940(98)00814-3; Tong XK, 2012, J NEUROSCI, V32, P4705, DOI 10.1523/JNEUROSCI.0169-12.2012; Tong XK, 2009, NEUROBIOL DIS, V35, P406, DOI 10.1016/j.nbd.2009.06.003; Townsend KP, 2002, ANN NY ACAD SCI, V977, P65, DOI 10.1111/j.1749-6632.2002.tb04799.x; Tsujimoto Y, 1997, CELL DEATH DIFFER, V4, P429, DOI 10.1038/sj.cdd.4400262; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wible EF, 2010, NEUROTHERAPEUTICS, V7, P62, DOI 10.1016/j.nurt.2009.11.003; Wu HT, 2011, NEUROSURGERY, V68, P1363, DOI 10.1227/NEU.0b013e31820c06b9	37	12	13	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUN	2013	33	6					826	833		10.1038/jcbfm.2013.24			8	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	156KP	WOS:000319821100005	23443172	Green Published, Bronze			2021-06-18	
J	Heffernan, ME; Huang, W; Sicard, KM; Bratane, BT; Sikoglu, EM; Zhang, NY; Fisher, M; King, JA				Heffernan, Meghan E.; Huang, Wei; Sicard, Kenneth M.; Bratane, Bernt T.; Sikoglu, Elif M.; Zhang, Nanyin; Fisher, Marc; King, Jean A.			Multi-Modal Approach for Investigating Brain and Behavior Changes in an Animal Model of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						animal model; cognition; functional connectivity; imaging; traumatic brain injury	AWAKE RAT-BRAIN; FUNCTIONAL CONNECTIVITY; DEFAULT MODE; HEAD-INJURY; WATER-MAZE; MRI; NETWORKS; MEMORY; FATIGUE	Use of novel approaches in imaging modalities is needed for enhancing diagnostic and therapeutic outcomes of persons with a traumatic brain injury (TBI). This study explored the feasibility of using functional magnetic resonance imaging (fMRI) in conjunction with behavioral measures to target dynamic changes in specific neural circuitries in an animal model of TBI. Wistar rats were randomly assigned to one of two groups (traumatic brain injury/sham operation). TBI rats were subjected to the closed head injury (CHI) model. Any observable motor deficits and cognitive deficits associated with the injury were measured using beam walk and Morris water maze tests, respectively. fMRI was performed to assess the underlying post-traumatic cerebral anatomy and function in acute (24 hours after the injury) and chronic (7 and 21 days after the injury) phases. Beam walk test results detected no significant differences in motor deficits between groups. The Morris water maze test indicated that cognitive deficits persisted for the first week after injury and, to a large extent, resolved thereafter. Resting state functional connectivity (rsFC) analysis detected initially diminished connectivity between cortical areas involved in cognition for the TBI group; however, the connectivity patterns normalized at 1 week and remained so at the 3 weeks post-injury time point. Taken together, we have demonstrated an objective in vivo marker for mapping functional brain changes correlated with injury-associated cognitive behavior deficits and offer an animal model for testing potential therapeutic interventions options.	[Heffernan, Meghan E.; Huang, Wei; Sikoglu, Elif M.; Zhang, Nanyin; King, Jean A.] Univ Massachusetts, Sch Med, Ctr Comparat NeuroImaging, Dept Psychiat, Worcester, MA 01655 USA; [Sicard, Kenneth M.; Bratane, Bernt T.; Fisher, Marc] Univ Massachusetts, Mem Med Ctr, Dept Neurol, Worcester, MA 01655 USA	King, JA (corresponding author), Univ Massachusetts, Sch Med, 55 Lake Ave North, Worcester, MA 01655 USA.	Jean.King@umassmed.edu	Zhang, Nanyin/N-3457-2014	Zhang, Nanyin/0000-0002-5824-9058	Massachusetts General Hospital	We would like to thank Dr. Michael Whalen from Massachusetts General Hospital for his support and collaboration during this study.	Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Davis AR, 2010, J NEUROSCI METH, V189, P84, DOI 10.1016/j.jneumeth.2010.03.012; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Liang ZF, 2012, NEUROIMAGE, V59, P1190, DOI 10.1016/j.neuroimage.2011.08.009; Liang ZF, 2011, J NEUROSCI, V31, P3776, DOI 10.1523/JNEUROSCI.4557-10.2011; Liu XA, 2011, CEREB CORTEX, V21, P374, DOI 10.1093/cercor/bhq105; Lux WE, 2007, J REHABIL RES DEV, V44, P951, DOI 10.1682/JRRD.2007.01.0009; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Pawela CP, 2010, NEUROIMAGE, V49, P2467, DOI 10.1016/j.neuroimage.2009.09.054; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Riese H, 1999, NEUROPSYCHOL REHABIL, V9, P189, DOI 10.1080/713755600; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Virley D, 2000, J CEREBR BLOOD F MET, V20, P563, DOI 10.1097/00004647-200003000-00015; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Zhang NY, 2010, J NEUROSCI METH, V189, P186, DOI 10.1016/j.jneumeth.2010.04.001	30	12	12	0	13	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUN	2013	30	11					1007	1012		10.1089/neu.2012.2366			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	166WD	WOS:000320589300011	23294038	Green Published, Bronze			2021-06-18	
J	Long, J; Cai, L; Li, JT; Zhang, L; Yang, HY; Wang, TH				Long, Jiang; Cai, Li; Li, Jintao; Zhang, Lei; Yang, Haiyang; Wang, Tinghua			JNK3 involvement in nerve cell apoptosis and neurofunctional recovery after traumatic brain injury star	NEURAL REGENERATION RESEARCH			English	Article						neural regeneration; JNK1; JNK2; JNK3; traumatic brain injury; TdT-mediated dUTP nick end labeling; reverse transcription-PCR; cell apoptosis; neurological function recovery; neuroregeneration	ACTIVATED PROTEIN-KINASE; CEREBRAL-ISCHEMIA; MAP KINASES; RAT-BRAIN; IN-VIVO; PATHWAYS; NEURONS; DEATH; P38; ERK	Increasing evidence has revealed that the activation of the JNK pathway participates in apoptosis of nerve cells and neurological function recovery after traumatic brain injury. However, which genes in the JNK family are activated and their role in traumatic brain injury remain unclear. Therefore, in this study, in situ end labeling, reverse transcription-PCR and neurological function assessment were adopted to investigate the alteration of JNK1, JNK2 and JNK3 gene expression in cerebral injured rats, and their role in cell apoptosis and neurological function restoration. Results showed that JNK3 expression significantly decreased at 1 and 6 hours and 1 and 7 days post injury, but that JNK1 and JNK2 expression remained unchanged. In addition, the number of apoptotic nerve cells surrounding the injured cerebral cortex gradually reduced over time post injury. The Neurological Severity Scores gradually decreased over 1, 3, 5, 14 and 28 days post injury. These findings suggested that JNK3 expression was downregulated at early stages of brain injury, which may be associated with apoptosis of nerve cells. Downregulation of JNK3 expression may promote the recovery of neurological function following traumatic brain injury.	[Long, Jiang; Cai, Li; Zhang, Lei; Yang, Haiyang] Kunming Med Univ, Affiliated Hosp 1, Dept Neurosurg, Kunming 650032, Yunnan Province, Peoples R China; [Li, Jintao; Wang, Tinghua] Kunming Med Univ, Inst Neurosci, Kunming 650500, Yunnan Province, Peoples R China	Long, J (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Dept Neurosurg, Kunming 650032, Yunnan Province, Peoples R China.	longjiang69@163.com; tinghua_neuron@263.net					Atzori C, 2001, J NEUROPATHOL EXP NE, V60, P1190; Brown R, 2008, NEUROSCI LETT, V432, P73, DOI 10.1016/j.neulet.2007.12.008; CERVOSNAVARRO J, 1991, J NEUROL SCI, V103, pS3; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Choi WS, 2011, METHODS MOL BIOL, V758, P279, DOI 10.1007/978-1-61779-170-3_19; Dash PK, 2004, NEUROCHEM RES, V29, P1275, DOI 10.1023/B:NERE.0000023614.30084.eb; Dillon RL, 2010, CANCER RES, V70, P4260, DOI 10.1158/0008-5472.CAN-10-0266; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Feng HL, 2000, ZHONGHUA CHUANGSHANG, V16, P97; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Hughes R, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-69; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Lee JY, 2012, ENDOCRINOLOGY, V153, P3815, DOI 10.1210/en.2012-1068; Liu Y, 2012, BRAIN RES, V1445, P73, DOI 10.1016/j.brainres.2012.01.031; Martinez-Lucas P, 2005, INTENS CARE MED, V31, P1168, DOI 10.1007/s00134-005-2715-0; Mazzitelli S, 2011, J NEUROSCI, V31, P16969, DOI 10.1523/JNEUROSCI.4491-11.2011; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; Nix P, 2011, P NATL ACAD SCI USA, V108, P10738, DOI 10.1073/pnas.1104830108; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Park MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025976; Pravdenkova SV, 1996, BRAIN RES, V729, P151, DOI 10.1016/0006-8993(96)00222-3; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Repici M, 2011, CEREBELLUM, V10, P281, DOI 10.1007/s12311-010-0244-z; Schafers M, 2003, J NEUROSCI, V23, P2517; Shi S, 2009, CELL BIOL INT, V33, P1095, DOI 10.1016/j.cellbi.2009.06.029; Song B, 2012, NEUROREPORT, V23, P67, DOI 10.1097/WNR.0b013e32834e7d69; Sozen T, 2009, STROKE, V40, P2519, DOI 10.1161/STROKEAHA.109.549592; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; Sugino T, 2000, J NEUROSCI, V20, P4506, DOI 10.1523/JNEUROSCI.20-12-04506.2000; The Ministry of Science and Technology of the People's Republic of China, 2006, GUID SUGG CAR US LAB; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Toyoda H, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-36; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zhang ZB, 2012, NEUROCHEM RES, V37, P948, DOI 10.1007/s11064-011-0687-8	38	12	12	0	6	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JUN	2013	8	16					1491	1499		10.3969/j.issn.1673-5374.2013.16.006			9	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	173ZD	WOS:000321121400006	25206445	DOAJ Gold			2021-06-18	
J	Straits-Troster, K; Gierisch, JM; Strauss, JL; Dyck, DG; Dixon, LB; Norell, D; Perlick, DA				Straits-Troster, Kristy; Gierisch, Jennifer M.; Strauss, Jennifer L.; Dyck, Dennis G.; Dixon, Lisa B.; Norell, Diane; Perlick, Deborah A.			Multifamily Group Treatment for Veterans With Traumatic Brain Injury: What Is the Value to Participants?	PSYCHIATRIC SERVICES			English	Article							THERAPY; SCHIZOPHRENIA; INTERVENTION; FAMILIES	Objective: This study evaluated the feasibility, acceptability, and helpfulness of implementation of multifamily group treatment for traumatic brain injury (TBI) among veterans who sustained a TBI during the wars in Iraq and Afghanistan and their families or caregivers. Methods: Veterans and their family members who participated in an open clinical trial (August 2010-March 2011) of multifamily psychoeducation for TBI at two Veterans Affairs medical centers were invited to one of three focus groups. Participants were asked about problems experienced before and during the intervention, aspects of treatment that were helpful, and improvements that would facilitate effective implementation of multifamily group treatment for TBI. Postintervention focus group transcripts were analyzed by utilizing qualitative content analysis. Results: Participants included eight veterans with TBI and eight family members. Five themes emerged: exploring common struggles and reducing isolation, building skills to cope with TBI and related problems, restoring relationships through communication and understanding, increasing understanding of the interconnection between TBI and posttraumatic stress disorder, and improving the multifamily group experience and increasing treatment engagement of veterans and families. Veterans and family members found multifamily group treatment for TBI highly acceptable and offered recommendations to improve and increase access to the program. Conclusions: The results supported the feasibility and acceptability of multifamily group treatment for TBI. Specific recommendations to improve this psychoeducational intervention and its implementation are offered.	[Straits-Troster, Kristy] Dept Vet Affairs VA Midatlantic Reg Mental Illnes, Durham, NC USA; [Straits-Troster, Kristy] Phoenix VA Hlth Care Syst, Phoenix, AZ 85012 USA; [Gierisch, Jennifer M.] Durham VA Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC USA; [Gierisch, Jennifer M.] Duke Univ, Dept Med, Durham, NC 27706 USA; [Strauss, Jennifer L.] Durham VA Med Ctr, Hlth Serv Res & Dev Serv, Durham, NC USA; [Strauss, Jennifer L.] Duke Univ, Dept Psychiat, Durham, NC 27706 USA; [Dyck, Dennis G.] Washington State Univ, Dept Psychol, Spokane, WA USA; [Dixon, Lisa B.] Columbia Univ, Dept Psychiat, New York, NY USA; [Dixon, Lisa B.] New York State Psychiat Inst & Hosp, Ctr Practice Innovat, New York, NY 10032 USA; [Norell, Diane] Eastern Washington Univ, Dept Occupat Therapy, Cheney, WA 99004 USA; [Perlick, Deborah A.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY USA; [Perlick, Deborah A.] VA MIRECC, Bronx, NY USA	Straits-Troster, K (corresponding author), Dept Vet Affairs VA Midatlantic Reg Mental Illnes, Durham, NC USA.	kristy.straits-troster@va.gov		Gierisch, Jennifer/0000-0002-5057-4964	U.S. Department of DefenseUnited States Department of Defense [W81XWH-08-2-0054]; Mental Illness Research, Education and Clinical Centers in Veterans Integrated Service Networks 3 and 6; Veterans Affairs Research Career Development AwardUS Department of Veterans Affairs	This study was supported by an award (W81XWH-08-2-0054) from the U.S. Department of Defense to Dr. Perlick, by the Mental Illness Research, Education and Clinical Centers in Veterans Integrated Service Networks 3 and 6, and by a Veterans Affairs Research Career Development Award to Dr. Strauss. The authors are grateful for the assistance of Joy Close, M. S. W., Caitlyn Campbell, B. S., Meenal Misal, B. A., and Caroline Holman, B. A., and appreciate the courage and sacrifice of the injured veterans and their families who participated in this study.	Chacon-Moscoso SMT, 2002, EVALUATION, V8, P413; Collins RC, 2008, J CLIN PSYCHOL, V64, P993, DOI 10.1002/jclp.20515; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Dausch BM, 2009, J TELEMED TELECARE, V15, P211, DOI 10.1258/jtt.2009.081216; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Glynn SM, 2006, SCHIZOPHRENIA BULL, V32, P451, DOI 10.1093/schbul/sbj066; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Krueger R., 1994, FOCUS GROUPS PRACTIC; McFarlane W.R., 2002, MULTIFAMILY GROUPS T; Monson CM, 2008, J CLIN PSYCHOL, V64, P958, DOI 10.1002/jclp.20511; Perlick DA, 2012, PSYCHIAT SERVICES; Perlick DA, 2011, PROF PSYCHOL-RES PR, V42, P70, DOI 10.1037/a0022319; Rodgers ML, 2007, AM J PHYS MED REHAB, V86, P482, DOI 10.1097/PHM.0b013e31805c00a1; Rotondi AJ, 2010, PSYCHIAT SERV, V61, P1099, DOI 10.1176/ps.2010.61.11.1099; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sammons MT, 2008, J CLIN PSYCHOL, V64, P921, DOI 10.1002/jclp.20519; Sautter FJ, 2009, J MARITAL FAM THER, V35, P343, DOI 10.1111/j.1752-0606.2009.00125.x; Sherman MD, 2012, PSYCHOL SERVICES; Sherman MD, 2009, PROF PSYCHOL-RES PR, V40, P593, DOI 10.1037/a0016333; Sherman MD, 2009, PSYCHIAT SERV, V60, P254, DOI 10.1176/appi.ps.60.2.254; Voils CI, 2008, FIELD METHOD, V20, P3, DOI 10.1177/1525822X07307463	22	12	13	0	4	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	1075-2730	1557-9700		PSYCHIAT SERV	Psychiatr. Serv.	JUN	2013	64	6					541	546		10.1176/appi.ps.001632012			6	Health Policy & Services; Public, Environmental & Occupational Health; Psychiatry	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychiatry	255XF	WOS:000327272700008	23450326				2021-06-18	
J	Zampolini, M; Corea, F; Avesani, R; Boldrini, P; De Tanti, A; Di Stefano, MG; Formisano, R; Lamberti, G; Lombardi, F; Mazzucchi, A; Pistarini, C; Taricco, M; Citterio, A				Zampolini, M.; Corea, F.; Avesani, R.; Boldrini, P.; De Tanti, A.; Di Stefano, M. G.; Formisano, R.; Lamberti, G.; Lombardi, F.; Mazzucchi, A.; Pistarini, C.; Taricco, M.; Citterio, A.		Giscar Grp	Rehabilitation of acquired brain injuries: a multicentric prospective survey	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Rehabilitation; Brain injuries; Health surveys		Background. The rehabilitation of the persons with Severe Acquired Brain Injury (ABI) is an important concern to be approached with a comprehensive program aimed to improve the recovery of patients. The efficacy of an early and intensive rehabilitation program has been shown in large number of studies. Few studies focused on the prevalence of TBI and the data are often extrapolated in indirect ways. Aim. An analysis of the demographic characteristics of the population included in the GISCAR (Gruppo Italian per lo Studio delle Gravi Cerebrolesioni Acquisite e Riabilitazione- Italian Group for the Study of the severe ABI) database, type and conditions associated to the index event; the treatment administered during hospitalization; and the prognosis according to outcome measures. Design. The study was an observational prospective survey looking at management of ABI (both traumatic and non-traumatic). Setting. In hospital rehabilitation. Population. Patients consecutively admitted in each of the 52 GISCAR centres. Methods. Every centre included a consecutive cohort and recorded demographic data and index event characteristics. Results. In the study population were included 2626 subjects suffering of a severe ABI. The difference of length of stay (LOS) was significantly different with 67.5 days for traumatic patients compared to the 80 days of non traumatic ones. In the study population the probability of discharge at home is significantly greater for the traumatic condition (odds ratio 0,4587; CI 0.3671-0.5731). The overall benefit of the rehabilitative treatment was encountered in a net gain in all disability scores taken into account: LCF classes; DRS as well as GOS scores. At discharge the main destination for severe ABI patients was home (67.2%). Conclusions. A large number of patients admitted in Italian rehabilitative facilities for a severe ABI suffered from a TBI, more often these subjects were young male victims of road accident. The majority of subjects during the rehabilitative hospitalization demonstrated a significant recovery. Clinical Rehabilitation Impact. Considering the evidence of an early treatment benefit the delay of-the rehabilitation program start is far from being satisfactory. The high frequency of the home discharge indicate a good compliance of national family network.	[Zampolini, M.; Corea, F.] Severe Acquired Brain Les, Operat Unit, Perugia, Italy; [Avesani, R.] Don Calabria Hosp, Dept Funct Reeduc, Verona, Italy; [Boldrini, P.] Ferrara Hosp, Operat Unito Rehabil Med F, Ferrara, Italy; [De Tanti, A.] Ctr Cardinal Ferrari, Parma, Italy; [Di Stefano, M. G.] Cuasso al Monte Hosp, Operat Unit Recovery & Funct Reeduc, Cuasso Al Monte, Varese, Italy; [Formisano, R.] Santa Lucia IRCCS Fdn, Rome, Italy; [Lamberti, G.] Severe Brain Les Unit, Caraglio, Cuneo, Italy; [Lombardi, F.] Correggio Hosp, Dept Intens Care Unit, Correggio, Reggio Emilia, Italy; [Mazzucchi, A.] ELIAS Neuroriabilitaz, Parma, Italy; [Pistarini, C.] Fdn Clin Lavoro S Maugeri, Pavia, Italy; [Taricco, M.] S Orsola Univ Hospitalm, Operat Unit Rehabil Med, Bologna, Italy; [Citterio, A.] Ist Mondino, Pavia, Italy	Zampolini, M (corresponding author), Severe Acquired Brain Les, Operat Unit, ASL 3 Umbria, Foligno, Italy.	m.zampo1ini@asl3.umbria.it	Pistarini, CATERINA/K-5234-2018; corea, francesco/ABH-1776-2020	Pistarini, CATERINA/0000-0001-8925-0484; corea, francesco/0000-0002-5864-9991; LOMBARDI, Francesco/0000-0002-7184-6391			Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; Avesani R, 2005, BRAIN INJURY, V19, P933, DOI 10.1080/02699050400002371; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; CALDWELL MTP, 1993, IRISH J MED SCI, V162, P309, DOI 10.1007/BF02960726; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; Cullen NK, 2009, PM&R, V1, P1069, DOI 10.1016/j.pmrj.2009.09.013; Engberg A, 1995, Acta Neurol Scand Suppl, V164, P1; FREEMAN J, 1981, REV INFECT DIS, V3, P658; High WM, 2006, ARCH PHYS MED REHAB, V87, P334, DOI 10.1016/j.apmr.2005.11.028; Hoffmann B, 2002, ACT NEUR S, V79, P33; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lannoo E, 2004, BRAIN INJURY, V18, P203, DOI 10.1080/02699050310001596905; Lippert-Gruner M, 2007, PHYSIOL RES, V56, P359; Mammi P, 2006, Eura Medicophys, V42, P17; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; Mazaux JM, 2001, J REHABIL MED, V33, P99; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Shah MK, 2004, BRAIN INJURY, V18, P111, DOI 10.1080/0269905031000149551; Shah MK, 2007, J NEUROL SCI, V260, P95, DOI 10.1016/j.jns.2007.04.012; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taricco M, 2006, Eura Medicophys, V42, P73; Tooth L, 2001, BRAIN INJURY, V15, P613, DOI 10.1080/02699050010013923; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; von Wild KRH, 2005, ACTA NEUROCHIR SUPPL, V93, P15; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; Young James A, 2007, Phys Med Rehabil Clin N Am, V18, P145, DOI 10.1016/j.pmr.2006.11.008; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	30	12	12	0	4	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087			EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	JUN	2013	49	3					365	372					8	Rehabilitation	Rehabilitation	200UD	WOS:000323095500010	23389644				2021-06-18	
J	Batty, RA; Rossell, SL; Francis, AJP; Ponsford, J				Batty, Rachel A.; Rossell, Susan L.; Francis, Andrew J. P.; Ponsford, Jennie			Psychosis Following Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						traumatic brain injury; psychosis; schizophrenia; review	RISK MENTAL STATE; II PSYCHIATRIC-DISORDERS; HEAD-INJURY; SUBSTANCE USE; NONAFFECTIVE PSYCHOSIS; CHRONIC-SCHIZOPHRENIA; LIFETIME PREVALENCE; CELL-DEATH; AXIS-I; SYMPTOMS	Psychosis following traumatic brain injury (PFTBI) has received modest empirical investigation, and is subsequently poorly understood, identified and treated. The current article reports on consistencies in PFTBI phenomenology according to the existing peer-reviewed literature. The potential for psychotic symptoms post TBI, aetiological propositions, prevalence, significance of onset latency and injury severity, clinical and cognitive neuropsychological presentation and injury localisation/neuroimaging data are reviewed. Substantial methodological limitations associated with the majority of publications informing this work are also discussed. Despite controversies in the literature, psychosis following TBI appears to be three times more prevalent than psychotic disorders in the general population, and comparable in presentation to other idiopathic psychotic spectrum disorders, including schizophrenia.	[Batty, Rachel A.; Rossell, Susan L.] Swinburne Univ Technol, Fac Life & Social Sci, Brain & Psychol Sci Res Ctr BPsyC, Melbourne, Vic 3122, Australia; [Batty, Rachel A.; Rossell, Susan L.] Alfred Hosp, Monash Alfred Psychiat Res Ctr MAPrc, Cognit Neuropsychiat Lab, Melbourne, Vic 3004, Australia; [Batty, Rachel A.; Rossell, Susan L.] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Batty, Rachel A.; Francis, Andrew J. P.] RMIT Univ, Sch Hlth Sci Psychol & Disabil, Bundoora, Vic 3083, Australia; [Ponsford, Jennie] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia; [Ponsford, Jennie] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Richmond, Vic 3121, Australia	Batty, RA (corresponding author), Brain & Psychol Sci Res Ctr, Neuroimaging Facil, POB 218, Hawthorn, Vic 3122, Australia.	rachel.ann.batty@gmail.com		Batty, Rachel A/0000-0001-6413-5332; Rossell, Susan/0000-0002-7415-8252			AbdelMalik P, 2003, ARCH GEN PSYCHIAT, V60, P231, DOI 10.1001/archpsyc.60.3.231; Abel KM, 2010, INT REV PSYCHIATR, V22, P417, DOI 10.3109/09540261.2010.515205; ACHTE KA, 1969, ACTA PSYCHIAT SCAND, V45, P1, DOI 10.1111/j.1600-0447.1969.tb06197.x; Ahlskog J. E., 1991, CLIN EXAMINATIONS NE; Albert N, 2011, SCHIZOPHR RES, V125, P257, DOI 10.1016/j.schres.2010.10.013; American Psychiatric Association (APA), 1994, DIAGN STAT MAN MENT, V4th; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; APA, 2000, DIAGN STAT MAN MENT; Bachus SE, 1996, J CLIN PSYCHIAT, V57, P72; Badcock JC, 2006, PERS INDIV DIFFER, V40, P77, DOI 10.1016/j.paid.2005.06.015; BAMRAH JS, 1991, BRIT J PSYCHIAT, V158, P117, DOI 10.1192/bjp.158.1.117; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Belina S, 2011, COLLEGIUM ANTROPOL, V35, P1197; Bell V, 2006, TRENDS COGN SCI, V10, P219, DOI 10.1016/j.tics.2006.03.004; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Borgwardt SJ, 2007, BIOL PSYCHIAT, V61, P1148, DOI 10.1016/j.biopsych.2006.08.009; Bourque F, 2012, CURR PHARM DESIGN, V18, P518, DOI 10.2174/138161212799316028; Broome MR, 2010, PSYCHOL MED, V40, P1987, DOI 10.1017/S0033291710000280; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; BUCKLEY P, 1993, AM J PSYCHIAT, V150, P146; Burg JS, 1996, J CLIN PSYCHOL MED S, V3, P243, DOI 10.1007/BF01993910; Butler PV, 2000, AUST NZ J PSYCHIAT, V34, P684, DOI 10.1046/j.1440-1614.2000.00758.x; Corcoran C, 2007, CURR PSYCHIATRY REV, V3, P25, DOI 10.2174/157340007779815646; Csernansky JG, 2002, AM J PSYCHIAT, V159, P2000, DOI 10.1176/appi.ajp.159.12.2000; David AS, 2005, J NEUROL NEUROSUR PS, V76, pI53, DOI 10.1136/jnnp.2004.060475; Davison K, 1969, CURRENT PROBLEMS NEU, P113; Egan MF, 2001, AM J PSYCHIAT, V158, P1827, DOI 10.1176/appi.ajp.158.11.1827; Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562; Evans JJ, 1997, PSYCHOL MED, V27, P635, DOI 10.1017/S0033291797004790; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Feinberg TE, 1999, CORTEX, V35, P373, DOI 10.1016/S0010-9452(08)70806-2; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; FRISTON KJ, 1992, BRAIN, V115, P367, DOI 10.1093/brain/115.2.367; Fujii D, 2004, J NEUROPSYCH CLIN N, V16, P306, DOI 10.1176/appi.neuropsych.16.3.306; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Fujii Daryl, 2002, Cogn Neuropsychiatry, V7, P41, DOI 10.1080/135468000143000131; Fujii DE, 2001, J NEUROPSYCH CLIN N, V13, P61, DOI 10.1176/appi.neuropsych.13.1.61; Fujii DEM, 1996, NEUROPSY NEUROPSY BE, V9, P133; Fusar-Poli P, 2012, EUR PSYCHIAT, V27, P181, DOI 10.1016/j.eurpsy.2011.06.006; Gard DE, 2009, SCHIZOPHR RES, V115, P74, DOI 10.1016/j.schres.2009.08.015; Gareishizadeh MA, 2012, IRAN J PUBLIC HEALTH, V41, P116; Gennarelli T. A., 1998, SEM CLIN NEUR, V3, P160; Gilleen J, 2005, PSYCHOL MED, V35, P5, DOI 10.1017/S0033291704003976; Glantz LA, 2006, SCHIZOPHR RES, V81, P47, DOI 10.1016/j.schres.2005.08.014; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Guerreiro DF, 2009, BRAIN INJURY, V23, P358, DOI 10.1080/02699050902800918; Harrison G, 2006, SCHIZOPHR RES, V88, P119, DOI 10.1016/j.schres.2006.07.001; Hartley S, 2012, BEHAV RES THER, V50, P65, DOI 10.1016/j.brat.2011.10.007; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Hillbom E., 1960, ACTA PSYCHIATRICA S, VS142, P1; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; Ho BC, 2003, ARCH GEN PSYCHIAT, V60, P585, DOI 10.1001/archpsyc.60.6.585; Hoofien D, 2001, BRAIN INJURY, V15, P189; Horn H, 2010, PSYCHIAT RES-NEUROIM, V182, P183, DOI 10.1016/j.pscychresns.2010.01.016; Hughes ME, 2012, BIOL PSYCHOL, V89, P220, DOI 10.1016/j.biopsycho.2011.10.013; JABLENSKY A, 1992, PSYCHOL MED, P1; Jessen F, 2003, AM J PSYCHIAT, V160, P1305, DOI 10.1176/appi.ajp.160.7.1305; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Joshua N, 2009, SCHIZOPHR RES, V112, P99, DOI 10.1016/j.schres.2009.03.033; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kendler KS, 1996, ARCH GEN PSYCHIAT, V53, P1022; Kim E, 2008, CURR OPIN PSYCHIATR, V21, P286, DOI 10.1097/YCO.0b013e3282fbcd21; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kochanek PM, 1998, SEMIN CLIN NEUROPSYC, P176; Koponen S, 2006, PSYCHIAT RES-NEUROIM, V146, P263, DOI 10.1016/j.pscychresns.2005.05.015; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kulhara P, 2001, PSYCHIAT CLIN N AM, V24, P449, DOI 10.1016/S0193-953X(05)70240-9; Kumar CTS, 2010, SCHIZOPHR RES, V124, P152, DOI 10.1016/j.schres.2010.07.006; Lawrie SM, 1999, LANCET, V353, P30, DOI 10.1016/S0140-6736(98)06244-8; Lewis A. J., 1942, P ROY SOC MED, V35, P607; LEZAK MD, 1979, CORTEX, V15, P63, DOI 10.1016/S0010-9452(79)80007-6; LIDDLE PF, 1987, BRIT J PSYCHIAT, V151, P145, DOI 10.1192/bjp.151.2.145; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; Mathalon DH, 2001, ARCH GEN PSYCHIAT, V58, P148, DOI 10.1001/archpsyc.58.2.148; Max JE, 1997, BRAIN INJURY, V11, P699; McAllister TW, 2002, NEUROREHABILITATION, V17, P357; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; MCGUFFIN P, 1994, BRIT J PSYCHIAT, V164, P593, DOI 10.1192/bjp.164.5.593; Medalia A, 2010, SCHIZOPHRENIA BULL, V36, P912, DOI 10.1093/schbul/sbq073; Murrey GJ, 2004, REHABIL PSYCHOL, V49, P259, DOI 10.1037/0090-5550.49.3.259; Must Anita, 2011, Neuropsychopharmacol Hung, V13, P211; Myers NL, 2011, CURR PSYCHIAT REP, V13, P305, DOI 10.1007/s11920-011-0208-0; Myin-Germeys I, 2003, CURR OPIN PSYCHIATR, V16, P443, DOI 10.1097/01.yco.0000079208.36371.cd; Nakagami E, 2010, SCHIZOPHRENIA BULL, V36, P935, DOI 10.1093/schbul/sbq043; Newburn G, 1998, CNS DRUGS, V9, P441, DOI 10.2165/00023210-199809060-00003; Nielsen AS, 2002, SCHIZOPHR RES, V55, P93, DOI 10.1016/S0920-9964(01)00205-5; OCALLAGHAN E, 1988, BRIT J PSYCHIAT, V153, P394, DOI 10.1192/bjp.153.3.394; Pantelis C, 2003, LANCET, V361, P281, DOI 10.1016/S0140-6736(03)12323-9; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Ponsford J., 2012, TRAUMATIC BRAIN INJU, P226; Ponsford J, 2012, TRAUMATIC BRAIN INJU; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Pridmore S, 2011, MALAYS J MED SCI, V18, P6; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rao V, 2003, INT REV PSYCHIATR, V15, P299, DOI 10.1080/09540260310001606674; Reitan RM., 1985, HALSTEAD REITAN NEUR; RINK A, 1995, AM J PATHOL, V147, P1575; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Rossler W, 2012, ADDICTION, V107, P1174, DOI 10.1111/j.1360-0443.2011.03760.x; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Rossell SL, 2006, SCHIZOPHR RES, V82, P121, DOI 10.1016/j.schres.2005.11.001; Rossell SL, 2010, EUR ARCH PSY CLIN N, V260, P571, DOI 10.1007/s00406-010-0101-6; RUTHERFORD WH, 1977, LANCET, V1, P1; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Senathi-Raja D. R., 2010, J REHABILITATION MED, V41, P666; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Smieskova R, 2012, CURR PHARM DESIGN, V18, P416, DOI 10.2174/138161212799316046; Snow P, 2012, TRAUMATIC BRAIN INJU, P34; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Stewart B, 2005, J NEUROPSYCH CLIN N, V17, P243, DOI 10.1176/appi.neuropsych.17.2.243; Sutterland AL, 2013, SOC PSYCH PSYCH EPID, V48, P1357, DOI 10.1007/s00127-013-0651-9; Switaj P, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-193; Tate DF, 2011, J INT NEUROPSYCH SOC, V17, P308, DOI 10.1017/S1355617710001670; TEASDALE G, 1974, LANCET, V2, P81; Verdoux H, 2002, SCHIZOPHR RES, V54, P59, DOI 10.1016/S0920-9964(01)00352-8; Wallace BE, 2001, J HEAD TRAUMA REHAB, V16, P165, DOI 10.1097/00001199-200104000-00006; West SL, 2011, NEUROREHABILITATION, V29, P1, DOI 10.3233/NRE-2011-0671; Westermeyer J, 2006, AM J ADDICTION, V15, P345, DOI 10.1080/10550490600860114; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8; Wisdom JP, 2011, PSYCHIAT SERV, V62, P1007, DOI 10.1176/appi.ps.62.9.1007; Zierhut K, 2010, PSYCHIAT RES-NEUROIM, V183, P187, DOI 10.1016/j.pscychresns.2010.03.007; Zierhut KC, 2013, BRAIN, V136, P804, DOI 10.1093/brain/aws335	131	12	13	0	20	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAY	2013	14	1			SI		21	41		10.1017/BrImp.2013.10			21	Clinical Neurology; Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	189EY	WOS:000322251300004					2021-06-18	
J	Cao, P; Liang, Y; Gao, X; Zhao, MG; Liang, GB				Cao, Peng; Liang, Yong; Gao, Xu; Zhao, Ming-Guang; Liang, Guo-Biao			RETRACTED: Administration of MS-275 Improves Cognitive Performance and Reduces Cell Death Following Traumatic Brain Injury in Rats (Retracted article. See vol. 20, pg. 1011, 2014)	CNS NEUROSCIENCE & THERAPEUTICS			English	Article; Retracted Publication						Hippocampus; Histone deacetylase; Inflammation; Morris water maze; MS-275; Traumatic brain injury	LATERAL FLUID-PERCUSSION; HISTONE DEACETYLASE INHIBITORS; ACUTE NEURONAL DEGENERATION; HDAC INHIBITORS; BEHAVIORAL DEFICITS; HUNTINGTONS-DISEASE; FLUORO-JADE; MOUSE MODEL; HEAD-INJURY; IN-VIVO	Aims The MS-275 is a selective inhibitor of class I histone deacetylases (HDACs), which has been reported as a potential strategy in some central nervous system diseases associated with neurodegeneration and disturbed learning. However, its role in traumatic brain injury is not well defined. In this study, we examined the behavioralcognitive performance as well as histology outcome in adult rats to evaluate whether postinjury administration of MS-275 (15 and 45mg/kg) would provide neuroprotection benefits and ameliorate cognitive deficits following fluid percussion injury. Methods Traumatic brain injury (2.15 ATMs) was produced using a fluid percussion device with the lateral orientation. MS-275 was administered (15 and 45mg/kg) systemically once daily for 7days starting at 30min after lateral fluid percussion TBI. Acquisition of spatial learning and memory retention was assessed using the Morris water maze (MWM) on days 1014 after TBI. Brain tissues were collected and stained with Fluoro-Jade B histofluorescence (for degenerating neurons) at 24h after injury and cresyl violet (for long-term neuronal survival) on day 14 postinjury. Results Behavioral outcome after TBI revealed MS-275 treatment groups, at all doses examined, performed significantly better in the Morris Water Maze (P<0.001). Acute histology analysis demonstrated that 45mg/kg MS-275 significantly reduced the number of degenerating neurons in the ipsilateral CA23 hippocampus at 24h postinjury (P=0.007). There was a trend for MS-275 to increase the survival of neurons in the CA23 hippocampus on 14days after TBI (P=0.164). Conclusion Our present data highlight the fact that MS-275 may provide neuroprotective effect and improve cognitive performance after TBI. We concluded that MS-275 is a potential novel treatment and will have an ameliorative effect on some of the pathological features associated with TBI.	[Cao, Peng; Liang, Yong; Gao, Xu; Zhao, Ming-Guang; Liang, Guo-Biao] Shenyang Northern Hosp, Dept Neurosurg, 83 Wenhua Rd, Shenyang 110018, Liaoning Provin, Peoples R China	Liang, GB (corresponding author), Shenyang Northern Hosp, Dept Neurosurg, 83 Wenhua Rd, Shenyang 110018, Liaoning Provin, Peoples R China.	liangguobiaosy@gmail.com					Adcock IM, 2007, BRIT J PHARMACOL, V150, P829, DOI 10.1038/sj.bjp.0707166; Bin Z, 2008, BRAIN RES, V1226, P181; Butler KV, 2008, CURR PHARM DESIGN, V14, P505; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Charrueau C, 2009, J NEUROTRAUM, V26, P1911, DOI 10.1089/neu.2008.0737; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; Dash PK, 2009, NEUROSCIENCE, V163, P1, DOI 10.1016/j.neuroscience.2009.06.028; Dash PK, 2004, NEUROCHEM RES, V29, P1275, DOI 10.1023/B:NERE.0000023614.30084.eb; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Deshpande LS, 2008, NEUROSCI LETT, V441, P115, DOI 10.1016/j.neulet.2008.05.113; Dietrich WD, 2004, ACTA NEUROCHIR SUPPL, V89, P69; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Faraco G, 2006, MOL PHARMACOL, V70, P1876, DOI 10.1124/mol.106.027912; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Feng JF, 2011, BRAIN RES, V1395, P62, DOI 10.1016/j.brainres.2011.04.022; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Glauben R, 2006, J IMMUNOL, V176, P5015, DOI 10.4049/jimmunol.176.8.5015; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; KOTAPKA MJ, 1994, J NEUROTRAUM, V11, P317, DOI 10.1089/neu.1994.11.317; Kozikowski AP, 2007, J MED CHEM, V50, P3054, DOI 10.1021/jm070178x; Kwon SH, 2002, J BIOL CHEM, V277, P2073, DOI 10.1074/jbc.M106699200; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Lin HS, 2007, BRIT J PHARMACOL, V150, P862, DOI 10.1038/sj.bjp.0707165; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Riba-Bosch A, 2004, NEUROSCIENCE, V125, P803, DOI 10.1016/j.neuroscience.2004.02.017; Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Simonini MV, 2006, P NATL ACAD SCI USA, V103, P1587, DOI 10.1073/pnas.0510341103; Sinn DI, 2007, NEUROBIOL DIS, V26, P464, DOI 10.1016/j.nbd.2007.02.006; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Thomas EA, 2009, MOL NEUROBIOL, V40, P33, DOI 10.1007/s12035-009-8067-y; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zhang ZY, 2010, NEUROSCIENCE, V169, P370, DOI 10.1016/j.neuroscience.2010.04.074; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zhong CL, 2005, J NEUROTRAUM, V22, P266, DOI 10.1089/neu.2005.22.266	52	12	12	0	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	MAY	2013	19	5					337	345		10.1111/cns.12082			9	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	133BQ	WOS:000318112800007	23551690	Green Published			2021-06-18	
J	Cegla, J; Jones, B; Seyani, L; Papadoulou, D; Wynne, K; Martin, NM; Meeran, K; Chapman, R; Donaldson, M; Goldstone, AP; Tan, T				Cegla, Jaimini; Jones, Ben; Seyani, Lata; Papadoulou, Deborah; Wynne, Katie; Martin, Niamh M.; Meeran, Karim; Chapman, Richard; Donaldson, Mandy; Goldstone, Anthony P.; Tan, Tricia			Comparison of the overnight metyrapone and glucagon stimulation tests in the assessment of secondary hypoadrenalism	CLINICAL ENDOCRINOLOGY			English	Article							PITUITARY-ADRENAL AXIS; INSULIN HYPOGLYCEMIA; GROWTH-HORMONE; CORTISOL RESPONSES; ACTH; SURGERY; ADRENOCORTICOTROPIN; INSUFFICIENCY; DYSFUNCTION	Objective The insulin tolerance test (ITT) is contraindicated in a proportion of patients with suspected ACTH deficiency. The aim of this study was to investigate the diagnostic accuracy of the glucagon stress test (GST) compared with the overnight metyrapone test (OMT) in patients with contraindications to ITT. Design This was a prospective comparison of the GST to the OMT in patients with suspected ACTH deficiency and contraindications to the ITT. The OMT was used as the standard for comparison. The study was conducted at two tertiary referral centres for pituitary disease. Patients Seventy-eight patients underwent contemporaneous OMT and GST of whom 61 had sufficient suppression of cortisol during the OMT to be included in the comparison. Forty had suffered traumatic brain injury, 36 had organic pituitary disorders and two were classified as other'. Measurements ACTH sufficiency was defined as 0800h 11-deoxycortisol200nmol/l on OMT and peak cortisol440nmol/l on GST, as per local reference ranges. Results There was significant discrepancy between the proportion of patients diagnosed with ACTH deficiency using the OMT (39%) and GST (89%). From our data, a GST peak cortisol cut-off of 350nm provides the combination of optimal sensitivity (71%) and specificity (57%), compared with a higher sensitivity (88%) but poor specificity (11%) using a cut-off of 440nm. Conclusions The GST should be used with caution as a diagnostic test of ACTH reserve. The OMT should be used in preference to the GST to assess the hypothalamic pituitary adrenal axis where ITT is contraindicated.	[Cegla, Jaimini; Jones, Ben; Papadoulou, Deborah; Wynne, Katie; Martin, Niamh M.; Meeran, Karim; Tan, Tricia] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Div Diabet Endocrinol & Metab, London W12 0NN, England; [Cegla, Jaimini; Jones, Ben; Seyani, Lata; Chapman, Richard; Donaldson, Mandy; Tan, Tricia] Univ London Imperial Coll Sci Technol & Med, Imperial Coll Healthcare NHS Trust, Dept Clin Biochem, Hammersmith Hosp, London, England; [Goldstone, Anthony P.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC Clin Sci Ctr, Metab & Mol Imaging Grp, London W12 0NN, England	Tan, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Div Diabet Endocrinol & Metab, 6th Floor,Commonwealth Bldg,Du Cane Rd, London W12 0NN, England.	t.tan@imperial.ac.uk	Tan, Tricia/ABD-5502-2020; Wynne, Katie/P-9465-2019; Tan, Tricia M.M./C-7140-2011	Tan, Tricia/0000-0001-5873-3432; Wynne, Katie/0000-0002-7980-3337; Jones, Benjamin/0000-0003-0461-2584; Goldstone, Anthony/0000-0001-8179-7071	NIHRNational Institute for Health Research (NIHR); Wellcome TrustWellcome TrustEuropean Commission	NMM is supported by an NIHR Clinical Senior Lectureship award. JC is supported by a Wellcome Trust Clinical Ph.D. Fellowship.	Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Berg C, 2010, EUR J ENDOCRINOL, V162, P477, DOI 10.1530/EJE-09-0824; Berneis K, 2002, J CLIN ENDOCR METAB, V87, P5470, DOI 10.1210/jc.2001-011959; Courtney CH, 2004, J CLIN ENDOCR METAB, V89, P1712, DOI 10.1210/jc.2003-031577; Courtney CH, 2000, CLIN ENDOCRINOL, V53, P309; DOLMAN LI, 1979, JAMA-J AM MED ASSOC, V241, P1251, DOI 10.1001/jama.241.12.1251; FAHY TJ, 1968, PSYCHOPHARMACOLOGIA, V12, P367, DOI 10.1007/BF00401416; FIAD TM, 1994, CLIN ENDOCRINOL, V40, P603, DOI 10.1111/j.1365-2265.1994.tb03011.x; Gibney J, 2008, J CLIN ENDOCR METAB, V93, P3763, DOI 10.1210/jc.2008-0154; Giordano R, 2008, CLIN ENDOCRINOL, V68, P935, DOI 10.1111/j.1365-2265.2007.03141.x; GRINSPOON SK, 1994, J CLIN ENDOCR METAB, V79, P923, DOI 10.1210/jc.79.4.923; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; John K, 1985, Padiatr Grenzgeb, V24, P391; LANDON J, 1966, J CLIN INVEST, V45, P437, DOI 10.1172/JCI105358; LINDHOLM J, 1987, CLIN ENDOCRINOL, V26, P53, DOI 10.1111/j.1365-2265.1987.tb03638.x; LITTLEY MD, 1989, CLIN ENDOCRINOL, V31, P527, DOI 10.1111/j.1365-2265.1989.tb01276.x; Mukherjee JJ, 1997, CLIN ENDOCRINOL, V47, P51, DOI 10.1046/j.1365-2265.1997.2151035.x; Orme SM, 1996, CLIN ENDOCRINOL, V45, P135, DOI 10.1046/j.1365-2265.1996.d01-1562.x; PERUCCA E, 1982, CLIN PHARMACOKINET, V7, P57, DOI 10.2165/00003088-198207010-00004; RAO RH, 1987, METABOLISM, V36, P658, DOI 10.1016/0026-0495(87)90150-8; Rasmussen E, 1998, CLIN PHARMACOL THER, V64, P150, DOI 10.1016/S0009-9236(98)90148-5; SPRUNT JG, 1968, ACTA ENDOCRINOL-COP, V59, P447, DOI 10.1530/acta.0.0590447; STEINER H, 1994, EXP CLIN ENDOCRINOL, V102, P33, DOI 10.1055/s-0029-1211262	23	12	14	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664	1365-2265		CLIN ENDOCRINOL	Clin. Endocrinol.	MAY	2013	78	5					738	742		10.1111/cen.12043			5	Endocrinology & Metabolism	Endocrinology & Metabolism	126KX	WOS:000317615300016	22998100				2021-06-18	
J	Chan, M; Al-Buali, W; Stewart, TC; Singh, RN; Kornecki, A; Seabrook, JA; Fraser, DD				Chan, M.; Al-Buali, W.; Stewart, T. Charyk; Singh, R. N.; Kornecki, A.; Seabrook, J. A.; Fraser, D. D.			Cervical spine injuries and collar complications in severely injured paediatric trauma patients	SPINAL CORD			English	Article						children; severe trauma; cervical spine; injury; clearance; collar complications	PRESSURE	Study design: A retrospective registry review. Objectives: To determine the incidence of cervical spine (CS) injuries and collar complications in severely injured paediatric trauma patients. Setting: Regional Trauma Centre, Children's Hospital. Methods: A retrospective review of 365 paediatric severe trauma patients (0-17 years), defined as an Injury Severity Score (ISS)>= 12, admitted to the paediatric intensive care unit (PICU). Results: Clinically significant CS injuries occurred in 5% (n=18/365) of trauma patients, in 9% (n=13/149) of traumatic brain injury (TBI) patients and in 11% (n=6/56) of in-hospital trauma deaths. CS injuries were suspected before imaging in 33% (n=6/18) of patients based on either motor/sensory impairment or shock. CS injuries were deemed unstable in 61% (n=11/18) of patients. Patients with CS injuries had higher ISS, and longer PICU and hospital stays (P<0.05). CS collar complications occurred in 10% of patients, mainly identified by day 6 and consisting of either erythema or ulcers. Patients with CS collar complications were older and more likely to have TBI, lower Glasgow Coma Scale (GCS) scores, longer PICU and hospital stays, and increased days to CS clearance (P<0.05). Three CS X-rays, together with flexion/extension views, were used most frequently for CS clearance. Conclusion: CS injuries were prevalent in severely injured paediatric trauma patients, particularly in those with TBI and in nonsurvivors. CS collar complications were associated with a lower GCS and longer CS clearance times. Attention to CS collar management protocols and earlier CS clearance with computed tomography/magnetic resonance imaging in obtunded patients might reduce CS collar complications.	[Chan, M.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Al-Buali, W.] King Faisal Univ, Khobar, Saudi Arabia; [Stewart, T. Charyk; Singh, R. N.; Kornecki, A.; Seabrook, J. A.; Fraser, D. D.] Univ Western Ontario, London, ON, Canada; [Singh, R. N.; Kornecki, A.; Seabrook, J. A.; Fraser, D. D.] Childrens Hlth Res Inst, London, ON, Canada; [Fraser, D. D.] Ctr Crit Illness Res, London, ON, Canada	Fraser, DD (corresponding author), Childrens Hosp, London Hlth Sci Ctr, Paediat Crit Care Med Off, Room C2-C82,800 Commissioners Rd East, London, ON N6C 2V5, Canada.	douglas.fraser@lhsc.on.ca					Browne Gary J, 2003, Emerg Med (Fremantle), V15, P133, DOI 10.1046/j.1442-2026.2003.00345.x; Chung S, 2011, J TRAUMA, V70, P873, DOI 10.1097/TA.0b013e3182108823; Duhem R, 2008, CHILD NERV SYST, V24, P343, DOI 10.1007/s00381-007-0497-0; Frank JB, 2002, SPINE, V27, P1176, DOI 10.1097/00007632-200206010-00008; Givens TG, 1996, J TRAUMA, V41, P310, DOI 10.1097/00005373-199608000-00019; Hadley Mark N, 2002, Clin Neurosurg, V49, P407; Hofbauer M, 2012, J TRAUMA ACUTE CARE, V73, P156, DOI 10.1097/TA.0b013e31824e32b5; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Kokoska ER, 2001, J PEDIATR SURG, V36, P100, DOI 10.1053/jpsu.2001.20022; Lustrin ES, 2003, RADIOGRAPHICS, V23, P539, DOI 10.1148/rg.233025121; Mohseni S, 2011, J PEDIATR SURG, V46, P1771, DOI 10.1016/j.jpedsurg.2011.03.007; Molano Alvarez Esteban, 2004, Enferm Intensiva, V15, P112; Patel JC, 2001, J PEDIATR SURG, V36, P373, DOI 10.1053/jpsu.2001.20720; Pizzutillo Peter D, 2006, Instr Course Lect, V55, P633; PLAISIER B, 1994, J TRAUMA, V37, P714, DOI 10.1097/00005373-199411000-00004; Platzer P, 2007, J TRAUMA, V62, P389, DOI 10.1097/01.ta.0000221802.83549.46; Polk-Williams A, 2008, J PEDIATR SURG, V43, P1718, DOI 10.1016/j.jpedsurg.2008.06.002; Powers J, 1997, J NURS CARE QUAL, V12, P46, DOI 10.1097/00001786-199710000-00008; Powers Jan, 2006, J Trauma Nurs, V13, P198; Viccellio P, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e20	20	12	13	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	MAY	2013	51	5					360	364		10.1038/sc.2013.6			5	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	139NR	WOS:000318590200004	23459123	Bronze			2021-06-18	
J	Gadegone, WM; Lokhande, V; Salphale, Y; Ramteke, A				Gadegone, W. M.; Lokhande, Vijayanand; Salphale, Yogesh; Ramteke, Alankar			Long proximal femoral nail in ipsilateral fractures proximal femur and shaft of femur	INDIAN JOURNAL OF ORTHOPAEDICS			English	Article						Fracture shaft femur; intracapsular neck fracture; ipsilateral fracture hip and shaft femur; long proximal femoral nail; pertrochanteric fracture	CONCOMITANT FRACTURES; RECONSTRUCTION NAIL; NECK; HIP; FIXATION	Background: Ipsilateral fractures of the proximal femur and femoral shaft are extremely uncommon injuries which occur in young adults who sustain a high energy trauma. A variety of management modalities have been tried to treat this complex fracture pattern ranging from conservative approach to recently introduced reconstruction nails. All these approaches have their own difficulties. We studied the outcome of long proximal femoral nail (LPFN) in the management of concomitant ipsilateral fracture of the proximal femur and femoral shaft. Materials and Methods: We analysed the prospective data of 36 consecutive patients who had sustained a high energy trauma (30 closed fractures and 6 open shaft fractures) who had concomitant ipsilateral fractures of the femoral shaft associated with proximal femur fractures treated with LPFN between December 2005 and December 2011. The mean age was 39 years (range 28-64 years). Twenty nine males and seven females were enrolled for this study. Results: The patients were followed up at three, six, twelve, and eighteen months. The mean healing time for the neck fractures was 4.8 months and for the shaft fractures was 6.2 months. The greater trochanter was splintered and widened in two cases which eventually consolidated. Two patients had superficial infection, two patients had lateral migration of the screws with coxa vara which was due to severe osteoporosis detected during the followup. We had two cases of nonunion of shaft fracture and one case of nonunion of neck fracture. Two cases of avascular necrosis of femoral head were detected after 2 years of followup. No cases of implant failure were noted. Limb shortening of less than 2 cms was noted in four of our patients. The functional assessment system of Friedman and Wyman was used for evaluating the results. In our series 59.9% (n = 23) were rated as good, 30.6% (n = 11) as fair, and 5.5% (n = 2) as poor. Conclusion: Long PFN is a reliable option for concomitant ipsilateral diaphyseal and proximal femur fractures.	[Gadegone, W. M.; Lokhande, Vijayanand; Salphale, Yogesh] Chandrapur Multispecial Hosp, Vivek Nagar Chandrapur, India; [Ramteke, Alankar] Chandrapur Multispecial Hosp, Dept Orthopaed & Traumatol, Vivek Nagar Chandrapur, India	Gadegone, WM (corresponding author), Mul Rd, Chandrapur 442401, India.	gadegone123@yahoo.co.in	Salphale, Yogesh/J-9765-2019; RAMTEKE, ALANKAR/AAH-8781-2019	Salphale, Yogesh/0000-0001-6893-7922; Ramteke, Alankar/0000-0003-4023-4074			Abalo A, 2008, J Orthop Surg (Hong Kong), V16, P35; Alho A, 1996, J TRAUMA, V40, P10, DOI 10.1097/00005373-199601000-00003; Alho A, 1997, ANN CHIR GYNAECOL FE, V86, P326; BARQUET A, 1985, ACTA ORTHOP SCAND, V56, P36, DOI 10.3109/17453678508992976; BENNETT FS, 1993, CLIN ORTHOP RELAT R, P168; BOSE WJ, 1992, J TRAUMA, V32, P71, DOI 10.1097/00005373-199201000-00015; BUCHOLZ RW, 1985, ORTHOPEDICS, V8, P1402; CASEY MJ, 1979, J BONE JOINT SURG AM, V61, P503, DOI 10.2106/00004623-197961040-00003; CHATURVEDI S, 1993, INJURY, V24, P243, DOI 10.1016/0020-1383(93)90178-9; Chen C H, 2001, Kaohsiung J Med Sci, V17, P207; Dousa P, 2002, Acta Chir Orthop Traumatol Cech, V69, P22; Dousa P, 2010, ACTA CHIR ORTHOP TR, V77, P378; Friedman RJ, 1986, CLIN ORTHOP RELAT R, V208, P1880; Gadegone WM, 2007, INT ORTHOP, V31, P403, DOI 10.1007/s00264-006-0170-3; Huny SH, 2004, INJURY, V35, P165, DOI 10.1016/S0020-1383(03)00278-X; Oh CW, 2006, ARCH ORTHOP TRAUM SU, V126, P448, DOI 10.1007/s00402-006-0161-2; Pavleka T, 2005, ZENTRALBL CHIR, V130, P148; RAMSER JR, 1993, CLIN ORTHOP RELAT R, P189; RUSSEL T, 1992, CAMPBELLS OPERATIVE, V2, P896; Russell TA, 1986, CLIN ORTHOP RELAT R, V208, P188; SWIONTKOWSKI MF, 1984, J BONE JOINT SURG AM, V66A, P260, DOI 10.2106/00004623-198466020-00013; Windolf J, 2005, LANGENBECK ARCH SURG, V390, P59, DOI 10.1007/s00423-004-0466-y; Winquist, 1993, J Am Acad Orthop Surg, V1, P95; Wiss D A, 1992, J Orthop Trauma, V6, P159, DOI 10.1097/00005131-199206000-00005; WU CC, 1991, ACTA ORTHOP SCAND, V62, P346, DOI 10.3109/17453679108994467; ZETTAS JP, 1981, CLIN ORTHOP RELAT R, P63	26	12	15	0	3	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0019-5413	1998-3727		INDIAN J ORTHOP	Indian J. Orthop.	MAY-JUN	2013	47	3					272	277		10.4103/0019-5413.109441			6	Orthopedics	Orthopedics	207QS	WOS:000323618600009	23798758	Green Published, Bronze			2021-06-18	
J	Popovic, V				Popovic, Vera			Approach to Testing Growth Hormone (GH) Secretion in Obese Subjects	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article							INSULIN-INDUCED HYPOGLYCEMIA; QUALITY-OF-LIFE; REPLACEMENT THERAPY; (GH)-RELEASING HORMONE; HYPOPITUITARY ADULTS; PREMATURE MORTALITY; CONSENSUS STATEMENT; ENDOCRINE-SOCIETY; PROVOCATIVE TESTS; DEFICIENT ADULTS	Identification of adults with GH deficiency (GHD) is challenging because clinical features of adult GHD are not distinctive and because clinical suspicion must be confirmed by biochemical tests. Adults are selected for testing for adult GHD if they have a high pretest probability of GHD, ie, if they have hypothalamic-pituitary disease, if they have received cranial irradiation or central nervous system tumor treatment, or if they survived traumatic brain injury or subarachnoid hemorrhage. Testing should only be carried out if a decision has already been made that if deficiency is found it will be treated. There are many pharmacological GH stimulation tests for the diagnosis of GHD; however, none fulfill the requirements for an ideal test having high discriminatory power; being reproducible, safe, convenient, and economical; and not being dependent on confounding factors such as age, gender, nutritional status, and in particular obesity. In obesity, GH secretion is reduced, GH clearance is enhanced, and stimulated GH secretion is reduced, causing a false-positive result. This functional hyposomatotropism in obesity is fully reversed by weight loss. In conclusion, GH stimulation tests should be avoided in obese subjects with very low pretest probability.	[Popovic, Vera] Univ Belgrade, Dept Neuroendocrinol, Ctr Clin, Fac Med, Belgrade 11000, Serbia	Popovic, V (corresponding author), Univ Belgrade, Dept Neuroendocrinol, Clin Ctr Serbia, Fac Med, Dr Subotic 13, Belgrade 11000, Serbia.	popver@eunet.rs			Ministry of Science Republic Serbia [175033]	This work was supported by research grant no. 175033 from the Ministry of Science Republic Serbia.	Abs R, 1999, CLIN ENDOCRINOL, V50, P703, DOI 10.1046/j.1365-2265.1999.00695.x; Aimaretti G, 1998, J CLIN ENDOCR METAB, V83, P1615, DOI 10.1210/jc.83.5.1615; Aimaretti G, 2000, EUR J ENDOCRINOL, V142, P347, DOI 10.1530/eje.0.1420347; BARINAGA M, 1985, NATURE, V314, P279, DOI 10.1038/314279a0; Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; BOWERS CY, 1993, J PEDIATR ENDOCRINOL, V6, P21; Bredella MA, 2009, J CLIN ENDOCR METAB, V94, P3995, DOI 10.1210/jc.2009-0438; Bulow B, 1997, CLIN ENDOCRINOL, V46, P75, DOI 10.1046/j.1365-2265.1997.d01-1749.x; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Clayton PE, 2005, EUR J ENDOCRINOL, V152, P165, DOI 10.1530/eje.1.01829; Clayton P, 2007, GROWTH HORM IGF RES, V17, P369, DOI 10.1016/j.ghir.2007.04.010; Clemmons DR, 2011, CLIN CHEM, V57, P555, DOI 10.1373/clinchem.2010.150631; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Darzy Ken H., 2009, V15, P1, DOI 10.1159/000207607; DEBOER H, 1995, ENDOCR REV, V16, P63, DOI 10.1210/er.16.1.63; Franco C, 2006, J CLIN ENDOCR METAB, V91, P4408, DOI 10.1210/jc.2006-0887; Friend K, 1996, J CLIN ENDOCR METAB, V81, P3746, DOI 10.1210/jc.81.10.3746; Gaillard RC, 2012, EUR J ENDOCRINOL, V166, P1069, DOI 10.1530/EJE-11-1028; Ghigo E, 2001, ENDOCRINE, V15, P29, DOI 10.1385/ENDO:15:1:029; Gibney J, 1999, J CLIN ENDOCR METAB, V84, P2596, DOI 10.1210/jc.84.8.2596; Gleeson HK, 2005, J CLIN ENDOCR METAB, V90, P1061, DOI 10.1210/jc.2004-0501; Glynn N, 2013, CLIN ENDOCRINOL, V78, P17, DOI 10.1111/cen.12010; Gomez JM, 2002, CLIN ENDOCRINOL, V56, P329, DOI 10.1046/j.1365-2265.2002.01472.x; Gotherstrom G, 2007, J CLIN ENDOCR METAB, V92, P1442, DOI 10.1210/jc.2006-1487; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; HO KY, 1987, J CLIN ENDOCR METAB, V64, P51, DOI 10.1210/jcem-64-1-51; Hoeck HC, 2000, J CLIN ENDOCR METAB, V85, P1467, DOI 10.1210/jc.85.4.1467; Hoffman AR, 2004, J CLIN ENDOCR METAB, V89, P2048, DOI 10.1210/jc.2003-030346; HOFFMAN DM, 1994, LANCET, V343, P1064, DOI 10.1016/S0140-6736(94)90181-3; JOHANSSON JO, 1994, ARTERIOSCLER THROMB, V14, P434, DOI 10.1161/01.ATV.14.3.434; Kelestimur F, 2006, CLIN ENDOCRINOL, V64, P667, DOI 10.1111/j.1365-2265.2006.02525.x; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Koltowska-Haggstrom M, 2006, EUR J ENDOCRINOL, V155, P109, DOI 10.1530/eje.1.02176; Lee P, 2009, CLIN ENDOCRINOL, V71, P82, DOI 10.1111/j.1365-2265.2008.03466.x; Lissett CA, 2004, HORM RES, V62, P44, DOI 10.1159/000080758; Lissett CA, 2003, CLIN ENDOCRINOL, V59, P773, DOI 10.1046/j.1365-2265.2003.01884.x; Makimura H, 2008, J CLIN ENDOCR METAB, V93, P4254, DOI 10.1210/jc.2008-1333; McKenna SP, 1999, QUAL LIFE RES, V8, P373, DOI 10.1023/A:1008987922774; Micic D, 1998, J CLIN ENDOCR METAB, V83, P2569, DOI 10.1210/jc.83.7.2569; Micmacher E, 2009, ARQ BRAS ENDOCRINOL, V53, P853, DOI 10.1590/S0004-27302009000700009; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Mukherjee A, 2009, EUR J ENDOCRINOL, V161, pS33, DOI 10.1530/EJE-09-0247; NASS R, 1995, J CLIN ENDOCR METAB, V80, P552, DOI 10.1210/jc.80.2.552; Pfeifer M, 2001, CLIN ENDOCRINOL, V54, P17, DOI 10.1046/j.1365-2265.2001.01179.x; Pijl H, 2001, J CLIN ENDOCR METAB, V86, P5509, DOI 10.1210/jc.86.11.5509; Popovic V, 2004, CLIN ENDOCRINOL, V60, P185, DOI 10.1046/j.1365-2265.2003.01955.x; Popovic V, 2000, LANCET, V356, P1137, DOI 10.1016/S0140-6736(00)02755-0; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Rosilio M, 2004, J CLIN ENDOCR METAB, V89, P1684, DOI 10.1210/jc.2003-030134; ROTH J, 1963, SCIENCE, V140, P987, DOI 10.1126/science.140.3570.987; Russell-Aulet M, 2001, J GERONTOL A-BIOL, V56, pM124, DOI 10.1093/gerona/56.2.M124; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Stochholm K, 2007, EUR J ENDOCRINOL, V157, P9, DOI 10.1530/EJE-07-0013; Tanriverdi F, 2011, J ENDOCRINOL INVEST, V34, P541, DOI 10.3275/7805; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; Toogood AA, 1996, CLIN ENDOCRINOL, V45, P399, DOI 10.1046/j.1365-2265.1996.8310842.x; Utz AL, 2008, J CLIN ENDOCR METAB, V93, P4033, DOI 10.1210/jc.2008-0930; van Dam EWCM, 2002, J CLIN ENDOCR METAB, V87, P4225, DOI 10.1210/jc.2002-012006; VELDHUIS JD, 1991, J CLIN ENDOCR METAB, V72, P51, DOI 10.1210/jcem-72-1-51; Yuen KCJ, 2009, J CLIN ENDOCR METAB, V94, P2702, DOI 10.1210/jc.2009-0299	62	12	12	0	2	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0021-972X	1945-7197		J CLIN ENDOCR METAB	J. Clin. Endocrinol. Metab.	MAY	2013	98	5					1789	1796		10.1210/jc.2013-1099			8	Endocrinology & Metabolism	Endocrinology & Metabolism	140WX	WOS:000318688200032	23650336	Bronze			2021-06-18	
J	Sun, KJ; Zhu, L; Wang, HD; Ji, XJ; Pan, H; Chen, M; Lu, TJ; Fan, YW; Cheng, HL; Hang, CH; Shi, JX				Sun, Kang-jian; Zhu, Lin; Wang, Han-dong; Ji, Xiang-jun; Pan, Hao; Chen, Min; Lu, Tin -jia; Fan, You-wu; Cheng, Hui-lin; Hang, Chun-hua; Shi, Ji-xin			Zinc as mediator of ubiquitin conjugation following traumatic brain injury	BRAIN RESEARCH			English	Article						Neuron; Traumatic brain injury; Ubiquitin; Zinc	HIPPOCAMPAL-NEURONS; IN-VITRO; EXPRESSION; PATHWAY; DEATH; DEUBIQUITINATION; AUTOFLUORESCENCE; NEUROTOXICITY; DEGRADATION; NEDD4-1	Previous studies have shown that pathological zinc accumulation and deposition of ubiquitinated protein aggregates are commonly detected in many acute neural injuries, such as trauma, epilepsy and ischemia. However, the underlying mechanisms are poorly understood. Here we assessed the effect of zinc on ubiquitin conjugation and subsequent neurodegeration following traumatic brain injury (TBI). First, we found that scavenging endogenous Zn2+ reduced trauma-induced ubiquitin conjugation and protected neurons from TBI insults in rat hippocampus. Second, we detected both zinc accumulation and increased ubiquitin conjugated protein following brain trauma in human cortical neurons. Our previous study has shown that zinc can induce ubiquitin conjugation in cultured hippocampal neurons. All these findings indicate that alterations in Zn2+ homeostasis may impair the protein degradation pathway and ultimately cause neuronal injury following traumatic brain injury. (C) 2013 Elsevier B.V. All rights reserved.	[Sun, Kang-jian; Zhu, Lin; Wang, Han-dong; Ji, Xiang-jun; Pan, Hao; Fan, You-wu; Cheng, Hui-lin; Hang, Chun-hua; Shi, Ji-xin] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China; [Chen, Min; Lu, Tin -jia] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurosci, Inst Neurosci State, Shanghai, Peoples R China	Zhu, L (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China.	linzhu75@163.com	Chen, Min/A-1134-2014		Jinling Hospital of Nanjing [10MA097]; Chines Postdoctoral Science FoundationChina Postdoctoral Science Foundation [201150M1572]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271377/H0910]	The authors gratefully acknowledge Professor Zhang-You Wang (Department of Cell Engineering, China Medical University, Shenyang) for providing us with silver lactate and Professor Zhi-Qi Xiong (Institute of Neuroscience State, Key Laboratory of Neuroscience, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China) for technical assistance. This work was financially supported by the Jinling Hospital of Nanjing (Grant No 10MA097), the Chines Postdoctoral Science Foundation (Grant No 201150M1572) and the National Natural Science Foundation of China ( Grant 81271377/H0910).	BERS DM, 1994, METHOD CELL BIOL, V40, P3; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; Chen M, 2009, J NEUROCHEM, V111, P1094, DOI 10.1111/j.1471-4159.2009.06401.x; CHOI DW, 1988, NEUROSCIENCE, V24, P67, DOI 10.1016/0306-4522(88)90312-0; Elleder M, 2001, HISTOCHEM J, V33, P273, DOI 10.1023/A:1017925023408; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Figueiredo-Pereira ME, 1999, MOL BIOL REP, V26, P65, DOI 10.1023/A:1006909918866; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Gil MLG, 2001, J NEUROL SCI, V192, P27, DOI 10.1016/S0022-510X(01)00587-1; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GULTEKIN SH, 1994, ARCH PATHOL LAB MED, V118, P168; He CZ, 2004, J NEUROL SCI, V217, P47, DOI 10.1016/j.jns.2003.08.016; Ide T, 1999, J CEREBR BLOOD F MET, V19, P750, DOI 10.1097/00004647-199907000-00004; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Kwak YD, 2010, J BIOL CHEM, V285, P9847, DOI 10.1074/jbc.M109.091637; Majetschak M, 2008, J TRAUMA, V64, P586, DOI 10.1097/TA.0b013e3181641bc5; Mizukami K, 2002, ACTA NEUROPATHOL, V103, P453, DOI 10.1007/s00401-001-0489-1; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601; Sensi SL, 2000, EUR J NEUROSCI, V12, P3813, DOI 10.1046/j.1460-9568.2000.00277.x; Sensi SL, 2004, CURR MOL MED, V4, P87, DOI 10.2174/1566524043479211; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Watanabe T, 2010, J NEUROL SCI, V298, P52, DOI 10.1016/j.jns.2010.08.026; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Yao XL, 2007, BRAIN RES, V1182, P116, DOI 10.1016/j.brainres.2007.08.076; Zhang LH, 2008, BRAIN RES BULL, V77, P55, DOI 10.1016/j.brainresbull.2008.03.014; Zhu L, 2012, BRAIN RES, V1438, P1, DOI 10.1016/j.brainres.2011.12.031; Zhu L, 2009, BRAIN RES, V1289, P96, DOI 10.1016/j.brainres.2009.07.015	31	12	12	0	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	APR 19	2013	1506						132	141		10.1016/j.brainres.2013.02.011			10	Neurosciences	Neurosciences & Neurology	134KJ	WOS:000318208800012	23419896				2021-06-18	
J	Ding, GL; Chopp, M; Poulsen, DJ; Li, L; Qu, CS; Li, QJ; Nejad-Davarani, SP; Budaj, JS; Wu, HT; Mahmood, A; Jiang, Q				Ding, Guang Liang; Chopp, Michael; Poulsen, David J.; Li, Lian; Qu, Changsheng; Li, Qingjiang; Nejad-Davarani, Siamak P.; Budaj, John S.; Wu, Hongtao; Mahmood, Asim; Jiang, Quan			MRI of Neuronal Recovery after Low-Dose Methamphetamine Treatment of Traumatic Brain Injury in Rats	PLOS ONE			English	Article							MARROW STROMAL CELL; DIFFUSE AXONAL INJURY; WHITE-MATTER INJURY; CEREBRAL-ISCHEMIA; EMBOLIC STROKE; ATROPHY; TRANSPLANTATION; SUBPOPULATION; ARCHITECTURE; EXPRESSION	We assessed the effects of low dose methamphetamine treatment of traumatic brain injury (TBI) in rats by employing MRI, immunohistology, and neurological functional tests. Young male Wistar rats were subjected to TBI using the controlled cortical impact model. The treated rats (n = 10) received an intravenous (iv) bolus dose of 0.42 mg/kg of methamphetamine at eight hours after the TBI followed by continuous iv infusion for 24 hrs. The control rats (n = 10) received the same volume of saline using the same protocol. MRI scans, including T2-weighted imaging (T2WI) and diffusion tensor imaging (DTI), were performed one day prior to TBI, and at 1 and 3 days post TBI, and then weekly for 6 weeks. The lesion volumes of TBI damaged cerebral tissue were demarcated by elevated values in T-2 maps and were histologically identified by hematoxylin and eosin (H&E) staining. The fractional anisotropy (FA) values within regions-of-interest (ROI) were measured in FA maps deduced from DTI, and were directly compared with Bielschowsky's silver and Luxol fast blue (BLFB) immunohistological staining. No therapeutic effect on lesion volumes was detected during 6 weeks after TBI. However, treatment significantly increased FA values in the recovery ROI compared with the control group at 5 and 6 weeks after TBI. Myelinated axons histologically measured using BLFB were significantly increased (p<0.001) in the treated group (25.84 +/- 1.41%) compared with the control group (17.05 +/- 2.95%). Significant correlations were detected between FA and BLFB measures in the recovery ROI (R = 0.54, p<0.02). Methamphetamine treatment significantly reduced modified neurological severity scores from 2 to 6 weeks (p<0.05) and foot-fault errors from 3 days to 6 weeks (p<0.05) after TBI. Thus, the FA data suggest that methamphetamine treatment improves white matter reorganization from 5 to 6 weeks after TBI in rats compared with saline treatment, which may contribute to the observed functional recovery.	[Ding, Guang Liang; Chopp, Michael; Li, Lian; Li, Qingjiang; Nejad-Davarani, Siamak P.; Budaj, John S.; Jiang, Quan] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Poulsen, David J.] Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA; [Qu, Changsheng; Wu, Hongtao; Mahmood, Asim] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Jiang, Q (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	qjiang1@hfhs.org	Nejad-Davarani, Siamak/AAH-8399-2021	Nejad-Davarani, Siamak/0000-0002-2415-6689; Ding, Guangliang/0000-0003-1286-5901	Department of DefenseUnited States Department of Defense [CDMRP DR080702 (W81XWH-11-2-0026)]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS064134]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS064134] Funding Source: NIH RePORTER	This work was financially supported by Department of Defense Grant CDMRP DR080702 (W81XWH-11-2-0026) and National Institutes of Health RO1 NS064134. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldskogius H, 1998, PROG NEUROBIOL, V55, P1, DOI 10.1016/S0301-0082(97)00093-2; Alexander DC, 2005, ANN NY ACAD SCI, V1064, P113, DOI 10.1196/annals.1340.018; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Bigler E D, 1987, Arch Clin Neuropsychol, V2, P293, DOI 10.1016/0887-6177(87)90017-5; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Braun AA, 2011, NEUROSCIENCE, V184, P164, DOI 10.1016/j.neuroscience.2011.03.045; CAMPBELL MJ, 1989, J COMP NEUROL, V282, P191, DOI 10.1002/cne.902820204; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cheung MM, 2009, NEUROIMAGE, V45, P386, DOI 10.1016/j.neuroimage.2008.12.018; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Ding GL, 2011, STROKE, V42, P3537, DOI 10.1161/STROKEAHA.111.622092; Ding GL, 2010, J NEUROSCI RES, V88, P3206, DOI 10.1002/jnr.22470; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DZIABIS MD, 1958, STAIN TECHNOL, V33, P96; GOTTRON F, 1995, NEUROSCI LETT, V194, P1, DOI 10.1016/0304-3940(95)11698-V; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Jiang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042845; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; KALCHEVA N, 1995, P NATL ACAD SCI USA, V92, P10894, DOI 10.1073/pnas.92.24.10894; Lazar M, 2008, MAGN RESON MED, V60, P774, DOI 10.1002/mrm.21725; Li L, 2012, J CEREBR BLOOD F MET, V32, P2023, DOI 10.1038/jcbfm.2012.106; Li LA, 2011, J NEUROTRAUM, V28, P535, DOI 10.1089/neu.2010.1619; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liu ZW, 2007, BRAIN RES, V1149, P172, DOI 10.1016/j.brainres.2007.02.047; Llewellyn BD, 2009, BIOTECH HISTOCHEM, V84, P159, DOI 10.1080/10520290903052899; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mamere AE, 2009, AM J NEURORADIOL, V30, P947, DOI 10.3174/ajnr.A1477; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McIntosh A, 2006, NEUROLOGY, V67, P2259, DOI 10.1212/01.wnl.0000249180.61312.d3; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; PECK DJ, 1992, MAGNET RESON MED, V26, P259, DOI 10.1002/mrm.1910260207; Rau TF, 2012, J TRAUMA ACUTE CARE, V73, pS165, DOI 10.1097/TA.0b013e318260896a; Rau TF, 2011, NEUROPHARMACOLOGY, V61, P677, DOI 10.1016/j.neuropharm.2011.05.010; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; Shojo H, 2006, BRAIN RES, V1078, P198, DOI 10.1016/j.brainres.2006.01.063; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Tanaka K, 2003, BRAIN RES, V989, P172, DOI 10.1016/S0006-8993(03)03317-1; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Xiong Y, 2012, J NEUROSURG, V116, P1081, DOI 10.3171/2012.1.JNS111729; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]	54	12	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61241	10.1371/journal.pone.0061241			9	Multidisciplinary Sciences	Science & Technology - Other Topics	130IU	WOS:000317908700017	23637800	DOAJ Gold, Green Published			2021-06-18	
J	Boone, DR; Sell, SL; Hellmich, HL				Boone, Deborah R.; Sell, Stacy L.; Hellmich, Helen Lee			Laser Capture Microdissection of Enriched Populations of Neurons or Single Neurons for Gene Expression Analysis After Traumatic Brain Injury	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Neuroscience; Issue 74; Neurobiology; Medicine; Biomedical Engineering; Anatomy; Physiology; Cellular Biology; Molecular Biology; Genetics; Surgery; Anesthesiology; Micromanipulation; Microdissection; Laser Capture Microdissection; LCM; Investigative Techniques; traumatic brain injury; TBI; hippocampus; Fluoro-Jade; gene expression analysis; gene expression; neurons; animal model	FLUORO-JADE; RNA	Long-term cognitive disability after TBI is associated with injury-induced neurodegeneration in the hippocampus-a region in the medial temporal lobe that is critical for learning, memory and executive function.(1,2) Hence our studies focus on gene expression analysis of specific neuronal populations in distinct subregions of the hippocampus. The technique of laser capture microdissection (LCM), introduced in 1996 by Emmert-Buck, et al.,(3) has allowed for significant advances in gene expression analysis of single cells and enriched populations of cells from heterogeneous tissues such as the mammalian brain that contains thousands of functional cell types.(4) We use LCM and a well established rat model of traumatic brain injury (TBI) to investigate the molecular mechanisms that underlie the pathogenesis of TBI. Following fluid-percussion TBI, brains are removed at pre-determined times post-injury, immediately frozen on dry ice, and prepared for sectioning in a cryostat. The rat brains can be embedded in OCT and sectioned immediately, or stored several months at -80 degrees C before sectioning for laser capture microdissection. Additionally, we use LCM to study the effects of TBI on circadian rhythms. For this, we capture neurons from the suprachiasmatic nuclei that contain the master clock of the mammalian brain. Here, we demonstrate the use of LCM to obtain single identified neurons (injured and degenerating, Fluoro-Jade-positive, or uninjured, Fluoro-Jade-negative) and enriched populations of hippocampal neurons for subsequent gene expression analysis by real time PCR and/or whole-genome microarrays. These LCM-enabled studies have revealed that the selective vulnerability of anatomically distinct regions of the rat hippocampus are reflected in the different gene expression profiles of different populations of neurons obtained by LCM from these distinct regions. The results from our single-cell studies, where we compare the transcriptional profiles of dying and adjacent surviving hippocampal neurons, suggest the existence of a cell survival rheostat that regulates cell death and survival after TBI.	[Boone, Deborah R.; Sell, Stacy L.; Hellmich, Helen Lee] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA	Hellmich, HL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	hhellmic@utmb.edu			Moody Foundation; Department of Anesthesiology;  [R01 NS052532]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS052532] Funding Source: NIH RePORTER	This work is funded by R01 NS052532 (to HLH), the Moody Foundation, and the Department of Anesthesiology. We thank Laurie Bolding, Christine Courteau Butler and Christy Perry for their editorial assistance, and Christy Perry for layout and excellent production of all figures, tables and artwork.	Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; Banks RE, 1999, ELECTROPHORESIS, V20, P689, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<689::AID-ELPS689>3.0.CO;2-J; Bast T, 2007, REV NEUROSCIENCE, V18, P253; Bota M, 2003, NAT NEUROSCI, V6, P795, DOI 10.1038/nn1096; Chen H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00098; Elstner M, 2011, ACTA NEUROPATHOL, V122, P75, DOI 10.1007/s00401-011-0828-9; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Fend F, 1999, AM J PATHOL, V154, P61, DOI 10.1016/S0002-9440(10)65251-0; Hellmich HL, 2005, ANESTHESIOLOGY, V102, P806, DOI 10.1097/00000542-200504000-00017; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Shah SA, 2006, EXP GERONTOL, V41, P1201, DOI 10.1016/j.exger.2006.07.006; Shimamura M, 2005, NEUROSCIENCE, V131, P87, DOI 10.1016/j.neuroscience.2004.10.041; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Ye XM, 2001, BRAIN RES PROTOC, V8, P104, DOI 10.1016/S1385-299X(01)00086-1; ZENG YC, 1995, MECH AGEING DEV, V79, P169, DOI 10.1016/0047-6374(94)01559-5	21	12	12	0	0	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	APR	2013		74							e50308	10.3791/50308			7	Multidisciplinary Sciences	Science & Technology - Other Topics	V36QY	WOS:000209227100031	23603738	Green Published, Bronze			2021-06-18	
J	Davis, JJ; Axelrod, BN; McHugh, TS; Hanks, RA; Millis, SR				Davis, Jeremy J.; Axelrod, Bradley N.; McHugh, Tara S.; Hanks, Robin A.; Millis, Scott R.			Number of impaired scores as a performance validity indicator	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Performance validity; Effort assessment; Forensic neuropsychology; Impaired scores	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL TESTS; NONCLINICAL SAMPLE; TEST BATTERIES; SUSPECT EFFORT; DIGIT SPAN; SPECIFICITY; SENSITIVITY; CLAIMANTS	This study examined embedded performance validity indicators (PVI) based on the number of impaired scores in an evaluation and the overall test battery mean (OTBM). Adult participants (N=175) reporting traumatic brain injury were grouped using eight PVI. Participants who passed all PVI (n=67) demonstrated fewer impaired scores and higher OTBM than those who failed two or more PVI (n=66). Impairment was defined at three levels: T scores < 40, 35, and 30. With specificity .90, sensitivity ranged from .51 to .71 for number of impaired scores and .74 for OTBM.	[Davis, Jeremy J.] Univ Utah, Sch Med, Div Phys Med & Rehabil, Salt Lake City, UT 84132 USA; [Axelrod, Bradley N.] John Dingell VA Med Ctr, Detroit, MI USA; [McHugh, Tara S.] Ottawa Hosp, Ottawa, ON, Canada; [Hanks, Robin A.; Millis, Scott R.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA	Davis, JJ (corresponding author), Univ Utah, Sch Med, Div Phys Med & Rehabil, 30 North 1900 East,1R55, Salt Lake City, UT 84132 USA.	jeremy.davis@hsc.utah.edu					Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Axelrod BN, 2008, APPL NEUROPSYCHOL, V15, P170, DOI 10.1080/09084280802324184; Axelrod BN, 2007, INT J NEUROSCI, V117, P1591, DOI 10.1080/00207450600941189; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Blair JR., 1989, CLIN NEUROPSYCHOL, V3, P129; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Crawford JR, 2007, NEUROPSYCHOLOGY, V21, P419, DOI 10.1037/0894-4105.21.4.419; Davis JJ, 2012, CLIN NEUROPSYCHOL, V26, P850, DOI 10.1080/13854046.2012.686631; Fox DD, 2011, CLIN NEUROPSYCHOL, V25, P488, DOI 10.1080/13854046.2011.554443; Gladsjo JA, 1999, NORMS LETT CATEGORY; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Griffin GAE, 1997, J CLIN PSYCHOL, V53, P757, DOI 10.1002/(SICI)1097-4679(199711)53:7<757::AID-JCLP14>3.0.CO;2-K; Heaton R. K, 1981, WISCONSIN CARD SORTI; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hosmer D. W., 2000, APPL LOGISTIC REGRES; Ingraham LJ, 1996, NEUROPSYCHOLOGY, V10, P120, DOI 10.1037/0894-4105.10.1.120; Iverson GL, 1998, BRAIN INJURY, V12, P275, DOI 10.1080/026990598122575; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Lezak M.D., 1983, NEUROPSYCHOLOGICAL A; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Matthews C, 1964, INSTRUCTION MANUAL A; Meyers J., 1995, REY COMPLEX FIGURE T; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Millis S. R., 2002, J FORENSIC NEUROPSYC, V2, P147; Moss A, 2003, BRAIN INJURY, V17, P377, DOI 10.1080/0269905031000070125; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Rohling ML, 2000, ARCH CLIN NEUROPSYCH, V15, P821, DOI 10.1016/S0887-6177(00)80311-X; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Sweet JJ, 2002, CLIN NEUROPSYCHOL, V16, P481, DOI 10.1076/clin.16.4.481.13914; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wilkinson G. S., 1993, WIDE RANGE ACHIEVEME; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791	40	12	12	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR 1	2013	35	4					413	420		10.1080/13803395.2013.781134			8	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	129LR	WOS:000317841600007	23514206				2021-06-18	
J	Osuka, A; Uno, T; Nakanishi, J; Hinokiyama, H; Takahashi, Y; Matsuoka, T				Osuka, Akinori; Uno, Taeko; Nakanishi, Jun; Hinokiyama, Hiromi; Takahashi, Yoshiaki; Matsuoka, Tetsuya			Energy expenditure in patients with severe head injury: Controlled normothermia with sedation and neuromuscular blockade	JOURNAL OF CRITICAL CARE			English	Article						Energy expenditure; Neuromuscular blockade; Indirect calorimetry; Head injury	MECHANICALLY VENTILATED PATIENTS; TRAUMATIC BRAIN-INJURY; CRITICALLY-ILL PATIENTS; OXYGEN-CONSUMPTION; INDIRECT CALORIMETRY; CARDIAC-SURGERY; RESUSCITATION; VALIDATION; GUIDELINES; PARALYSIS	Objectives: Providing optimal caloric intake is important for patients with severe traumatic brain injury. Insufficient nutrition worsens prognosis, and excessive nutrition may lead to complications such as weaning delay from mechanical ventilation. However, using controlled normothermia with sedation and neuromuscular blockade for patients with anticipated severe brain edema, the optimal caloric intake is still unclear. Methods: Ten patients with severe traumatic brain injury were studied. All patients received midazolam and vecuronium or pancuronium to control body temperature to 36.0 degrees C. Energy expenditure was measured using indirect calorimetry. Age, body height, body weight, heart rate, blood pressure, body temperature, and minute ventilation volume were evaluated at the time of the study. Differences between the mean measured energy expenditures (MEEs) and predicted basal energy expenditures (PEEs from the Harris-Benedict equation) were analyzed using paired t test. Furthermore, the relationships between these variables and MEEs were analyzed with multiple regression analysis. Results: The result of MEE was 1279 +/- 244 kcal/d. When compared with PEE, MEE/PEE was 87.2% +/- 10%. Multiple regression analysis showed that age, body height, body weight, heart rate, and minute ventilation volume were related with MEE. Conclusions: Energy expenditure in patients with severe traumatic brain injury who need mechanical ventilation and have received controlled normothermia with sedation and neuromuscular blockade was 13% less than predicted basal levels. Energy expenditure might be obtained from age, body height, body weight, heart rate, and minute ventilation. (C) 2013 Elsevier Inc. All rights reserved.	[Osuka, Akinori; Uno, Taeko; Nakanishi, Jun; Hinokiyama, Hiromi; Takahashi, Yoshiaki; Matsuoka, Tetsuya] Osaka Prefectural Senshu Crit Care Med Ctr, Izumisano, Osaka 5980048, Japan	Osuka, A (corresponding author), Osaka Prefectural Senshu Crit Care Med Ctr, Izumisano, Osaka 5980048, Japan.	akinori@sccmc.izumisano.osaka.jp	Osuka, Akinori/S-1936-2017	Osuka, Akinori/0000-0002-7575-7927			Barton Richard G., 1997, Journal of Burn Care and Rehabilitation, V18, P461, DOI 10.1097/00004630-199709000-00019; BRADFIELD RB, 1971, AM J CLIN NUTR, V24, P1148; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P539; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS77; Brosh A, 2007, J ANIM SCI, V85, P1213, DOI 10.2527/jas.2006-298; Bruder N, 1998, CRIT CARE MED, V26, P568, DOI 10.1097/00003246-199803000-00033; BRUDER N, 1994, CRIT CARE MED, V22, P1114, DOI 10.1097/00003246-199407000-00011; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; DAMASK MC, 1982, ANESTHESIOLOGY, V57, P213, DOI 10.1097/00000542-198209000-00011; Epstein CD, 2000, CRIT CARE MED, V28, P1363, DOI 10.1097/00003246-200005000-00017; Faisy C, 2003, AM J CLIN NUTR, V78, P241; Frankenfield David, 2006, Nutr Clin Pract, V21, P430, DOI 10.1177/0115426506021005430; Giner M, 1996, NUTRITION, V12, P23, DOI 10.1016/0899-9007(95)00015-1; Herndon DN, 2001, NEW ENGL J MED, V345, P1223, DOI 10.1056/NEJMoa010342; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Lemson J, 2008, INTENS CARE MED, V34, P2268, DOI 10.1007/s00134-008-1252-z; Livingstone MBE, 1997, BRIT J NUTR, V78, P869, DOI 10.1079/BJN19970205; MANTHOUS CA, 1995, AM J RESP CRIT CARE, V151, P210, DOI 10.1164/ajrccm.151.1.7812556; Marik PE, 1996, CHEST, V109, P1038, DOI 10.1378/chest.109.4.1038; McCall M, 2003, JPEN-PARENTER ENTER, V27, P27, DOI 10.1177/014860710302700127; Nolan JP, 2005, RESUSCITATION, V67, pS39, DOI 10.1016/j.resuscitation.2005.10.009; PALMISANO BW, 1984, ANESTHESIOLOGY, V61, P518, DOI 10.1097/00000542-198411000-00007; PAYNE PR, 1971, AM J CLIN NUTR, V24, P1164; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Pepe JL, 1999, J HEAD TRAUMA REHAB, V14, P462, DOI 10.1097/00001199-199910000-00007; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; RAURICH JM, 1994, JPEN-PARENTER ENTER, V18, P521, DOI 10.1177/0148607194018006521; Savard JF, 2008, CRIT CARE MED, V36, P1175, DOI 10.1097/CCM.0b013e3181691502; SUNDERLAND PM, 1992, NEUROSURGERY, V31, P246, DOI 10.1227/00006123-199208000-00009; Sunderland PM, 1992, NEUROSURGERY, V31, P252; Terao Y, 2003, CRIT CARE MED, V31, P830, DOI 10.1097/01.CCM.0000054868.93459.E1; Vernon DD, 2000, CRIT CARE MED, V28, P1569, DOI 10.1097/00003246-200005000-00051; WARNOLD I, 1977, AM J CLIN NUTR, V30, P304; Wilson RF, 1998, J HEAD TRAUMA REHAB, V13, P11, DOI 10.1097/00001199-199802000-00005	34	12	12	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441			J CRIT CARE	J. Crit. Care	APR	2013	28	2							218.e9	10.1016/j.jcrc.2012.05.012			5	Critical Care Medicine	General & Internal Medicine	110TF	WOS:000316468100024	22835423				2021-06-18	
J	Williams, G; Schache, A; Morris, ME				Williams, Gavin; Schache, Anthony; Morris, Meg E.			Running abnormalities after traumatic brain injury	BRAIN INJURY			English	Article						Brain injuries; gait; rehabilitation; biomechanics; running	HIGH-LEVEL MOBILITY; GAIT ANALYSIS; POWER-GENERATION; CLUSTER-ANALYSIS; DECISION-MAKING; ASSESSMENT-TOOL; WALKING SPEED; HIP FLEXORS; STROKE; ANKLE	Primary objectives: The aim of this study was to identify the type and incidence of running abnormalities following TBI when compared to a group of healthy controls (HC) and report if these abnormalities were similar to those which are present during gait. Research design: A convenience sample of 44 people with TBI receiving therapy for mobility limitations and a sample of 15 healthy controls (HCs). Main outcomes and results: Spatio-temporal, kinematic and kinetic data at self-selected walking and running speeds were collected. People with TBI ran at significantly slower self-selected speeds than HCs. At matched running speeds, people with TBI used a higher cadence and shorter step length. The most commonly observed biomechanical abnormalities occurred at the knee during stance phase. Few trunk, pelvic or hip abnormalities were detected. Ankle power generation at push-off was significantly reduced, whereas hip extensor power generation at initial contact was significantly increased. Conclusion: Many people with TBI may actually be capable of running, despite the presence of significant biomechanical abnormalities during gait. A stable trunk may be an important requirement for people following TBI to achieve running.	[Williams, Gavin] Epworth Med Fdn, Melbourne, Vic, Australia; [Williams, Gavin] Univ Melbourne, Sch Hlth Sci, Melbourne, Vic, Australia; [Schache, Anthony] Univ Melbourne, Sch Mech Engn, Melbourne, Vic, Australia; [Morris, Meg E.] La Trobe Univ, Sch Allied Hlth, Bundoora, Vic, Australia	Williams, G (corresponding author), Epworth Med Fdn, Physiotherapy Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.	gavin.williams@epworth.org.au	Schache, Anthony G/F-4482-2016	Schache, Anthony G/0000-0002-1041-5213; Morris, Meg/0000-0002-0114-4175; Williams, Gavin/0000-0003-2758-7473	Victorian Neurotrauma Initiative	This project was supported by a fellowship from the Victorian Neurotrauma Initiative.	Badke Mary Beth, 1993, Physiotherapy Canada, V45, P15; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Cantin JF, 2007, BRAIN INJURY, V21, P327, DOI 10.1080/02699050701209972; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Chua KSG, 2001, BRAIN INJURY, V15, P733, DOI 10.1080/02699050010009775; DeLuca PA, 1997, J PEDIATR ORTHOPED, V17, P608, DOI 10.1097/00004694-199709000-00007; Esquenazi A, 2004, J HEAD TRAUMA REHAB, V19, P109, DOI 10.1097/00001199-200403000-00004; Fock J, 2004, BRAIN INJURY, V18, P57, DOI 10.1080/0269905031000149498; Fuller DA, 2002, FOOT ANKLE INT, V23, P738, DOI 10.1177/107110070202300810; Gardner MB, 1998, PHYS THER, V78, P361, DOI 10.1093/ptj/78.4.361; GOWLAND C, 1993, STROKE, V24, P58, DOI 10.1161/01.STR.24.1.58; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Harrington ME, 2007, J BIOMECH, V40, P595, DOI 10.1016/j.jbiomech.2006.02.003; Jonkers I, 2009, GAIT POSTURE, V29, P129, DOI 10.1016/j.gaitpost.2008.07.010; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kay RM, 2000, CLIN ORTHOP RELAT R, P217; Kerrigan DC, 1996, ARCH PHYS MED REHAB, V77, P645, DOI 10.1016/S0003-9993(96)90002-7; Lindstrom B, 2009, J REHABIL MED, V41, P714, DOI 10.2340/16501977-0423; Liu MQ, 2008, J BIOMECH, V41, P3243, DOI 10.1016/j.jbiomech.2008.07.031; Malec JF., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Miller EW, 2008, PHYS THER, V88, P511, DOI 10.2522/ptj.20050240; Milot MH, 2007, J ELECTROMYOGR KINES, V17, P184, DOI 10.1016/j.jelekin.2006.01.001; Moriello G, 2009, J NEUROL PHYS THER, V33, P111, DOI 10.1097/NPT.0b013e3181a6ab6b; Mulroy S, 2003, GAIT POSTURE, V18, P114, DOI 10.1016/S0966-6362(02)00165-0; Nadeau S, 1999, CLIN BIOMECH, V14, P125, DOI 10.1016/S0268-0033(98)00062-X; Neptune RR, 2008, GAIT POSTURE, V28, P135, DOI 10.1016/j.gaitpost.2007.11.004; Novacheck TF, 1995, AAOS INSTR COURS LEC, V44, P497; Perry J, 1999, J HEAD TRAUMA REHAB, V14, P116, DOI 10.1097/00001199-199904000-00003; Powell JH, 1998, ARCH PHYS MED REHAB, V79, P1213, DOI 10.1016/S0003-9993(98)90265-9; Requiao LF, 2005, J ELECTROMYOGR KINES, V15, P393, DOI 10.1016/j.jelekin.2004.12.004; Rodda JM, 2004, J BONE JOINT SURG BR, V86B, P251, DOI 10.1302/0301-620X.86B2.13878; Rozumalski A, 2009, GAIT POSTURE, V30, P155, DOI 10.1016/j.gaitpost.2009.05.010; Saunders SW, 2005, CLIN BIOMECH, V20, P784, DOI 10.1016/j.clinbiomech.2005.04.004; Schache AG, 2007, GAIT POSTURE, V25, P440, DOI 10.1016/j.gaitpost.2006.05.018; SEABY L, 1989, Physiotherapy Canada, V41, P264; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; Thurman DJ, 1999, TRAUMATIC BRAIN INJU; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Williams G, 2004, AM J PHYS MED REHAB, V83, P910, DOI 10.1097/01.PHM.0000146503.25221.1D; Williams G, 2009, INT J THER REHABIL, V16, P2; Williams G, 2010, NEUROREHAB NEURAL RE, V24, P550, DOI 10.1177/1545968309357925; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Williams GP, 2010, J HEAD TRAUMA REHAB, V25, P164, DOI 10.1097/HTR.0b013e3181dc120b; Williams GP, 2009, BRAIN INJURY, V23, P307, DOI 10.1080/02699050902774170; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; WINTER DA, 1983, J BIOMECH, V16, P91, DOI 10.1016/0021-9290(83)90050-7	49	12	12	0	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2013	27	4					434	443		10.3109/02699052.2012.750754			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	117LG	WOS:000316954300008	23473505				2021-06-18	
J	Liu, NK; Zhang, YP; O'Connor, J; Gianaris, A; Oakes, E; Lu, QB; Verhovshek, T; Walker, CL; Shields, CB; Xu, XM				Liu, Nai-Kui; Zhang, Yi-Ping; O'Connor, Jeremy; Gianaris, Alexander; Oakes, Eddie; Lu, Qing-Bo; Verhovshek, Tom; Walker, Chandler L.; Shields, Christopher B.; Xu, Xiao-Ming			A bilateral head injury that shows graded brain damage and behavioral deficits in adult mice	BRAIN RESEARCH			English	Article						Traumatic brain injury; Controlled cortical impact; Closed head injury; Behavior; Histology	CONTROLLED CORTICAL IMPACT; COGNITIVE DEFICITS; MODEL; HISTOPATHOLOGY; MOUSE; RATS	Reliable animal models of traumatic brain injury (TBI) are essential to test novel hypotheses and therapeutic interventions. In this study, based on advantages of both the closed head injury (CHI) and controlled cortical impact (CCI) models, we developed a bilateral head injury model in mice. C57BL/6 mice were used in this study. A midline craniotomy (5 mm diameter) was performed extending 2 mm anteriorly and 3 mm posteriorly from the bregma, centered over the sagittal suture. The skull flap was left in place. A cortical impact on the surface of the skull flap was performed using an electromagnetic impactor. Here we report that the injury significantly decreased the neuroscore and increased foot drops in a severity-dependent manner. Severity-related deficits in performance on a rotarod device were also found at both slow and fast accelerations. These findings suggest that our TBI model can produce graded motor deficits. In addition, Morris water maze testing showed increased latency to locate a hidden platform in a severity-dependent manner, suggesting that our model can also produce graded memory deficits. Furthermore, an adhesive removal test revealed significant increases in time-to-contact and time-to-remove the adhesive tape from the paw in a severity-dependent manner, indicating that our TBI model produced graded somatosensory and motor deficits. Histological analysis presented a clear gradation in brain tissue damage following graded brain injuries. These findings collectively suggest that the current model may offer a sensitive, reliable and clinically-relevant model for assessments of therapeutic strategies for TBI. (C) 2012 Elsevier B.V. All rights reserved.	[Liu, Nai-Kui; O'Connor, Jeremy; Gianaris, Alexander; Oakes, Eddie; Lu, Qing-Bo; Verhovshek, Tom; Walker, Chandler L.; Xu, Xiao-Ming] Indiana Univ Sch Med, Stark Neurosci Res Inst, Spinal Cord & Brain Injury Res Grp, Dept Neurol Surg & Goodman Campbell Brain & Spine, Indianapolis, IN 46202 USA; [Zhang, Yi-Ping; Shields, Christopher B.] Norton Healthcare, Norton Neurosci Inst, Louisville, KY 40202 USA	Liu, NK (corresponding author), Indiana Univ Sch Med, Stark Neurosci Res Inst, Spinal Cord & Brain Injury Res Grp, 950 West Walnut St,R2 Bldg,Room 402, Indianapolis, IN 46202 USA.	nailiu@iupui.edu	Walker, Chandler L./D-2256-2014	Walker, Chandler L./0000-0002-8616-8263; Xu, Xiao-ming/0000-0002-7229-0081; O'Connor, Jeremy/0000-0002-7907-6432	Indiana Spinal Cord and Brain Injury Research Foundation; Mari Hulman George Endowment; State of Indiana (ISDH) [A70-2-079609, A70-9-079138]	This work was supported by Indiana Spinal Cord and Brain Injury Research Foundation and Mari Hulman George Endowment (XMX), and by the State of Indiana (ISDH, Grant # A70-2-079609 and A70-9-079138) (NKL).	Ahmad M, 2008, J NEUROSCI RES, V86, P3605, DOI 10.1002/jnr.21809; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Dixon CE, 2003, CRIT CARE MED, V31, P2222, DOI 10.1097/01.CCM.0000080493.04978.73; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Haar CV, 2011, BEHAV BRAIN RES, V224, P311, DOI 10.1016/j.bbr.2011.06.009; Hannay HJ, 1999, J NEUROTRAUM, V16, P1103, DOI 10.1089/neu.1999.16.1103; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/0897715042664876; MARKLUND N, 2010, BR J PHARM; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Nakamura M, 1999, J CEREBR BLOOD F MET, V19, P762, DOI 10.1097/00004647-199907000-00006; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Varma MR, 2002, BRAIN RES, V951, P191, DOI 10.1016/S0006-8993(02)03161-X; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116	24	12	12	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 7	2013	1499						121	128		10.1016/j.brainres.2012.12.031			8	Neurosciences	Neurosciences & Neurology	113ZX	WOS:000316710300011	23276498				2021-06-18	
J	Boycott, N; Yeoman, P; Vesey, P				Boycott, Naomi; Yeoman, Paddy; Vesey, Patrick			Factors Associated With Strain in Carers of People With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						carer; Caregiver Strain Index (CSI); Glasgow Outcome Scale (GOS); head injury; neurobehavioral functioning; Neurobehavioral Functioning Inventory (NFI); strain; traumatic brain injury (TBI)	GLASGOW OUTCOME SCALE; BLUNT HEAD-INJURY; FAMILY-MEMBERS; RELATIVES; INTERVENTION; DISTRESS; STRESS; SATISFACTION; VALIDATION; CAREGIVERS	Objective: To explore factors associated with strain in carers of patients with traumatic brain injury. Design: Cross-sectional cohort study. Participants: Forty-eight carers of patients with traumatic brain injury admitted to a neurosurgical unit over a 9-year period were assessed an average of 9.3 years after injury. Measures: Caregiver Strain Index (CSI), Neurobehavioral Functioning Inventory (NFI), Glasgow Outcome Scale (GOS), Virginia Prediction Tree Score, and carer and patient demographics. Procedure: Carers were assessed via postal survey for levels of strain using the CSI and for their perception of the patients' disabilities using the NFI. Results: Elevated levels of strain were found in 42% of carers. Using logistic regression, outcome as rated by the patients' general practitioner on the GOS and all subscales of the NFI (except Somatic) explained 41% to 57% of the variance in strain and predicted group membership correctly in 72.9% of cases. No individual variable contributed significantly to the explained variance in the model. Conclusion: A number of factors appear to combine to result in feelings of strain, but the GOS could be used as a crude screening tool. Interventions for cognitive, behavioral, and emotional difficulties may be most useful for carers.	[Boycott, Naomi] Nottinghamshire Healthcare NHS Trust, CLAHRC, Nottingham, England; [Yeoman, Paddy; Vesey, Patrick] Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Nottingham, England	Boycott, N (corresponding author), Univ Nottingham, CLAHRCNDL, Innovat Pk,Sir Colin Campbell Bldg,Triumph Rd, Nottingham NG7 2TU, England.	naomi.boycott@nottshc.nhs.uk			University of Nottingham	The authors thank the research tutors and supervisors at the University of Nottingham for the advice and support they provided. The project was funded as part of doctoral thesis in clinical psychology at the University of Nottingham.	ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/h0080313; Blake H, 2000, CLIN REHABIL, V14, P307, DOI 10.1191/026921500667530134; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1986, J HEAD TRAUMA REHAB, V2, P1; Bugge C, 1999, STROKE, V30, P1517, DOI 10.1161/01.STR.30.8.1517; Carnevale GJ, 2006, ARCH PHYS MED REHAB, V87, P1289, DOI 10.1016/j.apmr.2006.06.010; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; CONNOLLY D, 2001, BR J OCCUP THER, V64, P41, DOI DOI 10.1177/030802260106400108; Derogatis LR, 1975, BRIEF SYMPTOM INVENT; Field A. P, 2009, DISCOVERING STAT USI; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; KAY T, 1991, HEAD INJURY FAMILY M, P121; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; KREUTZER JS, 1994, BRAIN INJURY, V1, P102; Kreutzer JS., 1999, NEUROBEHAVIORAL FUNC; Lazarus R.S., 1984, STRESS APPRAISAL COP; Leathem J, 1996, BRAIN INJURY, V10, P27; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Oddy M, 2003, NEUROPSYCHOL REHABIL, V13, P259, DOI 10.1080/09602010244000345; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; SULLIVAN MT, 2004, DERMATOLOGY NURSING, V16, P385; TEASDALE G, 1974, LANCET, V2, P81; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; Watanabe Y, 2000, CLIN REHABIL, V14, P172, DOI 10.1191/026921500666833742; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Wilkinson PR, 1997, STROKE, V28, P507, DOI 10.1161/01.STR.28.3.507; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910	39	12	12	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2013	28	2					106	115		10.1097/HTR.0b013e31823fe07e			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	105HU	WOS:000316058300004	22495101				2021-06-18	
J	Poyry, T; Luoto, TM; Kataja, A; Brander, A; Tenovuo, O; Iverson, GL; Ohman, J				Poyry, Tiina; Luoto, Teemu M.; Kataja, Anneli; Brander, Antti; Tenovuo, Olli; Iverson, Grant L.; Ohman, Juha			Acute Assessment of Brain Injuries in Ground-Level Falls	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						computed tomograhpy; risk factors; traumatic brain injuries	MINOR HEAD-INJURY; OLDER-ADULTS; MILD; MANAGEMENT; MORTALITY; MECHANISM; PEOPLE; TRAUMA; COSTS	Objective: The purpose of this study was to characterize traumatic brain injuries (TBI) sustained in ground-level falls (GLFs). The focus was on factors associated with acute computed tomographic (CT) findings. Methods: The sample included 575 subjects examined and treated at the Tampere University Hospital emergency department (ED). Retrospective data collection consisted of subject-and injury-related data and clinical information from the emergency department. All CT scans were analyzed and systematically coded. Results: Ground-level falls were the mechanism of injury in 48.3% (n = 278) of the subjects. In the GLF group, independent risk factors for acute traumatic CT findings were long-term alcohol abuse, older age, being found on the ground, and left temporoparietal and occipital location of direct head impact. There were no significant differences in the incidence of any intracranial traumatic lesion type between those with GLFs and other causes of TBI. None of the classic clinical TBI severity markers studied were associated with acute traumatic CT findings in patients with GLFs. Conclusions: Older age and long-term alcohol abuse increase the likelihood of acute intracranial CT abnormalities. The pattern of intracranial traumatic CT findings does not differ from other causes of TBI. Clinical signs and indices of TBI severity did not predict traumatic CT findings.	[Poyry, Tiina; Luoto, Teemu M.; Ohman, Juha] Tampere Univ Hosp, Dept Neurosci & Rehabil, FI-33521 Tampere, Finland; [Kataja, Anneli; Brander, Antti] Tampere Univ Hosp, Med Imaging Ctr, Dept Radiol, FI-33521 Tampere, Finland; Univ Turku, Dept Neurol, FIN-20520 Turku, Finland; [Tenovuo, Olli] Turku Univ, Cent Hosp, Turku, Finland; [Iverson, Grant L.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada	Luoto, TM (corresponding author), Tampere Univ Hosp, POB 2000, FI-33521 Tampere, Finland.	teemu.luoto@pshp.fi	Luoto, Teemu/W-6468-2018	Luoto, Teemu/0000-0002-7329-3284; Iverson, Grant/0000-0001-7348-9570; Ohman, Juha/0000-0002-6592-1367			Ashley J, 1990, Health Trends, V22, P135; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Chang CM, 2011, INT J GERIATR PSYCH, V26, P602, DOI 10.1002/gps.2569; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; Harad FT, 1992, J TRAUMA, V32, P361; Hartholt KA, 2011, J TRAUMA, V71, P748, DOI 10.1097/TA.0b013e3181f6f5e5; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Helling TS, 1999, J TRAUMA, V46, P453, DOI 10.1097/00005373-199903000-00019; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Jagoda AS, 2010, PSYCHIAT CLIN N AM, V33, P797, DOI 10.1016/j.psc.2010.09.004; Kannus P, 2007, INJURY, V38, P81, DOI 10.1016/j.injury.2006.08.027; Lin CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018976; National Institute for Health and Clinical Excellence, 2007, HEAD INJ TRIAG ASS I; Norlund A, 2006, BMJ-BRIT MED J, V333, P469, DOI 10.1136/bmj.38918.659120.4F; Olson DM, 2005, AACN ADV CRIT CARE, V16, P441, DOI 10.1097/00044067-200510000-00003; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sarani B, 2009, J TRAUMA, V67, P954, DOI 10.1097/TA.0b013e3181ae6d39; Spaniolas K, 2010, J TRAUMA, V69, P821, DOI 10.1097/TA.0b013e3181efc6c6; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; STEIN SC, 1993, NEUROSURGERY, V32, P30; Stein SC, 2008, J TRAUMA, V65, P66, DOI 10.1097/TA.0b013e318068d75f; Stein SC, 2006, J TRAUMA, V61, P558, DOI 10.1097/01.ta.0000233766.60315.5e; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Velmahos GC, 2001, J AM COLL SURGEONS, V192, P147, DOI 10.1016/S1072-7515(00)00790-0; Vilke GM, 2000, AM J EMERG MED, V18, P159, DOI 10.1016/S0735-6757(00)90009-3; Vivanti A, 2011, J NUTR HEALTH AGING, V15, P388, DOI 10.1007/s12603-010-0302-8; Whitfield PC, 2009, HEAD INJURY: A MULTIDISCIPLINARY APPROACH, P1, DOI 10.1017/CBO9780511576515	31	12	12	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2013	28	2					89	97		10.1097/HTR.0b013e318250eadd			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	105HU	WOS:000316058300002	22613946				2021-06-18	
J	Puljula, J; Makinen, E; Cygnel, H; Kortelainen, ML; Hillbom, M				Puljula, J.; Makinen, E.; Cygnel, H.; Kortelainen, M-L; Hillbom, M.			Incidence of moderate-to-severe traumatic brain injuries after reduction in alcohol prices	ACTA NEUROLOGICA SCANDINAVICA			English	Article						alcohol; alcohol consumption; alcohol price; alcohol-related traumatic brain injury; moderate-to-severe traumatic brain injury; outcome	EMERGENCY-DEPARTMENT; TAX CUTS; VIOLENCE; MORTALITY; COUNTRIES; DRINKING; FINLAND; PATTERN	Objective Alcohol may be involved in 4050% of traumatic brain injuries (TBI). In Finland, the cutting of alcohol taxes by one third in 2004 resulted in a marked increase in per capita alcohol consumption. We investigated the consequences of increased alcohol consumption on the incidence of moderate-to-severe traumatic brain injury among a defined population. Material and methods We identified all residents of Northern Ostrobothia with acute moderate-to-severe TBI admitted to Oulu University Hospital in 1999 and in 2007 as well as those who died on the scene without being admitted to the hospital. Alcohol involvement was recorded by similar methods and equally often during both years. Incidence rates were calculated as number of subjects per 100,000 population. Logistic regression was performed to determine which factors predicted fatal TBI and associated with alcohol-related TBI. Results No significant increase from 1999 to 2007 occurred in the incidence of alcohol-related moderate-to-severe TBIs among the population of Northern Ostrobothnia. The total number of alcohol-related TBIs were 61/135 (45.2%) in 2007 and 52/126 (41.3%) 1999. Fall-related TBIs were more frequent in 2007 than in 1999. Alcohol and older age predicted fatal outcome. Alcohol was significantly (P<0.001) more often present in fatal TBIs (83/156, 53.2%) than in non-fatal TBIs (30/105, 28.6%). Male sex, fall, suicide, and assault significantly associated with alcohol-related TBI. Conclusions The reduction in alcohol prices and the concomitant increase in alcohol consumption did not increase the incidence of alcohol-related moderate-to-severe TBI.	[Puljula, J.; Makinen, E.; Cygnel, H.; Hillbom, M.] Univ Oulu, Dept Neurol, Oulu, Finland; [Puljula, J.; Makinen, E.; Cygnel, H.; Hillbom, M.] Oulu Univ Hosp, Oulu 90029, Oys, Finland; [Kortelainen, M-L] Univ Oulu, Dept Forens Med, Oulu, Finland	Puljula, J (corresponding author), Oulu Univ Hosp, Dept Neurol, Box 25, Oulu 90029, Oys, Finland.	jpuljula@paju.oulu.fi					BRUST JCM., 2004, NEUROLOGICAL ASPECTS, P317; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Elder RW, 2004, J STUD ALCOHOL, V65, P297, DOI 10.15288/jsa.2004.65.297; HELAKORPI S, 2007, KANSANTERVEYS, V14, P5; Herttua K, 2008, J EPIDEMIOL COMMUN H, V62, P995, DOI 10.1136/jech.2007.069575; Herttua K, 2010, FINNISH YB POPULAT S, VXLV; Herttua K, 2008, AM J EPIDEMIOL, V168, P1110, DOI 10.1093/aje/kwn216; Herttua K, 2007, ALCOHOL ALCOHOLISM, V42, P456, DOI 10.1093/alcalc/agl099; Hiltunen Laura, 2009, Duodecim, V125, P1802; Johnston JJE, 2004, EMERG MED J, V21, P185, DOI 10.1136/emj.2003.006130; Koski A, 2007, ADDICTION, V102, P362, DOI 10.1111/j.1360-0443.2006.01715.x; Luke LC, 2002, EMERG MED J, V19, P542, DOI 10.1136/emj.19.6.542; MAKELA P, 2009, YHTEISKUNTAPOLITIIKK, V0074; Makela P, 2001, ADDICTION, V96, P1575; Makela P, 2008, ADDICTION, V103, P181, DOI 10.1111/j.1360-0443.2007.02049.x; Makela P, 2009, ADDICTION, V104, P554, DOI 10.1111/j.1360-0443.2009.02517.x; MOLLERMADSEN B, 1986, Z RECHTSMED, V97, P141; National Institute of Health and Welfare, SCH HLTH PROM STUD; National Supervisory Authority for Welfare And Health, REG DEL ALC BEV I HL; Norstrom T, 1998, ADDICTION, V93, P689, DOI 10.1046/j.1360-0443.1998.9356895.x; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; PEPPIATT R, 1978, RESUSCITATION, V6, P37, DOI 10.1016/0300-9572(78)90034-5; Puljula J, 2007, ALCOHOL ALCOHOLISM, V42, P474, DOI 10.1093/alcalc/agm003; Raitasalo K, 2011, YHTEISKUNTAPOLITIIKK, V76, P17; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Sieri S, 2002, PUBLIC HEALTH NUTR, V5, P1287, DOI 10.1079/PHN2002405; Sivarajasingam V, 2006, INJURY, V37, P388, DOI 10.1016/j.injury.2006.01.035; Skog OJ, 2001, ADDICTION, V96, pS49; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x	31	12	12	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	MAR	2013	127	3					192	197		10.1111/j.1600-0404.2012.01697.x			6	Clinical Neurology	Neurosciences & Neurology	092CJ	WOS:000315096100011	22712513				2021-06-18	
J	Wang, T; Zhang, L; Zhang, M; Bao, H; Liu, W; Wang, Y; Wang, L; Dai, D; Chang, P; Dong, W; Chen, X; Tao, L				Wang, T.; Zhang, L.; Zhang, M.; Bao, H.; Liu, W.; Wang, Y.; Wang, L.; Dai, D.; Chang, P.; Dong, W.; Chen, X.; Tao, L.			[GLY14]-HUMANIN REDUCES HISTOPATHOLOGY AND IMPROVES FUNCTIONAL OUTCOME AFTER TRAUMATIC BRAIN INJURY IN MICE	NEUROSCIENCE			English	Article						traumatic brain injury; humanin; neuroprotection; apoptosis; autophagy	CONTROLLED CORTICAL IMPACT; INDUCED CELL-DEATH; MEMORY IMPAIRMENT; HUMANIN BINDS; AUTOPHAGY; APOPTOSIS; DEFICITS; NEUROPROTECTION; PERMEABILITY; CONTRIBUTES	Humanin (HN) has been identified as an endogenous peptide that inhibited AD-relevant neuronal cell death. HNG, a variant of HN in which the 14th amino acid serine was replaced with glycine, can reduce infarct volume and improve neurological deficits after ischemia/reperfusion injury. In this study, we aimed to examine the neuroprotective effect of HNG on traumatic brain injury (TBI) in mice and explored whether the protective effect was associated with regulating apoptosis and autophagy. Compared to vehicle-treated groups, mice administered HNG intracerebroventricularly (i.c.v.) prior to TBI had decreased cells with plasmalemma permeability in the injured cortex and hippocampus (48 h, P < 0.01), reduced brain lesion volume (days 14 and 28, P < 0.05), improved motor performance (days 1-4, P < 0.05) and ameliorated performance in the Morris water maze test (days 11-13, P < 0.05) post TBI. Reduced lesion volume (day 14, P < 0.05) was also observed even when HNG was administered intraperitoneally (i.p.) at 1 h and 2 h post TBI, and minor amelioration in motor and Morris water maze test deficits was also observed. Immunoblotting results showed that HNG pretreatment (i.c.v.) reversed TBI-induced cleavage of cysteinyl aspartate-specific protease-3 and poly ADPribose-polymerase and decline of Bcl-2, suppressed LC3II, Beclin-1 and vacuolar sorting protein 34 activation and maintained p62 levels in the injured cortex and hippocampus post TBI (compared with vehicle). In conclusion, HNG treatment improved morphological and functional outcomes after TBI in mice and the protective effect of HNG against TBI may be associated with down-regulating apoptosis and autophagy. (c) 2012 IBRO. Published by Elsevier Ltd. All rights reserved.	[Wang, T.; Zhang, L.; Zhang, M.; Bao, H.; Liu, W.; Wang, Y.; Wang, L.; Dai, D.; Chang, P.; Dong, W.; Chen, X.; Tao, L.] Soochow Univ, Coll Med, Dept Forens Sci, Suzhou 215123, Peoples R China; [Wang, T.; Zhang, L.; Zhang, M.; Bao, H.; Liu, W.; Wang, Y.; Wang, L.; Dai, D.; Chang, P.; Dong, W.; Chen, X.; Tao, L.] Soochow Univ, Coll Med, Lab Brain Injury, Suzhou 215123, Peoples R China; [Zhang, M.] Nantong Univ, Coll Med, Dept Forens Sci, Nantong 226001, Peoples R China	Chen, X (corresponding author), Soochow Univ, Coll Med, Dept Forens Sci, 199 Ren Ai Rd, Suzhou 215123, Peoples R China.	xiping.chen@163.com; luyang.tao@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30872666, 81172911, 81271379]; Shanghai Forensic Key Lab Foundation [KF1005]; Program Granted for Scientific Innovation Research of College Graduate in Jangsu Province [CXLX12_0823]	This study was supported by grants 30872666, 81172911 and 81271379 from the National Natural Science Foundation of China (to TL), the Shanghai Forensic Key Lab Foundation (KF1005, to CX), and Program Granted for Scientific Innovation Research of College Graduate in Jangsu Province (CXLX12_0823, to WT). The authors have no conflict of interest to declare. Authorship credit was based on the contributions to experimental conception and design (WT, ZL, ZM, CP, CX, and TL), data acquisition (WT, ZL, DD, DW, BH and LW), data analysis and interpretation (WT, WY, WL, ZM, CX, and TL), and manuscript preparation (WT, CX, and TL). We thank Dr. Robert Wu who polished this paper.	Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Choi JY, 2007, CHEM BIOL DRUG DES, V70, P383, DOI 10.1111/j.1747-0285.2007.00576.x; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1997, J NEUROSCI, V17, P9172; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Gray NA, 2003, J CLIN PSYCHIAT, V64, P3; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P460, DOI 10.1006/bbrc.2001.4765; Hunsberger JG, 2009, BRAIN RES, V1293, P76, DOI 10.1016/j.brainres.2009.06.103; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Jin H, 2010, NEUROCHEM INT, V56, P417, DOI 10.1016/j.neuint.2009.11.015; Kariya S, 2002, NEUROREPORT, V13, P903, DOI 10.1097/00001756-200205070-00034; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Krejcova G, 2004, J PEPT SCI, V10, P636, DOI 10.1002/psc.569; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Lamark T, 2009, CELL CYCLE, V8, P1986, DOI 10.4161/cc.8.13.8892; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Luciano F, 2005, J BIOL CHEM, V280, P15825, DOI 10.1074/jbc.M413062200; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mamiya T, 2001, BRIT J PHARMACOL, V134, P1597, DOI 10.1038/sj.bjp.0704429; Miao JT, 2008, NEUROPEPTIDES, V42, P557, DOI 10.1016/j.npep.2008.08.004; Morris RGM, 2001, PHILOS T R SOC B, V356, P1453, DOI 10.1098/rstb.2001.0945; Niikura T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016259; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Pozuelo-Rubio M, 2011, AUTOPHAGY, V7, P240, DOI 10.4161/auto.7.2.14286; Regan RF, 2001, J NEUROCHEM, V79, P545, DOI 10.1046/j.1471-4159.2001.00590.x; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; SCHMITT TH, 1993, ARCH BIOCHEM BIOPHYS, V307, P96, DOI 10.1006/abbi.1993.1566; Sponne I, 2004, MOL CELL NEUROSCI, V25, P95, DOI 10.1016/j.mcn.2003.09.017; Tajima H, 2005, J NEUROSCI RES, V79, P714, DOI 10.1002/jnr.20391; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Xu XS, 2008, BRAIN RES, V1227, P12, DOI 10.1016/j.brainres.2008.06.018; Xu XS, 2006, STROKE, V37, P2613, DOI 10.1161/01.STR.0000242772.94277.1f; Yamada M, 2008, NEUROPSYCHOPHARMACOL, V33, P2020, DOI 10.1038/sj.npp.1301591; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200; Zhang MY, 2012, J MOL NEUROSCI, V46, P631, DOI 10.1007/s12031-011-9651-y; Zhang WJ, 2012, PHARMACOL BIOCHEM BE, V100, P361, DOI 10.1016/j.pbb.2011.09.012; Zhao ST, 2012, NEUROCHEM RES, V37, P153, DOI 10.1007/s11064-011-0593-0	47	12	14	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	FEB 12	2013	231						70	81		10.1016/j.neuroscience.2012.11.019			12	Neurosciences	Neurosciences & Neurology	087EN	WOS:000314744200007	23178909				2021-06-18	
J	Gurkoff, GG; Gahan, JD; Ghiasvand, RT; Hunsaker, MR; Van, K; Feng, JF; Shahlaie, K; Berman, RF; Lyeth, BG; Folkerts, MM				Gurkoff, Gene G.; Gahan, Jennifer D.; Ghiasvand, Rahil T.; Hunsaker, Michael R.; Van, Ken; Feng, Jun-feng; Shahlaie, Kiarash; Berman, Robert F.; Lyeth, Bruce G.; Folkerts, Michael M.			Evaluation of Metric, Topological, and Temporal Ordering Memory Tasks after Lateral Fluid Percussion Injury	JOURNAL OF NEUROTRAUMA			English	Article						anatomical specificity; cognitive dysfunction; hippocampus; TBI; working memory	TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; MINOR HEAD-INJURY; SPATIAL INFORMATION; DORSAL HIPPOCAMPUS; PARIETAL CORTEX; DENTATE GYRUS; COGNITIVE DEFICITS; DEVELOPING RAT; CELL-DEATH	Impairments in learning and memory occur in as many as 50% of patients following traumatic brain injury (TBI). Similar impairments occur in rodent models of TBI, and the development of new memory testing procedures provides an opportunity to examine how TBI affects memory processing in specific neural memory systems. Specifically, metric, topological, and temporal ordering tasks are object-based tests for memory of spatial orientation and temporal sequencing working memory developed for use in rodents. Previous studies demonstrated that specific lesions of the dentate gyrus/CA3 of the hippocampus and the parietal cortex resulted in deficits in the metric and topological spatial orientation tasks, respectively. Lesions of the CA1 impaired a rat's ability to recall the temporal order of odors. The purpose of the following study was to determine whether moderate lateral fluid percussion TBI would generate deficits in these working memory tasks, and whether observed deficits were associated with cell loss in the CA2/3 and/or CA1 of the hippocampus. Two weeks following a moderate lateral fluid percussion TBI, adult rats demonstrated significant deficits in both the metric and temporal ordering tasks (p < 0.05) but not in the topological task. Stereological analysis identified a significant reduction in neurons in the CA2/3 (p < 0.05) but not the CA1 of the hippocampus. These data demonstrate the utility of three object-based tasks to expand our understanding of how different neural memory systems are affected by TBI.	[Gurkoff, Gene G.; Gahan, Jennifer D.; Ghiasvand, Rahil T.; Hunsaker, Michael R.; Van, Ken; Feng, Jun-feng; Shahlaie, Kiarash; Berman, Robert F.; Lyeth, Bruce G.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Gurkoff, Gene G.] Univ Calif Davis, Ctr Biophoton Sci & Technol, Natl Sci Fdn, Sacramento, CA 95817 USA; [Feng, Jun-feng] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai 200030, Peoples R China; [Folkerts, Michael M.] Pepperdine Univ, Dept Psychol, Malibu, CA 90263 USA	Folkerts, MM (corresponding author), Pepperdine Univ, Dept Psychol, 24255 Pacific Coast Highway, Malibu, CA 90263 USA.	michael.folkerts@pepperdine.edu	Hunsaker, Michael Ryan/H-5975-2019	Hunsaker, Michael Ryan/0000-0001-9210-2458; Lyeth, Bruce/0000-0003-4811-1474	NSF Center for Biophotonics Science and Technology [PHY0120999]	This work was supported by the NSF Center for Biophotonics Science and Technology, a designated NSF Science and Technology Center managed by the University of California at Davis under the cooperative agreement number PHY0120999. We thank Eric West, Vanessa Atkinson, and M. Hiram Dominguez for their expert technical assistance on this project.	Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Berman RF, 2000, J NEUROSURG, V93, P821, DOI 10.3171/jns.2000.93.5.0821; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bootes K, 2010, WORK, V36, P207, DOI [10.3233/WOR-2010-1021, 10.3233/WOR-2010-01021]; Brooks D N, 1979, Int Rehabil Med, V1, P166; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Conti AC, 1998, J NEUROSCI, V18, P5663; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Davis AR, 2010, J NEUROSCI METH, V189, P84, DOI 10.1016/j.jneumeth.2010.03.012; DeCoteau WE, 1998, BEHAV NEUROSCI, V112, P68, DOI 10.1037/0735-7044.112.1.68; Dietrich WD, 1996, J NEUROTRAUM, V13, P309, DOI 10.1089/neu.1996.13.309; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; GALLISTEL CR, 1990, COGNITION, V37, P1, DOI 10.1016/0010-0277(90)90016-D; Gilbert PE, 2004, NEUROBIOL LEARN MEM, V81, P39, DOI 10.1016/S1074-7427(03)00069-8; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Gilworth G, 2008, J REHABIL MED, V40, P334, DOI 10.2340/16501977-0169; Goodrich-Hunsaker NJ, 2008, NEUROBIOL LEARN MEM, V90, P389, DOI 10.1016/j.nlm.2008.05.002; Goodrich-Hunsaker NJ, 2008, BEHAV NEUROSCI, V122, P16, DOI 10.1037/0735-7044.122.1.16; Goodrich-Hunsaker NJ, 2005, BEHAV NEUROSCI, V119, P1307, DOI 10.1037/0735-7044.119.5.1307; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hoge J, 2007, NEUROBIOL LEARN MEM, V88, P225, DOI 10.1016/j.nlm.2007.04.013; Hopkins RO, 2004, NEUROPSYCHOLOGIA, V42, P1877, DOI 10.1016/j.neuropsychologia.2004.05.008; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Hunsaker MR, 2008, BEHAV NEUROSCI, V122, P643, DOI 10.1037/0735-7044.122.3.643; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P955, DOI 10.1002/hipo.20455; Kesner RP, 2010, NEUROBIOL LEARN MEM, V93, P111, DOI 10.1016/j.nlm.2009.08.010; Kessels RPC, 2004, J INT NEUROPSYCH SOC, V10, P907, DOI 10.1017/S1355617704106140; Kessels RPC, 2001, BRAIN RES REV, V35, P295, DOI 10.1016/S0165-0173(01)00058-3; Laeng B, 2006, NEUROPSYCHOLOGIA, V44, P1595, DOI 10.1016/j.neuropsychologia.2006.01.023; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McMillan TM, 1997, CURR OPIN NEUROL, V10, P479, DOI 10.1097/00019052-199712000-00008; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; POUCET B, 1993, PSYCHOL REV, V100, P163, DOI 10.1037/0033-295X.100.2.163; Poucet B, 2001, BEHAV PROCESS, V53, P155, DOI 10.1016/S0376-6357(00)00151-0; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Ragnarsson KT, 2002, RESTOR NEUROL NEUROS, V20, P103; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Reger ML, 2009, DEV PSYCHOBIOL, V51, P672, DOI 10.1002/dev.20402; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; St-Laurent M, 2011, HIPPOCAMPUS, V21, P409, DOI 10.1002/hipo.20757; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Turner RJ, 2011, BRAIN RES, V1393, P84, DOI 10.1016/j.brainres.2011.03.066; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; Whiting MD, 2006, J NEUROTRAUM, V23, P1529, DOI 10.1089/neu.2006.23.1529; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	73	12	13	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2013	30	4					292	300		10.1089/neu.2012.2463			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	093CM	WOS:000315169300006	23140483				2021-06-18	
J	Millett, PJ; Schoenahl, JY; Allen, MJ; Motta, T; Gaskill, TR				Millett, Peter J.; Schoenahl, Jean-Yves; Allen, Matthew J.; Motta, Tatiana; Gaskill, Trevor R.			An association between the inferior humeral head osteophyte and teres minor fatty infiltration: evidence for axillary nerve entrapment in glenohumeral osteoarthritis	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Humeral osteophytes; goat's beard; teres minor fatty infiltration; axillary neurovascular bundle	QUADRILATERAL SPACE SYNDROME; TENDON RELEASE; SHOULDER; INJURIES; MUSCLE; PERSPECTIVE; SPORTS; CYST	Background: Glenohumeral osteoarthritis often results in inferior humeral osteophytes. Anatomic studies suggest that the axillary neurovascular bundle is in close proximity to the glenohumeral capsule. We therefore hypothesize that an inferior humeral osteophyte of sufficient magnitude could encroach on the axillary nerve and result in measurable fatty infiltration of the teres minor muscle. Materials and methods: Preoperative magnetic resonance imaging studies of 91 consecutive arthritic shoulders were retrospectively reviewed. Two cohorts were established based on the presence of a humeral osteophyte. The distances from the axillary neurovascular bundle to various osseous structures were measured using calibrated software. Objective quantitative measurements of the degree of fatty infiltration of the teres minor muscles were obtained with image analysis software. Results were compared between cohorts. Results: The distance between the inferior humerus and axillary neurovascular bundle was inversely correlated to the size of the inferior humeral osteophyte (rho = -0.631, P < .001). Fatty infiltration of the teres minor was greater when an inferior osteophyte was present (11.9%) than when an osteophyte was not present (4.4%) (P = .004). A statistically significant correlation between the size of the humeral head spur and quantity of fat in the teres minor muscle belly (rho = 0.297, P = .005) was identified. Conclusion: These data are consistent with our hypothesis that the axillary nerve may be entrapped by the inferior humeral osteophyte often presenting with glenohumeral osteoarthritis. Entrapment may affect axillary nerve function and lead to changes in the teres minor muscle. Axillary neuropathy from an inferior humeral osteophyte may represent a contributing and treatable cause of pain in patients with glenohumeral osteoarthritis. Level of evidence: Level III, Case-Control Study, Epidemiology Study. (C) 2013 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Millett, Peter J.; Schoenahl, Jean-Yves; Gaskill, Trevor R.] Steadman Philippon Res Inst, Vail, CO 81657 USA; [Allen, Matthew J.; Motta, Tatiana] Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH 43210 USA	Millett, PJ (corresponding author), Steadman Philippon Res Inst, 181 W Meadow Dr, Vail, CO 81657 USA.	drmillett@steadmanclinic.net			Steadman Philippon Research Institute; Arthrex; Ossur; Smith Nephew; ArthroCare; OrthroRehab; Siemens	Dr Millett is a consultant for and receives payments from Arthrex and has stock options in Game Ready, which are related to the subject of this work. Dr Millett also receives support from the Steadman Philippon Research Institute. Companies that support the Steadman Philippon Research Institute include Arthrex, Ossur, Smith & Nephew, ArthroCare, OrthroRehab, and Siemens.	Amin MF, 2006, SKELETAL RADIOL, V35, P956, DOI 10.1007/s00256-006-0092-6; Apaydin N, 2010, SURG RADIOL ANAT, V32, P193, DOI 10.1007/s00276-009-0594-8; Aval SM, 2007, J AM ACAD ORTHOP SUR, V15, P281, DOI 10.5435/00124635-200705000-00006; Ball CM, 2003, J BONE JOINT SURG AM, V85A, P1497, DOI 10.2106/00004623-200308000-00010; BATEMAN JE, 1967, J BONE JOINT SURG AM, VA 49, P785, DOI 10.2106/00004623-196749040-00025; Bonnard C, 1999, J BONE JOINT SURG BR, V81B, P212, DOI 10.1302/0301-620X.81B2.8301; BRYAN WJ, 1986, AM J SPORT MED, V14, P113, DOI 10.1177/036354658601400203; Burkhead W Z Jr, 1992, J Shoulder Elbow Surg, V1, P31, DOI 10.1016/S1058-2746(09)80014-1; CAHILL BR, 1983, J HAND SURG-AM, V8, P65, DOI 10.1016/S0363-5023(83)80056-2; Duparc F, 1997, SURG RADIOL ANAT, V19, P127, DOI 10.1007/s00276-997-0127-2; Eakin CL, 1998, AM J SPORT MED, V26, P505, DOI 10.1177/03635465980260040501; ENGEL WK, 1966, ANN NY ACAD SCI, V138, P160; Gerber C, 2004, J BONE JOINT SURG AM, V86A, P1973, DOI 10.2106/00004623-200409000-00016; LOOMER R, 1989, CLIN ORTHOP RELAT R, P100; McCarty EC, 2004, AM J SPORT MED, V32, P909, DOI 10.1177/0363546503260064; McFarland EG, 2002, AM J SPORT MED, V30, P601, DOI 10.1177/03635465020300042101; McMinn R, 1966, NATURE, V195, P509; Meyer DC, 2004, J ORTHOPAED RES, V22, P1004, DOI 10.1016/j.orthres.2004.02.009; Millett PJ, 2011, ARTHROSCOPY, V27, P1296, DOI 10.1016/j.arthro.2011.03.089; PETRUCCI FS, 1982, J HAND SURG-AM, V7, P271, DOI 10.1016/S0363-5023(82)80178-0; Price MR, 2004, J BONE JOINT SURG AM, V86A, P2135, DOI 10.2106/00004623-200410000-00003; Robinson P, 2000, AM J ROENTGENOL, V175, P1103, DOI 10.2214/ajr.175.4.1751103; Safran MR, 2004, AM J SPORT MED, V32, P803, DOI 10.1177/0363546504264582; Sanders TG, 1999, ARTHROSCOPY, V15, P632, DOI 10.1053/ar.1999.v15.015063; Steinmann S P, 2001, J Am Acad Orthop Surg, V9, P328; Yoo JC, 2007, ARTHROSCOPY, V23, P1271, DOI 10.1016/j.arthro.2007.07.011	26	12	12	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	FEB	2013	22	2					215	221		10.1016/j.jse.2012.05.030			7	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	100DG	WOS:000315675400020	22939404				2021-06-18	
J	Schaaf, KPW; Kreutzer, JS; Danish, SJ; Pickett, TC; Rybarczyk, BD; Nichols, MG				Schaaf, Kathryn P. Wilder; Kreutzer, Jeffrey S.; Danish, Steven J.; Pickett, Treven C.; Rybarczyk, Bruce D.; Nichols, Michelle G.			Evaluating the Needs of Military and Veterans' Families in a Polytrauma Setting	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; polytrauma; military family needs; family needs questionnaire	TRAUMATIC BRAIN-INJURY; CAREGIVER BURDEN; REHABILITATION; INTERVENTION; INDIVIDUALS; PREDICTORS; SEQUELAE; OUTCOMES; SUPPORT; TEAM	Objective: To examine the perceived importance of needs and the extent to which they are Met among a sample of family members in an inpatient polytrauma setting. Method: The Family Needs Questionnaire was administered to 44 family members of patients at the Polytrauma Rehabilitation Center at McGuire Veterans Affairs Medical Center over a 30-month period. Results: Families rated health information needs as most important and most frequently met. conversely, family members rated emotional support and instrumental support needs as least important and most frequently unmet. Conclusion: Preliminary data suggest that the similarity between family needs in military and civilian settings is noteworthy, and provide direction for development of empirically based family intervention models for polytrauma settings.	[Schaaf, Kathryn P. Wilder; Kreutzer, Jeffrey S.; Pickett, Treven C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; [Kreutzer, Jeffrey S.] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23298 USA; [Kreutzer, Jeffrey S.; Pickett, Treven C.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23298 USA; [Danish, Steven J.; Rybarczyk, Bruce D.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23298 USA; [Pickett, Treven C.; Nichols, Michelle G.] McGuire VA Med Ctr, Richmond, VA USA; [Nichols, Michelle G.] Def & Vet Brain Injury Ctr, Washington, DC USA	Schaaf, KPW (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Box 980542, Richmond, VA 23298 USA.	wilderkp@vcu.edu	Nichols, Michelle/AAV-2740-2020	Nichols, Michelle/0000-0002-2078-9649			Collins RC, 2008, J CLIN PSYCHOL, V64, P993, DOI 10.1002/jclp.20515; Department of Veterans Affairs Veterans Health Administration, 2005, VHA HDB; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Hauber RP, 2002, J HEAD TRAUMA REHAB, V17, P535, DOI 10.1097/00001199-200212000-00005; Kim JW, 2007, SOC WORK HEALTH CARE, V45, P81, DOI 10.1300/J010v45n01_06; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreutzer J. S., 1988, FAMILY NEEDS QUESTIO; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Livingston LA, 2010, NEUROREHABILITATION, V27, P73, DOI 10.3233/NRE-2010-0582; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Moules S, 1999, BRAIN INJURY, V13, P983; Murray HM, 2006, BRAIN INJURY, V20, P575, DOI 10.1080/02699050600664590; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Riggio S, 2010, PSYCHIAT CLIN N AM, V33, P807, DOI 10.1016/j.psc.2010.08.004; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Witol AD, 1996, NEUROREHABILITATION, V7, P175, DOI 10.3233/NRE-1996-7303	27	12	12	0	6	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2013	58	1					106	110		10.1037/a0031693			5	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	095VA	WOS:000315361900014	23438007				2021-06-18	
J	Wamstad, JB; Norwood, KW; Rogol, AD; Gurka, MJ; DeBoer, MD; Blackman, JA; Buck, ML; Kuperminc, MN; Darring, JG; Patrick, PD				Wamstad, Julia B.; Norwood, Kenneth W.; Rogol, Alan D.; Gurka, Matthew J.; DeBoer, Mark D.; Blackman, James A.; Buck, Marcia L.; Kuperminc, Michelle N.; Darring, Jodi G.; Patrick, Peter D.			Neuropsychological recovery and quality-of-life in children and adolescents with growth hormone deficiency following TBI: A preliminary study	BRAIN INJURY			English	Article						Brain injury; growth hormone deficiency; neuropsychology; quality-of-life; cognition	TRAUMATIC BRAIN-INJURY; PITUITARY-FUNCTION; COGNITIVE FUNCTION; GH DEFICIENCY; PLASMA-LEVELS; HYPOPITUITARISM; CHILDHOOD; DIAGNOSIS; INSULIN; REPLACEMENT	Objective: To compare neurocognition and quality-of-life (QoL) in a group of children and adolescents with or without growth hormone deficiency (GHD) following moderate-to-severe traumatic brain injury (TBI). Study designs: Thirty-two children and adolescents were recruited from the TBI clinic at a children's hospital. Growth hormone (GH) was measured by both spontaneous overnight testing and following arginine/glucagon stimulation administration. Twenty-nine subjects participated in extensive neuropsychological assessment. Results: GHD as measured on overnight testing was significantly associated with a variety of neurocognitive and QoL measures. Specifically, subjects with GHD had significantly (p<0.05) lower scores on measures of visual memory and health-related quality-of-life. These scores were not explained by severity of injury or IQ (p>0.05). GHD noted in response to provocative testing was not associated with any neurocognitive or QoL measures. Conclusions: GHD following TBI is common in children and adolescents. Deficits in neurocognition and QoL impact recovery after TBI. It is important to assess potential neurocognitive and QoL changes that may occur as a result of GHD. It is also important to consider the potential added benefit of overnight GH testing as compared to stimulation testing in predicting changes in neurocognition or QoL.	[Wamstad, Julia B.; Norwood, Kenneth W.; Rogol, Alan D.; DeBoer, Mark D.; Blackman, James A.; Buck, Marcia L.; Kuperminc, Michelle N.; Darring, Jodi G.; Patrick, Peter D.] Riley Childrens Hosp, Dept Pediat, Indianapolis, IN USA; [Gurka, Matthew J.] W Virginia Univ, Dept Community Med, Morgantown, WV 26506 USA	Patrick, PD (corresponding author), Univ Virginia, 2270 Ivy Rd, Charlottesville, VA 22903 USA.	peterpatrick@embarqmail.com	Rogol, A.D./H-5871-2019	Rogol, A.D./0000-0002-7526-3142	Commonwealth Neurotrauma Initiative Trust Fund [07-302]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [M01RR000847, K08HD060739]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD060739] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000847] Funding Source: NIH RePORTER	This study has been supported by the following grants: Peter D. Patrick, PhD: Grant #07-302 of the Commonwealth Neurotrauma Initiative Trust Fund, administered by VA Department of Rehabilitative Services and GCRC, NIH Grant #M01RR000847. Mark D. DeBoer, MD, MSc, MCR: NIH Grant #K08HD060739. There are no additional declarations of interest.	Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, GROWTH HORM IGF RES, V14, pS114, DOI 10.1016/j.ghir.2004.03.025; Aleman A, 2000, NEUROPSYCHOBIOLOGY, V41, P73, DOI 10.1159/000026636; Arwert LI, 2006, NEUROENDOCRINOLOGY, V83, P12, DOI 10.1159/000093337; Arwert LI, 2005, NEUROENDOCRINOLOGY, V82, P32, DOI 10.1159/000090123; Badaru A, 2004, TRENDS ENDOCRIN MET, V15, P252, DOI 10.1016/j.tem.2004.06.004; Baum HBA, 1998, J CLIN ENDOCR METAB, V83, P3184, DOI 10.1210/jc.83.9.3184; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Falleti MG, 2006, PSYCHONEUROENDOCRINO, V31, P681, DOI 10.1016/j.psyneuen.2006.01.005; Florkowski CM, 1998, PSYCHONEUROENDOCRINO, V23, P57, DOI 10.1016/S0306-4530(97)00093-0; Gandrud LM, 2004, GROWTH HORM IGF RES, V14, P185, DOI 10.1016/j.ghir.2003.11.003; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Gioia G.A., 2000, BEHAV RATING INVENTO; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; Juul A, 2002, HORM RES, V58, P233, DOI 10.1159/000066265; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Kreitschmann-Andermahr I, 2008, GROWTH HORM IGF RES, V18, P472, DOI 10.1016/j.ghir.2008.08.007; Landgraf JM, 1996, CHILD HLTH QUESTIONN, V1st; Leon-Carrion J, 2007, BRAIN INJURY, V21, P871, DOI 10.1080/02699050701484849; Masel BE, 2004, GROWTH HORM IGF RES, V14, pS108, DOI 10.1016/j.ghir.2004.03.024; McDonald A, 2008, J PEDIATR-US, V152, P590, DOI 10.1016/j.jpeds.2007.12.046; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Nyberg F, 2000, FRONT NEUROENDOCRIN, V21, P330, DOI 10.1006/frne.2000.0200; Patrick PD, 2006, BRIAN INJURY TREATME; Patrick PD, 2011, INT NEUROTRAUMA LETT, V2, P25; Popovic V, 2005, GROWTH HORM IGF RES, V15, P177, DOI 10.1016/j.ghir.2005.02.003; Rasgon NL, 2011, NEUROBIOL AGING, V32, P1942, DOI 10.1016/j.neurobiolaging.2009.12.005; Roemmich JN, 2005, METABOLISM, V54, P1374, DOI 10.1016/j.metabol.2005.04.029; Rollero A, 1998, NEUROPSYCHOBIOLOGY, V38, P73, DOI 10.1159/000026520; Rose SR, 1996, J CLIN ENDOCR METAB, V81, P1063, DOI 10.1210/jc.81.3.1063; ROSENFELD RG, 1995, J CLIN ENDOCR METAB, V80, P1532, DOI 10.1210/jc.80.5.1532; Rothman MS, 2007, J NEUROPSYCH CLIN N, V19, P363, DOI 10.1176/appi.neuropsych.19.4.363; Schneider M, 2005, J NEUROTRAUM, V22, P937, DOI 10.1089/neu.2005.22.937; Sheslow D., 2003, WIDE RANGE ASSESSMEN, V2nd; Sonntag WE, 2005, AGEING RES REV, V4, P195, DOI 10.1016/j.arr.2005.02.001; Sparrow S, 2005, VINELAND ADAPTIVE BE; Stojanovic M, 2008, END ABSTR, V16, pP396; Tanaka T, 2002, GROWTH HORM IGF RES, V12, P323, DOI 10.1016/S1096-6374(02)00045-X; Tanner JM, 1978, GROWTH ADOLESCENCE; Tillmann V, 1997, J CLIN ENDOCR METAB, V82, P531, DOI 10.1210/jc.82.2.531; Urban RJ, 2005, BRAIN INJURY, V19, P349, DOI 10.1080/02699050400004807; Watson GS, 2004, EUR J PHARMACOL, V490, P97, DOI 10.1016/j.ejphar.2004.02.048; Wechsler D., 2003, WISC 4 ADM SCORING M; Wechsler D., 2011, WECHLSER ABBREVIATED; Wechsler D, 2003, WISC 4 TECHNICAL INT; Wechsler D, 1997, WAIS 3 ADM SCORING M	50	12	13	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2013	27	2					200	208		10.3109/02699052.2012.672786			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	083PX	WOS:000314478500008	23384217	Green Accepted			2021-06-18	
J	White, NJ; Wang, X; Bradbury, N; Moon-Massat, PF; Freilich, D; Auker, C; McCarron, R; Scultetus, A; Stern, SA				White, Nathan J.; Wang, Xu; Bradbury, Nicole; Moon-Massat, Paula F.; Freilich, Daniel; Auker, Charles; McCarron, Richard; Scultetus, Anke; Stern, Susan A.			FLUID RESUSCITATION OF UNCONTROLLED HEMORRHAGE USING A HEMOGLOBIN-BASED OXYGEN CARRIER: EFFECT OF TRAUMATIC BRAIN INJURY	SHOCK			English	Article						Hemorrhage; traumatic brain injury; shock; fluid resuscitation; hemoglobin-based oxygen carrier	BOVINE POLYMERIZED HEMOGLOBIN; SWINE MODEL; CEREBRAL-ISCHEMIA; SHOCK; HBOC-201; HYPOTENSION; MORTALITY; RESPONSES; SURVIVAL; DELAY	Animal models of combined traumatic brain injury (TBI) and hemorrhagic shock (HS) suggest a benefit of hemoglobin-based oxygen carrier (HBOC)-based resuscitation, but their use remains controversial, and little is known of the specific effects of TBI and high-pressure (large arterial injury) bleeding on resuscitation. We examine the effect of TBI and aortic tear injury on low-volume HBOC resuscitation in a swine polytrauma model and hypothesize that HBOC-based resuscitation will improve survival in the setting of aortic tear regardless of the presence of TBI. Anesthetized swine subjected to HS with aortic tear with or without fluid percussion TBI underwent equivalent limited resuscitation with HBOC, lactated Ringer's solution, or HBOC + nitroglycerine (vasoattenuated HBOC) and were observed for 6 h. There was no independent effect of TBI on survival time after adjustment for fluid type, and there was no interaction between TBI and resuscitation fluid type. However, total catheter hemorrhage volume required to reach target shock blood pressure was less with TBI (14.0 mL . kg(-1) [confidence interval, 12.4-15.6 mL . kg(-1)]) versus HS only (21.0 mL . kg(-1) [confidence interval, 19.5-22.5 mL . kg(-1)]), with equivalent lactate accumulation. Traumatic brain injury did not affect survival in this polytrauma model, but less hemorrhage was required in the presence of TBI to achieve an equivalent degree of shock suggesting globally impaired cardiovascular response to hemorrhage in the presence of TBI. There was also no benefit of HBOC-based fluid resuscitation over lactated Ringer's solution, contrary to models using liver injury as the source of hemorrhage, considering wound location is of paramount importance when choosing resuscitation strategy.	[White, Nathan J.; Wang, Xu; Bradbury, Nicole; Stern, Susan A.] Univ Washington, Harborview Med Ctr, Div Emergency Med, Seattle, WA 98104 USA; [Moon-Massat, Paula F.; Auker, Charles; McCarron, Richard; Scultetus, Anke] USN, NeuroTrauma Dept, OUMD, Med Res Ctr, Silver Spring, MD USA; [Freilich, Daniel] Bur Med & Surg, Washington, DC USA	White, NJ (corresponding author), Univ Washington, Harborview Med Ctr, Div Emergency Med, Box 359702,325 9th Ave, Seattle, WA 98104 USA.	whiten4@uw.edu		White, Nathan/0000-0002-3752-310X	Naval Medical Research Center (NMRC) [W81XWH-08-2-0166, HBOC-201]; National Center for Advancing Translational Sciences (NCATS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2 TR000421]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NCRRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR025015]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000421] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR025015] Funding Source: NIH RePORTER	This study was supported by the Naval Medical Research Center (NMRC) (CDMRP grant W81XWH-08-2-0166) and, in part, by the National Center for Advancing Translational Sciences (NCATS) (grant KL2 TR000421), a component of the National Institutes of Health (NIH); NMRC also provided HBOC-201 (Biopure; OPK Biotech). Dr White was funded under NCRR (grant KL2 RR025015).	American College of Surgeons Committee on Trauma, 2008, ATLS DOCT STUD MAN; ANDERSON ID, 1990, J TRAUMA, V30, P974, DOI 10.1097/00005373-199008000-00005; BARCROFT H, 1945, J PHYSIOL-LONDON, V104, P161, DOI 10.1113/jphysiol.1945.sp004113; Brain Trauma Foundation, 2003, UPD GUID MAN PROGN S; Bruttig SP, 2005, SHOCK, V24, P92, DOI 10.1097/01.shk.0000168872.37660.d2; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276; Dudkiewicz M, 2008, CRIT CARE MED, V36, P2838, DOI 10.1097/CCM.0b013e318186f6b3; Fulton R L, 1993, J Invest Surg, V6, P117, DOI 10.3109/08941939309141603; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Johnson T, 2006, CRIT CARE MED, V34, P1464, DOI 10.1097/01.CCM.0000215824.85190.89; Kerby JD, 2007, SHOCK, V27, P652, DOI 10.1097/01.shk.0000248584.10400.dc; Law MM, 1996, SHOCK, V6, P213, DOI 10.1097/00024382-199609010-00010; Manning JE, 2000, SHOCK, V13, P152, DOI 10.1097/00024382-200013020-00010; McMahon CG, 2008, CRIT CARE MED, V36, P216, DOI 10.1097/01.CCM.0000295425.41831.85; McMahon CG, 2010, J TRAUMA, V69, P1169, DOI 10.1097/TA.0b013e3181cc8889; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; OVERMAN RR, 1947, AM J PHYSIOL, V148, P289; Rice J, 2006, J TRAUMA, V61, P1085, DOI 10.1097/01.ta.0000236640.62893.fa; Rice J, 2006, SHOCK, V26, P302, DOI 10.1097/01.shk.0000226338.48033.c2; Rosenthal G, 2008, J NEUROSURG, V108, P575, DOI 10.3171/JNS/2008/108/3/0575; Sapsford W, 2007, J TRAUMA, V62, P868, DOI 10.1097/ta.0b013e318034204b; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Sayre MR, 1996, ACAD EMERG MED, V3, P840, DOI 10.1111/j.1553-2712.1996.tb03528.x; Stern SA, 2001, SHOCK, V15, P16, DOI 10.1097/00024382-200115010-00003; Stern SA, 2000, J NEUROSURG, V93, P305, DOI 10.3171/jns.2000.93.2.0305; Stern S, 2009, SHOCK, V31, P64, DOI 10.1097/SHK.0b013e3181778dc3; Teixeira PGR, 2007, J TRAUMA, V63, P1338, DOI 10.1097/TA.0b013e31815078ae; Teranishi K, 2012, INJURY, V43, P585, DOI 10.1016/j.injury.2010.09.042; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; York GB, 2003, J TRAUMA, V55, P873, DOI 10.1097/01.TA.0000092681.17874.6F; YUAN XQ, 1991, CIRC SHOCK, V35, P231; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408	35	12	15	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	FEB	2013	39	2					210	219		10.1097/SHK.0b013e31827fd62b			10	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	080ZF	WOS:000314282900015	23324891	Green Accepted			2021-06-18	
J	Yang, SG; Ma, YH; Liu, Y; Que, HP; Zhu, CQ; Liu, SJ				Yang, Shuguang; Ma, Yanhong; Liu, Yong; Que, Haiping; Zhu, Changqiang; Liu, Shaojun			Elevated serum haptoglobin after traumatic brain injury is synthesized mainly in liver	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						serum; haptoglobin; proteomics; rat; traumatic brain injury	HUMAN CEREBROSPINAL-FLUID; CELL-LINE; EXPRESSION; GENE; INTERLEUKIN-6; ELEMENT; TISSUE; RATS; MICE	Haptoglobin (Hp), an acute-phase response protein, is typically increased in the serum of adults after acute tissue injury. It is an antioxidant and may function as an injury-induced neuroprotective protein. However, the source of increased Hp is not clear. To investigate its source, we compared its time course expression profile in serum from rats with or without traumatic brain injury (TBI). Elevated Hp levels revealed by proteomic analysis were confirmed by Western blot, semiquantitative PCR, and real-time PCR. We found that Hp protein and mRNA levels were increased after TBI in both serum and liver, especially in liver. Both in vivo and in vitro data showed that Hp expression was increased in rat and human (HL7702) liver cells upon treatment with TBI serum. Addition of anti-interleukin-6 (IL-6) antibody downregulated the expression of Hp in liver cells induced by serum derived from rats and in liver of rats after TBI. These findings suggest that the increased Hp in serum came from the liver in response to TBI and that IL-6 is an important mediator of this induction. (C) 2012 Wiley Periodicals, Inc.	[Yang, Shuguang; Ma, Yanhong; Liu, Yong; Que, Haiping; Zhu, Changqiang; Liu, Shaojun] Inst Basic Med Sci, State Key Lab Prote, Beijing 100850, Peoples R China; [Yang, Shuguang; Ma, Yanhong; Liu, Yong; Que, Haiping; Zhu, Changqiang; Liu, Shaojun] Inst Basic Med Sci, Dept Neurobiol, Beijing 100850, Peoples R China; [Ma, Yanhong] 261th Hosp Chinese PLA, Dept Cardiol, Beijing, Peoples R China	Yang, SG (corresponding author), Inst Basic Med Sci, State Key Lab Prote, Beijing 100850, Peoples R China.	lionfmmu@yahoo.com.cn			Chinese National Key Project of Basic ResearchNational Basic Research Program of China [2009CB918301]; Chinese National Natural Science FoundationNational Natural Science Foundation of China (NSFC) [81000797]	Contract grant sponsor: Chinese National Key Project of Basic Research; Contract grant number: 2009CB918301; Contract grant sponsor: Chinese National Natural Science Foundation; Contract grant number: 81000797.	Amick Jonathan E., 2001, Pediatr Crit Care Med, V2, P260, DOI 10.1097/00130478-200107000-00013; Arredouani M, 2003, IMMUNOLOGY, V108, P144, DOI 10.1046/j.1365-2567.2003.01569.x; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Campbell SJ, 2005, AM J PATHOL, V166, P1487, DOI 10.1016/S0002-9440(10)62365-6; Conti A, 2004, J NEUROTRAUM, V21, P854, DOI 10.1089/0897715041526212; DArmiento J, 1997, GENE, V195, P19, DOI 10.1016/S0378-1119(97)00123-6; Ding QX, 2003, PROTEOMICS, V3, P1313, DOI 10.1002/pmic.200300452; El-Ghmati SM, 2002, SCAND J IMMUNOL, V55, P352, DOI 10.1046/j.1365-3083.2002.01067.x; Gao WM, 2007, J NEUROTRAUM, V24, P43, DOI 10.1089/neu.2006.0061; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Johnson Ginger, 1992, Applied and Theoretical Electrophoresis, V3, P47; Kim IS, 2001, BIOCHEM BIOPH RES CO, V284, P738, DOI 10.1006/bbrc.2001.5041; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; KUROSKY A, 1980, P NATL ACAD SCI-BIOL, V77, P3388, DOI 10.1073/pnas.77.6.3388; Lee MY, 2002, J CEREBR BLOOD F MET, V22, P1176; Lewis E J, 1992, Mediators Inflamm, V1, P39, DOI 10.1155/S0962935192000085; Lim YK, 2000, KIDNEY INT, V58, P1033, DOI 10.1046/j.1523-1755.2000.00261.x; MARINKOVIC S, 1990, MOL CELL BIOL, V10, P1573, DOI 10.1128/MCB.10.4.1573; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Petersen HH, 2004, VET RES, V35, P163, DOI 10.1051/vetres:2004002; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Sanchez DJ, 2001, NEUROSCI LETT, V303, P181, DOI 10.1016/S0304-3940(01)01748-7; SEVALJEVIC LJ, 1995, INT J BIOCHEM CELL B, V27, P185, DOI 10.1016/1357-2725(94)00073-K; Smeets MB, 2002, FEBS LETT, V529, P221, DOI 10.1016/S0014-5793(02)03343-4; Vejda S, 2002, MOL CELL PROTEOMICS, V1, P387, DOI 10.1074/mcp.M200004-MCP200; WADA T, 1970, J RETICULOENDOTH SOC, V8, P185; YANG FM, 1995, LAB INVEST, V73, P433; Yang S, 2008, NEUROSCIENCE, V154, P1107, DOI 10.1016/j.neuroscience.2008.04.012; Zhang ZY, 2009, WORLD J GASTROENTERO, V15, P4150, DOI 10.3748/wjg.15.4150	29	12	12	0	19	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012			J NEUROSCI RES	J. Neurosci. Res.	FEB	2013	91	2					230	239		10.1002/jnr.23159			10	Neurosciences	Neurosciences & Neurology	056JS	WOS:000312485300008	23172820				2021-06-18	
J	Bendorf, A; Kerridge, IH; Stewart, C				Bendorf, Aric; Kerridge, Ian H.; Stewart, Cameron			Intimacy or utility? Organ donation and the choice between palliation and ventilation	CRITICAL CARE			English	Article							TRAUMATIC BRAIN-INJURY; CIRCULATORY DEATH; LIFE; CARE; END; DONORS; TRANSPLANTATION; CULTURE; TRENDS; IMPACT	Organ donation after brain death provides the most important source for deceased organs for transplantation, both because of the number of potential organ donors that it makes available and also because of the unparalleled viability of the organs retrieved. Analysis of worldwide deceased organ donation rates demonstrates that all countries with high deceased organ donation rates (>20 donors per million population per year) have high brain death rates (>40 brain deaths per million population per year). This analysis makes it clear that countries striving to increase their deceased organ donor rates to world leading levels must increase the rates of donation after brain death. For countries with end-of-life care strategies that stress palliation, advance care planning and treatment withdrawal for the terminally ill, the adoption of initiatives to meaningfully raise deceased donor rates will require increasing the rate at which brain death is diagnosed. This poses a difficult, and perhaps intractable, medical, ethical and sociocultural challenge as the changes that would be required to increase rates of brain death would mean conjugating an intimate clinical and cultural focus on the dying patient with the notion of how this person's death might be best managed to be of benefit to others.	[Bendorf, Aric; Kerridge, Ian H.; Stewart, Cameron] Univ Sydney, Ctr Values Eth & Law Med VELiM, Sydney, NSW 2006, Australia; [Kerridge, Ian H.] Royal N Shore Hosp, Dept Haematol, St Leonards, NSW 2065, Australia; [Stewart, Cameron] Univ Sydney, Sydney Law Sch, Ctr Hlth Governance Law & Eth, Sydney, NSW 2006, Australia	Bendorf, A (corresponding author), Univ Sydney, Ctr Values Eth & Law Med VELiM, Level 1,Med Fdn Bldg K25,92-94 Parramatta Rd, Sydney, NSW 2006, Australia.	aric.bendorf@sydney.edu.au		Kerridge, Ian/0000-0001-7445-4660; Stewart, Cameron/0000-0003-3625-0899			Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Agence de la Biomedecine, 2011, RAPP ANN 2010 ACT DO; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; [Anonymous], 1968, JAMA, V205, P337; [Anonymous], 1979, Br Med J, V1, P332; AriThs P., 1974, W ATTITUDES DEATH; Ball CG, 2010, J TRAUMA, V69, P1323, DOI 10.1097/TA.0b013e3181f66878; Bellingham JM, 2011, SURGERY, V150, P692, DOI 10.1016/j.surg.2011.07.057; Bendorf A, 2012, INTERN MED J, V42, P866, DOI 10.1111/j.1445-5994.2012.02792.x; Bendorf A, 2012, 24 INT C TRANSPL SOC; British Medical Association, 2012, BUILD PROGR NEXT ORG; Busic M, 2012, ORGAN DONATION TRANS; Centro Nazionale Trapianti Istituto Superiore di Sanita, 2011, VAL QUAL ATT TRAP 20; Colheita e Transplantacao de Orgaos e Tecidos, 2010, REL EST 2009; Council of Europe, 2011, NEWSLETT TRANSPL, V16, P25; Council of Europe, 2006, NEWSLETT TRANSPL, P11; Devictor Denis J, 2004, Pediatr Crit Care Med, V5, P211, DOI 10.1097/01.PCC.0000123553.22405.E3; Dominguez-Gil B, 2011, TRANSPL INT, V24, P676, DOI 10.1111/j.1432-2277.2011.01257.x; DonateLife Australia, 2012, PERF REP 2011; FEEST TG, 1990, LANCET, V335, P1133, DOI 10.1016/0140-6736(90)91134-V; Flory J, 2004, HEALTH AFFAIR, V23, P194, DOI 10.1377/hlthaff.23.3.194; Higginson IJ, 1998, PALLIATIVE MED, V12, P353, DOI 10.1191/026921698672530176; Kehl Karen A, 2006, Am J Hosp Palliat Care, V23, P277, DOI 10.1177/1049909106290380; Kerridge IH, 2002, J MED ETHICS, V28, P89, DOI 10.1136/jme.28.2.89; Machado C, 1995, DEVEL NEUR, V9, P57; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Matesanz R, 2012, AM J TRANSPLANT, V12, P2498, DOI 10.1111/j.1600-6143.2012.04128.x; Mendcloff J, 2004, TRANSPLANTATION, V78, P1704, DOI 10.1097/01.TP.0000149787.97288.A2; Monette M, 2010, CAN MED ASS J; Nath J, 2011, LANCET, V377, P203, DOI 10.1016/S0140-6736(11)60038-X; National Health Service, 2011, POT DON AUD SUMM REP; Oosterlee A, 2006, EUROTRANSPLANT INT F; Organ Procurement and Transplantation Network, 2010, DEC DON REC US MECH; Organizacion Nacional de Trasplantes, 2010, PROGR GAR CAL PROC D; Orman ES, 2013, LIVER TRANSPLANT, V19, P59, DOI 10.1002/lt.23547; Perez K, 2012, ACCIDENT ANAL PREV, V46, P37, DOI 10.1016/j.aap.2011.12.004; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; Sheehy E, 2003, NEW ENGL J MED, V349, P667, DOI 10.1056/NEJMsa021271; Smith G. P., 2012, LAW BIOETHICS INTERS; Sprung CL, 2007, INTENS CARE MED, V33, P1732, DOI 10.1007/s00134-007-0693-0; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Stewart CL, 2011, PUBLIC HEALTH, V125, P905, DOI 10.1016/j.puhe.2011.10.001; Van Gelder F, 2007, TRANSPL INT, V20, P37; Walter T, 2003, BMJ-BRIT MED J, V327, P218, DOI 10.1136/bmj.327.7408.218; Zych B, 2012, EUR J CARDIO-THORAC, V42, P542, DOI 10.1093/ejcts/ezs096	45	12	12	0	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2013	17	3							316	10.1186/cc12553			6	Critical Care Medicine	General & Internal Medicine	285YN	WOS:000329431100072	23714404	DOAJ Gold, Green Published			2021-06-18	
J	Cockerham, GC; Lemke, S; Glynn-Milley, C; Zumhagen, L; Cockerham, KP				Cockerham, Glenn C.; Lemke, Sonne; Glynn-Milley, Catherine; Zumhagen, Lars; Cockerham, Kimberly P.			Visual Performance and the Ocular Surface in Traumatic Brain Injury	OCULAR SURFACE			English	Article						anticholinergic drugs; blast injury; corneal sensitivity; dry eye; medications; Ocular Surface Disease Index; pathophysiology; tear osmolarity; tear production; tear quality; traumatic brain injury; veteran rehabilitation	DRY EYE DISEASE; UNITED-STATES; RISK-FACTORS; RAT-BRAIN; PREVALENCE; DYSFUNCTION; IRAQI; GLAND; BIOMECHANICS; RELIABILITY	The pathophysiology of neurotrauma is reviewed and an original study investigating the prevalence of dry eye disease in a sample of veterans with traumatic brain injury (TBI) is presented. Fifty-three veterans with TBI were evaluated by history of injury, past ocular history, and medication use. Ocular Disease Surface Index (OSDI), ocular examination, cranial nerve evaluation, tear osmolarity, tear film break-up time (TFBUT), ocular surface staining and tear production testing were performed. A matched comparison group underwent similar testing. TBI causes were blast (44) or non-blast (9). TBI subjects scored significantly worse on the OSDI (P<.001), and ocular surface staining by Oxford scale (P<.001) than non-TBI subjects. Scores for tear film breakup (P=.6), basal tear production less than 3 mm (P=.13), and tear osmolarity greater than 314 mOsm/L (P=.15) were all higher in TBI subjects; significantly more TBI subjects had at least one abnormal dry eye measure than comparisons (P<.001). The OSDI related to presence of dry eye symptoms (P<.01). These effects were present in both blast and non-blast TBI. Seventy percent of TBI subjects were taking at least one medication in the following classes: antidepressant, atypical antipsychotic, anticonvulsant, or h1-antihistamine. There was no association between any medication class and the OSDI or dry eye measures. Reduced corneal sensation in 21 TBI subjects was not associated with OSDI, tear production, or TFBUT, but did correlate with reduced tear osmolarity (P=.05). History of refractive surgery, previous contact lens wear, facial nerve weakness, or meibomian gland dysfunction was not associated with DED. In summary, we found a higher prevalence of DED in subjects with TBI, both subjectively and objectively. This effect is unrelated to medication use, and it may persist for months to years. We recommend that patients with TBI from any cause be evaluated for DED using a battery of standard testing methods described in a protocol presented in this article. Further research into the pathophysiology and outcomes of DED in neurotrauma is needed.	[Cockerham, Glenn C.; Glynn-Milley, Catherine; Cockerham, Kimberly P.] Vet Adm Palo Alto Hlth Care Syst, Dept Ophthalmol, Palo Alto, CA 94304 USA; [Cockerham, Glenn C.; Cockerham, Kimberly P.] Stanford Univ, Sch Med, Dept Ophthalmol, Palo Alto, CA 94304 USA; [Lemke, Sonne] Vet Adm Palo Alto Hlth Care Syst, Ctr Hlth Care Evaluat, Palo Alto, CA 94304 USA; [Zumhagen, Lars] Univ Munster, Dept Ophthalmol, D-48149 Munster, Germany	Cockerham, GC (corresponding author), Vet Adm Palo Alto Hlth Care Syst, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	glenn.cockerham@va.gov	Cockerham, Kimberly/AAR-5917-2021		Veterans Administration Merit Review AwardUS Department of Veterans Affairs [C5018R]	Veterans Administration Merit Review Award C5018R. The sponsor had no role in the design or conduct of this research.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; [Anonymous], 2007, LANCET, V370, P1879; Berntsen DA, 2006, CORNEA, V25, P695, DOI 10.1097/01.ico.0000208814.94495.a6; Beuerman RW, 2004, DRY EYE OCULAR SURFA; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Bron AJ, 2007, OCUL SURF, V5, P108; Bruce BB, 2006, J NEUROL NEUROSUR PS, V77, P986, DOI 10.1136/jnnp.2006.088799; CAVANAGH HD, 1989, ACTA OPHTHALMOL, V67, P115; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Colyer MH, 2008, OPHTHALMOLOGY, V115, P2087, DOI 10.1016/j.ophtha.2008.05.013; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dastjerdi Mohammad H, 2009, Int Ophthalmol Clin, V49, P11, DOI 10.1097/IIO.0b013e31819242c9; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Dhaliwal A, 2006, J NEURO-OPHTHALMOL, V26, P4, DOI 10.1097/01.wno.0000204661.48806.1d; Dolgonos S, 2011, INVEST OPHTH VIS SCI, V52, P7852, DOI 10.1167/iovs.11-7604; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; Erdurman FC, 2011, EYE, V25, P1491, DOI 10.1038/eye.2011.212; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Coello AF, 2010, J NEUROSURG, V113, P547, DOI 10.3171/2010.6.JNS091620; Galor A, 2011, AM J OPHTHALMOL, V152, P377, DOI 10.1016/j.ajo.2011.02.026; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Hamrah P, 2010, OPHTHALMOLOGY, V117, P1930, DOI 10.1016/j.ophtha.2010.07.010; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; IOM, 2009, GULF WAR HLTH, V7; JEPPESEN KV, 1985, PHARMACOPSYCHIATRY, V18, P231, DOI 10.1055/s-2007-1017371; JONES LT, 1966, AM J OPHTHALMOL, V62, P47, DOI 10.1016/0002-9394(66)91676-X; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kaur C, 1997, NEUROSCI RES, V27, P317, DOI 10.1016/S0168-0102(97)01164-4; KEANE JR, 1993, NEUROLOGY, V43, P2439, DOI 10.1212/WNL.43.12.2439; Lambiase A, 2011, ARCH OPHTHALMOL-CHIC, V129, P981, DOI 10.1001/archophthalmol.2011.200; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Lemp MA, 2011, AM J OPHTHALMOL, V151, P792, DOI 10.1016/j.ajo.2010.10.032; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; McCann J D, 1994, Curr Opin Ophthalmol, V5, P3, DOI 10.1097/00055735-199412000-00002; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Moss SE, 2000, ARCH OPHTHALMOL-CHIC, V118, P1264; Murray CJL, 1996, GLOBAL HLTH STAT; Nakagawa A, 2008, ACTA NEUROCHIR SUPPL, V102, P421, DOI 10.1007/978-3-211-85578-2_82; Nassiri N, 2011, CORNEA, V1, P425; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owen-Smith MS, 1981, MED B US ARMY EUR, V38, P36; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Phillips YY, 1989, TXB MILITARY MED CON, P221; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Rutner D, 2006, BRAIN INJURY, V20, P1079, DOI 10.1080/02699050600909904; Saljo A, 2002, J NEUROTRAUM, V19, P985, DOI 10.1089/089771502320317131; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Sarkies N, 2004, EYE, V18, P1122, DOI 10.1038/sj.eye.6701571; Schaumberg DA, 2009, ARCH OPHTHALMOL-CHIC, V127, P763, DOI 10.1001/archophthalmol.2009.103; Schein OD, 1999, ARCH INTERN MED, V159, P1359, DOI 10.1001/archinte.159.12.1359; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Smith JA, 2007, OCUL SURF, V5, P93; Stanek S, 2000, MIL MED, V165, P591; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Sullivan BD, 2010, INVEST OPHTH VIS SCI, V51, P6125, DOI 10.1167/iovs.10-5390; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Tomlinson A, 2011, INVEST OPHTH VIS SCI, V52, P2006, DOI 10.1167/iovs.10-6997f; Veterans Health Administration, 2012, AN VA HLTH CAR UT OP; WARNER JEA, 1995, INT OPHTHALMOL CLIN, V35, P57, DOI 10.1097/00004397-199503510-00007; Warner N, 2010, CURR OPIN OPHTHALMOL, V21, P459, DOI 10.1097/ICU.0b013e32833f00c9; Weichel ED, 2008, OPHTHALMOLOGY, V115, P2235, DOI 10.1016/j.ophtha.2008.08.033; Wirtshafter JD, 1998, WALSH HOYTS CLIN NEU, V1, P917; Wong J, 2011, OCUL SURF, V9, P212, DOI 10.1016/S1542-0124(11)70034-9; Yazdani C, 2001, CLIN THER, V23, P1672, DOI 10.1016/S0149-2918(01)80136-3; Zhang X, 2006, NEUROLOGY, V66, P906, DOI 10.1212/01.wnl.0000203913.12088.93	77	12	12	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1542-0124	1937-5913		OCUL SURF	Ocul. Surf.	JAN	2013	11	1					25	34		10.1016/j.jtos.2012.09.004			10	Ophthalmology	Ophthalmology	080RF	WOS:000314260300007	23321357				2021-06-18	
J	Ilodigwe, D; Murray, GD; Kassell, NF; Torner, J; Kerr, RSC; Molyneux, AJ; Macdonald, RL				Ilodigwe, Don; Murray, Gordon D.; Kassell, Neal F.; Torner, James; Kerr, Richard S. C.; Molyneux, Andrew J.; Macdonald, R. Loch			Sliding dichotomy compared with fixed dichotomization of ordinal outcome scales in subarachnoid hemorrhage trials Clinical article	JOURNAL OF NEUROSURGERY			English	Article						clinical trial; statistical analysis; vascular disorders; subarachnoid hemorrhage; vasospasm	RUPTURED INTRACRANIAL ANEURYSMS; VEHICLE-CONTROLLED TRIAL; DOSE TIRILAZAD MESYLATE; TRAUMATIC BRAIN-INJURY; DOUBLE-BLIND; ENDOVASCULAR COILING; RANDOMIZED-TRIAL; NORTH-AMERICA; STROKE TRIALS; NEW-ZEALAND	Object. In randomized clinical trials of subarachnoid hemorrhage (SAH) in which the primary clinical outcomes are ordinal, it has been common practice to dichotomize the ordinal outcome scale into favorable versus unfavorable outcome. Using this strategy may increase sample sizes by reducing statistical power. Authors of the present study used SAH clinical trial data to determine if a sliding dichotomy would improve statistical power. Methods. Available individual patient data from tirilazad (3552 patients), clazosentan (the Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage trial [CONSCIOUS-1], 413 patients), and subarachnoid aneurysm trials (the International Subarachnoid Aneurysm Trial [ISAT], 2089 patients) were analyzed. Treatment effect sizes were examined using conventional fixed dichotomy, sliding dichotomy (logical or median split methods), or proportional odds modeling. Whether sliding dichotomy affected the difference in outcomes between the several age and neurological grade groups was also evaluated. Results. In the tirilazad data, there was no significant effect of treatment on outcome (fixed dichotomy: OR = 0.92, 95% CI 0.80-1.07; and sliding dichotomy: OR = 1.02, 95% CI 0.87-1.19). Sliding dichotomy reversed and increased the difference in outcome in favor of the placebo over clazosentan (fixed dichotomy: OR = 1.06, 95% CI 0.65-1.74; and sliding dichotomy: OR = 0.85, 95% CI 0.52-1.39). In the ISAT data, sliding dichotomy produced identical odds ratios compared with fixed dichotomy (fixed dichotomy vs sliding dichotomy, respectively: OR = 0.67, 95% CI 0.55-0.82 vs OR = 0.67, 95% CI 0.53-0.85). When considering the tirilazad and CONSCIOUS-1 groups based on age or World Federation of Neurosurgical Societies grade, no consistent effects of sliding dichotomy compared with fixed dichotomy were observed. Conclusions. There were differences among fixed dichotomy, sliding dichotomy, and proportional odds models in the magnitude and precision of odds ratios, but these differences were not as substantial as those seen when these methods were used in other conditions such as head injury. This finding suggests the need for different outcome scales for SAH. (http://thejns.org/doi/abs/10.3171/2012.9.JNS111383)	[Ilodigwe, Don; Macdonald, R. Loch] Univ Toronto, St Michaels Hosp,Div Neurosurg, Labatt Family Ctr Excellence Brain Injury & Traum, Keenan Res Ctr,Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Ilodigwe, Don; Macdonald, R. Loch] Univ Toronto, Inst Med Sci, Dept Surg, Toronto, ON M5B 1W8, Canada; [Kassell, Neal F.] Univ Virginia, Sch Med, Dept Neurol Surg, Charlottesville, VA 22908 USA; [Torner, James] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA; [Murray, Gordon D.] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Kerr, Richard S. C.] John Radcliffe Hosp, Dept Neurosurg, Oxford OX3 9DU, England; [Molyneux, Andrew J.] Univ Oxford, Oxford Neurovasc & Neuroradiol Res Unit, Oxford OX1 2JD, England	Macdonald, RL (corresponding author), Univ Toronto, St Michaels Hosp,Div Neurosurg, Labatt Family Ctr Excellence Brain Injury & Traum, Keenan Res Ctr,Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.	macdonaldlo@smh.ca		Murray, Gordon/0000-0001-9866-4734	Actelion Pharmaceuticals, Ltd.; Physicians Services Incorporated Foundation; Heart and Stroke Foundation of CanadaHeart & Stroke Foundation of Canada; Medical Research Council UKUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Cerecyte Coil Trial (Micrus Endovascular); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0800803, G0700479] Funding Source: researchfish	Actelion Pharmaceuticals, Ltd., was the sponsor of the CONSCIOUS-1 trial and they provided financial support for the exploratory analysis described in this article. The data analysis and writing are the work of the authors. Dr. Macdonald is the chief scientific officer for and has direct stock ownership in Edge Therapeutics, Inc.; is a consultant for Actelion Pharmaceuticals, Ltd.; and receives grant funding from Physicians Services Incorporated Foundation and the Heart and Stroke Foundation of Canada. Dr. Kassell has ownership in InSightec. Dr. Molyneux is a consultant for Actelion Pharmaceuticals, Ltd., and Micrus Endovascular Corp. and receives grant support from the Medical Research Council UK and Cerecyte Coil Trial (Micrus Endovascular).	Bath PMW, 2007, STROKE, V38, P1911, DOI 10.1161/STROKEAHA.106.474080; Bolland K, 1998, STAT MED, V17, P2835, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2835::AID-SIM933>3.3.CO;2-#; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Haley EC, 1997, J NEUROSURG, V86, P467, DOI 10.3171/jns.1997.86.3.0467; HALEY EC, 1995, J NEUROSURG, V82, P786, DOI 10.3171/jns.1995.82.5.0786; JENNETT B, 1975, LANCET, V1, P480; Kassell NF, 1996, J NEUROSURG, V84, P221, DOI 10.3171/jns.1996.84.2.0221; Lanzino G, 1999, J NEUROSURG, V90, P1011, DOI 10.3171/jns.1999.90.6.1011; Lanzino G, 1999, J NEUROSURG, V90, P1018, DOI 10.3171/jns.1999.90.6.1018; Lees KR, 2000, LANCET, V355, P1949, DOI 10.1016/S0140-6736(00)02326-6; Macdonald RL, 2008, STROKE, V39, P3015, DOI 10.1161/STROKEAHA.108.519942; McHugh GS, 2010, CLIN TRIALS, V7, P44, DOI 10.1177/1740774509356580; Mendelow AD, 2005, LANCET, V365, P387; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Sandset EC, 2011, LANCET, V377, P741, DOI 10.1016/S0140-6736(11)60104-9; Saver JL, 2007, STROKE, V38, P3055, DOI 10.1161/STROKEAHA.107.488536; Senn S, 2009, STAT MED, V28, P3189, DOI 10.1002/sim.3603; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	22	12	12	0	8	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	JAN	2013	118	1					3	12		10.3171/2012.9.JNS111383			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	062UQ	WOS:000312948800003	23039145	Bronze			2021-06-18	
J	Matsui, T; Motoki, Y; Yoshida, Y				Matsui, Tomohiro; Motoki, Yukari; Yoshida, Yusuke			Hypothermia Reduces Toll-Like Receptor 3-Activated Microglial Interferon-beta and Nitric Oxide Production	MEDIATORS OF INFLAMMATION			English	Article							CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; DOUBLE-STRANDED-RNA; NF-KAPPA-B; CEREBROSPINAL-FLUID; MESSENGER-RNA; IFN-BETA; ACTIVATION; CELLS; INNATE	Therapeutic hypothermia protects neurons after injury to the central nervous system (CNS). Microglia express toll-like receptors (TLRs) that play significant roles in the pathogenesis of sterile CNS injury. To elucidate the possible mechanisms involved in the neuroprotective effect of therapeutic hypothermia, we examined the effects of hypothermic culture on TLR3-activated microglial release of interferon (IFN)-beta and nitric oxide (NO), which are known to be associated with neuronal cell death. When rat or mouse microglia were cultured under conditions of hypothermia (33 degrees C) and normothermia (37 degrees C) with a TLR3 agonist, polyinosinic-polycytidylic acid, the production of IFN-beta and NO in TLR3-activated microglia at 48 h was decreased by hypothermia compared with that by normothermia. In addition, exposure to recombinant IFN-beta and sodium nitroprusside, an NO donor, caused death of rat neuronal pheochromocytoma PC12 cells in a concentration-dependent manner after 24 h. Taken together, these results suggest that the attenuation of microglial production of IFN-beta and NO by therapeutic hypothermia leads to the inhibition of neuronal cell death.	[Matsui, Tomohiro; Motoki, Yukari] Yamaguchi Univ, Grad Sch Med, Dept Lab Sci, Ube, Yamaguchi 7558505, Japan; [Yoshida, Yusuke] ACEL Inc, Midori Ku, Sagamihara, Kanagawa 2520131, Japan	Matsui, T (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Lab Sci, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	giants@yamaguchi-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [22791435]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [22791435] Funding Source: KAKEN	This research was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant-in-Aid for Young Scientists (B), no. 22791435 to T. Matsui. The authors would like to thank Enago (http://www.enago.jp/) for the English language review.	Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akwa Y, 1998, J IMMUNOL, V161, P5016; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Babcock AA, 2006, J NEUROSCI, V26, P12826, DOI 10.1523/JNEUROSCI.4937-05.2006; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Bsibsi M, 2010, J IMMUNOL, V184, P6929, DOI 10.4049/jimmunol.0902419; Cao CX, 2007, BIOCHEM BIOPH RES CO, V353, P509, DOI 10.1016/j.bbrc.2006.12.057; Carpentier PA, 2008, BRAIN BEHAV IMMUN, V22, P140, DOI 10.1016/j.bbi.2007.08.011; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Chen MY, 2009, EUR J IMMUNOL, V39, P2525, DOI 10.1002/eji.200838879; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Dedoni S, 2010, J NEUROCHEM, V115, P1421, DOI 10.1111/j.1471-4159.2010.07046.x; Gibbons H, 2003, MOL BRAIN RES, V110, P63, DOI 10.1016/S0169-328X(02)00585-5; Hanisch UK, 2008, TRENDS NEUROSCI, V31, P176, DOI 10.1016/j.tins.2008.01.005; Hoffmann O, 2007, J IMMUNOL, V178, P6476, DOI 10.4049/jimmunol.178.10.6476; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hua F, 2007, J NEUROIMMUNOL, V190, P101, DOI 10.1016/j.jneuroim.2007.08.014; Hua LWL, 2000, GLIA, V30, P74, DOI 10.1002/(SICI)1098-1136(200003)30:1<74::AID-GLIA8>3.0.CO;2-C; Hyakkoku K, 2010, NEUROSCIENCE, V171, P258, DOI 10.1016/j.neuroscience.2010.08.054; Johnson GB, 2003, CRIT REV IMMUNOL, V23, P15, DOI 10.1615/CritRevImmunol.v23.i12.20; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Khorooshi R, 2010, J IMMUNOL, V185, P1258, DOI 10.4049/jimmunol.0901753; Kim MO, 2002, J NEUROCHEM, V81, P1361, DOI 10.1046/j.1471-4159.2002.00949.x; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Lehnardt S, 2007, J NEUROIMMUNOL, V190, P28, DOI 10.1016/j.jneuroim.2007.07.023; Liu AX, 2005, J NEUROSCI, V25, P737, DOI 10.1523/JNEUROSCI.4174-04.2005; Loidl CF, 1998, BRAIN RES, V791, P303, DOI 10.1016/S0006-8993(98)00195-4; Maekawa S, 2002, CRIT CARE MED, V30, P2700, DOI 10.1097/00003246-200212000-00014; Makar TK, 2008, J NEUROIMMUNOL, V196, P67, DOI 10.1016/j.jneuroim.2008.02.014; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Matsui T, 2008, J NEUROTRAUM, V25, P709, DOI 10.1089/neu.2007.0482; Matsui T, 2012, NEUROCRIT CARE, V17, P293, DOI 10.1007/s12028-011-9639-z; Matsui T, 2012, INTENS CARE MED, V38, P1392, DOI 10.1007/s00134-012-2591-3; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Melton LM, 2003, GLIA, V44, P1, DOI 10.1002/glia.10276; Minghetti L, 1998, PROG NEUROBIOL, V54, P99, DOI 10.1016/S0301-0082(97)00052-X; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; Pais TF, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-43; Patro IK, 2010, INDIAN J EXP BIOL, V48, P104; Reyes-Vazquez C, 2012, BRAIN RES, V1442, P76, DOI 10.1016/j.brainres.2011.09.061; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Si QS, 1997, NEUROSCIENCE, V81, P223, DOI 10.1016/S0306-4522(97)00172-3; Stuve O, 1996, ANN NEUROL, V40, P853, DOI 10.1002/ana.410400607; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Town T, 2006, J IMMUNOL, V176, P3804, DOI 10.4049/jimmunol.176.6.3804; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Wada K, 1996, NEUROCHEM INT, V29, P461, DOI 10.1016/0197-0186(96)82655-6; Wang JP, 2005, J VIROL, V79, P8295, DOI 10.1128/JVI.79.13.8295-8302.2005; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Yamaguchi S, 2000, NEUROL RES, V22, P657; Zhang LJ, 2012, NEUROCHEM INT, V61, P1220, DOI 10.1016/j.neuint.2012.09.002; Zhang ZR, 2005, J NEUROIMMUNOL, V164, P154, DOI 10.1016/j.jneuroim.2005.03.014; Ziegler G, 2007, BIOCHEM BIOPH RES CO, V359, P574, DOI 10.1016/j.bbrc.2007.05.157	62	12	12	0	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0962-9351	1466-1861		MEDIAT INFLAMM	Mediat. Inflamm.		2013	2013								436263	10.1155/2013/436263			7	Cell Biology; Immunology	Cell Biology; Immunology	121CP	WOS:000317220600001	23589665	DOAJ Gold, Green Published			2021-06-18	
J	Negahban, H; Fattahizadeh, P; Ghasemzadeh, R; Salehi, R; Majdinasab, N; Mazaheri, M				Negahban, Hossein; Fattahizadeh, Parastoo; Ghasemzadeh, Roya; Salehi, Reza; Majdinasab, Nastaran; Mazaheri, Masood			The Persian Version of Community Integration Questionnaire in persons with multiple sclerosis: translation, reliability, validity, and factor analysis	DISABILITY AND REHABILITATION			English	Article						Community integration questionnaire; multiple sclerosis; Persian version; psychometric properties	TRAUMATIC BRAIN-INJURY; PSYCHOMETRIC PROPERTIES; CONCURRENT VALIDITY; QUALITY	Purpose: To culturally translate and validate the Community Integration Questionnaire (CIQ) in persons with multiple sclerosis (MS). Methods: After a forward-backward translation, 105 persons with MS completed the Persian versions of the CIQ and MS Quality of Life (MSQOL) questionnaires in the first visit. The CIQ was re-administered to a sample of 45 persons with MS 7-10 days after the first session. Test-retest reliability and internal consistency were assessed using intraclass correlation coefficient (ICC) and Cronbach's a coefficient, respectively. Construct validity was assessed by measuring associations between subscales of the Persian CIQ (including Home Integration (HI), Social Integration (SI), and Productivity (P)) and MSQOL (including Physical and Mental Components). Dimensionality was assessed through two methods of corrected item-subscale correlation and factor analysis. Results: The acceptable level of test-retest reliability (ICC >= 0.70) was obtained for the Persian CIQ. However, Cronbach's a coefficient of >= 0.70 was only seen for the HI. The correlations between the Persian CIQ and the Physical MSQOL were higher than those of Persian CIQ and the Mental MSQOL. The corrected item-subscale Spearman's correlation coefficient of 0.40 was exceeded by most items of the HI and 2 items of P. A total of four factors were detected and similar to the results of item-subscale correlation, the most variability was seen for the items of SI which loaded on different factors. Conclusions: Persian CIQ seems to be a reliable and valid instrument for monitoring the level of community integration following rehabilitation in persons with MS. Some modifications need to be made in the SI of the Persian CIQ to improve extraction of information regarding community integration of persons with MS.	[Negahban, Hossein; Fattahizadeh, Parastoo; Ghasemzadeh, Roya; Salehi, Reza] Ahvaz Jundishapur Univ Med Sci, Musculoskeletal Rehabil Res Ctr, Ahwaz, Iran; [Majdinasab, Nastaran] Ahvaz Jundishapur Univ Med Sci, Musculoskeletal Rehabil Res Ctr, Dept Neurol, Ahwaz, Iran; [Mazaheri, Masood] Isfahan Univ Med Sci, Musculoskeletal Res Ctr, Esfahan, Iran	Negahban, H (corresponding author), Ahvaz Jundishapur Univ Med Sci, Musculoskeletal Rehabil Res Ctr, Ahwaz, Iran.	honegahban@yahoo.com	Mazaheri, Masood/A-8207-2018; Ghasemzadeh, Roya/S-8225-2017; Negahban, Hossein/O-7405-2018; Majdinasab, Nastaran/M-8218-2017; Salehi, Reza/Q-5721-2017; Mazaheri, Masood/V-9739-2019	Ghasemzadeh, Roya/0000-0002-1402-4025; Negahban, Hossein/0000-0001-8387-1781; Majdinasab, Nastaran/0000-0001-5163-7210; Salehi, Reza/0000-0001-6793-7293; 	Ahvaz Jundishapur University of Medical Sciences [pht-9008]	This study is part of M.Sc thesis of Mrs Fattahizadeh. Special thanks to Ahvaz Jundishapur University of Medical Sciences for the financial support (Master thesis grant no: pht-9008). Also, we thank Prof. Willer for permitting us to validate the Persian-version of this instrument in our country, Iran. Finally, we would like to thank the two anonymous reviewers (especially reviewer# 1) for providing us with constructive comments and suggestions.	Bennell K., 2000, PHYS THER SPORT, V1, P32, DOI [10.1054/ptsp.2000.0009., DOI 10.1054/PTSP.2000.0009]; Bullinger M, 1998, J CLIN EPIDEMIOL, V51, P913, DOI 10.1016/S0895-4356(98)00082-1; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Dalemans RJ, 2010, ARCH PHYS MED REHAB, V91, P395, DOI 10.1016/j.apmr.2009.10.021; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Dijkers Marcel., 1998, TOP SPINAL CORD INJ, V4, P1, DOI [10.1310/BJJA-2018-45KL-0VTL, DOI 10.1310/BJJA-2018-45KL-0VTL]; Ehde DM, 2006, MULT SCLER J, V12, P629, DOI 10.1177/1352458506071346; Fayer P. M., 2000, QUALITY LIFE ASSESSM; Field A.P., 2005, DISCOVERING STAT USI; Ghaem H, 2007, NEUROL INDIA, V55, P369, DOI 10.4103/0028-3886.33316; Gontkovsky ST, 2009, NEUROREHABILITATION, V24, P185, DOI 10.3233/NRE-2009-0467; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hirsh AT, 2011, ARCH PHYS MED REHAB, V92, P1602, DOI 10.1016/j.apmr.2011.05.004; Kaplan CP, 2001, BRAIN INJURY, V15, P725, DOI 10.1080/02699050010005913; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Mazaheri M, 2011, DISABIL REHABIL, V33, P1737, DOI 10.3109/09638288.2010.544838; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; Minnes P, 2003, BRAIN INJURY, V17, P149, DOI 10.1080/02699050301828; Negahban H, 2011, DISABIL REHABIL, V33, P2305, DOI 10.3109/09638288.2011.570409; Negahban H, 2010, CLIN RHEUMATOL, V29, P479, DOI 10.1007/s10067-009-1344-3; Rintala DH, 2002, REHABIL PSYCHOL, V47, P144, DOI 10.1037//0090-5550.47.2.144; Saeki S, 2006, J REHABIL MED, V38, P333, DOI 10.1080/16501970600780245; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI DOI 10.1097/00001199-199308020-00009; Yasui NY, 2009, DISABIL REHABIL, V31, P761, DOI 10.1080/09638280802306638	29	12	12	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2013	35	17					1453	1459		10.3109/09638288.2012.741653			7	Rehabilitation	Rehabilitation	186IW	WOS:000322037800005	23330593				2021-06-18	
J	Parrish, J; Baldwin-Johnson, C; Volz, M; Goldsmith, Y				Parrish, Jared; Baldwin-Johnson, Cathy; Volz, Margaret; Goldsmith, Yvonne			Abusive head trauma among children in Alaska: a population-based assessment	INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH			English	Article						child maltreatment; child abuse; abusive head trauma; traumatic brain injury; surveillance; epidemiology	PUBLIC-HEALTH SURVEILLANCE; BRAIN-INJURIES; UNITED-STATES; MALTREATMENT; MORTALITY; UNDERASCERTAINMENT; CERTIFICATES	Background. Serious physical abuse resulting in a traumatic brain injury (TBI) has been implicated as an underreported cause of infant mortality. Nearly 80% of all abusive head trauma (AHT) occurs among children <2 years of age, with infants experiencing an incidence nearly 8 times that of 2-year olds. Objective. This study describes the validation of the CDC Pediatric Abusive Head Trauma (PAHT) definitions when applied to a multi-source database at the state level and provides a robust annual incidence estimate of AHT among children <2 years of age in Alaska. Design. AHT cases among children residing in Alaska during 2005-2010 were identified by applying the PAHT coding schema to a multi-source database which included vital death records, the Violent Death Reporting System (AK-VDRS), the Maternal Infant Mortality Review - Child Death Review (MIMR-CDR), the Alaska Trauma Registry (ATR), the inpatient Hospital Discharge Database (HDD) and Medicaid claims. Using these data, we calculated statewide AHT annual incidence rates. Results. The databases with the highest case capture rates were the ATR and Medicaid systems, both at 51%, followed by HDD at 38%. Combined, the ATR, HDD and Medicaid systems captured 91% of all AHT cases. The linkage and use of the PAHT definitions yielded an estimated sensitivity of 91% and specificity of 98%. During the study period, we detected an annual average incidence of 34.4 cases per 100,000 children aged <2 years (95% CI 25.1, 46.1) and a case fatality proportion of 22% (10/45). Among the AHT cases, 82% were infants. Significant differences (p<0.05) in AHT were noted by age and race, but not by sex. Conclusions. In Alaska, applying the CDC PAHT definition to the multi-source database enabled us to capture 49% more AHT cases than any of the individual database used in this analysis alone.	[Parrish, Jared; Goldsmith, Yvonne] Alaska Div Publ Hlth, MCH Epidemiol Unit, Anchorage, AK USA; [Parrish, Jared] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; [Baldwin-Johnson, Cathy; Volz, Margaret] Childrens Hosp Providence, Anchorage, AK USA	Parrish, J (corresponding author), Univ N Carolina, Injury Prevent Res Ctr, Bank Amer Bldg,Suite 500 137 East Franklin St,CB, Chapel Hill, NC 27599 USA.	jwp22@live.unc.edu					Alaska Division of Public Health, 2010, AL DIV PUBL HLTH EP; Alaska Health Care Commission, 2011, AL HOSP DIS IN PRESS; Barlow KM, 1998, SCOT MED J, V43, P112, DOI 10.1177/003693309804300407; BRUCE DA, 1989, PEDIATR ANN, V18, P482, DOI 10.3928/0090-4481-19890801-07; CDC, PREV SHAK BAB SYNDR; Crume TL, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.2.e18; Ellingson KD, 2008, AM J PREV MED, V34, pS157, DOI 10.1016/j.amepre.2007.12.021; Fujiwara T, 2012, AM J PREV MED, V43, P215, DOI 10.1016/j.amepre.2012.04.028; Herman-Giddens ME, 1999, JAMA-J AM MED ASSOC, V282, P463, DOI 10.1001/jama.282.5.463; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Jurczyk P, FRIL FINE GRAINED RE; Kaltner M, 2013, INJURY PREV, V19, P139, DOI 10.1136/injuryprev-2012-040331; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kelly P, 2008, J PAEDIATR CHILD H, V44, P99, DOI 10.1111/j.1440-1754.2007.01234.x; Leventhal JM, 2010, PEDIATRICS, V126, pE104, DOI 10.1542/peds.2009-1076; McKenzie K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-7; Overpeck MD, 1998, NEW ENGL J MED, V339, P1211, DOI 10.1056/NEJM199810223391706; Parks SE, 2012, PEDIAT ABUSIVE HEAD; Parrish JW, 2010, CHILD ABUSE NEGLECT, V34, P951, DOI 10.1016/j.chiabu.2010.07.002; Parrish JW, 2008, STATE ALASKA EPIDEMI; R Core Team, 2012, R LANG ENV STAT COMP; Schnitzer PG, 2008, AM J PUBLIC HEALTH, V98, P296, DOI 10.2105/AJPH.2006.087783; Schnitzer PG, 2004, AM J PREV MED, V27, P379, DOI 10.1016/j.amepre.2004.08.007; Scott D, 2009, CHILD ABUSE NEGLECT, V33, P791, DOI 10.1016/j.chiabu.2009.08.005; Sills MR, 2005, ARCH PEDIAT ADOL MED, V159, P665, DOI 10.1001/archpedi.159.7.665; Steenkamp M, 2006, INJURY PREV, V12, P3, DOI 10.1136/ip.2006.012518; WINN DG, 1995, PUBLIC HEALTH REP, V110, P277; Zolotor AJ, 2005, N C MED J, V66, P412	28	12	12	0	6	CO-ACTION PUBLISHING	JARFALLA	RIPVAGEN 7, JARFALLA, SE-175 64, SWEDEN	1239-9736	2242-3982		INT J CIRCUMPOL HEAL	Int. J. Circumpolar Health		2013	72			1			472	479	21216	10.3402/ijch.v72i0.21216			8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	235LZ	WOS:000325721900151	23986886	DOAJ Gold, Green Published			2021-06-18	
J	Rauh, MJ; Aralis, HJ; Melcer, T; Macera, CA; Sessoms, P; Bartlett, J; Galarneau, MR				Rauh, Mitchell J.; Aralis, Hilary J.; Melcer, Ted; Macera, Caroline A.; Sessoms, Pinata; Bartlett, Jamie; Galarneau, Michael R.			Effect of traumatic brain injury among US servicemembers with amputation	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						amputation; blasts; combat-related; military; occupational therapy; odds ratio; physical therapy; postinjury complications; prosthetic use; rehabilitative use; service discharge; traumatic brain injury	ARMY MEDICAL-CENTER; OPERATION IRAQI FREEDOM; ORTHOPEDIC TRAUMA; BATTLE CASUALTIES; AMPUTEE SOLDIERS; CARE; REHABILITATION; SEVERITY; PREVALENCE; DEPRESSION	Servicemembers with combat-related limb loss often require substantial rehabilitative care. The prevalence of traumatic brain injury (TBI), which may impair cognitive and functional abilities, among servicemembers has increased. The primary objectives of this study were to determine the frequency of TBI among servicemembers with traumatic amputation and examine whether TBI status was associated with discharge to civilian status and medical and rehabilitative service use postamputation. U.S. servicemembers who had a combat-related amputation while deployed in Iraq or Afghanistan between 2001 and 2006 were followed for 2 yr postamputation. Data collected includes injury mechanism; postinjury complications; Injury Severity Score (ISS); and follow-up data, including military service discharge status and number of medical, physical, occupational therapy, and prosthetic-related visits. Of the 546 servicemembers with combat-related amputations, 127 (23.3%) had a TBI diagnosis. After adjusting for ISS and amputation location, those with TBI had a significantly greater mean number of medical and rehabilitative outpatient and inpatient visits combined (p < 0.01). Those with TBI were also at greater odds of developing certain postinjury complications. We recommend that providers treating servicemembers with limb loss should assess for TBI because those who sustained TBI required increased medical and rehabilitative care.	[Rauh, Mitchell J.; Aralis, Hilary J.; Macera, Caroline A.; Sessoms, Pinata; Bartlett, Jamie] USN, Hlth Res Ctr, Warfighter Performance Dept, San Diego, CA 92106 USA; [Rauh, Mitchell J.] San Diego State Univ, Doctor Phys Therapy Program, San Diego, CA 92182 USA; [Rauh, Mitchell J.; Melcer, Ted; Galarneau, Michael R.] USN, Hlth Res Ctr, Med Modeling Simulat & Mission Support Dept, San Diego, CA 92106 USA; [Macera, Caroline A.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA	Rauh, MJ (corresponding author), USN, Hlth Res Ctr, Warfighter Performance Dept, 140 Sylvester Rd, San Diego, CA 92106 USA.	mrauh@mail.sdsu.edu	Bartlett, Jamie/B-9756-2014	Bartlett, Jamie/0000-0001-7934-7119; Sessoms, Pinata/0000-0002-6960-0659	Wounded, Ill, and Injured/Traumatic Brain Injury program of the U.S. Navy Bureau of Medicine and Surgery (DOD work unit) [60818]	This material was based on work supported by the Wounded, Ill, and Injured/Traumatic Brain Injury program of the U.S. Navy Bureau of Medicine and Surgery (DOD work unit no. 60818).	Army Medical Surveillance Activity, 2005, MED SURVEILLANCE MON, V11, P2; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Belanger HG, 2005, J REHABIL RES DEV, V42, P403, DOI 10.1682/JRRD.2004.08.0095; Blumentritt S., 2009, JPO J PROSTHET ORTHO, V21, P2, DOI [DOI 10.1097/JP0.0B013E318192E96A, 10.1097/JPO.0b013e318192e96a, DOI 10.1097/JPO.0b013e318192e96a]; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chwalisz K, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P537, DOI 10.1037/10361-025; Cole PA, 2005, J BONE JOINT SURG AM, V87A, P2823, DOI 10.2106/JBJS.E.01068; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Covey Dana C, 2008, Instr Course Lect, V57, P65; Crichlow RJ, 2006, J BONE JOINT SURG AM, V88A, P1927, DOI 10.2106/JBJS.D.02604; CURLEY MD, 1982, MIL MED, V147, P572; Demetriades D, 2006, J AM COLL SURGEONS, V202, P212, DOI 10.1016/j.jamcollsurg.2005.09.027; Drake AI, 2010, NEUROREHABILITATION, V26, P183, DOI 10.3233/NRE-2010-0554; Fischer H., 2013, US MILITARY CASUALTY; Gajewski Donald, 2006, J Am Acad Orthop Surg, V14, pS183; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Gunawardena NS, 2006, MIL MED, V171, P283, DOI 10.7205/MILMED.171.4.283; Gunderson EKE, 2005, MIL MED, V170, P172; Hafner BJ, 2007, ARCH PHYS MED REHAB, V88, P207, DOI 10.1016/j.apmr.2006.10.030; Hebela N, 2004, J BONE JOINT SURG AM, V86A, P2577, DOI 10.2106/00004623-200411000-00050; Heinemann AW, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P261, DOI 10.1037/10361-012; Hoaglund F T, 1983, J Rehabil R D, V20, P57; Javernick MA, 2006, MIL MED, V171, P200, DOI 10.7205/MILMED.171.3.200; KISHBAUGH D, 1995, MIL MED, V160, P82; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lin DL, 2004, J ORTHOP TRAUMA, V18, pS48, DOI 10.1097/00005131-200409001-00008; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; McCarthy ML, 2003, J BONE JOINT SURG AM, V85A, P1689, DOI 10.2106/00004623-200309000-00006; Melcer T, 2010, MIL MED, V175, P147, DOI 10.7205/MILMED-D-09-00120; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pasquina PF, 2008, J REHABIL RES DEV, V45, P953, DOI 10.1682/JRRD.2007.10.0163; Pasquina PF, 2006, ARCH PHYS MED REHAB, V87, pS34, DOI 10.1016/j.apmr.2005.11.026; Pasquina PF, 2006, MIL MED, V171, P206, DOI 10.7205/MILMED.171.3.206; Pasquina PF, 2004, J REHABIL RES DEV, V41, pVII; Pasquina PF, 2006, J PROSTHET ORTHOT, V18, P119; Potter Benjamin K, 2006, J Am Acad Orthop Surg, V14, pS188; Rybarczyk B, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P29, DOI 10.1037/10361-002; Smurr LM, 2008, J HAND THER, V21, P160, DOI 10.1197/j.jht.2007.09.006; Springer BA, 2006, MIL MED, V171, P203, DOI 10.7205/MILMED.171.3.203; Starr AJ, 2004, J BONE JOINT SURG AM, V86A, P1115, DOI 10.2106/00004623-200406000-00001; Stinner DJ, 2010, J TRAUMA, V68, P1476, DOI 10.1097/TA.0b013e3181bb9a6c; STONE LR, 1990, AM J PHYS MED REHAB, V69, P135, DOI 10.1097/00002060-199006000-00007; Uomoto JM, 2009, REHABIL PSYCHOL, V54, P259, DOI 10.1037/a0016907; Uzun O, 2003, MIL MED, V168, P106; WHITNEY MR, 2005, MIL MED TECH, V9, P38	46	12	12	0	11	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.		2013	50	2					161	172		10.1682/JRRD.2011.11.0212			12	Rehabilitation	Rehabilitation	149FF	WOS:000319303700005	23760997	Bronze			2021-06-18	
J	Sigurta, A; Zanaboni, C; Canavesi, K; Citerio, G; Beretta, L; Stocchetti, N				Sigurta, A.; Zanaboni, C.; Canavesi, K.; Citerio, G.; Beretta, L.; Stocchetti, N.			Intensive care for pediatric traumatic brain injury	INTENSIVE CARE MEDICINE			English	Article						Neurotrauma; Pediatrics; Intracranial pressure; Cerebral perfusion pressure; Outcome	SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; DECOMPRESSIVE CRANIECTOMY; CASE VOLUME; COMA SCALE; CHILDREN; MORTALITY; HYPERTENSION; MANAGEMENT; DATABASE	Purposes: The aims of this study are to describe a cohort of head-injured pediatric patients, focusing on current practice for intracranial pressure (ICP) monitoring and treatment and to verify the relationship between clinical and radiological parameters and the six-month outcome in a multivariable statistical model. Methods: A retrospective review was done of a prospectively collected database considering patients younger than 19 years admitted to three neuro-intensive care units (ICU). Patients were divided into four age groups: 0-5 (infant), 6-12 (children), 13-16 (pre-adolescent) and 17-18 years (adolescent). The ICP and cerebral perfusion pressure (CPP) were analyzed calculating average data and values exceeding thresholds for more than 5 min. Outcome was assessed 6 months after trauma using the Glasgow Outcome Score. Results: There were 199 patients, 155 male, included. Sixty percent had extracranial injuries. Pupils were abnormal in 38 %. Emergency evacuation of intracranial hematomas was necessary in 81 cases. The ICP was monitored in 117 patients; in 87 cases ICP was higher than 20 mmHg, with no differences among age groups. All but six patients received therapy to prevent raised ICP; barbiturates, deep hyperventilation or surgical decompression were used in 31 cases. At 6 months, mortality was 21 % and favorable outcome was achieved by 72 %. Significant predictors of outcome in the multivariable model were the Glasgow Coma Scale (GCS) motor score, pupils and ICP. Conclusions: Pediatric head injury is associated with a high incidence of intracranial hypertension. Early surgical treatment and intensive care may achieve favorable outcome in the majority of cases.	[Sigurta, A.; Canavesi, K.; Stocchetti, N.] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Neurointens Care Unit, Milan, Italy; [Sigurta, A.; Canavesi, K.; Stocchetti, N.] Univ Milan, Milan, Italy; [Zanaboni, C.] Ist Giannina Gaslini, I-16148 Genoa, Italy; [Citerio, G.] Azienda Osped San Gerardo, Neurointens Care Unit, Monza, Italy; [Beretta, L.] Fdn San Raffaele, Neurointens Care Unit, Milan, Italy	Sigurta, A (corresponding author), Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Neurointens Care Unit, Milan, Italy.	anna.sigurta@unimi.it	Stocchetti, Nino/O-7444-2017; Citerio, Giuseppe/B-1839-2015; Viani, Rafael/V-1196-2018	Stocchetti, Nino/0000-0003-3250-6834; Citerio, Giuseppe/0000-0002-5374-3161; 			Citerio G, 2000, ACTA NEUROCHIR, V142, P769, DOI 10.1007/s007010070091; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Cross DT, 2003, J NEUROSURG, V99, P810, DOI 10.3171/jns.2003.99.5.0810; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Hartman M, 2008, PEDIATRICS, V122, pE172, DOI 10.1542/peds.2007-3399; Heros RC, 2003, J NEUROSURG, V99, P805, DOI 10.3171/jns.2003.99.5.0805; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Madikians A, 2009, CURR TREAT OPTION NE, V11, P393, DOI 10.1007/s11940-009-0044-2; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; MORRAY JP, 1984, CRIT CARE MED, V12, P1018, DOI 10.1097/00003246-198412000-00002; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Ross JS, 2010, NEW ENGL J MED, V362, P1110, DOI 10.1056/NEJMsa0907130; Salvatore C, 2008, J NEUROSURG, V108, P74, DOI 10.3171/JNS/2008/108/01/0074; Sookplung P, 2009, CURR OPIN ANESTHESIO, V22, P572, DOI 10.1097/ACO.0b013e3283303884; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Wiegand C, 2007, DEV MED CHILD NEUROL, V49, P935, DOI 10.1111/j.1469-8749.2007.00935.x; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	29	12	14	0	17	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	JAN	2013	39	1					129	136		10.1007/s00134-012-2748-0			8	Critical Care Medicine	General & Internal Medicine	052JK	WOS:000312193700018	23179331				2021-06-18	
J	Sullivan, KA; Edmed, SL; Cunningham, LC				Sullivan, Karen A.; Edmed, Shannon L.; Cunningham, Lauren C.			A comparison of new and existing mild traumatic brain injury vignettes: Recommendations for research into post-concussion syndrome	BRAIN INJURY			English	Article						Mild traumatic brain injury; post-concussion syndrome; expectation-as-aetiology; illness expectations; neuropsychology	MINOR HEAD-INJURY; SYMPTOM EXPECTATION; KNOWLEDGE; ATTRIBUTIONS; CANADA	Objective: To review and compare the mild traumatic brain injury (mTBI) vignettes used in postconcussion syndrome (PCS) research, and to develop 3 new vignettes. Method: The new vignettes were devised using World Health Organization (WHO) mTBI diagnostic criteria [1]. Each vignette depicted a very mild (VM), mild (M), or severe (S) brain injury. Expert review (N=27) and readability analysis was used to validate the new vignettes and compare them to 5 existing vignettes. Results: The response rate was 44%. The M vignette and existing vignettes were rated as depicting a mTBI; however, the fit-to-criteria of these vignettes differed significantly. The fit-to-criteria of the M vignette was as good as that of 3 existing vignettes and significantly better than 2 other vignettes. As expected, the VM and S vignettes were a poor fit-to-criteria. Conclusions: These new vignettes will assist PCS researchers to test the limits of important etiology factors by varying the severity of depicted injuries.	[Sullivan, Karen A.; Edmed, Shannon L.] Queensland Univ Technol, Clin Neuropsychol Res Grp, Sch Psychol & Counselling, Brisbane, Qld 4001, Australia; [Sullivan, Karen A.; Edmed, Shannon L.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	Sullivan, KA (corresponding author), Queensland Univ Technol, Clin Neuropsychol Res Grp, Sch Psychol & Counselling, Brisbane, Qld 4001, Australia.	karen.sullivan@qut.edu.au			School of Psychology and Counselling, Queensland University of Technology	The Human Research Ethics Committee of Queensland University of Technology (QUT-HREC #1000000311) approved this research. This project was granted an occupational workplace health and safety clearance. Funding for this project was provided by the School of Psychology and Counselling, Queensland University of Technology. We have no relevant financial or other conflicts of interests to declare in relation to this work.	Agoritsas T, 2011, J CLIN EPIDEMIOL, V64, P107, DOI 10.1016/j.jclinepi.2010.02.007; Arzy S, 2009, J EVAL CLIN PRACT, V15, P804, DOI 10.1111/j.1365-2753.2008.01098.x; AUBREY JB, 1989, J NEUROL NEUROSUR PS, V52, P842, DOI 10.1136/jnnp.52.7.842; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Dunn TM, 2003, ARCH CLIN NEUROPSYCH, V18, P121, DOI 10.1016/S0887-6177(01)00188-3; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P254, DOI 10.1016/S0303-8467(01)00161-5; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P184, DOI 10.1016/S0303-8467(01)00143-3; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KLARE GR, 1974, READ RES QUART, V10, P62, DOI 10.2307/747086; Mackenzie JA, 2005, BRIT J CLIN PSYCHOL, V44, P417, DOI 10.1348/014466505X35696; McClure J, 2008, BRAIN INJURY, V22, P639, DOI 10.1080/02699050802255585; McClure J, 2006, BRAIN INJURY, V20, P1029, DOI 10.1080/02699050600909870; McClure J, 2011, J HEAD TRAUMA REHAB, V26, P392, DOI 10.1097/HTR.0b013e3181f8fd34; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; Schoenberg Ravdal, 2010, INT J SOC RES METHOD, V3, P63, DOI DOI 10.1080/136455700294932; Sullivan K, 2002, ARCH CLIN NEUROPSYCH, V17, P691, DOI 10.1016/S0887-6177(01)00171-8; Sullivan KA, J HEAD TRAUMA REHABI; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3	21	12	12	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2013	27	1					19	30		10.3109/02699052.2012.698360			12	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	059IY	WOS:000312699300003	23252435				2021-06-18	
J	Volman, V; Bazhenov, M; Sejnowski, TJ				Volman, Vladislav; Bazhenov, Maxim; Sejnowski, Terrence J.			Divide and Conquer: Functional Segregation of Synaptic Inputs by Astrocytic Microdomains Could Alleviate Paroxysmal Activity Following Brain Trauma	PLOS COMPUTATIONAL BIOLOGY			English	Article							NECROSIS-FACTOR-ALPHA; V PYRAMIDAL NEURONS; TNF-ALPHA; SEIZURES; RELEASE; MODEL; HYPEREXCITABILITY; ENDOCANNABINOIDS; EPILEPTOGENESIS; HIPPOCAMPUS	Traumatic brain injury often leads to epileptic seizures. Among other factors, homeostatic synaptic plasticity (HSP) mediates posttraumatic epileptogenesis through unbalanced synaptic scaling, partially compensating for the trauma-incurred loss of neural excitability. HSP is mediated in part by tumor necrosis factor alpha (TNF alpha), which is released locally from reactive astrocytes early after trauma in response to chronic neuronal inactivity. During this early period, TNFa is likely to be constrained to its glial sources; however, the contribution of glia-mediated spatially localized HSP to post-traumatic epileptogenesis remains poorly understood. We used computational model to investigate the reorganization of collective neural activity early after trauma. Trauma and synaptic scaling transformed asynchronous spiking into paroxysmal discharges. The rate of paroxysms could be reduced by functional segregation of synaptic input into astrocytic microdomains. Thus, we propose that trauma-triggered reactive gliosis could exert both beneficial and deleterious effects on neural activity.	[Volman, Vladislav; Sejnowski, Terrence J.] Salk Inst Biol Studies, Howard Hughes Med Inst, Computat Neurobiol Lab, La Jolla, CA 92037 USA; [Volman, Vladislav; Sejnowski, Terrence J.] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Volman, Vladislav] L 3 Appl Technol Simulat Engn & Testing, San Diego, CA USA; [Bazhenov, Maxim] Univ Calif Riverside, Dept Cell Biol & Neurosci, La Jolla, CA USA; [Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Volman, V (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Computat Neurobiol Lab, La Jolla, CA 92037 USA.	volman@salk.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS059740, R01 NS060870]; Howard Hughes Medical InstituteHoward Hughes Medical Institute; NSF-sponsored Center for Theoretical Biological Physics at UCSD [NSF PHY-0822283]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060870, R01NS059740] Funding Source: NIH RePORTER	This study was supported by NIH grants R01 NS059740 and R01 NS060870 and the Howard Hughes Medical Institute. Numerical simulations were performed using computational resources of NSF-sponsored Center for Theoretical Biological Physics at UCSD, grant NSF PHY-0822283. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballesteros-Yanez I, 2006, NEUROSCIENCE, V138, P403, DOI 10.1016/j.neuroscience.2005.11.038; Balosso S, 2009, NEUROSCIENCE, V161, P293, DOI 10.1016/j.neuroscience.2009.03.005; Bazhenov M, 2004, J NEUROPHYSIOL, V92, P1116, DOI 10.1152/jn.00529.2003; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Coiret G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037320; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; de Curtis M, 2001, PROG NEUROBIOL, V63, P541, DOI 10.1016/S0301-0082(00)00026-5; de Lanerolle NC, 2010, NEUROTHERAPEUTICS, V7, P424, DOI 10.1016/j.nurt.2010.08.002; De Pitta M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002293; Di Castro MA, 2011, NAT NEUROSCI, V14, P1276, DOI 10.1038/nn.2929; Dzhala VI, 2003, J NEUROSCI, V23, P7873; Frohlich F, 2010, J NEUROSCI, V30, P10734, DOI 10.1523/JNEUROSCI.1239-10.2010; Frohlich F, 2008, J NEUROSCI, V28, P1709, DOI 10.1523/JNEUROSCI.4263-07.2008; Gomez-Gonzalo M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000352; Grosche J, 1999, NAT NEUROSCI, V2, P139; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Ichiyama T, 2000, BRAIN RES, V857, P246, DOI 10.1016/S0006-8993(99)02439-7; Jin XM, 2011, CEREB CORTEX, V21, P1094, DOI 10.1093/cercor/bhq181; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Keller CJ, 2010, BRAIN, V133, P1668, DOI 10.1093/brain/awq112; Kirkman NJ, 2010, EPILEPSIA, V51, P454, DOI 10.1111/j.1528-1167.2009.02390.x; Krishnan GP, 2011, J NEUROSCI, V31, P8870, DOI 10.1523/JNEUROSCI.6200-10.2011; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; NADKARNI S, 2003, PHYS REV LETT, V91, P1; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; ORKAND RK, 1966, J NEUROPHYSIOL, V29, P788; Otani N, 2003, ACTA NEUROCHIR SUPPL, V86, P267; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Prince DA, 2009, EPILEPSIA, V50, P30, DOI 10.1111/j.1528-1167.2008.02008.x; Probert L, 1997, J NEUROIMMUNOL, V72, P137, DOI 10.1016/S0165-5728(96)00184-1; Ravizza T, 2011, NEUROSCI LETT, V497, P223, DOI 10.1016/j.neulet.2011.02.040; Salin P, 1995, J NEUROSCI, V15, P8234; Santhakumar V, 2003, J NEUROSCI, V23, P5865; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Santhakumar V, 2005, J NEUROPHYSIOL, V93, P437, DOI 10.1152/jn.00777.2004; SCHUZ A, 1989, J COMP NEUROL, V286, P442, DOI 10.1002/cne.902860404; Shandra AA, 2002, NEUROSCI RES, V42, P147, DOI 10.1016/S0168-0102(01)00309-1; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Silchenko AN, 2008, BIOL CYBERN, V98, P61, DOI 10.1007/s00422-007-0196-7; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Steinmetz CC, 2010, J NEUROSCI, V30, P14685, DOI 10.1523/JNEUROSCI.2210-10.2010; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stellwagen D, 2002, J NEUROSCI, V25, P3219; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Turrigiano GG, 2006, TRENDS MOL MED, V12, P458, DOI 10.1016/j.molmed.2006.08.002; Volman V, 2007, NEURAL COMPUT, V19, P303, DOI 10.1162/neco.2007.19.2.303; Volman V, 2011, J NEUROPHYSIOL, V106, P1933, DOI 10.1152/jn.00458.2011; Volman V, 2011, P NATL ACAD SCI USA, V108, P15402, DOI 10.1073/pnas.1112066108; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang HP, 2010, SCIENCE, V328, P106, DOI 10.1126/science.1183108; Yuhas Y, 1999, INFECT IMMUN, V67, P1455, DOI 10.1128/IAI.67.3.1455-1460.1999	65	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-734X	1553-7358		PLOS COMPUT BIOL	PLoS Comput. Biol.	JAN	2013	9	1							e1002856	10.1371/journal.pcbi.1002856			16	Biochemical Research Methods; Mathematical & Computational Biology	Biochemistry & Molecular Biology; Mathematical & Computational Biology	085ED	WOS:000314595600015	23357960	DOAJ Gold, Green Published			2021-06-18	
J	Yu, WY; Hwang, HF; Hu, MH; Chen, CY; Lin, MR				Yu, Wen-Yu; Hwang, Hei-Fen; Hu, Ming-Hsia; Chen, Chih-Yi; Lin, Mau-Roung			Effects of fall injury type and discharge placement on mortality, hospitalization, falls, and ADL changes among older people in Taiwan	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Falls; Older people; Fracture; Discharge placement; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; HIP FRACTURE; RISK-FACTORS; DISTAL FOREARM; CARE; EMERGENCY; OUTCOMES; EPIDEMIOLOGY; ADULTS; OPPORTUNITIES	A longitudinal study was conducted to investigate the effects of injury type and discharge placement on mortality, falls, hospital admissions, and changes in activities of daily living (ADLs) over a 12-month period among older fallers. Of 762 community-dwelling people aged 65 years or older who visited an emergency department (ED) of a general hospital in Taiwan due to a fall, 273 sustained a hip fracture, 157 had a vertebral fracture, 47 had a distal forearm fracture, 102 had a traumatic brain injury, and 183 had soft-tissue injuries. Results showed that, compared to patients with a soft-tissue injury, those with TBI had significantly higher risks of dying (rate ratio (RR) = 3.59) and hospital admissions (RR = 3.23) and better improvement in ADLs (1.93 points) at 6 months post-injury, and those who sustained a hip fracture (4.26 and 4.41 points), a vertebral fracture (3.81 and 3.83 points), or a distal-forearm fracture (2.80 and 2.80 points) had significantly better improvement in ADLs at 6 and 12 months post-injury. Patients discharged to a nursing home had a significantly increased risk of death (RR = 2.08) and hospital admission (RR = 2.05) than those returning to their usual residence during the first year post-injury. No significant differences in the occurrence of falls during the first post-injury year were found among patients with different injury types or between those with different discharge placements. In conclusion, among the five major fall injury types in older people, TBIs result in the highest risk of death and hospital admissions, while hip and vertebral fractures exhibited the largest improvement during the first year after injury. Additionally, nursing home care may be associated with increased risks of death and hospital admissions than home care. In addition to primary prevention of falls, further research to investigate mechanisms leading to TBIs during a fall is needed to facilitate effective secondary fall-prevention programs for older people. (C) 2012 Elsevier Ltd. All rights reserved.	[Yu, Wen-Yu] Taipei Med Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Hwang, Hei-Fen] Natl Taipei Coll Nursing, Dept Nursing, Taipei, Taiwan; [Hu, Ming-Hsia] Natl Taiwan Univ, Sch & Grad Inst Phys Therapy, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan; [Hu, Ming-Hsia] Natl Taiwan Univ Hosp, Phys Therapy Ctr, Taipei, Taiwan; [Chen, Chih-Yi; Lin, Mau-Roung] Taipei Med Univ, Coll Publ Hlth & Nutr, Inst Injury Prevent & Control, Taipei 110, Taiwan	Lin, MR (corresponding author), Taipei Med Univ, Coll Publ Hlth & Nutr, Inst Injury Prevent & Control, 250 Wu Hsing St, Taipei 110, Taiwan.	mrlin@tmu.edu.tw		HU, MING-HSIA/0000-0003-0904-255X			Aminzadeh F, 2002, ANN EMERG MED, V39, P238, DOI 10.1067/mem.2002.121523; Baron JA, 1996, EPIDEMIOLOGY, V7, P612, DOI 10.1097/00001648-199611000-00008; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Boockvar K, 2004, ARCH INTERN MED, V164, P545, DOI 10.1001/archinte.164.5.545; Boockvar KS, 2003, J AM GERIATR SOC, V51, P399, DOI 10.1046/j.1532-5415.2003.51115.x; Braithwaite RS, 2003, J AM GERIATR SOC, V51, P364, DOI 10.1046/j.1532-5415.2003.51110.x; Brauer CA, 2009, JAMA-J AM MED ASSOC, V302, P1573, DOI 10.1001/jama.2009.1462; Brennan J, 2003, OSTEOPOROSIS INT, V14, P515, DOI 10.1007/s00198-003-1404-5; Byers AL, 2003, J CLIN EPIDEMIOL, V56, P559, DOI 10.1016/S0895-4356(03)00028-3; Carpenter CR, 2009, ACAD EMERG MED, V16, P211, DOI 10.1111/j.1553-2712.2009.00351.x; Castle NG, 2001, MED CARE RES REV, V58, P291, DOI 10.1177/107755870105800302; Chen C.F., 2006, THESIS NATL CHUNG CH; Coleman EA, 2003, J AM GERIATR SOC, V51, P549, DOI 10.1046/j.1532-5415.2003.51185.x; COOPER C, 1992, J BONE MINER RES, V7, P221, DOI 10.1002/jbmr.5650070214; COX DR, 1972, J R STAT SOC B, V34, P187; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Department of Health, 2010, STAT YB REP CHIN ROC; Edwards BJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3324; ETTINGER B, 1992, J BONE MINER RES, V7, P449; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FILLENBAUM GG, 1981, J GERONTOL, V36, P428, DOI 10.1093/geronj/36.4.428; Frost ML, 2000, OSTEOPOROSIS INT, V11, P321, DOI 10.1007/s001980070121; Gass M, 2006, AM J MED, V119, p3S, DOI 10.1016/j.amjmed.2005.12.017; Goleburn C., 2001, J CLIN GEROPSYCHOLOG, V7, DOI [https://doi.org/10.1023/A:1011335027445, DOI 10.1023/A:1011335027445]; Grimmer K, 2004, INT J QUAL HEALTH C, V16, P465, DOI 10.1093/intqhc/mzh071; Gruneir A, 2010, J AM GERIATR SOC, V58, P510, DOI 10.1111/j.1532-5415.2010.02736.x; Herala M, 2000, J EPIDEMIOL COMMUN H, V54, P557, DOI 10.1136/jech.54.7.557; Hung WW, 2012, JAMA-J AM MED ASSOC, V307, P2185, DOI 10.1001/jama.2012.4842; International Association for the Study of Obesity. World Health Organization. International Obesity TaskForce, 2000, AS PAC PERSP RED OB; Kannus P, 1999, JAMA-J AM MED ASSOC, V281, P1895, DOI 10.1001/jama.281.20.1895; Keegan THM, 2004, AM J EPIDEMIOL, V159, P192, DOI 10.1093/aje/kwh026; KELSEY JL, 1992, AM J EPIDEMIOL, V135, P477, DOI 10.1093/oxfordjournals.aje.a116314; KOVAL KJ, 1995, CLIN ORTHOP RELAT R, P150; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Lim HJ, 2007, J TRAUMA, V63, P902, DOI 10.1097/01.ta.0000240110.14909.71; Magaziner J, 2003, AM J EPIDEMIOL, V157, P1023, DOI 10.1093/aje/kwg081; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Ministry of the Interior, 2009, SURV ELD PEOPL LIV C; Nevitt MC, 2005, J BONE MINER RES, V20, P131, DOI [10.1359/jbmr.2005.20.1.131, 10.1359/JBMR.041003]; Paniagua MA, 2006, AM J EMERG MED, V24, P413, DOI 10.1016/j.ajem.2005.12.005; Peel NM, 2002, INJ PREV, V8, P280, DOI 10.1136/ip.8.4.280; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Sanders AB, 2001, J AM GERIATR SOC, V49, P1390, DOI 10.1046/j.1532-5415.2001.49272.x; SATTIN RW, 1992, ANNU REV PUBL HEALTH, V13, P489, DOI 10.1146/annurev.pu.13.050192.002421; Sheikh JA., 1986, CLIN GERONTOLOGY GUI; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tsuboi M, 2007, J BONE JOINT SURG BR, V89B, P461, DOI 10.1302/0301-620X.89B4; United Nations, 2005, LIV ARR OLD PERS WOR	52	12	12	0	24	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	JAN	2013	50						887	894		10.1016/j.aap.2012.07.015			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	079SD	WOS:000314191600102	22878142				2021-06-18	
J	Crowe, LM; Catroppa, C; Anderson, V; Babl, FE				Crowe, Louise M.; Catroppa, Cathy; Anderson, Vicki; Babl, Franz E.			Head injuries in children under 3 years	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Head injuries; Infants	TRAUMATIC BRAIN-INJURY; YOUNG-CHILDREN; COMPUTED-TOMOGRAPHY; RISK-FACTORS; COMA SCALE; INFANTS; CHILDHOOD; AGE; EPIDEMIOLOGY; MECHANISMS	Background: A significant number of children under 3 years sustain a head injury every year. Despite this few studies have provided detailed information about these injuries. Methods: A retrospective review of the medical files all children aged 0-3 years who attended a paediatric emergency department for treatment over a 2-year period. Results: Children aged 0-6 months had the highest rate of moderate head injury. Children under 12 months were at the greatest risk of injury. Falls were the most common cause of injury including falls from caregiver's arms. Conclusions: Children under 12 months are at significant risk of head injury, many of these injuries could be prevented by increased parental supervision or improved home safety. (C) 2012 Elsevier Ltd. All rights reserved.	[Crowe, Louise M.; Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Melbourne, Vic, Australia; [Crowe, Louise M.; Catroppa, Cathy; Anderson, Vicki; Babl, Franz E.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia; [Babl, Franz E.] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia	Crowe, LM (corresponding author), Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	louise.crowe@mcri.edu.au		Crowe, Louise/0000-0003-4619-9708	Foundation for Children; Victorian Government's Operational Infrastructure Support Program	This study was supported by the Foundation for Children and the Victorian Government's Operational Infrastructure Support Program.	Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Barlow Karen, 2004, Pediatr Rehabil, V7, P195, DOI 10.1080/13638490410001715331; Bayreuther J, 2009, ARCH DIS CHILDHOOD-E, V94, P37, DOI 10.1136/adc.2007.132787; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Conners GP, 1999, PEDIATR EMERG CARE, V15, P241; Crowe L, CHILD NEUROPSYCHOL, P1; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Dedoukou X, 2004, ARCH PEDIAT ADOL MED, V158, P1002, DOI 10.1001/archpedi.158.10.1002; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Durkin MS, 1998, NEUROSURGERY, V42, P300, DOI 10.1097/00006123-199802000-00052; Falk Ann-Charlotte, 2007, Dev Neurorehabil, V10, P49, DOI 10.1080/13638490600864066; FAULKNER K, 1987, ACTA RADIOL, V28, P483; Ghahreman A, 2005, J NEUROSURG, V103, P213, DOI 10.3171/ped.2005.103.3.0213; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; HAHN YS, 1988, CHILD NERV SYST, V4, P34; Johnson K, 2005, CLIN RADIOL, V60, P464, DOI 10.1016/j.crad.2004.09.013; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kieslich M, 2001, DISABIL REHABIL, V23, P665; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lalloo R, 2003, INJURY, V34, P261, DOI 10.1016/S0020-1383(02)00277-2; Lawlor DA, 2004, J ROY SOC MED, V97, P121, DOI 10.1258/jrsm.97.3.121; Loh JK, 2002, SURG NEUROL, V58, P218, DOI 10.1016/S0090-3019(02)00830-3; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; Marton E, 2007, CHILD NERV SYST, V23, P873, DOI 10.1007/s00381-007-0314-9; Myhre MC, 2007, ACTA PAEDIATR, V96, P1159, DOI 10.1111/j.1651-2227.2007.00356.x; Ng SM, 2002, J PAEDIATR CHILD H, V38, P388, DOI 10.1046/j.1440-1754.2002.00012.x; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Settle F, 2005, J PAEDIATR CHILD H, V41, P130, DOI 10.1111/j.1440-1754.2005.00562.x; SIMPSON DA, 1991, CHILD NERV SYST, V7, P183; Spady DW, 2004, PEDIATRICS, V113, P522, DOI 10.1542/peds.113.3.522; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; WILLIAMS RA, 1991, J TRAUMA, V31, P1350, DOI 10.1097/00005373-199110000-00005; World Health Organization, 1992, INT CLASS DIS	40	12	14	0	16	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	DEC	2012	43	12					2141	2145		10.1016/j.injury.2012.07.195			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	028XM	WOS:000310458600031	22921385				2021-06-18	
J	Liu, H; Sarnaik, SM; Manole, MD; Chen, YM; Shinde, SN; Li, WJ; Rose, M; Alexander, H; Chen, J; Clark, RSB; Graham, SH; Hickey, RW				Liu, Hao; Sarnaik, Syana M.; Manole, Mioara D.; Chen, Yaming; Shinde, Sunita N.; Li, Wenjin; Rose, Marie; Alexander, Henry; Chen, Jie; Clark, Robert S. B.; Graham, Steven H.; Hickey, Robert W.			Increased cytochrome c in rat cerebrospinal fluid after cardiac arrest and its effects on hypoxic neuronal survival	RESUSCITATION			English	Article						Cerebrospinal fluid; Brain ischemia; Cardiac arrest; Cytochrome c	ACUTE BRAIN-DAMAGE; COGNITIVE IMPAIRMENT; SURROGATE MARKERS; CEREBRAL-ISCHEMIA; CELL-DEATH; RELEASE; APOPTOSIS; INJURY; STROKE; RESUSCITATION	Cerebrospinal fluid (CSF) proteins may be useful biomarkers of neuronal death and ultimate prognosis after hypoxic-ischemic brain injury. Cytochrome c has been identified in the CSF of children following traumatic brain injury. Cytochrome c is required for cellular respiration but it is also a central component of the intrinsic pathway of apoptosis. Thus, in addition to serving as a biomarker, cytochrome c release into CSF may have an effect upon survival of adjacent neurons. In this study, we use Western blot and ELISA to show that cytochrome c is elevated in CSF obtained from pediatric rats following resuscitation from cardiac arrest. Using biotinylated human cytochrome c in culture media we show that cytochrome c crosses the cell membrane and is incorporated into mitochondria of neurons exposed to anoxia. Lastly, we show that addition of human cytochrome c to primary neuronal culture exposed to anoxia improves survival. To our knowledge, this is the first study to show cytochrome c is elevated in CSF following hypoxic ischemic brain injury. Results from primary neuronal culture suggest that extracellular cytochrome c is able to cross the cell membrane of injured neurons, incorporate into mitochondria, and promote survival following anoxia. (c) 2012 Elsevier Ireland Ltd. All rights reserved.	[Liu, Hao; Li, Wenjin; Rose, Marie; Graham, Steven H.] VA Pittsburgh Healthcare Ctr, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA USA; [Liu, Hao; Shinde, Sunita N.; Li, Wenjin; Rose, Marie; Chen, Jie; Graham, Steven H.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15260 USA; [Sarnaik, Syana M.; Manole, Mioara D.; Hickey, Robert W.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15260 USA; [Chen, Yaming; Clark, Robert S. B.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Chen, Yaming; Alexander, Henry; Clark, Robert S. B.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA	Hickey, RW (corresponding author), UPMC, Childrens Hosp Pittsburgh, 1Childrens Hosp Dr,4401 Penn Ave, Pittsburgh, PA 15224 USA.	Robert.Hickey@chp.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21HD058846, K08HD40848, NIH R0137549, K08HD058798]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD058798] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD058846, K08HD040848] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024153] Funding Source: NIH RePORTER	This work was supported by NIH R21HD058846 and K08HD40848 (RWH), NIH R0137549 (SHG) and NIH K08HD058798 (MDM). The authors thank Pat Strickler for secretarial support.	Ahlemeyer B, 2002, BRAIN RES, V934, P107, DOI 10.1016/S0006-8993(02)02365-X; Fink Ericka L, 2004, Pediatr Crit Care Med, V5, P139, DOI 10.1097/01.PCC.0000112376.29903.8F; Hosoya M, 2005, PEDIATR INFECT DIS J, V24, P467, DOI 10.1097/01.inf.0000160995.07461.b8; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Li WJ, 2010, J NEUROCHEM, V113, P965, DOI 10.1111/j.1471-4159.2010.06674.x; Liu H, 2011, NEUROBIOL DIS, V41, P318, DOI 10.1016/j.nbd.2010.09.020; MartinAncel A, 1997, PEDIATRICS, V100, P789, DOI 10.1542/peds.100.5.789; Ouyang YB, 1999, J CEREBR BLOOD F MET, V19, P1126, DOI 10.1097/00004647-199910000-00009; Papaliagkas VT, 2009, CURR ALZHEIMER RES, V6, P279, DOI 10.2174/156720509788486626; Piel DA, 2008, SHOCK, V29, P612, DOI 10.1097/SHK.0b013e318157e962; Piel DA, 2007, CRIT CARE MED, V35, P2120, DOI 10.1097/01.CCM.0000278914.85340.FE; Radhakrishnan J, 2007, AM J PHYSIOL-HEART C, V292, pH767, DOI 10.1152/ajpheart.00468.2006; Renz A, 2001, BLOOD, V98, P1542, DOI 10.1182/blood.V98.5.1542; Riikonen RS, 1999, PEDIATR NEUROL, V20, P137, DOI 10.1016/S0887-8994(98)00122-2; Satchell MA, 2005, J CEREBR BLOOD F MET, V25, P919, DOI 10.1038/sj.jcbfm.9600088; Siman R, 2005, J CEREBR BLOOD F MET, V25, P1433, DOI 10.1038/sj.jcbfm.9600138; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Sugawara T, 1999, J NEUROSCI, V19, part. no.; Tarkowski E, 1999, STROKE, V30, P321, DOI 10.1161/01.STR.30.2.321; Tarkowski E, 1997, CLIN EXP IMMUNOL, V110, P492, DOI 10.1046/j.1365-2249.1997.4621483.x; Tehranian R, 2008, J NEUROTRAUM, V25, P755, DOI 10.1089/neu.2007.0441; Vila N, 2000, STROKE, V31, P2325, DOI 10.1161/01.STR.31.10.2325; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zhao H, 2005, J CEREBR BLOOD F MET, V25, P1119, DOI 10.1038/sj.jcbfm.9600111	25	12	12	1	12	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	DEC	2012	83	12					1491	1496		10.1016/j.resuscitation.2012.04.009			6	Critical Care Medicine; Emergency Medicine	General & Internal Medicine; Emergency Medicine	053IH	WOS:000312264200026	22554683	Green Accepted			2021-06-18	
J	Mulcahey, MJ; Calhoun, CL; Tian, F; Ni, P; Vogel, LC; Haley, SM				Mulcahey, M. J.; Calhoun, C. L.; Tian, F.; Ni, P.; Vogel, L. C.; Haley, S. M.			Evaluation of newly developed item banks for child-reported outcomes of participation following spinal cord injury	SPINAL CORD			English	Article						item response theory; computer adaptive testing; spinal cord injury; participation outcomes	TRAUMATIC BRAIN-INJURY; PSYCHOMETRIC PROPERTIES; DISABILITIES; HANDICAP; HEALTH	Study design: Multi-center, prospective calibration study. Objectives: To examine the psychometric properties of item banks designed for a computer adaptive test (CAT) of participation. Setting: Three pediatric specialty care hospitals in North America. Methods: Newly developed item banks containing questions about participation were administered to 381 children, 8-21 years. Unidimensionality was evaluated using categorical confirmatory factor analysis (CFA). CFA model fit was assessed by the comparative fit index (CFI), Tucker-Lewis index (TLI), root mean square error of approximation (RMSEA) and residual correlations. Pearson's correlations were calculated between simulated CATs and the full-item banks. Results: CFI = 0.905, TLI = 0.951 and RMSEA = 0.089 for the self-participation item bank; CFI - 0.924, TLI = 0.963 and RMSEA = 0.083 friend-participation item bank. The 15-(r = 0.96 self; r = 0.95 friend), 10-(r = 0.93 self; r = 0.92 friend) and 5-(r = 0.85 self; r = 0.85 friend) item simulated CATs and full-item banks were highly correlated. Conclusion: The newly developed self and friend-participation item banks met the required assumptions for CAT. Simulated CATs yielded scores comparable to full-item banks. The results of the study support the use of the item banks for a CAT of participation in children following spinal cord injury. Sponsorship: The study was funded by the Shriners Hospitals for Children Research Advisory Board (RAB #9146). Spinal Cord (2012) 50, 915-919; doi:10.1038/sc.2012.80; published online 21 August 2012	[Mulcahey, M. J.; Calhoun, C. L.] Shriners Hosp Children, Dept Clin Res, Philadelphia, PA 19140 USA; [Tian, F.; Ni, P.; Haley, S. M.] Boston Univ, Hlth & Disabil Res Inst, Sch Publ Hlth, Boston, MA USA; [Vogel, L. C.] Shriners Hosp Children, Dept Clin Res, Chicago, IL USA	Mulcahey, MJ (corresponding author), Shriners Hosp Children, Dept Clin Res, 3551 N Broad St, Philadelphia, PA 19140 USA.	mmulcahey@shrinenet.org		mulcahey, MJ/0000-0002-0837-714X	Shriners Hospitals for Children Research Advisory Board [9146]	Craig McDonald, MD, Mr Jason Kwanda and Ms Leah Bent are acknowledged for their assistance with the study. Dr Anita Bagley, Dr John Gaughan and Mr George Gorton are acknowledged for their critical review of the paper. Mr Brian O'Doherty is acknowledged for the figure production. The study was funded by the Shriners Hospitals for Children Research Advisory Board Grant 9146 (Mulcahey, PI).	Beauducel A, 2006, STRUCT EQU MODELING, V13, P186, DOI 10.1207/s15328007sem1302_2; Bollen K.A., 1989, STRUCTURAL EQUATIONS; Calhoun C, 2009, INT J PEDIAT, P854; Cardol M, 2001, ARCH PHYS MED REHAB, V82, P210, DOI 10.1053/apmr.2001.18218; DeVivo MJ, 2004, J SPINAL CORD MED, V27, pS4, DOI 10.1080/10790268.2004.11753778; Fougeyrollas P, 1998, INT J REHABIL RES, V21, P127, DOI 10.1097/00004356-199806000-00002; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Heinemann AW, 2011, ARCH PHYS MED REHAB, V92, P564, DOI 10.1016/j.apmr.2010.07.220; King GA, 2007, CHILD CARE HLTH DEV, V33, P28, DOI 10.1111/j.1365-2214.2006.00613.x; Linacre J, 1999, USERS GUIDE WINSTERS; Magasi S, 2010, ARCH PHYS MED REHAB, V91, pS17, DOI 10.1016/j.apmr.2010.07.011; Mulcahey MJ, 2009, DEV NEUROREHABIL, V12, P191, DOI 10.1080/17518420902998177; Muthen L.K., 2007, MPLUS STAT ANAL LATE; Noonan VK, 2009, SPINAL CORD, V47, P435, DOI 10.1038/sc.2008.171; Noreau L, 2007, DEV MED CHILD NEUROL, V49, P666, DOI 10.1111/j.1469-8749.2007.00666.x; Oladeji Oluwabunmi, 2007, Pediatr Phys Ther, V19, P296, DOI 10.1097/PEP.0b013e31815a12ef; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Van Brakel WH, 2006, DISABIL REHABIL, V28, P193, DOI 10.1080/09638280500192785; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519	20	12	12	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393			SPINAL CORD	Spinal Cord	DEC	2012	50	12					915	919		10.1038/sc.2012.80			5	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	052MA	WOS:000312200700014	22907639	Bronze			2021-06-18	
J	Vargas, BB; Channer, DD; Dodick, DW; Demaerschalk, BM				Vargas, Bert B.; Channer, Dwight D.; Dodick, David W.; Demaerschalk, Bart M.			Teleconcussion: An Innovative Approach to Screening, Diagnosis, and Management of Mild Traumatic Brain Injury	TELEMEDICINE AND E-HEALTH			English	Article						teleconcussion; concussion; traumatic brain injury; e-health; telemedicine		Concussion awareness and management in sports have gained a great deal of attention in light of research illustrating the potentially devastating consequences of repeated traumatic brain injuries. In order to address this public health crisis, numerous states have passed legislation that mandates medical clearance before being eligible to return to play of concussed athletes by a qualified healthcare provider. As the number of qualified healthcare providers with expertise in the diagnosis and management of concussions remains very small, patient safety and the ability to fulfill these legislative return-to-play requirements present unique problems to rural communities without easy access to subspecialty care. Telemedicine is a possible means by which to address the needs of the rural student-athlete.	[Vargas, Bert B.; Channer, Dwight D.; Dodick, David W.; Demaerschalk, Bart M.] Mayo Clin, Dept Neurol, Phoenix, AZ USA	Vargas, BB (corresponding author), Mayo Clin Hosp, 5777 E Mayo Blvd, Phoenix, AZ 85054 USA.	vargas.bert@mayo.edu					Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Demaerschalk BM, 2010, STROKE, V41, P1251, DOI 10.1161/STROKEAHA.109.574509; Doarn CR, 2010, TELEMED J E-HEALTH, V16, P378; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Klein Y, 2010, J TRAUMA, V69, P544, DOI 10.1097/TA.0b013e3181c99936; Latifi R, 2011, TELEMEDICINE FOR TRAUMA, EMERGENCIES AND DISASTER MANAGEMENT, P225; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meyer BC, 2008, LANCET NEUROL, V7, P787, DOI 10.1016/S1474-4422(08)70171-6; Miley ML, 2009, TELEMED J E-HEALTH, V15, P691, DOI 10.1089/tmj.2009.0018; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74	12	12	12	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1530-5627	1556-3669		TELEMED E-HEALTH	Telemed. e-Health	DEC	2012	18	10					803	806		10.1089/tmj.2012.0118			4	Health Care Sciences & Services	Health Care Sciences & Services	055TN	WOS:000312440600015	23101482				2021-06-18	
J	Whiting, DL; Simpson, GK; McLeod, HJ; Deane, FP; Ciarrochi, J				Whiting, Diane L.; Simpson, Grahame K.; McLeod, Hamish J.; Deane, Frank P.; Ciarrochi, Joseph			Acceptance and Commitment Therapy (ACT) for Psychological Adjustment after Traumatic Brain Injury: Reporting the Protocol for a Randomised Controlled Trial	BRAIN IMPAIRMENT			English	Article						Acceptance and Commitment Therapy; traumatic brain injury; psychological distress; randomised controlled trial; participation	COGNITIVE-BEHAVIOR THERAPY; HOSPITAL ANXIETY; DEPRESSION; REHABILITATION; PARTICIPATION; INDIVIDUALS; MANAGEMENT; AWARENESS; OUTCOMES; PROGRAM	Following a severe traumatic brain injury (TBI) there is a complex presentation of psychological symptoms which may impact on recovery. Validated treatments addressing these symptoms for this group of people are limited. This article reports on the protocol for a single-centre, two-armed, Phase II Randomised Control Trial (RCT) to address the adjustment process following a severe TBI. Participants will be recruited from Liverpool Brain Injury Rehabilitation Unit and randomly allocated to one of two groups, Acceptance and Commitment Therapy (ACT) or an active control (Befriending). The active treatment group utilises the six core processes of ACT with the intention of increasing participation and psychological flexibility and reducing psychological distress. A number of primary and secondary outcome measures, administered at assessment, post-treatment and 1-month follow-up, will be used to assess clinical outcomes. The publication of the protocol before the trial results are available addresses fidelity criterion (intervention design) for RCTs. This ensures transparency in the RCT and that it meets the guidelines according to the CONSORT statement. The protocol has also been registered on the Australian New Zealand Clinical Trials Registry ACTRN12610000851066.	[Whiting, Diane L.; Simpson, Grahame K.] Liverpool Hosp, Liverpool Brain Injury Rehabil Unit, Sydney, NSW, Australia; [Whiting, Diane L.; Deane, Frank P.] Univ Wollongong, Sch Psychol, Wollongong, NSW 2522, Australia; [Simpson, Grahame K.] Univ Sydney, Rehabil Studies Unit, Sydney, NSW 2006, Australia; [McLeod, Hamish J.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow G12 8QQ, Lanark, Scotland; [Ciarrochi, Joseph] Univ Western Sydney, Sch Social Sci & Psychol, Penrith, NSW 1797, Australia	Whiting, DL (corresponding author), Liverpool Hosp, Brain Injury Rehabil Unit, Locked Bag 7103, Liverpool Bc, NSW 1871, Australia.	diane.whiting@sswahs.nsw.gov.au	Whiting, Diane/AAN-2522-2021; Simpson, Grahame K/W-1074-2019; Ciarrochi, Joseph/F-5823-2016	Simpson, Grahame K/0000-0001-8156-9060; Ciarrochi, Joseph/0000-0003-0471-8100; Whiting, Diane/0000-0003-1912-6626; Deane, Frank/0000-0002-6247-7416; McLeod, Hamish/0000-0002-4225-1815			Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bendall S., 2003, BEFRIENDING MANUAL; Bendall S, 2006, BEHAV COGN PSYCHOTH, V34, P277, DOI 10.1017/S1352465806002815; Bentler P. M., 2006, EQS 6 STRUCTURAL EQU; Blanchet S, 2009, BRAIN INJURY, V23, P111, DOI 10.1080/02699050802649688; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Borrelli B, 2011, J PUBLIC HEALTH DENT, V71, pS52, DOI 10.1111/j.1752-7325.2011.00233.x; Brown FJ, 2009, J INTELLECT DISABILI, V13, P195, DOI 10.1177/1744629509346173; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Chawla N, 2007, J CLIN PSYCHOL, V63, P871, DOI 10.1002/jclp.20400; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; Ciarrochi J., 2008, CBT PRACTITIONERS GU; Dahl J, 2004, BEHAV THER, V35, P785, DOI 10.1016/S0005-7894(04)80020-0; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Doig E, 2009, AM J OCCUP THER, V63, P559, DOI 10.5014/ajot.63.5.559; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Feeley N, 2009, CAN J NURS RES, V41, P84; Fleming J, 2011, BRAIN INJURY, V25, P806, DOI 10.3109/02699052.2011.585508; Gregg JA, 2007, J CONSULT CLIN PSYCH, V75, P336, DOI 10.1037/0022-006X.75.2.336; Guillamondegui OD, 2011, COMP EFFECTIVENESS R, V25; Hardy GE, 1999, PSYCHOL ASSESSMENT, V11, P159, DOI 10.1037/1040-3590.11.2.159; Hart T, 2008, NEUROPSYCHOL REHABIL, V18, P1, DOI 10.1080/09602010601082359; Hayes S., 2003, ACCEPTANCE COMMITMEN; Hayes S. C., 2004, PRACTICAL GUIDE ACCE; Heled E, 2012, J CLIN EXP NEUROPSYC, V34, P151, DOI 10.1080/13803395.2011.625351; Hesser H, 2009, BEHAV RES THER, V47, P523, DOI 10.1016/j.brat.2009.02.002; Hibbard M. R., 2005, COGNITIVE BEHAV THER, P189; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hodgson J, 2005, BRAIN IMPAIR, V6, P169, DOI DOI 10.1375/BRIM.2005.6.3.169; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; Hsieh MY, 2012, BRAIN INJURY, V26, P126, DOI 10.3109/02699052.2011.635365; Kangas M, 2011, NEUROPSYCHOL REHABIL, V21, P250, DOI 10.1080/09602011.2010.540920; Kashdan TB, 2010, CLIN PSYCHOL REV, V30, P865, DOI 10.1016/j.cpr.2010.03.001; Khan-Bourne N, 2003, NEUROPSYCHOL REHABIL, V13, P89, DOI 10.1080/09602010244000318; Kinney A., 2001, J CONTEMP PSYCHOTHER, V31, P89, DOI DOI 10.1023/A:1010261422373; Lovibond S.H., 1995, MANUAL DEPRESSION AN; McBrinn J, 2008, BRAIN INJURY, V22, P765, DOI 10.1080/02699050802372208; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; Mead N, 2010, BRIT J PSYCHIAT, V196, P96, DOI 10.1192/bjp.bp.109.064089; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Mooney C. Z., 1993, SAGE U PAPER SERIES; MOOREY S, 1991, BRIT J PSYCHIAT, V158, P255, DOI 10.1192/bjp.158.2.255; Myles SM, 2004, INT J PSYCHOL PSYCHO, V4, P487; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Ownsworth T, 2008, J REHABIL MED, V40, P81, DOI 10.2340/16501977-0124; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ponsford J., 1995, TRAUMATIC BRAIN INJU; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Randolph C., 1998, RBANS MANUAL REPEATA; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Ruiz FJ, 2010, INT J PSYCHOL PSYCHO, V10, P125; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Schlund MW, 1999, BRAIN INJURY, V13, P889; Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; Soo C, 2009, COCHRANE DATABASE SY, V3; Soo C, 2011, BRAIN IMPAIR, V12, P54, DOI 10.1375/brim.12.1.54; Sylvester M., 2011, THESIS U NEVADA RENO; Tate RL, 2011, BRAIN IMPAIR, V12, P1, DOI 10.1375/brim.12.1.1; Tate RL, 2011, J REHABIL MED, V43, P609, DOI 10.2340/16501977-0829; Thompson ER, 2007, J CROSS CULT PSYCHOL, V38, P227, DOI 10.1177/0022022106297301; Veehof MM, 2011, PAIN, V152, P533, DOI 10.1016/j.pain.2010.11.002; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Whitehouse A. M., 1994, J COGN PSYCHOTHER, V8, P141; Whiting D, 2012, BRAIN INJURY, V26, P588; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Wood RL, 2011, J HEAD TRAUMA REHAB, V26, P202, DOI 10.1097/HTR.0b013e318217b46d; Wright B. A., 1960, PHYS DISABILITY PSYC; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	83	12	12	0	43	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2012	13	3					360	376		10.1017/BrImp.2012.28			17	Clinical Neurology; Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	072HI	WOS:000313660300006					2021-06-18	
J	Brenner, LA; Braden, CA; Bates, M; Chase, T; Hancock, C; Harrison-Felix, C; Hawley, L; Morey, C; Newman, J; Pretz, C; Staniszewski, K				Brenner, Lisa A.; Braden, Cynthia A.; Bates, Mike; Chase, Terry; Hancock, Celeste; Harrison-Felix, Cynthia; Hawley, Lenore; Morey, Clare; Newman, Jody; Pretz, Christopher; Staniszewski, Kristi			A Health and Wellness Intervention for Those With Moderate to Severe Traumatic Brain Injury: A Randomized Controlled Trial	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						health and wellness; traumatic brain injury; Veterans; intervention	QUALITY-OF-LIFE; COMMUNITY INTEGRATION; PARTICIPATION ASSESSMENT; BEHAVIOR-CHANGE; LIVING WELL; PROMOTION; DISABILITIES; OUTCOMES; PROGRAM; ADULTS	Objectives: To assess the efficacy of a standardized 12-week health and wellness group intervention for those with moderate to severe traumatic brain injury (TBI). Study Design: Randomized controlled trial. Participants: Seventy-four individuals with moderate to severe TBI recruited from the outpatient program at a rehabilitation hospital, a Veterans Affairs Medical Center, and the community. Method: Eligible participants were randomized to treatment (health and wellness therapy group) or wait-list control (treatment, n = 37; wait-list, n = 37). The primary outcome was the Health Promoting Lifestyle Profile-II. Results: The results of the mixed-model repeated-measures analysis indicated no differences between treatment and control groups engaging in activities to increase their health and well-being. Conclusions: Findings did not support the efficacy of the intervention. Results may have been impacted by the wide variability of individualized health and wellness goals selected by group members, the structure and/or content of the group, and/or the outcome measures selected.	[Brenner, Lisa A.] VISN 19 Mental Illness Res Educ & Clin Ctr MIRECC, Denver, CO USA; [Brenner, Lisa A.; Braden, Cynthia A.; Bates, Mike; Chase, Terry; Hancock, Celeste; Harrison-Felix, Cynthia; Hawley, Lenore; Morey, Clare; Newman, Jody; Pretz, Christopher; Staniszewski, Kristi] Craig Hosp, Denver, CO USA; [Brenner, Lisa A.] Univ Colorado Denver, Sch Med, Dept Psychiat, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado Denver, Sch Med, Dept Neurol, Aurora, CO USA; [Brenner, Lisa A.; Harrison-Felix, Cynthia] Univ Colorado Denver, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA	Brenner, LA (corresponding author), VISN 19 MIRECC, 1055 Clermont St, Denver, CO 80220 USA.	lisa.brenner@va.gov	Brenner, Lisa A./AAG-2442-2019		US Department of Education, Office of Special Education and Rehabilitation Services, National Institute on Disability and Rehabilitation Research [H133A070022]; Veterans Integrated Service Network (VISN) 19 Mental Illness Research Education and Clinical Center (MIRECC)	This research was supported by an award from the US Department of Education, Office of Special Education and Rehabilitation Services, National Institute on Disability and Rehabilitation Research to the Rocky Mountain Regional Brain Injury System (H133A070022). Additional support was provided by the Veterans Integrated Service Network (VISN) 19 Mental Illness Research Education and Clinical Center (MIRECC). The views expressed in this article are those of the authors and do not necessarily represent the official policy or position of the Department of Education, the National Institute on Disability and Rehabilitation Research, the Department of Veterans Affairs, or the US Government. The authors thank Craig Ravensloot, Jeff Cuthbert, Lisa Betthauser, and Melissa Sendroy-Terrill for their contributions to this project.	Abdullah N, 2006, NW PUBLIC HLTH, V23, P8; Adams T, 1997, AM J HEALTH PROMOT, V11, P208, DOI 10.4278/0890-1171-11.3.208; Ali R, 2002, ADDICTION, V97, P1183; [Anonymous], 2007, REH RES TRAIN CTR HL; BANDURA A, 1990, EVAL PROGRAM PLANN, V13, P9, DOI 10.1016/0149-7189(90)90004-G; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bandura A., 1995, SELF EFFICACY CHANGI; Bandura A., 1997, SELF EFFICACY EXERCI; Becker H, 1991, Am J Health Promot, V5, P449; Becker H.A., 1993, HEALTH VALUES, V17, P42; BERK RA, 1988, J QUANTITATIVE CRIMI, V0004; Bezner JR, 2001, ARCH PHYS MED REHAB, V82, P787, DOI 10.1053/apmr.2001.23269; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Braden CA, 2012, BRAIN INJURY, V26, P1315, DOI 10.3109/02699052.2012.706351; Branca B, 2004, J HEAD TRAUMA REHAB, V19, P40, DOI 10.1097/00001199-200401000-00005; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Driver S, 2006, BRAIN INJURY, V20, P133, DOI 10.1080/02699050500443822; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Hagen C, 1972, RANCHO LOS AMIGOS SC; Harrison T, 2006, FAM COMMUNITY HEALTH, V29, p12S, DOI 10.1097/00003727-200601001-00004; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Hassett LM, 2009, J REHABIL MED, V41, P247, DOI 10.2340/16501977-0316; Hawley L., 2008, GROUP INTERACTIVE ST; Hawley L, 2006, SOCIAL SKILLS TRAUMA; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hillier SL, 1997, BRAIN INJURY, V11, P661; Hoofien D, 2000, J CLIN EXP NEUROPSYC, V22, P305, DOI 10.1076/1380-3395(200006)22:3;1-V;FT305; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; LANIG IS, 1996, PRACTICAL GUIDE HLTH; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; Mann J, 2006, AM J MENT RETARD, V111, P62, DOI 10.1352/0895-8017(2006)111[62:HBCOAW]2.0.CO;2; McCullagh S, 2005, TXB TRAUMATIC BRAIN, P321; Moher D, 2012, INT J SURG, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Nieuwenhuijsen ER, 2006, DISABIL REHABIL, V28, P245, DOI 10.1080/09638280500197743; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Pavot W, 1993, J PSYCHOL ASSESS, V5, P164; Ravesloot C, 2005, REHABIL PSYCHOL, V50, P239, DOI 10.1037/0090-5550.50.3.239; Ravesloot CH, 2007, HEALTH EDUC RES, V22, P522, DOI 10.1093/her/cyl114; Rimmer JH, 2001, AM J HEALTH PROMOT, V16, P34, DOI 10.4278/0890-1171-16.1.34; Rimmer JH., 2001, CTR HLTH PROMOTION R; Roller S, 1991, STAY WELL POLIO NETW; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; *STAT U NEW YORK, 1993, GUID UN DAT SET MED; Stuifbergen A K, 1995, Sch Inq Nurs Pract, V9, P31; Stuifbergen A. K., 1995, SCHOLARLY INQUIRY NU, V9, P51; Stuifbergen AK, 2000, NURS RES, V49, P122, DOI 10.1097/00006199-200005000-00002; STUIFBERGEN AK, 1994, RES NURS HEALTH, V17, P3, DOI 10.1002/nur.4770170103; Stuifbergen AK, 2002, PROMOTING WELLNESS W; Stuifbergen Alexa K, 2003, J Neurosci Nurs, V35, P94; Stuifbergen Alexa K, 2004, J Holist Nurs, V22, P12; Stuijbergen AK, 2003, ARCH PHYS MED REHAB, V84, P467, DOI 10.1053/apmr.2003.50028; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; US Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND; Walker SN, 1996, P 1996 SCI SESS AM N; Ware JE., 1994, SF 36 PHYS MENTAL HL, V1st; Watt D, 1998, CAN MED ASSOC J, V158, P224; Weinert C, 1987, West J Nurs Res, V9, P589; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P957, DOI 10.1097/01.PHM.0000098504.78524.E2	71	12	12	0	21	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2012	27	6					E57	E68		10.1097/HTR.0b013e318273414c			12	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	039CU	WOS:000311221200006	23131971				2021-06-18	
J	Gosselin, N; Chen, JK; Bottari, C; Petrides, M; Jubault, T; Tinawi, S; de Guise, E; Ptito, A				Gosselin, Nadia; Chen, Jen-Kai; Bottari, Carolina; Petrides, Michael; Jubault, Thomas; Tinawi, Simon; de Guise, Elaine; Ptito, Alain			The Influence of Pain on Cerebral Functioning after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						functional magnetic resonance imaging; pain; prefrontal cortex; traumatic brain injury; working memory	SPORTS-RELATED CONCUSSION; RECIPROCAL RELATIONSHIP; STATISTICAL-ANALYSIS; PREFRONTAL CORTEX; FMRI DATA; DEPRESSION; MRI; ACTIVATION; ANATOMY; NETWORK	More than 75% of patients with mild traumatic brain injury (MTBI) report chronic pain whose potential detrimental effects on cognitive recovery need to be identified. The objective of this study was to investigate the relationship between pain, performance on a working memory task, gray matter density, and mid-dorsolateral prefrontal cortex (mid-DLPFC) activation in subjects with a MTBI. For comparison purposes, we performed identical correlation analyses with a group of subjects without MTBI who sustained sports injuries. Twenty-four subjects who experienced a MTBI in the past 12 months, 16 control subjects, and 29 subjects with sport injuries were included. One hour prior to entering the magnetic resonance scanner, the subjects were asked to fill out the pain Visual Analogue Scale. Subsequently, a high-resolution T1-weighted image was acquired followed by a functional magnetic resonance imaging session using the visual externally ordered working memory task. Results showed that MTBI subjects reporting severe pain in the hour preceding the testing had reduced mid-DLPFC activation during the working memory task and poorer performance on the task. Subjects with sport injuries and severe levels of pain showed the reverse pattern: pain was associated with higher activation in the mid-DLPFC and did not correlate with performance. Gray matter density measures were independent of pain level. This study showed that behavioral performance and cerebral functioning are affected by pain after a MTBI. Moreover, this study suggests that pain, cognition, and cerebral functioning interactions could not easily be generalized from one clinical population to another.	[Gosselin, Nadia; Petrides, Michael; Ptito, Alain] Montreal Neurol Hosp & Inst, Cognit Neurosci Unit, Montreal, PQ, Canada; [Gosselin, Nadia; Petrides, Michael; de Guise, Elaine; Ptito, Alain] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Chen, Jen-Kai] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Bottari, Carolina] Univ Montreal, Sch Rehabil, Montreal, PQ, Canada; [Jubault, Thomas] Inst Univ Geriatrie Montreal, Montreal, PQ, Canada; [Tinawi, Simon; de Guise, Elaine] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Montreal, PQ H3G 1A4, Canada; [Ptito, Alain] McGill Univ, Dept Psychol, Ctr Hlth, Montreal, PQ, Canada	Ptito, A (corresponding author), Montreal Neurol Inst, Cognit Neurosci Unit, Neuropsychol Dept, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	alain.ptito@mcgill.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Fonds pour la Recherche en Sante du QuebecFonds de la Recherche en Sante du Quebec	This study was supported by the Canadian Institutes of Health Research (grants to A.P. and M.P. and fellowships to N.G. and C.B.) and by the Fonds pour la Recherche en Sante du Quebec (fellowships to N.G. and J.K.C.). The authors are grateful to Dr. Diane Diorio, Mitra Feyz, Isabel Roy, and Cindy Hovington for their help with subject recruitment and/or technical support. We would also like to thank the staff of the Magnetic Resonance Imaging Unit of the McConnell Brain Imaging Centre, Montreal, Quebec, Canada for their assistance.	Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Beck A. T., 1996, BECK DEPRESSION INVE, VII; Bingel U, 2007, NEURON, V55, P157, DOI 10.1016/j.neuron.2007.05.032; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buhle J, 2010, PAIN, V149, P19, DOI 10.1016/j.pain.2009.10.027; Champod AS, 2007, P NATL ACAD SCI USA, V104, P14837, DOI 10.1073/pnas.0607101104; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chou KL, 2007, J AFFECT DISORDERS, V102, P115, DOI 10.1016/j.jad.2006.12.013; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Dick BD, 2003, CLIN NEUROPHYSIOL, V114, P1497, DOI 10.1016/S1388-2457(03)00133-0; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Gonzalez PG, 2011, PM&R, V3, pS413, DOI 10.1016/j.pmrj.2011.08.536; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Gosselin N, 2010, PHYSICIAN SPORTSMED, V38, P27, DOI 10.3810/psm.2010.10.1805; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HUSKISSON EC, 1982, J RHEUMATOL, V9, P768; Kroenke K, 2011, J PAIN, V12, P964, DOI 10.1016/j.jpain.2011.03.003; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maletic V, 2009, FRONT BIOSCI-LANDMRK, V14, P5291, DOI 10.2741/3598; May A, 2011, NEUROSCIENTIST, V17, P209, DOI 10.1177/1073858410396220; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Obermann M, 2009, NEUROLOGY, V73, P978, DOI 10.1212/WNL.0b013e3181b8791a; PETRIDES M, 1995, J NEUROSCI, V15, P359; Ruscheweyh R, 2011, PAIN, V152, P904, DOI 10.1016/j.pain.2011.01.013; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Seminowicz DA, 2007, PAIN, V130, P8, DOI 10.1016/j.pain.2007.03.036; Seminowicz DA, 2011, J NEUROSCI, V31, P7540, DOI 10.1523/JNEUROSCI.5280-10.2011; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Wiech K, 2008, TRENDS COGN SCI, V12, P306, DOI 10.1016/j.tics.2008.05.005; Wood Patrick B, 2010, Curr Rheumatol Rep, V12, P462, DOI 10.1007/s11926-010-0129-7; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Worsley KJ, 2003, STAT METHODS MED RES, V12, P401, DOI 10.1191/0962280203sm340ra	41	12	12	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2012	29	17					2625	2634		10.1089/neu.2012.2312			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	047QU	WOS:000311856400004	23016544				2021-06-18	
J	Lecours, A; Sirois, MJ; Ouellet, MC; Boivin, K; Simard, JF				Lecours, Alexandra; Sirois, Marie-Josee; Ouellet, Marie-Christine; Boivin, Karine; Simard, Jean-Francois			Long-Term Functional Outcome of Older Adults After a Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						older adults; rehabilitation; traumatic brain injury	INDEPENDENCE MEASURE; REHABILITATION; NEEDS; AGE; PREDICTION; MODERATE	Purpose: To identify factors associated with long-term independence in mobility and self-care activities of daily living of older adults after traumatic brain injury (TBI). Participants: One hundred thirty-six TBI survivors 55 years or older were assessed 2 to 4 years postinjury (mean of 3.2 years). Setting: Level I or level II trauma centers in Quebec, Canada. Main measures: Personal, injury-related, and environmental factors were gathered from hospital records or by telephone interview; a telephone version of the Functional Independence Measure motor scale was collapsed to 4 levels. Analysis: Logistic regression analyses identified factors associated with independence in mobility and self-care. Results: The strongest and most consistent factors associated with independence in mobility and self-care were fewer comorbid conditions, no difficulty of access to home modification services and home support services, male gender, younger age at time of injury, and shorter acute care length of stay. Conclusion: Factors associated with long-term functional outcome should be considered in the development of practice guidelines for rehabilitation of older adults who sustained a TBI.	[Lecours, Alexandra] Univ Quebec Trois Rivieres, Dept Ergotherapie, Bur 3831, Trois Rivieres, PQ G9A 5H7, Canada; [Lecours, Alexandra; Sirois, Marie-Josee; Simard, Jean-Francois] Hop Enfants Jesus, CHA Ctr Hosp Affilie Univ, Ctr FRSQ, Quebec City, PQ, Canada; [Ouellet, Marie-Christine] CIRRIS, Quebec City, PQ, Canada	Lecours, A (corresponding author), Univ Quebec Trois Rivieres, Dept Ergotherapie, Bur 3831, Pavillon Sante,3351,Boul Forges, Trois Rivieres, PQ G9A 5H7, Canada.	Alexandra.Lecours@uqtr.ca		Ouellet, Marie-Christine/0000-0003-3477-1893; Lecours, Alexandra/0000-0002-4485-7829	Fonds de la Recherche en Sante du QuebecFonds de la Recherche en Sante du Quebec [16891]; Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR) [107583]	This study was funded by the Fonds de la Recherche en Sante du Quebec through a master (2008-2010) training award to A. Lecours (award no. 16891) and by the Canadian Institutes for Health Research (grant no. 107583).	Arango-Lasprilla JC, 2010, ARCH PHYS MED REHAB, V91, P1495, DOI 10.1016/j.apmr.2010.07.010; Association des etablissements de readaptation en deficience physique du Quebec, 2010, STAT; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R, P73; Audet N, 2001, ENQUETE SOCIALE SANT; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Bond T.G., 2001, APPL RASCH MODEL FUN; Chang W C, 1997, J Outcome Meas, V1, P192; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Dumont C, 2003, THESIS U LAV DEP SAN, P232; Dutch Injury Surveillance System (LIS), 1999, DAT 1999; Englander J, 2007, BRAIN INJURY MED PRI, P315; FIELDS RB, 1994, TXB GERIATRIC NEUROP, P479; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Fleming J, 1999, BRAIN INJURY, V13, P417; Fougeyrollas P, 1998, CLASSIFICATION QUEBE, P38; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Goleburn C., 2001, J CLIN GEROPSYCHOLOG, V7, DOI [https://doi.org/10.1023/A:1011335027445, DOI 10.1023/A:1011335027445]; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; Gosman-Hedstrom G, 2000, DISABIL REHABIL, V22, P702, DOI 10.1080/09638280050191972; Gosman-Hedstrom G, 2004, DISABIL REHABIL, V26, P410, DOI 10.1080/09638280410001662978; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Information C. I. F. H, 2011, ONT TRAUM REG 2011 R; Institut Fur Experimentelle Psychologie, 2009, G POW 3; Jacoby SF, 2006, J NURS SCHOLARSHIP, V38, P133, DOI 10.1111/j.1547-5069.2006.00090.x; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; McCartan DP, 2008, BRAIN INJURY, V22, P305, DOI 10.1080/02699050801995124; Meldon SW, 2004, GERIATRIC EMERGENCY, P585; Ministere de la sante et des services sociaux, 2000, TRAUM PERS AG ORG IN; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Nilsson AL, 2005, ACTA NEUROL SCAND, V111, P264, DOI 10.1111/j.1600-0404.2005.00404.x; Ouellet MC, 2009, J REHABIL MED, V41, P179, DOI 10.2340/16501977-0306; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Richmond TS, 2002, J AM GERIATR SOC, V50, P215, DOI 10.1046/j.1532-5415.2002.50051.x; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sirois MJ, 2009, AM J PHYS MED REHAB, V88, P387, DOI 10.1097/PHM.0b013e31819c592f; Smith PM, 1996, ARCH PHYS MED REHAB, V77, P431, DOI 10.1016/S0003-9993(96)90029-5; Spirduso W., 2005, PHYS DIMENSIONS AGIN, P3; TEASDALE G, 1974, LANCET, V2, P81; Tennant A, 2004, MED CARE, V42, P37, DOI 10.1097/01.mlr.0000103529.63132.77; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Wright B. D., 1979, BEST TEST DESIGN RAS; Zasler N.D., 2007, BRAIN INJURY MED PRI, P1275	53	12	12	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2012	27	6					379	390		10.1097/HTR.0b013e31823b2385			12	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	039CU	WOS:000311221200009	22333676				2021-06-18	
J	Staffa, K; Ondruschka, B; Franke, H; Dressler, J				Staffa, Katharina; Ondruschka, Benjamin; Franke, Heike; Dressler, Jan			Cerebellar Gene Expression following Human Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						age of traumatic brain injuries; cerebellum; real-time polymerase chain reaction (PCR)	FIBRILLARY ACIDIC PROTEIN; MESSENGER-RNA EXPRESSION; HUMAN POSTMORTEM BRAIN; CLOSED-HEAD INJURY; CEREBRAL-CORTEX; SPINAL-CORD; TISSUE; ASTROCYTES; SERUM; S100B	Gene expression of specific brain biomarkers offers the possibility of shedding light on the difficult molecular pathways of traumatic brain injury (TBI) and may be useful to estimate the age of trauma. Gene expression rates of cerebellar injuries are not yet sufficiently established. In 12 cases (mean age 42 years) of TBI including a pathological change in cerebellum (with known survival times ranging from immediate death to 96 h), brain tissue samples from different brain regions were analyzed with real-time polymerase chain reaction (PCR) for expression of caspase-3, tyrosine kinase receptor B (TrkB), S100B, and glial fibrillary acidic protein (GFAP) mRNA. The pH was measured to gain information about a possible correlation to RNA degradation. For comparison, corresponding brain regions were arranged from control samples of subjects that died from sudden death. We found a correlation between pH and the degradation of RNA in samples from the contralateral site, where the samples with degraded RNA have a lower pH (p < 0.05). For short survival times, the expression changes of caspase-3 (p < 0.05) and the expression changes of TrkB (p < 0.1) in the cerebellum show a significant increase compared to the controls. The cerebellar gene expression changes seem to occur much faster and stronger compared to the other investigated regions, in particular the cerebral trauma site. These findings could make the cerebellum an important target area to study the expression changes after TBI.	[Staffa, Katharina; Ondruschka, Benjamin; Dressler, Jan] Univ Leipzig, Fac Med, Inst Legal Med, D-04103 Leipzig, Germany; [Franke, Heike] Univ Leipzig, Fac Med, Rudolf Boehm Inst Pharmacol & Toxicol, D-04103 Leipzig, Germany	Dressler, J (corresponding author), Univ Leipzig, Fac Med, Inst Legal Med, Johannisallee 28, D-04103 Leipzig, Germany.	Jan.Dressler@medizin.uni-leipzig.de					Ajtai BM, 1998, BRAIN RES, V802, P285, DOI 10.1016/S0006-8993(98)00622-2; Benisty S, 1998, NEUROSCIENCE, V86, P813, DOI 10.1016/S0306-4522(98)00126-2; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Elting JW, 2000, J NEUROL SCI, V181, P104, DOI 10.1016/S0022-510X(00)00442-1; Ferrer I, 2008, CELL TISSUE BANK, V9, P181, DOI 10.1007/s10561-008-9077-0; Franike H, 2009, GLIA, V57, P1031, DOI 10.1002/glia.20827; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; GOLDBERG WJ, 1987, J NEUROSCI RES, V17, P391, DOI 10.1002/jnr.490170410; HAJOS F, 1989, EXP BRAIN RES, V78, P164; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; Hausmann R, 2007, INT J LEGAL MED, V121, P175, DOI 10.1007/s00414-006-0122-x; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; James G, 2002, EUR J PHARMACOL, V447, P247, DOI 10.1016/S0014-2999(02)01756-9; KINGSBURY AE, 1995, MOL BRAIN RES, V28, P311, DOI 10.1016/0169-328X(94)00219-5; Lim JH, 2007, BRAIN RES, V1164, P1, DOI 10.1016/j.brainres.2007.06.020; Malhotra S. K., 1990, CYTOBIOS, V61, P246; Mexal S, 2006, BRAIN RES, V1106, P1, DOI 10.1016/j.brainres.2006.05.043; Monoranu CM, 2009, NEUROPATH APPL NEURO, V35, P329, DOI 10.1111/j.1365-2990.2008.01003a.x; Nishio T, 2005, NEUROSCIENCE, V132, P87, DOI 10.1016/j.neuroscience.2004.12.028; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Reichenbach A, 2010, BRAIN RES REV, V63, P11, DOI 10.1016/j.brainresrev.2010.02.003; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Ringger NC, 2004, J NEUROTRAUM, V21, P829, DOI 10.1089/0897715041526177; Schober ME, 2012, METAB BRAIN DIS, V27, P167, DOI 10.1007/s11011-012-9309-7; Siesjo BK, 1996, ADV NEUROL, V71, P209; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Weber M, 2006, NEUROSCIENCE, V138, P1215, DOI 10.1016/j.neuroscience.2005.11.059	31	12	14	0	10	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	2012	29	17					2716	2721		10.1089/neu.2011.2246			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	047QU	WOS:000311856400013	23030803				2021-06-18	
J	Barmparas, G; Singer, M; Ley, E; Chung, R; Malinoski, D; Margulies, D; Salim, A; Bukur, M				Barmparas, Galinos; Singer, Matthew; Ley, Eric; Chung, Rex; Malinoski, Darren; Margulies, Daniel; Salim, Ali; Bukur, Marko			Decreased Intracranial Pressure Monitor Use At Level II Trauma Centers Is Associated with Increased Mortality	AMERICAN SURGEON			English	Article							CENTER DESIGNATION; CRITICALLY-ILL; AMERICAN-COLLEGE; INJURED PATIENTS; UNITED-STATES; HEAD-INJURY; MANAGEMENT; DEMOGRAPHICS; OUTCOMES; IMPACT	Previous investigations suggest outcome differences at Level I and Level II trauma centers. We examined use of intracranial pressure (ICP) monitors at Level I and Level II trauma centers after traumatic brain injury (TBI) and its effect on mortality. The 2007 to 2008 National Trauma Databank was reviewed for patients with an indication for ICP monitoring based on Brain Trauma Foundation (BTF) guidelines. Demographic and clinical outcomes at Level I and Level II centers were compared by regression modeling. Overall, 15,921 patients met inclusion criteria; 11,017 were admitted to a Level I and 4,904 to a Level II trauma center. Patients with TBI admitted to a Level II trauma center had a lower rate of Injury Severity Score greater than 16 (80 vs 82%, P < 0.01) and lower frequency of head Abbreviated Injury Score greater than 3 (80 vs 82%, P < 0.01). After regression modeling, patients with TBI admitted to a Level II trauma center were 31 per cent less likely to receive an ICP monitor (adjusted odds ratio [AOR], 0.69; P < 0.01) and had a significantly higher mortality (AOR, 1.12; P < 0.01). Admission to a Level II trauma center after severe TBI is associated with a decreased use of ICP monitoring in patients who meet BTF criteria as well as an increased mortality. These differences should be validated prospectively to narrow these discrepancies in care and outcomes between Level I and Level II centers.	[Barmparas, Galinos; Singer, Matthew; Ley, Eric; Chung, Rex; Malinoski, Darren; Margulies, Daniel; Salim, Ali; Bukur, Marko] Cedars Sinai Med Ctr, Div Acute Care Surg, Los Angeles, CA 90048 USA	Bukur, M (corresponding author), Cedars Sinai Med Ctr, Div Acute Care Surg, 8635 W 3rd St,Suite 650W, Los Angeles, CA 90048 USA.	Marko.Bukur@cshs.org	Barmparas, Galinos/L-6530-2019	Bukur, Marko/0000-0002-1850-7147			American College of Surgeons, 2006, RES OPT CAR INJ PAT; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Balas EA, 1998, JAMA-J AM MED ASSOC, V279, P54, DOI 10.1001/jama.279.1.54; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Celli P, 1997, Minerva Chir, V52, P1467; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; Cornwell EE, 2003, ARCH SURG-CHICAGO, V138, P838, DOI 10.1001/archsurg.138.8.838; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; COSENTINO CM, 1991, J PEDIATR SURG, V26, P306, DOI 10.1016/0022-3468(91)90507-P; Davenport RA, 2010, BRIT J SURG, V97, P109, DOI 10.1002/bjs.6806; Demetriades D, 2006, J AM COLL SURGEONS, V202, P212, DOI 10.1016/j.jamcollsurg.2005.09.027; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Eastridge BJ, 2010, J TRAUMA, V69, pS5, DOI 10.1097/TA.0b013e3181e421f3; Ely EW, 1996, NEW ENGL J MED, V335, P1864, DOI 10.1056/NEJM199612193352502; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Harrington D, 2011, J TRAUMA, V71, P1453; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; Kraus JF, 1993, HEAD INJURY, P1; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; MacKenzie E., 1991, J HEAD TRAUMA REHAB, V6, P76, DOI [10.1097/00001199-199106000-00010, DOI 10.1097/00001199-199106000-00010]; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Recinos G, 2009, INJURY, V40, P856, DOI 10.1016/j.injury.2008.11.001; Rice TW, 2012, CRIT CARE MED, V40, P778, DOI 10.1097/CCM.0b013e318236f168; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; ROBERTS I, 2000, COCHRANE DB SYST REV, V2; Sarkar B, 2011, J TRAUMA, V71, P1447, DOI 10.1097/TA.0b013e3182325d32; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Wakai A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub4; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Ziran BH, 2008, PATIENT SAF SURG, V2, DOI 10.1186/1754-9493-2-18	40	12	12	0	4	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	OCT	2012	78	10					1166	1171					6	Surgery	Surgery	V32MB	WOS:000208954200034	23025964				2021-06-18	
J	Grape, S; Ravussin, P				Grape, Sina; Ravussin, Patrick			PRO: Osmotherapy for the Treatment of Acute Intracranial Hypertension	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						osmotherapy; mannitol; hypertonic saline; intracranial hypertension	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; ASSOCIATION-STROKE-COUNCIL; HYPERTONIC SALINE; VOLUME REGULATION; LUND CONCEPT; PHYSIOLOGICAL PRINCIPLES; CEREBROSPINAL-FLUID; BRIEF EPISODES	Persisting severe brain edema causes intracranial hypertension and is associated with poor patient outcome. The treatment of acute intracranial hypertension is complex and multimodal. The most important options for medical treatment include controlled ventilation and osmotherapy, maintenance of brain and body homeostasis, and sedation. Osmotherapy is recommended in all relevant guidelines. The 2 osmotic agents most frequently used are mannitol and hypertonic saline. Both reduce intracranial pressure and improve cerebral perfusion and cerebral oxygen delivery. However, hypertonic saline seems advantageous over mannitol in many situations. In multitrauma patients, hypertonic saline contributes to hemodynamic stabilization and to the prevention of secondary insults. In addition, hypertonic saline has neurohumoral and immunologic effects, which may be beneficial in cerebral resuscitation.	[Ravussin, Patrick] Hop Sion, Dept Anesthesiol & Reanimat, CHCVs, CH-1950 Sion, Switzerland	Ravussin, P (corresponding author), Hop Sion, Dept Anesthesiol & Reanimat, CHCVs, Av Grand Champsec 80, CH-1950 Sion, Switzerland.	patrick.ravussin@hopitalvs.ch					Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; Andrews PJD, 2006, INTENS CARE MED, V32, P1461, DOI 10.1007/s00134-006-0295-2; Angle N, 2000, SHOCK, V14, P503, DOI 10.1097/00024382-200014050-00002; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Bereczki D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001153.pub2; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Broderick J, 2007, CIRCULATION, V116, pE391, DOI 10.1161/CIRCULATIONAHA.107.183689; BURKE AM, 1981, J NEUROSURG, V55, P550, DOI 10.3171/jns.1981.55.4.0550; Chang Y, 2006, J APPL PHYSIOL, V100, P1445, DOI 10.1152/japplphysiol.00763.2005; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; Diringer MN, 2012, NEUROSURGERY, V70, P1215, DOI 10.1227/NEU.0b013e3182417bc2; Ditillo M, 2011, J TRAUMA, V71, P373; Dizdarevic K, 2012, CLIN NEUROL NEUROSUR, V114, P142, DOI 10.1016/j.clineuro.2011.10.005; DONATO T, 1994, ANESTH ANALG, V78, P58; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Grande PO, 2011, J NEUROSURG ANESTH, V23, P251, DOI 10.1097/ANA.0b013e31821a8f10; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; Hays AN, 2011, NEUROCRIT CARE, V14, P222, DOI 10.1007/s12028-010-9477-4; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Korenkov AI, 2000, NEUROSURG REV, V23, P145, DOI 10.1007/PL00011946; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P131; Liu Chang-Wen, 2010, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V22, P610; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Matta B, 1996, CRIT CARE MED, V24, P1743, DOI 10.1097/00003246-199610000-00023; McManus ML, 1998, ANESTHESIOLOGY, V88, P1586, DOI 10.1097/00000542-199806000-00023; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; Oreopoulos GD, 2000, SHOCK, V14, P409, DOI 10.1097/00024382-200014030-00029; Palma L, 2006, J Neurosurg Sci, V50, P63; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Roquilly A, 2011, CRIT CARE, V15, DOI 10.1186/cc10522; Rostami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027389; Sankar T, 2008, J NEUROSURG, V108, P1010, DOI 10.3171/JNS/2008/108/5/1010; SCALFANI MT, 2011, J CRIT CARE; SCHEGA H W, 1955, Langenbecks Arch Klin Chir Ver Dtsch Z Chir, V280, P479, DOI 10.1007/BF01441411; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; SUTHERLAND G, 1988, STROKE, V19, P571, DOI 10.1161/01.STR.19.5.571; Tan M, 2011, CRIT CARE, V15, DOI 10.1186/cc10579; Torre-Healy A, 2011, NEUROCRIT CARE; Wakai A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub4; Wang YF, 2012, J NEUROSCI, V32, P713, DOI 10.1523/JNEUROSCI.3872-11.2012; Weed LH, 1919, AM J PHYSIOL, V48, P531; WISE BL, 1963, J NEUROSURG, V20, P961, DOI 10.3171/jns.1963.20.11.0961; Wood RL, 2011, BRAIN INJURY, V25, P1296, DOI 10.3109/02699052.2011.624569; Zeng HK, 2010, NEUROSCIENCE, V166, P878, DOI 10.1016/j.neuroscience.2009.12.076; Zeynalov E, 2008, CRIT CARE MED, V36, P2634, DOI 10.1097/CCM.0b013e3181847853	56	12	13	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	OCT	2012	24	4					402	406					5	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	013GR	WOS:000309294400022	22955194				2021-06-18	
J	Kruer, RM; Ensor, CR				Kruer, Rachel M.; Ensor, Christopher R.			Colloids in the intensive care unit	AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY			English	Article							HYDROXYETHYL STARCH; INFLAMMATORY RESPONSE; SEVERE SEPSIS; ALBUMIN; RESUSCITATION; METAANALYSIS; HEMOSTASIS; SURGERY; THERAPY; RELEASE	Purpose. The most recent published evidence on the use of colloids versus crystalloids in critical care is reviewed, with a focus on population-dependent differences in safety and efficacy. Summary. Colloids offer a number of theoretical advantages over crystalloids for fluid resuscitation, but some colloids (e.g., hydroxyethyl starch solutions, dextrans) can have serious adverse effects, and albumin products entail higher costs. The results of the influential Saline Versus Albumin Fluid Evaluation (SAFE) trial and a subsequent SAFE subgroup analysis indicated that colloid therapy should not be used in patients with traumatic brain injury and other forms of trauma due to an increased mortality risk relative to crystalloid therapy. With regard to patients with severe sepsis, two meta-analyses published in 2011, which collectively evaluated 82 trials involving nearly 10,000 patients, indicated comparable outcomes with the use of either crystalloids or albumins. For patients requiring extracorporeal cardiopulmonary bypass (CPB) during heart surgery, the available evidence supports the use of a colloid, particularly albumin, for CPB circuit priming and postoperative volume expansion. In select patients with burn injury, the published evidence supports the use of supplemental colloids if adequate urine output cannot be maintained with a crystalloid-only rescue strategy. Conclusion. The results of the SAFE trial and a subgroup analysis of SAFE data suggest that colloids should be avoided in patients with trauma and traumatic brain injury. There are minimal differences in outcome between crystalloids and hypo-oncotic or iso-oncotic albumin for fluid resuscitation in severe sepsis; in select populations, such as patients undergoing cardiac surgery, the use of iso-oncotic albumin may confer a survival advantage and should be considered a first-line alternative. Am 1 Health-Syst Pharm. 2012; 69:1635-42	[Kruer, Rachel M.] Johns Hopkins Univ Hosp, Dept Pharm, Baltimore, MD 21287 USA; [Ensor, Christopher R.] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA	Kruer, RM (corresponding author), Johns Hopkins Univ Hosp, Dept Pharm, 600 N Wolfe St,Carnegie 180, Baltimore, MD 21287 USA.	rkruerl@jhmi.edu					Beck R, 1998, CIRC RES, V83, P923; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Cochran A, 2007, BURNS, V33, P25, DOI 10.1016/j.burns.2006.10.005; Cope JT, 1997, ANN THORAC SURG, V63, P78; de Jonge E, 2001, CRIT CARE MED, V29, P1261, DOI 10.1097/00003246-200106000-00038; Delaney AP, 2011, CRIT CARE MED, V39, P386, DOI 10.1097/CCM.0b013e3181ffe217; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Horstick G, 2002, CRIT CARE MED, V30, P851, DOI 10.1097/00003246-200204000-00023; Martin GS, 2005, CRIT CARE MED, V33, P1681, DOI 10.1097/01.CCM.0000171539.47006.02; Martin GS, 2004, AM J RESP CRIT CARE, V170, P1247, DOI 10.1164/rccm.200208-909ST; MCCANDLESS BK, 1991, AM J PHYSIOL, V260, pL571; Miller BE, 1997, J CARDIOTHOR VASC AN, V11, P355, DOI 10.1016/S1053-0770(97)90106-3; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nielsen VG, 1997, CRIT CARE MED, V25, P1565, DOI 10.1097/00003246-199709000-00026; Niemi TT, 2006, ANESTH ANALG, V102, P998, DOI 10.1213/01.ane.0000200285.20510.b6; Paparella D, 2002, EUR J CARDIO-THORAC, V21, P232, DOI 10.1016/S1010-7940(01)01099-5; Perel P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub4; Perner A, 2012, NEW ENGL J MED, V367, P481; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Rioux JP, 2009, CRIT CARE MED, V37, P1293, DOI 10.1097/CCM.0b013e31819cc1a0; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Roberts I, 1998, BMJ-BRIT MED J, V317, P235; Russell JA, 2004, J CARDIOTHOR VASC AN, V18, P429, DOI 10.1053/j.jvca.2004.05.019; SAFE study investigators, 2011, INTENS CARE MED, V37, P89; Schortgen F, 2008, INTENS CARE MED, V34, P2157, DOI 10.1007/s00134-008-1225-2; Sedrakyan A, 2003, CHEST, V123, P1853, DOI 10.1378/chest.123.6.1853; Vlachou E, 2010, BURNS, V36, P984, DOI 10.1016/j.burns.2010.04.001; Wilkes MM, 2001, ANN THORAC SURG, V72, P527, DOI 10.1016/S0003-4975(01)02745-X	29	12	12	1	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1079-2082	1535-2900		AM J HEALTH-SYST PH	Am. J. Health-Syst. Pharm.	OCT 1	2012	69	19					1635	1642		10.2146/ajhp110414			8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	015ZF	WOS:000309486200010	22997116				2021-06-18	
J	Sun, JH; Xie, CC; Liu, W; Lu, DY; Qiao, WD; Huang, Q; Huo, ZH; Shen, H; Lin, ZG				Sun, Jiahang; Xie, Chuncheng; Liu, Wei; Lu, Dunyue; Qiao, Weidong; Huang, Qi; Huo, Zhihui; Shen, Hong; Lin, Zhiguo			The effects of simvastatin on hippocampal caspase-3 and Bcl-2 expression following kainate-induced seizures in rats	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						simvastatin; status epilepticus; B-cell leukemia-2; cysteinyl aspartate-specific protease-3; kainic acid; hippocampus	TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; EXPERIMENTAL STATUS EPILEPTICUS; INDUCED NEURONAL NECROSIS; CELL-DEATH; DENTATE GYRUS; REDUCTASE INHIBITORS; ALZHEIMERS-DISEASE; DNA FRAGMENTATION; LIMBIC SEIZURES	Status epilepticus (SE) causes neuronal loss and apoptosis by inducing several apoptosis-regulatory genes. Two such genes, cysteinyl aspartate-specific protease-3 (caspase-3), an apoptosis activator, and B-cell leukemia-2 (Bcl-2), an apoptosis suppressor, are tightly regulated for their expression and activation. Statins, inhibitors of HMG-CoA reductase, have been recently recognized as neuroprotective drugs. However, their underlying mechanisms are still unclear. In this study, we examined the neuroprotective effects of simvastatin in a rat model of SE induced by kainic acid (KA). Feeding of simvastatin for 3 days after kainate injection rescued SE-induced neuronal apoptosis, as determined by histological examination of brain sections at the level of the dorsal hippocampus. Semi-quantitative RT-PCR showed that SE treatment markedly increased caspase-3 mRNA expression and reduced Bcl-2 mRNA expression in the hippocampus. Similarly, western blot analysis and immunohistochemical analysis of the rat hippocampus demonstrated that under SE treatment, caspase-3 protein levels significantly increased and peaked at 72 h, whereas Bcl-2 protein levels decreased from 6-24 h following SE. Interestingly, simvastatin could reverse the aforementioned SE-induced changes, suggesting that the neuroprotective effects of simvastatin against neuronal apoptosis may be achieved by inhibiting caspase-3 expression and increasing Bcl-2 expression.	[Xie, Chuncheng; Qiao, Weidong; Huo, Zhihui; Shen, Hong; Lin, Zhiguo] Harbin Med Univ, Affiliated Hosp 1, Dept Neurosurg, Harbin 150000, Peoples R China; [Sun, Jiahang; Liu, Wei] Harbin Med Univ, Affiliated Hosp 2, Dept Neurosurg, Harbin 150000, Peoples R China; [Lu, Dunyue] SUNY Hlth Sci Ctr, Dept Psychiat, Brooklyn, NY 11203 USA; [Huang, Qi] Harbin Med Univ, Dept Anat, Harbin, Peoples R China	Lin, ZG (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Neurosurg, Harbin 150000, Peoples R China.	linzhiguo@hotmail.com					Aktas O, 2003, J EXP MED, V197, P725, DOI 10.1084/jem.20021425; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Ananth C, 2001, J NEUROSCI RES, V66, P177, DOI 10.1002/jnr.1210; Balduini W, 2003, STROKE, V34, P2007, DOI 10.1161/01.STR.0000080677.24419.88; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Benarroch EE, 2007, NEUROLOGY, V69, P1635, DOI 10.1212/01.wnl.0000279590.22544.c3; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Bengzon J, 2002, PROG BRAIN RES, V135, P111; BOTTI RE, 1991, CLIN NEUROPHARMACOL, V14, P256, DOI 10.1097/00002826-199106000-00010; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Collins JA, 1997, J HISTOCHEM CYTOCHEM, V45, P923, DOI 10.1177/002215549704500702; DEGIORGIO CM, 1992, EPILEPSIA, V33, P23, DOI 10.1111/j.1528-1157.1992.tb02278.x; Dolga AM, 2009, J ALZHEIMERS DIS, V17, P327, DOI 10.3233/JAD-2009-1052; Dumas TC, 2000, EXP NEUROL, V166, P180, DOI 10.1006/exnr.2000.7500; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Ekdahl CT, 2001, EUR J NEUROSCI, V14, P937, DOI 10.1046/j.0953-816x.2001.01713.x; Endres M, 1998, P NATL ACAD SCI USA, V95, P8880, DOI 10.1073/pnas.95.15.8880; Engel T, 2010, FASEB J, V24, P853, DOI 10.1096/fj.09-145870; Faherty CJ, 1999, MOL BRAIN RES, V70, P159, DOI 10.1016/S0169-328X(99)00143-6; Fujikawa DG, 2002, J NEUROCHEM, V83, P229, DOI 10.1046/j.1471-4159.2002.01152.x; Fujikawa DG, 2000, EPILEPSIA, V41, pS9, DOI 10.1111/j.1528-1157.2000.tb01549.x; Fujikawa TG, 2000, EPILEPSIA, V41, P981, DOI 10.1111/j.1528-1157.2000.tb00283.x; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Henshall DC, 2000, NEUROLOGY, V55, P250, DOI 10.1212/WNL.55.2.250; Henshall DC, 2000, J NEUROCHEM, V74, P1215; Hoglund K, 2007, CNS DRUGS, V21, P449; Huang XM, 2007, MOVEMENT DISORD, V22, P377, DOI 10.1002/mds.21290; Kondratyev A, 2000, MOL BRAIN RES, V75, P216, DOI 10.1016/S0169-328X(99)00292-2; Kovacs R, 2002, J NEUROPHYSIOL, V88, P2909, DOI 10.1152/jn.00149.2002; Lee JK, 2008, NEUROSCI LETT, V440, P260, DOI 10.1016/j.neulet.2008.05.112; Leite JP, 2002, EPILEPSY RES, V50, P93, DOI 10.1016/S0920-1211(02)00072-4; Li G, 2010, J AM GERIATR SOC, V58, P1311, DOI 10.1111/j.1532-5415.2010.02906.x; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Marz P, 2007, GLIA, V55, P1, DOI 10.1002/glia.20422; Mahmood A, 2009, NEUROSURGERY, V65, P187, DOI 10.1227/01.NEU.0000343540.24780.D6; Murphy B, 2007, AM J PATHOL, V171, P1258, DOI 10.2353/ajpath.2007.070269; Narkilahti S, 2003, EUR J NEUROSCI, V18, P1486, DOI 10.1046/j.1460-9568.2003.02874.x; Niquet J, 2007, EPILEPSIA, V48, P1203, DOI 10.1111/j.1528-1167.2007.01102.x; Pahan K, 1997, J CLIN INVEST, V100, P2671, DOI 10.1172/JCI119812; PAN HY, 1993, ANN PHARMACOTHER, V27, P1029, DOI 10.1177/106002809302700902; Phillips RG, 2000, BRAIN RES, V859, P202, DOI 10.1016/S0006-8993(99)02453-1; Pitkanen A, 2007, EPILEPSIA, V48, P13, DOI 10.1111/j.1528-1167.2007.01063.x; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Radley JJ, 2003, BRAIN RES, V966, P1, DOI 10.1016/S0006-8993(02)03989-6; Ramirez C, 2011, J ALZHEIMERS DIS, V24, P161, DOI 10.3233/JAD-2010-101653; Tokuhara D, 2007, BRAIN DEV-JPN, V29, P2, DOI 10.1016/j.braindev.2006.05.003; Wahner AD, 2008, NEUROLOGY, V70, P1418, DOI 10.1212/01.wnl.0000286942.14552.51; Weiss S, 1996, NEUROSCIENCE, V74, P541, DOI 10.1016/0306-4522(96)00148-0; Wolazin B, 2006, ACTA NEUROL SCAND, V114, P63; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xiang ZM, 2009, EXP NEUROL, V215, P41, DOI 10.1016/j.expneurol.2008.09.010; Xie CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024966; Zipp F, 2007, TRENDS PHARMACOL SCI, V28, P342, DOI 10.1016/j.tips.2007.05.001	54	12	18	0	5	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	OCT	2012	30	4					739	746		10.3892/ijmm.2012.1076			8	Medicine, Research & Experimental	Research & Experimental Medicine	013IB	WOS:000309298000003	22842798	Bronze			2021-06-18	
J	Xie, ZY; Lei, B; Huang, Q; Deng, JM; Wu, MJ; Shen, WW; Cheng, Y				Xie, Zongyi; Lei, Bo; Huang, Qin; Deng, Jinmu; Wu, Mingjun; Shen, Weiwei; Cheng, Yuan			Neuroprotective effect of Cyclosporin A on the development of early brain injury in a subarachnoid hemorrhage model: A pilot study	BRAIN RESEARCH			English	Article						Cyclosporin A; Early brain injury; Subarachnoid hemorrhage; Apoptosis	MITOCHONDRIAL PERMEABILITY TRANSITION; CEREBRAL-BLOOD-FLOW; CELL-DEATH; SIGNALING PATHWAYS; DOSE-RESPONSE; ISCHEMIA; MECHANISMS; VASOSPASM; APOPTOSIS; INHIBITION	Cyclosporin A (CsA) has been demonstrated to be neuroprotective in ischemic and traumatic brain injuries by inhibiting mitochondrial permeability transition pore (mPTP) opening, thereby maintaining mitochondrial homeostasis and inhibiting pro-apoptotic protein release. The effects of CsA on early brain injury (EBI) after subarachnoid hemorrhage (SAH), however, have not been investigated. This study was designed to explore the effects of CsA on apoptotic signaling pathways and EBI after experimental SAH using four equal groups (n=36) of adult male SD rats, including the sham group, SAH+vehicle group, SAH+CsA2 group, and SAH+CsA10 group. The rat SAH model was induced by injection of 0.3 ml non-heparinized arterial blood into the prechiasmatic cistern. In the SAH+CsA2 and SAH+CsA10 groups, a dose of 2 mg/kg and 10 mg/kg CsA was directly administered by intercarotid injection at 15 min and again 24 h after SAH induction. Cerebral tissue samples were extracted 48 h after SAH. Increased expressions of Cytochrome C, apoptosis-inducing factor (AIF), and cleaved caspase-3 were observed in the cerebral cortex after SAH. Treatment with high dose (10 mg/kg) CsA markedly decreased expressions of Cytochrome C, AIF, and cleaved caspase-3, and inhibited apoptosis pathways. Administration of CsA following SAH significantly ameliorated EBI, including cortical apoptosis, brain edema, blood-brain barrier (BBB) impairment, and neurobehavioral deficits. These findings suggest that early administration of CsA may ameliorate EBI and provide neuroprotection in the SAH model through potential mechanisms that include blockage of mPTP opening and inhibition of apoptotic cell death pathways. (C) 2012 Elsevier B.V. All rights reserved.	[Xie, Zongyi; Lei, Bo; Huang, Qin; Deng, Jinmu; Cheng, Yuan] Chongqing Med Univ, Affiliated Hosp 2, Dept Neurosurg, Chongqing 400010, Peoples R China; [Wu, Mingjun] Chongqing Med Univ, Inst Biol Sci, Chongqing 400016, Peoples R China; [Shen, Weiwei] Sixth Peoples Hosp Chongqing City, Dept Internal Med, Chongqing 400060, Peoples R China	Xie, ZY (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Neurosurg, Chongqing 400010, Peoples R China.	zongyixie@yahoo.com.cn; chengyuancq023@yahoo.cn		Lei, Bo/0000-0002-5497-0905	Chongqing Natural Science FoundationNatural Science Foundation of Chongqing [CSTC, 2008BB5234]	This work was supported by the Chongqing Natural Science Foundation Project to Z.Y.X (no. CSTC, 2008BB5234). The authors are appreciative of Daqiang Li, M.D. and Ph.D. from Department of Biochemistry and Molecular Biology, George Washington University, for revising the manuscript.	Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Broekemeier KM, 1995, BIOCHEMISTRY-US, V34, P16440, DOI 10.1021/bi00050a027; Bulsara Ketan R, 2006, Neurosurg Focus, V21, pE11; Cahill J, 2007, NEUROSURGERY, V60, P531, DOI 10.1227/01.NEU.0000249287.99878.9B; Cahill J, 2009, STROKE, V40, pS86, DOI 10.1161/STROKEAHA.108.533315; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Chan PH, 2004, NEUROCHEM RES, V29, P1943, DOI 10.1007/s11064-004-6869-x; Cheng G., 2009, BMC NEURSOCI; Cho BB, 2008, J INVEST SURG, V21, P141, DOI 10.1080/08941930802029945; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Domanska-Janik K, 2004, MOL BRAIN RES, V121, P50, DOI 10.1016/j.molbrainres.2003.11.006; Friedrich V, 2012, NEUROSCI LETT, V512, P6, DOI 10.1016/j.neulet.2012.01.036; Gabryel B, 2009, CELL BIOL INT, V33, P739, DOI 10.1016/j.cellbi.2009.04.006; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Gao C, 2010, VASC PHARMACOL, V52, P77, DOI 10.1016/j.vph.2009.12.001; Gules I, 2003, ACT NEUR S, V86, P483; HANDA Y, 1991, NEUROSURGERY, V28, P380, DOI 10.1227/00006123-199103000-00007; Hansson MJ, 2003, BRAIN RES, V960, P99, DOI 10.1016/S0006-8993(02)03798-8; Hasegawa Y, 2011, ACTA NEUROCHIR SUPPL, V110, P43, DOI 10.1007/978-3-7091-0353-1_8; Ibarra A., 2002, IMMUNOSUPPRESSANT AN, P283; Kaminska B, 2004, J CELL MOL MED, V8, P45, DOI 10.1111/j.1582-4934.2004.tb00259.x; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kusaka G, 2004, J CEREBR BLOOD F MET, V24, P916, DOI 10.1097/01.WCB.0000125886.48838.7E; Lulic D, 2011, NEUROSURGERY, V68, P1172, DOI 10.1227/NEU.0b013e31820c6cdc; Manno EM, 1997, NEUROSURGERY, V40, P289, DOI 10.1097/00006123-199702000-00010; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Nau R, 2002, BRAIN PATHOL, V12, P329; Nicholson DW, 2003, SCIENCE, V299, P214, DOI 10.1126/science.1081274; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Osman MM, 2011, NEUROPEPTIDES, V45, P359, DOI 10.1016/j.npep.2011.04.002; Ostrowski RP, 2005, J CEREBR BLOOD F MET, V25, P554, DOI 10.1038/sj.jcbfm.9600048; Park S, 2004, STROKE, V35, P2412, DOI 10.1161/01.STR.0000141162.29864.e9; PETERSON JW, 1990, STROKE, V21, P133, DOI 10.1161/01.STR.21.1.133; Prunell GF, 2005, J NEUROSURG, V102, P1046, DOI 10.3171/jns.2005.102.6.1046; Prunell GF, 2003, NEUROSURGERY, V52, P165, DOI 10.1097/00006123-200301000-00022; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; RYBA M, 1991, ACTA NEUROCHIR, V108, P81, DOI 10.1007/BF01407672; RYBA M, 1991, ACTA NEUROCHIR, V112, P25, DOI 10.1007/BF01402450; Sehba FA, 2012, PROG NEUROBIOL, V97, P14, DOI 10.1016/j.pneurobio.2012.02.003; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Sun J, 2012, BRAIN RES, V1436, P101, DOI 10.1016/j.brainres.2011.11.055; Tsuboi H, 2001, NEUROIMMUNOMODULAT, V9, P1, DOI 10.1159/000049001; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Uchino H, 2002, NEUROBIOL DIS, V10, P219, DOI 10.1006/nbdi.2002.0514; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Wang L, 2005, ANN CLIN LAB SCI, V35, P79; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Xi GH, 2001, STROKE, V32, P2932, DOI 10.1161/hs1201.099820; Yamaguchi M, 2004, STROKE, V35, P1750, DOI 10.1161/01.STR.0000129898.68350.9f; Yatsushige H, 2007, J NEUROSCI RES, V85, P1436, DOI 10.1002/jnr.21281; Yoshimoto T, 1999, BRAIN RES, V839, P283, DOI 10.1016/S0006-8993(99)01733-3; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	56	12	15	0	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 7	2012	1472						113	123		10.1016/j.brainres.2012.06.053			11	Neurosciences	Neurosciences & Neurology	005TI	WOS:000308772600013	22796593				2021-06-18	
J	Amantini, A; Carrai, R; Lori, S; Peris, A; Amadori, A; Pinto, F; Grippo, A				Amantini, A.; Carrai, R.; Lori, S.; Peris, A.; Amadori, A.; Pinto, F.; Grippo, A.			Neurophysiological monitoring in adult and pediatric intensive care	MINERVA ANESTESIOLOGICA			English	Article						Coma; Electroencephalography; Evoked potentials, Somatosensory; Intensive care unit; Monitoring	SOMATOSENSORY-EVOKED POTENTIALS; TRAUMATIC BRAIN-INJURY; NONCONVULSIVE STATUS EPILEPTICUS; CONTINUOUS EEG; PROGNOSTIC VALUE; HEAD-INJURY; INTRACRANIAL-PRESSURE; COMATOSE CHILDREN; MILD HYPOTHERMIA; CEREBRAL ANOXIA	Clinical neurophysiology is both an extension of clinical examination and an integration of neuroimaging. It plays a role in diagnosis, prognosis and monitoring in the Intensive Care Unit (ICU). Electroencephalography (EEG) and somatosensory evoked potentials (SEPs) are the most informative neurophysiological tests. Both have a major prognostic role in the hypoxic-ischemic encephalopathy and traumatic brain injury (TBI). In the former the absence of bilateral cortical SEPs has an unfavorable prognostic significance of 100%, whereas bilateral normal SEPs has uncertain prognostic value. In TBI these SEP patterns have high early prognostic value for both bad and good outcome. Continuous EEG monitoring is indicated for diagnosis and treatment of non convulsive seizures and status epilepticus (NCSE), whereas SEPs are more able to indicate the occurrence of neurological deterioration. In our opinion EEG-SEP monitoring is also valuable for interpretation and management of ICP trends, contributing to optimise treatment in a single patient. The EEG seems to have the same prognostic utility in pediatric as in adult ICU. Recent reviews supported the use of SEPs in the integrated process of outcome prediction after acute brain injury in children. However differences in interpretation are needed and the issue is whether it is possible to establish an age limit over which the prediction of SEPs is similar to that in adults. There are only a few studies of seizure prevalence in pediatric ICU. The variability of frequency of NCSE in comatose children is high as in adults and, similar to the adult, remains unclear the impact on outcome. (Minerva Anestesiol 2012;78:1067-75)	[Amantini, A.; Carrai, R.; Lori, S.; Pinto, F.; Grippo, A.] AOU Careggi Teaching Hosp, Dept Neurosci, I-50134 Florence, Italy; [Peris, A.] Careggi Teaching Hosp, Intens Care Unit, Emergency Dept, Florence, Italy; [Amadori, A.] Careggi Teaching Hosp, Neurointens Care Unit, Dept Neurosci, Florence, Italy; [Carrai, R.; Grippo, A.] IRCCS, Neurol Rehabil Unit, Don Carlo Gnocchi Fdn, ONLUS, Florence, Italy	Amantini, A (corresponding author), AOU Careggi Teaching Hosp, Dept Neurosci, Viale Morgagni 85, I-50134 Florence, Italy.	aldo.amantini@unifi.it	grippo, antonello/AAP-6926-2020; Pinto, Fausto/G-9363-2015	Pinto, Fausto/0000-0002-8034-4529; Grippo, Antonello/0000-0002-9997-8564			Abend NS, 2011, NEUROLOGY, V76, P1071, DOI 10.1212/WNL.0b013e318211c19e; Al Thenayan E, 2008, NEUROLOGY, V71, P1535, DOI 10.1212/01.wnl.0000334205.81148.31; Alroughani R, 2009, SEIZURE-EUR J EPILEP, V18, P38, DOI 10.1016/j.seizure.2008.06.013; Amantini A, 2008, EUR J ANAESTH, V25, P196, DOI 10.1017/S0265021507003183; Amantini A, 2005, CLIN NEUROPHYSIOL, V116, P229, DOI 10.1016/j.clinph.2004.07.008; Amantini A, 2009, NEUROPHYSIOL CLIN, V39, P85, DOI 10.1016/j.neucli.2009.01.006; Amantini A, 2011, CLIN NEUROPHYSIOL, V122, pS114; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Bosco E, 2012, ALINA GONZALEZ QUEVE, P257; Bosco E, 2011, CRIT CARE, V15, DOI 10.1186/cc10315; Bouwes A, 2009, NEUROLOGY, V73, P1457, DOI 10.1212/WNL.0b013e3181bf98f4; BOYER MG, 1991, INJURY, V22, P315, DOI 10.1016/0020-1383(91)90014-6; Carrai R, 2011, CLIN NEUROPHYSIOL, V122, pS111; Carrai R, 2010, INTENS CARE MED, V36, P1112, DOI 10.1007/s00134-010-1884-7; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; Claassen J, 2005, J CLIN NEUROPHYSIOL, V22, P92, DOI 10.1097/01.WNP.0000145006.02048.3A; Drislane FW, 2008, J CLIN NEUROPHYSIOL, V25, P181, DOI 10.1097/WNP.0b013e31817be70e; Fischer C, 2006, CRIT CARE MED, V34, P1520, DOI 10.1097/01.CCM.0000215823.36344.99; Forsyth RJ, 2010, COCHRANE DB SYST REV, V2; Fossi S, 2006, NEUROPHYSIOL CLIN, V36, P195, DOI 10.1016/j.neucli.2006.09.001; Fossi S, 2007, NEUROL SCI, V28, pS59; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; Gagliardo A, 2008, EUR J NEUROL, V15, P408; Geocadin RG, 2008, CURR OPIN CRIT CARE, V14, P261, DOI 10.1097/MCC.0b013e3282fd68ea; Greiner HM, 2012, PEDIATRICS, V129, pE748, DOI 10.1542/peds.2011-2067; Guerit JM, 2009, NEUROPHYSIOL CLIN, V39, P71, DOI 10.1016/j.neucli.2009.03.002; Guerit JM, 2010, CURR OPIN CRIT CARE, V16, P98, DOI 10.1097/MCC.0b013e328337541a; Guerit JM., 2008, INTRAOPERATIVE MONIT, P829; Gutierrez-Colina AM, 2012, PEDIATR NEUROL, V46, P158, DOI 10.1016/j.pediatrneurol.2011.12.009; Hirsch LJ, 2005, J CLIN NEUROPHYSIOL, V22, P128, DOI 10.1097/01.WNP.0000158701.89576.4C; HOCKADAY JM, 1965, ELECTROEN CLIN NEURO, V18, P575, DOI 10.1016/0013-4694(65)90075-1; Holtkamp Martin, 2011, Ther Adv Neurol Disord, V4, P169, DOI 10.1177/1756285611403826; Hosain SA, 2005, PEDIATR NEUROL, V32, P162, DOI 10.1016/j.pediatrneurol.2004.09.008; Houlden DA, 2010, CRIT CARE MED, V38, P167, DOI 10.1097/CCM.0b013e3181c031b3; HUGHES JR, 1976, ELECTROEN CLIN NEURO, V40, P261, DOI 10.1016/0013-4694(76)90150-4; Husain AM, 2003, J NEUROL NEUROSUR PS, V74, P189, DOI 10.1136/jnnp.74.2.189; Jette N, 2006, ARCH NEUROL-CHICAGO, V63, P1750, DOI 10.1001/archneur.63.12.1750; JORDAN KG, 1993, J CLIN NEUROPHYSIOL, V10, P445, DOI 10.1097/00004691-199310000-00006; KONASIEWICZ SJ, 1994, CAN J NEUROL SCI, V21, P219, DOI 10.1017/S0317167100041196; Lee YC, 2010, NEUROLOGY, V74, P572, DOI 10.1212/WNL.0b013e3181cff761; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McCoy B, 2011, EPILEPSIA, V52, P1973, DOI 10.1111/j.1528-1167.2011.03291.x; Moulton RJ, 1998, CAN J NEUROL SCI, V25, pS7, DOI 10.1017/S031716710003465X; Olivecrona M, 2009, J NEUROSURG, V110, P300, DOI 10.3171/2008.4.17538; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; RAEGRANT AD, 1991, ELECTROEN CLIN NEURO, V79, P349, DOI 10.1016/0013-4694(91)90199-E; RamachandranNair R, 2005, CAN J NEUROL SCI, V32, P518, DOI 10.1017/S0317167100004546; RamachandranNair R, 2005, PEDIATR NEUROL, V33, P345, DOI 10.1016/j.pediatrneurol.2005.05.007; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; Rossetti AO, 2010, CRIT CARE, V14, DOI 10.1186/cc9276; Rossetti AO, 2010, CURR OPIN CRIT CARE; Saengpattrachai M, 2006, EPILEPSIA, V47, P1510, DOI 10.1111/j.1528-1167.2006.00624.x; Shahwan A, 2010, EPILEPSIA, V51, P1198, DOI 10.1111/j.1528-1167.2009.02517.x; Shewmon DA, 2000, J CLIN NEUROPHYSIOL, V17, P467, DOI 10.1097/00004691-200009000-00005; SYNEK VM, 1990, CLIN ELECTROENCEPHAL, V21, P25, DOI 10.1177/155005949002100111; Tiainen M, 2005, CRIT CARE MED, V33, P1736, DOI 10.1097/01.CCM.0000171536.63641.D9; Treiman DM, 2006, EPILEPSY RES, V68, pS77, DOI 10.1016/j.eplepsyres.2005.07.020; van Putten MJAM, 2004, STROKE, V35, P2489, DOI 10.1161/01.STR.0000144649.49861.1d; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wijman CAC, 2009, ANN NEUROL, V65, P394, DOI 10.1002/ana.21632; Wohlrab G, 2001, NEUROPEDIATRICS, V32, P271, DOI 10.1055/s-2001-19123; Young GB, 2010, NEUROLOGY, V75, P760, DOI 10.1212/WNL.0b013e3181f32141; Young GB, 2009, NEUROCRIT CARE, V11, P411, DOI 10.1007/s12028-009-9248-2; Young GB, 2005, NEUROCRIT CARE, V2, P159, DOI 10.1385/NCC:2:2:159; Young GB, 2000, J CLIN NEUROPHYSIOL, V17, P473, DOI 10.1097/00004691-200009000-00006; Zanatta P, 2012, MINERVA ANESTESIOL; Zandbergen EGJ, 2006, NEUROLOGY, V67, P583, DOI 10.1212/01.wnl.0000230162.35249.7f; Zhang Y, 2011, J CLIN NEUROPHYSIOL, V28, P497, DOI 10.1097/WNP.0b013e318231c852	70	12	15	0	6	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	SEP	2012	78	9					1067	1075					9	Anesthesiology; Critical Care Medicine	Anesthesiology; General & Internal Medicine	021QX	WOS:000309901500014	22672930				2021-06-18	
J	Clarke, MC; Kelleher, I; Clancy, M; Cannon, M				Clarke, Mary C.; Kelleher, Ian; Clancy, Maurice; Cannon, Mary			Predicting Risk and the Emergence of Schizophrenia	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Schizophrenia; Psychiatric risk factors; Environmental risk factors; Genetic risk factors; Prenatal stress; Obstetric complications; Cannabis	TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; NMDA-RECEPTOR ENCEPHALITIS; PSYCHOTIC-LIKE EXPERIENCES; PROSPECTIVE BIRTH COHORT; GENOME-WIDE ASSOCIATION; CLINICAL HIGH-RISK; PRENATAL EXPOSURE; CHILDHOOD TRAUMA; ADULT SCHIZOPHRENIA	This article gives an overview of genetic and environmental risk factors for schizophrenia. The presence of certain molecular, biological, and psychosocial factors at certain points in the life span, has been linked to later development of schizophrenia. All need to be considered in the context of schizophrenia as a lifelong brain disorder. Research interest in schizophrenia is shifting to late childhood/early adolescence for screening and preventative measures. This article discusses those environmental risk factors for schizophrenia for which there is the largest evidence base.	[Clarke, Mary C.; Kelleher, Ian; Clancy, Maurice; Cannon, Mary] Beaumont Hosp, Dept Psychiat, Royal Coll Surg Ireland, Educ & Res Ctr, Dublin 9, Ireland; [Clarke, Mary C.] Dept Psychol, Div Populat Hlth Sci, Dublin 2, Ireland	Clarke, MC (corresponding author), Beaumont Hosp, Dept Psychiat, Royal Coll Surg Ireland, Educ & Res Ctr, Dublin 9, Ireland.	maryclarke@rcsi.ie	Cannon, Mary/D-8227-2012; Kelleher, Ian/C-4855-2013	Cannon, Mary/0000-0002-0910-299X; Kelleher, Ian/0000-0003-1484-651X			ACHTE KA, 1969, ACTA PSYCHIAT SCAND, V45, P1, DOI 10.1111/j.1600-0447.1969.tb06197.x; Addington J, 2007, SCHIZOPHRENIA BULL, V33, P665, DOI 10.1093/schbul/sbl075; Agerbo E, 2012, SCHIZOPHR RES, V134, P246, DOI 10.1016/j.schres.2011.10.025; Arion D, 2007, BIOL PSYCHIAT, V62, P711, DOI 10.1016/j.biopsych.2006.12.021; Babulas V, 2006, AM J PSYCHIAT, V163, P927, DOI 10.1176/appi.ajp.163.5.927; BALDRIDGE E B, 1990, Emergency Medicine Clinics of North America, V8, P541; Barr WB, 1997, BRIT J PSYCHIAT, V170, P515, DOI 10.1192/bjp.170.6.515; Barry H, 2011, BRIT J PSYCHIAT, V199, P508, DOI 10.1192/bjp.bp.111.092197; Blanchard MM, 2010, SCHIZOPHR RES, V123, P71, DOI 10.1016/j.schres.2010.05.028; Boksa P, 2003, NEUROSCI BIOBEHAV R, V27, P91, DOI 10.1016/S0149-7634(03)00012-5; Boog G, 2003, J Gynecol Obstet Biol Reprod (Paris), V32, P720; Brown AS, 2007, ARCH GEN PSYCHIAT, V64, P31, DOI 10.1001/archpsyc.64.1.31; Brown AS, 2006, AM J PSYCHIAT, V163, P2178, DOI 10.1176/appi.ajp.163.12.2178; Brown AS, 2000, SCHIZOPHRENIA BULL, V26, P287, DOI 10.1093/oxfordjournals.schbul.a033453; Brown AS, 2000, AM J PSYCHIAT, V157, P438, DOI 10.1176/appi.ajp.157.3.438; Brown AS, 2005, AM J PSYCHIAT, V162, P767, DOI 10.1176/appi.ajp.162.4.767; Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774; Brown AS, 2001, BIOL PSYCHIAT, V49, P473, DOI 10.1016/S0006-3223(01)01068-X; Brown AS, 2011, ORIGINS SCHIZOPHRENI, P25; BRUTON CJ, 1994, NEUROLOGY, V44, P34, DOI 10.1212/WNL.44.1.34; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Byrne M, 2007, SCHIZOPHR RES, V97, P51, DOI 10.1016/j.schres.2007.07.018; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; Cannon M, 2002, EPIDEMIOLOGY SCHIZOP, P74; Cannon M, 2006, BRIT J PSYCHIAT, V189, P463, DOI 10.1192/bjp.bp.105.020552; Cannon TD, 2000, SCHIZOPHR B, V26, P249; Cannon TD, 2008, BIOL PSYCHIAT, V64, P797, DOI 10.1016/j.biopsych.2008.04.012; Cannon TD, 2008, ARCH GEN PSYCHIAT, V65, P28, DOI 10.1001/archgenpsychiatry.2007.3; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; Carrion RE, 2011, AM J PSYCHIAT, V168, P806, DOI 10.1176/appi.ajp.2011.10081209; Casadio P, 2011, ORIGINS SCHIZOPHRENI, P157; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; Clarke MC, 2012, BIOL PSYCHIAT, V71, P836, DOI 10.1016/j.biopsych.2012.01.011; Clarke MC, 2009, AM J PSYCHIAT, V166, P1025, DOI 10.1176/appi.ajp.2009.08010031; Clarke MC, 2006, SCHIZOPHRENIA BULL, V32, P3, DOI 10.1093/schbul/sbj028; Clarke MC, 2011, ORIGINS SCHIZOPHRENI, P96; Cougnard A, 2007, PSYCHOL MED, V37, P513, DOI 10.1017/S0033291706009731; Cui X, 2011, ORIGINS SCHIZOPHRENI, P282; Dalman Christina, 2003, Lakartidningen, V100, P1974; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; David AS, 2005, J NEUROL NEUROSUR PS, V76, pI53, DOI 10.1136/jnnp.2004.060475; Davidson K, 1969, SPECIAL PUBLICATION, pS113; Dean K, 2010, ARCH GEN PSYCHIAT, V67, P822, DOI 10.1001/archgenpsychiatry.2010.86; Devlin B, 2007, HUM GENET, V121, P675, DOI 10.1007/s00439-007-0358-7; Di Forti M, 2009, BRIT J PSYCHIAT, V195, P488, DOI 10.1192/bjp.bp.109.064220; Dickinson D, 2008, BRIT J PSYCHIAT, V193, P354, DOI 10.1192/bjp.bp.108.049387; Dickinson D, 2007, ARCH GEN PSYCHIAT, V64, P532, DOI 10.1001/archpsyc.64.5.532; Eastvold AD, 2007, SCHIZOPHR RES, V93, P266, DOI 10.1016/j.schres.2007.03.013; Epel E, 2001, PSYCHONEUROENDOCRINO, V26, P37, DOI 10.1016/S0306-4530(00)00035-4; Esquirol E., 1838, MALADIES MENTALES CO; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fatemi SH, 2009, SCHIZOPHRENIA BULL, V35, P528, DOI 10.1093/schbul/sbn187; Fleminger S, 2009, LISHMANS ORGANIC PSY, P167; FLORHENRY P, 1969, EPILEPSIA, V10, P363, DOI 10.1111/j.1528-1157.1969.tb03853.x; Frommann I, 2011, SCHIZOPHRENIA BULL, V37, P861, DOI 10.1093/schbul/sbp155; Gejman PV, 2011, ANNU REV GENOM HUM G, V12, P121, DOI 10.1146/annurev-genom-082410-101459; GIBBS EL, 1948, ARCH NEURO PSYCHIATR, V60, P331, DOI 10.1001/archneurpsyc.1948.02310040002001; Gilmore JH, 1997, SCHIZOPHR RES, V24, P365, DOI 10.1016/S0920-9964(96)00123-5; GOTTESMAN II, 1989, ARCH GEN PSYCHIAT, V46, P867; GOTTESMAN II, 1982, SCHIZOPHRENIA EPIGEN; Gschwandtner U, 2006, EUR ARCH PSY CLIN N, V256, P201, DOI 10.1007/s00406-005-0626-2; GUDMUNDS.G, 1966, ACTA NEUROL SCAND, VS 43, P9; Gunnell D, 2005, SCHIZOPHR RES, V79, P315, DOI 10.1016/j.schres.2005.07.022; Gunnell D, 2003, AM J EPIDEMIOL, V158, P291, DOI 10.1093/aje/kwg118; Hambrecht M, 2002, BRIT J PSYCHIAT, V181, pS30, DOI 10.1192/bjp.181.43.s30; Harley M, 2010, PSYCHOL MED, V40, P1627, DOI 10.1017/S0033291709991966; Harper KN, 2011, ORIGINS SCHIZOPHRENI, P58; Hawkins KA, 2004, SCHIZOPHR RES, V67, P115, DOI 10.1016/j.schres.2003.08.007; Heins M, 2011, AM J PSYCHIAT, V168, P1286, DOI 10.1176/appi.ajp.2011.10101531; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Henquet C, 2005, SCHIZOPHRENIA BULL, V31, P608, DOI 10.1093/schbul/sbi027; Henquet C, 2009, ACTA PSYCHIAT SCAND, V119, P156, DOI 10.1111/j.1600-0447.2008.01265.x; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hollister JM, 1996, ARCH GEN PSYCHIAT, V53, P19; HUTTUNEN MO, 1978, ARCH GEN PSYCHIAT, V35, P429; Iampietro MC, 2011, ORIGINS SCHIZOPHRENI, P120; Ibi D, 2010, BEHAV BRAIN RES, V206, P32, DOI 10.1016/j.bbr.2009.08.027; Ikeda M, 2010, BIOL PSYCHIAT, V67, P283, DOI 10.1016/j.biopsych.2009.08.034; Imamura Y, 1999, ACTA PSYCHIAT SCAND, V100, P344; Ingraham LJ, 2000, AM J MED GENET, V97, P18, DOI 10.1002/(SICI)1096-8628(200021)97:1<18::AID-AJMG4>3.0.CO;2-L; Insel BJ, 2008, ARCH GEN PSYCHIAT, V65, P1136, DOI 10.1001/archpsyc.65.10.1136; Insel BJ, 2005, SCHIZOPHR RES, V80, P331, DOI 10.1016/j.schres.2005.06.005; Jahshan C, 2010, NEUROPSYCHOLOGY, V24, P109, DOI 10.1037/a0016791; JENSEN I, 1979, J NEUROL NEUROSUR PS, V42, P256, DOI 10.1136/jnnp.42.3.256; Keefe RSE, 2006, SCHIZOPHR RES, V88, P26, DOI 10.1016/j.schres.2006.06.041; Kelleher I, 2011, PSYCHOL MED, V41, P1, DOI 10.1017/S0033291710001005; Kelleher I, SCHIZOPHR B IN PRESS; Kelleher I, 2012, PSYCHOL MED; Kelleher I, COGN NEUROP IN PRESS; Kelleher I, 2008, BRIT J PSYCHIAT, V193, P378, DOI 10.1192/bjp.bp.108.049536; Kelleher I, 2012, SCHIZOPHRENIA BULL, V38, P239, DOI 10.1093/schbul/sbr164; Khashan AS, 2008, ARCH GEN PSYCHIAT, V65, P146, DOI 10.1001/archgenpsychiatry.2007.20; Kim E, 2008, CURR OPIN PSYCHIATR, V21, P286, DOI 10.1097/YCO.0b013e3282fbcd21; Kim KR, 2011, COMPR PSYCHIAT, V52, P33, DOI 10.1016/j.comppsych.2010.04.010; Koenig JI, 2002, NEUROPSYCHOPHARMACOL, V27, P309; Kraeplin E, 1913, PSYCHIAT LEHRBUCH ST; KRINGLEN E, 1989, ARCH GEN PSYCHIAT, V46, P873; Laurens KR, 2007, SCHIZOPHR RES, V90, P130, DOI 10.1016/j.schres.2006.11.006; Lencz T, 2006, BIOL PSYCHIAT, V59, P863, DOI 10.1016/j.biopsych.2005.09.005; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; Malaspina D, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-71; Masurel-Paulet A, 2010, CLIN GENET, V78, P149, DOI 10.1111/j.1399-0004.2010.01374.x; McGlashan TH, 2001, SCHIZOPHRENIA BULL, V27, P563, DOI 10.1093/oxfordjournals.schbul.a006896; McGrath J, 2004, SCHIZOPHR RES, V67, P237, DOI 10.1016/j.schres.2003.08.005; McGrath J, 2003, SCHIZOPHR RES, V63, P73, DOI 10.1016/S0920-9964(02)00435-8; McGrath JJ, 2011, AM J PSYCHIAT, V168, P1235, DOI 10.1176/appi.ajp.2011.11081300; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; MEDNICK SA, 1988, ARCH GEN PSYCHIAT, V45, P189, DOI 10.1001/archpsyc.1988.01800260109013; Mitchell KJ, 2011, PSYCHOL MED, V41, P19, DOI 10.1017/S003329171000070X; Mittal VA, 2008, SCHIZOPHRENIA BULL, V34, P1083, DOI 10.1093/schbul/sbn080; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Morgan C, 2007, SCHIZOPHRENIA BULL, V33, P3, DOI 10.1093/schbul/sbl053; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; Myhrman A, 1996, BRIT J PSYCHIAT, V169, P637, DOI 10.1192/bjp.169.5.637; Need Anna C, 2010, Dialogues Clin Neurosci, V12, P37; Nelson B, 2010, AUST NZ J PSYCHIAT, V44, P625, DOI 10.3109/00048671003620210; Nicodemus KK, 2008, MOL PSYCHIATR, V18, P180; Nielsen AS, 2002, SCHIZOPHR RES, V55, P93, DOI 10.1016/S0920-9964(01)00205-5; Niendam TA, 2006, SCHIZOPHR RES, V84, P100, DOI 10.1016/j.schres.2006.02.005; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; O'Tuathaigh CMP, 2010, EUR J NEUROSCI, V31, P349, DOI 10.1111/j.1460-9568.2009.07069.x; Patterson PH, 2011, ORIGINS SCHIZOPHRENI, P335; Patterson PH, 2011, ORIGINS SCHIZOPHRENI, P255; Pflueger MO, 2007, SCHIZOPHR RES, V97, P14, DOI 10.1016/j.schres.2007.09.003; Polanczyk G, 2010, ARCH GEN PSYCHIAT, V67, P328, DOI 10.1001/archgenpsychiatry.2010.14; Poulton R, 2000, ARCH GEN PSYCHIAT, V57, P1053, DOI 10.1001/archpsyc.57.11.1053; Pukrop R, 2006, J CLIN EXP NEUROPSYC, V28, P1388, DOI 10.1080/13803390500434425; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Qin P, 2005, BMJ-BRIT MED J, V331, P23, DOI 10.1136/bmj.38488.462037.8F; Read J, 2005, ACTA PSYCHIAT SCAND, V112, P330, DOI 10.1111/j.1600-0447.2005.00634.x; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Schmidt-Kastner R, 2006, SCHIZOPHR RES, V84, P253, DOI 10.1016/j.schres.2006.02.022; Schmitz B, 1995, J EPILEPSY, V8, P295, DOI 10.1016/0896-6974(95)00051-8; SCHWARTZ S, 2006, PSYCHIAT EPIDEMIOLOG; Seidman LJ, 2010, ARCH GEN PSYCHIAT, V67, P578, DOI 10.1001/archgenpsychiatry.2010.66; Sharma S, 2010, J REPROD IMMUNOL, V85, P112, DOI 10.1016/j.jri.2010.01.002; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Simon AE, 2007, SCHIZOPHRENIA BULL, V33, P761, DOI 10.1093/schbul/sbm018; SLATER E, 1963, BRIT J PSYCHIAT, V109, P95, DOI 10.1192/bjp.109.458.95; Smith CW, 2006, SCHIZOPHR RES, V81, P211, DOI 10.1016/j.schres.2005.09.019; Sorensen HJ, 2004, BRIT J PSYCHIAT, V185, P366, DOI 10.1192/bjp.185.5.366; Sorensen HJ, 2003, AM J PSYCHIAT, V160, P464, DOI 10.1176/appi.ajp.160.3.464; Sorensen HJ, 2011, SCHIZOPHRENIA BULL, V37, P982, DOI 10.1093/schbul/sbp167; Sperner-Unterweger B, 2005, DRUGS, V65, P1493, DOI 10.2165/00003495-200565110-00004; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Sundram F, 2010, BRIT J PSYCHIAT, V197, P482, DOI 10.1192/bjp.bp.110.080218; Suvisaari JM, 1999, ARCH GEN PSYCHIAT, V56, P733, DOI 10.1001/archpsyc.56.8.733; Swinkels WAM, 2005, EPILEPSY BEHAV, V7, P37, DOI 10.1016/j.yebeh.2005.04.012; Tarantino LM, 2011, ORIGINS SCHIZOPHRENI, P300; Tienari P, 2004, BRIT J PSYCHIAT, V184, P216, DOI 10.1192/bjp.184.3.216; Trimble MR., 1991, PSYCHOSES EPILEPSY; van Os J, 2004, AM J PSYCHIAT, V161, P2312, DOI 10.1176/appi.ajp.161.12.2312; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; van Os J, 1998, BRIT J PSYCHIAT, V172, P324, DOI 10.1192/bjp.172.4.324; Vassos E, 2010, HUM MOL GENET, V19, P3477, DOI 10.1093/hmg/ddq259; Welham J, 2009, PSYCHOL MED, V39, P625, DOI 10.1017/S0033291708003760; Wood SJ, 2003, PSYCHOL MED, V33, P1239, DOI 10.1017/S0033291703008067; Woods SW, 2009, SCHIZOPHRENIA BULL, V35, P894, DOI 10.1093/schbul/sbp027; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979; Yung AR, 2003, SCHIZOPHR RES, V60, P21, DOI 10.1016/S0920-9964(02)00167-6; Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P283, DOI 10.1093/schbul/22.2.283; Ziermans TB, 2011, SCHIZOPHR RES, V126, P58, DOI 10.1016/j.schres.2010.10.022	167	12	13	0	41	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	SEP	2012	35	3					585	+		10.1016/j.psc.2012.06.003			29	Psychiatry	Psychiatry	016EF	WOS:000309499600004	22929868	Green Published, Green Accepted			2021-06-18	
J	Lee, TTC; Graham, JR; Sellbom, M; Gervais, RO				Lee, Tayla T. C.; Graham, John R.; Sellbom, Martin; Gervais, Roger O.			Examining the Potential for Gender Bias in the Prediction of Symptom Validity Test Failure by MMPI-2 Symptom Validity Scale Scores	PSYCHOLOGICAL ASSESSMENT			English	Article						Minnesota Multiphasic Personality Inventory-2; Symptom Validity scale (FBS); symptom validity tests; gender bias	FAKE BAD SCALE; MEMORY MALINGERING TOMM; TRAUMATIC BRAIN-INJURY; RESPONSE BIAS; CHRONIC PAIN; CLASSIFICATION ACCURACY; INCREMENTAL VALIDITY; METAANALYSIS; PERFORMANCE; LITIGANTS	Using a sample of individuals undergoing medico-legal evaluations (690 men, 519 women), the present study extended past research on potential gender biases for scores of the Symptom Validity (FBS) scale of the Minnesota Multiphasic Personality Inventory-2 by examining score- and item-level differences between men and women and determining the extent to which FBS scores were able to correctly identify men and women who were divided into credible responders (n = 837) and noncredible responders (n = 372) on the basis of performance on symptom validity tests. Results indicated that women had slightly higher raw FBS scores than men (d = .29), and significant differences between men and women in item endorsement were demonstrated for 14 FBS items. Step-down hierarchical logistic regression procedures indicated predictive bias (chi(2)Delta = 23.72, p < .001). Follow-up analyses indicated intercept bias (chi(2)Delta = 23.51, p < .001) but not slope bias (chi(2)Delta = 0.22, p = .64). However, using the test publisher's recommended FBS cutoff scores (Ben-Porath, Graham, & Tellegen, 2009), classification accuracies were similar for women and men (T > 80, h = -.02; T > 100, h = -.22, respectively). On the basis of these results, we conclude there is no evidence of clinically meaningful bias in predictions of symptom validity test failure made using FBS scores for men and women.	[Lee, Tayla T. C.; Graham, John R.] Kent State Univ, Dept Psychol, Kent, OH 44242 USA; [Sellbom, Martin] Univ Alabama, Dept Psychol, Tuscaloosa, AL 35487 USA; [Gervais, Roger O.] Univ Alberta, Dept Educ Psychol, Edmonton, AB T6G 2E1, Canada; [Gervais, Roger O.] Neurobehav Associates, Edmonton, AB, Canada	Lee, TTC (corresponding author), Kent State Univ, Dept Psychol, Kent Hall, Kent, OH 44242 USA.	tconnerl@gmail.com	Sellbom, Martin/I-9302-2014				Allen L.M., 1997, CARB 97 MANUAL COMPU; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arbisi PA, 2002, PSYCHOL ASSESSMENT, V14, P3, DOI 10.1037//1040-3590.14.1.3; Ben-Porath Y.S., 2009, MMPI 2 SYMPTOM VALID; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Ben-Porath YS, 2009, PSYCHOL INJ LAW, V2, P62, DOI 10.1007/s12207-009-9037-4; Bianchini KJ, 2008, ASSESSMENT, V15, P435, DOI 10.1177/1073191108317341; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; Brockhaus R, 2004, NERVENARZT, V75, P882, DOI 10.1007/s00115-003-1592-4; Bury AS, 2002, PSYCHOL ASSESSMENT, V14, P472, DOI 10.1037//1040-3590.14.4.472; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Butcher JN, 2008, PSYCHOL INJ LAW, V1, P191, DOI 10.1007/s12207-007-9002-z; Butcher JN., 2001, MINNESOTA MULTIPHASI; Camara WJ, 2000, PROF PSYCHOL-RES PR, V31, P141, DOI 10.1037/0735-7028.31.2.141; Cohen J, 1988, STAT POWER BEHAV SCI; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; Efendov AA, 2008, PSYCHOL ASSESSMENT, V20, P317, DOI 10.1037/a0013870; Gervais R.O., 2001, J FORENSIC NEUROPSYC, V2, DOI [DOI 10.1300/J151V02N02_01, https://doi.org/10.1300/J151v02n02_01]; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2011, J PERS ASSESS, V93, P508, DOI 10.1080/00223891.2011.594132; Gervais RO, 2010, ARCH CLIN NEUROPSYCH, V25, P274, DOI 10.1093/arclin/acq018; Gervais RO, 2009, CLIN NEUROPSYCHOL, V23, P996, DOI 10.1080/13854040902748249; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Gierok SD, 2005, ARCH CLIN NEUROPSYCH, V20, P755, DOI 10.1016/j.acn.2005.04.008; Green P., 2003, GREENS WORD MEMORY T; Green P., 1996, WORD MEMORY TEST USE; Green P., 2004, MEMORY COMPLAINTS IN; Green P., 1995, MANUAL ORAL WORD MEM; GREENE RL, 1987, J CONSULT CLIN PSYCH, V55, P497, DOI 10.1037/0022-006X.55.4.497; Greiffenstein MF, 2004, CLIN NEUROPSYCHOL, V18, P573, DOI 10.1080/13854040490888512; Greiffenstein MF, 2002, J CLIN PSYCHOL, V58, P1591, DOI 10.1002/jclp.10077; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, ARCH CLIN NEUROPSYCH, V21, P439, DOI 10.1016/j.acn.2006.06.004; Greve KW, 2009, ARCH PHYS MED REHAB, V90, P1117, DOI 10.1016/j.apmr.2009.01.018; Haber AH, 2006, CLIN NEUROPSYCHOL, V20, P524, DOI 10.1080/13854040590967595; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Iverson GL, 2007, CLIN NEUROPSYCHOL, V21, P532, DOI 10.1080/13854040600611392; LAUTENSCHLAGER GJ, 1986, APPL PSYCH MEAS, V10, P133, DOI 10.1177/014662168601000202; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; MEEHL PE, 1955, PSYCHOL BULL, V52, P194, DOI 10.1037/h0048070; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Nelson NW, 2007, J INT NEUROPSYCH SOC, V13, P440, DOI 10.1017/S1355617707070373; Nelson NW, 2010, CLIN NEUROPSYCHOL, V24, P701, DOI 10.1080/13854040903482863; Nelson NW, 2006, CLIN NEUROPSYCHOL, V20, P39, DOI 10.1080/13854040500459322; Nichols D., 2009, SOC PERS ASS ANN M C; PRITCHARD DA, 1980, J CONSULT CLIN PSYCH, V48, P263; Rogers R, 2003, ASSESSMENT, V10, P160, DOI 10.1177/1073191103010002007; Rogers R., 2008, CLIN ASSESSMENT MALI; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tellegen A., 2008, MMPI 2 RF TECHNICAL; Thomas ML, 2009, CLIN NEUROPSYCHOL, V23, P1067, DOI 10.1080/13854040902795000; Tombaugh TN, 1996, TEST MEMORY MALINGER; Williams CL, 2009, PSYCHOL INJ LAW, V2, P182, DOI 10.1007/s12207-009-9046-3; Wygant DB, 2007, ARCH CLIN NEUROPSYCH, V22, P489, DOI 10.1016/j.acn.2007.01.027	57	12	12	0	13	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	SEP	2012	24	3					618	627		10.1037/a0026458			10	Psychology, Clinical	Psychology	999AI	WOS:000308281100009	22309000				2021-06-18	
J	Patton, DA; McIntosh, AS; Kleiven, S; Frechede, B				Patton, Declan A.; McIntosh, Andrew S.; Kleiven, Svein; Frechede, Bertrand			Injury data from unhelmeted football head impacts evaluated against critical strain tolerance curves	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Brain injury; concussion; finite element; impact reconstruction; injury tolerance; strain	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; CEREBRAL CONCUSSION; EXPERIMENTAL-MODEL; SPORTS; TISSUE; EPIDEMIOLOGY; RESPONSES; SEVERITY; PLAYERS	Concussion is a prevalent injury in collision and contact sports, but the biomechanics of concussion has mainly been assessed for helmeted head impacts. Concussion and no-injury cases had previously been reconstructed using rigid body simulations from a larger video database of unhelmeted head impact cases from Australian rules football, rugby union and rugby league. The KTH finite element human head model was used to simulate the 27 concussion and 13 no-injury cases, and the maximum principle strain levels in the corpus callosum were evaluated. The rotational kinematics and strain levels were compared to critical strain tolerance curves and reconstructed pedestrian impacts from the literature. It was found that the 5% critical strain tolerance curve equated to a maximum principal strain level of approximately 0.20 and was associated with concussive impacts involving prolonged loss of consciousness. The results suggest rotational kinematics above 4500 rad/s(2) and 33 rad/s for peak resultant angular acceleration and maximum change in resultant angular velocity, respectively, as tentative tolerance levels for concussion involving prolonged loss of consciousness. Cases involving short duration or no loss of consciousness had similar rotational kinematics and strain levels in the corpus callosum, suggesting that these injuries are of similar severity. The findings support the hypothesis that sports concussions share some biomechanical characteristics with diffuse axonal injury.	[Patton, Declan A.; McIntosh, Andrew S.] Univ New S Wales, Fac Sci, Kensington, NSW 2052, Australia; [McIntosh, Andrew S.] Monash Univ, Australian Ctr Res Injury Sport & Prevent, Clayton, Vic 3800, Australia; [Kleiven, Svein] Royal Inst Technol, Sch Technol & Hlth, Stockholm, Sweden; [Frechede, Bertrand] UCBL IFSTTAR, UMRT9406, LBMC, Paris, France	Patton, DA (corresponding author), Univ New S Wales, Fac Sci, Kensington, NSW 2052, Australia.	declan@unswalumni.com	FRECHEDE, Bertrand/H-3091-2018	FRECHEDE, Bertrand/0000-0002-9292-3544			Ackerman MJ, 1998, P IEEE, V86, P504, DOI 10.1109/5.662875; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Anderson T, 2006, PRACT NEUROL, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Baumgartner D., 2001, P 2001 INT IRC C BIO, P353; Bottini E, 2000, BRIT J SPORT MED, V34, P94, DOI 10.1136/bjsm.34.2.94; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu RC, 2007, NEUROSURGERY, V60, P963, DOI 10.1227/01.NEU.0000255430.62291.7B; Cheng HM, 1996, PROCEEDINGS OF THE 1996 FIFTEENTH SOUTHERN BIOMEDICAL ENGINEERING CONFERENCE, P251, DOI 10.1109/SBEC.1996.493162; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Fournier E., 2000, IRCOBI INT RES COUNC, V2000, P223; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Gazzaniga M.S., 1998, COGNITIVE NEUROSCIEN; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Gordon KE, 2006, PEDIATR NEUROL, V34, P376, DOI 10.1016/j.pediatrneurol.2005.09.007; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Holbourn AHS, 1943, LANCET, V2, P438; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; JENNETT B, 1975, LANCET, V1, P480; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; King A.I., 2003, IRCOBI C LISB PORT, P1; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S., 2006, SCANDINAVIAN J FOREN, V2, P73; Kleiven S., 2002, THESIS KTH ROYAL I T; Kleiven S, 2002, TRAFFIC INJ PREV, V3, P303, DOI DOI 10.1080/15389580214633; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Leclerc S, 2001, SPORTS MED, V31, P629, DOI 10.2165/00007256-200131080-00007; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Levy ML, 2004, NEUROSURGERY, V55, P649, DOI 10.1227/01.NEU.0000134598.06114.89; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI 10.1016/j.jocn.2009.02.002; McCrory P, 2001, BRIT J SPORT MED, V35, P146, DOI 10.1136/bjsm.35.3.146; McCrory P, 2001, BRIT J SPORT MED; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; McIntosh AS, 1993, 37 STAPP CAR CRASH C, P43; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Neale M, 2004, INT RES COUNC BIOM I; Newman J, 1999, INT RES COUNC BIOM I, P17; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Nicolle S, 2005, BIORHEOLOGY, V42, P209; OMMAYA AK, 1966, SCIENCE, V153, P211, DOI 10.1126/science.153.3732.211; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; Poirier MP, 2000, PEDIATR EMERG CARE, V16, P278, DOI 10.1097/00006565-200008000-00018; Powell JW, 2001, J ATHL TRAINING, V36, P307; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; RYAN GA, 1995, J NEUROTRAUM, V12, P627, DOI 10.1089/neu.1995.12.627; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Terrell TR, 2004, SOUTH MED J, V97, P837, DOI 10.1097/01.SMJ.0000140091.58338.1E; Thibault L.E., 1990, P INT C BIOM IMP LYO, P191; TNO, 2005, MAD HUM MOD MAN V6 2; Ungerleider L., 1982, ANAL VISUAL BEHAV, P549; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	67	12	12	0	16	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	SEP-DEC	2012	226	P3-4			SI		177	184		10.1177/1754337112438305			8	Engineering, Mechanical; Sport Sciences	Engineering; Sport Sciences	999NH	WOS:000308320000004					2021-06-18	
J	Walker, ML; Akpele, I; Spence, SD; Henderson, V				Walker, Mark L.; Akpele, Ignatius; Spence, Stanston D.; Henderson, Vernon			The Role of Repeat Computed Tomography Scan in the Evaluation of Blunt Bowel Injury	AMERICAN SURGEON			English	Article							SOLID-ORGAN INJURY; INTRAABDOMINAL FREE FLUID; ORAL CONTRAST SOLUTION; ABDOMINAL-TRAUMA; DIAGNOSIS; RISK; CT	The precise role of repeat abdominal computed tomography (CT) imaging in the diagnosis and management of bowel injury is unclear. We reviewed 540 patients with blunt abdominal trauma managed at a Level II trauma center over a 5-year period to better define the role of repeat imaging. One hundred patients had a repeat abdominal CT scan within 72 hours of admission. These patients were young with multisystem injuries (mean +/- standard deviation age, 34 +/- 15 years; Injury Severity Score, 21 +/- 12; Glasgow Coma Score [GCS], 12 +/- 5). There were 14 patients with bowel injuries. All bowel-injured patients survived without abdominal morbidity. Time to repeat CT was shortest in the bowel injured group (20 +/- 10 hours). The repeat CT was most helpful in patients with significant closed head injury (mean GCS, 3 +/- 1) and in those with occult bowel injury. The repeat scan resulted in a change in clinical management in 26 patients. Regarding the presence of bowel perforation, the follow-up scan enhanced sensitivity from 30 to 82 per cent. The repeat abdominal CT is best used selectively in patients with blunt abdominal trauma and can provide clinically useful information to exclude bowel injury.	[Walker, Mark L.; Akpele, Ignatius; Spence, Stanston D.; Henderson, Vernon] Atlanta Med Ctr, Dept Surg, Atlanta, GA 30315 USA; [Walker, Mark L.; Akpele, Ignatius; Spence, Stanston D.; Henderson, Vernon] Surg Hlth Collect, Atlanta, GA USA; [Akpele, Ignatius] AIE Surg Practice, Atlanta, GA USA	Walker, ML (corresponding author), Atlanta Med Ctr, Dept Surg, 777 Cleveland Ave SW,Suite 305, Atlanta, GA 30315 USA.	ContactUs@surgicalhealthcollective.com					Allen TL, 2004, J TRAUMA, V56, P314, DOI 10.1097/01.TA.0000058118.86614.51; Brasel KJ, 2005, J TRAUMA, V59, P1057, DOI 10.1097/01.ta.0000187798.37920.4c; Brasel KJ, 1998, J TRAUMA, V44, P889, DOI 10.1097/00005373-199805000-00024; Deunk J, 2010, ANN SURG, V251, P512, DOI 10.1097/SLA.0b013e3181cfd342; Fakhry SM, 2003, J TRAUMA, V54, P295, DOI 10.1097/01.TA.0000046256.80836.AA; Gonzalez RP, 2004, J TRAUMA, V57, P739, DOI 10.1097/01.TA.0000147518.96480.B3; Griffey RT, 2009, AM J ROENTGENOL, V192, P887, DOI 10.2214/AJR.08.1351; Killeen KL, 2001, J TRAUMA, V51, P26, DOI 10.1097/00005373-200107000-00005; Lawson CM, 2011, J TRAUMA, V70, P452, DOI 10.1097/TA.0b013e3182028d71; Livingston DH, 2001, AM J SURG, V182, P6, DOI 10.1016/S0002-9610(01)00665-1; Malinoski DJ, 2010, J TRAUMA, V69, P84, DOI 10.1097/TA.0b013e3181db37f5; Mitsuhide K, 2005, J TRAUMA, V58, P696, DOI 10.1097/01.TA.0000159242.93309.F6; Molina DK, 2007, J TRAUMA, V63, P625, DOI 10.1097/01.ta.0000236055.33085.77; Ng AKT, 2002, J TRAUMA, V52, P1134, DOI 10.1097/00005373-200206000-00019; Poletti PA, 2004, J TRAUMA, V57, P1072, DOI 10.1097/01.TA.0000092680.73274.E1; Salottolo K, 2009, CRIT CARE MED, V37, P1336, DOI 10.1097/CCM.0b013e31819d6739; Stafford RE, 1999, ARCH SURG-CHICAGO, V134, P622, DOI 10.1001/archsurg.134.6.622; Stuhlfaut JW, 2004, RADIOLOGY, V233, P689, DOI 10.1148/radiol.2333031972; Venkatesh KR, 2007, J TRAUMA, V62, P216, DOI 10.1097/01.ta.0000222585.76302.17; Williams MD, 2003, J TRAUMA, V55, P906, DOI 10.1097/01.TA.0000093243.01377.9B; Wu CH, 2011, J TRAUMA, V71, P543, DOI 10.1097/TA.0b013e3181fef15e	21	12	12	0	3	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	SEP	2012	78	9					979	985					7	Surgery	Surgery	101AL	WOS:000315747300014	22964208				2021-06-18	
J	Walz, NC; Yeates, KO; Taylor, HG; Stancin, T; Wade, SL				Walz, Nicolay Chertkoff; Yeates, Keith Owen; Taylor, H. Gerry; Stancin, Terry; Wade, Shari L.			Emerging narrative discourse skills 18 months after traumatic brain injury in early childhood	JOURNAL OF NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; BEHAVIOR RATING INVENTORY; EXECUTIVE FUNCTION; WORKING-MEMORY; YOUNG-CHILDREN; COMPREHENSION; ADOLESCENCE; RELIABILITY; PREDICTORS; RECOVERY	This study examined the longer term effect of traumatic brain injury (TBI), approximately 18 months post-injury, on emerging narrative discourse skills of 85 children with orthopaedic injury (OI), 43 children with moderate TBI, and 19 children with severe TBI who were between 3 years and 6 years 11 months at injury. Children with TBI performed worse than children with OI on most discourse indices. Children with severe TBI were less proficient than children with moderate TBI at identifying unimportant story information. Age and pragmatic skills were predictors of discourse performance.	[Walz, Nicolay Chertkoff] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Dept Pediat, Cincinnati, OH 45229 USA; [Walz, Nicolay Chertkoff; Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Yeates, Keith Owen] Ohio State Univ, Dept Pediat, Columbus Childrens Hosp, Div Pediat Psychol, Columbus, OH 43210 USA; [Yeates, Keith Owen] Childrens Res Inst, Columbus, OH USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Div Dev & Behav Pediat & Pediat Psychol, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Univ Hosp Case Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH USA; [Stancin, Terry] Metrohlth Med Ctr, Dept Pediat, Div Pediat Psychol, Cleveland, OH USA; [Stancin, Terry] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil, Cincinnati, OH USA	Walz, NC (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Dept Pediat, MLC 10006,2800 Winslow Ave, Cincinnati, OH 45229 USA.	nicolay.walz@cchmc.org	Yeates, Keith/AAJ-4223-2020; Stancin, Terry/L-7993-2019	Yeates, Keith/0000-0001-7680-2892	CCHMC GCRC CReFF award, Institutional Clinical and Translational Science Award; NIH/NCRRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [1Ul1RR026314, K23 HD046690, R01 HD42729]; State of Ohio Emergency Medical Services; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042729] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD046690] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR026314] Funding Source: NIH RePORTER	Supported by a CCHMC GCRC CReFF award (as part of an Institutional Clinical and Translational Science Award, NIH/NCRR 1Ul1RR026314) and grant K23 HD046690 to Dr. Walz, grant R01 HD42729 to Dr. Wade, and by Trauma Research grants from the State of Ohio Emergency Medical Services to Dr. Taylor. The authors wish to acknowledge the contributions of Christine Abraham, Andrea Beebe, Lori Bernard, Anne Birnbaum, Beth Bishop, Tammy Matecun, Karen Oberjohn, Elizabeth Roth, Elizabeth Shaver, and Maegan Swartwout in data collection and Abby Burkhardt in coding and data management. The Cincinnati Children's Medical Center Trauma Registry, Rainbow Pediatric Trauma Center, Rainbow Babies & Children's Hospital, Columbus Children's Hospital Trauma Program, and MetroHealth Center Department of Pediatrics and Trauma Registry provided assistance with recruitment. We would also like to thank Sandy Chapman and Lori Cook for assistance with the discourse measure throughout the project.	Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; Achenbach T. M., 2001, MANUAL ASEBA PRESCHO; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Barnes MA, 2001, BRAIN LANG, V76, P253, DOI 10.1006/brln.2000.2385; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Blair C, 2002, AM PSYCHOL, V57, P111, DOI 10.1037//0003-066X.57.2.111; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; BROWN AL, 1983, J VERB LEARN VERB BE, V22, P1, DOI 10.1016/S0022-5371(83)80002-4; Caldarella, 2002, HOME COMMUNITY SOCIA; Carrow-Woolfolk E, 2000, COMPREHENSIVE ASSESS; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2000, TRAUM BRAIN INJ US A; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Chapman S. B., 1997, AM J SPEECH-LANG PAT, V6, P66; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; CHAPMAN SB, 1995, J HEAD TRAUMA REHAB, V10, P36, DOI 10.1097/00001199-199510000-00006; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; DENNIS M, 1991, DEV NEUROPSYCHOL, V7, P327, DOI 10.1080/87565649109540497; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Gioia G.A., 2000, BEHAV RATING INVENTO; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P249, DOI 10.1076/chin.8.4.249.13513; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Hanten G, 1999, DEV NEUROPSYCHOL, V16, P393, DOI 10.1207/S15326942DN1603_23; Harrison P., 2003, ADAPTIVE BEHAV ASSES; Ladd GW, 1999, ANNU REV PSYCHOL, V50, P333, DOI 10.1146/annurev.psych.50.1.333; Langlois JA, 2006, TRAUMATIC BRAIN INJU; MALONE LD, 1992, EXCEPT CHILDREN, V58, P270; Merrell K.W., 2002, PRESCHOOL KINDERGART; Merrell KW, 2001, PSYCHOL SCHOOLS, V38, P313, DOI 10.1002/pits.1021; PARKER JG, 1987, PSYCHOL BULL, V102, P357, DOI 10.1037/0033-2909.102.3.357; Peterson C, 1999, J CHILD LANG, V26, P49, DOI 10.1017/S0305000998003651; Reilly JS, 1998, BRAIN LANG, V61, P335, DOI 10.1006/brln.1997.1882; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TAYLOR HG, 2008, J INT NEUROPSYCH SOC, V14, P1; TEASDALE G, 1974, LANCET, V2, P81; Walz NC, 2010, J NEUROPSYCHOL, V4, P181, DOI 10.1348/174866410X488788; Walz NC, 2009, DEV NEUROPSYCHOL, V34, P507, DOI 10.1080/87565640902964490; Woodcock R.W., 2001, WOODCOCKJOHNSON 3 TE; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	51	12	12	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645	1748-6653		J NEUROPSYCHOL	J. Neuropsychol.	SEP	2012	6		2				143	160		10.1111/j.1748-6653.2011.02020.x			18	Psychology; Psychology, Experimental	Psychology	000ZN	WOS:000308429700001	22257728	Green Accepted			2021-06-18	
J	Wang, Y; Huang, X; Liang, QH; Fan, R; Qin, F; Guo, Y; Yan, KP; Liu, W; Luo, JK; Li, YH; Mao, XL; Liu, ZQ; Zhou, HH				Wang Yang; Huang Xi; Liang Qing-hua; Fan Rong; Qin Feng; Guo Yong; Yan Kui-po; Liu Wei; Luo Jie-kun; Li Yun-hui; Mao Xi-lian; Liu Zhao-qian; Zhou Hong-hao			A strategy for detecting absorbed bioactive compounds for quality control in the water extract of rhubarb by ultra performance liquid chromatography with photodiode array detector	CHINESE JOURNAL OF INTEGRATIVE MEDICINE			English	Article						quality control; absorbed bioactive compounds; rhubarb; ultra performance liquid chromatography; craniocerebral injury; anthraquinones	ANTHRAQUINONE DERIVATIVES; CONSTITUENTS; INJECTION; MEDICINE; PLANTS; UPLC; HPLC	To detect absorbed bioactive compounds of the water extract whose pharmacodynamic effect was craniocerebral protection for quality control assessment. Anthraquinones in water extract of rhubarb (WER), in cerebrospinal fluid (CSF) of patients with traumatic brain injury (TBI) and in ipsilateral cortex of TBI rats following oral WER were respectively explored by ultra performance liquid chromatography with photodiode array detector (UPLC-PDA) method developed in the present study. The effects of anthraquinones absorbed into injured cortex on superoxidase dismutase (SOD) activity in TBI rats were detected. The antioxidative anthraquinones absorbed into target organ were evaluated for quality control of WER. Anthraquinones in WER were aloe-emodin, rhein, emodin, chrysophanol, and physcion. Only the last anthraquinone was found in CSF and in ipsilateral cortex under this chromatographic condition. Physcion increased SOD activity in TBI rats significantly. Physcion was the main active compound of rhubarb against craniocerebral injury via antioxidant pathway. According to our strategy, the exploration of physcion suggested the possibility of a novel quality control of WER in treating TBI injury.	[Wang Yang; Huang Xi; Liang Qing-hua; Fan Rong; Qin Feng; Yan Kui-po; Liu Wei; Luo Jie-kun; Li Yun-hui] Cent S Univ, Xiangya Hosp, Inst Integrated Tradit Chinese & Western Med, Sch Tradit Chinese Med Encephalopathy, Changsha 410008, Hunan, Peoples R China; [Wang Yang; Huang Xi; Liang Qing-hua; Fan Rong; Qin Feng; Yan Kui-po; Liu Wei; Luo Jie-kun; Li Yun-hui] Cent S Univ, Xiangya Hosp, Natl Key Clin Specialist Vocat, Sch Tradit Chinese Med Encephalopathy, Changsha 410008, Hunan, Peoples R China; [Wang Yang; Huang Xi; Liang Qing-hua; Fan Rong; Yan Kui-po; Liu Wei; Luo Jie-kun; Li Yun-hui; Mao Xi-lian] Cent S Univ, Xiangya Hosp, Dept Integrated Tradit Chinese & Western Med, Changsha 410008, Hunan, Peoples R China; [Guo Yong] Cent S Univ, Dept Neurosurg, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Liu Zhao-qian; Zhou Hong-hao] Cent S Univ, Inst Clin Pharmacol, Changsha 410008, Hunan, Peoples R China	Huang, X (corresponding author), Cent S Univ, Xiangya Hosp, Inst Integrated Tradit Chinese & Western Med, Sch Tradit Chinese Med Encephalopathy, Changsha 410008, Hunan, Peoples R China.	tcmhuangx59@163.com		Liu, Zhaoqian/0000-0003-0428-3928; Qin, Feng/0000-0001-9521-7146	Fund for Key Laboratory of Traditional Chinese Medicine Gan of State Administration of Traditional Chinese Medicine; Major Research Plan of the National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [90409010]; Huge Project to Boost Chinese Drug Development [2009ZX09304-003]	Supported by the Fund for Key Laboratory of Traditional Chinese Medicine Gan of State Administration of Traditional Chinese Medicine, the Major Research Plan of the National Natural Science Foundation of China (No. 90409010), and was partly supported by the Huge Project to Boost Chinese Drug Development (No. 2009ZX09304-003)	Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Baranova AI, 2008, J NEUROSURG, V109, P502, DOI 10.3171/JNS/2008/109/9/0502; Chinese Pharmacopoeia Commission, 2005, PHARM PEOPL REP CHIN, VI, P17; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; De Smet PAGM, 2002, NEW ENGL J MED, V347, P2046, DOI 10.1056/NEJMra020398; Ding L, 2008, TALANTA, V74, P1344, DOI 10.1016/j.talanta.2007.09.001; Ding MY, 2003, ANAL SCI, V19, P1163, DOI 10.2116/analsci.19.1163; Drasar P, 2004, J CHROMATOGR B, V812, P3, DOI 10.1016/j.jchromb.2004.09.037; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gao GW, 2002, CENTRAL PLAINS MED J, V29, P8; Gao XY, 2009, J CHROMATOGR A, V1216, P2118, DOI 10.1016/j.chroma.2008.11.104; Gu JW, 2000, CHINESE MED J-PEKING, V113, P529; Gu JW, 2005, NEUROPHARMACOLOGY, V49, P103, DOI 10.1016/j.neuropharm.2005.02.003; He DX, 2009, J PHARMACEUT BIOMED, V49, P1123, DOI 10.1016/j.jpba.2009.02.014; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Huang X, 2009, J ETHNOPHARMACOL, V121, P68, DOI 10.1016/j.jep.2008.10.029; Iizuka A, 2004, J ETHNOPHARMACOL, V91, P89, DOI 10.1016/j.jep.2003.11.021; Jin W, 2007, RAPID COMMUN MASS SP, V21, P2351, DOI 10.1002/rcm.3086; Kerman M, 2005, EXP BRAIN RES, V163, P406, DOI 10.1007/s00221-005-2338-2; Koyama J, 2007, J CHROMATOGR A, V1145, P183, DOI 10.1016/j.chroma.2007.01.076; LAI YL, 1983, J APPL PHYSIOL, V54, P1754; Lee JH, 2003, J ETHNOPHARMACOL, V84, P5, DOI 10.1016/S0378-8741(02)00222-2; Lin CC, 2006, J SEP SCI, V29, P2584, DOI 10.1002/jssc.200500307; Liu LH, 2005, ELECTROPHORESIS, V26, P2999, DOI 10.1002/elps.200500069; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Mao Y, 2007, J PHARMACEUT BIOMED, V45, P510, DOI 10.1016/j.jpba.2007.05.031; Marklund N, 2001, J CEREBR BLOOD F MET, V21, P1259, DOI 10.1097/00004647-200111000-00002; Matsuda H, 2001, BIOORGAN MED CHEM, V9, P41, DOI 10.1016/S0968-0896(00)00215-7; Normile D, 2003, SCIENCE, V299, P188, DOI 10.1126/science.299.5604.188; Ren P, 2009, CHROMATOGRAPHIA, V70, P1515, DOI 10.1365/s10337-009-1341-3; Singh NP, 2005, J CHROMATOGR A, V1077, P202, DOI 10.1016/j.chroma.2005.03.130; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Verma SC, 2005, J CHROMATOGR A, V1097, P59, DOI 10.1016/j.chroma.2005.08.018; Wang FX, 2006, TALANTA, V70, P1170, DOI 10.1016/j.talanta.2006.03.008; Wang JB, 2008, J PHARMACEUT BIOMED, V47, P765, DOI 10.1016/j.jpba.2008.03.011; Wang Y, 2011, J ETHNOPHARMACOL, V133, P735, DOI 10.1016/j.jep.2010.11.006; Wang YS, 1990, CHIN TRADIT PATENT M, V12, P5; Wang ZJ, 2009, J PHARMACEUT BIOMED, V50, P232, DOI 10.1016/j.jpba.2009.04.001; Wu T, 2008, CHROMATOGRAPHIA, V68, P803, DOI 10.1365/s10337-008-0788-y; Xie PS, 2009, J CHROMATOGR A, V1216, P1933, DOI 10.1016/j.chroma.2008.08.045; Yan SK, 2005, J CHROMATOGR A, V1090, P90, DOI 10.1016/j.chroma.2005.07.066; Ye M, 2007, J AM SOC MASS SPECTR, V18, P82, DOI 10.1016/j.jasms.2006.08.009; 黄熙, 2002, [中国中西医结合杂志, Chinese Journal of Integrated Traditional and Western Medicine], V22, P251	45	12	13	3	40	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1672-0415	1993-0402		CHIN J INTEGR MED	Chin. J. Integr. Med.	SEP	2012	18	9					690	698		10.1007/s11655-012-1053-7			9	Integrative & Complementary Medicine	Integrative & Complementary Medicine	998GT	WOS:000308226200007	22936323				2021-06-18	
J	Holly, LT; Blaskiewicz, D; Wu, AG; Feng, C; Ying, Z; Gomez-Pinilla, F				Holly, Langston T.; Blaskiewicz, Donald; Wu, Aiguo; Feng, Cameron; Ying, Zhe; Gomez-Pinilla, Fernando			Dietary therapy to promote neuroprotection in chronic spinal cord injury Laboratory investigation	JOURNAL OF NEUROSURGERY-SPINE			English	Article						myelopathy; docosahexaenoic acid; curcumin; membrane; spinal cord injury; rat	TRAUMATIC BRAIN-INJURY; DOCOSAHEXAENOIC ACID; MECHANICAL COMPRESSION; SYNAPTIC PLASTICITY; CURCUMIN; COUNTERACTS; HOMEOSTASIS; MYELOPATHY; COGNITION; NEURONS	Object. The pathogenesis of cervical spondylotic myelopathy (CSM) is related to both primary mechanical and secondary biological injury. The authors of this study explored a novel, noninvasive method of promoting neuroprotection in myelopathy by using curcumin to minimize oxidative cellular injury and the capacity of omega-3 fatty acids to support membrane structure and improve neurotransmission. Methods. An animal model of CSM was created using a nonresorbable expandable polymer placed in the thoracic epidural space, which induced delayed myelopathy. Animals that underwent placement of the expandable polymer were exposed to either a diet rich in docosahexaenoic acid and curcumin (DHA-Cur) or a standard Western diet (WD). Twenty-seven animals underwent serial gait testing, and spinal cord molecular assessments were performed after the 6-week study period. Results. At the conclusion of the study period, gait analysis revealed significantly worse function in the WD group than in the DHA-Cur group. Levels of brain-derived neurotrophic factor (BDNF), syntaxin-3, and 4-hydroxynonenal (4-HNE) were measured in the thoracic region affected by compression and lumbar enlargement. Results showed that BDNF levels in the DHA-Cur group were not significantly different from those in the intact animals but were significantly greater than in the WD group. Significantly higher lumbar enlargement syntaxin-3 in the DHA-Cur animals combined with a reduction in lipid peroxidation (4-HNE) indicated a possible healing effect on the plasma membrane. Conclusions. Data in this study demonstrated that DHA-Cur can promote spinal cord neuroprotection and neutralize the clinical and biochemical effects of myelopathy. (http://thejns.org/doi/abs/10.3171/2012.5.SPINE1216)	[Holly, Langston T.; Blaskiewicz, Donald; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Ctr Hlth Sci, Los Angeles, CA 90095 USA; [Wu, Aiguo; Feng, Cameron; Ying, Zhe; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA	Holly, LT (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Ctr Hlth Sci, Box 956901, Los Angeles, CA 90095 USA.	lholly@mednet.ucla.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS056413]; Craig H. Neilsen Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS056413, R01NS050465] Funding Source: NIH RePORTER	This work was supported by NIH Grant No. RO1 NS056413 and the Craig H. Neilsen Foundation.	Calderon F, 2004, J NEUROCHEM, V90, P979, DOI 10.1111/j.1471-4159.2004.02520.x; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Hamaguchi T, 2010, CNS NEUROSCI THER, V16, P285, DOI 10.1111/j.1755-5949.2010.00147.x; Henderson FC, 2005, NEUROSURGERY, V56, P1101, DOI 10.1227/01.NEU.0000157929.85251.7C; Horrocks LA, 2004, PROSTAG LEUKOTR ESS, V70, P361, DOI 10.1016/j.plefa.2003.12.011; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Jyoti A, 2009, EPILEPSY BEHAV, V14, P300, DOI 10.1016/j.yebeh.2008.11.011; Kanoski SE, 2011, PHYSIOL BEHAV, V103, P59, DOI 10.1016/j.physbeh.2010.12.003; Kasahara K, 2006, SPINE, V31, P2059, DOI 10.1097/01.brs.0000231893.21964.f2; Kim David H, 2003, Spine J, V3, P510, DOI 10.1016/S1529-9430(03)00117-7; Kim P, 2004, ANN NEUROL, V55, P503, DOI 10.1002/ana.20018; Koda M, 2002, J NEUROTRAUM, V19, P777, DOI 10.1089/08977150260139147; Lapchak PA, 2011, EXPERT OPIN INV DRUG, V20, P13, DOI 10.1517/13543784.2011.542410; Maier IC, 2006, PHILOS T R SOC B, V361, P1611, DOI 10.1098/rstb.2006.1890; MCMAHON HT, 1995, J BIOL CHEM, V270, P2213, DOI 10.1074/jbc.270.5.2213; Merenda A, 2008, J NEUROTRAUM, V25, P527, DOI 10.1089/neu.2007.0359; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Sharma S, 2009, NEUROSCIENCE, V161, P1037, DOI 10.1016/j.neuroscience.2009.04.042; Sharma S, 2010, EXP NEUROL, V226, P191, DOI 10.1016/j.expneurol.2010.08.027; Stillwell W, 2005, REPROD NUTR DEV, V45, P559, DOI 10.1051/rnd:2005046; Wakade C, 2009, ANTIOXID REDOX SIGN, V11, P35, DOI 10.1089/ars.2008.2056; Wu A, 2008, NEUROSCIENCE, V155, P751, DOI 10.1016/j.neuroscience.2008.05.061; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu AG, 2011, NEUROREHAB NEURAL RE, V25, P332, DOI 10.1177/1545968310397706; Xu K, 2006, SPINE, V31, P1867, DOI 10.1097/01.brs.0000228772.53598.cc; Yamaura I, 2002, SPINE, V27, P21, DOI 10.1097/00007632-200201010-00008	27	12	14	0	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654			J NEUROSURG-SPINE	J. Neurosurg.-Spine	AUG	2012	17	2					134	140		10.3171/2012.5.SPINE1216			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	978SU	WOS:000306766900011	22735048	Green Accepted			2021-06-18	
J	Li, CY; Wu, PM; Hartings, JA; Wu, ZZ; Cheyuo, C; Wang, P; LeDoux, D; Shutter, LA; Ramaswamy, BR; Ahn, CH; Narayan, RK				Li, Chunyan; Wu, Pei-Ming; Hartings, Jed A.; Wu, Zhizhen; Cheyuo, Cletus; Wang, Ping; LeDoux, David; Shutter, Lori A.; Ramaswamy, Bharat Ram; Ahn, Chong H.; Narayan, Raj K.			Micromachined lab-on-a-tube sensors for simultaneous brain temperature and cerebral blood flow measurements	BIOMEDICAL MICRODEVICES			English	Article						Lab-on-a-tube; Temperature sensor; Cerebral blood flow sensor; Smart catheter; Traumatic brain injury	SECONDARY INSULTS; INJURED PATIENTS; PATHOPHYSIOLOGY; AUTOREGULATION; MANAGEMENT	This work describes the development of a micromachined lab-on-a-tube device for simultaneous measurement of brain temperature and regional cerebral blood flow. The device consists of two micromachined gold resistance temperature detectors with a 4-wire configuration. One is used as a temperature sensor and the other as a flow sensor. The temperature sensor operates with AC excitation current of 500 mu A and updates its outputs at a rate of 5 Hz. The flow sensor employs a periodic heating and cooling technique under constant-temperature mode and updates its outputs at a rate of 0.1 Hz. The temperature sensor is also used to compensate for temperature changes during the heating period of the flow sensor to improve the accuracy of flow measurements. To prevent thermal and electronic crosstalk between the sensors, the temperature sensor is located outside the "thermal influence" region of the flow sensor and the sensors are separated into two different layers with a thin-film Copper shield. We evaluated the sensors for accuracy, crosstalk and long-term drift in human blood-stained cerebrospinal fluid. These in vitro experiments showed that simultaneous temperature and flow measurements with a single lab-on-a-tube device are accurate and reliable over the course of 5 days. It has a resolution of 0.013 A degrees C and 0.18 ml/100 g/min; and achieves an accuracy of 0.1 A degrees C and 5 ml/100 g/min for temperature and flow sensors respectively. The prototype device and techniques developed here establish a foundation for a multi-sensor lab-on-a-tube, enabling versatile multimodality monitoring applications.	[Li, Chunyan; Wu, Pei-Ming; Narayan, Raj K.] N Shore Long Isl Jewish Hlth Syst, Cushing Neuromonitoring Lab, Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Hartings, Jed A.; Shutter, Lori A.] Univ Cincinnati UC, Dept Neurosurg, Inst Neurosci, UC Coll Med, Cincinnati, OH 45219 USA; [Wu, Zhizhen; Ramaswamy, Bharat Ram; Ahn, Chong H.] Univ Cincinnati, Microsyst & BioMEMS Lab, Dept Elect & Comp Engn, Cincinnati, OH 45221 USA; [Cheyuo, Cletus; Wang, Ping] N Shore Long Isl Jewish Hlth Syst, Dept Surg, Feinstein Inst Med Res, Manhasset, NY 11030 USA; [LeDoux, David] N Shore Univ Hosp, Neurosurg Intens Care Unit, Manhasset, NY 11030 USA; [Narayan, Raj K.] Hofstra N Shore LIJ Sch Med, Cushing Neurosci Inst, Hempstead, NY 11549 USA	Li, CY (corresponding author), N Shore Long Isl Jewish Hlth Syst, Cushing Neuromonitoring Lab, Feinstein Inst Med Res, Manhasset, NY 11030 USA.	cli11@nshs.edu	Shutter, Lori A/G-2957-2013; Cheyuo, Cletus/AAM-5785-2021	Hartings, Jed/0000-0001-8583-3471; Wang, Ping/0000-0002-1557-0394; Shutter, Lori/0000-0002-1390-0628	US Department of DefenseUnited States Department of Defense [PT090526P4 (W81XWH-10-1-0978)]	This work was supported by the US Department of Defense under project No. PT090526P4 (W81XWH-10-1-0978). The authors gratefully acknowledge Mr. Melvin O. Gonzalez at the North Shore University Hospital for performing polyethylene gas sterilization.	Cecil S, 2011, CRIT CARE NURSE, V31, P25, DOI 10.4037/ccn2010226; Chen J, 2003, J MICROELECTROMECH S, V12, P979, DOI 10.1109/JMEMS.2003.820261; Chunyan Li, 2012, 2012 IEEE 25th International Conference on Micro Electro Mechanical Systems (MEMS), P1021, DOI 10.1109/MEMSYS.2012.6170188; Dagal A, 2011, CURR OPIN ANESTHESIO, V24, P131, DOI 10.1097/ACO.0b013e3283445898; Elf K, 2008, NEUROL RES, V30, P1097, DOI 10.1179/174313208X319125; Grayson ACR, 2004, P IEEE, V92, P6, DOI 10.1109/JPROC.2003.820534; Haga Y, 2004, P IEEE, V92, P98, DOI 10.1109/JPROC.2003.820545; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hassler C, 2011, J POLYM SCI POL PHYS, V49, P18, DOI 10.1002/polb.22169; Hassler C, 2010, J BIOMED MATER RES B, V93B, P266, DOI 10.1002/jbm.b.31584; Hayward E, 2011, ANAEST INTENS CARE M, V12, P198, DOI 10.1016/j.mpaic.2011.02.004; Hsu JM, 2009, IEEE T BIO-MED ENG, V56, P23, DOI 10.1109/TBME.2008.2002155; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Keller E, 2003, NEUROIMAGE, V20, P828, DOI 10.1016/S1053-8119(03)00315-X; Krajewski KL, 2011, ACTA NEUROCHIR SUPPL, V110, P125, DOI 10.1007/978-3-7091-0353-1_22; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Li C., 2011, APPL PHYS LETT, V99; Li CY, 2008, BIOMED MICRODEVICES, V10, P671, DOI 10.1007/s10544-008-9178-3; Li CY, 2011, IEEE SENSOR, P1417; Li CY, 2012, BIOMED MICRODEVICES, V14, P109, DOI 10.1007/s10544-011-9589-4; Li CY, 2010, LAB CHIP, V10, P1476, DOI 10.1039/c000897d; Li CY, 2009, LAB CHIP, V9, P1988, DOI 10.1039/b900651f; Liptak B.G., 1995, PROCESS MEASUREMENT, P690; Menon P R, 2009, 15th International Conference on Solid-State Sensors, Actuators and Microsystems. Transducers 2009, P1892, DOI 10.1109/SENSOR.2009.5285687; Mette D, 2011, TRANSL STROKE RES, V2, P152, DOI 10.1007/s12975-010-0064-y; Michalski, 2001, TEMPERATURE MEASUREM, P88; Mohamed G., 2001, MEMS HDB, P2615; Orliaguet GA, 2008, PEDIATR ANESTH, V18, P455, DOI 10.1111/j.1460-9592.2008.02507.x; Rosenthal G, 2011, J NEUROSURG, V114, P62, DOI 10.3171/2010.6.JNS091360; Rubehn B, 2010, BIOMATERIALS, V31, P3449, DOI 10.1016/j.biomaterials.2010.01.053; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Schramm P, 2007, NEURORADIOLOGY, V49, pS35, DOI 10.1007/s00234-007-1471-3; Seymour JP, 2011, BIOMED MICRODEVICES, V13, P441, DOI 10.1007/s10544-011-9512-z; Stevens Wendy J, 2004, J Neurosci Nurs, V36, P332; Stuart RM, 2010, NEUROCRIT CARE, V12, P188, DOI 10.1007/s12028-010-9330-9; THALAYASINGAM S, 1989, MED BIOL ENG COMPUT, V27, P394, DOI 10.1007/BF02441431; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Vidgeon S.D., 2011, J INTENSIVE CARE SOC, V12, P126, DOI [10.1177/175114371101200208, DOI 10.1177/175114371101200208]; Wester BA, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/2/024002; Wintermark M, 2005, STROKE, V36, pE83, DOI 10.1161/01.STR.0000177884.72657.8b; Zink BJ, 2010, PSYCHIAT CLIN N AM, V33, P741, DOI 10.1016/j.psc.2010.08.005	42	12	12	1	13	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1387-2176	1572-8781		BIOMED MICRODEVICES	Biomed. Microdevices	AUG	2012	14	4					759	768		10.1007/s10544-012-9646-7			10	Engineering, Biomedical; Nanoscience & Nanotechnology	Engineering; Science & Technology - Other Topics	968BH	WOS:000305951500015	22552801				2021-06-18	
J	Onifer, SM; Quintero, JE; Gerhardt, GA				Onifer, Stephen M.; Quintero, Jorge E.; Gerhardt, Greg A.			Cutaneous and electrically evoked glutamate signaling in the adult rat somatosensory system	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Amperometry; Cutaneous stimulation; Dorsal column nuclei; Electrical stimulation; Microelectrode array; Spinal cord	SPINAL-CORD-INJURY; WHEAT-GERM-AGGLUTININ; DORSAL COLUMN NUCLEI; CUNEATE NUCLEUS; PREFRONTAL CORTEX; WGA-HRP; SOMATOTOPIC ORGANIZATION; CENTRAL PROJECTIONS; TRANSGANGLIONIC TRANSPORT; HORSERADISH-PEROXIDASE	Glutamate neurotransmission plays critical roles in normal central nervous system (CNS) function, neurodegenerative diseases, and neurotrauma. We determined whether glutamate signaling could be evoked within the anesthetized normal adult rat CNS with clinically relevant peripheral stimulation and recorded (at >1 Hz) with glutamate-sensitive, ceramic microelectrode arrays (MEAs). Basal glutamate levels and both forelimb cutaneous and electrical stimulation-evoked glutamate release were measured within the cuneate nucleus, a relay of the mammalian dorsal columns somatosensory system. The MEAs with triangular, sharp-point tips were more effective at tissue penetration than the flat, blunt tips. Basal glutamate levels of 2.1 +/- 4.4 mu M (mean +/- SD, n = 10 animals) were detected from 150 mu m to 1200 mu m below the brainstem dorsal surface. Cutaneous evoked glutamate signals showed an amplitude of 1.1 +/- 1.1 mu M and a duration of 7.3 +/- 6.5 s (26 signals, n = 6). Electrically evoked signals, like cutaneous ones, were both rapid and slowly rising. Electrically evoked signals, especially those evoked by stimulation trains, were more reproducible and had an amplitude of 1.2 +/- 1.4 mu M, duration of 19.4 +/- 17.3s, and latency from stimulus onset of 21.3 +/- 21.5 s (25 signals, n = 4). In contrast to cutaneous stimulation, glutamate signals evoked by electrical stimulation had longer durations and were recorded primarily in the middle and ventral cuneate nuclei. Importantly, both cutaneous and electrical stimulation of the contralateral forelimb and hindlimbs did not evoke glutamate signaling. With the use of MEAs, these results show, for the first time, somatosensory-pathway specific changes in glutamate levels during peripheral cutaneous and electrical stimulation. (C) 2012 Elsevier B.V. All rights reserved.	[Onifer, Stephen M.; Gerhardt, Greg A.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Onifer, Stephen M.; Quintero, Jorge E.; Gerhardt, Greg A.] Univ Kentucky, Coll Med, Dept Anat & Neurobiol, Lexington, KY 40536 USA; [Quintero, Jorge E.; Gerhardt, Greg A.] Univ Kentucky, Coll Med, Ctr Microelectrode Technol, Lexington, KY 40536 USA	Onifer, SM (corresponding author), Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, B457 Biomed & Biol Sci Res Bldg,741 S Limestone S, Lexington, KY 40536 USA.	smonif2@email.uky.edu; george.quintero@uky.edu; gregg@uky.edu			Kentucky Spinal Cord and Head Injury Research Trust [9-9]; USPHSUnited States Department of Health & Human ServicesUnited States Public Health Service [DA 017186]; NSFNational Science Foundation (NSF) [EEC-0310723]; DARPAUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [N66001-09-2080]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA017186] Funding Source: NIH RePORTER	This research was supported by the Kentucky Spinal Cord and Head Injury Research Trust Grant 9-9 (Stephen M. Onifer) and by USPHS Grant DA 017186, NSF Grant EEC-0310723, DARPA Grant N66001-09-2080 (Greg A. Gerhardt). The funding source had no involvement in study design. Greg A. Gerhardt is sole proprietor of and Jorge E. Quintero serves as a consultant to Quanteon LLC. The technical and artistic expertises of Laura Whitnel-Smith, Joshua Eason, Daisy Ramos, and David Onifer are gratefully appreciated.	American Spinal Injury Association, 2002, INT STAND NEUR CLASS; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; ARVIDSSON J, 1990, J COMP NEUROL, V292, P349, DOI 10.1002/cne.902920303; BASBAUM AI, 1973, J COMP NEUROL, V148, P347, DOI 10.1002/cne.901480304; BECK CHM, 1981, BRAIN RES BULL, V6, P503, DOI 10.1016/S0361-9230(81)80025-1; Bermejo PE, 2003, J COMP NEUROL, V463, P419, DOI 10.1002/cne.10747; BROMAN J, 1994, ANAT EMBRYOL, V189, P181; Burmeister JJ, 2002, J NEUROSCI METH, V119, P163, DOI 10.1016/S0165-0270(02)00172-3; Burmeister JJ, 2001, ANAL CHEM, V73, P1037, DOI 10.1021/ac0010429; Clapp-Lilly KL, 1999, J NEUROSCI METH, V90, P129, DOI 10.1016/S0165-0270(99)00064-3; Cook CJ, 1997, J NEUROSCI METH, V72, P161, DOI 10.1016/S0165-0270(96)02175-9; Cook CJ, 1996, PHYSIOL BEHAV, V60, P741; CROCKETT DP, 1993, BRAIN RES, V612, P41, DOI 10.1016/0006-8993(93)91642-6; Darvesh AS, 2011, EXPERT OPIN DRUG DIS, V6, P109, DOI 10.1517/17460441.2011.547189; Day BK, 2006, J NEUROCHEM, V96, P1626, DOI 10.1111/j.1471-4159.2006.03673.x; DEBIASI S, 1990, J HISTOCHEM CYTOCHEM, V38, P1745, DOI 10.1177/38.12.1701456; Garifoli A, 2010, ARCH ITAL BIOL, V148, P339, DOI 10.4449/aib.v148i4.1022; Greene E, 1935, T AM PHILOS SOC, V27, pii; Hascup ER, 2009, BRAIN RES, V1291, P12, DOI 10.1016/j.brainres.2009.06.084; Hascup KN, 2008, J PHARMACOL EXP THER, V324, P725, DOI 10.1124/jpet.107.131698; Hascup KN, 2011, NEUROPSYCHOPHARMACOL, V36, P1769, DOI 10.1038/npp.2011.60; Hascup KN, 2007, ELECTROCHEMICAL METH; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; IMAMURA J, 1986, NEUROSCI LETT, V70, P46, DOI 10.1016/0304-3940(86)90435-0; Kaas JH, 2008, EXP NEUROL, V209, P407, DOI 10.1016/j.expneurol.2007.06.014; LAMOTTE CC, 1991, J COMP NEUROL, V311, P546, DOI 10.1002/cne.903110409; MASLANY S, 1991, BRAIN RES, V564, P56, DOI 10.1016/0006-8993(91)91351-Z; MASLANY S, 1990, BRAIN RES, V507, P164, DOI 10.1016/0006-8993(90)90539-N; MASLANY S, 1992, NEUROSCI LETT, V139, P130, DOI 10.1016/0304-3940(92)90874-7; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; Mattinson CE, 2011, J NEUROSCI METH, V202, P199, DOI 10.1016/j.jneumeth.2011.08.020; NATHAN PW, 1986, BRAIN, V109, P1003, DOI 10.1093/brain/109.5.1003; NORD SG, 1967, J COMP NEUROL, V130, P343, DOI 10.1002/cne.901300406; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Onifer SM, 2005, EXP NEUROL, V192, P25, DOI 10.1016/j.expneurol.2004.10.016; Onifer SM, 2007, EXP NEUROL, V207, P238, DOI 10.1016/j.expneurol.2007.06.012; Onifer SM, 2011, RESTOR NEUROL NEUROS, V29, P275, DOI [10.3233/RNN-2011-0598, 10.3233/RNN-2011-598]; Parikh V, 2010, J NEUROSCI, V30, P3518, DOI 10.1523/JNEUROSCI.5712-09.2010; PAXINOS G, 1997, RAT BRAIN STEREOTAXI; PFALLER K, 1988, J COMP NEUROL, V268, P91, DOI 10.1002/cne.902680110; Quintero JE, 2007, EXP NEUROL, V208, P238, DOI 10.1016/j.expneurol.2007.08.002; Rutherford EC, 2007, J NEUROCHEM, V102, P712, DOI 10.1111/j.1471-4159.2007.04596.x; Stephens ML, 2011, NEUROBIOL AGING, V32, P811, DOI 10.1016/j.neurobiolaging.2009.05.009; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; Timmerman W, 1997, SYNAPSE, V27, P242, DOI 10.1002/(SICI)1098-2396(199711)27:3<242::AID-SYN9>3.0.CO;2-D; WEBSTER KE, 1987, NEUROSCI LETT, V76, P18, DOI 10.1016/0304-3940(87)90185-6; Xie J, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E11; YGGE J, 1989, J COMP NEUROL, V279, P199, DOI 10.1002/cne.902790204	48	12	12	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	JUL 15	2012	208	2					146	154		10.1016/j.jneumeth.2012.05.013			9	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	980GY	WOS:000306882800008	22627377				2021-06-18	
J	Gura, M; Silav, G; Isik, N; Elmaci, I				Gura, Melek; Silav, Gokalp; Isik, Nejat; Elmaci, Ilhan			Noninvasive Estimation of Cerebral Perfusion Pressure with Transcranial Doppler Ultrasonography in Traumatic Brain Injury	TURKISH NEUROSURGERY			English	Article						Cerebral perfusion pressure; Estimated cerebral perfusion pressure; Transcranial doppler ultrasonography; Traumatic brain injury	CRITICAL CLOSING PRESSURE; ZERO-FLOW PRESSURE; INTRACRANIAL HYPERTENSION; HEAD-INJURY; BLOOD-FLOW; AUTOREGULATION; CIRCULATION; MANAGEMENT; VELOCITY; ABSENCE	AIM: In traumatic brain injury (TBI) patients, to overcome the secondary insults, cerebral perfusion pressure (CPP) oriented therapy is recommended. The study is assigned to estimate CPP values with middle cerebral artery (MCA) flow velocities measured noninvasively using transcranial Doppler ultrasonography (TCD). MATERIAL and METHODS: Forty-seven TBI patients were studied. Intracranial pressure (ICP), mean arterial pressure (MAP) and MCA flow velocities of the patients were monitored. Invasive CPP was calculated as the difference between MAP and ICP. The formula : 'MAP x FVd/FVm +14' was used to estimate CPP noninvasively. Correlation of the noninvasive and invasive values were analysed. RESULTS: The mean values of noninvasive CPP and invasive CPP were 66.10 +/- 10.55 mmHg and 65.40 +/- 10.03 mmHg respectively. The correlation between noninvasive and invasive CPP measurements was strongly significant (p < 0.001) with a correlation coefficient of r = 0.920. CONCLUSION: With ICP monitoring systems, CPP is calculated and the therapy is guided according to these values. As it is recognized that brain perfusion can be assessed with TCD waveforms, noninvasive CPP estimation with MCA flow velocities may help to observe the trends in CPP values.	[Silav, Gokalp; Elmaci, Ilhan] Acibadem Maslak Hosp, Dept Neurosurg, Istanbul, Turkey; [Gura, Melek] MH Istanbul Medeniyet Univ, Goztepe Educ & Res Hosp, Dept Anesthesiol & Reanimat, Istanbul, Turkey; [Isik, Nejat] MH Istanbul Medeniyet Univ, Goztepe Educ & Res Hosp, Dept Neurosurg, Istanbul, Turkey	Silav, G (corresponding author), Acibadem Maslak Hosp, Dept Neurosurg, Istanbul, Turkey.	gsilav@yahoo.com	ISIK, NEJAT/E-9316-2013; Elmaci, Ilhan/AAF-3459-2021; Isik, Nejat/AAG-1716-2020	Elmaci, Ilhan/0000-0001-9433-0307; 			Aaslid R, 2003, STROKE, V34, P1645, DOI 10.1161/01.STR.0000077927.63758.B6; Aaslid R., 1986, INTRACRANIAL PRESSUR, P226; Belfort MA, 1999, AM J OBSTET GYNECOL, V181, P402, DOI 10.1016/S0002-9378(99)70569-7; Buhre W, 2003, BRIT J ANAESTH, V90, P291, DOI 10.1093/bja/aeg073; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; Cremer OL, 2004, ANESTH ANALG, V99, P1211, DOI 10.1213/01.ANE.0000133917.67728.2A; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Czosnyka M, 1999, J NEUROL NEUROSUR PS, V66, P606, DOI 10.1136/jnnp.66.5.606; Edaudard AR, 2005, BRIT J ANAESTH, V94, P216; Hancock SM, 2003, ANESTH ANALG, V96, P847, DOI 10.1213/01.ANE.0000047273.85729.A7; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KLINGELHOFER J, 1988, J NEUROL, V235, P159, DOI 10.1007/BF00314307; Ling GSF, 2005, NEUROCRIT CARE, V2, P75, DOI 10.1385/NCC:2:1:075; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Martin N A, 1993, Neurosurgery, V33, P761; MICHEL E, 1995, NEUROL RES, V17, P149, DOI 10.1080/01616412.1995.11740304; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Moreno J, 2000, NEUROSURG FOCUS, V8, P1; Nagai H, 1997, STROKE, V28, P603, DOI 10.1161/01.STR.28.3.603; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; Saqqur M, 2007, CRIT CARE MED, V35, pS216, DOI 10.1097/01.CCM.0000260633.66384.FB; Schmidt EA, 2001, J NEUROL NEUROSUR PS, V70, P198, DOI 10.1136/jnnp.70.2.198; Sloan MA, 2004, NEUROLOGY, V62, P1468, DOI 10.1212/WNL.62.9.1468; Sorteberg A, 2007, CONT NEUROSURGERY, V29, P1; Stacey M, 2002, BRIT J ANAESTH, V89, p96P; Steiner L A, 2003, Br J Anaesth, V90, P396, DOI 10.1093/bja/aeg532; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; The Brain Trauma Foundation, 2007, J NEUROTRAUM, pS45; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; Umamaheswara R, 2008, SAARC J ANAESTH, P58; Weyland A, 2000, J NEUROSURG ANESTH, V12, P210, DOI 10.1097/00008506-200007000-00002; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a; White H, 2006, INTENS CARE MED, V32, P981, DOI 10.1007/s00134-006-0173-y; ZURYNSKI Y, 1991, Neurological Research, V13, P248	35	12	13	1	4	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	JUL	2012	22	4					411	415		10.5137/1019-5149.JTN.4201-11.1			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	983RW	WOS:000307137400003	22843455	Bronze			2021-06-18	
J	Harris, AW; Jones, CA; Rowe, BH; Voaklander, DC				Harris, Andrew W.; Jones, C. Allyson; Rowe, Brian H.; Voaklander, Donald C.			A population-based study of sport and recreation-related head injuries treated in a Canadian health region	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Head injury; Mild traumatic brain injury; Sports and recreation; Emergency department; Population-based; Canadian	PROFESSIONAL FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURIES; UNITED-STATES; EMERGENCY-DEPARTMENTS; RECURRENT CONCUSSION; REFERRAL CENTER; HIGH-SCHOOLS; EPIDEMIOLOGY; AUSTRALIA; VICTORIA	Objectives: To report the rates of SR-related HIs presenting to EDs in a Canadian population-based sample. Design: Descriptive epidemiology study. Methods: Using administrative data, sport and recreation-related emergency department presentations for persons 0-35 years of age, from April 1997 through March 2008, were obtained from the Edmonton Zone (formerly the Capital Health Region), Alberta Health Services through the Ambulatory Care Classification System. Results: Of the 3,230,890 visits to the emergency departments of the five hospitals in Edmonton, 63,219 sport and recreation-related injury records and 4935 sport and recreation-head injury records were identified. Head injuries were most frequently treated for the activities of hockey (20.7%), cycling (12.0%), and skiing/snowboarding/sledding. Males accounted for 71.9% (n=3546) and patients less than 18 years of age sustained 3446 (69.8%) sport and recreation-head injuries. Conclusions: Sport and recreation-related head injuries most frequently treated in emergency departments involve common activities such as hockey, cycling, skiing/snowboarding/sledding, and soccer. Males and those less than 18 years of age sustain the majority of sport and recreation-related head injuries treated in emergency departments. These findings underscore the importance of sport-specific policies and safety promotion for the prevention of head injuries, in sports and recreational activities. (c) 2011 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Harris, Andrew W.; Jones, C. Allyson; Rowe, Brian H.; Voaklander, Donald C.] Univ Alberta, Sch Publ Hlth, Edmonton, AB T6G 2M7, Canada; [Rowe, Brian H.] Univ Alberta, Dept Emergency Med, Fac Med & Dent, Edmonton, AB T6G 2M7, Canada		awharris@ualberta.ca			Western Regional Training Centre for Health Services Research; Population Health Investigator Award from the Alberta Heritage Foundation; New Investigator Award from the Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); 21st Century Canada Research Chairs program of the Canadian Institutes of Health Research through the Government of Canada (Ottawa, ON)	The authors would like to thank the Edmonton Zone, Alberta Health Services (formerly the Capital Health Region) for providing the data for this research, as well as Brian Humeniuk at Alberta Health Services for extracting the data from the ACCS. AWH was supported by a graduate studentship from the Western Regional Training Centre for Health Services Research. CAJ is supported by a Population Health Investigator Award from the Alberta Heritage Foundation, and a New Investigator Award from the Canadian Institutes of Health Research. BHR is supported by the 21st Century Canada Research Chairs program of the Canadian Institutes of Health Research through the Government of Canada (Ottawa, ON).	Alberta Centre for Injury Control & Research, DAT HELD ALB CTR INJ; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; *CAN ASS EM PHYS, IMPL GUID CAN EM DEP; Canadian Institute for Health Information, 2009, INT STAT CLASS DIS H; Centers for Disease Control and Prevention, TRAUM BRAIN INJ US E; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Crowe LM, 2010, EMERG MED AUSTRALAS, V22, P56, DOI 10.1111/j.1742-6723.2009.01249.x; Cunningham J, 2011, J EMERG MED, V40, P262, DOI 10.1016/j.jemermed.2008.08.017; Cvijanovich NZ, 2001, PEDIATRICS, V108, P631, DOI 10.1542/peds.108.3.631; Davidson JA, 2005, EUR J EMERG MED, V12, P24, DOI 10.1097/00063110-200502000-00007; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Emery CA, 2009, PAED CHILD HEALT-CAN, V14, P439, DOI 10.1093/pch/14.7.439; Emery CA, 2006, CLIN J SPORT MED, V16, P20, DOI 10.1097/01.jsm.0000184638.72075.b7; Finch C, 1998, BRIT J SPORT MED, V32, P220, DOI 10.1136/bjsm.32.3.220; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; PUCKETT CD, 1998, ED ANNOTATION ICD 9; Sikic M, 2009, MED J AUSTRALIA, V190, P353, DOI 10.5694/j.1326-5377.2009.tb02446.x; Sosin DM, 1996, BRAIN INJURY, V10, P47; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003	30	12	12	0	17	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	JUL	2012	15	4					298	304		10.1016/j.jsams.2011.12.005			7	Sport Sciences	Sport Sciences	966YV	WOS:000305874200004	22244346				2021-06-18	
J	Lin, KH; Guo, NW; Liao, SC; Kuo, CY; Hu, PY; Hsu, JH; Hwang, YH; Guo, YL				Lin, Kuan-Han; Guo, Nai-Wen; Liao, Shih-Cheng; Kuo, Chun-Ya; Hu, Pei-Yi; Hsu, Jin-Huei; Hwang, Yaw-Huei; Guo, Yue Leon			Psychological Outcome of Injured Workers at 3 Months after Occupational Injury Requiring Hospitalization in Taiwan	JOURNAL OF OCCUPATIONAL HEALTH			English	Article						Comorbidity; Major depression; Occupational injury; Partial post-traumatic stress disorder (PPTSD); Post-traumatic stress disorder (PTSD)	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; PSYCHIATRIC MORBIDITY; EARTHQUAKE VICTIMS; RISK-FACTORS; HEAD-INJURY; FULL PTSD; COMORBIDITY; COMMUNITY; IMPAIRMENT	Psychological Outcome of Injured Workers at 3 Months after Occupational Injury Requiring Hospitalization in Taiwan: Kuan-Han LIN, et al. Institute of Occupational Medicine and Industrial Hygiene, National Taiwan University School of Public Health, Taiwan-Introduction: After a traumatic event, a significant proportion of victims develop psychiatric disorders. Trauma has been an important ailment among workers. This study aimed to determine the prevalence of post-traumatic stress disorder (PTSD) and other psychiatric disorders at three months after occupational injuries. Methods: Our study candidates were injured workers in Taiwan who were hospitalized for 3 days or longer aid received hospitalization benefits from the Labor Insurance program. A two-staged survey study was conducted. A self-reported questionnaire including the Brief Symptom Rating Scale (BSRS-50) and Post-traumatic Symptom Checklist (PTSC) was sent to workers at 3 months after injury. Those who met the criteria were recruited for the second stage phone interview with a psychiatrist using the Mini-international Neuropsychiatric Interview (MINI). Results: A total of 2001 workers completed the questionnaire (response rate 45.5%). Among them, 357 (17.8%) fulfilled the criteria for the MINI interview and were invited. A total of 148 (41.5%) completed the phone interview. The estimated rates of PTSD, partial PTSD (PPTSD), major depression, comorbid PTSD/PPTSD and major depression, and either PTSD/PPTSD or major depression were 2.7, 4.1, 3.0, 2.3, and 7.5%, respectively. The estimated rates of either PTSD/PPTSD or major depression among workers who suffered from intracranial injury, fracture, burn, crushing injury, and open wound of upper limbs were 10.4, 6.9, 5.9, 5.8 and 0%, respectively. Conclusions: At three months after occupational injuries, a significant proportion of workers suffered from psychiatric disorders. The rates of psychiatric disorders occurring after intracranial injuries were significantly higher than those occurring after non-intracranial injuries. (J Occup Health 2012; 54: 289-298)	[Lin, Kuan-Han; Guo, Yue Leon] Natl Taiwan Univ, Dept Environm & Occupat Med, Coll Med, Taipei 100, Taiwan; [Lin, Kuan-Han; Hwang, Yaw-Huei; Guo, Yue Leon] Natl Taiwan Univ, Sch Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei, Taiwan; [Liao, Shih-Cheng; Kuo, Chun-Ya] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Guo, Nai-Wen] Natl Cheng Kung Univ, Inst Behav Med, Tainan 70101, Taiwan; [Hu, Pei-Yi; Hsu, Jin-Huei] Councils Labor Affairs, Inst Occupat Safety & Hlth, Taipei, Taiwan	Guo, YL (corresponding author), Natl Taiwan Univ, Dept Environm & Occupat Med, Coll Med, Rm 339,I7,Xuzhou Rd, Taipei 100, Taiwan.	leonguo@ntu.edu.tw	Lin, Kuan-Han/AAF-7584-2020; Guo, Yue-Liang Leon/ABF-2314-2020; LIAO, SHIH-CHENG/C-5665-2017	HWANG, YAW-HUEI/0000-0003-1817-8969; Lin, Kuan-Han/0000-0003-2047-6025; GUO, Yue Leon/0000-0002-8530-4809; LIAO, SHIH-CHENG/0000-0003-4129-0879	Institute of Occupational Safety & Health, Council of Labor Affairs, Taiwan, R. O. C. [IOSH98-M315]	This study was supported by grant IOSH98-M315 from the Institute of Occupational Safety & Health, Council of Labor Affairs, Taiwan, R. O. C.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, P427; [Anonymous], 2008, REAL OCC BEN PAYM; [Anonymous], 2006, MAIN CAUS DEATH WORK; [Anonymous], 1996, REC NOT OCC ACC DIS, P3; Asmundson GJG, 1998, J ANXIETY DISORD, V12, P57, DOI 10.1016/S0887-6185(97)00049-2; BLANCHARD EB, 1995, J NERV MENT DIS, V183, P495, DOI 10.1097/00005053-199508000-00001; Blanchard EB, 1996, BEHAV RES THER, P34; Bleich A, 1997, BRIT J PSYCHIAT, V170, P479, DOI 10.1192/bjp.170.5.479; Breslau N, 2004, PSYCHOL MED, V34, P1205, DOI 10.1017/S0033291704002594; Breslau N, 2004, PSYCHOL MED, V34, P889, DOI 10.1017/S0033291703001612; CHEN CN, 1993, ARCH GEN PSYCHIAT, V50, P125; Cheung E, 2003, REHABIL PSYCHOL, V48, P109, DOI 10.1037/0090-5550.48.2.109; Chien IC, 2004, PSYCHIAT SERV, V55, P691, DOI 10.1176/appi.ps.55.6.691; COMPTON WM, 1991, AM J PSYCHIAT, V148, P1697; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; GARRISON CZ, 1995, J AM ACAD CHILD PSY, V34, P1193, DOI 10.1097/00004583-199509000-00017; Goenjian AK, 2000, AM J PSYCHIAT, V157, P911, DOI 10.1176/appi.ajp.157.6.911; Hsu CC, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200207000-00022; Jeon HJ, 2007, DEPRESS ANXIETY, V24, P577, DOI 10.1002/da.20270; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kuo CY, 2012, PSYCHIAT RE IN PRESS; Kuo HW, 2007, J PSYCHOSOM RES, V62, P495, DOI 10.1016/j.jpsychores.2004.11.012; Lee M B, 1990, J Formos Med Assoc, V89, P1081; Lee MB, 1990, CHINESE PSYCHIAT, V4, P10; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; MacDonald HA, 2003, J OCCUP REHABIL, V13, P63, DOI 10.1023/A:1022563930482; Marshall RD, 2001, AM J PSYCHIAT, V158, P1467, DOI 10.1176/appi.ajp.158.9.1467; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P1390, DOI 10.1176/appi.ajp.161.8.1390; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; Perkonigg A, 2000, ACTA PSYCHIAT SCAND, V101, P46, DOI 10.1034/j.1600-0447.2000.101001046.x; RUBONIS AV, 1991, PSYCHOL BULL, V109, P384, DOI 10.1037/0033-2909.109.3.384; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Statistic of General Health, 2008, STAT GEN HLTH; Stein MB, 1997, AM J PSYCHIAT, V154, P1114; Strauser DR, 2001, J REHABIL, V67, P26; TRANEL D, 2002, PRINCIPLES FRONTAL L, P338, DOI DOI 10.1093/ACPROF:OSO/9780195134971.001.0001; Warriner EM, 2003, J CLIN EXP NEUROPSYC, V25, P904, DOI 10.1076/jcen.25.7.904.16494; Wu HC, 2006, AUST NZ J PSYCHIAT, V40, P355, DOI 10.1111/j.1440-1614.2006.01802.x; Yang YK, 2003, GEN HOSP PSYCHIAT, V25, P253, DOI 10.1016/S0163-8343(03)00022-7; Zasler N. D., 2007, BRAIN INJURY MED PRI, P779	44	12	12	0	15	JAPAN SOC OCCUPATIONAL HEALTH	TOKYO	1-29-8 SHINJUKU, SHINJUKU-KU, TOKYO, 160, JAPAN	1341-9145			J OCCUP HEALTH	J. Occup. Health	JUL	2012	54	4					289	298		10.1539/joh.11-0211-OA			10	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	983UW	WOS:000307145200005	22672883	Bronze			2021-06-18	
J	Martins, AT; Faisca, LM; Esteves, F; Muresan, A; Reis, A				Martins, Ana T.; Faisca, Luis M.; Esteves, Francisco; Muresan, Angelica; Reis, Alexandra			Atypical moral judgment following traumatic brain injury	JUDGMENT AND DECISION MAKING			English	Article						moral judgment; social emotion recognition; frontal TBI	EMOTION RECOGNITION; SOCIAL EMOTIONS; PERCEPTION; DEFICITS; DAMAGE; BASES	Previous research has shown an association between emotions, particularly social emotions, and moral judgments. Some studies suggested an association between blunted emotion and the utilitarian moral judgments observed in patients with prefrontal lesions. In order to investigate how prefrontal brain damage affects moral judgment, we asked a sample of 29 TBI patients (12 females and 17 males) and 41 healthy participants (16 females and 25 males) to judge 22 hypothetical dilemmas split into three different categories (non-moral, impersonal and personal moral). The TBI group presented a higher proportion of affirmative (utilitarian) responses for personal moral dilemmas when compared to controls, suggesting an atypical pattern of utilitarian judgements. We also found a negative association between the performance on recognition of social emotions and the proportion of affirmative responses on personal moral dilemmas. These results suggested that the preference for utilitarian responses in this type of dilemmas is accompanied by difficulties in social emotion recognition. Overall, our findings suggest that deontological moral judgments are associated with normal social emotion processing and that frontal lobe plays an important role in both emotion and moral judgment.	[Martins, Ana T.; Faisca, Luis M.; Reis, Alexandra] Univ Algarve, Inst Biotechnol & Bioengn CBME, Fac Humanities & Social Sci, Cognit Neurosci Res Grp,Dept Psychol & Educ Sci, Faro, Portugal; [Esteves, Francisco] Inst Univ Lisboa, ISCTE, Ctr Invest & Intervencao Social, Lisbon, Portugal; [Muresan, Angelica] Ctr Med & Reabilitacao S, Sao Bras De Alportel, Portugal	Martins, AT (corresponding author), Univ Algarve, Inst Biotechnol & Bioengn CBME, Fac Humanities & Social Sci, Cognit Neurosci Res Grp,Dept Psychol & Educ Sci, Faro, Portugal.	atmartins@ualg.pt	Faisca, Luis/A-4633-2013; Reis, Alexandra A I/A-3888-2013; GNC, GNC/B-5716-2013; Martins, Ana Teresa/A-8885-2013; Esteves, Francisco/I-1206-2012	Faisca, Luis/0000-0003-4859-8817; Reis, Alexandra A I/0000-0001-5598-0999; Martins, Ana Teresa/0000-0002-3304-6051; Esteves, Francisco/0000-0002-5403-0091			Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Anderson SW, 2006, J INT NEUROPSYCH SOC, V12, P224, DOI 10.1017/S1355617706060346; Baron J, 2012, SYNTHESE, V189, P693, DOI 10.1007/s11229-012-0121-z; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Braun M, 2005, BRAIN COGNITION, V58, P193, DOI 10.1016/j.bandc.2004.11.003; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Choe SY, 2011, JUDGM DECIS MAK, V6, P580; Ciaramelli E., 2007, SOCIAL COGNITIVE AFF, V17, P344; Court JH, 1998, MANUAL RAVENS PROGR; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Demaree Heath A, 2005, Behav Cogn Neurosci Rev, V4, P3, DOI 10.1177/1534582305276837; Eslinger PJ, 2002, CURR OPIN NEUROL, V15, P91, DOI 10.1097/00019052-200202000-00014; Eslinger PJ, 1998, EUR NEUROL, V39, P193, DOI 10.1159/000007933; Gazzaniga M.S., 2009, COGNITIVE NEUROSCIEN, V3rd; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Kahane G, 2010, MIND LANG, V25, P561, DOI 10.1111/j.1468-0017.2010.01401.x; Keltner D., 2006, SOCIAL JUSTICE RES, V19, P208, DOI [10.1007/s11211-006-0006-8, DOI 10.1007/S11211-006-0006-8]; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Kohlberg Lawrence., 1981, ESSAYS MORAL DEV, V1; Martins A., 2007, PROVAS APTIDAO PEDAG; Mendez Mario F, 2009, Cogn Neuropsychiatry, V14, P165, DOI 10.1080/13546800902924122; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Moll J, 2003, NEUROREPORT, V14, P299, DOI 10.1097/01.wnr.0000057866.05120.28; Paxton JM, 2010, TOP COGN SCI, V2, P511, DOI 10.1111/j.1756-8765.2010.01096.x; Piaget J, 1965, MORAL JUDGMENT CHILD; Prehn K, 2008, SOC COGN AFFECT NEUR, V3, P33, DOI 10.1093/scan/nsm037; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Slovackova B, 2007, NURS ETHICS, V14, P320, DOI 10.1177/0969733007075867; Tamietto M, 2007, NEUROPSYCHOLOGIA, V45, P836, DOI 10.1016/j.neuropsychologia.2006.08.012; Tranel D, 2002, CORTEX, V38, P589, DOI 10.1016/S0010-9452(08)70024-8; Valdesolo P, 2006, PSYCHOL SCI, V17, P476, DOI 10.1111/j.1467-9280.2006.01731.x; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Wheatley T, 2005, PSYCHOL SCI, V16, P780, DOI 10.1111/j.1467-9280.2005.01614.x; Young L, 2006, J COGN CULT, V6, P291, DOI 10.1163/156853706776931312	39	12	13	0	24	SOC JUDGMENT & DECISION MAKING	TALLAHASSEE	FLORIDA STATE UNIV, TALLAHASSEE, FL 32306-1110 USA	1930-2975			JUDGM DECIS MAK	Judgm. Decis. Mak.	JUL	2012	7	4					478	487					10	Psychology, Multidisciplinary	Psychology	982UW	WOS:000307071900011		DOAJ Gold			2021-06-18	
J	Armstead, WM; Riley, J; Yarovoi, S; Cines, DB; Smith, DH; Higazi, A				Armstead, William M.; Riley, John; Yarovoi, Serge; Cines, Douglas B.; Smith, Douglas H.; Higazi, Abd Al-Roof			tPA-S481A Prevents Neurotoxicity of Endogenous tPA in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; cerebral autoregulation; cerebral circulation; signal transduction; tissue plasminogen activator	TISSUE-PLASMINOGEN ACTIVATOR; NMDA CEREBROVASODILATION; CEREBRAL HEMODYNAMICS; AGE; AUTOREGULATION; IMPAIRMENT; POTASSIUM; INCREASES; CHILDREN; NOC/OFQ	Traumatic brain injury (TBI) is associated with loss of autoregulation due to impaired responsiveness to cerebrovascular dilator stimuli, which leads to cerebral hypoperfusion and neuronal impairment or death. Upregulation of tissue plasminogen activator (tPA) post-TBI exacerbates loss of cerebral autoregulation and NMDA-receptor-mediated impairment of cerebral hemodynamics, and enhances excitotoxic neuronal death. However, the relationship between NMDA-receptor activation, loss of autoregulation, and neurological dysfunction is unclear. Here, we evaluated the potential therapeutic efficacy of a catalytically inactive tPA variant, tPA S481A, that acts by competing with wild-type tPA for binding, cleavage, and activation of NMDA receptors. Lateral fluid percussion brain injury was produced in anesthetized piglets. Pial artery reactivity was measured via a closed cranial window, and cerebrospinal fluid (CSF) extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK) was quantified by enzyme-linked immunosorbent assay (ELISA). tPA-S481A prevented impairment of cerebral autoregulation and reduced histopathologic changes after TBI by inhibiting upregulation of the ERK isoform of MAPK. Treatment with this tPA variant provides a novel approach for limiting neuronal toxicity caused by untoward NMDA-receptor activation mediated by increased tPA and glutamate following TBI.	[Armstead, William M.; Riley, John] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Yarovoi, Serge; Cines, Douglas B.; Higazi, Abd Al-Roof] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Smith, Douglas H.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Higazi, Abd Al-Roof] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Dept Clin Biochem, Sch Med, Jerusalem, Israel	Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu		Riley, John/0000-0002-7932-8935	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS53410, HD57355, HL76406, CA83121, HL76206, HL07971, HL81864, HL77760, HL82545]; University of Pennsylvania Institute for Translational Medicine and Therapeutics; Israeli Science FoundationIsrael Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD057355] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA083121] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007971, P01HL076406, R21HL081864, R01HL077760, R01HL076206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS053410] Funding Source: NIH RePORTER	This research was funded by National Institutes of Health grants NS53410 and HD57355 to W. M. A., HL76406, CA83121, HL76206, HL07971, and HL81864 to D. B. C., and HL77760 and HL82545 to A. A. R. H., the University of Pennsylvania Institute for Translational Medicine and Therapeutics (to D. B. C.), and the Israeli Science Foundation (to A.A.R.H.).	Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Armstead WM, 2006, NAT NEUROSCI, V9, P1150, DOI 10.1038/nn1757; Armstead William M, 2005, Pathophysiology, V12, P5, DOI 10.1016/j.pathophys.2005.01.002; Armstead WM, 2011, NEUROL RES, V33, P726, DOI 10.1179/016164110X12807570509853; Armstead WM, 2011, J NEUROTRAUM, V28, P451, DOI 10.1089/neu.2010.1659; Armstead WM, 2010, J NEUROTRAUM, V27, P391, DOI 10.1089/neu.2009.1094; Armstead WM, 2009, J CEREBR BLOOD F MET, V29, P524, DOI 10.1038/jcbfm.2008.142; Armstead WM, 2005, DEV BRAIN RES, V156, P139, DOI 10.1016/j.devbraines.2005.02.012; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 2002, DEV BRAIN RES, V139, P19, DOI 10.1016/S0165-3806(02)00511-4; Armstead WM, 2001, PEPTIDES, V22, P39, DOI 10.1016/S0196-9781(00)00354-5; Armstead WM, 1998, J NEUROTRAUM, V15, P721, DOI 10.1089/neu.1998.15.721; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Fanne Rami Abu, 2011, J Neurosurg, V114, P85, DOI 10.3171/2010.4.JNS10263; Faraci FM, 1998, PHYSIOL REV, V78, P53; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kulkarni M, 2002, J NEUROTRAUM, V19, P965, DOI 10.1089/089771502320317113; MERCHANT RE, 1999, ANN NY ACAD SCI, V890, P41; Nassar T, 2011, AM J RESP CELL MOL, V45, P1015, DOI 10.1165/rcmb.2010-0302OC; Nassar T, 2011, AM J PHYSIOL-LUNG C, V301, pL307, DOI 10.1152/ajplung.00429.2010; Nassar T, 2010, AM J RESP CELL MOL, V43, P703, DOI 10.1165/rcmb.2009-0257OC; Nicole O, 2001, NAT MED, V7, P59; Otani N, 2003, ACT NEUR S, V86, P287; Park L, 2008, P NATL ACAD SCI USA, V105, P1073, DOI 10.1073/pnas.0708823105; Richards HK, 2001, J CEREBR BLOOD F MET, V21, P779, DOI 10.1097/00004647-200107000-00002; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P625, DOI 10.1001/archpedi.1990.02150300019014; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37	30	12	12	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2012	29	9					1794	1802		10.1089/neu.2012.2328			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	954CN	WOS:000304924000009	22435890	Green Published			2021-06-18	
J	Bobinski, L; Olivecrona, M; Koskinen, LOD				Bobinski, Lukas; Olivecrona, Magnus; Koskinen, Lars-Owe D.			Dynamics of brain tissue changes induced by traumatic brain injury assessed with the Marshall, Morris-Marshall, and the Rotterdam classifications and its impact on outcome in a prostacyclin placebo-controlled study	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Traumatic subarachnoid hemorrhage; Marshall; Morris-Marshall; Rotterdam classification	COMPUTERIZED-TOMOGRAPHY SCAN; LOW-DOSE PROSTACYCLIN; SEVERE HEAD-INJURY; SUBARACHNOID HEMORRHAGE; PROGNOSTIC VALUE; PROGRESSION; LESION; MICRODIALYSIS; THERAPY	The present study evaluates the types and dynamics of intracranial pathological changes in patients with severe traumatic brain injury (sTBI) who participated in a prospective, randomized, double-blinded study of add-on treatment with prostacyclin. Further, the changes of brain CT scan and their correlation to Glasgow Coma Scale score (GCS), maximal intracranial pressure (ICPmax), minimal cerebral perfusion pressure (CPPmin), and Glasgow Outcome Score (GOS) at 3, 6, and 12 months were studied. Forty-eight subjects with severe traumatic brain injury were treated according to an ICP-targeted therapy protocol based on the Lund concept with the addition of prostacyclin or placebo. The first available CT scans (CTi) and follow-up scans nearest to 24 h (CT24) were evaluated using the Marshall, Rotterdam, and Morris-Marshall classifications. There was a significant correlation of the initial Marshall, Rotterdam, Morris-Marshall classifications and GOS at 3 and 12 months. The CT24 Marshall classification did not significantly correlate to GOS while the Rotterdam and the Morris-Marshall classification did. The CTi Rotterdam classification predicted outcome evaluated as GOS at 3 and 12 months. Prostacyclin treatment did not influence the dynamic of tissue changes. The Rotterdam classification seems to be appropriate for describing the evolution of the injuries on the CT scans and contributes in predicting of outcome in patients treated with an ICP-targeted therapy. The Morris-Marshall classification can also be used for prognostication of outcome but it describes only the impact of traumatic subarachnoid hemorrhage (tSAH).	[Bobinski, Lukas; Olivecrona, Magnus; Koskinen, Lars-Owe D.] Umea Univ, Div Neurosurg, Dept Pharmacol & Clin Neurosci, SE-90185 Umea, Sweden	Bobinski, L (corresponding author), Umea Univ, Div Neurosurg, Dept Pharmacol & Clin Neurosci, SE-90185 Umea, Sweden.	lukasbobinski@yahoo.com; magnus.olivecrona@neuro.umu.se; lars-owe.koskinen@neuro.umu.se	Koskinen, Lars-Owe/AAQ-8957-2020	Koskinen, Lars-Owe/0000-0003-3528-8502	Foundation for Clinical Neuroscience at Umea University; collecting Foundation at Umea University; Kempe Foundation; Carnegie Research Foundation; Capio Research Foundation	This study was financially supported by grants from the Foundation for Clinical Neuroscience at Umea University, collecting Foundation at Umea University, Kempe Foundation, Carnegie Research Foundation, and Capio Research Foundation, which is gratefully acknowledged.	Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Bentzer P, 2003, J NEUROTRAUM, V20, P447, DOI 10.1089/089771503765355522; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chesnut RM, 2000, J NEUROTRAUM, V17, P71; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; GAETANI P, 1995, J NEUROL NEUROSUR PS, V59, P635, DOI 10.1136/jnnp.59.6.635; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Grande P O, 1997, Acta Anaesthesiol Scand Suppl, V110, P36; Grande PO, 2000, ACTA ANAESTH SCAND, V44, P886, DOI 10.1034/j.1399-6576.2000.440718.x; Grande PO, 2002, INTENS CARE MED, V28, P529, DOI 10.1007/s00134-002-1236-3; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Lubillo S, 1999, J NEUROSURG, V91, P581, DOI 10.3171/jns.1999.91.4.0581; Lundblad C, 2008, J CEREBR BLOOD F MET, V28, P367, DOI 10.1038/sj.jcbfm.9600533; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marion DW, 2006, NEUROSURGERY, V58, P655; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; Morris GF, 1997, ACTA NEUROCHIR S, V71, P382; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Olivecrona M, 2009, J NEUROL NEUROSUR PS, V80, P1241, DOI 10.1136/jnnp.2008.158196; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Olivecrona M, 2012, BRAIN INJURY, V26, P67, DOI 10.3109/02699052.2011.635351; Olivecrona M, 2010, J NEUROSURG, V112, P1113, DOI 10.3171/2009.8.JNS09636; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; Procaccio F, 2000, J Neurosurg Sci, V44, P11; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Servadei F, 2000, NEUROSURGERY, V46, P70; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; YAMAKI T, 1990, ACTA NEUROCHIR, V103, P112, DOI 10.1007/BF01407516	41	12	13	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUN	2012	154	6					1069	1079		10.1007/s00701-012-1345-x			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	943II	WOS:000304113800017	22538327				2021-06-18	
J	Selig, HF; Hupfl, M; Trimmel, H; Voelckel, WG; Nagele, P				Selig, Harald F.; Huepfl, Michael; Trimmel, Helmut; Voelckel, Wolfgang G.; Nagele, Peter			Pediatric Trauma in the Austrian Alps: The Epidemiology of Sport-Related Injuries in Helicopter Emergency Medical Service	HIGH ALTITUDE MEDICINE & BIOLOGY			English	Article						pediatric; trauma; sports; alpine; mountain rescue; air ambulance; epidemiology	SNOWBOARDING INJURIES; MOUNTAIN RESCUE; AIR-RESCUE; CHILDREN; TRANSPORT; PATTERNS; SYSTEM; HEAD	Selig, Harald F., Michael Hupfl, Helmut Trimmel, Wolfgang G. Voelckel, Peter Nagele. Pediatric trauma in the Austrian Alps: The epidemiology of sport-related injuries in helicopter emergency medical service. High Alt. Med. Biol. 13: 112-117.-Background/Purpose: We aimed to examine the epidemiological characteristics and injury patterns of pediatric trauma in helicopter emergency medical service (HEMS) caused by sports/outdoor activities in alpine environment. Methods: This retrospective cohort study analyzed 912 primary HEMS missions for pediatric trauma (0-14 years of age) in Austrian Alps between 1 January 2006 and 30 June 2007. Children were stratified by age into toddlers (3-5 years), children in early (6-9 years), and late school age (10-14 years). Results: The majority of pediatric sports-related trauma in alpine environment was caused by skiing (82.1%; n = 749). Pediatric patients were predominately in late school age and boys (72.8%, n = 664 and 61.0%, n = 556, respectively) and a minority (16.0%, n = 146) was severely injured. Overall, fracture (47.0%, n = 429), contusion (17.9%, n = 163), and traumatic brain injury (17.0%, n = 155) were the most common prehospital diagnoses. The most frequent pattern of injury was related to the head/face and spine (36.3%, n = 331). Conclusions: The knowledge about epidemiological characteristics of HEMS use for injured children in alpine environment may be essential for training requirements of HEMS crews and operational considerations of HEMS providers. The incidence of head and spinal injuries requires support for initiatives to promote helmet wear and appropriate risk behavior amongst skiers and snowboarders.	[Selig, Harald F.; Huepfl, Michael] Med Univ Vienna, Dept Anesthesiol & Gen Intens Care & Pain Therapy, Vienna, Austria; [Trimmel, Helmut] Wiener Neustadt Gen Hosp, Dept Anesthesiol & Gen Intens Care, Vienna, Austria; [Trimmel, Helmut; Voelckel, Wolfgang G.] OEAMTC Christophorus Air Rescue Serv, Vienna, Austria; [Voelckel, Wolfgang G.] AUVA Trauma Ctr, Dept Anesthesiol & Crit Care Med, Salzburg, Austria; [Nagele, Peter] Washington Univ, Dept Anesthesiol, St Louis, MO USA	Selig, HF (corresponding author), Rhoen Clinicum AG, Clin Hand Surg Bad Neustadt, D-97616 Bad Neustadt an der Saale, Germany.	harald.se@gmx.at	Nagele, Peter/ABA-5189-2020; Nagele, Peter/AAW-1651-2020; Nagele, Peter/A-2922-2008	Nagele, Peter/0000-0001-8369-3858; Nagele, Peter/0000-0001-8369-3858			Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; Brooks MA, 2010, INJURY PREV, V16, P119, DOI 10.1136/ip.2009.022608; Caine D, 2008, CLIN SPORT MED, V27, P19, DOI 10.1016/j.csm.2007.10.008; Corra Stefano, 2004, Inj Control Saf Promot, V11, P281, DOI 10.1080/156609704/233/289788; Damore DT, 2003, PEDIATR EMERG CARE, V19, P65, DOI 10.1097/00006565-200304000-00001; DEMARTINES N, 1991, HELV CHIR ACTA, V58, P223; Hackam DJ, 1999, J PEDIATR SURG, V34, P65, DOI 10.1016/S0022-3468(99)90230-0; Hagel B, 2005, MED SPORT SCI, V48, P74, DOI 10.1159/000084284; Hayes JR, 2008, J PEDIATR SURG, V43, P928, DOI 10.1016/j.jpedsurg.2007.12.041; Heggie TW, 2010, BRIT J SPORT MED, V44, P50, DOI 10.1136/bjsm.2009.068049; Kaufmann M, 2006, WILD ENVIRON MED, V17, P8, DOI 10.1580/1080-6032(2006)17[8:CIIPAS]2.0.CO;2; Lischke V, 2001, WILD ENVIRON MED, V12, P74, DOI 10.1580/1080-6032(2001)012[0074:MAITEA]2.0.CO;2; MACNAB AJ, 1991, J TRAUMA, V31, P205, DOI 10.1097/00005373-199131020-00009; Macnab AJ, 2002, INJURY PREV, V8, P324, DOI 10.1136/ip.8.4.324; Marsigny B, 1999, WILD ENVIRON MED, V10, P152, DOI 10.1580/1080-6032(1999)010[0152:MMRITM]2.3.CO;2; McCowan Christy L, 2006, Air Med J, V25, P26, DOI 10.1016/j.amj.2005.10.005; Moront ML, 1996, J PEDIATR SURG, V31, P1183, DOI 10.1016/S0022-3468(96)90114-1; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Sacco DE, 1998, J TRAUMA, V44, P654, DOI 10.1097/00005373-199804000-00016; Selig HF, 2011, WIEN KLIN WOCHENSCHR, V123, P552, DOI 10.1007/s00508-011-0006-z; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; Skokan EG, 2003, AM J EMERG MED, V21, P95, DOI 10.1053/ajem.2003.50032; Taylor BL, 2000, ACAD EMERG MED, V7, P1376, DOI 10.1111/j.1553-2712.2000.tb00495.x; Tomazin I, 2003, HIGH ALT MED BIOL, V4, P479, DOI 10.1089/152702903322616236; Voelckel WG, 2008, NOTFALL RETTUNGSMED, V11, P240, DOI 10.1007/s10049-008-1056-2	25	12	12	0	9	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1527-0297			HIGH ALT MED BIOL	High Alt. Med. Biol.	JUN	2012	13	2					112	117		10.1089/ham.2011.1082			6	Biophysics; Public, Environmental & Occupational Health; Sport Sciences	Biophysics; Public, Environmental & Occupational Health; Sport Sciences	965JR	WOS:000305764400007	22724614				2021-06-18	
J	Stroman, PW; Bosma, RL; Kornelsen, J; Lawrence-Dewar, J; Wheeler-Kingshott, C; Cadotte, D; Fehlings, MG				Stroman, P. W.; Bosma, R. L.; Kornelsen, J.; Lawrence-Dewar, J.; Wheeler-Kingshott, C.; Cadotte, D.; Fehlings, M. G.			Advanced MR imaging techniques and characterization of residual anatomy	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Magnetic resonance imaging (MRI); Clinical applications; Functional MRI; Diffusion tensor imaging; Perfusion; Relaxation times; Multiple sclerosis; Traumatic brain injury	DEFAULT-MODE NETWORK; SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; BOLD SIGNAL FLUCTUATIONS; FUNCTIONAL CONNECTIVITY; MULTIPLE-SCLEROSIS; DIFFUSION TENSOR; RESTING-STATE; CERVICAL CORD; ALZHEIMERS-DISEASE	Advances in technology in recent decades have contributed to rapid developments in non-invasive methods for imaging human anatomy, and advanced imaging methods are now one of the primary tools for clinical diagnosis after neurological trauma or disease. Here we review the current and upcoming capabilities of one of the most rapidly developing methods, magnetic resonance imaging (MRI). The underlying theory is introduced so that the reasons for the strengths, weaknesses, and future expectations of this method, can be explained. Current techniques for imaging anatomical changes, inflammation, and changes in white matter, axonal integrity, blood flow and function, are reviewed. Applications for specific purposes of assessing traumatic injury in the brain or spinal cord, and for multiple-sclerosis are also presented, and are used as examples of how the advanced techniques are being used in practice. (C) 2012 Elsevier B.V. All rights reserved.	[Stroman, P. W.; Bosma, R. L.] Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada; [Stroman, P. W.] Queens Univ, Dept Diagnost Radiol, Kingston, ON K7L 3N6, Canada; [Stroman, P. W.] Queens Univ, Dept Phys, Kingston, ON K7L 3N6, Canada; [Kornelsen, J.] Natl Res Council Canada, Inst Biodiagnost, Winnipeg, MB R3B 1Y6, Canada; [Lawrence-Dewar, J.] Univ Manitoba, Dept Psychol, Winnipeg, MB R3T 2N2, Canada; [Wheeler-Kingshott, C.] UCL, Inst Neurol, London, England; [Cadotte, D.; Fehlings, M. G.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Fehlings, M. G.] Toronto Western Hosp, Univ Hlth Network, Spinal Program, Toronto, ON M5T 2S8, Canada	Stroman, PW (corresponding author), Queens Univ, Ctr Neurosci Studies, 19 Stuart St, Kingston, ON K7L 3N6, Canada.	stromanp@queensu.ca	Wheeler-Kingshott, Claudia A M Gandini/AAH-7480-2019	Wheeler-Kingshott, Claudia A M Gandini/0000-0002-4832-1300; Lawrence-Dewar, Jane/0000-0003-1529-5748; Fehlings, Michael/0000-0002-5722-6364; Kornelsen, Jennifer/0000-0003-0658-5321			Agosta F, 2008, MAGN RESON MED, V59, P1035, DOI 10.1002/mrm.21595; Agosta F, 2008, NEUROIMAGE, V39, P1542, DOI 10.1016/j.neuroimage.2007.10.048; Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; BINNIE CD, 1994, J NEUROL NEUROSUR PS, V57, P1308, DOI 10.1136/jnnp.57.11.1308; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bluhm RL, 2008, NEUROREPORT, V19, P887, DOI 10.1097/WNR.0b013e328300ebbf; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Bonavita S, 2011, MULT SCLER J, V17, P411, DOI 10.1177/1352458510394609; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Budde MD, 2008, NMR BIOMED, V21, P589, DOI 10.1002/nbm.1229; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Cheung MM, 2009, C P IEEE ENG MED BIO, V2009, P2715; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Deshpande G, 2009, HUM BRAIN MAPP, V30, P13, DOI 10.1002/hbm.20482; Dowell NG, 2009, J MAGN RESON IMAGING, V29, P454, DOI 10.1002/jmri.21656; Ellingson BM, 2008, AM J NEURORADIOL, V29, P1976, DOI 10.3174/ajnr.A1272; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Figley CR, 2010, MAGN RESON IMAGING, V28, P1234, DOI 10.1016/j.mri.2010.01.005; Filippi M, 2004, HUM BRAIN MAPP, V21, P108, DOI 10.1002/hbm.10160; Filippi M, 2009, NEUROIMAG CLIN N AM, V19, P59, DOI 10.1016/j.nic.2008.08.004; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Freund P, 2010, MULT SCLER J, V16, P1193, DOI 10.1177/1352458510376180; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Guye M, 2008, CURR OPIN NEUROL, V21, P393, DOI 10.1097/WCO.0b013e3283065cfb; Herrera JJ, 2008, J NEUROSCI RES, V86, P443, DOI 10.1002/jnr.21481; Hillary FG, 2011, INT J PSYCHOPHYSIOL; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Jezzard P, 2006, J MAGN RESON IMAGING, V23, P787, DOI 10.1002/jmri.20581; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Jones CK, 2004, MAGN RESON MED, V51, P495, DOI 10.1002/mrm.10713; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kim JH, 2010, J NEUROTRAUM, V27, P587, DOI 10.1089/neu.2009.1063; Kim JH, 2011, NMR BIOMED, V24, P163, DOI 10.1002/nbm.1567; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Latchaw RE, 2009, STROKE, V40, P3646, DOI 10.1161/STROKEAHA.108.192616; Laufs H, 2007, HUM BRAIN MAPP, V28, P1023, DOI 10.1002/hbm.20323; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Leypold BG, 2008, AM J NEURORADIOL, V29, P1012, DOI 10.3174/ajnr.A0962; Liu YJ, 2000, NATURE, V405, P1058, DOI 10.1038/35016590; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Logothetis NK, 2007, NAT NEUROSCI, V10, P1230, DOI 10.1038/nn1007-1230; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2004, MAGN RESON IMAGING, V22, P1517, DOI 10.1016/j.mri.2004.10.018; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Michielsen ME, 2011, NEUROREHAB NEURAL RE, V25, P223, DOI 10.1177/1545968310385127; Minty EP, 2009, MAGN RESON MED, V61, P883, DOI 10.1002/mrm.21936; Miyanji F, 2007, RADIOLOGY, V243, P820, DOI 10.1148/radiol.2433060583; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Murayama T, 2011, BRAIN INJURY, V25, P1047, DOI 10.3109/02699052.2011.607785; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Ong HH, 2008, NEUROIMAGE, V40, P1619, DOI 10.1016/j.neuroimage.2008.01.017; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pauling L, 1936, P NATL ACAD SCI USA, V22, P210, DOI 10.1073/pnas.22.4.210; PAULSON OB, 1987, SCIENCE, V237, P896, DOI 10.1126/science.3616619; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Petry KG, 2010, J NEURAL TRANSM, V117, P907, DOI 10.1007/s00702-010-0432-5; Petzold GC, 2008, NEURON, V58, P897, DOI 10.1016/j.neuron.2008.04.029; Puig J, 2011, AM J NEURORADIOL, V32, P857, DOI 10.3174/ajnr.A2400; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ronchi R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021070; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Schlaug G, 2009, ANN NY ACAD SCI, V1169, P385, DOI 10.1111/j.1749-6632.2009.04587.x; Schneider T, 2010, ANN M INT SOC MAGN R, P1561; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shimada K, 1999, SPINAL CORD, V37, P410, DOI 10.1038/sj.sc.3100858; Sibson NR, 1997, P NATL ACAD SCI USA, V94, P2699, DOI 10.1073/pnas.94.6.2699; Singh KD, 2008, NEUROIMAGE, V41, P100, DOI 10.1016/j.neuroimage.2008.01.051; Skandsen T, 2011, J NEUROTRAUM, V28, P691, DOI 10.1089/neu.2010.1590; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Strangman GE, 2009, NEUROREHAB NEURAL RE, V23, P226, DOI 10.1177/1545968308324225; Stroman PW, 2008, MAGN RESON MED, V59, P700, DOI 10.1002/mrm.21534; Stroman PW, 2011, ESSENTIALS FUNCTIONA, P217; Sundberg LM, 2010, J NEUROTRAUM, V27, P1753, DOI 10.1089/neu.2010.1369; Tavazzi E, 2010, INT J IMMUNOPATH PH, V23, P693, DOI 10.1177/039463201002300302; Toosy AT, 2002, NEUROSCI LETT, V330, P255, DOI 10.1016/S0304-3940(02)00700-0; Tu TW, 2010, J NEUROTRAUM, V27, P253, DOI 10.1089/neu.2009.1026; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Viswanathan A, 2007, NAT NEUROSCI, V10, P1308, DOI 10.1038/nn1977; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Whittall KP, 1997, MAGNET RESON MED, V37, P34, DOI 10.1002/mrm.1910370107; Wig GS, 2008, P NATL ACAD SCI USA, V105, P18555, DOI 10.1073/pnas.0804546105; Wong EC, 2005, J MAGN RESON IMAGING, V22, P727, DOI 10.1002/jmri.20459; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Yang JJ, 2010, CORTEX, V46, P354, DOI 10.1016/j.cortex.2009.05.002; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	109	12	13	1	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467			CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JUN	2012	114	5			SI		460	470		10.1016/j.clineuro.2012.01.003			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	941EN	WOS:000303946600008	22326716				2021-06-18	
J	Tansey, KE; McKay, WB; Kakulas, BA				Tansey, Keith E.; McKay, William Barry; Kakulas, Byron A.			Restorative neurology: Consideration of the new anatomy and physiology of the injured nervous system	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Neurotrauma; Neural plasticity; Functional recovery	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; SYNAPTIC PLASTICITY; ASSESSMENTS; MECHANISMS; RECOVERY; THERAPY	The adult human nervous system is an incredibly complex set of thousands to tens of thousands of connections between a hundred billion neurons that develops via an intricate spatial-temporal process and is shaped by experience. In addition, any one anatomical arrangement of neural circuits is usually capable of multiple physiological states. Following neurological injury, a new anatomy, and consequently a new spectrum of physiology, emerges within this nervous system with its mix of both injured and uninjured parts. It is this new combination of neural components that determines the extent to which natural functional recovery can occur and the extent to which clinical interventions can further that recovery. Detecting the new anatomy and physiology of the injured human nervous system is difficult but not impossible and some methods can track over time changes in neural structure or, more often, functions that correlate with neurological improvement. The goal of restorative neurology is to make best use of this new anatomy and physiology to facilitate neurological recovery. While we are still learning about how neurorehabilitation interventions generate functional recovery, we can begin to test hypothesis regarding the underlying mechanisms of neural plasticity and attempt to augment those processes. Published by Elsevier B.V.	[Tansey, Keith E.] Emory Univ, Sch Med, Atlanta Vet Adm Med Ctr, Crawford Res Inst,Shepherd Ctr,Dept Neurol, Atlanta, GA 30309 USA; [Tansey, Keith E.] Emory Univ, Sch Med, Atlanta Vet Adm Med Ctr, Crawford Res Inst,Shepherd Ctr,Dept Physiol, Atlanta, GA 30309 USA; [McKay, William Barry] Norton Neurosci Inst, Louisville, KY 40203 USA; [Kakulas, Byron A.] Univ Western Australia, Australian Neuromuscular Res Inst, Ctr Neuromuscular & Neurol Disorders, Crawley, WA 6009, Australia	Tansey, KE (corresponding author), Emory Univ, Sch Med, Atlanta Vet Adm Med Ctr, Crawford Res Inst,Shepherd Ctr,Dept Neurol, 2020 Peachtree Rd NW, Atlanta, GA 30309 USA.	keith_tansey@shepherd.org; william.mckay@nortonhealthcare.org; bkakulas@meddent.uwa.edu.au					Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Baptiste DC, 2006, J NEUROTRAUM, V23, P318, DOI 10.1089/neu.2006.23.318; Chen HW, 2010, PM&R, V2, pS306, DOI 10.1016/j.pmrj.2010.10.006; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Dimitrijevic M R, 1997, Adv Neurol, V72, P335; DIMITRIJEVIC MR, 1992, J NEUROTRAUM, V9, pS293; Dimitrijevic MR, 2012, RESTORATIVE NEUROLOG; Elgersma Y, 1999, CURR OPIN NEUROBIOL, V9, P209, DOI 10.1016/S0959-4388(99)80029-4; Ellaway PH, 2011, BRAIN RES BULL, V84, P343, DOI 10.1016/j.brainresbull.2010.08.007; Ellaway PH, 2004, SPINAL CORD, V42, P325, DOI 10.1038/sj.sc.3101596; Enoka RM, 1997, MUSCLE NERVE, pS66; Eyre JA, 2007, NEUROSCI BIOBEHAV R, V31, P1136, DOI 10.1016/j.neubiorev.2007.05.011; Field-Fote EC, 2011, PHYS THER, V91, P48, DOI 10.2522/ptj.20090359; Fioravante D, 2011, CURR OPIN NEUROBIOL, V21, P269, DOI 10.1016/j.conb.2011.02.003; Gasparetto EL, 2011, NEUROIMAG CLIN N AM, V21, P115, DOI 10.1016/j.nic.2011.02.003; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Ghez C, 1991, Curr Opin Neurobiol, V1, P664, DOI 10.1016/S0959-4388(05)80046-7; Hubbard IJ, 2009, OCCUP THER INT, V16, P175, DOI 10.1002/oti.275; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Knikou M, 2010, CLIN NEUROPHYSIOL, V121, P1655, DOI 10.1016/j.clinph.2010.01.039; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Looby S, 2011, RADIOL CLIN N AM, V49, P129, DOI 10.1016/j.rcl.2010.07.019; Low LK, 2006, PHILOS T R SOC B, V361, P1531, DOI 10.1098/rstb.2006.1883; Marino S, 2011, NEUROCRIT CARE, V14, P127, DOI 10.1007/s12028-010-9406-6; McKay WB, 2004, NEUROREHAB NEURAL RE, V18, P144, DOI 10.1177/0888439004267674; Meinzer M, 2007, NEUROREHABILITATION, V22, P311; Munakata Y, 2004, DEVELOPMENTAL SCI, V7, P141, DOI 10.1111/j.1467-7687.2004.00331.x; Nguyen DK, 1998, CAN J NEUROL SCI, V25, P5, DOI 10.1017/S0317167100033424; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Park DH, 2010, THESCIENTIFICWORLDJO, V10, P470, DOI 10.1100/tsw.2010.39; Reggia JA, 2004, MED ENG PHYS, V26, P711, DOI 10.1016/j.medengphy.2004.06.010; Scott SH, 2003, CURR OPIN NEUROL, V16, P693, DOI 10.1097/00019052-200312000-00008; Sterr A, 2006, COGN BEHAV NEUROL, V19, P48, DOI 10.1097/00146965-200603000-00006; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Winchester P, 2005, NEUROREHAB NEURAL RE, V19, P313, DOI 10.1177/1545968305281515	38	12	13	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JUN	2012	114	5			SI		436	440		10.1016/j.clineuro.2012.01.010			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	941EN	WOS:000303946600004	22300890				2021-06-18	
J	Graziani, G; Cucchiari, D; Aroldi, A; Angelini, C; Gaetani, P; Selmi, C				Graziani, Giorgio; Cucchiari, David; Aroldi, Adriana; Angelini, Claudio; Gaetani, Paolo; Selmi, Carlo			Syndrome of inappropriate secretion of antidiuretic hormone in traumatic brain injury: when tolvaptan becomes a life saving drug	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							HYPONATREMIA	Objective To outline the role of a new drug, tolvaptan, in treating severe and chronic hyponatraemia. Tolvaptan decreases aquaporin expression in renal collecting ducts, by inhibiting antidiuretic hormone (ADH)-V2 receptors, to promote free water clearance. Given its mechanism of action, this drug seems the ideal treatment for the syndrome of inappropriate antidiuretic hormone secretion (SIADH) when the osmotic imbalance leads to life threatening complications. Data sources A case is described of severe hyponatraemia deriving from SIADH secondary to meningoencephalitis in a patient admitted to hospital for traumatic brain injury. Data extraction Clinical, laboratory and radiological data at presentation and for a 1 year of follow-up were analysed. Data synthesis Tolvaptan ameliorated hyponatraemia, brain oedema and consciousness, and drug withdrawal led to recurrence of hyponatraemia and coma. Conclusions In patients with SIADH, which is not self-limited, and is associated with severe cognitive impairment, the use Tolvaptan may prove life saving and should be rigorously evaluated.	[Graziani, Giorgio; Cucchiari, David; Angelini, Claudio] Ist Clin Humanitas IRCCS, Dept Med, Nephrol & Dialysis Unit, Milan, Italy; [Aroldi, Adriana] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Med, Nephrol & Dialysis Unit, Milan, Italy; [Gaetani, Paolo] Ist Clin Humanitas IRCCS, Dept Neurol, Neurosurg Unit, Milan, Italy; [Selmi, Carlo] IRCCS Ist Clin Humanitas, Dept Med, Autoimmun & Metab Unit, Milan, Italy	Graziani, G (corresponding author), Ist Clin Humanitas IRCCS, Via Manzoni 56, I-20089 Rozzano, MI, Italy.	giorgio.graziani@humanitas.it		Gaetani, Paolo/0000-0003-0662-5872; Selmi, Carlo/0000-0002-0323-0376			Cole Chad D, 2004, Neurosurg Focus, V16, pE9; Ellison DH, 2007, NEW ENGL J MED, V356, P2064, DOI 10.1056/NEJMcp066837; Hannon MJ, 2010, EUR J ENDOCRINOL, V162, pS5, DOI 10.1530/EJE-09-1063; Kengne FG, 2008, QJM-INT J MED, V101, P583, DOI 10.1093/qjmed/hcn061; Murphy T, 2009, NEUROCRIT CARE, V11, P14, DOI 10.1007/s12028-008-9179-3; Rahman M, 2009, NEUROSURGERY, V65, P925, DOI 10.1227/01.NEU.0000358954.62182.B3; Renneboog B, 2006, AM J MED, V119, DOI [10.1016/j.amjmed.2005.09.026, DOI 10.1016/J.AMJMED.2005.09.026]; Schrier RW, 2010, NAT REV NEPHROL, V6, P185, DOI 10.1038/nrneph.2010.21; Sherlock M, 2009, POSTGRAD MED J, V85, P171, DOI 10.1136/pgmj.2008.072819	9	12	14	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	MAY	2012	83	5					510	512		10.1136/jnnp-2011-300576			3	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	925TX	WOS:000302785600010	22323742				2021-06-18	
J	Kim, JP; Chang, WS; Chang, JW				Kim, Joo Pyung; Chang, Won Seok; Chang, Jin Woo			The long-term surgical outcomes of secondary hemidystonia associated with post-traumatic brain injury	ACTA NEUROCHIRURGICA			English	Article						Deep brain stimulation; Globus pallidus internus; Hemidystonia; Post-traumatic dystonia	PALLIDUS INTERNUS STIMULATION; GLOBUS-PALLIDUS; BASAL GANGLIA; DELAYED-ONSET; GENERALIZED DYSTONIA; NEURONAL-ACTIVITY; HEAD TRAUMA; SYMPTOMATIC HEMIDYSTONIA; PALLIDOTOMY; HEMIBALLISMUS	The aim was to assess the effect of deep brain stimulation for secondary hemidystonias associated with focal post-traumatic brain injuries. Four patients underwent deep brain stimulation for the treatment of medically refractory secondary hemidystonia associated with post-traumatic brain injury. Clinical outcome assessments were based on Burke-Fahn-Marsden Dystonia Rating Scale movement and disability scores. Health-related quality of life was assessed using a 36-item short-form general health survey questionnaire administered preoperatively and at the last follow-up visit. Burke-Fahn-Marsden Dystonia Rating Scale movement scores had improved by 73.2% (range, 38.1-94.1) and disability scores had improved by 75% (range, 60-100) at the 2-year follow-up visit. The health-related quality of life assessment revealed satisfactory results at follow-up, such that body pain, general health, vitality, social functioning, as well as emotional and mental health improved significantly. Globus pallidus internus deep brain stimulation can be used to modulate and ameliorate secondary hemidystonia associated with focal post-traumatic brain injury.	[Kim, Joo Pyung; Chang, Won Seok; Chang, Jin Woo] Yonsei Univ, Dept Neurosurg, Brain Korea Project Med Sci 21, Severance Hosp,Brain Res Inst,Coll Med, Seoul 120752, South Korea	Chang, JW (corresponding author), Yonsei Univ, Dept Neurosurg, Brain Korea Project Med Sci 21, Severance Hosp,Brain Res Inst,Coll Med, 50 Yonsei Ro, Seoul 120752, South Korea.	jchang@yuhs.ac		Chang, Jin Woo/0000-0002-2717-0101	Industrial Source Technology Department of the Ministry of Knowledge Economy (MKE) of Korea [10033812]	The authors would like to thank Eun Jung Kweon (R.N.) for clinical data acquisition and assistance with this paper. We are also grateful to Yong Ho Kwak (Ph.D.), Bae Hwan Lee (Ph.D.) from the MER Analysis team of the Medical Research Support Section, Department of Physiology, Yonsei University College of Medicine for their help with the figures. This study was supported by the Industrial Source Technology Department Program (no. 10033812) of the Ministry of Knowledge Economy (MKE) of Korea.	Alkhani A, 2006, MOVEMENT DISORD, V21, P852, DOI 10.1002/mds.20838; Berardelli A, 1998, BRAIN, V121, P1195, DOI 10.1093/brain/121.7.1195; BURKE RE, 1980, J NEUROL NEUROSUR PS, V43, P789, DOI 10.1136/jnnp.43.9.789; BURTON K, 1984, NEUROLOGY, V34, P962, DOI 10.1212/WNL.34.7.962; Chang JW, 2002, J NEUROL NEUROSUR PS, V73, P588, DOI 10.1136/jnnp.73.5.588; Eltahawy HA, 2004, NEUROSURGERY, V54, P613, DOI 10.1227/01.NEU.0000108643.94730.21; Fernandez HH, 1999, MOVEMENT DISORD, V14, P695, DOI 10.1002/1531-8257(199907)14:4<695::AID-MDS1024>3.0.CO;2-3; Hutchison WD, 2003, ANN NEUROL, V53, P480, DOI 10.1002/ana.10474; Iacono RP, 1996, PEDIATR NEUROL, V14, P145, DOI 10.1016/0887-8994(96)00003-3; JANKOVIC J, 1994, NEUROLOGY, V44, P2006, DOI 10.1212/WNL.44.11.2006; King RB, 2001, J NEUROSURG, V94, P309, DOI 10.3171/jns.2001.94.2.0309; Krauss JK, 2004, J CLIN NEUROPHYSIOL, V21, P18, DOI 10.1097/00004691-200401000-00004; KRAUSS JK, 1994, J NEUROSURG, V80, P810, DOI 10.3171/jns.1994.80.5.0810; KRAUSS JK, 1992, MOVEMENT DISORD, V7, P263, DOI 10.1002/mds.870070313; Krystkowiak P, 1998, J NEUROL NEUROSUR PS, V65, P703, DOI 10.1136/jnnp.65.5.703; LEE MS, 1994, NEUROLOGY, V44, P1374, DOI 10.1212/WNL.44.8.1374; Lenz FA, 1998, J NEUROL NEUROSUR PS, V65, P767, DOI 10.1136/jnnp.65.5.767; Lindsey N., 2004, NEUROSURG FOCUS, V17, pE4; Loher TJ, 2000, J NEUROSURG, V92, P457, DOI 10.3171/jns.2000.92.3.0457; Lozano AM, 1997, MOVEMENT DISORD, V12, P865, DOI 10.1002/mds.870120606; MAKI Y, 1980, CHILD BRAIN, V7, P113; MARSDEN CD, 1985, BRAIN, V108, P463, DOI 10.1093/brain/108.2.463; MESSIMY R, 1977, REV NEUROL, V133, P199; Munchau A, 2000, J NEUROL NEUROSUR PS, V69, P494, DOI 10.1136/jnnp.69.4.494; Ondo WG, 1998, MOVEMENT DISORD, V13, P693, DOI 10.1002/mds.870130415; PETTIGREW LC, 1985, J NEUROL NEUROSUR PS, V48, P650, DOI 10.1136/jnnp.48.7.650; SELLAL F, 1993, MOVEMENT DISORD, V8, P515, DOI 10.1002/mds.870080418; SILVER JK, 1994, ARCH PHYS MED REHAB, V75, P885, DOI 10.1016/0003-9993(94)90113-9; Vitek JL, 1999, ANN NEUROL, V46, P22, DOI 10.1002/1531-8249(199907)46:1<22::AID-ANA6>3.0.CO;2-Z; Zhuang P, 2004, CLIN NEUROPHYSIOL, V115, P2542, DOI 10.1016/j.clinph.2004.06.006	30	12	12	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	MAY	2012	154	5					823	830		10.1007/s00701-012-1306-4			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	934PG	WOS:000303455800008	22367408				2021-06-18	
J	Kramer, AH; Jette, N; Pillay, NL; Federico, P; Zygun, DA				Kramer, Andreas H.; Jette, Nathalie; Pillay, Neelan; Federico, Paolo; Zygun, David A.			Epileptiform Activity in Neurocritical Care Patients	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							TRAUMATIC BRAIN-INJURY; CRITICALLY-ILL PATIENTS; ANEURYSMAL SUBARACHNOID HEMORRHAGE; NEURON-SPECIFIC ENOLASE; PERIODIC EEG PATTERNS; INTRACEREBRAL HEMORRHAGE; ELECTROGRAPHIC SEIZURES; NONCONVULSIVE SEIZURES; BACTERIAL-MENINGITIS; PROGNOSTIC-FACTORS	Background: Non-convulsive seizures have been reported to be common in neurocritical care patients. Many jurisdictions do not have sufficient resources to enable routine continuous electroencephaloaraphy (cEEG) and instead use primarily intermittent EEG, for which the diagnostic yield remains uncertain. Determining risk factors for epileptiform activity and seizures could help identify patients who might particularly benefit from EEG monitoring. Methods: We performed a cohort study involving neurocritical care patients with admission Glascow Coma Scale (GCS) scores <= 12, who underwent >= 1 EEG. EEGs were reviewed for presence of interictal discharges, periodic epileptiform discharges (PEDs), and seizures. Multivariate analysis was used to identify predictors of these findings and to describe their prognostic implications. Results: 393 patients met inclusion criteria. 34 underwent cEEG, usually because epileptiform activity was first detected on a routine EEG. The prevalence of PEDs or electrographic seizures was 13%, and was highest with anoxic encephalopathy and central nervous system infections. Other independent predictors for epileptiforrn activity included a history of convulsive seizure(s), increasing age, deeper coma, and female gender. Although patients with epileptiform activity had higher mortality, this association disappeared after adjustment for confounders. Conclusion: Approximately 7-8 neurocritical care patients must undergo intermittent EEG monitoring in order to diagnose one with PEDs or seizures. The predictors we identified could potentially help guide use of resources. Repeated intermittent studies, or cEEG, should be considered in patients with multiple risk factors, or when interictal discharges are identified on an initial EEG. It remains unclear whether aggressive prevention and treatment of electrographic seizures improves neurologic outcomes.	[Kramer, Andreas H.] Univ Calgary, Dept Crit Care Med, Foothills Med Ctr, Hotchkiss Brain Inst, Calgary, AB, Canada; [Kramer, Andreas H.] Univ Calgary, Dept Clin Neurosci, Foothills Med Ctr, Hotchkiss Brain Inst, Calgary, AB, Canada; [Jette, Nathalie; Zygun, David A.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada	Kramer, AH (corresponding author), Univ Calgary, Dept Crit Care Med, Foothills Med Ctr, Hotchkiss Brain Inst, Calgary, AB, Canada.						Alroughani R, 2009, SEIZURE-EUR J EPILEP, V18, P38, DOI 10.1016/j.seizure.2008.06.013; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; [Anonymous], 1988, J NEUROSURGERY, V68, P985; [Anonymous], 1991, CLIN EXAMINATION NEU, P354; Arboix A, 1997, STROKE, V28, P1590, DOI 10.1161/01.STR.28.8.1590; Badawy RAB, 2011, CLIN NEUROPHYSIOL, V122, P1086, DOI 10.1016/j.clinph.2010.10.048; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; BERGER AR, 1988, NEUROLOGY, V38, P1363, DOI 10.1212/WNL.38.9.1363; BRENNER RP, 1990, J CLIN NEUROPHYSIOL, V7, P249, DOI 10.1097/00004691-199004000-00007; Butzkueven H, 2000, NEUROLOGY, V55, P1315, DOI 10.1212/WNL.55.9.1315; Carrera E, 2008, ARCH NEUROL-CHICAGO, V65, P1612, DOI 10.1001/archneur.65.12.1612; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Correale J, 1998, NEUROLOGY, V50, P1388, DOI 10.1212/WNL.50.5.1388; DeGiorgio CM, 1999, NEUROLOGY, V52, P746, DOI 10.1212/WNL.52.4.746; Fraser DD, 2009, CRIT CARE MED, V37, P3181, DOI 10.1097/CCM.0b013e3181bdd98a; Frye CA, 2010, EPILEPSIA, V51, P135, DOI 10.1111/j.1528-1167.2010.02628.x; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Hirsch LJ, 2005, J CLIN NEUROPHYSIOL, V22, P128, DOI 10.1097/01.WNP.0000158701.89576.4C; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lowenstein DH, 1999, EPILEPSIA, V40, P120, DOI 10.1111/j.1528-1157.1999.tb02000.x; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Olivecrona M, 2009, J NEUROSURG, V110, P300, DOI 10.3171/2008.4.17538; Ronner HE, 2009, SEIZURE-EUR J EPILEP, V18, P257, DOI 10.1016/j.seizure.2008.10.010; Rosengart AJ, 2007, STROKE, V38, P2315, DOI 10.1161/STROKEAHA.107.484360; Rossetti AO, 2007, NEUROLOGY, V69, P255, DOI 10.1212/01.wnl.0000265819.36639.e0; Steiner T, 1997, STROKE, V28, P711, DOI 10.1161/01.STR.28.4.711; Suarez JI, 2006, CRIT CARE MED, V34, pS232, DOI 10.1097/01.CCM.0000231881.29040.25; Szabo K, 2005, BRAIN, V128, P1369, DOI 10.1093/brain/awh454; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Vagnerova K, 2008, ANESTH ANALG, V107, P201, DOI 10.1213/ane.0b013e31817326a5; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Varelas PN, 2004, CLIN EEG NEUROSCI, V35, P173, DOI 10.1177/155005940403500406; Veliskova J, 2010, EPILEPSIA, V51, P141, DOI 10.1111/j.1528-1167.2010.02629.x; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; Wigginton JG, 2010, CRIT CARE MED, V38, pS620, DOI 10.1097/CCM.0b013e3181f243a9; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao G, 2008, CRIT CARE, V12, P1; Young GB, 2005, NEUROCRIT CARE, V2, P5, DOI 10.1385/NCC:2:1:005; Young GB, 1997, CAN J NEUROL SCI, V24, P320, DOI 10.1017/S0317167100032996; Young GB, 1996, NEUROLOGY, V47, P83; Young JD, 2001, BRIT J ANAESTH, V87, P543, DOI 10.1093/bja/87.4.543; Zoons E, 2008, NEUROLOGY, V70, P2109, DOI 10.1212/01.wnl.0000288178.91614.5d; Zygun D, 2006, CRIT CARE, V10, DOI 10.1186/cc5007	50	12	12	0	1	CANADIAN JOURNAL NEUROLOGICAL SCIENCES INC	CALGARY	709-7015 MACLEOD TRAIL SW, CALGARY, AB T2H 2K6, CANADA	0317-1671			CAN J NEUROL SCI	Can. J. Neurol. Sci.	MAY	2012	39	3					328	337		10.1017/S0317167100013469			10	Clinical Neurology	Neurosciences & Neurology	946VR	WOS:000304386100012	22547513	Bronze			2021-06-18	
J	Kramer, C; Freeman, WD; Larson, JS; Hoffman-Snyder, C; Wellik, KE; Demaerschalk, BM; Wingerchuk, DM				Kramer, Christopher; Freeman, William D.; Larson, Joel S.; Hoffman-Snyder, Charlene; Wellik, Kay E.; Demaerschalk, Bart M.; Wingerchuk, Dean M.			Therapeutic Hypothermia for Severe Traumatic Brain Injury A Critically Appraised Topic	NEUROLOGIST			English	Article						brain injury; traumatic brain injury; head injury; induced hypothermia; therapeutic hypothermia; critically appraised topic	TERM MILD HYPOTHERMIA; INTRACRANIAL-PRESSURE	Background: Traumatic brain injury (TBI) is common and confers a high rate of disability and mortality. Current treatments are primarily supportive. Therapeutic hypothermia has been proposed for severe TBI because of its ability to reduce intracranial pressure and putative neuroprotective effects. Objective: To critically appraise the current evidence concerning the efficacy of therapeutic hypothermia in the treatment of severe TBI. Methods: The objective was addressed through the development of a structured, critically appraised topic. This incorporated a clinical scenario, background information, a structured question, literature search strategy, critical appraisal, results, evidence summary, commentary, and bottom line conclusions. Participants included consultant and resident neurologists, a medical librarian, clinical epidemiologists, and critical care and neurocritical care content experts. Results: A recent multicenter randomized controlled trial was selected for critical assessment; meta-analyses were also reviewed. Subjects with severe TBI were randomized to either rapid cooling to 33 degrees C for 48 hours (treatment, n = 52) or normothermia (control, n = 45). Outcome assessments included mortality and disability at 6 months as measured by the Glasgow Outcome Scale. Initiation of hypothermia began within 2.5 hours of injury and patients were rewarmed over a mean of 17.2 hours. The study was terminated for futility; no difference in outcome or mortality was detected between treatment groups. Post hoc subgroup analysis showed that among subjects who required hematoma evacuation, hypothermia was associated with a lower rate of poor clinical outcome (number needed to treat = 2.8; 95% confidence interval, 1.4-78.3, P = 0.02) and a trend toward a decrease in mortality (P = 0.16). Conclusions: Current cumulative evidence does not support general use of therapeutic hypothermia for acute severe TBI. However, further investigation of the role of therapeutic hypothermia may be warranted for specific TBI subgroups.	[Kramer, Christopher; Hoffman-Snyder, Charlene; Demaerschalk, Bart M.; Wingerchuk, Dean M.] Mayo Clin, Dept Neurol, Scottsdale, AZ 85259 USA; [Larson, Joel S.] Mayo Clin, Dept Crit Care Med, Scottsdale, AZ 85259 USA; [Wellik, Kay E.] Mayo Clin, Dept Lib Serv, Scottsdale, AZ 85259 USA; [Freeman, William D.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Kramer, Christopher; Hoffman-Snyder, Charlene; Demaerschalk, Bart M.; Wingerchuk, Dean M.] Mayo Clin, Dept Neurol, Phoenix, AZ USA; [Larson, Joel S.] Mayo Clin, Dept Crit Care Med, Phoenix, AZ USA; [Wellik, Kay E.] Mayo Clin, Dept Lib Serv, Phoenix, AZ USA	Wingerchuk, DM (corresponding author), Mayo Clin, Dept Neurol, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	wingerchuk.dean@mayo.edu		Freeman, M.D., William D./0000-0003-2326-0633	Mayo Clinic College of Medicine	D.M.W. and B.M.D., Co-Directors of Mayo Clinic Evidence Based Clinical Practice, Research, Informatics, and Training (MERIT) Center were supported by Clinician Educator grants from the Mayo Clinic College of Medicine.	Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Polderman KH, 2004, INTENS CARE MED, V30, P1860, DOI 10.1007/s00134-004-2383-5; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Povlishock JT, 2009, J NEUROTRAUM, V26, P333, DOI 10.1089/neu.2008.0604; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Sinclair HL, 2010, CRIT CARE, V14, DOI 10.1186/cc8220; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; Sydenham E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub4; Takeuchi S, 2011, LANCET NEUROL, V10, P404, DOI 10.1016/S1474-4422(11)70083-7; Zollman FS, 2011, MANUAL OF TRAUMATIC BRAIN INJURY MANAGEMENT, P1	20	12	14	1	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1074-7931			NEUROLOGIST	Neurologist	MAY	2012	18	3					173	177		10.1097/NRL.0b013e318253f8ef			5	Clinical Neurology	Neurosciences & Neurology	937IT	WOS:000303652900015	22549362				2021-06-18	
J	Papageorgiou, E; Hardiess, G; Wietholter, H; Ackermann, H; Dietz, K; Mallot, HA; Schiefer, U				Papageorgiou, Eleni; Hardiess, Gregor; Wiethoelter, Horst; Ackermann, Hermann; Dietz, Klaus; Mallot, Hanspeter A.; Schiefer, Ulrich			The neural correlates of impaired collision avoidance in hemianopic patients	ACTA OPHTHALMOLOGICA			English	Article						cerebrovascular damage; driving; fusiform gyrus; homonymous visual field defects; lesion analysis; parieto-occipital area; posterior cingulate gyrus; virtual reality	VISUAL-FIELD DEFECTS; TRAUMATIC BRAIN-INJURY; DRIVING PERFORMANCE; RIGHT-HEMISPHERE; WORKING-MEMORY; BEHAVIOR; ACTIVATION; HETEROGENEITY; LESIONS; UPDATE	. Purpose: The aim of this study was to assess the brain regions associated with impaired performance in a virtual, dynamic collision avoidance task, in a group of patients with homonymous visual field defects (HVFDs) because of unilateral vascular brain lesions. Methods: Overall task performance was quantitatively assessed as the number of collisions while crossing an intersection at two levels of traffic density. Twenty-six patients were divided into two subgroups using the median split method: patients with performance above average (HVFDA, i.e. lower number of collisions) and patients with performance below average (HVFDB, i.e. higher number of collisions). In order to identify the anatomical structures that might be specifically affected in HVFDB patients but spared in HVFDA patients, overlap, subtraction and voxel-based lesion-symptom mapping analyses were performed using the MRIcron software. Results: No significant difference in collision avoidance between patients with left- and right-hemispheric lesions was revealed. Separate lesion analysis in 12 patients with right- and 14 patients with left-hemispheric lesions showed that the cortical structures associated with impaired collision avoidance were the parieto-occipital region and posterior cingulate gyrus in the right hemisphere and the inferior occipital cortex and parts of the fusiform (occipito-temporal) gyrus in the left hemisphere. Conclusion: In the present collision avoidance paradigm, impaired performance of patients with right-hemispheric lesions is associated with damage in the dorsal processing stream and potential impact on the visual spatial working memory (WM), while impaired performance of patients with left-hemispheric lesions is associated with damage in the ventral stream and potential impact on the visual object WM.	[Papageorgiou, Eleni; Schiefer, Ulrich] Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, D-72076 Tubingen, Germany; [Hardiess, Gregor; Mallot, Hanspeter A.] Cognit Neurosci Lab, Dept Neurobiol, Tubingen, Germany; [Wiethoelter, Horst] Burger Hosp, Dept Neurol, Stuttgart, Germany; [Ackermann, Hermann] Rehabil Ctr, Bad Urach, Germany; [Dietz, Klaus] Univ Tubingen, Dept Med Biometry, D-72076 Tubingen, Germany	Papageorgiou, E (corresponding author), Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, Schleichstr 12-16, D-72076 Tubingen, Germany.	e_papage@yahoo.com	Mallot, Hanspeter A/H-7888-2016; Dietz, Klaus/R-9268-2016	Dietz, Klaus/0000-0001-8503-9737; Papageorgiou, Eleni/0000-0003-1931-4168	European Union (PERACT-Marie Curie Early Stage Research Training) [MEST-CT-2004-504321]; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB 550-A4, Graduiertenkolleg 778]	This study was supported by the following grants: European Union (PERACT-Marie Curie Early Stage Research Training, MEST-CT-2004-504321), Deutsche Forschungsgemeinschaft (SFB 550-A4) and Graduiertenkolleg 778. The authors are indebted to Regina Hofer and Elke Krapp (Department & Institute for Ophthalmology, Tubingen, Germany) for expert assistance with graphics.	Baddeley A. D., 1986, WORKING MEMORY; Bartolomeo P, 2006, ARCH NEUROL-CHICAGO, V63, P1238, DOI 10.1001/archneur.63.9.1238; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bowers AR, 2009, INVEST OPHTH VIS SCI, V50, P5137, DOI 10.1167/iovs.09-3799; Calhoun VD, 2002, HUM BRAIN MAPP, V16, P158, DOI 10.1002/hbm.10032; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Goodale MA, 2005, PROG BRAIN RES, V149, P269, DOI 10.1016/S0079-6123(05)49019-6; Hardiess G, 2010, VISION RES, V50, P1158, DOI 10.1016/j.visres.2010.04.004; Henriksson L, 2007, J NEUROL NEUROSUR PS, V78, P74, DOI 10.1136/jnnp.2006.099374; Horikawa E, 2005, BRAIN COGNITION, V58, P166, DOI 10.1016/j.bandc.2004.10.002; Jeong M, 2006, ANN NUCL MED, V20, P623, DOI 10.1007/BF02984660; Lobjois R, 2008, EXP BRAIN RES, V184, P457, DOI 10.1007/s00221-007-1117-7; Machner B, 2009, NEUROPSYCHOLOGIA, V47, P2704, DOI 10.1016/j.neuropsychologia.2009.05.016; Mazer BL, 1998, ARCH PHYS MED REHAB, V79, P743, DOI 10.1016/S0003-9993(98)90350-1; MEERWALDT JD, 1982, J NEUROL NEUROSUR PS, V45, P586, DOI 10.1136/jnnp.45.7.586; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Mesulam MM, 2001, NEUROIMAGE, V13, P1065, DOI 10.1006/nimg.2001.0768; Milner A. D. G. M., 1995, VISUAL BRAIN ACTION; Mitchell M.L., 2010, RES DESIGN EXPLAINED, V7th ed.; Nelles G, 2007, NEUROSCI LETT, V426, P34, DOI 10.1016/j.neulet.2007.08.028; Papageorgiou E, 2011, VISION RES; Papageorgiou E, 2007, GRAEF ARCH CLIN EXP, V245, P1749, DOI 10.1007/s00417-007-0644-z; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; RATCLIFF G, 1973, J NEUROL NEUROSUR PS, V36, P448, DOI 10.1136/jnnp.36.3.448; Rizzo M, 2001, ALZ DIS ASSOC DIS, V15, P10, DOI 10.1097/00002093-200101000-00002; Rorden C, 2004, NAT REV NEUROSCI, V5, P813, DOI 10.1038/nrn1521; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Sala J, 2003, NEUROPSYCHOLOGIA, V41, P341, DOI 10.1016/S0028-3932(02)00166-5; Schulte T, 1999, AM J PHYS MED REHAB, V78, P136, DOI 10.1097/00002060-199903000-00010; Spiers HJ, 2007, NEUROIMAGE, V36, P245, DOI 10.1016/j.neuroimage.2007.02.032; SZLYK JP, 1993, OPTOMETRY VISION SCI, V70, P1031, DOI 10.1097/00006324-199312000-00007; Tant MLM, 2002, VISION RES, V42, P1339, DOI 10.1016/S0042-6989(02)00044-5; Tant MLM, 2002, NEUROPSYCHOL REHABIL, V12, P419, DOI 10.1080/09602010244000183; Tucker DM, 1995, ANN NY ACAD SCI, V769, P213, DOI 10.1111/j.1749-6632.1995.tb38141.x; Uchiyama Y, 2003, NEUROSCI LETT, V352, P199, DOI 10.1016/j.neulet.2003.08.072; Ungerleider L., 1982, ANAL VISUAL BEHAV, P549; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Walter H, 2001, NEUROREPORT, V12, P1763, DOI 10.1097/00001756-200106130-00049; Wood JM, 2009, INVEST OPHTH VIS SCI, V50, P577, DOI 10.1167/iovs.08-2506; ZIHL J, 1995, NEUROPSYCHOLOGIA, V33, P287, DOI 10.1016/0028-3932(94)00119-A; ZIHL J, 1994, ST HEAL T, V11, P287; Zihl J, 2003, NEUROPSYCHCOLOGY OF VISION, P319	45	12	12	0	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-375X	1755-3768		ACTA OPHTHALMOL	Acta Ophthalmol.	MAY	2012	90	3					e198	e205		10.1111/j.1755-3768.2011.02315.x			8	Ophthalmology	Ophthalmology	932SS	WOS:000303311400006	22176680	Bronze			2021-06-18	
J	Unger, T; Lakowa, N; Bette, S; Engele, J				Unger, Tina; Lakowa, Nicole; Bette, Stefanie; Engele, Juergen			Transcriptional Regulation of the GLAST/EAAT-1 Gene in Rat and Man	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Astrocytes; Glutamate transporters; 3 '-UTR; Enhancer elements; Repressor elements	GLUTAMATE TRANSPORTER EXPRESSION; TRAUMATIC BRAIN-INJURY; GLIAL GLUTAMATE; ASTROCYTES; DISEASE; REGION; GLT-1; MICE; SCHIZOPHRENIA; MECHANISMS	Various acute and chronic brain diseases result in disturbed expression of the glial glutamate transporters, GLAST/EAAT-1 and GLT-1/EAAT-2, and subsequent secondary neuronal cell death. The idea that glutamate-induced brain damage can be prevented by restoring glutamate homeostasis in the injured brain, focussed previous efforts on identifying the network controlling astrocytic glutamate transport. Since most of this work was performed with rat astrocytes, we now sought to compare the transcriptional regulation of the GLAST/EAAT-1 gene in rat and man. Reporter gene assay demonstrated that the human GLAST/EAAT-1 promoter comprises the 2.3 kb region immediately flanking the 5'-end of the human GLAST/EAAT-1 gene. Cloning of the previously unknown promoter of rat GLAST/EAAT-1 gene demonstrated maximal reporter gene activity with a sequence comprising the 1.5 kb region flanking the 5'-end of the gene as well as non-coding exon 1, and intron 1-2. Although the promoter regions from both species lacked sequence homology, they contained numerous identical consensus motifs. In human promoter constructs, dbcAMP, PACAP, EGF, and TGF alpha, which represent potent stimulators of endogenous GLAST/EAAT-1 expression, only further increased reporter gene activity in the presence of the GLAST/EAAT-1 3'-UTR. By contrast, the rat GLAST/EAAT-1 3'-UTR only mediated the stimulatory increases of dbcAMP. Moreover, the GLAST/EAAT-1 3'-UTR repressed constitutive GLAST/EAAT-1 expression in man, but enhanced GLAST/EAAT-1 transcription in rat. Together, our findings suggest the existence of close functional similarities of the GLAST/EAAT-1 promoter regions in man and rat and further point to a species-specific function of the GLAST/EAAT-1 3'-UTR in constitutive and regulated GLAST/EAAT-1 expression.	[Unger, Tina; Lakowa, Nicole; Bette, Stefanie; Engele, Juergen] Univ Leipzig, Inst Anat, Fac Med, D-04103 Leipzig, Germany	Engele, J (corresponding author), Univ Leipzig, Inst Anat, Fac Med, Liebigstr 13, D-04103 Leipzig, Germany.	engj@medizin.uni-leipzig.de					Allritz C, 2010, J NEUROSCI RES, V88, P1234, DOI 10.1002/jnr.22303; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Behrens PF, 2002, BRAIN, V125, P1908, DOI 10.1093/brain/awf180; Bradford J, 2009, P NATL ACAD SCI USA, V106, P22480, DOI 10.1073/pnas.0911503106; Bringmann A, 2009, NEUROCHEM INT, V54, P143, DOI 10.1016/j.neuint.2008.10.014; Chao XD, 2010, NEUROCHEM RES, V35, P1224, DOI 10.1007/s11064-010-0178-3; Chen KH, 2011, J ALZHEIMERS DIS, V26, P755, DOI 10.3233/JAD-2011-110002; Faideau M, 2010, HUM MOL GENET, V19, P3053, DOI 10.1093/hmg/ddq212; Figiel M, 2000, J NEUROSCI, V20, P3596; Figiel M, 2003, EXP NEUROL, V183, P124, DOI 10.1016/S0014-4886(03)00134-1; Foran E, 2011, GLIA, V59, P1719, DOI 10.1002/glia.21218; Hazell AS, 2010, GLIA, V58, P148, DOI 10.1002/glia.20908; Hewett JA, 2009, J NEUROCHEM, V110, P1717, DOI 10.1111/j.1471-4159.2009.06288.x; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Karlsson RM, 2008, BIOL PSYCHIAT, V64, P810, DOI 10.1016/j.biopsych.2008.05.001; Karlsson RM, 2009, NEUROPSYCHOPHARMACOL, V34, P1578, DOI 10.1038/npp.2008.215; Ketheeswaranathan P, 2011, BRAIN RES, V1418, P93, DOI 10.1016/j.brainres.2011.08.029; Kim SY, 2003, J NEUROCHEM, V87, P1485, DOI 10.1046/j.1471-4159.2003.02128.x; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Olsen ML, 2010, BRAIN, V133, P1013, DOI 10.1093/brain/awq049; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Schluter K, 2002, EUR J NEUROSCI, V16, P836, DOI 10.1046/j.1460-9568.2002.02130.x; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Smicun Y, 1998, EUR J BIOCHEM, V251, P704, DOI 10.1046/j.1432-1327.1998.2510704.x; Swanson RA, 1997, J NEUROSCI, V17, P932; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Thomas MA, 2010, BIOCHEM J, V425, P575, DOI 10.1042/BJ20091109; Torres GE, 2007, CURR OPIN NEUROBIOL, V17, P304, DOI 10.1016/j.conb.2007.05.002; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zelenaia O, 2000, MOL PHARMACOL, V57, P667; Zhang R, 2009, J GENET GENOMICS, V36, P1, DOI 10.1016/S1673-8527(09)60001-1	34	12	12	0	3	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340			CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	MAY	2012	32	4					539	547		10.1007/s10571-011-9790-2			9	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	934AF	WOS:000303410000007	22252783				2021-06-18	
J	Yin, C; Zhou, S; Jiang, L; Sun, XC				Yin, Cheng; Zhou, Shuai; Jiang, Li; Sun, Xiaochuan			Mechanical injured neurons stimulate astrocytes to express apolipoprotein E through ERK pathway	NEUROSCIENCE LETTERS			English	Article						Neuron; Astrocyte; Mechanical injury; Apolipoprotein E; ERK pathway	TRAUMATIC BRAIN-INJURY; SIGNALING PATHWAY; LIPOPROTEINS; PROTEIN; MODEL; MICE; APOE	To explore the possible cellular source and mechanism of apolipoprotein E(apoE) expression in mechanical injured neuronal cultures. Primary cultured mouse cortical neurons were subjected into mechanical injury by needle scratching. The conditioned medium of wild type (WT) primary mouse astrocytes was collected and added into cultured injured apoE knockout (KO) neurons. Separately, the conditioned medium of injured apoE KO neurons was collected and added into cultured WT astrocytes. We used a specific inhibitor of extracellular signal-regulated kinase (ERK) to block the possible apoE-associated pathway between injured neurons and astrocytes. The apoE expression levels of the cells and secreted into medium were measured by Western blot, respectively. The apoE expression was increased in neurons after mechanically injury, and the injured neurons uptook the astrocyte-secreted apoE, as well. Furthermore, the injured neurons stimulated astrocytes to express more apoE through the ERK signaling pathway. Mechanical injury triggered the neurons to increasingly synthesized apoE and uptook exogenous apoE, while stimulators released from injured neurons elevated astrocytes in apoE expression and secretion. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Yin, Cheng; Zhou, Shuai; Jiang, Li; Sun, Xiaochuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing 400016, Peoples R China	Sun, XC (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, 1st Youyi Rd, Chongqing 400016, Peoples R China.	sunxch1445@gmail.com		sun, xiao chuan/0000-0001-6992-332X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30973087]	This research was supported by the National Natural Science Foundation of China (No. 30973087).	Aoki K, 2003, STROKE, V34, P875, DOI 10.1161/01.STR.0000064320.73388.C6; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; Champagne D, 2005, EXP NEUROL, V194, P31, DOI 10.1016/j.expneurol.2005.01.016; Harris FM, 2004, J BIOL CHEM, V279, P3862, DOI 10.1074/jbc.M309475200; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; Hayashi H, 2011, BIOL PHARM BULL, V34, P453, DOI 10.1248/bpb.34.453; Horsburgh K, 2002, J CEREBR BLOOD F MET, V22, P1189; Iwata A, 2005, J NEUROSCI RES, V82, P103, DOI 10.1002/jnr.20607; L'Episcopo F, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-49; LaDu MJ, 2001, NEUROCHEM INT, V39, P427, DOI 10.1016/S0197-0186(01)00050-X; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Matsuo M., 2010, BIOCHIM BIOPHYS ACTA, V1811, P31; Mukhin AG, 1997, J NEUROTRAUM, V14, P651, DOI 10.1089/neu.1997.14.651; Oh JY, 2010, J NEUROCHEM, V114, P685, DOI 10.1111/j.1471-4159.2010.06773.x; Orihara Y, 2002, INT J LEGAL MED, V116, P92, DOI 10.1007/s00414-001-0265-8; Osada N, 2009, NEUROCHEM INT, V54, P403, DOI 10.1016/j.neuint.2009.01.010; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Ricci G, 2009, J BIOL PHYS, V35, P317, DOI 10.1007/s10867-009-9157-9; Seitz A, 2003, J NEUROSCI RES, V71, P417, DOI 10.1002/jnr.10482; Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; Xu PT, 1999, AM J PATHOL, V154, P601, DOI 10.1016/S0002-9440(10)65305-9; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006	23	12	16	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	APR 25	2012	515	1					77	81		10.1016/j.neulet.2012.03.023			5	Neurosciences	Neurosciences & Neurology	932LW	WOS:000303293600015	22450050				2021-06-18	
J	Arun, P; Abu-Taleb, R; Valiyaveettil, M; Wang, Y; Long, JB; Nambiar, MP				Arun, Peethambaran; Abu-Taleb, Rania; Valiyaveettil, Manojkumar; Wang, Ying; Long, Joseph B.; Nambiar, Madhusoodana P.			Transient changes in neuronal cell membrane permeability after blast exposure	NEUROREPORT			English	Article						blast exposure; fluorescence release; fluorescence uptake; membrane integrity; SH-SY5Y cells; traumatic brain injury	NEUROTRAUMA	The biochemical mechanisms of explosive blast-induced traumatic brain injury and the subsequent long-term neurobehavioral abnormalities are still not completely understood. We studied the biochemical mechanism of blast traumatic brain injury using our recently reported in-vitro model system with a shock tube. Primary blast exposure of in-vitro models leads to neurobiological changes in an overpressure dose-dependent and time-dependent manner. Lactate dehydrogenase was released significantly into the extracellular medium without cell death after blast exposure, indicating compromised cell membrane integrity. We further explored the integrity of cell membrane after blast exposure by fluorescent dye uptake/release techniques in SH-SY5Y human neuroblastoma cells. Our data indicate that blast exposure leads to an overpressure-dependent transient increase in the release of preloaded calcein AM into the culture medium with proportional intracellular decrease. Uptake of an extracellular nucleic acid-binding dye TO-PRO-3 iodide was also increased significantly after blast exposure, indicating that the increased molecular transport is bidirectional and nuclear membrane integrity is also affected by blast exposure. These results suggest that blast exposure perturbs the integrity of the neuronal cell membrane, leading to increased bidirectional transport of molecules - a potential mechanism that can lead to traumatic brain injury. NeuroReport 23:342-346 (c) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Arun, Peethambaran; Abu-Taleb, Rania; Valiyaveettil, Manojkumar; Wang, Ying; Long, Joseph B.; Nambiar, Madhusoodana P.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA	Nambiar, MP (corresponding author), Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	madhusoodana.nambiar@amedd.army.mil			Center for Military Psychiatry and Neurosciences, Walter Reed Army Institute of Research	Support from COL Paul Bliese, Director, Center for Military Psychiatry and Neurosciences, Walter Reed Army Institute of Research, is greatly acknowledged.	Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P985; Kaur C., 1997, Annals Academy of Medicine Singapore, V26, P27; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Song ZL, 2007, AM J PHYSIOL-REG I, V292, pR423, DOI 10.1152/ajpregu.00495.2006; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Zhang X, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-84; Zhong P, 2001, ULTRASOUND MED BIOL, V27, P119, DOI 10.1016/S0301-5629(00)00322-7	12	12	12	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	APR 18	2012	23	6					342	346		10.1097/WNR.0b013e328351b58d			5	Neurosciences	Neurosciences & Neurology	922CU	WOS:000302525200002	22426026				2021-06-18	
J	Wang, YX; Gu, JX; Wang, JC; Feng, XM; Tao, YP; Jiang, BC; He, JS; Wang, Q; Yang, JD; Zhang, SF; Cai, J; Sun, Y				Wang, Yongxiang; Gu, Jiaxiang; Wang, Jingcheng; Feng, Xingmin; Tao, Yuping; Jiang, Baichuan; He, Jinshan; Wang, Qiang; Yang, Jiandong; Zhang, Shenfei; Cai, Jun; Sun, Yu			BDNF and NT-3 expression by using glucocorticoid-induced bicistronic expression vector pGC-BDNF-IRES-NT3 protects apoptotic cells in a cellular injury model	BRAIN RESEARCH			English	Article						Spinal cord injury; BDNF; Neurotrophin-3; Bicistronic expression vector, Apoptosis	SPINAL-CORD INJURY; UP-REGULATION; SURVIVAL; REGENERATION; MUSCLE	Spinal cord injury (SCI) is a severe traumatic disease in the central nervous system with high incidence and high morbidity. Recent study demonstrated that cell transplantation therapy may improve local microenvironment of the injury site and promote nerve regeneration to restore spinal cord functions. In this study, we constructed a glucocorticoid-induced bicistronic eukaryotic expression vector pGC-BDNF-IRES-NT3 by using molecular cloning techniques and examined the protective effect of neurotrophin-3 (NT-3) and brain-derived neurotrophic factor (BDNF) expressed by this vector in a rat spinal cord injury (SCI) model. We first connected glucocorticoid response element (GRE) to cytomegalovirus (CMV) promoter and then the GRE-CMV gene was inserted into pEGFP-1 vector to construct the eukaryotic expression vector pGC-EGFP. Western blot analysis was used to confirm the expression of EGFP by transfecting this vector in RN-DSC cells. The IRES was used to connect BDNF gene and NT-3 gene and replaced the EGFP gene in pGC-EGFP plasmid to form the bicistronic expression vector-pGC-BDNF-IRES-NT3. After RN-DSC cells were transfected with the plas mid and treated with glucocorticoid, BDNF and NT-3 expression in the culture medium were measured by ELISA method. Finally, we found that combination therapy with the transfection of this vector and glucocorticoid had an anti-apoptotic effect in a cellular SCI model of RN-DSC cells. Therefore, the co-expression of BDNF and NT-3 by using this vector rescued the injured cells. This provided useful information for the gene-modification cell transplantation combined with glucocorticoid for the treatment of SCI. (C) 2012 Elsevier B.V. All rights resented.	[Wang, Yongxiang; Gu, Jiaxiang; Wang, Jingcheng; Feng, Xingmin; Tao, Yuping; Jiang, Baichuan; He, Jinshan; Wang, Qiang; Yang, Jiandong; Zhang, Shenfei; Cai, Jun; Sun, Yu] Univ Yangzhou, Clin Med Coll Yangzhou, Dept Orthoped Surg, Yangzhou City 225001, Jiangsu, Peoples R China	Wang, JC (corresponding author), Univ Yangzhou, Clin Med Coll Yangzhou, Dept Orthoped Surg, 98 W Nantong Rd, Yangzhou City 225001, Jiangsu, Peoples R China.	001wjc@sina.com					Allera-Moreau C, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-74; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; GRIESBECK O, 1995, J NEUROSCI RES, V42, P21, DOI 10.1002/jnr.490420104; Hiebert GW, 2002, J NEUROSCI RES, V69, P160, DOI 10.1002/jnr.10275; Ikeda O, 2002, J NEUROPATH EXP NEUR, V61, P142, DOI 10.1093/jnen/61.2.142; Ikeda O, 2001, ACTA NEUROPATHOL, V102, P239; KRAUS JF, 1975, J CHRON DIS, V28, P471, DOI 10.1016/0021-9681(75)90057-0; Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; Novikova LN, 2000, EUR J NEUROSCI, V12, P776, DOI 10.1046/j.1460-9568.2000.00978.x; Que HP, 2011, IN VITRO CELL DEV-AN, V47, P558, DOI 10.1007/s11626-011-9443-2; Shinoda M, 1996, BRAIN RES, V722, P153, DOI 10.1016/0006-8993(96)00208-9; Tuszynski MH, 2003, EXP NEUROL, V181, P47, DOI 10.1016/S0014-4886(02)00055-9	13	12	13	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	APR 11	2012	1448						137	143		10.1016/j.brainres.2012.02.007			7	Neurosciences	Neurosciences & Neurology	926OO	WOS:000302840900015	22373651				2021-06-18	
J	Sherif, C; Di Ieva, A; Gibson, D; Pakrah-Bodingbauer, B; Widhalm, G; Krusche-Mandl, I; Erdoes, J; Gilloon, B; Matula, C				Sherif, Camillo; Di Ieva, Antonio; Gibson, Daniel; Pakrah-Bodingbauer, Bita; Widhalm, Georg; Krusche-Mandl, Irena; Erdoes, Jozsef; Gilloon, Benjamin; Matula, Christian			A management algorithm for cerebrospinal fluid leak associated with anterior skull base fractures: detailed clinical and radiological follow-up	NEUROSURGICAL REVIEW			English	Article						Anterior skull base fractures; Cerebrospinal fluid (CSF) leak; Intradural bicoronal approach; Microsurgery; Traumatic brain injury	FRONTOBASAL FRACTURES; SUBCRANIAL APPROACH; CLASSIFICATION; DIAGNOSIS; FISTULAS; REPAIR; TRAUMA	Detailed outcome data for the management of anterior skull base fractures associated with cerebrospinal fluid (CSF) leakage is lacking. We present detailed follow-up data of a single-center study using a predetermined algorithm for the management of CSF leakage secondary to traumatic fractures. A number of 138 consecutive patients were included in the analysis; all patients underwent high-resolution computed tomography (CT) scanning at time of admission with beta(2)-transferrin testing used to confirm CSF leakage. Patients with acute surgical indications were operated as emergent; leaks were repaired at the time of initial surgery in patients with intracranial pressure < 15 cm H2O. The remainder of the study population was managed conservatively including use of prophylactic antibiotics; lumbar drainage (LD) catheters were placed in those patients with leakage persisting beyond 48 h. Leaks lasting longer than 5 days underwent microsurgical repair using an intradural bicoronal approach. One-year follow-up assessment included evaluation of neurological status, Glasgow Outcome Scale (GOS), and repeat head CT. Twenty eight patients (26.9%) underwent emergent surgery, 15 of whom had simultaneous CSF leak repair, whereas 76 patients (73.1%) underwent delayed CSF leak repair between days 5 and 14. Postoperative meningitis rate was low (1.9%). Postoperative CSF leak (1.9%) was managed by intradural or transnasal endoscopic operation. Comparable rates of anosmia and frontal lobe hypodensities were seen in the surgical and conservatively managed subgroups. The presented algorithm, utilizing prophylactic antibiotics, trial of LD, acute and/or delayed intradural microsurgery, yields favorable outcomes. Large randomized controlled trials are needed to better define the role of prophylactic antibiotics and to better characterize the optimal timing and approach of surgical repair.	[Sherif, Camillo; Di Ieva, Antonio; Widhalm, Georg; Matula, Christian] Med Univ Vienna, Dept Neurosurg, A-1090 Vienna, Austria; [Sherif, Camillo; Pakrah-Bodingbauer, Bita] KA Rudolfstiftung, Dept Neurosurg, A-1030 Vienna, Austria; [Di Ieva, Antonio] Med Univ Vienna, Ctr Anat & Cell Biol, Dept Systemat Anat, A-1090 Vienna, Austria; [Gibson, Daniel; Gilloon, Benjamin] Dartmouth Hitchcock Med Ctr, Dept Radiol, Lebanon, NH 03756 USA; [Krusche-Mandl, Irena; Erdoes, Jozsef] Med Univ Vienna, Dept Traumatol, A-1090 Vienna, Austria	Sherif, C (corresponding author), Med Univ Vienna, Dept Neurosurg, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	camillo.sherif@meduniwien.ac.at	Nimsky, Christopher/E-3702-2014	Nimsky, Christopher/0000-0002-8216-9410; Widhalm, Georg/0000-0001-6014-0273; Di Ieva, Antonio/0000-0002-5341-5416			Bachli H, 2009, J CRANIO MAXILL SURG, V37, P305, DOI 10.1016/j.jcms.2009.01.008; Basu D, 2006, OTOLARYNG HEAD NECK, V135, P769, DOI 10.1016/j.otohns.2006.05.025; Bell RB, 2004, J ORAL MAXIL SURG, V62, P676, DOI 10.1016/j.joms.2003.08.032; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Chesnut R, 2000, MANAGEMENT PROGNOS 2; Friedman JA, 2001, WORLD J SURG, V25, P1062, DOI 10.1007/s00268-001-0059-7; Georgantopoulou A, 2003, BRIT J PLAST SURG, V56, P10, DOI 10.1016/S0007-1226(03)00013-4; Hegazy HM, 2000, LARYNGOSCOPE, V110, P1166, DOI 10.1097/00005537-200007000-00019; Katzen JT, 2003, J TRAUMA, V54, P1026, DOI 10.1097/01.TA.0000066180.14666.8B; Kral T, 1997, NEUROSURG REV, V20, P19, DOI 10.1007/BF01390521; Kruse J, 2006, J CRANIOMAXILLOFAC T, V4, P8; Kulkarni AR, 2005, EYE, V19, P1257, DOI 10.1038/sj.eye.6701753; Locatelli D, 2006, NEUROSURGERY, V58, P246, DOI 10.1227/01.NEU.0000193924.65297.3F; Loew F, 1984, Adv Tech Stand Neurosurg, V11, P169; Madhusudan G, 2006, PLAST RECONSTR SURG, V117, P2382, DOI 10.1097/01.prs.0000218794.28670.07; Manson PN, 2009, PLAST RECONSTR SURG, V124, P2096, DOI 10.1097/PRS.0b013e3181bf8394; OBERASCHER G, 1988, Rhinology (Utrecht), V26, P89; PROBST C, 1990, ACTA NEUROCHIR, V106, P37, DOI 10.1007/BF01809331; RAVEH J, 1988, J CRANIO MAXILL SURG, V16, P160, DOI 10.1016/S1010-5182(88)80042-8; Rocchi G, 2005, SURG NEUROL, V63, P559, DOI 10.1016/j.surneu.2004.07.047; ROUSSEAUX P, 1981, NEUROCHIRURGIE, V27, P15; Sakas DE, 1998, J NEUROSURG, V88, P471, DOI 10.3171/jns.1998.88.3.0471; Samii M, 2002, NEUROL RES, V24, P147, DOI 10.1179/016164102101199693; Schaller B, 2005, ACTA NEUROCHIR, V147, P355, DOI 10.1007/s00701-005-0487-5; Scholsem M, 2008, NEUROSURGERY, V62, P463, DOI [10.1227/01.NEU.0000297037.51609.07, 10.1227/01.neu.0000316014.97926.82, 10.1227/01.neu.0000325884.05871.aa]; Sepehrnia A, 1999, NEUROSURGERY, V44, P113, DOI 10.1097/00006123-199901000-00068; Talamonti G, 1995, J Neurosurg Sci, V39, P191; Wax MK, 1997, OTOLARYNG HEAD NECK, V116, P442, DOI 10.1016/S0194-5998(97)70292-4; Zapalac JS, 2002, OTOLARYNG HEAD NECK, V126, P669, DOI 10.1067/mhn.2002.125755	29	12	13	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	APR	2012	35	2					227	237		10.1007/s10143-011-0352-3			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	911HD	WOS:000301707000017	21947554				2021-06-18	
J	Xu, WW; Jiang, GS; Chen, YW; Wang, XY; Jiang, XD				Xu, Weiwei; Jiang, Gengsi; Chen, Yanwei; Wang, Xiangyu; Jiang, Xiaodan			Prediction of minimally conscious state with somatosensory evoked potentials in long-term unconscious patients after traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Somatosensory evoked potentials; traumatic brain injury; minimally conscious state; outcome	COMATOSE PATIENTS; VEGETATIVE STATE; PROGNOSTIC VALUE; CONDUCTION TIME; BILATERAL LOSS; HEAD-INJURY; RECOVERY; DISORDERS; DIAGNOSIS	BACKGROUND: To evaluate the predictive power of somatosensory evoked potentials (SEPs) for minimally conscious state (MCS) in long-term unconscious patients after traumatic brain injury (TBI). METHODS: SEPs were recorded in 58 patients with duration of unconsciousness >30 days after TBI. SEPs were classified into three grades. Predictors including age, sex, Glasgow Coma Scale (GCS), and cause of injury were also analyzed, respectively. The outcome was divided into two groups including unconscious group and MCS group. The outcome was assessed at 12 months after TBI. RESULTS: In 58 patients, 22 of 58 were minimally conscious, 3 of 58 dead, and 33 of 57 were still in vegetative state at 12 months after TBI. SEPs grade (p = 0.001) and GCS (p = 0.010) were significantly associated with the outcome. The area under the receiver operator characteristic curve of SEPs was 0.891 +/- 0.048 (p < 0.001; 95% confidence interval, 0.798-0.984) for predicting outcome, and of GCS score was only 0.746 +/- 0.066 (p < 0.002; 95% confidence interval, 0.616-0.876). The accuracy of the whole model for predicting unconscious and MCS was 91.7% and 86.4%, respectively. The overall correct prediction was as high as 89.7% (p < 0.001). CONCLUSIONS: SEPs are excellent in predicting the outcome of long-term unconscious patients after TBI. SEPs should be considered more often and more routinely used after TBI. (J Trauma. 2012;72:1024-1030. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Xu, Weiwei; Wang, Xiangyu; Jiang, Xiaodan] So Med Univ, Zhujiang Hosp, Dept Neurosurg, Guangzhou 510282, Guangdong, Peoples R China; [Xu, Weiwei; Wang, Xiangyu; Jiang, Xiaodan] Guangdong Neurosci Inst, Guangzhou 510282, Guangdong, Peoples R China; [Jiang, Gengsi] Dongguan Peoples Hosp, Dept Neurosurg, Dongguan, Peoples R China; [Chen, Yanwei] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China	Wang, XY (corresponding author), So Med Univ, Zhujiang Hosp, Dept Neurosurg, Guangzhou 510282, Guangdong, Peoples R China.	wang_xy123@yahoo.cn; xiaodan_jiang@sina.com					BEREK K, 1995, STROKE, V26, P543, DOI 10.1161/01.STR.26.4.543; Cant B R, 1987, Electroencephalogr Clin Neurophysiol Suppl, V39, P250; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; Chiappa KH, 1998, ELECTROEN CLIN NEURO, V106, P149, DOI 10.1016/S0013-4694(97)00118-1; Claassen J, 2001, CRIT CARE MED, V29, P494, DOI 10.1097/00003246-200103000-00005; Giacino JT, 1997, SEMIN NEUROL, V17, P105, DOI 10.1055/s-2008-1040919; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Guerit J. M., 1993, Neurophysiologie Clinique, V23, P209, DOI 10.1016/S0987-7053(05)80231-X; Houlden DA, 2010, CRIT CARE MED, V38, P167, DOI 10.1097/CCM.0b013e3181c031b3; HUME AL, 1979, ANN NEUROL, V5, P379, DOI 10.1002/ana.410050412; Kane NM, 1998, ELECTROEN CLIN NEURO, V106, P244, DOI 10.1016/S0013-4694(97)00141-7; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Logi F, 2003, CLIN NEUROPHYSIOL, V114, P1615, DOI 10.1016/S1388-2457(03)00086-5; MAUGUIERE F, 1983, BRAIN, V106, P271, DOI 10.1093/brain/106.2.271; NEWLON PG, 1983, NEUROSURGERY, V12, P613, DOI 10.1227/00006123-198306000-00003; Plum F., 1983, DIAGNOSIS STUPOR COM; Pohlmann-Eden, 1997, INTENS CARE MED, V23, P301; RUMPL E, 1983, ELECTROEN CLIN NEURO, V56, P583, DOI 10.1016/0013-4694(83)90026-3; Schwarz S, 1999, CRIT CARE MED, V27, P182, DOI 10.1097/00003246-199901000-00049; Serafetinides, 1965, BRAIN, V88, P107; Sherman AL, 2000, NEUROLOGY, V54, P889, DOI 10.1212/WNL.54.4.889; Sleigh JW, 1999, J NEUROSURG, V91, P577, DOI 10.3171/jns.1999.91.4.0577; SYNEK VM, 1990, CLIN ELECTROENCEPHAL, V21, P25, DOI 10.1177/155005949002100111; Theilen HJ, 2000, J NEUROL NEUROSUR PS, V68, P657, DOI 10.1136/jnnp.68.5.657; Wade DT, 1999, BMJ-BRIT MED J, V319, P841, DOI 10.1136/bmj.319.7213.841	25	12	12	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755			J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2012	72	4					1024	1029		10.1097/TA.0b013e31824475cc			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	925TO	WOS:000302784600049	22491621				2021-06-18	
J	Mirzayan, MJ; Probst, C; Samii, M; Krettek, C; Gharabaghi, A; Pape, HC; van Griensven, M; Samii, A				Mirzayan, M. J.; Probst, C.; Samii, M.; Krettek, C.; Gharabaghi, A.; Pape, H. C.; van Griensven, M.; Samii, A.			Histopathological features of the brain, liver, kidney and spleen following an innovative polytrauma model of the mouse	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article						Brain injury; Controlled cortical impact; Fracture; Mouse; Neuroprotection; Neurotrauma; Polytrauma	NEUROGENIC PULMONARY-EDEMA; HEAD-INJURY; FLUID PERCUSSION; EPINEPHRINE; PRESSURE; TRAUMA	Object: Among the various introduced experimental traumatic brain injury models, there is a clear paucity of proper experimental polytrauma models. To overcome this experimental gap we introduced such a polytrauma model in the mouse including traumatic brain injury. Here, we report on the histopathological features of the brain, lung, kidney, spleen and liver. Materials and methods: 20 male C57BL mice with a mean weight of 23 g were anesthetized with ketamine and xylazine. The anaesthetized animals were subjected to a controlled cortical impact (CCI) over the left parieto-temporal cortex using rounded-tip impounder for application of a standardized brain injury. Following fracture of the right femur using a guillotine, a volume-controlled hemorrhagic shock was induced. The control groups included animals with CCI only (n = 20) and animals with femur fracture plus hemorrhagic shock without CCI (n = 20). Subjects were sacrified at 96h following trauma. Brain, lung, kidney, spleen and liver of the animals underwent histopathological examinations. Results: The mortality rate at 96 h was 25% in the polytrauma group versus 10% in the control groups. Within the histopathological investigations, polytraumatized animals differ from those with a single trauma (traumatic brain injury or femur fracture with hemorrhagic shock) with various severity. Conclusion: The findings of this study show that such a polytrauma model can be standardized resulting in a reproducible damage. This model fulfills the requirements of a standardized animal model. It allows adequate analogies and inferences to the clinical situation of a polytrauma in humans. (C) 2010 Elsevier GmbH. All rights reserved.	[Mirzayan, M. J.] Hannover Med Sch, Dept Neurosurg, D-30625 Hannover, Germany; [Probst, C.; Krettek, C.] Hannover Med Sch, Dept Traumatol, D-30625 Hannover, Germany; [Samii, M.; Samii, A.] Int Neurosci Inst Hannover, Hannover, Germany; [Gharabaghi, A.] Univ Tubingen, Dept Neurosurg, Tubingen, Germany; [Pape, H. C.] Univ Penn, Dept Orthopaed Trauma, Pittsburgh, PA USA; [van Griensven, M.] AUVA Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria	Mirzayan, MJ (corresponding author), Hannover Med Sch, Dept Neurosurg, Carl Neuberg Str 1, D-30625 Hannover, Germany.	mirzayan@hotmail.com	van Griensven, Martijn/F-5808-2012	van Griensven, Martijn/0000-0001-5104-9881; Krettek, Christian/0000-0001-9807-0020			Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137; ASANO T, 1989, MOL CHEM NEUROPATHOL, V10, P101, DOI 10.1007/BF03159717; BOGGS DR, 1975, CLIN HAEMATOL, V4, P535; Campbell SJ, 2008, NEUROPHARMACOLOGY, V55, P780, DOI 10.1016/j.neuropharm.2008.06.074; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; CRITTENDEN DJ, 1982, J TRAUMA, V22, P766, DOI 10.1097/00005373-198209000-00008; DAVIS JM, 1991, J TRAUMA, V31, P725, DOI 10.1097/00005373-199106000-00001; GARCIAURIA J, 1981, J NEUROSURG, V54, P632, DOI 10.3171/jns.1981.54.5.0632; Haljamae H, 1988, Prog Clin Biol Res, V264, P17; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; HILTUNEN A, 1993, J ORTHOP RES, V11, P305, DOI 10.1002/jor.1100110219; Hinshaw LB, 1996, CRIT CARE MED, V24, P1072, DOI 10.1097/00003246-199606000-00031; Hofstetter T, 2007, J NEUROSURG, V106, P701, DOI 10.3171/jns.2007.106.4.701; Jiang J, 1997, Chin Med Sci J, V12, P41; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; MARON MB, 1979, J APPL PHYSIOL, V47, P153; Mirzayan MJ, 2008, NEUROL RES, V30, P457, DOI 10.1179/174313208X276907; Morken JJ, 2002, SHOCK, V18, P46, DOI 10.1097/00024382-200207000-00009; Pace N, 1977, BIOCHEM BIOPH RES CO, V56, P129; Regel G, 1996, WORLD J SURG, V20, P422, DOI 10.1007/s002689900067; REGEL G, 1993, UNFALLCHIRURG, V96, P350; SINGBARTL G, 1981, ANAESTHESIST, V30, P431; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stahel P, 2004, UNFALLCHIRURGIE; van Griensven M, 1999, SHOCK, V11, P259, DOI 10.1097/00024382-199904000-00006; van Griensven M, 2002, EXP TOXICOL PATHOL, V54, P203, DOI 10.1078/0940-2993-00247; WAUCHOB TD, 1984, ANAESTHESIA, V39, P529, DOI 10.1111/j.1365-2044.1984.tb07355.x; Yildirim E, 2004, EUR J CARDIO-THORAC, V25, P523, DOI 10.1016/j.ejcts.2003.12.021; YUAN X-Q, 1990, Journal of Neurotrauma, V7, P141, DOI 10.1089/neu.1990.7.141	30	12	13	0	5	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0940-2993	1618-1433		EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	MAR	2012	64	3					133	139		10.1016/j.etp.2010.07.007			7	Pathology; Toxicology	Pathology; Toxicology	922QG	WOS:000302562200001	20688496				2021-06-18	
J	Rammo, RA; DeFazio, MV; Bullock, MR				Rammo, Richard A.; DeFazio, Michael V.; Bullock, M. Ross			Management of Migrating Intracranial Bullets: Lessons Learned from Surviving an AK-47 Bullet Through the Lateral Brainstem	WORLD NEUROSURGERY			English	Article						Bullet; Foreign-body; Gunshot wound; Intracranial; Migration; Missile; Penetrating brain injury; Spontaneous movement; Traumatic brain injury	SPONTANEOUS MOVEMENT	OBJECTIVE: Survival after a gunshot wound (GSW) to the head is becoming more common, with an accompanying increase in spontaneous migration of these intracranial bullet fragments. This phenomenon is well described in current literature and is a potentially life-threatening delayed complication of GSW to the head. METHODS: We present the case of a 17-year-old boy who survived a penetrating GSW to the cranium and cerebellum after an accident involving an AK (Automatic Kalashnikov)-47 (7.62 mm). RESULTS: Following initial attempts to remove the bullet and associated hematoma from the cerebellar hemisphere, intraoperative fluoroscopy revealed that the bullet had migrated to lie within the right middle cerebellar peduncle with the development of intraoperative cardiac arrhythmia. The bullet could not be retrieved without risk of damage to the superior and inferior cerebellar arteries. The patient then developed bacterial meningitis, and further imaging revealed the bullet had again migrated under the cerebellar cortex to an accessible location. The infection was treated with aggressive antibiotic therapy and the bullet was removed from the posterior fossa, thus preventing recurrence of infection and further migration. The patient regained full motor, speech, and proprioceptive function within months after injury. CONCLUSION: The potential for spontaneous migration exists with any penetrating brain injury involving a retained foreign body. When a retained intracranial foreign body is unable to be safely extracted during initial debridement, close clinical evaluation is essential and plain-film or computed tomographic imaging should be considered in order to enhance the early detection of delayed-onset life-threatening deterioration, such as meningitis and occlusion of cerebrospinal fluid drainage, because of spontaneous migration.	[Bullock, M. Ross] Univ Miami, Dept Neurol Surg, Miller Sch Med, Coral Gables, FL 33124 USA; Jackson Mem Hosp, Lois Pope LIFE Ctr, Miami, FL 33136 USA	Bullock, MR (corresponding author), Univ Miami, Dept Neurol Surg, Miller Sch Med, Coral Gables, FL 33124 USA.	rbullock@med.miami.edu					Aarabi B, 2001, J TRAUMA, V51, pS3; Agrawal A, 2008, J NEPAL MED ASSOC, V47, P145; [Anonymous], 2001, J TRAUMA, V51, pS34; [Anonymous], 2001, J TRAUMA, V51, pS16; ARASIL E, 1982, J NEUROSURG, V56, P158, DOI 10.3171/jns.1982.56.1.0158; Duman H, 2002, NEUROL MED-CHIR, V42, P332, DOI 10.2176/nmc.42.332; Fujimoto Y, 2001, NEUROL MED-CHIR, V41, P499, DOI 10.2176/nmc.41.499; Griva F, 2000, SURG NEUROL, V54, P267, DOI 10.1016/S0090-3019(00)00300-1; Hughes BD, 2006, J NEUROSURG, V105, P233, DOI 10.3171/ped.2006.105.3.233; Kamenski Robert S, 2008, J Trauma, V65, pE13, DOI 10.1097/01.ta.0000224219.64266.4c; Karabagli H, 2005, PEDIATR NEUROSURG, V41, P148, DOI 10.1159/000085873; KAUFMAN HH, 1993, NEUROSURGERY, V32, P962, DOI 10.1227/00006123-199306000-00013; KERIN DS, 1983, SURG NEUROL, V20, P301, DOI 10.1016/0090-3019(83)90084-8; Kocak A, 2004, AM J FOREN MED PATH, V25, P246, DOI 10.1097/01.paf.0000127403.97576.0b; MILHORAT TH, 1993, NEUROSURGERY, V32, P140; Misser SK, 2005, SAMJ S AFR MED J, V95, P661; OTT K, 1976, J NEUROSURG, V44, P80, DOI 10.3171/jns.1976.44.1.0080; Ozkan U, 2006, CLIN NEUROL NEUROSUR, V108, P573, DOI 10.1016/j.clineuro.2005.03.002; Rapp LG, 1999, NEUROL RES, V21, P475, DOI 10.1080/01616412.1999.11740961; RENGACHARY SS, 1992, NEUROSURGERY, V30, P291, DOI 10.1227/00006123-199202000-00029; Rinaldi A, 2000, J Neurosurg Sci, V44, P107; Salvati M, 1997, J Neurosurg Sci, V41, P423; Yadav YR, 2006, NEUROL INDIA, V54, P453, DOI 10.4103/0028-3886.28138; YOUNG WF, 1993, SOUTHERN MED J, V86, P557, DOI 10.1097/00007611-199305000-00014	24	12	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR-APR	2012	77	3-4							591.e19	10.1016/j.wneu.2011.06.015			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	961GG	WOS:000305451600053	22120363				2021-06-18	
J	Shimada, R; Nakao, K; Furutani, R; Kibayashi, K				Shimada, Ryo; Nakao, Ken-ichiro; Furutani, Rui; Kibayashi, Kazuhiko			A rat model of changes in dural mast cells and brain histamine receptor H3 expression following traumatic brain injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Dura; Head trauma; Histamine receptor; Mast cell	TRYPTASE; EDEMA	Mast cells can secrete histamine in response to extrinsic stimuli. Histamine plays a role in the development of brain edema and can induce histamine receptor H3 (HRH3) expression in the brain to provide protective feedback effects against histamine neurotoxicity. We investigated time-dependent changes in dural mast cell numbers and HRH3 expression in the brain for one to 14 days after traumatic brain injury in a controlled cortical impact model in the rat. The number of tryptase-immunoreactive dural mast cells at the site of impact was significantly decreased one and four days after the injury. Furthermore, immunoreactivity and messenger RNA (mRNA) expression of HRH3 at the underlying cortical contusion site were significantly increased one and four days after the injury. These data suggest that histamine released from degranulated unstainable mast cells induces a transient increase in presynaptic autoinhibitory HRH3 immunoreactivity and mRNA expression as a mechanism to counteract histamine neurotoxicity. (C) 2011 Elsevier Ltd. All rights reserved.	[Shimada, Ryo; Nakao, Ken-ichiro; Furutani, Rui; Kibayashi, Kazuhiko] Tokyo Womens Med Univ, Sch Med, Dept Legal Med, Shinjuku Ku, Tokyo 1628666, Japan	Shimada, R (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Legal Med, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	shimada@research.twmu.ac.jp	Kazuhiko, Kibayashi/F-5173-2013	Kazuhiko, Kibayashi/0000-0001-6510-5215	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [19390186, 21659177]	This work was supported by grants to Kazuhiko Kibayashi from the Japan Society for the Promotion of Science (no. 19390186 and 21659177).	ARRANG JM, 1987, NEUROSCIENCE, V23, P149, DOI 10.1016/0306-4522(87)90279-X; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; BUTT AM, 1992, BRAIN RES, V569, P100, DOI 10.1016/0006-8993(92)90374-I; Santos PPD, 2011, ARCH ORAL BIOL, V56, P231, DOI 10.1016/j.archoralbio.2010.09.020; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Hyong A, 2008, BRAIN RES, V1215, P218, DOI 10.1016/j.brainres.2008.04.025; Kibayashi K, 2011, AM J FORENSIC MED PA; MOHANTY S, 1989, J NEUROL SCI, V90, P87, DOI 10.1016/0022-510X(89)90048-8; Nakao K, 2010, J NEUROTRAUM, V27, P1925, DOI 10.1089/neu.2010.1379; Nuutinen S, 2011, NEUROPHARMACOLOGY, V60, P1193, DOI 10.1016/j.neuropharm.2010.10.027; Onodera K, 1999, Nihon Yakurigaku Zasshi, V114, P89; Sander LE, 2006, GUT, V55, P498, DOI 10.1136/gut.2004.061762; Stokely ME, 2008, J NEUROTRAUM, V25, P52, DOI 10.1089/neu.2007.0397; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; WALLS AF, 1990, J PATHOL, V162, P119, DOI 10.1002/path.1711620204	15	12	13	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	MAR	2012	19	3					447	451		10.1016/j.jocn.2011.06.033			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	904AD	WOS:000301165100022	22277566				2021-06-18	
J	Sun, M; Yuan, W; Hertzler, DA; Cancelliere, A; Altaye, M; Mangano, FT				Sun, M.; Yuan, W.; Hertzler, D. A.; Cancelliere, A.; Altaye, M.; Mangano, F. T.			Diffusion tensor imaging findings in young children with benign external hydrocephalus differ from the normal population	CHILDS NERVOUS SYSTEM			English	Article						Benign external hydrocephalus; Benign extra axial fluid of infancy; Diffusion tensor imaging; Fractional anisotropy; Mean diffusivity; Pediatric hydrocephalus	TRAUMATIC BRAIN-INJURY; NORMAL-PRESSURE HYDROCEPHALUS; WHITE-MATTER MATURATION; CLINICAL ARTICLE; EARLY-CHILDHOOD; INFANTS; PREDICTORS	Purpose To compare a pediatric population diagnosed with benign external hydrocephalus (BEH) to normal age-matched controls using diffusion tensor imaging (DTI) techniques. Methods We retrospectively identified 17 BEH patients by specific clinical and neuroimaging criteria. Fractional anisotropy (FA) and mean diffusivity (MD) values obtained from DTI scans were compared to a population of age-matched controls and group differences were examined by mixed model analysis. A longitudinal comparison was completed on a subset that underwent multiple scans (n=8). Results In the genu of the corpus callosum (gCC), six of 15 BEH children had an FA value above the upper limit of 95% prediction interval, nine of 15 BEH children had MD values below the lower limit of 95% prediction interval. A similar trend applied to the other regions of interest (ROIs): splenium of the corpus callosum (sCC), ALIC, and PLIC. Statistical analysis demonstrated significant differences in FA within the gCC, sCC, and PLIC and in MD within the sCC between BEH patients and controls given (P=0.05). No statistical differences were identified at any ROIs at the later scans. Conclusions We found a significant increase in FA and decrease in MD in children with BEH compared with normal children in specific white matter (WM) ROIs, notably in the gCC and sCC; furthermore, in longitudinal comparison, DTI parameters normalized over time. The current study further demonstrates the ability of DTI to distinguish between subtle diffusion changes in periventricular white matter and establishes preliminary objective radiographic parameters for watchful observation of patients with BEH.	[Sun, M.; Hertzler, D. A.; Cancelliere, A.; Mangano, F. T.] Dept Neurosurg, Div Pediat Neurosurg, Cincinnati, OH 44529 USA; [Yuan, W.] Pediat Neuroimaging Res Consortium, Cincinnati, OH 44529 USA; [Altaye, M.] Univ Cincinnati, Div Biostat & Epidemiol, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 44529 USA	Mangano, FT (corresponding author), Dept Neurosurg, Div Pediat Neurosurg, MLC 2016,3333 Burnet Ave, Cincinnati, OH 44529 USA.	francesco.mangano@cchmc.org	Altaye, Mekibib/N-5274-2015		Cincinnati Children's Hospital Medical Center	This study was supported in part by the Robert L. McLaurin MD Faculty Development Scholarship at Cincinnati Children's Hospital Medical Center.	Air EL, 2010, J NEUROSURG-PEDIATR, V5, P385, DOI 10.3171/2009.11.PEDS09343; ALVAREZ LA, 1986, PEDIATRICS, V77, P901; Ashwal S, 2006, DEV NEUROSCI-BASEL, V28, P309, DOI 10.1159/000094157; Assaf Y, 2006, AM J NEURORADIOL, V27, P1717; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Boujraf S, 2002, MAGN RESON IMAGING, V20, P327, DOI 10.1016/S0730-725X(02)00501-5; Bradley WG, 2006, J MAGN RESON IMAGING, V24, P747, DOI 10.1002/jmri.20684; Cascio CJ, 2007, J AM ACAD CHILD PSY, V46, P213, DOI 10.1097/01.chi.0000246064.93200.e8; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Gao W, 2009, AM J NEURORADIOL, V30, P290, DOI 10.3174/ajnr.A1363; Gauvain KM, 2001, AM J ROENTGENOL, V177, P449, DOI 10.2214/ajr.177.2.1770449; Girard NJ, 2001, CHILD NERV SYST, V17, P239, DOI 10.1007/PL00013727; Hattingen E, 2010, NEUROSURGERY, V66, P917, DOI 10.1227/01.NEU.0000367801.35654.EC; Hermoye L, 2006, NEUROIMAGE, V29, P493, DOI 10.1016/j.neuroimage.2005.08.017; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kumar R, 2006, CHILD NERV SYST, V22, P1237, DOI 10.1007/s00381-006-0047-1; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Leliefeld PH, 2010, J NEUROSURG-PEDIATR, V5, P562, DOI 10.3171/2010.2.PEDS09309; Leliefeld PH, 2009, J NEUROSURG-PEDIATR, V4, P56, DOI 10.3171/2009.3.PEDS08337; Medina LS, 2001, AM J NEURORADIOL, V22, P564; Nevo Y, 2002, PEDIATR NEUROL, V27, P363, DOI 10.1016/S0887-8994(02)00454-X; O'Hayon BB, 1998, PEDIATR NEUROSURG, V29, P245, DOI 10.1159/000028730; Olney Ann Haskins, 2007, Semin Pediatr Neurol, V14, P128, DOI 10.1016/j.spen.2007.07.004; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Papasian NC, 2000, PEDIATR NEUROSURG, V33, P188, DOI 10.1159/000055951; Pena A, 2006, BRIT J RADIOL, V79, P101, DOI 10.1259/bjr/24908512; PETTIT RE, 1980, ARCH NEUROL-CHICAGO, V37, P518, DOI 10.1001/archneur.1980.00500570066011; Provenzale JM, 2007, AM J ROENTGENOL, V189, P476, DOI 10.2214/AJR.07.2132; Saksena S, 2008, CEREBELLUM, V7, P392, DOI 10.1007/s12311-008-0041-0; Schmithorst VJ, 2010, BRAIN COGNITION, V72, P16, DOI 10.1016/j.bandc.2009.06.005; Smith R, 1998, PEDIATR RADIOL, V28, P143, DOI 10.1007/s002470050315; Suara RO, 2001, J NATL MED ASSOC, V93, P70; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Tarnaris A, 2009, J NEUROSURG, V110, P837, DOI 10.3171/2007.9.17572; Wilde EA, 2006, J CHILD NEUROL, V21, P769, DOI 10.1177/08830738060210090201; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698; Yuan W, 2009, AM J NEURORADIOL, V30, P1792, DOI 10.3174/ajnr.A1663; Yuan W, 2008, J NEUROSURG-PEDIATR, V1, P263, DOI 10.3171/PED/2008/1/4/263	40	12	14	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	FEB	2012	28	2					199	208		10.1007/s00381-011-1651-2			10	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	897PU	WOS:000300666300004	22167268				2021-06-18	
J	Colantonio, A; Comper, P				Colantonio, A.; Comper, P.			Post-injury symptoms after work related traumatic brain injury in Canadian population	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Work; post-concussion syndrome; return to work; rehabilitation	POSTTRAUMATIC-STRESS-DISORDER; HEAD-INJURY; FOLLOW-UP; RELIABILITY; RETURN	Objectives: To examine the nature and extent of persistent post-injury symptoms of persons who have experienced a work-related traumatic brain injury (WrTBI) in Ontario, Canada. Methods: Using a retrospective case series design, post-injury symptoms, occupation, and work factors were examined for WrTBIs among an adult population. Data were abstracted from medical records of individuals who sustained a WrTBI and were discharged from a referral-based outpatient neurology service between the years of 1998 and 2001. Results: Of the 435 individuals who sustained a WrTBI, most were >= 45 years of age and male. Approximately 50% had injuries to the head only, while others had multiple injuries. The most common post-injury symptoms were headaches (85.1%), memory changes (74.3%), and mood/personality changes (68.3%). A small subset of individuals reported very long-term post-injury symptoms, and a majority of individuals had not yet returned to work. Conclusions: This study profiles the demographic and clinical characteristics of an outpatient injured worker population with a history of WrTBI which provides a basis for the planning and implementation of assessment and treatment programs for this clinical population.	[Colantonio, A.] Univ Toronto, Fac Med, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada; [Colantonio, A.; Comper, P.] Toronto Rehabil Inst UHN, Toronto, ON, Canada; [Colantonio, A.] Univ Toronto, Div Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON M5G 1V7, Canada	Colantonio, A (corresponding author), Univ Toronto, Fac Med, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765			Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Canadian Institute for Health Information, 2006, HEAD INJ CAN DEC CHA; Centers for Disease Control and Prevention, TRAUM BRAIN INJ; Colantonio A, 2010, CAN J PUBLIC HEALTH, V101, pS58, DOI 10.1007/BF03403848; Colantonio A, 2009, BRAIN INJURY, V23, P873, DOI 10.1080/02699050903036033; de Guise E, 2005, CAN J NEUROL SCI, V32, P186, DOI 10.1017/S0317167100003954; Engel L, 2009, EVAL HEALTH PROF, V32, P281, DOI 10.1177/0163278709338561; Health Canada, 2002, EC BURD ILLN CAN; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Kim H, 2006, NEUROREHABILITATION, V21, P269; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Kristman VL, 2008, BRAIN INJURY, V22, P51, DOI 10.1080/02699050701849991; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Ray SL, 2008, ARCH PSYCHIAT NURS, V22, P217, DOI 10.1016/j.apnu.2007.08.005; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Tricco AC, 2006, BRAIN INJURY, V20, P719, DOI 10.1080/02699050600664640; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Villemure R, 2011, BRAIN INJURY, V25, P53, DOI 10.3109/02699052.2010.531881; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	31	12	13	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815			WORK	Work		2012	43	2					195	201		10.3233/WOR-2012-1377			7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	012CX	WOS:000309214100009	22927617				2021-06-18	
J	Hsieh, MY; Ponsford, J; Wong, D; Schonberger, M; McKay, A; Haines, K				Hsieh, Ming-Yun; Ponsford, Jennie; Wong, Dana; Schoenberger, Michael; McKay, Adam; Haines, Kerrie			Development of a motivational interviewing programme as a prelude to CBT for anxiety following traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Anxiety; Motivational interviewing; Cognitive behaviour therapy; Traumatic brain injury	WORKING ALLIANCE INVENTORY; SCHEDULED TELEPHONE INTERVENTION; COGNITIVE-BEHAVIORAL THERAPY; CASE EXPERIMENTAL-DESIGN; PSYCHOTHERAPY-RESEARCH; PSYCHIATRIC-DISORDERS; DEPRESSION SCALE; HOSPITAL ANXIETY; EMOTIONAL STATUS; SELF-GENERATION	A brief preparatory programme, based on the principles of motivational interviewing (MI), was developed as a way of engaging clients with traumatic brain injury (TBI) and preparing them for a cognitive behaviour therapy (CBT) programme for anxiety. The MI + CBT programme was delivered to a male client in his early 40s with severe TBI at four months post-injury, using a single-subject design with repeated measures pre- and post-treatment. The client received three sessions of manualised MI, followed by nine sessions of CBT. The MI sessions focused on helping the client to develop more realistic goals and supporting his self-efficacy about his ability to cope with anxiety. Specific strategies were used to accommodate the client's cognitive limitations, such as the use of personally meaningful metaphors and role plays. Re-assessments were conducted at the end of MI, CBT and nine weeks post-treatment, using a semi-structured clinical interview and self-report measures of anxiety, mood and change expectancy. The client showed significant improvement in anxiety following treatment and a significant reduction in subjective units of distress (SUDS) between the MI and CBT phases. The results suggest the potential utility of MI in people with TBI, and the need to evaluate treatment protocols in a controlled trial.	[Hsieh, Ming-Yun; Ponsford, Jennie; Wong, Dana; McKay, Adam; Haines, Kerrie] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Hsieh, Ming-Yun; Ponsford, Jennie] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia; [McKay, Adam] Epworth Med Fdn, Melbourne, Vic, Australia; [Hsieh, Ming-Yun] Arbias, Melbourne, Vic, Australia; [Schoenberger, Michael] Univ Freiburg, Inst Psychol, Dept Rehabil Psychol & Psychotherapy, Freiburg, Germany	Ponsford, J (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu	Wong, Dana/AAD-3410-2020; McKay, Adam JD/M-6003-2017	McKay, Adam JD/0000-0002-0479-7681; Wong, Dana/0000-0001-9619-1929	Monash UniversityMonash University; Victorian Brain Injury Recovery Association	This study was supported by a grant from Monash University, and a scholarship from the Victorian Brain Injury Recovery Association. The funding sources had no role in study design, data collection or analysis. The authors alone were responsible for the content and writing of the paper. A portion of the preliminary findings of this paper was presented at the Australian Association of Cognitive and Behaviour Therapy conference in Melbourne, April 2010. The data reported herein are from the first author's doctoral thesis, which was supervised by the second, third and fourth authors. The authors would like to thank all participants who helped to make this work possible. Special thanks to the staff members at the Monash-Epworth Rehabilitation Research Unit, Epworth Hospital and The Victorian Rehabilitation Centre. We gratefully acknowledge Dr Henny Westra and Dr David Dozois, who generously provided us with their MI treatment manual for adaptation.	Andrews G., 2003, TREATMENT ANXIETY DI, V2nd; Arkowitz H., 2008, MOTIVATIONAL INTERVI; Beck J.S., 1995, COGNITIVE THERAPY BA; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bombardier CH, 1999, REHABIL PSYCHOL, V44, P52, DOI 10.1037/0090-5550.44.1.52; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Borckardt JJ, 2008, AM PSYCHOL, V63, P77, DOI 10.1037/0003-066X.63.2.77; Borckardt JJ, 2006, SMA SIMULATION MODEL; Bordin E. S., 1979, PSYCHOTHER-THEOR RES, V16, P252, DOI DOI 10.1037/H0085885; Burke B. L., 2004, J COGN PSYCHOTHER, V18, P309, DOI [DOI 10.1891/JC0P.18.4.309.64002, 10.1891/jcop.18.4.309.64002]; Burke BL, 2003, J CONSULT CLIN PSYCH, V71, P843, DOI 10.1037/0022-006X.71.5.843; Busseri MA, 2003, PSYCHOL ASSESSMENT, V15, P193, DOI 10.1037/1040-3590.15.2.193; Coughlin A, 2007, MEMORY INFORM PROCES; Cox WM, 2003, J ADDICT DIS, V22, P93, DOI 10.1300/J069v22n01_07; Cuijpers P, 2008, J CONSULT CLIN PSYCH, V76, P909, DOI 10.1037/a0013075; Dawkins N, 2006, BRAIN INJURY, V20, P1235, DOI 10.1080/02699050601076414; Devilly GJ, 2005, RELIABLE CLIN CHANGE, V4.0; Dozois DJA, 2005, BEHAV RES THER, V43, P1655, DOI 10.1016/j.brat.2004.12.001; Dozois DJA, 2004, BEHAV RES THER, V42, P711, DOI 10.1016/S0005-7967(03)00193-1; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; First M.B., 2007, STRUCTURED CLIN INTE; Fleming JM, 1996, BRAIN INJURY, V10, P1; Giles GM, 2006, J HEAD TRAUMA REHAB, V21, P168, DOI 10.1097/00001199-200603000-00009; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Goverover Y, 2010, AM J OCCUP THER, V64, P540, DOI 10.5014/ajot.2010.09020; Hatcher RL, 2006, PSYCHOTHER RES, V16, P12, DOI 10.1080/10503300500352500; Hettema J, 2005, ANNU REV CLIN PSYCHO, V1, P91, DOI 10.1146/annurev.clinpsy.1.102803.143833; HORVATH AO, 1989, J COUNS PSYCHOL, V36, P223, DOI 10.1037/0022-0167.36.2.223; Hsieh MY, 2012, BRAIN INJURY, V26, P126, DOI 10.3109/02699052.2011.635365; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kertes A, 2011, COGN BEHAV PRACT, V18, P55, DOI 10.1016/j.cbpra.2009.06.005; Lane-Brown A, 2010, J HEAD TRAUMA REHAB, V25, P459, DOI 10.1097/HTR.0b013e3181d98e1d; Lundahl BW, 2010, RES SOCIAL WORK PRAC, V20, P137, DOI 10.1177/1049731509347850; Manchester D, 2001, BRAIN DAM B, P157; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Mendel E., 2002, BRIT J LEARN DISABIL, V30, P153, DOI DOI 10.1046/J.1468-3156.2002.00209.X; Miller W. R., 2002, MOTIVATIONAL INTERVI; Moyers T. B., 2006, PERSONAL GOALS VALUE; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; PsycBITE Committee, 2010, RAT MAN SINGL UNPUB; Schefft BK, 2008, APPL NEUROPSYCHOL, V15, P61, DOI 10.1080/09084280801917806; Shallice, 1997, HAYLING BRIXTON TEST; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; Tate RL, 2008, NEUROPSYCHOL REHABIL, V18, P385, DOI 10.1080/09602010802009201; Westra H. A., 2003, MOTIVATIONAL INTERVI; Westra HA, 2007, J CONSULT CLIN PSYCH, V75, P363, DOI 10.1037/0022-006X.75.3.363; Westra HA, 2006, COGNITIVE THER RES, V30, P481, DOI 10.1007/s10608-006-9016-y; Westra HA, 2010, TREATMENT RESISTANT ANXIETY DISORDERS: RESOLVING IMPASSES TO SYMPTOM REMISSION, P199; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Wilson, 1991, NATL ADULT READING T; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P246, DOI DOI 10.1375/BRIM.7.3.246; Ylvisaker M, 2000, BRAIN IMPAIR, V1, P12, DOI DOI 10.1375/BRIM.1.1.12; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	57	12	13	0	16	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2012	22	4					563	584		10.1080/09602011.2012.676284			22	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	995SC	WOS:000308031600006	22632450				2021-06-18	
J	Johnson, SC; Silverberg, ND; Millis, SR; Hanks, RA				Johnson, Season C.; Silverberg, Noah D.; Millis, Scott R.; Hanks, Robin A.			Symptom Validity Indicators Embedded in the Controlled Oral Word Association Test	CLINICAL NEUROPSYCHOLOGIST			English	Article						Symptom validity; Verbal fluency; Controlled Oral Word Association Test; COWAT	TRAUMATIC BRAIN-INJURY; MALINGERED NEUROCOGNITIVE DYSFUNCTION; MILD COGNITIVE IMPAIRMENT; VERBAL FLUENCY; RESPONSE BIAS; PERFORMANCE PATTERNS; CHRONIC PAIN; BASE RATES; ADULTS	Embedded symptom validity measures facilitate the detection of below-capacity performance in neuropsychological assessment. A number of such indicators have been proposed for the Controlled Oral Word Association Test (COWAT), a widely used test of word generation. However, several of these embedded indicators have not been cross-validated and it is currently unclear which represent the optimal combination of predictors. This study used Bayesian Model Averaging (BMA) to determine the set of predictors that best differentiate between patients presenting with (n = 46) and without (n = 55) malingered neurocognitive dysfunction (MND). Mild traumatic brain injury was the most common diagnosis in the MND group (96%). BMA selected the COWAT total score and a measure of change in output over time. A logistic regression model combining these variables yielded good discriminability, with an AUC of .774, (95% confidence interval = .679 to .869), 78% of cases were classified correctly, with 67% sensitivity and 88% specificity. Two alternative models performed similarly, but the variables involved required slightly longer administration and/or calculation time, making them somewhat less desirable. These results support the use of a weighted combination of embedded symptom validity measures in the COWAT.	[Silverberg, Noah D.] GF Strong Rehab Ctr, Vancouver, BC V5Z 2G9, Canada; [Johnson, Season C.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Silverberg, Noah D.] Univ British Columbia, Dept Med, Dept Phys Med & Rehabil, Vancouver, BC, Canada; [Millis, Scott R.; Hanks, Robin A.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA	Silverberg, ND (corresponding author), GF Strong Rehab Ctr, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	noah.silverberg@vch.ca					Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; Benton A., 1994, MULTILINGUAL APHASIA; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Boone, 2007, ASSESSMENT FEIGNED C; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Brennan AM, 2006, APPL NEUROPSYCHOL, V13, P1, DOI 10.1207/s15324826an1301_1; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Crowe SF, 1998, J CLIN EXP NEUROPSYC, V20, P391, DOI 10.1076/jcen.20.3.391.810; Crowe SF, 2001, BRAIN COGNITION, V47, P323; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2009, ARCH PHYS MED REHAB, V90, P1117, DOI 10.1016/j.apmr.2009.01.018; Haines ME, 1995, NEUROPSYCHOL REV, V5, P125, DOI 10.1007/BF02208438; Haines ME, 2001, CLIN NEUROPSYCHOL, V15, P171, DOI 10.1076/clin.15.2.171.1891; Hardin JW, 2007, GEN LINEAR MODEL EXT; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kave G, 2011, J CLIN EXP NEUROPSYC, V33, P358, DOI 10.1080/13803395.2010.518703; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; MADIGAN D, 1994, J AM STAT ASSOC, V89, P1535, DOI 10.2307/2291017; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; MITTENBERG W, 2002, J FORENSIC NEUROPSYC, V3, P227, DOI DOI 10.1300/J151V03N01_03; Murphy KI, 2006, J INT NEUROPSYCH SOC, V12, P570, DOI 10.1017/S1355617706060590; Nutter-Upham KE, 2008, ARCH CLIN NEUROPSYCH, V23, P229, DOI 10.1016/j.acn.2008.01.005; R Core Team, 2012, R LANG ENV STAT COMP; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Silverberg ND, 2008, CLIN NEUROPSYCHOL, V22, P140, DOI 10.1080/13854040601160597; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; StataCorp, 2011, STAT STAT SOFTW REL; Taler V, 2008, J CLIN EXP NEUROPSYC, V30, P501, DOI 10.1080/13803390701550128; Traykov L, 2007, COGN BEHAV NEUROL, V20, P219, DOI 10.1097/WNN.0b013e31815e6254; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Zakzanis KK, 2011, J CLIN EXP NEUROPSYC, V33, P785, DOI 10.1080/13803395.2011.558496	38	12	13	0	14	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2012	26	7					1230	1241		10.1080/13854046.2012.709886			12	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	027DE	WOS:000310331200013	22856612				2021-06-18	
J	Martinez, E; Navarro, A; Ordonez, C; del Valle, E; Tolivia, J				Martinez, Eva; Navarro, Ana; Ordonez, Cristina; del Valle, Eva; Tolivia, Jorge			Amyloid-beta(25-35) Induces Apolipoprotein D Synthesis and Growth Arrest in HT22 Hippocampal Cells	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; amyloid-beta(25-35); apolipoprotein D; growth arrest; HT22; oxidative stress	MESSENGER-RNA EXPRESSION; AMYLOID-BETA; ALZHEIMERS-DISEASE; D GENE; OXIDATIVE STRESS; MOLECULAR CHARACTERIZATION; TISSUE DISTRIBUTION; RETINOIC ACID; MECHANISMS; BRAIN	Apolipoprotein D (ApoD) is a secreted glycoprotein that is markedly induced in several pathological and stressful conditions in the nervous system. In the central nervous system, ApoD expression is upregulated during aging, after traumatic brain injury, and in several human neuropathologies such as Alzheimer's disease (AD), where it is found associated with amyloid-beta (A beta) plaques. Recent studies have indicated that ApoD has an important function as a neuroprotective and antioxidant protein. The aim of this work is to study the effect of the peptide fragment A beta(25-35), which is believed to play a major role in the neurodegenerative process of AD, in ApoD expression in a mouse hippocampal cell line. In addition, we studied whether direct addition of exogenous human recombinant ApoD protein has neuroprotective effect against A beta(25-35) treatment on neuronal cells. Our results demonstrate that A beta(25-35) induces ApoD expression in hippocampal cells in response to stress-induced growth arrest. This observed relationship between A beta and ApoD expression could explain the elevated levels of ApoD found in AD brain, where it may be a neuroprotective molecule in the course of AD, probably related to its lipid transport function or a direct antioxidant property. However, the addition of exogenous human recombinant ApoD does not exert any protective effect, most likely due to its major structural modifications.	[Martinez, Eva; Navarro, Ana; del Valle, Eva; Tolivia, Jorge] Univ Oviedo, Dept Morfol & Biol Celular, Fac Biol & Med, E-33006 Oviedo, Spain; [Ordonez, Cristina] CIMA, Area Neurociencias, Pamplona, Spain	Tolivia, J (corresponding author), Univ Oviedo, Dept Morfol & Biol Celular, Fac Biol & Med, Julian Claveria S-N, E-33006 Oviedo, Spain.	jtolivia@uniovi.es	Tolivia, Jorge/D-2248-2010; del Valle, Eva/D-6820-2012; Martinez-Pinilla, Eva/C-7907-2013; Navarro, Ana/N-2092-2014	Tolivia, Jorge/0000-0001-8984-8849; del Valle, Eva/0000-0002-7959-4790; Martinez-Pinilla, Eva/0000-0002-0572-0926; Navarro, Ana/0000-0001-6206-6505	MECEuropean Commission; FEDEREuropean Commission [SAF2007-64076/, UNOV-11-MA-16]	This work was supported by MEC and FEDER (SAF2007-64076/) and UNOV-11-MA-16. EM was predoctoral fellow from "Ministerio de Educacion y Ciencia" Spain (AP-2005-3815) and CO was a predoctoral fellow from "Gobierno del Principado de Asturias" Spain (BP05-064).	Alvarez ML, 2003, OPHTHALMIC RES, V35, P111, DOI 10.1159/000069130; Bajo-Graneras R, 2011, GLIA, V59, P1551, DOI 10.1002/glia.21200; Bajo-Graneras R, 2011, J NEUROCHEM, V117, P949, DOI 10.1111/j.1471-4159.2011.07266.x; Belloir B, 2001, J NEUROSCI RES, V64, P61, DOI 10.1002/jnr.1054; BOYLES JK, 1990, J LIPID RES, V31, P2243; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulbarelli A, 2009, MOL CELL NEUROSCI, V40, P365, DOI 10.1016/j.mcn.2008.12.006; Butterfield DA, 2007, FREE RADICAL BIO MED, V43, P658, DOI 10.1016/j.freeradbiomed.2007.05.037; Butterfield DA, 2010, FREE RADICAL BIO MED, V48, P136, DOI 10.1016/j.freeradbiomed.2009.10.035; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; del Valle E, 2003, J HISTOCHEM CYTOCHEM, V51, P1285, DOI 10.1177/002215540305101005; Desai PP, 2005, NEUROBIOL DIS, V20, P574, DOI 10.1016/j.nbd.2005.04.012; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Do Carmo S, 2002, J BIOL CHEM, V277, P5514, DOI 10.1074/jbc.M105057200; Do Carmo S, 2008, J NEUROSCI, V28, P10330, DOI 10.1523/JNEUROSCI.2644-08.2008; Do Carmo S, 2007, BBA-MOL CELL RES, V1773, P954, DOI 10.1016/j.bbamcr.2007.03.007; Do Carmo S, 2009, AM J PHYSIOL-ENDOC M, V296, pE802, DOI 10.1152/ajpendo.90725.2008; Eichinger A, 2007, J BIOL CHEM, V282, P31068, DOI 10.1074/jbc.M703552200; Feng Z, 2004, J PINEAL RES, V37, P257, DOI 10.1111/j.1600-079X.2004.00164.x; Ganfornina MD, 2008, AGING CELL, V7, P506, DOI 10.1111/j.1474-9726.2008.00395.x; Ganfornina MD, 2010, GLIA, V58, P1320, DOI 10.1002/glia.21010; Ganfornina MD, 2005, DEV DYNAM, V232, P191, DOI 10.1002/dvdy.20193; Gella A, 2009, CELL ADHES MIGR, V3, P88, DOI 10.4161/cam.3.1.7402; Gillardon F, 1996, BRAIN RES, V706, P169, DOI 10.1016/0006-8993(95)01332-6; Glockner F, 2003, NEUROSCIENCE, V122, P103, DOI 10.1016/S0306-4522(03)00529-3; He X, 2009, NEUROSCI LETT, V455, P183, DOI 10.1016/j.neulet.2009.03.038; Hu CY, 2001, J NEUROCYTOL, V30, P209, DOI 10.1023/A:1012797623620; Kim WS, 2009, J NEUROCHEM, V109, P1053, DOI 10.1111/j.1471-4159.2009.06031.x; LAMBERT J, 1993, BIOCHIM BIOPHYS ACTA, V1172, P190, DOI 10.1016/0167-4781(93)90292-L; Lee WS, 2006, LIFE SCI, V78, P1268, DOI 10.1016/j.lfs.2005.06.036; Levros LC, 2010, BBA-MOL CELL RES, V1803, P1062, DOI 10.1016/j.bbamcr.2010.04.011; Li M, 2007, PROG NEUROBIOL, V83, P131, DOI 10.1016/j.pneurobio.2007.08.002; LopezBoado YS, 1996, J BIOL CHEM, V271, P32105, DOI 10.1074/jbc.271.50.32105; LOPEZBOADO YS, 1994, J BIOL CHEM, V269, P26871; Nasreen A, 2006, PROTEIN SCI, V15, P190, DOI 10.1110/ps.051775606; Navarro A, 2004, J HISTOCHEM CYTOCHEM, V52, P1031, DOI 10.1369/jhc.3a6213.2004; Navarro A, 2003, EXP NEUROL, V184, P697, DOI 10.1016/S0014-4886(03)00315-7; Navarro A, 2001, J HISTOTECHNOL, V24, P45; Navarro A, 2008, HISTOL HISTOPATHOL, V23, P995, DOI 10.14670/HH-23.995; Navarro A, 2010, AGE, V32, P85, DOI 10.1007/s11357-009-9117-0; Ordonez C, 2006, HISTOL HISTOPATHOL, V21, P361, DOI 10.14670/HH-21.361; Ordonez C, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.01.010; Perdomo G, 2010, J LIPID RES, V51, P1298, DOI 10.1194/jlr.M001206; Perdomo G, 2009, AGING-US, V1, P17; Perez C, 2012, AGE, V34, P895, DOI 10.1007/s11357-011-9286-5; PROVOST PR, 1991, FEBS LETT, V290, P139, DOI 10.1016/0014-5793(91)81244-3; PROVOST PR, 1991, J LIPID RES, V32, P1959; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Reindl M, 2001, J NEUROIMMUNOL, V119, P327, DOI 10.1016/S0165-5728(01)00378-2; Rickhag M, 2008, J CEREBR BLOOD F MET, V28, P551, DOI 10.1038/sj.jcbfm.9600552; Ruiz M, 2011, EXP GERONTOL, V46, P579, DOI 10.1016/j.exger.2011.02.014; Sanchez D, 2006, CURR BIOL, V16, P680, DOI 10.1016/j.cub.2006.03.024; Sanchez D, 2002, MECH DEVELOP, V110, P225, DOI 10.1016/S0925-4773(01)00578-0; Sarjeant JM, 2003, ARTERIOSCL THROM VAS, V23, P2172, DOI 10.1161/01.ATV.0000100404.05459.39; SEGUIN D, 1995, MOL BRAIN RES, V30, P242, DOI 10.1016/0169-328X(95)00008-G; SPREYER P, 1990, EMBO J, V9, P2479, DOI 10.1002/j.1460-2075.1990.tb07426.x; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Sung YJ, 2003, J BIOMED SCI, V10, P379, DOI 10.1159/000071157; Suresh S, 1998, J NEUROCHEM, V70, P242; Thomas EA, 2003, CURR MOL MED, V3, P408, DOI 10.2174/1566524033479681; Thomas EA, 2003, BIOL PSYCHIAT, V54, P136, DOI 10.1016/S0006-3223(02)01976-5; Thomas EA, 2001, J NEUROCHEM, V79, P1059, DOI 10.1046/j.1471-4159.2001.00654.x; Tolivia J, 2006, ANAL QUANT CYTOL, V28, P43; Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274; Vogt M, 2001, J MOL RECOGNIT, V14, P79, DOI 10.1002/1099-1352(200101/02)14:1<79::AID-JMR521>3.3.CO;2-W; Wernyj RP, 1999, MOL BRAIN RES, V64, P69, DOI 10.1016/S0169-328X(98)00307-6; Yagami T, 2004, BIOCHEM PHARMACOL, V67, P1153, DOI 10.1016/j.bcp.2003.11.005; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4; Zhang HY, 2008, CELL BIOL INT, V32, P1230, DOI 10.1016/j.cellbi.2008.07.006; Zhang L, 2010, NEUROCHEM INT, V57, P547, DOI 10.1016/j.neuint.2010.06.021; Zhang Y, 2011, MOL BIOL REP, V38, P1847, DOI 10.1007/s11033-010-0301-1	71	12	12	2	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2012	30	2					233	244		10.3233/JAD-2012-112102			12	Neurosciences	Neurosciences & Neurology	947BD	WOS:000304400700002	22398376				2021-06-18	
J	Nordvik, JE; Schanke, AK; Walhovd, K; Fjell, A; Grydeland, H; Landro, NI				Nordvik, Jan E.; Schanke, Anne-Kristine; Walhovd, Kristine; Fjell, Anders; Grydeland, Hakon; Landro, Nils I.			Exploring the relationship between white matter microstructure and working memory functioning following stroke: A single case study of computerized cognitive training	NEUROCASE			English	Article						Cognitive rehabilitation; Computerized cognitive training; Stroke; Diffusion tensor imaging; Fractional anisotropy	TRAUMATIC BRAIN-INJURY; SUBJECT DIFFUSION DATA; MULTIPLE-SCLEROSIS; SPATIAL STATISTICS; STRUCTURAL-CHANGES; VOXELWISE ANALYSIS; CONTROLLED-TRIAL; D1 RECEPTOR; MRI; PLASTICITY	Cognitive impairment is a well-known consequence of acquired brain injuries, including stroke. Computerized cognitive training (CCT) is a rehabilitation approach intended to enhance cognitive functioning. It is unclear whether CCT leads to generalized cognitive improvements in daily life functioning, or if the subjects improve performance only on the exercises involved in the training. The current study explores whether fractional anisotropy (FA), a measure of white matter microstructure, may serve as an indirect biological indicator of enhanced neuropsychological functioning, particularly working memory, following CCT. The findings suggest a possible relationship between changes in FA measures and working memory.	[Nordvik, Jan E.; Schanke, Anne-Kristine; Walhovd, Kristine; Fjell, Anders; Grydeland, Hakon; Landro, Nils I.] Univ Oslo, Dept Psychol, Ctr Study Human Cognit, N-0317 Oslo, Norway; [Schanke, Anne-Kristine] Sunnaas Rehabil Hosp, Nesodden, Norway	Nordvik, JE (corresponding author), Univ Oslo, Dept Psychol, Ctr Study Human Cognit, POB 1094 Blindern, N-0317 Oslo, Norway.	j.e.nordvik@psykologi.uio.no		Grydeland, Hakon/0000-0001-5061-464X; Nordvik, Jan E./0000-0003-0981-648X			Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R., 2007, NONLINEAR REGISTRATI; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; Batchelor J, 1988, J HEAD TRAUMA REHAB, V3, P78, DOI DOI 10.1097/00001199-198809000-00012; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Berryhill ME, 2008, NEUROPSYCHOLOGIA, V46, P1767, DOI 10.1016/j.neuropsychologia.2008.01.009; Buffon F, 2005, J CEREBR BLOOD F MET, V25, P641, DOI 10.1038/sj.jcbfm.9600054; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Cercignani M, 2003, AM J NEURORADIOL, V24, P638; Charlton RA, 2010, CORTEX, V46, P474, DOI 10.1016/j.cortex.2009.07.005; Chen SHA, 1997, BRAIN INJURY, V11, P197; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; De Groof G, 2009, J NEUROSCI, V29, P13557, DOI 10.1523/JNEUROSCI.1788-09.2009; De Groof G, 2008, EUR J NEUROSCI, V28, P2475, DOI 10.1111/j.1460-9568.2008.06545.x; DeFelipe J, 2006, NAT REV NEUROSCI, V7, P811, DOI 10.1038/nrn2005; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Dickinson D, 2010, AM J PSYCHIAT, V167, P170, DOI 10.1176/appi.ajp.2009.09020264; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Dineen RA, 2009, BRAIN, V132, P239, DOI 10.1093/brain/awn275; Draganski B, 2008, BEHAV BRAIN RES, V192, P137, DOI 10.1016/j.bbr.2008.02.015; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Engvig A, 2010, NEUROIMAGE, V52, P1667, DOI 10.1016/j.neuroimage.2010.05.041; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Haier Richard J, 2009, BMC Res Notes, V2, P174, DOI 10.1186/1756-0500-2-174; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jones S, 2006, NEUROSCI BIOBEHAV R, V30, P864, DOI 10.1016/j.neubiorev.2006.06.012; Klingberg T, 2007, EUR NEUROPSYCHOPHARM, V17, pS192, DOI 10.1016/S0924-977X(07)70216-X; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Klingberg T, 2009, AM J PSYCHIAT, V166, P515, DOI 10.1176/appi.ajp.2009.09030343; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; Landro NI, 2004, J NEUROL SCI, V217, P211, DOI 10.1016/j.jns.2003.10.012; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Man DWK, 2006, NEUROREHABILITATION, V21, P205; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; McNab F, 2009, SCIENCE, V323, P800, DOI 10.1126/science.1166102; Muller NG, 2006, NEUROSCIENCE, V139, P51, DOI 10.1016/j.neuroscience.2005.09.018; Nestor PG, 2010, NEUROPSYCHOLOGY, V24, P121, DOI 10.1037/a0016981; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; PONSFORD JL, 1988, J CLIN EXP NEUROPSYC, V10, P693, DOI 10.1080/01688638808402808; Ravizza SM, 2005, NEUROPSYCHOLOGIA, V43, P2057, DOI 10.1016/j.neuropsychologia.2005.03.014; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sachdev PS, 2009, J INT NEUROPSYCH SOC, V15, P915, DOI 10.1017/S1355617709990579; Sachdev PS, 2004, NEUROLOGY, V63, P1618, DOI 10.1212/01.WNL.0000142964.83484.DE; Schaechter JD, 2009, HUM BRAIN MAPP, V30, P3461, DOI 10.1002/hbm.20770; Schiavone F, 2009, J MAGN RESON IMAGING, V29, P23, DOI 10.1002/jmri.21572; Schlaug G, 2009, ANN NY ACAD SCI, V1169, P385, DOI 10.1111/j.1749-6632.2009.04587.x; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wechsler D., 2011, WECHLSER ABBREVIATED; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Williamson J, 2010, J CLIN EXP NEUROPSYC, V32, P673, DOI 10.1080/13803390903427406; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055	66	12	13	0	19	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	1355-4794			NEUROCASE	Neurocase		2012	18	2					139	151		10.1080/13554794.2011.568501			13	Clinical Neurology; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	920JP	WOS:000302400900008	21780988				2021-06-18	
J	Pape, TLB; Rosenow, JM; Harton, B; Patil, V; Guernon, A; Parrish, T; Froehlich, K; Burress, C; McNamee, S; Herrold, AA; Weiss, B; Wang, X				Pape, Theresa Louise-Bender; Rosenow, Joshua M.; Harton, Brett; Patil, Vijaya; Guernon, Ann; Parrish, Todd; Froehlich, Kathleen; Burress, Catherine; McNamee, Shane; Herrold, Amy A.; Weiss, Bessie; Wang, Xue			Preliminary framework for Familiar Auditory Sensory Training (FAST) provided during coma recovery	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						auditory stimulation; coma; disordered or impaired consciousness; minimally conscious state; plasticity; rehabilitation; story; traumatic brain injury; treatment; vegetative state	TRAUMATIC BRAIN-INJURY; MINIMALLY CONSCIOUS STATE; EVENT-RELATED POTENTIALS; VEGETATIVE STATE; MISMATCH NEGATIVITY; NEURAL PLASTICITY; OWN NAME; DISORDERS; CORTEX; REHABILITATION	Since there remains a need to examine the nature of the neural effect and therapeutic efficacy/effectiveness of sensory stimulation provided to persons in states of seriously impaired consciousness, a passive sensory stimulation intervention, referred to as the Familiar Auditory Sensory Training (FAST) protocol, was developed for examination in an ongoing, double-blind, randomized clinical trial (RCT). The FAST protocol is described in this article according to the preliminary framework, which is a synthesis of knowledge regarding principles of plasticity and capabilities of the human brain to automatically and covertly process sensory input. Feasibility issues considered during the development of the intervention are also described. To enable replication of this intervention, we describe procedures to create the intervention and lessons learned regarding the creation process. The potential effect of the intervention is illustrated using functional brain imaging of nondisabled subjects. This illustration also demonstrates the relevance of the rationale for designing the FAST protocol. To put the intervention within the context of the scientific development process, the article culminates with a description of the study design for the ongoing RCT examining the efficacy of the FAST protocol.	[Pape, Theresa Louise-Bender; Harton, Brett; Guernon, Ann; Herrold, Amy A.] Edward Hines Jr VA Hosp, Dept Vet Affairs VA Ctr Management Complex Chron, Ctr Excellence, Hines, IL 60141 USA; [Pape, Theresa Louise-Bender; Harton, Brett; Guernon, Ann; Herrold, Amy A.] Edward Hines Jr VA Hosp, Res Serv, Hines, IL 60141 USA; [Pape, Theresa Louise-Bender] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA; [Pape, Theresa Louise-Bender; Guernon, Ann] Marianjoy Rehabil Hosp, Wheaton, IL USA; [Rosenow, Joshua M.] Northwestern Univ, Dept Neurol Surg, Feinberg Sch Med, Chicago, IL 60611 USA; [Rosenow, Joshua M.; Weiss, Bessie] Northwestern Mem Hosp, Chicago, IL USA; [Pape, Theresa Louise-Bender; Patil, Vijaya] Edward Hines Jr VA Hosp, Hines, IL 60141 USA; [Patil, Vijaya] Loyola Univ Chicago, Stritch Sch Med, Dept Neurol, Maywood, IL USA; [Parrish, Todd; Wang, Xue] Northwestern Univ, Dept Radiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Froehlich, Kathleen; Burress, Catherine] Rehabil Inst Chicago, Brain Injury Program, Chicago, IL 60611 USA; [McNamee, Shane] Hunter Holmes McGuire VA Med Ctr, Phys Med & Rehabil Serv, Richmond, VA USA	Pape, TLB (corresponding author), Edward Hines Jr VA Hosp, POB 5000 M-C 151H,Bldg 1, Hines, IL 60141 USA.	Theresa.Pape@va.gov		Parrish, Todd/0000-0002-1184-1572; Bender Pape, Theresa/0000-0001-7738-5963	VA Office of Research and Development, Rehabilitation Research and Development Service [B4591R, B4949N]; Northwestern University's Clinical and Translation Sciences Institute; National Center for Research Resources, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025741]; Nick Kot Charity for TBI; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025741] Funding Source: NIH RePORTER	This material was based on work supported by VA Office of Research and Development, Rehabilitation Research and Development Service (grant B4591R and career development transition award B4949N); Northwestern University's Clinical and Translation Sciences Institute, which is supported by the National Center for Research Resources, National Institutes of Health (grant UL1RR025741); and The Nick Kot Charity for TBI (http://www.nkc4tbi.com).	Andrews K, 1996, BRAIN INJURY, V10, P797, DOI 10.1080/026990596123918; ANSELL BJ, 1991, J SPEECH HEAR RES, V34, P1017, DOI 10.1044/jshr.3405.1017; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Chiappa Keith H., 1997, P199; Cleeremans A, 1998, TRENDS COGN SCI, V2, P406, DOI 10.1016/S1364-6613(98)01232-7; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Gabriel DA, 2006, SPORTS MED, V36, P133, DOI 10.2165/00007256-200636020-00004; Garagnani M, 2011, NEUROIMAGE, V54, P170, DOI 10.1016/j.neuroimage.2010.08.031; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Giacino JT, 2009, PROG BRAIN RES, V177, P33, DOI 10.1016/S0079-6123(09)17704-X; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Giacino JT, 1996, NEUROREHABILITATION, V6, P69, DOI 10.3233/NRE-1996-6108; GUTZMANN H, 1987, ARCH GERONTOL GERIAT, V6, P61, DOI 10.1016/0167-4943(87)90039-2; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041; Imaizumi S, 1997, NEUROREPORT, V8, P2809, DOI 10.1097/00001756-199708180-00031; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Johansson BB, 2000, STROKE, V31, P223, DOI 10.1161/01.STR.31.1.223; JONES R, 1994, ARCH PHYS MED REHAB, V75, P164; KANE NM, 1993, LANCET, V341, P688, DOI 10.1016/0140-6736(93)90453-N; Kartje GL, 2006, BASIC NEUROCHEMISTRY, P517; Kleim JA, 2004, J NEUROSCI, V24, P628, DOI 10.1523/JNEUROSCI.3440-03.2004; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); KURTZ D, 1977, REV EEG NEUROPHYSIOL, V7, P62, DOI 10.1016/S0370-4475(77)80036-1; Lancioni GE, 2010, RES DEV DISABIL, V31, P1121, DOI 10.1016/j.ridd.2010.06.019; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Ludlow CL, 2008, J SPEECH LANG HEAR R, V51, pS240, DOI 10.1044/1092-4388(2008/019); MARSHALL JC, 1988, NATURE, V336, P766, DOI 10.1038/336766a0; May PJ, 2009, EUR J NEUROSCI, V29, P575, DOI 10.1111/j.1460-9568.2008.06596.x; Meinzer M, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-20; Menon DK, 1998, LANCET, V352, P200, DOI 10.1016/S0140-6736(05)77805-3; MORAY N, 1959, Q J EXP PSYCHOL, V11, P56, DOI 10.1080/17470215908416289; Moritz CH, 2001, MAGN RESON IMAGING, V19, P1129, DOI 10.1016/S0730-725X(01)00432-5; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Nakamura K, 2001, NEUROPSYCHOLOGIA, V39, P1047, DOI 10.1016/S0028-3932(01)00037-9; Nakase-Richardson R, 2009, NEUROLOGY, V73, P1120, DOI 10.1212/WNL.0b013e3181bacf34; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; National Institutes of Health, 1998, CONS DEV C BRAIN INJ; NUDO RJ, 1990, SOMATOSENS MOT RES, V7, P463, DOI 10.3109/08990229009144720; Overgaard M, 2009, PROG BRAIN RES, V177, P11, DOI 10.1016/S0079-6123(09)17702-6; Pantev C, 2011, NEUROSCI BIOBEHAV R, V35, P2140, DOI 10.1016/j.neubiorev.2011.06.010; Pape T., 2011, DISORDERS CONSCIOUSN; Pape T, 2012, NEURAL REPAIR REHABI; Pape T, 2001, ARCH PHYS MED REHAB, V82, P1291; Pape TLB, 2009, PM&R, V1, P152, DOI 10.1016/j.pmrj.2008.11.002; Pape TLB, 2005, J REHABIL RES DEV, V42, P19, DOI 10.1682/JRRD.2004.03.0033; Pape TLB, 2005, J REHABIL RES DEV, V42, P1, DOI 10.1682/JRRD.2004.03.0032; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Proverbio AM, 2001, NEUROPSYCHOLOGIA, V39, P815, DOI 10.1016/S0028-3932(01)00003-3; Pulvermuller F, 2001, STROKE, V32, P1621, DOI 10.1161/01.STR.32.7.1621; Qin PM, 2008, NEUROSCI LETT, V448, P24, DOI 10.1016/j.neulet.2008.10.029; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; SCHROGER E, 1992, NEUROSCI LETT, V146, P183, DOI 10.1016/0304-3940(92)90073-G; SCHWENDER D, 1994, ANESTHESIOLOGY, V80, P493, DOI 10.1097/00000542-199403000-00004; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shah NJ, 2001, BRAIN, V124, P804, DOI 10.1093/brain/124.4.804; SIGNORINO M, 1995, LANCET, V345, P255, DOI 10.1016/S0140-6736(95)90252-X; Spierer L, 2011, HEARING RES, V271, P88, DOI 10.1016/j.heares.2010.03.086; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; Vanier M, 2002, ACT NEUR S, V79, P53; VANLANCKER DR, 1989, J CLIN EXP NEUROPSYC, V11, P665, DOI 10.1080/01688638908400923; VANLANCKER DR, 1988, CORTEX, V24, P195, DOI 10.1016/S0010-9452(88)80029-7; von Kriegstein K, 2005, J COGNITIVE NEUROSCI, V17, P367, DOI 10.1162/0898929053279577; von Kriegstein K, 2003, COGNITIVE BRAIN RES, V17, P48, DOI 10.1016/S0926-6410(03)00079-X; Whyte J, 2003, AM J PHYS MED REHAB, V82, pS16, DOI 10.1097/01.PHM.0000086992.95121.C2; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020; Yasuda K, 2000, APHASIOLOGY, V14, P1067, DOI 10.1080/02687030050174638; Zatorre RJ, 1996, CEREB CORTEX, V6, P21, DOI 10.1093/cercor/6.1.21	75	12	12	0	6	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	7					1137	1152		10.1682/JRRD.2011.08.0154			16	Rehabilitation	Rehabilitation	149EZ	WOS:000319303100015	23341285	Bronze			2021-06-18	
J	Seo, JP; Kim, OL; Kim, SH; Chang, MC; Kim, MS; Son, SM; Jang, SH				Seo, Jeong Pyo; Kim, Oh Lyong; Kim, Seong Ho; Chang, Min Cheol; Kim, Min-Su; Son, Su Min; Jang, Sung Ho			Neural injury of uncinate fasciculus in patients with diffuse axonal injury	NEUROREHABILITATION			English	Article						Diffusion tensor imaging; brain injury; diffuse axonal injury; uncinate fasciculus	TRAUMATIC BRAIN-INJURY; LONGITUDINAL CHANGES; TENSOR; TRACTOGRAPHY; IMPAIRMENT; TRACKING; MR	The recent development of diffusion tensor imaging (DTI) allows visualization and estimation of the uncinate fascicul us (UF). We investigated injuries of the UF in patients with diffuse axonal injury (DAI) who showed no specific lesions except for DAI lesions on conventional brain MRI. Twenty-one chronic patients with DAI, and 21 age- and sex-matched normal control subjects were recruited for this study. Diffusion tensor images were acquired using a sensitivity-encoding head coil at 1.5 T and the UF was reconstructed using DTI-Studio software. Fractional anisotropy (FA), apparent diffusion coefficient (ADC) value, and fiber number of the UF were measured. In the DAI group, the FA values and fiber numbers were significantly decreased compared to those of the control group (P < 0.05). The FA value and fiber number decreased 8.4% and 26.5% in the DAI group compared to those of the control group. By contrast, the ADC value did not show any difference between the DAI and control groups (P > 0.05). Changes in the DTI parameters of the DAI group appeared to indicate neural injury of the UF. We believe that DTI can be a useful evaluation tool for detecting hidden neural injuries of UF in patients with DAI.	[Seo, Jeong Pyo; Chang, Min Cheol; Son, Su Min; Jang, Sung Ho] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, Taegu 705717, South Korea; [Kim, Oh Lyong; Kim, Seong Ho; Kim, Min-Su] Yeungnam Univ, Dept Neurosurg, Coll Med, Taegu 705717, South Korea	Jang, SH (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			Ministry of Education, Science and Technology of KoreaMinistry of Education, Science and Technology, Republic of Korea [11-1T-01]	This work was supported by the DGIST R&D Program of the Ministry of Education, Science and Technology of Korea (11-1T-01).	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Ahn YH, 2006, NEUROREHABILITATION, V21, P239; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2010, BRAIN IMAGING BEHAV, V4, P270, DOI 10.1007/s11682-010-9105-0; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; Hasan KM, 2009, BRAIN RES, V1276, P67, DOI 10.1016/j.brainres.2009.04.025; Holl N, 2011, SURG RADIOL ANAT, V33, P713, DOI 10.1007/s00276-011-0816-8; Hong JH, 2012, J HEAD TRAUMA REHAB, V27, P172, DOI 10.1097/HTR.0b013e318217192d; Hong JH, 2010, EUR NEUROL, V63, P252, DOI 10.1159/000277477; Jang SH, 2009, NEUROREHABILITATION, V25, P229, DOI 10.3233/NRE-2009-0519; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; Johnson CP, 2011, J INT NEUROPSYCH SOC, V17, P663, DOI 10.1017/S1355617711000464; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Marchina S, 2011, STROKE, V42, P2251, DOI 10.1161/STROKEAHA.110.606103; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; Nestor PG, 2004, NEUROPSYCHOLOGY, V18, P629, DOI 10.1037/0894-4105.18.4.629; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Papagno C, 2011, BRAIN, V134, P405, DOI 10.1093/brain/awq283; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Sato K, 2010, NEURORADIOLOGY, V52, P729, DOI 10.1007/s00234-010-0653-1; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schmahmann J. D., 2006, FIBER PATHWAYS BRAIN, P654; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stadlbauer A, 2008, EUR RADIOL, V18, P130, DOI 10.1007/s00330-007-0733-8; Sugiyama K, 2007, BRAIN INJURY, V21, P413, DOI 10.1080/02699050701311042; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Williams JM, 1991, MAS MEMORY ASSESSMEN, P127	40	12	12	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	30	4					323	328		10.3233/NRE-2012-0762			6	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	980HQ	WOS:000306884600010	22672947				2021-06-18	
J	Jeong, E; Lesiuk, TL				Jeong, Eunju; Lesiuk, Teresa L.			Development and Preliminary Evaluation of a Music-based Attention Assessment for Patients with Traumatic Brain Injury	JOURNAL OF MUSIC THERAPY			English	Article							SELECTIVE ATTENTION; DIVIDED ATTENTION; HEAD-INJURY; PERCEPTION ASSESSMENT; PREFRONTAL CORTEX; TASK; CONSISTENCY; TIME	Impairments in attention are commonly seen in individuals with traumatic brain injury (TBI). While visual attention assessment measurements have been rigorously developed and frequently used in cognitive neurorehabilitation, there is a paucity of auditory attention assessment measurements for patients with TBI. The purpose of this study was to field test a researcher-developed Music-based Attention Assessment (MAA), a melodic contour identification test designed to assess three different types of attention (i.e., sustained attention, selective attention, and divided attention), for patients with TBI. Additionally, this study aimed to evaluate the readability and comprehensibility of the test items and to examine the preliminary psychometric properties of the scale and test items. Fifteen patients diagnosed with TBI completed 3 different series of tasks in which they were required to identify melodic contours. The resulting data showed that (a) test items in each of the 3 subtests were found to have an easy to moderate level of item difficulty and an acceptable to high level of item discrimination, and (b) the musical characteristics (i.e., contour, congruence, and pitch interference) were found to be associated with the level of item difficulty, and (c) the internal consistency of the MAA as computed by Cronbach's alpha was .95. Subsequent studies using a larger sample of typical participants, along with individuals with TBI, are needed to confirm construct validity and internal consistency of the MAA. In addition, the authors recommend examination of criterion validity of the MAA as correlated with current neuropsychological attention assessment measurements.	[Jeong, Eunju; Lesiuk, Teresa L.] Univ Miami, Frost Sch Mus, Dept Mus Educ & Mus Therapy, Coral Gables, FL 33124 USA	Jeong, E (corresponding author), 5545 NW 112th Path, Doral, FL USA.	e.jeong@umiami.edu	Jeong, Eunju/L-2185-2017	Jeong, Eunju/0000-0002-5064-5419			ANDREWS MW, 1991, MUSIC PERCEPT, V8, P349; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; BENEDICT RHB, 1989, CLIN PSYCHOL REV, V9, P605; Bengtsson SL, 2009, CORTEX, V45, P62, DOI 10.1016/j.cortex.2008.07.002; Bigand E, 2000, INT J PSYCHOL, V35, P270, DOI 10.1080/002075900750047987; Boyle J.D., 1987, MEASUREMENT EVALUATI; Bregman A.S., 1990, AUDITORY SCENE ANAL; BREGMAN AS, 1971, J EXP PSYCHOL, V89, P244, DOI 10.1037/h0031163; BREGMAN AS, 1973, PERCEPT PSYCHOPHYS, V13, P308, DOI 10.3758/BF03214144; Crawley EJ, 2002, J EXP PSYCHOL HUMAN, V28, P367, DOI 10.1037//0096-1523.28.2.367; Cusack R, 2004, J EXP PSYCHOL HUMAN, V30, P643, DOI 10.1037/0096-1523.30.4.643; Davison LL, 2003, MUSIC PERCEPT, V21, P3, DOI 10.1525/mp.2003.21.1.3; Delis DC, 2001, DELISKAPLAN EXECUTIV; Deutsch D., 1982, PSYCHOL MUSIC, P99; DOWLING WJ, 1973, COGNITIVE PSYCHOL, V5, P322, DOI 10.1016/0010-0285(73)90040-6; Franzen M. D., 1984, HDB PSYCHOL ASSESSME, P19; Fritz JB, 2007, CURR OPIN NEUROBIOL, V17, P437, DOI 10.1016/j.conb.2007.07.011; Furr R.M., 2008, PSYCHOMETRICS INTRO; Fyk J., 1995, B COUNCIL RES MUSIC, V127, P72; Gallun FJ, 2007, PERCEPT PSYCHOPHYS, V69, P757, DOI 10.3758/BF03193777; GARRETT HE, 1966, STAT PSYCHOL ED; Gordon E.E., 1998, INTRO RES PSYCHOL MU; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Halstead WC, 1985, HALSTEAD REITAN NEUR; Henson RK, 2001, MEAS EVAL COUNS DEV, V34, P177, DOI 10.1080/07481756.2002.12069034; HUNTER LL, 1989, J MUSIC THER, V26, P79, DOI 10.1093/jmt/26.2.79; Janata P, 2002, COGN AFFECT BEHAV NE, V2, P121, DOI 10.3758/CABN.2.2.121; Johnson JA, 2007, J COGNITIVE NEUROSCI, V19, P907, DOI 10.1162/jocn.2007.19.6.907; Johnson JA, 2006, NEUROIMAGE, V31, P1673, DOI 10.1016/j.neuroimage.2006.02.026; JONES MR, 1984, ANN NY ACAD SCI, V423, P158, DOI 10.1111/j.1749-6632.1984.tb23426.x; JONES RE, 1986, J MUSIC THER, V23, P166, DOI 10.1093/jmt/23.3.166; Kaipio ML, 2000, NEUROREPORT, V11, P1463; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kewman D G, 1988, Brain Inj, V2, P131, DOI 10.3109/02699058809150937; Kim K., 2005, THESIS U MINNESOTA; Klein JM, 1996, PERCEPT PSYCHOPHYS, V58, P34, DOI 10.3758/BF03205473; Kline T. J., 2005, PSYCHOL TESTING PRAC; KRUMHANSL CL, 1986, MUSIC PERCEPT, V4, P153; LIPE A, 1995, J MUSIC THER, V32, P137, DOI 10.1093/jmt/32.3.137; Lipe AW, 2007, J MUSIC THER, V44, P369, DOI 10.1093/jmt/44.4.369; Lipscomb S. D., 1996, HDB MUSIC PSYCHOL, P83; Loose R., 2000, NEUROIMAGE, V11, P2; Macaluso E, 2002, CEREB CORTEX, V12, P357, DOI 10.1093/cercor/12.4.357; Macken WJ, 2003, J EXP PSYCHOL HUMAN, V29, P43, DOI 10.1037/0096-1523.29.1.43; Magee WL, 2007, NEUROREHABILITATION, V22, P319; MATEER CA, 1990, COGNITIVE REHABILITA, P68; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Niemann H, 1996, NEUROPSYCHOL REV, V6, P11, DOI 10.1007/BF01875418; OOSTERHOF A, 2001, CLASSROOM APPL ED ME; Osterlind S., 2006, MODERN MEASUREMENT T; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Ponsford J, 2004, SCI PRACT NEUROPSYCH, P59; Ponsford J., 2008, COGNITIVE NEUROREHAB, P507; RIDER MS, 1981, J MUSIC THER, V18, P110, DOI 10.1093/jmt/18.3.110; Schmidt KM, 2003, HDB PSYCHOL, V2, P429; Serences JT, 2007, CEREB CORTEX, V17, P284, DOI 10.1093/cercor/bhj146; SHINNCUNNINGHAM B, 2004, P ICAD 04 10 M INT C; Sloboda J., 1981, PSYCHOL MUSIC, V9, P39, DOI [10.1177/03057356810090010701, DOI 10.1177/03057356810090010701]; Snyder JS, 2007, PSYCHOL BULL, V133, P780, DOI 10.1037/0033-2909.133.5.780; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Solbakk AK, 2002, CLIN ELECTROENCEPHAL, V33, P102, DOI 10.1177/155005940203300306; Stephan KM, 2002, NEUROIMAGE, V15, P345, DOI 10.1006/nimg.2001.0929; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Talland G.A., 1965, DERANGED MEMORY; Talsma D, 2001, PSYCHOPHYSIOLOGY, V38, P736, DOI 10.1111/1469-8986.3850736; Trainor LJ, 2002, J COGNITIVE NEUROSCI, V14, P430, DOI 10.1162/089892902317361949; TREISMAN A, 1988, Q J EXP PSYCHOL-A, V40, P201, DOI 10.1080/02724988843000104; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; van Noorden L. P. A. S., 1975, THESIS U TECHNOLOGY; Waldon EG, 2006, J MUSIC THER, V43, P356, DOI 10.1093/jmt/43.4.356; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; YORK E, 1994, J MUSIC THER, V31, P280, DOI 10.1093/jmt/31.4.280; York E, 2000, PSYCHOL MUSIC, V28, P174, DOI [DOI 10.1177/0305735600282006, 10.1177/0305735600282006]	75	12	12	0	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-2917	2053-7395		J MUSIC THER	J. Music Ther.	WIN	2011	48	4					551	572		10.1093/jmt/48.4.551			22	Music; Rehabilitation	Music; Rehabilitation	872RN	WOS:000298827100007	22506304				2021-06-18	
J	Pan, Y; Shreiber, DI; Pelegri, AA				Pan, Yi; Shreiber, David I.; Pelegri, Assimina A.			A Transition Model for Finite Element Simulation of Kinematics of Central Nervous System White Matter	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Finite element methods; kinematics; transition kinematic model; white matter	DIFFUSE AXONAL INJURY; ELASTIC PROPERTIES; SPINAL-CORD; HUMAN HEAD; TISSUE; DAMAGE	Mechanical damage to axons is a proximal cause of deficits following traumatic brain injury and spinal cord injury. Axons are injured predominantly by tensile strain, and identifying the strain experienced by axons is a critical step toward injury prevention. White matter demonstrates complex nonlinear mechanical behavior at the continuum level that evolves from even more complex, dynamic, and composite behavior between axons and the "glial matrix" at the microlevel. In situ, axons maintain an undulated state that depends on the location of the white matter and the stage of neurodevelopment. When exposed to tissue strain, axons do not demonstrate pure affine or non-affine behavior, but instead transition from non-affine-dominated kinematics at low stretch levels to affine kinematics at high stretch levels. This transitional and predominant kinematic behavior has been linked to the natural coupling of axons to each other via the glial matrix. In this paper, a transitional kinematic model is applied to a micromechanics finite element model to simulate the axonal behavior within a white matter tissue subjected to uniaxial tensile stretch. The effects of the transition parameters and the volume fraction of axons on axonal behavior is evaluated and compared to previous experimental data and numerical simulations.	[Pan, Yi; Pelegri, Assimina A.] Rutgers State Univ, Dept Mech & Aerosp Engn, Piscataway, NJ 08854 USA; [Shreiber, David I.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA	Pelegri, AA (corresponding author), Rutgers State Univ, Dept Mech & Aerosp Engn, Piscataway, NJ 08854 USA.	yipan@rci.rutgers.edu; shreiber@rci.rutgers.edu; pelegri@jove.rutgers.edu		Pelegri, Assimina/0000-0003-1145-8175; Shreiber, David/0000-0001-8248-419X	New Jersey Commission on Brain Injury [10-3219-BIR-E-0]; NSFNational Science Foundation (NSF) [1000450]; Directorate For EngineeringNational Science Foundation (NSF)NSF - Directorate for Engineering (ENG) [1000450] Funding Source: National Science Foundation	Manuscript received April 9, 2011; revised June 20, 2011; accepted July 14, 2011. Date of publication July 29, 2011; date of current version November 18, 2011. This work was supported by the New Jersey Commission on Brain Injury Research Postdoctoral Fellowship Grant under Award 10-3219-BIR-E-0 and by NSF under Grant 1000450. Asterisk indicates corresponding author.	Arbogast KB, 1999, J BIOMECH, V32, P865, DOI 10.1016/S0021-9290(99)00042-1; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bain AC, 2003, J BIOMECH ENG-T ASME, V125, P798, DOI 10.1115/1.1632627; *DASS SYST, 2007, ABAQUS 6 7; Hao H, 2007, J BIOMECH ENG-T ASME, V129, P511, DOI 10.1115/1.2746372; Iorga L, 2008, J MECH MATER STRUCT, V3, P1279, DOI 10.2140/jomms.2008.3.1279; Karami G, 2009, J MECH BEHAV BIOMED, V2, P243, DOI 10.1016/j.jmbbm.2008.08.003; Maikos JT, 2008, J NEUROTRAUM, V25, P795, DOI 10.1089/neu.2007.0423; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Meaney DF, 2003, BIOMECH MODEL MECHAN, V1, P279, DOI 10.1007/s10237-002-0020-1; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2; PAN Y, 2011, AM SOC MECH ENG 2011; Pan Y, 2008, COMPOS SCI TECHNOL, V68, P2792, DOI 10.1016/j.compscitech.2008.06.007; Raul JS, 2006, INT J LEGAL MED, V120, P212, DOI 10.1007/s00414-005-0018-1; Shreiber DI, 2009, BIOMECH MODEL MECHAN, V8, P311, DOI 10.1007/s10237-008-0137-y; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Voo L, 1996, MED BIOL ENG COMPUT, V34, P375, DOI 10.1007/BF02520009	18	12	12	1	12	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294			IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	DEC	2011	58	12	2				3443	3446		10.1109/TBME.2011.2163189			4	Engineering, Biomedical	Engineering	852FR	WOS:000297341500004	21803674				2021-06-18	
J	Chao, OY; Huston, JP; von Bothmer, A; Pum, ME				Chao, O. Y.; Huston, J. P.; von Bothmer, A.; Pum, M. E.			CHRONIC PROGESTERONE TREATMENT OF MALE RATS WITH UNILATERAL 6-HYDROXYDOPAMINE LESION OF THE DORSAL STRIATUM EXASPERATES PARKINSONIAN SYMPTOMS	NEUROSCIENCE			English	Article						Parkinson's disease; progesterone; 6-OHDA; turning behavior; foot slips; forelimb use	TRAUMATIC BRAIN-INJURY; INDUCED DOPAMINE DEPLETION; SPINAL-CORD-INJURY; NERVOUS-SYSTEM; FUNCTIONAL RECOVERY; NEUROTROPHIC FACTOR; IN-VIVO; OVARIECTOMIZED RATS; GENE-EXPRESSION; CELL-LINE	Progesterone (PROG) shows neuroprotective effects in numerous lesion models, including a mouse model of Parkinson's disease (PD) induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). However, the possible beneficial effects of PROG on the behavioral and neurochemical impairments incurred in the hemiparkinsonian 6-hydroxydopamine (6-OHDA) model have not been investigated. Vehicle or PROG (4 mg/kg or 8 mg/kg) was daily applied over 13 days after unilateral injection of 6-OHDA into the dorsal striatum of male rats. Turning behavior, foot slips on a horizontal grid, and forelimb use during rearing in a cylinder were observed on days 4, 5, 9, 10, 13, and 14 postlesion, and then the brain samples were analyzed by HPLC-EC. Chronic 8 mg/kg of PROG administration increased the DOPAC/dopamine (DA) ratio in the lesioned striatum, ipsiversive turnings, and the number of hind limb slips and decreased the symmetrical use of forelimbs. Thus, contrary to hypothesis, the chronic treatment with PROG exasperated rather than alleviated the motor impairments in the hemiparkinsonian rats. Because previous studies with the MPTP model had shown protective effects when PROG treatment was administrated before the lesion, our results do not rule out such potential neuroprotective action with prelesion PROG treatment. However, our results raise the question of possible negative interactions between PROG and parkinsonian symptoms in males. (C) 2011 IBRO. Published by Elsevier Ltd. All rights reserved.	[Chao, O. Y.; Huston, J. P.; von Bothmer, A.; Pum, M. E.] Univ Dusseldorf, Ctr Behav Neurosci, D-40225 Dusseldorf, Germany	Huston, JP (corresponding author), Univ Dusseldorf, Ctr Behav Neurosci, Univ Str 1, D-40225 Dusseldorf, Germany.	Huston@uni-duesseldorf.de			Forschungskommission of the Medical Faculty of the University of Dusseldorf; DAADDeutscher Akademischer Austausch Dienst (DAAD)European Commission	This research was supported by the Forschungskommission of the Medical Faculty of the University of Dusseldorf and the DAAD.	Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; Aron L, 2011, TRENDS NEUROSCI, V34, P88, DOI 10.1016/j.tins.2010.11.001; Baldereschi M, 2000, NEUROLOGY, V55, P1358, DOI 10.1212/WNL.55.9.1358; Ballare C, 2003, MOL CELL BIOL, V23, P1994, DOI 10.1128/MCB.23.6.1994-2008.2003; Baron MS, 2002, J NEUROSCI, V22, P592, DOI 10.1523/JNEUROSCI.22-02-00592.2002; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Baulieu EE, 1996, CELL MOL NEUROBIOL, V16, P143, DOI 10.1007/BF02088173; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Bourque M, 2009, FRONT NEUROENDOCRIN, V30, P142, DOI 10.1016/j.yfrne.2009.04.014; Brooks David J, 2008, Neuropsychiatr Dis Treat, V4, P39; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Callier S, 2001, SYNAPSE, V41, P131, DOI 10.1002/syn.1067; Cavanaugh JE, 2006, J NEUROSCI RES, V84, P1367, DOI 10.1002/jnr.21024; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Deumens R, 2002, EXP NEUROL, V175, P303, DOI 10.1006/exnr.2002.7891; DIPAOLO T, 1986, EUR J PHARMACOL, V125, P11, DOI 10.1016/0014-2999(86)90077-4; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Dluzen D, 1997, BRAIN RES, V767, P340, DOI 10.1016/S0006-8993(97)00630-6; Dluzen DE, 1996, NEUROTOXICOL TERATOL, V18, P603, DOI 10.1016/0892-0362(96)00086-4; Ferraz AC, 2008, NEUROCHEM RES, V33, P1238, DOI 10.1007/s11064-007-9575-7; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Giachino C, 2003, ANN NY ACAD SCI, V1007, P335, DOI 10.1196/annals.1286.032; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Gillies GE, 2004, PHARMACOL BIOCHEM BE, V78, P513, DOI 10.1016/j.pbb.2004.04.022; Gillies GE, 2010, HORM BEHAV, V57, P23, DOI 10.1016/j.yhbeh.2009.06.002; Deniselle MCG, 2007, EXP NEUROL, V203, P406, DOI 10.1016/j.expneurol.2006.08.019; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Grandbois M, 2000, NEUROREPORT, V11, P343, DOI 10.1097/00001756-200002070-00024; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Kirik D, 1998, EXP NEUROL, V152, P259, DOI 10.1006/exnr.1998.6848; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Kulich SM, 2001, J NEUROCHEM, V77, P1058, DOI 10.1046/j.1471-4159.2001.00304.x; KURTZKE JF, 1988, NEUROLOGY, V38, P1558, DOI 10.1212/WNL.38.10.1558; Labombarda F, 2006, J NEUROTRAUM, V23, P181, DOI 10.1089/neu.2006.23.181; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Leonelli E, 2007, NEUROSCIENCE, V144, P1293, DOI 10.1016/j.neuroscience.2006.11.014; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lin E, 2008, J NEUROSCI RES, V86, P108, DOI 10.1002/jnr.21478; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; Magnaghi V, 2006, J PERIPHER NERV SYST, V11, P111, DOI 10.1111/j.1085-9489.2006.00075.x; Marder K, 1996, NEUROLOGY, V47, P155, DOI 10.1212/WNL.47.1.155; MAYEUX R, 1992, ARCH NEUROL-CHICAGO, V49, P492, DOI 10.1001/archneur.1992.00530290076015; Mehta A, 2005, EXP NEUROL, V193, P110, DOI 10.1016/j.expneurol.2005.01.001; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; MORISSETTE M, 1993, J NEUROCHEM, V60, P1876, DOI 10.1111/j.1471-4159.1993.tb13415.x; Morissette M, 2008, MOL CELL ENDOCRINOL, V290, P60, DOI 10.1016/j.mce.2008.04.008; Murphy SJ, 2000, STROKE, V31, P1173, DOI 10.1161/01.STR.31.5.1173; Murphy SJ, 2002, J CEREBR BLOOD F MET, V22, P1181; Obeso JA, 2000, TRENDS NEUROSCI, V23, pS2, DOI 10.1016/S1471-1931(00)00031-8; PETITCLERC M, 1995, PROG NEURO-PSYCHOPH, V19, P491, DOI 10.1016/0278-5846(95)00029-U; Ramirez AD, 2003, NEUROENDOCRINOLOGY, V77, P223, DOI 10.1159/000070277; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Rubin Susan M, 2007, Dis Mon, V53, P206, DOI 10.1016/j.disamonth.2007.02.002; Sayeed L, 2007, RESTOR NEUROL NEUROS, V25, P151; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schallert T, 2000, CONT NEUROS, P131; Schumacher M, 2000, J NEUROCYTOL, V29, P307, DOI 10.1023/A:1007152904926; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Schumacher M, 2007, ENDOCR REV, V28, P387, DOI 10.1210/er.2006-0050; SCHWARTING RKW, 1993, J NEUROSCI METH, V49, P199, DOI 10.1016/0165-0270(93)90125-B; Schwarting RKW, 1996, PROG NEUROBIOL, V50, P275, DOI 10.1016/S0301-0082(96)00040-8; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Silva MAD, 2008, NEUROSCIENCE, V157, P196, DOI 10.1016/j.neuroscience.2008.09.003; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Starkey ML, 2005, EXP NEUROL, V195, P524, DOI 10.1016/j.expneurol.2005.06.017; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P69; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Walsh S, 2011, NEUROSCIENCE, V175, P251, DOI 10.1016/j.neuroscience.2010.12.005; Woodlee MT, 2008, EXP NEUROL, V211, P511, DOI 10.1016/j.expneurol.2008.02.024; Woodlee MT, 2005, EXP NEUROL, V191, P310, DOI 10.1016/j.expneurol.2004.09.005; Wooten GF, 2004, J NEUROL NEUROSUR PS, V75, P637, DOI 10.1136/jnnp.2003.020982; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamada M, 1999, P NATL ACAD SCI USA, V96, P4078, DOI 10.1073/pnas.96.7.4078; Yang LC, 1998, J NEUROSCI, V18, P8145; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Yu L, 2000, J NEURAL TRANSM, V107, P1139, DOI 10.1007/s007020070027	79	12	12	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	NOV 24	2011	196						228	236		10.1016/j.neuroscience.2011.08.043			9	Neurosciences	Neurosciences & Neurology	837OO	WOS:000296213300020	21888950				2021-06-18	
J	Erickson, JA; Grenache, DG				Erickson, J. Alan; Grenache, David G.			Comparison of three assays for quantifying S-100B in serum	CLINICA CHIMICA ACTA			English	Article						S-100B; ELISA; Melanoma; Brain injury	PROGNOSTIC VALUE; PROTEIN; MARKER; INJURY; PREDICTION; S100B	Background: Serum S-100B has clinical value in monitoring malignant melanoma and in monitoring and predicting outcomes in patients with traumatic brain injury. Methods: Analytical performance characteristic and split-sample method comparison studies for three commercial S-100B immunoassays (CanAg (R) S100, Sangtec (R) 100, YK150 Human S-100 beta) were performed. Reference intervals (97.5th percentile) for each assay were established by non-parametric analysis of results from healthy volunteers. Results: Linearity results were slope = 1.014, intercept = 65.1, r(2) = 0.999 for the Sangtec assay; slope = 1.038, intercept = 31.1. r(2) = 0.999 for the CanAg assay; slope = 1.123, intercept = -105.4, r(2) = 0.997 for the YK150 assay. Within-run CVs were <= 5.7, <= 63 and <= 10.8 for the Sangtec. CanAg and YK150 ELISAs. respectively. Between-run CVs were <= 113, <= 5.9 and <= 9.5, respectively. Upper reference interval limits of 141,96 and 735 ng/I S-100B were established for the Sangtec, CanAg and YK150 ELISAs, respectively. Deming regression generated the following: CanAg vs. Sangtec, slope = 0.339, intercept =24.1, r(2) = 0.932; YK150 vs. Sangtec, slope = 0.266, intercept = -140.0, r(2) = 0.690; YK150 vs. CanAg, slope = 1.376, intercept= -13.1, r(2) = 0.860. Conclusions: The configurations, procedures and performance characteristics of the Sangtec and CanAg S-100B ELISAs are comparable and better than those of the YK150 assay. Poor agreement and large biases prevent interchangeable use of results. (C) 2011 Elsevier B.V. All rights reserved.	[Erickson, J. Alan; Grenache, David G.] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA; [Grenache, David G.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA	Erickson, JA (corresponding author), ARUP Labs, 500 Chipeta Way, Salt Lake City, UT 84108 USA.	ericksja@aruplab.com			ARUP Institute for Clinical and Experimental Pathology	Financial support was provided by the ARUP Institute for Clinical and Experimental Pathology.	Andres R, 2004, TUMORI J, V90, P607; Bertsch T, 2001, CLIN CHEM LAB MED, V39, P319, DOI 10.1515/CCLM.2001.050; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Boni R, 1997, BRIT J DERMATOL, V137, P39, DOI 10.1046/j.1365-2133.1997.17651853.x; Chen Da-qing, 2005, Chin J Traumatol, V8, P245; da Rocha AB, 2006, CLIN CHEM LAB MED, V44, P1234, DOI 10.1515/CCLM.2006.218; DiaSorin Inc, 2004, SANGT 100 ELISA INST; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Fujirebio Diagnostics AB, 2006, CANAG S100 EIA INSTR; Hallen M, 2008, CLIN CHEM LAB MED, V46, P1025, DOI 10.1515/CCLM.2008.190; Hamberg AP, 2003, MELANOMA RES, V13, P45, DOI 10.1097/00008390-200302000-00008; Korfias S, 2006, CURR MED CHEM, V13, P3719, DOI 10.2174/092986706779026129; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Nakamura K, 2005, CYTOKINE, V29, P95, DOI 10.1016/j.cyto.2004.10.002; Prohl J, 2007, CRIT CARE MED, V35, P1230, DOI 10.1097/01.CCM.0000261892.10559.85; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Reynolds MA, 2003, CLIN CHEM, V49, P1733, DOI 10.1373/49.10.1733; Smit LHM, 2008, ANTICANCER RES, V28, P2297; Smit LHM, 2005, INT J BIOL MARKER, V20, P34; Stigbrand T, 2000, INT J BIOL MARKER, V15, P33; Stranjalis G, 2007, ACTA NEUROCHIR, V149, P231, DOI 10.1007/s00701-006-1106-9; Stroick M, 2006, CURR MED CHEM, V13, P3053, DOI 10.2174/092986706778521751; Wiesmann M, 1997, ACTA NEUROCHIR, V139, P1155, DOI 10.1007/BF01410976; Yanaihara Institute Inc, 2007, YK150 HUM S 100 BET	26	12	12	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	NOV 20	2011	412	23-24					2122	2127		10.1016/j.cca.2011.07.020			6	Medical Laboratory Technology	Medical Laboratory Technology	843QC	WOS:000296686100017	21824469				2021-06-18	
J	Al-Dorzi, HM; Tamim, HM; Cherfan, A; Hassan, MA; Taher, S; Arabi, YM				Al-Dorzi, Hasan M.; Tamim, Hani M.; Cherfan, Antoine; Hassan, Mohamad A.; Taher, Saadi; Arabi, Yaseen M.			Impact of computerized physician order entry (CPOE) system on the outcome of critically ill adult patients: a before-after study	BMC MEDICAL INFORMATICS AND DECISION MAKING			English	Article						Intensive care unit; critical illness; CPOE; safety management; mortality; morbidity	INTENSIVE-CARE-UNIT; ADVERSE DRUG EVENTS; UNEXPECTED INCREASED MORTALITY; INFORMATION TECHNOLOGIES; UNINTENDED CONSEQUENCES; IMPLEMENTATION; ERRORS; RATES	Background: Computerized physician order entry (CPOE) systems are recommended to improve patient safety and outcomes. However, their effectiveness has been questioned. Our objective was to evaluate the impact of CPOE implementation on the outcome of critically ill patients. Methods: This was an observational before-after study carried out in a 21-bed medical and surgical intensive care unit (ICU) of a tertiary care center. It included all patients admitted to the ICU in the 24 months pre- and 12 months post-CPOE (Misys (R)) implementation. Data were extracted from a prospectively collected ICU database and included: demographics, Acute Physiology and Chronic Health Evaluation (APACHE) II score, admission diagnosis and comorbid conditions. Outcomes compared in different pre- and post-CPOE periods included: ICU and hospital mortality, duration of mechanical ventilation, and ICU and hospital length of stay. These outcomes were also compared in selected high risk subgroups of patients (age 12-17 years, traumatic brain injury, admission diagnosis of sepsis and admission APACHE II > 23). Multivariate analysis was used to adjust for imbalances in baseline characteristics and selected clinically relevant variables. Results: There were 1638 and 898 patients admitted to the ICU in the specified pre- and post-CPOE periods, respectively (age = 52 +/- 22 vs. 52 +/- 21 years, p = 0.74; APACHE II = 24 +/- 9 vs. 24 +/- 10, p = 0.83). During these periods, there were no differences in ICU (adjusted odds ratio (aOR) 0.98, 95% confidence interval [CI] 0.7-1.3) and in hospital mortality (aOR 1.00, 95% CI 0.8-1.3). CPOE implementation was associated with similar duration of mechanical ventilation and of stay in the ICU and hospital. There was no increased mortality or stay in the high risk subgroups after CPOE implementation. Conclusions: The implementation of CPOE in an adult medical surgical ICU resulted in no improvement in patient outcomes in the immediate phase and up to 12 months after implementation.	[Al-Dorzi, Hasan M.; Tamim, Hani M.; Cherfan, Antoine; Hassan, Mohamad A.; Taher, Saadi; Arabi, Yaseen M.] King Abdul Aziz Med City, Riyadh 11426, Saudi Arabia; [Al-Dorzi, Hasan M.; Tamim, Hani M.; Arabi, Yaseen M.] King Saud bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh 11426, Saudi Arabia	Arabi, YM (corresponding author), King Abdul Aziz Med City, Riyadh 11426, Saudi Arabia.	yaseenarabi@yahoo.com		Al-Dorzi, Hasan M/0000-0002-3772-8949; Arabi, Yaseen/0000-0001-5735-6241			Amarasingham R, 2009, ARCH INTERN MED, V169, P108, DOI 10.1001/archinternmed.2008.520; Ammenwerth E, 2008, J AM MED INFORM ASSN, V15, P585, DOI 10.1197/jamia.M2667; Arabi Y, 2006, CRIT CARE MED, V34, P605, DOI 10.1097/01.CCM.0000203947.60552.DD; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Ash JS, 2003, J AM MED INFORM ASSN, V10, P229, DOI 10.1197/jamia.M1204; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bates DW, 1999, J AM MED INFORM ASSN, V6, P313, DOI 10.1136/jamia.1999.00660313; Bouadma L, 2005, INTENS CARE MED, V31, P1446, DOI 10.1007/s00134-005-2766-2; Campbell EM, 2006, J AM MED INFORM ASSN, V13, P547, DOI 10.1197/jamia.M2042; Collins Sarah, 2006, AMIA Annu Symp Proc, P895; Colpaert K, 2006, CRIT CARE, V10, DOI 10.1186/cc3983; Del Beccaro MA, 2006, PEDIATRICS, V118, P290, DOI 10.1542/peds.2006-0367; Eslami S, 2008, INT J MED INFORM, V77, P365, DOI 10.1016/j.ijmedinf.2007.10.001; Han YY, 2005, PEDIATRICS, V116, P1506, DOI 10.1542/peds.2005-1287; Harrison MI, 2007, J AM MED INFORM ASSN, V14, P542, DOI 10.1197/jamia.M2384; *I MED, 2001, CROSS QUAL CHASM NEW; Karsh BT, 2010, J AM MED INFORM ASSN, V17, P617, DOI 10.1136/jamia.2010.005637; Keene A, 2007, PEDIATR CRIT CARE ME, V8, P268, DOI 10.1097/01.PCC.0000260781.78277.D9; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Longhurst CA, 2010, PEDIATRICS, V126, P14, DOI 10.1542/peds.2009-3271; Mekhjian HS, 2002, J AM MED INFORM ASSN, V9, P529, DOI 10.1197/jamia.M1038; Nebeker JR, 2005, ARCH INTERN MED, V165, P1111, DOI 10.1001/archinte.165.10.1111; Papshev D, 2001, AM J MANAG CARE, V7, P725; Rana R, 2006, CRIT CARE MED, V34, P1892, DOI 10.1097/01.CCM.0000220766.13623.FE; Sittig DF, 2006, PEDIATRICS, V118, P797, DOI 10.1542/peds.2005-3132; Southon FCG, 1997, J AM MED INFORM ASSN, V4, P112, DOI 10.1136/jamia.1997.0040112; Thompson W, 2004, CRIT CARE MED, V32, P1306, DOI 10.1097/01.CCM.0000127783.47103.8D; TIERNEY WM, 1993, JAMA-J AM MED ASSOC, V269, P379, DOI 10.1001/jama.269.3.379; Upperman JS, 2005, J PEDIATR SURG, V40, P57, DOI 10.1016/j.jpedsurg.2004.09.024	32	12	12	0	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-6947			BMC MED INFORM DECIS	BMC Med. Inform. Decis. Mak.	NOV 19	2011	11								71	10.1186/1472-6947-11-71			9	Medical Informatics	Medical Informatics	869KA	WOS:000298595600001	22098683	DOAJ Gold, Green Published			2021-06-18	
J	Adler, RH				Adler, Richard H.			Youth Sports and Concussions: Preventing Preventable Brain Injuries. One Client, One Cause, and A New Law	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Youth; Sports; Concussion; Brain		Effective concussion prevention and management for youth athletes requires both education and legislation. Education alone effectively begins the awareness of an issue, but does not change behavior. Education and legislation are required to prevent preventable concussion and brain injuries in youth athletes.	[Adler, Richard H.] Adler Giersch PS, Seattle, WA 98109 USA; [Adler, Richard H.] Brain Injury Assoc Washington, Seattle, WA 98122 USA	Adler, RH (corresponding author), Adler Giersch PS, 300 Taylor Ave N, Seattle, WA 98109 USA.	radler@adlergiersch.com					Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Wiersma LD, 2005, RES Q EXERCISE SPORT, V76, P324	2	12	12	0	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651			PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	NOV	2011	22	4					721	+		10.1016/j.pmr.2011.08.010			9	Rehabilitation	Rehabilitation	858SI	WOS:000297822600011	22050945				2021-06-18	
J	Laker, SR				Laker, Scott R.			Return-to-Play Decisions	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Sport; Concussion; Brain; Post-concussion syndrome	CHRONIC TRAUMATIC ENCEPHALOPATHY; INJURY SURVEILLANCE SYSTEM; METABOLIC BRAIN VULNERABILITY; 3RD INTERNATIONAL-CONFERENCE; COLLEGIATE FOOTBALL PLAYERS; REPETITIVE HEAD-INJURY; HIGH-SCHOOL; DESCRIPTIVE EPIDEMIOLOGY; POSTCONCUSSION SYNDROME; SPORTS CONCUSSION	Concussions occur as a result of forces directed to the head or neck, or from impulsive forces transmitted from the body to the head. They result in the rapid onset and spontaneous recovery of short-lived impairment of neurologic function. Concussions represent a functional, rather than structural, disturbance, and do not result in abnormalities on standard structural imaging. This article discusses a comprehensive approach to return to play in sports concussion, including managing athletes returning after prolonged postconcussion syndrome, multiple concussions, and intracranial hematomas and craniotomy.	Univ Colorado, Dept Phys Med & Rehabil, Aurora, CO 80045 USA	Laker, SR (corresponding author), Univ Colorado, Dept Phys Med & Rehabil, Mail Stop F493,12631 E 17th Ave,Room 2513, Aurora, CO 80045 USA.	scott.laker@ucdenver.edu					Agel J, 2007, J ATHL TRAINING, V42, P270; *AM AC NEUR, PRACT GUID ANN ANN C; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Cantu RC, 2007, NEUROSURGERY, V61, P223, DOI 10.1227/01.NEU.0000255514.73967.90; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Cantu RC, 2009, CURR SPORT MED REP, V8, P6, DOI 10.1249/JSR.0b013e31819677db; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davis G, 2010, BRIT J SPORT MED, V44, P1139, DOI 10.1136/bjsm.2008.048215; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dick R, 2007, J ATHL TRAINING, V42, P278; Dick R, 2007, J ATHL TRAINING, V42, P221; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2011, SPORTS HEALTH, V3, P46, DOI 10.1177/1941738110391732; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Heads Up: Concussion in Youth Sports, 2009, HEADS CONCUSSION YOU; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P581; Kubler-Ross E., 1997, DEATH DYING; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; KUTCHER JS, 2010, CLIN PRACTICE REFERE; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2002, J SCI MED SPORT, V5, P169, DOI 10.1016/S1440-2440(02)80002-0; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Miele Vincent J, 2006, Neurosurg Focus, V21, pE9; Mori T, 2006, ACTA NEUROCHIR SUPPL, V96, P40; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; *NCAA, 2011, 2010 2011 SPORTS MED; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pearsall AW, 2005, CLIN ORTHOP RELAT R, P50, DOI 10.1097/01.blo.0000159896.64176.72; Putukian M, 2009, BRIT J SPORT MED, V43, pI28, DOI 10.1136/bjsm.2009.058230; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Vagnozzi R, 2007, NEUROSURGERY, V61, P388, DOI DOI 10.1227/01.NEU.0000280002.41696; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Walker N, 2007, J R SOC PROMO HEALTH, V127, P174, DOI 10.1177/1466424007079494; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Wiese-Bjornstal DM, 1998, J APPL SPORT PSYCHOL, V10, P46, DOI 10.1080/10413209808406377; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA; PROTECT YOUNG ATHLET	81	12	12	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	NOV	2011	22	4					619	+		10.1016/j.pmr.2011.08.004			17	Rehabilitation	Rehabilitation	858SI	WOS:000297822600005	22050939				2021-06-18	
J	Lantz, PE; Couture, DE				Lantz, Patrick E.; Couture, Daniel E.			Fatal Acute Intracranial Injury, Subdural Hematoma, and Retinal Hemorrhages Caused by Stairway Fall	JOURNAL OF FORENSIC SCIENCES			English	Article; Proceedings Paper	62nd Annual Meeting of the American-Academy-of-Forensic-Sciences	FEB 22-27, 2010	Seattle, WA	Amer Acad Forens Sci		forensic science; retinal hemorrhages; subdural hematoma; shaken baby syndrome; child abuse; accidental fall; abusive head trauma; stairway fall; short fall	NONACCIDENTAL HEAD-INJURY; TRAUMATIC BRAIN-INJURY; YOUNG-CHILDREN; CHILDHOOD; INFANTS; POPULATION	We describe an infant with an acute subdural hematoma, a fatal head injury, and severe hemorrhagic retinopathy caused by a stairway fall. His cerebral and ocular findings are considered diagnostic of abusive head trauma by many authors. Our literature search of serious injuries or fatalities from stairway or low-height falls involving young children yielded 19 articles of primary data. These articles are discrepant, making the classification of a young child's death following a reported short fall problematic. This case report contradicts the prevalent belief of many physicians dealing with suspected child abuse that low-height falls by young children are without exception benign occurrences and cannot cause fatal intracranial injuries and severe retinal hemorrhages. The irreparable harm to a caregiver facing an erroneous allegation of child abuse requires physicians to thoroughly investigate and correctly classify pediatric accidental head injuries.	[Lantz, Patrick E.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Winston Salem, NC 27157 USA; [Couture, Daniel E.] Wake Forest Univ, Bowman Gray Sch Med, Dept Neurosurg, Winston Salem, NC 27157 USA	Lantz, PE (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Med Ctr Blvd, Winston Salem, NC 27157 USA.	plantz@wfubmc.edu					ALEXANDER R, 1990, AM J DIS CHILD, V144, P724, DOI 10.1001/archpedi.1990.02150300124032; Bechtel K, 2005, PEDIATRICS, V115, P192, DOI 10.1542/peds.2004-2150; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Behera C, 2010, MED SCI LAW, V50, P22, DOI 10.1258/msl.2009.009010; Betz P, 1996, FORENSIC SCI INT, V78, P71, DOI 10.1016/0379-0738(95)01866-2; Betz P, 1996, FORENSIC SCI INT, V82, P255; Block RW, 1999, CURR PROBL PEDIATR, V29, P253; Case M, 2002, AM J FOREN MED PATH, V23, P105, DOI 10.1097/00000433-200203000-00025; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; Chadwick DL, 2008, PEDIATRICS, V121, P1213, DOI 10.1542/peds.2007-2281; Chadwick DL, 2008, PEDIATR NEUROSURG, V44, P517, DOI 10.1159/000187129; CHADWICK DL, 1991, J TRAUMA, V31, P1353, DOI 10.1097/00005373-199110000-00006; Chadwick DL, 1992, J TRAUMA, V32, P672; Chadwick DL, 2007, PEDIATR NEUROSURG, V43, P433; CHIAVIELLO CT, 1994, PEDIATRICS, V94, P679; Chiesa A, 2009, PEDIATR CLIN N AM, V56, P317, DOI 10.1016/j.pcl.2009.02.001; David TJ, 1999, J ROY SOC MED, V92, P556, DOI 10.1177/014107689909201105; Denton S, 2004, AM J FOREN MED PATH, V25, P270, DOI 10.1097/01.paf.0000136663.52750.59; DiScala C, 2000, ARCH PEDIAT ADOL MED, V154, P16; Docherty E, 2010, EMERG MED J, V27, P207, DOI 10.1136/emj.2008.069179; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Ehsani JP, 2010, AM J FOREN MED PATH, V31, P287, DOI 10.1097/PAF.0b013e3181db7eb5; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Fujiwara T, 2008, PEDIATRICS, V122, pE841, DOI 10.1542/peds.2008-0387; Ganesh A, 2003, BR J OPHTHALMOL, V87, P9; Ganesh A, 2007, BRIT J OPHTHALMOL, V91, P396, DOI 10.1136/bjo.2006.099481; Gerber P, 2007, CHILD NERV SYST, V23, P499, DOI 10.1007/s00381-006-0267-4; GUTIERREZ FA, 1975, CHILD BRAIN, V1, P269; Hall J R, 1992, J Trauma, V32, P672, DOI 10.1097/00005373-199205000-00027; HALL JR, 1989, J TRAUMA, V29, P1273, DOI 10.1097/00005373-198909000-00015; Hall JR, 1990, J TRAUMA, V30, P1421; Hall JR, 1991, J TRAUMA, V31, P1353; Hall JR, 1991, J TRAUMA, V31, P1350; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Jenny C, 1999, JAMA-J AM MED ASSOC, V282, P29; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P657; Jenny C, 1999, JAMA-J AM MED ASSOC, V282, P1421; JOFFE M, 1988, PEDIATRICS, V82, P457; JOHNSON DL, 1993, NEUROSURGERY, V33, P231; Kairys SW, 2001, PEDIATRICS, V108, P206; Laposata Martha E, 2005, Am J Clin Pathol, V123 Suppl, pS119; Levin AV, 2009, EYE, V23, P1758, DOI 10.1038/eye.2009.199; Levin AV, 2009, PEDIATR CLIN N AM, V56, P333, DOI 10.1016/j.pcl.2009.02.003; Levin AV, 2002, NEUROSURG CLIN N AM, V13, P201, DOI 10.1016/S1042-3680(02)00004-9; Levin AV, 2009, CHILD ABUSE MED DIAG, P211; Levin AV, 2000, RECENT ADV PAEDIAT, P151; Matschke J, 2009, INT J LEGAL MED, V123, P189, DOI 10.1007/s00414-008-0293-8; Park SH, 2004, YONSEI MED J, V45, P229, DOI 10.3349/ymj.2004.45.2.229; Pierre-Kahn V, 2004, OPHTHALMOLOGY, V111, P1794, DOI 10.1016/j.ophtha.2004.06.009; Plunkett J, 2002, AM J FOREN MED PATH, V23, P103, DOI 10.1097/00000433-200203000-00023; Plunkett J, 2001, AM J FOREN MED PATH, V22, P1, DOI 10.1097/00000433-200103000-00001; Plunkett J, 2001, AM J FOREN MED PATH, V22, P332; Plunkett J, 2001, AM J FOREN MED PATH, V22, P415; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; REIBER GD, 1993, AM J FOREN MED PATH, V14, P201, DOI 10.1097/00000433-199309000-00005; Reiber GD, 2000, AM J FOREN MED PATH, V21, P198; Reyes HM, 1990, J TRAUMA, V30, P1422; RIVARA FP, 1993, PEDIATRICS, V92, P61; Rorke-Adams L, 2009, CHILD ABUSE MED DIAG, P53; Steinbok P, 2007, NEUROSURGERY, V60, P689, DOI 10.1227/01.NEU.0000255398.00410.6B; Stray-Pedersen A, 2011, FORENSIC SCI MED PAT, V7, P37, DOI 10.1007/s12024-010-9176-7; Sturm V, 2009, EYE, V23, P1535, DOI 10.1038/eye.2008.317; Trenchs V, 2008, CHILD NERV SYST, V24, P815, DOI 10.1007/s00381-008-0583-y; Vincent AL, 2010, CLIN EXP OPHTHALMOL, V38, P521, DOI 10.1111/j.1442-9071.2010.02324.x; Wang MY, 2001, J PEDIATR SURG, V36, P1528, DOI 10.1053/jpsu.2001.27037; WILLIAMS RA, 1991, J TRAUMA, V31, P1350, DOI 10.1097/00005373-199110000-00005; Williams RA, 1992, J TRAUMA, V32, P672; Wygnanski-Jaffe T, 2009, FORENSIC SCI MED PAT, V5, P291, DOI 10.1007/s12024-009-9134-4	70	12	12	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	NOV	2011	56	6					1648	1653		10.1111/j.1556-4029.2011.01892.x			6	Medicine, Legal	Legal Medicine	848MK	WOS:000297055500035	21827475				2021-06-18	
J	Wiseman-Hakes, C; Victor, JC; Brandys, C; Murray, BJ				Wiseman-Hakes, Catherine; Victor, J. Charles; Brandys, Clare; Murray, Brian J.			Impact of post-traumatic hypersomnia on functional recovery of cognition and communication	BRAIN INJURY			English	Article						Sleep disturbance; hypersomnia; excessive day-time sleepiness; traumatic brain injury; cognition; cognitive-communication; mood disturbance	TRAUMATIC BRAIN-INJURY; SLEEP DISTURBANCE; INSOMNIA; PREVALENCE; REHABILITATION; SCALE	Primary objective: To assess aspects of cognition and communication, in response to the treatment of post-traumatic hypersomnia and mood disturbance. Research design: A single case study; pre-post intervention. Methods and procedures: The participant was a male with severe TBI and cognitive-communication impairments, who subsequently developed sleep and mood disturbance and excessive daytime sleepiness. The Daily Cognitive-Communication and Sleep Profile (D-CCASP), Clinical Interview, Epworth and Stanford Sleepiness Scales and polysomnography assessed sleep and wakefulness. Cognitive-communication was also assessed by the D-CCASP. His sleep, wake and mood difficulties were pharmacologically managed. Main outcomes and results: Baseline polysomnography indicated abnormal sleep. There was a clear positive relationship between quality of sleep, language processing, attention and memory, seen across the phases of the medication intervention (p < 0.01). Conclusions: A comprehensive pharmacological management programme addressing the multi-factorial underlying aetiology was successful in improving sleep, arousal and mood. The D-CCASP was found to be clinically and statistically sensitive to reported changes in cognitive-communication function in relation to improvements in sleep and daytime arousal. These findings suggest that management of sleep/wake disturbances and mood post-traumatic brain injury can potentially facilitate improvements in cognitive-communication function which may, in turn, facilitate participation in rehabilitation and community integration.	[Wiseman-Hakes, Catherine] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5G 1V7, Canada; [Victor, J. Charles] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5G 1V7, Canada; [Brandys, Clare] Univ Toronto, Dept Psychiat, Toronto, ON M5G 1V7, Canada; [Murray, Brian J.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada	Wiseman-Hakes, C (corresponding author), Univ Toronto, Grad Dept Rehabil Sci, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	catherinew.hakes@utoronto.ca	Murray, Brian/E-6786-2016; Victor, J Charles/F-8765-2011; Wiseman-Hakes, Catherine/AAC-8303-2021	Murray, Brian/0000-0001-5085-0909; Victor, J Charles/0000-0003-1720-9356; Wiseman-Hakes, Catherine/0000-0001-8441-884X	Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Ministry of Health and Long-Term Care in Ontario, Canada	This work was conducted at Sunnybrook Health Sciences Centre, Toronto, Canada and was financially supported by Canadian Institutes for Health Research (CIHR) through a Fellowship in Clinical Research, and the Toronto Rehabilitation Institute who receives funding under the Provincial Rehabilitation Research Program from the Ministry of Health and Long-Term Care in Ontario, Canada. The views expressed do not necessarily reflect those of the Ministry.	Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Burke DT, 2004, J APPL RES, V4, P239; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2009, J CLIN SLEEP MED, V5, P137; Colantonio A, 2004, INT J REHABIL RES, V27, P209, DOI 10.1097/00004356-200409000-00006; Doghramji K, 1997, ELECTROEN CLIN NEURO, V103, P554, DOI 10.1016/S0013-4694(97)00010-2; Fellus J, 2007, BRAIN INJURY MED, P545; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Flanagan SR, 2007, J HEAD TRAUMA REHAB, V22, P67, DOI 10.1097/00001199-200701000-00009; Francisco GE, 1996, AM J PHYS MED REHAB, V75, P63, DOI 10.1097/00002060-199601000-00016; Fung C, 2011, CAN ASS OCC THER CAO; Giglio P., 2007, REV SLEEP MED, P29; Greenwald BD, 2009, PHYS MED REHABILITAT, P347; Hartley L. L., 1995, COGNITIVE COMMUNICAT; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; MacDonald S, 2010, BRAIN INJURY, V24, P486, DOI 10.3109/02699050903518118; MacLean, 1992, J Sleep Res, V1, P35; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Maquet P, 2003, SLEEP BRAIN PLASTICI; Morin CM, 2006, SLEEP MED, V7, P123, DOI 10.1016/j.sleep.2005.08.008; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Repchinsky C, 2010, COMPENDIUM PHARM SPE; Roth Thomas, 2007, J Clin Sleep Med, V3, pS7; SAS Institute Inc, 2008, SAS SYST WIND V9 2; Seyone C, 2006, SLEEP SLEEP DISORDER; Stickgold R, 2003, SLEEP BRAIN PLASTICI, P41; STICKGOLD R, 2003, SLEEP BRAIN PLASTICI, P17; Stickgold R, 2007, SLEEP MED, V8, P331, DOI 10.1016/j.sleep.2007.03.011; VANBEMMEL AL, 1993, PSYCHOPHARMACOLOGY, V113, P225, DOI 10.1007/BF02245702; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Winokur A, 2001, DEPRESS ANXIETY, V14, P19, DOI 10.1002/da.1043; Wiseman-Hakes C, 2009, CRIT REV PHYS REHABI, V21, P317, DOI DOI 10.1615/CRITREVPHYSREHABILMED.V21.I3-4.70	41	12	12	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2011	25	12					1256	1265		10.3109/02699052.2011.608215			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	829WF	WOS:000295615200013	21961569				2021-06-18	
J	Alvsaker, K; Walther, SM; Kleffelgard, I; Mongs, M; Draegebo, RA; Keller, A				Alvsaker, Kristin; Walther, Sten M.; Kleffelgard, Ingerid; Mongs, Malin; Draegebo, Randi Aas; Keller, Anne			INTER-RATER RELIABILITY OF THE EARLY FUNCTIONAL ABILITIES SCALE	JOURNAL OF REHABILITATION MEDICINE			English	Article						traumatic brain injury; rehabilitation outcome; assessment	TRAUMATIC BRAIN-INJURY; EARLY INTERVENTION; HEAD-INJURY; REHABILITATION; COMA; COEFFICIENT; TOMOGRAPHY	Objective: To investigate the inter-rater reliability of the Early Functional Abilities (EFA) scale. Design: An observational study of inter-rater reliability in an open cohort. Patients: Twenty-four patients with traumatic brain injury in need of medical or surgical intervention in the early rehabilitation section of the intensive care unit. Methods: The EFA was assessed by 4 different professions in the rehabilitation team. Inter-rater reliability was assessed using linear weighted kappa statistics. Results: The overall weighted kappa values of the different EFA items varied from 0.27 to 0.60. The items in the sensorimotor functional area had the highest pairwise agreement, with a mean kappa range of 0.68-0.76. The vegetative stability, position tolerance and wakefulness items had the lowest mean kappa values (0.49, 0.33 and 0.49, respectively). Agreement was good to excellent between the occupational therapist and physiotherapist across the majority of the items, whereas the physician and nurse agreed less with one another. Conclusion: The inter-rater reliability of the EFA scale was good for most items among all the raters. The scale may be used by all members of the interdisciplinary team after training in administration and scoring. A reduction in the number of items in the vegetative functional domain is recommended.	[Alvsaker, Kristin; Keller, Anne] Univ Oslo, Ulleval Hosp, Dept Phys Med & Rehabil, NO-0407 Oslo, Norway; [Alvsaker, Kristin; Walther, Sten M.; Kleffelgard, Ingerid; Mongs, Malin; Draegebo, Randi Aas] Univ Oslo, Ulleval Hosp, Intens Care Unit, NO-0407 Oslo, Norway; [Walther, Sten M.] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth, Div Cardiovasc Med, S-58183 Linkoping, Sweden	Alvsaker, K (corresponding author), Univ Oslo, Ulleval Hosp, Dept Phys Med & Rehabil, NO-0407 Oslo, Norway.	Kristin.Alvsaker@oslo-universitetssykehus.no					Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; Bland JM, 1996, BRIT MED J, V313, P41, DOI 10.1136/bmj.313.7048.41; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; COOMBES K, 2001, FACIAL ORAL TRACT TH, P47; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; DAVIS JZ, 1992, OCCUP THER PRACT, V3, P30; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Engberg AW, 2007, J HEAD TRAUMA REHAB, V22, P221, DOI 10.1097/01.HTR.0000281837.62226.54; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Fleiss JL, 1981, STAT METHODS RATES P, V2nd; FRANK U, 2008, TREATING TRACHEOTOMI; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Gjelsvik B. E. B., 2008, BOBATH CONCEPT ADULT; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Hanoa Rolf, 2008, Tidsskr Nor Laegeforen, V128, P66; Huber Lisa, 2010, AORN J, V92, P345, DOI 10.1016/j.aorn.2010.06.011; KLEFFELGARD I, 2008, 7 WORLD C BRAIN INJ; KRISTENSEN KS, TRANSLATION EARLY FU; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Lorentzen J, 2005, EVALUATION EARLY FUN; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; MAHONEY F I, 1965, Md State Med J, V14, P61; McCluggage WG, 1996, J CLIN PATHOL, V49, P833, DOI 10.1136/jcp.49.10.833; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; NORUP A, 2011, NEUROPSYCHOL REHABIL, P1; Prasad K, 1996, J CLIN EPIDEMIOL, V49, P755, DOI 10.1016/0895-4356(96)00013-3; SALLING B, 2000, DANISH TRANSLATION E; Schmidt, 2000, NEUROL REHABIL, V6, P125; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; TEASDALE G, 1974, LANCET, V2, P81; *US DEP HHS, 1998, REH PERS TRAUM BRAIN, V16, P1; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941; 2005, REHABILITATION PERSO	35	12	12	0	3	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977			J REHABIL MED	J. Rehabil. Med.	OCT	2011	43	10					892	899		10.2340/16501977-0855			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	844KF	WOS:000296745400004	21879231	DOAJ Gold			2021-06-18	
J	Grande, PO				Grande, Per-Olof			The Lund Concept for the Treatment of Patients With Severe Traumatic Brain Injury	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						Lund concept; brain edema; cerebral perfusion pressure; intracranial pressure; positive endexpiratory pressure; arterial blood pressure; bloodbrain barrier; traumatic head injury; US Trauma Foundation guideline	CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; PHYSIOLOGICAL PRINCIPLES; VOLUME REGULATION; VENOUS-PRESSURE; HYPERTENSION; MANAGEMENT; ARTERIAL; ABSENCE	Two different main concepts for the treatment of a severe traumatic brain injury have been established during the last 15 years, namely the more conventional concept recommended in well-established guidelines (eg, U.S. Guideline, European Guideline, Addelbrook's Guideline from Cambridge), on the one hand, and the Lund concept from the University Hospital of Lund, Sweden, on the other. Owing to the lack of well-controlled randomized outcome studies comparing these 2 main therapeutic approaches, we cannot conclude that one is better than the other. This paper is the PRO part in a PRO-CON debate in this journal on the Lund concept. Although the Lund concept is based on a physiology-oriented approach dealing with the hemodynamic principles of brain volume and brain perfusion regulation, traditional treatments are primarily based on a meta-analytic approach from clinical studies. High cerebral perfusion pressure has been an essential goal in the conventional treatments (the cerebral perfusion pressure-guided approach), even though it has been modified in a recent up date of U.S. guidelines. The Lund concept has instead concentrated on management of brain edema and intracranial pressure, along with improvement of cerebral perfusion and oxygenation (the intracranial pressure and perfusion-guided approach). Although conventional guidelines are restricted to clinical data from meta-analytic surveys, the physiological approach of Lund therapy finds support in both experimental and clinical studies. It offers a wider base and can also provide recommendations regarding fluid therapy, lung protection, optimal hemoglobin concentration, temperature control, the use of decompressive craniotomy, and ventricular drainage. This paper puts forward arguments in support of Lund therapy.	[Grande, Per-Olof] Univ Lund Hosp, Dept Anesthesia & Intens Care, SE-22185 Lund, Sweden; [Grande, Per-Olof] Lund Univ, Dept Anesthesia & Intens Care, S-22100 Lund, Sweden	Grande, PO (corresponding author), Univ Lund Hosp, Dept Anesthesia & Intens Care, SE-22185 Lund, Sweden.	per-olof.grande@med.lu.se			Faculty of Medicine, Lund University, Sweden [11581]; Region Skane, Sweden	Supported by grants from the Swedish Research Council (#11581), from the Faculty of Medicine, Lund University, Sweden, and from Region Skane, Sweden.	ASGEIRSSON B, 1994, INTENS CARE MED, V20, P567, DOI 10.1007/BF01705723; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Dubniks M, 2007, INTENS CARE MED, V33, P2192, DOI 10.1007/s00134-007-0756-2; Grande PO, 2009, ACTA ANAESTH SCAND, V53, P1233, DOI 10.1111/j.1399-6576.2009.02074.x; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P264, DOI 10.1034/j.1399-6576.2002.460307.x; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; Holbeck S, 2002, CRIT CARE MED, V30, P212, DOI 10.1097/00003246-200201000-00030; Jungner M, 2011, CRIT CARE MED, V39, P135, DOI 10.1097/CCM.0b013e3181fb7c94; Jungner M, 2010, ANESTHESIOLOGY, V112, P1194, DOI 10.1097/ALN.0b013e3181d94d6e; Kochanek PM, 2007, J NEUROTRAUM, V24, P1, DOI 10.1089/neu.2006.0209; Kongstad L, 1999, ACTA ANAESTH SCAND, V43, P501, DOI 10.1034/j.1399-6576.1999.430503.x; Kongstad L, 2001, J TRAUMA, V51, P490, DOI 10.1097/00005373-200109000-00011; Liu Chang-Wen, 2010, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V22, P610; LUCIA M, 2010, ANESTH ANALG, V111, P736; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Nygren A, 2010, ACTA ANAESTH SCAND, V54, P814, DOI 10.1111/j.1399-6576.2010.02244.x; Olivecrona M, 2009, J NEUROSURG, V110, P300, DOI 10.3171/2008.4.17538; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Rise IR, 1998, J NEUROSURG, V89, P454, DOI 10.3171/jns.1998.89.3.0454; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Roberts I, 2007, BRIT MED J, V334, P392, DOI 10.1136/bmj.39118.480023.BE; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Stahl N, 2001, INTENS CARE MED, V27, P1215, DOI 10.1007/s001340101004	30	12	13	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	OCT	2011	23	4					358	362		10.1097/01.ana.0000405612.20356.84			5	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	818ML	WOS:000294755700013	21908989				2021-06-18	
J	Mahajan, H; Spaeth, DM; Dicianno, BE; Collins, DM; Boninger, ML; Cooper, RA				Mahajan, Harshal; Spaeth, Donald M.; Dicianno, Brad E.; Collins, Diane M.; Boninger, Michael L.; Cooper, Rory A.			Comparison of Virtual Wheelchair Driving Performance of People With Traumatic Brain Injury Using an Isometric and a Conventional Joystick	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Assistive technology; Brain injuries, traumatic; Rehabilitation; User-computer interface; Wheelchairs, computer simulation	TARGET ACQUISITION; TECHNOLOGY; INDIVIDUALS	Mahajan H, Spaeth DM, Dicianno BE, Collins DM, Boninger ML, Cooper RA. Comparison of virtual wheelchair driving performance of people with traumatic brain injury using an isometric and a conventional joystick. Arch Phys Med Rehabil 2011;92:1298-304. Objective: To compare wheelchair driving performance in a driving simulator using a conventional joystick and an isometric joystick. Design: Randomized, cohort study. Setting: A research facility based in a hospital or in an independent living center. Participants: Participants (N=20; 12 men, 8 women; mean age +/- SD, 30.62 +/- 10.91y) who were at least 1 year post-TBI. Interventions: Driving performance using an isometric joystick compared with a conventional movement joystick. Main Outcome Measures: Average trial completion time, and trajectory-specific measures measured orthogonal to the center of driving tasks: root mean squared error, movement offset, movement error, and number of significant changes in heading. Results: After statistically controlling for driving speed, participants were able to complete the driving tasks faster with an isometric joystick than while using a conventional movement joystick. Compared with the conventional joystick, an isometric joystick used for driving forward demonstrated fewer driving errors. During reverse driving the conventional joystick performed better. Conclusions: The customizable isometric joystick seems to be a promising interface for driving a powered wheelchair for individuals with TBI.	[Mahajan, Harshal; Spaeth, Donald M.; Dicianno, Brad E.; Boninger, Michael L.; Cooper, Rory A.] VA Pittsburgh HealthCare Syst, Human Engn Res Lab, Pittsburgh, PA 15206 USA; [Mahajan, Harshal; Spaeth, Donald M.; Dicianno, Brad E.; Boninger, Michael L.; Cooper, Rory A.] VA Pittsburgh HealthCare Syst, Ctr Excellence Wheelchairs & Related Technol, Pittsburgh, PA 15206 USA; [Dicianno, Brad E.; Boninger, Michael L.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Mahajan, Harshal; Spaeth, Donald M.; Dicianno, Brad E.; Collins, Diane M.; Boninger, Michael L.; Cooper, Rory A.] Univ Pittsburgh, Dept Rehabil Sci & Technol, Pittsburgh, PA USA; [Dicianno, Brad E.; Boninger, Michael L.; Cooper, Rory A.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA	Cooper, RA (corresponding author), VA Pittsburgh HealthCare Syst, Human Engn Res Lab, 7180 Highland Dr,Bldg 4,2nd Fl E,151R1-H, Pittsburgh, PA 15206 USA.	rcooper@pitt.edu	Dicanno, Brad/AAC-5918-2019	Dicanno, Brad/0000-0003-0738-0192; Boninger, Michael/0000-0001-6966-919X; Collins, Diane/0000-0003-0646-0457	National Institute on Disability and Rehabilitation Research; U.S. Department of EducationUS Department of Education [H133A020502]; Human Engineering Research Laboratories, VA Pittsburgh HealthCare System; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD048465] Funding Source: NIH RePORTER	Supported by the National Institute on Disability and Rehabilitation Research, U.S. Department of Education (grant no. H133A020502), and with resources and facilities by the Human Engineering Research Laboratories, VA Pittsburgh HealthCare System. The contents of this publication do not represent the views of the Department of Veterans Affairs or the United States Government.	Bellolio MF, 2008, INT J EMERG MED, V1, P197, DOI 10.1007/s12245-008-0061-z; Cooper RA, 2000, IEEE T CONTR SYST T, V8, P112, DOI 10.1109/87.817696; Cooper RA, 2000, IEEE T BIO-MED ENG, V47, P902, DOI 10.1109/10.846684; Cooper RA, 2005, ASSIST TECHNOL, V17, P159, DOI 10.1080/10400435.2005.10132105; Cooper RA, 2002, MED ENG PHYS, V24, P703, DOI 10.1016/S1350-4533(02)00111-X; Dicianno BE, 2007, IEEE T NEUR SYS REH, V15, P144, DOI 10.1109/TNSRE.2007.891394; Dicianno BE, 2006, AM J PHYS MED REHAB, V85, P631, DOI 10.1097/01.phm.0000228519.54763.b4; Douglas S. A., 1999, P CHI 99, P215, DOI DOI 10.1145/302979.303042; Fehr L, 2000, J REHABIL RES DEV, V37, P353; Guiard Y, 2004, INT J HUM-COMPUT ST, V61, P875, DOI 10.1016/j.ijhcs.2004.09.005; Jones DK, 1998, PROCEEDINGS OF THE IEEE 24TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, P130, DOI 10.1109/NEBC.1998.664901; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Luaute J, 2006, NEUROSCI BIOBEHAV R, V30, P961, DOI 10.1016/j.neubiorev.2006.03.001; MacKenzie I. S., 2001, CHI 2001 Conference Proceedings. Conference on Human Factors in Computing Systems, P9; Niemeier J P, 2001, Top Stroke Rehabil, V8, P10; Phillips B, 1993, Assist Technol, V5, P36; Rao RS, 2000, IEEE T REHABIL ENG, V8, P118, DOI 10.1109/86.830956; Riemer-Reiss ML, 2000, J REHABIL, V66, P44; Roduit P, 2006, LECT NOTES COMPUT SC, V4095, P819; Scherer MJ, 2001, DISABIL REHABIL, V23, P387; Spaeth DM, 2008, ARCH PHYS MED REHAB, V89, P996, DOI 10.1016/j.apmr.2007.11.030; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Zhai SM, 2004, PRESENCE-TELEOP VIRT, V13, P113, DOI 10.1162/1054746041382393	25	12	12	0	16	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2011	92	8					1298	1304		10.1016/j.apmr.2011.03.011			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	803WL	WOS:000293612800016	21807150	Green Accepted			2021-06-18	
J	Schluter-Brust, K; Leistenschneider, P; Dargel, J; Springorum, HP; Eysel, P; Michael, JWP				Schlueter-Brust, K.; Leistenschneider, P.; Dargel, J.; Springorum, H. P.; Eysel, P.; Michael, J. W-P.			Acute Injuries in Taekwondo	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						injuries; acute; taekwondo; martial art; epidemiology	MARTIAL ARTS INJURIES; COMPETITION; SPORTS; CHAMPIONSHIPS; CONCUSSION; BLOWS; HEAD	Although Taekwondo is becoming an increasingly popular sport, there is a lack of reliable epidemiologic data on Taekwondo injuries. To perform an epidemiologic study on the variety of types of injury in professional and amateur Taekwondo athletes and to find a relation between Taekwondo style, skill level, weight-class and warm-up routine and the occurrence of injuries, we analysed the injury data using a 7-page questionnaire from a total of 356 Taekwondo athletes who were randomly selected. Overall, we registered a total of 2 164 injuries in 356 athletes. Most traumas were contusions and sprains in the lower extremities. Professional Taekwondo athletes have an increased risk of injury in comparison to recreational athletes. Taekwondo style, weight class and tournament frequency have an influence on the athlete's injury profile. Warm-up routines were found to have a positive effect on injury rates. Overall, Taekwondo may be considered a rather benign activity, if injuries during Taekwondo tournaments can be avoided. If not, Taekwondo can result in serious musculoskeletal problems.	[Schlueter-Brust, K.; Leistenschneider, P.; Dargel, J.; Springorum, H. P.; Eysel, P.; Michael, J. W-P.] Univ Cologne, Dept Orthoped Surg, D-50931 Cologne, Germany	Michael, JWP (corresponding author), Univ Cologne, Dept Orthoped Surg, Joseph Stelzmann St 9, D-50931 Cologne, Germany.	joern.michael@uk-koeln.de					American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Beis K, 2001, EUR J SPORT TRAUMA R, V23, P130; Birrer R B, 1983, Br J Sports Med, V17, P131; BIRRER RB, 1988, AM J SPORT MED, V16, P408, DOI 10.1177/036354658801600418; Burke DT, 2003, BRIT J SPORT MED, V37, P401, DOI 10.1136/bjsm.37.5.401; DICK R, 1988, NATL COLLEGIATE ATHL; Gong HS, 2007, BRIT J SPORT MED, V41, P917, DOI 10.1136/bjsm.2007.035501; Harriss DJ, 2009, INT J SPORTS MED, V30, P701, DOI 10.1055/s-0029-1237378; Junge A, 2009, AM J SPORT MED, V37, P2165, DOI 10.1177/0363546509339357; Kazemi M, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-22; Koh JO, 2004, CLIN J SPORT MED, V14, P72, DOI 10.1097/00042752-200403000-00004; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Koh JO, 2002, J SPORT MED PHYS FIT, V42, P348; Lee KT, 2009, PHYS THER SPORT, V10, P101, DOI 10.1016/j.ptsp.2009.05.002; MCLATCHIE GR, 1994, ENCY SPORTS MED, V5, P609; Pary LF, 2003, NEUROLOGY, V60, P1392, DOI 10.1212/01.WNL.0000055924.12065.A0; Pieter W, 2005, MED SPORT SCI, V48, P59, DOI 10.1159/000084283; Pieter W, 1998, J ROY SOC HEALTH, V118, P272, DOI 10.1177/146642409811800512; Pieter W, 1997, J TRAUMA, V43, P89, DOI 10.1097/00005373-199707000-00020; PIETER W, 1998, KINESIOLOGY, V30, P22, DOI DOI 10.1589/JPTS.28.231; PIETER W, 2002, ACSM 49 ANN M ST LOU; Zemper E D, 1989, Br J Sports Med, V23, P161; Zetaruk MN, 2005, BRIT J SPORT MED, V39, P29, DOI 10.1136/bjsm.2003.010322	23	12	12	3	17	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	AUG	2011	32	8					629	634		10.1055/s-0031-1275302			6	Sport Sciences	Sport Sciences	801SG	WOS:000293460100012	21563037				2021-06-18	
J	Stokell, R; Yu, AN; Williams, K; Treleaven, J				Stokell, Raina; Yu, Annie; Williams, Katrina; Treleaven, Julia			Dynamic and functional balance tasks in subjects with persistent whiplash: A pilot trial	MANUAL THERAPY			English	Article						Balance; Functional; Whiplash; Neck pain	JOINT POSITION ERROR; STANDING BALANCE; STEPPING TEST; NECK PAIN; DIZZINESS; STABILITY; INJURY	Disturbances in static balance have been demonstrated in subjects with persistent whiplash. Some also report loss of balance and falls. These disturbances may contribute to difficulties in dynamic tasks. The aim of this study was to determine whether subjects with whiplash had deficits in dynamic and functional balance tasks when compared to a healthy control group. Twenty subjects with persistent pain following a whiplash injury and twenty healthy controls were assessed in single leg stance with eyes open and closed, the step test, Fukuda stepping test, tandem walk on a firm and soft surface, Singleton test with eyes open and closed, a stair walking test and the timed 10 m walk with and without head movement. Subjects with whiplash demonstrated significant deficits (p < 0.01) in single leg stance with eyes closed, the step test, tandem walk on a firm and soft surface, stair walking and the timed 10 m walk with and without head movement when compared to the control subjects. Specific assessment and rehabilitation directed towards improving these deficits may need to be considered in the management of patients with persistent whiplash if these results are confirmed in a larger cohort. Crown Copyright (C) 2011 Published by Elsevier Ltd. All rights reserved.	[Stokell, Raina; Yu, Annie; Williams, Katrina; Treleaven, Julia] Univ Queensland, Sch Hlth & Rehabil Sci, Div Physiotherapy, Brisbane, Qld 4072, Australia	Treleaven, J (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Div Physiotherapy, Brisbane, Qld 4072, Australia.	j.treleaven@uq.edu.au	Treleaven, Julia M/F-8734-2010; Treleaven, Julia/N-1379-2019; Williams, Katrina/H-6511-2013	Treleaven, Julia M/0000-0002-6258-3972; Treleaven, Julia/0000-0002-6258-3972; Williams, Katrina/0000-0001-5096-7752			Alpini D, 2005, GAIT POSTURE, V22, P308, DOI 10.1016/j.gaitpost.2004.10.003; BOHANNON R, 1984, PHYS THER, V64, P1037; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; BONNANI M, 1998, PHYSIOTHERAPY RES IN, V3, P58; Field S, 2008, MANUAL THER, V13, P183, DOI 10.1016/j.math.2006.12.005; Herdman S, 2000, VESTIBULAR REHABILIT; Hill KD., 1996, PHYSIOTHER CAN, V48, P257, DOI DOI 10.3138/PTC.48.4.257; Honaker JA, 2009, J AM ACAD AUDIOL, V20, P311, DOI 10.3766/jaaa.20.5.4; LowChoy N, 2006, AUST J PHYSIOTHER, V52, P211; Michaelson P, 2003, J REHABIL MED, V35, P229, DOI 10.1080/16501970306093; Poole E, 2008, MANUAL THER, V13, P317, DOI 10.1016/j.math.2007.02.002; Sjostrom H, 2003, SPINE, V28, P1725, DOI 10.1097/00007632-200308010-00018; Tesio L, 1999, AM J PHYS MED REHAB, V78, P233, DOI 10.1097/00002060-199905000-00009; Treleaven J, 2006, MANUAL THER, V11, P99, DOI 10.1016/j.math.2005.04.003; Treleaven J, 2005, J REHABIL MED, V37, P224, DOI 10.1080/16501970510027989; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; Treleaven J, 2008, ARCH PHYS MED REHAB, V89, P522, DOI 10.1016/j.apmr.2007.11.002; Vernon H, 1996, J MUSCULOSKELET PAIN, V4, P95, DOI DOI 10.1300/J094V04N04_	18	12	12	0	8	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1356-689X			MANUAL THER	Man. Ther.	AUG	2011	16	4					394	398		10.1016/j.math.2011.01.012			5	Rehabilitation	Rehabilitation	798XH	WOS:000293245000015	21367648				2021-06-18	
J	Connell, S; Gao, J; Chen, J; Shi, RY				Connell, Sean; Gao, Jian; Chen, Jun; Shi, Riyi			Novel Model to Investigate Blast Injury in the Central Nervous System	JOURNAL OF NEUROTRAUMA			English	Article						axolemma; axonal injury; electrophysiology; military injury; neuronal cell death	MAMMALIAN SPINAL-CORD; IN-VITRO; BRAIN; CONDUCTION; DISRUPTION; MAGNITUDE; DYNAMICS; DEFICITS; NEURONS; STRAIN	Blast-induced neurotrauma (BINT) is a common injury modality associated with the current war efforts and increasing levels of terrorist activity. Exposure to the primary blast wave generated by explosive devices causes significant neurological deficits and is responsible for many of the war-related pathologies. Despite research efforts, the mechanism of injury is still poorly understood. To this end, we have established a novel ex vivo model for the direct observation and quantification of BINT at the tissue level. The model provides a quantifiable and reproducible method to illustrate the mechanism of BINT. Isolated sections of guinea pig spinal cord white matter were exposed to a supersonic shockwave using a blast generator with small-scaled explosives. The blast wave impact with isolated tissue was observed using focused shadowgraphy with a high-speed camera recording at 90,000 fps. Concurrently, functional deficits were measured by monitoring the production of compound action potentials using a double sucrose gap-recording chamber. Additionally, anatomical deficits were measured after blast exposure with a dye exclusion assay to visualize axonal membrane permeability. Our findings demonstrate that direct exposure to the blast wave compressed nervous tissue at a rate of 60 m/sec and led to significant functional deficits. Damage to the isolated spinal cord was marked by increased axonal permeability, suggesting rapid compression from the shockwave-generated high strain rates that resulted in membrane disruption. The model provides new insight into the mechanism of BINT and permits direct observation that may contribute to the development of appropriate treatment regimens.	[Shi, Riyi] Purdue Univ, Sch Vet Med, Dept Basic Med Sci, W Lafayette, IN 47906 USA; [Connell, Sean; Shi, Riyi] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47906 USA; [Gao, Jian; Chen, Jun] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47906 USA	Shi, RY (corresponding author), Purdue Univ, Sch Vet Med, Dept Basic Med Sci, 408 S Univ St, W Lafayette, IN 47906 USA.	riyi@purdue.edu	Gao, Jian/Q-6457-2016	Gao, Jian/0000-0003-3744-453X			Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; CLEMEDSON CJ, 1956, PHYSIOL REV, V36, P336; Coupland RM, 1999, BRIT MED J, V319, P407, DOI 10.1136/bmj.319.7207.407; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Hui OY, 2008, J NEUROTRAUM, V25, P19, DOI 10.1089/neu.2007.0340; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; Luo J, 2007, BRAIN RES, V1155, P10, DOI 10.1016/j.brainres.2007.03.091; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Moore DF, 2008, FUTUR NEUROL, V3, P243, DOI 10.2217/14796708.3.3.243; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ouyang Hui, 2009, J Neurosurg Spine, V10, P161, DOI 10.3171/2008.10.SPI08495; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Settles G.S., 2001, EXP FLUID MECH, P165, DOI 10.1007/978-3-642-56640-0; Shi R, 1999, J NEUROPHYSIOL, V81, P2406; Shi R, 1997, NEUROSCIENCE, V77, P553, DOI 10.1016/S0306-4522(96)00477-0; Shi R, 2000, J NEUROCYTOL, V29, P633, DOI 10.1023/A:1010879219775; Shi R, 1996, J NEUROPHYSIOL, V76, P1572; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Shi RY, 2004, J NEUROCYTOL, V33, P203, DOI 10.1023/B:NEUR.0000030695.76840.19; Simon CM, 2005, J NEUROTRAUM, V22, P1173; Simon C, 2007, J NEUROTRAUM, V24, P1282; Simon CM, 2009, J NEUROTRAUM, V26, P563, DOI 10.1089/neu.2008.0523; STUHMILLER JH, 1991, CONVENTIONAL WARFARE; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060	31	12	13	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2011	28	7					1229	1236		10.1089/neu.2011.1832			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	794BL	WOS:000292869600011	21529318				2021-06-18	
J	Mahmood, A; Qu, CS; Ning, RZ; Wu, HT; Goussev, A; Xiong, Y; Irtenkauf, S; Li, Y; Chopp, M				Mahmood, Asim; Qu, Changsheng; Ning, Riuzuo; Wu, Hongtao; Goussev, Anton; Xiong, Ye; Irtenkauf, Susan; Li, Yi; Chopp, Michael			Treatment of TBI with Collagen Scaffolds and Human Marrow Stromal Cells Increases the Expression of Tissue Plasminogen Activator	JOURNAL OF NEUROTRAUMA			English	Article						collagen scaffolds; marrow stromal cells; tissue plasminogen activator; traumatic brain injury	TRAUMATIC BRAIN-INJURY; PERIPHERAL-NERVE REGENERATION; FUNCTIONAL RECOVERY; ADULT RATS; TRANSPLANTATION; INDUCTION; SEIZURE; DEFICIT; BENEFIT; MODEL	This study examines the effects of combination therapy of collagen scaffolds and human marrow stromal cells (hMSCs) on the expression of tissue plasminogen activator (tPA) after traumatic brain injury (TBI) in rats. Adult male Wistar rats (n=48) were injured with controlled cortical impact and treated either with scaffolds suffused with hMSCs (3 x 10(6)) or hMSCs (3 x 10(6)) alone transplanted into the lesion cavity 1 week after TBI. A control group was treated with saline. Neurological function was assessed using the Morris Water Maze test (MWM) and modified Neurological Severity Scores (mNSS). The rats were sacrificed 14 days after TBI and brain samples were processed for immunohistochemical analysis and quantitative Western blot and quantitative real-time polymerase chain reaction (qRT-PCR) studies. Enhanced functional improvement was observed on both the mNSS and MWM tests in the scaffold + hMSC-treated group compared to the other two groups. Immunostaining with anti-human mitochondrial antibody (E5204) showed more hMSCs in the injury zone of the scaffold + hMSC group compared to the hMSC-alone group. Triple staining showed that more neurons were tPA-positive in the scaffold + hMSC group compared to the other two groups (p<0.05). Western blot analysis and qRT-PCR showed that scaffold + hMSC and hMSC-alone treatment enhanced the expression of tPA compared to controls (p<0.05), but tPA expression was significantly greater in the scaffold + hMSC group. The induction of tPA by hMSCs after TBI may be one of the mechanisms involved in promoting functional improvement after TBI.	[Mahmood, Asim; Qu, Changsheng; Ning, Riuzuo; Wu, Hongtao; Goussev, Anton; Xiong, Ye; Irtenkauf, Susan] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI 48202 USA; [Li, Yi; Chopp, Michael] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Mahmood, A (corresponding author), Henry Ford Hlth Syst, Dept Neurosurg, 2799 W Grand Blvd, Detroit, MI 48202 USA.	nsaam@neuro.hfh.edu	ning, ruizhuo/E-6401-2012	Xiong, Ye/0000-0001-9770-6031	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS066041] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS066041] Funding Source: Medline		BARNES P, 2008, PLOS, V3, P1; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Day LB, 1999, BEHAV NEUROSCI, V113, P914, DOI 10.1037/0735-7044.113.5.914; Day LB, 1996, BEHAV NEUROSCI, V110, P998; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Ellis V, 2003, PLASMINOGEN: STRUCTURE, ACTIVATION AND REGULATION, P19; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Lu DY, 2003, J HEAD TRAUMA REHAB, V18, P357, DOI 10.1097/00001199-200307000-00006; Lu DY, 2002, J NEUROSURG, V97, P935, DOI 10.3171/jns.2002.97.4.0935; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Mataga N, 2002, P NATL ACAD SCI USA, V99, P7717, DOI 10.1073/pnas.102088899; MOONEN G, 1982, NATURE, V298, P753, DOI 10.1038/298753a0; Nagai Nobuo, 2008, P314, DOI 10.1007/978-4-431-78847-8_22; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Park L, 2008, P NATL ACAD SCI USA, V105, P1073, DOI 10.1073/pnas.0708823105; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P443, DOI 10.1073/pnas.0406454102; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Qu CS, 2011, BRAIN RES, V1371, P129, DOI 10.1016/j.brainres.2010.10.088; Qu CS, 2009, J NEUROSURG, V111, P658, DOI 10.3171/2009.4.JNS081681; Rogove AD, 1998, CURR BIOL, V8, P19, DOI 10.1016/S0960-9822(98)70016-8; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637; SEEDS NW, 1995, SCIENCE, V270, P1992, DOI 10.1126/science.270.5244.1992; Seeds NW, 1999, P NATL ACAD SCI USA, V96, P14118, DOI 10.1073/pnas.96.24.14118; Siconolfi LB, 2001, J NEUROSCI, V21, P4336, DOI 10.1523/JNEUROSCI.21-12-04336.2001; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Stein SC, 2009, J NEUROTRAUM, V26, P1585, DOI [10.1089/neu.2008.0720, 10.1089/neu.2008-0720]; Teesalu T, 2003, PLASMINOGEN: STRUCTURE, ACTIVATION AND REGULATION, P251; WARE JH, 1995, J NEUROBIOL, V28, P9, DOI 10.1002/neu.480280103; Wu YP, 2000, J CELL BIOL, V148, P1295, DOI 10.1083/jcb.148.6.1295; Xin HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009027; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Yamada K, 1999, BRIT J PHARMACOL, V126, P235, DOI 10.1038/sj.bjp.0702309; Zou T, 2006, J NEUROPATH EXP NEUR, V65, P78, DOI 10.1097/01.jnen.0000195942.25163.f5	48	12	12	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2011	28	7					1199	1207		10.1089/neu.2010.1694			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	794BL	WOS:000292869600008	21355820	Green Published			2021-06-18	
J	Muellenbach, RM; Redel, A; Kustermann, J; Brack, A; Gorski, A; Rosner, T; Roewer, N; Wurmb, T				Muellenbach, R. M.; Redel, A.; Kuestermann, J.; Brack, A.; Gorski, A.; Roesner, T.; Roewer, N.; Wurmb, T.			Extracorporeal membrane oxygenation and severe traumatic brain injury. Is the ECMO-therapy in traumatic lung failure and severe traumatic brain injury really contraindicated?	ANAESTHESIST			German	Article						Multiple trauma; Acute respiratory distress syndrome; Extracorporeal membrane oxygenation; Brain injuries; Anticoagulation	RESPIRATORY-DISTRESS-SYNDROME; ARDS	Veno-venous extracorporeal membrane oxygenation (ECMO) may be lifesaving in multiple injured patients with acute respiratory distress syndrome (ARDS) due to chest trauma. To prevent circuit thrombosis or thrombembolic complications during ECMO systemic anticoagulation is recommended. Therefore, ECMO treatment is contraindicated in patients with intracranial bleeding. The management of veno-venous ECMO without systemic anticoagulation in a patient suffering from traumatic lung failure and severe traumatic brain injury is reported.	[Muellenbach, R. M.; Redel, A.; Kuestermann, J.; Brack, A.; Roewer, N.; Wurmb, T.] Unve Klinikum Wurzburg, Zentrum Operat Med, Klin & Poliklin Anasthesiol, D-97080 Wurzburg, Germany; [Redel, A.] Univ Klinikum Regensburg, Anasthesiol Klin, Regensburg, Germany; [Gorski, A.; Roesner, T.] Unve Klinikum Wurzburg, Klin & Poliklin Herz Thorax & Thorakale Gefasschi, D-97080 Wurzburg, Germany	Muellenbach, RM (corresponding author), Unve Klinikum Wurzburg, Zentrum Operat Med, Klin & Poliklin Anasthesiol, Oberdurrbacherstr 6, D-97080 Wurzburg, Germany.	Muellenbac_r@klinik.uni-wuerzburg.de					Arlt M, 2010, RESUSCITATION, V81, P804, DOI 10.1016/j.resuscitation.2010.02.020; Bein T, 2005, J TRAUMA, V58, P1294, DOI 10.1097/01.TA.0000173275.06947.5C; Brower RG, 2004, NEW ENGL J MED, V351, P327; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Cordell-Smith JA, 2006, INJURY, V37, P29, DOI 10.1016/j.injury.2005.03.027; Henzler D, 2004, ANAESTHESIST, V53, P235, DOI 10.1007/s00101-004-0653-9; Hilbert P, 2010, DTSCH ARZTEBL INT, V107, P463, DOI 10.3238/arztebl.2010.0463; Lim SC, 2004, CRIT CARE MED, V32, P2378, DOI 10.1097/01.CCM.0000147444.58070.72; Madershahian N, 2007, J CARDIAC SURG, V22, P180, DOI 10.1111/j.1540-8191.2007.00381.x; Moller T, 2010, ANASTH INTENSIV NOTF, V45, P544, DOI 10.1055/s-0030-1265745; Oliver WC, 2009, SEMIN CARDIOTHORAC V, V13, P154, DOI 10.1177/1089253209347384; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Regel G, 1996, WORLD J SURG, V20, P422, DOI 10.1007/s002689900067; Robinson CM, 2001, J BONE JOINT SURG BR, V83B, P781, DOI 10.1302/0301-620X.83B6.12440; SHAPIRO HM, 1978, J TRAUMA, V18, P254, DOI 10.1097/00005373-197804000-00005; Trupka A, 1994, Eur J Emerg Med, V1, P1, DOI 10.1097/00063110-199403000-00002; Wassermann J, 1998, CAN J ANAESTH, V45, P1044, DOI 10.1007/BF03012389	17	12	13	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	JUL	2011	60	7					647	652		10.1007/s00101-011-1872-5			6	Anesthesiology	Anesthesiology	797NU	WOS:000293135400007	21424309				2021-06-18	
J	Suarez, EP; Gonzalez, AS; Diaz, CP; Salido, AG; Garde, AMD; Flores, JC				Perez Suarez, Esther; Serrano Gonzalez, Ana; Perez Diaz, Carlos; Garcia Salido, Alberto; de Azagra Garde, Amelia Martinez; Casado Flores, Juan			Decompressive Craniectomy in 14 Children With Severe Head Injury: Clinical Results With Long-Term Follow-Up and Review of the Literature	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Decompressive craniectomy; Severe head injury; Traumatic brain injury; Intracranial pressure	TRAUMATIC BRAIN-INJURY; REFRACTORY INTRACRANIAL HYPERTENSION; CRANIOTOMY; MANAGEMENT; PRESSURE	Background: Decompressive craniectomy (DC) is a controversial therapeutic measure used in patients with intractable intracranial hypertension after severe head injury. This study describes the morbidity and mortality of DC in 14 children with a mean follow-up of 3.2 years. We review published evidence from the past 10 years on the indications for DC in pediatric brain trauma. We also examine timing, surgical technique, and the results of this procedure. Method: We retrospectively reviewed patients who underwent DC from 2002 to 2010. Clinical data were collected at admission, as were data on the indication for craniectomy, timing, and surgical technique. Perioperative intracranial pressure (ICP), complications of craniectomy, and Glasgow Outcome Scale score at 2 years were recorded as outcome variables. Results: Fourteen craniectomies were performed. The median presenting Glasgow Coma Scale score was 6.5 (range, 4-15). Ten patients were presented with anisocoria. In 13 patients, craniectomy initially decreased ICP to <25 mm Hg. Two patients (14%) had a poor prognosis on admission and died. The most frequent complications were hygroma (8 patients) and infections (3 patients). The mean Glasgow Outcome Scale score at the 2-year follow-up visit was 4.4 (range, 4-5). Behavioral and psychiatric abnormalities and poor academic performance were frequent (82%). Conclusions: DC reduces ICP in pediatric patients with traumatic brain injury. The mortality rate is low and long-term prognosis in survivors is good. Complications related to surgery are frequent. Wide craniectomy with duraplasty seems to be the most common technique. Defining the most appropriate indications and timing for DC in pediatric patients should be the objective of future prospective studies.	[Perez Suarez, Esther; Serrano Gonzalez, Ana; Garcia Salido, Alberto; de Azagra Garde, Amelia Martinez; Casado Flores, Juan] Childrens Hosp, Pediat Intens Care Unit, Madrid, Spain; [Perez Diaz, Carlos] Childrens Hosp, Pediat Neurosurg Serv, Madrid, Spain	Suarez, EP (corresponding author), Nino Jesus Pediat Univ Hosp, Pediat Intens Care Unit, Avda Menendez Pelayo 65, Madrid 28009, Spain.	eperez221981@hotmail.com	Garcia-Salido, Alberto/D-2294-2019	Garcia-Salido, Alberto/0000-0002-8038-7430			Adamo MA, 2009, J NEUROSURG-PEDIATR, V3, P334, DOI 10.3171/2008.12.PEDS08310; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS56; Cambra FJ, 2010, AN PEDIATR, V73, P12, DOI 10.1016/j.anpedi.2010.02.011; CLARK K, 1968, J NEUROSURG, V29, P367, DOI 10.3171/jns.1968.29.4.0367; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; GERL A, 1980, Zentralblatt fuer Neurochirurgie, V41, P125; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hejazi N, 2002, EUR J PEDIATR, V161, P99, DOI 10.1007/s00431-001-0864-x; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; JENNETT B, 1975, LANCET, V1, P480; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Rutigliano D, 2006, J PEDIATR SURG, V41, P83, DOI 10.1016/j.jpedsurg.2005.10.010; SAHUQUILLO J, 2007, COCHRANE DB SYST REV, V1; Swanson J, 1998, CURR OPIN NEUROBIOL, V8, P263, DOI 10.1016/S0959-4388(98)80150-5; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Walker PA, 2009, J TRAUMA, V67, pS120, DOI 10.1097/TA.0b013e3181ad323a; Wechsler D., 2005, WISC 4 ESCALA WECHSL; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953	25	12	13	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2011	71	1					133	140		10.1097/TA.0b013e318211071f			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	790RR	WOS:000292607400033	21818021				2021-06-18	
J	Stein, DG; Cekic, MM				Stein, Donald G.; Cekic, Milos M.			Progesterone and Vitamin D Hormone as a Biologic Treatment of Traumatic Brain Injury in the Aged	PM&R			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; D-RECEPTOR; SYNDROME SCORE; 1,25-DIHYDROXYVITAMIN D-3; ORGAN DYSFUNCTION; HYPOVITAMINOSIS-D; GROWTH-HORMONE; UNITED-STATES; D DEFICIENCY; HEAD-INJURY	There is growing recognition that traumatic brain injury is a highly variable and complex systemic disorder that is refractory to therapies that target individual mechanisms. It is even more complex in elderly persons, in whom frailty, previous comorbidities, altered metabolism, and a long history of medication use are likely to complicate the secondary effects of brain trauma. Progesterone, one of the few neuroprotective agents that has shown promise for the treatment of acute brain injury, is now in national and international phase 3 multicenter trials. New findings show that vitamin D hormone (VDH) and VDH deficiency in the aging process (and across the developmental spectrum) may interact with progesterone and treatment for traumatic brain injury. In this article we review the use of progesterone and VDH as biologics-based therapies along with recent studies demonstrating that the combination of progesterone and VDH may promote better functional outcomes than either treatment independently. PM R 2011;3:S100-5110	[Stein, Donald G.; Cekic, Milos M.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA	Stein, DG (corresponding author), Emory Univ, Sch Med, Dept Emergency Med, 1365 B Clifton Rd NE,Suite 5100, Atlanta, GA 30322 USA.	DsteiO4@emory.edu	Stein, Donald/AAJ-5139-2020; Cekic, Milos/AAR-8250-2020		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R015R01NS048451, 5R01HD61971-02]; H. Allen and Company; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS048451] Funding Source: NIH RePORTER	4A, royalties from the products of BHR Pharma related to some of the research described in this presentation; 7, BHR; 2A, consultant, BHR. The terms of this arrangement have been reviewed and approved by Emory University, which receives the principal share of any royalties and benefits. In accordance with its conflict of interest policies, the University itself is not required to disclose any similar information; 8B, NIH grants R015R01NS048451 and 5R01HD61971-02; 7, gift in support of research from H. Allen and Company	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Araujo AB, 2004, J CLIN ENDOCR METAB, V89, P5920, DOI 10.1210/jc.2003-031719; Atif F, 2009, MOL MED, V15, P328, DOI 10.2119/molmed.2009.00016; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; Beishuizen A, 2003, J ENDOTOXIN RES, V9, P3, DOI 10.1179/096805103125001298; Bochicchio GV, 2001, J TRAUMA, V50, P817, DOI 10.1097/00005373-200105000-00007; Boxer RS, 2008, J AM GERIATR SOC, V56, P454, DOI 10.1111/j.1532-5415.2007.01601.x; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Bulati Matteo, 2008, Immun Ageing, V5, P9, DOI 10.1186/1742-4933-5-9; Cantorna MT, 2004, AM J CLIN NUTR, V80, p1717S, DOI 10.1093/ajcn/80.6.1717S; Catania A, 2009, BRAIN BEHAV IMMUN, V23, P877, DOI 10.1016/j.bbi.2009.04.006; Cekic M, NEUROBIOL A IN PRESS; Cekic M, 2010, NEUROTHERAPEUTICS, V7, P81, DOI 10.1016/j.nurt.2009.10.017; Centers for Disease Control and Prevention, 2010, TRAUM BRAIN INJ US E; Chatfield SM, 2007, INTERN MED J, V37, P377, DOI 10.1111/j.1445-5994.2007.01339.x; Chen G, 2008, J SURG RES, V147, P92, DOI 10.1016/j.jss.2007.05.029; Chen G, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/93431; Corino A, 2007, CALCIFIED TISSUE INT, V80, P76, DOI 10.1007/s00223-006-0189-x; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Dang J, BRAIN BEHAV IN PRESS; DeLuca HF, 1998, NUTR REV, V56, pS4; Dickstein DL, 2007, AGING CELL, V6, P275, DOI 10.1111/j.1474-9726.2007.00289.x; Dilger RN, 2008, J LEUKOCYTE BIOL, V84, P932, DOI 10.1189/jlb.0208108; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Dujardin KS, 2001, J HEART LUNG TRANSPL, V20, P350, DOI 10.1016/S1053-2498(00)00193-5; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Ehrnthaller C, 2011, MOL MED, V17, P317, DOI 10.2119/molmed.2010.00149; Elmadfa I, 2008, ANN NUTR METAB, V52, P2, DOI 10.1159/000115339; Eyles D, 2003, NEUROSCIENCE, V118, P641, DOI 10.1016/S0306-4522(03)00040-X; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Faden AI, 2001, ARCH NEUROL-CHICAGO, V58, P1553, DOI 10.1001/archneur.58.10.1553; Fee DB, 2007, BRAIN RES, V1137, P146, DOI 10.1016/j.brainres.2006.12.024; Ferrucci L, 2004, AGING CLIN EXP RES, V16, P240, DOI 10.1007/BF03327390; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Frank MG, 2006, NEUROBIOL AGING, V27, P717, DOI 10.1016/j.neurobiolaging.2005.03.013; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Garcion E, 2002, TRENDS ENDOCRIN MET, V13, P100, DOI 10.1016/S1043-2760(01)00547-1; Gebhard F, 2000, ARCH SURG-CHICAGO, V135, P291, DOI 10.1001/archsurg.135.3.291; Gibson CL, 2009, NEUROSCIENTIST, V15, P324, DOI 10.1177/1073858409333069; Gilmer LK, 2008, J NEUROTRAUM, V25, P593, DOI 10.1089/neu.2007.0477; Gingrich MB, 2000, TRENDS NEUROSCI, V23, P399, DOI 10.1016/S0166-2236(00)01617-9; Godbout JP, 2006, NEUROL CLIN, V24, P521, DOI 10.1016/j.ncl.2006.03.010; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; Gordon CM, 2004, ARCH PEDIAT ADOL MED, V158, P531, DOI 10.1001/archpedi.158.6.531; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Griffin MD, 2003, ANNU REV NUTR, V23, P117, DOI 10.1146/annurev.nutr.23.011702.073114; Gruber CJ, 2003, MATURITAS, V46, pS71, DOI 10.1016/j.maturitas.2003.09.021; Guo O, 2004, J NEUROTRAUM, V21, P1303; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harwood PJ, 2005, J TRAUMA, V58, P446, DOI 10.1097/01.TA.0000153942.28015.77; Hayes CE, 2003, CELL MOL BIOL, V49, P277; Hewison M, 2000, J MOL ENDOCRINOL, V25, P141, DOI 10.1677/jme.0.0250141; Hirashima Y, 1997, NEUROCHEM RES, V22, P1249, DOI 10.1023/A:1021985030331; Holick MF, 2003, J CELL BIOCHEM, V88, P296, DOI 10.1002/jcb.10338; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Holick MF, 2003, RECENT RESULTS CANC, V164, P3; HOLICK MF, 1994, AM J CLIN NUTR, V60, P619; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holmoy T, 2010, ACTA NEUROL SCAND, V122, P88, DOI 10.1111/j.1600-0404.2010.01383.x; Ishrat T, 2010, EXP NEUROL, V226, P183, DOI 10.1016/j.expneurol.2010.08.023; Jiang C, 2009, INFLAMM RES, V58, P619, DOI 10.1007/s00011-009-0032-8; Jiang M, 2004, EXP GERONTOL, V39, P1603, DOI 10.1016/j.exger.2004.06.017; Kalueff AV, 2004, NEUROREPORT, V15, P1271, DOI 10.1097/01.wnr.0000129370.04248.92; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Lanfranco F, 2003, J ENDOCRINOL INVEST, V26, P861, DOI 10.1007/BF03345237; Larrosa M, 2001, MED CLIN-BARCELONA, V117, P611, DOI 10.1016/S0025-7753(01)72195-1; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Lim HB, 2007, ANAESTHESIA, V62, P474, DOI 10.1111/j.1365-2044.2007.04998.x; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Luoma JI, STEROIDS IN PRESS; Macmillan CSA, 2002, INTENS CARE MED, V28, P1012, DOI 10.1007/s00134-002-1382-7; Mahon BD, 2003, J CELL BIOCHEM, V89, P922, DOI 10.1002/jcb.10580; Malone DL, 2001, J TRAUMA, V51, P458, DOI 10.1097/00005373-200109000-00006; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; McArthur DL, 2004, BRAIN PATHOL, V14, P185, DOI 10.1111/j.1750-3639.2004.tb00052.x; McCarty MF, 2005, MED HYPOTHESES, V64, P1022, DOI 10.1016/j.mehy.2004.03.041; McCullough LD, 2003, TRENDS ENDOCRIN MET, V14, P228, DOI 10.1016/S1043-2760(03)00076-6; McGrath JJ, 2004, J STEROID BIOCHEM, V89-90, P557, DOI 10.1016/j.jsbmb.2004.03.070; McKeating EG, 1997, BRIT J ANAESTH, V78, P520; Melamed ML, 2008, ARTERIOSCL THROM VAS, V28, P1179, DOI 10.1161/ATVBAHA.108.165886; Melov S, 2004, TRENDS NEUROSCI, V27, P601, DOI 10.1016/j.tins.2004.08.004; Miller RR, 2007, J GERONTOL A-BIOL, V62, P1402, DOI 10.1093/gerona/62.12.1402; Moore ME, 2005, BIOCHEM SOC T, V33, P573, DOI 10.1042/BST0330573; Morley JE, 2006, MED CLIN N AM, V90, P837, DOI 10.1016/j.mcna.2006.05.019; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nadziejko C, 2004, INHAL TOXICOL, V16, P373, DOI 10.1080/08958370490439533; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Napolitano LM, 2000, J TRAUMA, V49, P647, DOI 10.1097/00005373-200010000-00011; Napolitano LM, 2000, J TRAUMA, p[49, 652]; NastKolb D, 1997, J TRAUMA, V42, P446, DOI 10.1097/00005373-199703000-00012; Norman AW, 2010, EXP BIOL MED, V235, P1034, DOI 10.1258/ebm.2010.010014; NUYTINCK HKS, 1988, ARCH SURG-CHICAGO, V123, P1519; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Pape HC, 2007, INJURY, V38, P1358, DOI 10.1016/j.injury.2007.09.026; PERRY VH, 1993, GLIA, V7, P60, DOI 10.1002/glia.440070111; Peterlik M, 2005, EUR J CLIN INVEST, V35, P290, DOI 10.1111/j.1365-2362.2005.01487.x; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Pfeifer M, 2002, OSTEOPOROSIS INT, V13, P187, DOI 10.1007/s001980200012; Popovich P, 2009, NAT MED, V15, P736, DOI 10.1038/nm0709-736; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Priego T, 2003, J ENDOCRINOL, V179, P107, DOI 10.1677/joe.0.1790107; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Rammos G, 2008, INT UROL NEPHROL, V40, P419, DOI 10.1007/s11255-007-9244-4; Richards JB, 2007, AM J CLIN NUTR, V86, P1420; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sayeed I, 2006, ANN EMERG MED, V47, P381, DOI 10.1016/j.annemergmed.2005.12.011; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Schumacher M, 2007, ENDOCR REV, V28, P387, DOI 10.1210/er.2006-0050; Schwartz N, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.012; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Sheffield LG, 1998, NEUROBIOL AGING, V19, P47, DOI 10.1016/S0197-4580(97)00168-1; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Stein DG, 2003, J HEAD TRAUMA REHAB, V18, P317, DOI 10.1097/00001199-200307000-00004; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Straub RH, 2000, J NEUROIMMUNOL, V109, P10, DOI 10.1016/S0165-5728(00)00296-4; Sullivan SS, 2005, J AM DIET ASSOC, V105, P971, DOI 10.1016/j.jada.2005.03.002; Tait AS, 2008, J LEUKOCYTE BIOL, V84, P924, DOI 10.1189/jlb.0208104; Talhouk RS, 2004, PROG NEURO-PSYCHOPH, V28, P625, DOI 10.1016/j.pnpbp.2004.01.012; Tangpricha V, 2002, AM J MED, V112, P659, DOI 10.1016/S0002-9343(02)01091-4; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Topinkova E, 2008, ANN NUTR METAB, V52, P6, DOI 10.1159/000115340; Townsend K, 2005, J STEROID BIOCHEM, V97, P103, DOI 10.1016/j.jsbmb.2005.06.004; Van den Berghe G, 2003, J CLIN ENDOCR METAB, V88, P4623, DOI 10.1210/jc.2003-030358; van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015; VERMEULEN A, 1995, HORM RES, V43, P25, DOI 10.1159/000184233; Vermeulen A, 2002, Aging Male, V5, P98, DOI 10.1080/713604678; Villoslada P, 2009, ANN NEUROL, V65, P124, DOI 10.1002/ana.21634; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Vodovotz Y, 2010, IMMUNOPHARM IMMUNOT, V32, P181, DOI 10.3109/08923970903369867; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Zygun D, 2005, CURR OPIN CRIT CARE, V11, P139, DOI 10.1097/01.ccx.0000155356.86241.c0; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	150	12	12	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	JUN	2011	3	6		S			S100	S110		10.1016/j.pmrj.2011.03.010			11	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	961BB	WOS:000305437800017	21703565	Green Accepted			2021-06-18	
J	Zeckey, C; Hildebrand, F; Pape, HC; Mommsen, P; Panzica, M; Zelle, BA; Sittaro, NA; Lohse, R; Krettek, C; Probst, C				Zeckey, Christian; Hildebrand, Frank; Pape, Hans-Christoph; Mommsen, Philipp; Panzica, Martin; Zelle, Boris A.; Sittaro, Nicola Alexander; Lohse, Ralf; Krettek, Christian; Probst, Christian			Head injury in polytrauma-Is there an effect on outcome more than 10 years after the injury?	BRAIN INJURY			English	Article						Head injury; multiple trauma; rehabilitation; polytrauma	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; MULTIPLE INJURIES; HEALTH SURVEY; MAJOR TRAUMA; FOLLOW-UP; SEVERITY; IMPACT; PREVALENCE; RECOVERY	Introduction: Head injuries are of great relevance for the prognosis of polytrauma patients during acute care. However, knowledge about the impact on the long-term outcome is sparse. Therefore, this study analysed the role of head injuries on the outcome of polytrauma patients more than 10 years after injury in a matched-pair analysis. Patients and methods: Out of 620 polytrauma patients with and without head injury, a matched-pair analysis with comparable age, injury severity and gender distribution and a minimum of 10 years follow-up was performed. The outcome and quality-of-life were measured using the Hannover Score for Polytrauma Outcome (HASPOC), Short Form 12 (SF-12), Glasgow Outcome Scale (GOS) and other parameters. Results: The matched-pair analysis consisted of 125 pairs (age 27.9 +/- 1.2 years, ISS 20.0 +/- 0.8 [head injury] vs ISS 19.8 +/- 0.8 [no head injury]). A significant difference was shown for the GOS Score only (GOS head injury 4.3 +/- 0.3 vs no head injury 4.9 +/- 0.2, p = 0.01). The psychological outcome was similar in both groups. Both groups reported comparable subjective rehabilitation satisfaction. Conclusions: Matching pairs of equally injured polytrauma patients of same gender with and without head injury 10 years following trauma indicated significantly worse results in the GOS due to head injury.	[Zeckey, Christian; Hildebrand, Frank; Mommsen, Philipp; Panzica, Martin; Krettek, Christian; Probst, Christian] Hannover Med Sch, Trauma Dept, D-30625 Hannover, Germany; [Pape, Hans-Christoph] Univ Aachen, Dept Orthopaed Trauma Surg, D-5100 Aachen, Germany; [Zelle, Boris A.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Pittsburgh, PA 15261 USA; [Sittaro, Nicola Alexander; Lohse, Ralf] Hannover Re Insurance, Hannover, Germany	Zeckey, C (corresponding author), Hannover Med Sch, Trauma Dept, D-30625 Hannover, Germany.	zeckey.christian@mh-hannover.de	Hildebrand, Frank/J-3176-2017; Mommsen, Philipp/ABC-3510-2020	Krettek, Christian/0000-0001-9807-0020; Pape, Hans-Christoph/0000-0002-2059-4980			Baez AA, 2007, PREHOSP DISASTER MED, V22, P230, DOI 10.1017/S1049023X00004726; Anke AGW, 2003, CLIN REHABIL, V17, P431, DOI 10.1191/0269215503cr629oa; Anke AGW, 1997, J TRAUMA, V42, P54, DOI 10.1097/00005373-199701000-00010; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brenneman FD, 1997, J TRAUMA, V42, P778, DOI 10.1097/00005373-199705000-00004; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; BULLINGER M, 1995, SOC SCI MED, V41, P1359, DOI 10.1016/0277-9536(95)00115-N; BURKE JM, 1994, BRAIN INJURY, V8, P71, DOI 10.3109/02699059409150960; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Ellert U, 2004, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V47, P1027, DOI 10.1007/s00103-004-0933-1; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Gabbe BJ, 2006, J TRAUMA, V61, P1393, DOI 10.1097/01.ta.0000225926.34180.47; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Holbrook TL, 2004, J TRAUMA, V56, P284, DOI 10.1097/01.TA.0000109758.75406.F8; Holtslag HR, 2007, CLIN REHABIL, V21, P373, DOI 10.1177/0269215507072084; Jenkinson C, 1997, J PUBLIC HEALTH MED, V19, P179, DOI 10.1093/oxfordjournals.pubmed.a024606; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Klemen P, 2006, ACTA ANAESTH SCAND, V50, P1250, DOI 10.1111/J.1399-6576.2006.01039.X; Livingston DH, 2009, J TRAUMA, V67, P341, DOI 10.1097/TA.0b013e3181a5cc34; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Luchette F, 2010, J TRAUMA, V69, P530; MACKENZIE EJ, 1988, J TRAUMA, V28, P281, DOI 10.1097/00005373-198803000-00003; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Neugebauer E, 2002, RESTOR NEUROL NEUROS, V20, P161; Ouellet MC, 2009, J HEAD TRAUMA REHAB, V24, P262, DOI 10.1097/HTR.0b013e3181a68b73; Pape HC, 2006, INJURY, V37, P1197, DOI 10.1016/j.injury.2006.07.032; Peleg G, 2009, BRAIN INJURY, V23, P800, DOI 10.1080/02699050903196696; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Probst C, 2007, CHIRURG, V78, P875, DOI 10.1007/s00104-007-1410-9; Probst C, 2009, INJURY, V40, P77, DOI 10.1016/j.injury.2008.10.004; Probst C, 2009, J TRAUMA, V66, P1212, DOI 10.1097/TA.0b013e318197b97c; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Sander AM, 2009, NEUROREHABILITATION, V24, P15, DOI 10.3233/NRE-2009-0450; Sauerland S, 2003, J NEUROTRAUM, V20, P953, DOI 10.1089/089771503770195803; Shifflette VK, 2010, J TRAUMA, V69, P88, DOI 10.1097/TA.0b013e3181e291e9; Stalp M, 2002, J TRAUMA, V52, P1160, DOI 10.1097/00005373-200206000-00023; Steel J, 2010, J TRAUMA, V69, P523, DOI 10.1097/TA.0b013e3181e90c24; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; von Elm E, 2008, SWISS MED WKLY, V138, P327, DOI 2008/23/smw-12025; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; ZECKEY C, 2010, ALCOHOL         0913; Zelle BA, 2005, INJURY, V36, P169, DOI 10.1016/j.injury.2004.06.004	46	12	12	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2011	25	6					551	559		10.3109/02699052.2011.568036			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	758FF	WOS:000290146300002	21534733				2021-06-18	
J	Wright, MJ; Schmitter-Edgecombe, M				Wright, Matthew J.; Schmitter-Edgecombe, Maureen			The Impact of Verbal Memory Encoding and Consolidation Deficits During Recovery From Moderate-to-Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						memory; neuropsychology; traumatic brain injury	CLOSED-HEAD INJURY; TEMPORAL-LOBE EPILEPSY; DIFFUSE AXONAL INJURY; LEARNING TEST; COGNITIVE REHABILITATION; RETRIEVAL DEFICITS; IMPAIRED PATIENTS; EPISODIC MEMORY; FOCAL LESIONS; HERA MODEL	Objective: Encoding and consolidation deficits appear to account for verbal memory impairment following traumatic brain injury (TBI). It is unknown whether these abilities vary during TBI recovery. We sought to determine the pattern and impact of verbal encoding and consolidation deficits following TBI. Methods: Twenty-three participants with moderate-to-severe TBI and 25 age-and education-matched control participants' verbal memory abilities were assessed at 2 time points approximately 1 year apart; assessments occurred at acute and chronic visits for TBI survivors. Main Outcome Measures: Rey Auditory Verbal Learning Test and Item Specific Deficit Approach indices of encoding, consolidation, and retrieval deficits. Results: In contrast to the controls, participants with TBI showed impaired verbal memory characterized by encoding and consolidation deficits at both time points. The TBI group's short-delayed recall and consolidation scores improved between the acute and chronic assessments. Encoding (primary) and consolidation (secondary) deficits emerged as predictors of acute and chronic recall in the TBI group. Also, acute visit encoding deficits predicted chronic visit delayed recall in TBI survivors, but acute consolidation deficits did not. Conclusions: These findings suggest that memory rehabilitation efforts focused on improving encoding of verbal material may be useful during both the acute and chronic phases of recovery following TBI.	[Wright, Matthew J.] Harbor UCLA Med Ctr, Dept Psychiat, Psychol Div, Torrance, CA 90502 USA; [Schmitter-Edgecombe, Maureen] Washington State Univ, Dept Psychol, Pullman, WA 99164 USA	Wright, MJ (corresponding author), Harbor UCLA Med Ctr, Dept Psychiat, Psychol Div, 1124 W Carson St,B-4 S, Torrance, CA 90502 USA.	mwright@labiomed.org			National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS047690]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047690] Funding Source: NIH RePORTER	The authors thank Jonathan Anderson, Randy McDonald, Logan Gantz, and Michael Walton for their assistance in data collection and coding. This research was supported by National Institute of Neurological Disorders and Stroke (NINDS) Grant NS047690.	AbouHamden A, 1997, J NEUROTRAUM, V14, P699, DOI 10.1089/neu.1997.14.699; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adams JH, 2001, J NEUROL NEUROSUR PS, V71, P521, DOI 10.1136/jnnp.71.4.521; Aggleton JP, 2006, TRENDS COGN SCI, V10, P455, DOI 10.1016/j.tics.2006.08.003; Alessio A, 2004, EPILEPSY BEHAV, V5, P22, DOI 10.1016/j.yebeh.2003.10.010; Ariza M, 2006, BRAIN INJURY, V20, P1053, DOI 10.1080/02699050600909862; Bernard F, 2001, NEUROREPORT, V12, P1737, DOI 10.1097/00001756-200106130-00044; BLACHSTEIN H, 1993, NEUROPSYCHOLOGY, V7, P530, DOI DOI 10.1037/0894-4105.7.4.530; Bor D, 2004, EUR J NEUROSCI, V19, P3365, DOI 10.1111/j.1460-9568.2004.03438.x; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; COHEN NJ, 2004, COGNITIVE NEUROSCIEN, P322; Craik FIM, 2002, MEMORY, V10, P305, DOI 10.1080/09658210244000135; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Delis DC, 1987, CALIFORNIA VERBAL LE; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Dolan RJ, 1999, HIPPOCAMPUS, V9, P25, DOI 10.1002/(SICI)1098-1063(1999)9:1<25::AID-HIPO3>3.3.CO;2-W; Dou ZL, 2006, BRAIN INJURY, V20, P219, DOI 10.1080/02699050500488215; Duchnick JJ, 2002, J CLIN EXP NEUROPSYC, V24, P840, DOI 10.1076/jcen.24.6.840.8405; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; ELLIS HC, 1983, FUNDAMENTALS HUMAN M, P84; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; GLISKY EL, 1986, NEUROPSYCHOLOGIA, V24, P313, DOI 10.1016/0028-3932(86)90017-5; GLISKY EL, 1986, J CLIN EXP NEUROPSYC, V8, P292, DOI 10.1080/01688638608401320; Habib R, 2003, TRENDS COGN SCI, V7, P241, DOI 10.1016/S1364-6613(03)00110-4; Hillary FG, 2003, J CLIN EXP NEUROPSYC, V25, P49, DOI 10.1076/jcen.25.1.49.13631; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; Leach K, 2006, BRAIN INJURY, V20, P1241, DOI 10.1080/02699050601049874; Lengenfelder J, 2007, REHABIL PSYCHOL, V52, P290, DOI 10.1037/0090-5550.52.3.290; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; Lezak M, 2004, NEUROPSYCHOLOGICAL A, P158; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A, P414; LILLIE RA, 2010, EVERYDAY IMPACT TRAU, P302; Lucas JA, 2006, CLIN NEUROPSYCHOLOGY, P351; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Nyberg L, 2002, COGNITIVE BRAIN RES, V13, P281, DOI 10.1016/S0926-6410(02)00052-6; Nyberg L, 1996, PSYCHON B REV, V3, P135, DOI 10.3758/BF03212412; O'Brien A, 2007, NEUROPSYCHOL REHABIL, V17, P273, DOI 10.1080/09602010600751160; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Schmidt M., 1996, REY AUDITORY VERBAL; SQUIRE LR, 1994, INT REV NEUROBIOL, V37, P243; Squire LR, 1998, HIPPOCAMPUS, V8, P205, DOI 10.1002/(SICI)1098-1063(1998)8:3<205::AID-HIPO3>3.3.CO;2-8; SQUIRE LR, 1980, NEUROPSYCHOLOGIA, V18, P369, DOI 10.1016/0028-3932(80)90134-7; STALLINGS G, 1995, J CLIN EXP NEUROPSYC, V17, P706, DOI 10.1080/01688639508405160; Strange BA, 2002, J NEUROSCI, V22, P523, DOI 10.1523/JNEUROSCI.22-02-00523.2002; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.0.CO;2-G; Turkstra LS, 2005, J MED SPEECH-LANG PA, V13, P205; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Vingerhoets G, 2006, EPILEPSY BEHAV, V8, P422, DOI 10.1016/j.yebeh.2005.11.013; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; Wilde MC, 1995, J CLIN EXP NEUROPSYC, V17, P849, DOI 10.1080/01688639508402434; Williamson D. J. G., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [10.1037/10198-001, DOI 10.1037/10198-001]; WILSON JTL, 1995, J NEUROL NEUROSUR PS, V59, P328, DOI 10.1136/jnnp.59.3.328; Wright MJ, 2010, J CLIN EXP NEUROPSYC, V32, P728, DOI 10.1080/13803390903512652; Wright MJ, 2009, J CLIN EXP NEUROPSYC, V31, P790, DOI 10.1080/13803390802508918; WRIGHT MJ, WORKING MEM IN PRESS; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263	61	12	13	1	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2011	26	3					182	191		10.1097/HTR.0b013e318218dcf9			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	760CY	WOS:000290301800002	21552067				2021-06-18	
J	Jawaid, A; Poon, M; Strutt, AM; Rice, LK; McDowell, EJ; Salamone, AR; Qureshi, SU; Simpson, E; Appel, SH; York, MK; Schulz, PE				Jawaid, A.; Poon, M.; Strutt, A. M.; Rice, L. K.; McDowell, E. J.; Salamone, A. R.; Qureshi, S. U.; Simpson, E.; Appel, S. H.; York, M. K.; Schulz, P. E.			Does apolipoprotein E genotype modify the clinical expression of ALS?	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						cohort study; motor neuron disease; neurological disorders; neuromuscular diseases; research methods	AMYOTROPHIC-LATERAL-SCLEROSIS; APOE EPSILON-4 ALLELE; CLOSED-HEAD INJURY; E-DEFICIENT MICE; ALZHEIMERS-DISEASE; E POLYMORPHISM; ONSET; AGE; ASSOCIATION; GENE	Background: The presence of the apolipoprotein E (ApoE) 4 genotype is associated with an earlier age of onset for Alzheimer's disease (AD) and several other neurodegenerative disorders. The objective of this study was to investigate the effect of ApoE genotypes on the clinical course of amyotrophic lateral sclerosis (ALS). Methods: Eight hundred and fifty-two consecutive patients with sporadic ALS evaluated at a tertiary care center were investigated for the effect of ApoE genotype on age of onset, rate of motor disease progression, cognitive functioning, and survival in ALS. Results: The frequencies of individual ApoE genotypes did not differ between patients with ALS and ALS-free Caucasian populations. Patients with different ApoE genotypes did not differ in the age of onset for ALS (years) (ApoE2 = 57.8 +/- 13.7, ApoE3 = 57.3 +/- 13.7, ApoE4 = 57.7 +/- 13.2; P = 0.97), the rate of disease progression (Appel ALS score/month) (ApoE2 = 2.91 +/- 2.66, ApoE3 = 2.67 +/- 2.66, ApoE4 = 2.61 +/- 2.47; P = 0.89), cognitive status (% cognitively impaired) (ApoE2 = 31.7, ApoE3 = 26.8, ApoE4 = 34.3, P = 0.28), or survival in years (ApoE2 = 3.79 +/- 3.70, ApoE3 = 3.17 +/- 2.27, ApoE4 = 3.05 +/- 1.75; P = 0.85). Conclusions: Our results suggest that ApoE genotype does not modify clinical course of sporadic ALS, in stark contrast to the influence of ApoE genotype on the disease course of AD and other neurodegenerative disorders.	[Jawaid, A.; Poon, M.; Strutt, A. M.; Rice, L. K.; McDowell, E. J.; Salamone, A. R.; Qureshi, S. U.; York, M. K.; Schulz, P. E.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Simpson, E.; Appel, S. H.] Methodist Neurol Inst, Houston, TX USA	Schulz, PE (corresponding author), Univ Texas Hlth Sci Ctr Houston, 6410 Fannin,Suite 1014, Houston, TX 77030 USA.	Paul.E.Schulz@uth.tmc.edu		Jawaid, Ali/0000-0002-5126-6744			APPEL V, 1987, ANN NEUROL, V22, P328, DOI 10.1002/ana.410220308; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Batulan Z, 2003, J NEUROSCI, V23, P5789; Bedlack RS, 2000, ARCH NEUROL-CHICAGO, V57, P1561, DOI 10.1001/archneur.57.11.1561; Borroni B, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-31; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Brooks BR, 1996, NEUROLOGY, V47, pS71, DOI 10.1212/WNL.47.4_Suppl_2.71S; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cosentino S, 2008, NEUROLOGY, V70, P1842, DOI 10.1212/01.wnl.0000304038.37421.cc; Drory VE, 2001, J NEUROL SCI, V190, P17, DOI 10.1016/S0022-510X(01)00569-X; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487; GOLDEN CJ, 1976, J CLIN PSYCHOL, V32, P654, DOI 10.1002/1097-4679(197607)32:3<654::AID-JCLP2270320336>3.0.CO;2-Z; GORDON NG, 1972, J CLIN PSYCHOL, V28, P167, DOI 10.1002/1097-4679(197204)28:2<167::AID-JCLP2270280212>3.0.CO;2-X; GROBER E, 1991, J CLIN EXP NEUROPSYC, V13, P933, DOI 10.1080/01688639108405109; HALLMAN DM, 1991, AM J HUM GENET, V49, P338; HIXSON JE, 1990, J LIPID RES, V31, P545; Jawaid A, 2010, EUR J NEUROL, V17, P733, DOI 10.1111/j.1468-1331.2009.02923.x; Lacomblez L, 2002, NEUROLOGY, V58, P1112, DOI 10.1212/WNL.58.7.1112; Li YJ, 2004, NEUROGENETICS, V5, P209, DOI 10.1007/s10048-004-0193-0; Li YJ, 2004, NEUROLOGY, V62, P2005, DOI 10.1212/01.WNL.0000128089.53030.AC; Lomnitski L, 1997, PHARMACOL BIOCHEM BE, V56, P669, DOI 10.1016/S0091-3057(96)00412-1; Louko AM, 2006, ACTA NEUROL SCAND, V114, P315, DOI 10.1111/j.1600-0404.2006.00676.x; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Moulard B, 1996, J NEUROL SCI, V139, P34, DOI 10.1016/0022-510X(96)00085-8; MUI S, 1995, ANN NEUROL, V38, P460, DOI 10.1002/ana.410380318; Muller W, 1998, BRAIN PATHOL, V8, P641; Parmenter BA, 2007, MULT SCLER J, V13, P25, DOI 10.1177/1352458506070682; Qureshi MM, 2006, AMYOTROPH LATERAL SC, V7, P173, DOI 10.1080/14660820600640596; Schiefermeier M, 2000, BRAIN, V123, P585, DOI 10.1093/brain/123.3.585; Srinivasan R, 2006, J NEUROL NEUROSUR PS, V77, P154, DOI 10.1136/jnnp.2005.063966; Strong MJ, 2009, AMYOTROPH LATERAL SC, V10, P131, DOI 10.1080/17482960802654364; Tian J, 2004, J NEUROL NEUROSUR PS, V75, P696, DOI 10.1136/jnnp.2003.012096; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tsuang DW, 2002, ARCH NEUROL-CHICAGO, V59, P1622, DOI 10.1001/archneur.59.10.1622; Van Everbroeck B, 2001, NEUROSCI LETT, V313, P69, DOI 10.1016/S0304-3940(01)02264-9; Verpillat P, 2002, EUR J HUM GENET, V10, P399, DOI 10.1038/sj.ejhg.5200820; Zetterberg H, 2008, J NEUROL SCI, V273, P67, DOI 10.1016/j.jns.2008.06.025	39	12	12	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	APR	2011	18	4					618	624		10.1111/j.1468-1331.2010.03225.x			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	736OI	WOS:000288503600017	20880000				2021-06-18	
J	Rutkoski, JD; Sippey, M; Gaines, BA				Rutkoski, John Daniel; Sippey, Megan; Gaines, Barbara A.			Traumatic Television Tip-Overs in the Pediatric Patient Population	JOURNAL OF SURGICAL RESEARCH			English	Article						pediatric trauma; television; tip-over	CHILDREN; INJURIES; TODDLERS; TIPOVERS; OUTCOMES; TRENDS	Background. Head trauma is the leading cause of injury in the pediatric patient population. Although falls are the most common reason for head injury, blunt objects are a significant contributor. The Consumer Product Safety Commission (CPSC) released the top five hidden hazards of the home in 2007 and listed "tip-overs'' as the third leading cause of morbidity and mortality. We, therefore, hypothesize that televisions continue to be a significant source of injury to children. Our intent is to examine the most common mechanisms, resulting injuries, and factors associated with television-related injuries so as to increase public awareness of this threat. Methods. Trauma patients admitted to our institution are entered into a state-mandated performance-improvement data collection system. After obtaining IRB approval, the medical records of all children admitted to our Level I Pediatric Trauma Center between 1/1/1999 and 7/27/2009 with television-related injuries were reviewed. Data points extracted included standard demographics, as well as television size, television support, final trauma level, Glasgow coma scale (GCS), injury severity score (ISS), intensive care unit (ICU) requirements, surgical procedures, final diagnoses, and hospital length of stay (LOS). Descriptive statistics were performed for the demographic data and intervals. Tests of significance were performed using Student's t-test and chi(2)/Fisher's exact test as appropriate. A P value < 0.05 was considered to be statistically significant. Results. Fifty-two children were seen at our institution with television tip-over related injuries during the study period. Nearly all injuries (50/52) occurred in the home, and 83% were an unwitnessed event. The mean age was 36 mo. The most common television size responsible for insult was 27 in., and the majority of these (26/52) were supported by a dresser. The mean ISS was 8.3. Patients admitted to the ICU had a higher ISS (12.2 [8.0-16.4] versus 6.8 [5.-8.4]; P = 0.003); however, there was no statistically significant association between television size and ISS (7.5 [4.6-10.4] < 27 in. versus 7.5 [7.8-13.4] >= 27 in.; P = 0.111). Injuries to the head were by far the most common (43/52) followed by orthopedic (n = 6) and blunt abdominal (n = 3). There was one death in the study population, and this resulted from a closed head injury. Conclusions. Television tip-overs continue to pose a threat to children and can result in significant injury. Most often affected are the toddlers learning to walk and exploring their surrounding environments. The use of a dresser as a stand appears to convey the greatest risk. These injuries are potentially preventable by adequately securing televisions to appropriate stands. (C) 2011 Elsevier Inc. All rights reserved.	[Rutkoski, John Daniel; Sippey, Megan; Gaines, Barbara A.] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Dept Pediat Gen & Thorac Surg, Pittsburgh, PA 15224 USA	Rutkoski, JD (corresponding author), Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Dept Pediat Gen & Thorac Surg, 400 45th St,Suite 7000 62, Pittsburgh, PA 15224 USA.	jdrutkoski@gmail.com					Bernard PA, 1998, PEDIATRICS, V102, part. no., DOI 10.1542/peds.102.3.e32; Borgenicht David, 1998, SESAME STREET UNPAVE; Cho JH, 2009, J PAEDIATR CHILD H, V45, P505, DOI 10.1111/j.1440-1754.2009.01556.x; DiScala C, 2001, ARCH PEDIAT ADOL MED, V155, P145, DOI 10.1001/archpedi.155.2.145; Gaines J, 2009, ACCIDENT ANAL PREV, V41, P1070, DOI 10.1016/j.aap.2009.06.010; Herr N, 2007, TELEVISION HLTH; LESCOHIER I, 1993, PEDIATRICS, V91, P721; MARGANITT B, 1992, PEDIATRICS, V89, P608; Morrison L, 2002, J PAEDIATR CHILD H, V38, P587, DOI 10.1046/j.1440-1754.2002.00059.x; Morrongiello BA, 2004, J PEDIATR PSYCHOL, V29, P415, DOI 10.1093/jpepsy/jsh046; Murray KJ, 2009, INJURY PREV, V15, P240, DOI 10.1136/ip.2009.021550; Scheidler MG, 2002, J PEDIATR SURG, V37, P572, DOI 10.1053/jpsu.2002.31612; Sikron F, 2007, CHILD CARE HLTH DEV, V33, P45, DOI 10.1111/j.1365-2214.2006.00622.x; *UND LAB, 1996, 1667 UL; Yahya RR, 2005, J NEUROSURG, V103, P219, DOI 10.3171/ped.2005.103.3.0219	15	12	12	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804			J SURG RES	J. Surg. Res.	APR	2011	166	2					199	204		10.1016/j.jss.2010.05.051			6	Surgery	Surgery	732ER	WOS:000288168300021	20863529				2021-06-18	
J	Shem, K; Medel, R; Wright, J; Kolakowsky-Hayner, SA; Duong, T				Shem, K.; Medel, R.; Wright, J.; Kolakowsky-Hayner, S. A.; Duong, T.			Return to work and school: a model mentoring program for youth and young adults with spinal cord injury	SPINAL CORD			English	Article						mentoring; peer support; spinal cord injury; disability	TRAUMATIC BRAIN INJURY; EMPLOYMENT	Study design: This is a prospective study. Objectives: Young individuals with spinal cord injury (SCI) need support to actively participate in the community after their injuries. The 'Back on Track' mentoring program was developed to match mentees with SCI with mentors to assist with post-injury adjustment. The objectives of this study were to improve the percentage of youth and young adults with SCI, who access post-secondary education or employment opportunities and to improve quality of life. Setting: This study had a community-based setting. Methods: Each mentee with SCI was matched with a community-based mentor, with or without a disability. The mentoring relationship was planned for 2 years. Participants were evaluated with standardized questionnaires at intake, at the time of post-secondary education or employment entry and 4 months post entry. Results: In total, 39 individuals with SCI, age 16-26 years, were enrolled. Average age of mentees was 19.8 years (s.d = 3.0). In total, 29 participants were matched with mentors, and 10 participants (34%) completed the program, with seven (24%) returning to school, two (6.9%) returning to work and one individual (3.4%) attending school part time. Conclusion: Although multiple barriers to success occurred, this program demonstrated that it could assist the youth and young adults with SCI to obtain post-secondary education and employment. This type of support system should be encouraged in order to improve the quality and satisfaction of life for young adults with disabilities. Spinal Cord (2011) 49, 544-548; doi: 10.1038/sc.2010.166; published online 7 December 2010	[Shem, K.; Medel, R.; Wright, J.; Kolakowsky-Hayner, S. A.; Duong, T.] Santa Clara Valley Med Ctr, Dept Phys Med & Rehabil, San Jose, CA 95128 USA	Shem, K (corresponding author), Santa Clara Valley Med Ctr, Dept Phys Med & Rehabil, 751 S Bascome Ave, San Jose, CA 95128 USA.	kazuko.shem@hhs.sccgov.org	Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909	Rehabilitation Services Administration [H235S040052]	This study was supported by a Rehabilitation Services Administration Grant # H235S040052.	CASTLE R, 1994, PARAPLEGIA, V32, P182, DOI 10.1038/sc.1994.33; DEVIVO MJ, 1987, ARCH PHYS MED REHAB, V68, P494; Inge K, 1998, J VOCATIONAL REHABIL, V10, P141, DOI DOI 10.1016/S1052-2263(98)00010-5; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kraus JF, 1993, HEAD INJURY, P1; Krause JS, 1998, ARCH PHYS MED REHAB, V79, P615, DOI 10.1016/S0003-9993(98)90033-8; KRAUSE JS, 1992, ARCH PHYS MED REHAB, V73, P564; Krause JS, 1996, ARCH PHYS MED REHAB, V77, P737; Krause JS, 1999, ARCH PHYS MED REHAB, V80, P1492; Lidal IB, 2009, DISABIL REHABIL, V31, P2174, DOI 10.3109/09638280902946952; *NAT SPIN CORD INJ, 2008, FACTS FIG GLANC; *NAT SPIN CORD INJ, 2003, FACTS FIG GLANC; Ottomanelli L, 2009, J REHABIL RES DEV, V46, P919, DOI 10.1682/JRRD.2008.10.0145; Patterson RW, 2005, TOP SPINAL CORD INJ, V10, P30; TARGETT P, 2003, SCI PSYCHOSOC PROCES, V16, P1; Wehman P, 2000, AM J PHYS MED REHAB, V79, P161, DOI 10.1097/00002060-200003000-00009; Yasuda S, 2002, NEUROREHABILITATION, V17, P177; Young AE, 2009, INT J REHABIL RES, V32, P1, DOI 10.1097/MRR.0b013e32831c8b19; YOUNG ME, 1994, REHABIL COUNS BULL, V37, P229	20	12	13	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	APR	2011	49	4					544	548		10.1038/sc.2010.166			5	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	744BZ	WOS:000289069400010	21135861	Bronze			2021-06-18	
J	Chen, X; Zhang, B; Chai, Y; Dong, B; Lei, P; Jiang, RC; Zhang, JN				Chen, Xin; Zhang, Bin; Chai, Yan; Dong, Bo; Lei, Ping; Jiang, Rongcai; Zhang, Jianning			Methylprednisolone exacerbates acute critical illness-related corticosteroid insufficiency associated with traumatic brain injury in rats	BRAIN RESEARCH			English	Article						Traumatic brain injury; Corticosteroid insufficiency; Apoptosis; Methylprednisolone	CELL-DEATH; HYPOTHALAMOPITUITARY DYSFUNCTION; POSTTRAUMATIC HYPOPITUITARISM; ADRENAL-RESPONSE; PITUITARY-GLAND; SEPTIC SHOCK; HEAD-INJURY; GLUCOCORTICOIDS; APOPTOSIS; DEFICITS	Emerging evidence demonstrates that severe illness could induce critical illness-related corticosteroid insufficiency (CIRCI) and cause poor prognosis. The purpose of this study was to test the hypothesis that methylprednisolone (MP), a synthetic glucocorticoid, promotes post-traumatic apoptosis in both the hypothalamus and pituitary, resulting in acute CIRCI and increased mortality in the acute phase of traumatic brain injury (TBI). We tested this hypothesis by measuring acute CIRCI in rats subjected to fluid percussion injury (FPI) and treated with MP (5-30 mg/kg). The corticosteroid response to TBI was evaluated using the corticosterone increase index (CII), where values less than 2.5 were considered indicative of acute CIRCI. The CII of MP treated rats was comparable to that of saline treated control rats before injury but was significantly decreased in injured rats receiving high-dose MP on post-injury day 7. Similarly, the incidence of acute CIRCI was significantly higher in the high-dose MP group on post-injury day 7. Furthermore, the CH of rats that did not survive post-injury was significantly lower compared to that of survival and was indicative of acute CIRCI. We also examined apoptosis in the paraventricular nucleus (PVN) of the hypothalamus and the adenohypophysis of the pituitary, using a TUNEL assay and transmission electron microscopy (TEM). The number of TUNEL-positive cells was significantly higher in injured rats treated with high-dose MP. No TUNEL-positive cells were detected in the adenohypophysis across experimental groups at either 7 or 14 days after TBI. However, autopsies performed on rats that did not survive post-injury revealed obvious apoptotic cells in the adenohypophysis. Moreover, TEM revealed morphological changes characteristic of apoptosis in both the PVN and adenohypophysis of high-dose MP treated rats. These data suggest that MP therapy for TBI could increase neuronal apoptosis in both the hypothalamus and pituitary and consequently exacerbate acute CIRCI and mortality induced by TBI. (C) 2011 Elsevier B.V. All rights reserved.	[Chen, Xin; Zhang, Bin; Chai, Yan; Lei, Ping; Jiang, Rongcai; Zhang, Jianning] Tianjin Neurol Inst, Tianjin 300052, Peoples R China; [Chen, Xin; Zhang, Bin; Lei, Ping; Jiang, Rongcai; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China; [Chen, Xin; Zhang, Bin; Chai, Yan; Lei, Ping; Jiang, Rongcai; Zhang, Jianning] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin 300052, Peoples R China; [Chen, Xin; Zhang, Bin; Chai, Yan; Lei, Ping; Jiang, Rongcai; Zhang, Jianning] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin 300052, Peoples R China; [Dong, Bo] Tianjin Chest Hosp, Dept Cardiol, Tianjin 300051, Peoples R China	Zhang, JN (corresponding author), Tianjin Neurol Inst, 154 Anshan Rd, Tianjin 300052, Peoples R China.	woshichenxin@sina.com; victorbin922@163.com; chaiyankelly@yahoo.cn; dongbo121@yahoo.com.cn; leiping1974@163.com; jianghope@gmail.com; jianningzhang@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81000533]; National Key Basic Research Program in ChinaNational Basic Research Program of China [2005CB522600]; Tianjin Medical University	This work was supported by grants from the National Natural Science Foundation of China (grant no. 81000533), National Key Basic Research Program in China (grant no. 2005CB522600), and "211 Project" Graduate Innovation Grant of Tianjin Medical University. The authors sincerely thank Dr. Jing-fei Dong from Thrombosis Research Section, Department of Medicine, Baylor College of Medicine, for his suggestion and edit during paper revision; the authors also thank Dr. Chrissandra Zagami, from Center for Neuronal Survival, Montreal Neurological Institute and Hospital, McGill University, for her advice and help for publication, and appreciate Li Liu, Weiyun Cui, Fanglian Chen, and Lei Zhou, from Tianjin Neurological Institute, for their assistance in technical support.	Allen T.C., 1992, LAB METHODS HISTOTEC, P53; Annane D, 2008, EUR RESPIR J, V31, P1150, DOI 10.1183/09031936.00040908; Bendel S, 2008, ANESTH ANALG, V106, P1813, DOI 10.1213/ane.0b013e318172fdba; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen X, 2010, NEUROL RES, V32, P1097, DOI 10.1179/016164110X12681290831162; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Du C, 1996, J CEREBR BLOOD F MET, V16, P195, DOI 10.1097/00004647-199603000-00003; EDWARDS OM, 1986, MEDICINE, V65, P281; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Fombonne J, 2004, MOL BIOL CELL, V15, P4938, DOI 10.1091/mbc.E04-07-0601; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Henzen C, 2000, LANCET, V355, P542, DOI 10.1016/S0140-6736(99)06290-X; Holloway RG, 2010, NEW ENGL J MED, V362, P1757, DOI 10.1056/NEJMp0907808; Jaattela M, 2003, NAT IMMUNOL, V4, P416, DOI 10.1038/ni0503-416; Ji RR, 1998, P NATL ACAD SCI USA, V95, P15635, DOI 10.1073/pnas.95.26.15635; Klose M, 2008, PITUITARY, V11, P255, DOI 10.1007/s11102-008-0102-x; LAURER HL, 2002, ENCY HUMAN BRAIN, P93; Llompart-Pou JA, 2008, NEUROCRIT CARE, V9, P230, DOI 10.1007/s12028-008-9115-6; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; Mesotten D, 2008, NAT CLIN PRACT ENDOC, V4, P496, DOI 10.1038/ncpendmet0921; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; Nicotera P, 1999, TRENDS PHARMACOL SCI, V20, P46, DOI 10.1016/S0165-6147(99)01304-8; Peng YS, 2009, CRIT CARE, V13, DOI 10.1186/cc7978; Peyton JL, 2009, J VET EMERG CRIT CAR, V19, P262, DOI 10.1111/j.1476-4431.2009.00407.x; RUFF R, 2004, YOUMANS NEUROLOGICAL, P5185; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; Sauerland S, 2004, LANCET, V364, P1291, DOI 10.1016/S0140-6736(04)17202-4; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schuetz Philipp, 2008, BMC Pulm Med, V8, P1, DOI 10.1186/1471-2466-8-1; van Herck H, 1998, LAB ANIM-UK, V32, P377, DOI 10.1258/002367798780599794	34	12	14	1	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 25	2011	1382						298	307		10.1016/j.brainres.2011.01.045			10	Neurosciences	Neurosciences & Neurology	745AF	WOS:000289135600034	21262204				2021-06-18	
J	Salvatore, AP; Fjordbak, BS				Salvatore, Anthony P.; Fjordbak, Bess Sirmon			Concussion Management: The Speech-Language Pathologist's Role	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; HEAD-INJURY; SPORTS; EPIDEMIOLOGY; PREDICTORS; STATEMENT; RECOVERY; IMPACT	This article outlines the areas of concern in the evaluation and treatment of sports-related concussion and the role of speech-language pathologists (SLPs) in the management of this diagnosis. The specific diagnostic criteria for concussion are an area of ongoing controversy relative to differentiation from mild traumatic brain injury (mTBI). Assessment has evolved from simple paper and pencil tasks and ad hoc sideline examinations to computer-based assessment in the office and on the sideline. Treatment protocols are evolving, showing a clear change from traditional models of service delivery in mTBI to one in which the individual with a concussion is asked to limit both physical and cognitive stimulation. This period of reduced stimulation varies, depending on the severity of the injury and the rate of recovery. SLPs can play an important role in the prevention and management of concussion.	[Salvatore, Anthony P.; Fjordbak, Bess Sirmon] Univ Texas El Paso, Dept Rehabil Sci, Speech Language Pathol Program, El Paso, TX USA	Salvatore, AP (corresponding author), Coll Hlth Sci 401, 1101 N Campbell St, El Paso, TX 79902 USA.						Allen EA, 2007, TRAUMA, V9, P181, DOI 10.1177/1460408607087717; American Speech-Language-Hearing Association, 2005, ROL SPEECH LANG PATH; American Speech-Language-Hearing Association, 2007, SCOP PRACT SPEECH LA; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 2007, NEUROSURGERY, V60, P963, DOI 10.1227/01.NEU.0000255430.62291.7B; Caridge N. E. F., 1981, HEAD INJURY; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cekic M, 2010, FUTUR NEUROL, V5, P37, DOI 10.2217/FNL.09.72; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; *DEF VET BRAIN INJ, 2006, CLIN PRACT GUID REC; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; Kontos AP, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P315, DOI 10.1007/0-387-32565-4_14; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee M., 2009, MANAGEMENT RECOMMEND; Lovell MR, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P111, DOI 10.1007/0-387-32565-4_6; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrea M, 2008, MILD TRAUMATIC BRAIN; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Meythaler J. M., 2006, BRAIN INJURY MED PRI, P1023; Nelson W. E., 1984, PHYSICIAN SPORTSMED, V12, P103; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Salvatore A. P., 2008, NEW DEV SPORTS REL C; Salvatore A. P., 2008, TEX SOC ALL HLTH PRO; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Springhouse Group, 2009, HDB SIGNS SYMPT; TEASDALE G, 1974, LANCET, V2, P81; Tegner Y, 1996, BRIT J SPORT MED, V30, P251, DOI 10.1136/bjsm.30.3.251; Tommasone BA, 2006, J ATHL TRAINING, V41, P470	44	12	12	0	9	DELMAR CENGAGE LEARNING	FLORENCE	PO BOX 6904, FLORENCE, KY 41022-6904 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	MAR	2011	19	1					1	12					12	Audiology & Speech-Language Pathology; Clinical Neurology	Audiology & Speech-Language Pathology; Neurosciences & Neurology	V34SR	WOS:000209106500002					2021-06-18	
J	Zgaljardic, DJ; Guttikonda, S; Grady, JJ; Gilkison, CR; Mossberg, KA; High, WM; Masel, BE; Urban, RJ				Zgaljardic, Dennis J.; Guttikonda, Sreedevi; Grady, James J.; Gilkison, Charles R.; Mossberg, Kurt A.; High, Walter M., Jr.; Masel, Brent E.; Urban, Randall J.			Serum IGF-1 concentrations in a sample of patients with traumatic brain injury as a diagnostic marker of growth hormone secretory response to glucagon stimulation testing	CLINICAL ENDOCRINOLOGY			English	Article							ADULT GH DEFICIENCY; INSULIN TOLERANCE-TEST; REPLACEMENT; GUIDELINES	P>Objective The diagnosis of growth hormone deficiency (GHD) in adults is established through growth hormone (GH) stimulation testing, which is often complex, expensive, time-consuming and may be associated with adverse side effects. The decision to perform GH provocative testing is influenced by clinical findings, medical history and biochemical evidence. We report in this study our experience using the glucagon stimulation test (GST) in assessing GHD in adult patients with traumatic brain injury (TBI) as it relates to baseline serum insulin-like growth factor-1 (IGF-1) concentrations. Design A receiver operating characteristic (ROC) curve analysis was performed to determine the optimal IGF-1 cut-off for diagnosis of GHD at different potential diagnostic GST cut-off values (< 3, < 5, & < 10 mu g/l). Patients One hundred and thirty-eight patients (98 men and 40 women) with a documented history of moderate to severe TBI were assessed for GHD using serum IGF-1 concentrations and the GST. Measurements IGF-1 values were compared with peak GH values obtained following the GST. Results An IGF-1 cut-off value of 175 mu g/l minimized the misclassification of GHD patients and GH-sufficient patients and provided a sensitivity of 83% and specificity of 40%, as well as a negative predictive power of 90% considering a criterion for peak GH response of < 3 mu g/l. Conclusions Our current findings are consistent with previous work assessing peak GH response using the insulin tolerance test (ITT) in a non-TBI sample, suggesting that diagnostic accuracy may be optimized if the GST is used when obtained serum IGF-1 concentrations are below 175 mu g/l. While the decision to perform provocative testing to assess GHD in adult patients should be based on the clinician's clinical impression, the findings from this retrospective study can provide useful clinical information and serve as a guide.	[Zgaljardic, Dennis J.] Univ Texas Med Branch, Dept Neuropsychol, Transit Learning Ctr, Galveston, TX 77550 USA; Univ Texas Med Branch, Dept Neurol, Galveston, TX 77550 USA; Univ Texas Med Branch, Div Rehabil Sci, Galveston, TX 77550 USA; [Guttikonda, Sreedevi; Gilkison, Charles R.; Urban, Randall J.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77550 USA; [Grady, James J.] Univ Texas Med Branch, Dept PMCH Epidemiol & Biostat, Galveston, TX 77550 USA; [Mossberg, Kurt A.] Univ Texas Med Branch, Dept Phys Therapy, Galveston, TX 77550 USA; [High, Walter M., Jr.] Univ Kentucky, Coll Med, Dept Phys Med & Rehabil, Lexington, KY USA	Zgaljardic, DJ (corresponding author), Univ Texas Med Branch, Dept Neuropsychol, Transit Learning Ctr, 1528 PO St, Galveston, TX 77550 USA.	dzgaljardic@tlc-galveston.org			Moody Endowment; Pfizer, Inc.Pfizer	This study was supported by grants from the Moody Endowment and Pfizer, Inc. We gratefully acknowledge Maria Briones-Galang, MD and Gerard Francisco, MD for research coordination and Renee Pearcy for editorial assistance. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Berg C, 2010, EUR J ENDOCRINOL, V162, P477, DOI 10.1530/EJE-09-0824; Bhagia V, 2010, BRAIN INJURY, V24, P560, DOI 10.3109/02699051003601705; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Brabant G, 2003, HORM RES, V60, P53, DOI 10.1159/000071871; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Casanueva FF, 2009, HORM RES, V71, P112, DOI 10.1159/000178051; Conceicao FL, 2003, J ENDOCRINOL INVEST, V26, P1065, DOI 10.1007/BF03345251; DEBOER H, 1995, ENDOCR REV, V16, P63, DOI 10.1210/er.16.1.63; Ghigo E, 2008, GROWTH HORM IGF RES, V18, P1, DOI 10.1016/j.ghir.2007.07.004; Gomez JM, 2002, CLIN ENDOCRINOL, V56, P329, DOI 10.1046/j.1365-2265.2002.01472.x; Hadjadj S, 2007, ANN ENDOCRINOL-PARIS, V68, P449, DOI 10.1016/j.ando.2007.08.004; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; JONES SL, 1994, CLIN ENDOCRINOL, V41, P123, DOI 10.1111/j.1365-2265.1994.tb03793.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Maison P, 2003, CIRCULATION, V108, P2648, DOI 10.1161/01.CIR.0000100720.01867.1D; Popovic Vera, 2005, Pituitary, V8, P239, DOI 10.1007/s11102-006-6047-z; *SPSS INC, 2001, SPSS WIND; Yuen KCJ, 2009, J CLIN ENDOCR METAB, V94, P2702, DOI 10.1210/jc.2009-0299	19	12	13	0	4	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0300-0664			CLIN ENDOCRINOL	Clin. Endocrinol.	MAR	2011	74	3					365	369		10.1111/j.1365-2265.2010.03935.x			5	Endocrinology & Metabolism	Endocrinology & Metabolism	718AY	WOS:000287093200013	21114510				2021-06-18	
J	Grossman, KJ; Goss, CW; Stein, DG				Grossman, Kimberly J.; Goss, Cynthia W.; Stein, Donald G.			Sickness behaviors following medial frontal cortical contusions in male rats	BEHAVIOURAL BRAIN RESEARCH			English	Article						Sickness behavior; Traumatic brain injury; Progesterone; Weight maintenance; Food consumption; Grooming; Exploratory activity; Lesion size	TRAUMATIC BRAIN-INJURY; CEREBRAL-ARTERY OCCLUSION; PROGESTERONE TREATMENT; METABOLIC-RESPONSE; PREFRONTAL CORTEX; NEURONAL LOSS; HEAD-INJURY; EDEMA; ALLOPREGNANOLONE; PROTECTS	Behaviors associated with sickness (food consumption, weight maintenance, exploratory activity and grooming frequency) were examined on post-surgical days 1, 3, 5, 7 and 9 in male rats treated with progesterone (4 mg/kg) and/or vehicle. Rats with medial frontal cortex contusions showed reduced food consumption on days 1 and 3 (p < 0.01), reduced weight maintenance on days 1, 3, 5, 7 and 9 (p < 0.01), reduced grooming frequency on day 1 (p < .01), and reduced exploratory activity on day 1 (p < 0.01), after injury compared to sham rats. Contusion induced behaviors were not attenuated with 5 days of progesterone treatment (p > 0.05). Progesterone did reduce lesion size at 9 days after injury (p < 0.05). Our results suggest sickness behaviors occur after traumatic brain injury and that they might not respond to some neurosteroidal agents. (C) 2010 Elsevier B.V. All rights reserved.	[Grossman, Kimberly J.; Goss, Cynthia W.] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; [Stein, Donald G.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA	Grossman, KJ (corresponding author), Emory Univ, Dept Psychol, 1365 B Clifton Rd NE,Suite 5100, Atlanta, GA 30322 USA.	kgrossm@gmail.com	Stein, Donald/AAJ-5139-2020		General Cologne Reinsurance Corporation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS-38664]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038664] Funding Source: NIH RePORTER	Aamir Dam for his assistance with behavioral testing preparations. Research supported by General Cologne Reinsurance Corporation and NIH R01 NS-38664.	Al-Adawi S, 1998, NEUROPSYCHOLOGY, V12, P115, DOI 10.1037/0894-4105.12.1.115; Asbury ET, 1998, BEHAV BRAIN RES, V97, P99, DOI 10.1016/S0166-4328(98)00031-X; Cavalli R, 1999, INT J PHARM, V182, P59, DOI 10.1016/S0378-5173(99)00066-6; Cervantes M, 2002, ARCH MED RES, V33, P6, DOI 10.1016/S0188-4409(01)00347-2; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; DICKERSON JWT, 1992, ADV EXP MED BIOL, V325, P23; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Galani R, 2001, RESTOR NEUROL NEUROS, V18, P161; GIPSEN WH, 1975, LIFE SCI, V17, P645; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Inui A, 2000, PHARMACOL REV, V52, P35; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; Kelley KW, 1997, ANN NY ACAD SCI, V823, P234, DOI 10.1111/j.1749-6632.1997.tb48395.x; KEPPEL G, 1991, ANAL RES HDB; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Paxinos G., 1982, RAT BRAIN; Pepe JL, 1999, J HEAD TRAUMA REHAB, V14, P462, DOI 10.1097/00001199-199910000-00007; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Roe SY, 1997, J NEUROTRAUM, V14, P399, DOI 10.1089/neu.1997.14.399; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Smith JS, 2000, NEURAL PLAST, V7, P73, DOI 10.1155/NP.2000.73; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820	36	12	12	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328			BEHAV BRAIN RES	Behav. Brain Res.	FEB 2	2011	217	1					202	208		10.1016/j.bbr.2010.09.029			7	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	710TK	WOS:000286539700029	20933021	Green Accepted			2021-06-18	
J	Frye, CA; Walf, A				Frye, Cheryl A.; Walf, Alicia			Progesterone, Administered Before Kainic Acid, Prevents Decrements in Cognitive Performance in the Morris Water Maze	DEVELOPMENTAL NEUROBIOLOGY			English	Article						dihydroprogesterone; allopregnanolone; neurosteroid; learning; ictal activity; hippocampus; neuroprotection	TRAUMATIC BRAIN-INJURY; GLOBAL CEREBRAL-ISCHEMIA; 4-DAY ESTROUS-CYCLE; FEMALE RAT-BRAIN; CELL-DEATH; MEDROXYPROGESTERONE ACETATE; OBJECT RECOGNITION; INDUCED NEUROPROTECTION; NEUROACTIVE STEROIDS; PREFRONTAL CORTEX	The nature of progesterone (P-4)'s neuroprotective effects is of interest. We investigated effects of P-4 when administered before, or after, kainic acid, which produces ictal activity and damage to the hippocampus, to mediate effects on spatial performance. The hypothesis was that P-4, compared with vehicle, would reduce decrements in Morris Water Maze performance induced by kainic acid. Experiment 1: We examined the effects of kainic acid on plasma stress hormone, corticosterone, and progestogen (P-4 and its metabolites) levels in plasma and the hippocampus after subcutaneous (s.c.) P-4 administration to ovariectomized rats. Rats administered kainic acid had the highest corticosterone levels immediately following injection. P-4 is 5 alpha-reduced to dihydroprogesterone (DHP) and subsequently metabolized to 5 alpha-pregnan-3 alpha-ol-20-one (3 alpha,5 alpha-THP) by 3 alpha-hydroxysteroid dehydrogenase. The regimen of P-4 used produced circulating and hippocampal levels of P-4, DHP, and 3 alpha,5 alpha-THP within a physiological range, which declined at 14 hours postinjection and were not altered by kainic acid. Experiment 2: The physiological P-4 regimen was administered to rats before, or after, kainic acid-induced seizures, and later effects on water maze performance were compared with that of rats administered vehicle. Rats administered kainic acid had significantly poorer performance in the water maze (i.e., increased latencies and distances to the hidden platform) than did rats administered vehicle. Administration of P-4 before, but not after, kainic acid prevented these performance deficits. Thus, these data suggest that a physiological regimen of P-4 can prevent some of the deficits in water maze performance produced by kainic acid. (C) 2010 Wiley Periodicals, Inc. Develop Neurobiol 71: 142-152, 2011	[Frye, Cheryl A.] SUNY Albany, Dept Psychol, Albany, NY 12222 USA; [Frye, Cheryl A.] SUNY Albany, Dept Biol, Albany, NY 12222 USA; [Frye, Cheryl A.; Walf, Alicia] SUNY Albany, Ctr Life Sci, Albany, NY 12222 USA	Frye, CA (corresponding author), SUNY Albany, Dept Psychol, 1400 Washington Ave, Albany, NY 12222 USA.	cafrye@albany.edu			National Institutes of Health (NIMH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH); National Science FoundationNational Science Foundation (NSF); NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R56MH067698, R01MH067698] Funding Source: NIH RePORTER	Contract grant sponsor: National Institutes of Health (NIMH) and National Science Foundation.	Asbury ET, 1998, BEHAV BRAIN RES, V97, P99, DOI 10.1016/S0166-4328(98)00031-X; Balasubramanian B, 2008, ENDOCRINOLOGY, V149, P5509, DOI 10.1210/en.2008-0712; BELANGER A, 1981, BIOL REPROD, V24, P591, DOI 10.1095/biolreprod24.3.591; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Buckmaster PS, 1997, J COMP NEUROL, V385, P385; BUTCHER RL, 1974, ENDOCRINOLOGY, V94, P1704, DOI 10.1210/endo-94-6-1704; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Carroll JC, 2008, NEUROSCI LETT, V445, P229, DOI 10.1016/j.neulet.2008.09.010; Cervantes M, 2002, ARCH MED RES, V33, P6, DOI 10.1016/S0188-4409(01)00347-2; Ciriza I, 2004, J NEUROENDOCRINOL, V16, P58, DOI 10.1111/j.1365-2826.2004.01121.x; Ciriza I, 2006, J NEUROBIOL, V66, P916, DOI 10.1002/neu.20293; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Follesa P, 2001, BRAIN RES REV, V37, P81, DOI 10.1016/S0165-0173(01)00125-4; Foy MR, 2008, LEARN MEMORY, V15, P820, DOI 10.1101/lm.1124708; Frank C, 2000, PROG NEURO-PSYCHOPH, V24, P1117, DOI 10.1016/S0278-5846(00)00124-X; Frye CA, 2000, PSYCHONEUROENDOCRINO, V25, P407, DOI 10.1016/S0306-4530(99)00068-2; Frye CA, 1999, J NEUROENDOCRINOL, V11, P839; Frye CA, 2000, PHARMACOL BIOCHEM BE, V67, P587, DOI 10.1016/S0091-3057(00)00392-0; FRYE CA, 1995, PHYSIOL BEHAV, V57, P5, DOI 10.1016/0031-9384(94)00197-D; FRYE CA, 1995, BRAIN RES, V696, P113, DOI 10.1016/0006-8993(95)00793-P; Frye CA, 1998, BRAIN RES, V808, P72, DOI 10.1016/S0006-8993(98)00764-1; Frye CA, 2008, INT REV NEUROBIOL, V83, P27, DOI 10.1016/S0074-7742(08)00003-2; Frye CA, 2008, NEUROBIOL LEARN MEM, V90, P171, DOI 10.1016/j.nlm.2008.03.005; Frye CA, 2008, NEUROSCI LETT, V437, P116, DOI 10.1016/j.neulet.2008.04.004; Frye CA, 2008, NEUROBIOL LEARN MEM, V89, P17, DOI 10.1016/j.nlm.2007.09.008; Frye CA, 2007, NEUROBIOL LEARN MEM, V88, P208, DOI 10.1016/j.nlm.2007.04.003; Frye CA, 2010, NEUROREPORT, V21, P590, DOI 10.1097/WNR.0b013e32833a7e14; Galea LAM, 2000, HORM BEHAV, V37, P86, DOI 10.1006/hbeh.1999.1560; Ghoumari AM, 2003, J NEUROCHEM, V86, P848, DOI 10.1046/j.1471-4159.2003.01881.x; Gonzalez SL, 2005, J STEROID BIOCHEM, V94, P143, DOI 10.1016/j.jsbmb.2005.01.016; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Guerra-Araiza C, 2003, J NEUROENDOCRINOL, V15, P984, DOI 10.1046/j.1365-2826.2003.01088.x; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Harburger LL, 2007, NEUROBIOL AGING, V28, P602, DOI 10.1016/j.neurobiolaging.2006.02.019; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Herzog AG, 2003, ANN NEUROL, V53, P390, DOI 10.1002/ana.10508; Herzog AG, 2009, NEUROTHERAPEUTICS, V6, P383, DOI 10.1016/j.nurt.2009.01.009; Hoffman GE, 2003, EXP NEUROL, V182, P124, DOI 10.1016/S0014-4886(03)00104-3; HORIKOSHI H, 1974, ENDOCRINOL JAPON, V21, P69; Jones NC, 2005, EUR J NEUROSCI, V21, P1547, DOI 10.1111/j.1460-9568.2005.03995.x; Lambert JJ, 2003, PROG NEUROBIOL, V71, P67, DOI 10.1016/j.pneurobio.2003.09.001; Li XD, 1997, J STEROID BIOCHEM, V60, P311, DOI 10.1016/S0960-0760(96)00195-1; Littleton-Kearney MT, 2005, J CEREBR BLOOD F MET, V25, P421, DOI 10.1038/sj.jcbfm.9600052; Lockhart EM, 2002, NEUROSCI LETT, V328, P33, DOI 10.1016/S0304-3940(02)00448-2; Melcangi RC, 1999, J NEUROBIOL, V40, P471, DOI 10.1002/(SICI)1097-4695(19990915)40:4<471::AID-NEU5>3.3.CO;2-G; Melcangi RC, 2001, INT REV NEUROBIOL, V46, P145; Mellon SH, 2001, BRAIN RES REV, V37, P3, DOI 10.1016/S0165-0173(01)00109-6; Morali G, 2005, NEUROSCI LETT, V382, P286, DOI 10.1016/j.neulet.2005.03.066; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nilsen J, 2002, NEUROREPORT, V13, P825, DOI 10.1097/00001756-200205070-00018; Nilsen J, 2002, ENDOCRINOLOGY, V143, P205, DOI 10.1210/en.143.1.205; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Ozacmak VH, 2009, PHYSIOL RES, V58, P909, DOI 10.33549/physiolres.931647; Palumbo MA, 1995, J ENDOCRINOL INVEST, V18, P853, DOI 10.1007/BF03349832; Paris JJ, 2008, REPRODUCTION, V136, P105, DOI 10.1530/REP-07-0512; PURDY RH, 1990, STEROIDS, V55, P290, DOI 10.1016/0039-128X(90)90031-6; Reyna-Neyra A, 2002, BRAIN RES BULL, V58, P607, DOI 10.1016/S0361-9230(02)00829-8; Rhodes ME, 2006, NEUROBIOL LEARN MEM, V85, P183, DOI 10.1016/j.nlm.2005.10.003; Rhodes ME, 2005, EPILEPSY BEHAV, V6, P320, DOI 10.1016/j.yebeh.2005.02.006; Rhodes ME, 2005, EPILEPSY BEHAV, V6, P140, DOI 10.1016/j.yebeh.2004.11.019; Rhodes ME, 2004, EPILEPSIA, V45, P1531, DOI 10.1111/j.0013-9580.2004.16504.x; Rhodes ME, 2004, PHARMACOL BIOCHEM BE, V78, P505, DOI 10.1016/j.pbb.2004.04.021; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; RODBARD D, 1974, CLIN CHEM, V20, P1255; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Rosario ER, 2006, BRAIN RES, V1099, P206, DOI 10.1016/j.brainres.2006.03.127; RUPPRECHT R, 1993, NEURON, V11, P523, DOI 10.1016/0896-6273(93)90156-L; Sandstrom NJ, 2001, BEHAV NEUROSCI, V115, P384, DOI 10.1037//0735-7044.115.2.384; Schumacher M, 2004, GROWTH HORM IGF RES, V14, pS18, DOI 10.1016/j.ghir.2004.03.007; SHAIKH AA, 1975, ENDOCRINOLOGY, V96, P37, DOI 10.1210/endo-96-1-37; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Singh M, 2005, ANN NY ACAD SCI, V1052, P145, DOI 10.1196/annals.1347.010; Singh M, 2001, ENDOCRINE, V14, P407, DOI 10.1385/ENDO:14:3:407; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Sugino N, 1996, ENDOCRINOLOGY, V137, P749, DOI 10.1210/en.137.2.749; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walf AA, 2005, NEUROPSYCHOPHARMACOL, V30, P1288, DOI 10.1038/sj.npp.1300708; Walf AA, 2006, NEUROBIOL LEARN MEM, V86, P35, DOI 10.1016/j.nlm.2006.01.004; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Wood GE, 2001, BEHAV NEUROSCI, V115, P175, DOI 10.1037//0735-7044.115.1.175; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100	87	12	12	0	2	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1932-8451			DEV NEUROBIOL	Dev. Neurobiol.	FEB	2011	71	2					142	152		10.1002/dneu.20832			11	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	718ED	WOS:000287102700002	20715152	Green Accepted			2021-06-18	
J	Gasparetto, EL; Lopes, FCR; Domingues, RC; Domingues, RC				Gasparetto, Emerson L.; Rueda Lopes, Fernanda C.; Domingues, Roberto C.; Domingues, Romeu C.			Diffusion Imaging in Traumatic Brain Injury	NEUROIMAGING CLINICS OF NORTH AMERICA			English	Article						Diffusion imaging; Traumatic brain injury; Magnetic resonance imaging; Computed tomography	WHITE-MATTER INJURY; CLOSED-HEAD INJURY; AXONAL INJURY; PROFESSIONAL BOXERS; TENSOR TRACTOGRAPHY; OUTCOME PREDICTION; CORPUS-CALLOSUM; ANISOTROPY; MODERATE; DAMAGE	Traumatic brain injury is a common cause of death worldwide, affecting mostly young people. The most feasible examination to be performed in the emergency room is computed tomography. Magnetic resonance (MR) imaging is becoming a significant tool in the evaluation of severe brain trauma. Diffusion-weighted imaging is an advanced MR imaging sequence that has been used to detect areas of ischemia and tumor malignancy. This article describes the recent advances in trauma based on diffusion-weighted MR imaging findings and in brain injury from head trauma based on diffusion-weighted MR imaging and diffusion tensor MR imaging findings. Current and potential clinical applications are discussed.	[Gasparetto, Emerson L.; Rueda Lopes, Fernanda C.; Domingues, Roberto C.; Domingues, Romeu C.] CDPI Clin Diagnost Por Imagem, Rio De Janeiro, Brazil; [Gasparetto, Emerson L.; Rueda Lopes, Fernanda C.] Univ Rio de Janeiro, Dept Radiol, Rio De Janeiro, Brazil; [Domingues, Roberto C.; Domingues, Romeu C.] Clin Multiimagem, Rio De Janeiro, Brazil	Gasparetto, EL (corresponding author), Estrada Da Barra Da Tijuca 1006 Ap 1106, BR-22641003 Rio De Janeiro, Brazil.	egasparetto@gmail.com					Ahn YH, 2006, NEUROREHABILITATION, V21, P239; Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bosnell R, 2008, DEV NEUROREHABIL, V11, P174, DOI 10.1080/17518420802289065; Chan JHM, 2003, NEURORADIOLOGY, V45, P34, DOI 10.1007/s00234-002-0891-y; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; DUCKWORTH JL, 2010, CURR OPIN CRIT CARE; Gallagher CN, 2007, CURR OPIN NEUROL, V20, P403, DOI 10.1097/WCO.0b013e32821b987b; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Hou DJ, 2007, J NEUROTRAUM, V24, P1558, DOI 10.1089/neu.2007.0339; Huisman TAGM, 2003, EUR RADIOL, V13, P2283, DOI 10.1007/s00330-003-1843-6; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jang SH, 2009, NEUROREHABILITATION, V24, P273, DOI 10.3233/NRE-2009-0478; Karaarslan E, 2008, EUR J RADIOL, V65, P402, DOI 10.1016/j.ejrad.2007.04.023; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Mamere AE, 2009, AM J NEURORADIOL, V30, P947, DOI 10.3174/ajnr.A1477; Muccio CF, 2009, BRAIN INJURY, V23, P466, DOI 10.1080/02699050902841912; Naganawa S, 2004, AM J NEURORADIOL, V25, P1553; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Nucifora PGP, 2007, RADIOLOGY, V245, P367, DOI 10.1148/radiol.2452060445; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Pasco A, 2006, EUR RADIOL, V16, P1501, DOI 10.1007/s00330-005-0086-0; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331; Schaefer PW, 2001, J NEUROL SCI, V186, pS25, DOI 10.1016/S0022-510X(01)00488-9; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Takayama H, 2000, CLIN NEUROL NEUROSUR, V102, P135, DOI 10.1016/S0303-8467(00)00079-2; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Zhang L, 2006, AM J NEURORADIOL, V27, P2000	41	12	13	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1052-5149	1557-9867		NEUROIMAG CLIN N AM	Neuroimaging Clin. N. Am.	FEB	2011	21	1					115	+		10.1016/j.nic.2011.02.003			12	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	757ZJ	WOS:000290128200007	21477754				2021-06-18	
J	Merten, T				Merten, T.			Symptom Validity Assessment and Forensic Evaluation of Cognitive and Mental Disorders	FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE			German	Article						symptom validity assessment; malingering; forensic assessment; symptom exaggeration; neuropsychological assessment; questionnaires	TRAUMATIC BRAIN-INJURY; WORD MEMORY TEST; MUNCHAUSEN-BY-PROXY; MALINGERED NEUROCOGNITIVE DYSFUNCTION; POSTTRAUMATIC-STRESS-DISORDER; NEGATIVE RESPONSE BIAS; TEST-PERFORMANCE; NEUROPSYCHOLOGICAL ASSESSMENT; CLASSIFICATION ACCURACY; SUBOPTIMAL EFFORT	Continuing from two previous reviews in this journal (Fortchr Neurol Psychiatr 2002; 70: 126 - 138; 2007; 75: 140 - 154), modern methods and research on symptom validity assessment are presented, with special emphasis on civil forensic examinations. In spite of continuing resistance from many professionals, symptom validity assessment is gradually gaining ground in German-speaking countries, but there is a developmental lag in European countries as a whole, as compared to developments in North America. Major research lines are presented, and questionnaire measures for the detection of a negative response bias are illustrated in more detail.	Vivantes Klinikum Friedrichshain, Neurol Klin, D-10249 Berlin, Germany	Merten, T (corresponding author), Vivantes Klinikum Friedrichshain, Neurol Klin, Landsberger Allee 49, D-10249 Berlin, Germany.	thomas.merten@vivantes.de					Aguerrevere LE, 2008, ARCH CLIN NEUROPSYCH, V23, P831, DOI 10.1016/j.acn.2008.06.008; Allen L.M., 1997, CARB 97 MANUAL COMPU; Allen MD, 2007, BRAIN INJURY, V21, P1425, DOI 10.1080/02699050701769819; Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Aronoff Gerald M, 2007, Pain Pract, V7, P178, DOI 10.1111/j.1533-2500.2007.00126.x; Axelrod BN, 2010, CLIN NEUROPSYCHOL, V24, P873, DOI 10.1080/13854040903527295; Bagby R. M., 2006, MMPI 2 PRACTITIONERS, P39, DOI DOI 10.1037/11287-003; Barrash J, 2004, J CLIN EXP NEUROPSYC, V26, P125, DOI 10.1076/jcen.26.1.125.23928; Bauer L, 2006, ARCH CLIN NEUROPSYCH, V21, P121, DOI 10.1016/j.acn.2005.06.010; Bianchini KJ, 2008, ASSESSMENT, V15, P435, DOI 10.1177/1073191108317341; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; Blaskewitz N, 2007, FORTSCHR NEUROL PSYC, V75, P140, DOI 10.1055/s-2006-932204; BLASKEWITZ N, 2009, THESIS HUMBOLDT U BE; Blaskewitz N., 2006, Z NEUROPSYCHOL, V17, P35, DOI DOI 10.1024/1016-264X.17.1.35; Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Blaskewitz N, 2009, APPL NEUROPSYCHOL, V16, P54, DOI 10.1080/09084280802644227; Boccaccini MT, 2006, J FORENSIC PSYCHOL P, V6, P51, DOI 10.1300/J158v06n03_03; Boone, 2007, ASSESSMENT FEIGNED C; Bourget D, 2007, J AM ACAD PSYCHIATRY, V35, P469; Bowler RM, 2006, NEUROTOXICOLOGY, V27, P315, DOI 10.1016/j.neuro.2005.10.007; Brickenkamp R., 2002, TEST D2 AUFMERKSAMKE; Brockhaus R, 2004, NERVENARZT, V75, P882, DOI 10.1007/s00115-003-1592-4; BROCKMEYER M, 2009, DIAGNOSTIK BESCHWERD, P280; Browndyke JN, 2008, BRAIN INJURY, V22, P481, DOI 10.1080/02699050802084894; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; BUSH SS, 2007, PRAXIS RECHTSPSYCHOL, V17, P155; BUSH SS, 2006, ETHICAL PRACTICE FOR; BUSH SS, 2009, DIAGNOSTIK BESCHWERD, P79; Busichio K, 2004, J INT NEUROPSYCH SOC, V10, P278, DOI 10.1017/S1355617704102178; Butcher JN., 2001, MINNESOTA MULTIPHASI; Carone DA, 2010, CLIN NEUROPSYCHOL, V24, P759, DOI 10.1080/13854041003712951; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Chafetz MD, 2007, ARCH CLIN NEUROPSYCH, V22, P1, DOI 10.1016/j.acn.2006.10.003; Chesterman LP, 2008, J FORENSIC PSYCHI PS, V19, P275, DOI 10.1080/14789940701841129; CHRISTIANSON SA, 2007, OFFENDERS MEMORIES V; Cima M, 2003, NERVENARZT, V74, P977, DOI 10.1007/s00115-002-1438-5; Cima M, 2003, CLIN NEUROPSYCHOL, V17, P235, DOI 10.1076/clin.17.2.235.16507; CIMA M, 2007, PRAXIS RECHTSPSYCHOL, V17, P47; Cima M, 2008, J FORENSIC SCI, V53, P975, DOI 10.1111/j.1556-4029.2008.00740.x; COLWELL K, 2005, AM J FORENS PSYCHOL, V23, P83; Constantinou M, 2003, CHILD NEUROPSYCHOL, V9, P81, DOI 10.1076/chin.9.2.81.14505; Courtney JC, 2003, CHILD NEUROPSYCHOL, V9, P109, DOI 10.1076/chin.9.2.109.14507; Day DO, 2010, J FORENSIC PSYCHOL P, V10, P13, DOI 10.1080/15228930903172981; Dean AC, 2008, CLIN NEUROPSYCHOL, V22, P705, DOI 10.1080/13854040701440493; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Denney RL, 1996, ARCH CLIN NEUROPSYCH, V11, P589, DOI 10.1016/0887-6177(95)00042-9; DETTENBORN H, 2009, DIAGNOSTIK BESCHWERD, P70; DIEDERICH C, 2009, EINSATZ SELBSTBEURTE; DIEDERICH C, 2009, 1 EUR S SYMPT VAL WU; Dohrenbusch R, 2009, SCHMERZ, V23, P241, DOI 10.1007/s00482-009-0789-2; Dohrenbusch R, 2009, SCHMERZ, V23, P231, DOI 10.1007/s00482-009-0788-3; DOHRENBUSCH R, 2007, BEGUTACHTUNG SOMATOF; Drob SL, 2009, J AM ACAD PSYCHIATRY, V37, P98; *DTSCH RENT, 2010, LEITL SOZ BEURT BEI; *DTSCH RENT BUND, SOZ BEG GES IN PRESS; EBERT A, 2007, AGGRAVATIONS SIMULAT; ENGEL R, VEI VERHALT IN PRESS; Engel R, 2000, MMPI 2 MINNESOTA MUL; ETTINGER AB, 2007, PSYCHIAT ISSUES EPIL; Everington C, 2007, BEHAV SCI LAW, V25, P545, DOI 10.1002/bsl.735; Fabra M, 2009, Versicherungsmedizin, V61, P111; FABRA M, 2003, KOMPENDIUM MED BEGUT; FAUST D, 1988, J CONSULT CLIN PSYCH, V56, P578, DOI 10.1037/0022-006X.56.4.578; Feldman MD, 2004, PSYCHOSOMATICS, V45, P365, DOI 10.1176/appi.psy.45.4.365; Flaro L., 2007, PRAXIS RECHTSPSYCHOL, V17, P125; Franke G.H., 2002, SCL 90 R SYMPTOM CHE; FRANKE GH, 2002, PSYCHOL BEITR, V44, P50; Frazier TW, 2008, ARCH CLIN NEUROPSYCH, V23, P501, DOI 10.1016/j.acn.2008.04.001; Frederick RI, 2009, J HEAD TRAUMA REHAB, V24, P105, DOI 10.1097/HTR.0b013e31819b1210; Freund HJ, 2005, HIGHER ORDER MOTOR D; Gast J, 2010, J FORENSIC PSYCHOL P, V10, P53, DOI 10.1080/15228930903173062; GERAERTS E, 2007, NEUROPRAXIS, V1, P8; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; GIGER P, 2009, DIAGNOSTIK BESCHWERD, P101; GIGER P, J FORENS PS IN PRESS; Giger P, 2010, PRAXIS RECHTSPSYCHOL, V20, P131; GIGER P, 2008, DIAGNOSTIK BESCHWERD; Gill David, 2007, Med Leg J, V75, P64; Gold, 2010, AM PSYCHIAT PUBLISHI; Gorny I., 2005, J FORENSIC NEUROPSYC, V4, P71, DOI DOI 10.1300/J151V04N04_05; GOULD R, 1986, J NERV MENT DIS, V174, P593, DOI 10.1097/00005053-198610000-00003; Granhag P. A., 2004, DETECTION DECEPTION; Graue LO, 2007, CLIN NEUROPSYCHOL, V21, P929, DOI 10.1080/13854040600932137; Green, 2004, GREENS MED SYMPTOM V; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2003, GREENS WORD MEMORY T; GREEN P, APPL NEUROL IN PRESS; Green P., 2008, GREENS NONVERBAL MED; Green P, 2004, REPORT PSYCHOL, V29, P303; Greene R. L., 2008, CLIN ASSESSMENT MALI, P159; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greiffenstein MF, 2010, CLIN NEUROPSYCHOL, V24, P305, DOI 10.1080/13854040903456222; Greve KW, 2010, CLIN NEUROPSYCHOL, V24, P137, DOI 10.1080/13854040902927546; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P1250, DOI 10.1080/13854040902828272; GREVE KW, 2009, DIAGNOSTIK BESCHWERD, P193; GUBBAY J, GUIDELINES 1 I UNPUB; GUDJONSSON GH, 1986, BRIT J CLIN PSYCHOL, V25, P35, DOI 10.1111/j.2044-8260.1986.tb00668.x; HALL HV, 2000, DETECTING MALINGERIN; Hanlon RE, 2010, ARCH CLIN NEUROPSYCH, V25, P1, DOI 10.1093/arclin/acp099; Harrison AG, 2007, ARCH CLIN NEUROPSYCH, V22, P577, DOI 10.1016/j.acn.2007.03.008; Harrison AG, 2010, ARCH CLIN NEUROPSYCH, V25, P89, DOI 10.1093/arclin/acp104; Hartman DE, 2002, ARCH CLIN NEUROPSYCH, V17, P709, DOI 10.1016/S0887-6177(01)00172-X; HAUSOTTER W, 1995, MED SACH, V91, P10; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Helmstaedter C., 2001, VERBALER LERNUND MER; Henry GK, 2008, CLIN NEUROPSYCHOL, V22, P158, DOI 10.1080/13825580601025916; Henry GK, 2006, CLIN NEUROPSYCHOL, V20, P786, DOI 10.1080/13854040500287749; Henry GK, 2009, CLIN NEUROPSYCHOL, V23, P153, DOI 10.1080/13854040801969524; HENRY M, 2009, DIAGNOSTIK BESCHWERD, P118; Henry M, 2010, J CLIN EXP NEUROPSYC, V32, P19, DOI 10.1080/13803390902791653; Heubrock D., 2000, TESTBATTERIE FORENSI; Hilsabeck RC, 2001, ARCH CLIN NEUROPSYCH, V16, P669, DOI 10.1016/S0887-6177(00)00077-9; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Hurley KE, 2006, MENT RETARD, V44, P112, DOI 10.1352/0047-6765(2006)44[112:AIMMUW]2.0.CO;2; Iverson G. L., 2010, HDB FORENSIC NEUROPS, P91; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Jenkins KG, 2009, CURR OPIN NEUROL, V22, P601, DOI 10.1097/WCO.0b013e32833299bb; JONES AB, 1917, MALINGERING SIMULATI; Kahneman D, 2009, AM PSYCHOL, V64, P515, DOI 10.1037/a0016755; KAPUR N, 1994, J NEUROL NEUROSUR PS, V57, P385, DOI 10.1136/jnnp.57.3.385; Kaufmann PM, 2009, CLIN NEUROPSYCHOL, V23, P1130, DOI 10.1080/13854040903107809; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; KLUMBIES G, 1980, PSYCHOTHERAPIE INNER; KOOL J, 2008, 408 BUND SOZ; Kopelman MD, 1995, HDB MEMORY DISORDERS, P427; KUBINGER K, PSYCHOL DIA IN PRESS; Lamberty G. J., 2008, UNDERSTANDING SOMATI; LANG CJG, 2010, MED SACH, V106, P128; Lange RT, 2006, ARCH CLIN NEUROPSYCH, V21, P552; Larrabee G. J., 2007, ASSESSMENT MALINGERE, P3; Larrabee G.J., 2005, FORENSIC NEUROPSYCHO; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; LARRABEE GJ, 2007, ASSESSMENT MALINGERE, P335; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P813, DOI 10.1080/13854040701625846; Larsen JD, 2010, BRAIN INJURY, V24, P89, DOI 10.3109/02699050903508218; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LEESHALEY PR, 2002, J FORENSIC NEUROPSYC, V3, P167, DOI DOI 10.1300/J151V03N01_01; Lindeboom, 2005, AMSTERDAM SHORT TERM; Lindstrom WA, 2009, ARCH CLIN NEUROPSYCH, V24, P659, DOI 10.1093/arclin/acp071; Lorenz J, 1998, NEUROREPORT, V9, P187, DOI 10.1097/00001756-199801260-00003; Lu PH, 2002, CLIN NEUROPSYCHOL, V16, P90, DOI 10.1076/clin.16.1.90.8328; MacAllister WS, 2009, CHILD NEUROPSYCHOL, V15, P521, DOI 10.1080/09297040902748226; Maercker A, 1998, DIAGNOSTICA, V44, P130; McCann J.T., 1998, MALINGERING DECEPTIO; McDermott BE, 2007, PSYCHIAT CLIN N AM, V30, P645, DOI 10.1016/j.psc.2007.07.007; McKinzey RK, 2003, BRIT J CLIN PSYCHOL, V42, P95, DOI 10.1348/014466503762842048; MCNABB AW, 1988, J NEUROL NEUROSUR PS, V51, P218, DOI 10.1136/jnnp.51.2.218; MEINS W, 2010, MED SACH, V106, P153; MERCKELBACH H, J CLIN EXP IN PRESS; MERCKELBACH H, 2007, PRAXIS RECHTSPSYCHOL, V17, P29; MERCKELBACH H, 2009, 1 EUR S SYMPT VAL AS; Merckelbach Harald, 2007, OFFENDERS MEMORIES V, P165, DOI DOI 10.1002/9780470713082.CH7; Merten T, 2008, AKTUEL NEUROL, V35, P8, DOI 10.1055/s-2007-986232; Merten T, 2007, NERVENARZT, V78, P511, DOI 10.1007/s00115-006-2101-3; Merten T, 2007, AKTUEL NEUROL, V34, P134, DOI 10.1055/s-2006-951966; Merten T, 2005, ARCH CLIN NEUROPSYCH, V20, P719, DOI 10.1016/j.acn.2005.04.004; Merten T, 2010, Versicherungsmedizin, V62, P126; Merten T, 2010, ORTHOPADE, V39, P329, DOI 10.1007/s00132-009-1550-3; Merten T, 2001, Z KLIN PSYCH PSYCHIA, V49, P417; Merten T, 2002, FORTSCHR NEUROL PSYC, V70, P126, DOI 10.1055/s-2002-20531; Merten T., 2007, PRAXIS RECHTSPSYCHOL, V17, P140; MERTEN T, 2009, DIAGNOSTIK BESCHWERD; MERTEN T, 2006, FORUM MED BEGUTACHTU, V2, P11; MERTEN T, 2009, MED SACH, V105, P228; MERTEN T, 2006, MED SACH, V102, P58; Merten T., 2010, GERMAN J PSYCHIAT, V13, P140; MERTEN T, 2004, Z NEUROPSYCHOL, V15, P81; Merten Th, 2004, Versicherungsmedizin, V56, P67; Merten Th, 2006, Versicherungsmedizin, V58, P19; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Merten T, 2009, PSYCHOL INJ LAW, V2, P284, DOI 10.1007/s12207-009-9057-0; Meyers J., 1995, REY COMPLEX FIGURE T; Meyers JE, 2002, ARCH CLIN NEUROPSYCH, V17, P157, DOI 10.1016/S0887-6177(00)00107-4; Miller, 2001, MILLER FORENSIC ASSE; Miller L, 2001, NEUROREHABILITATION, V16, P109; MILLER LS, 2006, J INT NEUROPSYCH SOC, V12, P159; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; MITTENBERG W, 2002, J FORENSIC NEUROPSYC, V3, P227, DOI DOI 10.1300/J151V03N01_03; Morel KR, 2008, J ANXIETY DISORD, V22, P1542, DOI 10.1016/j.janxdis.2008.03.008; Morel KR, 2008, CLIN NEUROPSYCHOL, V22, P350, DOI 10.1080/13854040701300531; Morel KR, 2009, ARCH CLIN NEUROPSYCH, V24, P635, DOI 10.1093/arclin/acp062; Morel KR, 1998, MANUAL MOREL EMOTION; Morgan J. E., 2009, NEUROPSYCHOLOGY MALI; MULLERFRANK C, 2006, BUZAKTUELL, V1, P21; Nagle AM, 2006, ARCH CLIN NEUROPSYCH, V21, P777, DOI 10.1016/j.acn.2006.06.011; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P132, DOI 10.1080/13803390902858874; OSTENDORF GM, 2010, VERSMED, V62, P45; PANKRATZ L, 1983, PERCEPT MOTOR SKILL, V57, P367, DOI 10.2466/pms.1983.57.2.367; PANKRATZ L, 1988, Z KLIN PSYCHOL PSYCH, V36, P130; Peebles R, 2005, CLIN PEDIATR, V44, P237, DOI 10.1177/000992280504400307; Powell MR, 2004, ARCH CLIN NEUROPSYCH, V19, P693, DOI 10.1016/j.acn.2004.04.001; Quinn CA, 2003, ARCH CLIN NEUROPSYCH, V18, P379, DOI 10.1016/S0887-6177(02)00150-6; Reinhard MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P533, DOI 10.1016/j.acn.2007.03.006; Rey A., 1958, LEXAMEN CLINIQUE PSY; Richman J, 2006, J OCCUP ENVIRON MED, V48, P303, DOI 10.1097/01.jom.0000183482.41957.c3; Rienstra A, 2010, ARCH CLIN NEUROPSYCH, V25, P371, DOI 10.1093/arclin/acq035; Rogers R, 2004, CHILD ABUSE NEGLECT, V28, P225, DOI 10.1016/j.chiabu.2003.08.004; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; Rogers R., 2008, CLIN ASSESSMENT MALI; Rosen G. M., 2004, POSTTRAUMATIC STRESS, P85, DOI 10.1002/9780470713570.ch5.; RUBENZER S, 2005, FOR DEFENSE, V4, P4; RUBENZER S, 2006, FEDERATION DEFENSE C, V56, P499; Rubenzer S, 2009, PSYCHOL INJ LAW, V2, P114, DOI 10.1007/s12207-009-9045-4; Ruchsow M, 2010, NERVENARZT, V81, P1085, DOI 10.1007/s00115-009-2921-z; Russeler J, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-37; Ruiz MA, 2002, PROF PSYCHOL-RES PR, V33, P294, DOI 10.1037//0735-7028.33.3.294; Salekin KL, 2009, APPL NEUROPSYCHOL, V16, P105, DOI 10.1080/09084280902864485; Samuel R. Z., 2005, PRIMARY PSYCHIAT, V12, P60; Schmand B, 1998, J NEUROL NEUROSUR PS, V64, P339, DOI 10.1136/jnnp.64.3.339; Schmidt-Atzert L, 2004, DIAGNOSTICA, V50, P124, DOI 10.1026/0012-1924.50.3.124; Schmidt-Atzert L, 1998, DIAGNOSTICA, V44, P142; Schroeder RW, 2010, CLIN NEUROPSYCHOL, V24, P326, DOI 10.1080/13854040903369441; Shandera AL, 2010, PSYCHOL ASSESSMENT, V22, P50, DOI 10.1037/a0016585; SINGH J, 2007, GER J PSYCHIAT, V10, P126; Singhal A, 2009, ARCH CLIN NEUROPSYCH, V24, P721, DOI 10.1093/arclin/acp074; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Spence SA, 2000, LANCET, V355, P1243, DOI 10.1016/S0140-6736(00)02096-1; Spitzer C, 2005, FRAGEBOGEN DISSOZIAT; Spreen O., 1998, COMPENDIUM NEUROPSYC; Steffan JS, 2003, ASSESSMENT, V10, P382, DOI 10.1177/1073191103259548; STETTLER TJ, 2009, THESIS PACIFIC U HIL; STEVENS A, 2009, MED SACH, V105, P100; STEVENS A, 2006, MED SACH, V102, P139; Stevens A, 2008, PSYCHIAT RES, V157, P191, DOI 10.1016/j.psychres.2007.01.003; Strauss E, 2002, ARCH CLIN NEUROPSYCH, V17, P423, DOI 10.1016/S0887-6177(01)00126-3; Strauss E, 1999, CLIN NEUROPSYCHOL, V13, P420, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT420; Streppel M, 2007, HNO, V55 Suppl 1, pE7, DOI 10.1007/s00106-006-1433-4; Streppel M, 2010, HNO, V58, P126, DOI 10.1007/s00106-009-2064-3; Stulemeijer M, 2007, BRAIN INJURY, V21, P309, DOI 10.1080/02699050701209980; SUHR JA, 2007, ASSESSMENT MALINGERE, P287; Sullivan BK, 2007, APPL NEUROPSYCHOL, V14, P189, DOI 10.1080/09084280701509083; Svitak M, 2007, Versicherungsmedizin, V59, P170; SWEET JJ, 1999, FORENSIC NEUROPSYCHO; THOMANN KD, 2009, HDB ORTHOPADISCH UNF; Tombaugh TN, 1996, TEST MEMORY MALINGER; Turner M, 1997, BRIT J PSYCHIAT, V171, P409, DOI 10.1192/bjp.171.5.409; TYDECKS S, 2006, INT J FORENSIC PSYCH, V1, P29; VAGNINI VL, 2008, J CLIN EXP NEUROPSYC, V26, P1; van Hooff JC, 2008, AM J BIOETHICS, V8, P25, DOI 10.1080/15265160701828501; van Hooff JC, 2009, INT J PSYCHOPHYSIOL, V73, P246, DOI 10.1016/j.ijpsycho.2009.04.002; Verschuere B, 2008, PSYCHOL CRIME LAW, V14, P523, DOI 10.1080/10683160801955183; Walters GD, 2009, J CLIN EXP NEUROPSYC, V31, P584, DOI 10.1080/13803390802363728; WIDDER B, BEGUTACHTUN IN PRESS; WIDDER B, 2010, MED SACH, V106, P34; WILBOURN AJ, 1995, NEUROL CLIN, V13, P385; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Wurzer W, 1992, POSTTRAUMATISCHE ORG; Ylioja SG, 2009, ARCH CLIN NEUROPSYCH, V24, P729, DOI 10.1093/arclin/acp078; ZIBERI M, 2009, 1 EUR S SYMPT VAL AS	255	12	12	0	11	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0720-4299	1439-3522		FORTSCHR NEUROL PSYC	Forschritte Neurol. Psychiatr.	FEB	2011	79	2					102	116		10.1055/s-0029-1245731			15	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	724HB	WOS:000287565600007	21117012				2021-06-18	
J	Anderson, JW; Schmitter-Edgecombe, M				Anderson, Jonathan W.; Schmitter-Edgecombe, Maureen			Recovery of Time Estimation Following Moderate to Severe Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						time estimation; temporal perception; temporal cognition; traumatic brain injury; closed head injury	CLOSED-HEAD-INJURY; SUBJECTIVE TIME; POSTTRAUMATIC AMNESIA; DURATION JUDGMENTS; BODY-TEMPERATURE; WORKING-MEMORY; INTERNAL CLOCK; REPRODUCTION; ORIENTATION; ATTENTION	Objective: Accurate time estimation abilities are thought to play an important role in efficient performance of many daily activities. This study investigated the role of episodic memory in the recovery of time estimation abilities following moderate to severe traumatic brain injury (TBI). Method: Using a prospective verbal time estimation paradigm, TBI participants were tested in the early phase of recovery from TBI and then again approximately one year later. Verbal time estimations were made for filled intervals both within (i.e., 10 s, 25 s) and beyond (i.e., 45 s 60 s) the time frame of working memory. Results: At baseline, when compared to controls, the TBI group significantly underestimated time durations at the 25 s, 45 s and 60 s intervals, indicating that the TBI group perceived less time as having passed than actually had passed. At follow-up, despite the presence of continued episodic memory impairment and little recovery in episodic memory performance, the TBI group exhibited estimates of time passage that were similar to controls. Conclusion: The pattern of data was interpreted at suggesting that episodic memory performance did not play a noteworthy role in the recovery of temporal perception in TB! participants.	[Anderson, Jonathan W.] Eastern Washington Univ, Dept Psychol, Cheney, WA 99004 USA; [Schmitter-Edgecombe, Maureen] Washington State Univ, Dept Psychol, Pullman, WA 99164 USA	Anderson, JW (corresponding author), Eastern Washington Univ, Dept Psychol, Cheney, WA 99004 USA.	janderson@ewu.edu			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS47690]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047690] Funding Source: NIH RePORTER	This study was partially supported by Grant R01 NS47690 from NINDS. We thank Randi McDonald, Shital Pavawalla, Jennifer McWilliams, Michelle Nuegen, Matthew Wright, and Ellen Woo for their support in coordinating data collection. We would also like to thank the TBI participants and the members of the Head Injury Research Team for their help in collecting and scoring the data.	Anderson JW, 2009, J CLIN EXP NEUROPSYC, V31, P425, DOI 10.1080/13803390802232667; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Baudouin A, 2006, ACTA PSYCHOL, V121, P285, DOI 10.1016/j.actpsy.2005.07.004; Benton A., 1994, MULTILINGUAL APHASIA; Block, 1996, TIME INTERNAL CLOCKS, V115, P143, DOI DOI 10.1016/S0166-4115(96)80057-4; Block R. A., 1990, COGNITIVE MODELS PSY, P1; Block R.A., 1990, COGNITIVE MODELS PSY, P59; Block RA, 1997, PSYCHON B REV, V4, P184, DOI 10.3758/BF03209393; Block RA, 1998, PSYCHOL AGING, V13, P584, DOI 10.1037/0882-7974.13.4.584; Brown SW, 1997, PERCEPT PSYCHOPHYS, V59, P1118, DOI 10.3758/BF03205526; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; BURNSIDE W, 1971, PERCEPT PSYCHOPHYS, V9, P404, DOI 10.3758/BF03210238; CAHOON RL, 1969, PERCEPT MOTOR SKILL, V28, P259, DOI 10.2466/pms.1969.28.1.259; *CEDR CORP, 1999, SUPERLAB PROB VERS E; Chaston A, 2004, BRAIN COGNITION, V55, P286, DOI 10.1016/j.bandc.2004.02.013; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Craik FIM, 1999, PERCEPT PSYCHOPHYS, V61, P549, DOI 10.3758/BF03211972; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Doob L. W., 1971, PATTERNING TIME; Eagleman DM, 2005, J NEUROSCI, V25, P10369, DOI 10.1523/JNEUROSCI.3487-05.2005; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Fraisse P., 1963, PSYCHOL TIME; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; HANCOCK PA, 1993, J GEN PSYCHOL, V120, P197, DOI 10.1080/00221309.1993.9711144; HICKS RE, 1976, AM J PSYCHOL, V89, P719, DOI 10.2307/1421469; HICKS RE, 1992, NATO ADV SCI INST SE, V66, P97; KIELHOFNER G, 1977, AM J OCCUP THER, V31, P235; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Kinsbourne M., 2000, NEUROBEHAV LANGUAGE, P315; Kinsbourne M, 1990, NEUROPSYCHOLOGICAL I, P319, DOI DOI 10.1017/CBO9780511665547.017; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LICHT D, 1985, INT J AGING HUM DEV, V21, P211, DOI 10.2190/RBYL-67QW-YJN0-ELBQ; Majdan A, 1996, J CLIN EXP NEUROPSYC, V18, P416, DOI 10.1080/01688639608408998; MARUM KD, 1972, PERCEPT MOTOR SKILL, V34, P244, DOI 10.2466/pms.1972.34.1.244; Matell MS, 2000, BIOESSAYS, V22, P94, DOI 10.1002/(SICI)1521-1878(200001)22:1<94::AID-BIES14>3.0.CO;2-E; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Meck WH, 2002, BRAIN COGNITION, V48, P195, DOI 10.1006/brcg.2001.1313; MEYERS CA, 1992, NEUROPSY NEUROPSY BE, V5, P28; Mimura M, 2000, J INT NEUROPSYCH SOC, V6, P517, DOI 10.1017/S1355617700655017; Myers JL., 2003, RES DESIGN STAT ANAL; NICHELLI P, 1993, COGNITIVE BRAIN RES, V1, P87, DOI 10.1016/0926-6410(93)90014-V; Ornstein R. E., 1969, EXPERIENCE TIME; Perbal S, 2003, NEUROPSYCHOLOGIA, V41, P1599, DOI 10.1016/S0028-3932(03)00110-6; Perbal S, 2000, NEUROCASE, V6, P347, DOI 10.1080/13554790008402782; POLYUKHOV AM, 1989, Z GERONTOL, V22, P79; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; RAO SM, 1984, ARCH NEUROL-CHICAGO, V41, P625, DOI 10.1001/archneur.1984.04210080033010; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; RICHARDS W, 1973, ACTA PSYCHOL, V37, P279, DOI 10.1016/0001-6918(73)90020-6; Rueda AD, 2009, NEUROPSYCHOLOGY, V23, P178, DOI 10.1037/a0014289; SCHMITTEREDGECO.M, 2008, J CLIN EXPT NEUROPSY, V30, P1; SHAW C, 1994, NEUROPSYCHOLOGIA, V32, P857, DOI 10.1016/0028-3932(94)90023-X; Smith A., 1991, SYMBOL DIGIT MODALIT; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Tabachnick BG, 2001, COMPUTER ASSISTED RE; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Ulbrich P, 2007, ACTA PSYCHOL, V125, P51, DOI 10.1016/j.actpsy.2006.06.004; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; WEARDEN JH, 1995, Q J EXP PSYCHOL-B, V48, P129; Wearden JH, 2003, TIME AND MIND II: INFORMATION PROCESSING PERSPECTIVES, P21; Wechsler D, 1997, WAIS 3 ADM SCORING M; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WILLIAMS JM, 1989, J CLIN EXP NEUROPSYC, V11, P713, DOI 10.1080/01688638908400927; Zakay D, 1997, CURR DIR PSYCHOL SCI, V6, P12, DOI 10.1111/1467-8721.ep11512604; Zakay D, 1999, ATTENTION PERFORM, V17, P557	68	12	12	0	4	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JAN	2011	25	1					36	44		10.1037/a0020333			9	Psychology, Clinical; Neurosciences; Psychology	Psychology; Neurosciences & Neurology	711AQ	WOS:000286558500004	20919767	Green Accepted			2021-06-18	
J	Barbe, MF; Ruggieri, MR				Barbe, Mary F.; Ruggieri, Michael R., Sr.			Innervation of Parasympathetic Postganglionic Neurons and Bladder Detrusor Muscle Directly After Sacral Root Transection and Repair Using Nerve Transfer	NEUROUROLOGY AND URODYNAMICS			English	Article						carbocyanines; denervation; nerve regrowth; urinary bladder	SPINAL-CORD-INJURY; URINARY-BLADDER; FUNCTIONAL REINNERVATION; CANINE BLADDER; REFLEX PATHWAY; RATS; RECONSTRUCTION; REGENERATION; ORGANIZATION; MICTURITION	Aims: This is a continuation of studies examining the effectiveness of root repairs and nerve transfers for bladder reinnervation. Our previous retrograde fluorogold tracing studies from the bladder to the spinal cord found regrowth of axons from the spinal cord through the nerve repair site to the bladder which was confirmed electrophysiologically [Ruggieri et al. J Neurotrauma 25: 214-24, 2006]. The current study determines whether the pattern of axonal regrowth from the repaired nerves or roots to the bladder is different between the surgical reanastomosis methods. Methods: The canine bladder was denervated by transection of all nerve roots from the sacral spinal cord mediating bladder contraction. Reinnervation surgeries included end-on-end repair of transected sacral ventral roots, transfer of coccygeal to sacral ventral roots (CGNT), or transfer of genitofemoral to pelvic nerves (GFNT). Results: Postmortem dialkylcarbocyanine dye tracing with Neurotrace DiI from the distal pelvic nerve to the bladder wall, combined with PGP9.5 neuronal immunohistochemistry, demonstrated innervation by DiI-labeled axons of only parasympathetic postganglionic intramural ganglia in normal controls and sham operated controls, but reinnervation of both intramural ganglia and detrusor muscle directly after repair of sacral ventral roots. GF NT and CG NT also resulted in reinnervation of both intramural ganglia and detrusor muscle, although to a lesser extent than repaired roots. Conclusions: Bladder reinnervation with either the same nerve (orthotopic reinnervation) or with either a primarily somatic nerve (coccygeal) or a primarily sensory nerve (genitofemoral) results in reinnervation of both intramural ganglia as well as direct innervation of detrusor muscle. Neurourol. Urodynam. 30:599-605, 2011. (C) 2011 Wiley-Liss, Inc.	[Ruggieri, Michael R., Sr.] Temple Univ, Sch Med, Dept Urol, Philadelphia, PA 19140 USA; [Barbe, Mary F.] Temple Univ, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA; [Ruggieri, Michael R., Sr.] Temple Univ, Dept Pharmacol, Philadelphia, PA 19140 USA; [Ruggieri, Michael R., Sr.] Temple Univ, Dept Comp & Elect Engn, Philadelphia, PA 19140 USA	Ruggieri, MR (corresponding author), Temple Univ, Sch Med, Dept Urol, 3400 N Broad St,715 OMS, Philadelphia, PA 19140 USA.	rugg@temple.edu	Ruggieri, Michael/C-6262-2011	Ruggieri, Michael/0000-0003-3052-3630; Barbe, Mary/0000-0002-5235-9803	Pfizer corporationPfizer; Shriners Hospitals; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS070267]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS070267] Funding Source: NIH RePORTER	MRR is principal investigator of a competitive research grant from the Pfizer corporation designed to determine the role of muscarinic receptor internalization in the sensitivity of the human bladder to cholinergic stimulation.; Grant sponsor: Shriners Hospitals; Grant sponsor: National Institutes of Health; Grant Numbers: R01NS070267.	Bradley W E, 1974, Urol Clin North Am, V1, P3; BROOKES SJH, 1991, NEUROSCIENCE, V42, P863, DOI 10.1016/0306-4522(91)90050-X; CONZEN MA, 1982, UROL RES, V10, P141; DEGROAT WC, 1981, J AUTONOM NERV SYST, V3, P135, DOI 10.1016/0165-1838(81)90059-X; DIXON JS, 1987, J ANAT, V151, P199; Gabella G, 1998, J NEUROCYTOL, V27, P141, DOI 10.1023/A:1006903507321; Hou CL, 2000, CHINESE J REPARATIVE, V14, P10; KOKOTAS NS, 1978, INVEST UROL, V16, P179; Lin HD, 2009, J NEUROSURG-SPINE, V10, P452, DOI 10.3171/2009.1.SPINE08540; Livshits A, 2004, SPINAL CORD, V42, P211, DOI 10.1038/sj.sc.3101574; Malessy MJA, 1998, J NEUROSURG, V89, P568, DOI 10.3171/jns.1998.89.4.0568; PETRAS JM, 1978, BRAIN RES, V153, P363, DOI 10.1016/0006-8993(78)90416-X; Ruggieri MR, 2008, J NEUROTRAUM, V25, P214, DOI 10.1089/neu.2007.0328; Ruggieri MR, 2008, J NEUROTRAUM, V25, P401, DOI 10.1089/neu.2007.0335; Ruggieri MR, 2006, J NEUROTRAUM, V23, P1125, DOI 10.1089/neu.2006.23.1125; Shefchyk SJ, 2002, PROG BRAIN RES, V137, P71; SUNDIN T, 1972, SCAND J UROL NEPHROL, V6, P176, DOI 10.3109/00365597209133634; Tsai EC, 2001, J HISTOCHEM CYTOCHEM, V49, P1111, DOI 10.1177/002215540104900905; WATANABE H, 1979, J ANAT, V128, P873; Xiao CG, 2005, J UROLOGY, V173, P2112, DOI 10.1097/01.ju.0000158072.31086.af; XIAO CG, 1994, PARAPLEGIA, V32, P300, DOI 10.1038/sc.1994.52; Xiao CG, 1999, J UROLOGY, V162, P936, DOI 10.1097/00005392-199909010-00094; Zhang CG, 2006, J PLAST RECONSTR AES, V59, P717, DOI 10.1016/j.bjps.2005.10.023; Zhang CG, 2004, MICROSURG, V24, P232, DOI 10.1002/micr.20015	24	12	13	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0733-2467			NEUROUROL URODYNAM	Neurourol. Urodyn.		2011	30	4					599	605		10.1002/nau.21042			7	Urology & Nephrology	Urology & Nephrology	749BM	WOS:000289437100023	21254198	Green Accepted			2021-06-18	
J	Krueger, CE; Rosen, HJ; Taylor, HG; Espy, KA; Schatz, J; Rey-Casserly, C; Kramer, JH				Krueger, Casey E.; Rosen, Howard J.; Taylor, H. Gerry; Espy, Kimberly A.; Schatz, Jeffrey; Rey-Casserly, Celiane; Kramer, Joel H.			Know Thyself: Real-World Behavioral Correlates of Self-Appraisal Accuracy	CLINICAL NEUROPSYCHOLOGIST			English	Article						Self-assessment; Self-concept; Awareness; Child behavior; Executive Function; Metacognition	TRAUMATIC BRAIN-INJURY; MEDIAL PREFRONTAL CORTEX; POSITIVE ILLUSORY BIAS; SICKLE-CELL-DISEASE; LOW-BIRTH-WEIGHT; EXECUTIVE FUNCTION; METACOGNITIVE EXPERIENCES; RATING INVENTORY; ACHIEVEMENT GAP; FRONTAL-CORTEX	Accurate appraisal of one's own abilities is one metacognitive skill considered to be an important factor affecting learning and behavior in childhood. The present study measured self-appraisal accuracy in children using tasks of executive function, and investigated relations between self-appraisal and informant ratings of real-world behaviors measured by the BRIEF. We examined self-appraisal accuracy on fluency tasks in 91 children ages 10-17. More accurate self-appraisal was correlated with fewer informant ratings of real-world behavior problems in inhibition and shifting, independent of actual performance. Findings suggest that self-appraisal represents cognitive processes that are at least partially independent of other functions putatively dependent on the frontal lobes, and these self-appraisal-specific processes have unique implications for optimal daily function.	[Krueger, Casey E.; Rosen, Howard J.; Kramer, Joel H.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Krueger, Casey E.] Baylor Hlth Care Syst, Frisco, TX USA; [Taylor, H. Gerry] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; [Espy, Kimberly A.] Univ Nebraska Lincoln, Res Off, Lincoln, NE USA; [Schatz, Jeffrey] Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA; [Rey-Casserly, Celiane] Harvard Univ, Sch Med, Dept Psychiat, Childrens Hosp Boston, Boston, MA 02115 USA	Krueger, CE (corresponding author), 7010 Preston Rd,Suite 240, Frisco, TX 75034 USA.	Casey.Krueger@BaylorHealth.edu			National Institute on Aging (NIA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [1 RO1-AG022983-01]; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [HHSN-271200623661C]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG022983, R01AG030688] Funding Source: NIH RePORTER	This work was supported by the National Institute on Aging (NIA) [grant number 1 RO1-AG022983-01 to J.K.] and National Institute of Neurological Disorders and Stroke (NINDS) [grant number HHSN-271200623661C to J.K.]. The authors report no conflicts of interest.	Al-Kandari FA, 2007, ANN NUCL MED, V21, P439, DOI 10.1007/s12149-007-0050-y; Anderson PJ, 2004, PEDIATRICS, V114, P50, DOI 10.1542/peds.114.1.50; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Barell J, 1992, MINDS MATTER FOREWOR, V1; Berkelhammer LD, 2007, CHILD NEUROPSYCHOL, V13, P120, DOI 10.1080/09297040600800956; Cohen GL, 2006, SCIENCE, V313, P1307, DOI 10.1126/science.1128317; College Board, 1976, STUD DESCR QUEST; Delis DC, 2001, DELISKAPLAN EXECUTIV; Dennis M., 1996, DEV NEUROPSYCHOL, V12, P17; Dermitzaki I, 2005, PSYCHOL REP, V97, P759, DOI 10.2466/PR0.97.7.759-768; Efklides A, 2009, PSICOTHEMA, V21, P76; Eslinger PJ, 2005, J NEUROL NEUROSUR PS, V76, P1630, DOI 10.1136/jnnp.2004.053157; Evangelista NM, 2008, J ABNORM CHILD PSYCH, V36, P779, DOI 10.1007/s10802-007-9210-8; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; FELSON RB, 1981, SOC PSYCHOL QUART, V44, P64, DOI 10.2307/3033866; Fernandez-Duque D, 2000, CONSCIOUS COGN, V9, P288, DOI 10.1006/ccog.2000.0447; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Godefroy O., 2008, REV NEUROL-FRANCE, V164, P119; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kim J, 2005, J INT NEUROPSYCH SOC, V11, P434, DOI 10.1017/S1355617705050563; Kircher TTJ, 2007, PSYCHOPATHOLOGY, V40, P254, DOI 10.1159/000101730; Koriat A., 2002, METACOGNITION PROCES; Krebs SS, 2010, BRIT J EDUC PSYCHOL, V80, P325, DOI 10.1348/000709910X485719; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; LARWOOD L, 1977, J APPL PSYCHOL, V62, P194, DOI 10.1037/0021-9010.62.2.194; Lawrence Vivienne, 2004, J Atten Disord, V7, P137, DOI 10.1177/108705470400700302; Luciana M, 1998, NEUROPSYCHOLOGIA, V36, P273, DOI 10.1016/S0028-3932(97)00109-7; Mahone EM, 2007, CLIN NEUROPSYCHOL, V21, P569, DOI 10.1080/13854040600762724; Major B, 2005, ANNU REV PSYCHOL, V56, P393, DOI 10.1146/annurev.psych.56.091103.070137; McAuley T, 2010, J INT NEUROPSYCH SOC, V16, P495, DOI 10.1017/S1355617710000093; Miyake A, 2010, SCIENCE, V330, P1234, DOI 10.1126/science.1195996; Owens JS, 2003, J CONSULT CLIN PSYCH, V71, P680, DOI 10.1037/0022-006X.71.4.680; Pannu JK, 2005, NEUROPSYCHOL REV, V15, P105, DOI 10.1007/s11065-005-7091-6; Pickup GJ, 2008, PSYCHOPATHOLOGY, V41, P206, DOI 10.1159/000125554; REEVE RA, 1985, J ABNORM CHILD PSYCH, V13, P343, DOI 10.1007/BF00912721; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Roebers CM, 2007, J EXP CHILD PSYCHOL, V97, P117, DOI 10.1016/j.jecp.2006.12.006; Rosen HJ, 2010, NEUROIMAGE, V49, P3358, DOI 10.1016/j.neuroimage.2009.11.041; Schmitz TW, 2007, NEUROSCI BIOBEHAV R, V31, P585, DOI 10.1016/j.neubiorev.2006.12.003; Schneider W, 2000, COGNITIVE DEV, V15, P115, DOI 10.1016/S0885-2014(00)00024-1; Schnyer DM, 2004, NEUROPSYCHOLOGIA, V42, P957, DOI 10.1016/j.neuropsychologia.2003.11.020; Semrud-Clikeman M, 2010, J AUTISM DEV DISORD, V40, P1017, DOI 10.1007/s10803-010-0951-9; Shimamura AP, 2000, CONSCIOUS COGN, V9, P313, DOI 10.1006/ccog.2000.0450; SIDAK Z, 1967, J AM STAT ASSOC, V62, P623; Skranes J, 2009, NEUROREPORT, V20, P263, DOI 10.1097/WNR.0b013e32832027fe; Webb SJ, 2001, DEV NEUROPSYCHOL, V19, P147, DOI 10.1207/S15326942DN1902_2; Williamson C, 2010, J NEUROL NEUROSUR PS, V81, P140, DOI 10.1136/jnnp.2008.166041	49	12	13	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2011	25	5					741	756		10.1080/13854046.2011.569759			16	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	882JE	WOS:000299559000004	21547852	Green Accepted			2021-06-18	
J	Lah, S; Epps, A; Levick, W; Parry, L				Lah, Suncica; Epps, Adrienne; Levick, Wayne; Parry, Louise			Implicit and explicit memory outcome in children who have sustained severe traumatic brain injury: Impact of age at injury (preliminary findings)	BRAIN INJURY			English	Article						Traumatic brain injury; children; memory	CHILDHOOD HEAD-INJURY; DEVELOPMENTAL-CHANGES; COGNITIVE-DEVELOPMENT; VISUAL COMPLEXITY; NAME AGREEMENT; RECOVERY; PLASTICITY; FAMILIARITY; PICTURES; LANGUAGE	Primary objective: To examine implicit and explicit memory outcome in children who had sustained severe traumatic brain injury (TBI) through childhood. Opposite patterns of impairments were expected: (i) impaired implicit memory in children with early TBI (TBI-EC, <6 years) and (ii) impaired explicit memory in children with late TBI (TBI-LC, >= 6 years). Research design: Children who had sustained severe TBI more then 1 year ago were assessed. Methods and procedure: Fourteen children who had sustained severe TBI (TBI-EC, n=10 and TBI-LC, n=4) between 8 months and 13 years 7 months of age and 13 non-injured control subjects (NC) participated. Implicit (repetition priming and skill learning) and explicit verbal memory were examined. Results: The TBI group performed worse on implicit (repetition priming) and explicit memory tasks compared to the NC group. Moreover, impairments were found in implicit and explicit memory in the TBI-EC, but not in the TBI-LC group. Conclusions: This study has shown, for the first time, that severe childhood TBI may compromise not only explicit, but also implicit memory. Nevertheless, instead of a selective implicit memory impairment, it was found that children who sustained injuries in early childhood present with impairments in both memory systems.	[Lah, Suncica] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Epps, Adrienne; Parry, Louise] Sydney Childrens Hosp Randwick, Sydney, NSW, Australia; [Levick, Wayne] John Hunter Childrens Hosp, Newcastle, NSW, Australia; [Levick, Wayne] Univ Newcastle, Newcastle, NSW 2308, Australia	Lah, S (corresponding author), Univ Sydney, Sch Psychol, Mungo Mac Callum Bldg, Sydney, NSW 2006, Australia.	sunnyl@psych.usyd.edu.au		Lah, Suncica/0000-0003-2282-4812	University of SydneyUniversity of Sydney	This research was supported by the research grant awarded to the first author by The University of Sydney. We wish to thank Drs Lisa Azizi and Ilana Hapner for assistance with recruitment and data collection.	Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V A, 1996, Appl Neuropsychol, V3, P128, DOI 10.1207/s15324826an0303&4_5; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson V, 2007, BRAIN INJURY, V21, P1399, DOI 10.1080/02699050701785070; Ballantyne AO, 2008, BRAIN, V131, P2975, DOI 10.1093/brain/awn176; BERMAN S, 1989, BEHAV RES METH INSTR, V21, P371, DOI 10.3758/BF03202800; Billingsley RL, 2002, J EXP CHILD PSYCHOL, V82, P251, DOI 10.1016/S0022-0965(02)00007-3; Brown TT, 2005, CEREB CORTEX, V15, P275, DOI 10.1093/cercor/bhh129; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Catroppa C, 2007, CHILD NEUROPSYCHOL, V13, P240, DOI 10.1080/09297040600837362; Cycowicz YM, 2000, MEMORY, V8, P19, DOI 10.1080/096582100387687; Delis D, 1994, CALIFORNIA VERBAL LE; DeMarie D, 2003, J EXP CHILD PSYCHOL, V84, P167, DOI 10.1016/S0022-0965(03)00004-3; Dennis M., 1988, CLIN NEUROPSYCHOLOGY, P85; DIGIULIO DV, 1994, BRAIN COGNITION, V25, P79, DOI 10.1006/brcg.1994.1024; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; DIRKS J, 1977, J EXP CHILD PSYCHOL, V23, P315, DOI 10.1016/0022-0965(77)90108-4; DONDERS J, 1993, BRAIN INJURY, V7, P431, DOI 10.3109/02699059309029686; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; Dumont R., 2004, ASSESSMENT CHILDRE S; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; GABRIELI JDE, 1995, PSYCHOL SCI, V6, P76, DOI 10.1111/j.1467-9280.1995.tb00310.x; Gleissner U, 2005, BRAIN, V128, P2822, DOI 10.1093/brain/awh597; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; GREENBAUM JL, 1989, B PSYCHONOMIC SOC, V27, P417; HEBB DO, 1947, AM PSYCHOL, V2, P737; HEINDEL WC, 1989, J NEUROSCI, V9, P582; HEYWOOD C, 1987, LANGUAGE DEV DISORDE, P146; HUTTENLOCHER PR, 1997, DEV PREFRONTAL CORTE, P69; Jacobs R, 2007, CORTEX, V43, P792, DOI 10.1016/S0010-9452(08)70507-0; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; Kennard MA, 1936, AM J PHYSIOL, V115, P138; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Kolb B, 2004, BRAIN COGNITION, V55, P104, DOI 10.1016/s0278-2626(03)00278-1; Kolb B., 1995, BRAIN PLASTICITY BEH; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; LORSBACH TC, 1989, CONTEMP EDUC PSYCHOL, V14, P67, DOI 10.1016/0361-476X(89)90006-4; Luciana M, 2003, DEV PSYCHOPATHOL, V15, P1017, DOI 10.1017/S095457940300049X; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; MEYER E, 1952, AMA AM J DIS CHILD, V84, P543, DOI 10.1001/archpedi.1952.02050050017001; Mills DL, 1997, DEV NEUROPSYCHOL, V13, P397, DOI 10.1080/87565649709540685; NEWCOMBE N, 1977, DEV PSYCHOL, V13, P337, DOI 10.1037/0012-1649.13.4.337; Pavlovic J, 2006, NEUROPEDIATRICS, V37, P13, DOI 10.1055/s-2006-923932; Piaget J, 1963, ORIGINS INTELLIGENCE; RUSSO R, 1995, J EXP CHILD PSYCHOL, V59, P566, DOI 10.1006/jecp.1995.1026; SCHACHTER DL, 1984, INFANTS AMNESICS DIS; SCHWARTZ BL, 1991, J EXP PSYCHOL LEARN, V17, P1177, DOI 10.1037/0278-7393.17.6.1177; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P149, DOI 10.1076/jcen.21.2.149.929; SNODGRASS JG, 1987, BEHAV RES METH INSTR, V19, P270, DOI 10.3758/BF03203798; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; SQUIRE LR, 1987, MEMORY BRAIN; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; TEUBER ML, 1975, CIBA F SYMP, V34, P159; THATCHER RW, 1992, BRAIN COGNITION, V20, P24, DOI 10.1016/0278-2626(92)90060-Y; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Ward H, 2002, J CLIN EXP NEUROPSYC, V24, P458, DOI 10.1076/jcen.24.4.458.1032; Wechsler D, 2003, WECHSLER INTELLIGENC, V4; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yeates KO, 2005, NEUROPSYCHOLOGY, V19, P618, DOI 10.1037/0894-4105.19.5.618	68	12	12	0	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2011	25	1					44	52		10.3109/02699052.2010.531693			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	731JI	WOS:000288101700006	21117914				2021-06-18	
J	Laxe, S; Zasler, N; Tschiesner, U; Lopez-Blazquez, R; Tormos, JM; Bernabeu, M				Laxe, Sara; Zasler, Nathan; Tschiesner, Uta; Lopez-Blazquez, Raquel; Tormos, Jose M.; Bernabeu, Montserrat			ICF use to identify common problems on a TBI neurorehabilitation unit in Spain	NEUROREHABILITATION			English	Article						Traumatic brain injury; disability; International Classification of Functioning; Disability and Health (ICF); multi-centre study	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; INTERNATIONAL CLASSIFICATION; HEALTH ICF; CORE SETS; PRACTICAL SCALE; DISABILITY; REHABILITATION; SATISFACTION; MODEL	Objective: To describe functioning and health of individuals with traumatic brain injury (TBI) based on the International Classification of Functioning, Disability and Health (ICF). Methods: A cross-sectional, prospective study was conducted in a neurorehabilitation hospital. Data collection included sociodemographic factors, single interviews based on the extended ICF Checklist 2.1 for TBI, patient ratings on general health and functioning status, WHOQoL, EQ5D and the Comorbidity Questionnaire. Results: 103 patients (81% males) were included in the study. The mean of age was 34 yrs. 24% were inpatients whereas 76% were outpatients. 130 out of 150 categories (87%) of the extended checklist were relevant in > 10% of patients. Differences in functioning and disability between patients in the shorter versus long term situation were noted to be predominantly in the ICF domains of Activities and Participation as well as in Body Functions. Correlations between EQ5D and ICF-based data collections were all p < 0.01. Conclusions: This study identified the most common problems in patients with TBI receiving Neurorehabilitation services based on the ICF. Results emphasize the need to describe disability and rehabilitation standards from a comprehensive perspective that not only includes Body Functions and Structures but also the ICF domains of Activities and Participation and Environmental factors.	[Laxe, Sara] Univ Autonoma Barcelona, Guttmann Inst Hosp Neurorehabil, Brain Injury Unit, Badalona, Spain; [Zasler, Nathan] Concuss Care Ctr Virginia, Richmond, VA USA; [Tschiesner, Uta] Univ Munich, Dept Otorhinolaryngol, Munich, Germany; [Tschiesner, Uta] Univ Munich, ICF Res Branch, Dept Biopsychosocial Hlth, Munich, Germany	Laxe, S (corresponding author), Univ Autonoma Barcelona, Guttmann Inst Hosp Neurorehabil, Brain Injury Unit, Badalona, Spain.	slaxe@guttmann.com		Tormos Munoz, Jose Maria/0000-0002-8764-2289			AIACHINI B, EUR J PHYS REHABIL M, V46, P27; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Bernabeu M, 2009, NEUROREHAB NEURAL RE, V23, P464, DOI 10.1177/1545968308328725; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Boldt C, 2005, DISABIL REHABIL, V27, P375, DOI 10.1080/09638280400013982; Brach M, 2004, J REHABIL MED, V36, P121, DOI 10.1080/16501960410016811; BROWN DSO, 1992, ARCH PHYS MED REHAB, V73, P758; Chiu WT, 2006, J NEUROTRAUM, V23, P1609, DOI 10.1089/neu.2006.23.1609; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2004, J REHABIL MED, V36, P128, DOI 10.1080/16501960410016055; Cieza A, 2004, J REHABIL MED, V36, P94, DOI 10.1080/16501960410016785; Cieza A, 2004, J REHABIL MED, V36, P9, DOI 10.1080/16501960410015353; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/165019702760279189; DEWALL J, JEMS, V35, P54; DEWALL J, JEMS, V35, P63; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Geyh S, 2004, J REHABIL MED, V36, P135, DOI 10.1080/16501960410016776; Grill E, 2005, DISABIL REHABIL, V27, P361, DOI 10.1080/09638280400013974; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Koskinen S, 2007, J REHABIL MED, V39, P467, DOI 10.2340/16501977-0077; Larkins Brigette, 2007, Seminars in Speech and Language, V28, P334, DOI 10.1055/s-2007-986530; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ptyushkin P, 2010, BRAIN INJURY, V24, P1519, DOI 10.3109/02699052.2010.523054; Ruof J, 2001, J REHABIL MED S, V44, P100; Sandberg MA, 2009, CLIN NEUROPSYCHOL, V23, P1416, DOI 10.1080/13854040903369425; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Scarponi F, 2009, DISABIL REHABIL, V31, pS134, DOI 10.3109/09638280903317906; Schwarzkopf SR, 2008, CLIN RHEUMATOL, V27, P1355, DOI 10.1007/s10067-008-0916-y; TEASDALE G, 1974, LANCET, V2, P81; TSCHIESNER U, 2009, HEAD NECK       0701; Tschiesner U, 2009, LARYNGOSCOPE, V119, P915, DOI 10.1002/lary.20211; van Echteld I, 2006, J RHEUMATOL, V33, P2475; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; *WHO, 2001, ICF INT CLASS FUNCT	39	12	13	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2011	29	1					99	110		10.3233/NRE-2011-0683			12	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	814JR	WOS:000294447000013	21876302				2021-06-18	
J	Narevic, E; Giles, GM; Rajadhyax, R; Managuelod, E; Monis, F; Diamond, F				Narevic, Egle; Giles, Gordon M.; Rajadhyax, Rashmi; Managuelod, Eva; Monis, Florencia; Diamond, Franco			The effects of enhanced program review and staff training on the management of aggression among clients in a long-term neurobehavioral rehabilitation program	AGING & MENTAL HEALTH			English	Article						mental disorder; quality assurance; non-aversive approach; support groups; geriatric patients	TRAUMATIC BRAIN-INJURY; PSYCHIATRIC-INPATIENTS; MEDICAL COMORBIDITY; BEHAVIOR; CARE; ASSAULTS; SCHIZOPHRENIA; MORTALITY; INTERVENTION; DISABILITY	Objective: This article examined the effects of staff training, staff support groups, and increased client behavior monitoring on the rate of physical aggression toward peers and objects in an older neurobehavioral population treated in a long-term neurorehabilitation program. Methods: During the 15 months of data collection, programmatic enhancements were introduced including: Staff training and support groups, comprehensive assessment and individualized program development, and client-centered weekly and systemic monthly behavior management review. Incidents of physical aggression were assessed using staff report. Data were corroborated using multiple sources including, medical records, written incident reports, and Overt Aggression Scale-Modified for Neurorehabilitation - Extended (OAS-MNR-E). Results: A total of 267 clients were present in the facility during the reporting period. The clients had neurobehavioral disability of various origins, 73% had a psychiatric diagnosis in addition to one or more medical diagnoses, and 58% had a dementia diagnosis. An already low rate of incidents of physical aggression per client month (0.02) was reduced by 77% following the implementation of programmatic enhancements. Conclusion: Enhanced systematic behavioral review of clients provided concurrently with staff training in non-aversive principles and ongoing staff support groups reduced the incidents of behavioral disregulation in older persons with psychiatric diagnoses, medical comorbidities, and neurobehavioral disabilities.	[Narevic, Egle; Giles, Gordon M.; Rajadhyax, Rashmi; Managuelod, Eva; Monis, Florencia; Diamond, Franco] Idylwood Care Ctr, Sunnyvale, CA USA; [Giles, Gordon M.] Samuel Merritt Univ, Fac Occupat Therapy, Oakland, CA USA	Narevic, E (corresponding author), Idylwood Care Ctr, 1002 W Fremont Ave, Sunnyvale, CA USA.	narevic_e@comcast.net					Ackerman SJ, 2003, CLIN PSYCHOL REV, V23, P1, DOI 10.1016/s0272-7358(02)00146-0; AIKEN GJM, 1984, MED SCI LAW, V24, P199, DOI 10.1177/002580248402400309; Bisconer SW, 2006, J PSYCHIATR MENT HLT, V13, P515, DOI 10.1111/j.1365-2850.2006.00973.x; Bowers L, 1999, J Psychiatr Ment Health Nurs, V6, P199, DOI 10.1046/j.1365-2850.1999.630199.x; BOWERS L, 1999, J MENTAL HLTH, V8, P339; BRAILSFORD DS, 1973, NURSING TIMES S, V69, P9; BROMLEY J, 1995, J INTELL DISABIL RES, V39, P341, DOI 10.1111/j.1365-2788.1995.tb00526.x; Brown S, 2000, BRIT J PSYCHIAT, V177, P212, DOI 10.1192/bjp.177.3.212; Cassidy EL, 2002, AGING MENT HEALTH, V6, P166, DOI 10.1080/13607860220126727; CHOU K, 1996, J GERONTOLOGICAL NUR, V22, P31; Conn L, 1983, ASSAULTS PSYCHIAT FA, P61; Dixon L, 1999, J NERV MENT DIS, V187, P496, DOI 10.1097/00005053-199908000-00006; Druss BG, 2002, MED CARE, V40, P129, DOI 10.1097/00005650-200202000-00007; Edberg AK, 2001, INT J NURS STUD, V38, P271, DOI 10.1016/S0020-7489(00)00076-6; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Feldt K S, 1992, J Gerontol Nurs, V18, P3; FLEMINGER S, 2003, COCHRANE LIB; FOTTRELL E, 1980, BRIT J PSYCHIAT, V136, P216, DOI 10.1192/bjp.136.3.216; Giles GM, 2006, J HEAD TRAUMA REHAB, V21, P168, DOI 10.1097/00001199-200603000-00009; Giles GM, 2005, BRAIN INJURY, V19, P753, DOI 10.1080/02699050500110108; Giles GM, 2007, BRAIN INJURY, V21, P505, DOI 10.1080/02699050701311729; Green CA, 2008, PSYCHIATR REHABIL J, V32, P9, DOI 10.2975/32.1.2008.9.22; HALLER RM, 1988, BRIT J PSYCHIAT, V152, P174, DOI 10.1192/bjp.152.2.174; Heflin L. J., 2001, FOCUS AUTISM OTHER D, V16, P93, DOI DOI 10.1177/108835760101600205; HODGKINSON PE, 1985, MED SCI LAW, V25, P288, DOI 10.1177/002580248502500411; HUSSIAN RA, 1981, GERIATRIC PSYCHOL BE; KELLY G, 2007, BRAIN IMPAIR, V8, P262, DOI DOI 10.1375/BRIM.8.3.262; Kisely S, 2005, BRIT J PSYCHIAT, V187, P552, DOI 10.1192/bjp.187.6.552; Kunik ME, 2000, J GERIATR PSYCH NEUR, V13, P49, DOI 10.1177/089198870001300108; Landreville P, 1998, Int Psychogeriatr, V10, P397, DOI 10.1017/S1041610298005481; LION JR, 1981, HOSP COMMUNITY PSYCH, V32, P487; Lyketsos CG, 2002, PSYCHOSOMATICS, V43, P24, DOI 10.1176/appi.psy.43.1.24; MADDEN DJ, 1976, AM J PSYCHIAT, V133, P422; Moniz-Cook E, 1998, INT J GERIATR PSYCH, V13, P149, DOI 10.1002/(SICI)1099-1166(199803)13:3<149::AID-GPS746>3.0.CO;2-Q; Morgan JC, 2008, GERONTOLOGIST, V48, P71, DOI 10.1093/geront/48.Supplement_1.71; NEWMAN SC, 1991, CAN J PSYCHIAT, V36, P239, DOI 10.1177/070674379103600401; RUBEN I, 1980, J NERV MENT DIS, V168, P243, DOI 10.1097/00005053-198004000-00010; Scully R, 1981, J Nurs Adm, V11, P48, DOI 10.1097/00005110-198103000-00008; TERESI J, 1993, GERONTOLOGIST, V33, P667, DOI 10.1093/geront/33.5.667; Twenge JM, 2001, J PERS SOC PSYCHOL, V81, P1058, DOI 10.1037/0022-3514.81.6.1058; Visser SM, 2008, AGING MENT HEALTH, V12, P47, DOI 10.1080/13607860701366012; Waddington L, 2002, BEHAV COGN PSYCHOTH, V30, P179, DOI 10.1017/S1352465802002059; Whittington R, 1996, BRIT J CLIN PSYCHOL, V35, P11, DOI 10.1111/j.2044-8260.1996.tb01158.x; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005	44	12	12	0	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	1360-7863			AGING MENT HEALTH	Aging Ment. Health		2011	15	1					103	112	PII 927578304	10.1080/13607863.2010.501070			10	Geriatrics & Gerontology; Gerontology; Psychiatry	Geriatrics & Gerontology; Psychiatry	714SH	WOS:000286828800013	20924812				2021-06-18	
J	Perry, JC; Oblak, J; Jung, JH; Cikajlo, I; Veneman, JF; Goljar, N; Bizovicar, N; Matjacic, Z; Keller, T				Perry, Joel C.; Oblak, Jakob; Jung, Je H.; Cikajlo, Imre; Veneman, Jan F.; Goljar, Nika; Bizovicar, Natasa; Matjacic, Zlatko; Keller, Thierry			Variable structure pantograph mechanism with spring suspension system for comprehensive upper-limb haptic movement training	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						arm therapy; haptic device; haptic training; pantograph mechanism; rehabilitation; rehabilitation robotics; series elastic actuation; stroke; stroke therapy; upper limb; wrist therapy	ROBOT; ARM; STROKE	Numerous haptic devices have been developed for upper-limb neurorehabilitation, but their widespread use has been largely impeded because of complexity and cost. Here, we describe a variable structure pantograph mechanism combined with a spring suspension system that produces a versatile rehabilitation robot, called Universal Haptic Pantograph, for movement training of the shoulder, elbow, and wrist. The variable structure is a 5-degree-of-freedom (DOF) mechanism composed of 7 joints, 11 joint axes, and 3 configurable joint locks that reduce the number of system DOFs to between 0 and 3. The resulting device has eight operational modes: Arm, Wrist, ISO (isometric) 1, ISO 2, Reach, Lift 1, Lift 2, and Steer. The combination of available work spaces (reachable areas) shows a high suitability for movement training of most upper-limb activities of daily living. The mechanism, driven by series elastic actuators, performs similarly in all operational modes, with a single control scheme and set of gains. Thus, a single device with minimal setup changes can be used to treat a variety of upper-limb impairments that commonly afflict veterans with stroke, traumatic brain injury, or other direct trauma to the arm. With appropriately selected design parameters, the developed multimode haptic device significantly reduces the costs of robotic hardware for full-arm rehabilitation while performing similarly to that of single-mode haptic devices. We conducted case studies with three patients with stroke who underwent clinical training using the developed mechanism in Arm, Wrist, and/or Reach operational modes. We assessed outcomes using Fugl-Meyer Motor Assessment and Wolf Motor Function Test scores showing that upper-limb ability improved significantly following training sessions.	[Perry, Joel C.; Jung, Je H.; Veneman, Jan F.; Keller, Thierry] Tecnalia Res & Innovat, Hlth & Qual Life Div, E-20009 Donostia San Sebastian, Spain; [Oblak, Jakob; Cikajlo, Imre; Goljar, Nika; Bizovicar, Natasa; Matjacic, Zlatko] Univ Rehabil Inst, Ljubljana, Slovenia	Keller, T (corresponding author), Tecnalia Res & Innovat, Hlth & Qual Life Div, Mikeletegi Pasealekua 1, E-20009 Donostia San Sebastian, Spain.	thierry.keller@tecnalia.com	Veneman, Jan/V-3570-2019; Cikajlo, Imre/A-8951-2012; Keller, Thierry/H-4262-2012; Cikajlo, Imre/AAD-5189-2019	Veneman, Jan/0000-0002-6408-6558; Keller, Thierry/0000-0003-4000-958X; Cikajlo, Imre/0000-0002-8428-7621; Jung, Dr Je Hyung/0000-0002-2525-8337	FIK; Spanish Ministry of Science and InnovationSpanish Government [PID-020100-2009-21]	This material was based on work supported in part by FIK and the Spanish Ministry of Science and Innovation, project PID-020100-2009-21.	Burgar CG, 2000, J REHABIL RES DEV, V37, P663; Che Fai Yeong, 2009, 2009 IEEE International Conference on Rehabilitation Robotics: Reaching Users & the Community (ICORR), P46, DOI 10.1109/ICORR.2009.5209475; Coote S., 2003, P 8 INT C REH ROB, P59; CRAIG JJ, 1989, INTRO ROBOTICS MECH, P277; Ellis MD, 2009, NEUROREHAB NEURAL RE, V23, P862, DOI 10.1177/1545968309332927; Fanin C., 2003, P 8 INT C REH ROB SE, P23; Gupta A, 2006, IEEE-ASME T MECH, V11, P280, DOI 10.1109/TMECH.2006.875558; Harwin WS, 2006, P IEEE, V94, P1717, DOI 10.1109/JPROC.2006.880671; Hesse S, 2003, ARCH PHYS MED REHAB, V84, P915, DOI 10.1016/S0003-9993(02)04954-7; Hidler Joseph, 2005, Top Stroke Rehabil, V12, P22, DOI 10.1310/RYT5-62N4-CTVX-8JTE; Kahn LE, 2006, J REHABIL RES DEV, V43, P619, DOI 10.1682/JRRD.2005.03.0056; Kayyali Ruba, 2007, HAVE 2007 - IEEE International Workshop on Haptic Audio Visual Environments and their Applications, P118; KOENEMAN EJ, 2004, P IEEE ENG MED BIOL, V4, P2711; Krebs H I, 1999, Technol Health Care, V7, P419; Krebs HI, 2007, IEEE T NEUR SYS REH, V15, P327, DOI 10.1109/TNSRE.2007.903899; Krebs HI, 2003, AUTON ROBOT, V15, P7, DOI 10.1023/A:1024494031121; *MOT MED INC, 2008, REOTHERAPY; Nef T, 2007, INT C REHAB ROBOT, P68, DOI 10.1109/ICORR.2007.4428408; Oblak J, 2010, IEEE T NEUR SYS REH, V18, P293, DOI 10.1109/TNSRE.2009.2034162; Perry Joel C, 2009, Applied Bionics and Biomechanics, V6, P175, DOI 10.1080/11762320902920575; Sanchez RJ, 2005, INT C REHAB ROBOT, P500; Sanchez RJ, 2006, IEEE T NEUR SYS REH, V14, P378, DOI 10.1109/TNSRE.2006.881553; Spencer S., 2008, 2008 2 IEEE RAS EMBS, P869, DOI DOI 10.1109/BIOROB.2008.4762902; Stienen AHA, 2007, INT C REHAB ROBOT, P820, DOI 10.1109/ICORR.2007.4428519; Sukal TM, 2007, EXP BRAIN RES, V183, P215, DOI 10.1007/s00221-007-1029-6; Takahashi CD, 2005, INT C REHAB ROBOT, P17; Toth A, 2005, INT C REHAB ROBOT, P127; van der Linde RQ, 2003, IND ROBOT, V30, P515, DOI 10.1108/01439910310506783	28	12	12	0	14	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2011	48	4					317	333		10.1682/JRRD.2010.03.0043			17	Rehabilitation	Rehabilitation	774GB	WOS:000291372200004	21674386	Bronze			2021-06-18	
J	Pistarini, C; Aiachini, B; Coenen, M; Pisoni, C				Pistarini, Caterina; Aiachini, Beatrice; Coenen, Michaela; Pisoni, Camilla		Italian Network	Functioning and disability in traumatic brain injury: the Italian patient perspective in developing ICF Core Sets	DISABILITY AND REHABILITATION			English	Article						International Classification of Functioning; Disability and Health; ICF; traumatic brain injury (MeSH); qualitative research (MeSH); focus groups (MeSH); patient perspective	QUALITY-OF-LIFE; PERSISTENT VEGETATIVE STATE; FOCUS GROUPS; INTERNATIONAL CLASSIFICATION; HEALTH-CARE; REHABILITATION; SATISFACTION; RETURN; MODEL; SCALE	Objective. The purpose of the study was to explore the aspects of functioning and health relevant to patients with traumatic brain injury (TBI) and to the caregivers of TBI patients explicitly involved in the preliminary study for the Development of the ICF Core Set for TBI using a qualitative research method. Method. The sampling of patients followed the maximum variation strategy. To respect this strategy, we involved patients with different degrees of impairment and so, for some people it was not possible to join the group because of their severe cognitive impairment, in this case we interviewed their caregivers. The focus groups were digitally recorded and transcribed verbatim. The meaning condensation procedure was used for the data analysis. After qualitative data analyses, the resulting concepts were linked to ICF categories according to established linking rules. Results. Eighteen focus groups and five single interviews were performed. Forty-one patients participated in 10 focus groups. Thirty-three caregivers participated in eight focus group and six caregivers underwent a single interview. Saturation at 10% cutoff was reached. Based on 10 patient focus groups, we linked the concepts to 144 2nd level ICF different categories. In the eight focus group with caregiver we linked the concepts to 129 2nd level categories. In the single interviews, we could link the concepts only to Environmental factors and we linked to 25 ICF different categories. Conclusion. A broad range of aspects of functioning and health as well as several Environmental factors important to patients with TBI were explored and included in the preparatory phase of the development of ICF Core Sets for TBI. Whereas patients focused on problems in mobility, employment and recreation and leisure the caregivers highlighted several issues related to self-care as being important for the patients.	[Pistarini, Caterina; Aiachini, Beatrice; Pisoni, Camilla] Coordinator Ctr IRCCS S Maugeri Fdn, Neurorehabil Unit, Sci Inst Pavia, Pavia, Italy; [Coenen, Michaela] Univ Munich, IHRS, Res Unit Biopsychosocial Hlth, Munich, Germany; [Coenen, Michaela] DIMDI, ICF Res Branch, WHO Collaborating Ctr Family Int Classificat Germ, Munich, Germany	Aiachini, B (corresponding author), Coordinator Ctr IRCCS S Maugeri Fdn, Neurorehabil Unit, Sci Inst Pavia, Pavia, Italy.	beatrice.aiachini@fsm.it	Pistarini, CATERINA/K-5234-2018; Pisoni, Camilla/P-8491-2019; aiachini, beatrice/AAC-1992-2020	Pistarini, CATERINA/0000-0001-8925-0484; Pisoni, Camilla/0000-0001-9292-9682; aiello, alessia/0000-0002-1616-3096; Coenen, Michaela/0000-0001-7492-7907			Alachini B, 2010, EUR J PHYS REHAB MED, V46, P27; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; BARNES MP, 2005, OXFORD HDB REHABILIT; Bernabeu M, 2009, NEUROREHAB NEURAL RE, V23, P464, DOI 10.1177/1545968308328725; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Carey A., 1994, CRITICAL ISSUES QUAL, P225; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2004, J REHABIL MED, V36, P9, DOI 10.1080/16501960410015353; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/165019702760279189; COENEN M, QUAL LIFE RES; Coenen M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1956; Curtis S, 2000, SOC SCI MED, V50, P1001, DOI 10.1016/S0277-9536(99)00350-0; Denzin N. K., 1978, RES ACT THEORETICAL; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P357, DOI 10.1001/jama.284.3.357; Grill E, 2005, DISABIL REHABIL, V27, P459, DOI 10.1080/09638280400014063; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Hagen C., 1972, LEVELS COGNITIVE FUN; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Jaracz K, 2008, NEUROL NEUROCHIR POL, V42, P525; JENNETT B, 1972, LANCET, V1, P734; Karlsson G., 1995, PSYCHOL QUALITATIVE, V2nd ed); Kirchberger I, 2010, SPINAL CORD, V48, P603, DOI 10.1038/sc.2009.184; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Knodel J., 1993, SAGE FOCUS EDITIONS, DOI [DOI 10.4135/9781483349008, 10.4135/9781483349008]; Krueger R. A., 2000, Focus groups: A practical guide for applied research; KRUEGER RA, 1995, QUAL HEALTH RES, V5, P524, DOI 10.1177/104973239500500412; KVALE S, 1996, INTERVIEWSAN INTRO Q; Leonardi M, 2009, DISABIL REHABIL, V31, pS128, DOI 10.3109/09638280903317765; Lovasik D, 2001, Crit Care Nurs Q, V23, P24; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; McNamee S, 2009, J REHABIL RES DEV, V46, P893, DOI 10.1682/JRRD.2008.08.0106; Morgan D., 1997, QUALITATIVE RES METH, V16; Morgan D.L., 1993, SUCCESSFUL FOCUS GRO, P3, DOI [DOI 10.4135/9781483349008, 10.4135/9781483349008.n1]; Morse J., 1994, CRITICAL ISSUES QUAL; Murphy E., 1998, HEALTH TECHNOL ASSES, V2, DOI [DOI 10.3310/HTA2160, 10.3310/hta2160]; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Patton MQ., 1990, QUALITATIVE EVALUATI; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Powell RA, 1996, INT J SOC PSYCHIATR, V42, P193, DOI 10.1177/002076409604200303; Ragnarsson KT, 2002, RESTOR NEUROL NEUROS, V20, P103; ROSENBERG JH, 1995, NEUROLOGY, V45, P1015; Sim J, 1998, J ADV NURS, V28, P345, DOI 10.1046/j.1365-2648.1998.00692.x; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Stucki G, 2002, DISABIL REHABIL, V24, P932, DOI 10.1080/09638280210148594; Stucki G, 2002, DISABIL REHABIL, V24, P281, DOI 10.1080/09638280110105222; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Varjacic M, 2010, COLLEGIUM ANTROPOL, V34, P157; Vaughn Sharon., 1996, FOCUS GROUP INTERVIE; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; World Health Organization, 2001, INT CLASS FUNCT DIS; Wrona RM, 2010, DISABIL REHABIL, V32, P650, DOI 10.3109/09638280903186327	55	12	13	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2011	33	23-24					2333	2345		10.3109/09638288.2011.570414			13	Rehabilitation	Rehabilitation	841GB	WOS:000296499500021	21501040				2021-06-18	
J	Chen, X; Lin, YP; Wang, D; Zhang, JN				Chen, Xin; Lin, Yun-Peng; Wang, Dong; Zhang, Jian-Ning			Dexamethasone exacerbates spatial acquisition deficits after traumatic brain injury in rats	NEUROLOGICAL RESEARCH			English	Article						Tramatic brain injury; Spatial acquisition deficits; Dexamethasone	PROLONGED GLUCOCORTICOID EXPOSURE; WATER-MAZE; STRESS; MEMORY; HIPPOCAMPUS; PRIMATES; NUMBER; MICE	Objectives: Given after traumatic brain injury (TBI), Dexamethasone (DXM) reduces cerebral edema but impairs retrograde memory. This study was designed to test the hypothesis that administration of DXM to rats with TBI promotes learning deficits that are correlated with the morphological changes of hippocampal pyramidal neurons. Methods: Adult male Wistar rats were subjected to fluid percussion injury (FPI), received DXM (5 and 10 mg/kg), and then trained for spatial acquisition. Brain sections were examined by H. E. and Golgi impregnation to quantitatively measure the morphological changes of hippocampal pyramidal neurons. Results: The latency and path length were significantly higher in rats with FPI than those in control groups, particularly in rats receiving post-trauma high-dose DXM. At the same time, Golgi impregnation revealed a significant decrease in the number of apical and basal dendrites of pyramidal neurons of ipsilateral hippocampus in rats after injury, but the decrease was greatest of CA3 pyramidal neurons of ipsilateral hippocampus in injured rats that also received high-dose DXM. Discussion: These findings indicate that the administration of high-dose DXM after TBI could worsen the dendritic atrophy of hippocampal CA3 pyramidal neurons and, as a result, exacerbate spatial acquisition deficits.	[Chen, Xin; Lin, Yun-Peng; Wang, Dong; Zhang, Jian-Ning] Tianjin Med Univ, Tianjin Neurol Inst, Gen Hosp, Dept Neurosurg,Lab TJIVR, Tianjin 300052, Peoples R China	Zhang, JN (corresponding author), Tianjin Med Univ, Tianjin Neurol Inst, Gen Hosp, Dept Neurosurg,Lab TJIVR, 154 Anshan Rd, Tianjin 300052, Peoples R China.	jianningzhang@hotmail.com			National 973 Project of ChinaNational Basic Research Program of China [2005CB522604]; Tianjin Science and Techonology Development Plan [05-YFGDSF02500]; Tianjin Natural Science FoundationNatural Science Foundation of Tianjin [033611511]; Tianjin Medical University	This work is supported by National 973 Project of China (grant no. 2005CB522604), Tianjin Science and Techonology Development Plan (grant no. 05-YFGDSF02500), Tianjin Natural Science Foundation (grant no. 033611511), and "211 Project" Graduate Innovation Grant of Tianjin Medical University. The authors sincerely appreciate Li Liu, Weiyun Cui, Fanglian Chen, Yan Chai, and Lei Zhou for excellent technical support.	ALLEN TC, 1992, METHODS HISTOTECHNOL, P53; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; FLUGGE G, 1988, EXP BRAIN RES, V72, P417; GABBOTT PL, 1984, J NEUROSCI METH, V11, P221, DOI 10.1016/0165-0270(84)90084-0; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; He WB, 2008, CELL MOL NEUROBIOL, V28, P277, DOI 10.1007/s10571-007-9180-y; JOHREN O, 1994, ANN NY ACAD SCI, V746, P429; LAURER HL, 2002, ENCY HUMAN BRAIN; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MICCO DJ, 1980, J COMP PHYSIOL PSYCH, V94, P624, DOI 10.1037/h0077700; MOGHADDAM B, 1993, J NEUROCHEM, V60, P1650, DOI 10.1111/j.1471-4159.1993.tb13387.x; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; RUFF R, 2004, YOUMANS NEUROLOGICAL, P5181; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; SAPOLSKY RM, 1990, J NEUROSCI, V10, P2897, DOI 10.1523/jneurosci.10-09-02897.1990; SHOLL DA, 1953, J ANAT, V87, P387; Tata DA, 2006, J COMP NEUROL, V498, P363, DOI 10.1002/cne.21071; UNO H, 1989, J NEUROSCI, V9, P1705, DOI 10.1523/jneurosci.09-05-01705.1989; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; WOOLLEY CS, 1990, BRAIN RES, V531, P225, DOI 10.1016/0006-8993(90)90778-A; Yao YY, 2007, EUR J PHARMACOL, V574, P20, DOI 10.1016/j.ejphar.2007.07.021	26	12	12	0	3	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	DEC	2010	32	10					1097	1102		10.1179/016164110X12681290831162			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	670LD	WOS:000283422300013	20483023				2021-06-18	
J	Donaldson, CJ; Hoffer, ME; Balough, BJ; Gottshall, KR				Donaldson, Chadwick J.; Hoffer, Michael E.; Balough, Ben J.; Gottshall, Kim R.			Prognostic assessments of medical therapy and vestibular testing in post-traumatic migraine-associated dizziness patients	OTOLARYNGOLOGY-HEAD AND NECK SURGERY			English	Article							BRAIN-INJURY; HISTORY; PROPHYLAXIS; DYSFUNCTION	OBJECTIVE: The aim of this study was to characterize our clinical population of patients suffering with post-traumatic migraine-associated dizziness (PTMAD) and determine any associations with medical interventions and vestibular testing metrics to help predict response to treatments. STUDY DESIGN: Retrospective chart review. SETTING: Tertiary referral center. SUBJECTS AND METHODS: The electronic medical records of 83 patients presenting to a tertiary referral center who were given a diagnosis of PTMAD and who had been treated were retrospectively reviewed. General characteristics, clinical treatment, pre- and post-vestibular therapy testing metrics, and success and failure outcomes were assessed. Patients were assigned into responder and nonresponder groups related to their headaches and evaluated at two specific time points. Medication failures and vestibular test metrics were compared to identify and predict clinical outcomes. RESULTS: Seventy-two of 82 patients (88%) were analyzed at two time points. Use of verapamil, topiramate, gabapentin, amitryptiline, and valproic acid showed no comparative treatment benefit in responders compared to nonresponders (P = 0.294). Findings associated with successful treatments include response to initial medication (P = 0.001), final dynamic gait index (DGI) scores (P = 0.029), final vertical dynamic visual acuity test (DVAT) scores (up, 0.007; down, 0.006), and both final and change in computerized dynamic posturography-sensory organization test (CDP-SOT) scores (P = 0.001, P = 0.032). The antipsychotic quetiapine was specifically associated with outcome failures (P = 0.003). CONCLUSION: Specific prophylactic antimigraine medications were not associated with improved outcomes in PTMAD patients. Initial clinical responses and vestibular test metrics may guide physicians to predict successful outcomes. Copyright (C) 2010. Published by Mosby, Inc.	[Donaldson, Chadwick J.; Hoffer, Michael E.; Balough, Ben J.; Gottshall, Kim R.] USN, Spatial Orientat Ctr, Dept Otolaryngol, San Diego Med Ctr, San Diego, CA 92134 USA	Donaldson, CJ (corresponding author), USN, Spatial Orientat Ctr, Dept Otolaryngol, San Diego Med Ctr, 34800 Bob Wilson Dr, San Diego, CA 92134 USA.						ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Benedek K, 2002, CEPHALALGIA, V22, P142, DOI 10.1046/j.1468-2982.2002.00351.x; Bikhazi P, 1997, AM J OTOL, V18, P350; Cass SP, 1997, ANN OTO RHINOL LARYN, V106, P182, DOI 10.1177/000348949710600302; Eggers Scott D Z, 2007, Curr Pain Headache Rep, V11, P217, DOI 10.1007/s11916-007-0193-5; EIDE PK, 1992, ACTA NEUROL SCAND, V86, P194, DOI 10.1111/j.1600-0404.1992.tb05065.x; Gottshall Kim R, 2005, Int Tinnitus J, V11, P81; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; Hofman PAM, 2002, J NEUROPSYCH CLIN N, V14, P176, DOI 10.1176/appi.neuropsych.14.2.176; Lempert T, 1997, BRAIN, V120, P1005, DOI 10.1093/brain/120.6.1005; Lempert T, 2009, J NEUROL, V256, P333, DOI 10.1007/s00415-009-0149-2; Lewis D, 2007, HEADACHE, V47, P1409, DOI 10.1111/j.1526-4610.2007.00867.x; Maione A, 2006, LARYNGOSCOPE, V116, P1782, DOI 10.1097/01.mlg.0000231302.77922.c5; Neuhauser H, 2009, NEUROL CLIN, V27, P379, DOI 10.1016/j.ncl.2008.11.004; Ramadan NM, 2007, HEADACHE, V47, pS52, DOI 10.1111/j.1526-4610.2007.00677.x; Vitkovic J, 2008, AUDIOL NEURO-OTOL, V13, P113, DOI 10.1159/000111783; Whitney SL, 2000, LARYNGOSCOPE, V110, P1528, DOI 10.1097/00005537-200009000-00022; Wrisley DM, 2003, ARCH PHYS MED REHAB, V84, P1528, DOI 10.1016/S0003-9993(03)00274-0; Wrisley DM, 2002, OTOL NEUROTOL, V23, P483, DOI 10.1097/00129492-200207000-00016	20	12	12	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0194-5998			OTOLARYNG HEAD NECK	Otolaryngol. Head Neck Surg.	DEC	2010	143	6					820	825		10.1016/j.otohns.2010.09.024			6	Otorhinolaryngology; Surgery	Otorhinolaryngology; Surgery	690BF	WOS:000284974400015	21109084				2021-06-18	
J	Gobbel, GT; Kondziolka, D; Fellows-Mayle, W; Uram, M				Gobbel, Glenn T.; Kondziolka, Douglas; Fellows-Mayle, Wendy; Uram, Martin			Manual Vs Automated Delivery of Cells for Transplantation: Accuracy, Reproducibility, and Impact on Viability	NEUROSURGERY			English	Article						Brain; Cell transplantation; Parkinson disease; Stroke	MARROW STROMAL CELLS; NEURAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; PARKINSONS-DISEASE; HUNTINGTONS-DISEASE; FUNCTIONAL RECOVERY; DOPAMINE NEURONS; SPINAL-CORD; RAT MODEL	BACKGROUND: Cellular transplantation holds promise for the management of a variety of neurological disorders. However, there is great variability in cell type, preparation methods, and implantation technique, which are crucial to clinical outcomes. OBJECTIVE: We compared manual injection with automated injection using a prototype device to determine the possible value of a mechanized delivery system. METHODS: Neural progenitor cells and bone marrow stromal cells were injected using manual or automated methods. Consistency of injection volumes and cell number and viability were evaluated immediately or 1 day after injection. RESULTS: When cells were delivered as a series of 3 manual injections from the same syringe, the variation in fluid volume was greater than for single manual injections. Automated delivery of a series of 3 injections resulted in a lower variability in the amount of delivery than manual injection for both cell lines (1.2%-2.6% coefficient of variability for automated delivery vs 4.3%-24.0% for manual delivery). The amount delivered from injection 1 to injection 3 increased significantly with manual injections, whereas the amount injected did not vary over the 3 injections for the automated unit. Cell viability 1 day after injection was typically 30% to 40% of the value immediately after injection for the bone marrow stromal cells and 30% to 70% for the neural progenitor cells. There were no significant differences in viability attributed to the method of injection. CONCLUSION: The automated delivery device led to enhanced consistency of volumetric cell delivery but did not improve cell viability in the methods tested. Automated techniques could be useful in standardizing reproducible procedures for cell transplantation and improve both preclinical and clinical research.	[Kondziolka, Douglas] Univ Pittsburgh, Dept Neurol Surg, UPMC Presbyterian, McGowan Inst Regenerat Med, Pittsburgh, PA 15213 USA; [Uram, Martin] MEDRAD Inc, Corp Innovat Dept, Indianola, PA USA	Kondziolka, D (corresponding author), Univ Pittsburgh, Dept Neurol Surg, UPMC Presbyterian, McGowan Inst Regenerat Med, Suite B-400,200 Lothrop St, Pittsburgh, PA 15213 USA.	kondziolkads@upmc.edu			Pittsburgh Tissue Engineering Initiative (PTEI); MEDRAD, Inc; NASANational Aeronautics & Space Administration (NASA) [NNJ06HE87G]	This study was supported by a grant from Pittsburgh Tissue Engineering Initiative (PTEI) and MEDRAD, Inc, based on work supported by NASA under award no. NNJ06HE87G. The authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	Bachoud-Levi A, 2000, LANCET, V356, P1975, DOI 10.1016/S0140-6736(00)03310-9; Behrstock S, 2006, GENE THER, V13, P379, DOI 10.1038/sj.gt.3302679; Borlongan CV, 2008, REGEN MED, V3, P249, DOI 10.2217/17460751.3.3.249; Fink JS, 2000, CELL TRANSPLANT, V9, P273, DOI 10.1177/096368970000900212; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Freeman TB, 2000, P NATL ACAD SCI USA, V97, P13877, DOI 10.1073/pnas.97.25.13877; Gobbel GT, 2003, BRAIN RES, V980, P221, DOI 10.1016/S0006-8993(03)02977-9; Kakinohana O, 2004, EXP NEUROL, V190, P122, DOI 10.1016/j.expneurol.2004.07.014; Kondziolka D, 2004, CELL TRANSPLANT, V13, P749, DOI 10.3727/000000004783983350; Kondziolka D, 2005, J NEUROSURG, V103, P38, DOI 10.3171/jns.2005.103.1.0038; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; Lu DY, 2002, J NEUROSURG, V97, P935, DOI 10.3171/jns.2002.97.4.0935; MADRAZO I, 1995, NEUROL RES, V17, P312, DOI 10.1080/01616412.1995.11740334; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Nelson PT, 2002, AM J PATHOL, V160, P1201, DOI 10.1016/S0002-9440(10)62546-1; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Ott HC, 2005, EUR J CARDIO-THORAC, V27, P1017, DOI 10.1016/j.ejcts.2005.01.065; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Philpott LM, 1997, CELL TRANSPLANT, V6, P203, DOI 10.1016/S0963-6897(97)00028-6; Pillarisetti A, 2007, IEEE T AUTOM SCI ENG, V4, P322, DOI 10.1109/TASE.2006.888051; Seyfried D, 2006, J NEUROSURG, V104, P313, DOI 10.3171/jns.2006.104.2.313; Stilley CS, 2004, NEUROLOGY, V63, P1320, DOI 10.1212/01.WNL.0000140700.44904.53; Svendsen CN, 1997, EXP NEUROL, V148, P135, DOI 10.1006/exnr.1997.6634; Svendsen CN, 1996, EXP NEUROL, V137, P376, DOI 10.1006/exnr.1996.0039; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Zhang J, 2005, EXP NEUROL, V195, P16, DOI 10.1016/j.expneurol.2005.03.018; Zhou YF, 2006, CANCER RES, V66, P10849, DOI 10.1158/0008-5472.CAN-06-2146	30	12	12	1	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	DEC	2010	67	6					1662	1668		10.1227/NEU.0b013e3181f9b1e2			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	685DF	WOS:000284606500047	21107197				2021-06-18	
J	Hammond, FM; Malec, JF				Hammond, F. M.; Malec, J. F.			The Traumatic Brain Injury Model Systems: a longitudinal database, research, collaboration and knowledge translation	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Brain injuries; Database; Outcome assessment (health care)		In 1988, the National Institute on Disability and Rehabilitation Research (NIDRR) launched the Traumatic Brain Injury Model Systems (TBIMS) program, creating the longest and largest longitudinal database on individuals with moderate-to-severe traumatic brain injury (TB!) available today. In addition to sustaining the longitudinal database, centers that successfully compete to be part of the TBIMS centers are also expected to complete local and collaborative research projects to further scientific knowledge about TBI. The research has focused on areas of the NIDRR Long Range Plan which emphasizes employment, health and function, technology for access and function, independent living and community integration, and other associated disability research areas. Centers compete for funded participation in the TBIMS on a 5-year cycle. Dissemination of scientific knowledge gained through the TBIMS is the responsibility of both individual centers and the TBIMS as a whole. This is accomplished through multiple venues that target a broad audience of those who need to receive the information and learn how to best apply it to practice. The sites produce many useful websites, manuals, publications and other materials to accomplish this translation of knowledge to practice.	[Hammond, F. M.; Malec, J. F.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Rehabil Hosp Indiana, Indianapolis, IN USA	Hammond, FM (corresponding author), Indiana Univ Sch Med, Dept Phys Med & Rehabil, Rehabil Hosp Indiana, Indianapolis, IN USA.						*CTR OUTC MEAS BRA, TBI MOD SYST DAT CTR; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; *NAT I DIS REH REH, NOT FIN LONG RANG PL; *NIDRR TRAUM BRAIN, TRAUM BRAIN INJ MOD; 2010 TBIMS PRESENTAT	5	12	13	0	1	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	DEC	2010	46	4					545	548					4	Rehabilitation	Rehabilitation	712SX	WOS:000286687600010	21224786				2021-06-18	
J	Otapowicz, D; Sobaniec, W; Okurowska-Zawada, B; Artemowicz, B; Sendrowski, K; Kulak, W; Bockowski, L; Kuzia-Smigielska, J				Otapowicz, D.; Sobaniec, W.; Okurowska-Zawada, B.; Artemowicz, B.; Sendrowski, K.; Kulak, W.; Bockowski, L.; Kuzia-Smigielska, J.			Dysphagia in children with infantile cerebral palsy	ADVANCES IN MEDICAL SCIENCES			English	Article						cerebral palsy; deglutition disorders; eating problems; dysarthria	TRAUMATIC BRAIN-INJURY; PREVALENCE; GROWTH	Purpose: Dysphagia is a significant health problem in children with infantile cerebral palsy (ICP), but not frequently discussed in the literature. The study objective was to analyse dysphagia symptoms in children with a pyramidal form of ICP, including the oral and pharyngeal phases of deglutition and dysarthria severity. We searched for a correlation between dysphagia severity and ICP type, mental development and occurrence of epilepsy. Material and Methods: A total of 67 children with a pyramidal form of infantile cerebral palsy were studied. Data were obtained based on case history elicited from the mothers, analysis of medical and psychological documentation, and logopaedic examination, including an examination of the action of swallowing. Results: Dysphagia symptoms were found in 41 (61%) studied children, most frequently referring only to the oral phase (25 children), with concomitant mild and moderate dysarthria. Oral and pharyngeal dysfunctions were observed in 14 children and coexisted with more pronounced dysarthria symptoms. The most severe disorders were mainly found in the pharyngeal phase in 2 children. A statistically significant correlation was noted between the severity of dysphagia symptoms and the ICP type (p<0.044) and mental development (p<0.00002)' Conclusions: Swallowing dysfunctions occur in the majority of children (> 50%) with ICP. More serious disorders involving the oral and pharyngeal phases mainly affect children with tetraplegia and profound mental impairment. These disorders continue from early infancy through childhood and adolescence and improvement has been mainly observed when only the oral phase of swallowing is affected. These are always accompanied by dysarthria symptoms, which are especially severe when dysphagia involves the oral and pharyngeal phases. Early assessment and stimulation of the swallowing function should be a common element in the rehabilitation and care of children with ICP	[Otapowicz, D.; Sobaniec, W.; Artemowicz, B.; Sendrowski, K.; Bockowski, L.; Kuzia-Smigielska, J.] Med Univ Bialystok, Dept Pediat Neurol & Rehabil, PL-15274 Bialystok, Poland; [Okurowska-Zawada, B.; Kulak, W.] Med Univ Bialystok, Dept Pediat Rehabil, PL-15274 Bialystok, Poland	Otapowicz, D (corresponding author), Med Univ Bialystok, Dept Pediat Neurol & Rehabil, 17 Waszyngtona Str, PL-15274 Bialystok, Poland.	dorota667@wp.pl	Kulak, Wojciech/T-4796-2018; Bockowski, Leszek/S-7862-2018; Okurowska-Zawada, Bozena/T-4992-2018	Kulak, Wojciech/0000-0003-1118-9139; Bockowski, Leszek/0000-0003-4522-8415; Okurowska-Zawada, Bozena/0000-0002-1915-4320; , Dorota/0000-0002-8036-1273			Borkowska M, 1989, ABC REHABILITACJI MO, P91; Cahill LM, 2005, BRAIN INJURY, V19, P41, DOI 10.1080/02699050410001719961; Calis EAC, 2008, DEV MED CHILD NEUROL, V50, P625, DOI 10.1111/j.1469-8749.2008.03047.x; CLOUSE RE, 2002, SLEISENGER FORDTRANS, P561; Croghan John E., 1994, Dysphagia, V9, P141, DOI 10.1007/BF00341256; Czochanska J, 1997, MOZGOWE PORAZENIE DZ, P16; Dabska M, 1997, MOZGOWE PORAZENIE DZ, P13; Del Giudice E, 1999, BRAIN DEV-JPN, V21, P307, DOI 10.1016/S0387-7604(99)00025-X; Dilling-Ostrowska E, 2002, POSTEPY DIAGNOSTYCE, V4, P57; Gisel E, 1992, CEREBRAL PALSY TODAY, V2, P1; Gisel E, 2008, DEV DISABIL RES REV, V14, P165, DOI 10.1002/ddrr.21; Gisel Erika G., 1994, Dysphagia, V9, P180, DOI 10.1007/BF00341263; Haberfellner H, 2001, DYSPHAGIA, V16, P83, DOI 10.1007/s004550010006; HELFRICHMILLER KR, 1986, ARCH PHYS MED REHAB, V67, P520; Humbert IA, 2007, DYSPHAGIA, V22, P266, DOI 10.1007/s00455-007-9080-9; JONES PM, 1989, DEV MED CHILD NEUROL, V31, P404; Kulak W, 2005, Rocz Akad Med Bialymst, V50 Suppl 1, P74; Kulak W, 2008, ADV MED SCI-POLAND, V53, P42, DOI 10.2478/v10039-008-0006-z; Kulak W, 2007, Adv Med Sci, V52 Suppl 1, P180; Lefton-Greif MA, 2008, PHYS MED REH CLIN N, V19, P837, DOI 10.1016/j.pmr.2008.05.007; Mackiewicz B, 2001, LOGOPEDIA, V29, P87; Mazanek E., 1997, MOZGOWE PORAZENIE DZ, P72; Michalowicz R, 2001, NEUROLOGIA DZIECIECA, P118; Morgan A, 2003, J HEAD TRAUMA REHAB, V18, P239, DOI 10.1097/00001199-200305000-00002; Otapowicz D, 2007, Adv Med Sci, V52 Suppl 1, P188; Otapowicz D, 2005, Rocz Akad Med Bialymst, V50 Suppl 1, P78; PARROTT L C, 1992, Dysphagia, V7, P209; Reilly S, 1996, J PEDIATR-US, V129, P877, DOI 10.1016/S0022-3476(96)70032-X; Reilly S, 2008, DEV MED CHILD NEUROL, V50, P567, DOI 10.1111/j.1469-8749.2008.03049.x; Robertson SJ, 1987, DYSARTHRIA PROFILE; Rogers Brian, 1996, Seminars in Speech and Language, V17, P269, DOI 10.1055/s-2008-1064104; Saarinen T, 2006, CEREB CORTEX, V16, P212, DOI 10.1093/cercor/bhi099; Smigielska-Kuzia J, 1997, KWAS WALPROINOWY HIS, P115; STALLINGS VA, 1993, DEV MED CHILD NEUROL, V35, P126; Stecko E, 2002, ZABURZENIA MOWY DZIE; Stecko E, 2001, MOZGOWE PORAZENIE DZ, P348; Sullivan PB, 2000, DEV MED CHILD NEUROL, V42, P674, DOI 10.1017/S0012162200001249; Vik T, 2001, Tidsskr Nor Laegeforen, V121, P1570; Wasko-Czopnik D, 1999, NOWA MEDYCYNA, V10, P5	39	12	17	0	9	MEDICAL UNIV BIALYSTOK	BIALYSTOK	UL KILINSKIEGO 1, BIALYSTOK, 15-089, POLAND	1896-1126			ADV MED SCI-POLAND	Adv. Med. Sci.	DEC	2010	55	2					222	227		10.2478/v10039-010-0034-3			6	Medicine, Research & Experimental	Research & Experimental Medicine	697OL	WOS:000285522800017	20934964				2021-06-18	
J	Schultke, E; Griebel, RW; Juurlink, BHJ				Schueltke, E.; Griebel, R. W.; Juurlink, B. H. J.			Quercetin attenuates inflammatory processes after spinal cord injury in an animal model	SPINAL CORD			English	Article						myeloperoxidase; neurotrauma; quercetin; rat; secondary injury	MYELOPEROXIDASE ACTIVITY; CELL-DEATH; RECOVERY	Objectives: We have shown earlier that administration of the flavonoid quercetin significantly contributed to recovery of motor function after spinal cord compression injury in the adult rat. Using the same animal model, we have now designed a set of experiments to test the hypothesis that quercetin attenuates oxidative stress-related inflammatory processes early after spinal cord trauma. Methods: Mid-thoracic spinal cord compression injury in adult male Wistar rats was caused by extradural application and closure of a 50 g calibrated aneurysm clip for 5 s. Myeloperoxidase (MPO) levels were determined in spinal cord tissue and serum of quercetin-treated animals and controls at 6, 12, 24 and 72 h after injury. The white blood count was followed until 72 h after injury. Results: In quercetin-treated animals, MPO activity was significantly decreased in tissue at 12 and 24 h and in serum at 6, 12 and 24 h after injury, compared with saline controls. In quercetin-treated animals, the prevalence of ED-1 and MPO positive cells was significantly lower than in saline controls. White blood count in venous blood was significantly decreased in quercetin-treated animals at 12 and 24 h after injury. Conclusion: Quercetin attenuated the recruitment of neutrophils to the site of injury. The resulting lower MPO release in the injured tissue is likely to decrease the extent of secondary injury and might at least partially explain the neuroprotective effect of the flavonoid quercetin. Spinal Cord (2010) 48, 857-861; doi:10.1038/sc.2010.45; published online 4 May 2010	[Schueltke, E.] Univ Freiburg, Dept Stereotact Neurosurg, Freiburg, Germany; [Schueltke, E.] Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK, Canada; [Schueltke, E.; Griebel, R. W.] Univ Saskatchewan, Dept Surg, Saskatoon, SK, Canada; [Juurlink, B. H. J.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh, Saudi Arabia	Schultke, E (corresponding author), Univ Freiburg, Dept Stereotact Neurosurg, Breisacher Str 64,BW S7N5E5, Freiburg, Germany.	elisabeth.schueltke@uniklinik-freiburg.de	Schultke, Elisabeth/M-3959-2013		Saskatchewan Health Research Foundation; Christopher Reeve Paralysis Foundation	We thank our technical assistants Arlene Drimmie and Connie Wong (Department of Anatomy and Cell Biology) and the students Angela Damant and Viktor Skihar for help with the animal care. Lloyd Jennett from RUH is thanked for technical support, fixing our anaesthesia machine whenever it breaks down. This work was supported by the Saskatchewan Health Research Foundation and by the Christopher Reeve Paralysis Foundation.	ANDERSON DK, 1992, J NEUROTRAUM, V9, P143, DOI 10.1089/neu.1992.9.143; BADWEY JA, 1980, ANNU REV BIOCHEM, V49, P695, DOI 10.1146/annurev.bi.49.070180.003403; BADWEY JA, 1991, ADV EXP MED BIOL, V341, P19; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Beattie MS, 2000, CONT NEUROS, P1; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; CARLSON SL, 1988, EXP NEUROL, V15, P77; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Kamencic H, 2001, FASEB J, V15, P243, DOI 10.1096/fj.00-0228com; Kettle AJ, 1997, REDOX REP, V3, P3, DOI 10.1080/13510002.1997.11747085; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; PINCEMAIL J, 1988, EXPERIENTIA, V44, P450, DOI 10.1007/BF01940544; RIVLIN AS, 1978, SURG NEUROL, V10, P39; Schultke E, 2003, J NEUROTRAUM, V20, P583, DOI 10.1089/089771503767168500; Schultke E, 2010, SPINAL CORD, V48, P112, DOI 10.1038/sc.2009.111; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; TATOR CH, 1979, CAN MED ASSOC J, V121, P1453; WINTERBOURN CC, 1985, BIOCHEM J, V228, P583, DOI 10.1042/bj2280583	20	12	12	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	DEC	2010	48	12					857	861		10.1038/sc.2010.45			5	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	688SZ	WOS:000284875100004	20440299	Bronze			2021-06-18	
J	Zlotnik, A; Gurevich, B; Artru, AA; Gruenbaum, SE; Dubilet, M; Leibowitz, A; Shaked, G; Ohayon, S; Shapira, Y; Teichberg, VI				Zlotnik, Alexander; Gurevich, Boris; Artru, Alan A.; Gruenbaum, Shaun E.; Dubilet, Michael; Leibowitz, Akiva; Shaked, Gad; Ohayon, Sharon; Shapira, Yoram; Teichberg, Vivian I.			The Effect of Hyperthermia on Blood Glutamate Levels	ANESTHESIA AND ANALGESIA			English	Article							TRAUMATIC BRAIN-INJURY; EXCITATORY AMINO-ACIDS; CLOSED-HEAD INJURY; CEREBROSPINAL-FLUID; IN-VIVO; EXTRACELLULAR GLUTAMATE; SCAVENGING ACTIVITY; RAT; BARRIER; PLASMA	INTRODUCTION: Glutamate neurotoxicity is determined by the balance between glutamate release within the brain and efflux of excess glutamate from the brain. Brain-to-blood efflux of glutamate is increased by decreasing the concentration of glutamate in blood. Little is known about the effect of hyperthermia on blood glutamate concentrations, and the effectiveness of blood glutamate-decreasing mechanisms in these conditions. Although hyperthermia is hypothesized to decrease blood glutamate concentrations by activation of stress mechanisms, blunting the stress response by blocking beta-adrenergic receptors should prevent this decrease. Furthermore, during hyperthermia there should be a concurrent process of leakage of glutamate from muscle tissue into blood, resulting in a contradictory increase of blood glutamate concentrations. In this study we investigated the effects of hyperthermia on blood glutamate levels and studied the effects of the beta-adrenergic receptor antagonist propranolol on stress-induced changes in glutamate levels. We then studied the effectiveness of the blood glutamate scavenger oxaloacetate on hyperthermia-induced increases of glutamate levels. MATERIALS AND METHODS: Twenty-four rats were randomly divided into 3 groups. Rats' body temperatures were increased (by 1 degrees C every 40 minutes) from 37 degrees C to 42 degrees C. The first group received 1 mL per 100 g of isotonic saline (control). The second group received 1 mL per 100 g of 1M oxaloacetate when the temperature reached 39 degrees C. The third group received 10 mg/kg of propranolol before initiation of the warming. RESULTS: Warming the rats from 37 degrees C to 39 degrees C decreased the blood glutamate levels in the control group (P < 0.01) and oxaloacetate treatment group (P < 0.0001), whereas further increases in temperature from 40 degrees C to 42 degrees C increased the blood glutamate levels (P < 0.01 and P < 0.0001, respectively). Pretreatment with propranolol prevented the decrease in blood glutamate concentrations seen in mild hyperthermia and did not affect the increase in blood glutamate levels seen at temperatures of 41 degrees C and 42 degrees C (P < 0.005). DISCUSSION: The results of this study demonstrated that hyperthermia leads to decreases in glutamate levels in the blood, presumably by activation of the sympathetic nervous system. Oxaloacetate, previously reported to reduce blood glutamate levels at 37 degrees C, was ineffective at temperatures over 40 degrees C. Propranolol pretreatment blunted the initial decrease in blood glutamate, and thereafter had no effect when compared with control and treatment groups. Understanding the mechanisms underlying glutamate regulation in the blood during states of hyperthermia and stress has important clinical implications in treating neurodegenerative conditions.	[Zlotnik, Alexander; Gurevich, Boris; Gruenbaum, Shaun E.; Dubilet, Michael; Leibowitz, Akiva; Ohayon, Sharon; Shapira, Yoram] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Dept Anesthesiol & Crit Care, IL-84105 Beer Sheva, Israel; [Artru, Alan A.] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; [Teichberg, Vivian I.] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Shaked, Gad] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Dept Surg, IL-84105 Beer Sheva, Israel	Leibowitz, A (corresponding author), Ben Gurion Univ Negev, Soroka Univ Med Ctr, Dept Anesthesiol & Crit Care, POB 151, IL-84105 Beer Sheva, Israel.		Leibowitz, Akiva/F-1397-2012	Leibowitz, Akiva/0000-0003-4244-1915			Al-Sarraf H, 2003, BRAIN RES, V994, P181, DOI 10.1016/j.brainres.2003.09.034; Al-Sarraf Hameed, 1997, Developmental Brain Research, V102, P47, DOI 10.1016/S0165-3806(97)00075-8; AlSarraf H, 1995, DEV BRAIN RES, V90, P151, DOI 10.1016/0165-3806(96)83495-X; AlSarraf H, 1997, DEV BRAIN RES, V102, P127, DOI 10.1016/S0165-3806(97)00089-8; Arakawa H, 1997, J PHARMACOL EXP THER, V280, P1296; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Benrabh H, 1996, NEUROSCI LETT, V210, P9, DOI 10.1016/0304-3940(96)12635-5; BERL S, 1961, J NEUROCHEM, V7, P186, DOI 10.1111/j.1471-4159.1961.tb13503.x; BERL S, 1962, J BIOL CHEM, V237, P2562; BLOMSTRAND E, 1988, ACTA PHYSIOL SCAND, V133, P115, DOI 10.1111/j.1748-1716.1988.tb08388.x; Blomstrand E, 2009, AMINO ACIDS, V37, P629, DOI 10.1007/s00726-008-0182-y; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; Cervellin G, 2010, CLIN CHEM LAB MED, V48, P749, DOI 10.1515/CCLM.2010.151; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DREWES LR, 1977, AM J PHYSIOL, V233, pE320; El-Wazir YM, 2008, AUTON NEUROSCI-BASIC, V143, P33, DOI 10.1016/j.autneu.2008.07.004; Falciglia M, 2007, CURR OPIN CLIN NUTR, V10, P498, DOI 10.1097/MCO.0b013e3281a3bf0a; Fu FH, 2002, PERCEPT MOTOR SKILL, V95, P1171, DOI 10.2466/PMS.95.8.1171-1178; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; Hammarqvist F, 2001, CLIN PHYSIOL, V21, P44, DOI 10.1046/j.1365-2281.2001.00291.x; Hawkins RA, 2006, J NUTR, V136, p218S, DOI 10.1093/jn/136.1.218S; Hawkins RA, 2009, AM J CLIN NUTR, V90, p867S, DOI 10.3945/ajcn.2009.27462BB; Hosoya K, 1999, J NEUROCHEM, V73, P1206, DOI 10.1046/j.1471-4159.1999.0731206.x; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; KANE RL, 1999, J BIOL CHEM, V274, P31891; KAYASHIMA S, 1995, EUR J APPL PHYSIOL O, V70, P413, DOI 10.1007/BF00618492; Kempski O, 1990, Adv Neurol, V52, P219; Koizumi H, 1997, BRAIN RES, V747, P304, DOI 10.1016/S0006-8993(96)01240-1; Koura SS, 1998, ACT NEUR S, V71, P244; MARLISS EB, 1971, J CLIN INVEST, V50, P814, DOI 10.1172/JCI106552; MUKHERJEE K, 1987, AVIAT SPACE ENVIR MD, V58, P18; Newsholme EA, 1996, EXPERIENTIA, V52, P413, DOI 10.1007/BF01919308; Obrenovitch TP, 1997, PROG NEUROBIOL, V51, P39, DOI 10.1016/S0301-0082(96)00049-4; Oehmichen M, 1979, Beitr Gerichtl Med, V37, P271; OLDENDORF WH, 1971, AM J PHYSIOL, V221, P1629; PALMER AM, 1993, J NEUROCHEM, V61, pS284; Richards DA, 2003, PHARMACOL RES, V48, P101, DOI 10.1016/S1043-6618(03)00081-1; Rose ME, 2002, BRAIN RES, V943, P15, DOI 10.1016/S0006-8993(02)02471-X; Schneider AM, 2000, BEHAV NEUROSCI, V114, P1256; SEN CK, 1992, J APPL PHYSIOL, V73, P1265; SERSHEN H, 1976, EXP NEUROL, V53, P465, DOI 10.1016/0014-4886(76)90086-8; Sharma HS, 2006, J NEURAL TRANSM, V113, P521, DOI 10.1007/s00702-005-0405-2; Shuaib A, 1996, ACT NEUR S, V67, P53; Smith QR, 2000, J NUTR, V130, p1016S, DOI 10.1093/jn/130.4.1016S; Stover JF, 2005, ACTA NEUROCHIR, V147, P847, DOI 10.1007/s00701-005-0562-y; Stover JF, 2000, ACT NEUR S, V76, P375; Suckow MA, 2006, AM COLL LAB, P1; Suehiro E, 1999, J NEUROTRAUM, V16, P285, DOI 10.1089/neu.1999.16.285; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Waynforth H. B., 1992, EXPT SURG TECHNIQUE; Zauner A, 1996, ACT NEUR S, V67, P40; Zhang H, 2001, CLIN CHEM, V47, P1458; Zhang Hong, 2008, Neurosci Bull, V24, P7, DOI 10.1007/s12264-008-1227-7; ZLOTNIK A, 2009, AM SOC AN ANN M NEW; ZLOTNIK A, 2008, 36 ANN M SOC NEUR AN; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2009, J NEUROSURG ANESTH, V21, P235, DOI 10.1097/ANA.0b013e3181a2bf0b; ZORNOW MH, 1995, J NEUROSURG ANESTH, V7, P148, DOI 10.1097/00008506-199504000-00022	63	12	12	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	DEC	2010	111	6					1497	1504		10.1213/ANE.0b013e3181fc0112			8	Anesthesiology	Anesthesiology	690AU	WOS:000284973300026	21048094				2021-06-18	
J	Patanwala, AE; Amini, A; Erstad, BL				Patanwala, Asad E.; Amini, Albert; Erstad, Brian L.			Use of hypertonic saline injection in trauma	AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY			English	Article						Brain injuries; Electrolytes; Mannitol; Osmotic agents; Protocols; Sodium chloride; Tonicity; Toxicity; Wounds and injuries	7.5-PERCENT SODIUM-CHLORIDE; ELEVATED INTRACRANIAL-PRESSURE; RANDOMIZED CONTROLLED-TRIAL; LACTATED RINGERS SOLUTION; SEVERELY BURNED CHILDREN; HEAD-INJURED PATIENTS; HEMORRHAGIC-SHOCK; BRAIN-INJURY; FLUID RESUSCITATION; NEUTROPHIL ACTIVATION	The use of hypertonic saline injection in trauma patients is discussed. Summary. Patients with hemorrhage, burns, and traumatic brain injury (TBI) may develop hypovolemic shock and require resuscitation. Compared with conventional isotonic crystalloids, hypertonic saline has several advantages, including hemodynamic, immune-modulating, and antiinflammatory effects, for use in trauma patients for resuscitation. In addition, hypertonic saline is also used in patients with TBI to reduce intracranial pressure (ICP). Overall, studies have not shown a difference in mortality or other clinically important outcomes with the use of hypertonic saline for resuscitation in trauma patients; however, most of these studies were not adequately powered to show significant differences. A recent Cochrane review concluded that there is no evidence that hypertonic crystalloids are better than isotonic or near-isotonic crystalloids for fluid resuscitation in trauma patients. Two recent trials that were adequately powered to investigate a mortality endpoint were halted for futility. A few small randomized controlled studies found that hypertonic saline was more effective than mannitol as a hyperosmolar agent for ICP reduction. Recent guidelines from the American Burn Association have suggested that hypertonic saline may be used for burn shock resuscitation by experienced providers with close monitoring to avoid excessive hypernatremia. One of the main concerns with the use of hypertonic saline is its potential to cause central pontine myelinolysis due to a rapid increase in serum sodium levels. Conclusion. There is no evidence that hypertonic saline provides any additional benefit over isotonic crystalloid solutions for trauma resuscitation. Hypertonic saline may be more effective than mannitol at reducing ICP in patients with TBI.	[Patanwala, Asad E.; Erstad, Brian L.] Univ Arizona, Coll Pharm, Dept Pharm Practice & Sci, Tucson, AZ 85721 USA; [Amini, Albert] Univ Arizona, Coll Med, Dept Surg, Tucson, AZ 85721 USA	Patanwala, AE (corresponding author), Univ Arizona, Coll Pharm, Dept Pharm Practice & Sci, 1295 N Martin,POB 210202, Tucson, AZ 85721 USA.	patanwala@pharmacy.arizona.edu					Alam HB, 2007, SURG CLIN N AM, V87, P55, DOI 10.1016/j.suc.2006.09.015; Alam HB, 2004, RESUSCITATION, V60, P91, DOI 10.1016/j.resuscitation.2003.08.006; Bahrami S, 2006, SHOCK, V25, P283, DOI 10.1097/01.shk.0000208808.03148.ea; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Bortolani A, 1996, Acta Chir Plast, V38, P132; BOWSERWALLACE BH, 1986, BURNS, V12, P402, DOI 10.1016/0305-4179(86)90035-5; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Bulger EM, 2008, ARCH SURG-CHICAGO, V143, P139, DOI 10.1001/archsurg.2007.41; Bulger EM, 2007, ANN SURG, V245, P635, DOI 10.1097/01.sla.0000251367.44890.ae; Bunn F, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/146151858.CD002045.PUB2; CALDWELL FT, 1979, ANN SURG, V189, P546, DOI 10.1097/00000658-197905000-00002; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Diringer MN, 2004, NEUROCRIT CARE, V1, P219, DOI 10.1385/NCC:1:2:219; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; GUNN ML, 1989, J TRAUMA, V29, P1261, DOI 10.1097/00005373-198909000-00013; Hartl R, 1997, ZBL CHIR, V122, P181; Hartl R, 1997, ACT NEUR S, V70, P126; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Himmelseher S, 2007, CURR OPIN ANESTHESIO, V20, P414, DOI 10.1097/ACO.0b013e3282eff9ea; Holcroft J W, 1989, Prog Clin Biol Res, V299, P331; HOLCROFT JW, 1987, ANN SURG, V206, P279, DOI 10.1097/00000658-198709000-00006; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; HUANG PP, 1995, ANN SURG, V221, P543, DOI 10.1097/00000658-199505000-00012; Huang SJ, 2006, SURG NEUROL, V65, P539, DOI 10.1016/j.surneu.2005.11.019; Jarvela K, 2003, ANAESTHESIA, V58, P878, DOI 10.1046/j.1365-2044.2003.03332.x; JELENKO C, 1979, CRIT CARE MED, V7, P157, DOI 10.1097/00003246-197904000-00003; Junger WG, 1997, SHOCK, V8, P235, DOI 10.1097/00024382-199710000-00001; Junger WG, 1997, J TRAUMA, V42, P437, DOI 10.1097/00005373-199703000-00011; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kortbeek JB, 2008, J TRAUMA, V64, P1638, DOI 10.1097/TA.0b013e3181744b03; Larive LL, 2004, NEUROCRIT CARE, V1, P435, DOI 10.1385/NCC:1:4:435; Laureno R, 1997, ANN INTERN MED, V126, P57, DOI 10.7326/0003-4819-126-1-199701010-00008; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; LIEN YHH, 1991, J CLIN INVEST, V88, P303, DOI 10.1172/JCI115292; MANINGAS PA, 1989, AM J SURG, V157, P528, DOI 10.1016/0002-9610(89)90654-5; Mannick JA, 2001, J AM COLL SURGEONS, V193, P237, DOI 10.1016/S1072-7515(01)01011-0; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; MONAFO WW, 1970, J TRAUM, V10, P575, DOI 10.1097/00005373-197007000-00006; MOYLAN JA, 1973, AM J SURG, V125, P580, DOI 10.1016/0002-9610(73)90141-4; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Murao Y, 2003, SHOCK, V20, P23, DOI 10.1097/01.shk.0000078832.57685.6c; Murao Y, 2003, SHOCK, V20, P29, DOI 10.1097/01.shk.0000071060.78689.f1; Murphy JT, 1999, ARCH SURG-CHICAGO, V134, P1091, DOI 10.1001/archsurg.134.10.1091; Nydam TL, 2009, SHOCK, V31, P466, DOI 10.1097/SHK.0b013e31818ec47d; Oda J, 2006, J TRAUMA, V60, P64, DOI 10.1097/01.ta.0000199431.66938.99; Papia G, 2008, SURGERY, V144, P814, DOI 10.1016/j.surg.2008.07.008; Pascual JL, 2003, J TRAUMA, V54, P121, DOI 10.1097/00005373-200301000-00015; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Pham TN, 2008, J BURN CARE RES, V29, P257, DOI 10.1097/BCR.0b013e31815f3876; Qureshi AI, 1999, J TRAUMA, V47, P659, DOI 10.1097/00005373-199910000-00009; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; REED RL, 1991, J TRAUMA, V31, P8, DOI 10.1097/00005373-199101000-00002; Rhee P, 2000, CRIT CARE MED, V28, P74, DOI 10.1097/00003246-200001000-00012; Rhee P, 1998, J TRAUMA, V44, P313, DOI 10.1097/00005373-199802000-00014; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Schatzmann C, 1998, ACT NEUR S, V71, P31; SHACKFORD SR, 1987, SURG GYNECOL OBSTET, V164, P127; SHIMAZAKI S, 1977, J TRAUMA, V17, P38, DOI 10.1097/00005373-197701000-00005; SILVA MR, 1990, CRIT CARE MED, V18, P203, DOI 10.1097/00003246-199002000-00015; Strandvik GF, 2009, ANAESTHESIA, V64, P990, DOI 10.1111/j.1365-2044.2009.05986.x; VASSAR MJ, 1990, ARCH SURG-CHICAGO, V125, P1309; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; VASSAR MJ, 1993, J TRAUMA, V34, P622, DOI 10.1097/00005373-199305000-00003; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; VELASCO IT, 1980, AM J PHYSIOL, V239, pH664; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Wade C, 1997, Acta Anaesthesiol Scand Suppl, V110, P77; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Wade CE, 2003, J TRAUMA, V54, pS144, DOI 10.1097/01.TA.0000047223.62617.AB; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Younes RN, 1997, SHOCK, V7, P79, DOI 10.1097/00024382-199702000-00001; YOUNES RN, 1992, SURGERY, V111, P380	75	12	15	0	11	AMER SOC HEALTH-SYSTEM PHARMACISTS	BETHESDA	7272 WISCONSIN AVE, BETHESDA, MD 20814 USA	1079-2082			AM J HEALTH-SYST PH	Am. J. Health-Syst. Pharm.	NOV 15	2010	67	22					1920	1928		10.2146/ajhp090523			9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	858BW	WOS:000297771900008	21048208				2021-06-18	
J	Hoskins, LL; Binder, LM; Chaytor, NS; Williamson, DJ; Drane, DL				Hoskins, Laura L.; Binder, Laurence M.; Chaytor, Naomi S.; Williamson, David J.; Drane, Daniel L.			Comparison of Oral and Computerized Versions of the Word Memory Test(dagger)	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Word Memory Test (WMT); Symptom validity testing; Computerized assessments; Neuropsychological assessment	PSYCHOGENIC NONEPILEPTIC SEIZURES; TRAUMATIC BRAIN-INJURY; CATEGORY TEST; TESTS; PERFORMANCE; EPILEPSY; EQUIVALENCE; EXAMINER; STANDARD; OBSERVER	A computer-administered version of the Word Memory Test (WMT) was compared with the orally administered version in two clinical samples to assess equivalency of the two versions. The two samples included inpatients at an epilepsy center (n = 67) and forensic and clinical referrals to a private practice (n = 58). A randomized procedure was used to assign participants to either version of the WMT. Only the results of the WMT primary effort measures were analyzed. Between-group comparisons of the WMT effort measures were conducted using Mann-Whitney nonparametric analysis. No significant differences were found between versions for several diagnostic subgroups. The data generally support equivalency of the orally administered version and the computerized version of the WMT effort measures in a mixed outpatient sample.	[Hoskins, Laura L.] N Shore Long Isl Jewish Hlth Syst, Dept Psychiat, Manhasset, NY 11030 USA; [Binder, Laurence M.] Independent Practice, Beaverton, OR 97005 USA; [Chaytor, Naomi S.] Univ Washington Reg Epilepsy Ctr, Harborview Med Ctr, Seattle, WA 98104 USA; [Chaytor, Naomi S.; Drane, Daniel L.] Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA; [Williamson, David J.] Ortho McNeil Janssen Sci Affairs LLC, Raritan, NJ 08869 USA; [Williamson, David J.] Univ S Alabama, Dept Neurol, Mobile, AL 36688 USA; [Drane, Daniel L.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA	Hoskins, LL (corresponding author), N Shore Univ Hosp, Dept Psychiat, 400 Community Dr, Manhasset, NY 11030 USA.	lhoskins@nshs.edu	Chaytor, Naomi/L-4315-2019	Chaytor, Naomi/0000-0001-8821-289X			AGNEW J, 1991, J OCCUP ENVIRON MED, V33, P1156, DOI 10.1097/00043764-199111000-00012; Allen LM, 2000, ARCH CLIN NEUROPSYCH, V15, P840, DOI 10.1016/S0887-6177(00)80345-5; ALLEN LM, 2002, WEBPSYCHEMPIRICIST; Berger S. G., 1994, ASSESSMENT, V1, P255; Binder JT, 1995, CLIN NEUROPSYCHOL, V9, P74, DOI DOI 10.1080/13854049508402061; Campbell KA, 1999, ASSESSMENT, V6, P21, DOI 10.1177/107319119900600103; Choca J., 1992, CLIN NEUROPSYCHOL, V6, P9, DOI [10.1080/13854049208404112, DOI 10.1080/13854049208404112]; Constantinou M, 2002, CLIN NEUROPSYCHOL, V16, P407, DOI 10.1076/clin.16.3.407.13853; Cragar DE, 2006, CLIN NEUROPSYCHOL, V20, P552, DOI 10.1080/13854040590947380; Drane DL, 2006, EPILEPSIA, V47, P1879, DOI 10.1111/j.1528-1167.2006.00611.x; Fortuny LA, 1996, CLIN NEUROPSYCHOL, V10, P419, DOI 10.1080/13854049608406702; FRENCH CC, 1990, J CLIN PSYCHOL, V46, P129, DOI 10.1002/1097-4679(199003)46:2<129::AID-JCLP2270460203>3.0.CO;2-Y; Goodrich-Hunsaker NJ, 2009, NEUROPSYCHOLOGY, V23, P529, DOI 10.1037/a0015444; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2003, GREENS WORD MEMORY T; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97, DOI DOI 10.1300/J151V02N03_05; Green P., 1995, MANUAL WORD MEMORY T; Green P., 2005, GREENS WORD MEMORY T; Green P., 1996, WORD MEMORY TEST USE; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Hartman DE, 2002, ARCH CLIN NEUROPSYCH, V17, P709, DOI 10.1016/S0887-6177(01)00172-X; HOFER PJ, 1985, COMPUT HUM BEHAV, V1, P305; KANE RL, 1992, NEUROPSYCHOL REV, V3, P1, DOI 10.1007/BF01108787; LETZ R, 1986, OCCUPATIONAL MED */*, V1, P197; Lichtenberger EO, 2006, J CLIN PSYCHOL, V62, P19, DOI 10.1002/jclp.20197; MEAD AD, 1993, PSYCHOL BULL, V114, P449, DOI 10.1037/0033-2909.114.3.449; Mercer WN, 1997, CLIN NEUROPSYCHOL, V11, P174, DOI 10.1080/13854049708407047; RUSSELL EW, 2000, CLIN GUIDE NEUROPSYC, P483; Schatz P, 2002, J HEAD TRAUMA REHAB, V17, P395, DOI 10.1097/00001199-200210000-00003; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Sweet JJ, 1999, STUD NEUROPSYCHOL DE, P255; Williamson DJ, 2005, EPILEPSIA, V46, P74; Williamson DJ, 2004, EPILEPSIA, V45, P179; WILLIAMSON DJ, 2007, ASSESSMENT FEIGNED C, P346; Wynkoop T. F., 2005, J FORENSIC NEUROPSYC, V4, P101; Yantz CL, 2007, CLIN NEUROPSYCHOL, V21, P663, DOI 10.1080/13854040600788158; Yantz CL, 2009, CLIN NEUROPSYCHOL, V23, P118, DOI 10.1080/13854040801894722	38	12	13	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV	2010	25	7					591	600		10.1093/arclin/acq060			10	Psychology, Clinical; Psychology	Psychology	673KK	WOS:000283658500001	20719808	Bronze			2021-06-18	
J	Ko, SB; Kim, CK; Lee, SH; Bae, HJ; Yoon, BW				Ko, Sang-Bae; Kim, Chi Kyung; Lee, Seung-Hoon; Bae, Hee-Joon; Yoon, Byung-Woo			Morphine-Sensitive Paroxysmal Sympathetic Storm in Pontine Intracerebral Hemorrhage	NEUROLOGIST			English	Article						autonomic; paroxysmal sympathetic storm; pontine hemorrhage	DIENCEPHALIC SEIZURES; BRAIN-INJURY	Paroxysmal sympathetic storm (PSS) is a rare complication of severe traumatic brain injury or cerebrovascular disease. Various medications have been tried in patients with PSS, but the clinical responses of the patients were variable. We report a classic case of PSS after spontaneous pontine hemorrhage in which the patient's fluctuating blood pressure and body temperature were dramatically stabilized using morphine.	[Ko, Sang-Bae; Kim, Chi Kyung; Lee, Seung-Hoon; Yoon, Byung-Woo] Seoul Natl Univ Hosp, Dept Neurol, Coll Med, Clin Res Ctr Stroke,Clin Res Inst, Seoul 110744, South Korea; [Bae, Hee-Joon] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Seoul, South Korea	Ko, SB (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Coll Med, Clin Res Ctr Stroke,Clin Res Inst, Yongon Dong 28, Seoul 110744, South Korea.	sangbai1378@gmail.com	Yoon, Byung Woo/J-5557-2012; Kim, Chi Kyung/AAR-9819-2020	Ko, Sang-Bae/0000-0002-9429-9597	Ministry of Health, Welfare and Family Affairs, Republic of KoreaMinistry of Health & Welfare, Republic of Korea [A060171]	Supported by the Korea Health 21 R&D project, Ministry of Health, Welfare and Family Affairs, Republic of Korea, grant (A060171).	Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; Diamond AL, 2005, NEUROCRIT CARE, V2, P288, DOI 10.1385/NCC:2:3:288; Gondim FAA, 2003, ARCH NEUROL-CHICAGO, V60, P1803, DOI 10.1001/archneur.60.12.1803; Reed MJ, 2006, EUR J EMERG MED, V13, P41, DOI 10.1097/00063110-200602000-00011	7	12	15	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1074-7931			NEUROLOGIST	Neurologist	NOV	2010	16	6					384	385		10.1097/NRL.0b013e3181b1cdff			2	Clinical Neurology	Neurosciences & Neurology	679YH	WOS:000284196200010	21150389				2021-06-18	
J	Birthi, P; Walters, C; Karandikar, N				Birthi, Pravardhan; Walters, Chadwick; Karandikar, Ninad			A Rare Case of Tardive Dyskinesia and Akathisia Induced by Citalopram	PM&R			English	Article								Depression is one of the most commonly encountered problems in clinical practice. It also is a very common condition in patients with traumatic brain injury (TBI). Citalopram is one of the most commonly used antidepressants agents, and as is true for all selective serotonin reuptake inhibitors (SSRIs), it exerts its antidepressant effect by blocking the reuptake of serotonin, thereby increasing extrasynaptic serotonin levels [1]. Tardive dyskinesia is a movement disorder characterized by involuntary movements of the tongue, lips, face, trunk, and extremities that has been shown to occur in patients treated long term with dopaminergic antagonist medications. The medications most commonly associated with this disorder are older anti psychotic agents such as haloperidol, fluphenazine, and trifluoperazine. Other nonantipsychotic medications associated with this syndrome include cinnarizine, flunarizine, and metoclopramide. Tardive dyskinesia is most common in patients with schizophrenia, schizoaffective disorder, or bipolar disorder who have undergone long-term treatment with antipsychotic medication. However, patients with fetal alcohol syndrome, other developmental deficits, and various brain disorders are vulnerable to the development of tardive dyskinesia, even after receiving a single close of the causative agent [2]. Extrapyramidal symptoms (EPS), such as akathisia, are commonly reported side effects of SSRIs. Tardive dyskinesias also have been reported in the literature in conjunction with the use of some SSRIs such as paroxetine, fluoxetine, and sertraline but not with citalopram. These side effects are thought to be a consequence of serotonergically mediated inhibition of the dopaminergic system. Here, we report a case of tardive dyskinesia and akathisia that occurred after the use of citalopram to treat depression in a patient with history of head injury.	[Birthi, Pravardhan; Walters, Chadwick; Karandikar, Ninad] Univ Kentucky, Lexington, KY 40506 USA	Birthi, P (corresponding author), Univ Kentucky, Lexington, KY 40506 USA.						Bezchlibnyk-Butler K, 2000, J PSYCHIATR NEUROSCI, V25, P241; Brasic JR, 2010, TARDIVE DYSKINESIA; de Lago E, 2007, LIFE SCI, V80, P979, DOI 10.1016/j.lfs.2006.11.029; Groenendijk C, SSRI SSNRI ANTIDEPRE; Han P, 2002, CASE MONTH COMPREHEN, V2; Lavalaye J, 2001, PSYCHOPHARMACOLOGY, V155, P107, DOI 10.1007/s002130000670; Leo RJ, 1996, J CLIN PSYCHIAT, V57, P449, DOI 10.4088/JCP.v57n1002; Lozsadi DA, 2004, MOVEMENT DISORD, V19, P708, DOI 10.1002/mds.10696	8	12	12	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482			PM&R	PM&R	OCT	2010	2	10					973	975		10.1016/j.pmrj.2010.05.007			3	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	V23SE	WOS:000208361700021	20970768				2021-06-18	
J	Gordon, KE; Dooley, JM; Fitzpatrick, EA; Wren, P; Wood, EP				Gordon, Kevin E.; Dooley, Joseph M.; Fitzpatrick, Eleanor A.; Wren, Patty; Wood, Ellen P.			Concussion or Mild Traumatic Brain Injury: Parents Appreciate the Nuances of Nosology	PEDIATRIC NEUROLOGY			English	Article							STATEMENT; SPORT	We explored whether parents of our pediatric patients valued the diagnostic terms "concussion," "minor traumatic brain injury," and "mild traumatic brain injury" as equivalent or nonequivalent. 1734 of 2304 parents attending a regional pediatric emergency department completed a brief questionnaire assessing the equivalence or nonequivalence of the diagnostic terms "concussion," "minor traumatic brain injury," and "mild traumatic brain injury" in a pairwise fashion. Many parents viewed these diagnostic terms as equivalent, when assessed side by side. For those who considered these diagnostic terms nonequivalent, concussion was regarded as considerably "better" (or less "worse") than minor traumatic brain injury (P < 0.001, chi(2) test) or mild traumatic brain injury (P < 0.001, chi(2) test). A moderate degree of variability was evident in parent/guardian responses. As a group, parents reported that concussion or mild/minor traumatic brain injuries are valued equivalently. However, many parents considered them different, with concussion reflecting a "better" (or less "worse") outcome. (C) 2010 by Elsevier Inc. All rights reserved.	[Gordon, Kevin E.; Dooley, Joseph M.; Wood, Ellen P.] IWK Hlth Ctr, Dept Pediat, Div Pediat Neurol, Halifax, NS B3K 6R8, Canada; [Fitzpatrick, Eleanor A.; Wren, Patty] IWK Hlth Ctr, Dept Emergency Med, Halifax, NS B3K 6R8, Canada; [Gordon, Kevin E.; Dooley, Joseph M.; Wood, Ellen P.] Dalhousie Univ, Dept Pediat, Div Pediat Neurol, Halifax, NS, Canada	Gordon, KE (corresponding author), IWK Hlth Ctr, Dept Pediat, Div Pediat Neurol, 5850 Univ Ave, Halifax, NS B3K 6R8, Canada.	kegor@dal.ca					Anderson T, 2006, PRACT NEUROL, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; FIENBERG SE, 1989, SCIENCE, V243, P1017, DOI 10.1126/science.243.4894.1017; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kelly JP, 1997, NEUROLOGY, V48, P581; Lauritsen JM., 2000, EPIDATA DATA ENTRY D; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Rutherford W. H., 1989, MILD HEAD INJURY, P217; *SSPS INC, 1997, SYSTAT VERS 9 0; Statistics Canada, 2006, CAN COMM HLTH SURV C; Thiessen ML, 2006, PEDIATR CLIN N AM, V53, P1, DOI 10.1016/j.pcl.2005.09.004	14	12	12	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	OCT	2010	43	4					253	257		10.1016/j.pediatrneurol.2010.05.012			5	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	676KC	WOS:000283908800005	20837303				2021-06-18	
J	Koizumi, H; Fujisawa, H; Kurokawa, T; Suehiro, E; Iwanaga, H; Nakagawara, J; Suzuki, M				Koizumi, Hiroyasu; Fujisawa, Hirosuke; Kurokawa, Tetsu; Suehiro, Eiichi; Iwanaga, Hideyuki; Nakagawara, Jyoji; Suzuki, Michiyasu			Recovered neuronal viability revealed by Iodine-123-iomazenil SPECT following traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						brain imaging; brain recovery; brain trauma; neuroradiology; SPECT	POSITRON-EMISSION-TOMOGRAPHY; TEMPORAL-LOBE EPILEPSY; I-123-IOMAZENIL SPECT; COMPUTED-TOMOGRAPHY; CEREBRAL INFARCTION; CORTICAL DAMAGE; SEVERITY; IOMAZENIL; IDENTIFICATION; INTEGRITY	We evaluated cortical damages following traumatic brain injury (TBI) in the acute phase with [(123)I] iomazenil (IMZ) single photon emission computed tomography (SPECT). In all, 12 patients with cerebral contusion following TBI were recruited. All patients underwent IMZ SPECT within 1 week after TBI. To investigate the changes in distribution of IMZ in the cortex in the chronic phase, after conventional treatment, patients underwent IMZ SPECT again. A decrease in the accumulation of radioligand for the central benzodiazepine receptor in the cortex corresponding to the contusion revealed with computed tomography (CT) scans and magnetic resonance imaging (MRI) were shown on IMZ SPECT in the acute phase in all patients. In 9 of 12 patients (75%), images of IMZ SPECT obtained in the chronic phase of TBI showed that areas with a decreased distribution of IMZ were remarkably reduced in comparison with those obtained in the acute phase. Both CT scans and MRI showed a normal appearance of the cortex morphologically, where the binding potential of IMZ recovered in the chronic phase. Reduced binding potential of radioligand for the central benzodiazepine receptor is considered to be an irreversible reaction; however, in this study, IMZ accumulation in the cortex following TBI was recovered in the chronic phase in several patients. [(123)I] iomazenil SPECT may have a potential to disclose a reversible vulnerability of neurons following TBI. Journal of Cerebral Blood Flow & Metabolism (2010) 30, 1673-1681; doi:10.1038/jcbfm.2010.75; published online 4 August 2010	[Koizumi, Hiroyasu; Fujisawa, Hirosuke; Kurokawa, Tetsu; Suehiro, Eiichi; Suzuki, Michiyasu] Yamaguchi Univ, Sch Med, Dept Neurosurg, Yamaguchi 7558505, Japan; [Iwanaga, Hideyuki] Yamaguchi Univ, Sch Med, Dept Radiol, Yamaguchi 7558505, Japan	Koizumi, H (corresponding author), Yamaguchi Univ, Sch Med, Dept Neurosurg, Yamaguchi 7558505, Japan.	hiroyasu@yamaguchi-u.ac.jp	Suehiro, Eiichi/I-5852-2019				Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; BEER HF, 1990, J NUCL MED, V31, P1007; BENAVIDES J, 1989, PHARM CEREBRAL ISCHE, P39; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; DEGIROLAMI U, 1984, J NEUROPATH EXP NEUR, V43, P57, DOI 10.1097/00005072-198401000-00005; DEY HM, 1994, J NUCL MED, V35, P399; GALE SD, 1995, J NEUROTRAUM, V12, P151, DOI 10.1089/neu.1995.12.151; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Goetz P, 2004, J NEUROTRAUM, V21, P645, DOI 10.1089/0897715041269731; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; HATAZAWA J, 1995, J NUCL MED, V36, P2154; HATAZAWA J, 1995, STROKE, V26, P2267, DOI 10.1161/01.STR.26.12.2267; Hattori N, 2004, J NUCL MED, V45, P775; Hattori N, 2003, J NUCL MED, V44, P1709; Heiss WD, 2000, STROKE, V31, P366, DOI 10.1161/01.STR.31.2.366; Heiss WD, 1997, STROKE, V28, P2045, DOI 10.1161/01.STR.28.10.2045; Heiss WD, 1998, STROKE, V29, P454, DOI 10.1161/01.STR.29.2.454; Kaneko K, 2006, NUCL MED COMMUN, V27, P893, DOI 10.1097/01.mnm.0000243380.79872.32; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; MIES G, 1983, STROKE, V14, P22, DOI 10.1161/01.STR.14.1.22; MINOSHIMA S, 1994, J NUCL MED, V35, P1528; Mizumura S, 2003, ANN NUCL MED, V17, P289, DOI 10.1007/BF02988523; Muller V, 2002, NUCL MED COMMUN, V23, P1191, DOI 10.1097/01.mnm.0000046211.83338.0c; Nakagawara J, 1997, STROKE, V28, P124, DOI 10.1161/01.STR.28.1.124; Rudolf J, 2000, LANCET, V355, P115, DOI 10.1016/S0140-6736(99)04280-4; Saur D, 2006, STROKE, V37, P2713, DOI 10.1161/01.STR.0000244827.36393.8f; Shiga T, 2006, EUR J NUCL MED MOL I, V33, P817, DOI 10.1007/s00259-005-0033-y; Umeoka S, 2007, J NEUROSURG, V107, P352, DOI 10.3171/JNS-07/08/0352; Wu HM, 2004, NEUROSURGERY, V55, P1306, DOI 10.1227/01.NEU.0000143028.08719.42; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613	31	12	13	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2010	30	10					1673	1681		10.1038/jcbfm.2010.75			9	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	657AK	WOS:000282382200002	20683454	Green Published, Bronze			2021-06-18	
J	Nakao, K; Kibayashi, K; Taki, T; Koyama, H				Nakao, Ken-ichiro; Kibayashi, Kazuhiko; Taki, Takashi; Koyama, Hiroyoshi			Changes in the Brain after Intracerebral Implantation of a Lead Pellet in the Rat	JOURNAL OF NEUROTRAUMA			English	Article						bullet; firearm; gunshot wound; lead; penetrating brain injury	TRAUMATIC BRAIN; CELL-DEATH; INJURY; METALLOTHIONEIN; EXPRESSION; HIPPOCAMPUS; ASTROCYTES; EXPOSURE; NEURONS; BULLET	In gunshot wounds to the head, the bullet containing neurotoxic lead may remain in the brain after trauma, and brain damage is therefore anticipated. We developed an animal model incorporating a lead ball implanted in the brain, or a glass ball as a control, and analyzed histological and biochemical changes in the brain for 28 days after surgery. The concentration of lead in the brain increased with time after implantation of the lead ball, while lead was not detected in brains implanted with a glass ball. A number of changes were noted following implantation of the lead ball. The number of neutrophils increased significantly at 7-28 days, while the number of macrophages also increased significantly with time. The number of neurons was significantly decreased by 28 days, and apoptotic cells were identified at 14-28 days. Expression of genes encoding N-methyl-D-aspartate receptors, which are related to cognitive function and help regulate apoptosis, was significantly suppressed at 7-21 days after implantation. Expression of metallothionein protein increased significantly with time. Metallothionein detoxifies lead and its overexpression is a known method of protection against lead neurotoxicity. These findings indicate that intracerebral lead induces neuronal degeneration that is attributable in part to the inflammation and apoptosis caused by leached lead. Although the severity of the brain damage primarily depends on the destructive effect of the moving bullet, the results of this study indicate that lead leaching from the residual bullet also damages the brain.	[Kibayashi, Kazuhiko] Tokyo Womens Med Univ, Dept Legal Med, Sch Med, Shinjuku Ku, Tokyo 1628666, Japan; [Nakao, Ken-ichiro; Koyama, Hiroyoshi] Saga Univ, Dept Forens Med, Fac Med, Saga 840, Japan	Kibayashi, K (corresponding author), Tokyo Womens Med Univ, Dept Legal Med, Sch Med, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	kibayash@research.twmu.ac.jp	Kazuhiko, Kibayashi/F-5173-2013	Kazuhiko, Kibayashi/0000-0001-6510-5215; Taki, Takashi/0000-0002-7350-538X	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [19390186, 21659177]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [22330027] Funding Source: KAKEN	This work was supported by grants to K.K. from the Japan Society for the Promotion of Science (no. 19390186 and 21659177).	Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; BELLINGER D, 1991, PEDIATRICS, V87, P219; Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020; Chan K-K, 2002, THEORY PRACTICE HIST, P243; Chao CC, 1996, GLIA, V16, P276, DOI 10.1002/(SICI)1098-1136(199603)16:3<276::AID-GLIA10>3.0.CO;2-X; Chung RS, 2008, J BIOL CHEM, V283, P15349, DOI 10.1074/jbc.M708446200; DIMAIO VJM, 1985, GUNSHOT WOUNDS PRACT, P1; El-Neweshy MS, 2011, EXP TOXICOL PATHOL, V63, P221, DOI 10.1016/j.etp.2009.12.003; Farrell SE, 1999, ACAD EMERG MED, V6, P208, DOI 10.1111/j.1553-2712.1999.tb00157.x; Gutierrez-Gonzalez R, 2008, CLIN NEUROL NEUROSUR, V110, P207, DOI 10.1016/j.clineuro.2007.09.014; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Hyong A, 2008, BRAIN RES, V1215, P218, DOI 10.1016/j.brainres.2008.04.025; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Kaminski KA, 2002, INT J CARDIOL, V86, P41, DOI 10.1016/S0167-5273(02)00189-4; KANE AB, 1999, ROBBINS COTRAN PATHO, V7, P415; Kuhlmann AC, 1997, NEUROSCI LETT, V233, P101, DOI 10.1016/S0304-3940(97)00633-2; Lau WK, 2002, BRAIN RES, V932, P10, DOI 10.1016/S0006-8993(01)03395-9; LINDENBERG R, 1993, SPITZ FISHERS MEDICO, P585; Luo JH, 1997, MOL PHARMACOL, V51, P79; Mizuno T, 2005, BRAIN RES, V1066, P78, DOI 10.1016/j.brainres.2005.10.050; NAIDOO SR, 2005, ENCY FORENSIC LEGAL, P271; Nathoo N, 2000, NEUROSURGERY, V47, P1117, DOI 10.1097/00006123-200011000-00018; Neal JW, 1996, NEUROPATH APPL NEURO, V22, P243; Nihei MK, 1999, MOL BRAIN RES, V66, P42, DOI 10.1016/S0169-328X(99)00005-4; Ozkan U, 2002, NEUROSURG REV, V25, P231, DOI 10.1007/s101430100173; Ozkan U, 2006, CLIN NEUROL NEUROSUR, V108, P573, DOI 10.1016/j.clineuro.2005.03.002; PENKOWA M, 1995, GLIA, V13, P217, DOI 10.1002/glia.440130308; Penkowa M, 1999, J NEUROSCI, V19, P2535; Pruitt BA, 2001, J TRAUMA, V51, pS1, DOI 10.1097/00005373-200108001-00001; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; RENGACHARY SS, 1992, NEUROSURGERY, V30, P291, DOI 10.1227/00006123-199202000-00029; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Sharifi AM, 2002, NEUROSCI LETT, V329, P45, DOI 10.1016/S0304-3940(02)00576-1; Shojo H, 2006, BRAIN RES, V1078, P198, DOI 10.1016/j.brainres.2006.01.063; Tsai AT, 2005, BIOMATERIALS, V26, P5835, DOI 10.1016/j.biomaterials.2005.03.003; Vikman P, 2007, J NEUROSURG, V107, P1015, DOI 10.3171/JNS-07/11/1015; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Wunnapuk K, 2007, BIOL TRACE ELEM RES, V120, P74, DOI 10.1007/s12011-007-8014-6; YAM LT, 1971, AM J CLIN PATHOL, V55, P283; YAMAMOTO I, 1985, SURG NEUROL, V23, P396, DOI 10.1016/0090-3019(85)90215-0; Zhang J, 2004, FREE RADICAL BIO MED, V37, P1037, DOI 10.1016/j.freeradbiomed.2004.06.037	42	12	12	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2010	27	10					1925	1934		10.1089/neu.2010.1379			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	665OZ	WOS:000283046600016	20698761				2021-06-18	
J	Xie, JR; Qian, ZY; Yang, TM; Li, WT; Hu, GX				Xie, Jieru; Qian, Zhiyu; Yang, Tianming; Li, Weitao; Hu, Guangxia			Minimally invasive assessment of the effect of mannitol and hypertonic saline therapy on traumatic brain edema using measurements of reduced scattering coefficient (mu '(s))	APPLIED OPTICS			English	Article							CEREBRAL EDEMA; INTRACRANIAL-PRESSURE; HEMORRHAGIC-SHOCK; INJURY; SURVIVAL	Minimally invasive functional near infrared spectroscopy (fNIRs) technology was utilized to assess the effects of mannitol and hypertonic saline (HS) in treating traumatic brain edema (TBE). Rats with TBE models were given mannitol or HS in different dosages for different groups. The reduced scattering coefficient (mu'(s)) of the local cortex of rats was simultaneously monitored and recorded in vivo and real time by the minimally invasive fNIRs system. Brain water content (BWC) was measured by the wet and dry weight method at 1, 6, 24, 72, and 120 h after injury and treatment. Effects of treating TBE with different dehydration agents were then assessed by recording mu'(s) and BWC before and after administration of dehydration. In this study, the dynamic changes of brain edema and the effects of dehydration therapy were continuously monitored. Results implied that mu'(s) of the local cortex in rats is a good indicator for assessing effects of treatment of TBE. By recording changes in the value of mu'(s), the following conclusions were obtained: HS is more effective than mannitol in reducing cerebral edema. The effect of dehydration of HS is only related to osmotic gradient and has no correlation with concentration. (C) 2010 Optical Society of America	[Xie, Jieru; Qian, Zhiyu; Li, Weitao; Hu, Guangxia] Nanjing Univ Aeronaut & Astronaut, Dept Biomed Engn, Nanjing 210016, Peoples R China; [Yang, Tianming] Southeast Univ, Sch Clin Med, Nanjing 210009, Peoples R China	Qian, ZY (corresponding author), Nanjing Univ Aeronaut & Astronaut, Dept Biomed Engn, 29 Yudao St, Nanjing 210016, Peoples R China.	zhiyu@nuaa.edu.cn			National High Technology Research and Development Program ("863" Program) of ChinaNational High Technology Research and Development Program of China [2008AA02Z438]; Natural Science Foundation of Jiangsu Province of ChinaNatural Science Foundation of Jiangsu Province [BK2009371]	This work was carried out in the Biophotonics Laboratory in the University of Aeronautics and Astronautics and was financially supported by the National High Technology Research and Development Program ("863" Program) of China (2008AA02Z438) and the Natural Science Foundation of Jiangsu Province of China (BK2009371).	Al-Rawi PG, 2001, STROKE, V32, P2492, DOI 10.1161/hs1101.098356; Ashman TA, 2006, MT SINAI J MED, V73, P999; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; BULLOCK MR, 2006, NEUROSURG QUART, V58, P306; Dai LJ, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2957974; Deitch EA, 2003, SHOCK, V19, P328, DOI 10.1097/00024382-200304000-00006; DONATO T, 1994, ANESTH ANALG, V78, P58; DORMAN HR, 1990, MEDICINE, V69, P153, DOI 10.1097/00005792-199005000-00003; Dziedzic T, 2003, CLIN NEUROL NEUROSUR, V105, P87, DOI 10.1016/S0303-8467(02)00106-3; FANTINI S, 1995, OPT ENG, V34, P32, DOI 10.1117/12.183988; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; GOLDWASSER P, 1984, ARCH INTERN MED, V144, P2214, DOI 10.1001/archinte.144.11.2214; HARTWELL RC, 1993, NEUROSURGERY, V32, P444, DOI 10.1227/00006123-199303000-00017; Hirsh M, 2002, CRIT CARE MED, V30, P861, DOI 10.1097/00003246-200204000-00025; James HE, 2006, ACT NEUR S, V96, P125; JIA W, 2001, J CAPITAL U MED SCI, V22, P216; Junger H, 2003, J MOL NEUROSCI, V21, P111, DOI 10.1385/JMN:21:2:111; KOBAYASHI H, 1995, SURG NEUROL, V44, P55, DOI 10.1016/0090-3019(95)00065-8; Kolsen-Petersen JA, 2004, ACTA ANAESTH SCAND, V48, P667, DOI 10.1111/j.1399-6576.2004.00396.x; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Oi Y, 2000, CRIT CARE MED, V28, P2843, DOI 10.1097/00003246-200008000-00027; OKIYAMA K, 1992, J NEUROSURG, V77, P607, DOI 10.3171/jns.1992.77.4.0607; Perez-Perez AJ, 2002, AM J NEPHROL, V22, P573, DOI 10.1159/000065279; Prough DS, 1998, CRIT CARE MED, V26, P997, DOI 10.1097/00003246-199806000-00013; QIAN Z, 2005, J MED PHYS, V22, P463; Qian Zhi-yu, 2004, Journal of Nanjing University of Aeronautics & Astronautics, V36, P369; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Rabinstein AA, 2006, NEUROLOGIST, V12, P59, DOI 10.1097/01.nrl.0000186810.62736.f0; Schwarz S, 2002, STROKE, V33, P136, DOI 10.1161/hs0102.100877; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Todd MM, 2006, ANESTHESIOLOGY, V105, P1176, DOI 10.1097/00000542-200612000-00017; Visweswaran P, 1997, J AM SOC NEPHROL, V8, P1028; WANG G, 2000, NEW CHIN MED, V31, P413; Wenham TN, 2008, ANAESTHESIA, V63, P558, DOI 10.1111/j.1365-2044.2008.05532.x; WHELAN TV, 1984, ARCH INTERN MED, V144, P2053, DOI 10.1001/archinte.144.10.2053; Xie JR, 2009, SPECTROSC SPECT ANAL, V29, P3254, DOI 10.3964/j.issn.1000-0593(2009)12-3254-05; Yada-Langui MM, 2004, EXP BIOL MED, V229, P684; ZENG H, 2002, CHIN J EMER MED, V11, P176; ZHU G, 1997, CHIN J NERV MENT DIS, V23, P286	40	12	12	0	4	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	OCT 1	2010	49	28					5407	5414		10.1364/AO.49.005407			8	Optics	Optics	657WO	WOS:000282449800028	20885479				2021-06-18	
J	Jiang, H; Peng, J; Zhou, ZY; Duan, Y; Chen, W; Cai, B; Yang, H; Zhang, W				Jiang Hua; Peng Jin; Zhou Zhi-yuan; Duan Yu; Chen Wei; Cai Bin; Yang Hao; Zhang Wei			Establishing H-1 nuclear magnetic resonance based metabonomics fingerprinting profile for spinal cord injury: a pilot study	CHINESE MEDICAL JOURNAL			English	Article						metabonomic; spinal cord injury; H-1 nuclear magnetic resonance; principal component analysis	POLYUNSATURATED FATTY-ACIDS; TRAUMATIC BRAIN-INJURY; METABOLIC RESPONSE; AMINO-ACIDS; DIAGNOSIS; HMDB; N-3	Background Spinal cord injury (SCI) is a complex trauma that consists of multiple pathological mechanisms involving cytotoxic, oxidation stress and immune-endocrine. This study aimed to establish plasma metabonomics fingerprinting atlas for SCI using H-1 nuclear magnetic resonance (NMR) based metabonomics methodology and principal component analysis techniques. Methods Nine Sprague-Dawley (SD) male rats were randomly divided into SCI, normal and sham-operation control groups. Plasma samples were collected for H-1 NMR spectroscopy 3 days after operation. The NMR data were analyzed using principal component analysis technique with Matlab software. Results Metabonomics analysis was able to distinguish the three groups (SCI, normal control, sham-operation). The fingerprinting atlas indicated that, compared with those without SCI, the SCI group demonstrated the following characteristics with regard to second principal component: it is made up of fatty acids, myc-inositol, arginine, very low-density lipoprotein (VLDL), low-density lipoprotein (LDL), triglyceride (TG), glucose, and 3-methyl-histamine. Conclusions The data indicated that SCI results in several significant changes in plasma metabolism early on and that a metabonomics approach based on H-1 NMR spectroscopy can provide a metabolic profile comprising several metabolite classes and allow for relative quantification of such changes. The results also provided support for further development and application of metabonomics technologies for studying SCI and for the utilization of multivariate models for classifying the extent of trauma within an individual. Chin Med J 2010;123(17):2315-2319	[Peng Jin; Duan Yu; Zhang Wei] Sichuan Univ, Dept Histol Embryol & Neurobiol, W China Med Sch, Chengdu 610041, Sichuan, Peoples R China; [Jiang Hua; Cai Bin] Sichuan Acad Med Sci, Metabon & Multidisciplinary Lab Trauma Res, East Branch, Chengdu 610101, Sichuan, Peoples R China; [Jiang Hua; Cai Bin] Sichuan Prov Peoples Hosp, Chengdu 610101, Sichuan, Peoples R China; [Zhou Zhi-yuan] Luzhou Med Coll, Dept Biochem, Luzhou 646000, Sichuan, Peoples R China; [Chen Wei] Beijing Union Med Coll Hosp, Dept Parenteral & Enteral Nutr, Beijing 100730, Peoples R China; [Yang Hao] Sichuan Univ, Dept Math, Chengdu 610041, Sichuan, Peoples R China	Zhang, W (corresponding author), Sichuan Univ, Dept Histol Embryol & Neurobiol, W China Med Sch, Chengdu 610041, Sichuan, Peoples R China.	zhangwi25091@gmail.com			Administration of Science and Technology of Sichuan Province [2007jy076]	This work was supported by a grant from Administration of Science and Technology of Sichuan Province (No. 2007jy076).	Aberg KM, 2009, ANAL BIOANAL CHEM, V394, P151, DOI 10.1007/s00216-009-2628-9; Baptiste DC, 2006, J NEUROTRAUM, V23, P318, DOI 10.1089/neu.2006.23.318; Betenbaugh M, 2008, CURR OPIN BIOTECH, V19, P411, DOI 10.1016/j.copbio.2008.08.009; Blondeau N, 2002, NEUROSCIENCE, V109, P231, DOI 10.1016/S0306-4522(01)00473-0; Ciosek P, 2005, TALANTA, V67, P590, DOI 10.1016/j.talanta.2005.03.006; Endres S, 1996, CURR OPIN LIPIDOL, V7, P48, DOI 10.1097/00041433-199602000-00011; Facheris M, 2004, J ALZHEIMERS DIS, V6, P177; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Jacobs WB, 2003, NEUROSURGERY, V53, P943, DOI 10.1227/01.NEU.0000083592.74383.B1; KEARNS PJ, 1992, JPEN-PARENTER ENTER, V16, P11, DOI 10.1177/014860719201600111; Kimura T, 2009, CURR OPIN CLIN NUTR, V12, P49, DOI 10.1097/MCO.0b013e3283169242; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; Li JJ, 2004, CHIN J REHABIL THEOR, V10, P412; Liu CL, 2002, CHINESE MED J-PEKING, V115, P740; NINNI W, 1998, ARCH PHYS MED REHAB, V79, P1433; Pan JLX, 2009, J TONGI U, V30, P131; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; PORTOCARRERO V, 2002, BRAIN RES, V927, P104; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Rodriguez DJ, 1997, SPINAL CORD, V35, P599, DOI 10.1038/sj.sc.3100439; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Tashiro T, 1998, NUTRITION, V14, P551, DOI 10.1016/S0899-9007(98)00048-3; Viant MR, 2005, NMR BIOMED, V18, P507, DOI 10.1002/nbm.980; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810	25	12	14	0	7	CHINESE MEDICAL ASSOC	BEIJING	42 DONGSI XIDAJIE, BEIJING 100710, PEOPLES R CHINA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	SEP 5	2010	123	17					2315	2319		10.3760/cma.j.issn.0366-6999.2010.17.006			5	Medicine, General & Internal	General & Internal Medicine	654FM	WOS:000282153900006	21034541	DOAJ Gold			2021-06-18	
J	Qu, CS; Mahmood, A; Ning, RZ; Xiong, Y; Zhang, L; Chen, JL; Jiang, H; Chopp, M				Qu, Changsheng; Mahmood, Asim; Ning, Ruizhuo; Xiong, Ye; Zhang, Li; Chen, Jieli; Jiang, Hao; Chopp, Michael			The Treatment of Traumatic Brain Injury with Velcade	JOURNAL OF NEUROTRAUMA			English	Article						neuroprotection; rats; traumatic brain injury; Velcade	NF-KAPPA-B; PROTEASOME INHIBITOR BORTEZOMIB; FOCAL CEREBRAL-ISCHEMIA; MANTLE CELL LYMPHOMA; MATRIX METALLOPROTEINASES; EMBOLIC STROKE; UP-REGULATION; PHASE-II; RATS; ACTIVATION	Traumatic brain injury (TBI) elicits a strong inflammatory response that contributes to the acute pathological processes seen following TBI, including cerebral edema and disruption of the blood-brain barrier (BBB), in addition to longer-term neurological damage and cognitive impairment. Proteasome inhibitors reduce vascular thrombotic and inflammatory events and consequently protect vascular function. In the present study we evaluated the neuroprotective effect of Velcade (R) (bortezomib), a potent and selective inhibitor of proteasomes, which is in clinical use for the treatment of multiple myeloma. When administered within 2 h after TBI onset, Velcade reduced inflammatory responses, lesion volume, and neurological functional deficits, and enhanced neuronal survival. Western blot and ELISA showed that Velcade decreased the expression of NF-kB. These results suggest that in the experimental setting, Velcade is an effective neuroprotective agent for the treatment of TBI.	[Chopp, Michael] Henry Ford Hosp, Dept Neurol, Henry Ford Hlth Syst, Detroit, MI 48202 USA; [Qu, Changsheng; Mahmood, Asim; Ning, Ruizhuo; Xiong, Ye] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI USA	Chopp, M (corresponding author), Henry Ford Hosp, Dept Neurol, Henry Ford Hlth Syst, E&R Bldg 3056,2799 W Grand Blvd, Detroit, MI 48202 USA.	chopp@neuro.hfh.edu	ning, ruizhuo/E-6401-2012	Xiong, Ye/0000-0001-9770-6031	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [PO1 NS42345, RO1 NS42259]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS042345, R01NS042259, R01NS062832] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health grants PO1 NS42345 and RO1 NS42259. Special thanks to Susan MacPhee-Gray for editorial assistance.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; CARRION JS, 2000, COMPLUTUM, V11, P1; Cavaletti G, 2007, EXP NEUROL, V204, P317, DOI 10.1016/j.expneurol.2006.11.010; Chen G, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/93431; CLAUSEN F, 2004, THESIS FM, V1359, P1; Clemens JA, 1997, STROKE, V28, P1073, DOI 10.1161/01.STR.28.5.1073; Day LB, 1999, BEHAV NEUROSCI, V113, P914, DOI 10.1037/0735-7044.113.5.914; Day LB, 1996, BEHAV NEUROSCI, V110, P998; Dechend R, 1999, CIRCULATION, V100, P1369, DOI 10.1161/01.CIR.100.13.1369; DelZoppo GJ, 1997, ANN NY ACAD SCI, V823, P132; Di Napoli Mario, 2003, Curr Opin Investig Drugs, V4, P333; Elliott PJ, 2003, J MOL MED, V81, P235, DOI 10.1007/s00109-003-0422-2; Fisher RI, 2006, J CLIN ONCOL, V24, P4867, DOI 10.1200/JCO.2006.07.9665; Gilardini A, 2008, CURR MED CHEM, V15, P3025, DOI 10.2174/092986708786848622; Henninger N, 2006, NEUROSCI LETT, V398, P300, DOI 10.1016/j.neulet.2006.01.015; Jakob C, 2007, BLOOD, V109, P2100, DOI 10.1182/blood-2006-04-016360; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Koreth J, 2009, BIOL BLOOD MARROW TR, V15, P1502, DOI 10.1016/j.bbmt.2009.07.016; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee SW, 2009, ANN RHEUM DIS, V68, P1761, DOI 10.1136/ard.2008.097709; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Magnani M., 2000, Current Drug Targets, V1, P387, DOI 10.2174/1389450003349056; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Monaco C, 2004, P NATL ACAD SCI USA, V101, P5634, DOI 10.1073/pnas.0401060101; Mun-Bryce S, 1998, J CEREBR BLOOD F MET, V18, P1163, DOI 10.1097/00004647-199811000-00001; Nawrocki ST, 2004, MOL CANCER THER, V3, P59; Nurmi A, 2004, STROKE, V35, P987, DOI 10.1161/01.STR.0000120732.45951.26; O'Connor OA, 2005, J CLIN ONCOL, V23, P676, DOI 10.1200/JCO.2005.02.050; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pan DS, 2007, BIOMED ENVIRON SCI, V20, P432; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; REH T, 1982, J COMP NEUROL, V211, P276, DOI 10.1002/cne.902110306; Roman-Blas JA, 2008, INT REV IMMUNOL, V27, P351, DOI 10.1080/08830180802295740; Rosenberg GA, 2001, BRAIN RES, V893, P104, DOI 10.1016/S0006-8993(00)03294-7; Schenkein D, 2002, CLIN LYMPHOMA, V3, P49, DOI 10.3816/CLM.2002.n.011; Schneider A, 1999, NAT MED, V5, P554; Shah SA, 2001, J CELL BIOCHEM, V82, P110, DOI 10.1002/jcb.1150; Shuaib A, 2002, STROKE, V33, P3033, DOI 10.1161/01.STR.0000039405.31526.06; Sinn DI, 2007, NEUROSCI RES, V58, P12, DOI 10.1016/j.neures.2007.01.006; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Williams AJ, 2006, NEUROCHEM INT, V49, P106, DOI 10.1016/j.neuint.2006.03.018; Yamada K, 1999, BRIT J PHARMACOL, V126, P235, DOI 10.1038/sj.bjp.0702309; Zhang L, 2006, THROMB HAEMOSTASIS, V95, P166, DOI 10.1160/TH05-07-0477	51	12	12	0	1	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2010	27	9					1625	1634		10.1089/neu.2010.1359			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	649TJ	WOS:000281796500009	20649468	Green Published			2021-06-18	
J	Quinlan, JD; Gauron, MR; Deschere, BR; Stephens, MB				Quinlan, Jeffrey D.; Gauron, Michael R.; Deschere, Bruce R.; Stephens, Mark B.			Care of the Returning Veteran	AMERICAN FAMILY PHYSICIAN			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; OPERATION IRAQI FREEDOM; VIETNAM VETERANS; US VETERANS; RISK; ARMY; AFGHANISTAN; DEPRESSION; SOLDIERS	Of the 23.8 million military veterans living in the United States, approximately 3 million have served in Operation Enduring Freedom or Operation Iraqi Freedom. The injuries and illnesses that affect veterans returning from combat are predictable. Blast injuries are common and most often present as mild traumatic brain injury, which is synonymous with concussion. Family physicians caring for returning veterans will also encounter conditions such as posttraumatic stress disorder at rates higher than those in the general population. The symptoms associated with posttraumatic stress disorder and mild traumatic brain injury often overlap and can present concurrently. Treatment of traumatic brain injury should be based on symptoms and guided by clinical practice guidelines from the U.S. Department of Veterans Affairs and Department of Defense. Family physicians should understand the range of post-war health concerns and screen returning service members for posttraumatic stress disorder, substance abuse, suicidality, and clinical depression. Family physicians are well positioned to offer continuity of care for issues affecting returning service members and to coordinate the delivery of specialized care when needed. (Am Fam Physician. 2010;82(1):43-49. Copyright (C) 2010 American Academy of Family Physicians.)	[Stephens, Mark B.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Bethesda, MD 20814 USA; [Quinlan, Jeffrey D.] USN, Med Support Command, Jacksonville, FL USA; [Gauron, Michael R.] Mike OCallaghan Fed Hosp, Family Med Residency Program, Nellis AFB, NV USA; [Deschere, Bruce R.] USN, Hosp Pensacola, Family Med Residency Program, Pensacola, FL USA	Stephens, MB (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	mstephens@usuhs.mil	Stephens, Mark/A-2679-2015				American Psychiatric Association, 2000, DIAGN STAT MAN MENT, P467; Ballenger JC, 2004, J CLIN PSYCHIAT, V65, P55; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bisson J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003388.pub3; Bullman TA, 1996, AM J PUBLIC HEALTH, V86, P662, DOI 10.2105/AJPH.86.5.662; BULLMAN TA, 1994, J NERV MENT DIS, V182, P604, DOI 10.1097/00005053-199411000-00002; Centers for Disease Control and Prevention, TRAUM BRAIN INJ; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kang HK, 2008, JAMA-J AM MED ASSOC, V300, P652, DOI 10.1001/jama.300.6.652; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Patel TH, 2004, J TRAUMA, V57, P201, DOI 10.1097/01.TA.0000133638.30269.38; ROTHBERG JM, 1990, JAMA-J AM MED ASSOC, V264, P2241, DOI 10.1001/jama.264.17.2241; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; *US DEP VET AFF, MAN TRAUM STRESS DIS; *US DEP VET AFF, REP BLUE RIBB WORK G; US Department of Veterans Affairs/Department of Defense, CLIN PRACT GUID MAN; *USA HOOAH 4 HLTH, DEPL GUID FAM DEPL S; Weathers F.W., 1991, PCL M DSM 4; Wessely S, 2005, BRIT J PSYCHIAT, V186, P459, DOI 10.1192/bjp.186.6.459; Yarvis JS, 2008, J WORKPLACE BEHAV HE, V23, P395, DOI 10.1080/15555240802547801	25	12	12	0	8	AMER ACAD FAMILY PHYSICIANS	KANSAS CITY	8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA	0002-838X	1532-0650		AM FAM PHYSICIAN	Am. Fam. Physician	JUL 1	2010	82	1					43	49					7	Primary Health Care; Medicine, General & Internal	General & Internal Medicine	621PV	WOS:000279594300008	20590069				2021-06-18	
J	Savard, M; Turgeon, AF; Gariepy, JL; Trottier, F; Langevin, S				Savard, Martin; Turgeon, Alexis F.; Gariepy, Jean-Luc; Trottier, Francois; Langevin, Stephan			Selective 4 Vessels Angiography in Brain Death: A Retrospective Study	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; NEUROLOGICAL DETERMINATION; BLOOD-FLOW; SPIRAL CT; DIAGNOSIS; RECOMMENDATIONS; PRESSURE; INJURY	Background: In Canada, ancillary tests, such as selective four vessels angiography (S4VA), are sometimes necessary for brain death (BD) diagnosis when the clinical exam cannot be completed or confounding factors are present. Recent Canadian guidelines assert that brain death is supported by the absence of arterial blood flow at the surface of the brain and that venous return should not be considered. However, neuropathologic and angiographic studies have suggested that arteries might still be patent in BD patients. Current clinical practices in BD diagnosis following S4VA need to be better understood. Methods: We conducted a retrospective study of all S4VA performed for the determination of BD in a level 1 NeuroTrauma centre from 2003 to 2007. The objective of the study was to describe the prevalence of intracranial arterial, capillary (parenchymogram) and venous opacification in our study population. All tests were reviewed independently by two neuroradiologists. Disagreements were resolved by consensus. Results: Thirty two patients were declared BD following S4VA during the study period. Nine of these patients (28%) presented some proximal opacification of intracranial arteries (95% CI 15-45%). As opposed, none had a cerebral capillary and deep venous drainage opacification (95% CI 0-10%). Conclusion: The absence of cerebral deep venous drainage or parenchymogram might represent a better objective marker of cerebral circulatory arrest for brain death diagnosis when the use of S4VA is required. These findings open the path for further research in enhancing our interpretation of angiographic studies for brain death diagnosis.	[Savard, Martin] Univ Laval, Hop Enfants Jesus, Dept Neurol Sci, Ctr Hosp Affill,Univ Quebec, Quebec City, PQ G1J 1Z4, Canada; [Turgeon, Alexis F.; Langevin, Stephan] Univ Laval, Hop Enfants Jesus, Dept Anaesthesiol, Serv Soins Intensifs, Quebec City, PQ G1J 1Z4, Canada; [Turgeon, Alexis F.] Univ Laval, Hop Enfants Jesus, Unite Rech Traumatol Urgence Soins Intensifs, Ctr Rech CHA, Quebec City, PQ G1J 1Z4, Canada; [Gariepy, Jean-Luc; Trottier, Francois] Univ Laval, Hop Enfants Jesus, Dept Radiol, Ctr Hosp Affill,Univ Quebec, Quebec City, PQ G1J 1Z4, Canada	Savard, M (corresponding author), Univ Laval, Hop Enfants Jesus, Dept Neurol Sci, Ctr Hosp Affill,Univ Quebec, 1401 18E Rue Quebec, Quebec City, PQ G1J 1Z4, Canada.		Savard, Martin/O-2549-2019		Fonds de la Recherche en Sante du Quebec (FRSQ)Fonds de la Recherche en Sante du Quebec [015102]	The authors thank Dr. Robert Laforce Jr. for his help in the final redaction of this manuscript. Dr. Turgeon is a recipient of a Clinical Research Career Award from the Fonds de la Recherche en Sante du Quebec (FRSQ) and is supported by an operational grant from the FRSQ (#015102).	Altman D, 1991, PRACTICAL STAT MED R; BRADAC GB, 1974, NEURORADIOLOGY, V7, P25, DOI 10.1007/BF00344671; Braun M, 1997, NEURORADIOLOGY, V39, P400, DOI 10.1007/s002340050432; Combes JC, 2007, TRANSPLANT P, V39, P16, DOI 10.1016/j.transproceed.2006.10.204; Daboussi A, 2009, J NEUROSURG ANESTH, V21, P339, DOI 10.1097/ANA.0b013e3181b1dbba; de Freitas GR, 2003, J NEUROL SCI, V210, P31, DOI 10.1016/S0022-510X(03)00065-0; Ducrocq X, 1998, J NEUROL SCI, V160, P41, DOI 10.1016/S0022-510X(98)00188-9; Dupas B, 1998, AM J NEURORADIOL, V19, P641; KOREIN J, 1977, ANN NEUROL, V2, P195, DOI 10.1002/ana.410020304; Kricheff I I, 1978, Ann N Y Acad Sci, V315, P168, DOI 10.1111/j.1749-6632.1978.tb50338.x; Langfitt T W, 1966, Acta Neurochir (Wien), V14, P96, DOI 10.1007/BF01401893; Leclerc X, 2007, J NEURORADIOLOGY, V34, P217, DOI 10.1016/j.neurad.2007.07.008; Leclerc X, 2006, J NEURORADIOLOGY, V33, P90, DOI 10.1016/S0150-9861(06)77237-6; Monteiro LM, 2006, INTENS CARE MED, V32, P1937, DOI 10.1007/s00134-006-0353-9; Munari M, 2005, CRIT CARE MED, V33, P2068, DOI 10.1097/01.CCM.0000179143.19233.6A; Park MK, 2005, PEDIATR CARDIOL, V26, P601, DOI 10.1007/s00246-004-0828-9; PETTY GW, 1990, NEUROLOGY, V40, P300, DOI 10.1212/WNL.40.2.300; POWERS AD, 1989, NEUROSURGERY, V24, P884, DOI 10.1227/00006123-198906000-00015; Quesnel C, 2007, INTENS CARE MED, V33, P2129, DOI 10.1007/s00134-007-0789-6; Shemie SD, 2008, CAN J NEUROL SCI, V35, P140, DOI 10.1017/S0317167100008544; Shemie SD, 2006, CAN MED ASSOC J, V174, pS1, DOI 10.1503/cmaj.045142; VANBUNNEN Y, 1989, ANN RADIOL, V32, P279; VLAHOVITCH B, 1971, NEURO-CHIR, V17, P81	23	12	13	0	0	CANADIAN JOURNAL NEUROLOGICAL SCIENCES INC	CALGARY	709-7015 MACLEOD TRAIL SW, CALGARY, AB T2H 2K6, CANADA	0317-1671			CAN J NEUROL SCI	Can. J. Neurol. Sci.	JUL	2010	37	4					492	497		10.1017/S0317167100010520			6	Clinical Neurology	Neurosciences & Neurology	630DX	WOS:000280253900011	20724258	Bronze			2021-06-18	
J	Yen, LE; Gregory, A; Kuhn, JE; Markle, R				Yen, Leslianne E.; Gregory, Andrew; Kuhn, John E.; Markle, Ross			The Ultimate Frisbee Injury Study: The 2007 Ultimate Players Association College Championships	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						ultimate; frisbee; injury; college	DESCRIPTIVE EPIDEMIOLOGY; SURVEILLANCE SYSTEM; SOCCER INJURIES; SPORTS; RISK; KNEE	Objective: To quantify and characterize the injuries incurred by ultimate players during the 2007 Ultimate Players Association College Championships. Design: Cross-sectional study. Setting: The Ultimate Players Association College Championships in Columbus, Ohio, in May 2007. Participants: Athletes who left the field of play due to injury time-outs (ITOs). There were 107 recorded ITOs. Interventions: During the 3 days of the 2007 College Championships, 86 games were observed by the research staff. Athletes calling an ITO were interviewed. Sex, activity at time of injury, type of injury, and associated contact, if any, were recorded. Main Outcome Measures: Return to play, injury type, and injured body part. Results: One injury prevented return to play in each of the 2 sex divisions, equivalent to 1.66 per 1000 athlete-exposures in championships bracket games. The majority of ITOs were related to contact, 53% in the men's division and 68% in the women's division. The lower extremities were injured in 53% and 51% of cases in the men's and women's divisions, respectively. Laying out was one of the most common activities at time of ITO (29% and 22% in men's and women's divisions, respectively) and accounted for all of the men's closed head injuries and 2 of the 3 women's closed head injuries. Conclusions: There was a low rate of play-ending injuries. There were no statistically significant associations. Physical contact and laying out were frequently linked with ITO.	[Yen, Leslianne E.] Minor & James Med, Seattle, WA 98104 USA; [Gregory, Andrew; Kuhn, John E.] Vanderbilt Orthopaed Inst, Nashville, TN USA; [Markle, Ross] James Madison Univ, Ctr Assessment & Res Studies, Harrisonburg, VA 22807 USA	Yen, LE (corresponding author), Minor & James Med, 515 Minor Ave,Ste 300, Seattle, WA 98104 USA.	Leslianne.Yen@minorandjames.com			2006 Ultimate Players Association; Vanderbilt Sports Medicine Fellowship	Funding was provided by a 2006 Ultimate Players Association Innovation Grant and by the Vanderbilt Sports Medicine Fellowship.; The authors thank the Vanderbilt Sports Medicine faculty who made this research possible through their fellowship program, support, and funding. The authors also acknowledge the Ultimate Players Association for the Innovation Grant that partially funded this research, Matt Lane for his photography, the volunteer research staff, and Jon Ladd, PhD.	Agel J, 2007, J ATHL TRAINING, V42, P270; ARENDT E, 1995, AM J SPORT MED, V23, P694, DOI 10.1177/036354659502300611; BACKX FJG, 1991, AM J SPORT MED, V19, P124, DOI 10.1177/036354659101900206; Boden BP, 2000, ORTHOPEDICS, V23, P573, DOI 10.3928/0147-7447-20000601-15; Dick R, 2007, J ATHL TRAINING, V42, P278; Emery CA, 2005, MED SPORT SCI, V48, P179, DOI [10.1159/000085396, 10.1159/000084289]; Griffin L Y, 2000, J Am Acad Orthop Surg, V8, P141; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Junge A, 2006, AM J SPORT MED, V34, P565, DOI 10.1177/0363546505281807; Kofotolis ND, 2007, AM J SPORT MED, V35, P458, DOI 10.1177/0363546506294857; MADDEN CC, 2003, DELEE DREZS ORTHOPAE; Marfleet P, 1991, Br J Sports Med, V25, P235; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McGuine T, 2006, CLIN J SPORT MED, V16, P488, DOI 10.1097/01.jsm.0000248848.62368.43; NOYES FR, 1983, J BONE JOINT SURG AM, V65, P154, DOI 10.2106/00004623-198365020-00003; Renstrom P, 2008, BRIT J SPORT MED, V42, P394, DOI 10.1136/bjsm.2008.048934; Reynolds Kristen H, 2006, WMJ, V105, P46; RISSER WL, 1994, PEDIATRICS, V94, P757; STRAND T, 1990, J NOR MED ASS, V110, P45; *UPA, UPA MEMB BREAKD; Yu B, 2007, BRIT J SPORT MED, V41, pI47, DOI 10.1136/bjsm.2007.037192; 2009 COLL RC PACKET; ULTIMATE FAQ	23	12	12	0	19	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2010	20	4					300	305		10.1097/JSM.0b013e3181ea8b1c			6	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	622EA	WOS:000279641800009	20606516				2021-06-18	
J	Bitner, BR; Brink, DC; Mathew, LC; Pautler, RG; Robertson, CS				Bitner, Brittany R.; Brink, Danielle C.; Mathew, Leela C.; Pautler, Robia G.; Robertson, Claudia S.			Impact of arginase II on CBF in experimental cortical impact injury in mice using MRI	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						arginase II; CBF; MRI; NO; TBI	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; NITRIC-OXIDE; L-ARGININE; MOUSE; HEMODYNAMICS; WATER	Traumatic brain injury (TBI) results in reduced cerebral blood flow (CBF) and low levels of the vasodilator nitric oxide (NO) may be involved. Arginase II negatively regulates NO production through competition for the substrate L-arginine. We determined whether arginase II-deficient (ArgII(-/-)) mice would show improved CBF after TBI through arterial spin-labeling magnetic resonance imaging (MRI). The ArgII(-/-) mice exhibit a significantly improved CBF recovery after trauma in the perilesional brain (P=0.0015) and in various other brain regions. In conclusion, arginase II deficiency leads to a better CBF recovery after TBI and implicates arginase II in hemodynamic processes. Journal of Cerebral Blood Flow & Metabolism (2010) 30, 1105-1109; doi: 10.1038/jcbfm.2010.47; published online 7 April 2010	[Brink, Danielle C.; Mathew, Leela C.; Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Bitner, Brittany R.; Pautler, Robia G.] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Bitner, Brittany R.; Pautler, Robia G.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	Robertson, CS (corresponding author), Baylor Coll Med, Dept Neurosurg, MEDT 7-84,Mail Stop BCM650, Houston, TX 77030 USA.	claudiar@bcm.edu			Mission Connect; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [POI-N538660]; Howard Hughes Medical Institutes Med into Grad Initiative; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER	This project was funded by a grant from Mission Connect (LCM) and the NIH grant POI-N538660 (CSR). The interdepartmental Program in Translational Biology and Molecular Medicine is funded in part by the Howard Hughes Medical Institutes Med into Grad Initiative.	Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; Cherian L, 2009, J NEUROTRAUM, V26, pA96; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Hlatky R, 2003, J NEUROTRAUM, V20, P995, DOI 10.1089/089771503770195849; Huynh NN, 2009, HYPERTENSION, V54, P294, DOI 10.1161/HYPERTENSIONAHA.108.121731; Lim HK, 2007, AM J PHYSIOL-HEART C, V293, pH3317, DOI 10.1152/ajpheart.00700.2007; Liu H, 2002, J NEUROTRAUM, V19, P327, DOI 10.1089/089771502753594891; Shi O, 2001, MOL CELL BIOL, V21, P811, DOI 10.1128/MCB.21.3.811-813.2001; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212	13	12	12	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUN	2010	30	6					1105	1109		10.1038/jcbfm.2010.47			5	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	604GH	WOS:000278267000004	20372170	Green Published, Bronze			2021-06-18	
J	Jones, KD; Young, T; Leppma, M				Jones, Karyn Dayle; Young, Tabitha; Leppma, Monica			Mild Traumatic Brain Injury and Posttraumatic Stress Disorder in Returning Iraq and Afghanistan War Veterans: Implications for Assessment and Diagnosis	JOURNAL OF COUNSELING AND DEVELOPMENT			English	Article								Mild traumatic brain injury (MTBI) and posttraumatic stress disorder (PTSD) are considered the "signature injuries" of combat soldiers returning from Iraq and Afghanistan. Both disorders can greatly affect the functioning of soldiers, yet the disorders often go undetected or are misdiagnosed by both military and civilian health care providers. This article provides information about MTBI and PTSD in returning combat soldiers along with implications for assessment and diagnosis.	[Jones, Karyn Dayle; Young, Tabitha; Leppma, Monica] Univ Cent Florida, Dept Child Family & Community Sci, Orlando, FL 32816 USA	Jones, KD (corresponding author), Univ Cent Florida, Dept Child Family & Community Sci, POB 161250, Orlando, FL 32816 USA.	kjones@mail.ucf.edu					American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Carlat DJ, 2005, PSYCHIAT INTERVIEW P; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; COLARUSSO LM, 2007, BOSTON GLOBE    0610; *DEP VET AFF, 2004, TRAUM BRAIN INJ; Department of Defence Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; Department of Veterans Affairs, 2007, SCREEN EV POSS TRAUM; Feinstein A, 2000, BRAIN COGNITION, V44, P78; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Keltner NL, 2007, PERSPECT PSYCHIATR C, V43, P223, DOI 10.1111/j.1744-6163.2007.00138.x; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Koch L, 1995, J REHABIL, V61, P50; Levin A., 2007, PSYCHIAT NEWS, V42, P15; Lew HL, 2005, AM J PHYS MED REHAB, V84, P393, DOI 10.1097/01.phm.0000163703.91647.a7; LUNG DS, 2007, THESIS; MATEO MA, 2003, J AM PSYCHIAT NURSES, V9, P129; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Petchprapai Nutthita, 2007, J Neurosci Nurs, V39, P260; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rona RJ, 2005, JAMA-J AM MED ASSOC, V293, P1257, DOI 10.1001/jama.293.10.1257; Schwab KA, 2006, NEUROLOGY, V66, pA235; TEASDALE G, 1974, LANCET, V2, P81; *TRAUM BRAIN INJ T, 2008, REP SURG GEN; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WHYTE J, 1988, REHABILITATION MED P, P585	30	12	12	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0748-9633	1556-6676		J COUNS DEV	J. Couns. Dev.	SUM	2010	88	3					372	376		10.1002/j.1556-6678.2010.tb00036.x			5	Psychology, Applied	Psychology	610CJ	WOS:000278707000015					2021-06-18	
J	Patel, DR; Reddy, V				Patel, Dilip R.; Reddy, Vinay			Sport-related Concussion in Adolescents	PEDIATRIC CLINICS OF NORTH AMERICA			English	Article						Concussion; Neuropsychological testing; Balance Error Scoring System; Sport Concussion Assessment Tool	TRAUMATIC BRAIN-INJURY; COMPUTERIZED COGNITIVE ASSESSMENT; COLLEGIATE FOOTBALL PLAYERS; TEST-RETEST RELIABILITY; HIGH-SCHOOL; HEAD-INJURY; STANDARDIZED ASSESSMENT; MONITORING RESOLUTION; CEREBRAL CONCUSSION; POSTURAL CONTROL	Sport-related concussion is a common problem encountered by pediatricians and other primary care physicians Assessment of concussion is based on clinical evaluation The Zurich consensus statement provides a basic framework to guide concussion management decisions and recommends an individualized approach and the exercising of clinical judgment in return-to-play decisions. This article reviews practice aspects of concussion for the adolescent athletes who present in the primary care office or clinic setting.	[Patel, Dilip R.; Reddy, Vinay] Michigan State Univ, Coll Human Med, Kalamazoo Ctr Med Studies, Dept Pediat & Human Dev, Kalamazoo, MI 49008 USA	Patel, DR (corresponding author), Michigan State Univ, Coll Human Med, Kalamazoo Ctr Med Studies, Dept Pediat & Human Dev, 1000 Oakland Dr, Kalamazoo, MI 49008 USA.		Patel, Dilip/AAV-7575-2020				Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; *AM AC PED AM COLL, 2005, PREP PHYS EV MON; [Anonymous], 2005, MED SCI SPORT EXER, V37, P2012, DOI 10.1249/01.mss.0000186726.18341.70; Barbic D, 2005, CLIN J SPORT MED, V15, P294, DOI 10.1097/01.jsm.0000171883.74056.21; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; BICKLEY LS, 2006, BATES GUIDES PHYS EX; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Bruce JM, 2004, NEUROLOGY, V63, P1516; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; CANTU RC, 2002, AM J SPORTS MED, V4, P152; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Collie A, 2003, BRIT J SPORT MED, V37, P556, DOI 10.1136/bjsm.37.6.556; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Davis GA, 2009, BRIT J SPORT MED, V43, pI36, DOI 10.1136/bjsm.2009.058123; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; Dvorak J, 2007, BRIT J SPORT MED, V41, pI44, DOI 10.1136/bjsm.2007.037960; Dyson R, 2006, BRIT J SPORT MED, V40, P346, DOI 10.1136/bjsm.2005.023077; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hayden MG, 2007, CHILD NERV SYST, V23, P431, DOI 10.1007/s00381-006-0277-2; Hunt T, 2010, CLIN SPORT MED, V29, P5, DOI 10.1016/j.csm.2009.09.002; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson G, 2007, CLIN J SPORT MED, V17, P31; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; LaBotz M, 2005, CLIN J SPORT MED, V15, P73, DOI 10.1097/01.jsm.0000157649.99867.fc; Landry GL, 2002, PEDIATR CLIN N AM, V49, P723, DOI 10.1016/S0031-3955(02)00024-X; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell Mark R, 2002, Curr Sports Med Rep, V1, P7; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; MADDOCKS D, 1989, SPORT HLTH S, V7, P6; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Maroon Joseph C, 2002, Clin Neurosurg, V49, P319; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2004, CLIN J SPORT MED, V14, P139, DOI 10.1097/00042752-200405000-00006; McCrory P, 2002, BRIT J SPORT MED, V36, P316, DOI 10.1136/bjsm.36.5.316; McCrory Paul, 2002, Curr Sports Med Rep, V1, P28; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McIntosh AS, 2009, MED SCI SPORT EXER, V41, P306, DOI 10.1249/MSS.0b013e3181864bee; McIntosh AS, 2001, BRIT J SPORT MED, V35, P167, DOI 10.1136/bjsm.35.3.167; MCRORY P, 2005, CLIN J SPORT MED, V15, P48; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Mori T, 2006, ACTA NEUROCHIR SUPPL, V96, P40; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; PATEL DR, 2006, CONT PEDIAT, V23, P62; PATEL DR, 2001, CONT PEDIAT, V18, P45; PATEL DR, 2009, PEDIAT PRACTICE SPOR, P110; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Piebes SK, 2009, J SCH NURS, V25, P270, DOI 10.1177/1059840509339782; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Reddy CC, 2009, CURR SPORT MED REP, V8, P10, DOI 10.1249/JSR.0b013e31819539ca; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Singh GD, 2009, DENT TRAUMATOL, V25, P515, DOI 10.1111/j.1600-9657.2009.00808.x; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Wisniewski JF, 2004, DENT TRAUMATOL, V20, P143, DOI 10.1111/j.1600-4469.2004.00259.x; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401; Yang J, 2008, BRIT J SPORT MED, V42, P664, DOI 10.1136/bjsm.2007.040923	113	12	13	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0031-3955	1557-8240		PEDIATR CLIN N AM	Pediatr. Clin. N. Am.	JUN	2010	57	3					649	670		10.1016/j.pcl.2010.03.006			22	Pediatrics	Pediatrics	621NH	WOS:000279585100003	20538149				2021-06-18	
J	Koenigkam-Santos, M; de Castro, M; Versiani, BR; Diniz, PRB; Santos, AC				Koenigkam-Santos, Marcel; de Castro, Margaret; Versiani, Beatriz R.; Diniz, Paula Rejane B.; Santos, Antonio Carlos			Kallmann syndrome and mirror movements: White matter quantitative evaluation with magnetic resonance imaging	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Kallmann syndrome; Synkinesis; Magnetic resonance imaging; Quantitative evaluation	TRAUMATIC BRAIN-INJURY; IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; PROTON MR SPECTROSCOPY; MULTIPLE-SCLEROSIS; TRANSFER RATIO; CLINICAL-ASSESSMENT; T2; DEFICIENCY; GLIOSIS; LESIONS	Kallmann syndrome (KS), characterized by the association of hypogonadotropic hypogonadism and anosmia, may present many other phenotypic abnormalities, including neurologic features as involuntary movements, called mirror movements (MM). MM etiology probably involves a complex mechanism comprising corticospinal tract abnormal development associated with deficient contralateral motor cortex inhibitory system. In this study, in order to address previous hypotheses concerning MM etiology, we identified and quantified white matter (WM) alterations in 21 KS patients, comparing subjects with and without MM and 16 control subjects, using magnetization transfer ratio (MTR) and T2 relaxometry (R2). Magnetization transfer and 12 double-echo images were acquired in a 1.5 T system. MTR and R2 were calculated pixel by pixel to initially create individual maps, and then, group average maps, co-registered with MNI305 stereotaxic coordinate system. After analysis of selected regions of interest, we demonstrated areas with higher 12 relaxation time and lower MTR values in KS patients, with and without MM, differently involving corticospinal tract projection, frontal lobes and corpus callosum. Higher MTR was observed only in pyramidal decussation when compared in both groups of patients with controls. In conclusion, we demonstrated that patients with KS have altered WM areas, presenting in a different manner in patients with and without MM. These data suggest axonal loss or disorganization involving abnormal pyramidal tracts and other associative/connective areas, relating to the presence or absence of MM. We also found a different pattern of alteration in pyramidal decussation, which can represent the primary area of neuronal disarrangement. (C) 2010 Elsevier B.V. All rights reserved.	[Koenigkam-Santos, Marcel] Univ Sao Paulo, Dept Radiol, Sch Med Ribeirao Preto, Div Radiol, BR-14048900 Ribeirao Preto, SP, Brazil; [de Castro, Margaret; Versiani, Beatriz R.] Univ Sao Paulo, Dept Internal Med, Sch Med Ribeirao Preto, Div Endocrinol & Metab, BR-14048900 Ribeirao Preto, SP, Brazil	Koenigkam-Santos, M (corresponding author), Univ Sao Paulo, Dept Radiol, Sch Med Ribeirao Preto, Div Radiol, Av Bandeirantes 3900,Campus Univ, BR-14048900 Ribeirao Preto, SP, Brazil.	marcelk46@yahoo.com.br	Santos, Marcel Koenigkam/AAB-7938-2020; Santos, Antonio/F-5419-2012; Santos, Marcel Koenigkam/B-8177-2013; de Castro, Margaret/A-4918-2009	Santos, Marcel Koenigkam/0000-0002-7160-4691; Santos, Marcel Koenigkam/0000-0002-7160-4691; de Castro, Margaret/0000-0003-4932-4623			Bagley LJ, 1999, AM J NEURORADIOL, V20, P977; BARNES D, 1988, BRAIN, V111, P83, DOI 10.1093/brain/111.1.83; Bernasconi A, 2000, NEUROIMAGE, V12, P739, DOI 10.1006/nimg.2000.0724; Berry I, 1999, J MAGN RESON IMAGING, V9, P441, DOI 10.1002/(SICI)1522-2586(199903)9:3<441::AID-JMRI12>3.0.CO;2-R; DOUSSET V, 1992, RADIOLOGY, V182, P483, DOI 10.1148/radiology.182.2.1732968; Filippi M, 1998, ANN NEUROL, V43, P809, DOI 10.1002/ana.410430616; Henkelman RM, 2001, NMR BIOMED, V14, P57, DOI 10.1002/nbm.683; KALTWASSER JP, 1990, BRIT J HAEMATOL, V74, P360, DOI 10.1111/j.1365-2141.1990.tb02596.x; Kimura H, 1996, AM J NEURORADIOL, V17, P1539; Koenigkam-Santos M, 2008, AM J NEURORADIOL, V29, P1799, DOI 10.3174/ajnr.A1202; Krams M, 1997, BRAIN, V120, P1217, DOI 10.1093/brain/120.7.1217; Krams M, 1999, NEUROLOGY, V52, P816, DOI 10.1212/WNL.52.4.816; LARSSON HBW, 1989, MAGNET RESON MED, V11, P337, DOI 10.1002/mrm.1910110308; Leinsinger GL, 1997, RADIOLOGY, V203, P545, DOI 10.1148/radiology.203.2.9114119; Mamere AE, 2009, AM J NEURORADIOL, V30, P947, DOI 10.3174/ajnr.A1477; Mayer M, 1999, BRAIN TOPOGR, V12, P49, DOI 10.1023/A:1022281607426; Mayston MJ, 1999, ANN NEUROL, V45, P583, DOI 10.1002/1531-8249(199905)45:5<583::AID-ANA6>3.0.CO;2-W; McGowan JC, 1999, NEUROLOGY, V53, pS3; Mukherjee P, 2006, NEUROIMAG CLIN N AM, V16, P19, DOI 10.1016/j.nic.2005.11.004; NASS R, 1985, NEUROLOGY, V35, P1059, DOI 10.1212/WNL.35.7.1059; Papanikolaou N, 2004, EUR RADIOL, V14, P115, DOI 10.1007/s00330-003-1946-0; Quinton R, 1996, J CLIN ENDOCR METAB, V81, P3010, DOI 10.1210/jc.81.8.3010; Quinton R, 2001, CLIN ENDOCRINOL, V55, P163, DOI 10.1046/j.1365-2265.2001.01277.x; Sato N, 2004, J CLIN ENDOCR METAB, V89, P1079, DOI 10.1210/jc.2003-030476; Seminara SB, 1998, ENDOCR REV, V19, P521, DOI 10.1210/er.19.5.521; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Trarbach EB, 2006, J CLIN ENDOCR METAB, V91, P4006, DOI 10.1210/jc.2005-2793; Versiani BR, 2007, CLIN ENDOCRINOL, V66, P173, DOI 10.1111/j.1365-2265.2006.02702.x; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113	29	12	13	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X			J NEUROL SCI	J. Neurol. Sci.	MAY 15	2010	292	1-2					40	44		10.1016/j.jns.2010.02.010			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	584WJ	WOS:000276784100008	20211475				2021-06-18	
J	Tu, J; Liao, JX; Stoodley, MA; Cunningham, AM				Tu, Jian; Liao, Jinxin; Stoodley, Marcus A.; Cunningham, Anne M.			Differentiation of Endogenous Progenitors in an Animal Model of Post-Traumatic Syringomyelia	SPINE			English	Article						adult progenitor/stem cell; astrocyte; differentiation; macrophage; rat; spinal cord injury; syringomyelia; trauma	SPINAL-CORD-INJURY; NEURAL STEM-CELLS; ADULT-MOUSE BRAIN; AMINO-ACIDS; ASTROGLIAL PROLIFERATION; QUISQUALIC ACID; FLUID-FLOW; RAT; MICROGLIA; MACROPHAGES	Study Design. An in vivo study to examine the differentiation of endogenous neural progenitor cells in an adult rat model of post-traumatic syringomyelia. Objective. To quantitatively evaluate the phenotypic fate of endogenous neural progenitor cells in post-traumatic syringomyelia. Summary of Background Data. Although neural progenitors have been identified in the central nervous system, their differentiation in experimental post-traumatic syringomyelia and possible role in the pathophysiology of this condition have not been investigated. Methods. Bromodeoxyuridine was used to label proliferating cells in a time-dependent rat model of posttraumatic syringomyelia. Eight neural markers were quantitatively analyzed to phenotype the cellular fate of these cells by double labeling immunohistochemistry. Results. Following syrinx induction, cell proliferation rate increased to 25-115 times that of cells in the intact and sham-operated controls with a peak at day 14 post-injury. In the earliest time points post-syrinx induction, ED1-expressing inflammatory cells formed a significant proportion of the proliferating population. Proliferating neural progenitor cells predominantly differentiated into NG2-expressing immature oligodendrocytes at all stages post-syrinx induction, except the final time point of 56 days. At this time, there was a peak in the number of newly generated astrocytes identified to have developed from labeled proliferating precursor cells. Conclusions. Endogenous neural progenitors proliferate markedly following induction of post-traumatic syringomyelia which consists of two stages, initial cyst formation and progressive cyst enlargement. During the former stage, macrophages proliferate in situ and contribute to the inflammatory process. The predominant cell type formed from progeny of the induced neural progenitors was characterized to be immature oliggodendrocytes. However, during the latter stage of cyst development, there was an increase in astrocytic progeny which may represent an environment more conductive to glial scar formation acting to limit further cyst enlargement.	[Tu, Jian; Stoodley, Marcus A.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [Tu, Jian; Liao, Jinxin; Stoodley, Marcus A.] Univ New S Wales, Prince Wales Med Res Inst, Sydney, NSW, Australia; [Cunningham, Anne M.] Univ New S Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia	Stoodley, MA (corresponding author), Macquarie Univ, Australian Sch Adv Med, Level 1,Dow Corning Bldg,3 Innovat Rd, Sydney, NSW 2109, Australia.	marcus@teamneuro.com	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; Stoodley, Marcus/0000-0002-4207-8493	Australian Brain Foundation; Westfield Research Laboratory, Sydney Children's Hospital	Supported by a project grant from Australian Brain Foundation. This work was performed, in part, in the Westfield Research Laboratory, Sydney Children's Hospital.	AIHARA N, 1995, J NEUROTRAUM, V38, P654; ALLIOT F, 1991, P NATL ACAD SCI USA, V88, P1541, DOI 10.1073/pnas.88.4.1541; Brodbelt AR, 2003, EUR SPINE J, V12, P300, DOI 10.1007/s00586-002-0492-9; Brodbelt AR, 2003, J NEUROTRAUM, V20, P883, DOI 10.1089/089771503322385818; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fedoroff S, 1997, J NEUROSCI RES, V50, P477; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GIULIAN D, 1985, J CELL BIOL, V101, P2411, DOI 10.1083/jcb.101.6.2411; GIULIAN D, 1985, SCIENCE, V228, P497, DOI 10.1126/science.3872478; HINTZE JL, 2007, NCSS STAT SOFTWARE 2; Hirji NS, 1999, INT ARCH ALLERGY IMM, V118, P180, DOI 10.1159/000024060; Horner PJ, 2000, J NEUROSCI, V20, P2218; HURLEY SD, 1996, TOPICAL ISSUES MICRO, P1; Kakulas B A, 1999, J Spinal Cord Med, V22, P119; Kurz H, 1998, GLIA, V22, P98, DOI 10.1002/(SICI)1098-1136(199801)22:1<98::AID-GLIA10>3.0.CO;2-V; Lang B, 2004, NEUROSCIENCE, V128, P775, DOI 10.1016/j.neuroscience.2004.06.033; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Lee TT, 2000, J NEUROSURG, V92, P149, DOI 10.3171/spi.2000.92.2.0149; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; Louro J, 2008, NEUROL RES, V30, P5, DOI 10.1179/174313208X284070; MARSALA M, 1994, J CEREBR BLOOD F MET, V14, P604, DOI 10.1038/jcbfm.1994.75; Mothe AJ, 2005, NEUROSCIENCE, V131, P177, DOI 10.1016/j.neuroscience.2004.10.011; Obermair FJ, 2008, PHYSIOLOGY, V23, P296, DOI 10.1152/physiol.00017.2008; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; Pedersen EB, 1997, J NEUROIMMUNOL, V76, P117, DOI 10.1016/S0165-5728(97)00038-6; PISHARODI M, 1985, APPL NEUROPHYSIOL, V48, P226; Popovich PG, 2003, EXP NEUROL, V182, P275, DOI 10.1016/S0014-4886(03)00120-1; Schaller B, 1999, J SPINAL DISORD, V12, P485; SIMPSON RK, 1990, NEUROCHEM RES, V15, P635, DOI 10.1007/BF00973755; SQUIER MV, 1994, J NEUROL NEUROSUR PS, V57, P1095, DOI 10.1136/jnnp.57.9.1095; Stoodley MA, 1999, NEUROSURGERY, V44, P1065, DOI 10.1097/00006123-199905000-00068; Takahashi M, 2003, J NEUROPATH EXP NEUR, V62, P185, DOI 10.1093/jnen/62.2.185; Tokumine J, 2003, J NEUROSCI RES, V74, P552, DOI 10.1002/jnr.10760; Urushitani M, 1998, ANN NEUROL, V44, P796, DOI 10.1002/ana.410440514; Yamamoto S, 2001, EXP NEUROL, V172, P115, DOI 10.1006/exnr.2001.7798; Yang LQ, 2001, SPINE, V26, P1842, DOI 10.1097/00007632-200109010-00004; YEZIERSKI RP, 1993, J NEUROTRAUM, V10, P445, DOI 10.1089/neu.1993.10.445	37	12	12	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	MAY 15	2010	35	11					1116	1121		10.1097/BRS.0b013e3181ba6ce4			6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	601PG	WOS:000278074000003	20421862				2021-06-18	
J	Archer, KR; Castillo, RC; MacKenzie, EJ; Bosse, MJ				Archer, Kristin R.; Castillo, Renan C.; MacKenzie, Ellen J.; Bosse, Michael J.		LEAP Study Grp	Perceived Need and Unmet Need for Vocational, Mental Health, and Other Support Services After Severe Lower-Extremity Trauma	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	85th Annual Meeting of the American-Congress-of-Rehabilitation-Medicine	OCT 16, 2008	Toronto, CANADA	Amer Congress Rehabil Med		Health services; Health services needs and demand; Lower extremity; Rehabilitation	POSTTRAUMATIC-STRESS-DISORDER; LOWER-LIMB AMPUTATION; VEHICLE ACCIDENT VICTIMS; LONG-TERM OUTCOMES; MAJOR TRAUMA; BRAIN-INJURY; ORTHOPEDIC TRAUMA; SELF-MANAGEMENT; FOLLOW-UP; PHYSICAL INJURY	Objectives: To examine the perceived need and unmet need for support services, the reasons for not obtaining services, and the factors contributing to unmet need for vocational and mental health services in patients with traumatic lower-extremity injury. Design: Multicenter, prospective observational study. Setting: Eight level I trauma centers. Participants: Patients (N=545) undergoing lower-extremity reconstruction or amputation from March 1994 to June 1997. Interventions: Not applicable. Main Outcome Measures: Perceived need and unmet need for support services at 3, 6, and 12 months after hospitalization. Results: Eighty-five percent of patients reported a need for at least 1 support service, and 32% reported an unmet need over the 12 months. The highest perceived need was for home nursing and legal, and for unmet need was vocational and mental health services. The main reason for patients not trying to obtain mental health assistance was thinking they would get better on their own, and for other support services was not knowing where to go. Patients treated by reconstruction compared with amputation, and being nonwhite were statistically associated with unmet needs for vocational and mental health services. Conclusions: The results suggest a significant amount of unmet need for vocational and mental health services during the first year after hospitalization in the severe lower-extremity trauma population with perceived need. Areas for future research are to objectively measure need and unmet need, and further investigate the disparities in unmet need by race and treatment type in this patient population. Recommendations for trauma centers include education and screening for mental health conditions and the need for support services during hospitalization and clinic visits, and increasing communication between surgeons and providers specializing in vocational, psychological, and socioeconomic issues.	[Archer, Kristin R.] Vanderbilt Univ, Med Ctr, Vanderbilt Orthopaed Inst, Dept Orthopaed & Rehabil,Sch Med, Nashville, TN 37232 USA; [Castillo, Renan C.; MacKenzie, Ellen J.] Johns Hopkins Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Injury Res & Policy, Baltimore, MD USA; [Bosse, Michael J.] Carolinas Med Ctr, Dept Orthopaed Surg, Charlotte, NC 28203 USA	Archer, KR (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Orthopaed Inst, Dept Orthopaed & Rehabil,Sch Med, Med Ctr ES Tower,Suite 4200, Nashville, TN 37232 USA.	kristin.archer@vanderbilt.edu			NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R0I-AR42659] Funding Source: Medline; NCIPC CDC HHS [CE00198-03] Funding Source: Medline; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE000198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR042659] Funding Source: NIH RePORTER		Airey CM, 2001, DISABIL REHABIL, V23, P509; ALSTON RJ, 1992, J APPL REHABILITATIO, V23, P12; Atherton R, 2006, DISABIL REHABIL, V28, P1201, DOI 10.1080/09638280600551674; Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0; BLANCHARD EB, 1995, BEHAV RES THER, V33, P529, DOI 10.1016/0005-7967(94)00079-Y; Bosse MJ, 2002, NEW ENGL J MED, V347, P1924, DOI 10.1056/NEJMoa012604; BRENNEMAN FD, 1995, J TRAUMA, V39, P320, DOI 10.1097/00005373-199508000-00021; Butcher JL, 1996, J TRAUMA, V41, P4, DOI 10.1097/00005373-199607000-00002; Carson JW, 2006, J PAIN, V7, P615, DOI 10.1016/j.jpain.2006.02.008; Castillo RC, 2005, ARCH PHYS MED REHAB, V86, P1722, DOI 10.1016/j.apmr.2005.03.005; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Crichlow RJ, 2006, J BONE JOINT SURG AM, V88A, P1927, DOI 10.2106/JBJS.D.02604; Darnall BD, 2005, ARCH PHYS MED REHAB, V86, P650, DOI 10.1016/j.apmr.2004.10.028; Ephraim PL, 2006, ARCH PHYS MED REHAB, V87, P328, DOI 10.1016/j.apmr.2005.11.010; Escolar-Reina P, 2009, ARCH PHYS MED REHAB, V90, P1734, DOI 10.1016/j.apmr.2009.05.012; FISHER GM, 1992, SOC SECUR BULL, V55, P3; FRIEMAN M, 1998, HLTH SERV RES 1, V33, P867; Gallagher P, 2007, AM J PHYS MED REHAB, V86, P205, DOI 10.1097/PHM.0b013e3180321439; GUSTILO RB, 1984, J TRAUMA, V24, P742, DOI 10.1097/00005373-198408000-00009; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Holbrook TL, 2001, J TRAUMA, V51, P287, DOI 10.1097/00005373-200108000-00010; Holbrook TL, 1998, J TRAUMA, V45, P315, DOI 10.1097/00005373-199808000-00018; HOLBROOK TL, 1994, J TRAUMA, V36, P74, DOI 10.1097/00005373-199401000-00011; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Holbrook TL, 2001, J TRAUMA, V50, P270, DOI 10.1097/00005373-200102000-00012; Horgan O, 2004, DISABIL REHABIL, V26, P837, DOI 10.1080/09638280410001708869; Jackson JC, 2007, J TRAUMA, V62, P80, DOI 10.1097/TA.0b013e31802ce9bd; Koren D, 1999, AM J PSYCHIAT, V156, P367; LORIG K, 1993, HEALTH EDUC QUART, V20, P17, DOI 10.1177/109019819302000104; MacKenzie EJ, 2000, J ORTHOP TRAUMA, V14, P455, DOI 10.1097/00005131-200009000-00001; MACKENZIE EJ, 1993, J ORTHOP TRAUMA, V7, P393, DOI 10.1097/00005131-199310000-00001; MacKenzie EJ, 2005, J BONE JOINT SURG AM, V87A, P1801, DOI 10.2106/JBJS.E.00032; MACKENZIE EJ, 1987, AM J PUBLIC HEALTH, V77, P329, DOI 10.2105/AJPH.77.3.329; MacKenzie EJ, 1998, AM J PUBLIC HEALTH, V88, P1630, DOI 10.2105/AJPH.88.11.1630; MacKenzie EJ, 2006, J TRAUMA, V61, P688, DOI 10.1097/01.ta.0000195985.56153.68; McCarthy M L, 1998, J Hand Ther, V11, P32; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; MCCARTHY ML, 1995, J TRAUMA, V39, P828, DOI 10.1097/00005373-199511000-00005; McCarthy ML, 2003, J BONE JOINT SURG AM, V85A, P1689, DOI 10.2106/00004623-200309000-00006; Michaels AJ, 1998, J TRAUMA, V44, P644, DOI 10.1097/00005373-199804000-00013; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; MICHAELS AJ, 1998, SURG FORUM, V49, P534; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P1390, DOI 10.1176/appi.ajp.161.8.1390; Ouellet MC, 2009, J REHABIL MED, V41, P179, DOI 10.2340/16501977-0306; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Ponsford J, 2008, J TRAUMA, V64, P1001, DOI 10.1097/TA.0b013e31809fec16; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Starr AJ, 2004, J BONE JOINT SURG AM, V86A, P1115, DOI 10.2106/00004623-200406000-00001; Ursano RJ, 1999, AM J PSYCHIAT, V156, P589; Vles WJ, 2005, J TRAUMA, V58, P126, DOI 10.1097/01.TA.0000112342.40296.1F; Wegener ST, 2009, ARCH PHYS MED REHAB, V90, P373, DOI 10.1016/j.apmr.2008.08.222; Zatzick D, 2004, J TRAUMA, V57, P360, DOI 10.1097/01.TA.0000141332.43183.7F; Zatzick DF, 2002, ARCH SURG-CHICAGO, V137, P200, DOI 10.1001/archsurg.137.2.200; Zatzick DF, 2002, AM J PSYCHIAT, V159, P941, DOI 10.1176/appi.ajp.159.6.941; Zatzick DF, 2001, MED CARE, V39, P327, DOI 10.1097/00005650-200104000-00004; Zatzick DF, 2007, PSYCHOL MED, V37, P1469, DOI 10.1017/S0033291707000943	57	12	13	0	14	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2010	91	5					774	780		10.1016/j.apmr.2010.01.006			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	594LK	WOS:000277539000015	20434616				2021-06-18	
J	Mauer, UM; Kunz, U				Mauer, Uwe Max; Kunz, Ulrich			Management of neurotrauma by surgeons and orthopedists in a military operational setting	NEUROSURGICAL FOCUS			English	Article						neurosurgery course; craniotomy; trauma surgeon; orthopedist	TRAUMA; NEUROSURGERY; INJURIES; PROTOCOL; HEAD	There is a considerable discrepancy between the potential demand for neurosurgeons and the actual availability of such specialists not only in civilian settings but even more so in military operational environments. For this reason, the Department of Neurosurgery at the German Armed Forces Hospital in Ulm conducts courses for surgeons and orthopedists on the management of patients with neurotrauma. Twelve such courses have already taken place. Each course lasts 1 week. Participants can expect to gain the theoretical knowledge and practical skills they need to provide initial surgical care for patients with traumatic brain injuries and/or spinal trauma. Surgical techniques are practiced above all in pig and human cadavers. At the end of the course, participants with previous surgical knowledge should be able to independently perform a craniotomy, from the planning of the procedure to the closure of the wound. Former course participants have successfully used their neurosurgical knowledge in countries of deployment where they managed patients during teleconsultation sessions and helped repatriate, or even provided surgical treatment to, patients with traumatic brain injuries. In these situations, it was particularly helpful when the physician deployed abroad and the neurosurgeon in Germany knew each other personally. In the future, efforts will be made to combine telemedicine and neuronavigation in an attempt to further improve direct support for physicians under military deployment conditions. (DOI: 10.3171/2010.1.FOCUS09328)	[Mauer, Uwe Max; Kunz, Ulrich] German Armed Forces Hosp, Dept Neurosurg, D-89070 Ulm, Germany	Mauer, UM (corresponding author), German Armed Forces Hosp, Dept Neurosurg, Oberer Eselsberg 40, D-89070 Ulm, Germany.	UweMaxMauer@bundeswehr.org					Amirjamshidi A, 2003, SURG NEUROL, V60, P105, DOI 10.1016/S0090-3019(03)00358-6; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Ko K, 2003, J TRAUMA, V55, P480, DOI 10.1097/01.TA.0000074111.04885.28; Kossmann T, 2004, INJURY, V35, P661, DOI 10.1016/j.injury.2004.03.005; Mauer U, 1995, WEHRMED MSCHR, V39, P160; Rosenfeld JV, 2004, INJURY, V35, P655, DOI 10.1016/j.injury.2004.03.006; Treacy PJ, 2005, ANZ J SURG, V75, P852, DOI 10.1111/j.1445-2197.2005.03549.x; Wade AL, 2007, J TRAUMA, V63, P836, DOI 10.1097/01.ta.0000251453.54663.66	8	12	16	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	MAY	2010	28	5							E10	10.3171/2010.1.FOCUS09328			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	589ZU	WOS:000277193600010	20568926				2021-06-18	
J	Fluckiger, C; Bechir, M; Brenni, M; Ludwig, S; Sommerfeld, J; Cottini, SR; Keel, M; Stocker, R; Stover, JF				Flueckiger, Carole; Bechir, Markus; Brenni, Mirko; Ludwig, Silke; Sommerfeld, Jutta; Cottini, Silvia R.; Keel, Marius; Stocker, Reto; Stover, John F.			Increasing hematocrit above 28% during early resuscitative phase is not associated with decreased mortality following severe traumatic brain injury	ACTA NEUROCHIRURGICA			English	Article						Critical care; Emergency room; Intracranial pressure; Transfusion; Secondary brain injury	BLOOD-CELL TRANSFUSION; ACUTE NORMOVOLEMIC HEMODILUTION; CEREBRAL OXYGENATION; TISSUE OXYGENATION; CRITICALLY-ILL; TEMPORAL PROFILE; PROGNOSTIC VALUE; ANEMIA; PERFUSION; FLOW	To prevent iatrogenic damage, transfusions of red blood cells should be avoided. For this, specific and reliable transfusion triggers must be defined. To date, the optimal hematocrit during the initial operating room (OR) phase is still unclear in patients with severe traumatic brain injury (TBI). We hypothesized that hematocrit values exceeding 28%, the local hematocrit target reached by the end of the initial OR phase, resulted in more complications, increased mortality, and impaired recovery compared to patients in whom hematocrit levels did not exceed 28%. Impact of hematocrit (independent variable) reached by the end of the OR phase on mortality and morbidity determined by the extended Glasgow outcome scale (eGOS; dependent variables) was investigated retrospectively in 139 TBI patients. In addition, multiple logistic regression analysis was performed to identify additional important variables. Following severe TBI, mortality and morbidity were neither aggravated by hematocrit above 28% reached by the end of the OR phase nor worsened by the required transfusions. Upon multiple logistic regression analysis, eGOS was significantly influenced by the highest intracranial pressure and the lowest cerebral perfusion pressure values during the initial OR phase. Based on this retrospective observational analysis, increasing hematocrit above 28% during the initial OR phase following severe TBI was not associated with improved or worsened outcome. This questions the need for aggressive transfusion management. Prospective analysis is required to determine the lowest acceptable hematocrit value during the OR phase which neither increases mortality nor impairs recovery. For this, a larger caseload and early monitoring of cerebral metabolism and oxygenation are indispensable.	[Brenni, Mirko; Stover, John F.] Univ Zurich Hosp, Inst Anesthesiol, CH-8091 Zurich, Switzerland; [Keel, Marius] Univ Zurich Hosp, Div Trauma Surg, CH-8091 Zurich, Switzerland	Stover, JF (corresponding author), Univ Zurich Hosp, Inst Anesthesiol, Raemistr 100, CH-8091 Zurich, Switzerland.	john.stover@access.unizh.ch	Christoph, Fluckiger/H-8169-2014	Christoph, Fluckiger/0000-0003-3058-5815	SUVA	This study was supported in part by grants from the SUVA funds to JFS and RS.	Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Cherry T, 2008, AM J CLIN PATHOL, V129, P287, DOI 10.1309/D3F7BXH466AE3G0P; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Duchesne JC, 2008, J TRAUMA, V65, P272, DOI 10.1097/TA.0b013e31817e5166; Ekelund A, 2002, ACTA NEUROCHIR, V144, P703, DOI 10.1007/s00701-002-0959-9; Frietsch T, 2004, EUR J ANAESTH, V21, P53, DOI 10.1017/S0265021504001097; Ge YL, 2007, ACTA ANAESTH SCAND, V51, P1331, DOI 10.1111/j.1399-6576.2007.01448.x; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; Gonzalez AM, 2007, SURGERY, V141, P630, DOI 10.1016/j.surg.2006.09.015; Habib RH, 2003, J THORAC CARDIOV SUR, V125, P1438, DOI 10.1016/S0022-5223(02)73291-1; Han SH, 2004, INT J CLIN PRACT, V58, P903, DOI 10.1111/j.1742-1241.2004.00120.x; Hare GMT, 2007, J APPL PHYSIOL, V103, P1021, DOI 10.1152/japplphysiol.01315.2006; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Klein HG, 2007, LANCET, V370, P415, DOI 10.1016/S0140-6736(07)61197-0; Kroppenstedt SN, 2003, CRIT CARE MED, V31, P2211, DOI 10.1097/01.CCM.0000080482.06856.62; Leal-Noval SR, 2008, CURR OPIN CRIT CARE, V14, P156, DOI 10.1097/MCC.0b013e3282f57577; Leal-Noval SR, 2006, INTENS CARE MED, V32, P1733, DOI 10.1007/s00134-006-0376-2; Madjdpour C, 2006, CRIT CARE MED, V34, pS102, DOI 10.1097/01.CCM.0000214317.26717.73; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McIntyre L, 2004, J TRAUMA, V57, P563, DOI 10.1097/01.TA.0000136158.93864.54; McIntyre LA, 2006, CURR OPIN CRIT CARE, V12, P575, DOI 10.1097/MCC.0b013e32801067f0; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Meier R, 2008, CRIT CARE, V12, DOI 10.1186/cc6974; Meixensberger J, 2004, NEUROL RES, V26, P414, DOI 10.1179/016164104225014094; Meixensberger J, 2001, NEUROL RES, V23, P801, DOI 10.1179/016164101101199379; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; Rosenthal G, 2008, J NEUROSURG, V108, P59, DOI 10.3171/JNS/2008/108/01/0059; Sarrafzadeh AS, 2003, BRIT J NEUROSURG, V17, P340, DOI 10.1080/02688690310001601234; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Thomale UW, 2007, IMMUNOBIOLOGY, V212, P567, DOI 10.1016/j.imbio.2007.01.007; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; Tinmouth A, 2006, TRANSFUSION, V46, P2014, DOI 10.1111/j.1537-2995.2006.01026.x; Tomiyama Y, 1999, AM J PHYSIOL-HEART C, V276, pH1190; Tomiyama Y, 2000, AM J PHYSIOL-HEART C, V279, pH1949; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Tsai AG, 2004, TRANSFUSION, V44, P1626, DOI 10.1111/j.0041-1132.2004.04128.x; Tschuor C, 2008, CRIT CARE, V12, DOI 10.1186/cc6931; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; van Bommel J, 2002, ANESTHESIOLOGY, V97, P660, DOI 10.1097/00000542-200209000-00021; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Weinberg JA, 2008, J TRAUMA, V65, P279, DOI 10.1097/TA.0b013e31817c9687; Weiskopf RB, 2006, ANESTHESIOLOGY, V104, P911, DOI 10.1097/00000542-200605000-00005; Weiskopf RB, 2005, CLIN NEUROPHYSIOL, V116, P1028, DOI 10.1016/j.clinph.2004.12.009; Weiskopf RB, 2000, ANESTHESIOLOGY, V92, P1646, DOI 10.1097/00000542-200006000-00023; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003	46	12	13	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	APR	2010	152	4					627	636		10.1007/s00701-009-0579-8			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	573WI	WOS:000275945600008	20033233	Green Accepted, Green Published			2021-06-18	
J	Kukaswadia, A; Warsh, J; Mihalik, JP; Pickett, W				Kukaswadia, Atif; Warsh, Joel; Mihalik, Jason P.; Pickett, William			Effects of Changing Body-Checking Rules on Rates of Injury in Minor Hockey	PEDIATRICS			English	Article						child; hockey; injury; physical activity; sports; trauma	ICE HOCKEY; BODYCHECKING; CONCUSSIONS	OBJECTIVE: In this study we explored the effects of the 2002 rule change in Ontario minor hockey, in which body-checking was introduced at the atom (ages 9-10) instead of the peewee (previously ages 12-13) age level. It was hypothesized that the introduction of body-checking at younger ages would result in higher overall rates of injury to minor hockey players, with concomitant increases in neurotraumatic injuries. PATIENTS AND METHODS: Participants included injured minor hockey players between the ages of 7 and 14 years in the Kingston area of Ontario, Canada. The Kingston sites of the Canadian Hospitals Injury Reporting and Prevention Program were used to identify injuries that presented to the only 2 emergency departments in this community. In our analyses, we compared rates and patterns of injury that required hospital-based emergency medicine care before (1997-1998 to 2001-2002 seasons) and after (2002-2003 to 2006-2007 seasons) implementation of the body-checking rule change. RESULTS: Overall rates of injury to minor hockey players declined in the years after the rule change. Rates of injury attributable to body-checking, as well as the natures and anatomic sites of injury caused by body-checking, remained consistent in the 2 study periods. CONCLUSIONS: In this historical study, we did not observe an increase in the overall rates of injury and concomitant neurotraumatic events. Increased enforcement of playing rules as well as temporal declines in emergency department use may have contributed to these findings. Pediatrics 2010;125:735-741	[Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Pickett, William] Kingston Gen Hosp, Clin Res Ctr, Kingston, ON K7L 2V7, Canada; [Kukaswadia, Atif; Warsh, Joel; Pickett, William] Queens Univ, Dept Epidemiol & Community Hlth, Kingston, ON, Canada; [Pickett, William] Queens Univ, Dept Emergency Med, Kingston, ON, Canada	Mihalik, JP (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 209 Fetzer Gymnasium,South Rd,CB 8700, Chapel Hill, NC 27599 USA.	jmihalik@email.unc.edu	Mihalik, Jason P/E-7059-2010	Mihalik, Jason/0000-0001-6085-8322	Ontario Neurotrauma Foundation; Public Health Agency of Canada	Funding for this research was obtained from a summer internship grant from the Ontario Neurotrauma Foundation and from the Public Health Agency of Canada, which funds the CHIRPP.	Anderson AJ, 2000, PEDIATRICS, V105, P657; BERNARD D, 1993, ASTM STP, V1212, P44; BIASCA N, 2005, EUR J TRAUMA, V31, P369; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; *HOCK CAN, BACKGR CHECK; *HOCK CAN, PLAYER REG; Hostetler SG, 2004, PEDIATRICS, V114, pE661, DOI 10.1542/peds.2004-1565; King WJ, 2006, CAN MED ASSOC J, V175, P163, DOI 10.1503/cmaj.060620; Mackenzie S G, 1999, Inj Prev, V5, P208; Macpherson A, 2006, PEDIATRICS, V117, P2334, DOI 10.1542/peds.2006-0929; Macpherson A, 2006, PEDIATRICS, V117; Maladiere E, 2001, INT J ORAL MAX SURG, V30, P291, DOI 10.1054/ijom.2001.0059; Marchie A, 2003, CAN MED ASSOC J, V169, P124; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; MONTELPARE WJ, 2004, ASTM INT, V1; Pickett W, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e365; Regnier G., 1989, SAFETY ICE HOCKEY, P84; ROY MA, 1989, PHYSICIAN SPORTSMED, V17, P119, DOI 10.1080/00913847.1989.11709735; *STAT CAN, COMM HIGHL KINGST; STUART MJ, 1995, MAYO CLIN PROC, V70, P350, DOI 10.4065/70.4.350; SULLIVAN P, 1992, CMAJ, V142, P157; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783; Willer B, 2005, MED SCI SPORT EXER, V37, P1658, DOI 10.1249/01.mss.0000181839.86170.06; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	26	12	12	0	7	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	APR	2010	125	4					735	741		10.1542/peds.2009-2083			7	Pediatrics	Pediatrics	577QR	WOS:000276239600018	20308211				2021-06-18	
J	Castaneda, MM; Cubilla, MA; Lopez-Vicchi, MM; Suburo, AM				Castaneda, Mauricio M.; Cubilla, Marisa A.; Lopez-Vicchi, Martin M.; Suburo, Angela M.			Endothelinergic cells in the subependymal region of mice	BRAIN RESEARCH			English	Article						Endothelin; Astrocyte; Subventricular zone; Subependymal zone; Cingulum; Adult neurogenesis; Granulocyte-colony stimulating factor; Neural stem cell; Stroke; Traumatic brain injury	NEURAL STEM-CELLS; ROSTRAL MIGRATORY STREAM; ADULT MAMMALIAN BRAIN; SUBVENTRICULAR ZONE; MARKER PROMININ-1; ISCHEMIC-STROKE; RAT-BRAIN; ASTROCYTES; RECEPTORS; NEUROGENESIS	Endothelin (ET) is a small peptide that activates astrocyte proliferation, regulates proliferation and migration of embryonic neural precursor cells and stimulates glioblastoma growth. We found that in mouse brain, ET and its receptor B (ETRB) were highly expressed in the subependymal zone (SEZ), an adult neurogenic niche. Cells with ET immunoreactivity (ET+ cells) selectively appeared along the lateral and dorsal walls of the lateral ventricle. They also appeared in the cingular region of the corpus callosum. Subependymal ET+ cells also displayed prominin (PRO), glial fibrillary acidic protein (GFAP) and ETRB immunoreactivities. ET+ processes traversed the ependymal epithelium and approached the ventricular lumen. Ependymal cells only showed ETRB-ir. A small but consistent number of ET+ cells displayed proliferation markers: 5-bromo-2'-deoxyuridine (BrdU) incorporation, and minichromosome maintenance protein 2 (Mcm2). Cortical injury and G-CSF increased subependymal endothelinergic cells and their proliferation markers. Our findings suggest that ET and ETRB might be associated with regulation of adult neural stem cells and their migration through neurogenic and gliogenic pathways. (C) 2010 Elsevier B.V. All rights reserved.	[Castaneda, Mauricio M.; Cubilla, Marisa A.; Lopez-Vicchi, Martin M.; Suburo, Angela M.] Univ Austral, Fac Ciencias Biomed, Buenos Aires, DF, Argentina	Suburo, AM (corresponding author), Univ Austral, Fac Ciencias Biomed, B1629AHJ, Buenos Aires, DF, Argentina.	amsuburo@cas.austral.edu.ar			Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); ANPCyTANPCyT [21399/2004]; MINCYT, Argentina; Universidad Austral	MMC and MAC are research fellows from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) and ANPCyT, MINCYT, Argentina, respectively. MML-V was a training fellow from the Comision de Investigaciones Cientificas de la Provincia de Buenos Aires (GC), and AMS is Principal Researcher from CONICET. Studies reported here were funded by grants from Universidad Austral, 2006 and 2007, and ANPCyT (21399/2004). We are very grateful to Guillermo Gaston and Soledad Arregui for their skilful technical assistance.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Alonso M, 2008, J NEUROSCI, V28, P11089, DOI 10.1523/JNEUROSCI.3713-08.2008; Alvarez-Buylla A, 1998, J NEUROSCI, V18, P1020; Alvarez-Buylla A, 2008, COLD SH Q B, V73, P357, DOI 10.1101/sqb.2008.73.019; BARONE FC, 1995, J CARDIOVASC PHARM, V26, pS404; Bartnik BL, 2001, BRAIN RES, V915, P133, DOI 10.1016/S0006-8993(01)02805-0; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Corbeil D, 2009, GLIA, V57, P860, DOI 10.1002/glia.20812; Corti S, 2007, EXP NEUROL, V205, P547, DOI 10.1016/j.expneurol.2007.03.021; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Danilov AI, 2009, GLIA, V57, P136, DOI 10.1002/glia.20741; Davenport A. P., 2006, V176, P295; Deleyrolle L, 2006, STEM CELLS, V24, P748, DOI 10.1634/stemcells.2005-0138; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Diederich K, 2009, J NEUROSCI, V29, P11572, DOI 10.1523/JNEUROSCI.0453-09.2009; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; EHRENREICH H, 1991, NEW BIOL, V3, P135; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Gotts JE, 2005, J NEUROSCI RES, V80, P160, DOI 10.1002/jnr.20434; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Iribarne M, 2008, AM J PATHOL, V172, P1030, DOI 10.2353/ajpath.2008.070605; Ishikawa N, 1997, EUR J NEUROSCI, V9, P895, DOI 10.1111/j.1460-9568.1997.tb01440.x; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kam M, 2009, J CHEM NEUROANAT, V37, P196, DOI 10.1016/j.jchemneu.2008.12.009; Koyama Y, 2005, J NEUROSCI RES, V80, P809, DOI 10.1002/jnr.20512; Koyama Y, 2003, EUR J NEUROSCI, V18, P887, DOI 10.1046/j.1460-9568.2003.02797.x; KREIPKE CW, 2009, NEUROL RES; Leung JWC, 2009, BRAIN RES, V1266, P121, DOI 10.1016/j.brainres.2009.01.070; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Mizuno N, 2005, P NATL ACAD SCI USA, V102, P12365, DOI 10.1073/pnas.0506101102; Morishita R, 2007, NEUROSCI RES, V59, P205, DOI 10.1016/j.neures.2007.06.1478; Naidoo V, 2005, CANCER-AM CANCER SOC, V104, P1049, DOI 10.1002/cncr.21277; Ostrow LW, 2005, BRAIN RES REV, V48, P488, DOI 10.1016/j.brainresrev.2004.09.005; Paolillo M, 2006, J NEURO-ONCOL, V79, P1, DOI 10.1007/s11060-005-9111-z; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Peretto P, 1997, BRAIN RES BULL, V42, P9, DOI 10.1016/S0361-9230(96)00116-5; Pfenninger CV, 2007, CANCER RES, V67, P5727, DOI 10.1158/0008-5472.CAN-07-0183; Platel JC, 2009, GLIA, V57, P66, DOI 10.1002/glia.20735; Riechers CC, 2004, NEUROSCIENCE, V124, P719, DOI 10.1016/j.neuroscience.2003.10.023; Rogers SD, 2003, GLIA, V41, P180, DOI 10.1002/glia.10173; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shinohara H, 2004, J BIOL CHEM, V279, P41141, DOI 10.1074/jbc.M406721200; Stenman E, 2007, EUR J PHARMACOL, V570, P142, DOI 10.1016/j.ejphar.2007.05.049; SUBURO AM, 1992, NEUROSCIENCE, V46, P881, DOI 10.1016/0306-4522(92)90191-4; Suzuki SO, 2003, J NEUROSCI, V23, P4240; Tabernero A, 2006, J NEUROCHEM, V96, P973, DOI 10.1111/j.1471-4159.2005.03623.x; Torbidoni V, 2005, EXP EYE RES, V81, P265, DOI 10.1016/j.exer.2004.12.024; Zerlin M, 2004, DEV BIOL, V270, P200, DOI 10.1016/j.ydbio.2004.02.024; Zhang RL, 2008, NEUROPHARMACOLOGY, V55, P345, DOI 10.1016/j.neuropharm.2008.05.027; Zhang RL, 2007, J CEREBR BLOOD F MET, V27, P1201, DOI 10.1038/sj.jcbfm.9600430	56	12	12	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 19	2010	1321						20	30		10.1016/j.brainres.2010.01.056			11	Neurosciences	Neurosciences & Neurology	576CH	WOS:000276120800003	20116370				2021-06-18	
J	McCauley, SR; Pedroza, C; Chapman, SB; Cook, LG; Hotz, G; Vasquez, AC; Levin, HS				McCauley, Stephen R.; Pedroza, Claudia; Chapman, Sandra B.; Cook, Lori G.; Hotz, Gillian; Vasquez, Ana C.; Levin, Harvey S.			Event-based prospective memory performance during subacute recovery following moderate to severe traumatic brain injury in children: Effects of monetary incentives	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Event-based prospective memory; Traumatic brain injury; Incentive; Motivation; Memory rehabilitation; Pediatrics	AGE; IMPAIRMENT; SENSITIVITY; INTENTIONS; REMEMBER; OUTCOMES; ADULTS; TERM	There are very few Studies investigating remediation of event-based prospective memory (EB-PM) impairments following traumatic brain injury (TBI). To address this, we used 2 levels of motivational enhancement (dollars vs. pennies) to improve EB-PM in children with moderate to severe TBI in the subacute recovery phase. Children with orthopedic injuries (OI; n = 61), moderate (n = 28), or severe (n = 30) TBI were compared. Significant effects included Group X Motivation Condition (F(2, 115) = 3.73, p < .03). The OI (p<.002) and moderate TBI (p<.03) groups performed significantly better under the high- versus low-incentive condition; however, the severe TBI group failed to demonstrate improvement (p = .38). EB-PM performance was better in adolescents compared to Younger children (p < .02). These results suggest that EB-PM can be significantly improved in the subacute phase with this level of monetary incentives in children with moderate, but not severe, TBI. Other strategies to improve EB-PM in these children at a similar point in recovery remain to be identified and evaluated. (JINS, 2010, 16, 335-341)	[McCauley, Stephen R.] Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [McCauley, Stephen R.; Vasquez, Ana C.; Levin, Harvey S.] Univ Texas Houston, Sch Med, Houston, TX USA; [McCauley, Stephen R.] Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA; [McCauley, Stephen R.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Pedroza, Claudia] Univ Texas Med Sch Houston, Ctr Clin Res & Evidence Based Med, Houston, TX USA; [Chapman, Sandra B.; Cook, Lori G.] Univ Texas Dallas, Ctr Brain Hlth, Inst Biomed Sci & Technol, Dallas, TX 75230 USA; [Hotz, Gillian] Univ Miami, Sch Med, Miami, FL USA	McCauley, SR (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, 1709 Dryden Rd,Suite 1200, Houston, TX 77030 USA.	mccauley@bcm.edu		Pedroza, Claudia/0000-0003-4235-1282	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23 HD040896, K23 HD-40896] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889, R01 NS021889] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD040896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER		Baddeley AD., 1990, HUMAN MEMORY; Best D. L., 1992, MEMORY IMPROVEMENT I, P122; BRANDIMONTE MA, 1994, Q J EXP PSYCHOL-A, V47, P565, DOI 10.1080/14640749408401128; COCKBURN J, 1995, CORTEX, V31, P87, DOI 10.1016/S0010-9452(13)80107-4; *COMM INJ SCAL, 1990, ABBR INJ SCAL; Driscoll I, 2005, NEUROPSYCHOLOGY, V19, P28, DOI 10.1037/0894-4105.19.1.28; Einstein G., 1996, PROSPECTIVE MEMORY T, P115; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Fortin S, 2002, BRAIN COGNITION, V48, P361, DOI 10.1006/brcg.2001.1378; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Furst C., 1986, COGNITIVE REHABILITA, V4, P24; GENTRY M, 1990, PERS SOC PSYCHOL B, V16, P241, DOI 10.1177/0146167290162005; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Guajardo NR, 2000, COGNITIVE DEV, V15, P75, DOI 10.1016/S0885-2014(00)00016-2; Hannon R, 1995, REHABIL PSYCHOL, V40, P289, DOI 10.1037/0090-5550.40.4.289; Harris J. E., 1984, EVERYDAY MEMORY ACTI, P71; Hauser RM, 1997, SOCIOL METHODOL, V27, P177, DOI 10.1111/1467-9531.271028; Henry JD, 2007, J CLIN EXP NEUROPSYC, V29, P457, DOI 10.1080/13803390600762717; Herrmann D., 1999, HDB APPL COGNITION, P377; HUPPERT FA, 1993, J CLIN EXP NEUROPSYC, V15, P805, DOI 10.1080/01688639308402597; Kerns KA, 2001, CHILD NEUROPSYCHOL, V7, P162, DOI 10.1076/chin.7.3.162.8744; Kerns KA, 2000, J INT NEUROPSYCH SOC, V6, P62, DOI 10.1017/S1355617700611074; Kidder DP, 1997, AGING NEUROPSYCHOL C, V4, P93, DOI 10.1080/13825589708256639; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Knight RG, 2006, J INT NEUROPSYCH SOC, V12, P8, DOI 10.1017/S1355617706060048; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; KVAVILASHVILI L, 1992, APPL COGNITIVE PSYCH, V6, P507, DOI 10.1002/acp.2350060605; KVAVILASHVILI L, 1987, BRIT J PSYCHOL, V78, P507, DOI 10.1111/j.2044-8295.1987.tb02265.x; Kvavilashvili L, 2001, DEV PSYCHOL, V37, P418, DOI 10.1037//0012-1649.37.3.418; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P615, DOI 10.1017/S1355617707070762; LOUDA J, 2007, Z NEUROPSYCHOL, V18, P91; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; Maujean A., 2003, BRAIN IMPAIR, V4, P135, DOI DOI 10.1375/BRIM.4.2.135.27024; MAYLOR EA, 1990, Q J EXP PSYCHOL-A, V42, P471, DOI 10.1080/14640749008401233; McCauley SR, 2004, DEV NEUROPSYCHOL, V25, P5, DOI 10.1207/s15326942dn2501&2_2; MCCAULEY SR, CHILD NEURO IN PRESS; McCauley SR, 2009, NEUROPSYCHOLOGY, V23, P201, DOI 10.1037/a0014192; McDaniel M A, 1993, Memory, V1, P23, DOI 10.1080/09658219308258223; Meacham J. A., 1982, MEMORY OBSERVED REME, P327; MEACHAM JA, 1976, CATALOG SELECTED DOC; Roche NL, 2007, NEUROPSYCHOL REHABIL, V17, P314, DOI 10.1080/09602010600831004; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; RUTHER NM, 1993, M SE PSYCH ASS ATL G; Salthouse TA, 2004, MEM COGNITION, V32, P1133, DOI 10.3758/BF03196887; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Thone-Otto AIT, 2003, INT J PSYCHOL, V38, P236, DOI 10.1080/00207590344000169; Ward H, 2004, BRAIN INJURY, V18, P471, DOI 10.1080/02699050310001646107; Ward H, 2007, CHILD NEUROPSYCHOL, V13, P219, DOI 10.1080/09297040600910003; WILKINS AJ, 1978, PRACTICAL ASPECTS ME; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson B.A, 1987, REHABILITATION MEMOR; Winograd E., 1988, PRACTICAL ASPECTS ME, V1, P348; Woods SP, 2008, ARCH CLIN NEUROPSYCH, V23, P257, DOI 10.1016/j.acn.2007.12.006; Woods SP, 2008, NEUROPSYCHOLOGY, V22, P110, DOI 10.1037/0894-4105.22.1.110; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617	60	12	12	0	9	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	2010	16	2					335	341		10.1017/S135561770999138X			7	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	562DZ	WOS:000275030900014	20109242				2021-06-18	
J	Ryu, WHA; Cullen, NK; Bayley, MT				Ryu, Won Hyung A.; Cullen, Nora K.; Bayley, Mark T.			Early neuropsychological tests as correlates of productivity 1 year after traumatic brain injury: a preliminary matched case-control study	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						employment; neuropsychological assessment; productivity; rehabilitation outcome; traumatic brain injury	FUNCTIONAL INDEPENDENCE; HEAD-INJURY; PERFORMANCE; COMMUNITY; SCALE; MODEL	This study explored the relative strength of five neuropsychological tests in correlating with productivity 1 year after traumatic brain injury (TBI). Six moderate-to-severe TBI patients who returned to work at 1-year post-injury were matched with six controls who were unemployed after 1 year based on age, severity of injury, and Functional Independence Measure scores. Five neuropsychological tests were administered to patients during inpatient rehabilitation. Two of the five tests (Symbol Digit and Block Design) discriminated TBI patients based on employment outcome. Symbol Digit and Rey Auditory Verbal Learning Test were significantly correlated with follow-up Functional Independence Measure scores. Results indicate that neuropsychological measures of visual perception (Block Design), and attention and mental speed (Symbol Digit) may be useful predictors of employment productivity after TBI; whereas attention and mental speed, learning and memory ability (Symbol Digit and Rey Auditory Verbal Learning Test) may predict functional outcomes. International Journal of Rehabilitation Research 33: 84-87 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Cullen, Nora K.; Bayley, Mark T.] Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada; [Ryu, Won Hyung A.; Cullen, Nora K.; Bayley, Mark T.] Univ Toronto, Toronto, ON M5S 1A1, Canada	Cullen, NK (corresponding author), Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	cullen.nora@torontorehab.on.ca	Ryu, Won H/AAU-6774-2020	Bayley, Mark/0000-0001-7860-9463; Cullen, Nora/0000-0001-6359-9418			Atchison TB, 2004, CLIN NEUROPSYCHOL, V18, P249, DOI 10.1080/13854040490501475; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Millis S R, 1994, Int J Neurosci, V79, P165; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Roberts CB, 2004, INT J REHABIL RES, V27, P145, DOI 10.1097/01.mrr.0000127142.43208.3b; Rosenthal M., 1999, REHABILITATION ADULT; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Sloan S., 2004, BRAIN IMPAIR, V5, P12, DOI DOI 10.1375/BRIM.5.1.12.35399; SmithKnapp K, 1996, BRAIN INJURY, V10, P651, DOI 10.1080/026990596124070; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd	17	12	12	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	MAR	2010	33	1					84	87		10.1097/MRR.0b013e32832e6b4b			4	Rehabilitation	Rehabilitation	562OS	WOS:000275062600013	19620876				2021-06-18	
J	Heskestad, B; Waterloo, K; Baardsen, R; Helseth, E; Romner, B; Ingebrigtsen, T				Heskestad, Ben; Waterloo, Knut; Baardsen, Roald; Helseth, Eirik; Romner, Bertil; Ingebrigtsen, Tor			No impact of early intervention on late outcome after minimal, mild and moderate head injury	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article							POST-CONCUSSION SYMPTOMS; TRAUMATIC BRAIN-INJURY; FOLLOW-UP; SEQUELAE; LIFE	Objectives: To evaluate the effect of an educational intervention on outcome after minimal, mild and moderate head injury. Methods: Three hundred and twenty six patients underwent stratified randomization to an intervention group (n = 163) or a control group (n = 163). Every second patient was allocated to the intervention group. Participants in this group were offered a cognitive oriented consultation two weeks after the injury, while subjects allocated to the control group were not. Both groups were invited to follow up 3 and 12 months after injury. Results: A total of 50 (15%) patients completed the study (intervention group n = 22 (13%), control group n = 28 (17%), not significant). There were no statistically significant differences between the intervention group and the control group. Conclusions: There was no effect on outcomes from an early educational intervention two weeks after head injury.	[Waterloo, Knut; Romner, Bertil; Ingebrigtsen, Tor] Univ Hosp N Norway, Dept Neurosurg, Tromso, Norway; [Heskestad, Ben; Baardsen, Roald] Stavanger Univ Hosp, Dept Neurosurg, Stavanger, Norway; [Heskestad, Ben; Helseth, Eirik] Oslo Univ Hospital Ulleval, Dept Neurosurg, Oslo, Norway; [Waterloo, Knut] Univ Hosp N Norway, Dept Psychol, Tromso, Norway; [Romner, Bertil; Ingebrigtsen, Tor] Univ Tromso, Fac Hlth Sci, Inst Clin Med, Tromso, Norway	Ingebrigtsen, T (corresponding author), Univ Hosp N Norway, Dept Neurosurg, Tromso, Norway.	tor.ingebrigtsen@unn.no	Helseth, Eirik/AAH-2466-2020	Ingebrigtsen, Tor/0000-0001-5966-9786			Anderson T, 2006, PRACT NEUROL, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; DE KRUIJK, 2002, J NEUROL NEUROSUR PS, V73, P167; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; EVANS RW, 1992, NEUROL CLIN, V10, P815; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; SCHWARTZ JE, 1993, J PSYCHOSOM RES, V37, P753, DOI 10.1016/0022-3999(93)90104-N; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; STEIN SC, 1996, NEUROSURGERY, V38, P245; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; THORNHILL S, 2000, BRIT MED J, V320, P727; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478	23	12	12	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	FEB 24	2010	18								10	10.1186/1757-7241-18-10			5	Emergency Medicine	Emergency Medicine	665NH	WOS:000283041900001	20181239	DOAJ Gold, Green Published			2021-06-18	
J	Zweckberger, K; Simunovic, F; Kiening, KL; Unterberg, AW; Sakowitz, OW				Zweckberger, Klaus; Simunovic, Filip; Kiening, Karl L.; Unterberg, Andreas W.; Sakowitz, Oliver W.			Anticonvulsive effects of the dopamine agonist lisuride maleate after experimental traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						Lisuride; Controlled cortical impact injury (CCII); Post-traumatic epileptic seizures; Secondary brain damage; Hypotension	CONTROLLED CORTICAL IMPACT; MAGNOCELLULAR NUCLEUS BASALIS; PROLACTIN-INDUCED EXPRESSION; CEREBRAL PERFUSION-PRESSURE; VOLUME-TARGETED THERAPY; NECROSIS-FACTOR-ALPHA; POSTTRAUMATIC EPILEPSY; PARKINSONS-DISEASE; RAT; MECHANISMS	Traumatic brain injury is a heterogeneous disease, encompassing a wide range of pathologies. The dopamine agonist lisuride is well established in the therapy of Parkinson's disease. Additionally to its dopaminergic effects it decreases prolactine release, reducing the amount of inflammatory mediators such as TNF-alpha or II-6. Lisuride has strong binding affinity to serotonergic and histaminergic receptors on neuronal and glial cells leading to scavenging of highly reactive free radicals. Due to its interaction with dopaminergic D2 and D4 receptors as well as 5-HT-1A receptors, NMDA-receptor signaling and glutamate-mediated excitotoxicity can be modulated beneficially. Despite of these promising neuroprotective effects, experimental data scrutinizing the effects of lisuride after acute brain injury are sparse. We therefore investigated the effect of lisuride after controlled cortical impact injury (CCII) in rats. 70 male Sprague-Dawley rats were randomized to lisuride or to placebo treatment by an initial s.c. loading dose (0.3 mglkg BW) and following continuous application (0.5 mg/kg/d) by s.c. implanted osmotic pumps. In three experimental groups we determined (sub)acute neuro-physiological changes after trauma. Mean arterial blood pressure, intracranial pressure, and electrical brain activity were monitored acutely for up to 3 h after trauma. Brain edema formation was assessed 24 h after CCII. Furthermore, contusion volumes were quantified by magnetic resonance tomography and neurological testing was performed for up to 7 days after injury. Associated with the administration of lisuride there was a significant reduction in duration and number of post-traumatic seizures. Despite of a sustained arterial hypotension following the initial bolus administration in the treatment group, contusion volumes and neurological function tests did not differ significantly in comparison to the control group. Overall, lisuride seems to have significant anticonvulsive effects but seems not to influence secondary brain damage in this experimental model. (C) 2010 Published by Elsevier Ireland Ltd.	[Zweckberger, Klaus; Simunovic, Filip; Kiening, Karl L.; Unterberg, Andreas W.; Sakowitz, Oliver W.] Univ Heidelberg Hosp, Dept Neurosurg, D-69120 Heidelberg, Germany	Zweckberger, K (corresponding author), Univ Heidelberg Hosp, Dept Neurosurg, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	klaus.zweckberger@med.uni-heidelberg.de					BARONTI F, 1992, ANN NEUROL, V32, P776, DOI 10.1002/ana.410320611; CARDWELL M, 1996, NEUROPHYSIOBIOLOGY, V34, P117; CARDWELL M, 1997, BRAIN RES, V771; CARRUBA MO, 1980, PSYCHOPHARMACOLOGY, V70, P223, DOI 10.1007/BF00427878; Chase T.N., 1989, NEUROLOGY S2, V39, P19; CHASE TN, 1989, NEUROLOGY, V39, P7; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; da Silva A M, 1992, Acta Neurochir Suppl (Wien), V55, P56; DEVITO WJ, 1995, J CELL BIOCHEM, V57, P290, DOI 10.1002/jcb.240570213; DEVITO WJ, 1995, MOL CELL ENDOCRINOL, V108, P125, DOI 10.1016/0303-7207(94)03465-6; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; Double KL, 2003, EXP NEUROL, V184, P530, DOI 10.1016/j.expneurol.2003.08.006; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; FARJO IB, 1979, BRIT J PHARMACOL, V67, P353, DOI 10.1111/j.1476-5381.1979.tb08687.x; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Fricker AD, 2005, MOL BRAIN RES, V138, P228, DOI 10.1016/j.molbrainres.2005.04.016; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gille G, 2002, J NEURAL TRANSM, V109, P157, DOI 10.1007/s007020200011; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; Harkany T, 2001, NEUROSCIENCE, V108, P629, DOI 10.1016/S0306-4522(01)00444-4; Horowski R, 1988, J Neural Transm Suppl, V27, P249; HOROWSKI R, 1979, N-S ARCH PHARMACOL, V306, P147, DOI 10.1007/BF00498984; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; ITIL TM, 1975, INT J CLIN PHARM BI, V12, P221; Jankovic J, 2007, CNS DRUGS, V21, P677, DOI 10.2165/00023210-200721080-00005; Johnson KW, 2003, CEPHALALGIA, V23, P117, DOI 10.1046/j.1468-2982.2003.00464.x; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; Kotecha SA, 2002, NEURON, V35, P1111, DOI 10.1016/S0896-6273(02)00859-0; Kroppenstedt SN, 1999, J NEUROSURG, V90, P520, DOI 10.3171/jns.1999.90.3.0520; Micieli G, 1996, FUNCT NEUROL, V11, P317; MIYAZAWA T, 1991, FOLIA PHARMACOL JPN, V98, P449, DOI 10.1254/fpj.98.6_449; Nobuhara K, 1993, Seishin Shinkeigaku Zasshi, V95, P392; Nordstrom C H, 2005, Acta Neurochir Suppl, V95, P475; Nordstrom CH, 2005, ANESTH ANALG, V101, P299, DOI 10.1213/01.ANE.0000156702.60474.2E; Nordstrom CH, 2005, NEUROCRIT CARE, V2, P83, DOI 10.1385/NCC:2:1:083; Nordstrom CH, 2003, ACTA NEUROCHIR SUPPL, V86, P355; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; O'Neill MJ, 1998, EUR J PHARMACOL, V352, P37, DOI 10.1016/S0014-2999(98)00333-1; Oosterink BJ, 1998, EUR J PHARMACOL, V358, P147, DOI 10.1016/S0014-2999(98)00614-1; Sakowitz OW, 2002, ACT NEUR S, V81, P221; STRACKE H, 1986, ARZNEIMITTEL-FORSCH, V36-2, P1834; Wang X, 2003, J NEUROSCI, V23, P9852; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	43	12	12	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	FEB 12	2010	470	2					150	154		10.1016/j.neulet.2009.12.075			5	Neurosciences	Neurosciences & Neurology	561AJ	WOS:000274946900013	20056133				2021-06-18	
J	Hanlon, RE; Rubin, LH; Jensen, M; Daoust, S				Hanlon, Robert E.; Rubin, Leah H.; Jensen, Marie; Daoust, Sarah			Neuropsychological Features of Indigent Murder Defendants and Death Row Inmates in Relation to Homicidal Aspects of Their Crimes	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Homicide; Forensic evaluation; Neuropsychology; Criminal behavior; Violence; Prisoners; Capital punishment; Murder	TRAUMATIC BRAIN-INJURY; POSITRON-EMISSION-TOMOGRAPHY; ANTISOCIAL-BEHAVIOR; SUBSTANCE-ABUSE; PRISON-INMATES; UNITED-STATES; HEAD-INJURY; VIOLENCE; AGGRESSION; DEFICITS	Neuropsychological features of 77 indigent murder defendants and death row inmates were examined in relation to criminal variables underlying their homicidal acts. Clinically, the sample was characterized by elevated rates of developmental disorders (49%), personality disorders (54%), Axis I psychiatric disorders (45%), substance abuse (86%), and history of violence (43%). By statute, killing more than one person is an aggravating factor in many jurisdictions that renders a murder defendant eligible for the death penalty. Individuals who committed a single murder were characterized by executive dysfunction, lower intelligence, slower speed of information processing, and a higher frequency of developmental disorders (58%), relative to those charged and/or convicted of killing two or more people, who were characterized by a significantly higher rate of personality disorders (79%) and a lower rate of developmental disorders (34%). Additionally, using the FBI criminal classification system for categorizing homicide by motive, a significant difference in the frequency of psychosis was found among subgroups associated with the following motives: Criminal enterprise; personal cause; and sex. The collective neuropsychological profile of the sample revealed that executive functions were significantly decreased, relative to memory functions, with over half of the sample (55%) demonstrating executive dysfunction.	[Hanlon, Robert E.] Neuropsychol Associates Chicago, Chicago, IL 60611 USA; [Hanlon, Robert E.; Daoust, Sarah] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Rubin, Leah H.] Univ Illinois, Chicago, IL USA; [Jensen, Marie] Depaul Univ, Chicago, IL 60604 USA	Hanlon, RE (corresponding author), Neuropsychol Associates Chicago, 645 N Michigan Ave,Suite 410, Chicago, IL 60611 USA.	r-hanlon@northwestern.edu					Anderson SW, 1999, NAT NEUROSCI, V2, P1032; Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; Barnfield TV, 1998, BRAIN INJURY, V12, P951, DOI 10.1080/026990598122007; BARR WB, 2008, CLIN NEUROPSYCHOLOGY, P238; BARR WB, 2005, FORENSIC NEUROPSYCHO, P239; BLAKE PY, 1995, NEUROLOGY, V45, P1641, DOI 10.1212/WNL.45.9.1641; BRICKMAN AS, 1984, J AM ACAD CHILD PSY, V23, P453, DOI 10.1016/S0002-7138(09)60324-1; Brook JS, 2001, J GENET PSYCHOL, V162, P228, DOI 10.1080/00221320109597963; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; BRYANT ET, 1984, J CONSULT CLIN PSYCH, V52, P323, DOI 10.1037/0022-006X.52.2.323; Coccaro EF, 1997, BIOL PSYCHIAT, V41, P273, DOI 10.1016/S0006-3223(96)00257-0; DABBS JM, 1987, PSYCHOSOM MED, V49, P174, DOI 10.1097/00006842-198703000-00007; Dahlberg LL, 1998, AM J PREV MED, V14, P259, DOI 10.1016/S0749-3797(98)00009-9; Denney R.L., 2008, CLIN NEUROPSYCHOLOGY, P91; Denney RL, 2000, J HEAD TRAUMA REHAB, V15, P804, DOI 10.1097/00001199-200004000-00005; DENNEY RL, 2005, FORENSIC NEUROPSYCHO, P425; DENNEY RL, 2007, ASSESSMENT FEIGNED C, P428; Federici AB, 2008, HAEMOPHILIA, V14, P1; FOSTER HG, 1993, PROG NEURO-PSYCHOPH, V17, P939, DOI 10.1016/0278-5846(93)90021-J; GARTNER J, 1996, ANN NY ACAD SCI, V794, P13; Gatzke-Kopp LM, 2001, J NEUROPSYCH CLIN N, V13, P486, DOI 10.1176/appi.neuropsych.13.4.486; Golden CJ, 1996, AGGRESS VIOLENT BEH, V1, P3, DOI 10.1016/1359-1789(95)00002-X; Golden CJ, 2002, STROOP COLOR WORD TE; Goodman M, 2004, ANN NY ACAD SCI, V1032, P104, DOI 10.1196/annals.1314.008; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2005, WORD MEMORY TEST WIN; GROVE WM, 1990, BIOL PSYCHIAT, V27, P1293, DOI 10.1016/0006-3223(90)90500-2; Hanlon R. E., 2005, FORENSIC NEUROPSYCHO, P268; Hare RD, 1993, CONSCIENCE DISTURBIN; Heaton RK., 2003, WISCONSIN CARD SORTI; HEATON RK, 2008, REVISED COMPREHENSIV; Ishikawa S. S., 2002, NEUROBIOLOGY CRIMINA, P81; Krakowski M, 2003, J NEUROPSYCH CLIN N, V15, P294, DOI 10.1176/appi.neuropsych.15.3.294; Langevin R., 1987, BEHAVIORAL SCI LAW, V5, P77; LAPIERRE D, 1995, NEUROPSYCHOLOGIA, V33, P139, DOI 10.1016/0028-3932(94)00110-B; Lewis DO, 2004, J AM ACAD PSYCHIATRY, V32, P408; LEWIS DO, 1986, AM J PSYCHIAT, V143, P838; Marcopulos B. A., 2008, CLIN NEUROPSYCHOLOGY, P176; MARTELL DA, 1992, LAW HUMAN BEHAV, V16, P313, DOI 10.1007/BF01044772; Mitchell DGV, 2002, NEUROPSYCHOLOGIA, V40, P2013, DOI 10.1016/S0028-3932(02)00056-8; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Pham TH, 2003, AGGRESSIVE BEHAV, V29, P393, DOI 10.1002/ab.10051; Raine A, 2000, ARCH GEN PSYCHIAT, V57, P119, DOI 10.1001/archpsyc.57.2.119; Raine A, 1996, ARCH GEN PSYCHIAT, V53, P544; Raine A, 1997, BIOL PSYCHIAT, V42, P495, DOI 10.1016/S0006-3223(96)00362-9; Raine A, 1998, BEHAV SCI LAW, V16, P319, DOI 10.1002/(SICI)1099-0798(199822)16:3<319::AID-BSL311>3.0.CO;2-G; Raine A., 1993, PSYCHOPATHOLOGY CRIM; REY A, 1958, L EXAMEN CLIN PSYCHO; Rogers R., 1992, SIRS STRUCTURED INTE; Rogers R., 1997, CLIN ASSESSMENT MALI, V2nd; Rosler M, 2004, EUR ARCH PSY CLIN N, V254, P365, DOI 10.1007/S00406-004-0516-Z; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Schofield PW, 2006, BRAIN INJURY, V20, P1409, DOI 10.1080/02699050601130443; Shields A, 1998, J CLIN CHILD PSYCHOL, V27, P381, DOI 10.1207/s15374424jccp2704_2; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Slick D., 1997, VICTORIA SYMPTOM VAL; SMITH SS, 1992, PERS INDIV DIFFER, V13, P1233, DOI 10.1016/0191-8869(92)90259-R; SPELLACY F, 1977, J CLIN PSYCHOL, V33, P966, DOI 10.1002/1097-4679(197710)33:4<966::AID-JCLP2270330409>3.0.CO;2-4; THOMSON, 2009, TOMM TEST MEMORY MAL; Tonkonogy J M, 1991, J Neuropsychiatry Clin Neurosci, V3, P189; Vitelli R, 1996, INT J OFFENDER THER, V40, P263, DOI 10.1177/0306624X96404002; Volavka J., 2002, NEUROBIOLOGY VIOLENC, V2nd ed; YATES KF, 2008, CLIN NEUROPSYCHOLOGY, P204	64	12	14	0	33	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2010	25	1					1	13		10.1093/arclin/acp099			13	Psychology, Clinical; Psychology	Psychology	547DI	WOS:000273865400001	20015966	Green Published, Bronze			2021-06-18	
J	Castano, B; Capdevila, E				Castano, Beatriz; Capdevila, Elisabet			Eating disorders in patients with traumatic brain injury: A report of four cases	NEUROREHABILITATION			English	Article						Brain injury; eating disorder; anorexia; hyperphagia; obesity; behavior disorder	FOOD-INTAKE; ANOREXIA-NERVOSA; LESIONS	Background: Traumatic brain injury (TBI) can lead to changes in eating behavior patterns with significant clinical manifestations. Methods: Medical records of four patients with severe TBI and eating disorders attending the neurorehabilitation program of our brain injury unit were reviewed. Conclusions: Several eating disorders observed among the four cases, may be present from early phases and remain years after the lesion. Symptoms do not adhere to the typical forms of anorexia and bulimia. Factors influencing the weight changes experienced by patients with brain injury included reduction in physical activity, metabolic disorders and treatment with psychotropic drugs.	[Castano, Beatriz; Capdevila, Elisabet] Neurorehabil Hosp, Guttmann Inst, Brain Injury Unit, Barcelona, Spain	Castano, B (corresponding author), Neurorehabil Hosp, Guttmann Inst, Brain Injury Unit, Cami Can Ruti S-N, Badalona 08916, Spain.	34618bcm@comb.cat					DOLAN RJ, 1988, PSYCHOL MED, V18, P349, DOI 10.1017/S0033291700007893; ERB JL, 2006, INT J EAT DISORDER, V8, P117; Fujii M, 1998, BRAIN INJURY, V12, P709, DOI 10.1080/026990598122278; GENTILINI M, 1987, J NEUROL NEUROSUR PS, V50, P900, DOI 10.1136/jnnp.50.7.900; Henson Martha B., 1993, Brain Injury, V7, P169, DOI 10.3109/02699059309008170; Howes HFR, 2005, BRAIN INJURY, V19, P403, DOI 10.1080/02699050400025158; KAUFMAN HH, 1987, NEUROSURGERY, V20, P254, DOI 10.1227/00006123-198702000-00010; LEWIN J, 1992, Brain Injury, V6, P199, DOI 10.3109/02699059209029660; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; NEWCOMER JW, J CLIN PSYCHIAT S1, V68, P20; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; Perucca E, 2002, CNS DRUGS, V16, P695, DOI 10.2165/00023210-200216100-00004; Rolls ET, 2005, PHYSIOL BEHAV, V85, P45, DOI 10.1016/j.physbeh.2005.04.012; Trummer M, 2002, ACTA NEUROCHIR, V144, P797, DOI 10.1007/s00701-002-0934-5; Uher R, 2005, J NEUROL NEUROSUR PS, V76, P852, DOI 10.1136/jnnp.2004.048819; Uher R, 2004, AM J PSYCHIAT, V161, P1238, DOI 10.1176/appi.ajp.161.7.1238; Wilson RF, 1998, J HEAD TRAUMA REHAB, V13, P11, DOI 10.1097/00001199-199802000-00005	17	12	12	0	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2010	27	2					113	116		10.3233/NRE-2010-0586			4	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	647VW	WOS:000281649100001	20871139				2021-06-18	
J	Davis, AS; Dean, RS				Davis, Andrew S.; Dean, Raymond S.			Assessing Sensory-Motor Deficits in Pediatric Traumatic Brain Injury	APPLIED NEUROPSYCHOLOGY			English	Article						children; neuropsychological assessment; sensory-motor; traumatic brain injury	CHILDREN; RECOVERY; GAIT	The assessment of sensory-motor functions is a key component of pediatric neuropsychological evaluations following traumatic brain injury (TBI). Sensory-motor processes have recently been shown to be related to larger neural structures and functions, rather than a secondary role played in the past. Recent research has shown sensory-motor functioning serves as a marker for the integrity of the central nervous system. Children's behavior following a TBI has greater variation than seen in adults, which may well relate to greater natural variation and maturational effects. With the recent findings of greater importance of sensory-motor functions, the need for psychometrically sound measures is stressed and various measures are outlined.	[Davis, Andrew S.] Ball State Univ, Teachers Coll, Dept Educ Psychol, Muncie, IN 47306 USA	Davis, AS (corresponding author), Ball State Univ, Teachers Coll, Dept Educ Psychol, Room 515, Muncie, IN 47306 USA.	davis@bsu.edu					*AM AC NEUR, 1996, WHIT PAP NEUR PROV N; Andrewes D, 2002, NEUROPSYCHOLOGY THEO; Caeyenberghs K, 2009, BRAIN, V132, P684, DOI 10.1093/brain/awn344; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Davis AS, 2009, ARCH CLIN NEUROPSYCH, V24, P273, DOI 10.1093/arclin/acp032; Dean R. S., 2003, EXAMINERS MANUAL DEA; DEAN RS, 2003, DEANWOODCOCK NEUROPS; DEAN RS, 1999, DEANWOODCOCK NEUROPS; DECKER SL, 2002, THESIS BALL STATE U; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; GOLDEN C, 1987, MANUAL LURIA NEBRASK; HAALAND KY, 1994, J CLIN EXP NEUROPSYC, V16, P448, DOI 10.1080/01688639408402655; Katz-Leurer M, 2009, DEV NEUROREHABIL, V12, P100, DOI 10.1080/17518420902800928; Korkman M, 1998, DEV NEUROPSYCHOLOGIC; Korkman M., 2007, NEPSY 2; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Reitan R, 1974, CLIN NEUROPSYCHOLOGY; Reitan RM, 1996, CLIN NEUROPSYCHOL, V10, P37, DOI 10.1080/13854049608406661; Reitan RM., 1969, MANUAL ADM NEUROPSYC; TITUS JB, 2002, THESIS BALL STATE U; Volpe AG, 2006, ARCH CLIN NEUROPSYCH, V21, P203, DOI 10.1016/j.acn.2005.12.005; Wolfson D., 1993, HALSTEAD REITAN NEUR; Woodcock R.W., 2001, WOODCOCKJOHNSON 3 TE	23	12	12	0	8	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2010	17	2					104	109	PII 922158471	10.1080/09084281003708951			6	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	596CX	WOS:000277662800005	20467950				2021-06-18	
J	Dennis, M				Dennis, Maureen			Language disorders in children with central nervous system injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Language disorders; Pragmatic; Semantic; Syntactic; Motor speech; Central nervous system injury	EARLY-ONSET HYDROCEPHALUS; ACQUIRED CHILDHOOD APHASIA; NEUROMOTOR SPEECH DEFICITS; TRAUMATIC BRAIN-INJURY; POSTERIOR-FOSSA TUMORS; CLOSED HEAD-INJURY; SPINA-BIFIDA; NARRATIVE DISCOURSE; CORPUS-CALLOSUM; FLUENT APHASIA	Children with injury to the central nervous system (CNS) exhibit a variety of language disorders that have been described by members of different disciplines, in different journals, using different descriptors and taxonomies. This paper is an overview of language deficits in children with CNS injury, whether congenital or acquired after a period of normal development. It first reviews the principal CNS conditions associated with language disorders in childhood. It then describes a functional taxonomy of language, with examples of the phenomenology and neurobiology of clinical deficits in children with CNS insults. Finally, it attempts to situate language in the broader realm of cognition and in current theoretical accounts of embodied cognition.	[Dennis, Maureen] Hosp Sick Children, Dept Psychol, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Dennis, Maureen] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Dennis, Maureen] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada	Dennis, M (corresponding author), Hosp Sick Children, Dept Psychol, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	maureen.dennis@sickkids.ca			National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01 HD35946, P01 HD35946-06]; National Institute of Neurological Diseases and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [2R01NS 21889-16]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1RO1 HD04946]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD035946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	Preparation of this paper was supported in part by National Institute of Child Health and Human Development Grants P01 HD35946 and P01 HD35946-06, "Spina Bifida: Cognitive and Neurobiological Variability," by National Institute of Neurological Diseases and Stroke Grant 2R01NS 21889-16, "Neurobehavioral Outcome of Head Injury in Children," and by National Institutes of Health Grant 1RO1 HD04946, "Social Outcomes in Pediatric Traumatic Brain Injury." I thank Arianna Stefanatos for assistance with manuscript preparation.	ALAJOUANINE T, 1965, BRAIN, V88, P653, DOI 10.1093/brain/88.4.653; American Speech-Language-Hearing Association, 2007, CHILDH APR SPEECH; AMMIRATI M, 1989, CHILD NERV SYST, V5, P12, DOI 10.1007/BF00706739; Anderson VA, 2000, SCI PRACT NEUROPSYCH, P117; APPLETON RE, 1995, ARCH DIS CHILD, V72, P386, DOI 10.1136/adc.72.5.386; ARAM DM, 1985, J CLIN EXP NEUROPSYC, V7, P55, DOI 10.1080/01688638508401242; Aram DMNJE, 1982, CHILD LANGUAGE DISOR; Aziz-Zadeh L, 2006, CURR BIOL, V16, P1818, DOI 10.1016/j.cub.2006.07.060; Band GPH, 2000, J EXP CHILD PSYCHOL, V75, P263, DOI 10.1006/jecp.1999.2538; Barnes MA, 1996, READING COMPREHENSION DIFFICULTIES, P251; Barnes MA, 2004, BRAIN LANG, V89, P47, DOI 10.1016/S0093-934X(03)00295-5; Barnes MA, 1998, BRAIN LANG, V61, P309, DOI 10.1006/brln.1998.1843; Barnes MA, 2001, BRAIN LANG, V76, P253, DOI 10.1006/brln.2000.2385; Barnes MA, 1996, J EXP CHILD PSYCHOL, V61, P216, DOI 10.1006/jecp.1996.0015; Barnes MA, 2007, J INT NEUROPSYCH SOC, V13, P854, DOI 10.1017/S1355617707071172; Bates E, 1999, DEV COGN NEUROSCI, P533; Bates E., 1992, HDB NEUROPSYCHOL, V7, P69; Berndt RS, 1997, BRAIN LANG, V60, P197, DOI 10.1006/brln.1997.1799; BEUN RJ, 1994, J PRAGMATICS, V21, P191, DOI 10.1016/0378-2166(94)90019-1; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Brentano F., 1973, PSYCHOL EMPIRICAL ST; BRINTON B, 1985, J COMMUN DISORD, V18, P245, DOI 10.1016/0021-9924(85)90002-4; BROWN JR, 1970, INT J NEUROL, V7, P302; BUCK R, 1994, J PRAGMATICS, V22, P265, DOI 10.1016/0378-2166(94)90112-0; Buckingham HW, 2008, HANDBOOK OF THE NEUROSCIENCE OF LANGUAGE, P127; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Cain K, 2001, MEM COGNITION, V29, P850, DOI 10.3758/BF03196414; CAPLAN D, 2006, LIFESPAN COGNITION M, P253; Caplan D., 1988, DISORDERS SYNTACTIC; Caplan D., 1992, LANGUAGE STRUCTURE P; Caplan D, 2007, BRAIN LANG, V101, P103, DOI 10.1016/j.bandl.2006.06.225; CARAMAZZA A, 1976, BRAIN LANG, V3, P572, DOI 10.1016/0093-934X(76)90048-1; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Chomsky Noam, 1968, SOUND PATTERN ENGLIS; Clifton C, 2001, ANNU REV PSYCHOL, V52, P167, DOI 10.1146/annurev.psych.52.1.167; COHEN MJ, 1994, BRAIN LANG, V47, P171, DOI 10.1006/brln.1994.1047; COOPER JA, 1978, J SPEECH HEAR DISORD, V43, P176, DOI 10.1044/jshd.4302.176; COOPER JA, 1987, J SPEECH HEAR DISORD, V52, P251, DOI 10.1044/jshd.5203.251; CRANBERG LD, 1987, NEUROLOGY, V37, P1165, DOI 10.1212/WNL.37.7.1165; CRYSTAL D, 1973, LINGUA, V32, P1; CURTISS S, 1997, P 21 ANN BOST U C LA, P103; DAILEY AT, 1995, J NEUROSURG, V83, P467, DOI 10.3171/jns.1995.83.3.0467; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246, DOI 10.1044/jshr.1202.246; DELBIGIO MR, 1993, ACTA NEUROPATHOL, V85, P573, DOI 10.1007/BF00334666; Dempster F.N., 1993, EMERGING THEMES COGN, P3, DOI DOI 10.1007/978-1-4613-9220-0_1; Denes G, 2008, HANDBOOK OF THE NEUROSCIENCE OF LANGUAGE, P361; Dennis M, 1998, BRAIN LANG, V61, P450, DOI 10.1006/brln.1997.1886; DENNIS M, 1994, BRAIN LANG, V46, P129, DOI 10.1006/brln.1994.1008; DENNIS M, 1981, ARCH NEUROL-CHICAGO, V38, P607, DOI 10.1001/archneur.1981.00510100035004; DENNIS M, 1992, TOP LANG DISORD, V13, P66, DOI 10.1097/00011363-199211000-00008; Dennis M, 2005, NEUROPSYCHOLOGIA, V43, P976, DOI 10.1016/j.neuropsychologia.2004.08.012; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; DENNIS M, 1980, BRAIN LANG, V10, P287, DOI 10.1016/0093-934X(80)90058-9; DENNIS M, 1975, BRAIN LANG, V2, P472, DOI 10.1016/S0093-934X(75)80084-8; DENNIS M, 1976, BRAIN LANG, V3, P404, DOI 10.1016/0093-934X(76)90036-5; Dennis M, 2001, J HEAD TRAUMA REHAB, V16, P456, DOI 10.1097/00001199-200110000-00005; Dennis M, 2000, APHASIOLOGY, V14, P391, DOI 10.1080/026870300401423; DENNIS M, 1993, J PEDIATR PSYCHOL, V18, P639, DOI 10.1093/jpepsy/18.5.639; DENNIS M, 1976, BRAIN LANG, V3, P147, DOI 10.1016/0093-934X(76)90013-4; DENNIS M, 1987, J CLIN EXP NEUROPSYC, V9, P593, DOI 10.1080/01688638708410771; DENNIS M, 1980, LANGUAGE DEV APHASIA, P45; DENNIS M, 2000, AUTISM, V4, P371; DENNIS M, 2004, BRAIN SPINAL TUMORS, P213; Di Cataldo A, 2001, PEDIATR HEMAT ONCOL, V18, P117; DOGIL G, 1995, APHASIOLOGY, V9, P577, DOI 10.1080/02687039508248716; Doxey D, 1999, PEDIATR NEUROSURG, V31, P131, DOI 10.1159/000028848; Edelstein K, 2004, J INT NEUROPSYCH SOC, V10, P877, DOI 10.1017/S1355617704106085; Eisele JA, 1998, BRAIN LANG, V61, P376, DOI 10.1006/brln.1997.1883; ENGLE RW, 1995, PSYCHOL SCI, V6, P122, DOI 10.1111/j.1467-9280.1995.tb00318.x; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; FELDMAN H, 1989, TOP EARLY CHILD SPEC, V9, P32, DOI 10.1177/027112148900900104; Fernandino L, 2010, BRAIN LANG, V112, P44, DOI 10.1016/j.bandl.2009.02.003; Fischer MH, 2008, Q J EXP PSYCHOL, V61, P825, DOI 10.1080/17470210701623605; Fletcher Jack M, 2002, Semin Pediatr Neurol, V9, P201, DOI 10.1053/spen.2002.35500; Fletcher JM, 2005, J NEUROSURG, V102, P268, DOI 10.3171/ped.2005.102.3.0268; Fletcher JM, 2000, SCI PRACT NEUROPSYCH, P25; Fletcher JM, 1996, CHILD NERV SYST, V12, P192, DOI 10.1007/BF00301250; FLETCHER P, 2005, DEV THEORY LANGUAGE; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Gennarelli T. A., 1998, SEM CLIN NEUR, V3, P160; Gentilucci M, 1998, EUR J NEUROSCI, V10, P752, DOI 10.1046/j.1460-9568.1998.00060.x; GERNSBACHER MA, 1991, J EXP PSYCHOL LEARN, V17, P245, DOI 10.1037/0278-7393.17.2.245; Gernsbacher MA, 1999, J PRAGMATICS, V31, P1619, DOI 10.1016/S0378-2166(99)00007-7; GERNSBACHER MA, 1995, CAN PSYCHOL, V36, P49, DOI 10.1037/h0084720; GERNSBACHER Morton Ann, 1990, LANGUAGE COMPREHENSI; GIBBS RW, 1991, J SPEECH HEAR RES, V34, P613, DOI 10.1044/jshr.3403.613; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Glover S, 2004, EXP BRAIN RES, V154, P103, DOI 10.1007/s00221-003-1659-2; Guttmann E, 1942, BRAIN, V65, P205, DOI 10.1093/brain/65.2.205; Hall W. S., 1986, MODELS MODULES STUDI, P26; Hannay HJ, 2000, J INT NEUROPSYCH SOC, V6, P351, DOI 10.1017/S1355617700633106; Harnishfeger KK, 1996, J EXP CHILD PSYCHOL, V62, P292, DOI 10.1006/jecp.1996.0032; HARNISHFEGER KK, 1994, LEARN INDIVID DIFFER, V6, P331, DOI 10.1016/1041-6080(94)90021-3; Harris M, 2003, DISCOURSE PROCESS, V36, P147, DOI 10.1207/S15326950DP3603_1; HASAN KM, 2008, J MAGN RESON, V7, P700; Hattiangadi N, 2005, BRAIN LANG, V92, P12, DOI 10.1016/j.bandl.2004.05.003; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; HAVERKATE H, 1990, J PRAGMATICS, V14, P77, DOI 10.1016/0378-2166(90)90065-L; HECAEN H, 1983, NEUROPSYCHOLOGIA, V21, P581, DOI 10.1016/0028-3932(83)90055-6; Hetherington R, 2004, CHILD NEUROPSYCHOL, V10, P117, DOI 10.1080/09297040490911122; HOFFMAN HJ, 1979, CHILD BRAIN, V5, P233; Houghton George, 1994, P53; Huber JF, 2006, CHILD NERV SYST, V22, P132, DOI 10.1007/s00381-005-1223-4; Huber JF, 2007, J CHILD NEUROL, V22, P848, DOI 10.1177/0883073807303995; Huber-Okrainec J, 2005, BRAIN LANG, V93, P349, DOI 10.1016/j.bandl.2004.11.002; Huber-Okrainec J, 2002, BRAIN LANG, V80, P592, DOI 10.1006/brln.2001.2620; HUDSON LJ, 1989, APHASIOLOGY, V3, P1, DOI 10.1080/02687038908248972; HUDSON LJ, 1990, ACQUIRED NEUROLOGICA, P245; Humphreys RP, 1989, CONCEPTS PEDIATR NEU, P57; HYND GW, 1995, J CHILD NEUROL, V10, P289, DOI 10.1177/088307389501000406; HYND GW, 1990, ARCH NEUROL-CHICAGO, V47, P919, DOI 10.1001/archneur.1990.00530080107018; Jarema G, 2008, HANDBOOK OF THE NEUROSCIENCE OF LANGUAGE, P137, DOI 10.1016/B978-0-08-045352-1.00013-6; JORDAN F M, 1990, Brain Injury, V4, P27; Jordan F M, 1988, Brain Inj, V2, P179, DOI 10.3109/02699058809150943; JORDAN FM, 1993, APHASIOLOGY, V7, P503, DOI 10.1080/02687039308248626; JORDAN FM, 1990, ACQUIRED NEUROLOGICA, P124; KARTTUNEN L, 1971, LANGUAGE, V47, P340, DOI 10.2307/412084; Kemmerer D, 2008, BRAIN LANG, V107, P16, DOI 10.1016/j.bandl.2007.09.003; Kempson R.M., 1975, PRESUPPOSITION DELIM; KINTSCH W, 1988, PSYCHOL REV, V95, P163, DOI 10.1037/0033-295X.95.2.163; Kiparsky Paul, 1970, PROGR LINGUISTICS, P143; Kipp K, 2005, BIOL PSYCHIAT, V57, P1256, DOI 10.1016/j.biopsych.2005.03.012; KLEIN SK, 1992, J CHILD NEUROL, V7, P50, DOI 10.1177/088307389200700109; KOHN B, 1980, BRAIN LANG, V9, P350, DOI 10.1016/0093-934X(80)90154-6; LANDAU WM, 1957, NEUROLOGY, V7, P523, DOI 10.1212/WNL.7.8.523; Levelt W. J. M., 1989, SPEAKING INTENTION A; Libben G, 2008, HANDBOOK OF THE NEUROSCIENCE OF LANGUAGE, P147, DOI 10.1016/B978-0-08-045352-1.00014-8; Lidzba K, 2008, BRAIN LANG, V106, P204, DOI 10.1016/j.bandl.2007.11.003; Liegeois F, 2008, BRAIN LANG, V106, P195, DOI 10.1016/j.bandl.2008.01.010; LINEBARGER M C, 1990, P55; LOONEN MCB, 1990, ARCH NEUROL-CHICAGO, V47, P1324, DOI 10.1001/archneur.1990.00530120068012; Love T, 2008, BRAIN LANG, V107, P203, DOI 10.1016/j.bandl.2007.11.004; LOVETT MW, 1986, BRAIN LANG, V29, P224, DOI 10.1016/0093-934X(86)90046-5; Lustig AP, 2002, APHASIOLOGY, V16, P507, DOI 10.1080/02687030244000211; LYON GR, 1995, ANN DYSLEXIA, V45, P3, DOI 10.1007/BF02648210; MACWHINNEY B, 1991, COGNITION, V40, P121, DOI 10.1016/0010-0277(91)90048-9; Mahon BZ, 2009, ANNU REV PSYCHOL, V60, P27, DOI 10.1146/annurev.psych.60.110707.163532; Majerus S, 2004, COGN NEUROPSYCHOL, V21, P491, DOI 10.1080/02643290342000104; MAKINO A, 1988, SURG NEUROL, V29, P393, DOI 10.1016/0090-3019(88)90048-1; Malle B.F., 2001, INTENTIONS INTENTION, P1; Martin A, 2003, COGN NEUROPSYCHOL, V20, P195, DOI 10.1080/02643290342000050; McCabe, 1997, PROBLEM MEANING BEHA, P377, DOI DOI 10.1016/S0166-4115(97)80142-2; McMillan HJ, 2009, CHILD NERV SYST, V25, P677, DOI 10.1007/s00381-008-0777-3; MENN L, 1990, CROSS LANGUAGE STUDY; Moleski M, 2000, ARCH CLIN NEUROPSYCH, V15, P603, DOI 10.1016/S0887-6177(99)00050-5; MORROW DG, 1990, INFERENCES TEXT COMP, P123; MURDOCH BE, 1990, ACQUIRED NEUROLOGICA, P177; Ni W, 2000, J COGNITIVE NEUROSCI, V12, P120, DOI 10.1162/08989290051137648; Noveck IA, 2008, TRENDS COGN SCI, V12, P425, DOI 10.1016/j.tics.2008.07.009; Ozanne AE, 1990, ACQUIRED NEUROLOGICA, P1; PAQUIER P, 1993, APHASIOLOGY, V7, P421, DOI 10.1080/02687039308248618; PAQUIER P, 1989, APHASIOLOGY, V3, P667, DOI 10.1080/02687038908249032; PAQUIER P, 1991, APHASIOLOGY, V5, P235, DOI 10.1080/02687039108248526; Pascual-Leone J, 2001, BEHAV BRAIN SCI, V24, P136, DOI 10.1017/S0140525X01453921; Paul LK, 2003, BRAIN LANG, V85, P313, DOI 10.1016/S0093-934X(03)00062-2; Perfetti CA, 2008, HANDBOOK OF THE NEUROSCIENCE OF LANGUAGE, P165, DOI 10.1016/B978-0-08-045352-1.00016-1; Perner J, 2002, CHILD DEV, V73, P752, DOI 10.1111/1467-8624.00436; Pitchford NJ, 2000, BRAIN LANG, V72, P129, DOI 10.1006/brln.1999.2267; Plante E, 2006, BRAIN LANG, V97, P332, DOI 10.1016/j.bandl.2005.12.004; Pollio, 1977, PSYCHOL POETICS GROW; Pugh KR, 2000, MENT RETARD DEV D R, V6, P207, DOI 10.1002/1098-2779(2000)6:3<207::AID-MRDD8>3.0.CO;2-P; RAPIN I, 1995, J CHILD NEUROL, V10, P267, DOI 10.1177/088307389501000401; Reilly JS, 1998, BRAIN LANG, V61, P335, DOI 10.1006/brln.1997.1882; REKATE HL, 1985, ARCH NEUROL-CHICAGO, V42, P697, DOI 10.1001/archneur.1985.04060070091023; Richards J. E., 2003, COGNITIVE NEUROSCIEN, P73; Ris MD, 2000, SCI PRACT NEUROPSYCH, P320; Saarni C., 1999, DEV EMOTIONAL COMPET; Sanford AJ, 2002, TRENDS COGN SCI, V6, P382, DOI 10.1016/S1364-6613(02)01958-7; SARTORI G, 1988, COGNITIVE NEUROPSYCH, V5, P105, DOI 10.1080/02643298808252928; Schmalhofer F, 2002, DISCOURSE PROCESS, V33, P105, DOI 10.1207/S15326950DP3302_01; SCHWARTZ RG, 2008, HDB LANGUAGE DISORDE; Searle J. R., 1969, SPEECH ACTS ESSAY PH, V626; Shriberg LD, 1997, J SPEECH LANG HEAR R, V40, P286, DOI 10.1044/jslhr.4002.286; Shriberg LD, 1997, J SPEECH LANG HEAR R, V40, P273, DOI 10.1044/jslhr.4002.273; Simos PG, 2000, CEREB CORTEX, V10, P809, DOI 10.1093/cercor/10.8.809; SMYTH V, 1990, ACQUIRED NEUROLOGICA, P148; Stark RE, 1995, BRAIN LANG, V51, P406, DOI 10.1006/brln.1995.1068; Stemmer B, 2008, HANDBOOK OF THE NEUROSCIENCE OF LANGUAGE, P175, DOI 10.1016/B978-0-08-045352-1.00017-3; Stromswold K, 1996, BRAIN LANG, V52, P452, DOI 10.1006/brln.1996.0024; Stronach ST, 2008, APHASIOLOGY, V22, P1054, DOI 10.1080/02687030701632187; Swinney D, 1996, J COGNITIVE NEUROSCI, V8, P174, DOI 10.1162/jocn.1996.8.2.174; TAYLOR EM, 1961, PSYCHOL APPRAISAL CH; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Ullman MT, 2008, HANDBOOK OF THE NEUROSCIENCE OF LANGUAGE, P189, DOI 10.1016/B978-0-08-045352-1.00018-5; Ullman MT, 1997, J COGNITIVE NEUROSCI, V9, P266, DOI 10.1162/jocn.1997.9.2.266; Valstar MJ, 2008, J INHERIT METAB DIS, V31, P240, DOI 10.1007/s10545-008-0838-5; van den Broek P, 1999, CONSTRUCTION OF MENTAL REPRESENTATIONS DURING READING, P71; Van Dijk T.A., 1983, STRATEGIES DISCOURSE; van Mourik M, 1998, PEDIATR NEUROL, V18, P411, DOI 10.1016/S0887-8994(97)00232-4; VANDONGEN HR, 1985, ANN NEUROL, V17, P306, DOI 10.1002/ana.410170316; VANDONGEN HR, 1994, NEUROLOGY, V44, P2040, DOI 10.1212/WNL.44.11.2040; VANDONGEN HR, 1977, CORTEX, V13, P131, DOI 10.1016/S0010-9452(77)80004-X; VANDONGEN HR, 1991, NATO ADV SCI I D-BEH, V60, P125; VANHOUT A, 1985, DEV MED CHILD NEUROL, V27, P231; VANHOUT A, 1991, NATO ADV SCI I D-BEH, V60, P117; VANLANCKERSIDTI.D, 2008, HDB NEUROSCIENCE LAN, P199; VISCHBRINK EG, 1984, BRAIN LANG, V23, P258, DOI 10.1016/0093-934X(84)90067-1; Warr-Leeper G.A., 1989, LANGUAGE, V20, P420, DOI [10.1044/0161-1461.2004.420, DOI 10.1044/0161-1461.2004.420]; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; WHITNEY P, 1987, READ RES QUART, V22, P299, DOI 10.2307/747970; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; Williams J, 2000, SCI PRACT NEUROPSYCH, P47; Williams LJ, 2005, PEDIATRICS, V116, P580, DOI 10.1542/peds.2005-0592; WITHERS HR, 1992, LANCET, V339, P156; WOODS BT, 1978, ANN NEUROL, V3, P273, DOI 10.1002/ana.410030315; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Zwaan RA, 2006, J EXP PSYCHOL GEN, V135, P1, DOI 10.1037/0096-3445.135.1.1; ZWAAN RA, 1995, PSYCHOL SCI, V6, P292, DOI 10.1111/j.1467-9280.1995.tb00513.x; Zwaan RA, 2004, PSYCHOL LEARN MOTIV, V44, P35; Zwaan RA, 1998, PSYCHOL BULL, V123, P162, DOI 10.1037/0033-2909.123.2.162; ZWAAN RA, BRAIN LANGU IN PRESS	215	12	13	1	18	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2010	32	4					417	432		10.1080/13803390903164355			16	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	589YV	WOS:000277191000009	20397297	Green Accepted			2021-06-18	
J	Eve, DJ; Fillmore, RW; Borlongan, CV; Sanberg, PR				Eve, David J.; Fillmore, Randolph W.; Borlongan, Cesar V.; Sanberg, Paul R.			Stem cells have the potential to rejuvenate regenerative medicine research	MEDICAL SCIENCE MONITOR			English	Article						stem cells; cell transplantation; regenerative medicine; tissue engineering; biomaterials	UMBILICAL-CORD BLOOD; LONG-TERM SURVIVAL; NEURAL PROGENITOR CELLS; MARROW STROMAL CELLS; AMYOTROPHIC-LATERAL-SCLEROSIS; TRAUMATIC BRAIN-INJURY; MEDIATED GENE-TRANSFER; HEMATOPOIETIC GROWTH-FACTORS; ACUTE MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR FUNCTION	The increasing number of publications featuring the use of stem cells in regenerative processes supports the idea that they are revolutionizing regenerative medicine research. In an analysis of the articles published in the journal Cell Transplantation - The Regenerative Medicine Journal between 2008 and 2009, which reveals the topics and categories that are on the cutting edge of regenerative medicine research, stem cells are becoming increasingly relevant as the "runner-up" category to "neuroscience" related articles. The high volume of stem cell research casts a bright light on the hope for stem cells and their role in regenerative medicine as a number of reports deal with research using stem cells entering, or seeking approval for, clinical trials. The "methods and new technologies" and "tissue engineering" sections were almost equally as popular, and in part, reflect attempts to maximize the potential of stem cells and other treatments for the repair of damaged tissue. Transplantation studies were again more popular than non-transplantation, and the contribution of stem cell-related transplants was greater than other types of transplants. The non-transplantation articles were predominantly related to new methods for the preparation, isolation and manipulation of materials for transplant by specific culture media, gene therapy, medicines, dietary supplements, and co-culturing with other cells and further elucidation of disease mechanisms. A sizeable proportion of the transplantation articles reported on how previously new methods may have aided the ability of the cells or tissue to exert beneficial effects following transplantation.	[Eve, David J.; Fillmore, Randolph W.; Borlongan, Cesar V.; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA	Eve, DJ (corresponding author), Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA.	deve@health.usf.edu	Borlongan, Cesar/I-5696-2012	Borlongan, Cesar/0000-0002-2966-9782			Abbah SA, 2008, CELL TRANSPLANT, V17, P1181, DOI 10.3727/096368908787236648; Abbas A, 2009, MED SCI MONITOR, V15, pMT121; Abu-Hammad T, 2008, MED SCI MONITOR, V14, pCR262; Acosta SA, 2008, CELL TRANSPLANT, V17, P457; Acosta SA, 2009, CELL TRANSPLANT, V18, P207; Agrawal A, 2008, CELL TRANSPLANT, V17, P1315, DOI 10.3727/096368908787648065; Airavaara M, 2009, CELL TRANSPLANT, V18, P207; AIRAVAARA M, 2008, CELL TRANSPLANT, V17, P457; Akesson E, 2008, CELL TRANSPLANT, V17, P1115, DOI 10.3727/096368908787236585; Akiyama M, 2009, CELL TRANSPLANT, V18, P443, DOI 10.3727/096368909788809820; Alberti E, 2009, MED SCI MONITOR, V15, pBR47; Alexander I, 2009, CELL TRANSPLANT, V18, P255, DOI 10.3727/096368909788534997; Ali MM, 2008, CELL TRANSPLANT, V17, P458; Alvarez-Mercado AI, 2008, CELL TRANSPLANT, V17, P845, DOI 10.3727/096368908786516837; Alvarez-Mercado AI, 2009, CELL TRANSPLANT, V18, P1069, DOI 10.3727/096368909X12483162197088; Amable RJ, 2008, CELL TRANSPLANT, V17, P458; Amann B, 2009, CELL TRANSPLANT, V18, P371, DOI 10.3727/096368909788534942; Amir G, 2009, CELL TRANSPLANT, V18, P275, DOI 10.3727/096368909788534898; Andres RH, 2008, CELL TRANSPLANT, V17, P458; Andres RH, 2009, CELL TRANSPLANT, V18, P208; Asiedu C, 2008, CELL TRANSPLANT, V17, P713, DOI 10.3727/096368908786092748; Astradsson A, 2008, CELL TRANSPLANT, V17, P459; Azari H, 2008, CELL TRANSPLANT, V17, P459; Aziz MTA, 2008, MED SCI MONITOR, V14, pBR249; Bachstetter AD, 2008, CELL TRANSPLANT, V17, P459; Bachstetter AD, 2009, CELL TRANSPLANT, V18, P208; Badri VK, 2008, CELL TRANSPLANT, V17, P460; Bae JY, 2009, CELL TRANSPLANT, V18, P505, DOI 10.1177/096368970901805-604; Bae JY, 2009, CELL TRANSPLANT, V18, P459, DOI 10.3727/096368909788809776; Baek SH, 2009, CELL TRANSPLANT, V18, P209; Bagga V, 2008, CELL TRANSPLANT, V17, P763, DOI 10.3727/096368908786516774; Bakay RAE, 2008, CELL TRANSPLANT, V17, P460; Bankiewicz K, 2008, CELL TRANSPLANT, V17, P460; Barone TA, 2008, CELL TRANSPLANT, V17, P461; Barton FB, 2009, CELL TRANSPLANT, V18, P753, DOI 10.3727/096368909X470874; Behrouz B, 2009, CELL TRANSPLANT, V18, P209; Behrstock S, 2008, CELL TRANSPLANT, V17, P753, DOI 10.3727/096368908786516819; Benabdallah BF, 2009, CELL TRANSPLANT, V18, P709, DOI 10.3727/096368909X470865; Benabdallah BF, 2008, CELL TRANSPLANT, V17, P337, DOI 10.3727/096368908784153913; Berk MA, 2009, CELL TRANSPLANT, V18, P209; Bernal GM, 2009, CELL TRANSPLANT, V18, P210; Bertuzzi F, 2009, CELL TRANSPLANT, V18, P203, DOI 10.3727/096368909788341270; Bidzan L, 2008, MED SCI MONITOR, V14, pCR473; Bierinx AS, 2008, CELL TRANSPLANT, V17, P1193, DOI 10.3727/096368908787236530; Bilic G, 2008, CELL TRANSPLANT, V17, P955, DOI 10.3727/096368908786576507; Bjugstad KB, 2008, CELL TRANSPLANT, V17, P409; Bjugstad KB, 2009, CELL TRANSPLANT, V18, P210; Block A, 2008, MED SCI MONITOR, V14, pBR88; Bobek V, 2008, CELL TRANSPLANT, V17, P461; Bobek V, 2009, CELL TRANSPLANT, V18, P211; Boger HA, 2008, CELL TRANSPLANT, V17, P461; Boger HA, 2009, CELL TRANSPLANT, V18, P211; Boldrin L, 2008, CELL TRANSPLANT, V17, P577, DOI 10.3727/096368908785095980; Bombard MC, 2008, CELL TRANSPLANT, V17, P462; Bonora-Centelles A, 2009, CELL TRANSPLANT, V18, P1319, DOI 10.3727/096368909X12483162197321; Borlongan CV, 2008, CELL TRANSPLANT, V17, P462; Bosio E, 2008, CELL TRANSPLANT, V17, P587, DOI 10.3727/096368908786092784; Brezillon NM, 2008, CELL TRANSPLANT, V17, P803, DOI 10.3727/096368908786516800; Brunet JF, 2009, CELL TRANSPLANT, V18, P787, DOI 10.3727/096368909X470847; Buchwald P, 2009, CELL TRANSPLANT, V18, P1223, DOI 10.3727/096368909X476968; Buzzeo MP, 2008, CELL TRANSPLANT, V17, P489, DOI 10.3727/096368908785096042; Cargnoni A, 2009, CELL TRANSPLANT, V18, P1147, DOI 10.3727/096368909X12483162196764; Cargnoni A, 2009, CELL TRANSPLANT, V18, P405, DOI 10.3727/096368909788809857; Carty N, 2008, CELL TRANSPLANT, V17, P462; Carvey PM, 2008, CELL TRANSPLANT, V17, P463; Castanheira P, 2009, CELL TRANSPLANT, V18, P423, DOI 10.3727/096368909788809811; Chang YS, 2009, CELL TRANSPLANT, V18, P869, DOI 10.3727/096368909X471189; Chao KC, 2008, CELL TRANSPLANT, V17, P657, DOI 10.3727/096368908786092801; Chen JC, 2008, CELL TRANSPLANT, V17, P495, DOI 10.3727/096368908785095971; Chermenina M, 2009, CELL TRANSPLANT, V18, P211; Cho DY, 2009, CELL TRANSPLANT, V18, P977, DOI 10.3727/096368909X12483162196962; Cho SR, 2009, CELL TRANSPLANT, V18, P1359, DOI 10.3727/096368909X475329; Choi UK, 2008, FOOD SCI BIOTECHNOL, V17, P899; Chopp M, 2009, CELL TRANSPLANT, V18, P691, DOI 10.3727/096368909X470883; Cicchetti F, 2009, CELL TRANSPLANT, V18, P211; Cobacho N, 2009, CELL TRANSPLANT, V18, P1341, DOI 10.3727/096368909X12483162197367; Cobianchi L, 2008, CELL TRANSPLANT, V17, P559, DOI 10.3727/096368908785096060; Coffey LCK, 2009, CELL TRANSPLANT, V18, P1213, DOI 10.3727/096368909X12483162196728; Collado LM, 2009, CELL TRANSPLANT, V18, P212; COLLIER TJ, 2008, CELL TRANSPLANT, V17, P457; Cornolti R, 2009, CELL TRANSPLANT, V18, P195, DOI 10.3727/096368909788341252; Daadi MM, 2009, CELL TRANSPLANT, V18, P212; Daadi MM, 2009, CELL TRANSPLANT, V18, P815, DOI 10.3727/096368909X470829; Das H, 2009, CELL TRANSPLANT, V18, P305, DOI 10.3727/096368909788534870; Davalli AM, 2008, CELL TRANSPLANT, V17, P1323, DOI 10.3727/096368908787648137; Souza BSD, 2009, CELL TRANSPLANT, V18, P1261, DOI 10.3727/096368909X470522; DELCASTILLO, 2009, CELL TRANSPLANT, V18, P1237; Detante O, 2009, CELL TRANSPLANT, V18, P1369, DOI 10.3727/096368909X474230; Diaz-Ruiz O, 2008, CELL TRANSPLANT, V17, P463; Dodiya HB, 2009, CELL TRANSPLANT, V18, P212; Dobrossy MD, 2008, CELL TRANSPLANT, V17, P1125; Donato MT, 2008, CELL TRANSPLANT, V17, P1211, DOI 10.3727/096368908787236620; Drowley L, 2009, CELL TRANSPLANT, V18, P1137, DOI 10.3727/096368909X471305; Ducray A, 2008, CELL TRANSPLANT, V17, P463; Dufour JM, 2008, CELL TRANSPLANT, V17, P525, DOI 10.3727/096368908785096033; Eidelberg D, 2008, CELL TRANSPLANT, V17, P464; El-Moursy SA, 2009, MED SCI MONITOR, V15, pBR339; ELBADRI N, 2008, CELL TRANSPLANT, V17, P464; Ellis-Behnke RG, 2009, CELL TRANSPLANT, V18, P1047, DOI 10.3727/096368909X471242; Emborg EM, 2009, CELL TRANSPLANT, V18, P213; Emborg ME, 2008, CELL TRANSPLANT, V17, P383; Epple-Farmer J, 2009, CELL TRANSPLANT, V18, P769, DOI 10.3727/096368909X470856; Estrada EJ, 2008, CELL TRANSPLANT, V17, P1295, DOI 10.3727/096368908787648119; Eve DJ, 2008, CELL TRANSPLANT, V17, P464; Eve DJ, 2009, CELL TRANSPLANT, V18, P213; Fan HB, 2008, CELL TRANSPLANT, V17, P1389, DOI 10.3727/096368908787648047; Faradji RN, 2009, CELL TRANSPLANT, V18, P1247, DOI 10.3727/096368909X474456; Federici T, 2009, CELL TRANSPLANT, V18, P213; Fenjves ES, 2008, CELL TRANSPLANT, V17, P793, DOI 10.3727/096368908786516828; Ferrero I, 2008, CELL TRANSPLANT, V17, P255, DOI 10.3727/096368908784153940; Formisano R, 2009, MED SCI MONITOR, V15, pCR101; Fort A, 2008, CELL TRANSPLANT, V17, P997, DOI 10.3727/096368908786991498; Fortress AM, 2009, CELL TRANSPLANT, V18, P214; Freed WJ, 2008, CELL TRANSPLANT, V17, P465; Freeman L, 2009, CELL TRANSPLANT, V18, P214; Friberg AS, 2008, CELL TRANSPLANT, V17, P1305, DOI 10.3727/096368908787648100; Fu RH, 2009, CELL TRANSPLANT, V18, P1029, DOI 10.3727/096368909X471260; Fujimoto KL, 2009, CELL TRANSPLANT, V18, P477, DOI 10.3727/096368909788809785; Fujita S, 2008, CELL TRANSPLANT, V17, P1169, DOI 10.3727/096368908787236611; Furlani D, 2009, CELL TRANSPLANT, V18, P319, DOI 10.3727/096368909788534906; Furmanski O, 2008, CELL TRANSPLANT, V17, P466; Gajavelli S, 2008, CELL TRANSPLANT, V17, P466; Gajavelli S, 2008, CELL TRANSPLANT, V17, P445; Galoyan AA, 2008, CELL TRANSPLANT, V17, P1061, DOI 10.3727/096368908786991579; Gao LR, 2009, CELL TRANSPLANT, V18, P1311, DOI 10.3727/096368909X474843; Gao YX, 2008, CELL TRANSPLANT, V17, P723, DOI 10.3727/096368908786516729; Garbuzova-Davis S, 2008, CELL TRANSPLANT, V17, P466; Garbuzova-Davis S, 2009, CELL TRANSPLANT, V18, P214; Garkavenko O, 2008, CELL TRANSPLANT, V17, P1381, DOI 10.3727/096368908787648056; Geffner LF, 2008, CELL TRANSPLANT, V17, P1277, DOI 10.3727/096368908787648074; Gemma C, 2008, CELL TRANSPLANT, V17, P467; Ghanem A, 2009, CELL TRANSPLANT, V18, P1289, DOI 10.3727/096368909X12483162197286; Ghosh D, 2008, CELL TRANSPLANT, V17, P351, DOI 10.3727/096368908784153869; Ghosh M, 2009, CELL TRANSPLANT, V18, P215; Glavaski-Joksimovic A, 2009, CELL TRANSPLANT, V18, P801, DOI 10.3727/096368909X470801; Golat BT, 2008, CELL TRANSPLANT, V17, P1135, DOI 10.3727/096368908787236512; Golshani R, 2009, CELL TRANSPLANT, V18, P215; Gombash SE, 2009, CELL TRANSPLANT, V18, P216; Gorenkova N, 2009, CELL TRANSPLANT, V18, P216; Granholm AC, 2008, CELL TRANSPLANT, V17, P467; Granholm AC, 2009, CELL TRANSPLANT, V18, P216; Grochmal-Bach B, 2009, MED SCI MONITOR, V15, pCR248; Grochmal-Bach B, 2009, MED SCI MONITOR, V15, pCS67; Grondin M, 2009, CELL TRANSPLANT, V18, P79, DOI 10.3727/096368909788237104; Grondin R, 2008, CELL TRANSPLANT, V17, P373, DOI 10.3727/096368908784423256; Gross RE, 2008, CELL TRANSPLANT, V17, P467; Gunji T, 2008, CELL TRANSPLANT, V17, P619, DOI 10.3727/096368908786092720; Hallett PJ, 2009, CELL TRANSPLANT, V18, P217; Hanson MS, 2008, CELL TRANSPLANT, V17, P1337, DOI 10.3727/096368908787648038; Hardjo M, 2009, CELL TRANSPLANT, V18, P89, DOI 10.3727/096368909788237140; Harvey BK, 2009, CELL TRANSPLANT, V18, P217; Hatayama N, 2009, CELL TRANSPLANT, V18, P529, DOI 10.1177/096368970901805-607; Hayashi T, 2009, CELL TRANSPLANT, V18, P217; Helbig G, 2008, MED SCI MONITOR, V14, pCR584; Heng BC, 2009, CELL TRANSPLANT, V18, P1111, DOI 10.3727/096368909X12483162197006; Hess DC, 2009, CELL TRANSPLANT, V18, P218; Hess S, 2009, CELL TRANSPLANT, V18, P261, DOI 10.3727/096368909788534979; Hirose N, 2008, CELL TRANSPLANT, V17, P211, DOI 10.3727/000000008783906919; Horne PH, 2008, CELL TRANSPLANT, V17, P829, DOI 10.3727/096368908786516792; Hossne NA, 2009, CELL TRANSPLANT, V18, P1299, DOI 10.3727/096368909X484671; Hu CJ, 2008, CELL TRANSPLANT, V17, P1067, DOI 10.3727/096368908786991506; Huang XS, 2009, CELL TRANSPLANT, V18, P887, DOI 10.3727/096368909X471152; Hung HS, 2009, CELL TRANSPLANT, V18, P1003, DOI 10.3727/096368909X12483162196683; Hunt DPJ, 2008, CELL TRANSPLANT, V17, P865, DOI 10.3727/096368908786516738; Iken M, 2009, CELL TRANSPLANT, V18, P745, DOI 10.3727/096368909X470838; Imamura R, 2008, CELL TRANSPLANT, V17, P135, DOI 10.3727/000000008783907044; Imamura T, 2008, CELL TRANSPLANT, V17, P267, DOI 10.3727/096368908784153850; Iop L, 2008, CELL TRANSPLANT, V17, P679, DOI 10.3727/096368908786092739; Isacson O, 2008, CELL TRANSPLANT, V17, P468; Ismail A, 2009, MED SCI MONITOR, V15, pBR243; Ito M, 2008, CELL TRANSPLANT, V17, P165, DOI 10.3727/000000008783906883; Jain A, 2009, CELL TRANSPLANT, V18, P218; JENSEN P, 2009, CELL TRANSPLANT, V18, P218; Jergova S, 2009, CELL TRANSPLANT, V18, P219; Jha RK, 2008, MED SCI MONITOR, V14, pBR14; Jiang Z, 2008, CELL TRANSPLANT, V17, P969, DOI 10.3727/096368908786576525; Jiang ZY, 2008, MED SCI MONITOR, V14, pCR515; Jinwal UK, 2009, CELL TRANSPLANT, V18, P219; Johansson S, 2009, CELL TRANSPLANT, V18, P219; Johnson JD, 2009, CELL TRANSPLANT, V18, P833, DOI 10.3727/096368909X471198; Gomez-Lechon MJ, 2008, CELL TRANSPLANT, V17, P887, DOI 10.3727/096368908786576534; Juang JH, 2008, CELL TRANSPLANT, V17, P641, DOI 10.3727/096368908786092766; Jung M, 2009, CELL TRANSPLANT, V18, P923, DOI 10.3727/096368909X471297; Kabatas S, 2008, CELL TRANSPLANT, V17, P468; Kaczmarek R, 2009, MED SCI MONITOR, V15, pBR227; Kandel I, 2009, MED SCI MONITOR, V15, pPH13; Karakostas T, 2008, CELL TRANSPLANT, V17, P468; Kawazoe T, 2008, CELL TRANSPLANT, V17, P203, DOI 10.3727/000000008783906964; Kawecki D, 2009, MED SCI MONITOR, V15, pCR628; Keene CD, 2008, CELL TRANSPLANT, V17, P469; Kelly L, 2009, CELL TRANSPLANT, V18, P220; Kenmochi T, 2008, CELL TRANSPLANT, V17, P61, DOI 10.3727/000000008783907026; KHAING ZZ, 2009, CELL TRANSPLANT, V18, P220; Kihara Y, 2009, CELL TRANSPLANT, V18, P639, DOI 10.1177/096368970901805-620; Kim H, 2009, CELL TRANSPLANT, V18, P513, DOI 10.1177/096368970901805-605; Kim HI, 2009, CELL TRANSPLANT, V18, P31, DOI 10.3727/096368909788237113; Kim YH, 2008, CELL TRANSPLANT, V17, P609, DOI 10.3727/096368908786092694; Kinomura M, 2008, CELL TRANSPLANT, V17, P143, DOI 10.3727/000000008783907008; Kishi Y, 2008, CELL TRANSPLANT, V17, P1095, DOI 10.3727/096368908786991560; Kitazawa Y, 2009, CELL TRANSPLANT, V18, P627, DOI 10.1177/096368970901805-619; Klein JA, 2008, CELL TRANSPLANT, V17, P585, DOI 10.3727/096368908785096015; Kneser M, 2009, MED SCI MONITOR, V15, pCR436; Kobayashi M, 2008, CELL TRANSPLANT, V17, P291, DOI 10.3727/096368908784153904; Kobayashi N, 2008, CELL TRANSPLANT, V17, P19, DOI 10.3727/000000008783906982; Kobayashi N, 2008, CELL TRANSPLANT, V17, P11, DOI 10.3727/000000008783907107; Kobayashi N, 2008, CELL TRANSPLANT, V17, P1; Kobayashi N, 2008, CELL TRANSPLANT, V17, P3, DOI 10.3727/000000008783907099; Kobayashi N, 2009, CELL TRANSPLANT, V18, P491, DOI 10.1177/096368970901805-602; Kobayashi N, 2009, CELL TRANSPLANT, V18, P489, DOI 10.1177/096368970901805-601; Kobayashi T, 2008, CELL TRANSPLANT, V17, P1243, DOI 10.3727/096368908787236602; Koenig S, 2009, CELL TRANSPLANT, V18, P69, DOI 10.3727/096368909788237186; Koestenbauer S, 2009, CELL TRANSPLANT, V18, P1059, DOI 10.3727/096368909X471288; Kordower JH, 2008, CELL TRANSPLANT, V17, P469; Kordower JH, 2008, CELL TRANSPLANT, V17, P361; Kotobuki N, 2008, CELL TRANSPLANT, V17, P705, DOI 10.3727/096368908786092793; Krausgrill B, 2009, CELL TRANSPLANT, V18, P847, DOI 10.3727/096368909X471134; Krynska B, 2008, CELL TRANSPLANT, V17, P469; Kuleshova LL, 2009, CELL TRANSPLANT, V18, P135, DOI 10.3727/096368909788341298; Kumaraswamy GK, 2008, CELL TRANSPLANT, V17, P469; Kuo TK, 2009, CELL TRANSPLANT, V18, P1013, DOI 10.3727/096368909X471206; Kuruba R, 2009, CELL TRANSPLANT, V18, P221; Kusaka M, 2008, CELL TRANSPLANT, V17, P129, DOI 10.3727/000000008783907116; Kusaka M, 2009, CELL TRANSPLANT, V18, P647, DOI 10.1177/096368970901805-621; Laconi S, 2008, CELL TRANSPLANT, V17, P1415, DOI 10.3727/096368908787648128; Lafreniere JF, 2009, CELL TRANSPLANT, V18, P719, DOI 10.3727/096368909X470900; Lane MA, 2008, CELL TRANSPLANT, V17, P470; Lau J, 2009, CELL TRANSPLANT, V18, P23, DOI 10.3727/096368909788237131; Lebson LA, 2008, CELL TRANSPLANT, V17, P470; Lee CT, 2009, CELL TRANSPLANT, V18, P221; Lee DC, 2008, CELL TRANSPLANT, V17, P471; Lee DC, 2009, CELL TRANSPLANT, V18, P222; Lee EJ, 2009, CELL TRANSPLANT, V18, P731, DOI 10.3727/096368909X470919; Lee JI, 2008, CELL TRANSPLANT, V17, P51, DOI 10.3727/000000008783907035; Lee SW, 2009, CELL TRANSPLANT, V18, P1123, DOI 10.3727/096368909X12483162196809; Lehec SC, 2009, CELL TRANSPLANT, V18, P941, DOI 10.3727/096368909X471323; Leiker M, 2008, CELL TRANSPLANT, V17, P911, DOI 10.3727/096368908786576444; Li Q, 2008, CELL TRANSPLANT, V17, P471; Li Q, 2009, CELL TRANSPLANT, V18, P222; Li QY, 2008, CELL TRANSPLANT, V17, P397; Li TS, 2008, CELL TRANSPLANT, V17, P695, DOI 10.3727/096368908786092702; Li W, 2009, MED SCI MONITOR, V15, pBR357; Li WY, 2008, CELL TRANSPLANT, V17, P1045, DOI 10.3727/096368908786991551; Licznerski P, 2008, CELL TRANSPLANT, V17, P471; Lieu CA, 2008, CELL TRANSPLANT, V17, P471; Lieu CA, 2009, CELL TRANSPLANT, V18, P222; Lim JY, 2008, CELL TRANSPLANT, V17, P472; Lin SZ, 2008, CELL TRANSPLANT, V17, P472; Lin SZ, 2009, CELL TRANSPLANT, V18, P949, DOI 10.3727/096368909X471215; Lindquist J, 2008, CELL TRANSPLANT, V17, P473; Liu DD, 2008, CELL TRANSPLANT, V17, P473; Liu SP, 2009, CELL TRANSPLANT, V18, P1039, DOI 10.3727/096368909X471224; Liu XL, 2008, CELL TRANSPLANT, V17, P649, DOI 10.3727/096368908786092711; Lopez C, 2008, CELL TRANSPLANT, V17, P859, DOI 10.3727/096368908786516783; Lopez-Gonzalez R, 2009, CELL TRANSPLANT, V18, P1171, DOI 10.3727/096368909X12483162197123; Lu N, 2009, MED SCI MONITOR, V15, pBR99; Lu XM, 2008, CELL TRANSPLANT, V17, P1423, DOI 10.3727/096368908787648155; Luan LM, 2008, CELL TRANSPLANT, V17, P417; Luebke-Wheeler JL, 2009, CELL TRANSPLANT, V18, P1281, DOI 10.3727/096368909X474258; Luo Y, 2008, CELL TRANSPLANT, V17, P473; Luo Y, 2009, CELL TRANSPLANT, V18, P223; Ma BF, 2009, CELL TRANSPLANT, V18, P223; Macklis JD, 2009, CELL TRANSPLANT, V18, P223; Macri R, 2008, CELL TRANSPLANT, V17, P473; Madhavan L, 2008, CELL TRANSPLANT, V17, P474; Madhavan L, 2009, CELL TRANSPLANT, V18, P224; Magalhaes R, 2008, CELL TRANSPLANT, V17, P813, DOI 10.3727/096368908786516765; Magatti M, 2009, CELL TRANSPLANT, V18, P899, DOI 10.3727/096368909X471314; Magnasco A, 2008, CELL TRANSPLANT, V17, P1157, DOI 10.3727/096368908787236567; Mai XL, 2009, CELL TRANSPLANT, V18, P171, DOI 10.3727/096368909788341306; Maksoud YA, 2009, CELL TRANSPLANT, V18, P224; Mancarella R, 2008, CELL TRANSPLANT, V17, P1271, DOI 10.3727/096368908787236639; Manfredsson FP, 2009, CELL TRANSPLANT, V18, P225; Manfredsson FP, 2009, CELL TRANSPLANT, V18, P224; Marschinke F, 2009, CELL TRANSPLANT, V18, P225; Martens TP, 2009, CELL TRANSPLANT, V18, P297, DOI 10.3727/096368909788534915; Martinez I, 2008, CELL TRANSPLANT, V17, P987, DOI 10.3727/096368908786576499; Marupudi NI, 2008, CELL TRANSPLANT, V17, P474; Marupudi NI, 2009, CELL TRANSPLANT, V18, P225; Matsuda R, 2009, CELL TRANSPLANT, V18, P39, DOI 10.3727/096368909788237122; Matsumoto S, 2009, CELL TRANSPLANT, V18, P549, DOI 10.1177/096368970901805-610; Matsumoto S, 2009, CELL TRANSPLANT, V18, P557, DOI 10.1177/096368970901805-611; Matsumura K, 2009, CELL TRANSPLANT, V18, P521, DOI 10.1177/096368970901805-606; McGregor L, 2008, CELL TRANSPLANT, V17, P475; Mei J, 2009, CELL TRANSPLANT, V18, P101, DOI 10.3727/096368909788237168; Melzi R, 2008, CELL TRANSPLANT, V17, P1361, DOI 10.3727/096368908787648146; Mervis RF, 2008, CELL TRANSPLANT, V17, P475; Mervis RF, 2009, CELL TRANSPLANT, V18, P226; Meyburg J, 2009, CELL TRANSPLANT, V18, P777, DOI 10.3727/096368909X470775; Michalik M, 2009, MED SCI MONITOR, V15, pBR194; Mijiti A, 2009, CELL TRANSPLANT, V18, P657, DOI 10.1177/096368970901805-622; Miki A, 2009, CELL TRANSPLANT, V18, P13, DOI 10.3727/096368909788237159; Miller C, 2009, CELL TRANSPLANT, V18, P226; Ming D, 2009, MED SCI MONITOR, V15, pMT105; Miyagi S, 2008, CELL TRANSPLANT, V17, P173, DOI 10.3727/000000008783906874; Miyamoto Y, 2009, CELL TRANSPLANT, V18, P677, DOI 10.1177/096368970901805-624; Miyamoto Y, 2009, CELL TRANSPLANT, V18, P619, DOI 10.1177/096368970901805-618; Monahan AJ, 2009, CELL TRANSPLANT, V18, P226; Monahan AJ, 2008, CELL TRANSPLANT, V17, P363; Moradian S, 2009, CELL TRANSPLANT, V18, P227; Moreira RO, 2009, MED SCI MONITOR, V15, pBR65; Mothe AJ, 2008, CELL TRANSPLANT, V17, P735, DOI 10.3727/096368908786516756; Musso J, 2009, CELL TRANSPLANT, V18, P227; Nasseri BA, 2009, CELL TRANSPLANT, V18, P361, DOI 10.3727/096368909788534924; Naujok O, 2008, CELL TRANSPLANT, V17, P1231, DOI 10.3727/096368908787236549; Navarro-Alvarez N, 2008, CELL TRANSPLANT, V17, P111, DOI 10.3727/000000008783907125; Navarro-Alvarez N, 2008, CELL TRANSPLANT, V17, P27, DOI 10.3727/000000008783906900; Neckel ND, 2009, CELL TRANSPLANT, V18, P227; Neuss S, 2008, CELL TRANSPLANT, V17, P977, DOI 10.3727/096368908786576462; Nevalainen N, 2009, CELL TRANSPLANT, V18, P228; Newman MB, 2008, CELL TRANSPLANT, V17, P475; Newman MB, 2009, CELL TRANSPLANT, V18, P228; Nguyen T, 2009, CELL TRANSPLANT, V18, P228; Nikas JB, 2009, CELL TRANSPLANT, V18, P229; NIKKHAH G, 2008, CELL TRANSPLANT, V17, P476; Nikkhah G, 2009, CELL TRANSPLANT, V18, P119, DOI 10.3727/096368909788341324; Nikolic WV, 2008, CELL TRANSPLANT, V17, P477; Nishie M, 2009, CELL TRANSPLANT, V18, P665, DOI 10.1177/096368970901805-623; Noguchi H, 2008, CELL TRANSPLANT, V17, P69, DOI 10.3727/000000008783907062; Noguchi H, 2008, CELL TRANSPLANT, V17, P121, DOI 10.3727/000000008783906991; Noguchi H, 2009, CELL TRANSPLANT, V18, P563, DOI 10.1177/096368970901805-612; Noguchi H, 2009, CELL TRANSPLANT, V18, P541, DOI 10.1177/096368970901805-609; Noguchi H, 2009, CELL TRANSPLANT, V18, P497, DOI 10.1177/096368970901805-603; Nolan K, 2008, CELL TRANSPLANT, V17, P241, DOI 10.3727/096368908784153931; O'Malley JA, 2008, CELL TRANSPLANT, V17, P477; Ohta Y, 2008, CELL TRANSPLANT, V17, P877, DOI 10.3727/096368908786576516; Oishi K, 2008, CELL TRANSPLANT, V17, P35, DOI 10.3727/000000008783906937; Oishi K, 2009, CELL TRANSPLANT, V18, P581, DOI 10.1177/096368970901805-614; Oishi K, 2009, CELL TRANSPLANT, V18, P573, DOI 10.1177/096368970901805-613; Olson L, 2008, CELL TRANSPLANT, V17, P477; Ono M, 2008, CELL TRANSPLANT, V17, P231, DOI 10.3727/000000008783907143; Pabon MM, 2009, CELL TRANSPLANT, V18, P229; Parihar VK, 2009, CELL TRANSPLANT, V18, P229; Park DH, 2009, CELL TRANSPLANT, V18, P230; Park DH, 2009, CELL TRANSPLANT, V18, P985, DOI 10.3727/096368909X471279; Park DH, 2009, MED SCI MONITOR, V15, pRA233; Park DH, 2008, MED SCI MONITOR, V14, pRA206; Park DH, 2009, MED SCI MONITOR, V15, pRA23; Patel AN, 2008, CELL TRANSPLANT, V17, P303, DOI 10.3727/096368908784153922; Patel AN, 2009, CELL TRANSPLANT, V18, P243, DOI 10.3727/096368909788534960; Paumier KL, 2008, CELL TRANSPLANT, V17, P478; Pendharkar AV, 2009, CELL TRANSPLANT, V18, P230; Petrofsky JS, 2009, MED SCI MONITOR, V15, pCR325; Piao CS, 2008, CELL TRANSPLANT, V17, P478; Piao CS, 2009, CELL TRANSPLANT, V18, P231; Praud C, 2008, CELL TRANSPLANT, V17, P1035, DOI 10.3727/096368908786991588; Priest C, 2009, CELL TRANSPLANT, V18, P231; Qi YY, 2009, CELL TRANSPLANT, V18, P1161, DOI 10.3727/096368909X12483162197169; Quaglia A, 2008, CELL TRANSPLANT, V17, P1403, DOI 10.3727/096368908787648083; Quarta M, 2008, MED SCI MONITOR, V14, pBR286; Quintanilha LF, 2008, CELL TRANSPLANT, V17, P943, DOI 10.3727/096368908786576453; Rachubinski A, 2009, CELL TRANSPLANT, V18, P231; RAFAEL H, 2008, MED SCI MONITOR, V14, pCR473; Rafael H, 2008, MED SCI MONITOR, V14, pLE15; Rafael H, 2009, MED SCI MONITOR, V15, pLE5; Rajab A, 2008, CELL TRANSPLANT, V17, P1015, DOI 10.3727/096368908786991533; Ramachandra R, 2008, CELL TRANSPLANT, V17, P479; Rehnmark A, 2009, CELL TRANSPLANT, V18, P232; Revoltella RP, 2008, CELL TRANSPLANT, V17, P665, DOI 10.3727/096368908786092685; Rising A, 2008, CELL TRANSPLANT, V17, P479; Rodriguez-Mulero S, 2008, CELL TRANSPLANT, V17, P1025, DOI 10.3727/096368908786991524; Ross JM, 2009, CELL TRANSPLANT, V18, P232; Rossignol J, 2009, CELL TRANSPLANT, V18, P233; Sabek OM, 2008, CELL TRANSPLANT, V17, P785, DOI 10.3727/096368908786516747; Sakai S, 2009, CELL TRANSPLANT, V18, P933, DOI 10.3727/096368909X471143; Sanchez-Ramos J, 2009, CELL TRANSPLANT, V18, P233; Santiago LY, 2009, CELL TRANSPLANT, V18, P145, DOI 10.3727/096368909788341289; Sanz-Ruiz R, 2009, CELL TRANSPLANT, V18, P245, DOI 10.3727/096368909788534889; Sasaki K, 2008, CELL TRANSPLANT, V17, P1221, DOI 10.3727/096368908787236666; Schafer R, 2008, CELL TRANSPLANT, V17, P923, DOI 10.3727/096368908786576480; Seidel M, 2009, CELL TRANSPLANT, V18, P695, DOI 10.3727/096368909X470810; Selenica MB, 2008, CELL TRANSPLANT, V17, P479; Selenica MLB, 2009, CELL TRANSPLANT, V18, P233; Shahaduzzaman SD, 2009, CELL TRANSPLANT, V18, P234; Sharma AD, 2008, CELL TRANSPLANT, V17, P313, DOI 10.3727/096368908784153896; Sherman W, 2009, CELL TRANSPLANT, V18, P333, DOI 10.3727/096368909788534933; Shytle RD, 2008, CELL TRANSPLANT, V17, P480; Silva SA, 2009, CELL TRANSPLANT, V18, P343, DOI 10.3727/096368909788534951; Sinden J, 2009, CELL TRANSPLANT, V18, P234; Singec I, 2009, CELL TRANSPLANT, V18, P234; Singh RP, 2008, CELL TRANSPLANT, V17, P480; Singh RP, 2009, CELL TRANSPLANT, V18, P1197, DOI 10.3727/096368909X12483162197204; Singh RP, 2009, CELL TRANSPLANT, V18, P55, DOI 10.3727/096368909788237177; Sladek JR, 2008, CELL TRANSPLANT, V17, P480; Sladek JR, 2008, CELL TRANSPLANT, V17, P427; Sladek JR, 2009, CELL TRANSPLANT, V18, P234; Sladek JR, 2009, CELL TRANSPLANT, V18, P689, DOI 10.3727/096368909X470892; Smith AJ, 2009, CELL TRANSPLANT, V18, P235; Snyder EY, 2009, CELL TRANSPLANT, V18, P207, DOI 10.3727/096368909788341315; Soderstrom KE, 2008, CELL TRANSPLANT, V17, P585; Solan A, 2009, CELL TRANSPLANT, V18, P915, DOI 10.3727/096368909X471161; Sommaggio R, 2009, CELL TRANSPLANT, V18, P1381, DOI 10.3727/096368909X474249; Sortwell CE, 2008, CELL TRANSPLANT, V17, P481; Spieles-Engemann AL, 2008, CELL TRANSPLANT, V17, P481; Spieles-Engemann AL, 2009, CELL TRANSPLANT, V18, P235; Stancati JA, 2008, CELL TRANSPLANT, V17, P482; Steece-Collier K, 2008, CELL TRANSPLANT, V17, P482; Steece-Collier K, 2009, CELL TRANSPLANT, V18, P236; Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195; Stoner S, 2009, CELL TRANSPLANT, V18, P236; Storn V, 2008, CELL TRANSPLANT, V17, P543, DOI 10.3727/096368908785095999; Stromberg I, 2008, CELL TRANSPLANT, V17, P482; Stromberg I, 2009, CELL TRANSPLANT, V18, P237; Suarez-Pinzon WL, 2008, CELL TRANSPLANT, V17, P631, DOI 10.3727/096368908786092775; Sumitran-Holgersson S, 2009, CELL TRANSPLANT, V18, P183, DOI 10.3727/096368909788341333; Sun JH, 2008, CELL TRANSPLANT, V17, P279, DOI 10.3727/096368908784153878; Suzuki C, 2008, CELL TRANSPLANT, V17, P223, DOI 10.3727/000000008783907053; Suzuki M, 2008, CELL TRANSPLANT, V17, P482; Tai JH, 2008, CELL TRANSPLANT, V17, P1349, DOI 10.3727/096368908787648092; Tanaka Y, 2009, CELL TRANSPLANT, V18, P381, DOI 10.3727/096368909788809794; Tate CC, 2008, CELL TRANSPLANT, V17, P483; Tateishi K, 2008, CELL TRANSPLANT, V17, P549, DOI 10.3727/096368908785096024; Taupin P, 2008, MED SCI MONITOR, V14, pLE6; Taupin P, 2009, MED SCI MONITOR, V15, pLE1; Teng YD, 2009, CELL TRANSPLANT, V18, P237; Terpstra BT, 2008, CELL TRANSPLANT, V17, P483; Thai HM, 2009, CELL TRANSPLANT, V18, P283, DOI 10.3727/096368909788535004; Thanos CG, 2009, CELL TRANSPLANT, V18, P1395, DOI 10.3727/096368909X12483162197402; Tharavanij T, 2009, CELL TRANSPLANT, V18, P453, DOI 10.3727/096368909788809848; Thompson VB, 2009, CELL TRANSPLANT, V18, P237; Tian C, 2008, CELL TRANSPLANT, V17, P325, DOI 10.3727/096368908784153841; Timmer M, 2009, CELL TRANSPLANT, V18, P238; Tokdemir M, 2009, MED SCI MONITOR, V15, pPI1; Tokiwa T, 2008, CELL TRANSPLANT, V17, P179, DOI 10.3727/000000008783907080; Torrente Y, 2008, CELL TRANSPLANT, V17, P1103, DOI 10.3727/096368908787236576; Torres EM, 2008, CELL TRANSPLANT, V17, P535, DOI 10.3727/096368908785096006; Tredget EB, 2008, CELL TRANSPLANT, V17, P599, DOI 10.3727/096368908786092757; Tsuruga Y, 2008, CELL TRANSPLANT, V17, P1083, DOI 10.3727/096368908786991542; Ueda M, 2008, CELL TRANSPLANT, V17, P91, DOI 10.3727/000000008783906892; Valeikiene V, 2008, MED SCI MONITOR, V14, pCR221; van der Windt DJ, 2008, CELL TRANSPLANT, V17, P1005, DOI 10.3727/096368908786991515; Vaysse L, 2008, CELL TRANSPLANT, V17, P484; VAZEY EM, 2008, CELL TRANSPLANT, V17, P484; Vazin T, 2008, CELL TRANSPLANT, V17, P485; Vazin T, 2009, CELL TRANSPLANT, V18, P238; Vergani A, 2009, CELL TRANSPLANT, V18, P827, DOI 10.3727/096368909X472278; Vidal I, 2008, CELL TRANSPLANT, V17, P507, DOI 10.3727/096368908785096051; Vinerean HV, 2008, CELL TRANSPLANT, V17, P567, DOI 10.3727/096368908785095962; Vorobyeva TM, 2009, CELL TRANSPLANT, V18, P239; Vriens AP, 2008, CELL TRANSPLANT, V17, P1199, DOI 10.3727/096368908787236521; Wakeman DR, 2009, CELL TRANSPLANT, V18, P239; Walczak P, 2009, CELL TRANSPLANT, V18, P239; Wang L, 2009, CELL TRANSPLANT, V18, P240; Wee YM, 2008, CELL TRANSPLANT, V17, P1257, DOI 10.3727/096368908787236657; Weeks BS, 2009, MED SCI MONITOR, V15, pRA256; Weeks BS, 2009, MED SCI MONITOR, V15, pBR43; Weeks BS, 2008, MED SCI MONITOR, V14, pBR279; Wehberg KE, 2009, CELL TRANSPLANT, V18, P353, DOI 10.3727/096368909788534988; Wei YY, 2009, CELL TRANSPLANT, V18, P159, DOI 10.3727/096368909788341261; Wei YD, 2008, MED SCI MONITOR, V14, pBR198; Weyrauch UM, 2009, CELL TRANSPLANT, V18, P471, DOI 10.3727/096368909788809802; White TE, 2008, CELL TRANSPLANT, V17, P485; Womble TA, 2008, CELL TRANSPLANT, V17, P485; Womble TA, 2009, CELL TRANSPLANT, V18, P240; Woods RL, 2009, CELL TRANSPLANT, V18, P241; Worden LT, 2009, CELL TRANSPLANT, V18, P241; Xue YQ, 2008, CELL TRANSPLANT, V17, P486; Yamasaki T, 2008, MED SCI MONITOR, V14, pCS23; Yamashita T, 2009, CELL TRANSPLANT, V18, P999, DOI 10.3727/096368909X471233; Yang T, 2009, CELL TRANSPLANT, V18, P391, DOI 10.3727/096368909788809767; Yerebakan C, 2009, CELL TRANSPLANT, V18, P855, DOI 10.3727/096368909X471170; Yokokawa M, 2008, CELL TRANSPLANT, V17, P1145, DOI 10.3727/096368908787236594; Yoshida Y, 2008, CELL TRANSPLANT, V17, P83, DOI 10.3727/000000008783907017; Yoshida Y, 2009, CELL TRANSPLANT, V18, P535, DOI 10.1177/096368970901805-608; Young W, 2009, CELL TRANSPLANT, V18, P951, DOI 10.3727/096368909X471251; Yu CH, 2009, CELL TRANSPLANT, V18, P1081, DOI 10.3727/096368909X12483162196647; Yu DH, 2008, CELL TRANSPLANT, V17, P1371, DOI 10.3727/096368908787648029; Yu GL, 2008, MED SCI MONITOR, V14, pRA163; Yu S, 2009, CELL TRANSPLANT, V18, P241; Yu SJ, 2009, CELL TRANSPLANT, V18, P111, DOI 10.3727/096368909788341243; Yuasa T, 2008, CELL TRANSPLANT, V17, P187, DOI 10.3727/000000008783906973; Yuasa T, 2009, CELL TRANSPLANT, V18, P683, DOI 10.1177/096368970901805-625; Yukawa H, 2008, CELL TRANSPLANT, V17, P43, DOI 10.3727/000000008783907071; Yukawa H, 2009, CELL TRANSPLANT, V18, P591, DOI 10.1177/096368970901805-615; Yukawa H, 2009, CELL TRANSPLANT, V18, P611, DOI 10.1177/096368970901805-617; Yukawa H, 2009, CELL TRANSPLANT, V18, P601, DOI 10.1177/096368970901805-616; Yurek DM, 2009, CELL TRANSPLANT, V18, P1183, DOI 10.3727/096368909X12483162196881; Zahir T, 2008, CELL TRANSPLANT, V17, P245, DOI 10.3727/096368908784153887; Zakzanis KK, 2009, MED SCI MONITOR, V15, pCR140; Zayko O, 2008, CELL TRANSPLANT, V17, P486; Zhang D, 2008, CELL TRANSPLANT, V17, P159, DOI 10.3727/000000008783907134; Zhang HQ, 2008, CELL TRANSPLANT, V17, P195, DOI 10.3727/000000008783906955; Zhang JH, 2008, MED SCI MONITOR, V14, pRA1; Zhao LR, 2008, CELL TRANSPLANT, V17, P487; Zhao XD, 2008, CELL TRANSPLANT, V17, P99, DOI 10.3727/000000008783906928; Zhao YM, 2008, CELL TRANSPLANT, V17, P775, DOI 10.3727/096368908786516846; Zheng CL, 2009, CELL TRANSPLANT, V18, P1093, DOI 10.3727/096368909X12483162197042; Zhu Y, 2009, CELL TRANSPLANT, V18, P242; Zinnanti WJ, 2008, CELL TRANSPLANT, V17, P487; Zou XH, 2009, CELL TRANSPLANT, V18, P433, DOI 10.3727/096368909788809839	489	12	13	0	25	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor		2010	16	10					RA197	RA217					21	Medicine, Research & Experimental	Research & Experimental Medicine	670SF	WOS:000283446900020	20885363				2021-06-18	
J	Goldstein, G; Allen, DN; Caponigro, JM				Goldstein, Gerald; Allen, Daniel N.; Caponigro, Janelle M.			A retrospective study of heterogeneity in neurocognitive profiles associated with traumatic brain injury	BRAIN INJURY			English	Article						Brain injury; assessment; cluster analysis; intelligence	VERBAL-LEARNING TEST; PATTERNS; SUBTYPES; PERFORMANCE	Research design: The study was retrospective, applying cluster analyses and associated statistical tests to an established database. Methods and procedures: Neuropsychological data from veterans with brain trauma were cluster analysed using the WAIS-R and Halstead-Reitan Battery (HRB). External validity of the cluster solutions was evaluated. Experimental interventions: The study was based upon use of an established database that contained cognitive test data and information regarding diagnosis and clinical history. Main outcomes and results: The WAIS-R clusters described sub-groups with near normal function, preserved verbal but impaired problem-solving abilities or global impairment. The HRB clusters differed in level of performance with Near Normal, Moderately Impaired and Globally Impaired clusters. Cluster membership was associated with age and employment status, but not with neurological findings. Conclusion: The outcome of traumatic brain injury is heterogeneous and mainly associated with demographic considerations.	[Goldstein, Gerald; Caponigro, Janelle M.] VA Pittsburgh Healthcare Syst, MIRECC, Pittsburgh, PA 15206 USA; [Allen, Daniel N.] Univ Nevada Las Vegas, Dept Psychol, Las Vegas, NV USA	Goldstein, G (corresponding author), VA Pittsburgh Healthcare Syst, MIRECC, 7180 Highland Dr 151R, Pittsburgh, PA 15206 USA.	ggold@nb.net		Allen, Daniel/0000-0003-4868-2242	DVA VISN IV Mental Illness Research, Education and Clinical Center, VA Pittsburgh Healthcare System, Pittsburgh, PA; Medical Research Service, Department of Veterans AffairsUS Department of Veterans Affairs	This research was supported by the DVA VISN IV Mental Illness Research, Education and Clinical Center, VA Pittsburgh Healthcare System, Pittsburgh, PA and the Medical Research Service, Department of Veterans Affairs.	Aldenderfer M.S., 1984, CLUSTER ANAL; ALLEN DN, 2006, M AM PSYCH ASS NEW O; Chan RCK, 2003, BRAIN INJURY, V17, P131, DOI 10.1080/0269905021000010168; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; Demery JA, 2002, J CLIN EXP NEUROPSYC, V24, P818, DOI 10.1076/jcen.24.6.818.8400; Deshpande SA, 1996, J CLIN EXP NEUROPSYC, V18, P836, DOI 10.1080/01688639608408306; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Heaton RK, 2004, REVISED COMPREHENSIV; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Moore A D, 1989, Brain Inj, V3, P171, DOI 10.3109/02699058909004549; Mottram L, 2006, DEV NEUROPSYCHOL, V30, P865, DOI 10.1207/s15326942dn3003_6; *PSYCH ASS AM, 1952, DIAGN STAT MAN MENT; Reitan R.M., 1993, HALSTEADREITAN NEURO; REITAN RM, 2000, MILD HEAD INJURY INT; RUSSELL EW, 1970, ASSESSMENT BRAIN DAM; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; TEILER A, 1998, J CONSULT CLIN PSYCH, V58, P531; Teuber H. L., 1964, FRONTAL GRANULAR COR, P410; van der Heijden P, 2003, ASSESSMENT, V10, P115, DOI 10.1177/1073191103010002001; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925	23	12	12	0	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	4					625	635		10.3109/02699051003670882			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	570ML	WOS:000275682300007	20235765				2021-06-18	
J	Ilves, P; Lintrop, M; Talvik, I; Sisko, A; Talvik, T				Ilves, Pilvi; Lintrop, Mare; Talvik, Inga; Sisko, Annika; Talvik, Tiina			Predictive value of clinical and radiological findings in inflicted traumatic brain injury	ACTA PAEDIATRICA			English	Article						Head trauma; Infants; Inflicted traumatic brain injury; Shaken baby syndrome	SHAKEN BABY SYNDROME; YOUNG-CHILDREN; HEAD-INJURY; PRACTICAL SCALE; CHILDHOOD; INFANTS; ESTONIA; ABUSE; IMPACT; MILD	Aims: The aim of this study is to evaluate the value of early radiological investigations in predicting the long-term neurodevelopmental outcome of infants with inflicted traumatic brain injury (ITBI). Methods: Clinical and radiological investigations of 24 infants with ITBI were performed during the acute phase of injury (1-3 days), and during the early (4 days up to 3 months) and late (> 9 months) postinjury phases. The clinical outcome in survivors (n = 22) was based on the Rankin Disability Scale and the Glasgow Outcome Score. Results: Five out of 24 infants (21%) had a poor neurodevelopmental outcome (death and severe disability), 17 infants (71%) had different developmental problems and 2 infants were normal at the mean age of 62 (54-70) (95% CI) months. A low initial Glasgow Coma Scale score of 8 or below [p < 0.05, OR 13.0 (1.3-133.3)], the development of brain oedema [p < 0.005, OR 13.0 (1.6-773)], focal changes in the basal ganglia during the acute phase [p < 0.01, OR 45 (2.1-937.3)], the development of new intracerebral focal changes early postinjury [p < 0.05, OR 24.1(1.0-559.1)], a decrease in white matter [p < 0.01, OR 33 (1.37-793.4)] and the development of severe atrophy before 3 months postinjury [p < 0.05, OR 24 (11.0-559.1)] were significantly correlated with a poor neurodevelopmental outcome. Conclusions: Early clinical and radiological findings in ITBI are of prognostic value for neurodevelopmental outcome.	[Ilves, Pilvi; Lintrop, Mare] Univ Tartu, Dept Radiol, EE-51014 Tartu, Estonia; [Ilves, Pilvi; Lintrop, Mare] Tartu Univ Hosp, Radiol Clin, Tartu, Estonia; [Talvik, Inga; Talvik, Tiina] Univ Tartu, Dept Pediat, EE-51014 Tartu, Estonia; [Sisko, Annika] N Estonia Med Ctr, Diagnost Clin, Tallinn, Estonia; [Talvik, Inga; Talvik, Tiina] Tartu Univ Hosp, Childrens Clin, Tartu, Estonia	Ilves, P (corresponding author), Univ Tartu, Dept Radiol, L Puusepa 2, EE-51014 Tartu, Estonia.	pilvi.ilves@kliinikum.ee	Ilves, PIlvi/G-4934-2017	Ilves, PIlvi/0000-0002-0094-4998	TARLA 2695; GARLA 6627;  [SF0180161s08]	The study was supported by grant SF0180161s08, TARLA 2695, GARLA 6627. The authors wish to thank P. Kool for help in the statistical analysis of the data.	ALEXANDER RC, 1986, J PEDIATR-US, V109, P975, DOI 10.1016/S0022-3476(86)80279-7; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Barlow Karen, 2004, Pediatr Rehabil, V7, P195, DOI 10.1080/13638490410001715331; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Bonnier C, 2003, PEDIATRICS, V112, P808, DOI 10.1542/peds.112.4.808; Demaerel P, 2002, EUR RADIOL, V12, P849, DOI 10.1007/s00330-001-1145-9; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Foerster BR, 2009, J PEDIATR-US, V154, P573, DOI 10.1016/j.jpeds.2008.09.051; Gill JR, 2009, ARCH PATHOL LAB MED, V133, P619, DOI 10.1043/1543-2165-133.4.619; Husson B, 2002, STROKE, V33, P1280, DOI 10.1161/01.STR.0000014504.18199.0D; Ilves P, 2009, ACTA PAEDIATR, V98, P459, DOI 10.1111/j.1651-2227.2008.01119.x; JENKINS A, 1986, LANCET, V2, P445; JENNETT B, 1975, LANCET, V1, P480; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; KRUGMAN RD, 1993, PEDIATRICS, V92, P872; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; McNeely PD, 2006, AM J NEURORADIOL, V27, P1725; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; RANKIN J, 1957, Scott Med J, V2, P200; Squier W, 2008, DEV MED CHILD NEUROL, V50, P10, DOI 10.1111/j.1469-8749.2007.02004.x; Talvik I, 2007, ACTA PAEDIATR, V96, P1164, DOI 10.1111/j.1651-2227.2007.00362.x; Talvik I, 2006, ACTA PAEDIATR, V95, P799, DOI 10.1080/08035250500464923; TEASDALE G, 1974, LANCET, V2, P81; Tung GA, 2006, PEDIATRICS, V118, P626, DOI 10.1542/peds.2006-0130; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Ventsel G, 2008, NEUROEPIDEMIOLOGY, V30, P20, DOI 10.1159/000113302; ZEPP F, 1992, NEUROPEDIATRICS, V23, P188, DOI 10.1055/s-2008-1071338	30	12	12	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0803-5253			ACTA PAEDIATR	Acta Paediatr.		2010	99	9					1329	1336		10.1111/j.1651-2227.2010.01820.x			8	Pediatrics	Pediatrics	639JH	WOS:000280970600020	20377537				2021-06-18	
J	Kelts, EA				Kelts, Eric A.			Traumatic brain injury and visual dysfunction: A limited overview	NEUROREHABILITATION			English	Article									[Kelts, Eric A.] Porter Adventist Hosp, Denver, CO USA	Kelts, EA (corresponding author), 7400 E Arapahoe Rd,Suite 100, Centennial, CO 80112 USA.	ekeltsmd@yahoo.com					Centers for Disease Control and Prevention, 2010, TRAUM BRAIN INJ US E; Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; KEANE JR, 1982, NEUROLOGY, V32, pA146; PADULA WV, BRAIN INJURY MED PRI, V207, P511; TROBE JD, 2001, NEUROLOGY VISION, P32; Van Stavern GP, 2001, J NEURO-OPHTHALMOL, V21, P112, DOI 10.1097/00041327-200106000-00012	6	12	14	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2010	27	3					223	229		10.3233/NRE-2010-0601			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	684FM	WOS:000284535800004	21098990				2021-06-18	
J	Kochanek, PM; Bell, MJ; Bayir, H				Kochanek, Patrick M.; Bell, Michael J.; Bayir, Huelya			Quo Vadis 2010? - Carpe Diem: Challenges and Opportunities in Pediatric Traumatic Brain Injury	DEVELOPMENTAL NEUROSCIENCE			English	Article						Traumatic brain injury; Head injury; Head trauma; Child abuse; Biomarker; Imaging; Treatment	NEURON-SPECIFIC ENOLASE; IMPAIRED CEREBRAL AUTOREGULATION; CONTROLLED CORTICAL IMPACT; TISSUE OXYGEN-TENSION; SEVERE HEAD-INJURY; ALPHA-II-SPECTRIN; CEREBROSPINAL-FLUID; MODERATE HYPOTHERMIA; OXIDATIVE STRESS; IMMATURE BRAIN	Traumatic brain injury (TBI) in infants and children remains a public health problem of enormous magnitude. It is a complex and heterogeneous condition that presents many diagnostic, therapeutic and prognostic challenges. A number of investigative teams are studying pediatric TBI both in experimental models and in clinical studies at the bedside. This review builds on work presented in a prior supplement to Developmental Neuroscience that was published in 2006, and addresses several active areas of research on this topic, including (1) the application of novel imaging methods, (2) the use of serum and/or CSF biomarkers of injury, (3) advances in neuromonitoring, (4) the development and testing of novel therapies, (5) developments in modeling pediatric TBI, (6) the consideration of a new approach to classification of pediatric TBI, and (7) assessing the potential impact of the development of pediatric and neonatal neurocritical care services on the management and outcome of pediatric TBI. Copyright (C) 2011 S. Karger AG, Basel	[Kochanek, Patrick M.; Bell, Michael J.; Bayir, Huelya] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Kochanek, Patrick M.; Bell, Michael J.; Bayir, Huelya] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Bell, Michael J.; Bayir, Huelya] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA	Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	kochanekpm@ccm.upmc.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X	 [NS30318]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030318, P50NS030318, P01NS030318] Funding Source: NIH RePORTER	Work on this review was supported in part by NS30318. We thank Cara Boyer, Fran Mistrick and Marci Provins for their assistance with manuscript preparation.	Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Aikman J, 2006, DEV NEUROSCI-BASEL, V28, P457, DOI 10.1159/000094171; Ashwal S, 2006, DEV NEUROSCI-BASEL, V28, P309, DOI 10.1159/000094157; Ashwal S, 2010, DEV NEUROSCI-BASEL, V32, P343, DOI 10.1159/000316801; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Babikian T, 2010, DEV NEUROSCI-BASEL, V32, P431, DOI 10.1159/000320667; Baltagi SA, 2010, PEDIATR CRIT CARE ME, V11, P179, DOI 10.1097/PCC.0b013e3181cf4652; Bayir H, 2007, ANN NEUROL, V62, P154, DOI 10.1002/ana.21168; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Bell MJ, 2009, NEUROCRIT CARE, V10, P4, DOI 10.1007/s12028-008-9061-3; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; Berger RP, 2010, DEV NEUROSCI-BASEL, V32, P396, DOI 10.1159/000316803; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; BOGAERT YE, 1994, FREE RADICAL BIO MED, V16, P811, DOI 10.1016/0891-5849(94)90197-X; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Cernak I, 2010, DEV NEUROSCI-BASEL, V32, P442, DOI 10.1159/000320085; Chambers IR, 2005, CHILD NERV SYST, V21, P195, DOI 10.1007/s00381-004-1060-x; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; CLIFTON G, 2009, P 3 INT HYP S LUND, P8; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Covey MV, 2010, DEV NEUROSCI-BASEL, V32, P488, DOI 10.1159/000321607; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; EXO J, 2010, PEDIAT CRIT CARE MED; Foley LM, 2009, J NEUROTRAUM, V26, P1509, DOI 10.1089/neu.2008.0747; FRASER DD, 2010, PEDIAT CRIT CARE MED; Gao WM, 2007, J NEUROTRAUM, V24, P43, DOI 10.1089/neu.2006.0061; Glass HC, 2010, NEUROCRIT CARE, V12, P421, DOI 10.1007/s12028-009-9324-7; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Haqqani AS, 2007, J NEUROTRAUM, V24, P54, DOI 10.1089/neu.2006.0079; Hlatky R, 2008, J NEUROSURG, V108, P53, DOI 10.3171/JNS/2008/108/01/0053; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Hutchison JS, 2010, DEV NEUROSCI-BASEL, V32, P406, DOI 10.1159/000323260; Ichord RN, 2007, J NEUROTRAUM, V24, P106, DOI 10.1089/neu.2006.0087; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; KERNIE SG, 2009, P 2 JOINT S INT NAT; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kochanek PM, 2010, JAMA-J AM MED ASSOC, V303, P2190, DOI 10.1001/jama.2010.715; Kochanek PM, 2009, PEDIATR CRIT CARE ME, V10, P517, DOI 10.1097/PCC.0b013e3181ab88cd; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; MAEKAWA T, 2009, P 3 INT HYP S LUND, P8; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Mehta A, 2010, DEV NEUROSCI-BASEL, V32, P413, DOI 10.1159/000316804; Naim MY, 2010, DEV NEUROSCI-BASEL, V32, P466, DOI 10.1159/000322448; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Berger RP, 2006, PEDIATR CRIT CARE ME, V7, P557, DOI 10.1097/01.PCC.0000244426.37793.23; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Puccio AM, 2009, J NEUROTRAUM, V26, P1241, DOI [10.1089/neu.2008.0624, 10.1089/neu.2008-0624]; Richards EM, 2006, FREE RADICAL BIO MED, V40, P1960, DOI 10.1016/j.freeradbiomed.2006.01.022; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Rosenthal G, 2009, CRIT CARE MED, V37, P379, DOI 10.1097/CCM.0b013e318193265f; Rutherford M, 2010, LANCET NEUROL, V9, P39, DOI 10.1016/S1474-4422(09)70295-9; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Sharma Pushpa, 2009, J Emerg Trauma Shock, V2, P67, DOI 10.4103/0974-2700.50739; Shore PM, 2007, J NEUROTRAUM, V24, P75, DOI 10.1089/neu.2006.0062; Stiefel MF, 2006, J NEUROSURG, V105, P281, DOI 10.3171/ped.2006.105.4.281; Su E, 2010, DEV NEUROSCI-BASEL, V32, P385, DOI 10.1159/000321342; TASKER RC, 2010, DEV NEUROSCI; Tasker RC, 2006, DEV NEUROSCI-BASEL, V28, P302, DOI 10.1159/000094156; Topjian AA, 2009, PEDIATR CRIT CARE ME, V10, P479, DOI 10.1097/PCC.0b013e318198bdb5; Tsuru-Aoyagi K, 2009, ANN NEUROL, V65, P540, DOI 10.1002/ana.21600; Vavilala MS, 2006, DEV NEUROSCI-BASEL, V28, P348, DOI 10.1159/000094161; Vavilala MS, 2007, J NEUROTRAUM, V24, P87, DOI 10.1089/neu.2006.0058; Vereczki V, 2006, J CEREBR BLOOD F MET, V26, P821, DOI 10.1038/sj.jcbfm.9600234; WRIGHT J, 2010, DEV NEUROSCI; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Ye Q, 2008, CIRCULATION, V118, P149, DOI 10.1161/CIRCULATIONAHA.107.746354; Zhao M, 2001, NAT MED, V7, P1241, DOI 10.1038/nm1101-1241; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4	81	12	13	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2010	32	5-6					335	342		10.1159/000323016			8	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	725RO	WOS:000287663900002	21252553	Bronze, Green Published			2021-06-18	
J	Munjal, SK; Panda, NK; Pathak, A				Munjal, Sanjay K.; Panda, Naresh K.; Pathak, Ashis			Audiological Deficits After Closed Head Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Closed head injury; Audiological deficits; Hearing loss	HEARING-LOSS; EVOKED-POTENTIALS; BRAIN-INJURY; TRAUMA; RESPONSES	Background: Damage to the peripheral auditory structures has long been recognized as a common component of head injury. It is estimated that a majority of patients with skull trauma have resultant hearing impairment. Damage to the peripheral and/or central auditory pathways can occur as a primary or secondary injury. Considering the high incidence of hearing loss, it was considered worthwhile to conduct an in-depth investigation by administering a comprehensive audiological test battery on head-injured patients. Method: The sample population consisted of 290 subjects with closed head injury (study group) and 50 subjects with otologically normal subjects (control group). The subjects in the study group were further divided into mild (n = 150), moderate (n = 100), and severe (it = 40) category on the basis of Glasgow Coma Scale score. The audiological assessment consisted of pure tone audiometry, speech audiometry, tympanometry, acoustic reflex testing, auditory brain stern response audiometry, and middle latency re-spouse audiometry. Results and Conclusions: It is concluded that there is higher prevalence of hearing impairment in the study group compared with control group. Majority of the patients who incur hearing loss after closed head injury have mild degree of hearing impairment. A significant difference between the study and control group observed on majority of the auditory brain stern response and middle latency response parameters studied.	[Munjal, Sanjay K.; Panda, Naresh K.] Postgrad Inst Med Educ & Res, Dept Otolaryngol Head & Neck Surg, Chandigarh 160012, India; [Pathak, Ashis] Postgrad Inst Med Educ & Res, Dept Neurosurg, Chandigarh 160012, India	Munjal, SK (corresponding author), Postgrad Inst Med Educ & Res, Dept Otolaryngol Head & Neck Surg, Chandigarh 160012, India.	sanjaymunjall@rediffmail.com					ALHADY MRA, 1990, J LARYNGOL OTOL, V104, P927, DOI 10.1017/S0022215100114410; BARBER HO, 1969, ANN OTO RHINOL LARYN, V78, P239, DOI 10.1177/000348946907800204; Bergemalm PO, 2001, ACTA OTO-LARYNGOL, V121, P724, DOI 10.1080/00016480152583674; ELWANY S, 1988, J LARYNGOL OTOL, V102, P755, DOI 10.1017/S0022215100106383; Fenton GW, 1996, CLIN ELECTROENCEPHAL, V27, P174; Fitzgerald DC, 1996, J TRAUMA, V40, P488, DOI 10.1097/00005373-199603000-00034; GHORAYEB BY, 1987, ARCH OTOLARYNGOL, V113, P749; GREENBERG RP, 1977, J NEUROSURG, V47, P150, DOI 10.3171/jns.1977.47.2.0150; GRIFFITHS MV, 1979, J LARYNGOL OTOL, V93, P253, DOI 10.1017/S0022215100086990; GROVE WE, 1947, ANN OTO RHINOL LARYN, V56, P264; HALL JW, 1986, EAR HEARING, V7, P383, DOI 10.1097/00003446-198612000-00007; Heid Lorant, 2004, Int Tinnitus J, V10, P94; JERGER J, 1970, ARCHIV OTOLARYNGOL, V92, P311; KAYE AH, 1991, HEAD INJURIES, P59; Lew HL, 2004, AM J PHYS MED REHAB, V83, P210, DOI 10.1097/01.PHM.0000113402.85460.59; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A, P176; LIDEN G, 1974, ARCH OTOLARYNGOL, V99, P23; Nosan DK, 1997, OTOLARYNG HEAD NECK, V117, P67, DOI 10.1016/S0194-5998(97)70209-2; PODOSHIN L, 1975, ARCH OTOLARYNGOL, V101, P15; SCHOENHUBER R, 1987, ARCH NEUROL-CHICAGO, P1181; SCHUKNECHT HF, 1956, ARCHIV OTOLARYNGOL, V63, P513; SOUSTIEL JF, 1995, BRAIN INJURY, V9, P805, DOI 10.3109/02699059509008236; VARTIAINEN E, 1985, ACTA OTO-LARYNGOL, V99, P529, DOI 10.3109/00016488509182257; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514; ZIMMERMAN WD, 1993, LARYNGOSCOPE, V103, P87	25	12	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JAN	2010	68	1					13	18		10.1097/TA.0b013e3181c9f274			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	543NR	WOS:000273585800004	20065751				2021-06-18	
J	Nijboer, JMM; van der Naalt, J; ten Duis, HJ				Nijboer, Johanna M. M.; van der Naalt, Joukje; ten Duis, Hendrik-Jan			Patients beyond salvation? Various categories of trauma patients with a minimal Glasgow Coma Score	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Trauma; Glasgow Coma Scale; Brain injury; Haemorrhagic shock; Outcome	SEVERE HEAD-INJURY; BRAIN-INJURY; PRACTICAL SCALE; MORTALITY; IMPACT; HYPOTHERMIA; VARIABLES; RECOVERY	Introduction: Trauma patients in an unresponsive state upon presentation to the Emergency Department have a poor prognosis. Rapid assessment of injuries combined with life-preserving therapy is required but de. ning the optimal strategy can be complicated when multiple organ systems are involved. This study analysed various categories of trauma patients with a Glasgow Coma Scale (GCS) of 3 on admission and evaluated the relation between injuries, clinical condition, treatment and outcome. Patients and methods: A retrospective cohort-study, performed at a level 1 Trauma Center from 2002 to 2005. Trauma patients of all ages with GCS of 3 (without sedation) and Injury Severity Score (ISS) >= 16 were included. The collected patient data comprised data on demographics, mechanism of injury, physiological condition on admission, diagnosis, ISS, treatment, admission to Intensive Care Unit, complications and outcome. Results: Ninety-seven patients were included and divided into three groups based on the pathology that caused the GCS of 3: traumatic brain injury N = 48 (49%), anoxic brain injury N = 27 (28%) and haemorrhagic shock N = 22 (23%). The overall mortality was 81%; 91% of the haemorrhagic shock patients, 81% of the ABI patients and 77% of the TBI patients died. Eighteen patients survived of whom five patients (5%) made a good recovery. The pupillary light response and pH on admission were related to mortality. No relation with ISS, age or hypothermia was found. Discussion: Distinguishing salvageable patients from those beyond salvation remains problematic. This study illustrated the diversity of patients, their injuries and their condition upon presentation to the hospital as well as the limitations of therapy. Conclusion: Trauma patients with a GCS of 3 have a poor outcome. Despite aggressive treatment only 5% of the patients made a good recovery. Pupil reactivity and the pH on admission were found to be related to mortality. (C) 2009 Elsevier Ltd. All rights reserved.	[Nijboer, Johanna M. M.; ten Duis, Hendrik-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, NL-9700 AB Groningen, Netherlands; [van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9700 AB Groningen, Netherlands	Nijboer, JMM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Surg, NL-9700 AB Groningen, Netherlands.	j.m.m.nijboer@chir.umcg.nl; j.van.der.naalt@neuro.umcg.nl; h.j.ten.duis@chir.umcg.nl					Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Gentilello LM, 1997, ANN SURG, V226, P439, DOI 10.1097/00000658-199710000-00005; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; JENNETT B, 1975, LANCET, V1, P480; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; LEVY DE, 1985, JAMA-J AM MED ASSOC, V253, P1420, DOI 10.1001/jama.253.10.1420; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Probst C, 2006, EUR J TRAUMA, V32, P357; Quigley MR, 1997, J TRAUMA, V42, P7, DOI 10.1097/00005373-199701000-00003; Rixen D, 2001, UNFALLCHIRURG, V104, P230, DOI 10.1007/s001130050719; Ruchholtz S, 2008, DTSCH ARZTEBL INT, V105, P225, DOI 10.3238/arztebl.2008.0225; Rudehill A, 2002, J NEUROTRAUM, V19, P855, DOI 10.1089/08977150260190447; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; STEINEMANN S, 1990, J TRAUMA, V30, P200, DOI 10.1097/00005373-199002000-00011; TEASDALE G, 1974, LANCET, V2, P81; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; van Olden GDJ, 2004, AM J EMERG MED, V22, P522, DOI 10.1016/j.ajem.2004.08.013; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408	30	12	15	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	JAN	2010	41	1					52	57		10.1016/j.injury.2009.05.030			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	547ND	WOS:000273895400010	19570534				2021-06-18	
S	Olden, M; Cukor, J; Rizzo, A; Rothbaum, B; Difede, J		Barchas, JD; Difede, J		Olden, Megan; Cukor, Judith; Rizzo, Albert 'Skip'; Rothbaum, Barbara; Difede, JoAnn			House calls revisited: leveraging technology to overcome obstacles to veteran psychiatric care and improve treatment outcomes	PSYCHIATRIC AND NEUROLOGIC ASPECTS OF WAR	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	89th Annual Conference of the Association for Research in Nervous and Mental Disease	DEC 16, 2009	Rockefeller Univ, New York, NY		Rockefeller Univ	telemedicine; virtual reality; videoconferencing; OIF/OEF veterans; barriers to care	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; COGNITIVE-BEHAVIORAL THERAPY; MENTAL-HEALTH PROBLEMS; EXPOSURE THERAPY; FAMILY CAREGIVERS; RANDOMIZED-TRIAL; ANGER MANAGEMENT; TELEPSYCHIATRY; TELEMEDICINE	Despite an increasing number of military service members in need of mental health treatment following deployment to Iraq and Afghanistan, numerous psychological and practical barriers limit access to care. Perceived stigma about admitting psychological difficulties as well as frequent long distances to treatment facilities reduce many veterans' willingness and ability to receive care. Telemedicine and virtual human technologies offer a unique potential to expand services to those in greatest need. Telemedicine-based treatment has been used to address multiple psychiatric disorders, including posttraumatic stress disorder, depression, and substance use, as well as to provide suicide risk assessment and intervention. Clinician education and training has also been enhanced and expanded through the use of distance technologies, with trainees practicing clinical skills with virtual patients and supervisors connecting with clinicians via videoconferencing. The use of these innovative and creative vehicles offers a significant and as yet unfulfilled promise to expand delivery of high-quality psychological therapies, regardless of clinician and patient location.	[Olden, Megan; Cukor, Judith; Difede, JoAnn] Cornell Univ, Weill Cornell Med Coll, Dept Psychiat, 525 E 68th St,Box 200, New York, NY 10065 USA; [Rizzo, Albert 'Skip'] Univ So Calif, Dept Psychiat, Inst Creat Technol, Playa Vista, CA USA; [Rizzo, Albert 'Skip'] Univ So Calif, Sch Gerontol, Playa Vista, CA USA; [Rothbaum, Barbara] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA	Olden, M (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Psychiat, 525 E 68th St,Box 200, New York, NY 10065 USA.	meo9011@med.cornell.edu			NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [TL1 RR024998] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [TL1RR024998] Funding Source: NIH RePORTER		Barretro A, 2006, J APPL BEHAV ANAL, V39, P333, DOI 10.1901/jaba.2006.173-04; Becker CB, 2004, BEHAV RES THER, V42, P277, DOI 10.1016/S0005-7967(03)00138-4; Beutler LE, 2004, J CLIN PSYCHOL, V60, P317, DOI 10.1002/jclp.10266; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Britt TW, 2007, MIL MED, V172, P157, DOI 10.7205/MILMED.172.2.157; Burnam A, 2009, HEALTH AFFAIR, V28, P771, DOI 10.1377/hlthaff.28.3.771; Burnam MA, 2008, INVISIBLE WOUNDS WAR, P245; Cahill SP, 2006, J TRAUMA STRESS, V19, P597, DOI 10.1002/jts.20173; Caspar F, 2004, J CLIN PSYCHOL, V60, P221, DOI 10.1002/jclp.10260; Cawkill P, 2004, J R Army Med Corps, V150, P91; Courtois CA, 2009, PSYCHOL TRAUMA-US, V1, P3, DOI 10.1037/a0015224; Deitsch SE, 2000, J TELEMED TELECARE, V6, P184, DOI 10.1258/1357633001935194; Department of Defence Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; DIFEDE J, 2006, NOVEL APPROACHES DIA, P219; Dobscha SK, 2005, TELEMED J E-HEALTH, V11, P84, DOI 10.1089/tmj.2005.11.84; Druss BG, 1997, PSYCHOSOMATICS, V38, P451, DOI 10.1016/S0033-3182(97)71422-1; Elliott TR, 2008, BEHAV RES THER, V46, P1220, DOI 10.1016/j.brat.2008.08.004; FOA EB, 1999, AM J CLIN PSYCHIAT, V60, P5; Fortney JC, 2007, J GEN INTERN MED, V22, P1086, DOI 10.1007/s11606-007-0201-9; Frueh BC, 2007, BEHAV MODIF, V31, P856, DOI 10.1177/0145445507302125; Frueh BC, 2007, J TELEMED TELECARE, V13, P142, DOI 10.1258/135763307780677604; Garcia-Lizana F, 2010, PERSPECT PSYCHIATR C, V46, P119, DOI 10.1111/j.1744-6163.2010.00247.x; Germain Vanessa, 2009, Cognitive Behaviour Therapy, V38, P42, DOI 10.1080/16506070802473494; Gilkey SL, 2009, FAM SOC, V90, P37, DOI 10.1606/1044-3894.3843; Glueckauf RL, 2002, REHABIL PSYCHOL, V47, P49, DOI 10.1037/0090-5550.47.1.49; Godleski L, 2008, BEHAV SCI LAW, V26, P271, DOI 10.1002/bsl.811; Himle MB, 2010, COGN BEHAV PRACT, V17, P329, DOI 10.1016/j.cbpra.2010.02.006; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Institute of Medicine (IOM), 2008, TREATM POSTTR STRESS; Jong Michael, 2004, Int J Circumpolar Health, V63, P422; Kaplan MS, 2007, J EPIDEMIOL COMMUN H, V61, P619, DOI 10.1136/jech.2006.054346; King VL, 2009, J SUBST ABUSE TREAT, V36, P331, DOI 10.1016/j.jsat.2008.06.011; Langston V, 2007, MIL MED, V172, P931, DOI 10.7205/MILMED.172.9.931; Lutz BJ, 2009, DISABIL REHABIL, V31, P402, DOI 10.1080/09638280802069558; Morland LA, 2004, J TELEMED TELECARE, V10, P286, DOI 10.1258/1357633042026387; Morland LA, 2010, J CLIN PSYCHIAT, V71, P855, DOI 10.4088/JCP.09m05604blu; Myers K, 2006, J ADOLESCENT HEALTH, V38, P643, DOI 10.1016/j.jadohealth.2005.07.015; Myers KM, 2008, TELEMED J E-HEALTH, V14, P131, DOI 10.1089/tmj.2007.0035; Nelson EL, 2006, COUNS PSYCHOTHER RES, V6, P191, DOI 10.1080/14733140600862303; Oakes J, 2008, J GAMBL STUD, V24, P107, DOI 10.1007/s10899-007-9074-4; Pietrzak RH, 2009, PSYCHIAT SERV, V60, P1118, DOI 10.1176/ps.2009.60.8.1118; Rees CS, 2005, PROF PSYCHOL-RES PR, V36, P649, DOI 10.1037/0735-7028.36.6.649; Reilly RO, 2007, PSYCHIAT SERV, V58, P836; RIZZO AA, 2010, AM BEHAV SC IN PRESS; Rotondi AJ, 2005, REHABIL PSYCHOL, V50, P325, DOI 10.1037/0090-5550.50.4.325; Ruskin PE, 2004, AM J PSYCHIAT, V161, P1471, DOI 10.1176/appi.ajp.161.8.1471; Sander AM, 2009, J HEAD TRAUMA REHAB, V24, P248, DOI 10.1097/HTR.0b013e3181ad593a; Savin D, 2006, J AM ACAD CHILD PSY, V45, P484, DOI 10.1097/01.chi.0000198594.68820.59; Shepherd L, 2006, J PAIN SYMPTOM MANAG, V32, P453, DOI 10.1016/j.jpainsymman.2006.05.018; Shore JH, 2007, GEN HOSP PSYCHIAT, V29, P199, DOI 10.1016/j.genhosppsych.2007.01.013; Shore JH, 2004, TELEMED J E-HEALTH, V10, pS64; Stecker T, 2007, PSYCHIAT SERV, V58, P1358, DOI 10.1176/appi.ps.58.10.1358; Steffen AM, 2000, BEHAV THER, V31, P281, DOI 10.1016/S0005-7894(00)80016-7; Taylor DM, 2009, TELEMED J E-HEALTH, V15, P646, DOI 10.1089/tmj.2008.0165; Tuerk PW, 2010, J TRAUMA STRESS, V23, P116, DOI 10.1002/jts.20494; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Wade SL, 2009, J PEDIATR PSYCHOL, V34, P517, DOI 10.1093/jpepsy/jsn081; Warner CH, 2008, MIL MED, V173, P563, DOI 10.7205/MILMED.173.6.563; WILLIAMS JB, 2007, ANN GEN PSYCHIAT, V6; Witmans MB, 2008, BEHAV SLEEP MED, V6, P207, DOI 10.1080/15402000802371312; WRAY BT, 2003, AUSTR ASS COGN BEH T; Yellowlees PM, 2008, J AM ACAD CHILD PSY, V47, P103, DOI 10.1097/chi.0b013e31815a56a7	63	12	12	0	21	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN STREET, MALDEN 02148, MA USA	0077-8923		978-1-57331-804-4	ANN NY ACAD SCI	Ann.NY Acad.Sci.		2010	1208						133	+		10.1111/j.1749-6632.2010.05756.x			4	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	BSK28	WOS:000284742000017	20955335	Green Accepted			2021-06-18	
J	Perkins, RA; Ryalls, JH; Carson, CK; Whiteside, JD				Perkins, Rosalie A.; Ryalls, Jack H.; Carson, Cecyle K.; Whiteside, Janet D.			Acoustic analyses of two recovered cases of foreign accent syndrome	APHASIOLOGY			English	Article						Foreign accent syndrome; Brain injury; Acoustic analysis; Formant frequencies; Voice onset time; Vowel duration	SPEECH; APHASIA	Recently, a growing number of studies have been published involving phonetic and acoustic analyses on the rare motor-speech disorder known as Foreign Accent Syndrome (FAS). These studies have relied on pre- and post-trauma speech samples to investigate the acoustic and phonetic properties of individual cases of FAS speech. This study presents detailed acoustic analyses of the speech characteristics of two new cases of FAS using identical pre- and post-recovery speech samples, thus affording a new level of control in the study of Foreign Accent Syndrome. Participants include a 48-year-old female who began speaking with an "Eastern European" accent following a traumatic brain injury, and a 45-year-old male who presented with a "British" accent following a subcortical cerebral vascular accident (CVA). The acoustic analysis was based on 18 real words comprised of the stop consonants /p/, /t/, /k/; /b/, /d/, /g/ combined with the peripheral vowels /i/, /a/ and /u/ and ending in a voiceless stop. Computer-based acoustic measures included: (1) voice onset time (VOT), (2) vowel durations, (3) whole word durations, (4) first, second and third formant frequencies, and (5) fundamental frequency. Formant frequencies were measured at three points in the vowel duration: (a) 20%, (b) 50%, and (c) 80% to assess differences in vowel 'onglides' and 'offglides'. The acoustic analysis allowed precise quantification of the major phonetic features associated with the foreign quality of participants' FAS speech. Results indicated post-recovery changes in both duration and frequency measures, including a tendency toward more normal VOT production of voiced stops, changes in average vowel durations, as well as evidence from formant frequency values of vowel backing for both participants. The implications of this study for future research and clinical applications are also considered.	[Perkins, Rosalie A.] Univ Cent Florida, Dept Commun Sci & Disorders, Orlando, FL 32816 USA	Perkins, RA (corresponding author), Univ Cent Florida, Dept Commun Sci & Disorders, POB 162215, Orlando, FL 32816 USA.	RosaliePerkins@gmail.com					ARDILA A, 1988, APHASIOLOGY, V2, P493, DOI 10.1080/02687038808248955; Armorer A. N., 2003, THESIS U S FLORIDA T; BLUMSTEIN SE, 1987, BRAIN LANG, V31, P215, DOI 10.1016/0093-934X(87)90071-X; BLUMSTEIN SE, 1980, BRAIN LANG, V9, P153, DOI 10.1016/0093-934X(80)90137-6; Coelho CA, 2001, J MED SPEECH-LANG PA, V9, P227; Dankovicova J, 2001, CLIN LINGUIST PHONET, V15, P195, DOI 10.1080/02699200010004656; Ferguson SH, 2002, J ACOUST SOC AM, V112, P259, DOI 10.1121/1.1482078; Fridriksson J, 2005, NEUROCASE, V11, P319, DOI 10.1080/13554790591006302; GRAFFRADFORD NR, 1986, BRAIN LANG, V28, P86, DOI 10.1016/0093-934X(86)90093-3; Gurd JM, 2006, J NEUROLINGUIST, V19, P424, DOI 10.1016/j.jneuroling.2006.03.004; Gurd JM, 2001, CORTEX, V37, P715, DOI 10.1016/S0010-9452(08)70622-1; GURD JM, 1988, NEUROPSYCHOLOGIA, V26, P237, DOI 10.1016/0028-3932(88)90077-2; HILLENBRAND J, 1995, J ACOUST SOC AM, V97, P3099, DOI 10.1121/1.411872; INGRAM JCL, 1992, J PHONETICS, V20, P457, DOI 10.1016/S0095-4470(19)30650-3; KENT RD, 1979, J SPEECH HEAR RES, V22, P627, DOI 10.1044/jshr.2203.627; Kurowski K., 2006, J NEUROLINGUIST, V54, P1; Kurowski KM, 1996, BRAIN LANG, V54, P1, DOI 10.1006/brln.1996.0059; LISKER L, 1964, WORD, V20, P384, DOI 10.1080/00437956.1964.11659830; MERTUS J, 1999, BROWN LAB INTERACTIV; Miller N, 2006, J NEUROLINGUIST, V19, P385, DOI 10.1016/j.jneuroling.2006.03.005; Moen I, 2000, APHASIOLOGY, V14, P5, DOI 10.1080/026870300401577; PERKINS RA, 2007, THESIS U CENTRAL FLO; Ryalls J, 2006, CLIN LINGUIST PHONET, V20, P157, DOI 10.1080/02699200400026900; Ryalls J., 2004, J MULTILINGUAL COMMU, V2, P61, DOI DOI 10.1080/1476967031000090980; Ryalls J., 2000, INTRO SPEECH SCI BAS; Varley R, 2006, J NEUROLINGUIST, V19, P356, DOI 10.1016/j.jneuroling.2006.03.002; WHITAKER HA, 1982, NEUROPSYCHOLOGY COGN, V1, P168; Whiteside SP, 1998, CORTEX, V34, P221, DOI 10.1016/S0010-9452(08)70749-4	28	12	12	1	8	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0268-7038			APHASIOLOGY	Aphasiology		2010	24	10					1132	1154		10.1080/02687030903022211			23	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	659PV	WOS:000282580300002					2021-06-18	
J	Schmidt, AT; Orsten, KD; Hanten, GR; Li, XQ; Levin, HS				Schmidt, Adam T.; Orsten, Kimberley D.; Hanten, Gerri R.; Li, Xiaoqi; Levin, Harvey S.			Family environment influences emotion recognition following paediatric traumatic brain injury	BRAIN INJURY			English	Article						Children; traumatic brain injury; family functioning; emotional prosody; face emotion; social cognition	LONG-TERM OUTCOMES; FACIAL EXPRESSION; SOCIAL COGNITION; CHILDREN; PREDICTORS; TEMPERAMENT; PERCEPTION; BEHAVIOR; BURDEN; IDENTIFICATION	Objective: This study investigated the relationship between family functioning and performance on two tasks of emotion recognition (emotional prosody and face emotion recognition) and a cognitive control procedure (the Flanker task) following paediatric traumatic brain injury (TBI) or orthopaedic injury (OI). Methods: A total of 142 children (75 TBI, 67 OI) were assessed on three occasions: baseline, 3 months and 1 year post-injury on the two emotion recognition tasks and the Flanker task. Caregivers also completed the Life Stressors and Resources Scale (LISRES) on each occasion. Growth curve analysis was used to analyse the data. Results: Results indicated that family functioning influenced performance on the emotional prosody and Flanker tasks but not on the face emotion recognition task. Findings on both the emotional prosody and Flanker tasks were generally similar across groups. However, financial resources emerged as significantly related to emotional prosody performance in the TBI group only (p = 0.0123). Conclusions: Findings suggest family functioning variables-especially financial resources-can influence performance on an emotional processing task following TBI in children.	[Schmidt, Adam T.; Orsten, Kimberley D.; Hanten, Gerri R.; Li, Xiaoqi; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA	Schmidt, AT (corresponding author), 1709 Dryden Rd,12th Floor, Houston, TX 77030 USA.	ats1978@gmail.com			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS21889]; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This work was supported by NINDS grant # NS21889 to HSL and by a NICHD T32 Fellowship to ATS.	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2001, NEUROPSYCHOLOGY, V15, P396, DOI 10.1037//0894-4105.15.3.396; Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1285, DOI 10.1016/S0028-3932(99)00023-8; Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Allerdings MD, 2006, BRAIN COGNITION, V60, P193, DOI 10.1016/j.bandc.2004.09.018; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; Bradley RH, 2001, CHILD DEV, V72, P1844, DOI 10.1111/1467-8624.t01-1-00382; BRONFENBRENNER U, 1986, DEV PSYCHOL, V22, P723, DOI 10.1037/0012-1649.22.6.723; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; COPES WS, 1988, J TRAUMA, V28, P78, DOI 10.1097/00005373-198801000-00011; Cornell AH, 2007, J CLIN CHILD ADOLESC, V36, P305, DOI 10.1080/15374410701444181; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; DUROCHER TD, 2004, SOCIAL DEV, V13, P171; Eisenberg N, 1998, PSYCHOL INQ, V9, P317, DOI 10.1207/s15327965pli0904_1; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Frick PJ, 2004, J CLIN CHILD ADOLESC, V33, P54, DOI 10.1207/S15374424JCCP3301_6; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hanten G, 2009, TOP LANG DISORD, V29, P236, DOI 10.1097/TLD.0b013e3181b531f0; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; KOCHANSKA G, 1993, CHILD DEV, V64, P325, DOI 10.1111/j.1467-8624.1993.tb02913.x; KOCHANSKA G, 1995, CHILD DEV, V66, P597, DOI 10.1111/j.1467-8624.1995.tb00892.x; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Lemerise EA, 2000, CHILD DEV, V71, P107, DOI 10.1111/1467-8624.00124; Levin HS, 2006, ARCH PHYS MED REHAB, V87, pS1, DOI 10.1016/j.apmr.2006.09.010; Lew HL, 2005, J REHABIL RES DEV, V42, P29, DOI 10.1682/JRRD.2004.05.0056; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Montgomery V, 2002, J TRAUMA, V52, P1121, DOI 10.1097/00005373-200206000-00016; MOOS RH, 1988, SOC SCI MED, V27, P999, DOI 10.1016/0277-9536(88)90291-2; Moos RH, 1994, LISRES A LIFE STRESS; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Osberg JS, 1997, BRAIN INJURY, V11, P11; Rudolph KD, 1999, CHILD DEV, V70, P660, DOI 10.1111/1467-8624.00048; SCHMIDT AT, NEUROPSYCHO IN PRESS; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Morris AS, 2007, SOC DEV, V16, P361, DOI 10.1111/j.1467-9507.2007.00389.x; Snodgrass C, 2006, BRAIN INJURY, V20, P825, DOI 10.1080/02699050600832585; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeung WJ, 2002, CHILD DEV, V73, P1861, DOI 10.1111/1467-8624.t01-1-00511	63	12	12	0	20	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	13-14					1550	1560		10.3109/02699052.2010.523047			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	691QV	WOS:000285096800004	21058900	Green Accepted			2021-06-18	
J	Williams, G; Pallant, J; Greenwood, K				Williams, Gavin; Pallant, Julie; Greenwood, Ken			Further development of the High-level Mobility Assessment Tool (HiMAT)	BRAIN INJURY			English	Article						Brain injuries; rehabilitation; gait disorders; neurologic; outcome assessment	TRAUMATIC BRAIN-INJURY; RASCH MEASUREMENT MODEL; STROKE PATIENTS; SCALE; VALIDITY; BALANCE; INDEX	Primary objectives: The high-level mobility assessment tool (HiMAT) was developed to measure high-level mobility limitations following traumatic brain injury (TBI). Rasch analysis was used in the development to ensure cognitive deficits would have a minimal impact on performance. The main aim of this study was to investigate the dimensionality of the HiMAT using recently developed advanced testing procedures. Research design: Results from the original sample of 103 adults with TBI used to develop the HiMAT were re-analysed using the RUMM2020 program. Revised minimal detectable change (MDC95) scores were also calculated. Main outcomes and results: Rasch analysis of all 13 HiMAT items suggested that the scale was multidimensional, showing a clear separation between the stair and non-stair items. The nine non-stair items of the HiMAT showed good overall fit, excellent internal consistency, with no disordered thresholds or misfitting items, however removal of one item was required to ensure a unidimensional scale. The final 8-item solution showed good model fit (p = 0.93), excellent internal consistency (PSI = 0.96), no disordered thresholds, no misfitting items and no differential item functioning for age or sex. The revised HiMAT total score is 32 points and the MDC95 was calculated to be +/-2 points. Conclusion: The results of this study demonstrate that the revised HiMAT is unidimensional and valid to use in rehabilitation and community settings where there is no access to stairs.	[Williams, Gavin] Epworth Med Fdn, Melbourne, Vic, Australia; [Williams, Gavin] Univ Melbourne, Sch Physiotherapy, Melbourne, Vic 3010, Australia; [Pallant, Julie] Univ Melbourne, Sch Rural Hlth, Melbourne, Vic 3010, Australia; [Greenwood, Ken] RMIT Univ, Sch Hlth Sci, Melbourne, Vic, Australia	Williams, G (corresponding author), Epworth Med Fdn, Physiotherapy Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.	gavin.williams@epworth.org.au	Greenwood, Kenneth M/J-8993-2015	Greenwood, Kenneth M/0000-0002-8420-6588; Williams, Gavin/0000-0003-2758-7473			Andrich D., 2003, RUMM2020; Antonucci G, 2002, ARCH PHYS MED REHAB, V83, P1442, DOI 10.1053/apmr.2002.34618; BELVEDERE S, J CLIN EPID IN PRESS; CARR JH, 1985, PHYS THER, V65, P175, DOI 10.1093/ptj/65.2.175; Caty GD, 2008, ARCH PHYS MED REHAB, V89, P284, DOI 10.1016/j.apmr.2007.08.155; Collen F M, 1991, Int Disabil Stud, V13, P50; DUNCAN P, 1995, MOTOR CONTROL THEORY, P319; Granger CV, 1983, GUIDE USE UNIFORM DA; Howe JA, 2006, CLIN REHABIL, V20, P885, DOI 10.1177/0269215506072183; Lincoln N, 1979, Physiotherapy, V65, P48; MacKnight C, 2000, J CLIN EPIDEMIOL, V53, P1242, DOI 10.1016/S0895-4356(00)00255-9; Marchetti GF, 2006, PHYS THER, V86, P1651, DOI 10.2522/ptj.20050402; Pallant JF, 2007, BRIT J CLIN PSYCHOL, V46, P1, DOI 10.1348/014466506X96931; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; Tennant A, 2006, RASCH MEASUREMENT T, V20, P1048; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; Wu M.L., 1998, ACER CONQUEST GEN IT	21	12	12	0	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	7-8					1027	1031		10.3109/02699052.2010.490517			5	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	620MW	WOS:000279505000013	20545456				2021-06-18	
J	Wong, MN; Murdoch, B; Whelan, BM				Wong, Min Ney; Murdoch, Bruce; Whelan, Brooke-Mai			Language disorders subsequent to mild traumatic brain injury (MTBI): Evidence from four cases	APHASIOLOGY			English	Article						MTBI; Cognition; General language; High-level language	CLOSED-HEAD-INJURY; REHABILITATION; PERFORMANCE; IMPAIRMENT; DISCOURSE; FLUENCY; ADULTS	Background: The majority of cognitive research conducted within the mild traumatic brain injury (MTBI) population has been predominantly neuropsychologically based, lacking in-depth linguistic analysis. The effect of MTBI on language function has received little attention and remains largely unexplored. Aims: This study was undertaken to explore in detail cognitive-linguistic impairments following MTBI, via the application of a comprehensive assessment battery. Methods & Procedures: Four participants with MTBI were administered a comprehensive battery of cognitive-linguistic assessments at 6 months post injury. The control group consisted of 10 age-, sex- and education-level-matched, non-neurologically impaired participants. Non-parametric group comparisons between the MTBI and matched controls participants were carried out, followed by case-by-case analysis. Outcomes & Results: Non-parametric between-group comparisons failed to reveal statistically significant differences between the MTBI and control participants across subtests. In case-by-case analyses, however, below normal performance on a range of subtests was demonstrated by the MTBI participants. Conclusions: Findings suggest high-level cognitive-linguistic deficits may occur as a consequence of MTBI and imply that MTBI mechanisms may have the capacity to alter frontal lobe functioning. It is suggested that more sensitive measures of cognitive and high-level language function are needed in the assessment of MTBI.	[Wong, Min Ney] Univ Queensland, Ctr Neurogen Commun Disorders Res, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia	Wong, MN (corresponding author), Univ Queensland, Ctr Neurogen Commun Disorders Res, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.	min.wong@uq.edu.au	Murdoch, Bruce E/C-1397-2012	Wong, Min Ney/0000-0003-0585-3566; Whelan, Brooke-Mai/0000-0002-7909-3160			Adamovich B. B., 1992, SCALES COGNITIVE ABI; ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Barrow IM, 2006, BRAIN INJURY, V20, P845, DOI 10.1080/02699050600832445; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Bigler E. D., 1990, TRAUMATIC BRAIN INJU; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Chapey R., 2008, LANGUAGE INTERVENTIO; Copland DA, 2000, J MED SPEECH-LANG PA, V8, P1; Curl RM, 1996, J HEAD TRAUMA REHAB, V11, P75, DOI 10.1097/00001199-199602000-00009; De Gaspari D, 2006, PARKINSONISM RELAT D, V12, P289, DOI 10.1016/j.parkreldis.2006.01.001; DODD DH, 1980, COGNITION MENTAL STR; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Frattali CM, 1995, AM SPEECH LANGUAGE H; Gioia G.A., 2000, BEHAV RATING INVENTO; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; Guilford J. P., 1967, NATURE HUMAN INTELLI; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Heaton RK, 1999, J CLIN EXP NEUROPSYC, V21, P571, DOI 10.1076/jcen.21.4.572.882; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; Hinchliffe FJ, 2001, TRAUMATIC BRAIN INJU, P199; Holland A, 1999, COMMUNICATION ACTIVI; Huisingh R, 1990, WORD TEST REVISED TE; Isaki E, 2000, BRAIN INJURY, V14, P441; Japp J., 2005, BRAIN INJURY RETURNI; Kaplan E., 1983, BOSTON NAMING TEST; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kertesz A., 1982, W APHASIA BATTERY; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; Levin HS, 1989, MILD HEAD INJURY; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; LINDFORS J, 1987, CHILDRENS LANGUAGE L; Lucas JA, 2005, CLIN NEUROPSYCHOL, V19, P243, DOI 10.1080/13854040590945337; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Randolph C, 1999, ARCH CLIN NEUROPSYCH, V14, P489, DOI 10.1016/S0887-6177(98)00023-7; Randolph C., 2001, REPEATABLE BATTERY A; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; ROSENTHAL M, 1993, ANN EMERG MED, V22, P1048, DOI 10.1016/S0196-0644(05)82749-0; Saltapidas H, 2007, J HEAD TRAUMA REHAB, V22, P132, DOI 10.1097/01.HTR.0000265101.75177.8d; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; Secord, 1989, TEST LANGUAGE COMPET; SNOW P, 1995, TRAUMATIC BRAIN INJU, P137; Spreen O, 1969, NEUROSENSORY CTR COM; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Terrell TR, 2004, SOUTH MED J, V97, P837, DOI 10.1097/01.SMJ.0000140091.58338.1E; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; *UN DAT SYST MED R, 1996, FUNCT IND MEAS; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wehman Paul, 1993, Brain Injury, V7, P31, DOI 10.3109/02699059309008154; Whelan BM, 2007, J HEAD TRAUMA REHAB, V22, P192, DOI 10.1097/01.HTR.0000271120.04405.db; Whelan BM, 2006, BRAIN LANG, V99, P183, DOI 10.1016/j.bandl.2006.06.100; Wrightson P, 1999, MILD HEAD INJURY GUI; Ylvisaker M., 2001, LANGUAGE INTERVENTIO; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU	60	12	12	1	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology		2010	24	10					1155	1169		10.1080/02687030903168212			15	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	659PV	WOS:000282580300003					2021-06-18	
B	Ylvisaker, M; Feeney, T		Anderson, V; Jacobs, R; Anderson, PJ		Ylvisaker, Mark; Feeney, Timothy			Helping children without making them helpless: Facilitating development of executive self-regulation in children and adolescents	EXECUTIVE FUNCTIONS AND THE FRONTAL LOBES: A LIFESPAN PERSPECTIVE	Studies on Neuropsychology Neurology and Cognition		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; LONG-TERM METHYLPHENIDATE; READING-COMPREHENSION; BEHAVIORAL INTERVENTIONS; YOUNG-CHILDREN; STUDENTS; TBI; SUPPORTS; OUTCOMES; CHOICE		[Ylvisaker, Mark] Coll St Rose, Sch Educ, Albany, NY 12203 USA; [Feeney, Timothy] Sch Community Support Serv, Schenectady, NY USA	Ylvisaker, M (corresponding author), Coll St Rose, Sch Educ, Albany, NY 12203 USA.						ABIKOFF H, 1991, J LEARN DISABIL, V24, P205, DOI 10.1177/002221949102400404; Abikoff H, 2004, J AM ACAD CHILD PSY, V43, P820, DOI 10.1097/01.chi.0000128797.91601.1a; Anderson V, 2002, PRINCIPLES FRONTAL L, P504; Aspinwall LG, 2000, LAWS LIF SYMP SER, V2, P163; Baker S., 2002, LEARNING DISABILITIE, V17, P65, DOI DOI 10.1111/1540-5826.00032; Barkley R. A., 1997, ADHD NATURE SELF CON; Barkley Russell A, 2004, J Psychiatr Pract, V10, P39, DOI 10.1097/00131746-200401000-00005; Baumeister R.F., 2004, HDB SELF REGULATION; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Berk Laura E., 2001, AWAKENING CHILDRENS; Block C. C., 2002, COMPREHENSION INSTRU; Borkowski J. G., 1996, ATTENTION MEMORY EXE, P235; Borkowski J. G., 2000, ISSUES MEASUREMENT M; BORKOWSKI JG, 1988, J EDUC PSYCHOL, V80, P46, DOI 10.1037/0022-0663.80.1.46; Borkowski JG., 1990, DIMENSIONS THINKING, P53; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Bronson MB, 2000, SELF-REGULATION IN EARLY CHILDHOOD, P1; Brown R, 1996, J EDUC PSYCHOL, V88, P18, DOI 10.1037/0022-0663.88.1.18; Bulgren J.A., 2006, TEACHING ADOLESCENTS, P79; Burgess P. W., 2002, PRINCIPLES FRONTAL L, P557, DOI 10.1093/acprof:oso/9780195134971.003.0033; Catroppa C, 2006, Pediatr Rehabil, V9, P89, DOI 10.1080/13638490500155458; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Cicerone K. D., 2005, REHABILITATION TRAUM, P71; Damasio A., 1994, DESCARTESERROR EMOTI; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Deshler D. D., 1988, ALTERNATIVE ED DELIV, P391; ESLINGER PJ, 1997, DEV PREFRONTAL CORTE, P295; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; FEENEY T, J POSITIVE IN PRESS; Feeney T, 2006, BRAIN INJURY, V20, P629, DOI 10.1080/02699050600744194; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Fitzsimons GM., 2004, HDB SELF REGULATION, P151; Flavell J.H., 2002, COGNITIVE DEV, V4th; Gersten R, 2001, REV EDUC RES, V71, P279, DOI 10.3102/00346543071002279; Gillham JE, 2000, LAWS LIF SYMP SER, V2, P3; Grafman J, 1995, ANN NY ACAD SCI, V769, P337, DOI 10.1111/j.1749-6632.1995.tb38149.x; Grafman J., 1993, J HEAD TRAUMA REHAB, V8, P73, DOI DOI 10.1097/00001199-199303000-00008; Graham S., 2003, HDB LEARNING DISABIL, P323; Gresham FM, 2001, EXCEPT CHILDREN, V67, P331; GROLNICK WS, 1987, J PERS SOC PSYCHOL, V52, P890, DOI 10.1037/0022-3514.52.5.890; GROLNICK WS, 1989, J EDUC PSYCHOL, V81, P143, DOI 10.1037/0022-0663.81.2.143; Guthrie JT, 2000, J EDUC PSYCHOL, V92, P331, DOI 10.1037/0022-0663.92.2.331; Hechtman L, 2004, J AM ACAD CHILD PSY, V43, P812, DOI 10.1097/01.chi.0000128796.84202.eb; Hill EL, 2004, TRENDS COGN SCI, V8, P26, DOI 10.1016/j.tics.2003.11.003; Horner RH, 2005, EXCEPT CHILDREN, V71, P165, DOI 10.1177/001440290507100203; Kaemingk K, 1999, DEV NEUROPSYCHOL, V15, P111, DOI 10.1080/87565649909540741; Kelly T., 2000, CLIN NEUROPSYCHOL, V1, P38; Kim AH, 2004, J LEARN DISABIL-US, V37, P105, DOI 10.1177/00222194040370020201; Landry SH, 2003, DEV NEUROPSYCHOL, V24, P559, DOI 10.1207/S15326942DN242&3_04; Landry SH, 2002, DEV NEUROPSYCHOL, V21, P15, DOI 10.1207/S15326942DN2101_2; Landry SH, 2001, DEV PSYCHOL, V37, P387, DOI 10.1037//0012-1649.37.3.387; Larsen R., 2004, HDB SELFREGULATION R, P40; Laurent AC, 2004, TOP LANG DISORD, V24, P286, DOI 10.1097/00011363-200410000-00006; MANN L, 1979, TRAIL PROCESS HIST P; Martin JE, 2003, EXCEPT CHILDREN, V69, P431, DOI 10.1177/001440290306900403; McCabe L. A., 2004, HDB SELF REGULATION, P340; Meichenbaum D., 1977, COGNITIVE BEHAV MODI; Meichenbaum D, 1998, NURTURING INDEPENDEN; Mischel W., 2004, HDB SELF REGULATION, P99; Nybo T, 1999, BRAIN INJURY, V13, P759; PALINSCAR AS, 1989, TEACHING UNDERSTANDI, V1; Peterson C, 1993, LEARNED HELPLESSNESS; Pressley M., 2002, READING INSTRUCTION; Pressley M.P., 1995, COGNITIVE STRATEGY I, V2nd; Reeve J, 1999, J EDUC PSYCHOL, V91, P537, DOI 10.1037/0022-0663.91.3.537; Reid R, 2005, EXCEPT CHILDREN, V71, P361; Resnick L.B., 1987, ED LEARNING THINK; Robinson TR, 1999, J EDUC PSYCHOL, V91, P195, DOI 10.1037/0022-0663.91.2.195; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; ROLLS ET, 1998, PREFRONTAL CORTEX EX, P67; RUSSELL J, 1998, AUTISM EXECUTIVE DIS; Ryan, 2002, HDB SELF DETERMINATI, P183; Ryan R, 2002, HDB SELF DETERMINATI; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; SAMSOTI FJ, 2004, FOCUS AUTISM OTHER D, V19, P194; Schlund MW, 2002, BRAIN INJURY, V16, P347, DOI 10.1080/02699050110103977; Schlund MW, 2002, BRAIN INJURY, V16, P527, DOI 10.1080/02699050110113679; Schmeichel B.J., 2004, HDB SELF REGULATION, P84, DOI DOI 10.1016/J.CEDPSYCH.2015.01.001; SchmitterEdgecombe M, 1996, J HEAD TRAUMA REHAB, V11, P17, DOI 10.1097/00001199-199604000-00003; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Skinner B.F, 1953, SCI HUMAN BEHAV; Sternberg RJ., 1993, TRANSFER TRIAL INTEL; Swanson H. L., 1999, LEARNING DISABILITIE, V14, P129, DOI [DOI 10.1207/SLDRP1403_1, DOI 10.1207/SLDRP1403_]; Swanson H. L., 2001, LEARNING DISABILITIE, V16, P109, DOI [10.1111/0938-8982.00012, DOI 10.1111/0938-8982.00012]; Sweet AP, 2002, IMPROVING COMPREHENS, P17; TRANEL D, 2002, PRINCIPLES FRONTAL L, P338, DOI DOI 10.1093/ACPROF:OSO/9780195134971.001.0001; Vohs K.D., 2004, HDB SELF REGULATION, P1; Vygotsky L. S., 1962, THOUGHT LANGUAGE; Waber DP, 2006, DEV NEUROPSYCHOL, V29, P459, DOI 10.1207/s15326942dn2903_5; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Wehmeyer M, 1997, EXCEPT CHILDREN, V63, P245, DOI 10.1177/001440299706300207; Wehmeyer M., 1995, ARCS SELF DETERMINAT; Wehmeyer M. L., 1998, TEACHING SELF DETERM; Wehmeyer ML, 2000, EXCEPT CHILDREN, V66, P439, DOI 10.1177/001440290006600401; Williams GC, 1996, J PERS SOC PSYCHOL, V70, P767, DOI 10.1037/0022-3514.70.4.767; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M., 2003, BRAIN IMPAIR, V4, P1, DOI [10.1375/brim.4.1.1.27031, DOI 10.1375/brim.4.1.1.27031]; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P246, DOI DOI 10.1375/BRIM.7.3.246; Ylvisaker M, 2000, BRAIN IMPAIR, V1, P12, DOI DOI 10.1375/BRIM.1.1.12; YLVISAKER M, 1998, TRAUMATIC BRAIN INJU, P181; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; Ylvisaker Mark, 2002, Pediatr Rehabil, V5, P51, DOI 10.1080/1363849021000041891	105	12	12	0	0	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND			978-1-13687-354-6	STUD NEUROPSYCHOL NE			2010							409	438					30	Psychology, Biological; Psychology, Developmental; Psychology; Psychology, Experimental	Psychology	BVE09	WOS:000291249500020					2021-06-18	
J	Yoneyama-Sarnecky, T; Olivas, AD; Azari, S; Ferriero, DM; Manvelyan, HM; Noble-Haeusslein, LJ				Yoneyama-Sarnecky, Tomoko; Olivas, Andrea D.; Azari, Soraya; Ferriero, Donna M.; Manvelyan, Hovhannes M.; Noble-Haeusslein, Linda J.			Heme Oxygenase-2 Modulates Early Pathogenesis after Traumatic Injury to the Immature Brain	DEVELOPMENTAL NEUROSCIENCE			English	Article						Oxidative damage; Cell death; Motor recovery; Neuroprotection; Murine; Cortical lesion; Dentate	GLUTATHIONE-PEROXIDASE ACTIVITY; OXIDATIVE STRESS; RAT-BRAIN; CEREBRAL-ISCHEMIA; MESSENGER-RNA; NITRIC-OXIDE; INTRACEREBRAL HEMORRHAGE; ENDOTHELIAL-CELLS; IRON ACCUMULATION; CARBON-MONOXIDE	We determined if heme oxygenase-2 (HO-2), an enzyme that degrades the pro-oxidant heme, confers neuroprotection in the developing brain after traumatic brain injury (TBI). Male HO-2 wild-type (WT) and homozygous knockout (KO) mice at postnatal day 21 were subjected to TBI and euthanized 1, 7, and 14 days later. Relative cerebral blood flow, measured by laser Doppler, cortical and hippocampal pathogenesis, and motor recovery were evaluated at all time points. Cerebral blood flow was found to be similar between experimental groups. Blood flow significantly decreased immediately after injury, returned to baseline by 1 day, and was significantly elevated by 7 days, post-injury. Nonheme iron preferentially accumulated in the ipsilateral cortex, hippocampus, and external capsule in both WT and KO brain-injured genotypes. There were, however, a significantly greater number of TUNEL-positive cells in the hippocampal dentate gyrus and a significantly greater cortical lesion volume in KOs relative to WTs within the first week post-injury. By 14 days post-injury, however, cortical lesion volume and cell density in the hippocampal CA3 region and dorsal thalamus were similar between the two groups. Assays of fine motor function (grip strength) over the first 2 weeks post-injury revealed a general pattern of decreased strength in the contralateral forelimbs of KOs as compared to WTs. Together, these findings demonstrate that deficiency in HO-2 alters both the kinetics of secondary damage and fine motor recovery after TBI. Copyright (C) 2010 S. Karger AG, Basel	[Yoneyama-Sarnecky, Tomoko; Olivas, Andrea D.; Azari, Soraya; Manvelyan, Hovhannes M.; Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Ferriero, Donna M.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Ferriero, Donna M.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA	Noble-Haeusslein, LJ (corresponding author), 521 Parnassus Ave,Room C-224, San Francisco, CA 94143 USA.	linda.noble@ucsf.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS050159]; Alvera Kan Endowed Chair; UCSF Linker Foundation Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS065937, R01NS077767, R01NS050159] Funding Source: NIH RePORTER	This research was supported by NIH grant NS050159, the Alvera Kan Endowed Chair, and a UCSF Linker Foundation Fellowship.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; APPLEGATE LA, 1991, CANCER RES, V51, P974; Baranano DE, 2001, P NATL ACAD SCI USA, V98, P10996, DOI 10.1073/pnas.191351298; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Brouard S, 2002, J BIOL CHEM, V277, P17950, DOI 10.1074/jbc.M108317200; Chang EF, 2005, J CEREBR BLOOD F MET, V25, P1401, DOI 10.1038/sj.jcbfm.9600147; Chang EF, 2003, J NEUROSCI, V23, P3689; Chen K, 2000, J NEUROCHEM, V75, P304, DOI 10.1046/j.1471-4159.2000.0750304.x; Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7; Dennery PA, 2000, CURR TOP CELL REGUL, V36, P181; Dennery PA, 1998, J CLIN INVEST, V101, P1001, DOI 10.1172/JCI448; Dore S, 1999, MOL MED, V5, P656, DOI 10.1007/BF03401984; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; Dore S, 2000, NEUROSCIENCE, V99, P587, DOI 10.1016/S0306-4522(00)00216-5; Dringen R, 2000, EUR J BIOCHEM, V267, P4903, DOI 10.1046/j.1432-1327.2000.01651.x; Durkin MS, 1998, NEUROSURGERY, V42, P300, DOI 10.1097/00006123-199802000-00052; Dwyer BE, 1996, MOL BRAIN RES, V38, P251, DOI 10.1016/0169-328X(95)00341-O; DWYER BE, 1995, MOL BRAIN RES, V30, P37, DOI 10.1016/0169-328X(94)00273-H; Elbirt KK, 1999, P ASSOC AM PHYSICIAN, V111, P438; ESCALONA SK, 1982, PEDIATRICS, V70, P670; EWING JF, 1991, P NATL ACAD SCI USA, V88, P5364, DOI 10.1073/pnas.88.12.5364; EWING JF, 1993, J NEUROCHEM, V60, P1512, DOI 10.1111/j.1471-4159.1993.tb03315.x; Ewing JF, 1997, BRAIN RES PROTOC, V1, P165, DOI 10.1016/S1385-299X(96)00027-X; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Ferris CD, 1999, NAT CELL BIOL, V1, P152; Foresti R, 1999, FREE RADICAL RES, V31, P459, DOI 10.1080/10715769900301031; Foresti R, 1997, J BIOL CHEM, V272, P18411, DOI 10.1074/jbc.272.29.18411; Fukuda K, 1996, BRAIN RES, V736, P68, DOI 10.1016/0006-8993(96)00680-4; FUKUDA K, 1995, NEUROSCI LETT, V199, P127, DOI 10.1016/0304-3940(95)12042-3; Geddes JW, 1996, NEUROSCI LETT, V210, P205, DOI 10.1016/0304-3940(96)12703-8; Gu YX, 2009, STROKE, V40, P2241, DOI 10.1161/STROKEAHA.108.539536; Hayashi S, 2004, GENE, V336, P241, DOI 10.1016/j.gene.2004.04.002; Hua Y, 2008, ACTA NEUROCHIR SUPPL, V105, P3; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MAINES MD, 1992, BIOCHIM BIOPHYS ACTA, V1131, P166, DOI 10.1016/0167-4781(92)90072-8; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; MAINES MD, 1988, FASEB J, V2, P2557; Maines MD, 1996, BRAIN RES, V722, P83, DOI 10.1016/0006-8993(96)00184-9; MCCOUBREY WK, 1994, GENE, V139, P155, DOI 10.1016/0378-1119(94)90749-8; Nakamura T, 2004, J NEUROSURG, V100, P672, DOI 10.3171/jns.2004.100.4.0672; Noppens R, 2004, EXP TOXICOL PATHOL, V56, P113, DOI 10.1016/j.etp.2004.04.005; Potts Mathew B, 2006, NeuroRx, V3, P143; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Regan RF, 2000, NEUROSCI LETT, V282, P1, DOI 10.1016/S0304-3940(00)00817-X; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Ryter SW, 2002, MOL CELL BIOCHEM, V234, P249, DOI 10.1023/A:1015957026924; Soares MP, 2002, ANTIOXID REDOX SIGN, V4, P321, DOI 10.1089/152308602753666370; Stone BS, 2008, ANN NEUROL, V64, P535, DOI 10.1002/ana.21517; Suttner DM, 1999, FASEB J, V13, P1800; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Tsuru-Aoyagi K, 2009, ANN NEUROL, V65, P540, DOI 10.1002/ana.21600; Turner CP, 1998, J CEREBR BLOOD F MET, V18, P257, DOI 10.1097/00004647-199803000-00004; VILE GF, 1994, P NATL ACAD SCI USA, V91, P2607, DOI 10.1073/pnas.91.7.2607; Wong RJ, 2002, PEDIATR RES, V51, p328A; Yager JY, 1997, NEUROSCI BIOBEHAV R, V21, P167, DOI 10.1016/S0149-7634(96)00006-1	57	12	12	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2010	32	1					81	90		10.1159/000258700			10	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	574FQ	WOS:000275975000007	20389079	Bronze, Green Published			2021-06-18	
J	Apivatthakakul, T; Phornphutkul, C; Laohapoonrungsee, A; Sirirungruangsarn, Y				Apivatthakakul, Theerachai; Phornphutkul, Chanakarn; Laohapoonrungsee, Anupong; Sirirungruangsarn, Yuddhasert			Less Invasive Plate Osteosynthesis in Humeral Shaft Fractures	OPERATIVE ORTHOPADIE UND TRAUMATOLOGIE			English	Article						Less invasive plate osteosynthesis; Humeral shaft fracture; Radial nerve palsy		Objective Stable internal fixation of the humeral shaft by less invasive percutaneous plate insertion using two separate (proximal and distal) incisions, indirect reduction by closed manipulation and fixation to preserve the soft tissue and blood supply at the fracture zone. Early mobilization of the shoulder and elbow to ensure a good functional outcome. Indications Humeral shaft fractures (classified according to AO classification as: 12-A, B, C). Humeral shaft fractures extending to the proximal or distal shaft, small or deformed medullary canal or open growth plate. Contraindications Humeral shaft fractures with primary radial nerve palsy. Proximal humeral shaft fractures extending to the humeral head. Distal humeral fractures extending to the elbow joint. Surgical Technique Two incisions proximal and distal to the fracture zone are used. A 3-cm proximal incision lies between the lateral border of the proximal part of the biceps and the medial border of the deltoid. Distally, a 3-cm incision is made along the lateral border of the biceps. The interval between biceps and brachialis is identified. The biceps is retracted medially to expose the musculocutaneous nerve. The brachialis muscle has dual innervation, the medial half being innervated by the musculocutaneous nerve and the lateral half by the radial nerve. The brachialis is split longitudinally at its midline. The musculocutaneous nerve is retracted along with the medial half of the brachialis, while the lateral half of the brachialis serves as a cushion to protect the radial nerve. A deep subbrachial tunnel is created from the distal to the proximal incision. The selected plate is tied with a suture to a hole at the tip of the tunneling instrument for pulling the plate back along the prepared track. The plate is aligned in the correct position on the anterior surface of the humerus. Traction is applied and the fracture reduced to restore alignment by image intensifier, followed by plate fixation with at least two bicortical locking screws or three bicortical conventional screws in each fragment. Results Between January 2003 and January 2006,23 patients were operated on using the less invasive plate osteosynthesis technique. The minimum follow-up period of 12 months was completed in 20 patients. The mean healing time was 14.6 weeks, defined as three of four cortices having stable bridging callus. In one patient with delayed union, healing was observed after 28 weeks. Functional outcomes were evaluated using the Constant Score and the Hospital for Special Surgery (HSS) Score. 19 patients had good to excellent elbow function with a mean HSS Score Of 93.5 points. All patients achieved satisfactory shoulder function with a mean Constant Score Of 85.8 points compared to 90.6 on the healthy side. Complications observed were one paresthesia of lateral cutaneous nerve of forearm (no radial nerve injury) and one loosening of the LCP (Locking Compression Plate) screws due to technical error.	[Apivatthakakul, Theerachai; Phornphutkul, Chanakarn; Laohapoonrungsee, Anupong; Sirirungruangsarn, Yuddhasert] Chiang Mai Univ, Fac Med, Dept Orthopaed, Chiang Mai 50200, Thailand	Apivatthakakul, T (corresponding author), Chiang Mai Univ, Fac Med, Dept Orthopaed, Chiang Mai 50200, Thailand.	tapivath@gmail.com		Apivatthakakul, Theerachai/0000-0001-8374-9540			Apivatthakakul T, 2005, INJURY, V36, P530, DOI 10.1016/j.injury.2004.05.036; APIVATTHAKAKUL T, 2006, AO MANUAL FRACTURE M, P145; CAMDEN P, 1992, INJURY, V23, P245, DOI 10.1016/S0020-1383(05)80008-7; CONSTANT CR, 1987, CLIN ORTHOP RELAT R, P160; Dabezies E J, 1992, J Orthop Trauma, V6, P10; DELLOCA AAF, 2002, INJURY, V33, pA1; Farragos AF, 1999, J ORTHOP TRAUMA, V13, P258, DOI 10.1097/00005131-199905000-00006; FIGGIE MP, 1990, CLIN ORTHOP RELAT R, P123; HELFET DL, 1997, INJURY S, V28, P42; Jiang R, 2007, ARCH ORTHOP TRAUM SU, V127, P531, DOI 10.1007/s00402-007-0313-z; Krettek C, 2001, INJURY, V32, P4, DOI 10.1016/S0020-1383(01)00056-0; KRETTEK C, 1997, INJURY S1, V28, P20; Lin J, 1999, CLIN ORTHOP RELAT R, P201; Livani B, 2004, INJURY, V35, P587, DOI 10.1016/j.injury.2003.12.003; Oh CW, 2003, CLIN ORTHOP RELAT R, P286, DOI 10.1097/01.blo.0000048137.30533.06; SARMIENTO A, 1977, J BONE JOINT SURG AM, V59, P596, DOI 10.2106/00004623-197759050-00004	16	12	16	0	19	URBAN & VOGEL	MUNICH	NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY	0934-6694	1439-0981		OPER ORTHOP TRAUMATO	Oper. Orthopade Traumatol.	DEC	2009	21	6					602	613		10.1007/s00064-009-2008-9			12	Orthopedics	Orthopedics	538AR	WOS:000273156600008	20087720				2021-06-18	
J	Aydin, S; Yilmazlar, S; Aker, S; Korfali, E				Aydin, Selcuk; Yilmazlar, Selcuk; Aker, Sibel; Korfali, Ender			Anatomy of the Floor of the Third Ventricle in Relation to Endoscopic Ventriculostomy	CLINICAL ANATOMY			English	Article						anatomy; cadaveric study; endoscopic third ventriculostomy; hypothalamus; complication; third ventricular floor	TRAUMATIC BASILAR ANEURYSM; 3-DIMENSIONAL CONSTRUCTIVE INTERFERENCE; 3RD VENTRICULOSTOMY; LILIEQUISTS MEMBRANE; COMPLICATIONS; HYDROCEPHALUS; SERIES	Neuroanatomical structures that form the floor of the third ventricle (FTV) and neighboring tissues are important in the context of third ventriculostomy (TV) procedures. Thorough knowledge of the anatomical and histological organization of the region would be useful in understanding and preventing surgical complications. Taking the third ventricle region as a model, we aimed to simulate TV and make measurements of 23 cadaver brains, as well as perform histological examinations of the third ventricular floor on five cadaver brains. During the endoscopic TV, we examined the degree to which the structures surrounding the FTV were affected by surgical simulation. To make a clinical comparison, the distance between the center of the FTV and the basilar apex was measured on cranial magnetic resonance images (MRIs) of 15 subjects with normal ventricular systems and 15 subjects with moderately enlarged ventricles. Histological examination revealed that the ependynnal cells and arachnoid membrane formed the inner and outer surfaces of the third ventricle floor, respectively, whereas the stroma was made up of glial cells exclusively. This region was gliotic and avascular. When cadaver brains with normal and hydrocephalic ventricles were compared, there were significant differences in the distance between the center of the floor and the basilar apex (P < 0.001). On the basis of our study, the optimal site for TV fenestration and balloon inflation is just anterior to the mamillary bodies to avoid injury to neighboring structures. Clin. Anat. 22:916-924, 2009. (C) 2009 Wiley-Liss, Inc.	[Aydin, Selcuk; Yilmazlar, Selcuk; Korfali, Ender] Uludag Univ, Sch Med, Dept Neurosurg, TR-16059 Bursa, Turkey; [Aker, Sibel] Uludag Univ, Sch Med, Dept Pathol, TR-16059 Bursa, Turkey	Yilmazlar, S (corresponding author), Uludag Univ, Sch Med, Dept Neurosurg, Gorukle Kampus, TR-16059 Bursa, Turkey.	selsus@uludag.edu.tr	, selcuk/AAH-5070-2021	, selcuk/0000-0003-3633-7919			Abtin K, 1998, PEDIATR NEUROSURG, V28, P35, DOI 10.1159/000028616; Amini MM, 2005, J SOL-GEL SCI TECHN, V36, P19, DOI 10.1007/s10971-005-4790-7; Baykan N, 2005, J NEUROSURG ANESTH, V17, P33; Bonanni R, 2004, EUR NEUROL, V51, P118, DOI 10.1159/000076793; Brockmeyer D, 1998, PEDIATR NEUROSURG, V28, P236, DOI 10.1159/000028657; Buxton N, 1998, CLIN ANAT, V11, P187, DOI 10.1002/(SICI)1098-2353(1998)11:3<187::AID-CA6>3.0.CO;2-Q; Buxton N, 2000, NEUROSURGERY, V46, P999; Di Roio C, 1999, ANN FR ANESTH, V18, P776, DOI 10.1016/S0750-7658(00)88456-7; Dusick JR, 2008, SURG NEUROL, V69, P5, DOI 10.1016/j.surneu.2007.08.024; El-Dawlatly AA, 2000, ANESTH ANALG, V91, P1142, DOI 10.1097/00000539-200011000-00019; Froelich SC, 2008, NEUROSURGERY, V63, P1, DOI 10.1227/01.neu.0000335004.22628.ee; Fukuhara T, 2000, NEUROSURGERY, V46, P1100, DOI 10.1097/00006123-200005000-00015; Fushimi Y, 2003, RADIOLOGY, V229, P360, DOI 10.1148/radiol.2292021507; Fushimi Yasutaka, 2006, Radiat Med, V24, P85, DOI 10.1007/BF02493273; Gangemi M, 2004, NEUROSURGERY, V55, P129, DOI 10.1227/01.NEU.0000126938.12817.DC; Grant JA, 1997, SURG NEUROL, V47, P210, DOI 10.1016/S0090-3019(96)00457-0; Gray H., 1918, ANATOMY HUMAN BODY; HANDLER MH, 1994, NEUROSURGERY, V35, P525, DOI 10.1227/00006123-199409000-00025; Hellwig D, 2005, NEUROSURG REV, V28, P1, DOI 10.1007/s10143-004-036-2; Hopf NJ, 1999, NEUROSURGERY, V44, P795, DOI 10.1097/00006123-199904000-00062; Iaccarino C, 2009, J NEUROSURG, V110, P852, DOI 10.3171/2008.4.17539; Jenkinson MD, 2009, J NEUROSURG, V110, P861, DOI 10.3171/2008.10.JNS17667; Kim LJ, 2005, ACTA NEUROCHIR, V147, P219, DOI 10.1007/s00701-004-0401-6; Kunz M, 2008, J NEUROSURG, V109, P931, DOI 10.3171/JNS/2008/109/11/0931; Lu J, 2005, J NEUROSURG, V103, P337, DOI 10.3171/jns.2005.103.2.0337; MARINKOVIC SV, 1993, NEUROSURGERY, V33, P80, DOI 10.1227/00006123-199307000-00012; McLaughlin MR, 1997, NEUROSURGERY, V41, P1400, DOI 10.1097/00006123-199712000-00034; Nakahara Y, 2004, NEUROL MED-CHIR, V44, P408, DOI 10.2176/nmc.44.408; Navarro R, 2006, CHILD NERV SYST, V22, P506, DOI 10.1007/s00381-005-0031-1; Rezende MTS, 2008, NEURORADIOLOGY, V50, P443, DOI 10.1007/s00234-007-0357-3; Rhoton AL, 2002, NEUROSURGERY, V51, pS207, DOI 10.1227/01.NEU.0000028161.91504.4F; Rovira A, 1999, AM J NEURORADIOL, V20, P1647; Santamarta D, 2005, ACTA NEUROCHIR, V147, P377, DOI 10.1007/s00701-005-0484-8; Schroeder HWS, 1999, J NEUROSURG, V90, P153, DOI 10.3171/jns.1999.90.1.0153; Schroeder HWS, 2002, J NEUROSURG, V96, P1032, DOI 10.3171/jns.2002.96.6.1032; Vandertop PW, 1998, NEUROSURGERY, V43, P647, DOI 10.1097/00006123-199809000-00157	36	12	12	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0897-3806	1098-2353		CLIN ANAT	Clin. Anat.	NOV	2009	22	8					916	924		10.1002/ca.20867			9	Anatomy & Morphology	Anatomy & Morphology	515DG	WOS:000271446200011	19806669				2021-06-18	
J	Curcoy, AI; Trenchs, V; Morales, M; Serra, A; Pineda, M; Pou, J				Curcoy, A. I.; Trenchs, V.; Morales, M.; Serra, A.; Pineda, M.; Pou, J.			Do retinal haemorrhages occur in infants with convulsions?	ARCHIVES OF DISEASE IN CHILDHOOD			English	Article							SHAKEN-BABY SYNDROME; INFLICTED CHILDHOOD NEUROTRAUMA; NOTHING GOES WRONG; HEAD-INJURY; YOUNG-CHILDREN; NUMERATORS; IF	Aim: To determine the prevalence of retinal haemorrhages in infants presenting with convulsions and admitted to hospital, and to consider whether this finding indicates shaken baby syndrome. Methods: Prospective study of children aged 15 days to 2 years admitted with a diagnosis of first convulsion over a 2-year period ( May 2004-May 2006). All infants were examined by an experienced ophthalmologist using indirect ophthalmoscopy within 72 h of admission. Results: 182 of 389 children seen in the accident and emergency department were admitted and two were found to have retinal haemorrhages. Both children were eventually diagnosed as being abused. Conclusions: Convulsions alone are unlikely to cause retinal haemorrhages in children under 2 years of age.	[Curcoy, A. I.; Trenchs, V.; Pou, J.] Hosp Univ St Joan de Deu, Dept Pediat, Barcelona, Spain; [Morales, M.; Serra, A.] Hosp Univ St Joan de Deu, Dept Ophthalmol, Barcelona, Spain; [Pineda, M.] Hosp Univ St Joan de Deu, Dept Neurol, Barcelona, Spain	Curcoy, AI (corresponding author), Passeig St Joan de Deu 2, Barcelona 08950, Spain.	acurcoy@hsjdbcn.org					Aghadoost D, 2004, Indian Pediatr, V41, P1271; BUYS YM, 1992, OPHTHALMOLOGY, V99, P1718; CAFFEY J, 1974, PEDIATRICS, V54, P396; Barcenilla AIC, 2006, PEDIATR EMERG CARE, V22, P495, DOI 10.1097/01.pec.0000227385.46143.20; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; EYPASCH E, 1995, BRIT MED J, V311, P619, DOI 10.1136/bmj.311.7005.619; Gardner HB, 2008, PEDIATR NEUROSURG, V44, P434, DOI 10.1159/000149917; Gardner HB, 2007, PEDIATR NEUROSURG, V43, P433, DOI 10.1159/000106399; Gayle Michael O., 1995, Journal of Emergency Medicine, V13, P233, DOI 10.1016/0736-4679(94)00145-6; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Greeley CS, 2008, PEDIATR NEUROSURG, V44, P90, DOI 10.1159/000111260; HANLEY JA, 1983, JAMA-J AM MED ASSOC, V249, P1743, DOI 10.1001/jama.249.13.1743; KAUR B, 1990, ARCH DIS CHILD, V65, P1369, DOI 10.1136/adc.65.12.1369; King WJ, 2003, CAN MED ASSOC J, V168, P155; LeFanu J, 2004, BMJ-BRIT MED J, V328, P767, DOI 10.1136/bmj.328.7442.767; Mei-Zahav M, 2002, ARCH DIS CHILD, V86, P334, DOI 10.1136/adc.86.5.334; NEWMAN TB, 1995, JAMA-J AM MED ASSOC, V274, P1013, DOI 10.1001/jama.1995.03530130019013; Punt J, 2006, ARCH DIS CHILD, V91, P714; Punt J, 2004, Pediatr Rehabil, V7, P173, DOI 10.1080/13638490410001711515; Richards PG, 2006, ARCH DIS CHILD, V91, P205, DOI 10.1136/adc.2005.090761; Sandramouli S, 1997, ARCH DIS CHILD, V76, P449, DOI 10.1136/adc.76.5.449; Squier W, 2008, DEV MED CHILD NEUROL, V50, P10, DOI 10.1111/j.1469-8749.2007.02004.x; Tyagi AK, 1998, BRIT J OPHTHALMOL, V82, P659, DOI 10.1136/bjo.82.6.659	24	12	12	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-9888			ARCH DIS CHILD	Arch. Dis. Child.	NOV	2009	94	11					873	875		10.1136/adc.2007.132522			5	Pediatrics	Pediatrics	511UD	WOS:000271194000012	19666457				2021-06-18	
J	Kim, T; Chung, S; Lanzino, G				Kim, TaeHong; Chung, SeungEun; Lanzino, Giuseppe			Carotid artery-hypoglossal nerve relationships in the neck: an anatomical work	NEUROLOGICAL RESEARCH			English	Article						Hypoglossal nerve; sternocleidomastoid artery; carotid endarterectomy	SURGICAL ANATOMY; ENDARTERECTOMY; INJURIES; RELEVANCE; SURGERY	Objective: To review the surgical anatomy of the hypoglossal nerve in the neck, analyse its relationship to surrounding structures and offer landmarks to identify the nerve during carotid endarterectomy. Method: The carotid bifurcation, external carotid artery, internal carotid artery, extracranial part of the hypoglossal nerve, occipital artery, sternocleidomastoid artery and surrounding neurovascular structures were dissected and studied on 15 formalin-fixed adult cadaver heads (30 sides and 15 pairs) via a surgical microscope. Landmarks for the hypoglossal nerve and measurements of its distance from the carotid bifurcation are described. The relationship between the sternocleidomastoid artery and the occipital artery is also described. Results: The distance from the carotid bifurcation to the point at which the hypoglossal nerve crosses over the internal carotid artery was variable, ranging from 3.89 to 37.03 mm (mean, 20.95 +/- 7.78 mm). The distance from the bifurcation to the point at which the hypoglossal nerve crosses over the external carotid artery ranged from 2.63 to 29.43 mm (mean, 15.33 +/- 7.86 mm; Table 1). The sternocleidomastoid artery had a very characteristic course and close relationship with the hypoglossal nerve. Ascending for a short distance in a cranial direction, it crossed over the hypoglossal nerve and then descended toward the sternocleidomastoid muscle. The sternocleidomastoid artery originated from the occipital artery (33.4%), the external carotid artery-internal carotid artery junction (30%), the external carotid artery itself (30%) or even the lingual artery (6.6%). Conclusion: The relationship between the hypoglossal nerve and the carotid bifurcation is quite variable, and this explains the vulnerability of the nerve during carotid endarterectomy. The sternocleidomastoid artery is a good landmark for identifying the hypoglossal nerve. If there is exact anatomical knowledge about the relationship between the sternocleidomastoid artery and the hypoglossal nerve, the incidence of nerve injuries during carotid endarterectomy can be minimized. [Neurol Res 2009; 31: 895-899]	[Lanzino, Giuseppe] Mayo Clin, Mayo Coll Med, Dept Neurol Surg, Rochester, MN 55905 USA; [Kim, TaeHong; Lanzino, Giuseppe] Univ Illinois, Coll Med, Microneurosurg Lab, Dept Neurosurg, Peoria, IL 61656 USA; [Chung, SeungEun] Wooridul Hosp, Dept Radiol, Seoul, South Korea; [Kim, TaeHong] Inje Univ, Sanggyepaik Hosp, Dept Neurosurg, Seoul, South Korea	Lanzino, G (corresponding author), Mayo Clin, Mayo Coll Med, Dept Neurol Surg & Radiol, 200 1st St SW, Rochester, MN 55905 USA.	lanzino.giuseppe@mayo.edu					ALDOORI MI, 1988, J CARDIOVASC SURG, V29, P432; Alvernia JE, 2006, NEUROSURGERY, V58, P114, DOI 10.1227/01.NEU.0000193519.00443.34; Bademci G, 2005, CEREBROVASC DIS, V19, P404, DOI 10.1159/000086101; Bademci G, 2005, MINIM INVAS NEUROSUR, V48, P108, DOI 10.1055/s-2004-830228; Bademci G, 2006, J CLIN NEUROSCI, V13, P841, DOI 10.1016/j.jocn.2005.12.028; Ballotta E, 1999, SURGERY, V125, P85, DOI 10.1016/S0039-6060(99)70292-8; Bejjani GK, 1998, NEUROSURGERY, V43, P842, DOI 10.1097/00006123-199810000-00072; Chaturvedi S, 2005, NEUROLOGY, V65, P794, DOI 10.1212/01.wnl.0000176036.07558.82; DILENGE D, 1974, RADIOLOGY SKULL BRAI, V2, P1202; EVANS WE, 1982, ANN SURG, V196, P461, DOI 10.1097/00000658-198210000-00009; Fernando DA, 1999, CARDIOVASC SURG, V7, P287, DOI 10.1016/S0967-2109(98)00070-2; FISHER DF, 1984, J VASC SURG, V1, P727, DOI 10.1067/mva.1984.avs0010727; Gray H., 1980, GRAYS ANATOMY, P676; HANS SS, 1989, AM J SURG, V157, P431, DOI 10.1016/0002-9610(89)90593-X; Hayashi N, 2005, NEUROL MED-CHIR, V45, P25, DOI 10.2176/nmc.45.25; Imparato AM, 1972, STROKE, V3, P576, DOI 10.1161/01.STR.3.5.576; Kierner AC, 1999, ARCH SURG-CHICAGO, V134, P144, DOI 10.1001/archsurg.134.2.144; LIAPIS CD, 1981, SURGERY, V89, P56; MANIGLIA AJ, 1991, HEAD NECK-J SCI SPEC, V13, P121, DOI 10.1002/hed.2880130207; RABSON JA, 1985, BRIT J PLAST SURG, V38, P208, DOI 10.1016/0007-1226(85)90051-7; THEODOTOU B, 1985, STROKE, V16, P894, DOI 10.1161/01.STR.16.5.894; WEISS K, 1987, J CARDIOVASC SURG, V28, P171	22	12	12	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	NOV	2009	31	9					895	899		10.1179/174313209X385590			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	530XQ	WOS:000272626700003	19215658				2021-06-18	
J	Peterson, E; Chesnut, RM				Peterson, Eric; Chesnut, Randall M.			Static Autoregulation is Intact in Majority of Patients With Severe Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	67th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma/Meeting of the Association-for-Acute-Medicine	SEP 24-27, 2008	Maui, HI	Amer Assoc Surg Trauma, Assoc Acute Med		Traumatic brain injury; Autoregulation; CTP; Static autoregulation	DYNAMIC CEREBRAL AUTOREGULATION; HEAD-INJURY; BLOOD-FLOW; REACTIVITY; PRESSURE	Background: The management of severe traumatic brain injury (sTBI) patients with and without intact cerebral pressure autoregulation (CPA) varies markedly. Recent studies analyzing beat-to-beat interactions between intracranial pressure (ICP) and systolic blood pressure, or transcranial Doppler velocity changes during a rapid drop in cerebral perfusion pressure (CPP), suggest that CPA is disrupted after sTBI. We use computed tomography perfusion (CTP) to guide blood pressure manipulation in sTBI and have found CPA results that differ with this literature. We present these results here and suggest modifying Our basic concepts of CPA disruption. Methods: We tested CPA in 24 consecutive sTBI patients using CTP. ICP was monitored intraparenchymally and blood pressure with an arterial line. After a CTP study at baseline, a phenylephrine infusion was used to raise the CPP by 20 mm Hg, and a second CTP was performed immediately thereafter. Quantitative analysis of cerebral blood flow (CBF) was done offline. CPA was considered intact if CBF was unchanged despite the increase in CPP and disrupted if CBF rose after CPP manipulation. Results: CPA was intact in 25 of 33 patients (75.7%) and disrupted in 8 of 33 patients (24.3%). The mean age was significantly different for the 2 groups; 52 years for the disrupted group, 29 years for the intact group (p < 0.0003). The mean ICP change was also statistically different; 3.8 for the disrupted group and 1.5 for the intact group (p < 0.006). Injury Severity Score (ISS), Glasgow Coma Scale, and CPP were not statistically different between the two groups. Conclusion: By using direct measurement of CBF in response to a CPP challenge, we found CPA disruption to be much less common than reported in similar groups of sTBI patients. This difference reflects potentially important separate aspects of CPA. We suggest that CPA measurement using beat-to-beat interactions and transcranial Doppler measurements reflect dynamic CPA processes (dynamic autoregulation), whereas Our method reflects steady-state conditions (static autoregulation). If the major disruption of CPA after sTBI involves dynamic vascular responsiveness, perhaps we need more focus on this aspect and less on static-CPP manipulation in terms of pathophysiology and treatment.	[Peterson, Eric; Chesnut, Randall M.] Univ Washington, Med Ctr, Harborview Med Ctr, Dept Neurol Surg, Seattle, WA 98104 USA	Peterson, E (corresponding author), Univ Washington, Med Ctr, Harborview Med Ctr, Dept Neurol Surg, 325 9th Ave, Seattle, WA 98104 USA.	ericpete@u.washington.edu		Chesnut, Randall/0000-0001-6377-3666			BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Carey BJ, 2000, STROKE, V31, P2895, DOI 10.1161/01.STR.31.12.2895; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; INGVAR DAVID H., 1964, ACTA ANAETH SCAND SUPPL, V15, P43; Kastrup A, 1998, STROKE, V29, P1311, DOI 10.1161/01.STR.29.7.1311; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; MARMAROU A, 1993, ACTA NEUROCHIR, P18; REICH T, 1989, STROKE, V20, P453, DOI 10.1161/01.STR.20.4.453; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; Strebel S, 1997, SURG NEUROL, V47, P128, DOI 10.1016/S0090-3019(96)00459-4; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014	15	12	12	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2009	67	5					944	949		10.1097/TA.0b013e3181ae6e6d			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	518XO	WOS:000271729500008	19901652				2021-06-18	
J	Arien-Zakay, H; Lecht, S; Bercu, MM; Amariglio, N; Rechavi, G; Galski, H; Lazarovici, P; Nagler, A				Arien-Zakay, H.; Lecht, S.; Bercu, M. M.; Amariglio, N.; Rechavi, G.; Galski, H.; Lazarovici, P.; Nagler, A.			Interferon-gamma-induced neuronal differentiation of human umbilical cord blood-derived progenitors	LEUKEMIA			English	Article						human umbilical cord blood; neuronal progenitors; IFN-gamma; NGF; neuronal differentiation; gene expression	NERVE GROWTH-FACTOR; NEUROBLASTOMA-CELL-DIFFERENTIATION; TRAUMATIC BRAIN INJURY; STEM-CELLS; IFN-GAMMA; NEURITE OUTGROWTH; GENE-EXPRESSION; IN-VITRO; PC12 CELLS; PROMOTES DIFFERENTIATION	Human umbilical cord blood (HUCB) provides a source of progenitors for cell therapy. We isolated and characterized an HUCB-derived population of progenitors (HUCBNP), differentiated toward neuronal phenotype by human neuroblastoma-conditioning medium (CM) and nerve growth factor (NGF), which have been found to confer neuroprotection toward hypoxia-mediated neuronal injury. This study investigated whether interferon-gamma (IFN-gamma) contributes to HUCBNP differentiation. IFN-gamma was detected in the CM used for the induction of differentiation of HUCBNP and a neutralizing antibody of IFN-gamma significantly inhibited either IFN-gamma or CM-induced differentiation. Transcriptome analysis of CM-differentiated HUCBNP, identified 86 genes as highly upregulated, among them 25 were IFN-induced (such as 2',5'-oligoadenylate synthetase 1 and 2, IFN-induced protein and transmembrane proteins, STAT1 (IFN-gamma-creceptor signal transducer and activator of transcription) and chemokine C-X-C motif ligand 5). Treatment of HUCBNP with human recombinant IFN-gamma, inhibited cell proliferation in a dose-dependent manner. IFN-gamma (1-100 ng/ml) enhanced neuronal differentiation, expressed by neurite outgrowths and increased expression of the neuronal markers beta-tubulin III, microtubule-associated protein 2, neuronal nuclei, neurofilament M and neuronal-specific enolase. IFN-gamma additively cooperated with NGF to induce the differentiation of HUCBNP. These data indicate that IFN-gamma promotes neuronal differentiation of HUCB-derived progenitors, proposing its use in future protocols towards cell therapy. Leukemia (2009) 23, 1790-1800; doi: 10.1038/leu.2009.106; published online 21 May 2009	[Arien-Zakay, H.; Lecht, S.; Bercu, M. M.; Galski, H.; Lazarovici, P.] Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol & Expt Therapeut, Fac Med, IL-91120 Jerusalem, Israel; [Amariglio, N.; Rechavi, G.] Chaim Sheba Med Ctr, Sheba Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Rechavi, G.; Nagler, A.] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Galski, H.; Nagler, A.] Chaim Sheba Med Ctr, Lab Mol Immunobiol, Div Hematol & Bone Marrow Transplantat, IL-52621 Tel Hashomer, Israel; [Galski, H.; Nagler, A.] Chaim Sheba Med Ctr, Cord Blood Bank, IL-52621 Tel Hashomer, Israel	Lazarovici, P (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol & Expt Therapeut, Fac Med, POB 12065, IL-91120 Jerusalem, Israel.	philipl@ekmd.huji.ac.il	Lazarovici, Philip/S-5261-2018; Lecht, Shimon/AAC-5890-2019	Lazarovici, Philip/0000-0003-3650-4721; Lecht, Shimon/0000-0002-6499-2390	Molecular Pharmacology and Therapeutics at The Hebrew University of Jerusalem, Israel	The authors would like to thank Mrs Jasmine Jacob-Hirsch for the technical help with functional genomics. PL is affiliated with and supported in part by David R Bloom Center for Pharmacy and the Dr Adolf and Klara Brettler Center for Research in Molecular Pharmacology and Therapeutics at The Hebrew University of Jerusalem, Israel.	Arien-Zakay H, 2007, J MOL NEUROSCI, V32, P179, DOI 10.1007/s12031-007-0027-2; Arien-Zakay H, 2009, EXP NEUROL, V216, P83, DOI 10.1016/j.expneurol.2008.11.006; BARISH ME, 1991, DEV BIOL, V144, P412, DOI 10.1016/0012-1606(91)90433-4; Baron R, 2008, FASEB J, V22, P2843, DOI 10.1096/fj.08-105866; Cetinkaya C, 2007, MOL CANCER THER, V6, P2634, DOI 10.1158/1535-7163.MCT-06-0492; Chen Chun-Ta, 2008, Pediatrics and Neonatology, V49, P77, DOI 10.1016/S1875-9572(08)60017-0; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen SH, 2006, EXP NEUROL, V199, P67, DOI 10.1016/j.expneurol.2005.11.015; Cho SG, 2005, NEUROSCI LETT, V378, P49, DOI 10.1016/j.neulet.2004.12.073; Cohen Y, 2004, BLOOD REV, V18, P167, DOI 10.1016/S0268-960X(03)00064-X; CORRIAS MV, 1995, INT J CANCER, V62, P223, DOI 10.1002/ijc.2910620219; Dafny N, 2005, EUR J PHARMACOL, V523, P1, DOI 10.1016/j.ejphar.2005.08.029; De Ambrosis A, 2007, INT J CANCER, V120, P39, DOI 10.1002/ijc.22173; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Domanska-Janik K, 2008, INT J DEV BIOL, V52, P237, DOI 10.1387/ijdb.072315kd; El-Badri NS, 2006, STEM CELLS DEV, V15, P497, DOI 10.1089/scd.2006.15.497; GAVIRIA JM, 2008, CLIN USE RECOMBINANT; Goldstein G, 2007, CURR PHARM DESIGN, V13, P1363, DOI 10.2174/138161207780618759; Harris DT, 2007, EXPERT OPIN BIOL TH, V7, P1311, DOI 10.1517/14712598.7.9.1311; Hooker A, 1998, J INTERF CYTOK RES, V18, P287, DOI 10.1089/jir.1998.18.287; IMPROTA T, 1988, EXP CELL RES, V179, P1, DOI 10.1016/0014-4827(88)90342-4; Indraccolo S, 2007, J IMMUNOL, V178, P1122, DOI 10.4049/jimmunol.178.2.1122; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; JONAKAIT GM, 1994, NEURON, V12, P1149; Kamolz LP, 2006, BURNS, V32, P16, DOI 10.1016/j.burns.2005.08.020; Katzir I, 2002, J MOL NEUROSCI, V18, P251, DOI 10.1385/JMN:18:3:251; Kim SJ, 2007, NEUROCHEM RES, V32, P1399, DOI 10.1007/s11064-007-9323-z; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Lazarovici P, 2006, CURR PHARM DESIGN, V12, P2609, DOI 10.2174/138161206777698738; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Margalit O, 2005, BLOOD REV, V19, P223, DOI 10.1016/j.blre.2004.11.003; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; McGuckin C, 2008, NAT PROTOC, V3, P1046, DOI 10.1038/nprot.2008.69; Mousa A, 1999, CYTOKINE, V11, P55, DOI 10.1006/cyto.1998.0381; Nan ZH, 2005, ANN NY ACAD SCI, V1049, P84, DOI 10.1196/annals.1334.009; Neuhoff S, 2007, EXP HEMATOL, V35, P1119, DOI 10.1016/j.exphem.2007.03.019; Nunes VA, 2007, BIOL CELL, V99, P185, DOI 10.1042/BC20060075; Parish CL, 2002, J NEUROSCI, V22, P8034; PLIOPLYS AV, 1988, J NEUROL SCI, V85, P209, DOI 10.1016/0022-510X(88)90157-8; PONZONI M, 1992, CANCER RES, V52, P931; Ridge J, 1996, IN VITRO CELL DEV-AN, V32, P238; Rozzo C, 1997, CELL DEATH DIFFER, V4, P713, DOI 10.1038/sj.cdd.4400304; Shearer WT, 1999, CLIN DIAGN LAB IMMUN, V6, P311, DOI 10.1128/CDLI.6.3.311-315.1999; Song JH, 2005, J BIOL CHEM, V280, P12896, DOI 10.1074/jbc.M412139200; Stoll G, 2000, J NEURAL TRANSM-SUPP, P81; Tan JQ, 2000, BLOOD, V96, P1230, DOI 10.1182/blood.V96.4.1230.h8001230_1230_1238; Tavor S, 2008, LEUKEMIA, V22, P2151, DOI 10.1038/leu.2008.238; Tekautz TM, 2006, BBA-MOL CELL RES, V1763, P1000, DOI 10.1016/j.bbamcr.2006.06.014; Uwabe KI, 2005, J BIOL CHEM, V280, P34268, DOI 10.1074/jbc.M502667200; Vasaturo F, 1998, INT J ONCOL, V12, P895; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Wald O, 2006, J IMMUNOL, V176, P4716, DOI 10.4049/jimmunol.176.8.4716; Wong G, 2004, EXP NEUROL, V187, P171, DOI 10.1016/j.expneurol.2004.01.009; Wu YY, 1996, J BIOL CHEM, V271, P13023, DOI 10.1074/jbc.271.22.13023	55	12	13	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0887-6924	1476-5551		LEUKEMIA	Leukemia	OCT	2009	23	10					1790	1800		10.1038/leu.2009.106			11	Oncology; Hematology	Oncology; Hematology	506YX	WOS:000270816300012	19458627	Bronze			2021-06-18	
J	Harris, JL; Reeves, TM; Phillips, LL				Harris, Janna L.; Reeves, Thomas M.; Phillips, Linda L.			Injury Modality, Survival Interval, and Sample Region Are Critical Determinants of qRT-PCR Reference Gene Selection during Long-Term Recovery from Brain Trauma	JOURNAL OF NEUROTRAUMA			English	Article						genomics; molecular biological approaches; neuroplasticity; synaptic loss and deafferentation; traumatic brain injury	TIME RT-PCR; REAL-TIME; MESSENGER-RNA; HOUSEKEEPING GENES; QUANTITATIVE PCR; RIBOSOMAL-RNA; BETA-ACTIN; INSITU HYBRIDIZATION; SYNAPTIC PLASTICITY; DENERVATED NEUROPIL	In the present study we examined expression of four real-time quantitative RT-PCR reference genes commonly applied to rodent models of brain injury. Transcripts for beta-actin, cyclophilin A, GAPDH, and 18S rRNA were assessed at 2-15 days post-injury, focusing on the period of synaptic recovery. Diffuse moderate central fluid percussion injury (FPI) was contrasted with unilateral entorhinal cortex lesion (UEC), a model of targeted deafferentation. Expression in UEC hippocampus, as well as in FPI hippocampus and parietotemporal cortex was analyzed by qRT-PCR. Within-group variability of gene expression was assessed and change in expression relative to paired controls was determined. None of the four common reference genes tested was invariant across brain region, survival time, and type of injury. Cyclophilin A appeared appropriate as a reference gene in UEC hippocampus, while beta-actin was most stable for the hippocampus subjected to FPI. However, each gene may fail as a suitable reference with certain test genes whose RNA expression is targeted for measurement. In FPI cortex, all reference genes were significantly altered over time, compromising their utility for time-course studies. Despite such temporal variability, certain genes may be appropriate references if limited to single survival times. These data provide an extended baseline for identification of appropriate reference genes in rodent studies of recovery from brain injury. In this context, we outline additional considerations for selecting a qRT-PCR normalization strategy in such studies. As previously concluded for acute post-injury intervals, we stress the importance of reference gene validation for each brain injury paradigm and each set of experimental conditions.	[Harris, Janna L.; Reeves, Thomas M.; Phillips, Linda L.] Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, Sch Med, Richmond, VA 23298 USA	Phillips, LL (corresponding author), Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, Sch Med, POB 980709, Richmond, VA 23298 USA.	llphilli@vcu.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS44372, NS57758]; Virginia Commonwealth Neurotrauma Initiative [07-302F]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS044372, R01NS057758, R56NS044372] Funding Source: NIH RePORTER	The authors wish to thank Lesley K. Harris, Raiford T. Black, and Nancy N. Lee for excellent technical assistance. All qRT-PCR was performed in the Nucleic Acids Research Facilities, Center for the Study of Biological Complexity, Virginia Commonwealth University. This work was supported by NIH grants NS44372 and NS57758, and Virginia Commonwealth Neurotrauma Initiative 07-302F.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arckens L, 2003, EUR J NEUROSCI, V18, P61, DOI 10.1046/j.1460-9568.2003.02726.x; Blain JF, 2004, NEUROBIOL DIS, V15, P510, DOI 10.1016/j.nbd.2003.12.001; Bond BC, 2002, MOL BRAIN RES, V106, P101, DOI 10.1016/S0169-328X(02)00417-5; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Bustin SA, 2005, EXPERT REV MOL DIAGN, V5, P493, DOI 10.1586/14737159.5.4.493; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Chen J, 2001, LAB INVEST, V81, P913, DOI 10.1038/labinvest.3780300; Cook NL, 2009, J NEUROSCI RES, V87, P34, DOI 10.1002/jnr.21846; Coulson DTR, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-46; Dash PK, 2004, NEUROCHEM RES, V29, P1275, DOI 10.1023/B:NERE.0000023614.30084.eb; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Farwell W, 1998, NEUROCHEM RES, V23, P539, DOI 10.1023/A:1022486619201; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Harris J, 2008, J NEUROTRAUM, V25, P857; Harris J, 2006, J NEUROTRAUM, V23, P988; Harris JL, 2005, J NEUROTRAUM, V22, P1166; Harrison DC, 2000, MOL BRAIN RES, V75, P143, DOI 10.1016/S0169-328X(99)00305-8; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Johansson S, 2007, BRAIN RES, V1132, P20, DOI 10.1016/j.brainres.2006.11.026; Keppel, 1991, DESIGN ANAL RES HDB; Kerber G, 2003, J MOL NEUROSCI, V21, P149, DOI 10.1385/JMN:21:2:149; Kobayashi MS, 2004, J NEUROSCI RES, V76, P512, DOI 10.1002/jnr.20094; LEVINE G, 1991, GUIDE SPSS ANAL VARI; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; LOESCHE J, 1977, BRAIN RES BULL, V2, P31, DOI 10.1016/0361-9230(77)90022-3; Meldgaard M, 2006, J NEUROSCI METH, V156, P101, DOI 10.1016/j.jneumeth.2006.02.008; Molteni R, 2002, EUR J NEUROSCI, V16, P1107, DOI 10.1046/j.1460-9568.2002.02158.x; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; PHILLIPS LL, 1987, MOL BRAIN RES, V2, P251, DOI 10.1016/0169-328X(87)90032-5; PHILLIPS LL, 1990, MOL BRAIN RES, V8, P249, DOI 10.1016/0169-328X(90)90024-8; Price M, 2003, MOL BRAIN RES, V117, P58, DOI 10.1016/S0169-328X(03)00285-7; Rhinn H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-62; Tanic N, 2007, J MOL NEUROSCI, V32, P38, DOI 10.1007/s12031-007-0006-7; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang YL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-59; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; Zhong H, 1999, BIOCHEM BIOPH RES CO, V259, P523, DOI 10.1006/bbrc.1999.0815	48	12	12	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2009	26	10					1669	1681		10.1089/neu.2009.0875			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	507CT	WOS:000270829200006	19505177	Green Published			2021-06-18	
J	Otto, F; Illes, S; Opatz, J; Laryea, M; Theiss, S; Hartung, HP; Schnitzler, A; Siebler, M; Dihne, M				Otto, Frauke; Illes, Sebastian; Opatz, Jessica; Laryea, Maurice; Theiss, Stephan; Hartung, Hans-Peter; Schnitzler, Alfons; Siebler, Mario; Dihne, Marcel			Cerebrospinal Fluid of Brain Trauma Patients Inhibits in vitro Neuronal Network Function via NMDA Receptors	ANNALS OF NEUROLOGY			English	Article							EMBRYONIC STEM-CELLS; PRECURSORS	Neurological diseases frequently induce pathological changes of cerebrospinal fluid (CSF) that might secondarily influence brain activity, as the CSF-brain barrier is partially permeable. However, functional effects of CSF on neuronal network activity have not been specified to date. Here, we report that CSF specimens from patients with reduced Glasgow Coma Scale values caused by severe traumatic brain injury suppress synchronous activity of in vitro-generated neuronal networks in comparison with controls. We present evidence that underlying mechanisms include increased N-methyl-D-aspartate receptor activity mediated by a CSF fraction containing elevated amino acid concentrations. These proof-of-principle data suggest that determining effects of CSF specimens on neuronal network activity might be of diagnostic value.	[Otto, Frauke; Illes, Sebastian; Opatz, Jessica; Theiss, Stephan; Hartung, Hans-Peter; Schnitzler, Alfons; Siebler, Mario; Dihne, Marcel] Univ Dusseldorf, Dept Neurol, D-40225 Dusseldorf, Germany; [Laryea, Maurice] Univ Dusseldorf, Dept Gen Pediat, D-40225 Dusseldorf, Germany; [Schnitzler, Alfons] Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, D-40225 Dusseldorf, Germany	Dihne, M (corresponding author), Univ Dusseldorf, Dept Neurol, Moorenstr 5, D-40225 Dusseldorf, Germany.	Marcel.Dihne@uni-duesseldorf.de	Dihne, Marcel/G-1995-2010; Illes, Sebastian/N-3598-2015; Schnitzler, Alfons/Q-5520-2019; Schnitzler, Alfons/K-4625-2014	Illes, Sebastian/0000-0002-2328-5382; Schnitzler, Alfons/0000-0002-6414-7939; Schnitzler, Alfons/0000-0002-6414-7939	Bundesministerium fur Bildung Lind Forschung (BMBF)Federal Ministry of Education & Research (BMBF) [01GN0503]; Christiane & Claudia Hempel-Stiftung fur Klinische Stammzellforschung; Hannelore-Kohl-Stiftung ZNS; Forschungskommission der medizinischen Fakultat der Heinrich-Heine-Universitat Dusseldorf	This work was supported by the Bundesministerium fur Bildung Lind Forschung (BMBF, 01GN0503, M.D.), the "Christiane & Claudia Hempel-Stiftung fur Klinische Stammzellforschung" (M.D.), the "Hannelore-Kohl-Stiftung ZNS" (M.S.) and the Forschungskommission der medizinischen Fakultat der Heinrich-Heine-Universitat Dusseldorf (FOKO, F.O.).	Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Ban J, 2007, STEM CELLS, V25, P738, DOI 10.1634/stemcells.2006-0246; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Chiang MF, 2006, ACTA NEUROCHIR, V148, P615, DOI 10.1007/s00701-006-0771-z; Danysz W, 1998, PHARMACOL REV, V50, P597; Davson H, 1987, PHYSL PATHOPHYSIOLOG; Dihne M, 2006, STEM CELLS, V24, P1458, DOI 10.1634/stemcells.2005-0413; Illes S, 2007, EXP NEUROL, V207, P171, DOI 10.1016/j.expneurol.2007.05.020; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Nat R, 2007, GLIA, V55, P385, DOI 10.1002/glia.20463; Nilsson OG, 2006, NEUROSURGERY, V59, P521, DOI 10.1227/01.NEU.0000227521.58701.E5; Otto F, 2003, J NEUROSCI METH, V128, P173, DOI 10.1016/S0165-0270(03)00186-9; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Toczylowska B, 2006, BRAIN RES, V1104, P183, DOI 10.1016/j.brainres.2006.05.057; Wagenaar DA, 2005, J NEUROSCI, V25, P680, DOI 10.1523/JNEUROSCI.4209-04.2005; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	22	12	12	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	OCT	2009	66	4					546	555		10.1002/ana.21808			10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	507SJ	WOS:000270874700015	19847897				2021-06-18	
J	Malmivaara, K; Hernesniemi, J; Salmenpera, R; Ohman, J; Roine, RP; Siironen, J				Malmivaara, Kirsi; Hernesniemi, Juha; Salmenpera, Ritva; Ohman, Juha; Roine, Risto P.; Siironen, Jari			SURVIVAL AND OUTCOME OF NEUROSURGICAL PATIENTS REQUIRING VENTILATORY SUPPORT AFTER INTENSIVE CARE UNIT STAY	NEUROSURGERY			English	Article						Cost-effectiveness; Health-related quality of life; Prolonged treatment; Quality-adjusted life years	TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; COST-EFFECTIVENESS ANALYSIS; LONG-TERM MORTALITY; QUALITY-OF-LIFE; INTRACEREBRAL HEMORRHAGE; SUBDURAL HEMATOMAS; WITHDRAWAL; SURGERY; COHORT	OBJECTIVE: The aim of this study was to analyze the clinical outcome of severely ill neurosurgical patients whose need for artificial life support was extended. We sought to determine whether these patients benefit from extended treatment both in life expectancy and quality of life. Furthermore, we evaluated the direct cost of the neurosurgical treatment. METHODS: The study group comprised a consecutive series of 346 neurosurgical patients in poor condition who were discharged from the intensive care unit but still in need of artificial respiratory support. The patients had various neurosurgical diagnoses and were treated between 2000 and 2003 at the Department of Neurosurgery, Helsinki University Central Hospital. We followed the outcome of these patients by specially formatted questionnaires 6 months and 1, 2, and 5 years after treatment. Their health-related quality of life was evaluated with EuroQol EQ-5D; quality-adjusted life years (QALY) gained with the treatment and the costs of a QALY were calculated. RESULTS: The median follow-up time was 5 years. The mortality rate was 27% at 30 days, 45% at 1 year, and 59% at 5 years after treatment. Of the patients, 20% had a good recovery (Glasgow Outcome Scale [GOS] scores 4 and 5), 18% had severe disability (GOS score 3), none was in a vegetative state (GOS score 2), 59% were dead (GOS score 1), and 3% were lost to follow-up. Of the survivors, 69% lived at home, 22% in a nursing home, 2% were in a hospital, and 7% were lost to follow-up. The median EQ-5D index value was lower than the median index value for the general population: 0.71 (25th percentile [Q1] 0.38 and 75th percentile [Q3] 0.85) versus 0.85 (Q1 0.73 and Q3 1.00). The median cost of the direct neurosurgical treatment per patient was 15 000 (sic) (25th percentile, 10 000 (sic) 75th percentile, 22 000 (sic)). Surviving patients gained a mean of 17 +/- 13 QALYs. The cost of 1 QALY was 2521 (sic). CONCLUSION: Prolonged intensive care unit and step-down unit treatment of critically ill neurosurgical patients seems to be clinically justified. Moreover, direct costs of neurosurgical treatment were reasonably low.	[Malmivaara, Kirsi; Hernesniemi, Juha; Salmenpera, Ritva; Siironen, Jari] Univ Helsinki, Cent Hosp, Dept Neurosurg, FI-00260 Helsinki 26, Finland; [Ohman, Juha] Tampere Univ, Cent Hosp, Dept Neurosurg, SF-33520 Tampere, Finland; [Roine, Risto P.] Hosp Dist Helsinki, Helsinki, Finland; [Roine, Risto P.] Uusimaa Hosp, Grp Adm External Examinat & Evaluat, Helsinki, Finland	Malmivaara, K (corresponding author), Univ Helsinki, Cent Hosp, Dept Neurosurg, Topeliuksenkatu 5, FI-00260 Helsinki 26, Finland.	kirsi.malmivaara@helsinki.fi		Ohman, Juha/0000-0002-6592-1367			Ahlstrom A, 2005, INTENS CARE MED, V31, P1222, DOI 10.1007/s00134-005-2681-6; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Brunner-La Rocca HP, 2007, LANCET, V370, P1552; Burke RE, 2005, J EMERG MED, V29, P9, DOI 10.1016/j.jemermed.2005.01.003; Cook D, 2006, CRIT CARE MED, V34, pS317, DOI 10.1097/01.CCM.0000237042.11330.A9; Eefting F, 2003, CIRCULATION, V108, P2870, DOI 10.1161/01.CIR.0000100723.50363.2C; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Hlatky R, 2004, NEUROSURGERY, V55, P1318, DOI 10.1227/01.NEU.0000143029.42638.2C; Hop JW, 2001, J NEUROSURG, V95, P957, DOI 10.3171/jns.2001.95.6.0957; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Jeremic B, 2004, AM J CLIN ONCOL-CANC, V27, P195, DOI 10.1097/01.coc.0000055059.97106.15; Karinen P, 1999, NEUROSURGERY, V45, P780, DOI 10.1097/00006123-199910000-00009; Kind P, 1999, UK POPULATION NORMS, P172; Lacut K, 2007, FUND CLIN PHARMACOL, V21, P327, DOI 10.1111/j.1472-8206.2007.00488.x; LAUKONTAUS S, 2006, THESIS HELSINKI U HE; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; Manno EM, 2006, NEUROL CLIN, V24, P159, DOI 10.1016/j.ncl.2005.10.005; McGuire AJ, 2007, CEREBROVASC DIS, V23, P221, DOI 10.1159/000097645; Patel ST, 2000, J VASC SURG, V32, P247, DOI 10.1067/mva.2000.105959; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; PICKARD JD, 1990, BRIT MED J, V301, P629, DOI 10.1136/bmj.301.6753.629; POON WS, 1992, NEUROSURGERY, V30, P681; Ronkainen A, 2001, STROKE, V32, P2850, DOI 10.1161/hs1201.099711; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; Sanders GD, 2005, NEW ENGL J MED, V353, P1471, DOI 10.1056/NEJMsa051989; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Stegmayr B, 2004, STROKE, V35, P2059, DOI 10.1161/01.STR.0000138451.07853.b6; Strauss D, 2004, NEUROREHABILITATION, V19, P257; Teno JM, 2000, J AM GERIATR SOC, V48, pS70, DOI 10.1111/j.1532-5415.2000.tb03144.x; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; WEINSTEIN M, 1995, COST EFFECTIVENESS R, P77	36	12	12	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	SEP	2009	65	3					530	538		10.1227/01.NEU.0000350861.97585.CE			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	488CB	WOS:000269325600013	19687698				2021-06-18	
J	Stell, A; Sinnott, R; Jiang, JP; Donald, R; Chambers, I; Citerio, G; Enblad, P; Gregson, B; Howells, T; Kiening, K; Nilsson, P; Ragauskas, A; Sahuquillo, J; Piper, I				Stell, Anthony; Sinnott, Richard; Jiang, Jipu; Donald, Rob; Chambers, Iain; Citerio, Giuseppe; Enblad, Per; Gregson, Barbara; Howells, Tim; Kiening, Karl; Nilsson, Pelle; Ragauskas, Arminas; Sahuquillo, Juan; Piper, Ian			Federating distributed clinical data for the prediction of adverse hypotensive events	PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES			English	Article; Proceedings Paper	UK e-Science All Hands Meeting	SEP 08-11, 2008	Edinburgh, SCOTLAND			data federation; hypotension prediction; clinical grids	HEAD-INJURED PATIENTS; BRAIN-INJURY; MANAGEMENT; CARE	The ability to predict adverse hypotensive events, where a patient's arterial blood pressure drops to abnormally low (and dangerous) levels, would be of major benefit to the fields of primary and secondary health care, and especially to the traumatic brain injury domain. A wealth of data exist in health care systems providing information on the major health indicators of patients in hospitals (blood pressure, temperature, heart rate, etc.). It is believed that if enough of these data could be drawn together and analysed in a systematic way, then a system could be built that will trigger an alarm predicting the onset of a hypotensive event over a useful time scale, e. g. half an hour in advance. In such circumstances, avoidance measures can be taken to prevent such events arising. This is the basis for the Avert-IT project (http://www.avert-it.org), a collaborative EU-funded project involving the construction of a hypotension alarm system exploiting Bayesian neural networks using techniques of data federation to bring together the relevant information for study and system development.	[Stell, Anthony; Sinnott, Richard; Jiang, Jipu] Univ Glasgow, Natl E Sci Ctr, Glasgow G12 8QQ, Lanark, Scotland; [Donald, Rob] Univ Glasgow, Dept Stat, Glasgow G12 8QQ, Lanark, Scotland; [Donald, Rob] C3 Amulet Ltd, Dingwall IV15 9XL, Scotland; [Chambers, Iain] James Cook Univ Hosp, Middlesbrough TS4, Cleveland, England; [Citerio, Giuseppe] Hosp San Gerardo, I-20052 Monza, Italy; [Enblad, Per; Howells, Tim; Nilsson, Pelle] Univ Uppsala Hosp, Dept Neurosurg, S-75185 Uppsala, Sweden; [Gregson, Barbara] Newcastle Gen Hosp, Dept Neurosurg, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Kiening, Karl] Univ Heidelberg Hosp, D-69120 Heidelberg, Germany; [Ragauskas, Arminas] Kaunas Univ Hosp, LT-44029 Kaunas, Lithuania; [Sahuquillo, Juan] Vall Hebron Univ Hosp, Barcelona 08035, Spain; [Piper, Ian] So Gen Hosp, Glasgow G51 4TF, Lanark, Scotland	Stell, A (corresponding author), Univ Glasgow, Natl E Sci Ctr, Glasgow G12 8QQ, Lanark, Scotland.	a.stell@nesc.gla.ac.uk	Sahuquillo, Juan/B-3577-2008; Citerio, Giuseppe/B-1839-2015; Ragauskas, Art/J-7486-2016; sinnott, richard/E-7197-2014	Sahuquillo, Juan/0000-0003-0713-5875; Citerio, Giuseppe/0000-0002-5374-3161; Ragauskas, Art/0000-0002-3536-554X; sinnott, richard/0000-0001-5998-222X; Gregson, Barbara/0000-0003-4868-9137			Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; DONALD R, 2008, EVENT DEFINITION ANA; Howells T. P., 1995, Journal of Neurotrauma, V12, P471; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Mancia G, 2007, EUR HEART J, V28, P1462, DOI 10.1093/eurheartj/ehm236; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Piek J, 1998, INTENS CARE MED, V24, P1221, DOI 10.1007/s001340050748; Piper I, 2003, ACTA NEUROCHIR, V145, P615, DOI 10.1007/s00701-003-0066-6; SINNOTT RO, 2008, HDB RES COMPUTATIONA; SINNOTT RO, 2008, P HEALTHGRID CHIC IL; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Tarassenko L., 2005, 3rd IEE International Seminar on Medical Applications of Signal Processing, P71, DOI 10.1049/ic:20050334	14	12	12	0	3	ROYAL SOC	LONDON	6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	1364-503X	1471-2962		PHILOS T R SOC A	Philos. Trans. R. Soc. A-Math. Phys. Eng. Sci.	JUL 13	2009	367	1898					2679	2690		10.1098/rsta.2009.0042			12	Multidisciplinary Sciences	Science & Technology - Other Topics	461PW	WOS:000267281800007	19487204				2021-06-18	
J	Chang, CM; Lee, MH; Wang, TC; Weng, HH; Chung, CY; Yang, JT				Chang, Chia-Mao; Lee, Ming-Hsueh; Wang, Ting-Chung; Weng, Hsu-Huei; Chung, Chiu-Yen; Yang, Jen-Tsung			Brain protection by methylprednisolone in rats with spinal cord injury	NEUROREPORT			English	Article						apoptosis; ascending brain injury; methylprednisolone; spinal cord injury	INDUCED MYOCARDIAL APOPTOSIS; CELL-DEATH; IMMATURE HEARTS; GRANULOSA-CELLS; TNF-ALPHA; KAPPA-B; GLUCOCORTICOIDS; DEXAMETHASONE; ACTIVATION; EXPRESSION	Traumatic spinal cord injury is clinically treated by high doses of methylprednisolone. However, the effect of methylprednisolone on the brain in spinal cord injury patients has been little investigated. This experimental study examined Bcl-2 and Bax protein expression and Nissl staining to evaluate an apoptosis-related intracellular signaling event and final neuron death, respectively. Spinal cord injury produced a significant apoptotic change and cell death not only in the spinal cord but also in the supraventricular cortex and hippocampal cornu ammonis 1 region in the rat brains. The treatment of methylprednisolone increased the Bcl-2/Bax ratio and prevented neuron death for 1-7 days after spinal cord injury. These findings suggest that rats with spinal cord injury show ascending brain injury that could be restricted through methylprednisolone management, NeuroReport 20:968-972 (C) 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins.	[Weng, Hsu-Huei] Chang Gung Mem Hosp, Dept Diagnost Radiol, Chiayi, Taiwan; [Weng, Hsu-Huei] Chang Gung Inst Technol, Dept Resp Care, Chiayi, Taiwan; [Chung, Chiu-Yen] Natl Chung Cheng Univ, Dept Chem Engn, Chiayi, Taiwan; [Chang, Chia-Mao; Lee, Ming-Hsueh; Wang, Ting-Chung; Yang, Jen-Tsung] Chang Gung Univ, Coll Med, Dept Neurosurg, Tao Yuan, Taiwan; [Chang, Chia-Mao; Lee, Ming-Hsueh; Wang, Ting-Chung; Yang, Jen-Tsung] Chang Gung Mem Hosp, Dept Neurosurg, Chiayi, Taiwan	Yang, JT (corresponding author), Chang Gung Mem Hosp, Dept Neurosurg, 6 Sect W,Chia Pu Rd, Pu Tz City 613, Chia Yi, Taiwan.	jents716@ms32.hinet.net	Lee, Ming-Hsueh/H-8034-2015; Yang, Jen-Tsung/C-3187-2011; Weng, Hsu-Huei/N-8329-2014	Lee, Ming-Hsueh/0000-0001-5341-7764; Weng, Hsu-Huei/0000-0002-2020-8912; Chang, Chia Mao/0000-0003-3862-791X	Chang Gung Medical Research Council [660302, 660342]; National Science Council of TaiwanMinistry of Science and Technology, Taiwan [3191]	The authors acknowledge Tsong-Hai Lee for valuable discussions. This work was supported by Grant CMRPG 660302 and CMRPG 660342 from the Chang Gung Medical Research Council and Grant NMRPG 3191 from the National Science Council of Taiwan.	Costas MA, 2000, BBA-MOL CELL RES, V1499, P122, DOI 10.1016/S0167-4889(00)00113-0; Cramer SC, 2005, BRAIN, V128, P2941, DOI 10.1093/brain/awh648; Del Poeta G, 2003, BLOOD, V101, P2125, DOI 10.1182/blood-2002-06-1714; Ekert P, 1997, BRAIN RES, V747, P9, DOI 10.1016/S0006-8993(96)01201-2; Evans-Storms RB, 2000, ENDOCRINOLOGY, V141, P1854, DOI 10.1210/en.141.5.1854; FENG ZW, 1995, J CELL BIOL, V131, P1095, DOI 10.1083/jcb.131.4.1095; Fumagalli F, 2009, NEUROSCIENCE, V159, P936, DOI 10.1016/j.neuroscience.2009.01.030; Gascoyne DM, 2003, J BIOL CHEM, V278, P18022, DOI 10.1074/jbc.M301812200; HALL ED, 1993, CELL MOL NEUROBIOL, V13, P415, DOI 10.1007/BF00711581; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HALL ED, 1992, J NEUROSURG, V76, P13, DOI 10.3171/jns.1992.76.1.0013; Huang TS, 1998, AM J PHYS MED REHAB, V77, P108, DOI 10.1097/00002060-199803000-00004; Lema PP, 2004, J VET PHARMACOL THER, V27, P321, DOI 10.1111/j.1365-2885.2004.00597.x; Nemoto S, 2002, ANN THORAC SURG, V74, P836; PALLINI R, 1988, J NEUROSURG, V68, P124, DOI 10.3171/jns.1988.68.1.0124; Pearl JM, 2002, ANN THORAC SURG, V74, P830, DOI 10.1016/S0003-4975(02)03843-2; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Ramu J, 2007, EXP NEUROL, V204, P58, DOI 10.1016/j.expneurol.2006.09.015; Sasson R, 2002, BIOCHEM BIOPH RES CO, V294, P51, DOI 10.1016/S0006-291X(02)00431-X; Sasson R, 2001, ENDOCRINOLOGY, V142, P802, DOI 10.1210/en.142.2.802; Sinha S, 2004, J NEUROL NEUROSUR PS, V75, P1632, DOI 10.1136/jnnp.2003.028647; SUZUKI S, 1994, ACTA NEUROCHIR, V131, P184, DOI 10.1007/BF01808610; Tian DS, 2007, BRAIN RES, V1135, P177, DOI 10.1016/j.brainres.2006.11.085; Xu YJ, 2006, BRAIN RES, V1087, P175, DOI 10.1016/j.brainres.2006.03.003; Zurita M, 2002, J NEUROSURG, V96, P83, DOI 10.3171/spi.2002.96.1.0083	26	12	18	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	JUL 1	2009	20	10					968	972		10.1097/WNR.0b013e32832d0a28			5	Neurosciences	Neurosciences & Neurology	466AW	WOS:000267633600014	19525878				2021-06-18	
J	Javouhey, E; Guerin, AC; Martin, JL; Floret, D; Chiron, M				Javouhey, Etienne; Guerin, Anne-Celine; Martin, Jean-Louis; Floret, Daniel; Chiron, Mireille		SERAC Grp	Management of severely injured children in road accidents in France: Impact of the acute care organization on the outcome	PEDIATRIC CRITICAL CARE MEDICINE			English	Article; Proceedings Paper	34th Congress of the Societe-de-Reanimation-de-Langue-Francaise	JAN 18-20, 2006	Paris, FRANCE	Soc Reanimat Langue Francaise		severe trauma; children; acute care management; healthcare organization; outcome; road accident	SEVERE HEAD-INJURY; TRAUMATIC-BRAIN-INJURY; INTENSIVE-CARE; IMPLEMENTATION; SURVIVAL; THERAPY	Objective: To examine the impact of acute care management on outcome in children severely injured in road accidents. Design and Setting: Prospective follow-up study conducted in 12 French pediatric intensive care units over a 24-month period. Patients: Excluding those in refractory shock or in brain death at admission, a total of 125 children aged < 17 years admitted to the pediatric intensive care unit with severe trauma (Injury Severity Score >= 16) were included. Results: Intracranial pressure (ICP) monitoring and admission into a trauma resuscitation room (TRR) were used as proxy markers for the center management aggressiveness. Centers which admitted to TRR and monitored ICP when indicated in > 75% of cases were called aggressive centers. Children with an ICP monitoring indication admitted to a TRR and monitored, as well as those without an indication treated in a TRR, were judged appropriately managed. A poor outcome at pediatric intensive care unit discharge was defined as a difference between the baseline and discharge pediatric overall performance category above 3, or a hospital death. Children with traumatic brain injury appropriately managed in a less-aggressive center were more likely to have a poor outcome than those appropriately managed in an aggressive center (odds ratio 7.56, 95% confidence interval 1.5-38.4), after adjustment for severity, age, and type of road user. Conclusions: The management in a more aggressive center for children admitted to TRR and monitored for ICP, when indicated, is associated with a better outcome. This could be explained by a more extensive experience in trauma management. (Pediatr Crit Care Med 2009; 10:472-478)	[Javouhey, Etienne; Floret, Daniel] Hosp Civils Lyon, Serv Reanimat & Urgences Pediat, Hop Femme Mere Enfant, Grpment Hosp Est, Bron, France; [Javouhey, Etienne; Guerin, Anne-Celine; Martin, Jean-Louis; Floret, Daniel; Chiron, Mireille] Joint Unit INRETS, UMR T 9405, Bron, France; InVS, F-94415 St Maurice, France; Univ Lyon 1, F-69622 Villeurbanne, France	Javouhey, E (corresponding author), Hosp Civils Lyon, Serv Reanimat & Urgences Pediat, Hop Femme Mere Enfant, Grpment Hosp Est, Bron, France.	etienne.javouhey@chu-lyon.fr	Martin, Jean-Louis/X-6588-2019; Javouhey, Etienne/G-3651-2013	Martin, Jean-Louis/0000-0002-3426-9601; Liet, Jean-Michel/0000-0002-4104-673X			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS5; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Adnet F, 2004, RESUSCITATION, V63, P7, DOI 10.1016/j.resuscitation.2004.04.001; Allouch H, 1999, PRESSE MED, V28, P799; [Anonymous], 1990, ABBREVIATED INJURY S; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Boulard G, 1999, PRESSE MED, V28, P793; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; *CAR CHILDR EM DEP, 2001, PEDIATRICS, V107, P777; Cheron G, 2004, ARCH PEDIATRIE, V11, P44, DOI 10.1016/j.arcped.2003.09.031; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; Hall JR, 1996, J PEDIATR SURG, V31, P72, DOI 10.1016/S0022-3468(96)90322-X; Javouhey E, 2006, EUR J PEDIATR, V165, P519, DOI 10.1007/s00431-006-0118-z; Jeevaratnam DR, 1996, BRIT MED J, V312, P944; KASOFF SS, 1988, PEDIATR NEUROSCI, V14, P241, DOI 10.1159/000120397; KUMAR R, 1991, CHILD NERV SYST, V7, P299, DOI 10.1007/BF00304824; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; Meyer P G, 2001, Curr Opin Crit Care, V7, P81, DOI 10.1097/00075198-200104000-00005; *MIN SANT PROT SOC, 2004, B OFF SOC MDLSEDLP; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Potoka DA, 2001, J TRAUMA, V51, P824, DOI 10.1097/00005373-200111000-00002; Ruchholtz S, 2002, INTENS CARE MED, V28, P1395, DOI 10.1007/s00134-002-1446-8; Society of Critical Care Medicine, 2003, Crit Care Med, V31, pS407; Thakker JC, 1997, CRIT CARE MED, V25, P1396, DOI 10.1097/00003246-199708000-00030; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; Tilford JM, 2000, PEDIATRICS, V106, P289, DOI 10.1542/peds.106.2.289; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; Wetzel RC, 2002, CRIT CARE MED, V30, pS468, DOI 10.1097/00003246-200211001-00012	32	12	12	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JUL	2009	10	4					472	478		10.1097/PCC.0b013e318198b1cb			7	Critical Care Medicine; Pediatrics	General & Internal Medicine; Pediatrics	468SI	WOS:000267840500007	19307817				2021-06-18	
J	Lambru, G; Castellini, P; Manzoni, GC; Torelli, P				Lambru, Giorgio; Castellini, Paola; Manzoni, Gian Camillo; Torelli, Paola			Post-Traumatic Cluster Headache: From the Periphery to the Central Nervous System?	HEADACHE			English	Article						cluster headache; mild head trauma; post-traumatic cluster headache	INJURY; PATHOGENESIS	A correlation between head trauma and cluster headache is believed to exist. We report a case of post-traumatic episodic cluster headache that fulfills the criteria of the International Classification of Headache Disorders, 2nd edition. The distinctive features of this case are: a close temporal relation between head trauma and headache onset; pain ipsilateral to the side of trauma; mild severity of trauma; episodic course well-responsive to low doses of verapamil. Given the close temporal relation between the 2 events, multiple hypotheses can be advanced about a possible role of head trauma in the pathogenesis of cluster headache.	[Lambru, Giorgio; Castellini, Paola; Manzoni, Gian Camillo; Torelli, Paola] Univ Parma, Osped Maggiore, Dept Neurol, Headache Ctr, I-43100 Parma, Italy	Lambru, G (corresponding author), Univ Parma, Osped Maggiore, Dept Neurol, Headache Ctr, Via Gramsci 14, I-43100 Parma, Italy.			Torelli, Paola/0000-0002-4072-2353			Carter Dale M, 2004, Curr Pain Headache Rep, V8, P133, DOI 10.1007/s11916-004-0027-7; Evers S, 1997, CEPHALALGIA, V17, P680, DOI 10.1046/j.1468-2982.1997.1706680.x; FORMISANO R, 1990, ITAL J NEUROL SCI, V11, P303, DOI 10.1007/BF02333864; Goadsby PJ, 2002, LANCET NEUROL, V1, P251, DOI 10.1016/S1474-4422(02)00104-7; HAYES RL, 1994, SEMIN NEUROL, V14, P25, DOI 10.1055/s-2008-1041055; Lenaerts ME, 2008, CEPHALALGIA, V28, P12, DOI 10.1111/j.1468-2982.2008.01608.x; Levy MJ, 2005, BRAIN, V128, P1921, DOI 10.1093/brain/awh525; Matharu M, 2008, CURR PAIN HEADACHE R, V12, P132, DOI 10.1007/s11916-008-0025-2; MATHEW NT, 1988, HEADACHE, V28, P297; May A, 2005, LANCET, V366, P843, DOI 10.1016/S0140-6736(05)67217-0; NAPPI G, 1985, HEADACHE DIAGNOSTIC; Packard RC, 1997, HEADACHE, V37, P142, DOI 10.1046/j.1526-4610.1997.3703142.x; Packard RC, 2008, CURR PAIN HEADACHE R, V12, P67, DOI 10.1007/s11916-008-0013-6; Rahmann A, 2003, HEADACHE, V43, P130, DOI 10.1046/j.1526-4610.2003.03031.x; REIK L, 1987, HEADACHE, V27, P509, DOI 10.1111/j.1526-4610.1987.hed2709509.x; Rigamonti A, 2008, HEADACHE, V48, P467, DOI 10.1111/j.1526-4610.2007.01034.x; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; TURKEWITZ LJ, 1992, HEADACHE, V32, P504, DOI 10.1111/j.1526-4610.1992.hed3210504.x; YOUNG WB, 2005, CHRONIC DAILY HEADAC, P185	20	12	12	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	JUL-AUG	2009	49	7					1059	1061		10.1111/j.1526-4610.2009.01456.x			3	Clinical Neurology	Neurosciences & Neurology	467PM	WOS:000267752100014	19496832				2021-06-18	
J	Choi, R; Andres, RH; Steinberg, GK; Guzman, R				Choi, Raymond; Andres, Robert H.; Steinberg, Gary K.; Guzman, Raphael			Intraoperative hypothermia during vascular neurosurgical procedures	NEUROSURGICAL FOCUS			English	Article						intraoperative hypothermia; vascular cerebral aneurysm; subarachnoid hemorrhage	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; INTRACRANIAL ANEURYSM SURGERY; TRANSIENT FOREBRAIN ISCHEMIA; HOSPITAL CARDIAC-ARREST; COLD INTRAVENOUS FLUID; CIRCULATORY ARREST; MILD HYPOTHERMIA; DEEP HYPOTHERMIA; CARDIOPULMONARY BYPASS	Increasing evidence in animal models and clinical trials for stroke, hypoxic encephalopathy for children, and traumatic brain injury have shown that mild hypothermia may attenuate ischemic damage and improve neurological outcome. However, it is less clear if mild intraoperative hypothermia during vascular neurosurgical procedures results in improved outcomes for patients. This review examines the scientific evidence behind hypothermia as a treatment and discusses factors that may be important for the use of this adjuvant technique, including cooling temperature, duration of hypothermia, and rate of rewarming. (DOI: 10.3171/2009.3.FOCUS0927)	[Choi, Raymond; Andres, Robert H.; Steinberg, Gary K.; Guzman, Raphael] Stanford Univ, Dept Neurosurg, Med Ctr, Stanford, CA 94305 USA	Guzman, R (corresponding author), Stanford Univ, Dept Neurosurg, Med Ctr, 300 Pasteur Dr,R211, Stanford, CA 94305 USA.	raphaelg@stanford.edu		Guzman, Raphael/0000-0001-9620-0581			Aebert H, 1998, EUR J CARDIO-THORAC, V13, P223, DOI 10.1016/S1010-7940(98)00018-9; Anderson SW, 2006, ANN NEUROL, V60, P518, DOI 10.1002/ana.21018; BAKER KZ, 1994, ANESTHESIOLOGY, V81, P361, DOI 10.1097/00000542-199408000-00014; BAUMGARTNER WA, 1983, SURGERY, V94, P242; Bernard S, 2003, RESUSCITATION, V56, P9, DOI 10.1016/S0300-9572(02)00276-9; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; BUSTO R, 1989, NEUROSCI LETT, V101, P299, DOI 10.1016/0304-3940(89)90549-1; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; Clifton G L, 1992, Tex Med, V88, P66; CLIFTON GL, 1995, J NEUROSURG ANESTH, V7, P152, DOI 10.1097/00008506-199504000-00023; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; DAW E F, 1964, Can Anaesth Soc J, V11, P382, DOI 10.1007/BF03003422; DEMPSEY RJ, 1987, NEUROSURGERY, V21, P177, DOI 10.1227/00006123-198708000-00007; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; DRAKE CG, 1964, J NEUROSURG, V21, P575, DOI 10.3171/jns.1964.21.7.0575; Enomoto S, 1996, ANESTHESIOLOGY, V84, P1392, DOI 10.1097/00000542-199606000-00016; Foroohar M, 2000, SURG NEUROL, V54, P304, DOI 10.1016/S0090-3019(00)00294-9; Gluckman PD, 2006, NEW ENGL J MED, V354, P1644; Grady RE, 2002, J NEUROSURG ANESTH, V14, P137, DOI 10.1097/00008506-200204000-00008; Graham SH, 2001, J CEREBR BLOOD F MET, V21, P99, DOI 10.1097/00004647-200102000-00001; Hildebrand F, 2005, CYTOKINE, V31, P382, DOI 10.1016/j.cyto.2005.06.008; Hindman BJ, 1999, NEUROSURGERY, V44, P23, DOI 10.1097/00006123-199901000-00009; Horiguchi T, 2003, J NEUROTRAUM, V20, P511, DOI 10.1089/089771503765355577; Horstmann S, 2003, STROKE, V34, P2165, DOI 10.1161/01.STR.0000088062.86084.F2; Ibayashi S, 2000, NEUROCHEM RES, V25, P369, DOI 10.1023/A:1007593004806; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kawahara F, 2003, ACTA ANAESTH SCAND, V47, P419, DOI 10.1034/j.1399-6576.2003.00063.x; Kawai N, 2000, ACT NEUR S, V76, P529; Kawanishi M, 2003, ACT NEUR S, V86, P453; Kimura T, 2002, EXP BRAIN RES, V145, P83, DOI 10.1007/s00221-002-1095-8; KUBOYAMA K, 1993, CRIT CARE MED, V21, P1348, DOI 10.1097/00003246-199309000-00019; KWAK R, 1972, BRAIN NERVE, V24, P403; Lavinio A, 2007, BRIT J ANAESTH, V99, P237, DOI 10.1093/bja/aem118; Lawton MT, 1998, NEUROSURGERY, V43, P10, DOI 10.1097/00006123-199807000-00009; Levati A, 2007, J NEUROSURG ANESTH, V19, P25, DOI 10.1097/01.ana.0000211022.96054.4d; Maier CM, 2002, NEUROBIOL DIS, V11, P28, DOI 10.1006/nbdi.2002.0513; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Maxwell WL, 2005, J NEUROTRAUM, V22, P873, DOI 10.1089/neu.2005.22.873; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MICHENFELDER JD, 1968, ANESTHESIOLOGY, V29, P1107, DOI 10.1097/00000542-196811000-00005; MICHENFELDER JD, 1965, SURG CLIN N AM, V45, P889; MICHENFELDER JD, 1992, J CEREBR BLOOD F MET, V12, P877, DOI 10.1038/jcbfm.1992.120; MILDE LN, 1992, J NEUROSURG ANESTH, V4, P211, DOI 10.1097/00008506-199207000-00012; PATEL PM, 1994, BRAIN RES, V650, P205, DOI 10.1016/0006-8993(94)91783-3; Pemberton PL, 2003, ANAESTHESIA, V58, P370; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2005, CRIT CARE MED, V33, P2744, DOI 10.1097/01.CCM.0000190427.88735.19; Polderman KH, 2004, CRIT CARE MED, V32, P313, DOI 10.1097/01.CCM.0000104936.28288.7A; Preston E, 2004, ACTA NEUROPATHOL, V108, P406, DOI 10.1007/s00401-004-0905-4; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Sato K, 2000, ACTA NEUROCHIR, V142, P1013, DOI 10.1007/s007010070056; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shimohata T, 2007, J CEREBR BLOOD F MET, V27, P1463, DOI 10.1038/sj.jcbfm.9600450; Shimohata T, 2007, STROKE, V38, P375, DOI 10.1161/01.STR.0000254616.78387.ee; SILVERBERG GD, 1981, J NEUROSURG, V55, P337, DOI 10.3171/jns.1981.55.3.0337; SPETZLER RF, 1988, J NEUROSURG, V68, P868, DOI 10.3171/jns.1988.68.6.0868; Steinberg GK, 2004, NEUROSURGERY, V55, P307, DOI 10.1227/01.NEU.0000129683.99430.8C; SUTTON LN, 1991, STROKE, V22, P1567, DOI 10.1161/01.STR.22.12.1567; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975; UIHLEIN A, 1966, J AMER MED ASSOC, V195, P639, DOI 10.1001/jama.195.8.639; Van Hemelrijck A, 2003, J NEUROCHEM, V87, P66, DOI 10.1046/j.1471-4159.2003.01977.x; Wang GJ, 2002, NEUROSCIENCE, V114, P1081, DOI 10.1016/S0306-4522(02)00350-0; Young WL, 2002, ANESTHESIOLOGY, V96, P497, DOI 10.1097/00000542-200202000-00038; Zhao H, 2005, J NEUROSCI, V25, P9794, DOI 10.1523/JNEUROSCI.3163-05.2005; Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249; Zheng Z, 2004, NEUROL RES, V26, P884, DOI 10.1179/016164104X2357	68	12	13	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	MAY	2009	26	5							E24	10.3171/2009.3.FOCUS0927			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	439VY	WOS:000265656800024	19409003	Bronze			2021-06-18	
J	Makwana, M; Serchov, T; Hristova, M; Bohatschek, M; Gschwendtner, A; Kalla, R; Liu, ZQ; Heumann, R; Raivich, G				Makwana, Milan; Serchov, Tsvetan; Hristova, Mariya; Bohatschek, Marion; Gschwendtner, Andreas; Kalla, Roger; Liu, ZhiQiang; Heumann, Rolf; Raivich, Genndij			Regulation and function of neuronal GTP-Ras in facial motor nerve regeneration	JOURNAL OF NEUROCHEMISTRY			English	Article						axonal regeneration; central sprouting; lymphocyte influx; motor neuron cell death; oncogene	GROWTH-FACTOR; SYMPATHETIC NEURONS; AXONAL REGENERATION; SENSORY NEURONS; INJURED BRAIN; SCIATIC-NERVE; NEUROGLIAL ACTIVATION; RETROGRADE TRANSPORT; SIGNAL-TRANSDUCTION; NEUROTROPHIC FACTOR	Activation of Ras into the GTP-binding, 'ON' state is a key switch in the neurotrophin-mediated neuronal survival and neurite outgrowth, in vitro as well as in vivo. In the current study we explored changes in GTP-Ras levels following facial nerve injury and the ensuing regeneration and the effects of perturbing these changes in vivo using synapsin-promoter mediated neuronal expression of constitutively active Val12H-Ras (synRas). Quantification of GTP-Ras and total Ras revealed a precipitous drop in the relative GTP-Ras levels in the axotomized facial motor nucleus, to 40% of normal levels at 2 days after cut, followed by a partial recovery to 50-65% at 4-28 days. On western blots, control and axotomized nuclei from synRas mutants showed a 2.2- and 2.5-fold elevation in GTP-Ras, respectively, compared with their wild type littermate controls (p < 5%, anova, TUKEY post-hoc), with the levels in the axotomized synRas nucleus slightly but not significantly above that in the uninjured littermate control (p = 9.9%). Similar increase was also observed in the pERK but not pAKT targets of the Ras cascade. This moderate elevation of GTP-Ras strongly curtailed post-traumatic neuronal cell death (-65%), the influx of T-cells (-48%) as well as other parameters of neuroinflammatory response. Although synRas did not affect the speed of axonal regeneration or functional recovery it caused a very pronounced increase in central axonal sprouting. These current data emphasize the role of reduced active Ras, and by extension, the reduced overall level of retrograde neurotrophin signalling after axotomy, in mediating post-traumatic cell death and inflammation and in restricting the sprouting response. Moreover, the neuroprotective and central sprouting-enhancing effects of neuronal Val12H-Ras could help promote recovery in CNS injury.	[Makwana, Milan; Hristova, Mariya; Bohatschek, Marion; Raivich, Genndij] UCL, EGA Inst Womens Hlth, Dept Obstet & Gynaecol, Perinatal Brain Repair Grp, London WC1E 6HX, England; [Serchov, Tsvetan; Heumann, Rolf] Ruhr Univ Bochum, Fak Chem, Dept Mol Neurobiochem NC7, D-4630 Bochum, Germany; [Gschwendtner, Andreas; Kalla, Roger; Liu, ZhiQiang] Max Planck Inst Neurobiol, Dept Neuromorphol, Martinsried, Germany; [Raivich, Genndij] UCL, Dept Anat & Dev Biol, London, England	Raivich, G (corresponding author), UCL, EGA Inst Womens Hlth, Dept Obstet & Gynaecol, Perinatal Brain Repair Grp, 86-96 Chenies Mews, London WC1E 6HX, England.	g.raivich@ucl.ac.uk	Raivich, Gennadij/A-6770-2011; Kalla, Roger/O-3126-2016; Heumann, Rolf/AAK-4390-2020; Raivich, Gennadij/AAL-7229-2021	Makwana, Milan/0000-0002-5198-5466; Serchov, Tsvetan/0000-0002-2234-2875			ABERCROMBIE M, 1946, J ANAT, V80, P37; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BORASIO GD, 1989, NEURON, V2, P1087; BORASIO GD, 1993, J CELL BIOL, V121, P665, DOI 10.1083/jcb.121.3.665; Cafferty WBJ, 2008, TRENDS NEUROSCI, V31, P215, DOI 10.1016/j.tins.2008.02.004; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Eleore L, 2005, EUR J NEUROSCI, V21, P669, DOI 10.1111/j.1460-9568.2005.03887.x; GIBBS JB, 1984, P NATL ACAD SCI-BIOL, V81, P5704, DOI 10.1073/pnas.81.18.5704; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Gorfe AA, 2008, STRUCTURE, V16, P885, DOI 10.1016/j.str.2008.03.009; GRAEBER MB, 1986, J NEUROCYTOL, V15, P363; Guo HF, 1997, SCIENCE, V276, P795, DOI 10.1126/science.276.5313.795; Ha GK, 2008, J NEUROIMMUNOL, V199, P18, DOI 10.1016/j.jneuroim.2008.04.027; Hanz S, 2006, J NEUROCHEM, V99, P13, DOI 10.1111/j.1471-4159.2006.04089.x; HENDRY IA, 1992, PHARMACOL THERAPEUT, V56, P265, DOI 10.1016/0163-7258(92)90020-Z; HEUMANN R, 1987, J CELL BIOL, V104, P1623, DOI 10.1083/jcb.104.6.1623; Heumann R, 2000, J CELL BIOL, V151, P1537, DOI 10.1083/jcb.151.7.1537; Holmes FE, 2000, P NATL ACAD SCI USA, V97, P11563, DOI 10.1073/pnas.210221897; Ibanez CF, 2007, TRENDS CELL BIOL, V17, P519, DOI 10.1016/j.tcb.2007.09.003; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; Klesse LJ, 1998, J NEUROSCI, V18, P10420; Kloss CUA, 1999, J COMP NEUROL, V411, P162, DOI 10.1002/(SICI)1096-9861(19990816)411:1<162::AID-CNE12>3.0.CO;2-W; LEEVERS SJ, 1992, EMBO J, V11, P569, DOI 10.1002/j.1460-2075.1992.tb05088.x; Maier IC, 2006, PHILOS T R SOC B, V361, P1611, DOI 10.1098/rstb.2006.1890; MAKWANA M, 2007, SOC NEUR ABS, V136, P15; MEYER M, 1992, J CELL BIOL, V119, P45, DOI 10.1083/jcb.119.1.45; Michalski B, 2008, J NEUROCHEM, V105, P1244, DOI 10.1111/j.1471-4159.2008.05224.x; Moller JC, 1996, GLIA, V17, P121; MOORE RY, 1989, J COMP NEUROL, V282, P512, DOI 10.1002/cne.902820404; Moran LB, 2004, BRAIN RES REV, V44, P154, DOI 10.1016/j.brainresrev.2003.11.004; NAGATA Y, 1987, J NEUROCHEM, V49, P296, DOI 10.1111/j.1471-4159.1987.tb03429.x; Namikawa K, 2000, J NEUROSCI, V20, P2875; NOBES CD, 1995, EUR J NEUROSCI, V7, P344, DOI 10.1111/j.1460-9568.1995.tb01069.x; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; Omidvar N, 2006, MOL CELL BIOL, V26, P3966, DOI 10.1128/MCB.26.10.3966-3975.2006; PARAVICINI U, 1975, BRAIN RES, V84, P279, DOI 10.1016/0006-8993(75)90982-8; Park JI, 2005, EXP CELL RES, V303, P79, DOI 10.1016/j.yexcr.2004.09.028; Raivich G, 1998, J NEUROSCI, V18, P5804; RAIVICH G, 1991, NEURON, V7, P151, DOI 10.1016/0896-6273(91)90083-C; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Raivich G, 2003, J NEUROSCI RES, V72, P726, DOI 10.1002/jnr.10621; Raivich G, 1995, PROG BRAIN RES, V104, P3; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Raivich G, 2007, BRAIN RES REV, V53, P287, DOI 10.1016/j.brainresrev.2006.09.005; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rodriguez-Viciana P, 2005, COLD SH Q B, V70, P461, DOI 10.1101/sqb.2005.70.044; Romero MI, 2007, J NEUROSCI, V27, P2124, DOI 10.1523/JNEUROSCI.4363-06.2007; RUFER M, 1994, J NEUROSCI RES, V39, P412, DOI 10.1002/jnr.490390408; SCHWAB ME, 1977, AGENTS ACTIONS, V7, P361, DOI 10.1007/BF01969569; Serpe CJ, 1999, J NEUROSCI, V19; Shoemaker SE, 2006, J NEUROBIOL, V66, P1322, DOI 10.1002/neu.20297; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; VERGE VMK, 1990, J NEUROSCI, V10, P926; VIRDEE K, 1995, EUR J NEUROSCI, V7, P2159, DOI 10.1111/j.1460-9568.1995.tb00637.x; Werner A, 2000, J NEUROSCI, V20, P1822; Werner A, 2001, CELL TISSUE RES, V305, P25, DOI 10.1007/s004410100393; Xin JP, 2008, BRAIN BEHAV IMMUN, V22, P528, DOI 10.1016/j.bbi.2007.10.006; Xue LZ, 2000, J BIOL CHEM, V275, P8817, DOI 10.1074/jbc.275.12.8817; Yan CYI, 1998, J NEUROSCI, V18, P4042; ZHOU XF, 1994, J NEUROSCI METH, V54, P95, DOI 10.1016/0165-0270(94)90163-5; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	62	12	14	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	MAR	2009	108	6					1453	1463		10.1111/j.1471-4159.2009.05890.x			11	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	412AT	WOS:000263696300012	19284475	Bronze			2021-06-18	
J	Scott, CA; Rapport, LJ; Bryer, RC; Griffen, J; Hanks, R; Mckay, C				Scott, Carolyn A.; Rapport, Lisa J.; Bryer, Renee Coleman; Griffen, Julie; Hanks, Robin; McKay, Cherisse			Self-assessment of driving ability and the decision to resume driving following stroke	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Stroke; Driving; Self-assessment; Decision making; Cognitive estimation	TRAUMATIC BRAIN-INJURY; RIGHT-HEMISPHERE STROKE; COGNITIVE ESTIMATION; ALZHEIMERS-DISEASE; OLDER DRIVERS; REHABILITATION; ACCIDENT; SKILL; PREDICTORS; AWARENESS	The decision to resume driving after stroke can be complicated by the sequelae of stroke as well as the established finding that even healthy adults overestimate their driving ability. This study evaluated whether stroke survivors (n = 67) disproportionately overestimated their driving ability as compared to healthy significant others ( n = 67). Comparison to a known target reduced self-bias among both groups, but shift toward enhanced accuracy was significantly greater among survivors than significant others. Additionally, self-bias may reflect a pervasive trait of cognitive ability, as overestimation of driving ability was paralleled on a cognitive estimation task. Use of a specific criterion can facilitate accurate self-ratings of driving ability among survivors; however, actual decisions regarding driving status may be unrelated to self-view.	[Scott, Carolyn A.; Rapport, Lisa J.; Bryer, Renee Coleman; Griffen, Julie; Hanks, Robin] Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA; [McKay, Cherisse] Bloorview Kids Rehab Toronto, Toronto, ON, Canada	Rapport, LJ (corresponding author), Wayne State Univ, Dept Psychol, 5057 Woodward Ave, Detroit, MI 48202 USA.	rapport@wayne.edu			National Institute on Disabilities and Rehabilitation Research [H133G050134]; Wayne State University Thesis	This research was supported by a grant from the National Institute on Disabilities and Rehabilitation Research, awarded to the second author (H133G050134), and by a Wayne State University Thesis grant, awarded to the first author.	*AM HEART ASS, 2003, STROK FACTS US; Axelrod B. N., 1994, ASSESSMENT, V1, P269, DOI DOI 10.1177/107319119400100307; Berkowitz L., 1988, ADV EXPT SOCIAL PSYC, V21, P181, DOI [10.1016/S0065-2601(08)60227-0, DOI 10.1016/S0065-2601(08)60227-0]; Brand M, 2003, NEUROPSYCHOLOGIA, V41, P575, DOI 10.1016/S0028-3932(02)00183-5; BREWER MB, 1994, J PERS SOC PSYCHOL, V66, P268, DOI 10.1037/0022-3514.66.2.268; BROWN JD, 1986, SOC COGNITION, V4, P353, DOI 10.1521/soco.1986.4.4.353; Bullard SE, 2004, ARCH CLIN NEUROPSYCH, V19, P835, DOI 10.1016/j.acn.2003.12.002; Coleman BR., 2005, DRIVER REHABILITATIO, P165; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; Della Sala S, 2004, J NEUROL, V251, P156, DOI 10.1007/s00415-004-0292-8; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; FINN P, 1986, ACCIDENT ANAL PREV, V18, P289, DOI 10.1016/0001-4575(86)90043-6; Fisk GD, 2002, ARCH PHYS MED REHAB, V83, P469, DOI 10.1053/apmr.2002.31179; Freeman MR, 1995, INT J NEUROSCI, V83, P269, DOI 10.3109/00207459508986343; Fricke J., 2001, AUST OCCUP THER J, V48, P118, DOI [10.1046/j.0045-0766.2001.00246.x, DOI 10.1046/J.0045-0766.2001.00246.X]; GILLEN G, 1998, STROKE REHABILITATIO; Glendon AI, 1996, RISK ANAL, V16, P755, DOI 10.1111/j.1539-6924.1996.tb00826.x; Gregersen NP, 1996, ACCIDENT ANAL PREV, V28, P243, DOI 10.1016/0001-4575(95)00066-6; Groeger JA, 1996, BRIT J PSYCHOL, V87, P61, DOI 10.1111/j.2044-8295.1996.tb02577.x; GROEGER JA, 1989, ACCIDENT ANAL PREV, V21, P155, DOI 10.1016/0001-4575(89)90083-3; Hartman-Maeir A, 2003, DISABIL REHABIL, V25, P35, DOI 10.1080/0963828021000007897; Hartman-Maeir A, 2002, J REHABIL MED, V34, P158, DOI 10.1080/16501970213236; Haselkorn JK, 1998, ARCH PHYS MED REHAB, V79, P738, DOI 10.1016/S0003-9993(98)90349-5; Heikkila VM, 1999, ACTA NEUROL SCAND, V99, P349, DOI 10.1111/j.1600-0404.1999.tb07363.x; Hopewell CA, 2002, J HEAD TRAUMA REHAB, V17, P48, DOI 10.1097/00001199-200202000-00007; Jehkonen M, 2000, ACTA NEUROL SCAND, V102, P378, DOI 10.1034/j.1600-0404.2000.102006378.x; LEGHSMITH J, 1986, J ROY SOC MED, V79, P200, DOI 10.1177/014107688607900404; Liddle J., 2003, BRIT J OCCUP THER, V66, DOI [https://doi.org/10.1177/030802260306600307, DOI 10.1177/030802260306600307]; Lundqvist A, 2000, APPL COGNITIVE PSYCH, V14, P135, DOI 10.1002/(SICI)1099-0720(200003/04)14:2<135::AID-ACP628>3.0.CO;2-S; Mackenzie C, 2003, APHASIOLOGY, V17, P107, DOI 10.1080/729255215; MARKUS H, 1986, AM PSYCHOL, V41, P954, DOI 10.1037/0003-066X.41.9.954; Marottoli RA, 1997, J AM GERIATR SOC, V45, P202, DOI 10.1111/j.1532-5415.1997.tb04508.x; Marottoli RA, 1998, ACCIDENT ANAL PREV, V30, P331, DOI 10.1016/S0001-4575(97)00100-0; MATHEWS ML, 1986, ACCIDENT ANAL PREV, V18, P299; MCCORMICK IA, 1986, ACCIDENT ANAL PREV, V18, P205, DOI 10.1016/0001-4575(86)90004-7; McKenna FP, 2006, HEALTH PSYCHOL, V25, P163, DOI 10.1037/0278-6133.25.2.163; MCKENNA FP, 1991, ACCIDENT ANAL PREV, V23, P45, DOI 10.1016/0001-4575(91)90034-3; Milner A. D. G. M., 1995, VISUAL BRAIN ACTION; Muise JG, 1997, PERCEPT MOTOR SKILL, V85, P1203, DOI 10.2466/pms.1997.85.3f.1203; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Poissant L, 2003, BIOMED CENTRAL, V43, P225; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; RAPPORT LJ, 1993, ARCH PHYS MED REHAB, V74, P621, DOI 10.1016/0003-9993(93)90160-C; REYNOLDS WM, 1982, J CLIN PSYCHOL, V38, P119, DOI 10.1002/1097-4679(198201)38:1<119::AID-JCLP2270380118>3.0.CO;2-I; SHALLICE T, 1978, CORTEX, V14, P294, DOI 10.1016/S0010-9452(78)80055-0; SVENSON O, 1981, ACTA PSYCHOL, V47, P143, DOI 10.1016/0001-6918(81)90005-6; TITCHENER EB, 2008, LECT ELEMENTARY PSYC; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; WILLS TA, 1981, PSYCHOL BULL, V90, P245, DOI 10.1037/0033-2909.90.2.245	50	12	12	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2009	31	3					353	362		10.1080/13803390802169067			10	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	423QF	WOS:000264510100009	18608674				2021-06-18	
J	Seo, W; Oh, H				Seo, WhaSook; Oh, HyunSoo			Comparisons of Acute Physiological Parameters Influencing Outcome in Patients with Traumatic Brain Injury and Hemorrhagic Stroke	WORLDVIEWS ON EVIDENCE-BASED NURSING			English	Article						physiological parameters; outcome; traumatic brain injury; hemorrhagic stroke	DISABILITY RATING-SCALE; MORTALITY; PREDICTORS	Background: Although several factors are known to influence prognosis after acute brain injury, physiologic derangements were found to be associated with, or contributing to, increased mortality and disability in these patients. Aims: This study was conducted to identify acute physiological parameters that significantly predict outcome and compare the identified parameters in patients with traumatic brain injury (TBI) and hemorrhagic stroke. Methods: Participants were 190 adult patients with TBI or hemorrhagic stroke who were admitted within 24 hours of injury. Details concerning potential physiological predictors were collected, that is, blood pressure (BP), heart rate, respiratory rate, body temperature, hematocrit, partial pressure of oxygen and carbon dioxide in arterial blood, serum osmolality, pH, total cholesterol, and glucose levels on admission. Mortality and functional and cognitive ability 6 months after injury were measured as outcome variables. Results: Most physiological parameters, with the exceptions of blood glucose, total cholesterol, and osmolality, were significant prognostic predictors in TBI and hemorrhagic stroke. However, the physiological parameters and their predictabilities differed in patients with TBI and hemorrhagic stroke, which indicated that physiological predictors depend on chosen outcome and brain injury type. Conclusions and Implications: In critical care units, the most important aims of nursing care are decreasing mortality and disability rates. In order to achieve such goals, acute physiological parameters such as BP, respiratory rate, heart rate, PaO2, PaCO2, and temperature should be monitored and managed, with the aim of reducing the risk of secondary brain injury.	[Seo, WhaSook; Oh, HyunSoo] Inha Univ, Coll Med, Dept Nursing, Inchon 402751, South Korea	Seo, W (corresponding author), Inha Univ, Coll Med, Dept Nursing, YongHyun Dong 253, Inchon 402751, South Korea.	wschang@inha.ac.kr					Bhalla A, 2001, QJM-INT J MED, V94, P167, DOI 10.1093/qjmed/94.3.167; Caronna JJ, 2000, CRIT CARE MED, V28, P1656, DOI 10.1097/00003246-200005000-00071; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; HENON H, 1995, STROKE, V26, P392, DOI 10.1161/01.STR.26.3.392; Horenstein RB, 2002, STROKE, V33, P1863, DOI 10.1161/01.STR.0000020093.67593.0B; Labi MLC, 1998, J NEUROL REHABIL, V12, P45; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rordorf G, 2000, CRIT CARE MED, V28, P1301, DOI 10.1097/00003246-200005000-00007; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430; WANG Y, 1954, J CLIN EPIDEMIOL, V54, P766; Yoshimoto Y, 2001, STROKE, V32, P1989, DOI 10.1161/hs0901.095646	12	12	12	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-102X	1741-6787		WORLDV EVID-BASED NU	Worldviews Evid.-Based Nurs.		2009	6	1					36	43		10.1111/j.1741-6787.2008.00139.x			8	Nursing	Nursing	419TN	WOS:000264242700005	19302545				2021-06-18	
B	Thatcher, RW; Lubar, JF		Budzynski, TH; Budzynski, HK; Evans, JR; Abarbanel, A		Thatcher, Robert W.; Lubar, Joel F.			History of the scientific standards of QEEG normative databases	INTRODUCTION TO QUANTITATIVE EEG AND NEUROFEEDBACK: ADVANCED THEORY AND APPLICATIONS, 2ND EDITION			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; ELECTROMAGNETIC TOMOGRAPHY LORETA; TEST-RETEST RELIABILITY; NOISE COVARIANCE MODEL; SCHOOL-AGE CHILDREN; CLOSED-HEAD INJURY; QUANTITATIVE EEG; BIOPHYSICAL LINKAGE; COHERENCE; POWER		[Thatcher, Robert W.] Appl Neurosci Inc, EEG & NeuroImaging Lab, St Petersburg, FL USA; [Lubar, Joel F.] Univ Tennessee, Brain Res & Neuropsychol Lab, Knoxville, TN USA	Thatcher, RW (corresponding author), Appl Neurosci Inc, EEG & NeuroImaging Lab, St Petersburg, FL USA.						ADEY W R, 1964, Physiologist, V72, P65; Adey W. R., 1964, ANN NY ACAD SCI, V31, P844; ADEY WR, 1961, EXP NEUROL, V3, P501, DOI 10.1016/S0014-4886(61)80002-2; Arruda JE, 1996, INT J PSYCHOPHYSIOL, V23, P63, DOI 10.1016/0167-8760(96)00032-3; Berger H, 1934, ARCH PSYCHIAT NERVEN, V102, P538, DOI 10.1007/BF01813827; Berger H, 1932, ARCH PSYCHIAT NERVEN, V97, P6, DOI 10.1007/BF01815532; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Bosch-Bayard J, 2001, CLIN ELECTROENCEPHAL, V32, P47, DOI 10.1177/155005940103200203; Brazis PW, 2007, LOCALIZATION CLIN NE; BURGESS A, 1993, ELECTROEN CLIN NEURO, V86, P219, DOI 10.1016/0013-4694(93)90101-Z; Coburn KL, 2006, J NEUROPSYCH CLIN N, V18, P460, DOI 10.1176/appi.neuropsych.18.4.460; Cohen J., 1977, STAT POWER ANAL BEHA, P1; Cooley W., 1971, MULTIVARIATE DATA AN; CorsiCabrera M, 1997, ELECTROEN CLIN NEURO, V102, P248, DOI 10.1016/S0013-4694(96)95179-6; DUFFY FH, 1994, CLIN ELECTROENCEPHAL, V25, pR6, DOI 10.1177/155005949402500403; GASSER T, 1988, ELECTROEN CLIN NEURO, V69, P91, DOI 10.1016/0013-4694(88)90204-0; GASSER T, 1988, ELECTROEN CLIN NEURO, V69, P100, DOI 10.1016/0013-4694(88)90205-2; Gordon E, 2005, CLIN EEG NEUROSCI, V36, P64, DOI 10.1177/155005940503600205; Granger C. W. J., 1964, SPECTRAL ANAL EC TIM; Hagne I., 1973, AUTOMATION CLIN ELEC, P103; Hamilton-Bruce M A, 1991, Clin Exp Neurol, V28, P219; Harmony T, 1993, Int J Neurosci, V68, P263, DOI 10.3109/00207459308994281; Hayes W. L., 1973, STAT SOCIAL SCI; Heilman K.M.V.E., 1993, CLIN NEUROPSYCHOLOGY; Hellstrom-Westas L, 2005, EARLY HUM DEV, V81, P255, DOI 10.1016/j.earlhumdev.2005.01.006; Herscovitch P, 1994, FUNCTIONAL NEUROIMAG, P29; Hoechstetter K, 2004, BRAIN TOPOGR, V16, P233; Hoffman D. A., 2006, Journal of Neurotherapy, V10, P57, DOI 10.1300/J184v10n01_05; Hoffman D. A., 1995, J NEUROTHERAPY, V1, P14, DOI [10.1300/ J184v01n01_03, DOI 10.1300/J184V01N01_03]; Hori J, 2001, ANN BIOMED ENG, V29, P436, DOI 10.1114/1.1366674; Hughes JR, 1999, J NEUROPSYCH CLIN N, V11, P190, DOI 10.1176/jnp.11.2.190; Huizenga HM, 2002, IEEE T BIO-MED ENG, V49, P533, DOI 10.1109/TBME.2002.1001967; JOHN ER, 1988, SCIENCE, V239, P162, DOI 10.1126/science.3336779; JOHN ER, 1977, SCIENCE, V196, P1393, DOI 10.1126/science.867036; JOHN ER, 1980, SCIENCE, V210, P1255, DOI 10.1126/science.7434026; JOHN ER, 1977, FUNCTIONAL NEUROSCIE, V2; JOHN ER, 1990, MACHINERY MIND DATA; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Kropotov JD, 2005, INT J PSYCHOPHYSIOL, V55, P23, DOI 10.1016/j.ijpsycho.2004.05.011; Lubar JF, 2003, INT J PSYCHOPHYSIOL, V49, P175, DOI 10.1016/S0167-8760(03)00115-6; LUND TR, 1995, PSYCHOPHYSIOLOGY, V32, P66, DOI 10.1111/j.1469-8986.1995.tb03407.x; Machado C, 2004, CLIN EEG NEUROSCI, V35, P116, DOI 10.1177/155005940403500303; MAS F, 1993, CLIN ELECTROENCEPHAL, V24, P118, DOI 10.1177/155005949302400309; MATOUSEK M, 1973, ELECTROEN CLIN NEURO, V35, P603, DOI 10.1016/0013-4694(73)90213-7; Matousek M., 1973, DIGITAL TIME SERIES, P75; Nunez P., 1981, ELECT FIELDS BRAIN; Nunez P. L., 1995, NEOCORTICAL DYNAMICS; Nunnally J.C., 1978, PSYCHOMETRIC THEORY; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; Otnes R. K., 1972, DIGITAL TIME SERIES; PASCUALMARQUI RD, 2001, J NEUROTHERAPY, V4, P35, DOI DOI 10.1300/J184V04N04_06; POLLOCK VE, 1991, ELECTROEN CLIN NEURO, V79, P20, DOI 10.1016/0013-4694(91)90152-T; Prichep L., 1987, HDB ELECTROENCEPHALO, P449; Prichep LS, 2005, CLIN EEG NEUROSCI, V36, P82, DOI 10.1177/155005940503600207; Raichle ME, 2002, P NATL ACAD SCI USA, V99, P10237, DOI 10.1073/pnas.172399499; Roche RAP, 2004, NEUROSCI LETT, V362, P1, DOI 10.1016/j.neulet.2003.11.064; RUIJS MBM, 1994, NEUROPEDIATRICS, V25, P73, DOI 10.1055/s-2008-1071589; SALINSKY MC, 1991, ELECTROEN CLIN NEURO, V79, P382, DOI 10.1016/0013-4694(91)90203-G; Slewa-Younan S, 2002, CLIN NEUROPHYSIOL, V113, P1640, DOI 10.1016/S1388-2457(02)00239-0; Slobounov S, 2002, CLIN NEUROPHYSIOL, V113, P185, DOI 10.1016/S1388-2457(01)00737-4; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; Thatcher RW, 2007, CLIN EEG NEUROSCI, V38, P35, DOI 10.1177/155005940703800109; Thatcher RW, 2005, CLIN EEG NEUROSCI, V36, P116, DOI 10.1177/155005940503600211; Thatcher R. W., 2003, Journal of Neurotherapy, V7, P87, DOI 10.1300/J184v07n03_05; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; Thatcher R W, 1995, J Neuroimaging, V5, P35; Thatcher R. W., 2006, INT SOC NEURONAL REG; Thatcher R. W., 1989, ELECTROENCEPHALOGR C, V73, DOI [10.1016/0013-4694(89)90188-0, DOI 10.1016/0013-4694(89)90188-0, https://doi.org/10.1016/0013-4694(89)90188-0]; Thatcher R. W., 2000, 8 ANN ISNR C ST PAUL; Thatcher R. W., 2007, HUMAN BRAIN IN PRESS; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; Thatcher RW, 1997, J NEUROTRAUM, V14, P1, DOI 10.1089/neu.1997.14.1; Thatcher RW, 2005, CLIN NEUROPHYSIOL, V116, P2129, DOI 10.1016/j.clinph.2005.04.026; Thatcher RW, 2005, CLIN EEG NEUROSCI, V36, P1, DOI 10.1177/155005940503600103; THATCHER RW, 1986, ELECTROEN CLIN NEURO, V64, P123, DOI 10.1016/0013-4694(86)90107-0; THATCHER RW, 1987, SCIENCE, V236, P1110, DOI 10.1126/science.3576224; Thatcher RW, 1998, NEUROIMAGE, V8, P307, DOI 10.1006/nimg.1998.0365; Thatcher RW, 2000, CLIN ELECTROENCEPHAL, V31, P38, DOI 10.1177/155005940003100110; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Thatcher RW, 2001, CLIN NEUROPHYSIOL, V112, P1729, DOI 10.1016/S1388-2457(01)00609-5; Thatcher RW., 1998, J NEUROTHERAPY, V2, P8, DOI [DOI 10.1300/J184V02N04_, 10.1300/J184v02n04_02, DOI 10.1300/J184V02N04_02]; THATCHER RW, 1994, FUNCTIONAL NEUROIMAG, P269; THATCHER RW, 1983, COGNITIVE PROCESSING; THATCHER RW, 1977, FDN COGNITIVE PROCES, V1; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Van Egren L., 1996, CLIN ELECTROENCEPHAL, V27, P164; von Bierbrauer A., 1993, EEG EMG Z ELEKTROENZ, V23, P151; Waldorp LJ, 2001, IEEE T BIO-MED ENG, V48, P737, DOI 10.1109/10.923793; Winer BJ., 1971, STAT PRINCIPLES EXPT	90	12	12	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS			978-0-08-092315-4				2009							29	59		10.1016/B978-0-12-374534-7.00002-2			31	Neurosciences	Neurosciences & Neurology	BEO09	WOS:000317520800004					2021-06-18	
J	Till, C; Christensen, BK; Green, RE				Till, Christine; Christensen, Bruce K.; Green, Robin E.			Use of the Personality Assessment Inventory (PAI) in individuals with traumatic brain injury	BRAIN INJURY			English	Article						Personality Assessment Inventory (PAI); validity; traumatic brain injury; self-report; neurologic symptoms	HEAD-INJURY; PSYCHIATRIC-DISORDERS; MMPI-2 INTERPRETATION; CROSS-VALIDATION; FOLLOW-UP; AXIS-I; DEPRESSION; RECOVERY; PSYCHOPATHOLOGY; POPULATION	Primary objective: To evaluate the extent to which the Personality Assessment Inventory (PAI) is confounded by symptoms that are transdiagnostic between psychopathology and neurological sequelae. Methods: Sixty-one adults with moderate-to-severe traumatic brain injury (TBI) completed the PAI over the first year post-injury. Items that discriminated brain-injured individuals from a normative sample were identified using effect size analyses and were then subjected to principal components analysis (PCA) with varimax rotation. To explore whether the items identified in the PCA may be considered transdiagnostic in nature, an expert rating task and correlations with objective outcome measures were employed. Results: Effect sizes analyses identified 21 items that discriminated adults with TBI from the normative sample. Eight items associated with component 1 of the PCA were considered to be transdiagnostic. These items reflected health concerns and thinking problems from the Somatic Complaints, Depression and Schizophrenia scales. Items belonging to the other components reflected behaviours that are commonly associated with TBI, but not considered transdiagnostic. Conclusion: Using a comprehensive and multi-modal approach, results demonstrated good convergent validity for a small sub-set of items as being transdiagnostic. Overall, the findings support the PAI as a useful measure of psychiatric and emotional disturbances among persons with TBI.	[Till, Christine] York Univ, Dept Psychol, Toronto, ON M3J 1P3, Canada; [Till, Christine; Green, Robin E.] Univ Ctr, Toronto Rehabil Inst, Toronto, ON, Canada; [Christensen, Bruce K.] McMaster Univ, Dept Psychiat & Behav Neurosci, Toronto, ON, Canada; [Christensen, Bruce K.; Green, Robin E.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Green, Robin E.] Univ Toronto, Dept Rehabil Sci, Toronto, ON, Canada	Till, C (corresponding author), York Univ, Dept Psychol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	ctill@yorku.ca		Green, Robin/0000-0001-9451-3963; Till, Christine/0000-0001-5030-3155			Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Bagby RM, 2002, J PERS ASSESS, V78, P69, DOI 10.1207/S15327752JPA7801_05; Beck AT., 1996, BECK DEPRESSION INVE, V2; Bowen A, 1999, BRAIN INJURY, V13, P547; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Burke J M, 1989, Brain Inj, V3, P35, DOI 10.3109/02699058909008071; Christensen BK, 1995, J INT NEUROPSYCH SOC, V1, P121; Cohen J., 1983, APPL MULTIPLE REGRES; Demakis GJ, 2007, ARCH CLIN NEUROPSYCH, V22, P123, DOI 10.1016/j.acn.2006.09.004; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; FORER S, 1982, J ORGAN REHABIL EVAL, V2, P29; Gass CS, 1996, J CLIN PSYCHOL, V52, P569, DOI 10.1002/(SICI)1097-4679(199609)52:5<569::AID-JCLP12>3.3.CO;2-7; GASS CS, 1991, J CLIN PSYCHOL, V47, P253, DOI 10.1002/1097-4679(199103)47:2<253::AID-JCLP2270470210>3.0.CO;2-A; Gass CS, 1997, ARCH CLIN NEUROPSYCH, V12, P199, DOI 10.1016/S0887-6177(96)00032-7; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Karlin BE, 2005, J CLIN PSYCHOL, V61, P1571, DOI 10.1002/jclp.20209; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kurtz JE, 2007, J PERS ASSESS, V88, P66, DOI 10.1207/s15327752jpa8801_09; LaChapelle DL, 2005, APPL NEUROPSYCHOL, V12, P143, DOI 10.1207/S15324826AN1203_4; Leon-Carrion J, 2001, BRAIN INJURY, V15, P175, DOI 10.1080/026990501458407; MALIA K, 1995, BRAIN INJURY, V9, P697, DOI 10.3109/02699059509008226; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Morey L. C., 1991, PERSONALITY ASSESSME; MOREY LC, 2003, ESSENTIALS PAI INTER; Nelson LD, 2003, ARCH CLIN NEUROPSYCH, V18, P419, DOI 10.1016/S0887-6177(02)00158-0; Novack TA, 2000, BRAIN INJURY, V14, P987; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; O'Connor Paul, 2006, Adv Neurol, V98, P227; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Piotrowski C, 2000, PSYCHOL REP, V86, P65, DOI 10.2466/PR0.86.1.65-66; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P359, DOI 10.1097/00001199-200507000-00007; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Rayls KR, 2000, CLIN NEUROPSYCHOL, V14, P546, DOI 10.1076/clin.14.4.546.7194; Ruocco AC, 2007, BRAIN INJURY, V21, P1233, DOI 10.1080/02699050701716919; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; Tabachnick B.G., 1989, USING MULTIVARIATE S; Tombough T., 1996, TEST MEMORY MALINGER; TUOKKO H, 1991, Brain Injury, V5, P287, DOI 10.3109/02699059109008098; Van Balen HGG, 1999, INT J REHABIL RES, V22, P249, DOI 10.1097/00004356-199912000-00001; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470	50	12	12	0	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2009	23	7-8					655	665	PII 912685420	10.1080/02699050902970794			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	462QL	WOS:000267370600010	19557569				2021-06-18	
J	Vikamaa, P; Makitie, AA; Railo, M; Tornwall, J; Alback, A; Lepantalo, M				Vikamaa, Pirkka; Makitie, Antti A.; Railo, Mikael; Tornwall, Jyrki; Alback, Anders; Lepantalo, Mauri			Midline mandibulotomy and interposition grafting for lesions involving the internal carotid artery below the skull base	JOURNAL OF VASCULAR SURGERY			English	Article							VERTICAL RAMUS OSTEOTOMY; RESECTION; EXPOSURE; ANEURYSMS; CANCER; TUMORS	Background: The distal part of the internal carotid artery (ICA) close to the skull base can be reached surgically with different approaches. Exposure using the standard lateral incision is eventually limited by bony structures which preclude the wide-angled operative field necessary for en bloc resection of tumors or primary vascular pathology that abuts the parapharyngeal space. In these unusual cases, use of a combined midline mandibulotomy and neck incision provides necessary operative exposure. Aim: We report our experience using combined midline mandibulotomy and neck incision for exposure of high carotid lesions. We also discuss different surgical and endovascular approaches in light of the literature. Patients and Methods. Five patients were operated on for high ICA lesions: 2 for malignant head and neck tumors, 1 for an extended paraganglioma, and 2 for large symptomatic ICA aneurysms. All ICAs were reconstructed with an autologous vein interposition graft and the distal anastomoses were performed within the most distal 3 cm of the ICA adjacent to the orifice of bony carotid canal. Results: All operations were technically successful with no operative mortality or strokes. One aneurysm patient and the paraganglioma patient had minimal long-term sequelae from this procedure. One patient with an extended lingual epidermoid carcinoma was recurrence free at 3.6 years. One aneurysm patient died due to aspiration pneumonia 30 days postoperatively and another patient had early recurrent tumor growth and died due to that after 15 months. Four patients (80%) suffered a major cranial nerve injury in the operation mainly due to the extensive nature of the disease process. Conclusion: Exposure of the distal carotid artery using midline mandibulotomy is rarely required. However, this technique represents an excellent option for cases of malignancies arising from the oral cavity which abut the carotid artery and instances in which primary carotid pathology extends medially alongside the parapharyngeal space. Performance of these cases should be accomplished by a multidisciplinary, surgical team comprised of head and neck and vascular specialists. High rates of cranial nerve deficits should be anticipated. (J Vasc Surg 2009;49:86-92.)	[Vikamaa, Pirkka; Railo, Mikael; Alback, Anders; Lepantalo, Mauri] Univ Helsinki, Cent Hosp, Dept Surg, Div Vasc Surg, FI-00029 Helsinki, Finland; [Makitie, Antti A.] Univ Helsinki, Cent Hosp, Div Otorhinolaryngol, FI-00029 Helsinki, Finland; [Tornwall, Jyrki] Univ Helsinki, Cent Hosp, Div Maxillofacial Surg, FI-00029 Helsinki, Finland	Vikamaa, P (corresponding author), Univ Helsinki, Cent Hosp, Dept Surg, Div Vasc Surg, POB 340, FI-00029 Helsinki, Finland.	pirkka.vikatmaa@hus.fi					Alimi YS, 1996, J VASC SURG, V24, P249, DOI 10.1016/S0741-5214(96)70100-3; Amin MR, 1999, LARYNGOSCOPE, V109, P1402, DOI 10.1097/00005537-199909000-00007; Beretta F, 2006, NEUROSURGERY, V59, P25, DOI 10.1227/01.NEU.0000219877.43072.49; Chazono H, 2005, ACTA OTO-LARYNGOL, V125, P196, DOI 10.1080/00016480410017486-1; DOSSA C, 1990, J VASC SURG, V12, P319, DOI 10.1067/mva.1990.22486; DUBNER S, 1991, HEAD NECK-J SCI SPEC, V13, P389, DOI 10.1002/hed.2880130502; El-Sabrout R, 2000, J VASC SURG, V31, P702, DOI 10.1067/mva.2000.104101; HERNANDEZ MT, 2006, J VASC SURG, V44, P642; Hertzer NR, 2000, J VASC SURG, V31, P823, DOI 10.1067/mva.2000.105675; Kumins NH, 2001, ANN VASC SURG, V15, P25, DOI 10.1007/BF02693796; LARSEN PE, 1992, J VASC SURG, V15, P226, DOI 10.1016/0741-5214(92)70033-H; Longo G Matthew, 2005, Semin Vasc Surg, V18, P178, DOI 10.1053/j.semvascsurg.2005.09.002; MCCREADY RA, 1989, J VASC SURG, V10, P274; MOCK CN, 1991, J VASC SURG, V13, P846; Muhm M, 2002, ACTA OTO-LARYNGOL, V122, P561, DOI 10.1080/00016480260092417; Ozlugedik S, 2005, ACTA OTO-LARYNGOL, V125, P1111, DOI 10.1080/00016480510035421; ROSSOKHIN AV, 2000, ANTOLOGIYA SOVREMENN, V1, P23; SHAHA AR, 1991, SEMIN SURG ONCOL, V7, P25, DOI 10.1002/ssu.2980070107; Shohat I, 2005, INT J ORAL MAX SURG, V34, P639, DOI 10.1016/j.ijom.2005.03.002; Wright JG, 1996, J VASC SURG, V23, P775, DOI 10.1016/S0741-5214(96)70239-2	20	12	13	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	JAN	2009	49	1					86	92		10.1016/j.jvs.2008.08.047			7	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	395UA	WOS:000262547800015	18951752				2021-06-18	
J	Yoganandan, N; Maiman, DJ; Guan, YB; Pintar, F				Yoganandan, Narayan; Maiman, Dennis J.; Guan, Yabo; Pintar, Frank			Importance of Physical Properties of the Human Head on Head-Neck Injury Metrics	TRAFFIC INJURY PREVENTION			English	Article						Sled test; Injury; Spine injury; Crashworthiness; Side impact; Three-dimensional	CERVICAL-SPINE; NORMAL RANGE; WHIPLASH; DRIVERS; ACCELERATIONS; KINEMATICS; MOTION; PAIN	Objectives: To demonstrate the importance of using specimen-specific head physical properties in head-neck dynamics. Methods: Eight postmortem human subjects were subjected to side impact. A 9-axis accelerometer package was used to obtain head translational accelerations. After test, the head was isolated at the skull base, circumference, breadth, and length were obtained, and mass, center of gravity, and occipital condylar locations and moments of inertia were determined. Using specimen-specific and gathered accelerations, 3-dimensional head center of gravity accelerations and forces and moments at the occipital condyles were computed. Head physical properties were also extracted from regression equations using external dimensions of each subject. Using these properties and gathered kinematics, above-described accelerations and forces and moments were computed and compared with specimen-specific results. Results: Head masses predicted by stature and total body mass were more in close agreement with specimen-specific data than head masses predicted by head circumference or head circumference and head length. The center of gravity to the occipital condyle vector was shorter in the literature-based dataset than the actual specimen-specific vector. Differences in moments of inertias between predicted and specimen-specific data ranged from -15 to 59 percent. Variations in peak antero-posterior shear, lateral shear, and axial force ranged from -12 to 46 percent, -21 to 78 percent, and -17 to 50 percent. Differences in peak lateral moment, sagittal moment, and axial torque ranged from -45 to 78 percent, -86 to 327 percent, and -96 to 112 percent. These were normalized using specimen-specific data. Conclusions: Considerable variations in physical properties and injury metrics between data obtained from literature-based regression equations and actual data for each specimen suggest the critical importance of specimen-specific data to accurately describe the biodynamic response and establish tolerance criteria. Because neck dynamics control head kinematics (and vice versa), these results emphasize the need to determine physical properties of each specimen following impact tests.	[Yoganandan, Narayan; Maiman, Dennis J.; Guan, Yabo; Pintar, Frank] Med Coll Wisconsin, VA Med Ctr, Milwaukee, WI 53226 USA	Yoganandan, N (corresponding author), Med Coll Wisconsin, VA Med Ctr, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.	yoga@mcw.edu			VA Medical ResearchUS Department of Veterans Affairs; Federal Aviation Administration	This study was supported in part by VA Medical Research and the Federal Aviation Administration. The assistance of John Humm is gratefully acknowledged.	BACKAITIS SH, 1993, BIOMECHANICS IMPACT; Beier G, 1980, P 5 INT C BIOK IMP, P218; Chapline JF, 2000, ACCIDENT ANAL PREV, V32, P287, DOI 10.1016/S0001-4575(99)00126-8; Clark CR, 1998, CERVICAL SPINE; Clauser C. E., 1969, WEIGHT VOLUME CTR MA; Cusick JF, 2001, SPINE, V26, P1252, DOI 10.1097/00007632-200106010-00015; Dolinis J, 1997, INJURY, V28, P173, DOI 10.1016/S0020-1383(96)00186-6; Emily Sun R.S, 1998, DEV IMPROVED INJURY; Ewing C., 1977, P 21 STAPP CAR CRASH, P549; EWING C, 1978, P 22 STAPP CAR CRASH, P103; Ewing C. L., 1973, P 17 STAPP CAR CRASH, V17, P309, DOI 10.4271/730976; EWING CL, 1975, P 19 STAPP CAR CRASH, P487; HALL MC, 1965, LUSCHKAS JOINT; HEITPLATZ F, 2003, P 18 TECHN C ENH SAF, P1; Kallieris D, 1996, SHOCK VIB, V3, P337, DOI 10.1155/1996/878572; KALLIERIS D, 1981, P STAPP CAR CRASH C; KIM A, 2000, FRONTIERS WHIPLASH T, P435; Kim A., 2003, STAPP CAR CRASH J, V47, P489; Kumaresan S, 1997, BIO-MED MATER ENG, V7, P221; Kumaresan S, 1999, MED ENG PHYS, V21, P689, DOI 10.1016/S1350-4533(00)00002-3; LIND B, 1989, ARCH PHYS MED REHAB, V70, P692; McIntosh AS, 2007, ACCIDENT ANAL PREV, V39, P326, DOI 10.1016/j.aap.2006.09.001; MELVIN JW, 1985, REV BIOMECHANICAL IM; Mertz H. J., 1967, THESIS WAYNE STATE U; Myers Barry S., 1995, Critical Reviews in Biomedical Engineering, V23, P307; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Philippens M., 2000, P IRCOBI MONTP FRANC, P363; Pintar FA, 1998, SPINE, V23, P1957, DOI 10.1097/00007632-199809150-00007; Pintar Frank A, 2005, Stapp Car Crash J, V49, P33; Richter M, 2000, EUR SPINE J, V9, P109, DOI 10.1007/s005860050220; Schmera G, 2002, FLUCT NOISE LETT, V2, pL117, DOI 10.1142/S0219477502000695; Stemper BD, 2004, SPINE, V29, P1764, DOI 10.1097/01.BRS.0000134563.10718.A7; Stemper BD, 2003, J BIOMECH, V36, P1281, DOI 10.1016/S0021-9290(03)00159-3; Stemper BD, 2007, P IRCOBI, P249; Thunnissen J, 1995, P 39 STAPP CAR CRASH, P439, DOI [DOI 10.4271/952721, 10.4271/952721]; VANDENKROONENBE.A, 1998, P 42 STAPP CAR CRASH, P207; Viano David C, 2003, Traffic Inj Prev, V4, P228, DOI 10.1080/15389580309880; WALKER LB, 1973, P 17 STAPP CAR CRASH, P525; Winkelstein BA, 1998, BIOM HLTH R, V21, P266; WISMANS J, 1983, P 27 STAPP CAR CRASH, P137; WISMANS J, 1987, P 31 STAPP CAR CRASH, P1; WISMANS J, 1986, P 30 STAPP CAR CRASH, P131; WISMANS J, 1984, P 28 STAPP CAR CRASH, P161; Yoganandan N, 2006, J BIOMECH, V39, P1347, DOI 10.1016/j.jbiomech.2005.03.016; Yoganandan N, 1999, SPINE, V24, P83, DOI 10.1097/00007632-199901010-00021; Yoganandan N, 1997, J BIOMECH ENG-T ASME, V119, P87, DOI 10.1115/1.2796070; Yoganandan N, 2003, SPINE, V28, P2317, DOI 10.1097/01.BRS.0000085356.89103.A5; Yoganandan N, 2000, Stapp Car Crash J, V44, P189; YOGANANDAN N, 1986, SPINE, V11, P855, DOI 10.1097/00007632-198611000-00001; Yoganandan N, 1996, MED ENG PHYS, V18, P289, DOI 10.1016/1350-4533(95)00054-2; Yoganandan N, 1990, SAE T, V98, P1790; YOGANANDAN N, 1998, FRONTIERS HEAD NECK; Yoganandan N, 2009, TRAFFIC INJ PREV, V10, P51, DOI 10.1080/15389580802524876; Yoganandan N, 2008, TRAFFIC INJ PREV, V9, P162, DOI 10.1080/15389580701775942; YOUDAS JW, 1992, PHYS THER, V72, P770, DOI 10.1093/ptj/72.11.770	55	12	13	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.		2009	10	5					488	496	PII 914724058	10.1080/15389580903132801			9	Public, Environmental & Occupational Health; Transportation	Public, Environmental & Occupational Health; Transportation	493JR	WOS:000269733200013	19746313				2021-06-18	
J	Kim, H; Colantonio, A				Kim, Hwan; Colantonio, Angela			Intentional Traumatic Brain Injury in Ontario, Canada	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Epidemiology; Traumatic brain injury; Intentional; Self-inflicted; Assault	MODEL SYSTEMS; VIOLENCE	Background., Violence and traumatic brain injury (TBI) are two major public health concerns. This violence-related TBI, however, has not been studied in Canada and there is little literature on a profile of risk factors and injury severity regarding TBI because of self-inflicted/ suicidal and assault/homicidal injury compared with unintentional TBI. Methods: Cross-sectional study using the comprehensive data set (CDS) of Ontario trauma registry (OTR) from 1993 to 2001. Selling. Data from a large trauma registry were used to assess demographic and injury-related characteristics, injury severity and incident time associated with Till that were either caused unintentionally, were self-inflicted or resulted from an assault. Results. This Study identified 1,409 (8.0%) intentional TBIs and 16,211 (92.0%) unintentional TBIs. Of the intentional TBIs, 389 (27.6%) was self-inflicted TBI (Si-TBI) and 1,020 (72.4%) was other-inflicted TBI (Oi-TBI). The most common cause of Si-TBI was "jumping from high places" (32.1%), followed by "firearms"(30.6%). About. half of Oi-TBI was because of "fight and brawl" (48.3%), followed by "struck by objects" (26.1%). Si-TBI was associated with younger age, female gender, and having more alcohol/drug abuse history. For Oi-TBI, younger age, male gender, having more alcohol/drug abuse history were independently associated. Conclusion: This research provides the first comprehensive overview of intentional TBI based on Canadian data. The CDS of the OTR provided the ability to identify who is at risk for intentional TBI. Prevention programs and more targeted rehabilitation services should be designed for this vulnerable population.	[Kim, Hwan] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Grad Dept Rehabil Sci, Toronto, ON M5G 1V7, Canada; Toronto Rehabil Inst, Saunderson Family Chair Acquired Brain Injury Res, Toronto, ON, Canada	Kim, H (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, Grad Dept Rehabil Sci, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	hwan.kim@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765	Toronto Rehabilitation Institute (TRI); Ontario Neurotrauma Foundation (ONF); Ontario Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario; Ontario Work Study Program	This study was financially supported by the Toronto Rehabilitation Institute (TRI), the Ontario Neurotrauma Foundation (ONF), the Ontario Ministry of Health and Long Term Care, and the Ontario Work Study Program..	Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; *CAN I HLTH INF, 2004, NAT TRAUM REG AN B H; *CAN I HLTH INF, 2001, 2001 REP HOSP INJ AD; Canadian Institute for Health Information (CIHI), 2002, HOSP COSTS TRAUM ADM; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Garber BG, 1996, J TRAUMA, V40, P733, DOI 10.1097/00005373-199605000-00008; Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; Krug E.G., 2002, WORLD REPORT VIOLENC; McGuire LM, 1998, BRAIN INJURY, V12, P207, DOI 10.1080/026990598122683; Pickett William, 2004, Chronic Dis Can, V25, P32; *SMARTRISK, 2005, ONT INJ COMP, V2; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Woo B. H., 2000, REHABILITATION PEOPL	15	12	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2008	65	6					1287	1292		10.1097/TA.0b013e31817196f5			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	383WV	WOS:000261706000018	19077615	Green Published			2021-06-18	
J	von Ruden, C; Benninger, E; Mayer, D; Trentz, O; Labler, L				von Rueden, Christian; Benninger, Emanuel; Mayer, Dieter; Trentz, Otmar; Labler, Ludwig			Bogota-VAC - A Newly Modified Temporary Abdominal Closure Technique	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Abdominal compartment syndrome (ACS); Intra-abdominal pressure (IAP); Temporary abdominal closure (TAC); Vacuum-assisted closure (VAC); Volume reserve capacity (VRC)	COMPARTMENT SYNDROME; TRAUMA; PACK	Background: We present Bogota-VAC, a newly modified temporary abdominal closure (TAC) technique for open abdomen condition after abdominal compartment syndrome (ACS). Methods: A thin isolation bag (Bogota bag) and a vacuum assisted closure (VAC) system were combined. A matching bag was tension-free fixed on the abdominal fascia by fascia suture. A ring shaped black polyurethane foam of the VAC system was placed into the gap between Bogota bag, abdominal fascia and the wound edge. A constant negative topic pressure of 50-75 mmHg was used in the VAC system. Results: Intra-abdominal pressure (IAP: 22 +/- 2 mmHg) of four patients with ACS after severe traumatic brain injury and one patient with isolated ACS after blunt abdominal trauma decreased significantly (p = 0.01) after decompressive laparotomy and treatment with Bogota-VAC (IAP: 10 +/- 2 mmHg) and remained low, measured via urinary bladder pressure. Intracranial pressure (ICP) in the four traumatic brain injury patients decreased from 42 +/- 13 mmHg to 15 +/- 3 mmHg after abdominal decompression. Cerebral perfusion pressure (57 14 mmHg) increased to 74 +/- 2 mmHg. Conclusion: The advantage of the presented Bogota-VAC is leak tightness, wound conditioning (soft tissue/fascia), skin protection and facilitation of nursing in combination with highest volume reserve capacity (VRC), thus preventing recurrent increased intra-abdominal and intracranial pressure in the initial phase after decompression of ACS compared to other TAC techniques.	[von Rueden, Christian; Benninger, Emanuel; Trentz, Otmar; Labler, Ludwig] Univ Zurich Hosp, Dept Surg, Div Trauma Surg, CH-8091 Zurich, Switzerland; [Mayer, Dieter] Univ Zurich Hosp, Dept Surg, Div Cardiovasc Surg, CH-8091 Zurich, Switzerland	von Ruden, C (corresponding author), Univ Zurich Hosp, Dept Surg, Div Trauma Surg, Ramistr 100, CH-8091 Zurich, Switzerland.	christian.vonrueden@usz.ch	Mayer, Dieter O/E-7617-2011	Mayer, Dieter O/0000-0001-5933-7749			Balogh Z, 2003, SHOCK, V20, P483, DOI 10.1097/01.shk.0000093346.68755.43; Barker DE, 2000, J TRAUMA, V48, P201, DOI 10.1097/00005373-200002000-00001; Benninger E, 2008, J SURG RES, V144, P102, DOI 10.1016/j.jss.2007.02.021; BROCK WB, 1995, AM SURGEON, V61, P30; COLLICOTT P E, 1980, Journal of the American Medical Association, V243, P1156, DOI 10.1001/jama.243.11.1156; CUESTA MA, 1991, WORLD J SURG, V15, P74, DOI 10.1007/BF01658968; Fernstrom A., 1996, Scandinavian Journal of Nutrition/Naringsforskning, V40, P2; HOWDIESHELL TR, 1995, WORLD J SURG, V19, P154, DOI 10.1007/BF00317004; Labler L, 2005, EUR J TRAUMA, V31, P488; Saggi B, 1998, J TRAUMA, V45, P597, DOI 10.1097/00005373-199809000-00033; Shapiro MB, 2000, J TRAUMA, V49, P969, DOI 10.1097/00005373-200011000-00033; Suliburk JW, 2003, J TRAUMA, V55, P1155, DOI 10.1097/01.TA.0000100218.03754.6A; *WORLD SOC ABD COM, CONS DEF REC	13	12	12	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	DEC	2008	34	6					582	586		10.1007/s00068-008-8007-y			5	Emergency Medicine	Emergency Medicine	384EB	WOS:000261726000010	26816283				2021-06-18	
J	Conti, A; Angileri, FF; Longo, M; Pitrone, A; Granata, F; La Rosa, G				Conti, Alfredo; Angileri, Filippo Flavio; Longo, Marcello; Pitrone, Antonio; Granata, Francesca; La Rosa, Giovanni			Intra-arterial nimodipine to treat symptomatic cerebral vasospasm following traumatic subarachnoid haemorrhage. Technical case report	ACTA NEUROCHIRURGICA			English	Article						Intra-arterial Nimodipine; Endovascular; Cerebral vasospasm; Brain injury	PAPAVERINE INFUSION; ARTERIAL SPASM; BLOOD-FLOW; HEMORRHAGE; ANGIOPLASTY; MANAGEMENT; EFFICACY; THERAPY	Intra-arterial Nimodipine administration can be an effective alternative to papaverine or balloon angioplasty for the treatment of cerebral vasospasm refractory to medical therapy. It has been used for intractable vasospasm due to aneurysmal subarachnoid haemorrhage (SAH) with convincing results and no significant complications in small case series. This report describes of a patient with symptomatic and angiographically documented vasospasm following traumatic SAH which was refractory to maximal medical therapy and successfully treated with intra-arterial infusion of Nimodipine. This first reported technical note is with special reference to the nimodipine administration modalities, clinical and neuroradiological criteria of selection as well as the follow up of the patient.	[Conti, Alfredo; Angileri, Filippo Flavio; La Rosa, Giovanni] Univ Messina, Policlin Univ, Dept Neurosurg, I-98125 Messina, Italy; [Longo, Marcello; Pitrone, Antonio; Granata, Francesca] Univ Messina, Dept Neuroradiol, I-98125 Messina, Italy	Conti, A (corresponding author), Univ Messina, Policlin Univ, Dept Neurosurg, Via Consolare Valeria 1, I-98125 Messina, Italy.	alfredo.conti@unime.it	Granata, Francesca/K-5842-2016; Angileri, Filippo/N-8556-2019; Longo, Marcello/K-5854-2016; Angileri, Filippo Flavio/J-3533-2012; Conti, Alfredo/H-3022-2019; Angileri, Filippo/AAL-4851-2021	Granata, Francesca/0000-0002-6939-1009; Angileri, Filippo/0000-0002-1107-4115; Longo, Marcello/0000-0003-1117-1772; Angileri, Filippo Flavio/0000-0002-1107-4115; Conti, Alfredo/0000-0002-9408-2662; 			Arakawa Y, 2001, NEUROSURGERY, V48, P723, DOI 10.1097/00006123-200104000-00004; Biondi A, 2004, AM J NEURORADIOL, V25, P1067; Boker D K, 1985, Neurochirurgia (Stuttg), V28 Suppl 1, P118; CLOUSTON JE, 1995, AM J NEURORADIOL, V16, P27; Elliott JP, 1998, J NEUROSURG, V88, P277, DOI 10.3171/jns.1998.88.2.0277; Feng L, 2002, AM J NEURORADIOL, V23, P1284; Firat MM, 2005, AM J NEURORADIOL, V26, P1357; GROTENHUIS JA, 1984, J NEUROSURG, V61, P231, DOI 10.3171/jns.1984.61.2.0231; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; Hui C, 2005, CLIN RADIOL, V60, P1030, DOI 10.1016/j.crad.2005.04.004; Langham J, 2003, COCHRANE DB SYST REV; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Polin RS, 2000, J NEUROSURG, V92, P284, DOI 10.3171/jns.2000.92.2.0284; Rosenwasser RH, 1999, NEUROSURGERY, V44, P975, DOI 10.1097/00006123-199905000-00022; SANDER D, 1993, J NEUROL SCI, V119, P1, DOI 10.1016/0022-510X(93)90185-2; Terada T, 1997, ACTA NEUROCHIR, V139, P227, DOI 10.1007/BF01844756; Vajkoczy P, 2001, STROKE, V32, P498, DOI 10.1161/01.STR.32.2.498	18	12	13	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	NOV	2008	150	11					1197	1202		10.1007/s00701-008-0141-0			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	371MG	WOS:000260834800012	18958388				2021-06-18	
J	Avila, MA; Sell, SL; Kadoi, Y; Prough, DS; Hellmich, HL; Velasco, M; Dewitt, DS				Avila, Marcela A.; Sell, Stacy L.; Kadoi, Yuji; Prough, Donald S.; Hellmich, Helen L.; Velasco, Marco; Dewitt, Douglas S.			L-Arginine decreases fluid-percussion injury-induced neuronal nitrotyrosine immunoreactivity in rats	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						immunoreactivity; L-arginine; nitrotyrosine; rats; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; SPINAL-CORD-INJURY; OXIDE SYNTHASE EXPRESSION; CORTICAL IMPACT INJURY; NITRIC-OXIDE; IN-VIVO; TYROSINE NITRATION; POLY(ADP-RIBOSE) POLYMERASE; LIPID-PEROXIDATION	Peroxynitrite is a powerful oxidant capable of nitrating phenolic moieties, such as tyrosine or tyrosine residues in proteins and increases after traumatic brain injury (TBI). First, we tested the hypothesis that TBI increases nitrotyrosine (NT) immunoreactivity in the brain by measuring the number of NT-immunoreactive neurons in the cerebral cortex and hippocampus of rats subjected to parasagittal fluid-percussion TBI. Second, we tested the hypothesis that treatment with L-arginine, a substrate for nitric oxide synthase, further increases NT immunoreactivity over TBI alone. Rats were anesthetized with isoflurane and subjected to TBI, sham TBI, or TBI followed by treatment with L-arginine (100 mg/kg). Twelve, 24, or 72 h after TBI, brains were harvested. Coronal sections (10 mu m) were incubated overnight with rabbit polyclonal anti-NT antibody, rinsed, and incubated with a biotinylated secondary antibody. The antigen-antibody complex was visualized using a peroxidase-conjugated system with diaminobenzidine as the chromagen. The number of NT-positive cortical and hippocampal neurons increased significantly in both ipsilateral and contralateral hemispheres up to 72 h after TBI compared with the sham-injured group. Remarkably, treatment with L-arginine reduced the number of NT-positive neurons after TBI in both cortex and hippocampus. Our results indicate that L-arginine actually prevents TBI-induced increases in NT immunoreactivity.	[Avila, Marcela A.; Sell, Stacy L.; Kadoi, Yuji; Prough, Donald S.; Hellmich, Helen L.; Dewitt, Douglas S.] Univ Texas Med Branch, Dept Anesthesiol, Charles R Allen Res Labs, Galveston, TX 77555 USA; [Velasco, Marco] Vel Lab Res, Houston, TX USA	Dewitt, DS (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Charles R Allen Res Labs, 610 Texas Ave, Galveston, TX 77555 USA.	ddewitt@utmb.edu	De Velasco, Marco/R-1022-2019; Prough, Donald S/G-5793-2013; AVILA, MATIAS/Y-6342-2019	De Velasco, Marco/0000-0002-4011-6572; Prough, Donald S/0000-0001-7994-532X; AVILA, MATIAS/0000-0001-6570-3557	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01NS019355]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019355] Funding Source: NIH RePORTER	This work was supported in part by the National Institutes of Health Grant no. 5R01NS019355.	Ahn Edward S, 2005, Clin Neurosurg, V52, P348; Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Bank U, 1999, J INTERF CYTOK RES, V19, P1277, DOI 10.1089/107999099312957; Bao F, 2003, J NEUROSCI RES, V71, P220, DOI 10.1002/jnr.10481; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Bartnik BL, 2007, J NEUROTRAUM, V24, P181, DOI 10.1089/neu.2006.0038; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BECKMAN JS, 1991, J DEV PHYSIOL, V15, P53; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Duguet A, 2001, AM J RESP CRIT CARE, V164, P1119, DOI 10.1164/ajrccm.164.7.2010085; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; FABIAN RH, 1995, J CEREBR BLOOD F MET, V15, P242, DOI 10.1038/jcbfm.1995.30; Forster C, 1999, ACTA NEUROPATHOL, V97, P215, DOI 10.1007/s004010050977; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Ha HC, 2000, NEUROBIOL DIS, V7, P225, DOI 10.1006/nbdi.2000.0324; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hlatky R, 2002, ACT NEUR S, V81, P331; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; Kagan VE, 2001, ANTIOXID REDOX SIGN, V3, P189, DOI 10.1089/152308601300185160; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Kumura E, 1996, AM J PHYSIOL-CELL PH, V270, pC748; LaPlaca MC, 1999, J NEUROCHEM, V73, P205, DOI 10.1046/j.1471-4159.1999.0730205.x; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Liu DX, 2000, J NEUROCHEM, V75, P2144, DOI 10.1046/j.1471-4159.2000.0752144.x; Liu DX, 2005, J NEUROTRAUM, V22, P1123, DOI 10.1089/neu.2005.22.1123; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Mateo RD, 2007, J NUTR, V137, P652; Mesenge C, 1998, EUR J PHARMACOL, V353, P53, DOI 10.1016/S0014-2999(98)00432-4; MORIKAWA E, 1994, STROKE, V25, P429, DOI 10.1161/01.STR.25.2.429; *NAT RES COUNC, 1996, GUID CAR US LAB AN; ODonnell VB, 1997, BIOCHEMISTRY-US, V36, P15216, DOI 10.1021/bi971891z; PICKARD JD, 1981, J CEREBR BLOOD F MET, V1, P361, DOI 10.1038/jcbfm.1981.41; Prough DS, 2006, SHOCK, V26, P290, DOI 10.1097/01.shk.0000225405.66693.49; Rauhala P, 1996, SYNAPSE, V23, P58, DOI 10.1002/(SICI)1098-2396(199605)23:1<58::AID-SYN7>3.0.CO;2-G; Rehman A, 1997, BRIT J PHARMACOL, V122, P1702, DOI 10.1038/sj.bjp.0701556; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; Sell SL, 2008, ANESTHESIOLOGY, V108, P873, DOI 10.1097/ALN.0b013e31816c8a15; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; VESPA PM, 2007, CRIT CARE MED, V35, P1216; Viera L, 1999, METHOD ENZYMOL, V301, P373; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Wei EP, 1996, AM J PHYSIOL-HEART C, V271, pH1262; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Whiteman M, 1999, BIOCHEM BIOPH RES CO, V258, P168, DOI 10.1006/bbrc.1999.0564; Whiteman M, 2003, J BIOL CHEM, V278, P8380, DOI 10.1074/jbc.M211086200; Wu GY, 2007, J NUTR, V137, p1673S, DOI 10.1093/jn/137.6.1673S; Xia Y, 1998, J BIOL CHEM, V273, P22635, DOI 10.1074/jbc.273.35.22635; Xu J, 2001, J NEUROTRAUM, V18, P523, DOI 10.1089/089771501300227323; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117	59	12	12	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2008	28	10					1733	1741		10.1038/jcbfm.2008.66			9	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	351SB	WOS:000259445100010	18612319				2021-06-18	
J	Cattelani, R; Roberti, R; Lombardi, F				Cattelani, R.; Roberti, R.; Lombardi, F.			Adverse effects of apathy and neurobehavioral deficits on the community integration of traumatic brain injury subjects	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						neurobehavioral manifestations; brain injuries; interpersonal relations	MENTAL-RETARDATION; PARTICIPATION; INDIVIDUALS; TRANSITION; DISABILITY; EMPLOYMENT; PEOPLE; ADULTS; WORK	Aim. The aim of this study was to provide insight into the adverse effects of neurobehavioral features on the community integration of young adults who have had prior severe traumatic brain injury (TBI) with a positive longterm outcome in either functional or intellectual abilities. TBI subjects were compared with patients suffering from a health condition classified as mild intellectual disability (MID). Methods. Twenty-five subjects with prior severe TBI, but with substantially normalized perceptual-motor and intellectual functioning, were retrospectively selected according to demographic and clinical admission criteria. The TBI subject group was compared with a selected group of 34 MID subjects. The measures used were: the Wechsler Adult Intelligence Scale-Revised (WAIS-R), Instrumental Activity of Daily Living Scale (IADLS), Community Integration Questionnaire (CIQ), and Social Behaviour Check-list (SBC). The presence/absence of dysfunctional family environment and affective close relationships were also reported. Results. Significant differences between TBI and MID subjects (with greatest scores in TBI group) refer to: WAIS-R Full Scale IQ (FSIQ, indicating an average intellectual level), CIQ-Social integration (indicating a greater level than MID group), and SBC-Defective-type behaviour (indicating a greater level of apathy than MID group). Conclusion. Defective-type behaviour-synthesized into the term 'apathy'-has the following features: 1) can explain the unsatisfying community integration of TBI subjects with respect to the general population; and 2) best explains the similar CIQ-home integration and CIQ-productive activities compared to subjects presenting a higher intellectual disadvantage (MID patients). The multidisciplinary approach to the complex community integration process of TBI subjects might consider the high frequency of apathy as a primarily target of the community integration management.	[Cattelani, R.] Univ Parma, Fac Med & Chirurg, Dept Neurosci, Sez Neurol,Neurol Unit, I-43100 Parma, Italy; [Roberti, R.] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Lombardi, F.] Sebastiano Hosp Correggio, Reggio Emilia, Italy	Cattelani, R (corresponding author), Univ Parma, Fac Med & Chirurg, Dept Neurosci, Sez Neurol,Neurol Unit, Via Gramsci 14, I-43100 Parma, Italy.	cattel@unipr.it		LOMBARDI, Francesco/0000-0002-7184-6391			*AAMR, 2002, MENT RET DEF CLASS S; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; APA, 2000, DIAGN STAT MAN MENT; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Borod J. C, 2000, NEUROPSYCHOLOGY EMOT; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; CANTAGALLO A, 2002, EURA MEDICOPHYS, V38, P167; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Cattelani R., 2006, NEUROPSICOLOGIA SIND; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Clegg J, 2001, BRIT J MED PSYCHOL, V74, P151, DOI 10.1348/000711201160885; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P1, DOI 10.1097/00001199-200102000-00004; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Dumont C, 2004, J HEAD TRAUMA REHAB, V19, P431, DOI 10.1097/00001199-200411000-00002; Glenn MB, 2002, BRAIN INJURY, V16, P509, DOI 10.1080/02699050110119132; Hughes C, 2001, MENT RETARD DEV D R, V7, P84, DOI 10.1002/mrdd.1012; HUGHES C, 2000, TRANSITION HDB; KAPLAN SP, 1990, REHABILITATION COUNS, V34, P17; Kolitz BP, 2003, ARCH PHYS MED REHAB, V84, P277, DOI 10.1053/apmr.2003.50100; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lombardi F., 1997, GIORNALE ITALIANO ME, V1, P23; Luftig RL, 2005, RES DEV DISABIL, V26, P317, DOI 10.1016/j.ridd.2003.08.001; MARIN RS, 1990, AM J PSYCHIAT, V147, P22; Marit RS, 2005, J HEAD TRAUMA REHAB, V20, P377, DOI 10.1097/00001199-200507000-00009; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; ORSINI A, 1997, CONTRIBUTO TARATURA; Rao V, 2007, PSYCHOSOMATICS, V48, P217, DOI 10.1176/appi.psy.48.3.217; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Reiss S, 2004, MENT RETARD, V42, P77, DOI 10.1352/0047-6765(2004)42<77:CAMRBI>2.0.CO;2; REISS S, 2000, WHO I AM 16 BASIC DE; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Wechsler, 1981, WAIS R MANUAL; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M., 2003, BRAIN IMPAIR, V4, P1, DOI [10.1375/brim.4.1.1.27031, DOI 10.1375/brim.4.1.1.27031]	39	12	16	0	9	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	SEP	2008	44	3					245	251					7	Rehabilitation	Rehabilitation	347DZ	WOS:000259122100003	18762734				2021-06-18	
